{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 318761, "items": [{"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T21:47:37Z", "timestamp": 1574286457079}, "reference-count": 55, "publisher": "American Society for Biochemistry & Molecular Biology (ASBMB)", "issue": "18", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Biol. Chem."], "published-print": {"date-parts": [[2009, 5, 1]]}, "DOI": "10.1074/jbc.m809152200", "type": "journal-article", "created": {"date-parts": [[2009, 3, 14]], "date-time": "2009-03-14T00:13:24Z", "timestamp": 1236989604000}, "page": "11792-11805", "source": "Crossref", "is-referenced-by-count": 61, "title": ["Identification of PpoA fromAspergillus nidulansas a Fusion Protein of a Fatty Acid Heme Dioxygenase/Peroxidase and a Cytochrome P450"], "prefix": "10.1074", "volume": "284", "author": [{"given": "Florian", "family": "Brodhun", "sequence": "first", "affiliation": []}, {"given": "Cornelia", "family": "G\u00f6bel", "sequence": "additional", "affiliation": []}, {"given": "Ellen", "family": "Hornung", "sequence": "additional", "affiliation": []}, {"given": "Ivo", "family": "Feussner", "sequence": "additional", "affiliation": []}], "member": "28", "published-online": {"date-parts": [[2009, 3, 13]]}, "reference": [{"key": "2017062216242000000_284.18.11792.1", "DOI": "10.1038/nature04341", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.2", "volume": "171", "first-page": "3982", "year": "1989", "journal-title": "J. Bacteriol.", "DOI": "10.1128/jb.171.7.3982-3988.1989", "doi-asserted-by": "crossref"}, {"key": "2017062216242000000_284.18.11792.3", "volume": "65", "first-page": "3668", "year": "1999", "journal-title": "Appl. Environ. Microbiol."}, {"key": "2017062216242000000_284.18.11792.4", "DOI": "10.1074/jbc.M100732200", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.5", "DOI": "10.1128/MMBR.66.3.447-459.2002", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.6", "DOI": "10.1128/EC.3.6.1398-1411.2004", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.7", "DOI": "10.1111/j.1365-2958.2005.05000.x", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.8", "DOI": "10.1016/S0040-4039(00)97482-3", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.9", "volume": "20", "first-page": "1486", "year": "1991", "journal-title": "J. Chem. Soc. Chem. Commun."}, {"key": "2017062216242000000_284.18.11792.10", "DOI": "10.1126/science.232.4746.105", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.11", "volume": "1168", "first-page": "68", "year": "1993", "journal-title": "Biochim. Biophys. Acta", "DOI": "10.1016/0005-2760(93)90267-D", "doi-asserted-by": "crossref"}, {"key": "2017062216242000000_284.18.11792.12", "volume": "1124", "first-page": "59", "year": "1992", "journal-title": "Biochim. Biophys. Acta", "DOI": "10.1016/0005-2760(92)90126-G", "doi-asserted-by": "crossref"}, {"key": "2017062216242000000_284.18.11792.13", "volume": "267", "first-page": "14738", "year": "1992", "journal-title": "J. Biol. Chem."}, {"key": "2017062216242000000_284.18.11792.14", "DOI": "10.1074/jbc.271.24.14112", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.15", "DOI": "10.1074/jbc.273.33.20744", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.16", "DOI": "10.1074/jbc.M310840200", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.17", "DOI": "10.1099/mic.0.27880-0", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.18", "DOI": "10.1146/annurev.biochem.69.1.145", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.19", "DOI": "10.1128/IAI.73.8.4548-4559.2005", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.20", "DOI": "10.1074/jbc.M705366200", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.21", "DOI": "10.1016/j.ab.2007.04.045", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.22", "DOI": "10.1074/jbc.M705068200", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.23", "DOI": "10.1016/0378-1119(89)90359-4", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.24", "unstructured": "Antonini, E., and Brunori, M. (1971) Hemoglobin and Myoglobin and Their Reaction with Ligands, North Holland Publishing Co., Amsterdam"}, {"key": "2017062216242000000_284.18.11792.25", "volume": "239", "first-page": "2379", "year": "1964", "journal-title": "J. Biol. Chem."}, {"key": "2017062216242000000_284.18.11792.26", "DOI": "10.1016/0090-6980(87)90246-2", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.27", "volume": "239", "first-page": "2370", "year": "1964", "journal-title": "J. Biol. Chem."}, {"key": "2017062216242000000_284.18.11792.28", "DOI": "10.1128/AEM.71.12.8024-8030.2005", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.29", "volume": "1738", "first-page": "121", "year": "2005", "journal-title": "Biochim. Biophys. Acta", "DOI": "10.1016/j.bbalip.2005.11.007", "doi-asserted-by": "crossref"}, {"key": "2017062216242000000_284.18.11792.30", "DOI": "10.1021/bi00059a010", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.31", "DOI": "10.1074/jbc.272.34.21565", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.32", "volume": "269", "first-page": "5527", "year": "1994", "journal-title": "J. Biol. Chem."}, {"key": "2017062216242000000_284.18.11792.33", "DOI": "10.1042/BJ20051595", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.34", "DOI": "10.1194/jlr.M700055-JLR200", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.35", "DOI": "10.1194/jlr.M600446-JLR200", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.36", "DOI": "10.1194/jlr.D500006-JLR200", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.37", "DOI": "10.1016/j.jplph.2005.11.006", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.38", "volume": "265", "first-page": "20073", "year": "1990", "journal-title": "J. Biol. Chem."}, {"key": "2017062216242000000_284.18.11792.39", "DOI": "10.1016/j.febslet.2008.09.031", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.40", "DOI": "10.1074/jbc.M110420200", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.41", "DOI": "10.1074/jbc.M004281200", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.42", "DOI": "10.1074/jbc.M009377200", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.43", "DOI": "10.1016/j.tim.2007.01.005", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.44", "DOI": "10.1126/science.1876834", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.45", "DOI": "10.1105/tpc.10.9.1523", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.46", "volume": "254", "first-page": "829", "year": "1979", "journal-title": "J. Biol. Chem."}, {"key": "2017062216242000000_284.18.11792.47", "DOI": "10.1006/abbi.1994.1087", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.48", "DOI": "10.1016/j.bbrc.2008.06.060", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.49", "DOI": "10.1146/annurev.pharmtox.45.120403.100030", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.50", "DOI": "10.1038/nature07307", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.51", "DOI": "10.1016/j.jmb.2006.09.039", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.52", "DOI": "10.1074/jbc.274.23.16162", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.53", "DOI": "10.1021/bi010914d", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.54", "DOI": "10.1038/367243a0", "doi-asserted-by": "publisher"}, {"key": "2017062216242000000_284.18.11792.55", "DOI": "10.1016/0003-2697(76)90527-3", "doi-asserted-by": "publisher"}], "container-title": ["Journal of Biological Chemistry"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1074/jbc.M809152200", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 24]], "date-time": "2017-06-24T02:35:30Z", "timestamp": 1498271730000}, "score": 74.28871, "issued": {"date-parts": [[2009, 3, 13]]}, "references-count": 55, "journal-issue": {"published-online": {"date-parts": [[2009, 4, 24]]}, "published-print": {"date-parts": [[2009, 5, 1]]}, "issue": "18"}, "alternative-id": ["10.1074/jbc.M809152200"], "URL": "http://dx.doi.org/10.1074/jbc.m809152200", "relation": {"cites": []}, "ISSN": ["0021-9258", "1083-351X"], "issn-type": [{"value": "0021-9258", "type": "print"}, {"value": "1083-351X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T05:03:14Z", "timestamp": 1574398994171}, "reference-count": 34, "publisher": "Wiley", "issue": "9", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1425, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012, 5]]}, "DOI": "10.1111/j.1742-4658.2011.08352.x", "type": "journal-article", "created": {"date-parts": [[2011, 9, 16]], "date-time": "2011-09-16T00:41:17Z", "timestamp": 1316133677000}, "page": "1594-1606", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Linoleic acid positioning in psi factor producing oxygenase A, a fusion protein with an atypical cytochrome P450 activity"], "prefix": "10.1111", "volume": "279", "author": [{"given": "Christian", "family": "Koch", "sequence": "first", "affiliation": []}, {"given": "Alistair J.", "family": "Fielding", "sequence": "additional", "affiliation": []}, {"given": "Florian", "family": "Brodhun", "sequence": "additional", "affiliation": []}, {"given": "Marina", "family": "Bennati", "sequence": "additional", "affiliation": []}, {"given": "Ivo", "family": "Feussner", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2011, 10, 7]]}, "reference": [{"key": "10.1111/j.1742-4658.2011.08352.x-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "148", "DOI": "10.1016/j.plipres.2009.02.002", "article-title": "Biosynthesis of oxylipins in non-mammals", "volume": "48", "author": "Andreou", "year": "2009", "journal-title": "Prog Lipid Res"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "3982", "DOI": "10.1128/jb.171.7.3982-3988.1989", "article-title": "Isolation of a sexual sporulation hormone from Aspergillus nidulans", "volume": "171", "author": "Champe", "year": "1989", "journal-title": "J Bacteriol"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "882", "DOI": "10.1111/j.1365-2958.2005.05000.x", "article-title": "Oxylipins act as determinants of natural product biosynthesis and seed colonization in Aspergillus nidulans", "volume": "59", "author": "Tsitsigiannis", "year": "2006", "journal-title": "Mol Microbiol"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1016/j.tim.2007.01.005", "article-title": "Oxylipins as developmental and host-fungal communication signals", "volume": "15", "author": "Tsitsigiannis", "year": "2007", "journal-title": "Trends Microbiol"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "1047", "DOI": "10.1111/j.1742-4658.2011.08027.x", "article-title": "Oxylipins in fungi", "volume": "278", "author": "Brodhun", "year": "2011", "journal-title": "FEBS J"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "4", "DOI": "10.1016/j.fgb.2010.05.005", "article-title": "The lipid language of plant-fungal interactions", "volume": "48", "author": "Christensen", "year": "2011", "journal-title": "Fungal Genet Biol"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "4548", "DOI": "10.1128/IAI.73.8.4548-4559.2005", "article-title": "Aspergillus cyclooxygenase-like enzymes are associated with prostaglandin production and virulence", "volume": "73", "author": "Tsitsigiannis", "year": "2005", "journal-title": "Infect Immun"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "1809", "DOI": "10.1099/mic.0.27880-0", "article-title": "Three putative oxylipin biosynthetic genes integrate sexual and asexual development in Aspergillus nidulans", "volume": "151", "author": "Tsitsigiannis", "year": "2005", "journal-title": "Microbiology"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "378", "DOI": "10.1111/j.1365-2958.2007.06045.x", "article-title": "Reciprocal oxylipin-mediated cross-talk in the Aspergillus-seed pathosystem", "volume": "67", "author": "Brodhagen", "year": "2008", "journal-title": "Mol Microbiol"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "11792", "DOI": "10.1074/jbc.M809152200", "article-title": "Identification of PpoA from Aspergillus nidulans as a fusion protein of a fatty acid heme dioxygenase/peroxidase and a cytochrome P450", "volume": "284", "author": "Brodhun", "year": "2009", "journal-title": "J Biol Chem"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB11|cit11", "first-page": "14738", "article-title": "A linoleic acid (8R)-dioxygenase and hydroperoxide isomerase of the fungus Gaeumannomyces graminis", "volume": "267", "author": "Brodowsky", "year": "1992", "journal-title": "J Biol Chem"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "728", "DOI": "10.1002/cbic.201000669", "article-title": "Influence of substrate dideuteration on the reaction of the bifunctional heme enzyme Psi factor producing oxygenase A (PpoA)", "volume": "12", "author": "Nadler", "year": "2011", "journal-title": "ChemBioChem"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "9052", "DOI": "10.1021/ja202207t", "article-title": "Multifrequency electron paramagnetic resonance characterization of PpoA, a CYP450 fusion protein that catalyzes fatty acid dioxygenation", "volume": "133", "author": "Fielding", "year": "2011", "journal-title": "J Am Chem Soc"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "34707", "DOI": "10.1074/jbc.M705366200", "article-title": "Identification of dioxygenases required for Aspergillus development: studies of products, stereochemistry, and the reaction mechanism", "volume": "282", "author": "Garscha", "year": "2007", "journal-title": "J Biol Chem"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB15|cit15", "author": "Werck-Reichhart", "volume": "1", "year": "2000", "article-title": "Cytochromes P450: a success story", "journal-title": "Genome Biol", "DOI": "10.1186/gb-2000-1-6-reviews3003", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "1522", "DOI": "10.1016/j.phytochem.2009.08.005", "article-title": "Mechanistic aspects of CYP74 allene oxide synthases and related cytochrome P450 enzymes", "volume": "70", "author": "Brash", "year": "2009", "journal-title": "Phytochemistry"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "1028", "DOI": "10.1002/prot.22242", "article-title": "Identification of selectivity-determining residues in cytochrome P450 monooxygenases: a systematic analysis of the substrate recognition site 5", "volume": "74", "author": "Seifert", "year": "2009", "journal-title": "Proteins"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "13883", "DOI": "10.1073/pnas.0804099105", "article-title": "Modes of heme binding and substrate access for cytochrome P450 CYP74A revealed by crystal structures of allene oxide synthase", "volume": "105", "author": "Li", "year": "2008", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "40", "DOI": "10.1186/1471-2105-9-40", "article-title": "I-TASSER server for protein 3D structure prediction", "volume": "9", "author": "Zhang", "year": "2008", "journal-title": "BMC Bioinformatics"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "725", "DOI": "10.1038/nprot.2010.5", "article-title": "I-TASSER: a unified platform for automated protein structure and function prediction", "volume": "5", "author": "Roy", "year": "2010", "journal-title": "Nat Protoc"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "34", "DOI": "10.1186/1472-6807-10-34", "article-title": "Prediction and analysis of the modular structure of cytochrome P450 monooxygenases", "volume": "10", "author": "Sirim", "year": "2010", "journal-title": "BMC Struct Biol"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "29805", "DOI": "10.1074/jbc.M401779200", "article-title": "Characterization of the heme environment in Arabidopsis thaliana fatty acid \u03b1-dioxygenase-1", "volume": "279", "author": "Liu", "year": "2004", "journal-title": "J Biol Chem"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "3547", "DOI": "10.1016/j.febslet.2008.09.031", "article-title": "Critical amino acids for the 8(R)-dioxygenase activity of linoleate diol synthase. A comparison with cyclooxygenases", "volume": "582", "author": "Garscha", "year": "2008", "journal-title": "FEBS Lett"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "13755", "DOI": "10.1074/jbc.M808665200", "article-title": "Leucine/valine residues direct oxygenation of linoleic acid by (10R)- and (8R)-dioxygenases: expression and site-directed mutagenesis of (10R)-dioxygenase with epoxyalcohol synthase activity", "volume": "284", "author": "Garscha", "year": "2009", "journal-title": "J Biol Chem"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "553", "DOI": "10.1042/BJ20091096", "article-title": "PpoC from Aspergillus nidulans is a fusion protein with only one active haem", "volume": "425", "author": "Brodhun", "year": "2010", "journal-title": "Biochem J"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "523", "DOI": "10.1021/bi051235w", "article-title": "Role of Tyr348 in Tyr385 radical dynamics and cyclooxygenase inhibitor interactions in prostaglandin H synthase-2", "volume": "45", "author": "Rogge", "year": "2006", "journal-title": "Biochemistry"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1038/nature07307", "article-title": "Structural insights into the evolutionary paths of oxylipin biosynthetic enzymes", "volume": "455", "author": "Lee", "year": "2008", "journal-title": "Nature"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "11490", "DOI": "10.1021/bi010914d", "article-title": "Comparisons of hydroperoxide isomerase and monooxygenase activities of cytochrome P450 for conversions of allylic hydroperoxides and alcohols to epoxyalcohols and diols: probing substrate reorientation in the active site", "volume": "40", "author": "Kupfer", "year": "2001", "journal-title": "Biochemistry"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB29|cit29", "first-page": "141", "article-title": "On the mechanism of prostacyclin and thromboxane A2 biosynthesis", "volume": "264", "author": "Hecker", "year": "1989", "journal-title": "J Biol Chem"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "121", "DOI": "10.1016/j.bbalip.2005.11.007", "article-title": "Characterization of heme environment and mechanism of peroxide bond cleavage in human prostacyclin synthase", "volume": "1738", "author": "Yeh", "year": "2005", "journal-title": "Biochim Biophys Acta"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "471", "DOI": "10.1006/abbi.1995.1190", "article-title": "Interactions of peroxyquinols with cytochromes P450 2B1, 3A1, and 3A5: influence of the apoprotein on heterolytic versus homolytic O-O bond cleavage", "volume": "317", "author": "Correia", "year": "1995", "journal-title": "Arch Biochem Biophys"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "1605", "DOI": "10.1002/jcc.20084", "article-title": "UCSF Chimera - a visualization system for exploratory research and analysis", "volume": "25", "author": "Pettersen", "year": "2004", "journal-title": "J Comput Chem"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "W116", "DOI": "10.1093/nar/gkl282", "article-title": "CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues", "volume": "34", "author": "Dundas", "year": "2006", "journal-title": "Nucleic Acids Res"}, {"key": "10.1111/j.1742-4658.2011.08352.x-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "2253", "DOI": "10.1021/cr0307143", "article-title": "Structure and chemistry of cytochrome P450", "volume": "105", "author": "Denisov", "year": "2005", "journal-title": "Chem Rev"}], "container-title": ["FEBS Journal"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1742-4658.2011.08352.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 20]], "date-time": "2017-06-20T06:23:43Z", "timestamp": 1497939823000}, "score": 45.69286, "subtitle": ["Linoleic acid binding to PpoA"], "issued": {"date-parts": [[2011, 10, 7]]}, "references-count": 34, "journal-issue": {"published-print": {"date-parts": [[2012, 5]]}, "issue": "9"}, "URL": "http://dx.doi.org/10.1111/j.1742-4658.2011.08352.x", "relation": {"cites": []}, "ISSN": ["1742-464X"], "issn-type": [{"value": "1742-464X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T10:37:52Z", "timestamp": 1574332672638}, "reference-count": 41, "publisher": "Portland Press Ltd.", "issue": "3", "content-domain": {"domain": ["portlandpress.com"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2010, 2, 1]]}, "abstract": "<jats:p>In Aspergillus nidulans Ppos [psi (precocious sexual inducer)-producing oxygenases] are required for the production of so-called psi factors, compounds that control the balance between the sexual and asexual life cycle of the fungus. The genome of A. nidulans harbours three different ppo genes: ppoA, ppoB and ppoC. For all three enzymes two different haem-containing domains are predicted: a fatty acid haem peroxidase/dioxygenase domain in the N-terminal region and a P450 haem-thiolate domain in the C-terminal region. Whereas PpoA was shown to use both haem domains for its bifunctional catalytic activity (linoleic acid 8-dioxygenation and 8-hydroperoxide isomerization), we found that PpoC apparently only harbours a functional haem peroxidase/dioxygenase domain. Consequently, we observed that PpoC catalyses mainly the dioxygenation of linoleic acid (18:2\u03949Z,12Z), yielding 10-HPODE (10-hydroperoxyoctadecadienoic acid). No isomerase activity was detected. Additionally, 10-HPODE was converted at lower rates into 10-KODE (10-keto-octadecadienoic acid) and 10-HODE (10-hydroxyoctadecadienoic acid). In parallel, decomposition of 10-HPODE into 10-ODA (10-octadecynoic acid) and volatile C-8 alcohols that are, among other things, responsible for the characteristic mushroom flavour. Besides these principle differences we also found that PpoA and PpoC can convert 8-HPODE and 10-HPODE into the respective epoxy alcohols: 12,13-epoxy-8-HOME (where HOME is hydroxyoctadecenoic acid) and 12,13-epoxy-10-HOME. By using site-directed mutagenesis we demonstrated that both enzymes share a similar mechanism for the oxidation of 18:2\u03949Z,12Z; they both use a conserved tyrosine residue for catalysis and the directed oxygenation at the C-8 and C-10 is most likely controlled by conserved valine/leucine residues in the dioxygenase domain.</jats:p>", "DOI": "10.1042/bj20091096", "type": "journal-article", "created": {"date-parts": [[2009, 11, 2]], "date-time": "2009-11-02T15:33:51Z", "timestamp": 1257176031000}, "page": "553-565", "update-policy": "http://dx.doi.org/10.1042/crossmark_policy", "source": "Crossref", "is-referenced-by-count": 35, "title": ["PpoC from Aspergillus nidulans is a fusion protein with only one active haem"], "prefix": "10.1042", "volume": "425", "author": [{"given": "Florian", "family": "Brodhun", "sequence": "first", "affiliation": [{"name": "Department of Plant Biochemistry, Albrecht-von-Haller-Institute for Plant Sciences, Georg-August-University, Justus-von-Liebig-Weg 11, D-37077 G\u00f6ttingen, Germany"}]}, {"given": "Stefan", "family": "Schneider", "sequence": "additional", "affiliation": [{"name": "Department of Plant Biochemistry, Albrecht-von-Haller-Institute for Plant Sciences, Georg-August-University, Justus-von-Liebig-Weg 11, D-37077 G\u00f6ttingen, Germany"}]}, {"given": "Cornelia", "family": "G\u00f6bel", "sequence": "additional", "affiliation": [{"name": "Department of Plant Biochemistry, Albrecht-von-Haller-Institute for Plant Sciences, Georg-August-University, Justus-von-Liebig-Weg 11, D-37077 G\u00f6ttingen, Germany"}]}, {"given": "Ellen", "family": "Hornung", "sequence": "additional", "affiliation": [{"name": "Department of Plant Biochemistry, Albrecht-von-Haller-Institute for Plant Sciences, Georg-August-University, Justus-von-Liebig-Weg 11, D-37077 G\u00f6ttingen, Germany"}]}, {"given": "Ivo", "family": "Feussner", "sequence": "additional", "affiliation": [{"name": "Department of Plant Biochemistry, Albrecht-von-Haller-Institute for Plant Sciences, Georg-August-University, Justus-von-Liebig-Weg 11, D-37077 G\u00f6ttingen, Germany"}]}], "member": "288", "published-online": {"date-parts": [[2010, 1, 15]]}, "reference": [{"key": "2019102523481369600_B1", "doi-asserted-by": "crossref", "first-page": "3837", "DOI": "10.1016/S0040-4039(00)97482-3", "article-title": "Structural elucidation of sporogenic fatty acid metabolites from Aspergillus nidulans", "volume": "31", "author": "Mazur", "year": "1990", "journal-title": "Tetrahedron Lett."}, {"key": "2019102523481369600_B2", "doi-asserted-by": "crossref", "first-page": "1486", "DOI": "10.1039/c39910001486", "article-title": "Structure and synthesis of sporogenic Psi factors from Aspergillus nidulans", "volume": "20", "author": "Mazur", "year": "1991", "journal-title": "J. Chem. Soc. Chem. Commun."}, {"key": "2019102523481369600_B3", "doi-asserted-by": "crossref", "first-page": "3982", "DOI": "10.1128/jb.171.7.3982-3988.1989", "article-title": "Isolation of a sexual sporulation hormone from Aspergillus nidulans", "volume": "171", "author": "Champe", "year": "1989", "journal-title": "J. Bacteriol."}, {"key": "2019102523481369600_B4", "first-page": "1383", "article-title": "An endogenous inducer of sexual development in Aspergillus nidulans", "volume": "133", "author": "Champe", "year": "1987", "journal-title": "J. Gen. Microbiol."}, {"key": "2019102523481369600_B5", "doi-asserted-by": "crossref", "first-page": "25766", "DOI": "10.1074/jbc.M100732200", "article-title": "Genetic connection between fatty acid metabolism and sporulation in Aspergillus nidulans", "volume": "276", "author": "Calvo", "year": "2001", "journal-title": "J. Biol. Chem."}, {"key": "2019102523481369600_B6", "doi-asserted-by": "crossref", "first-page": "447", "DOI": "10.1128/MMBR.66.3.447-459.2002", "article-title": "Relationship between secondary metabolism and fungal development", "volume": "66", "author": "Calvo", "year": "2002", "journal-title": "Microbiol. Mol. Biol. Rev."}, {"key": "2019102523481369600_B7", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1016/j.tim.2007.01.005", "article-title": "Oxylipins as developmental and host-fungal communication signals", "volume": "15", "author": "Tsitsigiannis", "year": "2007", "journal-title": "Trends Microbiol."}, {"key": "2019102523481369600_B8", "doi-asserted-by": "crossref", "first-page": "148", "DOI": "10.1016/j.plipres.2009.02.002", "article-title": "Biosynthesis of oxylipins in non-mammals", "volume": "48", "author": "Andreou", "year": "2009", "journal-title": "Prog. Lipid Res."}, {"key": "2019102523481369600_B9", "doi-asserted-by": "crossref", "first-page": "11344", "DOI": "10.1074/jbc.M310840200", "article-title": "The lipid body protein, PpoA, coordinates sexual and asexual sporulation in Aspergillus nidulans", "volume": "279", "author": "Tsitsigiannis", "year": "2004", "journal-title": "J. Biol. Chem."}, {"key": "2019102523481369600_B10", "doi-asserted-by": "crossref", "first-page": "4548", "DOI": "10.1128/IAI.73.8.4548-4559.2005", "article-title": "Aspergillus cyclooxygenase-like enzymes are associated with prostaglandin production and virulence", "volume": "73", "author": "Tsitsigiannis", "year": "2005", "journal-title": "Infect. Immun."}, {"key": "2019102523481369600_B11", "first-page": "1809", "article-title": "Three putative oxylipin biosynthetic genes integrate sexual and asexual development in Aspergillus nidulans", "volume": "151", "author": "Tsitsigiannis", "year": "2005", "journal-title": "Microbiolology"}, {"key": "2019102523481369600_B12", "doi-asserted-by": "crossref", "first-page": "882", "DOI": "10.1111/j.1365-2958.2005.05000.x", "article-title": "Oxylipins act as determinants of natural product biosynthesis and seed colonization in Aspergillus nidulans", "volume": "59", "author": "Tsitsigiannis", "year": "2006", "journal-title": "Mol. Microbiol."}, {"key": "2019102523481369600_B13", "doi-asserted-by": "crossref", "first-page": "1398", "DOI": "10.1128/EC.3.6.1398-1411.2004", "article-title": "Endogenous lipogenic regulators of spore balance in Aspergillus nidulans", "volume": "3", "author": "Tsitsigiannis", "year": "2004", "journal-title": "Eukaryotic Cell"}, {"key": "2019102523481369600_B14", "doi-asserted-by": "crossref", "first-page": "11792", "DOI": "10.1074/jbc.M809152200", "article-title": "Identification of PpoA from Aspergillus nidulans as a fusion protein of a fatty acid heme dioxygenase/peroxidase and a cytochrome P450", "volume": "284", "author": "Brodhun", "year": "2009", "journal-title": "J. Biol. Chem."}, {"key": "2019102523481369600_B15", "doi-asserted-by": "crossref", "first-page": "34707", "DOI": "10.1074/jbc.M705366200", "article-title": "Identification of dioxygenases required for Aspergillus development: studies of products, stereochemistry, and the reaction mechanism", "volume": "282", "author": "Garscha", "year": "2007", "journal-title": "J. Biol. Chem."}, {"key": "2019102523481369600_B16", "doi-asserted-by": "crossref", "first-page": "13755", "DOI": "10.1074/jbc.M808665200", "article-title": "Leucine/valine residues direct oxygenation of linoleic Acid by (10R)- and (8R)-dioxygenases: expression and site-directed mutagenesis of (10R)-dioxygenase with epoxyalcohol synthase activity", "volume": "284", "author": "Garscha", "year": "2009", "journal-title": "J. Biol. Chem."}, {"key": "2019102523481369600_B17", "doi-asserted-by": "crossref", "first-page": "4352", "DOI": "10.1002/1521-3773(20001201)39:23<4352::AID-ANIE4352>3.0.CO;2-U", "article-title": "Wound-activated chemical defense in unicellular planktonic algae", "volume": "39", "author": "Pohnert", "year": "2000", "journal-title": "Angew. Chem. Int. Ed. Engl."}, {"key": "2019102523481369600_B18", "doi-asserted-by": "crossref", "first-page": "303", "DOI": "10.1042/BJ20051595", "article-title": "Radical scavenger can scavenge lipid allyl radicals complexed with lipoxygenase at lower oxygen content", "volume": "395", "author": "Koshiishi", "year": "2006", "journal-title": "Biochem. J."}, {"key": "2019102523481369600_B19", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1016/0090-6980(87)90246-2", "article-title": "Prostaglandin-G2 levels during reaction of prostaglandin-h synthase with arachidonic-acid", "volume": "34", "author": "Kulmacz", "year": "1987", "journal-title": "Prostaglandins"}, {"key": "2019102523481369600_B20", "doi-asserted-by": "crossref", "first-page": "1105", "DOI": "10.1038/nature04341", "article-title": "Sequencing of Aspergillus nidulans and comparative analysis with A. fumigatus and A. oryzae", "volume": "438", "author": "Galagan", "year": "2005", "journal-title": "Nature"}, {"key": "2019102523481369600_B21", "doi-asserted-by": "crossref", "first-page": "14112", "DOI": "10.1074/jbc.271.24.14112", "article-title": "Purification and characterization of linoleate 8-dioxygenase from the fungus Gaeumannomyces graminis as a novel hemoprotein", "volume": "271", "author": "Su", "year": "1996", "journal-title": "J. Biol. Chem."}, {"key": "2019102523481369600_B22", "doi-asserted-by": "crossref", "first-page": "2828", "DOI": "10.1021/ja00243a048", "article-title": "10-Hydroperoxy-8,12-octadecadienoic acid. A diagnostic probe of alkoxyl radical generation in metal\u2013hydroperoxide reactions", "volume": "109", "author": "Labeque", "year": "1987", "journal-title": "J. Am. Chem. Soc."}, {"key": "2019102523481369600_B23", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1016/0005-2760(84)90293-5", "article-title": "The formation of 1-octen-3-ol from the 10-hydroperoxide isomer of linoleic acid by a hydroperoxide lyase in mushrooms (Psalliota bispora)", "volume": "794", "author": "Wurzenberger", "year": "1984", "journal-title": "Biochem. Biophys. Acta"}, {"key": "2019102523481369600_B24", "doi-asserted-by": "crossref", "first-page": "18", "DOI": "10.1016/0005-2760(84)90292-3", "article-title": "Origin of the oxygen in the products of the enzymatic cleavage reaction of linoleic acid to 1-octen-3-ol and 10-oxo-trans-8-decenoic acid in mushrooms (Psalliota bispora)", "volume": "794", "author": "Wurzenberger", "year": "1984", "journal-title": "Biochem. Biophys. Acta"}, {"key": "2019102523481369600_B25", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1016/0005-2760(84)90117-6", "article-title": "Stereochemistry of the cleavage of the 10-hydroperoxide isomer of linoleic acid to 1-octen-3-ol by a hydroperoxide lyase from mushrooms (Psalliota bispora)", "volume": "795", "author": "Wurzenberger", "year": "1984", "journal-title": "Biochem. Biophys. Acta"}, {"key": "2019102523481369600_B26", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1016/j.bbalip.2006.03.008", "article-title": "Biosynthesis of C9-aldehydes in the moss Physcomitrella patens", "volume": "1761", "author": "Stumpe", "year": "2006", "journal-title": "Biochim. Biophys. Acta"}, {"key": "2019102523481369600_B27", "doi-asserted-by": "crossref", "first-page": "158", "DOI": "10.1002/anie.200460686", "article-title": "Unprecedented lipoxygenase/hydroperoxide lyase pathways in the moss Physcomitrella patens", "volume": "44", "author": "Wichard", "year": "2005", "journal-title": "Angew. Chem. Int. Ed. Engl."}, {"key": "2019102523481369600_B28", "author": "Grosch", "first-page": "95", "year": "1987", "article-title": "Reactions of hydroperoxides-products of low molecular weight", "volume-title": "Autoxidation of Unsaturated Lipids"}, {"key": "2019102523481369600_B29", "doi-asserted-by": "crossref", "first-page": "10347", "DOI": "10.1074/jbc.M009377200", "article-title": "Prostaglandin endoperoxide H synthase-1: the functions of cyclooxygenase active site residues in the binding, positioning, and oxygenation of arachidonic acid", "volume": "276", "author": "Thuresson", "year": "2001", "journal-title": "J. Biol. Chem."}, {"key": "2019102523481369600_B30", "doi-asserted-by": "crossref", "first-page": "3547", "DOI": "10.1016/j.febslet.2008.09.031", "article-title": "Critical amino acids for the 8(R)-dioxygenase activity of linoleate diol synthase. A comparison with cyclooxygenases", "volume": "582", "author": "Garscha", "year": "2008", "journal-title": "FEBS Lett."}, {"key": "2019102523481369600_B31", "doi-asserted-by": "crossref", "first-page": "22648", "DOI": "10.1074/jbc.M110420200", "article-title": "Catalytic properties of rice \u03b1-oxygenase. A comparison with mammalian prostaglandin H synthases", "volume": "277", "author": "Koeduka", "year": "2002", "journal-title": "J. Biol. Chem."}, {"key": "2019102523481369600_B32", "doi-asserted-by": "crossref", "first-page": "20744", "DOI": "10.1074/jbc.273.33.20744", "article-title": "A protein radical and ferryl intermediates are generated by linoleate diol synthase, a ferric hemeprotein with dioxygenase and hydroperoxide isomerase activities", "volume": "273", "author": "Su", "year": "1998", "journal-title": "J. Biol. Chem."}, {"key": "2019102523481369600_B33", "doi-asserted-by": "crossref", "first-page": "145", "DOI": "10.1146/annurev.biochem.69.1.145", "article-title": "Cyclooxygenases: structural, cellular, and molecular biology", "volume": "69", "author": "Smith", "year": "2000", "journal-title": "Annu. Rev. Biochem."}, {"key": "2019102523481369600_B34", "doi-asserted-by": "crossref", "first-page": "2253", "DOI": "10.1021/cr0307143", "article-title": "Structure and chemistry of cytochrome P450", "volume": "105", "author": "Denisov", "year": "2005", "journal-title": "Chem. Rev."}, {"key": "2019102523481369600_B35", "doi-asserted-by": "crossref", "first-page": "855", "DOI": "10.1194/jlr.M600446-JLR200", "article-title": "Intramolecular rearrangement of linolenate peroxyl radicals in lipoxygenase reactions at lower oxygen content", "volume": "48", "author": "Takajo", "year": "2007", "journal-title": "J. Lipid Res."}, {"key": "2019102523481369600_B36", "doi-asserted-by": "crossref", "first-page": "2506", "DOI": "10.1194/jlr.D500006-JLR200", "article-title": "Quantification of lipid alkyl radicals trapped with nitroxyl radical via HPLC with postcolumn thermal decomposition", "volume": "46", "author": "Koshiishi", "year": "2005", "journal-title": "J. Lipid Res."}, {"key": "2019102523481369600_B37", "doi-asserted-by": "crossref", "first-page": "252", "DOI": "10.1046/j.1432-1033.2001.01872.x", "article-title": "Proximal cysteine residue is essential for the enzymatic activities of cytochrome P450cam", "volume": "268", "author": "Yoshioka", "year": "2001", "journal-title": "Eur. J. Biochem."}, {"key": "2019102523481369600_B38", "doi-asserted-by": "crossref", "first-page": "2280", "DOI": "10.1271/bbb.67.2280", "article-title": "Linoleic acid 10-hydroperoxide as an intermediate during formation of 1-octen-3-ol from linoleic acid in Lentinus decadetes", "volume": "67", "author": "Matsui", "year": "2003", "journal-title": "Biosci. Biotechnol. Biochem."}, {"key": "2019102523481369600_B39", "doi-asserted-by": "crossref", "first-page": "1539", "DOI": "10.1271/bbb.69.1539", "article-title": "Stereochemical correlation between 10-hydroperoxyoctadecadienoic acid and 1-octen-3-ol in Lentinula edodes and Tricholoma matsutake mushrooms", "volume": "69", "author": "Akakabe", "year": "2005", "journal-title": "Biosci. Biotechnol. Biochem."}, {"key": "2019102523481369600_B40", "doi-asserted-by": "crossref", "first-page": "7588", "DOI": "10.1074/jbc.M411738200", "article-title": "A multifunctional lipoxygenase with fatty acid hydroperoxide cleaving activity from the moss Physcomitrella patens", "volume": "280", "author": "Senger", "year": "2005", "journal-title": "J. Biol. Chem."}, {"key": "2019102523481369600_B41", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1038/367243a0", "article-title": "The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1", "volume": "367", "author": "Picot", "year": "1994", "journal-title": "Nature"}], "container-title": ["Biochemical Journal"], "language": "en", "link": [{"URL": "http://portlandpress.com/biochemj/article-pdf/425/3/553/661232/bj4250553.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://portlandpress.com/biochemj/article-pdf/425/3/553/661232/bj4250553.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 26]], "date-time": "2019-10-26T04:10:32Z", "timestamp": 1572063032000}, "score": 41.380005, "issued": {"date-parts": [[2010, 1, 15]]}, "references-count": 41, "journal-issue": {"published-print": {"date-parts": [[2010, 2, 1]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1042/bj20091096", "relation": {"cites": []}, "ISSN": ["0264-6021", "1470-8728"], "issn-type": [{"value": "0264-6021", "type": "print"}, {"value": "1470-8728", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T12:10:51Z", "timestamp": 1574511051028}, "reference-count": 73, "publisher": "American Chemical Society (ACS)", "issue": "23", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Am. Chem. Soc."], "published-print": {"date-parts": [[2011, 6, 15]]}, "DOI": "10.1021/ja202207t", "type": "journal-article", "created": {"date-parts": [[2011, 5, 6]], "date-time": "2011-05-06T15:38:16Z", "timestamp": 1304696296000}, "page": "9052-9062", "source": "Crossref", "is-referenced-by-count": 13, "title": ["Multifrequency Electron Paramagnetic Resonance Characterization of PpoA, a CYP450 Fusion Protein that Catalyzes Fatty Acid Dioxygenation"], "prefix": "10.1021", "volume": "133", "author": [{"given": "Alistair J.", "family": "Fielding", "sequence": "first", "affiliation": []}, {"given": "Florian", "family": "Brodhun", "sequence": "additional", "affiliation": []}, {"given": "Christian", "family": "Koch", "sequence": "additional", "affiliation": []}, {"given": "Roberta", "family": "Pievo", "sequence": "additional", "affiliation": []}, {"given": "Vasyl", "family": "Denysenkov", "sequence": "additional", "affiliation": []}, {"given": "Ivo", "family": "Feussner", "sequence": "additional", "affiliation": []}, {"given": "Marina", "family": "Bennati", "sequence": "additional", "affiliation": []}], "member": "316", "container-title": ["Journal of the American Chemical Society"], "language": "en", "link": [{"URL": "https://pubs.acs.org/doi/pdf/10.1021/ja202207t", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 28]], "date-time": "2019-09-28T02:33:56Z", "timestamp": 1569638036000}, "score": 37.051918, "issued": {"date-parts": [[2011, 6, 15]]}, "references-count": 73, "journal-issue": {"published-print": {"date-parts": [[2011, 6, 15]]}, "issue": "23"}, "alternative-id": ["10.1021/ja202207t"], "URL": "http://dx.doi.org/10.1021/ja202207t", "ISSN": ["0002-7863", "1520-5126"], "issn-type": [{"value": "0002-7863", "type": "print"}, {"value": "1520-5126", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T06:36:47Z", "timestamp": 1574318207642}, "reference-count": 0, "publisher": "Worldwide Protein Data Bank", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.2210/pdb2wiy/pdb", "type": "component", "created": {"date-parts": [[2009, 8, 18]], "date-time": "2009-08-18T19:00:23Z", "timestamp": 1250622023000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Cytochrome P450 XplA heme domain P21212"], "prefix": "10.2210", "author": [{"given": "F.", "family": "Sabbadin", "sequence": "first", "affiliation": []}, {"given": "R.", "family": "Jackson", "sequence": "additional", "affiliation": []}, {"given": "N.C.", "family": "Bruce", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Grogan", "sequence": "additional", "affiliation": []}], "member": "7763", "published-online": {"date-parts": [[2009, 8, 18]]}, "deposited": {"date-parts": [[2019, 9, 27]], "date-time": "2019-09-27T08:36:11Z", "timestamp": 1569573371000}, "score": 34.323814, "issued": {"date-parts": [[2009, 8, 18]]}, "references-count": 0, "URL": "http://dx.doi.org/10.2210/pdb2wiy/pdb"}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T06:36:47Z", "timestamp": 1574318207817}, "reference-count": 0, "publisher": "Worldwide Protein Data Bank", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.2210/pdb2wiv/pdb", "type": "component", "created": {"date-parts": [[2009, 8, 18]], "date-time": "2009-08-18T19:00:23Z", "timestamp": 1250622023000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Cytochrome-P450 XplA heme domain P21"], "prefix": "10.2210", "author": [{"given": "F.", "family": "Sabbadin", "sequence": "first", "affiliation": []}, {"given": "R.", "family": "Jackson", "sequence": "additional", "affiliation": []}, {"given": "N.C.", "family": "Bruce", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Grogan", "sequence": "additional", "affiliation": []}], "member": "7763", "published-online": {"date-parts": [[2009, 8, 18]]}, "deposited": {"date-parts": [[2019, 9, 27]], "date-time": "2019-09-27T08:35:57Z", "timestamp": 1569573357000}, "score": 34.323814, "issued": {"date-parts": [[2009, 8, 18]]}, "references-count": 0, "URL": "http://dx.doi.org/10.2210/pdb2wiv/pdb"}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T18:58:41Z", "timestamp": 1574449121492}, "publisher-location": "Boston, MA", "reference-count": 26, "publisher": "Springer US", "isbn-type": [{"value": "9781461290780", "type": "print"}, {"value": "9781461319412", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1987]]}, "DOI": "10.1007/978-1-4613-1941-2_42", "type": "book-chapter", "created": {"date-parts": [[2012, 2, 1]], "date-time": "2012-02-01T03:24:00Z", "timestamp": 1328066640000}, "page": "325-331", "source": "Crossref", "is-referenced-by-count": 3, "title": ["The Fatty Acid-Anchored Four Heme Cytochrome of the Photosynthetic Reaction Center from the Purple Bacterium Rhodopseudomonas Viridis"], "prefix": "10.1007", "author": [{"given": "K. A.", "family": "Weyer", "sequence": "first", "affiliation": []}, {"given": "F.", "family": "Lottspeich", "sequence": "additional", "affiliation": []}, {"given": "W.", "family": "Sch\u00e4fer", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Michel", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "42_CR1", "author": "G Feher", "first-page": "349", "year": "1978", "unstructured": "Feher, G. & Okamura, M.Y. (1978) in \u201cThe Photosynthetic Bacteria\u201d, eds. Clayton, R.K. & Sistrom, W.R. ( Plenum Press, New York ), pp. 349\u2013386.", "volume-title": "The Photosynthetic Bacteria"}, {"key": "42_CR2", "unstructured": "Hoff, A.J. (1982) in \u201cMolecular Biology, Biochemistry, and Biophysics\u201d, Vol. 35, ed. Fong, F.K. ( Springer, Berlin ), pp. 80\u2013151, 322\u2013326."}, {"key": "42_CR3", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1146/annurev.bb.11.060182.000421", "volume": "11", "author": "WW Parson", "year": "1982", "unstructured": "Parson, W.W. (1982). Ann. Rev. Biophys. Bioeng. 11: 57\u201380.", "journal-title": "Ann. Rev. Biophys. Bioeng"}, {"key": "42_CR4", "doi-asserted-by": "publisher", "first-page": "329", "DOI": "10.1111/j.1751-1097.1971.tb06177.x", "volume": "14", "author": "JP Thornber", "year": "1971", "unstructured": "Thornber, J.P. & Olson, J.M. (1971) Photochem. Photobiol. 14: 329\u2013341.", "journal-title": "Photochem. Photobiol."}, {"key": "42_CR5", "author": "JP Thornber", "first-page": "55", "year": "1977", "unstructured": "Thornber, J.P., Dutton, P.L., Fajer, J., Forman, A., Holten, D., Olson, J.M., Parson, W.W., Prince, R.C., Tiede, D.M. & Windsor, T.W. (1977) in \u201cProc. of the Fourth International Congress on Photosynthesis\u201d, eds. Hall, D.O., Coombs, J. & Goodwin, T.W., ( The Biochemical Society, London ), pp. 55\u201370.", "volume-title": "Proc. of the Fourth International Congress on Photosynthesis"}, {"key": "42_CR6", "doi-asserted-by": "publisher", "first-page": "567", "DOI": "10.1016/0022-2836(82)90216-9", "volume": "158", "author": "H Michel", "year": "1982", "unstructured": "Michel, H. (1982) J. Mol. Biol. 158: 567\u2013572.", "journal-title": "J. Mol. Biol"}, {"key": "42_CR7", "doi-asserted-by": "publisher", "first-page": "385", "DOI": "10.1016/S0022-2836(84)80011-X", "volume": "180", "author": "J Deisenhofer", "year": "1984", "unstructured": "Deisenhofer, J., Epp, O., Miki, K., Huber, R. & Michel, H. (1984) J. Mol. Biol. 180: 385\u2013398.", "journal-title": "J. Mol. Biol."}, {"key": "42_CR8", "doi-asserted-by": "crossref", "first-page": "1667", "DOI": "10.1002/j.1460-2075.1985.tb03835.x", "volume": "4", "author": "H Michel", "year": "1985", "unstructured": "Michel, H., Weyer, K.A., Gruenberg, H. & Lottspeich, F. (1985) EMBO J. 4: 1667\u20131672.", "journal-title": "Embo J"}, {"key": "42_CR9", "doi-asserted-by": "crossref", "first-page": "1149", "DOI": "10.1002/j.1460-2075.1986.tb04340.x", "volume": "5", "author": "H Michel", "year": "1986", "unstructured": "Michel, H., Weyer, K.A., Gruenberg, H., Dunger, I., Oesterhelt, D. & Lottspeich, F. (1986) EMBO J. 5: 1149\u20131158.", "journal-title": "Embo J"}, {"key": "42_CR10", "unstructured": "Weyer, K.A., Lottspeich, F., Gruenberg, H., Lang, F., Oesterhelt, D. & Michel, H., in preparation"}, {"key": "42_CR11", "unstructured": "Deisenhofer, J., Epp, Sinning, I. & Michel, H., in preparation"}, {"key": "42_CR12", "doi-asserted-by": "publisher", "first-page": "618", "DOI": "10.1038/318618a0", "volume": "318", "author": "J Deisenhofer", "year": "1985", "unstructured": "Deisenhofer, J., Epp, O., Miki, K., Huber, R. & Michel, H. (1985) Nature 318: 618\u2013624.", "journal-title": "Nature"}, {"key": "42_CR13", "first-page": "105", "volume": "35", "author": "For review see", "year": "1982", "unstructured": "For review see: Meyer, T. & Kamen, M.D. (1982) Adv. Prot. Chem. 35: 105\u2013212.", "journal-title": "Adv. Prot. Chem."}, {"key": "42_CR14", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/0079-6107(85)90004-5", "volume": "45", "author": "For review see", "year": "1985", "unstructured": "For review see: Mathews, F.S. (1985) Prog. Biophys. molec. Biol. 45: 1\u201356.", "journal-title": "Prog. Biophys. molec. Biol."}, {"key": "42_CR15", "doi-asserted-by": "publisher", "first-page": "524", "DOI": "10.1016/S0076-6879(83)91049-2", "volume": "91", "author": "MO Dayhoff", "year": "1983", "unstructured": "Dayhoff, M.O., Barker, W.. & Hunt, L.T. (1983) Methods Enzymol. 91: 524\u2013545.", "journal-title": "Methods Enzymol"}, {"key": "42_CR16", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/0005-2728(84)90133-6", "volume": "764", "author": "D.A. Shill", "year": "1984", "unstructured": "Shill, D.A. & Wood, P.M. (1984) Biochim. Biophys. Acta 764: 1\u20137", "journal-title": "Biochim. Biophys. Acta"}, {"key": "42_CR17", "author": "H Michel", "first-page": "371", "year": "1986", "unstructured": "Michel, H. & Deisenhofer, J. (1986) in \u201cEncyclopedia of Plant Physiology: Photosynthesis III\u201d, Vol. 19, eds. Staehelin, A.C. & Arntzen, C.J., ( Springer, Berlin ), pp. 371\u2013381.", "volume-title": "Encyclopedia of Plant Physiology: Photosynthesis III"}, {"key": "42_CR18", "doi-asserted-by": "publisher", "first-page": "229", "DOI": "10.1016/0014-5793(77)80793-X", "volume": "79", "author": "GR Moore", "year": "1971", "unstructured": "Moore, G.R. & Williams, R.J.P. (1971) FEBS Lett. 79: 229\u2013232.", "journal-title": "FEBS Lett"}, {"key": "42_CR19", "unstructured": "Dracheva, S.M., Drachev, L.A., Zaberezhnaya, S.M., Konstantinov, A.A., Semenov, A.Yu. & Skulachev, V.P. (1986) FEBS Lett. 205: 41\u201346."}, {"key": "42_CR20", "unstructured": "Weyer, K.A., Schaefer, W., Lottspeich, F. & Michel, H. (1987) Biochemistry, in press"}, {"key": "42_CR21", "doi-asserted-by": "publisher", "first-page": "284", "DOI": "10.1111/j.1432-1033.1973.tb02757.x", "volume": "34", "author": "K Hantke", "year": "1973", "unstructured": "Hantke, K. & Braun, V. (1973) Eur. J. Biochem. 34: 284\u2013296.", "journal-title": "Eur. J. Biochem"}, {"key": "42_CR22", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1016/S0070-2161(08)60324-X", "volume": "24", "author": "For review see", "year": "1985", "unstructured": "For review see: Duffaud, G.D., Lehnhardt, S.K., March P.E., & Inouye, M. (1985) Current Topics in Membranes and Transport 24: 65\u2013105.", "journal-title": "Current Topics in Membranes and Transport"}, {"key": "42_CR23", "doi-asserted-by": "publisher", "first-page": "3506", "DOI": "10.1073/pnas.78.6.3506", "volume": "78", "author": "JS Lai", "year": "1981", "unstructured": "Lai, J.S., Sarvas, M., Brammar, W.J., Neugebauer, K., & Wu, H.C. (1981) Proc. Natl. Acad. Sci. USA 78: 3506\u20133510.", "journal-title": "Natl. Acad. Sci. USA"}, {"key": "42_CR24", "unstructured": "24.Inouye, S., Franceschini, T., Sato, M., Itakura, K., & Inouye, M. (1983)EMB0 J. 2: 87\u201391."}, {"key": "42_CR25", "first-page": "1835", "volume": "261", "author": "S Politt", "year": "1986", "unstructured": "Politt, S., Inouye, S., Inouye M. (1986) J. Biol. Chem. 261: 1835\u20131837.", "journal-title": "J. Biol. Chem"}, {"key": "42_CR26", "author": "C Tanford", "first-page": "7", "year": "1980", "unstructured": "Tanford, C. (1980) in \u201cThe Hydrophobic Effect: Formation of Micelles and Biological Membranes\u201d, ed. Tanford, Ch. ( John Wiley & Sons, New York ), pp. 7.", "volume-title": "in The Hydrophobic Effect: Formation of Micelles and Biological Membranes, ed. Tanford, Ch"}], "container-title": ["Cytochrome Systems"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-4613-1941-2_42", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 26]], "date-time": "2019-04-26T04:34:37Z", "timestamp": 1556253277000}, "score": 33.672924, "issued": {"date-parts": [[1987]]}, "ISBN": ["9781461290780", "9781461319412"], "references-count": 26, "URL": "http://dx.doi.org/10.1007/978-1-4613-1941-2_42", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T22:55:08Z", "timestamp": 1574117708814}, "reference-count": 67, "publisher": "American Society for Biochemistry & Molecular Biology (ASBMB)", "issue": "33", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Biol. Chem."], "published-print": {"date-parts": [[2001, 8, 17]]}, "DOI": "10.1074/jbc.m105011200", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T14:58:38Z", "timestamp": 1027695518000}, "page": "30885-30891", "source": "Crossref", "is-referenced-by-count": 77, "title": ["Stimulation of Cytochrome P450 Reactions by Apo-cytochromeb5"], "prefix": "10.1074", "volume": "276", "author": [{"given": "Hiroshi", "family": "Yamazaki", "sequence": "first", "affiliation": []}, {"given": "Tsutomu", "family": "Shimada", "sequence": "additional", "affiliation": []}, {"given": "Martha V.", "family": "Martin", "sequence": "additional", "affiliation": []}, {"given": "F. Peter", "family": "Guengerich", "sequence": "additional", "affiliation": []}], "member": "28", "published-online": {"date-parts": [[2001, 6, 18]]}, "reference": [{"key": "2017062210083652000_276.33.30885.1", "author": "Palmer", "volume": "267", "first-page": "665", "year": "1992", "journal-title": "J. Biol. Chem."}, {"key": "2017062210083652000_276.33.30885.2", "unstructured": "Ortiz de Montellano P. R. (1995) Cytochrome P450, Structure, Mechanism, and Biochemistry (Plenum Press, New York)."}, {"key": "2017062210083652000_276.33.30885.3", "author": "Porter", "volume": "266", "first-page": "13469", "year": "1991", "journal-title": "J. Biol. Chem."}, {"key": "2017062210083652000_276.33.30885.4", "unstructured": "Lewis D. F. V. (1996) Cytochromes P450, Structure, Function and Mechanism (Taylor and Francis, Bristol, PA)."}, {"key": "2017062210083652000_276.33.30885.5", "DOI": "10.1021/tx0002583", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.6", "DOI": "10.1021/tx00022a001", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.7", "DOI": "10.1016/0003-9861(71)90186-X", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.8", "author": "Imai", "volume": "89", "first-page": "351", "year": "1981", "journal-title": "J. Biochem. (Tokyo)", "DOI": "10.1093/oxfordjournals.jbchem.a133209", "doi-asserted-by": "crossref"}, {"key": "2017062210083652000_276.33.30885.9", "DOI": "10.1016/0006-291X(80)90303-4", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.10", "author": "Miki", "volume": "88", "first-page": "307", "year": "1980", "journal-title": "J. Biochem. (Tokyo)", "DOI": "10.1093/oxfordjournals.jbchem.a132976", "doi-asserted-by": "crossref"}, {"key": "2017062210083652000_276.33.30885.11", "author": "Noshiro", "volume": "88", "first-page": "1521", "year": "1980", "journal-title": "J. Biochem. (Tokyo)", "DOI": "10.1093/oxfordjournals.jbchem.a133123", "doi-asserted-by": "crossref"}, {"key": "2017062210083652000_276.33.30885.12", "unstructured": "Peterson J. A. Prough R. A. (1986) in Cytochrome P-450, ed Ortiz de Montellano P. R. (Plenum Press, New York), pp 89\u2013117.", "DOI": "10.1007/978-1-4757-9939-2_4", "doi-asserted-by": "crossref"}, {"key": "2017062210083652000_276.33.30885.13", "author": "Schenkman", "volume": "31", "first-page": "351", "year": "1999", "journal-title": "Drug Metab. Dispos.", "DOI": "10.1081/DMR-100101923", "doi-asserted-by": "crossref"}, {"key": "2017062210083652000_276.33.30885.14", "author": "Tamburini", "volume": "258", "first-page": "13444", "year": "1983", "journal-title": "J. Biol. Chem."}, {"key": "2017062210083652000_276.33.30885.15", "author": "Tamburini", "volume": "260", "first-page": "4007", "year": "1985", "journal-title": "J. Biol. Chem."}, {"key": "2017062210083652000_276.33.30885.16", "DOI": "10.1016/0167-4838(92)90120-3", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.17", "DOI": "10.1074/jbc.273.27.17036", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.18", "author": "B\u00f6sterling", "volume": "257", "first-page": "4375", "year": "1982", "journal-title": "J. Biol. Chem."}, {"key": "2017062210083652000_276.33.30885.19", "author": "Velick", "volume": "221", "first-page": "265", "year": "1956", "journal-title": "J. Biol. Chem."}, {"key": "2017062210083652000_276.33.30885.20", "DOI": "10.1021/bi972390g", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.21", "DOI": "10.1021/bi00281a007", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.22", "DOI": "10.1074/jbc.271.44.27438", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.23", "author": "Noshiro", "volume": "116", "first-page": "521", "year": "1981", "journal-title": "Eur. J. Biochem.", "DOI": "10.1111/j.1432-1033.1981.tb05367.x", "doi-asserted-by": "crossref"}, {"key": "2017062210083652000_276.33.30885.24", "author": "Pompon", "volume": "259", "first-page": "15377", "year": "1984", "journal-title": "J. Biol. Chem."}, {"key": "2017062210083652000_276.33.30885.25", "DOI": "10.1021/bi9719399", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.26", "DOI": "10.1021/bi980908q", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.27", "DOI": "10.1021/bi00026a020", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.28", "DOI": "10.1006/abbi.1997.0125", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.29", "DOI": "10.1074/jbc.273.6.3158", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.30", "DOI": "10.1006/abbi.2000.2136", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.31", "DOI": "10.1021/bi001522u", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.32", "DOI": "10.1073/pnas.90.24.11748", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.33", "author": "Guengerich", "volume": "261", "first-page": "5051", "year": "1986", "journal-title": "J. Biol. Chem."}, {"key": "2017062210083652000_276.33.30885.34", "DOI": "10.1021/bi00141a015", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.35", "DOI": "10.1006/abbi.1996.0022", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.36", "DOI": "10.1006/abbi.1997.0378", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.37", "author": "Yamazaki", "volume": "27", "first-page": "999", "year": "1999", "journal-title": "Drug Metab. Dispos."}, {"key": "2017062210083652000_276.33.30885.38", "DOI": "10.1021/bi980674a", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.39", "DOI": "10.1021/bi002305w", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.40", "author": "Falzone", "volume": "40", "first-page": "4879", "year": "2001", "journal-title": "Biochemistry", "DOI": "10.1021/bi002681g", "doi-asserted-by": "crossref"}, {"key": "2017062210083652000_276.33.30885.41", "DOI": "10.1073/pnas.83.21.8064", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.42", "DOI": "10.1006/abbi.1993.1401", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.43", "DOI": "10.1006/abbi.1997.0525", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.44", "DOI": "10.1021/bi992765t", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.45", "author": "Shen", "volume": "264", "first-page": "7584", "year": "1989", "journal-title": "J. Biol. Chem."}, {"key": "2017062210083652000_276.33.30885.46", "DOI": "10.1006/abbi.2000.1708", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.47", "DOI": "10.1006/abbi.1997.0534", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.48", "DOI": "10.1016/S0076-6879(78)52010-7", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.49", "author": "Shimada", "volume": "261", "first-page": "909", "year": "1986", "journal-title": "J. Biol. Chem."}, {"key": "2017062210083652000_276.33.30885.50", "author": "Mihara", "volume": "78", "first-page": "1057", "year": "1975", "journal-title": "J. Biochem. (Tokyo)", "DOI": "10.1093/oxfordjournals.jbchem.a130983", "doi-asserted-by": "crossref"}, {"key": "2017062210083652000_276.33.30885.51", "DOI": "10.1021/bi00013a034", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.52", "author": "Omura", "volume": "239", "first-page": "2370", "year": "1964", "journal-title": "J. Biol. Chem."}, {"key": "2017062210083652000_276.33.30885.53", "unstructured": "Falk, J. E. (1964) Porphyrins and Metalloporphyrins, pp. 81 and 240\u2013241, Elsevier, Amsterdam."}, {"key": "2017062210083652000_276.33.30885.54", "DOI": "10.1016/0003-2697(86)90224-1", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.55", "DOI": "10.1006/abbi.1998.0659", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.56", "DOI": "10.1016/S0006-2952(96)00836-2", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.57", "author": "Hasemann", "volume": "2", "first-page": "41", "year": "1995", "journal-title": "Structure", "DOI": "10.1016/S0969-2126(01)00134-4", "doi-asserted-by": "crossref"}, {"key": "2017062210083652000_276.33.30885.58", "DOI": "10.1074/jbc.M004281200", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.59", "DOI": "10.1016/0006-291X(74)90395-7", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.60", "author": "Krasny", "volume": "13", "first-page": "759", "year": "1977", "journal-title": "Mol. Pharmacol."}, {"key": "2017062210083652000_276.33.30885.61", "DOI": "10.1042/bj1900465", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.62", "DOI": "10.1021/bi00610a033", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.63", "DOI": "10.1016/0003-9861(88)90492-4", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.64", "author": "Yamano", "volume": "2", "first-page": "673", "year": "1978", "journal-title": "Pharmacol. Ther."}, {"key": "2017062210083652000_276.33.30885.65", "author": "Guengerich", "volume": "250", "first-page": "7405", "year": "1975", "journal-title": "J. Biol. Chem."}, {"key": "2017062210083652000_276.33.30885.66", "DOI": "10.1016/0006-2952(96)00208-0", "doi-asserted-by": "publisher"}, {"key": "2017062210083652000_276.33.30885.67", "DOI": "10.1021/tx0002132", "doi-asserted-by": "publisher"}], "container-title": ["Journal of Biological Chemistry"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1074/jbc.M105011200", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 23]], "date-time": "2017-06-23T09:16:20Z", "timestamp": 1498209380000}, "score": 31.93283, "subtitle": ["EVIDENCE AGAINST TRANSFER OF HEME FROM CYTOCHROME P450 3A4 TO APO-CYTOCHROMEb5OR HEME OXYGENASE"], "issued": {"date-parts": [[2001, 6, 18]]}, "references-count": 67, "journal-issue": {"published-online": {"date-parts": [[2001, 8, 10]]}, "published-print": {"date-parts": [[2001, 8, 17]]}, "issue": "33"}, "alternative-id": ["10.1074/jbc.M105011200"], "URL": "http://dx.doi.org/10.1074/jbc.m105011200", "relation": {"cites": []}, "ISSN": ["0021-9258", "1083-351X"], "issn-type": [{"value": "0021-9258", "type": "print"}, {"value": "1083-351X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T00:25:08Z", "timestamp": 1575419108330}, "publisher-location": "Basel", "reference-count": 10, "publisher": "Birkh\u00e4user Basel", "isbn-type": [{"value": "9783034865579", "type": "print"}, {"value": "9783034865562", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1983]]}, "DOI": "10.1007/978-3-0348-6556-2_142", "type": "book-chapter", "created": {"date-parts": [[2013, 12, 29]], "date-time": "2013-12-29T21:57:25Z", "timestamp": 1388354245000}, "page": "322-323", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Protoplast Fusion within Aspergillus Nidulans Group by Nutritional Selection"], "prefix": "10.1007", "author": [{"given": "F.", "family": "Kevei", "sequence": "first", "affiliation": []}, {"given": "J. F.", "family": "Peberdy", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "142_CR1", "doi-asserted-by": "publisher", "first-page": "201", "DOI": "10.1007/BF00447138", "volume": "105", "author": "J Ann\u00e9", "year": "1975", "unstructured": "Ann\u00e9, J., Peberdy, J. F. (1975) Arch. Microbiol. 105: 201\u2013205.", "journal-title": "Arch. Microbiol"}, {"key": "142_CR2", "doi-asserted-by": "publisher", "first-page": "50", "DOI": "10.1007/BF01924674", "volume": "31", "author": "L Ferenczy", "year": "1975", "unstructured": "Ferenczy, L., Kevei, F., Szegedi, M. (1975) Experientia, 31: 50\u201352.", "journal-title": "Experientia"}, {"key": "142_CR3", "doi-asserted-by": "publisher", "first-page": "255", "DOI": "10.1099/00221287-102-2-255", "volume": "102", "author": "F Kevei", "year": "1977", "unstructured": "Kevei, F., Peberdy, J. F. (1977) J. gen. Microbiol., 102: 255\u2013262.", "journal-title": "J. gen. Microbiol."}, {"key": "142_CR4", "doi-asserted-by": "publisher", "first-page": "213", "DOI": "10.1007/BF00337798", "volume": "170", "author": "F Kevei", "year": "1979", "unstructured": "Kevei, F., Peberdy, J. F. (1979) Molec. gen. Genet., 170: 213\u2013218.", "journal-title": "Molec. gen. Genet."}, {"key": "142_CR5", "doi-asserted-by": "publisher", "first-page": "201", "DOI": "10.1111/j.1574-6968.1977.tb00614.x", "volume": "1", "author": "RBG Dales", "year": "1977", "unstructured": "Dales, R. B. G., Croft, J. H. (1977) FEMS Microbiol. Letters, 1: 201\u2013203.", "journal-title": "FEMS Microbiol. Letters"}, {"key": "142_CR6", "author": "JH Croft", "first-page": "339", "year": "1977", "unstructured": "Croft, J. H., Jinks, J. L. (1977) In Genetics and Physiology of Aspergillus, J. E. Smith, J. A. Pateman (Eds.). Academic Press, London, New York, San Francisco. pp. 339\u2013360.", "volume-title": "Genetics and Physiology of Aspergillus"}, {"key": "142_CR7", "author": "RBG Dales", "first-page": "73", "year": "1980", "unstructured": "Dales, R. B. G., Croft, J. H.(1980) In Advances in Protoplast Research, L. Ferenczy, G. L. Farkas (Eds.). Akad\u00e9miai Kiad\u00f3, Budapest, Pergamon Press, Oxford, pp.73\u201384.", "volume-title": "Advances in Protoplast Research"}, {"key": "142_CR8", "author": "JH Croft", "first-page": "85", "year": "1980", "unstructured": "Croft, J. H., Dales, R. B. G., Turner, G., Earl, A. J.(1980). Ibid. pp.85\u201392.", "volume-title": "Advances in Protoplast Research"}, {"key": "142_CR9", "doi-asserted-by": "publisher", "first-page": "50", "DOI": "10.1007/BF01924674", "volume": "31", "author": "L Ferenczy", "year": "1976", "unstructured": "Ferenczy, L., Kevei, F., Szegedi, M., Frank\u00f3, A., Rojik, I. (1976) Experientia, 31: 50\u201352.", "journal-title": "Experientia"}, {"key": "142_CR10", "first-page": "255", "volume": "102", "author": "AC Hastie", "year": "1970", "unstructured": "Hastie, A. C.(1970) J. gen. Microbiol., 102: 255\u2013262.", "journal-title": "J. gen. Microbiol"}], "container-title": ["Protoplasts 1983"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-0348-6556-2_142", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 24]], "date-time": "2019-05-24T22:18:55Z", "timestamp": 1558736335000}, "score": 30.7992, "issued": {"date-parts": [[1983]]}, "ISBN": ["9783034865579", "9783034865562"], "references-count": 10, "URL": "http://dx.doi.org/10.1007/978-3-0348-6556-2_142", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T03:16:08Z", "timestamp": 1574306168176}, "reference-count": 0, "publisher": "Microbiology Society", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of General Microbiology"], "published-print": {"date-parts": [[1977, 10, 1]]}, "DOI": "10.1099/00221287-102-2-255", "type": "journal-article", "created": {"date-parts": [[2009, 6, 8]], "date-time": "2009-06-08T23:47:47Z", "timestamp": 1244504867000}, "page": "255-262", "source": "Crossref", "is-referenced-by-count": 58, "title": ["Interspecific Hybridization between Aspergillus nidulans and Aspergillus rugulosus by Fusion of Somatic Protoplasts"], "prefix": "10.1099", "volume": "102", "author": [{"given": "F.", "family": "KEVEI", "sequence": "first", "affiliation": []}, {"given": "J. F.", "family": "PEBERDY", "sequence": "additional", "affiliation": []}], "member": "345", "container-title": ["Journal of General Microbiology"], "language": "en", "deposited": {"date-parts": [[2019, 8, 12]], "date-time": "2019-08-12T16:13:54Z", "timestamp": 1565626434000}, "score": 30.190464, "issued": {"date-parts": [[1977, 10, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1977, 10, 1]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1099/00221287-102-2-255", "ISSN": ["0022-1287"], "issn-type": [{"value": "0022-1287", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T17:29:37Z", "timestamp": 1574270977697}, "publisher-location": "Boston, MA", "reference-count": 1515, "publisher": "Springer US", "isbn-type": [{"value": "9780306483240", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1007/0-387-27447-2_10", "type": "book-chapter", "created": {"date-parts": [[2007, 2, 4]], "date-time": "2007-02-04T12:39:28Z", "timestamp": 1170592768000}, "page": "377-530", "source": "Crossref", "is-referenced-by-count": 157, "title": ["Human Cytochrome P450 Enzymes"], "prefix": "10.1007", "author": [{"given": "F. Peter", "family": "Guengerich", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "10_CR1", "author": "L.M. Distlerath", "first-page": "133", "year": "1987", "unstructured": "Distlerath, L.M. and F.P. Guengerich (1987). Enzymology of human liver cytochromes P-450. In F.P. Guengerich (ed.) Mammalian Cytochromes P-450, Vol. 1. CRC Press, Boca Raton, FL, pp. 133\u2013198.", "volume-title": "Mammalian Cytochromes P-450"}, {"key": "10_CR2", "doi-asserted-by": "publisher", "first-page": "826", "DOI": "10.1016/0006-291X(79)91482-7", "volume": "88", "author": "P. Beaune", "year": "1979", "unstructured": "Beaune, P., P. Dansette, J.P. Flinois, S. Columelli, D. Mansuy, and J.P. Leroux (1979). Partial purification of human liver cytochrome P-450. Biochem. Biophys. Res. Commun. 88, 826\u2013832.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR3", "doi-asserted-by": "publisher", "first-page": "206", "DOI": "10.1016/0003-9861(80)90274-X", "volume": "199", "author": "P. Wang", "year": "1980", "unstructured": "Wang, P., P.S. Mason, and F.P. Guengerich (1980). Purification of human liver cytochrome P-450 and comparison to the enzyme isolated from rat liver. Arch. Biochem. Biophys. 199, 206\u2013219.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR4", "doi-asserted-by": "publisher", "first-page": "5375", "DOI": "10.1021/bi00292a019", "volume": "22", "author": "P.P. Wang", "year": "1983", "unstructured": "Wang, P.P., P. Beaune, L.S. Kaminsky, G.A. Dannan, F.F. Kadlubar, D. Larrey et al. (1983). Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes. Biochemistry 22, 5375\u20135383.", "journal-title": "Biochemistry"}, {"key": "10_CR5", "doi-asserted-by": "publisher", "first-page": "584", "DOI": "10.1016/S0140-6736(77)91430-1", "volume": "ii", "author": "A. Mahgoub", "year": "1977", "unstructured": "Mahgoub, A., J.R. Idle, L.G. Dring, R. Lancaster, and R.L. Smith (1977). Polymorphic hydroxylation of debrisoquine in man. Lancet ii, 584\u2013586.", "journal-title": "Lancet"}, {"key": "10_CR6", "first-page": "856", "volume": "41", "author": "T. Shimada", "year": "1992", "unstructured": "Shimada, T., C.-H. Yun, H. Yamazaki, J.-C. Gautier, P.H. Beaune, and F.P. Guengerich (1992). Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol. Pharmacol. 41, 856\u2013864.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR7", "first-page": "9057", "volume": "260", "author": "L.M. Distlerath", "year": "1985", "unstructured": "Distlerath, L.M., P.E.B. Reilly, M.V. Martin, G.G. Davis, G.R. Wilkinson, and F.P. Guengerich (1985). Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism. J. Biol. Chem. 260, 9057\u20139067.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR8", "first-page": "679", "volume": "40", "author": "C.-H. Yun", "year": "1991", "unstructured": "Yun, C.-H., T. Shimada, and F.P. Guengerich (1991). Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol. Pharmacol. 40, 679\u2013685.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR9", "first-page": "909", "volume": "261", "author": "T. Shimada", "year": "1986", "unstructured": "Shimada, T., K.S. Misono, and F.P. Guengerich (1986). Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. J. Biol. Chem. 261, 909\u2013921.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR10", "first-page": "11734", "volume": "261", "author": "J. Gut", "year": "1986", "unstructured": "Gut, J., T. Catin, P. Dayer, T. Kronbach, U. Zanger, and U.A. Meyer (1986). Debrisoquine/sparteinetype polymorphism of drug oxidation: Purification and characterization of two functionally different human liver cytochrome P-450 isozymes involved in impaired hydroxylation of the prototype substrate bufuralol. J. Biol. Chem. 261, 11734\u201311743.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR11", "doi-asserted-by": "publisher", "first-page": "3165", "DOI": "10.1016/0006-2952(86)90403-X", "volume": "35", "author": "C. Birgersson", "year": "1986", "unstructured": "Birgersson, C., E.T. Morgan, H. J\u00f6rnvall, and C. von Bahr (1986). Purification of a desmethylimipramine and debrisoquine hydroxylating cytochrome P-450 from human liver. Biochem. Pharmacol. 35, 3165\u20133166.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR12", "first-page": "5051", "volume": "261", "author": "F.P. Guengerich", "year": "1986", "unstructured": "Guengerich, F.P., M.V. Martin, P.H. Beaune, P. Kremers, T. Wolff, and D.J. Waxman (1986). Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J. Biol. Chem. 261, 5051\u20135060.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR13", "doi-asserted-by": "publisher", "first-page": "6310", "DOI": "10.1073/pnas.82.18.6310", "volume": "82", "author": "P.B. Watkins", "year": "1985", "unstructured": "Watkins, P.B., S.A. Wrighton, P. Maurel, E.G. Schuetz, G. Mendez-Picon, G.A. Parker et al. (1985). Identification of an inducible form of cytochrome P-450 in human liver. Proc. Natl. Acad. Sci. USA 82, 6310\u20136314.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR14", "first-page": "405", "volume": "29", "author": "S.A. Wrighton", "year": "1986", "unstructured": "Wrighton, S.A., C. Campanile, P.E. Thomas, S.L. Maines, P.B. Watkins, G. Parker et al. (1986). Identification of a human liver cytochrome P-450 homologous to the major isosafrole-inducible cytochrome P-450 in the rat. Mol. Pharmacol. 29, 405\u2013410.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR15", "doi-asserted-by": "crossref", "first-page": "1017", "DOI": "10.1172/JCI113154", "volume": "80", "author": "S.A. Wrighton", "year": "1987", "unstructured": "Wrighton, S.A., P.E. Thomas, P. Willis, S.L. Maines, P.B. Watkins, W. Levin et al. (1987). Purification of a human liver cytochrome P-450 immunochemically related to several cytochromes P-450 purified from untreated rats. J. Clin. Invest. 80, 1017\u20131022.", "journal-title": "J. Clin. Invest."}, {"key": "10_CR16", "first-page": "243", "volume": "40", "author": "F.J. Gonzalez", "year": "1989", "unstructured": "Gonzalez, F.J. (1989). The molecular biology of cytochrome P450s. Pharmacol. Rev. 40, 243\u2013288.", "journal-title": "Pharmacol. Rev."}, {"key": "10_CR17", "first-page": "7321", "volume": "266", "author": "J.R. Larson", "year": "1991", "unstructured": "Larson, J.R., M.J. Coon, and T.D. Porter (1991). Alcohol-inducible cytochrome P-450IIE1 lacking the hydrophobic NH2-terminal segment retains catalytic activity and is membrane-bound when expressed in Escherichia coli. J. Biol. Chem. 266, 7321\u20137324.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR18", "first-page": "19186", "volume": "266", "author": "Y.C. Li", "year": "1991", "unstructured": "Li, Y.C. and J.Y.L. Chiang (1991). The expression of a catalytically active cholesterol 7\u03b1-hydroxylase cytochrome P-450 in Escherichia coli. J. Biol. Chem. 266, 19186\u201319191.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR19", "doi-asserted-by": "publisher", "first-page": "5597", "DOI": "10.1073/pnas.88.13.5597", "volume": "88", "author": "H.J. Barnes", "year": "1991", "unstructured": "Barnes, H.J., M.P. Arlotto, and M.R. Waterman (1991). Expression and enzymatic activity of recombinant cytochrome P450 17\u03b1-hydroxylase in Escherichia coli. Proc. Natl. Acad. Sci. USA 88, 5597\u20135601.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR20", "doi-asserted-by": "crossref", "first-page": "551", "DOI": "10.3109/10408449609037477", "volume": "26", "author": "F.P. Guengerich", "year": "1996", "unstructured": "Guengerich, F.P., E.M.J. Gillam, and T. Shimada (1996). New applications of bacterial systems to problems in toxicology. Crit. Rev. Toxicol. 26, 551\u2013583.", "journal-title": "Crit. Rev. Toxicol."}, {"key": "10_CR21", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1089/dna.1987.6.1", "volume": "6", "author": "D.W. Nebert", "year": "1987", "unstructured": "Nebert, D.W., M. Adesnik, M.J. Coon, R.W. Estabrook, F.J. Gonzalez, F.P. Guengerich et al. (1987). The P450 gene superfamily: Recommended nomenclature. DNA 6, 1\u201311.", "journal-title": "DNA"}, {"key": "10_CR22", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1089/dna.1993.12.1", "volume": "12", "author": "D.R. Nelson", "year": "1993", "unstructured": "Nelson, D.R., T. Kamataki, D.J. Waxman, F.P. Guengerich, R.W. Estabrook, R. Feyereisen et al. (1993). The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 12, 1\u201351.", "journal-title": "DNA Cell Biol"}, {"key": "10_CR23", "author": "F.P. Guengerich", "first-page": "473", "year": "1995", "unstructured": "Guengerich, F.P. (1995). Human cytochrome P450 enzymes. In P.R. Ortiz de Montellano (ed.), Cytochrome P450. Plenum Press, New York, pp. 473\u2013535.", "volume-title": "Cytochrome P450", "DOI": "10.1007/978-1-4757-2391-5_14", "doi-asserted-by": "crossref"}, {"key": "10_CR24", "first-page": "12495", "volume": "259", "author": "B.G. Niranjan", "year": "1984", "unstructured": "Niranjan, B.G., N.M. Wilson, C.R. Jefcoate, and N.G. Avadhani (1984). Hepatic mitochondrial cytochrome P-450 system: Distinctive features of cytochrome P-450 involved in the activation of aflatoxin B1 and benzo(a)pyrene. J. Biol. Chem. 259, 12495\u201312501.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR25", "doi-asserted-by": "publisher", "first-page": "589", "DOI": "10.1083/jcb.139.3.589", "volume": "139", "author": "S. Addya", "year": "1997", "unstructured": "Addya, S., H.K. Anandatheerthavarada, G. Biswas, S.V. Bhagwat, J. Mullick, and N.G. Avadhani (1997). Targeting of NH2-terminal-processed microsomal protein to mitochondria: A novel pathway for the biogensis of hepatic mitochondrial P450MT2. J. Cell Biol. 139, 589\u2013599.", "journal-title": "J. Cell Biol."}, {"key": "10_CR26", "doi-asserted-by": "publisher", "first-page": "40583", "DOI": "10.1074/jbc.M203292200", "volume": "277", "author": "M.A. Robin", "year": "2002", "unstructured": "Robin, M.A., H.K. Anandatheerthavarada, G. Biswas, N.B. Sepuri, D.M. Gordon, D. Pain et al. (2002). Bimodal targeting of microsomal CYP2E1 to mitochondria through activation of an N-terminal chimeric signal by cAMP-mediated phosphorylation. J. Biol. Chem. 277, 40583\u201340593.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR27", "doi-asserted-by": "publisher", "first-page": "167", "DOI": "10.1097/00000539-199601000-00031", "volume": "82", "author": "T. Tateishi", "year": "1996", "unstructured": "Tateishi, T., Y. Krivoruk, Y.-F. Ueng, A.J.J. Wood, F.P. Guengerich, and M. Wood (1996). Identification of human liver cytochrome P450 3A4 as the enzyme responsible for fentanyl and sulfentanyl N-dealkylation. Anesth. Analg. 82, 167\u2013172.", "journal-title": "Anesth. Analg."}, {"key": "10_CR28", "first-page": "414", "volume": "270", "author": "T. Shimada", "year": "1994", "unstructured": "Shimada, T., H. Yamazaki, 4. Mimura, Y. Inui, and F.P. Guengerich (1994). Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270, 414\u2013423.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR29", "doi-asserted-by": "publisher", "first-page": "1155", "DOI": "10.1016/S0140-6736(02)11203-7", "volume": "360", "author": "D.W. Nebert", "year": "2002", "unstructured": "Nebert, D.W. and D.W. Russell (2002). Clinical importance of the cytochromes P450. Lancet 360, 1155\u20131162.", "journal-title": "Lancet"}, {"key": "10_CR30", "doi-asserted-by": "publisher", "first-page": "3213", "DOI": "10.1016/0006-2952(85)90337-5", "volume": "34", "author": "A.M.H. Brodie", "year": "1985", "unstructured": "Brodie, A.M.H. (1985). Aromatase inhibition and its pharmacologic implications. Biochem. Pharmacol. 34, 3213\u20133219.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR31", "doi-asserted-by": "publisher", "first-page": "153", "DOI": "10.1016/S0003-9861(02)00364-8", "volume": "409", "author": "F.J. Gonzalez", "year": "2003", "unstructured": "Gonzalez, F.J. and S. Kimura (2003). Study of P450 function using gene knockout and transgenic mice. Arch. Biochem. Biophys. 409, 153\u2013158.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR32", "doi-asserted-by": "publisher", "first-page": "83", "DOI": "10.1081/DMR-120001392", "volume": "34", "author": "S. Rendic", "year": "2002", "unstructured": "Rendic, S. (2002). Summary of information on human CYP enzymes: Human P450 metabolism data. Drug Metab. Rev. 34, 83\u2013448.", "journal-title": "Drug Metab. Rev."}, {"key": "10_CR33", "doi-asserted-by": "publisher", "first-page": "487", "DOI": "10.1126/science.286.5439.487", "volume": "286", "author": "W.E. Evans", "year": "1999", "unstructured": "Evans, W.E. and M.V. Relling (1999). Pharmacogenomics: Translating function genomics into rational therapeutics. Science 286, 487\u2013491.", "journal-title": "Science"}, {"key": "10_CR34", "doi-asserted-by": "publisher", "first-page": "391", "DOI": "10.1021/tx00022a001", "volume": "4", "author": "F.P. Guengerich", "year": "1991", "unstructured": "Guengerich, F.P. and T. Shimada (1991). Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol. 4, 391\u2013407.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR35", "doi-asserted-by": "publisher", "first-page": "223", "DOI": "10.1016/0165-6147(90)90245-4", "volume": "11", "author": "D.D. Breimer", "year": "1990", "unstructured": "Breimer, D.D. and J.H. Schellens (1990). A \u201ccocktail\u201d strategy to assess in vivo oxidative drug metabolism in humans. Trends Pharmacol. Sci. 11, 223\u2013225.", "journal-title": "Trends Pharmacol. Sci."}, {"key": "10_CR36", "author": "D.D. Breimer", "first-page": "13", "year": "1994", "unstructured": "Breimer, D.D. (1994). Genetic polymorphisms in drug metabolism; clinical implications and consequences in ADME studies. In S. Walker, C. Lumley, and N. McAuslane (eds), The Relevance of Ethnic Factors in the Clinical Evaluation of Medicines. Kluwer Academic Publishers, Dordrecht/Boston/London, pp. 13\u201326.", "volume-title": "The Relevance of Ethnic Factors in the Clinical Evaluation of Medicines", "DOI": "10.1007/978-94-011-1420-2_2", "doi-asserted-by": "crossref"}, {"key": "10_CR37", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.3109/10408448509037460", "volume": "14", "author": "F.P. Guengerich", "year": "1985", "unstructured": "Guengerich, F.P. and D.C. Liebler (1985). Enzymatic activation of chemicals to toxic metabolites. Crit. Rev. Toxicol. 14, 259\u2013307.", "journal-title": "Crit. Rev. Toxicol."}, {"key": "10_CR38", "doi-asserted-by": "crossref", "first-page": "835", "DOI": "10.1001/jama.1957.72980250010016", "volume": "165", "author": "A.G. Motulsky", "year": "1957", "unstructured": "Motulsky, A.G. (1957). Drug reactions, enzymes and biochemical genetics. J. Am. Med. Assoc. 165, 835\u2013837.", "journal-title": "J. Am. Med. Assoc."}, {"key": "10_CR39", "author": "W. Kalow", "year": "1962", "unstructured": "Kalow, W. (1962). Pharmacogenetics. W.B. Saunders, Philadelphia, PA.", "volume-title": "Pharmacogenetics"}, {"key": "10_CR40", "first-page": "296", "volume": "237", "author": "H. Remmer", "year": "1957", "unstructured": "Remmer, H. (1957). The acceleration of evipan oxidation and the demethylation of methylaminopyrine by barbiturates. Naunyn-Schmiedeberg\u2019s Arch. Exp. Pathol. Pharmakol. 237, 296\u2013307.", "journal-title": "Naunyn-Schmiedeberg\u2019s Arch. Exp. Pathol. Pharmakol."}, {"key": "10_CR41", "doi-asserted-by": "publisher", "first-page": "301", "DOI": "10.1016/0163-7258(93)90026-A", "volume": "58", "author": "D.S. Keeney", "year": "1993", "unstructured": "Keeney, D.S. and M.R. Waterman (1993). Regulation of steroid hydroxylase gene expression: Importance to physiology and disease. Pharmacol. Ther. 58, 301\u2013317.", "journal-title": "Pharmacol. Ther."}, {"key": "10_CR42", "first-page": "450", "volume": "16", "author": "A.H. Conney", "year": "1956", "unstructured": "Conney, A.H., E.C. Miller, and J.A. Miller (1956). The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. Cancer Res. 16, 450\u2013459.", "journal-title": "Cancer Res"}, {"key": "10_CR43", "doi-asserted-by": "publisher", "first-page": "183", "DOI": "10.1007/BF00562059", "volume": "16", "author": "M. Eichelbaum", "year": "1979", "unstructured": "Eichelbaum, M., N. Spannbrucker, B. Steincke, and H.J. Dengler (1979). Defective N-oxidation of sparteine in man: A new pharmacogenetic defect. Eur. J. Clin. Pharmacol. 16, 183\u2013187.", "journal-title": "Eur. J. Clin. Pharmacol."}, {"key": "10_CR44", "doi-asserted-by": "crossref", "first-page": "584", "DOI": "10.1002/cpt1979265584", "volume": "26", "author": "N.M. Woolhouse", "year": "1979", "unstructured": "Woolhouse, N.M., B. Andoh, A. Mahgoub, T.P. Sloan, J.R. Idle, and R.L. Smith (1979). Debrisoquin hydroxylation polymorphism among Ghanaians and Caucasians. Clin. Pharmacol. Ther. 26, 584\u2013591.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR45", "doi-asserted-by": "publisher", "first-page": "11825", "DOI": "10.1073/pnas.90.24.11825", "volume": "90", "author": "I. Johansson", "year": "1993", "unstructured": "Johansson, I., E. Lundqvist, L. Bertilsson, M.L. Dahl, F. Sjoqvist, and M. Ingelman Sundberg (1993). Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine. Proc. Natl. Acad. Sci. USA 90, 11825\u201311829.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR46", "doi-asserted-by": "publisher", "first-page": "943", "DOI": "10.1016/S0140-6736(78)90724-9", "volume": "i", "author": "R.L. Smith", "year": "1978", "unstructured": "Smith, R.L., J.R. Idle, A.A. Mahgoub, T.P. Sloan, and R. Lancaster (1978). Genetically determined defects of oxidation at carbon centres of drugs. Lancet i, 943\u2013944.", "journal-title": "Lancet"}, {"key": "10_CR47", "doi-asserted-by": "publisher", "first-page": "442", "DOI": "10.1038/331442a0", "volume": "331", "author": "F.J. Gonzalez", "year": "1988", "unstructured": "Gonzalez, F.J., R.C. Skoda, S. Kimura, M. Umeno, U.M. Zanger, D.W. Nebert et al. (1988). Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 331, 442\u2013446.", "journal-title": "Nature"}, {"key": "10_CR48", "doi-asserted-by": "crossref", "first-page": "402", "DOI": "10.1038/clpt.1985.194", "volume": "38", "author": "K. Nakamura", "year": "1985", "unstructured": "Nakamura, K., F. Goto, W.A. Ray, C.B. McAllister, E. Jacqz, G.R. Wilkinson et al. (1985). Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations. Clin. Pharmacol. Ther. 38, 402\u2013408.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR49", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1046/j.1472-8206.2003.00119.x", "volume": "17", "author": "A.K. Daly", "year": "2003", "unstructured": "Daly, A.K. (2003). Pharmacogenetics of the major polymorphic metabolizing enzymes. Fundam. Clin. Pharmacol. 17, 27\u201341.", "journal-title": "Fundam. Clin. Pharmacol."}, {"key": "10_CR50", "doi-asserted-by": "publisher", "first-page": "167", "DOI": "10.2133/dmpk.17.167", "volume": "17", "author": "K. Nagata", "year": "2002", "unstructured": "Nagata, K. and Y. Yamazoe (2002). Genetic polymorphism of human cytochrome P450 involved in drug metabolism. Drug Metab. Pharmacokinet. 17, 167\u2013189.", "journal-title": "Drug Metab. Pharmacokinet."}, {"key": "10_CR51", "doi-asserted-by": "publisher", "first-page": "193", "DOI": "10.1097/00008571-199606000-00001", "volume": "6", "author": "A.K. Daly", "year": "1996", "unstructured": "Daly, A.K., J. Brockm\u00f6ller, F. Broly, M. Eichelbaum, W.E. Evans, F.J. Gonzalez et al. (1996). Nomenclature for human CYP2D6 alleles. Pharmacogenetics 6, 193\u2013201.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR52", "first-page": "943", "volume": "48", "author": "A. Gaedigk", "year": "1991", "unstructured": "Gaedigk, A., M. Blum, R. Gaedigk, M. Eichelbaum, and U.A. Meyer (1991). Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism. Am. J. Hum. Genet. 48, 943\u2013950.", "journal-title": "Am. J. Hum. Genet."}, {"key": "10_CR53", "doi-asserted-by": "crossref", "first-page": "1260", "DOI": "10.1124/mol.60.6.1260", "volume": "60", "author": "J. Corchero", "year": "2001", "unstructured": "Corchero, J., C.P. Granvil, T.E. Akiyama, G.P. Hayhurst, S. Pimprale, L. Feigenbaum et al. (2001). The CYP2D6 humanized mouse: Effect of the human CYP2D6 transgene and HNF4\u03b1 on the disposition of debrisoquine in the mouse. Mol. Pharmacol. 60, 1260\u20131267.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR54", "first-page": "188", "volume": "57", "author": "E.G. Schuetz", "year": "2000", "unstructured": "Schuetz, E.G., D.R. Umbenhauer, K. Yasuda, C. Brimer, L. Nguyen, M.V. Relling et al. (2000). Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr 1 genes. Mol. Pharmacol. 57, 188\u2013197.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR55", "doi-asserted-by": "publisher", "first-page": "474", "DOI": "10.1067/mcp.2002.128388", "volume": "72", "author": "C.L. Cummins", "year": "2002", "unstructured": "Cummins, C.L., C.Y. Wu, and L.Z. Benet (2002). Sex-related differences in the clearance of cytochrome P450 3A4 substrates may be caused by P-glycoprotein. Clin. Pharmacol. Ther. 72, 474\u2013489.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR56", "doi-asserted-by": "crossref", "first-page": "777", "DOI": "10.1139/y90-119", "volume": "68", "author": "K.W. Renton", "year": "1990", "unstructured": "Renton, K.W. and L.C. Knickle (1990). Regulation of hepatic cytochrome P-450 during infectious disease. Can. J. Physiol. Pharmacol. 68, 777\u2013781.", "journal-title": "Can. J. Physiol. Pharmacol."}, {"key": "10_CR57", "doi-asserted-by": "publisher", "first-page": "661", "DOI": "10.1016/0378-4274(92)90245-F", "volume": "64/65", "author": "R. Kato", "year": "1992", "unstructured": "Kato, R. and Y. Yamazoe (1992). Sex-specific cytochrome P450 as a cause of sex-and species-related differences in drug toxicity. Toxicol. Lett. 64/65, 661\u2013667.", "journal-title": "Toxicol. Lett."}, {"key": "10_CR58", "doi-asserted-by": "publisher", "first-page": "4430", "DOI": "10.1021/bi00470a024", "volume": "29", "author": "M. Komori", "year": "1990", "unstructured": "Komori, M., K. Nishio, M. Kitada, K. Shiramatsu, K. Muroya, M. Soma et al. (1990). Fetus-specific expression of a form of cytochrome P-450 in human livers. Biochemistry 29, 4430\u20134433.", "journal-title": "Biochemistry"}, {"key": "10_CR59", "doi-asserted-by": "publisher", "first-page": "625", "DOI": "10.1111/j.1432-1033.1997.00625.x", "volume": "247", "author": "D. Lacroix", "year": "1997", "unstructured": "Lacroix, D., M. Sonnier, A. Moncion, G. Cheron, and T. Cresteil (1997). Expression of CYP3A in the human liver: Evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur. J. Biochem. 247, 625\u2013634.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR60", "doi-asserted-by": "publisher", "first-page": "131", "DOI": "10.1016/0163-7258(88)90115-5", "volume": "36", "author": "C.M. Loi", "year": "1988", "unstructured": "Loi, C.M. and R.E. Vestal (1988). Drug metabolism in the elderly. Pharmacol. Ther. 36, 131\u2013149.", "journal-title": "Pharmacol. Ther."}, {"key": "10_CR61", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.2165/00003088-199019050-00002", "volume": "19", "author": "C. Durnas", "year": "1990", "unstructured": "Durnas, C., C.M. Loi, and B.J. Cusack (1990). Hepatic drug metabolism and aging. Clin. Pharmacokinet. 19, 359\u2013389.", "journal-title": "Clin. Pharmacokinet."}, {"key": "10_CR62", "doi-asserted-by": "publisher", "first-page": "727", "DOI": "10.1016/0006-2952(95)00192-3", "volume": "50", "author": "J. George", "year": "1995", "unstructured": "George, J., K. Byth, and G.C. Farrell (1995). Age but not gender selectively affects expression of individual cytochrome P450 proteins in human liver. Biochem. Pharmacol. 50, 727\u2013730.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR63", "doi-asserted-by": "publisher", "first-page": "345", "DOI": "10.1124/dmd.31.4.345", "volume": "31", "author": "A.Y.H. Lu", "year": "2003", "unstructured": "Lu, A.Y.H., R.W. Wang, and J.H. Lin (2003). Cytochrome P450 in vitro reaction phenotyping: A re-evaluation of approaches used for P450 isoform identification. Drug Metab. Dispos. 31, 345\u2013350.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR64", "author": "M.A. Correia", "year": "2004", "unstructured": "Correia, M.A. and P.R. Ortiz de Montellano (2004, in press). Inhibition and degradation of cytochrome P450 enzymes. In P. R. Ortiz de Montellano (ed.), Cytochrome P450: Structure, Mechanism, and Biochemistry. Plenum Press, New York (Chap. 7 of this monograph).", "volume-title": "Cytochrome P450: Structure, Mechanism, and Biochemistry"}, {"key": "10_CR65", "author": "M.A. Correia", "year": "2004", "unstructured": "Correia, M.A. (2004, in press). Isoform functional markers, isoform substrate specificities, and fluorescent substrate assays. In P.R. Ortiz de Montellano (ed.), Cytochrome P450: Structure, Mechanism, and Biochemistry. Plenum Press, New York (Appendix of this monograph).", "volume-title": "Cytochrome P450: Structure, Mechanism, and Biochemistry"}, {"key": "10_CR66", "first-page": "4026", "volume": "54", "author": "J.W. Harris", "year": "1994", "unstructured": "Harris, J.W., A. Rahman, B.-R. Kim, F.P. Guengerich, and J.M. Collins (1994). Metabolism of taxol by human hepatic microsomes and liver slices: Participation of cytochrome P450 3A4 and of an unknown P450 enzyme. Cancer Res. 54, 4026\u20134035.", "journal-title": "Cancer Res"}, {"key": "10_CR67", "doi-asserted-by": "publisher", "first-page": "1441", "DOI": "10.1124/dmd.30.12.1441", "volume": "30", "author": "T.H. Tran", "year": "2002", "unstructured": "Tran, T.H., L.L. von Moltke, K. Venkatakrishnan, B.W. Granda, M.A. Gibbs, R.S. Obach et al. (2002). Microsomal protein concentration modifies the apparent inhibitory potency of CYP3A inhibitors. Drug Metab. Dispos. 30, 1441\u20131445.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR68", "doi-asserted-by": "publisher", "first-page": "1497", "DOI": "10.1124/dmd.30.12.1497", "volume": "30", "author": "R.P. Austin", "year": "2002", "unstructured": "Austin, R.P., P. Barton, S.L. Cockroft, M.C. Wenlock, and R.J. Riley (2002). The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties. Drug Metab. Dispos. 30, 1497\u20131503.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR69", "first-page": "3378", "volume": "47", "author": "J.S.H. Yoo", "year": "1987", "unstructured": "Yoo, J.S.H., R.J. Cheung, C.J. Patten, D. Wade, and C.S. Yang (1987). Nature of N-nitrosodimethylamine demethylase and its inhibitors. Cancer Res. 47, 3378\u20133383.", "journal-title": "Cancer Res"}, {"key": "10_CR70", "first-page": "1", "volume": "26", "author": "N. Chauret", "year": "1998", "unstructured": "Chauret, N., A. Gauthier, and D.A. Nicoll-Griffith (1998). Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes. Drug Metab. Dispos. 26, 1\u20134.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR71", "doi-asserted-by": "publisher", "first-page": "1311", "DOI": "10.1124/dmd.30.12.1311", "volume": "30", "author": "R. Yuan", "year": "2002", "unstructured": "Yuan, R., S. Madani, X.X. Wei, K. Reynolds, and S.M. Huang (2002). Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions. Drug Metab. Dispos. 30, 1311\u20131319.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR72", "first-page": "500", "volume": "33", "author": "F.P. Guengerich", "year": "1988", "unstructured": "Guengerich, F.P. (1988). Oxidation of 17\u03b1-ethynylestradiol by human liver cytochrome P-450. Mol. Pharmacol. 33, 500\u2013508.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR73", "doi-asserted-by": "publisher", "first-page": "7696", "DOI": "10.1073/pnas.86.20.7696", "volume": "86", "author": "M.A. Butler", "year": "1989", "unstructured": "Butler, M.A., M. Iwasaki, F.P. Guengerich, and F.F. Kadlubar (1989). Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. USA 86, 7696\u20137700.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR74", "doi-asserted-by": "publisher", "first-page": "7348", "DOI": "10.1073/pnas.81.23.7348", "volume": "81", "author": "L.M. Distlerath", "year": "1984", "unstructured": "Distlerath, L.M. and F.P. Guengerich (1984). Characterization of a human liver cytochrome P-450 involved in the oxidation of debrisoquine and other drugs using antibodies raised to the analogous rat enzyme. Proc. Natl. Acad. Sci. USA 81, 7348\u20137352.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR75", "doi-asserted-by": "publisher", "first-page": "16013", "DOI": "10.1021/bi00049a015", "volume": "34", "author": "P. Soucek", "year": "1995", "unstructured": "Soucek, P., M.V. Martin, Y.-F. Ueng, and F.P. Guengerich (1995). Identification of a common epitope near the conserved heme-binding region with polyclonal antibodies raised against cytochrome P450 family 2 proteins. Biochemistry 34, 16013\u201316021.", "journal-title": "Biochemistry"}, {"key": "10_CR76", "doi-asserted-by": "publisher", "first-page": "524", "DOI": "10.1016/0003-9861(79)90122-X", "volume": "192", "author": "P.E. Thomas", "year": "1979", "unstructured": "Thomas, P.E., D. Koreniowski, D. Ryan, and W. Levin (1979). Preparation of monospecific antibodies against two forms of rat liver cytochrome P-450 and quantitation of these antigens in microsomes. Arch. Biochem. Biophys. 192, 524\u2013532.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR77", "first-page": "1493", "volume": "28", "author": "K. Venkatakrishnan", "year": "2000", "unstructured": "Venkatakrishnan, K., L.L. von Moltke, M.H. Court, J.S. Harmatz, C.L. Crespi, and D.J. Greenblatt (2000). Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: Ratios of accessory proteins as sources of discrepancies between the approaches. Drug Metab. Dispos. 28, 1493\u20131504.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR78", "first-page": "326", "volume": "297", "author": "K. Venkatakrishnan", "year": "2001", "unstructured": "Venkatakrishnan, K., L.L. von Moltke, and D.J. Greenblatt (2001). Application of the relative activity factor approach in scaling from heterologously expressed cytochromes P450 to human liver microsomes: Studies on amitriptyline as a model substrate. J. Pharmacol. Exp. Ther. 297, 326\u2013337.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR79", "doi-asserted-by": "publisher", "first-page": "1149", "DOI": "10.1177/00912700122012724", "volume": "41", "author": "K. Venkatakrishnan", "year": "2001", "unstructured": "Venkatakrishnan, K., L.L. von Moltke, and D.J. Greenblatt (2001). Human drug metabolism and the cytochromes P450: Application and relevance of in vitro models. J. Clin. Pharmacol. 41, 1149\u20131179.", "journal-title": "J. Clin. Pharmacol."}, {"key": "10_CR80", "doi-asserted-by": "publisher", "first-page": "175", "DOI": "10.1046/j.1365-2125.2003.01721.x", "volume": "55", "author": "M.G. Soars", "year": "2003", "unstructured": "Soars, M.G., H.V. Gelboin, K.W. Krausz, and R.J. Riley (2003). A comparison of relative abundance, activity factor and inhibitory monoclonal antibody approaches in the characterization of human CYP enzymology. Br. J. Clin. Pharmacol. 55, 175\u2013181.", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "10_CR81", "doi-asserted-by": "publisher", "first-page": "285", "DOI": "10.1146/annurev.pharmtox.43.100901.140233", "volume": "43", "author": "M. Schwab", "year": "2003", "unstructured": "Schwab, M., M. Eichelbaum, and M.F. Fromm (2003). Genetic polymorphisms of the human mdr1 drug transporter. Annu. Rev. Pharmacol. Toxicol. 43, 285\u2013307.", "journal-title": "Annu. Rev. Pharmacol. Toxicol."}, {"key": "10_CR82", "doi-asserted-by": "publisher", "first-page": "116", "DOI": "10.1097/00008571-199206000-00003", "volume": "2", "author": "M.A. Butler", "year": "1992", "unstructured": "Butler, M.A., N.P. Lang, J.F. Young, N.E. Caporaso, P. Vineis, R.B. Hayes et al. (1992). Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics 2, 116\u2013127.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR83", "doi-asserted-by": "crossref", "first-page": "399", "DOI": "10.1111/j.1365-2125.1991.tb05552.x", "volume": "31", "author": "C.H. Ahsan", "year": "1991", "unstructured": "Ahsan, C.H., A.G. Renwick, B. Macklin, V.F. Challenor, D.G. Waller, and C.F. George (1991). Ethnic differences in the pharmacokinetics of oral nifedipine. Br. J. Clin. Pharmacol. 31, 399\u2013403.", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "10_CR84", "first-page": "4", "volume": "279", "author": "R.B. Kim", "year": "1996", "unstructured": "Kim, R.B., H. Yamazaki, M. Mimura, T. Shimada, F.P. Guengerich, K. Chiba et al. (1996). Chlorzoxazone 6-hydroxylation in Japanese and Caucasians. In vitro and in vivo differences. J. Pharmacol. Exp. Ther. 279, 4\u201311.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR85", "first-page": "4875", "volume": "42", "author": "A.H. Conney", "year": "1982", "unstructured": "Conney, A.H. (1982). Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Res. 42, 4875\u20134917.", "journal-title": "Cancer Res"}, {"key": "10_CR86", "doi-asserted-by": "publisher", "first-page": "415", "DOI": "10.1126/science.1925598", "volume": "254", "author": "T.R. Sutter", "year": "1991", "unstructured": "Sutter, T.R., K. Guzman, K.M. Dold, and W.F. Greenlee (1991). Targets for dioxin: Genes for plasminogen activator inhibitor-2 and interleukin-1\u03b2. Science 254, 415\u2013418.", "journal-title": "Science"}, {"key": "10_CR87", "doi-asserted-by": "publisher", "first-page": "255", "DOI": "10.1124/mol.61.2.255", "volume": "61", "author": "S.P. Rivera", "year": "2002", "unstructured": "Rivera, S.P., S.T. Saarikoski, and O. Hankinson (2002). Identification of a novel dioxin-inducible cytochrome P450. Mol. Pharmacol. 61, 255\u2013259.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR88", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1136/bmj.284.6312.295", "volume": "284", "author": "R.R. Shah", "year": "1982", "unstructured": "Shah, R.R., N.S. Oates, J.R. Idle, R.L. Smith, and J.D.F. Lockhart (1982). Impaired oxidation of debrisoquine in patients with perhexiline neuropathy. Br. Med. J. 284, 295\u2013299.", "journal-title": "Br. Med. J."}, {"key": "10_CR89", "doi-asserted-by": "publisher", "first-page": "361", "DOI": "10.1097/00008571-199710000-00004", "volume": "7", "author": "D.J. Steward", "year": "1997", "unstructured": "Steward, D.J., R.L. Haining, K.R. Henne, G. Davis, T.H. Rushmore, W.F. Trager et al. (1997). Genetic association between sensitivity to warfarin and expression of CYP2C9*3. Pharmacogenetics 7, 361\u2013367.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR90", "doi-asserted-by": "publisher", "first-page": "717", "DOI": "10.1016/S0140-6736(98)04474-2", "volume": "353", "author": "G.P. Aithal", "year": "1999", "unstructured": "Aithal, G.P., C.P. Day, P.J. Kesteven, and A.K. Daly (1999). Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet 353, 717\u2013719.", "journal-title": "Lancet"}, {"key": "10_CR91", "doi-asserted-by": "publisher", "first-page": "408", "DOI": "10.1046/j.1365-2125.2002.01572_6.x", "volume": "53", "author": "A.K. Daly", "year": "2002", "unstructured": "Daly, A.K., C.P. Day, and G.P. Aithal (2002). CYP2C9 polymorphism and warfarin dose requirements. Brit. J. Clin. Pharmacol. 53, 408\u2013409.", "journal-title": "Brit. J. Clin. Pharmacol."}, {"key": "10_CR92", "first-page": "52", "volume": "266", "author": "K. Chiba", "year": "1993", "unstructured": "Chiba, K., K. Kobayashi, K. Manabe, M. Tani, T. Kamataki, and T. Ishizaki (1993). Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4\u2032-hydroxylation J. Pharmacol. Exp. Ther. 266, 52\u201359.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR93", "first-page": "1081", "volume": "24", "author": "W.G. Karam", "year": "1996", "unstructured": "Karam, W.G., J.A. Goldstein, J.M. Lasker, and B.I. Ghanayem (1996). Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes. Drug Metab. Dispos. 24, 1081\u20131087.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR94", "doi-asserted-by": "crossref", "first-page": "189", "DOI": "10.1530/acta.0.0850189", "volume": "85", "author": "H.M. Bolt", "year": "1977", "unstructured": "Bolt, H.M., M. Bolt, and H. Kappus (1977). Interaction of rifampicin treatment with pharmacokinetics and metabolism of ethinyloestradiol in man. Acta Endocrinol. 85, 189\u2013197.", "journal-title": "Acta Endocrinol"}, {"key": "10_CR95", "doi-asserted-by": "publisher", "first-page": "112", "DOI": "10.1046/j.1365-2125.2003.01716.x", "volume": "55", "author": "U.I. Schwarz", "year": "2003", "unstructured": "Schwarz, U.I., B. Buschel, and W. Kirch (2003). Unwanted pregnancy on self-medication with St. John\u2019s wort despite hormonal contraception. Br. J. Clin. Pharmacol. 55, 112\u2013113.", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "10_CR96", "author": "F.P. Guengerich", "first-page": "203", "year": "1999", "unstructured": "Guengerich, F.P. (1999). Inhibition of drug metabolizing enzymes: Molecular and biochemical aspects. In T. F. Woolf (ed.), Handbook of Drug Metabolism. Marcel Dekker, New York, pp. 203\u2013227.", "volume-title": "Handbook of Drug Metabolism", "DOI": "10.1201/b13995-9", "doi-asserted-by": "crossref"}, {"key": "10_CR97", "first-page": "357", "volume": "12", "author": "D.G. Bailey", "year": "1990", "unstructured": "Bailey, D.G., J.D. Spence, B. Edgar, C.D. Bayliff, and J.M.O. Arnold (1990). Ethanol enhances the hemodynamic effects of felodipine. Clin. Invest. Med. 12, 357\u2013362.", "journal-title": "Clin. Invest. Med."}, {"key": "10_CR98", "first-page": "181", "volume": "47", "author": "B. Edgar", "year": "1990", "unstructured": "Edgar, B., D.G. Bailey, R. Bergstrand, G. Johnsson, and L. Lurje (1990). Formulation dependent interaction between felodipine and grapefruit juice. Clin. Pharmacol. Ther. 47, 181.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR99", "doi-asserted-by": "publisher", "first-page": "252", "DOI": "10.1021/tx970192k", "volume": "11", "author": "K. He", "year": "1998", "unstructured": "He, K., R. Iyer, R.N. Hayes, M.W. Sinz, T.F. Woolf, and P.F. Hollenberg (1998). Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem. Res. Toxicol. 11, 252\u2013259.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR100", "first-page": "1228", "volume": "25", "author": "P. Schmiedlin-Ren", "year": "1997", "unstructured": "Schmiedlin-Ren, P., D.J. Edwards, M.E. Fitzsimmons, K. He, K.S. Lown, P.M. Woster et al. (1997). Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Drug Metab. Dispos. 25, 1228\u20131233.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR101", "first-page": "255", "volume": "25", "author": "D. Reimers", "year": "1971", "unstructured": "Reimers, D. and A. Jezek (1971). Rifampicin und andere antituberkulotika bei gleichzeitiger oraler kontrzeption. Przx. Pneumolonology 25, 255\u2013262.", "journal-title": "Przx. Pneumolonology"}, {"key": "10_CR102", "doi-asserted-by": "crossref", "first-page": "1521", "DOI": "10.1055/s-0028-1107071", "volume": "98", "author": "L. H. B. Nocke-Finck", "year": "1973", "unstructured": "Nocke-Finck, L. H. Brewer, and D. Reimers (1973). Wirkung van rifampicin auf den menstrationszylkus und die \u00f6strogenausscheidung bei einnahme oraler kontrazeptive. Deutsch. Med. Wochenschrifften 98, 1521\u20131523.", "journal-title": "Deutsch. Med. Wochenschrifften"}, {"key": "10_CR103", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.2165/00003088-199427010-00001", "volume": "27", "author": "K.T. Kivist\u00f6", "year": "1994", "unstructured": "Kivist\u00f6, K.T., P.J. Neuvonen, and U. Klotz (1994). Inhibition of terfenadine metabolism: Pharmacokinetic and pharmacodynamic consequences. Clin. Pharmacokinet. 27, 1\u20135.", "journal-title": "Clin. Pharmacokinet."}, {"key": "10_CR104", "doi-asserted-by": "publisher", "first-page": "1339", "DOI": "10.1001/jama.275.17.1339", "volume": "275", "author": "D. Thompson", "year": "1996", "unstructured": "Thompson, D. and G. Oster (1996). Use of terfenadine and contraindicated drugs. J. Am. Med. Assoc. 275, 1339\u20131341.", "journal-title": "J. Am. Med. Assoc."}, {"key": "10_CR105", "doi-asserted-by": "crossref", "first-page": "149", "DOI": "10.3109/00498258509045345", "volume": "15", "author": "T. Fischbach", "year": "1985", "unstructured": "Fischbach, T. and W. Lenk (1985). Additional routes in the metabolism of phenacetin. Xenobiotica 15, 149\u2013164.", "journal-title": "Xenobiotica"}, {"key": "10_CR106", "first-page": "287", "volume": "30", "author": "F.P. Guengerich", "year": "1986", "unstructured": "Guengerich, F.P., D. M\u00fcller-Enoch, and I.A. Blair (1986). Oxidation of quinidine by human liver cytochrome P-450. Mol. Pharmacol. 30, 287\u2013295.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR107", "author": "J.R. Halpert", "first-page": "21", "year": "1997", "unstructured": "Halpert, J.R. and F.P. Guengerich (1997). Enzyme inhibition and stimulation. In F. P. Guengerich (ed.), Biotransformation, Vol. 3, Comprehensive Toxicology. Elsevier Science Ltd., Oxford, pp. 21\u201335.", "volume-title": "Biotransformation, Vol. 3, Comprehensive Toxicology"}, {"key": "10_CR108", "first-page": "58", "volume": "290", "author": "L.E. Witherow", "year": "1999", "unstructured": "Witherow, L.E. and J.B. Houston (1999). Sigmoidal kinetics of CYP3A substrates: An approach for scaling dextromethorphan metabolism in hepatic microsomes and isolated hepatocytes to predict in vivo clearance in rat. J. Pharmacol. Exp. Ther. 290, 58\u201365.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR109", "doi-asserted-by": "publisher", "first-page": "1419", "DOI": "10.1126/science.7089530", "volume": "216", "author": "J.M. Lasker", "year": "1982", "unstructured": "Lasker, J.M., M.-T. Huang, and A.H. Conney (1982). In vivo activation of zoxazolamine metabolism by flavone. Science 216, 1419\u20131421.", "journal-title": "Science"}, {"key": "10_CR110", "first-page": "287", "volume": "277", "author": "C.A. Lee", "year": "1996", "unstructured": "Lee, C.A., J.H. Lillibridge, S.D. Nelson, and J.T. Slattery (1996). Effects of caffeine and theophylline on acetaminophen pharmacokinetics: P450 inhibition and activation. J. Pharmacol. Exp. Ther. 277, 287\u2013291.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR111", "first-page": "1043", "volume": "28", "author": "J.S. Ngui", "year": "2000", "unstructured": "Ngui, J.S., W. Tang, R.A. Stearns, M.G. Shou, R.R. Miller, Y. Zhang et al. (2000). Cytochrome P450 3A4-mediated interaction of diclofenac and quinidine. Drug Metab. Dispos. 28, 1043\u20131050.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR112", "doi-asserted-by": "publisher", "first-page": "841", "DOI": "10.1046/j.1432-1327.1999.00098.x", "volume": "259", "author": "A.B. Shapiro", "year": "1999", "unstructured": "Shapiro, A.B., K. Fox, P. Lam, and V. Ling (1999). Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Eur. J. Biochem. 259, 841\u2013850.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR113", "first-page": "535", "volume": "176", "author": "G.C. Mueller", "year": "1948", "unstructured": "Mueller, G.C. and J.A. Miller (1948). The metabolism of 4-dimethylaminoazobenzene by rat liver homogenates. J. Biol. Chem. 176, 535\u2013544.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR114", "first-page": "195", "volume": "187", "author": "D.J. Jollow", "year": "1973", "unstructured": "Jollow, D.J., J.R. Mitchell, W.Z. Potter, D.C. Davis, J.R. Gillette, and B.B. Brodie (1973). Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J. Pharmacol. Exp. Ther. 187, 195\u2013202.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR115", "doi-asserted-by": "publisher", "first-page": "321", "DOI": "10.1146/annurev.pa.22.040182.001541", "volume": "22", "author": "R.A. Neal", "year": "1982", "unstructured": "Neal, R.A. and J. Halpert (1982). Toxicology of thiono-sulfur compounds. Annu. Rev. Pharmacol. Toxicol. 22, 321\u2013339.", "journal-title": "Annu. Rev. Pharmacol. Toxicol."}, {"key": "10_CR116", "doi-asserted-by": "publisher", "first-page": "63", "DOI": "10.1126/science.6849116", "volume": "219", "author": "K.D. Wing", "year": "1983", "unstructured": "Wing, K.D., A.H. Glickman, and J.E. Casida (1983). Oxidative bioactivation of S-alkyl phosphorothiolate pesticides: Stereospecificity of profenofos insecticide activation. Science 219, 63\u201365.", "journal-title": "Science"}, {"key": "10_CR117", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.3109/10408448909017908", "volume": "20", "author": "D.W. Nebert", "year": "1989", "unstructured": "Nebert, D.W. (1989). The Ah locus: Genetic differences in toxicity, cancer, mutation, and birth defects Crit. Rev. Toxicol. 20, 153\u2013174.", "journal-title": "Crit. Rev. Toxicol."}, {"key": "10_CR118", "doi-asserted-by": "publisher", "first-page": "12063", "DOI": "10.1074/jbc.271.20.12063", "volume": "271", "author": "S.S.T. Lee", "year": "1996", "unstructured": "Lee, S.S.T., J.T.M. Buters, T. Pineau, P. Fernandez-Salguero, and F.J. Gonzalez (1996). Role of CYP2E1 in the hepatotoxicity of acetaminophen. J. Biol. Chem. 271, 12063\u201312067.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR119", "doi-asserted-by": "publisher", "first-page": "1977", "DOI": "10.1073/pnas.96.5.1977", "volume": "96", "author": "J.T.M. Buters", "year": "1999", "unstructured": "Buters, J.T.M., S. Sakai, T. Richter, T. Pineau, D.L. Alexander, \u00dc. Savas et al. (1999). Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas. Proc. Natl. Acad. Sci. USA 96, 1977\u20131982.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR120", "first-page": "6242", "volume": "243", "author": "D.W. Nebert", "year": "1968", "unstructured": "Nebert, D.W. and H.V. Gelboin (1968). Substrate-inducible microsomal arylhydroxylase in mammalian cell culture: Assay and properties of induced enzyme. J. Biol. Chem. 243, 6242\u20136249.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR121", "first-page": "327", "volume": "25", "author": "G. Kellerman", "year": "1973", "unstructured": "Kellerman, G., M. Luyten-Kellerman, and C.R. Shaw (1973). Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes. Am. J. Hum. Genet. 25, 327\u2013331.", "journal-title": "Am. J. Hum. Genet."}, {"key": "10_CR122", "doi-asserted-by": "crossref", "first-page": "934", "DOI": "10.1056/NEJM197311012891802", "volume": "298", "author": "G. Kellerman", "year": "1973", "unstructured": "Kellerman, G., C.R. Shaw, and M. Luyten-Kellerman (1973). Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N. Engl. J. Med. 298, 934\u2013937.", "journal-title": "N. Engl. J. Med."}, {"key": "10_CR123", "first-page": "2757", "volume": "41", "author": "B. Paigen", "year": "1981", "unstructured": "Paigen, B., E. Ward, A. Reilly, L. Houten, H.L. Gurtoo, J. Minowada et al. (1981). Seasonal variation of aryl hydrocarbon hydroxylase activity in human lymphocytes. Cancer Res. 41, 2757\u20132761.", "journal-title": "Cancer Res"}, {"key": "10_CR124", "first-page": "5030", "volume": "42", "author": "R.E. Kouri", "year": "1982", "unstructured": "Kouri, R.E., C.E. McKinney, D.J. Slomiany, D.R. Snodgrass, N.P. Wray, and T.L. McLemore (1982). Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res. 42, 5030\u20135037.", "journal-title": "Cancer Res"}, {"key": "10_CR125", "doi-asserted-by": "publisher", "first-page": "312", "DOI": "10.1097/00008571-199312000-00005", "volume": "3", "author": "C. Chang", "year": "1993", "unstructured": "Chang, C., D.R. Smith, V.S. Prasad, C.L. Sidman, D.W. Nebert, and A. Puga (1993). Ten nucleotide differences, five of which cause amino acid changes, are associated with the Ah receptor locus polymorphism of C57BL/6 and DBA/2 mice. Pharmacogenetics 3, 312\u2013321.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR126", "first-page": "911", "volume": "44", "author": "K.M. Dolwick", "year": "1993", "unstructured": "Dolwick, K.M., J.V. Schmidt, L.A. Carver, H.I. Swanson, and C.A. Bradfield (1993). Cloning and expression of a human Ah receptor cDNA. Mol. Pharmacol. 44, 911\u2013917.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR127", "doi-asserted-by": "publisher", "first-page": "S149", "DOI": "10.1097/00008571-199512001-00018", "volume": "5", "author": "Y. Fujii-Kuriyama", "year": "1995", "unstructured": "Fujii-Kuriyama, Y., M. Ema, J. Mimura, N. Matsushita, and K. Sogawa (1995). Polymporphic forms of the Ah receptor and induction of the CYP1A1 gene. Pharmacogenetics 5, S149\u2013S153.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR128", "doi-asserted-by": "publisher", "first-page": "151", "DOI": "10.1097/00008571-199506000-00003", "volume": "5", "author": "K. Kawajiri", "year": "1995", "unstructured": "Kawajiri, K., J. Watanabe, H. Eguchi, K. Nakachi, C. Kiyohara, and S. Hayashi (1995). Polymorphisms of human Ah receptor gene are not involved in lung cancer. Pharmacogenetics 5, 151\u2013158.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR129", "doi-asserted-by": "crossref", "first-page": "407", "DOI": "10.1093/oxfordjournals.jbchem.a123594", "volume": "110", "author": "S. Hayashi", "year": "1991", "unstructured": "Hayashi, S., J. Watanabe, K. Nakachi, and K. Kawajiri (1991). Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J. Biochem. (Tokyo) 110, 407\u2013411.", "journal-title": "J. Biochem. (Tokyo)"}, {"key": "10_CR130", "doi-asserted-by": "publisher", "first-page": "20", "DOI": "10.1097/00008571-199110000-00004", "volume": "1", "author": "T. Tefre", "year": "1991", "unstructured": "Tefre, T., D. Ryberg, A. Haugen, D.W. Nebert, V. Skaug, A. Brogger et al. (1991). Human CYP1A1 (cytochrome P1450) gene: Lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics 1, 20\u201325.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR131", "first-page": "485", "volume": "1", "author": "A. Hirvonen", "year": "1992", "unstructured": "Hirvonen, A., K. Husgafvel-Pursiainen, A. Karjalainen, S. Anttila, and H. Vainio (1992). Point-mutational Msp1 and Ile-Val polymorphisms closely linked in the CYP1A1 gene: Lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol. Biomarkers Prev. 1, 485\u2013489.", "journal-title": "Cancer Epidemiol. Biomarkers Prev."}, {"key": "10_CR132", "doi-asserted-by": "publisher", "first-page": "21", "DOI": "10.1097/00008571-199402000-00003", "volume": "4", "author": "P.J. Wedlund", "year": "1994", "unstructured": "Wedlund, P.J., S. Kimura, F.J. Gonzalez, and D.W. Nebert (1994). I462V mutation in the human CYP1A1 gene: Lack of correlation with either the Msp I 1.9kb (M2) allele or CYP1A1 inducibility in a three-generation family of East Mediterranean descent. Pharmacogenetics 4, 21\u201326.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR133", "first-page": "3926", "volume": "56", "author": "Z.-Y. Zhang", "year": "1996", "unstructured": "Zhang, Z.-Y., M.J. Fasco, L. Huang, F.P. Guengerich, and L.S. Kaminsky (1996). Characterization of purified recombinant human CYP 1A1-Ile462 and Val462: Assessment of a role for the rare allele in carcinogenesis. Cancer Res. 56, 3926\u20133933.", "journal-title": "Cancer Res"}, {"key": "10_CR134", "doi-asserted-by": "publisher", "first-page": "227", "DOI": "10.1006/bbrc.1997.6051", "volume": "231", "author": "I. Persson", "year": "1997", "unstructured": "Persson, I., I. Johansson, and M. Ingelman-Sundberg (1997). In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility. Biochem. Biophys. Res. Commun. 231, 227\u2013230.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR135", "first-page": "219", "volume": "12", "author": "K. Toide", "year": "2003", "unstructured": "Toide, K., H. Yamazaki, R. Nagashima, K. Itoh, S. Iwano, Y. Takahashi et al. (2003). Aryl hydrocarbon hydroxylase represents CYP1B1, and not CYP1A1, in human freshly isolated white cells: Trimodal distribution of Japaneses population according to induction of CYP1B1 mRNA by environmental dioxins. Cancer Epidemiol. Biomarkers Prev. 12, 219\u2013222.", "journal-title": "Cancer Epidemiol. Biomarkers Prev."}, {"key": "10_CR136", "doi-asserted-by": "crossref", "first-page": "365", "DOI": "10.1289/ehp.98106365", "volume": "106", "author": "F.P. Guengerich", "year": "1998", "unstructured": "Guengerich, F.P. (1998). The environmental genome project: Functional analysis of polymorphisms. Environ. Health Perspect. 106, 365\u2013368.", "journal-title": "Environ. Health Perspect."}, {"key": "10_CR137", "doi-asserted-by": "publisher", "first-page": "169", "DOI": "10.1038/312169a0", "volume": "312", "author": "R. Ayesh", "year": "1984", "unstructured": "Ayesh, R., J.R. Idle, J.C. Ritchie, M.J. Crothers, and M.R. Hetzel (1984). Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature 312, 169\u2013170.", "journal-title": "Nature"}, {"key": "10_CR138", "doi-asserted-by": "crossref", "first-page": "149", "DOI": "10.3109/13547509609079352", "volume": "1", "author": "A. d\u2019Errico", "year": "1996", "unstructured": "d\u2019Errico, A., E. Taioli, X. Chen, and P. Vineis (1996). Genetic metabolic polymorphisms and the risk of cancer: A review of the literature. BioMarkers 1, 149\u2013173.", "journal-title": "BioMarkers"}, {"key": "10_CR139", "first-page": "5284", "volume": "51", "author": "T. Shimada", "year": "1991", "unstructured": "Shimada, T. and F.P. Guengerich (1991). Activation of amino-\u03b1-carboline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and a copper phthalo-cyanine cellulose extract of cigarette smoke condensate by cytochrome P-450 enzymes in rat and human liver microsomes. Cancer Res. 51, 5284\u20135291.", "journal-title": "Cancer Res"}, {"key": "10_CR140", "doi-asserted-by": "publisher", "first-page": "457", "DOI": "10.1016/S0300-483X(02)00450-X", "volume": "181", "author": "P. Vineis", "year": "2002", "unstructured": "Vineis, P. (2002). The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicology 181, 457\u2013462.", "journal-title": "Toxicology"}, {"key": "10_CR141", "doi-asserted-by": "publisher", "first-page": "573", "DOI": "10.1086/301764", "volume": "62", "author": "I. Stoilov", "year": "1998", "unstructured": "Stoilov, I., A.N. Akarsu, I. Alozie, A. Child, M. Barsoum-Homsy, M.E. Turacli et al. (1998). Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. Am. J. Hum. Genet. 62, 573\u2013584.", "journal-title": "Am. J. Hum. Genet."}, {"key": "10_CR142", "doi-asserted-by": "publisher", "first-page": "163", "DOI": "10.1080/00498250110043490", "volume": "31", "author": "T. Shimada", "year": "2001", "unstructured": "Shimada, T., J. Watanabe, F.P. Guengerich, K. Inoue, and E.M.J. Gillam (2001). Specificity of 17\u03b2-oestradiol and benzo[a]pyrene oxidation by polymorphic human cytochrome P450 1B1 variants substituted at residues 48, 119, and 432. Xenobiotica 31, 163\u2013176.", "journal-title": "Xenobiotica"}, {"key": "10_CR143", "doi-asserted-by": "publisher", "first-page": "25", "DOI": "10.1097/00008571-200002000-00004", "volume": "10", "author": "J. Watanabe", "year": "2000", "unstructured": "Watanabe, J., T. Shimada, E.M.J. Gillam, T. Ikuta, K. Suemasu, Y. Higashi et al. (2000). Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics 10, 25\u201333.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR144", "first-page": "147", "volume": "9", "author": "W. Zheng", "year": "2000", "unstructured": "Zheng, W., DW. Xie, F. Jin, J.R. Cheng, Q. Dai, W.Q. Wen et al. (2000). Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 9, 147\u2013150.", "journal-title": "Cancer Epidemiol. Biomarkers Prev."}, {"key": "10_CR145", "first-page": "675", "volume": "3", "author": "N.P. Lang", "year": "1994", "unstructured": "Lang, N.P., M.A. Butler, J. Massengill, M. Lawson, R.C. Stotts, M. Maurer-Jensen et al. (1994). Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps Cancer Epidemiol. Biomarkers Prev. 3, 675\u2013682.", "journal-title": "Cancer Epidemiol. Biomarkers Prev."}, {"key": "10_CR146", "first-page": "3218", "volume": "49", "author": "T. Shimada", "year": "1989", "unstructured": "Shimada, T., M. Iwasaki, M.V. Martin, and F.P. Guengerich (1989). Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA1535/pSK1002. Cancer Res. 49, 3218\u20133228.", "journal-title": "Cancer Res"}, {"key": "10_CR147", "first-page": "890", "volume": "11", "author": "N. Ariyoshi", "year": "2002", "unstructured": "Ariyoshi, N., M. Miyamoto, Y. Umetsu, H. Kunitoh, H. Dosaka-Akita, Y. Sawamura et al. (2002). Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers. Cancer Epidemiol. Biomarkers Prev. 11, 890\u2013894.", "journal-title": "Cancer Epidemiol. Biomarkers Prev."}, {"key": "10_CR148", "doi-asserted-by": "publisher", "first-page": "750", "DOI": "10.1038/31623", "volume": "393", "author": "M.L. Pianezza", "year": "1998", "unstructured": "Pianezza, M.L., E.M. Sellers, and R.F. Tyndale (1998). Nicotine metabolism defect reduces smoking. Nature 393, 750.", "journal-title": "Nature"}, {"key": "10_CR149", "doi-asserted-by": "publisher", "first-page": "162", "DOI": "10.1097/00008571-199406000-00008", "volume": "4", "author": "R.B. Kim", "year": "1994", "unstructured": "Kim, R.B., D. O\u2019Shea, and G.R. Wilkinson (1994). Relationship in healthy subjects between CYP2E1 genetic polymorphism and the 6-hydroxylation of chlorozoxazone: A putative measure of CYP2E1 activity. Pharmacogenetics 4, 162\u2013165.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR150", "doi-asserted-by": "crossref", "first-page": "485", "DOI": "10.3109/03602539308993983", "volume": "25", "author": "C. Ioannides", "year": "1993", "unstructured": "Ioannides, C. and D.V. Parke (1993). Induction of cytochrome P4501 as an indicator of potential chemical carcinogenesis. Drug Metab. Rev. 25, 485\u2013501.", "journal-title": "Drug Metab. Rev."}, {"key": "10_CR151", "unstructured": "Rice, J.M., B.A. Diwan, J.M. Ward, R.W. Nims, and R.A. Lubet (1992). Phenobarbital and related compounds: Approaches to interspecies extrapolation. In Relevance of Animal Studies to the Evaluation of Human Cancer Risk. Wiley-Liss, Inc., pp. 231\u2013249."}, {"key": "10_CR152", "doi-asserted-by": "publisher", "first-page": "803", "DOI": "10.1093/jnci/81.10.803", "volume": "81", "author": "J.H. Olsen", "year": "1989", "unstructured": "Olsen, J.H., J.D. Boice Jr., J.P.A. Jensen and J.F. Fraumeni Jr. (1989). Cancer among epileptic patients exposed to anticonvulsant drugs. J. Natl. Cancer Inst. 81, 803\u2013808.", "journal-title": "J. Natl. Cancer Inst."}, {"key": "10_CR153", "doi-asserted-by": "publisher", "first-page": "170", "DOI": "10.1006/rtph.1994.1068", "volume": "20", "author": "W.M. Kluwe", "year": "1994", "unstructured": "Kluwe, W.M. (1994). The relevance of hepatic peroxisome proliferation in rats to assessment of human carcinogenic risk for pharmaceuticals. Regul. Toxicol. Pharmacol. 20, 170\u2013186.", "journal-title": "Regul. Toxicol. Pharmacol."}, {"key": "10_CR154", "doi-asserted-by": "crossref", "first-page": "1189", "DOI": "10.1124/mol.60.6.1189", "volume": "60", "author": "R.S. Thomas", "year": "2001", "unstructured": "Thomas, R.S., D.R. Rank, S.G. Penn, G.M. Zastrow, K.R. Hayes, K. Pande et al. (2001). Identification of toxicologically predictive gene sets using cDNA microarrays. Mol. Pharmacol. 60, 1189\u20131194.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR155", "first-page": "4315", "volume": "50", "author": "C.J. Omiecinski", "year": "1990", "unstructured": "Omiecinski, C.J., C.A. Redlich, and P. Costa (1990). Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues: Detection by the polymerase chain reaction. Cancer Res. 50, 4315\u20134321.", "journal-title": "Cancer Res"}, {"key": "10_CR156", "doi-asserted-by": "crossref", "first-page": "426", "DOI": "10.1111/j.1349-7006.1991.tb01866.x", "volume": "82", "author": "M. Kitada", "year": "1991", "unstructured": "Kitada, M., M. Taneda, K. Itahashi, and T. Kamataki (1991). Four forms of cytochrome P-450 in human fetal liver: Purification and their capacity to activate promutagens. Jpn. J. Cancer Res. 82, 426\u2013432.", "journal-title": "Jpn. J. Cancer Res."}, {"key": "10_CR157", "doi-asserted-by": "crossref", "first-page": "305", "DOI": "10.3109/03602539409029800", "volume": "26", "author": "M. Kitada", "year": "1994", "unstructured": "Kitada, M. and T. Kamataki (1994). Cytochrome P450 in human fetal liver: Significance and fetal-specific expression. Drug Metab. Rev. 26, 305\u2013323.", "journal-title": "Drug Metab. Rev."}, {"key": "10_CR158", "doi-asserted-by": "publisher", "first-page": "130", "DOI": "10.1006/abbi.2001.2323", "volume": "389", "author": "N. Liu", "year": "2001", "unstructured": "Liu, N., Q.Y. Zhang, D. Vakharia, D. Dunbar, and L.S. Kaminsky (2001). Induction of CYP1A by benzo[k]fluoranthene in human hepatocytes: CYP1A1 or CYP1A2?. Arch. Biochem. Biophys. 389, 130\u2013134.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR159", "doi-asserted-by": "publisher", "first-page": "261", "DOI": "10.1016/0003-9861(86)90116-5", "volume": "244", "author": "J.B. Fagan", "year": "1986", "unstructured": "Fagan, J.B., J.V. Pastewka, S.R. Chalberg, E. Gozukara, F.P. Guengerich, and H.V. Gelboin (1986). Noncoordinate regulation of the mRNAs encoding cytochromes P-450BNF/MC-B and p-450ISF/BNF-G. Arch. Biochem. Biophys. 244, 261\u2013272.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR160", "unstructured": "Kim, J.H., M.E. Sherman, F.C. Curreiro, F.P. Guengerich, P.T. Strickland, and T.R. Sutter (2004, in press). Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers. Toxicol. Appl. Pharmacol.", "DOI": "10.1016/j.taap.2003.11.015", "doi-asserted-by": "crossref"}, {"key": "10_CR161", "doi-asserted-by": "publisher", "first-page": "1629", "DOI": "10.1016/0024-3205(77)90241-7", "volume": "21", "author": "R.A. Prough", "year": "1977", "unstructured": "Prough, R.A., Z. Sipal, and S.W. Jakobsson (1977). Metabolism of benzo(a)pyrene by human lung microsomal fractions. Life Sci. 21, 1629\u20131636.", "journal-title": "Life Sci"}, {"key": "10_CR162", "first-page": "3916", "volume": "44", "author": "T. Fujino", "year": "1984", "unstructured": "Fujino, T., K. Gottlieb, D.K. Manchester, S.S. Park, D. West, H.L. Gurtoo et al. (1984). Monoclonal antibody phenotyping of interindividual differences in cytochrome P-450-dependent reactions of single and twin human placenta. Cancer Res. 44, 3916\u20133923.", "journal-title": "Cancer Res"}, {"key": "10_CR163", "doi-asserted-by": "publisher", "first-page": "1031", "DOI": "10.1126/science.7375915", "volume": "208", "author": "K. Robie-Suh", "year": "1980", "unstructured": "Robie-Suh, K., R. Robinson, H.V. Gelboin, and F.P. Guengerich (1980). Aryl hydrocarbon hydroxylase is inhibited by antibody to rat liver cytochrome P-450. Science 208, 1031\u20131033.", "journal-title": "Science"}, {"key": "10_CR164", "first-page": "515", "volume": "24", "author": "T. Shimada", "year": "1996", "unstructured": "Shimada, T., H. Yamazaki, M. Mimura, N. Wakamiya, F.P. Guengerich, and Y. Inui (1996). Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal livers and adult lungs. Drug Metab. Dispos. 24, 515\u2013522.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR165", "doi-asserted-by": "publisher", "first-page": "1333", "DOI": "10.1093/jnci/82.16.1333", "volume": "82", "author": "T.L. McLemore", "year": "1990", "unstructured": "McLemore, T.L., S. Adelberg, M.C. Liu, N.A. McMahon, S.J. Yu, W.C. Hubbard et al. (1990). Expression of CYP1A1 gene in patients with lung cancer: Evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J. Natl. Cancer Inst. 82, 1333\u20131339.", "journal-title": "J. Natl. Cancer Inst."}, {"key": "10_CR166", "doi-asserted-by": "publisher", "first-page": "741", "DOI": "10.1097/00008571-200011000-00008", "volume": "10", "author": "S. Anttila", "year": "2000", "unstructured": "Anttila, S., X.D. Lei, E. Elovaara, A. Karjalainen, W.M. Sun, H. Vainio et al. (2000). An uncommon phenotype of poor inducibility of CYP1A1 in human lung is not ascribable to polymorphisms in the AHR, ARNT, or CYP1A1 genes. Pharmacogenetics 10, 741\u2013751.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR167", "doi-asserted-by": "publisher", "first-page": "501", "DOI": "10.1097/00008571-200108000-00005", "volume": "11", "author": "S. Anttila", "year": "2001", "unstructured": "Anttila, S., P. Tuominen, A. Hirvonen, M. Nurminen, A. Karjalainen, O. Hankinson et al. (2001). CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptor. Pharmacogenetics 11, 501\u2013509.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR168", "author": "C.A. Bradfield", "year": "2004", "unstructured": "Bradfield, C.A. (2004, in press). Induction of P450 enzymes: Receptors. In P.R. Ortiz De Montellano (ed.), Cytochrome P450: Structure, Mechanism, and Biochemistry, Plenum, New York (Chap. 8 of this monograph).", "volume-title": "Cytochrome P450: Structure, Mechanism, and Biochemistry"}, {"key": "10_CR169", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1289/ehp.877679", "volume": "76", "author": "G.W. Lucier", "year": "1987", "unstructured": "Lucier, G.W., K.G. Nelson, R.B. Everson, T.K. Wong, R.M. Philpot, T. Tiernan et al. (1987). Placental markers of human exposure to polycholrinated biphenyls and polychlorinated dibenzofurans. Environ. Health Perspect. 76, 79\u201387.", "journal-title": "Environ. Health Perspect."}, {"key": "10_CR170", "doi-asserted-by": "crossref", "first-page": "737", "DOI": "10.1016/0016-5085(90)90963-2", "volume": "99", "author": "D. Diaz", "year": "1990", "unstructured": "Diaz, D., I. Fabre, M. Daujat, B. Saintaubert, P. Bories, H. Michel et al. (1990). Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome-P450. Gastroenterology 99, 737\u2013747.", "journal-title": "Gastroenterology"}, {"key": "10_CR171", "first-page": "1868", "volume": "52", "author": "C.-H. Yun", "year": "1992", "unstructured": "Yun, C.-H., T. Shimada, and F.P. Guengerich (1992). Roles of human liver cytochrome P-4502C and 3A enzymes in the 3-hydroxylation of benzo[a]pyrene. Cancer Res. 52, 1868\u20131874.", "journal-title": "Cancer Res"}, {"key": "10_CR172", "doi-asserted-by": "crossref", "first-page": "372", "DOI": "10.1016/S0076-6879(78)52041-7", "volume": "52", "author": "R.A. Prough", "year": "1978", "unstructured": "Prough, R.A., M.D. Burke, and R.T. Mayer (1978). Direct fluorometric methods for measuring mixed-function oxidase activity. Meth. Enzymol. 52, 372\u2013377.", "journal-title": "Meth. Enzymol."}, {"key": "10_CR173", "doi-asserted-by": "publisher", "first-page": "436", "DOI": "10.1006/abbi.1994.1330", "volume": "312", "author": "Z. Guo", "year": "1994", "unstructured": "Guo, Z., E.M.J. Gillam, S. Ohmori, R.H. Tukey, and F.P. Guengerich (1994). Expression of modified human cytochrome P450 1A1 in Escherichia coli: Effects of 5\u2032 substitution, stabilization, purification, spectral characterization, and catalytic properties. Arch. Biochem. Biophys. 312, 436\u2013446.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR174", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1002/mc.2940100307", "volume": "10", "author": "M. Shou", "year": "1994", "unstructured": "Shou, M., K.R. Korzekwa, C.L. Crespi, F.J. Gonzalez, and H.V. Gelboin (1994). The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene rans-7,8-dihydrodiol. Mol. Carcinogen. 10, 159\u2013168.", "journal-title": "Mol. Carcinogen."}, {"key": "10_CR175", "doi-asserted-by": "publisher", "first-page": "136", "DOI": "10.1021/tx00043a018", "volume": "8", "author": "E. Bauer", "year": "1995", "unstructured": "Bauer, E., Z. Guo, Y.-F. Ueng, L.C. Bell, and F.P. Guengerich (1995). Oxidation of benzo[a]pyrene by recombinant human cytochrome P450 enzymes. Chem. Res. Toxicol. 8, 136\u2013142.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR176", "doi-asserted-by": "publisher", "first-page": "201", "DOI": "10.1006/abbi.1996.0161", "volume": "328", "author": "M. Shou", "year": "1996", "unstructured": "Shou, M., K.W. Krausz, F.J. Gonzalez, and H.V. Gelboin (1996). Metabolic activation of the potent carcinogen dibenzo[a,h]anthracene by cDNA-expressed human cytochromes P450. Arch. Biochem. Biophys. 328, 201\u2013207.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR177", "doi-asserted-by": "publisher", "first-page": "2429", "DOI": "10.1093/carcin/17.11.2429", "volume": "17", "author": "M. Shou", "year": "1996", "unstructured": "Shou, M., K.W. Krausz, F.J. Gonzalez, and H.V. Gelboin (1996). Metabolic activation of the potent carcinogen dibenzo[a,l]pyrene by human recombinant cytochromes P450, lung and liver microsomes. Carcinogenesis 17, 2429\u20132433.", "journal-title": "Carcinogenesis"}, {"key": "10_CR178", "first-page": "2979", "volume": "56", "author": "T. Shimada", "year": "1996", "unstructured": "Shimada, T., C.L. Hayes, H. Yamazaki, S. Amin, S.S. Hecht, F.P. Guengerich et al. (1996). Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Res. 56, 2979\u20132984.", "journal-title": "Cancer Res"}, {"key": "10_CR179", "doi-asserted-by": "publisher", "first-page": "610", "DOI": "10.1016/0006-291X(85)90460-7", "volume": "130", "author": "S.K. Balani", "year": "1985", "unstructured": "Balani, S.K., H.J.C. Yeh, D.E. Ryan, P.E. Thomas, W. Levin, and D.M. Jerina (1985). Absolute configuration of the 5,6-oxide formed from 7,12-dimethylbenz[a]anthracene by cytochrome P450c. Biochem. Biophys. Res. Commun. 130, 610\u2013616.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR180", "doi-asserted-by": "publisher", "first-page": "53", "DOI": "10.1016/S0300-483X(99)00098-0", "volume": "139", "author": "D.F.V. Lewis", "year": "1999", "unstructured": "Lewis, D.F.V., B.G. Lake, S.G. George, M. Dickins, P.J. Eddershaw, M.H. Tarbit et al. (1999). Molecular modeling of CYP family enzymes CYP1A1, CYP1A2, CYP1A6, and CYP1B1 based on sequence homology with CYP102. Toxicology 139, 53\u201379.", "journal-title": "Toxicology"}, {"key": "10_CR181", "doi-asserted-by": "publisher", "first-page": "1048", "DOI": "10.1021/tx980090+", "volume": "11", "author": "T. Shimada", "year": "1998", "unstructured": "Shimada, T., H. Yamazaki, M. Foroozesch, N.E. Hopkins, W.L. Alworth, and F.P. Guengerich (1998). Selectivity of polycyclic inhibitors for human cytochromes P450 1A1, 1A2, and 1B1. Chem. Res. Toxicol. 11, 1048\u20131056.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR182", "first-page": "3367", "volume": "50", "author": "M.E. McManus", "year": "1990", "unstructured": "McManus, M.E., W.M. Burgess, M.E. Veronese, A. Huggett, L.C. Quattrochi, and R.H. Tukey (1990). Metabolism of 2-acetylaminofluorene and benzo[a]pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. Cancer Res. 50, 3367\u20133376.", "journal-title": "Cancer Res"}, {"key": "10_CR183", "doi-asserted-by": "publisher", "first-page": "350", "DOI": "10.1006/bbrc.1995.1668", "volume": "210", "author": "M.G. Mercurio", "year": "1995", "unstructured": "Mercurio, M.G., S.J. Shiff, R.A. Galbraith, and S. Sassa (1995). Expression of cytochrome P450 mRNAs in the colon and the rectum in normal human subjects. Biochem. Biophys. Res. Commun. 210, 350\u2013355.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR184", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1002/cpt19741519", "volume": "15", "author": "E.J. Pantuck", "year": "1974", "unstructured": "Pantuck, E.J., K.-C. Hsiao, A. Maggio, K. Nakamura, R. Kuntzman, and A.H. Conney (1974). Effect of cigarette smoking on phenacetin metabolism. Clin. Pharmacol. Ther. 15, 9\u201317.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR185", "doi-asserted-by": "publisher", "first-page": "72", "DOI": "10.1126/science.161.3836.72", "volume": "161", "author": "E.S. Vesell", "year": "1968", "unstructured": "Vesell, E.S. and J.G. Page (1968). Genetic control of drug levels in man: Antipyrine. Science 161, 72\u201373.", "journal-title": "Science"}, {"key": "10_CR186", "doi-asserted-by": "publisher", "first-page": "473", "DOI": "10.1097/00008571-200208000-00008", "volume": "12", "author": "B.B. Rasmussen", "year": "2002", "unstructured": "Rasmussen, B.B., T.H. Brix, K.O. Kyvik, and K. Br\u00f8sen (2002). The interindividual differences in the 3-demethylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharmacogenetics 12, 473\u2013478.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR187", "doi-asserted-by": "publisher", "first-page": "23", "DOI": "10.1016/j.abb.2003.11.019", "volume": "422", "author": "H. Zhou", "year": "2004", "unstructured": "Zhou, H., P.D. Josephy, D. Kim, and F.P. Guengerich (2004). Functional characterization of four allelic variants of human cytochrome P450 1A2. Arch. Bioch. Biophys. 422, 23\u201330.", "journal-title": "Arch. Bioch. Biophys."}, {"key": "10_CR188", "doi-asserted-by": "crossref", "first-page": "503", "DOI": "10.1038/clpt.1993.63", "volume": "53", "author": "W. Kalow", "year": "1993", "unstructured": "Kalow, W. and B.K. Tang (1993). The use of caffeine for enzyme assays: A critical appraisal. Clin. Pharmacol. Ther. 53, 503\u2013514.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR189", "first-page": "6949", "volume": "269", "author": "L.C. Quattrochi", "year": "1994", "unstructured": "Quattrochi, L.C., T. Vu, and R.H. Tukey (1994). The human CYP1A2 gene and induction by 3-methylcholanthrene: A region of DNA that supports Ah-receptor binding and promoter-specific induction. J. Biol. Chem. 269, 6949\u20136954.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR190", "doi-asserted-by": "publisher", "first-page": "945", "DOI": "10.1124/jpet.102.039982", "volume": "303", "author": "S.R. Kondraganti", "year": "2002", "unstructured": "Kondraganti, S.R., W.W. Jiang, and B. Moorthy (2002). Differential regulation of expression of hepatic and pulmonary cytochrome P4501A enzymes by 3-methylcholanthrene in mice lacking the CYP1A2 gene. J. Pharmacol. Exp. Ther. 303, 945\u2013951.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR191", "first-page": "4388", "volume": "256", "author": "G.J. Fisher", "year": "1981", "unstructured": "Fisher, G.J., H. Fukushima, and J.L. Gaylor (1981). Isolation, purification, and properties of a unique form of cytochrome P-450 in microsomes of isosafrole-treated rats. J. Biol. Chem. 256, 4388\u20134394.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR192", "doi-asserted-by": "publisher", "first-page": "1561", "DOI": "10.1093/carcin/13.9.1561", "volume": "13", "author": "K. Vistisen", "year": "1992", "unstructured": "Vistisen, K., H.E. Poulsen, and S. Loft (1992). Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine. Carcinogenesis 13, 1561\u20131568.", "journal-title": "Carcinogenesis"}, {"key": "10_CR193", "doi-asserted-by": "crossref", "first-page": "170", "DOI": "10.1038/clpt.1992.126", "volume": "52", "author": "K.L. Rost", "year": "1992", "unstructured": "Rost, K.L., H. Br\u00f6sicke, J. Brockm\u00f6ller, M. Scheffler, H. Helg, and I. Roots (1992). Increase of cytochrome P450IA2 activity by omeprazole: Evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin. Clin. Pharmacol. Ther. 52, 170\u2013180.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR194", "doi-asserted-by": "crossref", "first-page": "759", "DOI": "10.1096/fasebj.6.2.1537466", "volume": "6", "author": "C.W. Fisher", "year": "1992", "unstructured": "Fisher, C.W., D.L. Caudle, C. Martin-Wixtrom, L.C. Quattrochi, R.H. Tukey, M.R. Waterman et al. (1992). High-level expression of functional cytochrome P450 1A2 in Escherichia coli, FASEB J. 6, 759\u2013764.", "journal-title": "FASEB J"}, {"key": "10_CR195", "doi-asserted-by": "publisher", "first-page": "168", "DOI": "10.1006/abbi.1994.1099", "volume": "309", "author": "P. Sandhu", "year": "1994", "unstructured": "Sandhu, P., Z. Guo, T. Baba, M.V. Martin, R.H. Tukey, and F.P. Guengerich (1994). Expression of modified human cytochrome P450 1A2 in Escherichia coli: Stabilization, purification, spectral characterization, and catalytic activities of the enzyme. Arch. Biochem. Biophys. 309, 168\u2013177.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR196", "doi-asserted-by": "publisher", "first-page": "511", "DOI": "10.1021/tx00034a019", "volume": "6", "author": "C.J. Patten", "year": "1993", "unstructured": "Patten, C.J., P.E. Thomas, R.L. Guy, M. Lee, F.J. Gonzalez, F.P. Guengerich et al. (1993). Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem. Res. Toxicol. 6, 511\u2013518.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR197", "doi-asserted-by": "publisher", "first-page": "613", "DOI": "10.1016/S0009-9236(96)90001-6", "volume": "59", "author": "G. Engel", "year": "1996", "unstructured": "Engel, G., U. Hofmann, H. Heidemann, J. Cosme, and M. Eichelbaum (1996). Antipyrine as a probe for human oxidative drug metabolism: Identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation. Clin. Pharmacol. Ther. 59, 613\u2013623.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR198", "first-page": "568", "volume": "46", "author": "H. Yamazaki", "year": "1994", "unstructured": "Yamazaki, H., Z. Guo, M. Persmark, M. Mimura, F.J. Gonzalez, C. Sugahara et al. (1994). Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes. Mol. Pharmacol. 46, 568\u2013577.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR199", "first-page": "116", "volume": "3", "author": "F. Berthou", "year": "1993", "unstructured": "Berthou, F., V. Carriere, D. Ratanasavanh, T. Goasduff, F. Morel, J.C. Gautier et al. (1993). On the specificity of chlorozoxazone as drug probe of cytochrome P4502E1. In Abstracts, 5th European ISSX Meeting, Vol. 3. p. 116, 26\u201329 September, Tours, France.", "journal-title": "Abstracts, 5th European ISSX Meeting"}, {"key": "10_CR200", "first-page": "139", "volume": "4", "author": "T.F. Woolf", "year": "1993", "unstructured": "Woolf, T.F., W.F. Pool, M. Kukan, S. Bezek, K. Kunze, and W.F. Trager (1993). Characterization of tacrine metabolism and bioactivation using heterologous expression systems and inhibition studies: Evidence for CYP1A2 involvement. In Abstracts, 5th North American ISSX Meeting, Vol. 4, p. 139, 17\u201321 October, Tucson, AZ.", "journal-title": "Abstracts, 5th North American ISSX Meeting"}, {"key": "10_CR201", "doi-asserted-by": "publisher", "first-page": "423", "DOI": "10.1016/S0006-2952(96)00713-7", "volume": "53", "author": "G.G. Benoit", "year": "1997", "unstructured": "Benoit, G.G., C.F. Naud, M.A. Simard, and A.L. Astier (1997). Noninterference of cytochrome P4501A2 in the cytotoxicity of tacrine using genetically engineered V79 Chinese hamster cells for stable expression of the human or rat isoform and two human hepatocyte cell lines. Biochem. Pharmacol. 53, 423\u2013427.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR202", "doi-asserted-by": "publisher", "first-page": "205", "DOI": "10.1016/0006-2952(95)00120-O", "volume": "50", "author": "Z.Y. Zhang", "year": "1995", "unstructured": "Zhang, Z.Y. and L.S. Kaminsky (1995). Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation. Biochem. Pharmacol. 50, 205\u2013211.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR203", "doi-asserted-by": "publisher", "first-page": "979", "DOI": "10.1093/carcin/13.6.979", "volume": "13", "author": "H. Yamazaki", "year": "1992", "unstructured": "Yamazaki, H., Y. Oda, Y. Funae, S. Imaoka, Y. Inui, F.P. Guengerich et al. (1992). Participation of rat liver cytochrome P450 2E1 in the activation of N-nitrosodimethylamine and N-diethylnitrosamine to products genotoxic in Salmonella typhimurium NM2009. Carcinogenesis 13, 979\u2013985.", "journal-title": "Carcinogenesis"}, {"key": "10_CR204", "doi-asserted-by": "publisher", "first-page": "659", "DOI": "10.1021/tx970217f", "volume": "11", "author": "H. Yamazaki", "year": "1998", "unstructured": "Yamazaki, H., P.M. Shaw, F.P. Guengerich, and T. Shimada (1998). Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Chem. Res. Toxicol. 11, 659\u2013665.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR205", "doi-asserted-by": "crossref", "first-page": "1305", "DOI": "10.1056/NEJM198611203152101", "volume": "315", "author": "J.J. Michnovicz", "year": "1986", "unstructured": "Michnovicz, J.J., R.J. Hershcopr, H. Naganuma, H.L. Bradlow, and J. Fishman (1986). Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. New Engl. J. Med. 315, 1305\u20131309.", "journal-title": "New Engl. J. Med."}, {"key": "10_CR206", "doi-asserted-by": "publisher", "first-page": "6295", "DOI": "10.1073/pnas.82.18.6295", "volume": "82", "author": "H.L. Bradlow", "year": "1985", "unstructured": "Bradlow, H.L., R.J. Hershcopf, C.P. Martucci, and J. Fishman (1985). Estradiol 16\u03b1-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: A possible model for the hormonal etiology of breast cancer in humans. Proc. Natl. Acad. Sci. USA 82, 6295\u20136299.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR207", "doi-asserted-by": "crossref", "first-page": "749", "DOI": "10.1096/fasebj.6.2.1347023", "volume": "6", "author": "K. Hiroya", "year": "1992", "unstructured": "Hiroya, K., M. Ishigooka, T. Shimizu, and M. Hatano (1992). Role of Glu318 and Thr319 in the catalytic function of cytochrome P450d (P4501A2): Effects of mutations on the methanol hydroxylation. FASEB J. 6, 749\u2013751.", "journal-title": "FASEB J"}, {"key": "10_CR208", "doi-asserted-by": "publisher", "first-page": "1528", "DOI": "10.1021/bi00120a033", "volume": "31", "author": "M. Ishigooka", "year": "1992", "unstructured": "Ishigooka, M., T. Shimizu, K. Hiroya, and M. Hatano (1992). Role of Glu318 at the putative distal site in the catalytic function of cytochrome P450d. Biochemistry 31, 1528\u20131531.", "journal-title": "Biochemistry"}, {"key": "10_CR209", "doi-asserted-by": "publisher", "first-page": "1490", "DOI": "10.1021/bi00220a007", "volume": "30", "author": "T. Shimizu", "year": "1991", "unstructured": "Shimizu, T., A.J.M. Sadeque, G.N. Sadeque, M. Hatano, and Y. Fujii-Kuriyama (1991). Ligand binding studies of engineered cytochrome P-450d wild type, peroximal mutants, and distal mutants. Biochemistry 30, 1490\u20131496.", "journal-title": "Biochemistry"}, {"key": "10_CR210", "first-page": "191", "volume": "43", "author": "U. Fuhr", "year": "1993", "unstructured": "Fuhr, U., G. Strobl, F. Manaut, E.M. Anders, F. S\u00f6rgel, E. Lopez-de-Brinas et al. (1993). Quinolone antibacterial agents: Relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2. Mol. Pharmacol. 43, 191\u2013199.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR211", "doi-asserted-by": "publisher", "first-page": "395", "DOI": "10.1023/A:1007947411145", "volume": "11", "author": "J.J. Lozano", "year": "1997", "unstructured": "Lozano, J.J., E. L\u00f3pez-de-Bri\u00f1as, N.B. Centeno, F. Sanz, and R. Guigo (1997). Three-dimensional modelling of human cytochrome P450 1A2 and its interaction with caffeine and MeIQ. J. Comput. Aided Mol. Des. 11, 395\u2013408.", "journal-title": "J. Comput. Aided Mol. Des."}, {"key": "10_CR212", "doi-asserted-by": "publisher", "first-page": "5283", "DOI": "10.1021/bi990142+", "volume": "38", "author": "A. Parikh", "year": "1999", "unstructured": "Parikh, A., P.D. Josephy, and F.P. Guengerich (1999). Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties. Biochemistry 38, 5283\u20135289.", "journal-title": "Biochemistry"}, {"key": "10_CR213", "doi-asserted-by": "publisher", "first-page": "11319", "DOI": "10.1021/bi000869u", "volume": "39", "author": "C.-H. Yun", "year": "2000", "unstructured": "Yun, C.-H., G.P. Miller, and F.P. Guengerich (2000). Rate-determining steps in phenacetin oxidation by human cytochrome P450 1A2 and selected mutants. Biochemistry 39, 11319\u201311329.", "journal-title": "Biochemistry"}, {"key": "10_CR214", "doi-asserted-by": "publisher", "first-page": "4521", "DOI": "10.1021/bi002906n", "volume": "40", "author": "C.-H. Yun", "year": "2001", "unstructured": "Yun, C.-H., G.P. Miller, and F.P. Guengerich (2001). Oxidations of p-alkoxyacylanilides by human cytochrome P450 1A2: Structure-activity relationships and simulation of rate constants of individual steps in catalysis. Biochemistry 40, 4521\u20134530.", "journal-title": "Biochemistry"}, {"key": "10_CR215", "doi-asserted-by": "crossref", "first-page": "7262", "DOI": "10.1021/bi010402z", "volume": "40", "author": "G.P. Miller", "year": "2001", "unstructured": "Miller, G.P. and F.P. Guengerich (2001). Binding and oxidation of alkyl 4-nitrophenyl ethers by rabbit cytochrome P450 1A2: Evidence for two binding sites. Biochemistry 40, 7262\u20137272.", "journal-title": "Biochemistry"}, {"key": "10_CR216", "doi-asserted-by": "publisher", "first-page": "7407", "DOI": "10.1021/bi973011m", "volume": "37", "author": "J.K. Racha", "year": "1998", "unstructured": "Racha, J.K., A.E. Rettie, and K.L. Kunze (1998). Mechanism-based inactivation of human cytochrome P450 1A2 by furafylline: Detection of a 1:1 adduct to protein and evidence for the formation of a novel imidazomethide intermediate. Biochemistry 37, 7407\u20137419.", "journal-title": "Biochemistry"}, {"key": "10_CR217", "doi-asserted-by": "publisher", "first-page": "69", "DOI": "10.1016/0041-008X(87)90307-3", "volume": "90", "author": "R. Voorman", "year": "1987", "unstructured": "Voorman, R. and S.D. Aust (1987). Specific binding of polyhalogenated aromatic hydrocarbon inducers of cytochrome P-450d to the cytochrome and inhibition of its estradiol 2-hydroxylase activity. Toxicol. Appl. Pharmacol. 90, 69\u201378.", "journal-title": "Toxicol. Appl. Pharmacol."}, {"key": "10_CR218", "doi-asserted-by": "crossref", "first-page": "651", "DOI": "10.1111/j.1365-2125.1990.tb03686.x", "volume": "29", "author": "D. Sesardic", "year": "1990", "unstructured": "Sesardic, D., A. Boobis, B. Murray, S. Murray, J. Segura, R. De La Torre et al. (1990). Furafylline is a potent and selective inhibitor of cytochrome P450 1A2 in man. Br. J. Clin. Pharmacol. 29, 651\u2013663.", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "10_CR219", "doi-asserted-by": "crossref", "first-page": "445", "DOI": "10.1002/cpt1978234445", "volume": "23", "author": "A. Kappas", "year": "1978", "unstructured": "Kappas, A., A.P. Alvares, K.E. Anderson, E.J. Pantuck, C.B. Pantuck, R. Chang et al. (1978). Effect of charcoal-broiled beef on antipyrine and theophylline metabolism. Clin. Pharmacol. Ther. 23, 445\u2013450.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR220", "first-page": "956", "volume": "66", "author": "C.H. Feldman", "year": "1980", "unstructured": "Feldman, C.H., V.E. Hutchinson, C.E. Pippenger, T.A. Blemenfeld, B.R. Feldman, and W.J. Davis (1980). Effect of dietary protein and carbohydrate on theophylline metabolism in children. Pediatrics 66, 956\u2013962.", "journal-title": "Pediatrics"}, {"key": "10_CR221", "doi-asserted-by": "crossref", "first-page": "970", "DOI": "10.1210/endo-129-2-970", "volume": "129", "author": "S. Otto", "year": "1991", "unstructured": "Otto, S., C. Marcus, C. Pidgeon, and C. Jefcoate (1991). A novel adrenocorticotropin-inducible cytochrome P450 from rat adrenal microsomes catalyzes polycyclic aromatic hydrocarbon metabolism. Endocrinology 129, 970\u2013982.", "journal-title": "Endocrinology"}, {"key": "10_CR222", "doi-asserted-by": "publisher", "first-page": "106", "DOI": "10.1006/abbi.2001.2482", "volume": "393", "author": "B.P. Murray", "year": "2001", "unstructured": "Murray, B.P. and M.A. Correia (2001). Ubiquitin-dependent 26S proteasomal pathway: A role in the degradation of native human liver CYP3A4 expressed in Saccharomyces cerevisiae? Arch. Biochem. Biophys. 393, 106\u2013116.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR223", "first-page": "3026", "volume": "57", "author": "G.I. Murray", "year": "1997", "unstructured": "Murray, G.I., M.C. Taylor, M.C. McFadyen, J.A. McKay, W.F. Greenlee, M.D. Burke et al. (1997). Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res. 57, 3026\u20133031.", "journal-title": "Cancer Res"}, {"key": "10_CR224", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1093/toxsci/71.1.11", "volume": "71", "author": "T.K.H. Chang", "year": "2003", "unstructured": "Chang, T.K.H., J. Chen, V. Pillay, J.-Y. Ho, and S.M. Bandiera (2003). Real-time polymerase chain reaction analysis of CYP1B1 gene expression in human liver. Toxicol. Sci. 71, 11\u201319.", "journal-title": "Toxicol. Sci."}, {"key": "10_CR225", "doi-asserted-by": "publisher", "first-page": "641", "DOI": "10.1093/hmg/6.4.641", "volume": "6", "author": "I. Stoilov", "year": "1997", "unstructured": "Stoilov, I., A.N. Akarsu, and M. Sarfarazi (1997). Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum. Mol. Genet. 6, 641\u2013647.", "journal-title": "Hum. Mol. Genet."}, {"key": "10_CR226", "first-page": "617", "volume": "25", "author": "T. Shimada", "year": "1997", "unstructured": "Shimada, T., E.M.J. Gillam, T.R. Sutter, P.T. Strickland, F.P. Guengerich, and H. Yamazaki (1997). Roles of recombinant human cytochrome P450 1B1 in the oxidation of xenobiotic chemicals. Drug Metab. Dispos. 25, 617\u2013622.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR227", "first-page": "1176", "volume": "29", "author": "T. Shimada", "year": "2001", "unstructured": "Shimada, T., Y. Oda, E.M.J. Gillam, F.P. Guengerich, and K. Inoue (2001). Metabolic activation of polycyclic aromatic hydrocarbons and their dihydrodiol derivatives and other procarcinogens by cytochrome P450 1A1 and 1B1 allelic variants and other human cytochrome P450 enzymes in Salmonella typhimurium NM2009. Drug Metab. Dispos. 29, 1176\u20131182.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR228", "first-page": "129", "volume": "472", "author": "H. Yamazaki", "year": "2000", "unstructured": "Yamazaki, H., N. Hatanaka, R. Kizu, K. Hayakawa, N. Shimada, F.P. Guengerich et al. (2000). Bioactivation of diesel exhaust particle extracts and their major nitrated polycyclic aromatic hydrocarbon components, 1-nitropyrene and dinitropyrenes, by human cytochrome P450s 1A1, 1A2, and 1B1. Chem. Res. Toxicol. 472, 129\u2013138.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR229", "doi-asserted-by": "publisher", "first-page": "9776", "DOI": "10.1073/pnas.93.18.9776", "volume": "93", "author": "C.L. Hayes", "year": "1996", "unstructured": "Hayes, C.L., D.C. Spink, B.C. Spink, J.Q. Cao, N.J. Walker, and T.R. Sutter (1996). 17\u03b2-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl. Acad. Sci. USA 93, 9776\u20139781.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR230", "doi-asserted-by": "publisher", "first-page": "1607", "DOI": "10.1093/carcin/20.8.1607", "volume": "20", "author": "T. Shimada", "year": "1999", "unstructured": "Shimada, T., J. Watanabe, K. Kawajiri, T.R. Sutter, F.P. Guengerich, E.M.J. Gillam et al. (1999). Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis 20, 1607\u20131614.", "journal-title": "Carcinogenesis"}, {"key": "10_CR231", "doi-asserted-by": "publisher", "first-page": "623", "DOI": "10.1021/tx990028s", "volume": "12", "author": "T. Shimada", "year": "1999", "unstructured": "Shimada, T., E.M.J. Gillam, Y. Oda, F. Tsumura, T.R. Sutter, F.P. Guengerich et al. (1999). Metabolism of benzo[a]pyrene to trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase. Chem. Res. Toxicol. 12, 623\u2013629.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR232", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.1006/abbi.1997.0339", "volume": "347", "author": "Savas", "year": "1997", "unstructured": "Savas, \u00dc., C.P. Carstens, and C.R. Jefcoate (1997). Recombinant mouse CYP1B1 expressed in Escherichia coli exhibits selective binding by polycyclic hydrocarbons and metabolism which parallels C3H10T1/2 cell microsomes, but differs from human recombinant CYP1B1. Arch. Biochem. Biophys. 347, 181\u2013192.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR233", "first-page": "3440", "volume": "60", "author": "I.H. Hanna", "year": "2000", "unstructured": "Hanna, I.H., S. Dawling, N. Roodi, F.P. Guengerich, and F. Parl (2000). Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: Association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res. 60, 3440\u20133444.", "journal-title": "Cancer Res"}, {"key": "10_CR234", "doi-asserted-by": "publisher", "first-page": "207", "DOI": "10.1093/carcin/18.1.207", "volume": "18", "author": "M. Shou", "year": "1997", "unstructured": "Shou, M., K.R. Korzekwa, E.N. Brooks, K.W. Krausz, F.J. Gonzalez, and H.V. Gelboin (1997). Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone. Carcinogenesis 18, 207\u2013214.", "journal-title": "Carcinogenesis"}, {"key": "10_CR235", "doi-asserted-by": "publisher", "first-page": "1113", "DOI": "10.1021/tx9801007", "volume": "11", "author": "J.L. Bolton", "year": "1998", "unstructured": "Bolton, J.L., E. Pisha, F. Zhang, and S. Qiu (1998). Role of quinoids in estrogen carcinogenesis. Chem. Res. Toxicol. 11, 1113\u20131127.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR236", "doi-asserted-by": "publisher", "first-page": "9220", "DOI": "10.1073/pnas.92.20.9220", "volume": "92", "author": "J.G. Liehr", "year": "1995", "unstructured": "Liehr, J.G., M.J. Ricci, C.R. Jefcoate, E.V. Hannigan, J.A. Hokanson, and B.T. Zhu (1995). 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: Implications for the mechanism of uterine tumorigenesis. Proc. Natl. Acad. Sci. USA 92, 9220\u20139224.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR237", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1515/DMDI.1999.15.1.1", "volume": "15", "author": "D.F.V. Lewis", "year": "1999", "unstructured": "Lewis, D.F.V., M. Dickins, P.J. Eddershaw, M.H. Tarbit, and P.S. Goldfarb (1999). Cytochrome P450 substrate specificities, substrate structural templates and enzyme active site geometries. Drug Metabol. Drug Interact. 15, 1\u201349.", "journal-title": "Drug Metabol. Drug Interact."}, {"key": "10_CR238", "doi-asserted-by": "publisher", "first-page": "218", "DOI": "10.1126/science.275.5297.218", "volume": "275", "author": "M. Jang", "year": "1997", "unstructured": "Jang, M., L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W.W. Beecher et al. (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218\u2013220.", "journal-title": "Science"}, {"key": "10_CR239", "doi-asserted-by": "publisher", "first-page": "20", "DOI": "10.1006/bbrc.1999.1152", "volume": "262", "author": "Y.-J. Chun", "year": "1999", "unstructured": "Chun, Y.-J., M.-F. Kim, and F.P. Guengerich (1999). Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem. Biophys. Res. Commun. 262, 20\u201324.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR240", "doi-asserted-by": "publisher", "first-page": "774", "DOI": "10.1038/sj.bjc.6600197", "volume": "86", "author": "G.A. Potter", "year": "2002", "unstructured": "Potter, G.A., L.H. Patterson, E. Wanogho, P.J. Perry, P.C. Butler, T. Ijaz et al. (2002). The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br. J. Cancer 86, 774\u2013778.", "journal-title": "Br. J. Cancer"}, {"key": "10_CR241", "first-page": "8164", "volume": "61", "author": "Y.-J. Chun", "year": "2001", "unstructured": "Chun, Y.-J., S. Kim, D. Kim, S.-K. Lee, and F.P. Guengerich (2001). A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis. Cancer Res. 61, 8164\u20138170.", "journal-title": "Cancer Res"}, {"key": "10_CR242", "doi-asserted-by": "publisher", "first-page": "11126", "DOI": "10.1021/ja971396q", "volume": "119", "author": "L. Shen", "year": "1997", "unstructured": "Shen, L., S. Qiu, R.B. van Breemen, F. Zhang, Y. Chen, and J.L. Bolton (1997). Reaction of the premarin metabolite 4-hydroxyequilenin semiquinone radical with 2\u2032-deoxyguanosine: Formation of unusual cyclic adducts. J. Am. Chem. Soc. 119, 11126\u201311127.", "journal-title": "J. Am. Chem. Soc."}, {"key": "10_CR243", "doi-asserted-by": "publisher", "first-page": "1322", "DOI": "10.1021/bi00457a031", "volume": "29", "author": "S. Yamano", "year": "1990", "unstructured": "Yamano, S., J. Tatsuno, and F.J. Gonzalez (1990). The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry 29, 1322\u20131329.", "journal-title": "Biochemistry"}, {"key": "10_CR244", "doi-asserted-by": "publisher", "first-page": "403", "DOI": "10.1016/0006-2952(95)02184-1", "volume": "51", "author": "J. Hakkola", "year": "1996", "unstructured": "Hakkola, J., M. Pasanen, J. Hukkanen, O. Pelkonen, J. M\u00e4enp\u00e4\u00e4, R.J. Edwards et al. (1996). Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta. Biochem. Pharmacol. 51, 403\u2013411.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR245", "doi-asserted-by": "publisher", "first-page": "149", "DOI": "10.1146/annurev.pharmtox.43.100901.140251", "volume": "43", "author": "X. Ding", "year": "2003", "unstructured": "Ding, X. and L.S. Kaminsky (2003). Human extrahepatic cytochromes P450: Function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. Toxicol. 43, 149\u2013173.", "journal-title": "Annu. Rev. Pharmacol. Toxicol."}, {"key": "10_CR246", "doi-asserted-by": "publisher", "first-page": "611", "DOI": "10.1093/carcin/23.4.611", "volume": "23", "author": "W. Godoy", "year": "2002", "unstructured": "Godoy, W., R.M. Albano, E.G. Moraes, P.R. Pinho, R.A. Nunes, E.H. Saito et al. (2002). CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: Regional and inter-individual variation in expression and relevance to nitrosamine metabolism. Carcinogenesis 23, 611\u2013616.", "journal-title": "Carcinogenesis"}, {"key": "10_CR247", "doi-asserted-by": "publisher", "first-page": "427", "DOI": "10.1002/hep.510270217", "volume": "27", "author": "H. Raunio", "year": "1998", "unstructured": "Raunio, H., R. Juvonen, M. Pasanen, O. Pelkonen, P. Paakko, and Y. Soini (1998). Cytochrome P4502A6 (CYP2A6) expression in human hepatocellular carcinoma. Hepatology 27, 427\u2013432.", "journal-title": "Hepatology"}, {"key": "10_CR248", "first-page": "849", "volume": "299", "author": "J.M. Rae", "year": "2001", "unstructured": "Rae, J.M., M.D. Johnson, M.E. Lippman, and D.A. Flockhart (2001). Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: Studies with cDNA and oligonucleotide expression arrays. J. Pharmacol. Exp. Ther. 299, 849\u2013857.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR249", "first-page": "1321", "volume": "28", "author": "M.T. Donato", "year": "2000", "unstructured": "Donato, M.T., P. Viitala, C. Rodriguez-Antona, A. Lindfors, J.V. Castell, H. Raunio et al. (2000). CYP2A5/CYP2A6 expression in mouse and human hepatocytes treated with various in vivo inducers. Drug Metab. Dispos. 28, 1321\u20131326.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR250", "doi-asserted-by": "publisher", "first-page": "668", "DOI": "10.1053/jhep.2001.22176", "volume": "33", "author": "R. Jover", "year": "2001", "unstructured": "Jover, R., R. Bort, M.J. Gomez-Lechon, and J.V. Castell (2001). Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: A study using adenovirus-mediated antisense targeting. Hepatology 33, 668\u2013675.", "journal-title": "Hepatology"}, {"key": "10_CR251", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1042/bj3060161", "volume": "306", "author": "S. Ding", "year": "1995", "unstructured": "Ding, S., B.G. Lake, T. Friedberg, and C.R. Wolf (1995). Expression and alternative splicing of the cytochrome P-450 CYP2A7. Biochem. J. 306, 161\u2013166.", "journal-title": "Biochem. J."}, {"key": "10_CR252", "doi-asserted-by": "publisher", "first-page": "275", "DOI": "10.1002/humu.10126", "volume": "20", "author": "M. Oscarson", "year": "2002", "unstructured": "Oscarson, M., R.A. McLellan, V. Asp, M. Ledesma, M.L. Ruiz, B. Sinues et al. (2002). Characterization of a novel CYP2A7/CYP2A6 hybrid allel (CYP2A6*12) that causes reduced CYP2A6 activity. Hum. Mutat. 20, 275\u2013283.", "journal-title": "Hum. Mutat."}, {"key": "10_CR253", "doi-asserted-by": "publisher", "first-page": "903", "DOI": "10.1016/S0278-6915(97)00066-5", "volume": "35", "author": "H. Hadidi", "year": "1997", "unstructured": "Hadidi, H., K. Zahlsen, J.R. Idle, and S. Cholerton (1997). A single amino acid substitution (Leu60His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin. Food Chem. Toxicol. 35, 903\u2013907.", "journal-title": "Food Chem. Toxicol."}, {"key": "10_CR254", "doi-asserted-by": "publisher", "first-page": "72", "DOI": "10.1067/mcp.2001.112688", "volume": "69", "author": "M. Nakajima", "year": "2001", "unstructured": "Nakajima, M., J.-T. Kwon, N. Tanaka, T. Zenta, Y. Yamamoto, H. Yamamoto et al. (2001). Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans. Clin. Pharmacol. Ther. 69, 72\u201378.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR255", "first-page": "548", "volume": "29", "author": "R.F. Tyndale", "year": "2001", "unstructured": "Tyndale, R.F. and E.M. Sellers (2001). Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk. Drug Metab. Dispos. 29, 548\u2013552.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR256", "doi-asserted-by": "publisher", "first-page": "511", "DOI": "10.1046/j.1365-2125.2002.01667.x", "volume": "54", "author": "R. Yoshida", "year": "2002", "unstructured": "Yoshida, R., M. Nakajima, Y. Watanabe, J.T. Kwon, and T. Yokoi (2002). Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism. Br. J. Clin. Pharmacol. 54, 511\u2013517.", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "10_CR257", "doi-asserted-by": "publisher", "first-page": "383", "DOI": "10.1046/j.1469-1809.2000.6450383.x", "volume": "64", "author": "D.F. Gu", "year": "2000", "unstructured": "Gu, D.F., L.J. Hinks, N.E. Morton, and I.N. Day (2000). The use of long PCR to confirm three common alleles at the CYP2A6 locus and the relationship between genotype and smoking habit. Ann. Hum. Genet. 64, 383\u2013390.", "journal-title": "Ann. Hum. Genet."}, {"key": "10_CR258", "doi-asserted-by": "crossref", "first-page": "747", "DOI": "10.1124/mol.58.4.747", "volume": "58", "author": "Y. Rao", "year": "2000", "unstructured": "Rao, Y., E. Hoffmann, M. Zia, L. Bodin, M. Zeman, E.M. Sellers et al. (2000). Duplications and defects in the CYP2A6 gene: Identification, genotyping, and in vivo effects on smoking. Mol. Pharmacol. 58, 747\u2013755.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR259", "doi-asserted-by": "publisher", "first-page": "1245", "DOI": "10.1016/S0169-409X(02)00065-0", "volume": "54", "author": "C. Xu", "year": "2002", "unstructured": "Xu, C., S. Goodz, E.M. Sellers, and R.F. Tyndale (2002). CYP2A6 genetic variation and potential consequences. Adv. Drug Deliv. Rev. 54, 1245\u20131256.", "journal-title": "Adv. Drug Deliv. Rev."}, {"key": "10_CR260", "doi-asserted-by": "publisher", "first-page": "163", "DOI": "10.1097/00007691-200202000-00026", "volume": "24", "author": "R.F. Tyndale", "year": "2002", "unstructured": "Tyndale, R.F. and E.M. Sellers (2002). Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior. Ther. Drug Monit. 24, 163\u2013171.", "journal-title": "Ther. Drug Monit."}, {"key": "10_CR261", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1016/S1383-5742(99)00040-X", "volume": "428", "author": "T. Kamataki", "year": "1999", "unstructured": "Kamataki, T., K. Nunoya, Y. Sakai, H. Kushida, and K. Fujita (1999). Genetic polymorphism of CYP2A6 in relation to cancer. Mutat. Res. 428, 125\u2013130.", "journal-title": "Mutat. Res."}, {"key": "10_CR262", "doi-asserted-by": "publisher", "first-page": "658", "DOI": "10.1006/bbrc.1999.1089", "volume": "261", "author": "M. Miyamoto", "year": "1999", "unstructured": "Miyamoto, M., Y. Umetsu, H. Dosaka-Akita, Y. Sawamura, J. Yokota, H. Kunitoh et al. (1999). CYP2A6 gene deletion reduces susceptibility to lung cancer. Biochem. Biophys. Res. Commun. 261, 658\u2013660.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR263", "doi-asserted-by": "publisher", "first-page": "898", "DOI": "10.1016/S0140-6736(98)04984-8", "volume": "353", "author": "S.J. London", "year": "1999", "unstructured": "London, S.J., J.R. Idle, A.K. Daly, and G.A. Coetzee (1999). Genetic variation of CYP2A6, smoking, and risk of cancer. Lancet 353, 898\u2013899.", "journal-title": "Lancet"}, {"key": "10_CR264", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1007/978-1-4615-0667-6_29", "volume": "500", "author": "T.G. Schulz", "year": "2001", "unstructured": "Schulz, T.G., P. Ruhnau, and E. Hallier (2001). Lack of correlation between CYP2A6 genotype and smoking habits. Adv. Exp. Med. Biol. 500, 213\u2013215.", "journal-title": "Adv. Exp. Med. Biol."}, {"key": "10_CR265", "doi-asserted-by": "publisher", "first-page": "357", "DOI": "10.1046/j.0306-5251.2001.01500.x", "volume": "52", "author": "H. Raunio", "year": "2001", "unstructured": "Raunio, H., A. Rautio, H. Gullsten, and O. Pelkonen (2001). Polymorphisms of CYP2A6 and its practical consequences. Br. J. Clin. Pharmacol. 52, 357\u2013363.", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "10_CR266", "doi-asserted-by": "publisher", "first-page": "151", "DOI": "10.1016/S0300-483X(02)00513-9", "volume": "183", "author": "A.R. Tricker", "year": "2003", "unstructured": "Tricker, A.R. (2003). Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour. Toxicology 183, 151\u2013173.", "journal-title": "Toxicology"}, {"key": "10_CR267", "doi-asserted-by": "publisher", "first-page": "39", "DOI": "10.1097/00008571-200102000-00005", "volume": "11", "author": "M.A. Loriot", "year": "2001", "unstructured": "Loriot, M.A., S. Rebuissou, M. Oscarson, S. Cenee, M. Miyamoto, N. Ariyoshi et al. (2001). Genetic polymorphisms of cytochrome P450 2A6 in a casecontrol study on lung cancer in a French population. Pharmacogenetics 11, 39\u201344.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR268", "first-page": "486", "volume": "36", "author": "X. Zhang", "year": "2001", "unstructured": "Zhang, X., K. Amemo, S. Ameno, K. Iwahashi, H. Kinoshita, T. Kubota et al. (2001). Lack of association between smoking and CYP2A6 gene polymorphisms in a Japanese population. Nihon Arukoru Yakubutsu Igakkai Zasshi 36, 486\u2013490.", "journal-title": "Nihon Arukoru Yakubutsu Igakkai Zasshi"}, {"key": "10_CR269", "first-page": "91", "volume": "29", "author": "M. Oscarson", "year": "2001", "unstructured": "Oscarson, M. (2001). Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: Implications for interindividual differences in nicotine metabolism. Drug Metab. Dispos. 29, 91\u201395.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR270", "doi-asserted-by": "publisher", "first-page": "865", "DOI": "10.1081/DMR-120015696", "volume": "34", "author": "M. Nakajima", "year": "2002", "unstructured": "Nakajima, M., Y. Kuroiwa, and T. Yokoi (2002). Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6. Drug Metab. Rev. 34, 865\u2013877.", "journal-title": "Drug Metab. Rev."}, {"key": "10_CR271", "doi-asserted-by": "publisher", "first-page": "129", "DOI": "10.1016/0163-7258(93)90053-G", "volume": "57", "author": "A.K. Daly", "year": "1993", "unstructured": "Daly, A.K., S. Cholerton, W. Gregory, and J.R. Idle (1993). Metabolic polymorphisms. Pharmacol. Ther. 57, 129\u2013160.", "journal-title": "Pharmacol. Ther."}, {"key": "10_CR272", "doi-asserted-by": "crossref", "first-page": "325", "DOI": "10.1016/0378-4347(92)80166-N", "volume": "575", "author": "S. Cholerton", "year": "1992", "unstructured": "Cholerton, S., M.E. Idle, A. Vas, F.J. Gonzalez, and J.R. Idle (1992). Comparison of a novel thin-layer chromatographic-fluorescence detection method with a spectrofluorometric method for the determination of 7-hydroxycoumarin in human urine. J. Chromatogr. 575, 325\u2013330.", "journal-title": "J. Chromatogr."}, {"key": "10_CR273", "doi-asserted-by": "publisher", "first-page": "227", "DOI": "10.1097/00008571-199210000-00005", "volume": "2", "author": "A. Rautio", "year": "1992", "unstructured": "Rautio, A., H. Kraul, A. Kojo, E. Salmela, and O. Pelkonen (1992). Interindividual variability of coumarin 7-hydroxylation in healthy volunteers. Pharmacogenetics 2, 227\u2013233.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR274", "doi-asserted-by": "publisher", "first-page": "190", "DOI": "10.1006/abbi.1999.1388", "volume": "370", "author": "P. Soucek", "year": "1999", "unstructured": "Soucek, P. (1999). Expression of cytochrome P450 2A6 in Escherichia coli: Purification, spectral and catalytic characterization, and preparation of polyclonal antibodies. Arch. Biochem. Biophys. 370, 190\u2013200.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR275", "first-page": "377", "volume": "11", "author": "S. Nowell", "year": "2002", "unstructured": "Nowell, S., C. Sweeney, G. Hammons, F.F. Kadlubar, and N.P. Lang (2002). CYP2A6 activity determined by caffeine phenotyping: Association with colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev. 11, 377\u2013383.", "journal-title": "Cancer Epidemiol. Biomarkers Prev."}, {"key": "10_CR276", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1016/S0378-4274(00)00286-1", "volume": "124", "author": "A. Gal Le", "year": "2001", "unstructured": "Le Gal, A., Y. Dreano, P.G. Gervasi, and F. Berthou (2001). Human cytochrome P450 2A6 is the major enzyme involved in the metabolism of three alkoxyethers used as oxyfuels. Toxicol. Lett. 124, 47\u201358.", "journal-title": "Toxicol. Lett."}, {"key": "10_CR277", "doi-asserted-by": "publisher", "first-page": "342", "DOI": "10.1006/abbi.1994.1246", "volume": "311", "author": "R.J. Duescher", "year": "1994", "unstructured": "Duescher, R.J. and A.A. Elfarra (1994). Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: Evidence for major roles by cytochrome P450 2A6 and 2E1. Arch. Biochem. Biophys. 311, 342\u2013349.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR278", "doi-asserted-by": "publisher", "first-page": "239", "DOI": "10.1097/00008571-199806000-00006", "volume": "8", "author": "K. Nunoya", "year": "1998", "unstructured": "Nunoya, K., T. Yokoi, K. Kimura, K. Inoue, T. Kodama, M. Funayama et al. (1998). A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502). Pharmacogenetics 8, 239\u2013249.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR279", "first-page": "437", "volume": "289", "author": "K. Nunoya", "year": "1999", "unstructured": "Nunoya, K., T. Yokoi, K. Kimura, T. Kainuma, K. Satoh, M. Kinoshita et al. (1999). A new CYP2A6 gene deletion responsible for the in vivo polymorphic metabolism of (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride in humans. J. Pharmacol. Exp. Ther. 289, 437\u2013442.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR280", "first-page": "1457", "volume": "28", "author": "T. Komatsu", "year": "2000", "unstructured": "Komatsu, T., H. Yamazaki, N. Shimada, M. Nakajima, and T. Yokoi (2000). Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes. Drug Metab. Dispos. 28, 1457\u20131463.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR281", "first-page": "4409", "volume": "6", "author": "K. Ikeda", "year": "2000", "unstructured": "Ikeda, K., K. Yoshisue, E. Matsushima, S. Nagayama, K. Kobayashi, C.A. Tyson et al. (2000). Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro, Clin. Cancer Res. 6, 4409\u20134415.", "journal-title": "Clin. Cancer Res."}, {"key": "10_CR282", "doi-asserted-by": "publisher", "first-page": "509", "DOI": "10.1097/00000542-200108000-00037", "volume": "95", "author": "Y. Minoda", "year": "2001", "unstructured": "Minoda, Y. and E.D. Kharasch (2001). Halothane-dependent lipid peroxidation in human liver microsomes is catalyzed by cytochrome P4502A6 (CYP2A6). Anesthesiology 95, 509\u2013514.", "journal-title": "Anesthesiology"}, {"key": "10_CR283", "doi-asserted-by": "publisher", "first-page": "1293", "DOI": "10.1093/carcin/11.8.1293", "volume": "11", "author": "C.L. Crespi", "year": "1990", "unstructured": "Crespi, C.L., B.W. Penman, J.A. Leakey, M.P. Arlotto, A. Stark, A. Parkinson et al. (1990). Human cytochrome P450IIA3:cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1. Carcinogenesis 11, 1293\u20131300.", "journal-title": "Carcinogenesis"}, {"key": "10_CR284", "doi-asserted-by": "publisher", "first-page": "1789", "DOI": "10.1093/carcin/13.10.1789", "volume": "13", "author": "H. Yamazaki", "year": "1992", "unstructured": "Yamazaki, H., Y. Inui, C.-H. Yun, M. Mimura, F.P. Guengerich, and T. Shimada (1992). Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis 13, 1789\u20131794.", "journal-title": "Carcinogenesis"}, {"key": "10_CR285", "first-page": "1757", "volume": "52", "author": "T.J. Smith", "year": "1992", "unstructured": "Smith, T.J., Z. Guo, F.J. Gonzalez, F.P. Guengerich, G.D. Stoner, and C.S. Yang (1992). Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells. Cancer Res. 52, 1757\u20131763.", "journal-title": "Cancer Res"}, {"key": "10_CR286", "doi-asserted-by": "publisher", "first-page": "1197", "DOI": "10.1093/carcin/12.7.1197", "volume": "12", "author": "C.L. Crespi", "year": "1991", "unstructured": "Crespi, C.L., B.W. Penman, H.V. Gelboin, and F.J. Gonzalez (1991). A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. Carcinogenesis 12, 1197\u20131201.", "journal-title": "Carcinogenesis"}, {"key": "10_CR287", "doi-asserted-by": "publisher", "first-page": "2859", "DOI": "10.1093/carcin/15.12.2859", "volume": "15", "author": "H.F. Tiano", "year": "1994", "unstructured": "Tiano, H.F., R.L. Wang, M. Hosokawa, C. Crespi, K.R. Tindall, and R. Langenbach (1994). Human CYP2A6 activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): Mutational specificity in the gpt gene of AS52 cells. Carcinogenesis 15, 2859\u20132866.", "journal-title": "Carcinogenesis"}, {"key": "10_CR288", "doi-asserted-by": "publisher", "first-page": "1254", "DOI": "10.1021/tx990128y", "volume": "12", "author": "L.B. Weymarn von", "year": "1999", "unstructured": "von Weymarn, L.B., N.D. Felicia, X. Ding, and S.E. Murphy (1999). N-Nitrosobenzylmethylamine hydroxylation and coumarin 7-hydroxylation: Catalysis by rat esophageal microsomes and cytochrome P450 2A3 and 2A6 enzymes. Chem. Res. Toxicol. 12, 1254\u20131261.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR289", "doi-asserted-by": "publisher", "first-page": "1227", "DOI": "10.1093/carcin/21.6.1227", "volume": "21", "author": "H. Kushida", "year": "2000", "unstructured": "Kushida, H., K. Fujita, A. Suzuki, M. Yamada, T. Endo, T. Nohmi et al. (2000). Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase. Carcinogenesis 21, 1227\u20131232.", "journal-title": "Carcinogenesis"}, {"key": "10_CR290", "doi-asserted-by": "publisher", "first-page": "339", "DOI": "10.1002/em.10036", "volume": "38", "author": "K. Fujita", "year": "2001", "unstructured": "Fujita, K. and T. Kamataki (2001). Predicting the mutagenicity of tobacco-related N-nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH-cytochrome P450 reductase. Environ. Mol. Mutagen. 38, 339\u2013346.", "journal-title": "Environ. Mol. Mutagen."}, {"key": "10_CR291", "first-page": "1212", "volume": "24", "author": "M. Nakajima", "year": "1996", "unstructured": "Nakajima, M., T. Yamamoto, K. Nunoya, T. Yokoi, K. Nagashima, K. Inoue et al. (1996). Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab. Dispos. 24, 1212\u20131217.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR292", "first-page": "1608", "volume": "282", "author": "E.S. Messina", "year": "1997", "unstructured": "Messina, E.S., R.F. Tyndale, and E.M. Sellers (1997). A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J. Pharmacol. Exp. Ther. 282, 1608\u20131614.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR293", "doi-asserted-by": "publisher", "first-page": "65", "DOI": "10.1007/s002040050588", "volume": "73", "author": "H. Yamazaki", "year": "1999", "unstructured": "Yamazaki, H., K. Inoue, M. Hashimoto, and T. Shimada (1999). Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes. Arch. Toxicol. 73, 65\u201370.", "journal-title": "Arch. Toxicol."}, {"key": "10_CR294", "first-page": "1010", "volume": "277", "author": "M. Nakajima", "year": "1996", "unstructured": "Nakajima, M., T. Yamamoto, K. Nunoya, T. Yokoi, K. Nagashima, K. Inoue et al. (1996). Characterization of CYP2A6 involved in 3\u2032-hydroxylation of cotinine in human liver microsomes. J. Pharmacol. Exp. Ther. 277, 1010\u20131015.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR295", "doi-asserted-by": "publisher", "first-page": "12493", "DOI": "10.1073/pnas.220207697", "volume": "97", "author": "S.S. Hecht", "year": "2000", "unstructured": "Hecht, S.S., J.B. Hochalter, P.W. Villata, and S.E. Murphy (2000). 2\u2032-Hydroxylation of nicotine by cytochrome P450 2A6 and human liver microsomes: Formation of a lung carcinogen precursor. Proc. Natl. Acad. Sci. USA 97, 12493\u201312497.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR296", "first-page": "5074", "volume": "60", "author": "T. Su", "year": "2000", "unstructured": "Su, T., Z.P. Bao, Q.Y. Zhang, T.J. Smith, J.Y. Hong, and X.X. Ding (2000). Human cytochrome P450 CYP2A13: Predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 60, 5074\u20135079.", "journal-title": "Cancer Res"}, {"key": "10_CR297", "doi-asserted-by": "publisher", "first-page": "13817", "DOI": "10.1021/bi001229u", "volume": "39", "author": "E.M.J. Gillam", "year": "2000", "unstructured": "Gillam, E.M.J., L.M. Notley, H. Cai, J.J. DeVoss, and F.P. Guengerich (2000). Oxidation of indole by cytochrome P450 enzymes. Biochemistry 39, 13817\u201313824.", "journal-title": "Biochemistry"}, {"key": "10_CR298", "doi-asserted-by": "publisher", "first-page": "280", "DOI": "10.1006/abio.2001.5098", "volume": "292", "author": "K. Nakamura", "year": "2001", "unstructured": "Nakamura, K., I.H. Hanna, H. Cai, Y. Nishimura, K.M. Williams, and F.P. Guengerich (2001). Coumarin substrates for cytochrome P450 2D6 fluorescence assays. Anal. Biochem. 292, 280\u2013286.", "journal-title": "Anal. Biochem."}, {"key": "10_CR299", "doi-asserted-by": "publisher", "first-page": "632", "DOI": "10.1038/339632a0", "volume": "339", "author": "R.L.P. Lindberg", "year": "1989", "unstructured": "Lindberg, R.L.P. and M. Negishi (1989). Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue. Nature 339, 632\u2013634.", "journal-title": "Nature"}, {"key": "10_CR300", "doi-asserted-by": "publisher", "first-page": "17830", "DOI": "10.1074/jbc.M009432200", "volume": "276", "author": "K. Kitagawa", "year": "2001", "unstructured": "Kitagawa, K., N. Kunugita, M. Kitagawa, and T. Kawamoto (2001). CYP2A6*6, a novel polymorphism in cytochrome P450 2A6, has a single amino acid substitution (R128Q) that inactivates enzymatic activity. J. Biol. Chem. 276, 17830\u201317835.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR301", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/S0300-483X(98)00149-8", "volume": "133", "author": "D.F.V. Lewis", "year": "1999", "unstructured": "Lewis, D.F.V., M. Dickins, B.G. Lake, P.J. Eddershaw, M.H. Tarbit, and P.S. Goldfarb (1999). Molecular modeling of the human cytochrome P450 isoform CYP2A6 and investigations of CYP2A substrate selectivity. Toxicology 133, 1\u201333.", "journal-title": "Toxicology"}, {"key": "10_CR302", "doi-asserted-by": "publisher", "first-page": "55", "DOI": "10.1081/DMR-120001390", "volume": "34", "author": "D.F. Lewis", "year": "2002", "unstructured": "Lewis, D.F. (2002). Molecular modeling of human cytochrome P450-substrate interactions. Drug Metab. Rev. 34, 55\u201367.", "journal-title": "Drug Metab. Rev."}, {"key": "10_CR303", "doi-asserted-by": "publisher", "first-page": "305", "DOI": "10.1080/00498250110112015", "volume": "32", "author": "D.F. Lewis", "year": "2002", "unstructured": "Lewis, D.F. (2002). Homology modelling of human CYP2 family enzymes based on the CYP2C5 crystal structure. Xenobiotica 32, 305\u2013323.", "journal-title": "Xenobiotica"}, {"key": "10_CR304", "first-page": "29", "volume": "19", "author": "D.F. Lewis", "year": "2002", "unstructured": "Lewis, D.F. and J.W. Gorrod (2002). Molecular orbital calculations and nicotine metabolism: A rationale for experimentally observed metabolite ratios. Drug Metabol. Drug Interact. 19, 29\u201339.", "journal-title": "Drug Metabol. Drug Interact."}, {"key": "10_CR305", "doi-asserted-by": "publisher", "first-page": "168", "DOI": "10.1021/tx00020a008", "volume": "4", "author": "F.P. Guengerich", "year": "1991", "unstructured": "Guengerich, F.P., D.-H. Kim, and M. Iwasaki (1991). Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4, 168\u2013179.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR306", "doi-asserted-by": "publisher", "first-page": "39", "DOI": "10.1016/S0009-9236(98)90020-0", "volume": "64", "author": "E.D. Kharasch", "year": "1998", "unstructured": "Kharasch, E.D., D.C. Hankins, P.J. Baxter, and K.E. Thummel (1998). Single-dose disulfiram does not inhibit CYP2A6 activity. Clin. Pharmacol. Ther. 64, 39\u201345.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR307", "first-page": "786", "volume": "29", "author": "S.E. Murphy", "year": "2001", "unstructured": "Murphy, S.E., L.M. Johnson, L.M. Losey, S.G. Carmella, and S.S. Hecht (2001). Consumption of watercress fails to alter coumarin metabolism in humans. Drug Metab. Dispos. 29, 786\u2013788.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR308", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1006/abbi.1997.9964", "volume": "341", "author": "A.J. Draper", "year": "1997", "unstructured": "Draper, A.J., A. Madan, and A. Parkinson (1997). Inhibition of coumarin 7-hydroxylase activity in human liver microsomes. Arch. Biochem. Biophys. 341, 47\u201361.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR309", "first-page": "897", "volume": "26", "author": "W.J. Zhang", "year": "2001", "unstructured": "Zhang, W.J., T. Kilicarslan, R.F. Tyndale, and E.M. Sellers (2001). Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro. Drug Metab. Dispos. 26, 897\u2013902.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR310", "first-page": "217", "volume": "29", "author": "P. Taavitsainen", "year": "2001", "unstructured": "Taavitsainen, P., R. Juvonen, and O. Pelkonen (2001). In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor. trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene. Drug Metab. Dispos. 29, 217\u2013222.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR311", "first-page": "1407", "volume": "25", "author": "L.L. Koenigs", "year": "1997", "unstructured": "Koenigs, L.L., R.M. Peter, S.J. Thompson, A.E. Rettie, and W.F. Trager (1997). Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen. Drug Metab. Dispos. 25, 1407\u20131415.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR312", "doi-asserted-by": "publisher", "first-page": "35", "DOI": "10.1067/mcp.2000.107651", "volume": "68", "author": "E.M. Sellers", "year": "2000", "unstructured": "Sellers, E.M., H.L. Kaplan, and R.F. Tyndale (2000). Inhibition of cytochrome P450 2A6 increases nicotine\u2019s oral bioavailability and decreases smoking. Clin. Pharmacol. Ther. 68, 35\u201343.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR313", "doi-asserted-by": "publisher", "first-page": "10047", "DOI": "10.1021/bi980003c", "volume": "37", "author": "L.L. Koenigs", "year": "1998", "unstructured": "Koenigs, L.L. and W.F. Trager (1998). Mechanism-based inactivation of P450 2A6 by furanocoumarins. Biochemistry 37, 10047\u201310061.", "journal-title": "Biochemistry"}, {"key": "10_CR314", "first-page": "701", "volume": "26", "author": "S.C. Khojasteh-Bakht", "year": "1998", "unstructured": "Khojasteh-Bakht, S.C., L.L. Koenigs, R.M. Peter, W.F. Trager, and S.D. Nelson (1998). (R)-(+)-Menthofuran is a potent, mechanism-based inactivator of human liver cytochrome P450 2A6. Drug Metab. Dispos. 26, 701\u2013704.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR315", "doi-asserted-by": "publisher", "first-page": "799", "DOI": "10.1007/s00228-001-0396-3", "volume": "57", "author": "X. Wen", "year": "2002", "unstructured": "Wen, X., J.S. Wang, P.J. Neuvonen, and J.T. Backman (2002). Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes. Eur. J. Clin. Pharmacol. 57, 799\u2013804.", "journal-title": "Eur. J. Clin. Pharmacol."}, {"key": "10_CR316", "doi-asserted-by": "publisher", "first-page": "185", "DOI": "10.1517/14622416.3.2.185", "volume": "3", "author": "L.A. Howard", "year": "2002", "unstructured": "Howard, L.A., E.M. Sellers, and R.F. Tyndale (2002). The role of pharmacogenetically-variable cytochrome P450 enzymes in drug abuse and dependence. Pharmacogenomics 3, 185\u2013199.", "journal-title": "Pharmacogenomics"}, {"key": "10_CR317", "doi-asserted-by": "publisher", "first-page": "96", "DOI": "10.1002/1097-0215(20010320)95:2<96::AID-IJC1017>3.0.CO;2-2", "volume": "95", "author": "W. Tan", "year": "2001", "unstructured": "Tan, W., G.F. Chen, D.Y. Xing, C.Y. Song, F.F. Kadlubar, and D.X. Lin (2001). Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population. Int. J. Cancer 95, 96\u2013101.", "journal-title": "Int. J. Cancer"}, {"key": "10_CR318", "first-page": "795", "volume": "5", "author": "S. Satarug", "year": "1996", "unstructured": "Satarug, S., M.A. Lang, P. Yongvanit, P. Sithithaworn, E. Mairiang, P. Mairiang et al. (1996). Induction of cytochrome P450 2A6 expression in humans by the carcinogenic parasite infection, opisthorchiasis viverrini. Cancer Epidemiol. Biomarkers Prev. 5, 795\u2013800.", "journal-title": "Cancer Epidemiol. Biomarkers Prev."}, {"key": "10_CR319", "doi-asserted-by": "publisher", "first-page": "177", "DOI": "10.1016/S0300-483X(97)00119-4", "volume": "123", "author": "M. Pasanen", "year": "1997", "unstructured": "Pasanen, M., Z. Rannala, A. Tooming, E.A. Sotaniemi, O. Pelkonen, and A. Rautio (1997). Hepatitis A impairs the function of human hepatic CYP2A6 in vivo. Toxicology 123, 177\u2013184.", "journal-title": "Toxicology"}, {"key": "10_CR320", "doi-asserted-by": "publisher", "first-page": "1407", "DOI": "10.1016/S0006-2952(99)00015-5", "volume": "57", "author": "S. Koskela", "year": "1999", "unstructured": "Koskela, S., J. Hakkola, J. Hukkanen, O. Pelkonen, M. Sorri, A. Saranen et al. (1999). Expression of CYP2A genes in human liver and extrahepatic tissues. Biochem. Pharmacol. 57, 1407\u20131413.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR321", "doi-asserted-by": "publisher", "first-page": "321", "DOI": "10.1016/S0014-5793(99)01364-2", "volume": "460", "author": "M. Oscarson", "year": "1999", "unstructured": "Oscarson, M., R.A. McLellan, H. Gullsten, J.A.G. Agundez, J. Benitez, A. Rautio et al. (1999). Identification and characterisation of novel polymorphisms in the CYP2A locus: Implications for nicotine metabolism. FEBS Lett. 460, 321\u2013327.", "journal-title": "FEBS Lett"}, {"key": "10_CR322", "first-page": "651", "volume": "57", "author": "P. Fernandez-Salguero", "year": "1995", "unstructured": "Fernandez-Salguero, P., S.M.G. Hoffman, S. Cholerton, H. Mohrenweiser, H. Raunio, A. Rautio et al. (1995). A genetic polymorphism in coumarin 7-hydroxylation. Sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. Am. J. Hum. Genet. 57, 651\u2013660.", "journal-title": "Am. J. Hum. Genet."}, {"key": "10_CR323", "doi-asserted-by": "publisher", "first-page": "1407", "DOI": "10.1016/S0006-2952(99)00015-5", "volume": "57", "author": "S. Koskela", "year": "1999", "unstructured": "Koskela, S., J. Hakkola, J. Hukkanen, O. Pelkonen, M. Sorri, A. Saranen et al. (1999). Expression of CYP2A genes in human liver and extrahepatic tissues. Biochem. Pharmacol. 57, 1407\u20131413.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR324", "doi-asserted-by": "publisher", "first-page": "416", "DOI": "10.1124/jpet.302.2.416", "volume": "302", "author": "X. Zhang", "year": "2002", "unstructured": "Zhang, X., T. Su, Q.Y. Zhang, J. Gu, M. Caggana, H. Li et al. (2002). Genetic polymorphisms of the human CYP2A13 gene: Identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant. J. Pharmacol. Exp. Ther. 302, 416\u2013423.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR325", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1080/0049825021000022302", "volume": "33", "author": "L.B. Weymarn Von", "year": "2003", "unstructured": "Von Weymarn, L.B. and S.E. Murphy (2003). CYP2A13-catalysed coumarin metabolism: Comparison with CYP2A5 and CYP2A6. Xenobiotica 33, 73\u201381.", "journal-title": "Xenobiotica"}, {"key": "10_CR326", "first-page": "1048", "volume": "21", "author": "M. Mimura", "year": "1993", "unstructured": "Mimura, M., T. Baba, Y. Yamazaki, S. Ohmori, Y. Inui, F.J. Gonzalez et al. (1993). Characterization of cytochrome P450 2B6 in human liver microsomes. Drug Metab. Dispos. 21, 1048\u20131056.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR327", "doi-asserted-by": "publisher", "first-page": "391", "DOI": "10.1080/20024091064273", "volume": "32", "author": "J. Hukkanen", "year": "2002", "unstructured": "Hukkanen, J., A. Pelkonen, J. Hakkola, and H. Raunio (2002). Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit. Rev. Toxicol. 32, 391\u2013411.", "journal-title": "Crit. Rev. Toxicol."}, {"key": "10_CR328", "doi-asserted-by": "publisher", "first-page": "569", "DOI": "10.1016/0006-291X(74)90278-2", "volume": "60", "author": "T.A. Hoeven van der", "year": "1974", "unstructured": "van der Hoeven, T.A., D.A. Haugen, and M.J. Coon (1974). Cytochrome P-450 purified to apparent homogeneity from phenobarbital-induced rabbit liver microsomes: Catalytic activity and other properties. Biochem. Biophys. Res. Commun. 60, 569\u2013575.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR329", "doi-asserted-by": "publisher", "first-page": "8", "DOI": "10.1016/0006-291X(74)90164-8", "volume": "60", "author": "Y. Imai", "year": "1974", "unstructured": "Imai, Y. and R. Sato (1974). A gel-electrophoretically homogeneous preparation of cytochrome P-450 from liver microsomes of phenobarbital-pretreated rabbits. Biochem. Biophys. Res. Commun. 60, 8\u201314.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR330", "doi-asserted-by": "publisher", "first-page": "983", "DOI": "10.1073/pnas.82.4.983", "volume": "82", "author": "I.R. Phillips", "year": "1985", "unstructured": "Phillips, I.R., E.A. Shephard, A. Ashworth, and B.R. Rabin (1985). Isolation and sequence of a human cytochrome P-450 cDNA clone. Proc. Natl. Acad. Sci. USA 82, 983\u2013987.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR331", "first-page": "517", "volume": "27", "author": "D.M. Stresser", "year": "1999", "unstructured": "Stresser, D.M. and D. Kupfer (1999). Monospecific antipeptide antibody to cytochrome P-450 2B6. Drug Metab. Dispos. 27, 517\u2013525.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR332", "first-page": "985", "volume": "25", "author": "E.L. Code", "year": "1997", "unstructured": "Code, E.L., C.L. Crespi, B.W. Penman, F.J. Gonzalez, T.K.H. Chang, and D.J. Waxman (1997). Human cytochrome P4502B6. Interindividual hepatic expression, substrate specificity, and role in procarcinogen activation. Drug Metab. Dispos. 25, 985\u2013993.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR333", "first-page": "1253", "volume": "286", "author": "S. Ekins", "year": "1998", "unstructured": "Ekins, S., M. VandenBranden, B.J. Ring, J.S. Gillespie, T.J. Yang, H.V. Gelboin et al. (1998). Further characterization of the expression in liver and catalytic activity of CYP2B6. J. Pharmacol. Exp. Ther. 286, 1253\u20131259.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR334", "doi-asserted-by": "publisher", "first-page": "1041", "DOI": "10.1016/0006-2952(96)00052-4", "volume": "51", "author": "S. Imaoka", "year": "1996", "unstructured": "Imaoka, S., T. Yamada, T. Hiroi, K. Hayashi, T. Sakaki, Y. Yabusaki et al. (1996). Multiple forms of human P450 expressed in Saccharomyces cerevisiae: Systematic characterization and comparison with those of the rat. Biochem. Pharmacol. 51, 1041\u20131050.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR335", "first-page": "655", "volume": "27", "author": "P. Roy", "year": "1999", "unstructured": "Roy, P., L.J. Yu, C.L. Crespi, and D.J. Waxman (1999). Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles. Drug Metab. Dispos. 27, 655\u2013666.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR336", "doi-asserted-by": "publisher", "first-page": "295", "DOI": "10.1097/00008571-199906000-00004", "volume": "9", "author": "L. Gervot", "year": "1999", "unstructured": "Gervot, L., B. Rochat, J.C. Gautier, F. Bohnenstengel, H. Kroemer, V. de Berardinis et al. (1999). Human CYP2B6: Expression, inducibility and catalytic activities. Pharmacogenetics 9, 295\u2013306.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR337", "doi-asserted-by": "publisher", "first-page": "206", "DOI": "10.1006/abbi.2000.1708", "volume": "376", "author": "I.H. Hanna", "year": "2000", "unstructured": "Hanna, I.H., J.R. Reed, F.P. Guengerich, and P.F. Hollenberg (2000). Expression of human cytochrome P450 2B6 in Escherichia coli: Characterization of catalytic activity and expression levels in human liver. Arch. Biochem. Biophys. 376, 206\u2013216.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR338", "doi-asserted-by": "publisher", "first-page": "6043", "DOI": "10.1074/jbc.274.10.6043", "volume": "274", "author": "T. Sueyoshi", "year": "1999", "unstructured": "Sueyoshi, T., T. Kawamoto, I. Zelko, P. Honkakoski, and M. Neigishi (1999). The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J. Biol. Chem. 274, 6043\u20136046.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR339", "doi-asserted-by": "publisher", "first-page": "227", "DOI": "10.1016/S0014-5793(98)00746-7", "volume": "431", "author": "R. Jover", "year": "1998", "unstructured": "Jover, R., R. Bort, M.J. Gomezlechon, and J.V. Castell (1998). Re-expression of C/EBP\u03b1 induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells. FEBS Lett. 431, 227\u2013230.", "journal-title": "FEBS Lett"}, {"key": "10_CR340", "first-page": "427", "volume": "60", "author": "B. Goodwin", "year": "2001", "unstructured": "Goodwin, B., L.B. Moore, C.M. Stoltz, D.D. McKee, and S.A. Kliewer (2001). Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor. Mol. Pharmacol. 60, 427\u2013431.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR341", "doi-asserted-by": "publisher", "first-page": "259", "DOI": "10.1038/nrd753", "volume": "1", "author": "T.M. Willson", "year": "2002", "unstructured": "Willson, T.M. and S.A. Kliewer (2002). PXR, CAR and drug metabolism. Nat. Rev. Drug Discov. 1, 259\u2013266.", "journal-title": "Nat. Rev. Drug Discov."}, {"key": "10_CR342", "doi-asserted-by": "publisher", "first-page": "366", "DOI": "10.1124/mol.62.2.366", "volume": "62", "author": "J. Makinen", "year": "2002", "unstructured": "Makinen, J., C. Frank, J. Jyrkkarinne, J. Gynther, C. Carlberg, and P. Honkakoski (2002). Modulation of mouse and human phenobarbital-responsive enhancer module by nuclear receptors. Mol. Pharmacol. 62, 366\u2013378.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR343", "doi-asserted-by": "publisher", "first-page": "25125", "DOI": "10.1074/jbc.M201323200", "volume": "277", "author": "L. Drocourt", "year": "2002", "unstructured": "Drocourt, L., J.C. Ourlin, J.M. Pascussi, P. Maurel, and M.J. Vilarem (2002). Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J. Biol. Chem. 277, 25125\u201325132.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR344", "doi-asserted-by": "publisher", "first-page": "7", "DOI": "10.1124/dmd.31.1.7", "volume": "31", "author": "T.K. Chang", "year": "2003", "unstructured": "Chang, T.K., S.M. Bandiera, and J. Chen (2003). Constitutive androstane receptor and pregnane X receptor gene expression in human liver: Interindividual variability and correlation with CYP2B6 mRNA levels. Drug Metab. Dispos. 31, 7\u201310.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR345", "doi-asserted-by": "publisher", "first-page": "17277", "DOI": "10.1074/jbc.M300138200", "volume": "278", "author": "J.M. Maglich", "year": "2003", "unstructured": "Maglich, J.M., D.J. Parks, L.B. Moore, J.L. Collins, B. Goodwin, A.N. Billin et al. (2003). Identification of a novel human CAR agonist and its use in the identification of CAR target genes. J. Biol. Chem. 278, 17277\u201317283.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR346", "doi-asserted-by": "publisher", "first-page": "14146", "DOI": "10.1074/jbc.M212482200", "volume": "278", "author": "H. Wang", "year": "2003", "unstructured": "Wang, H., S. Faucette, T. Sueyoshi, R. Moore, S. Ferguson, M. Negishi et al. (2003). A novel distal enhancer module regulated by PXR/CAR is essential for the maximal induction of CYP2B6 gene expression. J. Biol. Chem. 278, 14146\u201314152.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR347", "doi-asserted-by": "publisher", "first-page": "189", "DOI": "10.1093/nar/18.1.189", "volume": "18", "author": "J.S. Miles", "year": "1990", "unstructured": "Miles, J.S., A.W. McLaren, F.J. Gonzalez, and C.R. Wolf (1990). Alternative splicing in the human cytochrome P450IIB6 gene: Use of a cryptic exon within intron 3 and splice acceptor site within exon 4. Nucleic Acids Res. 18, 189.", "journal-title": "Nucleic Acids Res"}, {"key": "10_CR348", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1016/S0076-6879(02)57664-3", "volume": "357", "author": "U.M. Zanger", "year": "2002", "unstructured": "Zanger, U.M., J. Fischer, K. Klein, and T. Lang (2002). Detection of single nucleotide polymorphisms in CYP2B6 gene. Meth. Enzymol. 357, 45\u201353.", "journal-title": "Meth. Enzymol."}, {"key": "10_CR349", "doi-asserted-by": "publisher", "first-page": "399", "DOI": "10.1097/00008571-200107000-00004", "volume": "11", "author": "T. Lang", "year": "2001", "unstructured": "Lang, T., K. Klein, J. Fischer, A.K. Nussler, P. Neuhaus, U. Hofmann et al. (2001). Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics 11, 399\u2013415.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR350", "doi-asserted-by": "publisher", "first-page": "1256", "DOI": "10.1006/bbrc.2001.4524", "volume": "281", "author": "N. Ariyoshi", "year": "2001", "unstructured": "Ariyoshi, N., M. Miyazaki, K. Toide, Y. Sawamura, and T. Kamataki (2001). A single nucleotide polymorphism of CYP2B6 found in Japanese enhances catalytic activity by autoactivation. Biochem. Biophys. Res. Commun. 281, 1256\u20131260.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR351", "first-page": "7929", "volume": "251", "author": "D.A. Haugen", "year": "1976", "unstructured": "Haugen, D.A. and M.J. Coon (1976). Properties of electrophoretically homogenous phenobarbitalinducible and \u03b2-naphthoflavone-inducible forms of liver microsomal cytochrome P-450. J. Biol. Chem. 251, 7929\u20137939.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR352", "first-page": "1", "volume": "9", "author": "M.J. Coon", "year": "1981", "unstructured": "Coon, M.J. (1981). The 1980 Bernard B. Brodie Award lecture. Drug metabolism by cytochrome P-450: Progress and perspectives. Drug Metab. Dispos. 9, 1\u20134.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR353", "first-page": "3970", "volume": "252", "author": "F.P. Guengerich", "year": "1977", "unstructured": "Guengerich, F.P. (1977). Separation and purification of multiple forms of microsomal cytochrome P-450. Activities of different forms of cytochrome P-450 towards several compounds of environmental interest. J. Biol. Chem. 252, 3970\u20133979.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR354", "first-page": "337", "volume": "2", "author": "A.Y.H. Lu", "year": "1978", "unstructured": "Lu, A.Y.H. and S.B. West (1978). Reconstituted mammalian mixed-function oxidases: Requirements, specificities and other properties. Pharmacol. Ther. 2, 337\u2013338.", "journal-title": "Pharmacol. Ther."}, {"key": "10_CR355", "doi-asserted-by": "publisher", "first-page": "719", "DOI": "10.1081/DMR-100101942", "volume": "31", "author": "S. Ekins", "year": "1999", "unstructured": "Ekins, S. and S.A. Wrighton (1999). The role of CYP2B6 in human xenobiotic metabolism. Drug Metab. Rev. 31, 719\u2013754.", "journal-title": "Drug Metab. Rev."}, {"key": "10_CR356", "first-page": "5629", "volume": "53", "author": "T.K.H. Chang", "year": "1993", "unstructured": "Chang, T.K.H., G.F. Weber, C.L. Crespi, and D.J. Waxman (1993). Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes. Cancer Res. 53, 5629\u20135637.", "journal-title": "Cancer Res"}, {"key": "10_CR357", "doi-asserted-by": "publisher", "first-page": "53", "DOI": "10.1038/sj.tpj.6500157", "volume": "3", "author": "H.J. Xie", "year": "2003", "unstructured": "Xie, H.J., U. Yasar, S. Lundgren, L. Griskevicius, Y. Terelius, M. Hassan et al. (2003). Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation. Pharmacogenomics J. 3, 53\u201361.", "journal-title": "Pharmacogenomics J"}, {"key": "10_CR358", "first-page": "887", "volume": "29", "author": "Y. Yanagihara", "year": "2001", "unstructured": "Yanagihara, Y., S. Kariya, M. Ohtani, K. Uchino, T. Aoyama, Y. Yamamura et al. (2001). Involvement of CYP2B6 in N-demethylation of ketamine in human liver microsomes. Drug Metab. Dispos. 29, 887\u2013890.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR359", "doi-asserted-by": "publisher", "first-page": "110", "DOI": "10.1097/00000542-200101000-00021", "volume": "94", "author": "M.H. Court", "year": "2001", "unstructured": "Court, M.H., S.X. Duan, L.M. Hesse, K. Venkatakrishnan, and D.J. Greenblatt (2001). Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes. Anesthesiology 94, 110\u2013119.", "journal-title": "Anesthesiology"}, {"key": "10_CR360", "first-page": "948", "volume": "24", "author": "H. Heyn", "year": "1996", "unstructured": "Heyn, H., R.B. White, and J.C. Stevens (1996). Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin. Drug Metab. Dispos. 24, 948\u2013954.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR361", "first-page": "775", "volume": "26", "author": "J.W. Ko", "year": "1998", "unstructured": "Ko, J.W., Z. Desta, and D.A. Flockhart (1998). Human N-demethylation of (S)-mephenytoin by cytochrome P450s 2C9 and 2B6. Drug Metab. Dispos. 26, 775\u2013778.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR362", "doi-asserted-by": "publisher", "first-page": "165", "DOI": "10.1097/00008571-199706000-00001", "volume": "7", "author": "S. Ekins", "year": "1997", "unstructured": "Ekins, S., M. VandenBranden, B.J. Ring, and S.A. Wrighton (1997). Examination of purported probes of human CYP2B6. Pharmacogenetics 7, 165\u2013179.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR363", "doi-asserted-by": "publisher", "first-page": "455", "DOI": "10.1006/bbrc.1995.1991", "volume": "212", "author": "N. Ariyoshi", "year": "1995", "unstructured": "Ariyoshi, N., K. Oguri, N. Koga, H. Yoshimura, and Y. Funae (1995). Metabolism of highly persistent PCB congener, 2, 4,5, 2\u2032,4\u2032,5\u2032-hexachlorobiphenyl, by human CYP2B6. Biochem. Biophys. Res. Commun. 212, 455\u2013460.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR364", "doi-asserted-by": "publisher", "first-page": "361", "DOI": "10.1080/004982599238560", "volume": "29", "author": "D.F.V. Lewis", "year": "1999", "unstructured": "Lewis, D.F.V., B.G. Lake, M. Dickins, P.J. Eddershaw, M.H. Tarbit, and P.S. Goldfarb (1999). Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: Evaluation of CYP2B6 substrate characteristics, the cytochrome b 5 binding site and comparisons with CYP2B1 and CYP2B4. Xenobiotica 29, 361\u2013393.", "journal-title": "Xenobiotica"}, {"key": "10_CR365", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1515/DMDI.2001.18.3-4.221", "volume": "18", "author": "D.F. Lewis", "year": "2001", "unstructured": "Lewis, D.F., S. Modi, and M. Dickins (2001). Quantitative structure-activity relationships (QSARs) within substrates of human cytochromes P450 involved in drug metabolism. Drug Metabol. Drug Interact. 18, 221\u2013242.", "journal-title": "Drug Metabol. Drug Interact."}, {"key": "10_CR366", "doi-asserted-by": "publisher", "first-page": "327", "DOI": "10.1007/s00894-002-0104-y", "volume": "8", "author": "C. Bathelt", "year": "2002", "unstructured": "Bathelt, C., R.D. Schmid, and J. Pleiss (2002). Regioselectivity of CYP2B6: Homology modeling, molecular dynamics simulation, docking. J. Mol. Model. (Online) 8, 327\u2013335.", "journal-title": "J. Mol. Model."}, {"key": "10_CR367", "first-page": "1141", "volume": "290", "author": "T.L. Domanski", "year": "1999", "unstructured": "Domanski, T.L., K.M. Schultz, F. Roussel, J.C. Stevens, and J.R. Halpert (1999). Structure-function analysis of human cytochrome P-450 2B6 using a novel substrate, site-directed mutagenesis, and molecular modeling. J. Pharmacol. Exp. Ther. 290, 1141\u20131147.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR368", "doi-asserted-by": "publisher", "first-page": "13121", "DOI": "10.1073/pnas.2133986100", "volume": "100", "author": "E.E. Scott", "year": "2003", "unstructured": "Scott, E.E., Y.A. He, M.A. Wester, C.C. Clin, J.R. Halpert, E.F. Johnson, and C.D. Stout (2003). An open conformation of mammalian cytochrome P450 2B4 at 1.6-\u00c5 resolution. Proc. Natl. Acad. Sci. U.S.A. 100, 13121\u201313122.", "journal-title": "Proc. Natl. Acad. Sci. U.S.A."}, {"key": "10_CR369", "first-page": "390", "volume": "25", "author": "Z. Guo", "year": "1997", "unstructured": "Guo, Z., S. Raeissi, R.B. White, and J.C. Stevens (1997). Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes. Drug Metab. Dispos. 25, 390\u2013393.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR370", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1016/S0003-9861(02)00259-X", "volume": "403", "author": "M. Stiborova", "year": "2002", "unstructured": "Stiborova, M., L. Borek-Dohalska, P. Hodek, J. Mraz, and E. Frei (2002). New selective inhibitors of cytochromes P450 2B and their application to antimutagenesis of tamoxifen. Arch. Biochem. Biophys. 403, 41\u201349.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR371", "doi-asserted-by": "publisher", "first-page": "525", "DOI": "10.1124/dmd.30.5.525", "volume": "30", "author": "J.M. Rae", "year": "2002", "unstructured": "Rae, J.M., N.V. Soukhova, D.A. Flockhart, and Z. Desta (2002). Triethylenethiophosphoramide is a specific inhibitor of cytochrome P4502B6: Implications for cyclophosphamide metabolism. Drug Metab. Dispos. 30, 525\u2013530.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR372", "doi-asserted-by": "publisher", "first-page": "549", "DOI": "10.1124/jpet.300.2.549", "volume": "300", "author": "U.M. Kent", "year": "2002", "unstructured": "Kent, U.M., D.E. Mills, R.V. Rajnarayanan, W.L. Alworth, and P.F. Hollenberg (2002). Effect of 17\u03b1-ethynylestradiol on activities of cytochrome P450 2B (P450 2B) enzymes: Characterization of inactivation of P450s 2B1 and 2B6 and identification of metabolites. J. Pharmacol. Exp. Ther. 300, 549\u2013558.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR373", "doi-asserted-by": "publisher", "first-page": "753", "DOI": "10.1007/BF00541938", "volume": "26", "author": "A. K\u00fcpfer", "year": "1984", "unstructured": "K\u00fcpfer, A. and R. Preisig (1984). Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in man. Eur. J. Clin. Pharmacol. 26, 753\u2013759.", "journal-title": "Eur. J. Clin. Pharmacol."}, {"key": "10_CR374", "doi-asserted-by": "crossref", "first-page": "773", "DOI": "10.1038/clpt.1984.256", "volume": "36", "author": "P.J. Wedlund", "year": "1984", "unstructured": "Wedlund, P.J., W.S. Aslanian, C.B. McAllister, G.R. Wilkinson, and R.A. Branch (1984). Mephenytoin hydroxylation deficiency in Caucasians: Frequency of a new oxidative drug metabolism polymorphism. Clin. Pharmacol. Ther. 36, 773\u2013780.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR375", "first-page": "1112", "volume": "241", "author": "R.G. Knodell", "year": "1987", "unstructured": "Knodell, R.G., S.D. Hall, G.R. Wilkinson, and F.P. Guengerich (1987). Hepatic metabolism of tolbutamide: Characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition. J. Pharmacol. Exp. Ther. 241, 1112\u20131119.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR376", "doi-asserted-by": "publisher", "first-page": "4993", "DOI": "10.1021/bi00438a014", "volume": "28", "author": "W.R. Brian", "year": "1989", "unstructured": "Brian, W.R., P.K. Srivastava, D.R. Umbenhauer, R.S. Lloyd, and F.P. Guengerich (1989). Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae. Biochemistry 28, 4993\u20134999.", "journal-title": "Biochemistry"}, {"key": "10_CR377", "doi-asserted-by": "publisher", "first-page": "6929", "DOI": "10.1021/bi00418a039", "volume": "27", "author": "C. Ged", "year": "1988", "unstructured": "Ged, C., D.R. Umbenhauer, T.M. Bellew, R.W. Bork, P.K. Srivastava, N. Shinriki et al. (1988). Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4\u2032-hydroxylase. Biochemistry 27, 6929\u20136940.", "journal-title": "Biochemistry"}, {"key": "10_CR378", "doi-asserted-by": "publisher", "first-page": "3247", "DOI": "10.1021/bi00227a012", "volume": "30", "author": "M. Romkes", "year": "1991", "unstructured": "Romkes, M., M.B. Faletto, J.A. Blaisdell, J.L. Raucy, and J.A. Goldstein (1991). Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry 30, 3247\u20133255.", "journal-title": "Biochemistry"}, {"key": "10_CR379", "doi-asserted-by": "publisher", "first-page": "240", "DOI": "10.1006/abbi.1993.1506", "volume": "306", "author": "S.A. Wrighton", "year": "1993", "unstructured": "Wrighton, S.A., J.C. Stevens, G.W. Becker, and M. VandenBranden (1993). Isolation and characterization of human liver cytochrome P450 2C19: Correlation between 2C19 and S-mephenytoin 4\u2032-hydroxylation. Arch. Biochem. Biophys. 306, 240\u2013245.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR380", "doi-asserted-by": "publisher", "first-page": "1743", "DOI": "10.1021/bi00173a017", "volume": "33", "author": "J.A. Goldstein", "year": "1994", "unstructured": "Goldstein, J.A., M.B. Faletto, M. Romkes-Sparks, T. Sullivan, S. Kitareewan, J.L. Raucy et al. (1994). Evidence that CYP2C19 is the major (S)-mephenytoin 4\u2032-hydroxylase in humans. Biochemistry 33, 1743\u20131752.", "journal-title": "Biochemistry"}, {"key": "10_CR381", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1097/00008571-199602000-00002", "volume": "6", "author": "D.R. Nelson", "year": "1996", "unstructured": "Nelson, D.R., L. Koymans, T. Kamataki, J.J. Stegeman, R. Feyereisen, D.J. Waxman et al. (1996). P450 superfamily: Update on new sequences, gene mapping, accession numbers, and nomenclature. Pharmacogenetics 6, 1\u201342.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR382", "doi-asserted-by": "publisher", "first-page": "597", "DOI": "10.1097/00008571-200110000-00006", "volume": "11", "author": "D. Dai", "year": "2001", "unstructured": "Dai, D., D.C. Zeldin, J.A. Blaisdell, B. Chanas, S.J. Coulter, B.I. Ghanayem et al. (2001). Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid. Pharmacogenetics 11, 597\u2013607.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR383", "doi-asserted-by": "publisher", "first-page": "289", "DOI": "10.1002/(SICI)1099-0461(1999)13:6<289::AID-JBT1>3.0.CO;2-N", "volume": "13", "author": "T.S. Klose", "year": "1999", "unstructured": "Klose, T.S., J.A. Blaisdell, and J.A. Goldstein (1999). Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs. J. Biochem. Mol. Toxicol. 13, 289\u2013295.", "journal-title": "J. Biochem. Mol. Toxicol."}, {"key": "10_CR384", "doi-asserted-by": "publisher", "first-page": "1579", "DOI": "10.1016/S0006-2952(02)01354-0", "volume": "64", "author": "N. Bahadur", "year": "2002", "unstructured": "Bahadur, N., J.B. Leathart, E. Mutch, D. Steimel-Crespi, S.A. Dunn, R. Gilissen et al. (2002). CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6\u03b1-hydroxylase activity in human liver microsomes. Biochem. Pharmacol. 64, 1579\u20131589.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR385", "first-page": "242", "volume": "29", "author": "S. Gerbal-Chaloin", "year": "2001", "unstructured": "Gerbal-Chaloin, S., J.M. Pascussi, L. Pichard-Garcia, M. Daujat, F. Waechter, J.M. Fabre et al. (2001). Induction of CYP2C genes in human hepatocytes in primary culture. Drug Metab. Dispos. 29, 242\u2013251.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR386", "doi-asserted-by": "publisher", "first-page": "1427", "DOI": "10.1248/bpb.24.1427", "volume": "24", "author": "A. Soyama", "year": "2001", "unstructured": "Soyama, A., Y. Saito, N. Hanioka, N. Murayama, O. Nakajima, N. Katori et al. (2001). Nonsynonymous single nucleotide alterations found in the CYP2C8 gene result in reduced in vitro paclitaxel metabolism. Biol. Pharm. Bull. 24, 1427\u20131430.", "journal-title": "Biol. Pharm. Bull."}, {"key": "10_CR387", "first-page": "5543", "volume": "54", "author": "A. Rahman", "year": "1994", "unstructured": "Rahman, A., K.R. Korzekwa, J. Grogan, F.J. Gonzalez, and J.W. Harris (1994). Selective biotransformation of taxol to 6\u03b1-hydroxytaxol by human cytochrome P450 2C8. Cancer Res. 54, 5543\u20135546.", "journal-title": "Cancer Res"}, {"key": "10_CR388", "doi-asserted-by": "publisher", "first-page": "305", "DOI": "10.1016/0003-9861(89)90112-4", "volume": "269", "author": "M.A. Leo", "year": "1989", "unstructured": "Leo, M.A., J.M. Lasker, J.L. Raucy, C.I. Kim, M. Black, and C.S. Lieber (1989). Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8. Arch. Biochem. Biophys. 269, 305\u2013312.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR389", "first-page": "1260", "volume": "27", "author": "H. Yamazaki", "year": "1999", "unstructured": "Yamazaki, H., A. Shibata, M. Suzuki, M. Nakajima, N. Shimada, F.P. Guengerich et al. (1999). Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P450 2C8 and 3A4 in human liver microsomes. Drug Metab. Dispos. 27, 1260\u20131266.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR390", "doi-asserted-by": "publisher", "first-page": "6363", "DOI": "10.1021/bi027391+", "volume": "42", "author": "C. Marques-Soares", "year": "2003", "unstructured": "Marques-Soares, C., S. Dijols, A.-C. Macherey, M.R. Wester, E.F. Johnson, P.M. Dansette et al. (2003). Sulfaphenazole derivatives as tools for comparing cytochrome P450 2C5 and human cytochrome P450 2Cs: Identification of a new high affinity substrate common to those CYP 2C enzymes. Biochemistry 42, 6363\u20136369.", "journal-title": "Biochemistry"}, {"key": "10_CR391", "doi-asserted-by": "publisher", "first-page": "9335", "DOI": "10.1021/bi034556l", "volume": "42", "author": "M.R. Wester", "year": "2003", "unstructured": "Wester, M.R., E.F. Johnson, C. Marques-Soares, P. Dansette, D. Mansuy, and C.D. Stout (2003). The structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3 \u00c5 resolution: Evidence for multiple substrate binding modes. Biochemistry 42, 9335\u20139345.", "journal-title": "Biochemistry"}, {"key": "10_CR392", "doi-asserted-by": "publisher", "first-page": "9497", "DOI": "10.1074/jbc.M312516200", "volume": "279", "author": "G.A. Schoch", "year": "2004", "unstructured": "Schoch, G.A., J.K. Yano, M.R. Wester, K.J. Griffin, C.D. Stout, and E.F. Johnson (2004). Structure of human microsomal cytochrome P450 2C8. Evidence for a peripheral fatty acid binding site. J. Biol. Chem. 279, 9497\u20139503.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR393", "doi-asserted-by": "publisher", "first-page": "3622", "DOI": "10.1021/jm010861y", "volume": "44", "author": "N.T. Ha-Duong", "year": "2001", "unstructured": "Ha-Duong, N.T., S. Dijols, C. Marques-Soares, C. Minoletti, P.M. Dansette, and D. Mansuy (2001). Synthesis of sulfaphenazole derivatives and their use as inhibitors and tools for comparing the active sites of human liver cytochromes P450 of the 2C subfamily. J. Med. Chem. 44, 3622\u20133631.", "journal-title": "J. Med. Chem."}, {"key": "10_CR394", "doi-asserted-by": "publisher", "first-page": "189", "DOI": "10.1006/abbi.2001.2511", "volume": "394", "author": "N.T. Ha-Duong", "year": "2001", "unstructured": "Ha-Duong, N.T., C. Marques-Soares, S. Dijols, M.A. Sari, P.M. Dansette, and D. Mansuy (2001). Interaction of new sulfaphenazole derivatives with human liver cytochrome P4502Cs: Structural determinants required for selective recognition by CYP2C9 and for inhibition of human CYP2Cs. Arch. Biochem. Biophys. 394, 189\u2013200.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR395", "doi-asserted-by": "publisher", "first-page": "219", "DOI": "10.1007/BF00614021", "volume": "9", "author": "W. Zilly", "year": "1975", "unstructured": "Zilly, W., D.D. Breimer, and E. Richter (1975). Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance. Eur. J. Clin. Pharmacol. 9, 219\u2013227.", "journal-title": "Eur. J. Clin. Pharmacol."}, {"key": "10_CR396", "doi-asserted-by": "publisher", "first-page": "1094", "DOI": "10.1021/bi00378a016", "volume": "26", "author": "D.R. Umbenhauer", "year": "1987", "unstructured": "Umbenhauer, D.R., M.V. Martin, R.S. Lloyd, and F.P. Guengerich (1987). Cloning and sequence determination of a complementary DNA related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylase. Biochemistry 26, 1094\u20131099.", "journal-title": "Biochemistry"}, {"key": "10_CR397", "first-page": "845", "volume": "245", "author": "R.G. Knodell", "year": "1988", "unstructured": "Knodell, R.G., R.K. Dubey, G.R. Wilkinson, and F.P. Guengerich (1988). Oxidative metabolism of hexobarbital in human liver: Relationship to polymorphic S-mephenytoin 4-hydroxylation. J. Pharmacol. Exp. Ther. 245, 845\u2013849.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR398", "first-page": "443", "volume": "35", "author": "T. Yasumori", "year": "1989", "unstructured": "Yasumori, T., N. Murayama, Y. Yamazoe, A. Abe, Y. Nogi, T. Fukasawa et al. (1989). Expression of a human P-450IIC gene in yeast cells using galactose-inducible expression system. Mol. Pharmacol. 35, 443\u2013449.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR399", "first-page": "69", "volume": "40", "author": "P.K. Srivastava", "year": "1991", "unstructured": "Srivastava, P.K., C.-H. Yun, P.H. Beaune, C. Ged, and F.P. Guengerich (1991). Separation of human liver tolbutamine hydroxylase and (S)-mephenytoin 4\u2032-hydroxylase cytochrome P-450 enzymes. Mol. Pharmacol. 40, 69\u201379.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR400", "doi-asserted-by": "publisher", "first-page": "441", "DOI": "10.1097/00008571-199712000-00002", "volume": "7", "author": "J.M. Treluyer", "year": "1997", "unstructured": "Treluyer, J.M., G. Gueret, G. Cheron, M. Sonnier, and T. Cresteil (1997). Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in-vivo/in-vitro correlation and inducibility. Pharmacogenetics 7, 441\u2013452.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR401", "doi-asserted-by": "publisher", "first-page": "283", "DOI": "10.2165/00003088-200342030-00003", "volume": "42", "author": "S.S. Brenner", "year": "2003", "unstructured": "Brenner, S.S., C. Herrlinger, K. Dilger, T.E. Murdter, U. Hofmann, C. Marx et al. (2003). Influence of age and cytochrome P450 2C9 genotype on the steady-state disposition of diclofenac and celecoxib. Clin. Pharmacokinet. 42, 283\u2013292.", "journal-title": "Clin. Pharmacokinet."}, {"key": "10_CR402", "first-page": "347", "volume": "29", "author": "R.S. Obach", "year": "2001", "unstructured": "Obach, R.S., Q.Y. Zhang, D. Dunbar, and L.S. Kaminsky (2001). Metabolic characterization of the major human small intestinal cytochrome P450s. Drug Metab. Dispos. 29, 347\u2013352.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR403", "doi-asserted-by": "publisher", "first-page": "437", "DOI": "10.1111/j.1432-1033.1990.tb19140.x", "volume": "191", "author": "F. Morel", "year": "1990", "unstructured": "Morel, F., P.H. Beaune, D. Ratanasavanh, J.-P. Flinois, C.-S. Yang, F.P. Guengerich et al. (1990). Expression of cytochrome P-450 enzymes in cultured human hepatocytes. Eur. J. Biochem. 191, 437\u2013444.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR404", "doi-asserted-by": "publisher", "first-page": "475", "DOI": "10.1124/jpet.102.033837", "volume": "302", "author": "J.L. Raucy", "year": "2002", "unstructured": "Raucy, J.L., L. Mueller, K. Duan, S.W. Allen, S. Strom, and J.M. Lasker (2002). Expression and induction of CYP2C P450 enzymes in primary cultures of human hepatocytes. J. Pharmacol. Exp. Ther. 302, 475\u2013482.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR405", "doi-asserted-by": "publisher", "first-page": "209", "DOI": "10.1074/jbc.M107228200", "volume": "277", "author": "S. Gerbal-Chaloin", "year": "2002", "unstructured": "Gerbal-Chaloin, S., M. Daujat, J.M. Pascussi, L. Pichard-Garcia, M.J. Vilarem, and P. Maurel (2002). Transcriptional regulation of CYP2C9 gene. Role of glucocorticoid receptor and constitutive androstane receptor. J. Biol. Chem. 277, 209\u2013217.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR406", "doi-asserted-by": "publisher", "first-page": "737", "DOI": "10.1124/mol.62.3.737", "volume": "62", "author": "S.S. Ferguson", "year": "2002", "unstructured": "Ferguson, S.S., E.L. LeCluyse, M. Negishi, and J.A. Goldstein (2002). Regulation of human CYP2C9 by the constitutive androstane receptor: Discovery of a new distal binding site. Mol. Pharmacol. 62, 737\u2013746.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR407", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1016/S0304-4165(02)00483-X", "volume": "1619", "author": "J.M. Pascussi", "year": "2003", "unstructured": "Pascussi, J.M., S. Gerbal-Chaloin, L. Drocourt, P. Maurel, and M.J. Vilarem (2003). The expression of CYP2B6, CYP2C9 and CYP3A4 genes: A tangle of networks of nuclear and steroid receptors. Biochim. Biophys. Acta 1619, 243\u2013253.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "10_CR408", "doi-asserted-by": "publisher", "first-page": "8028", "DOI": "10.1021/bi00025a008", "volume": "34", "author": "G.C. Ibeanu", "year": "1995", "unstructured": "Ibeanu, G.C. and J.A. Goldstein (1995). Transcriptional regulation of human CYP2C genes: Functional comparison of CYP2C9 and CYP2C18 promoter regions. Biochemistry 34, 8028\u20138036.", "journal-title": "Biochemistry"}, {"key": "10_CR409", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.2337/diab.28.1.41", "volume": "28", "author": "J. Scott", "year": "1978", "unstructured": "Scott, J. and P.L. Poffenbarger (1978). Pharmacogenetics of tolbutamide metabolism in humans. Diabetes 28, 41\u201351.", "journal-title": "Diabetes"}, {"key": "10_CR410", "first-page": "1073", "volume": "27", "author": "S. Ohgiya", "year": "1992", "unstructured": "Ohgiya, S., M. Komori, H. Ohi, K. Shiramatsu, N. Shinriki, and T. Kamataki (1992). Six-base deletion occurring in messages of human cytochrome P-450 in the CYP2C subfamily results in reduction of tolbutamide hydroxylase activity. Biochem. Int. 27, 1073\u20131081.", "journal-title": "Biochem. Int."}, {"key": "10_CR411", "doi-asserted-by": "publisher", "first-page": "285", "DOI": "10.1097/00008571-199412000-00001", "volume": "4", "author": "J.A. Goldstein", "year": "1994", "unstructured": "Goldstein, J.A. and S.M.F. Demorais (1994). Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics 4, 285\u2013299.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR412", "doi-asserted-by": "publisher", "first-page": "103", "DOI": "10.1097/00008571-199704000-00003", "volume": "7", "author": "K. Inoue", "year": "1997", "unstructured": "Inoue, K., H. Yamazaki, K. Imiya, S. Akasaka, F.P. Guengerich, and T. Shimada (1997). Relationship between CYP2C9 and CYP2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4\u2032-hydroxylation in livers of Japanese and Caucasian populations. Pharmacogenetics 7, 103\u2013113.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR413", "doi-asserted-by": "publisher", "first-page": "251", "DOI": "10.1097/00008571-200204000-00010", "volume": "12", "author": "C.R. Lee", "year": "2002", "unstructured": "Lee, C.R., J.A. Goldstein, and J.A. Pieper (2002). Cytochrome P450 2C9 polymorphisms: A comprehensive review of the in-vitro and human data. Pharmacogenetics 12, 251\u2013263.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR414", "doi-asserted-by": "publisher", "first-page": "1257", "DOI": "10.1016/S0169-409X(02)00076-5", "volume": "54", "author": "H.G. Xie", "year": "2002", "unstructured": "Xie, H.G., H.C. Prasad, R.B. Kim, and C.M. Stein (2002). CYP2C9 allelic variants: Ethnic distribution and functional significance. Adv. Drug Deliv. Rev. 54, 1257\u20131270.", "journal-title": "Adv. Drug Deliv. Rev."}, {"key": "10_CR415", "doi-asserted-by": "crossref", "first-page": "382", "DOI": "10.1124/mol.60.2.382", "volume": "60", "author": "L.J. Dickmann", "year": "2001", "unstructured": "Dickmann, L.J., A.E. Rettie, M.B. Kneller, R.B. Kim, A.J. Wood, C.M. Stein et al. (2001). Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans. Mol. Pharmacol. 60, 382\u2013387.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR416", "doi-asserted-by": "publisher", "first-page": "175", "DOI": "10.1067/mcp.2001.117367", "volume": "70", "author": "M. Shintani", "year": "2001", "unstructured": "Shintani, M., I. Ieiri, K. Inoue, K. Mamiya, H. Ninomiya, N. Tashiro et al. (2001). Genetic polymorphisms and functional characterization of the 5\u2032-flanking region of the human CYP2C9 gene: In vitro and in vivo studies. Clin. Pharmacol. Ther. 70, 175\u2013182.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR417", "doi-asserted-by": "crossref", "first-page": "1841", "DOI": "10.1093/oxfordjournals.molbev.a003726", "volume": "18", "author": "S.C. Warner", "year": "2001", "unstructured": "Warner, S.C., C. Finta, and P.G. Zaphiropoulos (2001). Intergenic transcripts containing a novel human cytochrome P450 2C exon 1 spliced to sequences from the CYP2C9 gene. Mol. Biol. Evol. 18, 1841\u20131848.", "journal-title": "Mol. Biol. Evol."}, {"key": "10_CR418", "doi-asserted-by": "publisher", "first-page": "25", "DOI": "10.1016/S0006-291X(02)02592-5", "volume": "299", "author": "U. Yasar", "year": "2002", "unstructured": "Yasar, U., S. Lundgren, E. Eliasson, A. Bennet, B. Wiman, U. de Faire et al. (2002). Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms. Biochem. Biophys. Res. Commun. 299, 25\u201328.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR419", "doi-asserted-by": "publisher", "first-page": "525", "DOI": "10.1046/j.1365-2125.1998.00721.x", "volume": "45", "author": "J.O. Miners", "year": "1998", "unstructured": "Miners, J.O. and D.J. Birkett (1998). Cytochrome P4502C9: An enzyme of major importance in human drug metabolism. Br. J. Clin. Pharmacol. 45, 525\u2013538.", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "10_CR420", "doi-asserted-by": "publisher", "first-page": "31", "DOI": "10.1007/s002280100268", "volume": "57", "author": "G.M. Giancarlo", "year": "2001", "unstructured": "Giancarlo, G.M., K. Venkatakrishnan, B.W. Granda, L.L. von Moltke, and D.J. Greenblatt (2001). Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: Inhibition by sulfaphenazole, omeprazole, and ticlopidine. Eur. J. Clin. Pharmacol. 57, 31\u201336.", "journal-title": "Eur. J. Clin. Pharmacol."}, {"key": "10_CR421", "doi-asserted-by": "publisher", "first-page": "199", "DOI": "10.1006/abbi.2000.1705", "volume": "376", "author": "A.J. Draper", "year": "2000", "unstructured": "Draper, A.J. and B.D. Hammock (2000). Identification of CYP2C9 as a human liver microsomal linoleic acid epoxygenase. Arch. Biochem. Biophys. 376, 199\u2013205.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR422", "doi-asserted-by": "publisher", "first-page": "517", "DOI": "10.1016/S0006-2952(00)00356-7", "volume": "60", "author": "L.C. McSorley", "year": "2000", "unstructured": "McSorley, L.C. and A.K. Daly (2000). Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylation. Biochem. Pharmacol. 60, 517\u2013526.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR423", "doi-asserted-by": "publisher", "first-page": "84", "DOI": "10.1177/0091270002239710", "volume": "43", "author": "C.R. Lee", "year": "2003", "unstructured": "Lee, C.R., J.A. Pieper, R.F. Frye, A.L. Hinderliter, J.A. Blaisdell, and J.A. Goldstein (2003). Tolbutamide, flurbiprofen, and losartan as probes of CYP2C9 activity in humans. J. Clin. Pharmacol. 43, 84\u201391.", "journal-title": "J. Clin. Pharmacol."}, {"key": "10_CR424", "doi-asserted-by": "publisher", "first-page": "423", "DOI": "10.1046/j.1365-2125.2002.01660.x", "volume": "54", "author": "M. Sandberg", "year": "2002", "unstructured": "Sandberg, M., U. Yasar, P. Stromberg, J.O. Hoog, and E. Eliasson (2002). Oxidation of celecoxib by polymorphic cytochrome P450 2C9 and alcohol dehydrogenase. Br. J. Clin. Pharmacol. 54, 423\u2013429.", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "10_CR425", "doi-asserted-by": "publisher", "first-page": "223", "DOI": "10.1097/00008571-200104000-00006", "volume": "11", "author": "C. Tang", "year": "2001", "unstructured": "Tang, C., M. Shou, T.H. Rushmore, Q. Mei, P. Sandhu, E.J. Woolf et al. (2001). In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: Correlation with CYP2C9 genotype and in-vivo pharmacokinetics. Pharmacogenetics 11, 223\u2013235.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR426", "first-page": "567", "volume": "28", "author": "C.Y. Tang", "year": "2000", "unstructured": "Tang, C.Y., M.G. Shou, and A.D. Rodrigues (2000). Substrate-dependent effect of acetonitrile on human liver microsomal cytochrome P4502C9 (CYP2C9) activity. Drug Metab. Dispos. 28, 567\u2013572.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR427", "doi-asserted-by": "publisher", "first-page": "329", "DOI": "10.1006/abbi.1997.0125", "volume": "342", "author": "H. Yamazaki", "year": "1997", "unstructured": "Yamazaki, H., E.M.J. Gillam, M.-S. Dong, W.W. Johnson, F.P. Guengerich, and T. Shimada (1997). Reconstitution of recombinant human cytochrome P450 2C9 and comparison with cytochrome P450 and other forms: Effects of cytochrome P450:P450 and cytochrome P450:b 5 interactions. Arch. Biochem. Biophys. 342, 329\u2013337.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR428", "doi-asserted-by": "publisher", "first-page": "329", "DOI": "10.1006/prep.2001.1578", "volume": "24", "author": "H. Yamazaki", "year": "2002", "unstructured": "Yamazaki, H., T. Komatsu, K. Ohyama, M. Nakamura, S. Asahi, N. Shimada et al. (2002). Roles of NADPH-P450 reductase and apo-and holo-cytochrome b 5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli. Protein Expr. Purif. 24, 329\u2013337.", "journal-title": "Protein Expr. Purif."}, {"key": "10_CR429", "doi-asserted-by": "publisher", "first-page": "12852", "DOI": "10.1021/bi980674a", "volume": "37", "author": "W.L. Backes", "year": "1998", "unstructured": "Backes, W.L., C.J. Batie, and G.F. Cawley (1998). Interactions among P450 enzymes when combined in reconstituted systems: Formation of a 2B4-1A2 complex with a high affinity for NADPH cytochrome P450 reductase. Biochemistry 37, 12852\u201312859.", "journal-title": "Biochemistry"}, {"key": "10_CR430", "doi-asserted-by": "publisher", "first-page": "1194", "DOI": "10.1124/dmd.30.11.1194", "volume": "30", "author": "J.M. Hutzler", "year": "2002", "unstructured": "Hutzler, J.M., D. Kolwankar, M.A. Hummel, and T.S. Tracy (2002). Activation of CYP2C9-mediated metabolism by a series of dapsone analogs: Kinetics and structural requirements. Drug Metab. Dispos. 30, 1194\u20131200.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR431", "doi-asserted-by": "publisher", "first-page": "16", "DOI": "10.1016/S0003-9861(02)00665-3", "volume": "410", "author": "J.M. Hutzler", "year": "2003", "unstructured": "Hutzler, J.M., L.C. Wienkers, J.L. Wahlstrom, T.J. Carlson, and T.S. Tracy (2003). Activation of cytochrome P450 2C9-mediated metabolism: Mechanistic evidence in support of kinetic observations. Arch. Biochem. Biophys. 410, 16\u201324.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR432", "doi-asserted-by": "publisher", "first-page": "370", "DOI": "10.1021/bi962359z", "volume": "36", "author": "Y.-F. Ueng", "year": "1997", "unstructured": "Ueng, Y.-F., T. Kuwabara, Y.-J. Chun, and F.P. Guengerich (1997). Cooperativity in oxidations catalyzed by cytochrome P450 3A4. Biochemistry 36, 370\u2013381.", "journal-title": "Biochemistry"}, {"key": "10_CR433", "doi-asserted-by": "publisher", "first-page": "95", "DOI": "10.1097/00008571-200003000-00001", "volume": "10", "author": "K. Takanashi", "year": "2000", "unstructured": "Takanashi, K., H. Tainaka, K. Kobayashi, T. Yasumori, M. Hosakawa, and K. Chiba (2000). CYP2C9 Ile359 and Leu359 variants: Enzyme kinetic study with seven substrates. Pharmacogenetics 10, 95\u2013104.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR434", "doi-asserted-by": "publisher", "first-page": "729", "DOI": "10.1007/s00228-001-0376-7", "volume": "57", "author": "U. Yasar", "year": "2001", "unstructured": "Yasar, U., E. Eliasson, C. Forslund-Bergengren, G. Tybring, M. Gadd, F. Sjoqvist et al. (2001). The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro. Eur. J. Clin. Pharmacol. 57, 729\u2013735.", "journal-title": "Eur. J. Clin. Pharmacol."}, {"key": "10_CR435", "doi-asserted-by": "publisher", "first-page": "983", "DOI": "10.1006/bbrc.2000.2538", "volume": "270", "author": "M. Ridderstrom", "year": "2000", "unstructured": "Ridderstrom, M., C. Masimirembwa, S. Trump-Kallmeyer, M. Ahlefelt, C. Otter, and T.B. Andersson (2000). Arginines 97 and 108 in CYP2C9 are important determinants of the catalytic function. Biochem. Biophys. Res. Commun. 270, 983\u2013987.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR436", "doi-asserted-by": "publisher", "first-page": "921", "DOI": "10.1042/BJ20021841", "volume": "370", "author": "J.U. Flanagan", "year": "2003", "unstructured": "Flanagan, J.U., L.A. McLaughlin, M.J. Paine, M.J. Sutcliffe, G.C. Roberts, and C.R. Wolf (2003). Role of conserved Asp293 of cytochrome P450 2C9 in substrate recognition and catalytic activity. Biochem. J. 370, 921\u2013926.", "journal-title": "Biochem. J."}, {"key": "10_CR437", "doi-asserted-by": "publisher", "first-page": "16", "DOI": "10.1006/abbi.1999.1468", "volume": "372", "author": "M. He", "year": "1999", "unstructured": "He, M., K.R. Korzekwa, J.P. Jones, A.E. Rettie, and W.F. Trager (1999). Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9. Arch. Biochem. Biophys. 372, 16\u201328.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR438", "doi-asserted-by": "publisher", "first-page": "16205", "DOI": "10.1021/bi961950t", "volume": "35", "author": "A. Mancy", "year": "1997", "unstructured": "Mancy, A., S. Dijols, S. Poli, F.P. Guengerich, and D. Mansuy (1997). Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: Molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the sub-strate binding topology. Biochemistry 35, 16205\u201316212.", "journal-title": "Biochemistry"}, {"key": "10_CR439", "doi-asserted-by": "publisher", "first-page": "10365", "DOI": "10.1021/bi00033a007", "volume": "34", "author": "A. Mancy", "year": "1995", "unstructured": "Mancy, A., P. Broto, S. Dijols, P.M. Dansette, and D. Mansuy (1995). The substrate binding site of human liver cytochrome P450 2C9: An approach using designed tienilic acid derivatives and molecular modeling. Biochemistry 34, 10365\u201310375.", "journal-title": "Biochemistry"}, {"key": "10_CR440", "doi-asserted-by": "publisher", "first-page": "1937", "DOI": "10.1021/bi001678u", "volume": "40", "author": "C.C. Tsao", "year": "2001", "unstructured": "Tsao, C.C., M.R. Wester, B. Ghanayem, S.J. Coulter, B. Chanas, E.F. Johnson et al. (2001). Identification of human CYP2C19 residues that confer S-mephenytoin 4\u2032-hydroxylation activity to CYP2C9. Biochemistry 40, 1937\u20131944.", "journal-title": "Biochemistry"}, {"key": "10_CR441", "doi-asserted-by": "publisher", "first-page": "16270", "DOI": "10.1021/bi981704c", "volume": "37", "author": "F. Jung", "year": "1998", "unstructured": "Jung, F., K.J. Griffin, T.H. Richardson, M. Yang, and E.F. Johnson (1998). Identification of amino acid substitutions that confer a high affinity for sulphaphenazole binding and a high catalytic efficiency for warfarin metabolism to P450 2C19. Biochemistry 37, 16270\u201316279.", "journal-title": "Biochemistry"}, {"key": "10_CR442", "doi-asserted-by": "publisher", "first-page": "931", "DOI": "10.1124/dmd.30.8.931", "volume": "30", "author": "T. Niwa", "year": "2002", "unstructured": "Niwa, T., A. Kageyama, K. Kishimoto, Y. Yabusaki, F. Ishibashi, and M. Katagiri (2002). Amino acid residues affecting the activities of human cytochrome P450 2C9 and 2C19. Drug Metab. Dispos. 30, 931\u2013936.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR443", "doi-asserted-by": "publisher", "first-page": "80", "DOI": "10.1016/S0003-9861(02)00548-9", "volume": "409", "author": "A. Melet", "year": "2003", "unstructured": "Melet, A., N. Assrir, P. Jean, M. Pilar Lopez-Garcia, C. Marques-Soares, M. Jaouen et al. (2003). Substrate selectivity of human cytochrome P450 2C9: Importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid. Arch. Biochem. Biophys. 409, 80\u201391.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR444", "doi-asserted-by": "publisher", "first-page": "1245", "DOI": "10.1021/bi027085w", "volume": "42", "author": "F.P. Guengerich", "year": "2003", "unstructured": "Guengerich, F.P., I.H. Hanna, M.V. Martin, and E.M.J. Gillam (2003). Role of glutamic acid 216 in cytochrome P450 2D6 substrate binding and catalysis. Biochemistry 42, 1245\u20131253.", "journal-title": "Biochemistry"}, {"key": "10_CR445", "doi-asserted-by": "publisher", "first-page": "235", "DOI": "10.1080/004982598239236", "volume": "28", "author": "D.F.V. Lewis", "year": "1998", "unstructured": "Lewis, D.F.V., M. Dickins, R.J. Weaver, P.J. Eddershaw, P.S. Goldfarb, and M.H. Tarbit (1998). Molecular modelling of human CYP2C subfamily enzymes CYP2C9 and CYP2C19: Rationalization of substrate specificity and site-directed mutagensis experiments in the CYP2C subfamily. Xenobiotica 28, 235\u2013268.", "journal-title": "Xenobiotica"}, {"key": "10_CR446", "doi-asserted-by": "crossref", "first-page": "909", "DOI": "10.1124/mol.59.4.909", "volume": "59", "author": "L. Afzelius", "year": "2001", "unstructured": "Afzelius, L., I. Zamora, M. Ridderstrom, T.B. Andersson, A. Karlen, and C.M. Masimirembwa (2001). Competitive CYP2C9 inhibitors: Enzyme inhibition studies, protein homology modeling, and three-dimensional quantitative structure-activity relationship analysis. Mol. Pharmacol. 59, 909\u2013919.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR447", "doi-asserted-by": "publisher", "first-page": "4072", "DOI": "10.1021/jm0109107", "volume": "44", "author": "M. Ridderstr\u00f6m", "year": "2001", "unstructured": "Ridderstr\u00f6m, M., I. Zamora, O. Fjellstr\u00f6m, and T.B. Andersson (2001). Analysis of selective regions in the active sites of human cytochromes P450, 2C8, 2C9, 2C18, and 2C19 homology models using GRID/CPCA. J. Med. Chem. 44, 4072\u20134081.", "journal-title": "J. Med. Chem."}, {"key": "10_CR448", "doi-asserted-by": "publisher", "first-page": "1983", "DOI": "10.1021/jm0110791", "volume": "45", "author": "M.J. Groot de", "year": "2002", "unstructured": "de Groot, M.J., A.A. Alex, and B.C. Jones (2002). Development of a combined protein and pharmacophore model for cytochrome P450 2C9. J. Med. Chem. 45, 1983\u20131993.", "journal-title": "J. Med. Chem."}, {"key": "10_CR449", "doi-asserted-by": "publisher", "first-page": "464", "DOI": "10.1038/nature01862", "volume": "424", "author": "P.A. Williams", "year": "2003", "unstructured": "Williams, P.A., J. Cosme, A. Ward, H.C. Angove, D. Matak Vinkovic, and H. Jhoti (2003). Crystal structure of human cytochrome P450 2C9 with bound warfarin. Nature 424, 464\u2013468.", "journal-title": "Nature"}, {"key": "10_CR450", "first-page": "A609", "volume": "17", "author": "M.R. Wester", "year": "2003", "unstructured": "Wester, M.R., C.D. Stout, G. Schoch, J.K. Yano, and E.F. Johnson (2003). Crystallization of human P450 2C9. FASEB J. 17, A609.", "journal-title": "FASEB J"}, {"key": "10_CR451", "doi-asserted-by": "crossref", "first-page": "403", "DOI": "10.1038/clpt.1990.46", "volume": "47", "author": "M.E. Veronese", "year": "1990", "unstructured": "Veronese, M.E., J.O. Miners, D. Randles, D. Gregov, and D.J. Birkett (1990). Validation of the tolbutamide metabolic ratio for population screening with use of sulfaphenazole to produce model phenotypic poor metabolizers. Clin. Pharmacol. Ther. 47, 403\u2013411.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR452", "doi-asserted-by": "publisher", "first-page": "631", "DOI": "10.1124/dmd.30.6.631", "volume": "30", "author": "X. Wen", "year": "2002", "unstructured": "Wen, X., J.S. Wang, J.T. Backman, J. Laitila, and P.J. Neuvonen (2002). Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively. Drug Metab. Dispos. 30, 631\u2013635.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR453", "doi-asserted-by": "publisher", "first-page": "547", "DOI": "10.1046/j.0306-5251.2001.01474.x", "volume": "52", "author": "X. Wen", "year": "2001", "unstructured": "Wen, X., J.S. Wang, K.T. Kivisto, P.J. Neuvonen, and J.T. Backman (2001). In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: Preferential inhibition of cytochrome P450 2C9 (CYP2C9). Br. J. Clin. Pharmacol. 52, 547\u2013553.", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "10_CR454", "doi-asserted-by": "publisher", "first-page": "389", "DOI": "10.1016/S0049-3848(97)00270-3", "volume": "88", "author": "Z.Y. Zhang", "year": "1997", "unstructured": "Zhang, Z.Y., J. Kerr, R.S. Wexler, H.Y. Li, A.J. Robinson, P.P. Harlow et al. (1997). Warfarin analog inhibition of human CYP2C9-catalyzed S-warfarin 7-hydroxylation. Thromb. Res. 88, 389\u2013398.", "journal-title": "Thromb. Res."}, {"key": "10_CR455", "doi-asserted-by": "publisher", "first-page": "551", "DOI": "10.1073/pnas.84.2.551", "volume": "84", "author": "P. Beaune", "year": "1987", "unstructured": "Beaune, P., P.M. Dansette, D. Mansuy, L. Kiffel, M. Finck, C. Amar et al. (1987). Human antiendoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc. Natl. Acad. Sci. USA 84, 551\u2013555.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR456", "doi-asserted-by": "publisher", "first-page": "1624", "DOI": "10.1016/S0006-291X(05)81594-3", "volume": "186", "author": "P.M. Dansette", "year": "1992", "unstructured": "Dansette, P.M., D.C. Thang, H. El Amri, and D. Mansuy (1992). Evidence for thiophene-S-oxide as a primary reactive metabolite of thiophene in vivo: Formation of a dihydrothiophene sulfoxide mercapturic acid. Biochem. Biophys. Res. Commun. 186, 1624\u20131630.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR457", "doi-asserted-by": "crossref", "first-page": "199", "DOI": "10.1016/S1054-3589(08)60175-1", "volume": "30", "author": "P. Beaune", "year": "1994", "unstructured": "Beaune, P., D. Pessayre, P. Dansette, D. Mansuy, and M. Manns (1994). Autoantibodies against cytochromes P450: Role in human diseases. Adv. Pharmacol. 30, 199\u2013245.", "journal-title": "Adv. Pharmacol."}, {"key": "10_CR458", "doi-asserted-by": "publisher", "first-page": "625", "DOI": "10.1046/j.1365-2125.1999.00935.x", "volume": "47", "author": "D.J. Carlile", "year": "1999", "unstructured": "Carlile, D.J., N. Hakooz, M.K. Bayliss, and J.B. Houston (1999). Microsomal prediction of in vivo clearance of CYP2C9 substrates in humans. Br. J. Clin. Pharmacol. 47, 625\u2013635.", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "10_CR459", "doi-asserted-by": "publisher", "first-page": "349", "DOI": "10.1046/j.0306-5251.2001.01499.x", "volume": "52", "author": "J.A. Goldstein", "year": "2001", "unstructured": "Goldstein, J.A. (2001). Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. Br. J. Clin. Pharmacol. 52, 349\u2013355.", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "10_CR460", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.1016/S0163-7258(96)00140-4", "volume": "73", "author": "L.S. Kaminsky", "year": "1997", "unstructured": "Kaminsky, L.S. and Z.Y. Zhang (1997). Human P450 metabolism of warfarin. Pharmacol. Ther. 73, 67\u201374.", "journal-title": "Pharmacol. Ther."}, {"key": "10_CR461", "doi-asserted-by": "publisher", "first-page": "1195", "DOI": "10.1016/S0006-2952(97)00304-3", "volume": "54", "author": "H. Yamazaki", "year": "1997", "unstructured": "Yamazaki, H. and T. Shimada (1997). Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R-and S-warfarin enantiomers. Biochem. Pharmacol. 54, 1195\u20131203.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR462", "doi-asserted-by": "publisher", "first-page": "24", "DOI": "10.1002/chir.530030106", "volume": "3", "author": "K.L. Kunze", "year": "1991", "unstructured": "Kunze, K.L., A.C. Eddy, M. Gibaldi, and W.F. Trager (1991). Metabolic enantiomeric interactions: The inhibition of human (S)-warfarin-7-hydroxylase by (R)-warfarin. Chirality 3, 24\u201329.", "journal-title": "Chirality"}, {"key": "10_CR463", "doi-asserted-by": "publisher", "first-page": "54", "DOI": "10.1021/tx00025a009", "volume": "5", "author": "A.E. Rettie", "year": "1992", "unstructured": "Rettie, A.E., K.R. Korzekwa, K.L. Kunze, R.F. Lawrence, A.C. Eddy, T. Aoyama et al. (1992). Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: A role for P-4502C9 in the etiology of (S)-warfarin-drug interactions. Chem. Res. Toxicol. 5, 54\u201359.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR464", "doi-asserted-by": "publisher", "first-page": "39", "DOI": "10.1097/00008571-199402000-00005", "volume": "4", "author": "A.E. Rettie", "year": "1994", "unstructured": "Rettie, A.E., L.C. Wienkers, F.J. Gonzalez, W.F. Trager, and K.R. Korzekwa (1994). Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9. Pharmacogenetics 4, 39\u201342.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR465", "doi-asserted-by": "publisher", "first-page": "103", "DOI": "10.1080/004982598239614", "volume": "28", "author": "H. Yamazaki", "year": "1998", "unstructured": "Yamazaki, H., K. Inoue, and T. Shimada (1998). Roles of two allelic variants (Arg144Cys and Ile359Leu) of cytochrome P4502C9 in the oxidation of tolbutamide and warfarin by human liver microsomes. Xenobiotica 28, 103\u2013115.", "journal-title": "Xenobiotica"}, {"key": "10_CR466", "doi-asserted-by": "publisher", "first-page": "702", "DOI": "10.1067/mcp.2002.129321", "volume": "72", "author": "M.G. Scordo", "year": "2002", "unstructured": "Scordo, M.G., V. Pengo, E. Spina, M.L. Dahl, M. Gusella, and R. Padrini (2002). Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance. Clin. Pharmacol. Ther. 72, 702\u2013710.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR467", "doi-asserted-by": "publisher", "first-page": "1690", "DOI": "10.1001/jama.287.13.1690", "volume": "287", "author": "M.K. Higashi", "year": "2002", "unstructured": "Higashi, M.K., D.L. Veenstra, L.M. Kondo, A.K. Wittkowsky, S.L. Srinouanprachanh, F.M. Farin et al. (2002). Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy. J. Am. Med. Assoc. 287, 1690\u20131698.", "journal-title": "J. Am. Med. Assoc."}, {"key": "10_CR468", "first-page": "1185", "volume": "87", "author": "D. Tassies", "year": "2002", "unstructured": "Tassies, D., C. Freire, J. Pijoan, S. Maragall, J. Monteagudo, A. Ordinas et al. (2002). Pharmacogenetics of acenocoumarol: Cytochrome P450 CYP2C9 polymorphisms influence dose requirements and stability of anticoagulation. Haematologica 87, 1185\u20131191.", "journal-title": "Haematologica"}, {"key": "10_CR469", "doi-asserted-by": "publisher", "first-page": "120", "DOI": "10.1093/toxsci/70.1.120", "volume": "70", "author": "P.R. Gentry", "year": "2002", "unstructured": "Gentry, P.R., C.E. Hack, L. Haber, A. Maier, and H.J. Clewell, III (2002). An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: Examples with warfarin and parathion. Toxicol. Sci. 70, 120\u2013139.", "journal-title": "Toxicol. Sci."}, {"key": "10_CR470", "doi-asserted-by": "publisher", "first-page": "562", "DOI": "10.1067/mcp.2002.127913", "volume": "72", "author": "C.R. Lee", "year": "2002", "unstructured": "Lee, C.R., J.A. Pieper, A.L. Hinderliter, J.A. Blaisdell, and J.A. Goldstein (2002). Evaluation of cytochrome P4502C9 metabolic activity with tolbutamide in CYP2C91 heterozygotes. Clin. Pharmacol. Ther. 72, 562\u2013571.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR471", "doi-asserted-by": "publisher", "first-page": "111", "DOI": "10.1097/00008571-200203000-00005", "volume": "12", "author": "J.H. Shon", "year": "2002", "unstructured": "Shon, J.H., Y.R. Yoon, K.A. Kim, Y.C. Lim, K.J. Lee, J.Y. Park et al. (2002). Effects of CYP2C19 and CYP2C9 genetic polymorphisms on the disposition of and blood glucose lowering response to tolbutamide in humans. Pharmacogenetics 12, 111\u2013119.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR472", "doi-asserted-by": "publisher", "first-page": "91", "DOI": "10.1097/00008571-200203000-00002", "volume": "12", "author": "J. Miners", "year": "2002", "unstructured": "Miners, J. (2002). CYP2C9 polymorphism: Impact on tolbutamide pharmacokinetics and response. Pharmacogenetics 12, 91\u201392.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR473", "doi-asserted-by": "publisher", "first-page": "2089", "DOI": "10.1097/00004872-200210000-00030", "volume": "20", "author": "P. Hallberg", "year": "2002", "unstructured": "Hallberg, P., J. Karlsson, L. Kurland, L. Lind, T. Kahan, K. Malmqvist et al. (2002). The CYP2C9 genotype predicts the blood pressure response to irbesartan: Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial. J. Hypertens. 20, 2089\u20132093.", "journal-title": "J. Hypertens."}, {"key": "10_CR474", "first-page": "285", "volume": "23", "author": "C.-H. Yun", "year": "1995", "unstructured": "Yun, C.-H., H.S. Lee, H. Lee, J.K. Rho, H.G. Jeong, and F.P. Guengerich (1995). Oxidation of the angiotensin II receptor antagonist losartan (DuP 753) in human liver microsomes: Role of cytochrome P450 3A(4) in formation of the active metabolite EXP 3174. Drug Metab. Dispos. 23, 285\u2013289.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR475", "first-page": "207", "volume": "23", "author": "R.A. Stearns", "year": "1995", "unstructured": "Stearns, R.A., P.K. Chakravarty, R. Chen, and S.H.L. Chiu (1995). Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes: Role of cytochrome P4502C and 3A subfamily members. Drug Metab. Dispos. 23, 207\u2013215.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR476", "doi-asserted-by": "publisher", "first-page": "511", "DOI": "10.1097/00008571-200008000-00004", "volume": "10", "author": "G.P. Aithal", "year": "2000", "unstructured": "Aithal, G.P., C.P. Day, J.B. Leathart, and A.K. Daly (2000). Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced hepatitis. Pharmacogenetics 10, 511\u2013518.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR477", "doi-asserted-by": "publisher", "first-page": "1323", "DOI": "10.1093/carcin/22.8.1323", "volume": "22", "author": "C. Martinez", "year": "2001", "unstructured": "Martinez, C., E. Garcia-Martin, J.M. Ladero, J. Sastre, F. Garcia-Gamito, M. Diaz-Rubio et al. (2001). Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk. Carcinogenesis 22, 1323\u20131326.", "journal-title": "Carcinogenesis"}, {"key": "10_CR478", "doi-asserted-by": "publisher", "first-page": "665", "DOI": "10.1093/carcin/23.4.665", "volume": "23", "author": "U. Yasar", "year": "2002", "unstructured": "Yasar, U., E. Eliasson, and M.L. Dahl (2002). Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk. Carcinogenesis 23, 665; author reply 667\u2013668.", "journal-title": "Carcinogenesis"}, {"key": "10_CR479", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1016/S0304-3835(02)00015-0", "volume": "180", "author": "E. Garcia-Martin", "year": "2002", "unstructured": "Garcia-Martin, E., C. Martinez, J.M. Ladero, F.J. Gamito, A. Rodriguez-Lescure, and J.A. Agundez (2002). Influence of cytochrome P450 CYP2C9 genotypes in lung cancer risk. Cancer Lett. 180, 41\u201346.", "journal-title": "Cancer Lett"}, {"key": "10_CR480", "doi-asserted-by": "publisher", "first-page": "7828", "DOI": "10.1021/bi9903289", "volume": "38", "author": "C. Minoletti", "year": "1999", "unstructured": "Minoletti, C., S. Dijols, P.M. Dansette, and D. Mansuy (1999). Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: Application to the design of a specific substrate of CYP 2C18. Biochemistry 38, 7828\u20137836.", "journal-title": "Biochemistry"}, {"key": "10_CR481", "doi-asserted-by": "publisher", "first-page": "157", "DOI": "10.1006/abbi.1996.9817", "volume": "338", "author": "T.H. Richardson", "year": "1997", "unstructured": "Richardson, T.H., K.J. Griffin, F. Jung, J.L. Raucy, and E.F. Johnson (1997). Targeted antipeptide antibodies to cytochrome P450 2C18 based on epitope mapping of an inhibitory monoclonal antibody to P450 2C5. Arch. Biochem. Biophys. 338, 157\u2013164.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR482", "doi-asserted-by": "publisher", "first-page": "2585", "DOI": "10.1093/nar/27.13.2585", "volume": "27", "author": "P.G. Zaphiropoulos", "year": "1999", "unstructured": "Zaphiropoulos, P.G. (1999). RNA molecules containing exons originating from different members of the cytochrome P450 2C gene subfamily (CYP2C) in human epidermis and liver. Nucleic Acids Res. 27, 2585\u20132590.", "journal-title": "Nucleic Acids Res"}, {"key": "10_CR483", "doi-asserted-by": "publisher", "first-page": "914", "DOI": "10.1016/S0959-8049(98)00034-3", "volume": "34", "author": "K. Mace", "year": "1998", "unstructured": "Mace, K., E.D. Bowman, P. Vautravers, P.G. Shields, C.C. Harris, and A.M. Pfeifer (1998). Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues. Eur. J. Cancer 34, 914\u2013920.", "journal-title": "Eur. J. Cancer"}, {"key": "10_CR484", "doi-asserted-by": "publisher", "first-page": "199", "DOI": "10.1211/0022357001773850", "volume": "52", "author": "M. Mizugaki", "year": "2000", "unstructured": "Mizugaki, M., M. Hiratsuka, Y. Agatsuma, Y. Matsubara, K. Fujii, S. Kure et al. (2000). Rapid detection of CYP2C18 genotypes by real-time fluorescence polymerase chain reaction. J. Pharm. Pharmacol. 52, 199\u2013205.", "journal-title": "J. Pharm. Pharmacol."}, {"key": "10_CR485", "doi-asserted-by": "crossref", "first-page": "888", "DOI": "10.3748/wjg.v8.i5.888", "volume": "8", "author": "J. Zhu-Ge", "year": "2002", "unstructured": "Zhu-Ge, J., Y.N. Yu, Y.L. Qian, and X. Li (2002). Establishment of a transgenic cell line stably expressing human cytochrome P450 2C18 and identification of a CYP2C18 clone with exon 5 missing. World J. Gastroenterol. 8, 888\u2013892.", "journal-title": "World J. Gastroenterol."}, {"key": "10_CR486", "doi-asserted-by": "publisher", "first-page": "204", "DOI": "10.1002/(SICI)1097-0134(19991101)37:2<204::AID-PROT6>3.0.CO;2-O", "volume": "37", "author": "V.A. Payne", "year": "1999", "unstructured": "Payne, V.A., Y.T. Chang, and G.H. Loew (1999). Homology modeling and substrate binding study of human CYP2C18 and CYP2C19 enzymes. Proteins 37, 204\u2013217.", "journal-title": "Proteins"}, {"key": "10_CR487", "doi-asserted-by": "publisher", "first-page": "8466", "DOI": "10.1021/bi00399a065", "volume": "26", "author": "U.T. Meier", "year": "1987", "unstructured": "Meier, U.T. and U.A. Meyer (1987). Genetic polymorphism of human cytochrome P-450 (S)-mephenytoin 4-hydroxylase. Studies with human autoantibodies suggest a functionally altered cytochrome P-450 isozyme as cause of the genetic deficiency. Biochemistry 26, 8466\u20138474.", "journal-title": "Biochemistry"}, {"key": "10_CR488", "doi-asserted-by": "publisher", "first-page": "53", "DOI": "10.1016/0163-7258(89)90047-8", "volume": "43", "author": "G.R. Wilkinson", "year": "1989", "unstructured": "Wilkinson, G.R., F.P. Guengerich, and R.A. Branch (1989). Genetic polymorphism of S-mephenytoin hydroxylation. Pharmacol. Ther. 43, 53\u201376.", "journal-title": "Pharmacol. Ther."}, {"key": "10_CR489", "doi-asserted-by": "crossref", "first-page": "313", "DOI": "10.1038/clpt.1990.34", "volume": "47", "author": "T. Yasumori", "year": "1990", "unstructured": "Yasumori, T., N. Murayama, Y. Yamazoe, and R. Kato (1990). Polymorphism in hydroxylation of mephenytoin and hexobarbital stereoisomers in relation to hepatic P-450 human-2. Clin. Pharmacol. Ther. 47, 313\u2013322.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR490", "doi-asserted-by": "publisher", "first-page": "192", "DOI": "10.1067/mcp.2002.126174", "volume": "72", "author": "M.J. Kim", "year": "2002", "unstructured": "Kim, M.J., J.S. Bertino, Jr., A. Gaedigk, Y. Zhang, E.M. Sellers, and A.N. Nafziger (2002). Effect of sex and menstrual cycle phase on cytochrome P450 2C19 activity with omeprazole used as a biomarker. Clin. Pharmacol. Ther. 72, 192\u2013199.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR491", "doi-asserted-by": "crossref", "first-page": "471", "DOI": "10.1111/j.1365-2125.1990.tb03799.x", "volume": "30", "author": "H.H. Zhou", "year": "1990", "unstructured": "Zhou, H.H., L.B. Anthony, A.J. Wood, and G.R. Wilkinson (1990). Induction of polymorphic 4\u2032-hydroxylation of S-mephenytoin by rifampicin. Br. J. Clin. Pharmacol. 30, 471\u2013475.", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "10_CR492", "doi-asserted-by": "publisher", "first-page": "703", "DOI": "10.1097/00008571-200212000-00004", "volume": "12", "author": "J. Blaisdell", "year": "2002", "unstructured": "Blaisdell, J., H. Mohrenweiser, J. Jackson, S. Ferguson, S. Coulter, B. Chanas et al. (2002). Identification and functional characterization of new potentially defective alleles of human CYP2C19. Pharmacogenetics 12, 703\u2013711.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR493", "doi-asserted-by": "publisher", "first-page": "913", "DOI": "10.2165/00003088-200241120-00002", "volume": "41", "author": "Z. Desta", "year": "2002", "unstructured": "Desta, Z., X. Zhao, J.G. Shin, and D.A. Flockhart (2002). Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Clin. Pharmacokinet. 41, 913\u2013958.", "journal-title": "Clin. Pharmacokinet."}, {"key": "10_CR494", "first-page": "15419", "volume": "269", "author": "S.M.F. Morais de", "year": "1994", "unstructured": "de Morais, S.M.F., G.R. Wilkinson, J. Blaisdell, K. Nakamura, U.A. Meyer, and J.A. Goldstein (1994). The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J. Biol. Chem. 269, 15419\u201315422.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR495", "first-page": "356", "volume": "284", "author": "R.J. Ferguson", "year": "1998", "unstructured": "Ferguson, R.J., S.M. De Morais, S. Benhamou, C. Bouchardy, J. Blaisdell, G. Ibeanu et al. (1998). A new genetic defect in human CYP2C19: Mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin. J. Pharmacol. Exp. Ther. 284, 356\u2013361.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR496", "first-page": "354", "volume": "28", "author": "M.R. Wester", "year": "2000", "unstructured": "Wester, M.R., J.M. Lasker, E.F. Johnson, and J.L. Raucy (2000). CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes. Drug Metab. Dispos. 28, 354\u2013359.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR497", "first-page": "470", "volume": "12", "author": "L.S. Kaminsky", "year": "1984", "unstructured": "Kaminsky, L.S., D.A. Dunbar, P.P. Wang, P. Beaune, D. Larrey, F.P. Guengerich et al. (1984). Human hepatic cytochrome P-450 composition as probed by in vitro microsomal metabolism of warfarin. Drug Metab. Dispos. 12, 470\u2013477.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR498", "first-page": "610", "volume": "24", "author": "L.C. Wienkers", "year": "1996", "unstructured": "Wienkers, L.C., C.J. Wurden, E. Storch, K.L. Kunze, A.E. Rettie, and W.F. Trager (1996). Formation of (R)-8-hydroxywarfarin in human liver microsomes: A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19. Drug Metab. Dispos. 24, 610\u2013614.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR499", "doi-asserted-by": "publisher", "first-page": "663", "DOI": "10.1124/dmd.30.6.663", "volume": "30", "author": "W. Zhang", "year": "2002", "unstructured": "Zhang, W., Y. Ramamoorthy, R.F. Tyndale, S.D. Glick, I.M. Maisonneuve, M.E. Kuehne et al. (2002). Metabolism of 18-methoxycoronaridine, an ibogaine analog, to 18-hydroxycoronaridine by genetically variable CYP2C19. Drug Metab. Dispos. 30, 663\u2013669.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR500", "first-page": "1964", "volume": "8", "author": "Y. Ando", "year": "2002", "unstructured": "Ando, Y., E. Fuse, and W.D. Figg (2002). Thalidomide metabolism by the CYP2C subfamily. Clin. Cancer Res. 8, 1964\u20131973.", "journal-title": "Clin. Cancer Res."}, {"key": "10_CR501", "doi-asserted-by": "publisher", "first-page": "161", "DOI": "10.1006/abbi.1997.0302", "volume": "346", "author": "H. Yamazaki", "year": "1997", "unstructured": "Yamazaki, H. and T. Shimada (1997). Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Arch. Biochem. Biophys. 346, 161\u2013169.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR502", "doi-asserted-by": "publisher", "first-page": "68", "DOI": "10.1006/taap.2001.9294", "volume": "177", "author": "W.A. Kappers", "year": "2001", "unstructured": "Kappers, W.A., R.J. Edwards, S. Murray, and A.R. Boobis (2001). Diazinon is activated by CYP2C19 in human liver. Toxicol. Appl. Pharmacol. 177, 68\u201376.", "journal-title": "Toxicol. Appl. Pharmacol."}, {"key": "10_CR503", "doi-asserted-by": "publisher", "first-page": "12496", "DOI": "10.1074/jbc.271.21.12496", "volume": "271", "author": "G.C. Ibeanu", "year": "1996", "unstructured": "Ibeanu, G.C., B.I. Ghanayem, P. Linko, L. Li, L.G. Pedersen, and J.A. Goldstein (1996). Identification of residues 99, 220, and 221 of human cytochrome P450 2C19 as key determinants of omeprazole hydroxylase activity. J. Biol. Chem. 271, 12496\u201312501.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR504", "doi-asserted-by": "publisher", "first-page": "341", "DOI": "10.1097/00008571-200106000-00009", "volume": "11", "author": "T. Furuta", "year": "2001", "unstructured": "Furuta, T., N. Shirai, M. Takashima, F. Xiao, H. Hanai, K. Nakagawa et al. (2001). Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin. Pharmacogenetics 11, 341\u2013348.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR505", "doi-asserted-by": "publisher", "first-page": "453", "DOI": "10.1067/mcp.2002.127637", "volume": "72", "author": "T. Furuta", "year": "2002", "unstructured": "Furuta, T., N. Shirai, F. Watanabe, S. Honda, K. Takeuchi, T. Iida et al. (2002). Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole. Clin. Pharmacol. Ther. 72, 453\u2013460.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR506", "doi-asserted-by": "publisher", "first-page": "923", "DOI": "10.1248/bpb.25.923", "volume": "25", "author": "T. Kita", "year": "2002", "unstructured": "Kita, T., T. Sakaeda, N. Aoyama, T. Sakai, Y. Kawahara, M. Kasuga et al. (2002). Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: Pharmacokinetic considerations. Biol. Pharm. Bull. 25, 923\u2013927.", "journal-title": "Biol. Pharm. Bull."}, {"key": "10_CR507", "doi-asserted-by": "publisher", "first-page": "386", "DOI": "10.1248/bpb.26.386", "volume": "26", "author": "T. Kita", "year": "2003", "unstructured": "Kita, T., T. Sakaeda, T. Baba, N. Aoyama, M. Kakumoto, Y. Kurimoto et al. (2003). Different contribution of CYP2C19 in the in vitro metabolism of three proton pump inhibitors. Biol. Pharm. Bull. 26, 386\u2013390.", "journal-title": "Biol. Pharm. Bull."}, {"key": "10_CR508", "doi-asserted-by": "publisher", "first-page": "1719", "DOI": "10.1016/S0024-3205(00)00757-8", "volume": "67", "author": "T.K. Chau", "year": "2000", "unstructured": "Chau, T.K., S. Marakami, B. Kawai, K. Nasu, T. Kubota, and A. Ohnishi (2000). Genotype analysis of the CYP2C19 gene in HCV-seropositive patients with cirrhosis and hepatocellular carcinoma. Life Sci. 67, 1719\u20131724.", "journal-title": "Life Sci"}, {"key": "10_CR509", "doi-asserted-by": "publisher", "first-page": "605", "DOI": "10.1097/00008571-200010000-00004", "volume": "10", "author": "P.L. Roddam", "year": "2000", "unstructured": "Roddam, P.L., S. Rollinson, E. Kane, E. Roman, A. Moorman, R. Cartwright et al. (2000). Poor metabolizers at the cytochrome P450 2D6 and 2C19 loci are at increased risk of developing adult acute leukaemia. Pharmacogenetics 10, 605\u2013615.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR510", "doi-asserted-by": "publisher", "first-page": "583", "DOI": "10.1111/j.1432-1033.1991.tb16411.x", "volume": "202", "author": "J.M. Treluyer", "year": "1991", "unstructured": "Treluyer, J.M., E. Jacqz-Aigrain, F. Alvarez, and T. Cresteil (1991). Expression of CYP2D6 in developing human liver. Eur. J. Biochem. 202, 583\u2013588.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR511", "doi-asserted-by": "publisher", "first-page": "79", "DOI": "10.1006/bbrc.1997.7775", "volume": "241", "author": "J.M. Guidice Lo", "year": "1997", "unstructured": "Lo Guidice, J.M., D. Marez, N. Sabbagh, M. LegrandAndreoletti, C. Spire, E. Alca\u00efde et al. (1997). Evidence for CYP2D6 expression in human lung. Biochem. Biophys. Res. Commun. 241, 79\u201385.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR512", "doi-asserted-by": "publisher", "first-page": "237", "DOI": "10.1097/00008571-200104000-00007", "volume": "11", "author": "I. Siegle", "year": "2001", "unstructured": "Siegle, I., P. Fritz, K. Eckhardt, U.M. Zanger, and M. Eichelbaum (2001). Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain. Pharmacogenetics 11, 237\u2013245.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR513", "doi-asserted-by": "publisher", "first-page": "1376", "DOI": "10.1046/j.1471-4159.2002.01069.x", "volume": "82", "author": "S. Miksys", "year": "2002", "unstructured": "Miksys, S., Y. Rao, E. Hoffmann, D.C. Mash, and R.F. Tyndale (2002). Regional and cellular expression of CYP2D6 in human brain: Higher levels in alcoholics. J. Neurochem. 82, 1376\u20131387.", "journal-title": "J. Neurochem."}, {"key": "10_CR514", "doi-asserted-by": "publisher", "first-page": "979", "DOI": "10.1016/0024-3205(78)90363-6", "volume": "22", "author": "J.R. Idle", "year": "1978", "unstructured": "Idle, J.R., A. Mahgoub, R. Lancaster, and R.L. Smith (1978). Hypotensive response to debrisoquine and hydroxylation phenotype. Life Sci. 22, 979\u2013984.", "journal-title": "Life Sci"}, {"key": "10_CR515", "doi-asserted-by": "publisher", "first-page": "333", "DOI": "10.1016/S0140-6736(82)91583-5", "volume": "i", "author": "G. Alvan", "year": "1982", "unstructured": "Alvan, G., C. von Bahr, P. Seideman, and F. Sjoqvist (1982). High plasma concentrations of \u03b2-receptor blocking drugs and deficient debrisoquine hydroxylation. Lancet i, 333.", "journal-title": "Lancet"}, {"key": "10_CR516", "doi-asserted-by": "crossref", "first-page": "321", "DOI": "10.1136/jmg.20.5.321", "volume": "20", "author": "D.A.P. Evans", "year": "1983", "unstructured": "Evans, D.A.P., D. Harmer, D.Y. Downham, E.J. Whibley, J.R. Idle, J. Ritchie et al. (1983). The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions. J. Med. Genet. 20, 321\u2013329.", "journal-title": "J. Med. Genet."}, {"key": "10_CR517", "doi-asserted-by": "publisher", "first-page": "5240", "DOI": "10.1073/pnas.85.14.5240", "volume": "85", "author": "R.C. Skoda", "year": "1988", "unstructured": "Skoda, R.C., F.J. Gonzalez, A. Demierre, and U.A. Meyer (1988). Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs. Proc. Natl. Acad. Sci. USA 85, 5240\u20135243.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR518", "doi-asserted-by": "crossref", "first-page": "669", "DOI": "10.1097/01213011-199912000-00002", "volume": "9", "author": "A. Gaedigk", "year": "1999", "unstructured": "Gaedigk, A., R.R. Gotschall, N.S. Forbes, S.D. Simon, G.L. Kearns, and J.S. Leeder (1999). Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data. Pharmacogenetics 9, 669\u2013682.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR519", "doi-asserted-by": "publisher", "first-page": "577", "DOI": "10.1097/00008571-200010000-00001", "volume": "10", "author": "S. Raimundo", "year": "2000", "unstructured": "Raimundo, S., J. Fischer, M. Eichelbaum, E.U. Griese, M. Schwab, and U.M. Zanger (2000). Elucidation of the genetic basis of the common \u2018intermediate metabolizer\u2019 phenotype for drug oxidation by CYP2D6. Pharmacogenetics 10, 577\u2013581.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR520", "doi-asserted-by": "publisher", "first-page": "573", "DOI": "10.1097/00008571-200110000-00004", "volume": "11", "author": "U.M. Zanger", "year": "2001", "unstructured": "Zanger, U.M., J. Fischer, S. Raimundo, T. Stuven, B.O. Evert, M. Schwab et al. (2001). Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6. Pharmacogenetics 11, 573\u2013585.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR521", "doi-asserted-by": "publisher", "first-page": "26", "DOI": "10.1097/00008571-199110000-00005", "volume": "1", "author": "R. Tyndale", "year": "1991", "unstructured": "Tyndale, R., T. Aoyama, F. Broly, T. Matsunaga, T. Inaba, W. Kalow et al. (1991). Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: Possible association with the poor metabolizer phenotype. Pharmacogenetics 1, 26\u201332.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR522", "doi-asserted-by": "publisher", "first-page": "1291", "DOI": "10.1124/jpet.102.039891", "volume": "303", "author": "A. Yu", "year": "2002", "unstructured": "Yu, A., B.M. Kneller, A.E. Rettie, and R.L. Haining (2002). Expression, purification, biochemical characterization, and comparative function of human cytochrome P450 2D6.1, 2D6.2, 2D6.10, and 2D6.17 allelic isoforms. J. Pharmacol. Exp. Ther. 303, 1291\u20131300.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR523", "doi-asserted-by": "publisher", "first-page": "166", "DOI": "10.1016/S0888-7543(02)00031-9", "volume": "81", "author": "B. Fletcher", "year": "2003", "unstructured": "Fletcher, B., D.B. Goldstein, A.L. Bradman, M.E. Weale, N. Bradman, and M.G. Thomas (2003). High-throughput analysis of informative CYP2D6 compound haplotypes. Genomics 81, 166\u2013174.", "journal-title": "Genomics"}, {"key": "10_CR524", "first-page": "516", "volume": "274", "author": "M.L. Dahl", "year": "1995", "unstructured": "Dahl, M.L., I. Johansson, L. Bertilsson, M. Ingelman-Sundberg, and F. Sjoqvist (1995). Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis. J. Pharmacol. Exp. Ther. 274, 516\u2013520.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR525", "doi-asserted-by": "publisher", "first-page": "327", "DOI": "10.1016/S0378-1119(98)00567-8", "volume": "226", "author": "E. Lundqvist", "year": "1999", "unstructured": "Lundqvist, E., I. Johansson, and M. Ingelman-Sundberg (1999). Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes. Gene 226, 327\u2013338.", "journal-title": "Gene"}, {"key": "10_CR526", "doi-asserted-by": "publisher", "first-page": "30", "DOI": "10.1016/0014-5793(96)00779-X", "volume": "392", "author": "R. Lovlie", "year": "1996", "unstructured": "Lovlie, R., A.K. Daly, A. Molven, J.R. Idle, and V.M. Steen (1996). Ultrarapid metabolizers of debrisoquine: Characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene. FEBS Lett. 392, 30\u201334.", "journal-title": "FEBS Lett"}, {"key": "10_CR527", "doi-asserted-by": "publisher", "first-page": "116", "DOI": "10.1055/s-2002-31517", "volume": "35", "author": "M.D. K\u00f6hnke", "year": "2002", "unstructured": "K\u00f6hnke, M.D., E.U. Griese, D. Stosser, I. Gaertner, and G. Barth (2002). Cytochrome P450 2D6 deficiency and its clinical relevance in a patient treated with risperidone. Pharmacopsychiatry 35, 116\u2013118.", "journal-title": "Pharmacopsychiatry"}, {"key": "10_CR528", "doi-asserted-by": "crossref", "first-page": "611", "DOI": "10.1021/tx0002583", "volume": "14", "author": "F.P. Guengerich", "year": "2001", "unstructured": "Guengerich, F.P. (2001). Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem. Res. Toxicol. 14, 611\u2013650.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR529", "first-page": "2116", "volume": "45", "author": "T. Wolff", "year": "1985", "unstructured": "Wolff, T., L.M. Distlerath, M.T. Worthington, J.D. Groopman, G.J. Hammons, F.F. Kadlubar et al. (1985). Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling. Cancer Res. 45, 2116\u20132122.", "journal-title": "Cancer Res"}, {"key": "10_CR530", "doi-asserted-by": "publisher", "first-page": "2211", "DOI": "10.1093/carcin/12.12.2211", "volume": "12", "author": "S.A. Islam", "year": "1991", "unstructured": "Islam, S.A., C.R. Wolf, M.S. Lennard, and M.J.E. Sternberg (1991). A three-dimensional molecular template for substrates of human cytochrome P450 involved in debrisoquine 4-hydroxylation. Carcinogenesis 12, 2211\u20132219.", "journal-title": "Carcinogenesis"}, {"key": "10_CR531", "doi-asserted-by": "publisher", "first-page": "1136", "DOI": "10.1021/jm00061a004", "volume": "36", "author": "G.R. Strobl", "year": "1993", "unstructured": "Strobl, G.R., S. von Kruedener, J. St\u00f6ckigt, F.P. Guengerich, and T. Wolff (1993). Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: Molecular modeling and inhibition studies. J. Med. Chem. 36, 1136\u20131145.", "journal-title": "J. Med. Chem."}, {"key": "10_CR532", "doi-asserted-by": "publisher", "first-page": "211", "DOI": "10.1021/tx00026a010", "volume": "5", "author": "L. Koymans", "year": "1992", "unstructured": "Koymans, L., N.P.E. Vermeulen, S.A.B.E. van Acker, J.M. te Koppele, J.J.P. Heykants, K. Lavrijsen et al. (1992). A predictive model for substrates of cytochrome P450-debrisoquine (2D6). Chem. Res. Toxicol. 5, 211\u2013219.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR533", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1021/tx960129f", "volume": "10", "author": "M.J. Groot de", "year": "1997", "unstructured": "de Groot, M.J., G.J. Bijloo, B.J. Martens, F.A.A. van Acker, and N.P.E. Vermeulen (1997). A refined substrate model for human cytochrome P450 2D6. Chem. Res. Toxicol. 10, 41\u201348.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR534", "first-page": "1377", "volume": "29", "author": "A.L. Upthagrove", "year": "2001", "unstructured": "Upthagrove, A.L. and W.L. Nelson (2001). Importance of amine pKa and distribution coefficient in the metabolism of fluorinated propranolol derivatives. Preparation, identification of metabolite regioisomers, and metabolism by CYP2D6. Drug Metab. Dispos. 29, 1377\u20131388.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR535", "doi-asserted-by": "publisher", "first-page": "14215", "DOI": "10.1021/bi0110037", "volume": "40", "author": "G.P. Miller", "year": "2001", "unstructured": "Miller, G.P., I.H. Hanna, Y. Nishimura, and F.P. Guengerich (2001). Oxidation of phenylethylamine derivatives by cytochrome P450 2D6: The issue of substrate protonation in binding and catalysis. Biochemistry 40, 14215\u201314223.", "journal-title": "Biochemistry"}, {"key": "10_CR536", "doi-asserted-by": "publisher", "first-page": "286", "DOI": "10.1021/tx00039a003", "volume": "7", "author": "J.M. Grace", "year": "1994", "unstructured": "Grace, J.M., M.T. Kinter, and T.L. Macdonald (1994). Atypical metabolism of deprenyl and its enantiomer, (S)-(+)-N,\u03b1-dimethyl-N-propynylphenethylamine, by cytochrome P450 2D6. Chem. Res. Toxicol. 7, 286\u2013290.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR537", "doi-asserted-by": "publisher", "first-page": "539", "DOI": "10.1080/004982598239290", "volume": "28", "author": "T. Niwa", "year": "1998", "unstructured": "Niwa, T., Y. Yabusaki, K. Honma, N. Matsuo, K. Tatsuta, F. Ishibashi et al. (1998). Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones. Xenobiotica 28, 539\u2013547.", "journal-title": "Xenobiotica"}, {"key": "10_CR538", "unstructured": "Hiroi, T., T. Chow, S. Imaoka, and Y. Funae (2000). Catalytic specificity of each CYP2D isoform in rat and human. Abstracts, 13th Int. Sympos. Microsomes and Drug Oxidations, 10\u201314 July, Stresa: p. 113."}, {"key": "10_CR539", "doi-asserted-by": "publisher", "first-page": "11025", "DOI": "10.1021/bi020341k", "volume": "41", "author": "F.P. Guengerich", "year": "2002", "unstructured": "Guengerich, F.P., G.P. Miller, I.H. Hanna, M.V. Martin, S. L\u00e9ger, C. Black et al. (2002). Diversity in the oxidation of substrates by cytochrome P450 2D6. Lack of an obligatory role of aspartate 301-substrate electrostatic bonding. Biochemistry 41, 11025\u201311034.", "journal-title": "Biochemistry"}, {"key": "10_CR540", "doi-asserted-by": "publisher", "first-page": "85", "DOI": "10.1097/00008571-199704000-00001", "volume": "7", "author": "C. Martinez", "year": "1997", "unstructured": "Martinez, C., J.A. Agundez, G. Gervasini, R. Martin, and J. Benitez (1997). Tryptamine: A possible endogenous substrate for CYP2D6. Pharmacogenetics 7, 85\u201393.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR541", "doi-asserted-by": "publisher", "first-page": "307", "DOI": "10.1097/00008571-200306000-00002", "volume": "13", "author": "A.M. Yu", "year": "2003", "unstructured": "Yu, A.M., J.R. Idle, T. Herraiz, A. K\u00fcpfer, and F.J. Gonzalez (2003). Screening for endogenous substrates reveals that CYP2D6 is a 5-methoxyindolethylamine O-demethylase. Pharmacogenetics 13, 307\u2013319.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR542", "doi-asserted-by": "publisher", "first-page": "173", "DOI": "10.1097/00008571-200303000-00007", "volume": "13", "author": "A.M. Yu", "year": "2003", "unstructured": "Yu, A.M., J.R. Idle, L.G. Byrd, K.W. Krausz, A. Kupfer, and F.J. Gonzalez (2003). Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6. Pharmacogenetics 13, 173\u2013181.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR543", "doi-asserted-by": "publisher", "first-page": "281", "DOI": "10.1007/BF00125503", "volume": "7", "author": "L. Koymans", "year": "1993", "unstructured": "Koymans, L., N.P.E. Vermeulen, A. Baarslag, and G. Donne-Op den Kelder (1993). A preliminary 3D model for cytochrome P450 2D6 constructed by homology model building. J. Comput. Aided Mol. Des. 7, 281\u2013289.", "journal-title": "J. Comput. Aided Mol. Des."}, {"key": "10_CR544", "doi-asserted-by": "publisher", "first-page": "1079", "DOI": "10.1021/tx960003i", "volume": "9", "author": "M.J. Groot de", "year": "1996", "unstructured": "de Groot, M.J., N.P.E. Vermeulen, J.D. Kramer, F.A.A. van Acker, and G.M. Donn\u00e9-Op den Kelder (1996). A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structure of P450 101, P450 102, and P450 108. Chem. Res. Toxicol. 9, 1079\u20131091.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR545", "doi-asserted-by": "publisher", "first-page": "319", "DOI": "10.1080/004982597240497", "volume": "27", "author": "D.F.V. Lewis", "year": "1997", "unstructured": "Lewis, D.F.V., P.J. Eddershaw, P.S. Goldfarb, and M.H. Tarbit (1997). Molecular modeling of cytochrome P4502D6 (CYP2D6) based on an alignment with CYP102: Structural studies on specific CYP2D6 substrate metabolism. Xenobiotica 27, 319\u2013340.", "journal-title": "Xenobiotica"}, {"key": "10_CR546", "doi-asserted-by": "publisher", "first-page": "4540", "DOI": "10.1021/bi952742o", "volume": "35", "author": "S. Modi", "year": "1996", "unstructured": "Modi, S., M.J. Paine, M.J. Sutcliffe, L.Y. Lian, W.U. Primrose, C.R. Wolf et al. Roberts (1996). A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding. Biochemistry 35, 4540\u20134550.", "journal-title": "Biochemistry"}, {"key": "10_CR547", "doi-asserted-by": "publisher", "first-page": "4062", "DOI": "10.1021/jm991058v", "volume": "42", "author": "M.J. Groot de", "year": "1999", "unstructured": "de Groot, M.J., M.J. Ackland, V.A. Horne, A.A. Alex, and B.C. Jones (1999). A novel approach to predicting P450 mediated drug metabolism. CYP2D6 catalyzed N-dealkylation reactions and qualitative metabolite predictions using a combined protein and pharmacophore model for CYP2D6. J. Med. Chem. 42, 4062\u20134070.", "journal-title": "J. Med. Chem."}, {"key": "10_CR548", "doi-asserted-by": "publisher", "first-page": "216", "DOI": "10.1002/prot.10192", "volume": "49", "author": "S.B. Kirton", "year": "2002", "unstructured": "Kirton, S.B., C.A. Kemp, N.P. Tomkinson, S. St.-Gallay, and M.J. Sutcliffe (2002). Impact of incorporating the 2C5 crystal structure into comparative models of cytochrome P450 2D6. Proteins 49, 216\u2013231.", "journal-title": "Proteins"}, {"key": "10_CR549", "doi-asserted-by": "publisher", "first-page": "74", "DOI": "10.1021/jm0209578", "volume": "46", "author": "J. Venhorst", "year": "2003", "unstructured": "Venhorst, J., A.M. ter Laak, J.N. Commandeur, Y. Funae, T. Hiroi, and N.P. Vermeulen (2003). Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities. J. Med. Chem. 46, 74\u201386.", "journal-title": "J. Med. Chem."}, {"key": "10_CR550", "doi-asserted-by": "publisher", "first-page": "234", "DOI": "10.1097/00008571-199508000-00007", "volume": "5", "author": "C.L. Crespi", "year": "1995", "unstructured": "Crespi, C.L., D.T. Steimel, B.W. Penman, K.R. Korzekwa, P. Fernandez-Salguero, J.T.M. Buters et al. (1995). Comparison of substrate metabolism by wild type CYP2D6 protein and a variant containing methionine, not valine, at position 374. Pharmacogenetics 5, 234\u2013243.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR551", "doi-asserted-by": "crossref", "first-page": "647", "DOI": "10.1042/bj3160647", "volume": "316", "author": "S.W. Ellis", "year": "1996", "unstructured": "Ellis, S.W., K. Rowland, M.J. Ackland, E. Rekka, A.P. Simula, M.S. Lennard et al. (1996). Influence of amino acid residue 374 of cytochrome P-450 2D6(CYP2D6) on the regio-and enantio-selective metabolism of metoprolol. Biochem. J. 316, 647\u2013654.", "journal-title": "Biochem. J."}, {"key": "10_CR552", "doi-asserted-by": "publisher", "first-page": "29055", "DOI": "10.1074/jbc.270.44.26326", "volume": "270", "author": "S.W. Ellis", "year": "1995", "unstructured": "Ellis, S.W., G.P. Hayhurst, G. Smith, T. Lightfoot, M.M.S. Wong, A.P. Simula et al. (1995). Evidence that aspartic acid 301 is a critical substrate-contact residue in the active site of cytochrome P450 2D6. J. Biol. Chem. 270, 29055\u201329058.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR553", "doi-asserted-by": "publisher", "first-page": "255", "DOI": "10.1006/abbi.2001.2510", "volume": "393", "author": "I.H. Hanna", "year": "2001", "unstructured": "Hanna, I.H., M.-S. Kim, and F.P. Guengerich (2001). Heterologous expression of cytochrome P450 2D6 mutants, electron transfer, and catalysis of bufuralol hydroxylation. The role of aspartate 301 in structural integrity. Arch. Biochem. Biophys. 393, 255\u2013261.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR554", "doi-asserted-by": "publisher", "first-page": "4021", "DOI": "10.1074/jbc.M209519200", "volume": "278", "author": "M.J. Paine", "year": "2003", "unstructured": "Paine, M.J., L.A. McLaughlin, J.U. Flanagan, C.A. Kemp, M.J. Sutcliffe, G.C. Roberts et al. (2003). Residues glutamate 216 and aspartate 301 are key determinants of substrate specificity and product regioselectivity in cytochrome P450 2D6. J. Biol. Chem. 278, 4021\u20134027.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR555", "doi-asserted-by": "crossref", "first-page": "783", "DOI": "10.1042/bj3310783", "volume": "331", "author": "G. Smith", "year": "1998", "unstructured": "Smith, G., S. Modi, I. Pillai, L.-Y. Lian, M.J. Sutcliffe, M.P. Pritchard et al. (1998). Determinants of the substrate specificity of human cytochrome P-450 CYP2D6: Design and construction of a mutant with testosterone hydroxylase activity. Biochem. J. 331, 783\u2013792.", "journal-title": "Biochem. J."}, {"key": "10_CR556", "doi-asserted-by": "publisher", "first-page": "1357", "DOI": "10.1093/carcin/17.6.1357", "volume": "17", "author": "H. Wiseman", "year": "1996", "unstructured": "Wiseman, H. and D.F. Lewis (1996). The metabolism of tamoxifen by human cytochromes P450 is rationalized by molecular modelling of the enzyme-substrate interactions: Potential importance to its proposed anti-carcinogenic/carcinogenic actions. Carcinogenesis 17, 1357\u20131360.", "journal-title": "Carcinogenesis"}, {"key": "10_CR557", "doi-asserted-by": "publisher", "first-page": "219", "DOI": "10.1080/004982500237622", "volume": "30", "author": "T. Lightfoot", "year": "2000", "unstructured": "Lightfoot, T., S.W. Ellis, J. Mahling, M.J. Ackland, F.E. Blaney, G.J. Bijloo et al. (2000). Regioselectivity hydroxylation of debrisoquine by cytochrome P4502D6: Implications for active site modelling. Xenobiotica 30, 219\u2013233.", "journal-title": "Xenobiotica"}, {"key": "10_CR558", "doi-asserted-by": "publisher", "first-page": "565", "DOI": "10.1042/0264-6021:3450565", "volume": "345", "author": "S.W. Ellis", "year": "2000", "unstructured": "Ellis, S.W., G.P. Hayhurst, T. Lightfoot, G. Smith, J. Harlow, K. Rowland-Yeo et al. (2000). Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6. Biochem. J. 345, 565\u2013571.", "journal-title": "Biochem. J."}, {"key": "10_CR559", "doi-asserted-by": "publisher", "first-page": "373", "DOI": "10.1042/0264-6021:3550373", "volume": "355", "author": "G.P. Hayhurst", "year": "2001", "unstructured": "Hayhurst, G.P., J. Harlow, J. Chowdry, E. Gross, E. Hilton, M.S. Lennard et al. (2001). Influence of phenylalanine-481 substitutions on the catalytic activity of cytochrome P450 2D6. Biochem. J. 355, 373\u2013379.", "journal-title": "Biochem. J."}, {"key": "10_CR560", "doi-asserted-by": "publisher", "first-page": "477", "DOI": "10.1097/00008571-200108000-00003", "volume": "11", "author": "Y. Ramamoorthy", "year": "2001", "unstructured": "Ramamoorthy, Y., R.F. Tyndale, and E.M. Sellers (2001). Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates. Pharmacogenetics 11, 477\u2013487.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR561", "doi-asserted-by": "publisher", "first-page": "4461", "DOI": "10.1021/bi962633p", "volume": "36", "author": "S. Modi", "year": "1997", "unstructured": "Modi, S., D.E. Gilham, M.J. Sutcliffe, L.-Y. Lian, W.U. Primrose, C.R. Wolf et al. (1997). 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine as a substrate of cytochrome P450 2D6: Allosteric effects of NADPH-cytochrome P450 reductase. Biochemistry 36, 4461\u20134470.", "journal-title": "Biochemistry"}, {"key": "10_CR562", "doi-asserted-by": "publisher", "first-page": "39553", "DOI": "10.1074/jbc.M106841200", "volume": "276", "author": "I.H. Hanna", "year": "2001", "unstructured": "Hanna, I.H., J.A. Krauser, H. Cai, M.-S. Kim, and F.P. Guengerich (2001). Diversity in mechanisms of substrate oxidation by cytochrome P450 2D6. Lack of an allosteric role of NADPH-cytochrome P450 reductase in catalytic regioselectivity. J. Biol. Chem. 276, 39553\u201339561.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR563", "doi-asserted-by": "publisher", "first-page": "33711", "DOI": "10.1074/jbc.M205146200", "volume": "277", "author": "F.P. Guengerich", "year": "2002", "unstructured": "Guengerich, F.P., G.P. Miller, I.H. Hanna, H. Sato, and M.V. Martin (2002). Oxidation of methoxyphenethylamines by cytochrome P450 2D6. Analysis of rate-limiting steps. J. Biol. Chem. 277, 33711\u201333719.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR564", "doi-asserted-by": "publisher", "first-page": "303", "DOI": "10.1006/abbi.2000.1936", "volume": "380", "author": "T. Fukuda", "year": "2000", "unstructured": "Fukuda, T., Y. Nishida, S. Imaoka, T. Hiroi, M. Naohara, Y. Funae et al. (2000). The decreased in vivo clearance of CYP2D6 substrates by CYP2D6*10 might be caused not only by the low-expression but also by low affinity of CYP2D6. Arch. Biochem. Biophys. 380, 303\u2013308.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR565", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1016/0024-3205(84)90332-1", "volume": "34", "author": "S.V. Otton", "year": "1984", "unstructured": "Otton, S.V., T. Inaba, and W. Kalow (1984). Competitive inhibition of sparteine oxidation in human liver by \u03b2-adrenoceptor antagonists and other cardiovascular drugs. Life Sci. 34, 73\u201380.", "journal-title": "Life Sci"}, {"key": "10_CR566", "first-page": "863", "volume": "29", "author": "J.R. Palamanda", "year": "2001", "unstructured": "Palamanda, J.R., C.N. Casciano, L.A. Norton, R.P. Clement, L.V. Favreau, C.C. Lin et al. (2001). Mechanism-based inactivation of CYP2D6 by 5-fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine. Drug Metab. Dispos. 29, 863\u2013867.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR567", "doi-asserted-by": "crossref", "first-page": "827", "DOI": "10.1038/clpt.1983.257", "volume": "34", "author": "N.S. Oates", "year": "1983", "unstructured": "Oates, N.S., R.R. Shah, J.R. Idle, and R.L. Smith (1983). Influence of oxidation polymorphism on phenformin kinetics and dynamics. Clin. Pharmacol. Ther. 34, 827\u2013834.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR568", "first-page": "601P", "volume": "14", "author": "N.S. Oates", "year": "1982", "unstructured": "Oates, N.S., R.R. Shah, P.L. Drury, J.R. Idle, and R.L. Smith (1982). Captopril-induced agranulocytosis associated with an impairment of debrisoquine hydroxylation. Br. J. Pharmacol. 14, 601P.", "journal-title": "Br. J. Pharmacol."}, {"key": "10_CR569", "doi-asserted-by": "publisher", "first-page": "465", "DOI": "10.1097/00008571-200208000-00007", "volume": "12", "author": "T. Rau", "year": "2002", "unstructured": "Rau, T., R. Heide, K. Bergmann, H. Wuttke, U. Werner, N. Feifel, and T. Eschenhagen (2002). Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment. Pharmacogenetics 12, 465\u2013472.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR570", "doi-asserted-by": "publisher", "first-page": "1633", "DOI": "10.1016/S0278-6915(02)00117-5", "volume": "40", "author": "J.L. Dorne", "year": "2002", "unstructured": "Dorne, J.L., K. Walton, W. Slob, and A.G. Renwick (2002). Human variability in polymorphic CYP2D6 metabolism: Is the kinetic default uncertainty factor adequate? Food Chem. Toxicol. 40, 1633\u20131656.", "journal-title": "Food Chem. Toxicol."}, {"key": "10_CR571", "doi-asserted-by": "publisher", "first-page": "246", "DOI": "10.1097/00004714-200004000-00019", "volume": "20", "author": "W.H. Chou", "year": "2000", "unstructured": "Chou, W.H., F.X. Yan, J. de Leon, J. Barnhill, T. Rogers, M. Cronin et al. (2000). Extension of a pilot study: Impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness. J. Clin. Psychopharmacol. 20, 246\u2013251.", "journal-title": "J. Clin. Psychopharmacol."}, {"key": "10_CR572", "doi-asserted-by": "publisher", "first-page": "453", "DOI": "10.2165/00003088-200241070-00001", "volume": "41", "author": "M.L. Dahl", "year": "2002", "unstructured": "Dahl, M.L. (2002). Cytochrome P450 phenotyping/genotyping in patients receiving antipsychotics: Useful aid to prescribing?. Clin. Pharmacokinet. 41, 453\u2013470.", "journal-title": "Clin. Pharmacokinet."}, {"key": "10_CR573", "doi-asserted-by": "publisher", "first-page": "154", "DOI": "10.1016/S0006-3223(01)01353-1", "volume": "52", "author": "E.M. Scolnick", "year": "2002", "unstructured": "Scolnick, E.M. (2002). Discovery and development of antidepressants: A perspective from a pharmaceutical discovery company. Biol. Psychiatry 52, 154\u2013156.", "journal-title": "Biol. Psychiatry"}, {"key": "10_CR574", "first-page": "3675", "volume": "49", "author": "N. Caporaso", "year": "1989", "unstructured": "Caporaso, N., R.B. Hayes, M. Dosemeci, R. Hoover, R. Ayesh, M. Hetzel et al. (1989). Lung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype. Cancer Res. 49, 3675\u20133679.", "journal-title": "Cancer Res"}, {"key": "10_CR575", "first-page": "251", "volume": "56", "author": "C. Bouchardy", "year": "1996", "unstructured": "Bouchardy, C., S. Benhamou, and P. Dayer (1996). The effect of tobacco on lung cancer risk depends on CYP2D6 activity. Cancer Res. 56, 251\u2013253.", "journal-title": "Cancer Res"}, {"key": "10_CR576", "first-page": "215", "volume": "7", "author": "G.L. Shaw", "year": "1998", "unstructured": "Shaw, G.L., R.T. Falk, J.N. Frame, B. Weiffenbach, J.V. Nesbitt, H.I. Pass et al. (1998). Genetic polymorphism of CYP2D6 and lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 7, 215\u2013219.", "journal-title": "Cancer Epidemiol. Biomarkers Prev."}, {"key": "10_CR577", "doi-asserted-by": "publisher", "first-page": "227", "DOI": "10.1097/00008571-199806000-00005", "volume": "8", "author": "A. Rostami-Hodjegan", "year": "1998", "unstructured": "Rostami-Hodjegan, A., M.S. Lennard, H.F. Woods, and G.T. Tucker (1998). Meta-analysis of studies of the CYP2D6 polymorphism in relation to lung cancer and Parkinson\u2019s desease. Pharmacogenetics 8, 227\u2013238.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR578", "doi-asserted-by": "publisher", "first-page": "7", "DOI": "10.1097/00008571-199802000-00002", "volume": "8", "author": "M. Legrand-Andreoletti", "year": "1998", "unstructured": "Legrand-Andreoletti, M., I. Stucker, D. Marez, P. Galais, J. Cosme, N. Sabbagh et al. (1998). Cytochrome P450 CYP2D6 gene polymorphism and lung cancer susceptibility in Caucasians. Pharmacogenetics 8, 7\u201314.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR579", "doi-asserted-by": "publisher", "first-page": "389", "DOI": "10.1007/s002280050219", "volume": "51", "author": "P.M. Christensen", "year": "1997", "unstructured": "Christensen, P.M., P.C. G\u00f8tzsche, and K. Br\u00f8sen (1997). The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of lung cancer: A meta-analysis. Eur. J. Clin. Pharmacol. 51, 389\u2013393.", "journal-title": "Eur. J. Clin. Pharmacol."}, {"key": "10_CR580", "doi-asserted-by": "publisher", "first-page": "128", "DOI": "10.1097/00008571-199206000-00004", "volume": "2", "author": "C.M. Fleming", "year": "1992", "unstructured": "Fleming, C.M., A. Kaisary, G.R. Wilkinson, P. Smith, and R.A. Branch (1992). The ability to 4-hydroxylate debrisoquine is related to recurrence of bladder cancer. Pharmacogenetics 2, 128\u2013134.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR581", "doi-asserted-by": "publisher", "first-page": "433", "DOI": "10.1097/00008571-199810000-00008", "volume": "8", "author": "S.F. Worrall", "year": "1998", "unstructured": "Worrall, S.F., M. Corrigan, A. High, D. Starr, C. Matthias, C.R. Wolf et al. (1998). Susceptibility and outcome in oral cancer: Preliminary data showing an association with polymorphism in cytochrome P450 CYP2D6. Pharmacogenetics 8, 433\u2013439.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR582", "doi-asserted-by": "publisher", "first-page": "1213", "DOI": "10.1016/S0140-6736(85)90743-3", "volume": "ii", "author": "A. Barbeau", "year": "1985", "unstructured": "Barbeau, A., M. Roy, S. Paris, T. Cloutier, L. Plasse, and J. Poirier (1985). Ecogenetics of Parkinson\u2019s disease: 4-hydroxylation of debrisoquine. Lancet ii, 1213\u20131215.", "journal-title": "Lancet"}, {"key": "10_CR583", "doi-asserted-by": "publisher", "first-page": "1017", "DOI": "10.1016/0140-6736(92)90537-D", "volume": "339", "author": "M. Armstrong", "year": "1992", "unstructured": "Armstrong, M., A.K. Daly, S. Cholerton, D.N. Bateman, and J.R. Idle (1992). Mutant debrisoquine hydroxylation genes in Parkinson\u2019s disease. Lancet 339, 1017\u20131018.", "journal-title": "Lancet"}, {"key": "10_CR584", "doi-asserted-by": "publisher", "first-page": "290", "DOI": "10.1002/mds.1041", "volume": "16", "author": "B.S. Harhangi", "year": "2001", "unstructured": "Harhangi, B.S., B.A. Oostra, P. Heutink, C.M. van Duijn, A. Hofman, and M.M. Breteler (2001). CYP2D6 polymorphism in Parkinson\u2019s disease: The Rotterdam Study. Mov. Disord. 16, 290\u2013293.", "journal-title": "Mov. Disord."}, {"key": "10_CR585", "doi-asserted-by": "publisher", "first-page": "851", "DOI": "10.1080/00207450290025860", "volume": "112", "author": "M.F. Allam", "year": "2002", "unstructured": "Allam, M.F., A. Serrano del Castillo, and R. Fernandez-Crehuet Navajas (2002). Smoking and Parkinson\u2019s disease: Explanatory hypothesis. Int. J. Neurosci. 112, 851\u2013854.", "journal-title": "Int. J. Neurosci."}, {"key": "10_CR586", "doi-asserted-by": "publisher", "first-page": "8256", "DOI": "10.1073/pnas.85.21.8256", "volume": "85", "author": "U.M. Zanger", "year": "1988", "unstructured": "Zanger, U.M., H.P. Hauri, J. Loeper, J.C. Homberg, and U.A. Meyer (1988). Antibodies against human cytochrome P-450dbl in autoimmune hepatitis type II. Proc. Natl. Acad. Sci. USA 85, 8256\u20132860.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR587", "doi-asserted-by": "crossref", "first-page": "503", "DOI": "10.1007/BF02919749", "volume": "10", "author": "M.P. Manns", "year": "1991", "unstructured": "Manns, M.P. (1991). Cytochrome P450 enzymes as human autoantigens. Immunol. Res. 10, 503\u2013507.", "journal-title": "Immunol. Res."}, {"key": "10_CR588", "doi-asserted-by": "crossref", "first-page": "1370", "DOI": "10.1172/JCI115443", "volume": "88", "author": "M.P. Manns", "year": "1991", "unstructured": "Manns, M.P., K.J. Griffin, K.F. Sullivan, and E.F. Johnson (1991). LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J. Clin. Invest. 88, 1370\u20131378.", "journal-title": "J. Clin. Invest."}, {"key": "10_CR589", "doi-asserted-by": "crossref", "first-page": "203", "DOI": "10.1016/0016-5085(93)90853-5", "volume": "104", "author": "J. Loeper", "year": "1993", "unstructured": "Loeper, J., V. Descatoire, M. Maurice, P. Beaune, J. Belghiti, D. Houssin et al. (1993). Cytochromes P-450 in human hepatocyte plasma membrane: Recognition by several autoantibodies. Gastroenterology 104, 203\u2013216.", "journal-title": "Gastroenterology"}, {"key": "10_CR590", "doi-asserted-by": "publisher", "first-page": "449", "DOI": "10.1136/gut.46.4.449", "volume": "46", "author": "D. Vergani", "year": "2000", "unstructured": "Vergani, D. (2000). LKM antibody: Getting in some target practice. Gut 46, 449\u2013450.", "journal-title": "Gut"}, {"key": "10_CR591", "doi-asserted-by": "publisher", "first-page": "103", "DOI": "10.1016/S0022-1759(02)00016-9", "volume": "262", "author": "S. Vitozzi", "year": "2002", "unstructured": "Vitozzi, S., P. Lapierre, I. Djilali-Saiah, and F. Alvarez (2002). Autoantibody detection in type 2 autoimmune hepatitis using a chimera recombinant protein. J. Immunol. Meth. 262, 103\u2013110.", "journal-title": "J. Immunol. Meth."}, {"key": "10_CR592", "doi-asserted-by": "publisher", "first-page": "734", "DOI": "10.1016/0168-8278(95)80041-7", "volume": "23", "author": "W. Nolte", "year": "1995", "unstructured": "Nolte, W., F. Polzien, B. Sattler, G. Ramadori, and H. Hartmann (1995). Recurrent episodes of acute hepatitis associated with LKM-1 (cytochrome P450 2D6) antibodies in identical twin brothers. J. Hepatol. 23, 734\u2013739.", "journal-title": "J. Hepatol."}, {"key": "10_CR593", "doi-asserted-by": "publisher", "first-page": "78", "DOI": "10.1016/0006-291X(65)90429-8", "volume": "21", "author": "W.H. Orme-Johnson", "year": "1965", "unstructured": "Orme-Johnson, W.H. and D.M. Ziegler (1965). Alcohol mixed function oxidase activity of mammalian liver micoromes. Biochem. Biophys. Res. Commun. 21, 78\u201382.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR594", "first-page": "2505", "volume": "245", "author": "C.S. Lieber", "year": "1970", "unstructured": "Lieber, C.S. and L.M. DeCarli (1970). Hepatic microsomal ethanol oxidizing system: In vitro chracteristics and adaptive properties in vivo. J. Biol. Chem. 245, 2505\u20132512.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR595", "doi-asserted-by": "publisher", "first-page": "404", "DOI": "10.1016/0003-9861(74)90492-5", "volume": "163", "author": "R. Teschke", "year": "1974", "unstructured": "Teschke, R., Y. Hasumura, and C.S. Lieber (1974). Hepatic microsomal ethanol-oxidizing system: Solubilization, isolation and characterization. Arch. Biochem. Biophys. 163, 404\u2013415.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR596", "first-page": "6385", "volume": "260", "author": "D.E. Ryan", "year": "1985", "unstructured": "Ryan, D.E., L. Ramanathan, S. Iida, P.E. Thomas, M. Haniu, J.E. Shively et al. (1985). Characterization of a major form of rat hepatic microsomal cytochrome P-450 induced by isoniazid. J. Biol. Chem. 260, 6385\u20136393.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR597", "doi-asserted-by": "publisher", "first-page": "292", "DOI": "10.1016/0003-9861(87)90347-X", "volume": "258", "author": "S.A. Wrighton", "year": "1987", "unstructured": "Wrighton, S.A., P.E. Thomas, D.E. Ryan, and W. Levin (1987). Purification and characterization of ethanol-inducible human hepatic cytochrome P-450HLj. Arch. Biochem. Biophys. 258, 292\u2013297.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR598", "doi-asserted-by": "publisher", "first-page": "9006", "DOI": "10.1021/bi00425a019", "volume": "27", "author": "M. Umeno", "year": "1988", "unstructured": "Umeno, M., O.W. McBride, C.-S. Yang, H.V. Gelboin, and F.J. Gonzalez (1988). Human ethanol-inducible P450IIE1: Complete gene sequence, promoter characterization, chromosome mapping, and cDNA-directed expression. Biochemistry 27, 9006\u20139013.", "journal-title": "Biochemistry"}, {"key": "10_CR599", "first-page": "1189", "volume": "256", "author": "F.P. Guengerich", "year": "1991", "unstructured": "Guengerich, F.P. and C.G. Turvy (1991). Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. J. Pharmacol. Exp. Ther. 256, 1189\u20131194.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR600", "doi-asserted-by": "publisher", "first-page": "476", "DOI": "10.1111/j.1432-1033.1996.0476z.x", "volume": "238", "author": "I. Vieira", "year": "1996", "unstructured": "Vieira, I., M. Sonnier, and T. Cresteil (1996). Developmental expression of CYP2E1 in the human liver: Hypermethylation control of gene expression during the neonatal period. Eur. J. Biochem. 238, 476\u2013483.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR601", "doi-asserted-by": "publisher", "first-page": "149", "DOI": "10.1146/annurev.pharmtox.43.100901.140251", "volume": "43", "author": "X. Ding", "year": "2003", "unstructured": "Ding, X. and L.S. Kaminsky (2003). Human extrahepatic cytochromes P450: Function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. Toxicol. 43, 149\u2013173.", "journal-title": "Annu. Rev. Pharmacol. Toxicol."}, {"key": "10_CR602", "doi-asserted-by": "publisher", "first-page": "1019", "DOI": "10.1073/pnas.91.3.1019", "volume": "91", "author": "M. Warner", "year": "1994", "unstructured": "Warner, M. and J.A. Gustafsson (1994). Effect of ethanol on cytochrome P450 in the rat brain. Proc. Natl. Acad. Sci. USA 91, 1019\u20131023.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR603", "doi-asserted-by": "publisher", "first-page": "23", "DOI": "10.1006/abbi.1999.1477", "volume": "373", "author": "S.C. Upadhya", "year": "2000", "unstructured": "Upadhya, S.C., P.S. Tirumalai, M.R. Boyd, T. Mori, and V. Ravindranath (2000). Cytochrome P4502E (CYP2E) in brain: Constitutive expression, induction by ethanol and localization by fluorescence in situ hybridization. Arch. Biochem. Biophys. 373, 23\u201334.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR604", "doi-asserted-by": "crossref", "first-page": "179", "DOI": "10.1016/0964-1955(94)90088-4", "volume": "30B", "author": "K. Kazakoff", "year": "1994", "unstructured": "Kazakoff, K., P. Iversen, T. Lawson, J. Baron, F.P. Guengerich, and P. Pour (1994). Involvement of cytochrome P450 2E1-like isoform in the activation of N-nitrosobis(2-oxopropyl)amine in the rat nasal mucosa. Eur. J. Cancer 30B, 179\u2013185.", "journal-title": "Eur. J. Cancer"}, {"key": "10_CR605", "doi-asserted-by": "crossref", "first-page": "426", "DOI": "10.1136/gut.42.3.426", "volume": "42", "author": "I.D. Norton", "year": "1998", "unstructured": "Norton, I.D., M.V. Apte, P.S. Haber, G.W. McCaughan, R.C. Pirola, and J.S. Wilson (1998). Cytochrome P4502E1 is present in rat pancreas and is induced by chronic ethanol administration. Gut 42, 426\u2013430.", "journal-title": "Gut"}, {"key": "10_CR606", "doi-asserted-by": "publisher", "first-page": "9141", "DOI": "10.1073/pnas.88.20.9141", "volume": "88", "author": "J.R. Larson", "year": "1991", "unstructured": "Larson, J.R., M.J. Coon, and T.D. Porter (1991). Purification and properties of a shortened form of cytochrome P-450 2E1: Deletion of the NH2-terminal membrane-insertion signal peptide does not alter the catalytic activities. Proc. Natl. Acad. Sci. USA 88, 9141\u20139145.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR607", "doi-asserted-by": "publisher", "first-page": "59", "DOI": "10.1006/abbi.1994.1280", "volume": "312", "author": "E.M.J. Gillam", "year": "1994", "unstructured": "Gillam, E.M.J., Z. Guo, and F.P. Guengerich (1994). Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties. Arch. Biochem. Biophys. 312, 59\u201366.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR608", "doi-asserted-by": "publisher", "first-page": "309", "DOI": "10.1016/S0014-5793(99)01361-7", "volume": "460", "author": "E.P.A. Neve", "year": "1999", "unstructured": "Neve, E.P.A. and M. Ingelman-Sundberg (1999). A soluble NH2-terminally truncated catalytically active form of rat cytochrome P450 2E1 targeted to liver mitochondria. FEBS Lett. 460, 309\u2013314.", "journal-title": "FEBS Lett"}, {"key": "10_CR609", "doi-asserted-by": "publisher", "first-page": "24680", "DOI": "10.1074/jbc.M100363200", "volume": "276", "author": "M.A. Robin", "year": "2001", "unstructured": "Robin, M.A., H.K. Anandatheerthavarada, J.K. Fang, M. Cudic, L. Otvos, and N.G. Avadhani (2001). Mitochondrial targeted cytochrome P450 2E1 (P450 MT5) contains an intact N-terminus and requires mitochondrial specific electron transfer proteins for activity. J. Biol. Chem. 276, 24680\u201324689.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR610", "doi-asserted-by": "publisher", "first-page": "17130", "DOI": "10.1074/jbc.M000957200", "volume": "275", "author": "E.P. Neve", "year": "2000", "unstructured": "Neve, E.P. and M. Ingelman-Sundberg (2000). Molecular basis for the transport of cytochrome P450 2E1 to the plasma membrane. J. Biol. Chem. 275, 17130\u201317135.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR611", "doi-asserted-by": "publisher", "first-page": "2280", "DOI": "10.1021/bi00382a031", "volume": "26", "author": "P.E. Thomas", "year": "1987", "unstructured": "Thomas, P.E., S. Bandiera, S.L. Maines, D.E. Ryan, and W. Levin (1987). Regulation of cytochrome P-450j, a high-affinity N-nitrosodimethylamine demethylase, in rat hepatic microsomes. Biochemistry 26, 2280\u20132289.", "journal-title": "Biochemistry"}, {"key": "10_CR612", "doi-asserted-by": "publisher", "first-page": "429", "DOI": "10.1002/bies.950120906", "volume": "12", "author": "D.R. Koop", "year": "1990", "unstructured": "Koop, D.R. and D.J. Tierney (1990). Multiple mechanisms in the regulation of ethanol-inducible cytochrome P450IIE1. BioEssays 12, 429\u2013435.", "journal-title": "BioEssays"}, {"key": "10_CR613", "doi-asserted-by": "crossref", "first-page": "4495", "DOI": "10.1128/MCB.10.9.4495", "volume": "10", "author": "T. Ueno", "year": "1990", "unstructured": "Ueno, T. and F.J. Gonzalez (1990). Transcriptional control of the rat hepatic CYP2E1 gene. Mol. Cell Biol. 10, 4495\u20134505.", "journal-title": "Mol. Cell Biol."}, {"key": "10_CR614", "doi-asserted-by": "publisher", "first-page": "304", "DOI": "10.1006/bbrc.1999.1817", "volume": "266", "author": "K.J. Woodcroft", "year": "1999", "unstructured": "Woodcroft, K.J. and R.F. Novak (1999). The role of phosphatidylinositol 3-kinase, Src kinase, and protein kinase A signaling pathways in insulin and glucagon regulation of CYP2E1 expression. Biochem. Biophys. Res. Commun. 266, 304\u2013307.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR615", "doi-asserted-by": "publisher", "first-page": "49", "DOI": "10.1053/jhep.2000.8532", "volume": "32", "author": "E. Siewert", "year": "2000", "unstructured": "Siewert, E., R. Bort, R. Kluge, P.C. Heinrich, J. Castell, and R. Jover (2000). Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent. Hepatology 32, 49\u201355.", "journal-title": "Hepatology"}, {"key": "10_CR616", "doi-asserted-by": "publisher", "first-page": "221", "DOI": "10.1023/A:1007625925095", "volume": "16", "author": "D. Lagadic-Gossmann", "year": "2000", "unstructured": "Lagadic-Gossmann, D., C. Lerche, M. Rissel, F. Joannard, M. Galisteo, A. Guillouzo et al. (2000). The induction of the human hepatic CYP2E1 gene by interleukin 4 is transcriptional and regulated by protein kinase C. Cell Biol. Toxicol. 16, 221\u2013233.", "journal-title": "Cell Biol. Toxicol."}, {"key": "10_CR617", "doi-asserted-by": "publisher", "first-page": "1048", "DOI": "10.1124/jpet.102.041582", "volume": "304", "author": "J. Hakkola", "year": "2003", "unstructured": "Hakkola, J., Y. Hu, and M. Ingelman-Sundberg (2003). Mechanisms of down-regulation of CYP2E1 expression by inflammatory cytokines in rat hepatoma cells. J. Pharmacol. Exp. Ther. 304, 1048\u20131054.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR618", "doi-asserted-by": "publisher", "first-page": "1072", "DOI": "10.1016/0006-291X(90)90976-T", "volume": "166", "author": "S.G. Kim", "year": "1990", "unstructured": "Kim, S.G. and R.F. Novak (1990). Induction of rat hepatic P450IIE1 (CYP 2E1) by pyridine: Evidence for a role of protein synthesis in the absence of transcriptional activation. Biochem. Biophys. Res. Commun. 166, 1072\u20131079.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR619", "doi-asserted-by": "publisher", "first-page": "180", "DOI": "10.1006/abbi.2000.1704", "volume": "376", "author": "T.A. Kocarek", "year": "2000", "unstructured": "Kocarek, T.A., R.C. Zangar, and R.F. Novak (2000). Post-transcriptional regulation of rat CYP2E1 expression: Role of CYP2E1 mRNA untranslated regions in control of translational efficiency and message stability. Arch. Biochem. Biophys. 376, 180\u2013190.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR620", "doi-asserted-by": "publisher", "first-page": "29632", "DOI": "10.1074/jbc.270.50.29632", "volume": "270", "author": "B.J. Roberts", "year": "1995", "unstructured": "Roberts, B.J., B.J. Song, Y. Soh, S.S. Park, and S.E. Shoaf (1995). Ethanol induces CYP2E1 by protein stabilization: Role of ubiquitin conjugation in the rapid degradation of CYP2E1. J. Biol. Chem. 270, 29632\u201329635.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR621", "doi-asserted-by": "publisher", "first-page": "25", "DOI": "10.1006/abbi.1997.9907", "volume": "341", "author": "M.X. Yang", "year": "1997", "unstructured": "Yang, M.X. and A.I. Cederbaum (1997). Characterization of cytochrome P4502E1 turnover in transfected HepG2 cells expressing human CYP2E1. Arch. Biochem. Biophys. 341, 25\u201333.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR622", "first-page": "213", "volume": "291", "author": "M.g. Emery", "year": "1999", "unstructured": "Emery, M.g., C. Jubert, K.E. Thummel, and E.D. Kharasch (1999). Duration of cytochrome P-450 2E1 (CYP2E1) inhibition and estimation of functional CYP2E1 enzyme half-life after single-dose disulfiram administration in humans. J. Pharmacol. Exp. Ther. 291, 213\u2013219.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR623", "first-page": "1165", "volume": "25", "author": "J.Y. Chien", "year": "1997", "unstructured": "Chien, J.Y., K.E. Thummel, and J.T. Slattery (1997). Pharmacokinetic consequences of induction of CYP2E1 by ligand stabilization. Drug Metab. Dispos. 25, 1165\u20131175.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR624", "doi-asserted-by": "crossref", "first-page": "321", "DOI": "10.1093/oxfordjournals.jbchem.a124526", "volume": "116", "author": "J. Watanabe", "year": "1994", "unstructured": "Watanabe, J., S. Hayashi, and K. Kawajiri (1994). Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5\u2032-flanking region. J. Biochem. (Tokyo) 116, 321\u2013326.", "journal-title": "J. Biochem. (Tokyo)"}, {"key": "10_CR625", "doi-asserted-by": "publisher", "first-page": "543", "DOI": "10.1097/00008571-199812000-00011", "volume": "8", "author": "K.S. Fairbrother", "year": "1998", "unstructured": "Fairbrother, K.S., J. Grove, I. de Waziers, D.T. Steimel, C.P. Day, C.L. Crespi et al. (1998). Detection and characterization of novel polymorphisms in the CYP2E1 gene. Pharmacogenetics 8, 543\u2013552.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR626", "first-page": "1", "volume": "432", "author": "E. Fritsche", "year": "2000", "unstructured": "Fritsche, E., G.S. Pittman, and D.A. Bell (2000). Localization, sequence analysis, and ethnic distribution of a 96-bp insertion in the promoter of the human CYP2E1 gene. Mutat. Res. 432, 1\u20135.", "journal-title": "Mutat. Res."}, {"key": "10_CR627", "doi-asserted-by": "publisher", "first-page": "411", "DOI": "10.1097/00008571-199810000-00006", "volume": "8", "author": "H. Powell", "year": "1998", "unstructured": "Powell, H., N.R. Kitteringham, M. Pirmohamed, D.A. Smith, and B.K. Park (1998). Expression of cytochrome P4502E1 in human liver: Assessment by mRNA, genotype and phenotype. Pharmacogenetics 8, 411\u2013421.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR628", "doi-asserted-by": "publisher", "first-page": "372", "DOI": "10.1007/s002040000151", "volume": "74", "author": "K. Inoue", "year": "2000", "unstructured": "Inoue, K., H. Yamazaki, and T. Shimada (2000). Characterization of liver microsomal 7-ethoxycoumarin O-deethylation and chlorzoxazone 6-hydroxylation activities in Japanese and Caucasian subjects genotyped for CYP2E1 gene. Arch. Toxicol. 74, 372\u2013378.", "journal-title": "Arch. Toxicol."}, {"key": "10_CR629", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.1038/clpt.1994.150", "volume": "56", "author": "D. O\u2019Shea", "year": "1994", "unstructured": "O\u2019Shea, D., S.N. Davis, R.B. Kim, and G.R. Wilkinson (1994). Effect of fasting and obesity in humans on the 6-hydroxylation of chloroxazone: A putative probe of CYP2E1 activity. Clin. Pharmacol. Ther. 56, 359\u2013367.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR630", "first-page": "13607", "volume": "260", "author": "D.R. Koop", "year": "1985", "unstructured": "Koop, D.R. and J.P. Casazza (1985). Identification of ethanol-inducible P-450 isozyme 3a as the acetone and acetol monooxygenase of rabbit microsomes. J. Biol. Chem. 260, 13607\u201313612.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR631", "first-page": "83", "volume": "105", "author": "F.Y. Bondoc", "year": "1999", "unstructured": "Bondoc, F.Y., Z. Bao, W.Y. Hu, F.J. Gonzalez, Y. Wang, C.S. Yang et al. (1999). Acetone catabolism by cytochrome P450 2E1: Studies with CYP2E1-null mice. Biochem. Pharmacol. 105, 83\u201388.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR632", "first-page": "438", "volume": "21", "author": "T. Kashiwagi", "year": "1982", "unstructured": "Kashiwagi, T., S. Ji, J.J. Lemasters, and R.G. Thurman (1982). Rates of alcohol dehydrogenase-dependent ethanol metabolism in periportal and pericentral regions of the perfused rat liver. Mol. Pharmacol. 21, 438\u2013443.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR633", "first-page": "G1259", "volume": "277", "author": "H. Kono", "year": "1999", "unstructured": "Kono, H., B.U. Bradford, M. Yin, K.K. Sulik, D.R. Koop, J.M. Peters et al. (1999). CYP2E1 is not involved in early alcohol-induced liver injury. Am. J. Physiol. 277, G1259\u2013G1267.", "journal-title": "Am. J. Physiol."}, {"key": "10_CR634", "doi-asserted-by": "publisher", "first-page": "689", "DOI": "10.1016/0006-291X(91)91427-E", "volume": "179", "author": "Y. Terelius", "year": "1991", "unstructured": "Terelius, Y., C. Norsten-H\u00f6\u00f6g, T. Cronholm, and M. Ingelman-Sundberg (1991). Acetaldehyde as a substrate for ethanol-inducible cytochrome P450 (CYP2E1). Biochem. Biophys. Res. Commun. 179, 689\u2013694.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR635", "first-page": "527", "volume": "280", "author": "S. Kunitoh", "year": "1997", "unstructured": "Kunitoh, S., S. Imaoka, T. Hiroi, Y. Yabusaki, T. Monna, and Y. Funae (1997). Acetaldehyde as well as ethanol is metabolized by human CYP2E1. J. Pharmacol. Exp. Ther. 280, 527\u2013532.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR636", "doi-asserted-by": "publisher", "first-page": "23833", "DOI": "10.1074/jbc.274.34.23833", "volume": "274", "author": "L.C. Bell-Parikh", "year": "1999", "unstructured": "Bell-Parikh, L.C. and F.P. Guengerich (1999). Kinetics of cytochrome P450 2E1-catalyzed oxidation of ethanol to acetic acid via acetaldehyde. J. Biol. Chem. 274, 23833\u201323840.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR637", "doi-asserted-by": "publisher", "first-page": "1975", "DOI": "10.1016/0006-2952(93)90639-E", "volume": "46", "author": "W. Tassaneeyakul", "year": "1993", "unstructured": "Tassaneeyakul, W., M.E. Veronese, D.J. Birkett, F.J. Gonzalez, and J.O. Miners (1993). Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques. Biochem. Pharmacol. 46, 1975\u20131981.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR638", "doi-asserted-by": "publisher", "first-page": "566", "DOI": "10.1021/tx00018a012", "volume": "3", "author": "R. Peter", "year": "1990", "unstructured": "Peter, R., R.G. B\u00f6cker, P.H. Beaune, M. Iwasaki, F.P. Guengerich, and C.-S. Yang (1990). Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450 IIE1. Chem. Res. Toxicol. 3, 566\u2013573.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR639", "first-page": "438", "volume": "23", "author": "H. Yamazaki", "year": "1995", "unstructured": "Yamazaki, H., Z. Guo, and F.P. Guengerich (1995). Selectivity of cytochrome P450 2E1 in chlorzoxazone 6-hydroxylation. Drug Metab. Dispos. 23, 438\u2013440.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR640", "author": "R. Preussmann", "first-page": "643", "year": "1984", "unstructured": "Preussmann, R. and B.W. Stewart (1984). N-Nitroso carcinogens. In C.E. Searle (ed.), Chemical Carcinogens, Vol. 2. American Chemical Society, Washington, D. C., pp. 643\u2013828.", "volume-title": "Chemical Carcinogens"}, {"key": "10_CR641", "doi-asserted-by": "publisher", "first-page": "127", "DOI": "10.1016/0009-2797(76)90002-8", "volume": "13", "author": "M.F. Argus", "year": "1976", "unstructured": "Argus, M.F., J.C. Arcos, K.M. Pastor, B.C. Wu, and N. Venkatesan (1976). Dimethylnitrosaminedemethylase: Absence of increased enzyme catabolism and multiplicity of effector sites in repression. Hemoprotein involvement. Chem. Biol. Interact. 13, 127\u2013140.", "journal-title": "Chem. Biol. Interact."}, {"key": "10_CR642", "doi-asserted-by": "crossref", "first-page": "610", "DOI": "10.1042/bst0020610", "volume": "2", "author": "B.G. Lake", "year": "1974", "unstructured": "Lake, B.G., C.E. Heading, J.C. Phillips, S.D. Gangolli, and A.G. Lloyd (1974). Some studies on the metabolism in vitro of dimethylnitrosamine by rat liver. Biochem. Soc. Transact. 2, 610\u2013612.", "journal-title": "Biochem. Soc. Transact."}, {"key": "10_CR643", "doi-asserted-by": "publisher", "first-page": "158", "DOI": "10.1016/0003-9861(86)90412-1", "volume": "248", "author": "W. Levin", "year": "1986", "unstructured": "Levin, W., P.E. Thomas, N. Oldfield, and D.E. Ryan (1986). N-Demethylation of N-nitrosodimethylamine catalyzed by purified rat hepatic microsomal cytochrome P-450: Isozyme specificity and role of cytochrome b 5. Arch. Biochem. Biophys. 248, 158\u2013165.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR644", "doi-asserted-by": "publisher", "first-page": "6731", "DOI": "10.1021/bi00370a001", "volume": "25", "author": "S.A. Wrighton", "year": "1986", "unstructured": "Wrighton, S.A., P.E. Thomas, D.T. Molowa, M. Haniu, J.E. Shively, S.L. Maines et al. (1986). Characterization of ethanol-inducible human liver N-nitrosodimethylamine demethylase. Biochemistry 25, 6731\u20136735.", "journal-title": "Biochemistry"}, {"key": "10_CR645", "doi-asserted-by": "publisher", "first-page": "756", "DOI": "10.1139/cjpp-76-7-8-756", "volume": "76", "author": "M.C. Bastien", "year": "1998", "unstructured": "Bastien, M.C. and J.P. Villeneuve (1998). Characterization of cytochrome P450 2E1 activity by the [14C]nitrosodimethylamine breath test. Can. J. Physiol. Pharmacol. 76, 756\u2013763.", "journal-title": "Can. J. Physiol. Pharmacol."}, {"key": "10_CR646", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.3109/10408449309104072", "volume": "23", "author": "J.L. Raucy", "year": "1993", "unstructured": "Raucy, J.L., J.C. Kraner, and J.M. Lasker (1993). Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit. Rev. Toxicol. 23, 1\u201320.", "journal-title": "Crit. Rev. Toxicol."}, {"key": "10_CR647", "doi-asserted-by": "publisher", "first-page": "266", "DOI": "10.1007/s002040050386", "volume": "71", "author": "J.Y. Hong", "year": "1997", "unstructured": "Hong, J.Y., C.S. Yang, M. Lee, Y.Y. Wang, W. Huang, Y. Tan et al. (1997). Role of cytochromes P450 in the metabolism of methyl tert-butyl ether in human livers. Arch. Toxicol. 71, 266\u2013269.", "journal-title": "Arch. Toxicol."}, {"key": "10_CR648", "doi-asserted-by": "publisher", "first-page": "911", "DOI": "10.1124/dmd.30.8.911", "volume": "30", "author": "H. Wang", "year": "2002", "unstructured": "Wang, H., B. Chanas, and B.I. Ghanayem (2002). Cytochrome P450 2E1 (CYP2E1) is essential for acrylonitrile metabolism to cyanide: Comparative studies using CYP2E1-null and wild-type mice. Drug Metab. Dispos. 30, 911\u2013917.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR649", "doi-asserted-by": "publisher", "first-page": "557", "DOI": "10.1124/jpet.103.049072", "volume": "305", "author": "U. Hoffler", "year": "2003", "unstructured": "Hoffler, U., H.A. El-Masri, and B.I. Ghanayem (2003). Cytochrome P450 2E1 (CYP2E1) is the principal enzyme responsible for urethane metabolism: Comparative studies using CYP2E1-null and wildtype mice. J. Pharmacol. Exp. Ther. 305, 557\u2013564.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR650", "doi-asserted-by": "publisher", "first-page": "836", "DOI": "10.1021/tx00042a018", "volume": "7", "author": "S.E. Clarke", "year": "1994", "unstructured": "Clarke, S.E., S.J. Baldwin, J.C. Bloomer, A.D. Ayrton, R.S. Sozio, and R.J. Chenery (1994). Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomes. Chem. Res. Toxicol. 7, 836\u2013842.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR651", "first-page": "1037", "volume": "23", "author": "P.J. Castle", "year": "1995", "unstructured": "Castle, P.J., J.L. Merdink, J.R. Okita, S.A. Wrighton, and R.T. Okita (1995). Human liver lauric acid hydroxylase activities. Drug Metab. Dispos. 23, 1037\u20131043.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR652", "doi-asserted-by": "publisher", "first-page": "469", "DOI": "10.1006/bbrc.1999.1702", "volume": "265", "author": "E.M.J. Gillam", "year": "1999", "unstructured": "Gillam, E.M.J., A.M. Aguinaldo, L.M. Notley, D. Kim, R.G. Mundkowski, A. Volkov et al. (1999). Formation of indigo by recombinant mammalian cytochrome P450. Biochem. Biophys. Res. Commun. 265, 469\u2013472.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR653", "doi-asserted-by": "publisher", "first-page": "31475", "DOI": "10.1074/jbc.C100238200", "volume": "276", "author": "J. Adachi", "year": "2001", "unstructured": "Adachi, J., Y. Mori, S. Matsui, H. Takigami, J. Fujino, H. Kitagawa et al. (2001). Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J. Biol. Chem. 276, 31475\u201331478.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR654", "first-page": "400", "volume": "281", "author": "D.K. Spracklin", "year": "1997", "unstructured": "Spracklin, D.K., D.C. Hankins, J.M. Fisher, K.E. Thummel, and E.D. Kharasch (1997). Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro. J. Pharmacol. Exp. Ther. 281, 400\u2013411.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR655", "doi-asserted-by": "publisher", "first-page": "766", "DOI": "10.1097/00000542-199903000-00019", "volume": "90", "author": "E.D. Kharasch", "year": "1999", "unstructured": "Kharasch, E.D., D.C. Hankins, and K. Cox (1999). Clinical isoflurane metabolism by cytochrome P450 2E1. Anesthesiology 90, 766\u2013771.", "journal-title": "Anesthesiology"}, {"key": "10_CR656", "doi-asserted-by": "publisher", "first-page": "29643", "DOI": "10.1074/jbc.272.47.29643", "volume": "272", "author": "L.C. Bell", "year": "1997", "unstructured": "Bell, L.C. and F.P. Guengerich (1997). Oxidation kinetics of ethanol by human cytochrome P450 2E1. Rate-limiting product release accounts for effects of isotopic hydrogen substitution and cytochrome b 5 on steady-state kinetics. J. Biol. Chem. 272, 29643\u201329651.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR657", "doi-asserted-by": "publisher", "first-page": "301", "DOI": "10.1016/0006-2952(96)00208-0", "volume": "52", "author": "H. Yamazaki", "year": "1996", "unstructured": "Yamazaki, H., M. Nakano, E.M.J. Gillam, L.C. Bell, F.P. Guengerich, and T. Shimada (1996). Requirements for cytochrome b 5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes. Biochem. Pharmacol. 52, 301\u2013309.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR658", "doi-asserted-by": "crossref", "first-page": "61", "DOI": "10.1016/S0027-5107(01)00236-6", "volume": "484", "author": "M.T. Cooper", "year": "2001", "unstructured": "Cooper, M.T. and T.D. Porter (2001). Cytochrome b5 coexpression increases the CYP2E1-dependent mutagenicity of dialkylnitrosamines in methyltransferase-deficient strains of Salmonella typhimurium. Mutat. Res. 484, 61\u201368.", "journal-title": "Mutat. Res."}, {"key": "10_CR659", "doi-asserted-by": "publisher", "first-page": "139", "DOI": "10.1016/S0163-7258(02)00327-3", "volume": "97", "author": "J.B. Schenkman", "year": "2003", "unstructured": "Schenkman, J.B. and I. Jansson (2003). The many roles of cytochrome b 5. Pharmacol. Ther. 97, 139\u2013152.", "journal-title": "Pharmacol. Ther."}, {"key": "10_CR660", "doi-asserted-by": "publisher", "first-page": "287", "DOI": "10.1080/004982597240613", "volume": "27", "author": "Y. Tan", "year": "1997", "unstructured": "Tan, Y., S.P. White, S.R. Paranawithana, and C.S. Yang (1997). A hypothetical model for the active site of human cytochrome P4502E1. Xenobiotica 27, 287\u2013299.", "journal-title": "Xenobiotica"}, {"key": "10_CR661", "doi-asserted-by": "publisher", "first-page": "93", "DOI": "10.1016/S0887-2333(02)00098-X", "volume": "17", "author": "D.F. Lewis", "year": "2003", "unstructured": "Lewis, D.F., B.G. Lake, M.G. Bird, G.D. Loizou, M. Dickins, and P.S. Goldfarb (2003). Homology modelling of human CYP2E1 based on the CYP2C5 crystal structure: Investigation of enzyme-substrate and enzyme-inhibitor interactions. Toxicol. In Vitro 17, 93\u2013105.", "journal-title": "Toxicol. In Vitro"}, {"key": "10_CR662", "doi-asserted-by": "publisher", "first-page": "5731", "DOI": "10.1021/bi000129l", "volume": "39", "author": "S.V. Smith", "year": "2000", "unstructured": "Smith, S.V., A.P. Koley, R. Dai, R.C. Robinson, H. Leong, A. Markowitz et al. (2000). Conformational modulation of human cytochrome P450 2E1 by ethanol and other substrates: A CO flash photolysis study. Biochemistry 39, 5731\u20135737.", "journal-title": "Biochemistry"}, {"key": "10_CR663", "doi-asserted-by": "publisher", "first-page": "11076", "DOI": "10.1073/pnas.92.24.11076", "volume": "92", "author": "H. Yin", "year": "1995", "unstructured": "Yin, H., M.W. Anders, K.R. Korzekwa, L. Higgins, K.E. Thummel, E.D. Kharasch et al. (1995). Designing safer chemicals: Predicting the rates of metabolism of halogenated alkanes. Proc. Natl. Acad. Sci. USA 92, 11076\u201311080.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR664", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1002/jbt.10055", "volume": "17", "author": "D.F. Lewis", "year": "2003", "unstructured": "Lewis, D.F., C. Sams, and G.D. Loizou (2003). A quantitative structure-activity relationship analysis on a series of alkyl benzenes metabolized by human cytochrome P450 2E1. J. Biochem. Mol. Toxicol. 17, 47\u201352.", "journal-title": "J. Biochem. Mol. Toxicol."}, {"key": "10_CR665", "doi-asserted-by": "crossref", "first-page": "299", "DOI": "10.1093/jnci/51.1.299", "volume": "51", "author": "L.K. Keefer", "year": "1973", "unstructured": "Keefer, L.K., W. Lijinsky, and H. Garcia (1973). Deuterium isotope effect on the carcinogenicity of dimethylnitrosamine in rat liver. J. Natl. Cancer Inst. 51, 299\u2013302.", "journal-title": "J. Natl. Cancer Inst."}, {"key": "10_CR666", "first-page": "3373", "volume": "47", "author": "D. Wade", "year": "1987", "unstructured": "Wade, D., C.S. Yang, C.J. Metral, J.M. Roman, J.A. Hrabie, C.W. Riggs et al. (1987). Deuterium isotope effect on denitrosation and demethylation of N-nitrosodimethylamine by rat liver microsomes. Cancer Res. 47, 3373\u20133377.", "journal-title": "Cancer Res."}, {"key": "10_CR667", "doi-asserted-by": "publisher", "first-page": "408", "DOI": "10.1021/tx00022a002", "volume": "4", "author": "C.S. Yang", "year": "1991", "unstructured": "Yang, C.S., H. Ishizaki, M. Lee, D. Wade, and A. Fadel (1991). Deuterium isotope effect in the interaction of N-nitrosodimethylamine, ethanol, and related compounds with cytochrome P-450IIE1. Chem. Res. Toxicol. 4, 408\u2013413.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR668", "doi-asserted-by": "crossref", "first-page": "A1325", "DOI": "10.1096/fj.02-1078fje", "volume": "17", "author": "W. Calcutt", "year": "2003", "unstructured": "Calcutt, W. and F.P. Guengerich (2003). Kinetic isotope effects in dialkylnitrosamine dealkylations catalyzed by human cytochrome P450s 2A6 and 2E1. FASEB J. 17, A1325.", "journal-title": "FASEB J."}, {"key": "10_CR669", "doi-asserted-by": "publisher", "first-page": "230", "DOI": "10.1016/0041-008X(89)90328-1", "volume": "97", "author": "R.H. Reitz", "year": "1989", "unstructured": "Reitz, R.H., A. Mendrala, and F.P. Guengerich (1989). In vitro metabolism of methylene chloride in human and animal tissues: Use in physiologically-based pharmacokinetic models. Toxicol. Appl. Pharmacol. 97, 230\u2013246.", "journal-title": "Toxicol. Appl. Pharmacol."}, {"key": "10_CR670", "doi-asserted-by": "publisher", "first-page": "1331", "DOI": "10.1016/0006-291X(90)91595-J", "volume": "172", "author": "S.J. Pernecky", "year": "1990", "unstructured": "Pernecky, S.J., T.D. Porter, and M.J. Coon (1990). Expression of rabbit cytochrome P-450IIE2 in yeast and stabilization of the enzyme by 4-methylpyrazole. Biochem. Biophys. Res. Commun. 172, 1331\u20131337.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR671", "doi-asserted-by": "publisher", "first-page": "377", "DOI": "10.1021/tx00016a017", "volume": "3", "author": "D.R. Koop", "year": "1990", "unstructured": "Koop, D.R. (1990). Inhibition of ethanol-inducible cytochrome P450IIE1 by 3-amino-1, 2,4-triazole. Chem. Res. Toxicol. 3, 377\u2013383.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR672", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/0009-2797(79)90064-4", "volume": "25", "author": "D. Hultmark", "year": "1979", "unstructured": "Hultmark, D., K. Sundh, L. Johansson, and E. Arrhenius (1979). Ethanol inhibition of vinyl chloride metabolism in isolated rat hepatocytes. Chem. Biol. Interact. 25, 1\u20136.", "journal-title": "Chem. Biol. Interact."}, {"key": "10_CR673", "doi-asserted-by": "publisher", "first-page": "155", "DOI": "10.1016/0041-008X(82)90036-9", "volume": "63", "author": "L.C.K. Wong", "year": "1982", "unstructured": "Wong, L.C.K., J.M. Winston, C.B. Hong, and H. Plotnick (1982). Carcinogenicity and toxicity of 1,2-dibromoethane in the rat. Toxicol. Appl. Pharmacol. 63, 155\u2013165.", "journal-title": "Toxicol. Appl. Pharmacol."}, {"key": "10_CR674", "doi-asserted-by": "publisher", "first-page": "531", "DOI": "10.1016/0006-2952(94)90185-6", "volume": "47", "author": "M.K. Kwak", "year": "1994", "unstructured": "Kwak, M.K., S.G. Kim, J.Y. Kwak, R.F. Novak, and N.D. Kim (1994). Inhibition of cytochrome P4502E1 expression by organosulfur compounds allylsulfide, allylmercaptan and allylmethylsulfide in rats. Biochem. Pharmacol. 47, 531\u2013539.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR675", "first-page": "1110", "volume": "29", "author": "M. Nakajima", "year": "2001", "unstructured": "Nakajima, M., R. Yoshida, N. Shimada, H. Yamazaki, and T. Yokoi (2001). Inhibition and inactivation of human cytochrome P450 isoforms by phenethyl isothiocyanate. Drug Metab. Dispos. 29, 1110\u20131113.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR676", "doi-asserted-by": "crossref", "first-page": "553", "DOI": "10.1111/j.1472-8206.1998.tb00985.x", "volume": "12", "author": "D. Lucas", "year": "1998", "unstructured": "Lucas, D., C. Farez, L.G. Bardou, J. Vaisse, J.R. Attali, and P. Valensi (1998). Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation. Fundam. Clin. Pharmacol. 12, 553\u2013558.", "journal-title": "Fundam. Clin. Pharmacol."}, {"key": "10_CR677", "first-page": "495", "volume": "8", "author": "L. Marchand Le", "year": "1999", "unstructured": "Le Marchand, L., G.R. Wilkinson, and L.R. Wilkens (1999). Genetic and dietary predictors of CYP2E1 activity: A phenotyping study in Hawaii Japanese using chlorzoxazone. Cancer Epidemiol. Biomarkers Prev. 8, 495\u2013500.", "journal-title": "Cancer Epidemiol. Biomarkers Prev."}, {"key": "10_CR678", "doi-asserted-by": "publisher", "first-page": "459", "DOI": "10.1016/0741-8329(93)90065-V", "volume": "10", "author": "M. Morimoto", "year": "1993", "unstructured": "Morimoto, M., A.L. Hagbjork, A.A. Nanji, M. Ingelman-Sundberg, K.O. Lindros, P.C. Fu et al. (1993). Role of cytochrome P4502E1 in alcoholic liver disease pathogenesis. Alcohol 10, 459\u2013464.", "journal-title": "Alcohol"}, {"key": "10_CR679", "doi-asserted-by": "publisher", "first-page": "122", "DOI": "10.1053/jhep.2002.33720", "volume": "36", "author": "K. Morgan", "year": "2002", "unstructured": "Morgan, K., S.W. French, and T.R. Morgan (2002). Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology 36, 122\u2013134.", "journal-title": "Hepatology"}, {"key": "10_CR680", "doi-asserted-by": "crossref", "first-page": "944", "DOI": "10.1124/mol.51.6.944", "volume": "51", "author": "D.R. Koop", "year": "1997", "unstructured": "Koop, D.R., B. Klopfenstein, Y. Iimuro, and R.G. Thurman (1997). Gadolinium chloride blocks alcohol-dependent liver toxicity in rats treated chronically with intragastric alcohol despite the induction of CYP2E1. Mol. Pharmacol. 51, 944\u2013950.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR681", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1124/mol.55.2.223", "volume": "55", "author": "S.D. Lytton", "year": "1999", "unstructured": "Lytton, S.D., A. Helander, Z.Q. Zhang-Gouillon, K. Stokkeland, R. Bordone, S. Aric\u00f3 et al. (1999). Autoantibodies against cytochromes P-4502E1 and P-4503a in alcoholics. Mol. Pharmacol. 55, 223\u2013233.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR682", "doi-asserted-by": "publisher", "first-page": "206", "DOI": "10.1053/gast.1996.v111.pm8698201", "volume": "111", "author": "P. Clot", "year": "1996", "unstructured": "Clot, P., E. Albano, E. Eliasson, M. Tabone, S. Arico, Y. Israel et al. (1996). Cytochrome P4502E1 hydroxyethyl radical adducts as the major antigen in autoantibody formation among alcoholics. Gastroenterology 111, 206\u2013216.", "journal-title": "Gastroenterology"}, {"key": "10_CR683", "doi-asserted-by": "publisher", "first-page": "1159", "DOI": "10.1021/tx960083q", "volume": "9", "author": "M. Bourdi", "year": "1996", "unstructured": "Bourdi, M., W. Chen, R.M. Peter, J.L. Martin, J.T.M. Buters, S.D. Nelson et al. (1996). Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis. Chem. Res. Toxicol. 9, 1159\u20131166.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR684", "doi-asserted-by": "publisher", "first-page": "1313", "DOI": "10.1016/0006-2952(89)90338-9", "volume": "38", "author": "G. Ekstr\u00f6m", "year": "1989", "unstructured": "Ekstr\u00f6m, G. and M. Ingelman-Sundberg (1989). Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem. Pharmacol. 38, 1313\u20131319.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR685", "doi-asserted-by": "publisher", "first-page": "987", "DOI": "10.1002/hep.510300433", "volume": "30", "author": "N. Nieto", "year": "1999", "unstructured": "Nieto, N., S.L. Friedman, P. Greenwel, and A.I. Cederbaum (1999). CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells. Hepatology 30, 987\u2013996.", "journal-title": "Hepatology"}, {"key": "10_CR686", "doi-asserted-by": "publisher", "first-page": "1539", "DOI": "10.1016/S0891-5849(01)00743-2", "volume": "31", "author": "A.I. Cederbaum", "year": "2001", "unstructured": "Cederbaum, A.I., D. Wu, M. Mari, and J. Bai (2001). CYP2E1-dependent toxicity and oxidative stress in HepG2 cells. Free Radic. Biol. Med. 31, 1539\u20131543.", "journal-title": "Free Radic. Biol. Med."}, {"key": "10_CR687", "doi-asserted-by": "crossref", "first-page": "1213", "DOI": "10.1289/ehp.021101213", "volume": "110", "author": "J. Wan", "year": "2002", "unstructured": "Wan, J., J. Shi, L. Hui, D. Wu, X. Jin, N. Zhao et al. (2002). Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning. Environ. Health Perspect. 110, 1213\u20131218.", "journal-title": "Environ. Health Perspect."}, {"key": "10_CR688", "doi-asserted-by": "crossref", "first-page": "254", "DOI": "10.1111/j.1349-7006.1991.tb01838.x", "volume": "82", "author": "F. Uematsu", "year": "1991", "unstructured": "Uematsu, F., H. Kikuchi, M. Motomiya, T. Abe, I. Sagami, T. Ohmachi et al. (1991). Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer. Jpn. J. Cancer Res. 82, 254\u2013256.", "journal-title": "Jpn. J. Cancer Res."}, {"key": "10_CR689", "doi-asserted-by": "publisher", "first-page": "259", "DOI": "10.1097/00008571-199212000-00003", "volume": "2", "author": "A. Hirvonen", "year": "1992", "unstructured": "Hirvonen, A., K. Husgafvel-Pursiainen, S. Anttila, A. Karjalainen, M. Sorsa, and H. Vainio (1992). Metabolic cytochrome P450 genotypes and assessment of individual susceptibility to lung cancer. Pharmacogenetics 2, 259\u2013263.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR690", "doi-asserted-by": "publisher", "first-page": "264", "DOI": "10.1097/00008571-199212000-00004", "volume": "2", "author": "M. Ingelman-Sundberg", "year": "1992", "unstructured": "Ingelman-Sundberg, M., I. Johansson, I. Persson, Q.Y. Yue, M.L. Dahl, L. Bertilsson et al. (1992). Genetic polymorphism of cytochromes P450: Interethnic differences and relationship to incidence of lung cancer. Pharmacogenetics 2, 264\u2013271.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR691", "doi-asserted-by": "publisher", "first-page": "207", "DOI": "10.1016/0014-5793(93)80547-8", "volume": "319", "author": "I. Persson", "year": "1993", "unstructured": "Persson, I., I. Johansson, H. Bergling, M.L. Dahl, J., Seideg\u00e5rd, R. Rylander et al. (1993). Genetic polymorphism of cytochrome P4502E1 in a Swedish population: Relationship to incidence of lung cancer. FEBS Lett. 319, 207\u2013211.", "journal-title": "FEBS Lett."}, {"key": "10_CR692", "doi-asserted-by": "publisher", "first-page": "151", "DOI": "10.1097/00008571-199604000-00002", "volume": "6", "author": "S.J. London", "year": "1996", "unstructured": "London, S.J., A.K. Daly, J. Cooper, C.L. Carpenter, W.C. Navidi, L. Ding et al. (1996). Lung cancer risk in relation to the CYP2E1 RsaI genetic polymorphism among African-Americans and Caucasians in Los Angeles County. Pharmacogenetics 6, 151\u2013158.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR693", "first-page": "515", "volume": "3", "author": "S. Kato", "year": "1994", "unstructured": "Kato, S., P.G. Shields, N.E. Caporaso, H. Sugimura, G.E. Trivers, M.A. Tucker et al. (1994). Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer. Cancer Epidemiol. Biomarkers Prev. 3, 515\u2013518.", "journal-title": "Cancer Epidemiol. Biomarkers Prev."}, {"key": "10_CR694", "doi-asserted-by": "crossref", "first-page": "15S", "DOI": "10.1111/j.1530-0277.2002.tb02696.x", "volume": "26", "author": "S. Itoga", "year": "2002", "unstructured": "Itoga, S., F. Nomura, Y. Makino, T. Tomonaga, H. Shimada, T. Ochiai et al. (2002). Tandem repeat polymorphism of the CYP2E1 gene: An association study with esophageal cancer and lung cancer. Alcohol. Clin. Exp. Res. 26, 15S\u201319S.", "journal-title": "Alcohol. Clin. Exp. Res."}, {"key": "10_CR695", "doi-asserted-by": "publisher", "first-page": "734", "DOI": "10.1002/1097-0215(20000901)87:5<734::AID-IJC17>3.0.CO;2-E", "volume": "87", "author": "C. Bouchardy", "year": "2000", "unstructured": "Bouchardy, C., A. Hirvonen, C. Coutelle, P.J. Ward, P. Dayer, and S. Benhamou (2000). Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract. Int. J. Cancer 87, 734\u2013740.", "journal-title": "Int. J. Cancer"}, {"key": "10_CR696", "doi-asserted-by": "publisher", "first-page": "437", "DOI": "10.1016/S1368-8375(00)00099-3", "volume": "37", "author": "S. Liu", "year": "2001", "unstructured": "Liu, S., J.Y. Park, S.P. Schantz, J.C. Stern, and P. Lazarus (2001). Elucidation of CYP2E1 5\u2032 regulatory RsaI/PstI allelic variants and their role in risk for oral cancer. Oral Oncol. 37, 437\u2013445.", "journal-title": "Oral Oncol"}, {"key": "10_CR697", "doi-asserted-by": "publisher", "first-page": "S141", "DOI": "10.1097/00008571-199512001-00016", "volume": "5", "author": "S. Kato", "year": "1995", "unstructured": "Kato, S., M. Onda, N. Matsukura, A. Tokunaga, T. Tajiri, D.Y. Kim et al. (1995). Cytochrome P4502E1 (CYP2E1) genetic polymorphism in a case-control study of gastric cancer and liver disease. Pharmacogenetics 5, S141\u2013S144.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR698", "first-page": "475", "volume": "11", "author": "R.H. Wong", "year": "2002", "unstructured": "Wong, R.H., C.L. Du, J.D. Wang, C.C. Chan, J.C. Luo, and T.J. Cheng (2002). XRCC1 and CYP2E1 polymorphisms as susceptibility factors of plasma mutant p53 protein and anti-p53 antibody expression in vinyl chloride monomerexposed polyvinyl chloride workers. Cancer Epidemiol. Biomarkers Prev. 11, 475\u2013482.", "journal-title": "Cancer Epidemiol. Biomarkers Prev."}, {"key": "10_CR699", "doi-asserted-by": "publisher", "first-page": "5491", "DOI": "10.1021/bi00475a012", "volume": "29", "author": "P.T. Nhamburo", "year": "1990", "unstructured": "Nhamburo, P.T., S. Kimura, O.W. McBride, C.A. Kozak, H.V. Gelboin, and F.J. Gonzalez (1990). The human CYP2F gene subfamily: Identification of a cDNA encoding a new cytochrome P450, cDNA-directed expression, and chromosome mapping. Biochemistry 29, 5491\u20135499.", "journal-title": "Biochemistry"}, {"key": "10_CR700", "first-page": "4636", "volume": "51", "author": "M. Czerwinski", "year": "1991", "unstructured": "Czerwinski, M., T.L. McLemore, R.M. Philpot, P.T. Nhamburo, K. Korzekwa, H.V. Gelboin et al. (1991). Metabolic activation of 4-ipomeanol by complementary DNA-expressed human cytochromes P-450: Evidence for species-specific metabolism. Cancer Res. 51, 4636\u20134638.", "journal-title": "Cancer Res"}, {"key": "10_CR701", "first-page": "798", "volume": "27", "author": "D.L. Lanza", "year": "1999", "unstructured": "Lanza, D.L., E. Code, C.L. Crespi, F.J. Gonzalez, and G.S. Yost (1999). Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells. Drug Metab. Dispos. 27, 798\u2013803.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR702", "doi-asserted-by": "publisher", "first-page": "891", "DOI": "10.1021/tx00042a026", "volume": "7", "author": "T. Nakajima", "year": "1994", "unstructured": "Nakajima, T., E. Elovaara, F.J. Gonzalez, H.V. Gelboin, H. Raunio, O. Pelkonen et al. (1994). Styrene metabolism by cDNA-expressed human hepatic and pulmonary cytochromes P450. Chem. Res. Toxicol. 7, 891\u2013896.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR703", "doi-asserted-by": "publisher", "first-page": "15473", "DOI": "10.1074/jbc.M300319200", "volume": "278", "author": "B.A. Carr", "year": "2003", "unstructured": "Carr, B.A., J. Wan, R.N. Hines, and G.S. Yost (2003). Characterization of the human lung CYP2F1 gene and identification of a novel lungspecific binding motif. J. Biol. Chem. 278, 15473\u201315483.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR704", "doi-asserted-by": "publisher", "first-page": "3460", "DOI": "10.1074/jbc.271.7.3460", "volume": "271", "author": "S. Wu", "year": "1996", "unstructured": "Wu, S., C.R. Moomaw, K.B. Tomer, J.R. Falck, and D.C. Zeldin (1996). Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J. Biol. Chem. 271, 3460\u20133468.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR705", "first-page": "1111", "volume": "50", "author": "D.C. Zeldin", "year": "1996", "unstructured": "Zeldin, D.C., J. Foley, J. Ma, J.E. Boyle, J.M.S. Pascual, C.R. Moomaw et al. (1996). CYP2J subfamily P450s in the lung: Expression, localization, and potential functional significance. Mol. Pharmacol. 50, 1111\u20131117.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR706", "doi-asserted-by": "crossref", "first-page": "931", "DOI": "10.1124/mol.51.6.931", "volume": "51", "author": "D.C. Zeldin", "year": "1997", "unstructured": "Zeldin, D.C., J. Foley, S.M. Goldsworthy, M.E. Cook, J.E. Boyle, J. Ma et al. (1997). CYP2J subfamily cytochrome P450s in the gastrointestinal tract: Expression, localization, and potential functional significance. Mol. Pharmacol. 51, 931\u2013943.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR707", "doi-asserted-by": "publisher", "first-page": "36059", "DOI": "10.1074/jbc.R100030200", "volume": "276", "author": "D.C. Zeldin", "year": "2001", "unstructured": "Zeldin, D.C. (2001). Epoxygenase pathways of arachidonic acid metabolism. J. Biol. Chem. 276, 36059\u201336062.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR708", "doi-asserted-by": "publisher", "first-page": "840", "DOI": "10.1124/mol.61.4.840", "volume": "61", "author": "L.M. King", "year": "2002", "unstructured": "King, L.M., J. Ma, S. Srettabunjong, J. Graves, J.A. Bradbury, L. Li et al. (2002). Cloning of CYP2J2 gene and identification of functional polymorphisms. Mol. Pharmacol. 61, 840\u2013852.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR709", "doi-asserted-by": "publisher", "first-page": "18", "DOI": "10.1016/S0003-9861(02)00553-2", "volume": "409", "author": "D.R. Nelson", "year": "2003", "unstructured": "Nelson, D.R. (2003). Comparison of P450s from human and fugu: 420 million years of vertebrate P450 evolution. Arch. Biochem. Biophys. 409, 18\u201324.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR710", "doi-asserted-by": "publisher", "first-page": "529", "DOI": "10.1006/bbrc.2001.4390", "volume": "281", "author": "T. Rylander", "year": "2001", "unstructured": "Rylander, T., E.P.A. Neve, M. Ingelman-Sundberg, and M. Oscarson (2001). Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1). Biochem. Biophys. Res. Commun. 281, 529\u2013535.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR711", "doi-asserted-by": "publisher", "first-page": "5311", "DOI": "10.1073/pnas.83.14.5311", "volume": "83", "author": "D.T. Molowa", "year": "1986", "unstructured": "Molowa, D.T., E.G. Schuetz, S.A. Wrighton, P.B. Watkins, P. Kremers, G. Mendez-Picon et al. (1986). Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. Proc. Natl. Acad. Sci. USA 83, 5311\u20135315.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR712", "doi-asserted-by": "publisher", "first-page": "8064", "DOI": "10.1073/pnas.83.21.8064", "volume": "83", "author": "P.H. Beaune", "year": "1986", "unstructured": "Beaune, P.H., D.R. Umbenhauer, R.W. Bork, R.S. Lloyd, and F.P. Guengerich (1986). Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase. Proc. Natl. Acad. Sci. USA 83, 8064\u20138068.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR713", "first-page": "910", "volume": "264", "author": "R.W. Bork", "year": "1989", "unstructured": "Bork, R.W., T. Muto, P.H. Beaune, P.K. Srivastava, R.S. Lloyd, and F.P. Guengerich (1989). Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity. J. Biol. Chem. 264, 910\u2013919.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR714", "first-page": "A2242", "volume": "4", "author": "J. Kolars", "year": "1990", "unstructured": "Kolars, J., P. Schmiedelin-Ren, W. Dobbins, R. Merion, S. Wrighton, and P. Watkins (1990). Heterogeneity of P-450 IIIA expression in human gut epithelia. FASEB J. 4, A2242.", "journal-title": "FASEB J"}, {"key": "10_CR715", "doi-asserted-by": "crossref", "first-page": "1871", "DOI": "10.1172/JCI116064", "volume": "90", "author": "J.C. Kolars", "year": "1992", "unstructured": "Kolars, J.C., P. Schmiedlin-Ren, J.D. Schuetz, C. Fang, and P.B. Watkins (1992). Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J. Clin. Invest. 90, 1871\u20131878.", "journal-title": "J. Clin. Invest."}, {"key": "10_CR716", "doi-asserted-by": "publisher", "first-page": "1596", "DOI": "10.1021/jm00159a007", "volume": "29", "author": "R.H. B\u00f6cker", "year": "1986", "unstructured": "B\u00f6cker, R.H. and F.P. Guengerich (1986). Oxidation of 4-ary1-and 4-alky1-substituted 2,6-dimethy1-3,5-bis(alkoxycarbonyl)-1,4-dihy-dropyridines by human liver microsomes and immunochemical evidence for the involvement of a form of cytochrome P-450. J. Med. Chem. 29, 1596\u20131603.", "journal-title": "J. Med. Chem."}, {"key": "10_CR717", "doi-asserted-by": "publisher", "first-page": "424", "DOI": "10.1016/0003-9861(88)90655-8", "volume": "263", "author": "D.J. Waxman", "year": "1988", "unstructured": "Waxman, D.J., C. Attisano, F.P. Guengerich, and D.P. Lapenson (1988). Cytochrome P-450 steroid hormone metabolism catalyzed by human liver microsomes. Arch. Biochem. Biophys. 263, 424\u2013436.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR718", "doi-asserted-by": "publisher", "first-page": "462", "DOI": "10.1073/pnas.86.2.462", "volume": "86", "author": "T. Shimada", "year": "1989", "unstructured": "Shimada, T. and F.P. Guengerich (1989). Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc. Natl. Acad. Sci. USA 86, 462\u2013465.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR719", "doi-asserted-by": "publisher", "first-page": "11280", "DOI": "10.1021/bi00503a018", "volume": "29", "author": "W.R. Brian", "year": "1990", "unstructured": "Brian, W.R., M.-A. Sari, M. Iwasaki, T. Shimada, L.S. Kaminsky, and F.P. Guengerich (1990). Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae. Biochemistry 29, 11280\u201311292.", "journal-title": "Biochemistry"}, {"key": "10_CR720", "doi-asserted-by": "publisher", "first-page": "363", "DOI": "10.1021/tx00016a015", "volume": "3", "author": "F.P. Guengerich", "year": "1990", "unstructured": "Guengerich, F.P. (1990). Mechanism-based inactivation of human liver cytochrome P-450 IIIA4 by gestodene. Chem. Res. Toxicol. 3, 363\u2013371.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR721", "doi-asserted-by": "publisher", "first-page": "88", "DOI": "10.1006/taap.1997.8117", "volume": "144", "author": "J.D. Kelley", "year": "1997", "unstructured": "Kelley, J.D., D.L. Eaton, F.P. Guengerich, and R.A. Coulombe, Jr. (1997). Aflatoxin B1 activation in human lung. Toxicol. Appl. Pharmacol. 144, 88\u201395.", "journal-title": "Toxicol. Appl. Pharmacol."}, {"key": "10_CR722", "doi-asserted-by": "publisher", "first-page": "1108", "DOI": "10.1124/dmd.30.10.1108", "volume": "30", "author": "I. Koch", "year": "2002", "unstructured": "Koch, I., R. Weil, R. Wolbold, J. Brockmoller, E. Hustert, O. Burk et al. (2002). Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA. Drug Metab. Dispos. 30, 1108\u20131114.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR723", "doi-asserted-by": "publisher", "first-page": "571", "DOI": "10.1097/00008571-200008000-00011", "volume": "10", "author": "T. Nakamoto", "year": "2000", "unstructured": "Nakamoto, T., I. Hase, S. Imaoka, T. Hiroi, Y. Oda, A. Asada et al. (2000). Quantitative RT-PCR for CYP3A4 mRNA in human peripheral lymphocytes: Induction of CYP3A4 in lymphocytes and in liver by rifampicin. Pharmacogenetics 10, 571\u2013575.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR724", "doi-asserted-by": "publisher", "first-page": "485", "DOI": "10.2165/00003088-199937060-00004", "volume": "37", "author": "S.N. Wildt de", "year": "1999", "unstructured": "de Wildt, S.N., G.L. Kearns, J.S. Leeder, and J.N. van den Anker (1999). Cytochrome P450 3A. Ontogeny and drug disposition. Clin. Pharmacokinet. 37, 485\u2013505.", "journal-title": "Clin. Pharmacokinet."}, {"key": "10_CR725", "first-page": "460", "volume": "47", "author": "M. Mouelhi El", "year": "1987", "unstructured": "El Mouelhi, M., M.S. Didolkar, E.G. Elias, F.P. Guengerich, and F.C. Kauffman (1987). Hepatic drug metabolizing enzymes in primary and secondary tumors of human liver. Cancer Res. 47, 460\u2013466.", "journal-title": "Cancer Res."}, {"key": "10_CR726", "doi-asserted-by": "publisher", "first-page": "42", "DOI": "10.1007/s002800100291", "volume": "48", "author": "K. Fujitaka", "year": "2001", "unstructured": "Fujitaka, K., T. Oguri, T. Isobe, Y. Fujiwara, and N. Kohno (2001). Induction of cytochrome P450 3A4 by docetaxel in peripheral mononuclear cells and its expression in lung cancer. Cancer Chemother. Pharmacol. 48, 42\u201346.", "journal-title": "Cancer Chemother. Pharmacol."}, {"key": "10_CR727", "doi-asserted-by": "publisher", "first-page": "145", "DOI": "10.1038/sj.neo.7900017", "volume": "1", "author": "S.J. Hughes", "year": "1999", "unstructured": "Hughes, S.J., M.A. Morse, C.M. Weghorst, H. Kim, P.B. Watkins, F.P. Guengerich et al. (1999). Cytochromes P450 are expressed in proliferating cells in Barrett\u2019s metaplasia. Neoplasia 1, 145\u2013153.", "journal-title": "Neoplasia"}, {"key": "10_CR728", "doi-asserted-by": "publisher", "first-page": "133", "DOI": "10.1007/BF01899734", "volume": "37", "author": "K. Inoue", "year": "1992", "unstructured": "Inoue, K., J. Inazawa, H. Nakagawa, T. Shimada, H. Yamazaki, F.P. Guengerich et al. (1992). Assignment of the human cytochrome P450 nifedipine oxidase gene (CYP3A4) to band 7q22.1 by in situ fluorescence hybridization. Jpn. J. Hum. Genet. 37, 133\u2013138.", "journal-title": "Jpn. J. Hum. Genet."}, {"key": "10_CR729", "doi-asserted-by": "publisher", "first-page": "457", "DOI": "10.1016/0003-9861(72)90239-1", "volume": "152", "author": "A.Y.H. Lu", "year": "1972", "unstructured": "Lu, A.Y.H., A. Somogyi, S. West, R. Kuntzman, and A.H. Conney (1972). Pregnenolone-16\u03b1-carbonitrile: A new type of inducer of drug-metabolizing enzymes. Arch. Biochem. Biophys. 152, 457\u2013462.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR730", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1146/annurev.pharmtox.39.1.1", "volume": "39", "author": "F.P. Guengerich", "year": "1999", "unstructured": "Guengerich, F.P. (1999). Human cytochrome P-450 3A4: Regulation and role in drug metabolism. Annu. Rev. Pharmacol. Toxicol. 39, 1\u201317.", "journal-title": "Annu. Rev. Pharmacol. Toxicol."}, {"key": "10_CR731", "first-page": "10", "volume": "50", "author": "J.L. Barwick", "year": "1996", "unstructured": "Barwick, J.L., L.C. Quattrochi, A.S. Mills, C. Potenza, R.H. Tukey, and P.S. Guzelian (1996). Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes. Mol. Pharmacol. 50, 10\u201316.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR732", "first-page": "2007", "volume": "259", "author": "E.G. Schuetz", "year": "1984", "unstructured": "Schuetz, E.G. and P.S. Guzelian (1984). Induction of cytochrome P-450 by glucocorticoids in rat liver: II. Evidence that glucocorticoids regulate induction of cytochrome P-450 by a nonclassical receptor mechanism. J. Biol. Chem. 259, 2007\u20132012.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR733", "doi-asserted-by": "publisher", "first-page": "92", "DOI": "10.1038/nm0198-092", "volume": "4", "author": "C. Calleja", "year": "1998", "unstructured": "Calleja, C., J.M. Pascussi, J.C. Mani, P. Maurel, and M.J. Vilarem (1998). The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor. Nat. Med. 4, 92\u201396.", "journal-title": "Nat. Med."}, {"key": "10_CR734", "doi-asserted-by": "publisher", "first-page": "1090", "DOI": "10.1038/2575", "volume": "4", "author": "D.W. Ray", "year": "1998", "unstructured": "Ray, D.W., A.M. Lovering, J.R. Davis, and A. White (1998). Rifampicin: A glucocorticoid receptor ligand?. Nat. Med. 4, 1090\u20131091.", "journal-title": "Nat. Med."}, {"key": "10_CR735", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1016/S0092-8674(00)80900-9", "volume": "92", "author": "S.A. Kliewer", "year": "1998", "unstructured": "Kliewer, S.A., J.T. Moore, L. Wade, J.L. Staudinger, M.A. Watson, S.A. Jones et al. (1998). An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92, 73\u201382.", "journal-title": "Cell"}, {"key": "10_CR736", "doi-asserted-by": "crossref", "first-page": "1016", "DOI": "10.1172/JCI3703", "volume": "102", "author": "J.M. Lehmann", "year": "1998", "unstructured": "Lehmann, J.M., D.D. McKee, M.A. Watson, T.M. Wilson, J.T. Moore, and S.A. Kliewer (1998). The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest. 102, 1016\u20131023.", "journal-title": "J. Clin. Invest."}, {"key": "10_CR737", "doi-asserted-by": "publisher", "first-page": "1513", "DOI": "10.1016/S0006-2952(02)01298-4", "volume": "64", "author": "X. Coumoul", "year": "2002", "unstructured": "Coumoul, X., M. Diry, and R. Barouki (2002). PXR-dependent induction of human CYP3A4 gene expression by organochlorine pesticides. Biochem. Pharmacol. 64, 1513\u20131519.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR738", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1016/S0076-6879(02)57675-8", "volume": "357", "author": "S.A. Jones", "year": "2002", "unstructured": "Jones, S.A., L.B. Moore, G.B. Wisely, and S.A. Kliewer (2002). Use of in vitro pregnane X receptor assays to assess CYP3A4 induction potential of drug candidates. Meth. Enzymol. 357, 161\u2013170.", "journal-title": "Meth. Enzymol."}, {"key": "10_CR739", "doi-asserted-by": "publisher", "first-page": "412", "DOI": "10.1124/jpet.102.038653", "volume": "303", "author": "J. Raucy", "year": "2002", "unstructured": "Raucy, J., L. Warfe, M.F. Yueh, and S.W. Allen (2002). A cell-based reporter gene assay for determining induction of CYP3A4 in a high-volume system. J. Pharmacol. Exp. Ther. 303, 412\u2013423.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR740", "doi-asserted-by": "publisher", "first-page": "795", "DOI": "10.1124/dmd.30.7.795", "volume": "30", "author": "G. Luo", "year": "2002", "unstructured": "Luo, G., M. Cunningham, S. Kim, T. Burn, J. Lin, M. Sinz et al. (2002). CYP3A4 induction by drugs: Correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes. Drug Metab. Dispos. 30, 795\u2013804.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR741", "doi-asserted-by": "publisher", "first-page": "555", "DOI": "10.1097/00008571-200110000-00003", "volume": "11", "author": "J. Zhang", "year": "2001", "unstructured": "Zhang, J., P. Kuehl, E.D. Green, J.W. Touchman, P.B. Watkins, A. Daly et al. (2001). The human pregnane X receptor: Genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics 11, 555\u2013572.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR742", "doi-asserted-by": "crossref", "first-page": "1329", "DOI": "10.1124/mol.56.6.1329", "volume": "56", "author": "B. Goodwin", "year": "1999", "unstructured": "Goodwin, B., E. Hodgson, and C. Liddle (1999). The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol. Pharmacol. 56, 1329\u20131339.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR743", "doi-asserted-by": "publisher", "first-page": "1029", "DOI": "10.1124/dmd.30.9.1029", "volume": "30", "author": "W. El-Sankary", "year": "2002", "unstructured": "El-Sankary, W., V. Bombail, G.G. Gibson, and N. Plant (2002). Glucocorticoid-mediated induction of CYP3A4 is decreased by disruption of a protein: DNA interaction distinct from the pregnane X receptor response element. Drug Metab. Dispos. 30, 1029\u20131034.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR744", "doi-asserted-by": "publisher", "first-page": "32453", "DOI": "10.1074/jbc.M111245200", "volume": "277", "author": "A. Takeshita", "year": "2002", "unstructured": "Takeshita, A., M. Taguchi, N. Koibuchi, and Y. Ozawa (2002). Putative role of the orphan nuclear receptor SXR (steroid and xenobiotic receptor) in the mechanism of CYP3A4 inhibition by xenobiotics. J. Biol. Chem. 277, 32453\u201332458.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR745", "doi-asserted-by": "publisher", "first-page": "359", "DOI": "10.1124/mol.62.2.359", "volume": "62", "author": "B. Goodwin", "year": "2002", "unstructured": "Goodwin, B., E. Hodgson, D.J. D\u2019Costa, G.R. Robertson, and C. Liddle (2002). Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. Mol. Pharmacol. 62, 359\u2013365.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR746", "doi-asserted-by": "crossref", "first-page": "1399", "DOI": "10.1124/mol.60.6.1399", "volume": "60", "author": "K.E. Thummel", "year": "2001", "unstructured": "Thummel, K.E., C. Brimer, K. Yasuda, J. Thottassery, T. Senn, Y. Lin et al. (2001). Transcriptional control of intestinal cytochrome P-4503A by 1\u03b1,25-dihydroxy vitamin D3. Mol. Pharmacol. 60, 1399\u20131406.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR747", "doi-asserted-by": "publisher", "first-page": "182", "DOI": "10.1016/S0006-291X(02)00860-4", "volume": "296", "author": "H. Hara", "year": "2002", "unstructured": "Hara, H., Y. Yasunami, and T. Adachi (2002). Alteration of cellular phosphorylation state affects vitamin D receptor-mediated CYP3A4 mRNA induction in Caco-2 cells. Biochem. Biophys. Res. Commun. 296, 182\u2013188.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"issue": "Suppl 2", "key": "10_CR748", "doi-asserted-by": "publisher", "first-page": "54", "DOI": "10.1016/S0168-8278(97)80497-7", "volume": "26", "author": "J.C. Ourlin", "year": "1997", "unstructured": "Ourlin, J.C., Y. Jounaidi, P. Maurel, and M.J. Vilarem (1997). Role of the liver-enriched transcription factors C/EBP\u03b1 and DBP in the expression of human CYP3A4 and CYP3A7. J. Hepatol. 26(Suppl 2), 54\u201362.", "journal-title": "J. Hepatol."}, {"key": "10_CR749", "doi-asserted-by": "publisher", "first-page": "220", "DOI": "10.1038/nm815", "volume": "9", "author": "R.G. Tirona", "year": "2003", "unstructured": "Tirona, R.G., W. Lee, B.F. Leake, L.B. Lan, C.B. Cline, V. Lamba et al. (2003). The orphan nuclear receptor HNF4\u03b1 determines PXR-and CAR-mediated xenobiotic induction of CYP3A4. Nat. Med. 9, 220\u2013224.", "journal-title": "Nat. Med."}, {"key": "10_CR750", "doi-asserted-by": "crossref", "first-page": "1799", "DOI": "10.1096/fj.02-0195fje", "volume": "16", "author": "R. Jover", "year": "2002", "unstructured": "Jover, R., R. Bort, M.J. Gomez-Lechon, and J.V. Castell (2002). Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: Molecular mechanism and transcription factors involved. FASEB J. 16, 1799\u20131801.", "journal-title": "FASEB J"}, {"key": "10_CR751", "first-page": "509", "volume": "218", "author": "G. Danan", "year": "1981", "unstructured": "Danan, G., V. Descatoire, and D. Pessayre (1981). Self-induction by erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. J. Pharmacol. Exp. Ther. 218, 509\u2013514.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR752", "doi-asserted-by": "publisher", "first-page": "591", "DOI": "10.1016/0006-2952(94)00477-4", "volume": "49", "author": "C. Bensoussan", "year": "1995", "unstructured": "Bensoussan, C., M. Delaforge, and D. Mansuy (1995). Particular ability of cytochromes P450 3A to form inhibitory P450-iron-metabolite complexes upon metabolic oxidation of amino drugs. Biochem. Pharmacol. 49, 591\u2013602.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR753", "doi-asserted-by": "publisher", "first-page": "11318", "DOI": "10.1021/bi010690z", "volume": "40", "author": "X.Y. Wang", "year": "2001", "unstructured": "Wang, X.Y., K.F. Medzihradszky, D. Maltby, and M.A. Correia (2001). Phosphorylation of native and heme-modified CYP3A4 by protein kinase C: A mass spectrometric characterization of the phosphorylated peptides. Biochemistry 40, 11318\u201311326.", "journal-title": "Biochemistry"}, {"key": "10_CR754", "doi-asserted-by": "publisher", "first-page": "357", "DOI": "10.1007/s00228-002-0487-9", "volume": "58", "author": "S.K. Sy", "year": "2002", "unstructured": "Sy, S.K., A. Ciaccia, W. Li, E.A. Roberts, A. Okey, W. Kalow et al. (2002). Modeling of human hepatic CYP3A4 enzyme kinetics, protein, and mRNA indicates deviation from log-normal distribution in CYP3A4 gene expression. Eur. J. Clin. Pharmacol. 58, 357\u2013365.", "journal-title": "Eur. J. Clin. Pharmacol."}, {"key": "10_CR755", "doi-asserted-by": "publisher", "first-page": "288", "DOI": "10.1016/S0009-9236(99)70037-8", "volume": "66", "author": "S.E. Ball", "year": "1999", "unstructured": "Ball, S.E., J. Scatina, J. Kao, G.M. Ferron, R. Fruncillo, P. Mayer et al. (1999). Population distribution and effects on drug metabolism of a genetic variant in the 5\u2032 promoter region of CYP3A4. Clin. Pharmacol. Ther. 66, 288\u2013294.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR756", "doi-asserted-by": "publisher", "first-page": "355", "DOI": "10.1097/00008571-200207000-00003", "volume": "12", "author": "A.B. Spurdle", "year": "2002", "unstructured": "Spurdle, A.B., B. Goodwin, E. Hodgson, J.L. Hopper, X. Chen, D.M. Purdie et al. (2002). The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer. Pharmacogenetics 12, 355\u2013366.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR757", "doi-asserted-by": "publisher", "first-page": "447", "DOI": "10.1097/00008571-200107000-00008", "volume": "11", "author": "R. Eiselt", "year": "2001", "unstructured": "Eiselt, R., T.L. Domanski, A. Zibat, R. Mueller, E. Presecan-Siedel, E. Hustert et al. (2001). Identification and functional characterization of eight CYP3A4 protein variants. Pharmacogenetics 11, 447\u2013458.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR758", "doi-asserted-by": "publisher", "first-page": "196", "DOI": "10.1067/mcp.2002.121371", "volume": "71", "author": "E. Garcia-Martin", "year": "2002", "unstructured": "Garcia-Martin, E., C. Martinez, R.M. Pizarro, F.J. Garcia-Gamito, H. Gullsten, H. Raunio et al. (2002). CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity. Clin. Pharmacol. Ther. 71, 196\u2013204.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR759", "doi-asserted-by": "publisher", "first-page": "121", "DOI": "10.1097/00008571-200203000-00006", "volume": "12", "author": "J.K. Lamba", "year": "2002", "unstructured": "Lamba, J.K., Y.S. Lin, K. Thummel, A. Daly, P.B. Watkins, S. Strom et al. (2002). Common allelic variants of cytochrome P4503A4 and their prevalence in different populations. Pharmacogenetics 12, 121\u2013132.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR760", "first-page": "825", "volume": "299", "author": "D. Dai", "year": "2001", "unstructured": "Dai, D., J. Tang, R. Rose, E. Hodgson, R.J. Bienstock, H.W. Mohrenweiser et al. (2001). Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos. J. Pharmacol. Exp. Ther. 299, 825\u2013831.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR761", "doi-asserted-by": "publisher", "first-page": "1271", "DOI": "10.1016/S0169-409X(02)00066-2", "volume": "54", "author": "J.K. Lamba", "year": "2002", "unstructured": "Lamba, J.K., Y.S. Lin, E.G. Schuetz, and K.E. Thummel (2002). Genetic contribution to variable human CYP3A-mediated metabolism. Adv. Drug Deliv. Rev. 54, 1271\u20131294.", "journal-title": "Adv. Drug Deliv. Rev."}, {"key": "10_CR762", "doi-asserted-by": "publisher", "first-page": "883", "DOI": "10.1124/dmd.30.8.883", "volume": "30", "author": "J.A. Williams", "year": "2002", "unstructured": "Williams, J.A., B.J. Ring, V.E. Cantrell, D.R. Jones, J. Eckstein, K. Ruterbories et al. (2002). Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7. Drug Metab. Dispos. 30, 883\u2013891.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR763", "doi-asserted-by": "publisher", "first-page": "355", "DOI": "10.1016/0003-9861(91)90551-S", "volume": "290", "author": "R.W. Wang", "year": "1991", "unstructured": "Wang, R.W., P.H. Kari, A.Y.H. Lu, P.E. Thomas, F.P. Guengerich, and K.P. Vyas (1991). Biotransformation of lovastatin. IV. Identification of cytochrome P-450 3A proteins as the major enzymes responsible for the oxidative metabolism of lovastatin in rat and human liver microsomes. Arch. Biochem. Biophys. 290, 355\u2013361.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR764", "first-page": "1126", "volume": "23", "author": "S.E.W. Huskey", "year": "1995", "unstructured": "Huskey, S.E.W., D.C. Dean, R.R. Miller, G.H. Rasmusson, and S.H.L. Chiu (1995). Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride. Drug Metab. Dispos. 23, 1126\u20131135.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR765", "doi-asserted-by": "crossref", "first-page": "630", "DOI": "10.1038/clpt.1988.87", "volume": "43", "author": "T. Kronbach", "year": "1988", "unstructured": "Kronbach, T., V. Fischer, and U.A. Meyer (1988). Cyclosporine metabolism in human liver: Identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin. Pharmacol. Ther. 43, 630\u2013635.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR766", "first-page": "197", "volume": "17", "author": "J. Combalbert", "year": "1989", "unstructured": "Combalbert, J., I. Fabre, G. Fabre, I. Dalet, J. Derancourt, J.P. Cano et al. (1989). Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily. Drug Metab. Dispos. 17, 197\u2013207.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR767", "first-page": "552", "volume": "26", "author": "T. Koudriakova", "year": "1998", "unstructured": "Koudriakova, T., E. Iatsimirskaia, I. Utkin, E. Gangl, P. Vouros, E. Storozhuk et al. (1998). Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: Mechanism-based inactivation of cytochrome P4503A by ritonavir. Drug Metab. Dispos. 26, 552\u2013561.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR768", "first-page": "392", "volume": "28", "author": "J.S. Warrington", "year": "2000", "unstructured": "Warrington, J.S., R.I. Shader, L.L. von Moltke, and D.J. Greenblatt (2000). In vitro biotransformation of sildenafil (Viagra): Identification of human cytochromes and potential drug interactions. Drug Metab. Dispos. 28, 392\u2013397.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR769", "first-page": "303", "volume": "27", "author": "S. Kudo", "year": "1999", "unstructured": "Kudo, S., M.G. Okumura, and T. Ishizaki (1999). Cytochrome P-450 isoforms involved in carboxylic acid ester cleavage of Hantzsch pyridine ester of pranidipine. Drug Metab. Dispos. 27, 303\u2013308.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR770", "doi-asserted-by": "publisher", "first-page": "2712", "DOI": "10.1021/bi0119971", "volume": "41", "author": "Z. Zhang", "year": "2002", "unstructured": "Zhang, Z., Y. Li, R.A. Stearns, P.R. Ortiz De Montellano, T.A. Baillie, and W. Tang (2002). Cytochrome P450 3A4-mediated oxidative conversion of a cyano to an amide group in the metabolism of pinacidil. Biochemistry 41, 2712\u20132718.", "journal-title": "Biochemistry"}, {"key": "10_CR771", "doi-asserted-by": "publisher", "first-page": "365", "DOI": "10.1006/abbi.1998.0659", "volume": "353", "author": "N.A. Hosea", "year": "1998", "unstructured": "Hosea, N.A. and F.P. Guengerich (1998). Oxidation of non-ionic detergents by cytochrome P450 enzymes. Arch. Biochem. Biophys. 353, 365\u2013373.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR772", "doi-asserted-by": "publisher", "first-page": "38685", "DOI": "10.1074/jbc.M105127200", "volume": "276", "author": "K. Bodin", "year": "2001", "unstructured": "Bodin, K., L. Bretillon, Y. Aden, L. Bertilsson, U. Broome, C. Einarsson, and U. Diczfalusy (2001). Antiepileptic drugs increase plasma levels of 4\u03b2-hydroxycholesterol in humans: Evidence for involvement of cytochrome P450 3A4. J. Biol. Chem. 276, 38685\u201338689.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR773", "doi-asserted-by": "publisher", "first-page": "31534", "DOI": "10.1074/jbc.M201712200", "volume": "277", "author": "K. Bodin", "year": "2002", "unstructured": "Bodin, K., U. Andersson, E. Rystedt, E. Ellis, M. Norlin, I. Pikuleva et al. (2002). Metabolism of 4\u03b2-hydroxycholesterol in humans. J. Biol. Chem. 277, 31534\u201331540.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR774", "doi-asserted-by": "crossref", "first-page": "46", "DOI": "10.1016/S0005-2760(98)00175-1", "volume": "1437", "author": "C. Furster", "year": "1999", "unstructured": "Furster, C. and K. Wikvall (1999). Identification of CYP3A4 as the major enzyme responsible for 25-hydroxylation of 5\u03b2-cholestane-3\u03b1,7\u03b1,12\u03b1-triol in human liver microsomes. Biochim. Biophys. Acta 1437, 46\u201352.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "10_CR775", "doi-asserted-by": "publisher", "first-page": "34579", "DOI": "10.1074/jbc.M103025200", "volume": "276", "author": "A. Honda", "year": "2001", "unstructured": "Honda, A., G. Salen, Y. Matsuzaki, A.K. Batta, G. Xu, E. Leitersdorf et al. (2001). Side chain hydroxylations in bile acid biosynthesis catalyzed by CYP3A are markedly up-regulated in Cyp27-/- mice but not in cerebrotendinous xanthomatosis. J. Biol. Chem. 276, 34579\u201334585.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR776", "doi-asserted-by": "publisher", "first-page": "833", "DOI": "10.1073/pnas.0336235100", "volume": "100", "author": "I. Dussault", "year": "2003", "unstructured": "Dussault, I., H.D. Yoo, M. Lin, E. Wang, M. Fan, A.K. Batta et al. (2003). Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance. Proc. Natl. Acad. Sci. USA 100, 833\u2013838.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR777", "doi-asserted-by": "publisher", "first-page": "1897", "DOI": "10.1093/carcin/23.11.1897", "volume": "23", "author": "D.J. Boocock", "year": "2002", "unstructured": "Boocock, D.J., K. Brown, A.H. Gibbs, E. Sanchez, K.W. Turteltaub, and I.N. White (2002). Identification of human CYP forms involved in the activation of tamoxifen and irreversible binding to DNA. Carcinogenesis 23, 1897\u20131901.", "journal-title": "Carcinogenesis"}, {"key": "10_CR778", "doi-asserted-by": "publisher", "first-page": "218", "DOI": "10.1021/tx00044a006", "volume": "8", "author": "Y.-F. Ueng", "year": "1995", "unstructured": "Ueng, Y.-F., T. Shimada, H. Yamazaki, and F.P. Guengerich (1995). Oxidation of aflatoxin B1 by bacterial recombinant human cytochrome P450 enzymes. Chem. Res. Toxicol. 8, 218\u2013225.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR779", "doi-asserted-by": "publisher", "first-page": "1603", "DOI": "10.1021/ja00084a001", "volume": "116", "author": "R. Iyer", "year": "1994", "unstructured": "Iyer, R., B. Coles, K.D. Raney, R. Thier, F.P. Guengerich, and T.M. Harris (1994). DNA adduction by the potent carcinogen aflatoxin B1: Mechanistic studies. J. Am. Chem. Soc. 116, 1603\u20131609.", "journal-title": "J. Am. Chem. Soc."}, {"key": "10_CR780", "doi-asserted-by": "publisher", "first-page": "188", "DOI": "10.1006/abio.1997.2145", "volume": "248", "author": "C.L. Crespi", "year": "1997", "unstructured": "Crespi, C.L., V.P. Miller, and B.W. Penman (1997). Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Anal. Biochem. 248, 188\u2013190.", "journal-title": "Anal. Biochem."}, {"key": "10_CR781", "doi-asserted-by": "publisher", "first-page": "845", "DOI": "10.1124/dmd.30.7.845", "volume": "30", "author": "D.M. Stresser", "year": "2002", "unstructured": "Stresser, D.M., S.D. Turner, A.P. Blanchard, V.P. Miller, and C.L. Crespi (2002). Cytochrome P450 fluorometric substrates: Identification of isoform-selective probes for rat CYP2D2 and human CYP3A4. Drug Metab. Dispos. 30, 845\u2013852.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR782", "doi-asserted-by": "publisher", "first-page": "215", "DOI": "10.1006/abio.1999.4348", "volume": "276", "author": "N. Chauret", "year": "1999", "unstructured": "Chauret, N., N. Tremblay, R.L. Lackman, J.-Y. Gauthier, J.M. Silva, J. Marois et al. (1999). Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a selective fluorescent probe. Anal. Biochem. 276, 215\u2013226.", "journal-title": "Anal. Biochem."}, {"key": "10_CR783", "doi-asserted-by": "publisher", "first-page": "716", "DOI": "10.1046/j.1365-2125.1999.00073.x", "volume": "48", "author": "K.E. Kenworthy", "year": "1999", "unstructured": "Kenworthy, K.E., J.C. Bloomer, S.E. Clarke, and J.B. Houston (1999). CYP3A4 drug interactions: Correlation of 10 in vitro probe substrates. Br. J. Clin. Pharmacol. 48, 716\u2013727.", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "10_CR784", "doi-asserted-by": "publisher", "first-page": "2507", "DOI": "10.1016/0006-2952(88)90238-9", "volume": "37", "author": "J.H.M. Schellens", "year": "1988", "unstructured": "Schellens, J.H.M., P.A. Soons, and D.D. Breimer (1988). Lack of bimodality in nifedipine plasma kinetics in a large population of healthy subjects. Biochem. Pharmacol. 37, 2507\u20132510.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR785", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1038/clpt.1992.17", "volume": "51", "author": "K. Lown", "year": "1992", "unstructured": "Lown, K., J. Kolars, K. Turgeon, R. Merion, S.A. Wrighton, and P.B. Watkins (1992). The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease. Clin. Pharmacol. Ther. 51, 229\u2013238.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR786", "doi-asserted-by": "crossref", "first-page": "565", "DOI": "10.1002/hep.1840120319", "volume": "12", "author": "D.A. Gremse", "year": "1990", "unstructured": "Gremse, D.A., H.H. A-Kader, T.J. Schroeder, and W.F. Balistreri (1990). Assessment of lidocaine metabolite formation as a quantitative liver function test in children. Hepatology 12, 565\u2013569.", "journal-title": "Hepatology"}, {"key": "10_CR787", "doi-asserted-by": "crossref", "first-page": "492", "DOI": "10.1038/clpt.1994.62", "volume": "55", "author": "D.G. May", "year": "1994", "unstructured": "May, D.G., J. Porter, G.R. Wilkinson, and R.A. Branch (1994). Frequency distribution of dapsone N-hydroxylase, a putative probe for P450 3A4 activity, in a white population. Clin. Pharmacol. Ther. 55, 492\u2013500.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR788", "first-page": "235", "volume": "4", "author": "K.E. Thummel", "year": "1993", "unstructured": "Thummel, K.E., D.D. Shen, R.L. Carithers, Jr., P. Hartwell, T.D. Podoll, W.F. Tarager et al. (1993). Prediction of in vivo midazolam clearance from hepatic CYP3A content and midazolam 1\u2032-hydroxylation activity in liver transplant patients. In Abstracts, 5th North American ISSX Meeting, Vol. 4. p. 235, 17\u201321 October, Tucson, AZ.", "journal-title": "Abstracts, 5th North American ISSX Meeting"}, {"key": "10_CR789", "doi-asserted-by": "publisher", "first-page": "643", "DOI": "10.1046/j.1365-2125.2002.01687.x", "volume": "54", "author": "S. Wanwimolruk", "year": "2002", "unstructured": "Wanwimolruk, S., M.F. Paine, S.N. Pusek, and P.B. Watkins (2002). Is quinine a suitable probe to assess the hepatic drug-metabolizing enzyme CYP3A4? Br. J. Clin. Pharmacol. 54, 643\u2013651.", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "10_CR790", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1111/j.1365-2125.1989.tb03516.x", "volume": "28", "author": "C. Ged", "year": "1989", "unstructured": "Ged, C., J.M. Rouillon, L. Pichard, J. Combalbert, N. Bressot, P. Bories et al. (1989). The increase in urinary excretion of 6\u03b2-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction. Br. J. Clin. Pharmacol. 28, 373\u2013387.", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "10_CR791", "doi-asserted-by": "crossref", "first-page": "120", "DOI": "10.1038/clpt.1990.126", "volume": "48", "author": "P.B. Watkins", "year": "1990", "unstructured": "Watkins, P.B., T.A. Hamilton, T.M. Annesley, C.N. Ellis, J.C. Kolars, and J.J. Voorhees (1990). The erythromycin breath test as a predictor of cyclosporine blood levels. Clin. Pharmacol. Ther. 48, 120\u2013129.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR792", "doi-asserted-by": "crossref", "first-page": "621", "DOI": "10.1038/clpt.1993.199", "volume": "54", "author": "M.T. Kinirons", "year": "1993", "unstructured": "Kinirons, M.T., D. Oshea, T.E. Downing, A.T. Fitzwilliam, L. Joellenbeck, J.D. Groopman et al. (1993). Absence of correlations among 3 putative in vivo probes of human cytochrome P4503A activity in young healthy men. Clin. Pharmacol. Ther. 54, 621\u2013629.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR793", "doi-asserted-by": "crossref", "first-page": "608", "DOI": "10.1038/clpt.1994.185", "volume": "56", "author": "Y. Krivoruk", "year": "1994", "unstructured": "Krivoruk, Y., M.T. Kinirons, A.J.J. Wood, and M. Wood (1994). Metabolism of cytochrome P4503A substrates in vivo administered by the same route: Lack of correlation between alfentanil clearance and erythromycin breath test. Clin. Pharmacol. Ther. 56, 608\u2013614.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR794", "doi-asserted-by": "crossref", "first-page": "40S", "DOI": "10.1177/009127009703700121", "volume": "37", "author": "K.T. Kivist\u00f6", "year": "1997", "unstructured": "Kivist\u00f6, K.T. and H.K. Kroemer (1997). Use of probe drugs as predictors of drug metabolism in humans. J. Clin. Pharmacol. 37, 40S\u201348S.", "journal-title": "J. Clin. Pharmacol."}, {"key": "10_CR795", "doi-asserted-by": "publisher", "first-page": "491", "DOI": "10.1016/S0009-9236(96)90177-0", "volume": "59", "author": "K.E. Thummel", "year": "1996", "unstructured": "Thummel, K.E., D. O\u2019Shea, M.F. Paine, D.D. Shen, K.L. Kunze, J.D. Perkins et al. (1996). Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism. Clin. Pharmacol. Ther. 59, 491\u2013502.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR796", "doi-asserted-by": "publisher", "first-page": "524", "DOI": "10.1067/mcp.2002.128387", "volume": "72", "author": "M.F. Paine", "year": "2002", "unstructured": "Paine, M.F., D.A. Wagner, K.A. Hoffmaster, and P.B. Watkins (2002). Cytochrome P450 3A4 and P-glycoprotein mediate the interaction between an oral erythromycin breath test and rifampin. Clin. Pharmacol. Ther. 72, 524\u2013535.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR797", "first-page": "311", "volume": "49", "author": "E.G. Schuetz", "year": "1996", "unstructured": "Schuetz, E.G., W.T. Beck, and J.D. Schuetz (1996). Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol. Pharmacol. 49, 311\u2013318.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR798", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1006/abbi.1993.1401", "volume": "305", "author": "E.M.J. Gillam", "year": "1993", "unstructured": "Gillam, E.M.J., T. Baba, B.-R. Kim, S. Ohmori, and F.P. Guengerich (1993). Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Arch. Biochem. Biophys. 305, 123\u2013131.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR799", "doi-asserted-by": "publisher", "first-page": "6063", "DOI": "10.1021/bi00141a015", "volume": "31", "author": "S. Imaoka", "year": "1992", "unstructured": "Imaoka, S., Y. Imai, T. Shimada, and Y. Funae (1992). Role of phospholipids in reconstituted cytochrome P450 3A forms and mechanism of their activation of catalytic activity. Biochemistry 31, 6063\u20136069.", "journal-title": "Biochemistry"}, {"key": "10_CR800", "doi-asserted-by": "publisher", "first-page": "318", "DOI": "10.1006/bbrc.1996.0593", "volume": "221", "author": "M. Ingelman-Sundberg", "year": "1996", "unstructured": "Ingelman-Sundberg, M., A.-L. Hagbj\u00f6rk, Y.-F. Ueng, H. Yamazaki, and F.P. Guengerich (1996). High rates of substrate hydroxylation by human cytochrome P450 3A4 in reconstituted membranous vesicles: Influence of membrane charge. Biochem. Biophys. Res. Commun. 221, 318\u2013322.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR801", "doi-asserted-by": "publisher", "first-page": "109", "DOI": "10.1111/j.1432-1033.1992.tb17027.x", "volume": "207", "author": "M.A. Peyronneau", "year": "1992", "unstructured": "Peyronneau, M.A., J.P. Renaud, G. Truan, P. Urban, D. Pompon, and D. Mansuy (1992). Optimization of yeast-expressed human liver cytochrome-P450 3A4 catalytic activities by coexpressing NADPH-cytochrome P450 reductase and cytochrome b 5. Eur. J. Biochem. 207, 109\u2013116.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR802", "doi-asserted-by": "publisher", "first-page": "14741", "DOI": "10.1021/bi9719399", "volume": "36", "author": "F.P. Guengerich", "year": "1997", "unstructured": "Guengerich, F.P. and W.W. Johnson (1997). Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: Rapid reduction in absence of substrate and variations among cytochrome P450 systems. Biochemistry 36, 14741\u201314750.", "journal-title": "Biochemistry"}, {"key": "10_CR803", "doi-asserted-by": "publisher", "first-page": "11748", "DOI": "10.1073/pnas.90.24.11748", "volume": "90", "author": "M.S. Shet", "year": "1993", "unstructured": "Shet, M.S., C.W. Fisher, P.L. Holmans, and R.W. Estabrook (1993). Human cytochrome P450 3A4: Enzymatic properties of a purified recombinant fusion protein containing NADPH-P450 reductase. Proc. Natl. Acad. Sci. USA 90, 11748\u201311752.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR804", "doi-asserted-by": "publisher", "first-page": "374", "DOI": "10.1006/abbi.1995.1177", "volume": "317", "author": "E.M.J. Gillam", "year": "1995", "unstructured": "Gillam, E.M.J., Z. Guo, Y.-F. Ueng, H. Yamazaki, I. Cock, P.E.B. Reilly et al. (1995). Expression of cytochrome P450 3A5 in Escherichia coli: Effects of 5\u2032 modifications, purification, spectral characterization, reconstitution conditions, and catalytic activities. Arch. Biochem. Biophys. 317, 374\u2013384.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR805", "doi-asserted-by": "publisher", "first-page": "174", "DOI": "10.1006/abbi.1996.0022", "volume": "325", "author": "H. Yamazaki", "year": "1996", "unstructured": "Yamazaki, H., M. Nakano, Y. Imai, Y.-F. Ueng, F.P. Guengerich, and T. Shimada (1996). Roles of cytochrome b 5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Arch. Biochem. Biophys. 325, 174\u2013182.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR806", "first-page": "999", "volume": "27", "author": "H. Yamazaki", "year": "1999", "unstructured": "Yamazaki, H., M. Nakajima, M. Nakamura, S. Asahi, N. Shimada, E.M.J. Gillam et al. (1999). Enhancement of cytochrome P-450 3A4 catalytic activities by cytochrome b 5 in bacterial membranes. Drug Metab. Dispos. 27, 999\u20131004.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR807", "doi-asserted-by": "publisher", "first-page": "784", "DOI": "10.1038/nbt0897-784", "volume": "15", "author": "A. Parikh", "year": "1997", "unstructured": "Parikh, A., E.M.J. Gillam, and F.P. Guengerich (1997). Drug metabolism by Escherichia coli expressing human cytochromes P450. Nat. Biotechnol. 15, 784\u2013788.", "journal-title": "Nat. Biotechnol."}, {"key": "10_CR808", "doi-asserted-by": "publisher", "first-page": "210", "DOI": "10.1016/S0014-5793(96)01196-9", "volume": "397", "author": "J.A.R. Blake", "year": "1996", "unstructured": "Blake, J.A.R., M. Pritchard, S. Ding, G.C.M. Smith, B. Burchell, C.R. Wolf et al. (1996). Coexpression of a human P450 (CYP3A4) and P450 reductase generates a highly functional monooxygenase system in Escherichia coli, FEBS Lett. 397, 210\u2013214.", "journal-title": "FEBS Lett"}, {"key": "10_CR809", "doi-asserted-by": "publisher", "first-page": "952", "DOI": "10.1002/jps.10091", "volume": "91", "author": "M. Nakajima", "year": "2002", "unstructured": "Nakajima, M., K. Tane, S. Nakamura, N. Shimada, H. Yamazaki, and T. Yokoi (2002). Evaluation of approach to predict the contribution of multiple cytochrome P450s in drug metabolism using relative activity factor: Effects of the differences in expression levels of NADPH-cytochrome P450 reductase and cytochrome b 5 in the expression system and the differences in the marker activities. J. Pharm. Sci. 91, 952\u2013963.", "journal-title": "J. Pharm. Sci."}, {"key": "10_CR810", "doi-asserted-by": "crossref", "first-page": "61", "DOI": "10.1093/oxfordjournals.jbchem.a131913", "volume": "83", "author": "M. Noshiro", "year": "1978", "unstructured": "Noshiro, M. and T. Omura (1978). Immunochemical study on the electron pathway from NADH to cytochrome P-450 of liver microsomes. J. Biochem. (Tokyo) 83, 61\u201377.", "journal-title": "J. Biochem. (Tokyo)"}, {"key": "10_CR811", "doi-asserted-by": "publisher", "first-page": "11412", "DOI": "10.1021/bi980908q", "volume": "37", "author": "A. Perret", "year": "1998", "unstructured": "Perret, A. and D. Pompon (1998). Electron shuttle between membrane-bound cytochrome P450 3A4 and b 5 rules uncoupling mechanisms. Biochemistry 37, 11412\u201311424.", "journal-title": "Biochemistry"}, {"key": "10_CR812", "doi-asserted-by": "publisher", "first-page": "27438", "DOI": "10.1074/jbc.271.11.6483", "volume": "271", "author": "H. Yamazaki", "year": "1996", "unstructured": "Yamazaki, H., W.W. Johnson, Y.-F. Ueng, T. Shimada, and F.P. Guengerich (1996). Lack of electron transfer from cytochrome b 5 in stimulation of catalytic activities of cytochrome P450 3A4: Characterization of a reconstituted cytochrome P450 3A4/NADPH-cytochrome P450 reductase system and studies with apo-cytochrome b 5. J. Biol. Chem. 271, 27438\u201327444.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR813", "doi-asserted-by": "publisher", "first-page": "3158", "DOI": "10.1074/jbc.273.6.3158", "volume": "273", "author": "R.J. Auchus", "year": "1998", "unstructured": "Auchus, R.J., T.C. Lee, and W.L. Miller (1998). Cytochrome b 5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer. J. Biol. Chem. 273, 3158\u20133165.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR814", "doi-asserted-by": "publisher", "first-page": "329", "DOI": "10.1006/abbi.2001.2501", "volume": "393", "author": "A.E. Aitken", "year": "2001", "unstructured": "Aitken, A.E., L.J. Roman, P.A. Loughran, M. de la Garza, and B.S.S. Masters (2001). Expressed CYP4A4 metabolism of prostaglandin E-1 and arachidonic acid. Arch. Biochem. Biophys. 393, 329\u2013338.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR815", "doi-asserted-by": "publisher", "first-page": "5018", "DOI": "10.1021/bi002305w", "volume": "40", "author": "O.L. Guryev", "year": "2001", "unstructured": "Guryev, O.L., A.A. Gilep, S.A. Usanov, and R.W. Estabrook (2001). Interaction of apo-cytochrome b 5 with cytochromes P4503A4 and P45017A: Relevance of heme transfer reactions. Biochemistry 40, 5018\u20135031.", "journal-title": "Biochemistry"}, {"key": "10_CR816", "doi-asserted-by": "publisher", "first-page": "30885", "DOI": "10.1074/jbc.M105011200", "volume": "276", "author": "H. Yamazaki", "year": "2001", "unstructured": "Yamazaki, H., T. Shimada, M.V. Martin, and F.P. Guengerich (2001). Stimulation of cytochrome P450 reactions by apo-cytochrome b 5. Evidence against transfer of heme from cytochrome P450 3A4 to apo-cytochrome b 5 or heme oxygenase. J. Biol. Chem. 276, 30885\u201330891.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR817", "first-page": "424", "volume": "291", "author": "S. Ekins", "year": "1999", "unstructured": "Ekins, S., G. Bravi, J.H. Wikel, and S.A. Wrighton (1999). Three-dimensional-quantitative structure activity relationship analysis of cytochrome P-450 3A4 substrates. J. Pharmacol. Exp. Ther. 291, 424\u2013433.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR818", "first-page": "429", "volume": "290", "author": "S. Ekins", "year": "1999", "unstructured": "Ekins, S., G. Bravi, S. Binkley, J.S. Gillespie, B.J. Ring, J.H. Wikel et al. (1999). Three-and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors. J. Pharmacol. Exp. Ther. 290, 429\u2013438.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR819", "first-page": "594", "volume": "290", "author": "J.C. Stevens", "year": "1999", "unstructured": "Stevens, J.C., T.L. Domanski, G.R. Harlow, R.B. White, E. Orton, and J.R. Halpert (1999). Use of the steroid derivative RPR 106541 in combination with site-directed mutagenesis for enhanced cytochrome P-450 3A4 structure/function analysis. J. Pharmacol. Exp. Ther. 290, 594\u2013602.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR820", "first-page": "585", "volume": "293", "author": "T.L. Domanski", "year": "2000", "unstructured": "Domanski, T.L., Y.A. He, G.R. Harlow, and J.R. Halpert (2000). Dual role of human cytochrome P450 3A4 residue Phe-304 in substrate specificity and cooperativity. J. Pharmacol. Exp. Ther. 293, 585\u2013591.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR821", "doi-asserted-by": "publisher", "first-page": "4406", "DOI": "10.1021/bi992372u", "volume": "39", "author": "S.M. Fowler", "year": "2000", "unstructured": "Fowler, S.M., R.J. Riley, M.P. Pritchard, M.J. Sutcliffe, T. Friedberg, and C.R. Wolf (2000). Amino acid 305 determines catalytic center accessibility in CYP3A4. Biochemistry 39, 4406\u20134414.", "journal-title": "Biochemistry"}, {"key": "10_CR822", "doi-asserted-by": "publisher", "first-page": "483", "DOI": "10.1021/tx000218z", "volume": "14", "author": "L. Xue", "year": "2001", "unstructured": "Xue, L., H.F. Wang, Q. Wang, G.D. Szklarz, T.L. Domanski, J.R. Halpert et al. (2001). Influence of P450 3A4 SRS-2 residues on cooperativity and/or regioselectivity of aflatoxin B1 oxidation. Chem. Res. Toxicol. 14, 483\u2013491.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR823", "doi-asserted-by": "publisher", "first-page": "452", "DOI": "10.1124/dmd.30.4.452", "volume": "30", "author": "S.M. Fowler", "year": "2002", "unstructured": "Fowler, S.M., J.M. Taylor, T. Friedberg, C.R. Wolf, and R.J. Riley (2002). CYP3A4 active site volume modification by mutagenesis of leucine 211. Drug Metab. Dispos. 30, 452\u2013456.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR824", "doi-asserted-by": "publisher", "first-page": "2089", "DOI": "10.1016/0006-2952(92)90333-E", "volume": "44", "author": "D.A. Smith", "year": "1992", "unstructured": "Smith, D.A. and B.C. Jones (1992). Speculations on the substrate structure-activity relationship (SSAR) of cytochrome P450 enzymes. Biochem. Pharmacol. 44, 2089\u20132098.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR825", "doi-asserted-by": "publisher", "first-page": "2071", "DOI": "10.1021/bi00431a016", "volume": "28", "author": "T.L. Macdonald", "year": "1989", "unstructured": "Macdonald, T.L., W.G. Gutheim, R.B. Martin, and F.P. Guengerich (1989). Oxidation of substituted N,N-dimethylanilines by cytochrome P-450: Estimation of the effective oxidation-reduction potential of cytochrome P-450. Biochemistry 28, 2071\u20132077.", "journal-title": "Biochemistry"}, {"key": "10_CR826", "doi-asserted-by": "publisher", "first-page": "8380", "DOI": "10.1021/bi00026a020", "volume": "34", "author": "H. Yamazaki", "year": "1995", "unstructured": "Yamazaki, H., Y.-F. Ueng, T. Shimada, and F.P. Guengerich (1995). Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of NADPH-cytochrome P450 reductase with other flavoproteins, iron-sulfur proteins, and oxygen surrogates. Biochemistry 34, 8380\u20138389.", "journal-title": "Biochemistry"}, {"key": "10_CR827", "doi-asserted-by": "publisher", "first-page": "2644", "DOI": "10.1021/bi00683a013", "volume": "14", "author": "D.B. Northrop", "year": "1975", "unstructured": "Northrop, D.B. (1975). Steady-state analysis of kinetic isotope effects in enzymic reactions. Biochemistry 14, 2644\u20132651.", "journal-title": "Biochemistry"}, {"key": "10_CR828", "author": "S.A. Kuby", "year": "1991", "unstructured": "Kuby, S.A. (1991). A Study of Enzymes, Vol. I, Enzyme Catalysis, Kinetics, and Substrate Binding. CRC Press, Boca Raton, FL.", "volume-title": "A Study of Enzymes, Vol. I, Enzyme Catalysis, Kinetics, and Substrate Binding"}, {"key": "10_CR829", "author": "C. Walsh", "year": "1979", "unstructured": "Walsh, C. (1979). Enzymatic Reaction Mechanisms. W. H. Freeman Co, San Francisco, CA.", "volume-title": "Enzymatic Reaction Mechanisms"}, {"key": "10_CR830", "first-page": "1599", "volume": "29", "author": "R.S. Obach", "year": "2001", "unstructured": "Obach, R.S. (2001). Mechanism of cytochrome P4503A4-and 2D6-catalyzed dehydrogenation of ezlopitant as probed with isotope effects using five deuterated analogs. Drug Metab. Dispos. 29, 1599\u20131607.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR831", "doi-asserted-by": "publisher", "first-page": "78", "DOI": "10.1016/0003-9861(71)90456-5", "volume": "144", "author": "F.J. Wiebel", "year": "1971", "unstructured": "Wiebel, F.J., J.C. Leutz, L. Diamond, and H.V. Gelboin (1971). Aryl hydrocarbon (benzo[a]pyrene) hydroxylase in microsomes from rat tissues: Differential inhibition and stimulation by benzoflavones and organic solvents. Arch. Biochem. Biophys. 144, 78\u201386.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR832", "doi-asserted-by": "crossref", "first-page": "475", "DOI": "10.1002/cpt1977224475", "volume": "22", "author": "J. Kapitulnik", "year": "1977", "unstructured": "Kapitulnik, J., P.J. Poppers, M.K. Buening, J.G. Fortner, and A.H. Conney (1977). Activation of monooxygenases in human liver by 7,8-benzoflavone. Clin. Pharmacol. Ther. 22, 475\u2013485.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR833", "doi-asserted-by": "publisher", "first-page": "348", "DOI": "10.1016/0006-291X(78)90616-2", "volume": "82", "author": "M.K. Buening", "year": "1978", "unstructured": "Buening, M.K., J.G. Fortner, A. Kappas, and A.H. Conney (1978). 7,8-Benzoflavone stimulates the metabolic activation of aflatoxin B1 to mutagens by human liver. Biochem. Biophys. Res. Commun. 82, 348\u2013355.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR834", "first-page": "493", "volume": "33", "author": "G.E. Schwab", "year": "1988", "unstructured": "Schwab, G.E., J.L. Raucy, and E.F. Johnson (1988). Modulation of rabbit and human hepatic cytochrome P-450-catalyzed steroid hydroxylations by \u03b1-naphthoflavone. Mol. Pharmacol. 33, 493\u2013499.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR835", "doi-asserted-by": "publisher", "first-page": "5929", "DOI": "10.1021/bi992765t", "volume": "39", "author": "N.A. Hosea", "year": "2000", "unstructured": "Hosea, N.A., G.P. Miller, and F.P. Guengerich (2000). Elucidation of distinct binding sites for cytochrome P450 3A4. Biochemistry 39, 5929\u20135939.", "journal-title": "Biochemistry"}, {"key": "10_CR836", "author": "F.P. Guengerich", "first-page": "97", "year": "1994", "unstructured": "Guengerich, F.P., B.-R. Kim, E.M.J. Gillam, and T. Shimada (1994). Mechanisms of enhancement and inhibition of cytochrome P450 catalytic activity In M. C. Lechner (ed.), Proceedings, 8th International Conference on Cytochrome P450: Biochemistry, Biophysics, and Molecular Biology, John Libbey Eurotext, Paris, pp. 97\u2013101.", "volume-title": "Proceedings, 8th International Conference on Cytochrome P450: Biochemistry, Biophysics, and Molecular Biology"}, {"key": "10_CR837", "doi-asserted-by": "publisher", "first-page": "217", "DOI": "10.1093/carcin/13.2.217", "volume": "13", "author": "C.-H. Yun", "year": "1992", "unstructured": "Yun, C.-H., T. Shimada, and F.P. Guengerich (1992). Contributions of human liver cytochrome P-450 enzymes to the N-oxidation of 4, 4\u2032-methylene-bis(2-chloroaniline). Carcinogenesis 13, 217\u2013222.", "journal-title": "Carcinogenesis"}, {"key": "10_CR838", "first-page": "502", "volume": "25", "author": "R.W. Wang", "year": "1997", "unstructured": "Wang, R.W., D.J. Newton, T.D. Scheri, and A.Y.H. Lu (1997). Human cytochrome P450 3A4-catalyzed testosterone 6\u03b2-hydroxylation and erythromycin N-demethylation. Drug Metab. Dispos. 25, 502\u2013507.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR839", "first-page": "1", "volume": "290", "author": "E. Ludwig", "year": "1999", "unstructured": "Ludwig, E., J. Schmid, K. Beschke, and T. Ebner (1999). Activation of human cytochrome P-450 3A4-catalyzed meloxicam 5\u2032-methylhydroxylation by quinidine and hydroquinidine in vitro. J. Pharmacol. Exp. Ther. 290, 1\u20138.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR840", "first-page": "360", "volume": "28", "author": "R.W. Wang", "year": "2000", "unstructured": "Wang, R.W., D.J. Newton, N. Liu, W.M. Atkins, and A.Y.H. Lu (2000). Human cytochrome P-450 3A4: In vitro drug-drug interaction patterns are substrate-dependent. Drug Metab. Dispos. 28, 360\u2013366.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR841", "doi-asserted-by": "publisher", "first-page": "49", "DOI": "10.1006/abbi.2001.2401", "volume": "391", "author": "M.L. Schrag", "year": "2001", "unstructured": "Schrag, M.L. and L.C. Wienkers (2001). Covalent alteration of the CYP3A4 active site: Evidence for multiple substrate binding domains. Arch. Biochem. Biophys. 391, 49\u201355.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR842", "doi-asserted-by": "publisher", "first-page": "1143", "DOI": "10.1124/dmd.30.10.1143", "volume": "30", "author": "Y. Masubuchi", "year": "2002", "unstructured": "Masubuchi, Y., A. Ose, and T. Horie (2002). Diclofenac-induced inactivation of CYP3A4 and its stimulation by quinidine. Drug Metab. Dispos. 30, 1143\u20131148.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR843", "doi-asserted-by": "publisher", "first-page": "6450", "DOI": "10.1021/bi00187a009", "volume": "33", "author": "M. Shou", "year": "1994", "unstructured": "Shou, M., J. Grogan, J.A. Mancewicz, K.W. Krausz, F.J. Gonzalez, H.V. Gelboin et al. (1994). Activation of CYP3A4: Evidence for the simultaneous binding of two substrates in a cytochrome P450 active site. Biochemistry 33, 6450\u20136455.", "journal-title": "Biochemistry"}, {"key": "10_CR844", "doi-asserted-by": "publisher", "first-page": "4137", "DOI": "10.1021/bi9715627", "volume": "37", "author": "K.R. Korzekwa", "year": "1998", "unstructured": "Korzekwa, K.R., N. Krishnamachary, M. Shou, A. Ogai, R.A. Parise, A.E. Rettie et al. (1998). Evaluation of atypical cytochrome P450 kinetics with two-substrate models: Evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites. Biochemistry 37, 4137\u20134147.", "journal-title": "Biochemistry"}, {"key": "10_CR845", "doi-asserted-by": "publisher", "first-page": "2256", "DOI": "10.1074/jbc.M008799200", "volume": "276", "author": "M. Shou", "year": "2001", "unstructured": "Shou, M., R. Dai, D. Cui, K.R. Korzekwa, T.A. Baillie, and T.H. Rushmore (2001). A kinetic model for the metabolic interaction of two substrates at the active site of cytochrome P450 3A4. J. Biol. Chem. 276, 2256\u20132262.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR846", "first-page": "1644", "volume": "29", "author": "K.E. Kenworthy", "year": "2001", "unstructured": "Kenworthy, K.E., S.E. Clarke, J. Andrews, and J.B. Houston (2001). Multisite kinetic models for CYP3A4: Simultaneous activation and inhibition of diazepam and testosterone metabolism. Drug Metab. Dispos. 29, 1644\u20131651.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR847", "doi-asserted-by": "publisher", "first-page": "1512", "DOI": "10.1124/dmd.30.12.1512", "volume": "30", "author": "A. Galetin", "year": "2002", "unstructured": "Galetin, A., S.E. Clarke, and J.B. Houston (2002). Quinidine and haloperidol as modifiers of CYP3A4 activity: Multisite kinetic model approach. Drug Metab. Dispos. 30, 1512\u20131522.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR848", "doi-asserted-by": "publisher", "first-page": "223", "DOI": "10.1006/abbi.1997.0525", "volume": "350", "author": "T.L. Domanski", "year": "1998", "unstructured": "Domanski, T.L., J. Liu, G.R. Harlow, and J.R. Halpert (1998). Analysis of four residues within substrate recognition site 4 of human cytochrome P450 3A4: Role in steroid hydroxylase activity and \u03b1-naphthoflavone stimulation. Arch. Biochem. Biophys. 350, 223\u2013232.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR849", "doi-asserted-by": "publisher", "first-page": "6636", "DOI": "10.1073/pnas.95.12.6636", "volume": "95", "author": "G.R. Harlow", "year": "1998", "unstructured": "Harlow, G.R. and J.R. Halpert (1998). Analysis of human cytochrome P450 3A4 cooperativity: Construction and characterization of a site-directed mutant that displays hyperbolic steroid hydroxylation kinetics. Proc. Natl. Acad. Sci. USA 95, 6636\u20136641.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR850", "doi-asserted-by": "publisher", "first-page": "92", "DOI": "10.1016/S0003-9861(02)00484-8", "volume": "409", "author": "Y.A. He", "year": "2003", "unstructured": "He, Y.A., F. Roussel, and J.R. Halpert (2003). Analysis of homotropic and heterotropic cooperativity of diazepam oxidation by CYP3A4 using site-directed mutagenesis and kinetic modeling. Arch. Biochem. Biophys. 409, 92\u2013101.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR851", "doi-asserted-by": "publisher", "first-page": "10150", "DOI": "10.1021/bi010758a", "volume": "40", "author": "T.L. Domanski", "year": "2001", "unstructured": "Domanski, T.L., Y.A. He, K.K. Khan, F. Roussel, Q. Wang, and J.R. Halpert (2001). Phenylalanine and tryptophan scanning mutagenesis of CYP3A4 substrate recognition site residues and effect on substrate oxidation and cooperativity. Biochemistry 40, 10150\u201310160.", "journal-title": "Biochemistry"}, {"key": "10_CR852", "doi-asserted-by": "publisher", "first-page": "11866", "DOI": "10.1021/ja027552x", "volume": "124", "author": "M.J. Dabrowski", "year": "2002", "unstructured": "Dabrowski, M.J., M.L. Schrag, L.C. Wienkers, and W.M. Atkins (2002). Pyrene-pyrene complexes at the active site of cytochrome P450 3A4: Evidence for a multiple substrate binding site. J. Am. Chem. Soc. 124, 11866\u201311867.", "journal-title": "J. Am. Chem. Soc."}, {"key": "10_CR853", "doi-asserted-by": "publisher", "first-page": "3050", "DOI": "10.1073/pnas.050406897", "volume": "97", "author": "J. Cupp-Vickery", "year": "2000", "unstructured": "Cupp-Vickery, J., R. Anderson, and Z. Hatziris (2000). Crystal structures of ligand complexes of P450eryF exhibiting homotropic cooperativity. Proc. Natl. Acad. Sci. USA 97, 3050\u20133055.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR854", "doi-asserted-by": "publisher", "first-page": "356", "DOI": "10.1124/dmd.31.4.356", "volume": "31", "author": "K.K. Khan", "year": "2003", "unstructured": "Khan, K.K., H. Liu, and J.R. Halpert (2003). Homotropic versus heterotorpic cooperativity of cytochrome P450eryF: A substrate oxidation and spectral titration study. Drug Metab. Dispos. 31, 356\u2013359.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR855", "doi-asserted-by": "publisher", "first-page": "5014", "DOI": "10.1074/jbc.270.10.5014", "volume": "270", "author": "A.P. Koley", "year": "1995", "unstructured": "Koley, A.P., J.T.M. Buters, R.C. Robinson, A. Markowitz, and F.K. Friedman (1995). CO binding kinetics of human cytochrome P450 3A4: Specific interaction of substrates with kinetically distinguishable conformers. J. Biol. Chem. 270, 5014\u20135018.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR856", "doi-asserted-by": "publisher", "first-page": "3149", "DOI": "10.1074/jbc.272.6.3149", "volume": "272", "author": "A.P. Koley", "year": "1997", "unstructured": "Koley, A.P., J.T.M. Buters, R.C. Robinson, A. Markowitz, and F.K. Friedman (1997). Differential mechanisms of cytochrome P450 inhibition and activation by \u03b1-naphthoflavone. J. Biol. Chem. 272, 3149\u20133152.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR857", "doi-asserted-by": "publisher", "first-page": "706", "DOI": "10.1016/S0300-9084(97)82528-X", "volume": "78", "author": "A.P. Koley", "year": "1996", "unstructured": "Koley, A.P., R.C. Robinson, and F.K. Friedman (1996). Cytochrome P450 conformation and substrate interactions as probed by CO binding kinetics. Biochimie 78, 706\u2013713.", "journal-title": "Biochimie"}, {"key": "10_CR858", "doi-asserted-by": "publisher", "first-page": "455", "DOI": "10.1016/S0006-2952(96)00836-2", "volume": "53", "author": "A.P. Koley", "year": "1997", "unstructured": "Koley, A.P., R.C. Robinson, A. Markowitz, and F.K. Friedman (1997). Drug-drug interactions: Effect of quinidine on nifedipine binding to human cytochrome P450 3A4. Biochem. Pharmacol. 53, 455\u2013460.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR859", "doi-asserted-by": "publisher", "first-page": "2916", "DOI": "10.1046/j.1432-1327.2000.01305.x", "volume": "267", "author": "E. Anzenbacherova\u2019", "year": "2000", "unstructured": "Anzenbacherova\u2019, E., N. Bec, P. Anzenbacher, J. Hudecek, P. Soucek, C. Jung et al. (2000). Flexibility and stability of the structure of cytochromes P450 3A4 and BM-3. Eur. J. Biochem. 267, 2916\u20132920.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR860", "doi-asserted-by": "publisher", "first-page": "184", "DOI": "10.1110/ps.21302", "volume": "11", "author": "B. Ma", "year": "2002", "unstructured": "Ma, B., M. Shatsky, H.J. Wolfson, and R. Nussinov (2002). Multiple diverse ligands binding at a single protein site: A matter of pre-existing populations. Protein Sci. 11, 184\u2013197.", "journal-title": "Protein Sci"}, {"key": "10_CR861", "doi-asserted-by": "publisher", "first-page": "447", "DOI": "10.1016/S1367-5931(02)00341-1", "volume": "6", "author": "H.A. Carlson", "year": "2002", "unstructured": "Carlson, H.A. (2002). Protein flexibility and drug design: How to hit a moving target. Curr. Opin. Chem. Biol. 6, 447\u2013452.", "journal-title": "Curr. Opin. Chem. Biol."}, {"key": "10_CR862", "doi-asserted-by": "publisher", "first-page": "1571", "DOI": "10.2174/1381612023394232", "volume": "8", "author": "H.A. Carlson", "year": "2002", "unstructured": "Carlson, H.A. (2002). Protein flexibility is an important component of structure-based drug discovery. Curr. Pharm. Des. 8, 1571\u20131578.", "journal-title": "Curr. Pharm. Des."}, {"key": "10_CR863", "doi-asserted-by": "publisher", "first-page": "1615", "DOI": "10.1126/science.287.5458.1615", "volume": "287", "author": "I. Schlichting", "year": "2000", "unstructured": "Schlichting, I., J. Berendzen, K. Chu, A.M. Stock, S.A. Maves, D.E. Benson et al. (2000). The catalytic pathway of cytochrome P450cam at atomic resolution. Science 287, 1615\u20131622.", "journal-title": "Science"}, {"key": "10_CR864", "doi-asserted-by": "publisher", "first-page": "338", "DOI": "10.1021/tx0002132", "volume": "14", "author": "W.M. Atkins", "year": "2001", "unstructured": "Atkins, W.M., R.W. Wang, and A.Y.H. Lu (2001). Allosteric behavior in cytochrome P450-dependent in vitro drug-drug interactions: A prospective based on conformational dynamics. Chem. Res. Toxicol. 14, 338\u2013347.", "journal-title": "Chem. Res. Toxicol."}, {"key": "10_CR865", "author": "I.H. Segel", "year": "1975", "unstructured": "Segel, I.H. (1975). Enzyme Kinetics. Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems. John Wiley & Sons, New York.", "volume-title": "Enzyme Kinetics. Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems"}, {"key": "10_CR866", "doi-asserted-by": "publisher", "first-page": "33258", "DOI": "10.1074/jbc.M204425200", "volume": "277", "author": "W.M. Atkins", "year": "2002", "unstructured": "Atkins, W.M., W.D. Lu, and D.L. Cook (2002). Is there a toxicological advantage for non-hyperbolic kinetics in cytochrome P450 catalysis? Functional allostery from \u201cdistributive catalysis.\u201d J. Biol. Chem. 277, 33258\u201333266.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR867", "doi-asserted-by": "publisher", "first-page": "91", "DOI": "10.1006/taap.2002.9535", "volume": "185", "author": "K. Petrillo Di", "year": "2002", "unstructured": "Di Petrillo, K., S. Wood, V. Kostrubsky, K. Chatfield, J. Bement, S. Wrighton et al. (2002). Effect of caffeine on acetaminophen hepatotoxicity in cultured hepatocytes treated with ethanol and isopentanol. Toxicol. Appl. Pharmacol. 185, 91\u201397.", "journal-title": "Toxicol. Appl. Pharmacol."}, {"key": "10_CR868", "doi-asserted-by": "publisher", "first-page": "185", "DOI": "10.2174/1389200013338658", "volume": "2", "author": "W. Tang", "year": "2001", "unstructured": "Tang, W. and R.A. Stearns (2001). Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions. Curr. Drug Metab. 2, 185\u2013198.", "journal-title": "Curr. Drug Metab."}, {"key": "10_CR869", "doi-asserted-by": "publisher", "first-page": "1251", "DOI": "10.1124/jpet.102.047530", "volume": "305", "author": "A.C. Egnell", "year": "2003", "unstructured": "Egnell, A.C., J.B. Houston, and C.S. Boyer (2003). In vivo CYP3A4 heteroactivation is a possible mechanism for the drug interaction between felbamate and carbamazepine. J. Pharmacol. Exp. Ther. 305, 1251\u20131262.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR870", "first-page": "403", "volume": "21", "author": "C.-H. Yun", "year": "1993", "unstructured": "Yun, C.-H., R.A. Okerholm, and F.P. Guengerich (1993). Oxidation of the antihistaminic drug terfenadine in human liver microsomes: Role of cytochrome P450 3A(4) in N-dealkylation and C-hydroxylation. Drug Metab. Dispos. 21, 403\u2013409.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR871", "doi-asserted-by": "publisher", "first-page": "2309", "DOI": "10.1016/0006-2952(83)90178-8", "volume": "32", "author": "M. Delaforge", "year": "1983", "unstructured": "Delaforge, M., M. Jaouen, and D. Mansuy (1983). Dual effects of macrolide antibiotics on rat liver cytochrome P-450: Induction and formation of metabolite-complexes: A structure-activity relationship. Biochem. Pharmacol. 32, 2309\u20132318.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR872", "first-page": "180", "volume": "47", "author": "D.G. Bailey", "year": "1990", "unstructured": "Bailey, D.G., B. Edgar, J.D. Spence, C. Munzo, and J.M.O. Arnold (1990). Felodipine and nifedipine interactions with grapefruit juice. Clin. Pharmacol. Ther. 47, 180.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR873", "doi-asserted-by": "publisher", "first-page": "357", "DOI": "10.1097/00004714-200108000-00001", "volume": "21", "author": "D.J. Greenblatt", "year": "2001", "unstructured": "Greenblatt, D.J., K.C. Patki, L.L. von Moltke, and R.I. Shader (2001). Drug interactions with grapefruit juice: An update. J. Clin. Psychopharmacol. 21, 357\u2013359.", "journal-title": "J. Clin. Psychopharmacol."}, {"key": "10_CR874", "doi-asserted-by": "publisher", "first-page": "2275", "DOI": "10.1093/carcin/11.12.2275", "volume": "11", "author": "F.P. Guengerich", "year": "1990", "unstructured": "Guengerich, F.P. and D.-H. Kim (1990). In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis 11, 2275\u20132279.", "journal-title": "Carcinogenesis"}, {"key": "10_CR875", "doi-asserted-by": "crossref", "first-page": "106", "DOI": "10.1002/j.1552-4604.1998.tb04398.x", "volume": "38", "author": "L.L. Moltke von", "year": "1998", "unstructured": "von Moltke, L.L., D.J. Greenblatt, J.M. Grassi, B.W. Granda, S.X. Duan, S.M. Fogelman et al. (1998). Protease inhibitors as inhibitors of human cytochromes P450: High risk associated with ritonavir. J. Clin. Pharmacol. 38, 106\u2013111.", "journal-title": "J. Clin. Pharmacol."}, {"key": "10_CR876", "doi-asserted-by": "publisher", "first-page": "1055", "DOI": "10.1055/s-2002-36360", "volume": "68", "author": "M. Unger", "year": "2002", "unstructured": "Unger, M., U. Holzgrabe, W. Jacobsen, C. Cummins, and L.Z. Benet (2002). Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (kava-kava). Planta Med. 68, 1055\u20131058.", "journal-title": "Planta Med"}, {"key": "10_CR877", "doi-asserted-by": "publisher", "first-page": "160", "DOI": "10.1124/jpet.301.1.160", "volume": "301", "author": "H.L. Lin", "year": "2002", "unstructured": "Lin, H.L., U.M. Kent, and P.F. Hollenberg (2002). Mechanism-based inactivation of cytochrome P450 3A4 by 17\u03b1-ethynylestradiol: Evidence for heme destruction and covalent binding to protein. J. Pharmacol. Exp. Ther. 301, 160\u2013167.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR878", "doi-asserted-by": "publisher", "first-page": "333", "DOI": "10.1046/j.1365-2125.2000.00271.x", "volume": "50", "author": "S. Palovaara", "year": "2000", "unstructured": "Palovaara, S., K.T. Kivisto, P. Tapanainen, P. Manninen, P.J. Neuvonen, and K. Laine (2000). Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1\u2032-hydroxylation. Br. J. Clin. Pharmacol. 50, 333\u2013337.", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "10_CR879", "doi-asserted-by": "publisher", "first-page": "477", "DOI": "10.1016/0010-7824(88)90088-1", "volume": "38", "author": "H. Kuhl", "year": "1988", "unstructured": "Kuhl, H., C. Jung-Hoffmann, and F. Heidt (1988). Alterations in the serum levels of gestodene and SHBG during 12 cycles of treatment with 30 \u03bcg ethinylestradiol and 75\u03bcg gestodene. Contraception 38, 477\u2013486.", "journal-title": "Contraception"}, {"key": "10_CR880", "doi-asserted-by": "publisher", "first-page": "729", "DOI": "10.1007/s002280050543", "volume": "54", "author": "A. Balogh", "year": "1998", "unstructured": "Balogh, A., S. Gessinger, U. Svarovsky, M. Hippius, U. Mellinger, G. Klinger et al. (1998). Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans?. Eur. J. Clin. Pharmacol. 54, 729\u2013734.", "journal-title": "Eur. J. Clin. Pharmacol."}, {"key": "10_CR881", "doi-asserted-by": "publisher", "first-page": "193", "DOI": "10.1016/0006-291X(86)90265-2", "volume": "138", "author": "F.P. Guengerich", "year": "1986", "unstructured": "Guengerich, F.P. (1986). Covalent binding to apoprotein is a major fate of heme in a variety of reactions in which cytochrome P-450 is destroyed. Biochem. Biophys. Res. Commun. 138, 193\u2013198.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR882", "doi-asserted-by": "publisher", "first-page": "17448", "DOI": "10.1021/bi9808464", "volume": "37", "author": "K. He", "year": "1998", "unstructured": "He, K., L.M. Bornheim, A.M. Falick, D. Maltby, H. Yin, and M.A. Correia (1998). Identification of the heme-modified peptides from cumene hydroperoxide-inactivated cytochrome P450 3A4. Biochemistry 37, 17448\u201317457.", "journal-title": "Biochemistry"}, {"key": "10_CR883", "doi-asserted-by": "publisher", "first-page": "79", "DOI": "10.1016/S1056-8719(01)00121-6", "volume": "45", "author": "L.C. Wienkers", "year": "2001", "unstructured": "Wienkers, L.C. (2001). Problems associated with in vitro assessment of drug inhibition of CYP3A4 and other P-450 enzymes and its impact on drug discovery. J. Pharmacol. Toxicol. Methods 45, 79\u201384.", "journal-title": "J. Pharmacol. Toxicol. Methods"}, {"key": "10_CR884", "first-page": "50", "volume": "6", "author": "N.J. Plant", "year": "2003", "unstructured": "Plant, N.J. and G.G. Gibson (2003). Evaluation of the toxicological relevance of CYP3A4 induction. Curr. Opin. Drug Discov. Devel. 6, 50\u201356.", "journal-title": "Curr. Opin. Drug Discov. Devel."}, {"key": "10_CR885", "first-page": "1277", "volume": "64", "author": "G.C. Yee", "year": "1984", "unstructured": "Yee, G.C., M.S. Kennedy, R. Storb, and E.D. Thomas (1984). Effect of hepatic dysfunction on oral cyclosporine pharmacokinetics in marrow transplant patients. Blood 64, 1277\u20131279.", "journal-title": "Blood"}, {"key": "10_CR886", "doi-asserted-by": "crossref", "first-page": "1222", "DOI": "10.1002/j.1552-4604.1994.tb04735.x", "volume": "34", "author": "L.L. Moltke von", "year": "1994", "unstructured": "von Moltke, L.L. D.J. Greenblatt, S.X. Duan, J.S. Harmatz, and R.I. Shader (1994). In vitro prediction of the terfenadine-ketoconazole pharmacokinetic interaction. J. Clin. Pharmacol. 34, 1222\u20131227.", "journal-title": "J. Clin. Pharmacol."}, {"key": "10_CR887", "doi-asserted-by": "publisher", "first-page": "201", "DOI": "10.1016/S0278-6915(02)00209-0", "volume": "41", "author": "J.L. Dorne", "year": "2003", "unstructured": "Dorne, J.L., K. Walton, and A.G. Renwick (2003). Human variability in CYP3A4 metabolism and CYP3A4-related uncertainty factors for risk assessment. Food Chem. Toxicol. 41, 201\u2013224.", "journal-title": "Food Chem. Toxicol."}, {"key": "10_CR888", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.3748/wjg.v9.i2.359", "volume": "9", "author": "L.Q. Yang", "year": "2003", "unstructured": "Yang, L.Q., S.J. Li, Y.F. Cao, X.B. Man, W.F. Yu, H.Y. Wang et al. (2003). Different alterations of cytochrome P450 3A4 isoform and its gene expression in livers of patients with chronic liver diseases. World J. Gastroenterol. 9, 359\u2013363.", "journal-title": "World J. Gastroenterol."}, {"key": "10_CR889", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1016/S0009-9236(96)90022-3", "volume": "59", "author": "C.C. Lang", "year": "1996", "unstructured": "Lang, C.C., R.M. Brown, M.T. Kinirons, M.-A. Deathridge, F.P. Guengerich, D. Kelleher et al. (1996). Decreased intestinal P450 3A4 in celiac sprue: Reversal following successful gluten free diet. Clin. Pharmacol. Ther. 59, 41\u201346.", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "10_CR890", "doi-asserted-by": "publisher", "first-page": "35", "DOI": "10.1081/DMR-120018248", "volume": "35", "author": "S. Zhou", "year": "2003", "unstructured": "Zhou, S., Y. Gao, W. Jiang, M. Huang, A. Xu, and J.W. Paxton (2003). Interactions of herbs with cytochrome P450. Drug Metab. Rev. 35, 35\u201398.", "journal-title": "Drug Metab. Rev."}, {"key": "10_CR891", "doi-asserted-by": "publisher", "first-page": "7500", "DOI": "10.1073/pnas.130155097", "volume": "97", "author": "L.B. Moore", "year": "2000", "unstructured": "Moore, L.B., B. Goodwin, S.A. Jones, G.B. Wisely, C.J. Serabjit-Singh, T.M. Willson et al. (2000). St. John\u2019s wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc. Natl. Acad. Sci. USA 97, 7500\u20137502.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR892", "doi-asserted-by": "publisher", "first-page": "1430", "DOI": "10.1021/bi0268753", "volume": "42", "author": "R.E. Watkins", "year": "2003", "unstructured": "Watkins, R.E., J.M. Maglich, L.B. Moore, G.B. Wisely, S.M. Noble, P.R. Davis-Searles et al. (2003). 2.1 \u00c5 crystal structure of human PXR in complex with the St. John\u2019s wort compound hyperforin. Biochemistry 42, 1430\u20131438.", "journal-title": "Biochemistry"}, {"key": "10_CR893", "doi-asserted-by": "publisher", "first-page": "349", "DOI": "10.1046/j.1365-2125.2002.01683.x", "volume": "54", "author": "L. Henderson", "year": "2002", "unstructured": "Henderson, L., Q.Y. Yue, C. Bergquist, B. Gerden, and P. Arlett (2002). St. John\u2019s wort (Hypericum perforatum): Drug interactions and clinical outcomes. Br. J. Clin. Pharmacol. 54, 349\u2013356.", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "10_CR894", "doi-asserted-by": "crossref", "first-page": "433", "DOI": "10.1016/0016-5085(94)90602-5", "volume": "106", "author": "J.C. Kolars", "year": "1994", "unstructured": "Kolars, J.C., P. Benedict, P. Schmiedlin-Ren, and P.B. Watkins (1994). Aflatoxin B1-adduct formation in rat and human small bowel enterocytes. Gastroenterology 106, 433\u2013439.", "journal-title": "Gastroenterology"}, {"key": "10_CR895", "doi-asserted-by": "publisher", "first-page": "13176", "DOI": "10.1073/pnas.95.22.13176", "volume": "95", "author": "C.A. Felix", "year": "1998", "unstructured": "Felix, C.A., A.H. Walker, B.J. Lange, T.M. Williams, N.J. Winick, N.-K.V. Cheung et al. (1998). Association of CYP3A4 genotype with treatment-related leukemia. Proc. Natl. Acad. Sci. USA 95, 13176\u201313181.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR896", "doi-asserted-by": "publisher", "first-page": "129", "DOI": "10.1002/ijc.1568", "volume": "97", "author": "Y. Miyoshi", "year": "2002", "unstructured": "Miyoshi, Y., A. Ando, Y. Takamura, T. Taguchi, Y. Tamaki, and S. Noguchi (2002). Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues. Int. J. Cancer 97, 129\u2013132.", "journal-title": "Int. J. Cancer"}, {"key": "10_CR897", "doi-asserted-by": "publisher", "first-page": "605", "DOI": "10.1097/00008571-200211000-00004", "volume": "12", "author": "J.G. Blanco", "year": "2002", "unstructured": "Blanco, J.G., M.J. Edick, M.L. Hancock, N.J. Winick, T. Dervieux, M.D. Amylon et al. (2002). Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies. Pharmacogenetics 12, 605\u2013611.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR898", "doi-asserted-by": "publisher", "first-page": "1225", "DOI": "10.1093/jnci/90.16.1225", "volume": "90", "author": "T.R. Rebbeck", "year": "1998", "unstructured": "Rebbeck, T.R., J.M. Jaffe, A.H. Walker, A.J. Wein, and S.B. Malkowicz (1998). Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J. Natl. Cancer Inst. 90, 1225\u20131228.", "journal-title": "J. Natl. Cancer Inst."}, {"key": "10_CR899", "first-page": "653", "volume": "9", "author": "M.T. Tayeb", "year": "2002", "unstructured": "Tayeb, M.T., C. Clark, L. Sharp, N.E. Haites, P.H. Rooney, G.I. Murray et al. (2002). CYP3A4 promoter variant is associated with prostate cancer risk in men with benign prostate hyperplasia. Oncol. Rep. 9, 653\u2013655.", "journal-title": "Oncol. Rep."}, {"key": "10_CR900", "doi-asserted-by": "publisher", "first-page": "928", "DOI": "10.1038/sj.bjc.6600825", "volume": "88", "author": "M.T. Tayeb", "year": "2003", "unstructured": "Tayeb, M.T., C. Clark, N.E. Haites, L. Sharp, G.I. Murray, and H.L. McLeod (2003). CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia. Br. J. Cancer 88, 928\u2013932.", "journal-title": "Br. J. Cancer"}, {"key": "10_CR901", "doi-asserted-by": "publisher", "first-page": "1587", "DOI": "10.1093/jnci/91.18.1587", "volume": "91", "author": "Y. Ando", "year": "1999", "unstructured": "Ando, Y., T. Tateishi, Y. Sekido, T. Yamamoto, T. Satoh, Y. Hasegawa et al. (1999). Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J. Natl. Cancer Inst. 91, 1587\u20131588.", "journal-title": "J. Natl. Cancer Inst."}, {"key": "10_CR902", "doi-asserted-by": "publisher", "first-page": "553", "DOI": "10.1007/s00439-002-0731-5", "volume": "110", "author": "R.A. Kittles", "year": "2002", "unstructured": "Kittles, R.A., W. Chen, R.K. Panguluri, C. Ahaghotu, A. Jackson, C.A. Adebamowo et al. (2002). CYP3A4-V and prostate cancer in African Americans: Causal or confounding association because of population stratification?. Hum. Genet. 110, 553\u2013560.", "journal-title": "Hum. Genet."}, {"key": "10_CR903", "doi-asserted-by": "crossref", "first-page": "630", "DOI": "10.1093/jnci/94.8.630", "volume": "94", "author": "L. Wojnowski", "year": "2002", "unstructured": "Wojnowski, L., E. Hustert, K. Klein, M. Goldammer, M. Haberl, J. Kirchheiner et al. (2002). Re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J. Natl. Cancer Inst. 94, 630\u2013631.", "journal-title": "J. Natl. Cancer Inst."}, {"key": "10_CR904", "first-page": "97", "volume": "86", "author": "S.A. Wrighton", "year": "1989", "unstructured": "Wrighton, S.A., B.J. Ring, P.B. Watkins, and M. VandenBranden (1989). Identification of a polymorphically expressed member of the human cytochrome P-450III family. Mol. Pharmacol. 86, 97\u2013105.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR905", "first-page": "10388", "volume": "264", "author": "T. Aoyama", "year": "1989", "unstructured": "Aoyama, T., S. Yamano, D.J. Waxman, D.P. Lapenson, U.A. Meyer, V. Fischer et al. (1989). Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. J. Biol. Chem. 264, 10388\u201310395.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR906", "doi-asserted-by": "publisher", "first-page": "79", "DOI": "10.1016/0014-5793(95)00367-I", "volume": "364", "author": "G.I. Murray", "year": "1995", "unstructured": "Murray, G.I., S. Pritchard, W.T. Melvin, and M.D. Burke (1995). Cytochrome P450 CYP3A5 in the human anterior pituitary gland. FEBS Lett. 364, 79\u201382.", "journal-title": "FEBS Lett."}, {"key": "10_CR907", "doi-asserted-by": "publisher", "first-page": "676", "DOI": "10.1006/bbrc.1999.0960", "volume": "260", "author": "Y. Yamakoshi", "year": "1999", "unstructured": "Yamakoshi, Y., T. Kishimoto, K. Sugimura, and H. Kawashima (1999). Human prostate CYP3A5: Identification of a unique 5\u2032-untranslated sequence and characterization of purified recombinant protein. Biochem. Biophys. Res. Commun. 260, 676\u2013681.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR908", "doi-asserted-by": "publisher", "first-page": "745", "DOI": "10.1124/jpet.102.038208", "volume": "304", "author": "J. Hukkanen", "year": "2003", "unstructured": "Hukkanen, J., T. Vaisanen, A. Lassila, R. Piipari, S. Anttila, O. Pelkonen et al. (2003). Regulation of CYP3A5 by glucocorticoids and cigarette smoke in human lung-derived cells. J. Pharmacol. Exp. Ther. 304, 745\u2013752.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR909", "doi-asserted-by": "publisher", "first-page": "379", "DOI": "10.1097/00008571-199610000-00001", "volume": "6", "author": "S.K. Janardan", "year": "1996", "unstructured": "Janardan, S.K., K.S. Lown, P. Schmiedlin-Ren, K.E. Thummel, and P.B. Watkins (1996). Selective expression of CYP3A5 and not CYP3A4 in human blood. Pharmacogenetics 6, 379\u2013385.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR910", "doi-asserted-by": "publisher", "first-page": "193", "DOI": "10.1159/000047142", "volume": "80", "author": "J. Hakkola", "year": "2001", "unstructured": "Hakkola, J., H. Raunio, R. Purkunen, S. Saarikoski, K. Vahakangas, O. Pelkonen et al. (2001). Cytochrome P450 3A expression in the human fetal liver: Evidence that CYP3A5 is expressed in only a limited number of fetal livers. Biol. Neonate 80, 193\u2013201.", "journal-title": "Biol. Neonate"}, {"key": "10_CR911", "doi-asserted-by": "publisher", "first-page": "1741", "DOI": "10.1006/bbrc.1994.2870", "volume": "205", "author": "Y. Jouna\u00efdi", "year": "1994", "unstructured": "Jouna\u00efdi, Y., P.S. Guzelian, and M.J. Vilarem (1994). Sequence of the 5\u2032-flanking region of CYP3A5: Comparative analysis with CYP3A4 and CYP3A7. Biochem. Biophys. Res. Commun. 205, 1741\u20131747.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR912", "first-page": "63", "volume": "49", "author": "J.D. Schuetz", "year": "1996", "unstructured": "Schuetz, J.D., E.G. Schuetz, J.V. Thottassery, P.S. Guzelian, S. Strom, and D. Sun (1996). Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells. Mol. Pharmacol. 49, 63\u201372.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR913", "doi-asserted-by": "publisher", "first-page": "162", "DOI": "10.1124/mol.62.1.162", "volume": "62", "author": "Y.S. Lin", "year": "2002", "unstructured": "Lin, Y.S., A.L. Dowling, S.D. Quigley, F.M. Farin, J. Zhang, J. Lamba et al. (2002). Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism. Mol. Pharmacol. 62, 162\u2013172.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR914", "doi-asserted-by": "publisher", "first-page": "773", "DOI": "10.1097/00008571-200112000-00005", "volume": "11", "author": "E. Hustert", "year": "2001", "unstructured": "Hustert, E., M. Haberl, O. Burk, R. Wolbold, Y.Q. He, K. Klein et al. (2001). The genetic determinants of the CYP3A5 polymorphism. Pharmacogenetics 11, 773\u2013779.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR915", "doi-asserted-by": "publisher", "first-page": "415", "DOI": "10.1097/00008571-200007000-00005", "volume": "10", "author": "A. Paulussen", "year": "2000", "unstructured": "Paulussen, A., K. Lavrijsen, H. Bohets, J. Hendrickx, P. Verhasselt, W. Luyten et al. (2000). Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans. Pharmacogenetics 10, 415\u2013424.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR916", "doi-asserted-by": "publisher", "first-page": "1491", "DOI": "10.1124/dmd.30.12.1491", "volume": "30", "author": "P.S. Shih", "year": "2002", "unstructured": "Shih, P.S. and J.D. Huang (2002). Pharmacokinetics of midazolam and 1\u2032-hydroxymidazolam in Chinese with different CYP3A5 genotypes. Drug Metab. Dispos. 30, 1491\u20131496.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR917", "first-page": "207", "volume": "38", "author": "S.A. Wrighton", "year": "1990", "unstructured": "Wrighton, S.A., W.R. Brian, M.A. Sari, M. Iwasaki, F.P. Guengerich, J.L. Raucy et al. (1990). Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol. Pharmacol. 38, 207\u2013213.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR918", "first-page": "180", "volume": "27", "author": "M.A. Gibbs", "year": "1999", "unstructured": "Gibbs, M.A., K.E. Thummel, D.D. Shen, and K.L. Kunze (1999). Inhibition of cytochrome P-450 3A(CYP3A) in human intestinal and liver microsomes: Comparison of Ki values and impact of CYP3A5 expression. Drug Metab. Dispos. 27, 180\u2013187.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR919", "doi-asserted-by": "publisher", "first-page": "1993", "DOI": "10.1016/0006-2952(79)90214-4", "volume": "28", "author": "T. Kamataki", "year": "1979", "unstructured": "Kamataki, T., M. Sugiura, Y. Yamazoe, and R. Kato (1979). Purification and properties of cytochrome P-450 and NADPH-cytochrome c (P-450) reductase from human liver microsomes. Biochem. Pharmacol. 28, 1993\u20132000.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR920", "doi-asserted-by": "publisher", "first-page": "275", "DOI": "10.1016/0003-9861(85)90383-2", "volume": "241", "author": "M. Kitada", "year": "1985", "unstructured": "Kitada, M., T. Kamataki, K. Itahashi, T. Rikihisa, R. Kato, and Y. Kanakubo (1985). Purification and properties of cytochrome P-450 from homogenates of human fetal livers. Arch. Biochem. Biophys. 241, 275\u2013280.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR921", "doi-asserted-by": "publisher", "first-page": "1154", "DOI": "10.1016/0006-291X(85)90211-6", "volume": "131", "author": "M. Kitada", "year": "1985", "unstructured": "Kitada, M., T. Kamataki, K. Itahashi, T. Rikihisa, R. Kato, and Y. Kanakubo (1985). Immunochemical examinations of cytochrome P-450 in various tissues of human fetuses using antibodies to human fetal cytochrome P-450, P-450 HFLa. Biochem. Biophys. Res. Commun. 131, 1154\u20131159.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR922", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1111/j.1447-0756.1993.tb00392.x", "volume": "19", "author": "Y. Okajima", "year": "1993", "unstructured": "Okajima, Y., N. Inaba, I. Fukazawa, Y. Ota, Y. Hirai, N. Sato et al. (1993). Immunohistochemical and immunoelectron microscopic study of cytochrome P-450 of human fetal livers (P-450HFLa): Implications for an onco-feto-placental enzyme. Asia Oceania J. Obstet. Gynaecol. 19, 329\u2013341.", "journal-title": "Asia Oceania J. Obstet. Gynaecol."}, {"key": "10_CR923", "doi-asserted-by": "crossref", "first-page": "1018", "DOI": "10.1172/JCI116607", "volume": "92", "author": "J.D. Schuetz", "year": "1993", "unstructured": "Schuetz, J.D., S. Kauma, and P.S. Guzelian (1993). Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta. J. Clin. Invest. 92, 1018\u20131024.", "journal-title": "J. Clin. Invest."}, {"key": "10_CR924", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1124/dmd.31.1.1", "volume": "31", "author": "M.A. Sarkar", "year": "2003", "unstructured": "Sarkar, M.A., V. Vadlamuri, S. Ghosh, and D.D. Glover (2003). Expression and cyclic variability of CYP3A4 and CYP3A7 isoforms in human endometrium and cervix during the menstrual cycle. Drug Metab. Dispos. 31, 1\u20136.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR925", "doi-asserted-by": "publisher", "first-page": "379", "DOI": "10.1016/0006-2952(96)00216-X", "volume": "52", "author": "J. Hakkola", "year": "1996", "unstructured": "Hakkola, J., H. Raunio, R. Purkunen, O. Pelkonen, S. Saarikoski, T. Cresteil et al. (1996). Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem. Pharmacol. 52, 379\u2013383.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR926", "first-page": "922", "volume": "46", "author": "H.Y.L. Yang", "year": "1994", "unstructured": "Yang, H.Y.L., Q.P. Lee, A.E. Rettie, and M.R. Juchau (1994). Functional cytochrome P4503A isoforms in human embryonic tissues: Expression during organogenesis. Mol. Pharmacol. 46, 922\u2013928.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR927", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1097/00008571-199402000-00002", "volume": "4", "author": "J.D. Schuetz", "year": "1994", "unstructured": "Schuetz, J.D., D.L. Beach, and P.S. Guzelian (1994). Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 4, 11\u201320.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR928", "doi-asserted-by": "publisher", "first-page": "2567", "DOI": "10.1016/S0024-3205(97)01011-4", "volume": "61", "author": "T. Tateishi", "year": "1997", "unstructured": "Tateishi, T., H. Nakura, M. Asoh, M. Watanabe, M. Tanaka, T. Kumai et al. (1997). A comparison of hepatic cytochrome P450 protein expression between infancy and postinfancy. Life Sci. 61, 2567\u20132574.", "journal-title": "Life Sci."}, {"key": "10_CR929", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1093/oxfordjournals.jbchem.a122632", "volume": "106", "author": "M. Komori", "year": "1989", "unstructured": "Komori, M., K. Nishio, H. Ohi, M. Kitada, and T. Kamataki (1989). Molecular cloning and sequence analysis of cDNA containing entire coding region for human fetal liver cytochrome P-450. J. Biochem. (Tokyo) 106, 161\u2013163.", "journal-title": "J. Biochem. (Tokyo)"}, {"key": "10_CR930", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1016/0167-4781(92)90520-A", "volume": "1130", "author": "S. Itoh", "year": "1992", "unstructured": "Itoh, S., T. Yanagimoto, S. Tagawa, H. Hashimoto, R. Kitamura et al. (1992). Genomic organization of human fetal specific P-450IIIA7 (cytochrome P-450HFLa)-related gene (s) and interaction of transcriptional regulatory factor with its DNA element in the 5\u2032 flanking region. Biochim. Biophys. Acta 1130, 133\u2013138.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "10_CR931", "doi-asserted-by": "publisher", "first-page": "689", "DOI": "10.1006/bbrc.1996.1231", "volume": "225", "author": "J. Greuet", "year": "1996", "unstructured": "Greuet, J., L. Pichard, C. Bonfils, J. Domergue, and P. Maurel (1996). The fetal specific gene CYP3A7 is inducible by rifampicin in adult human hepatocytes in primary culture. Biochem. Biophys. Res. Commun. 225, 689\u2013694.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR932", "doi-asserted-by": "publisher", "first-page": "377", "DOI": "10.1006/bbrc.1999.0745", "volume": "260", "author": "J.M. Pascussi", "year": "1999", "unstructured": "Pascussi, J.M., Y. Jounaidi, L. Drocourt, J. Domergue, C. Balabaud, P. Maurel et al. (1999). Evidence for the presence of a functional pregnane X receptor response element in the CYP3A7 promoter gene. Biochem. Biophys. Res. Commun. 260, 377\u2013381.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR933", "doi-asserted-by": "publisher", "first-page": "139", "DOI": "10.1006/bbrc.2000.4066", "volume": "280", "author": "G. Bertilsson", "year": "2001", "unstructured": "Bertilsson, G., A. Berkenstam, and P. Blomquist (2001). Functionally conserved xenobiotic responsive enhancer in cytochrome P450 3A7. Biochem. Biophys. Res. Commun. 280, 139\u2013144.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR934", "first-page": "38010", "volume": "276", "author": "T. Saito", "year": "2001", "unstructured": "Saito, T., Y. Takahashi, H. Hashimoto, and T. Kamataki (2001). Novel transcriptional regulation of the human CYP3A7 gene by Sp1 and Sp3 through nuclear factor \u03baB-like element. J. Biol. Chem. 276, 38010\u201338022.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR935", "doi-asserted-by": "publisher", "first-page": "13", "DOI": "10.1016/S0378-1119(00)00470-4", "volume": "260", "author": "C. Finta", "year": "2000", "unstructured": "Finta, C. and P.G. Zaphiropoulos (2000). The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons. Gene 260, 13\u201323.", "journal-title": "Gene"}, {"key": "10_CR936", "doi-asserted-by": "publisher", "first-page": "24280", "DOI": "10.1074/jbc.M202345200", "volume": "277", "author": "O. Burk", "year": "2002", "unstructured": "Burk, O., H. Tegude, I. Koch, E. Hustert, R. Wolbold, H. Glaeser, K. et al. (2002). Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine. J. Biol. Chem. 277, 24280\u201324288.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR937", "doi-asserted-by": "publisher", "first-page": "453", "DOI": "10.1016/0006-2952(87)90350-9", "volume": "36", "author": "M. Kitada", "year": "1987", "unstructured": "Kitada, M., T. Kamataki, K. Itahashi, T. Rikihisa, and Y. Kanakubo (1987). Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidations. Biochem. Pharmacol. 36, 453\u2013456.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR938", "first-page": "13534", "volume": "262", "author": "M. Kitada", "year": "1987", "unstructured": "Kitada, M., T. Kamataki, K. Itahashi, T. Rikihisa, and Y. Kanakubo (1987). P-450 HFLa, a form of cytochrome P-450 purified from human fetal livers, is the 16\u03b1-hydroxylase of dehydroepiandrosterone 3-sulfate. J. Biol. Chem. 262, 13534\u201313537.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR939", "first-page": "15", "volume": "100", "author": "S. Ohmori", "year": "1998", "unstructured": "Ohmori, S., N. Fujiki, H. Nakasa, H. Nakamura, I. Ishii, K. Itahashi et al. (1998). Steroid hydroxylation by human fetal CYP3A7 and human NADPH-cytochrome P450 reductase coexpressed in insect cells using baculovirus. Res. Commun. Mol. Pathol. Pharmacol. 100, 15\u201328.", "journal-title": "Res. Commun. Mol. Pathol. Pharmacol."}, {"key": "10_CR940", "doi-asserted-by": "publisher", "first-page": "1643", "DOI": "10.1016/0006-2952(94)90543-6", "volume": "47", "author": "J.C. Gorski", "year": "1994", "unstructured": "Gorski, J.C., S.D. Hall, D.R. Jones, M. VandenBranden, and S.A. Wrighton (1994). Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily. Biochem. Pharmacol. 47, 1643\u20131653.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR941", "doi-asserted-by": "publisher", "first-page": "81", "DOI": "10.1006/abbi.1997.0286", "volume": "346", "author": "E.M.J. Gillam", "year": "1997", "unstructured": "Gillam, E.M.J., R.M. Wunsch, Y.-F. Ueng, T. Shimada, P.E.B. Reilly, T. Kamataki et al. (1997). Expression of cytochrome P450 3A7 in Escherichia coli: Effects of 5\u2032 modification and catalytic characterization of recombinant enzymes expressed in bicistronic format with NADPH-cytochrome P450 reductase. Arch. Biochem. Biophys. 346, 81\u201390.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR942", "doi-asserted-by": "publisher", "first-page": "323", "DOI": "10.1016/0003-9861(95)90016-0", "volume": "320", "author": "H. Hashimoto", "year": "1995", "unstructured": "Hashimoto, H., Y. Yanagawa, M. Sawada, S. Itoh, T. Deguchi, and T. Kamataki (1995). Simultaneous expression of human CYP3A7 and N-acetyltransferase in Chinese hamster CHL cells results in high cytotoxicity for carcinogenic heterocyclic amines. Arch. Biochem. Biophys. 320, 323\u2013329.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR943", "first-page": "641", "volume": "57", "author": "Y. Li", "year": "1997", "unstructured": "Li, Y., T. Yokoi, M. Katsuki, J.S. Wang, J.D. Groopman, and T. Kamataki (1997). In vivo activation of aflatoxin B1 in C57BL/6N mice carrying a human fetus-specific CYP3A7 gene. Cancer Res. 57, 641\u2013645.", "journal-title": "Cancer Res"}, {"key": "10_CR944", "doi-asserted-by": "publisher", "first-page": "150", "DOI": "10.1006/bbrc.1998.9202", "volume": "250", "author": "A. Yamada", "year": "1998", "unstructured": "Yamada, A., K. Fujita, T. Yokoi, S. Muto, A. Suzuki, Y. Gondo et al. (1998). In vivo detection of mutations induced by aflatoxin B1 using human CYP3A7/HITEC hybrid mice. Biochem. Biophys. Res. Commun. 250, 150\u2013153.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR945", "doi-asserted-by": "publisher", "first-page": "235", "DOI": "10.1006/abbi.1996.0214", "volume": "329", "author": "Y. Li", "year": "1996", "unstructured": "Li, Y., T. Yokoi, R. Kitamura, M. Sasaki, M. Gunji, M. Katsuki et al. (1996). Establishment of transgenic mice carrying human fetus-specific CYP3A7. Arch. Biochem. Biophys. 329, 235\u2013240.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR946", "first-page": "1051", "volume": "28", "author": "H. Chen", "year": "2000", "unstructured": "Chen, H., A.G. Fantel, and M.R. Juchau (2000). Catalysis of the 4-hydroxylation of retinoic acids by CYP3A7 in human fetal hepatic tissues. Drug Metab. Dispos. 28, 1051\u20131057.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR947", "doi-asserted-by": "publisher", "first-page": "623", "DOI": "10.1006/bbrc.2000.2340", "volume": "269", "author": "E. Inoue", "year": "2000", "unstructured": "Inoue, E., Y. Takahashi, Y. Imai, and T. Kamataki (2000). Development of bacterial expression system with high yield of CYP3A7, a human fetuspecific form of cytochrome P450. Biochem. Biophys. Res. Commun. 269, 623\u2013627.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR948", "first-page": "4990", "volume": "59", "author": "N. Kondoh", "year": "1999", "unstructured": "Kondoh, N., T. Wakatsuki, A. Ryo, A. Hada, T. Aihara, S. Horiuchi et al. (1999). Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res. 59, 4990\u20134996.", "journal-title": "Cancer Res"}, {"key": "10_CR949", "doi-asserted-by": "publisher", "first-page": "111", "DOI": "10.1097/00008571-200103000-00002", "volume": "11", "author": "K. Gellner", "year": "2001", "unstructured": "Gellner, K., R. Eiselt, E. Hustert, H. Arnold, I. Koch, M. Haberl et al. (2001). Genomic organization of the human CYP3A locus: Identification of a new, inducible CYP3A gene. Pharmacogenetics 11, 111\u2013121.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR950", "doi-asserted-by": "crossref", "first-page": "386", "DOI": "10.1124/mol.59.2.386", "volume": "59", "author": "T.L. Domanski", "year": "2001", "unstructured": "Domanski, T.L., C. Finta, J.R. Halpert, and P.G. Zaphiropoulos (2001). cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450. Mol. Pharmacol. 59, 386\u2013392.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR951", "doi-asserted-by": "publisher", "first-page": "1349", "DOI": "10.1006/bbrc.2001.4505", "volume": "281", "author": "A. Westlind", "year": "2001", "unstructured": "Westlind, A., S. Malmebo, I. Johansson, C. Otter, T.B. Andersson, M. Ingelman-Sundberg et al. (2001). Cloning and tissue distribution of a novel human cytochrome P450 of the CYP3A subfamily, CYP3A43. Biochem. Biophys. Res. Commun. 281, 1349\u20131355.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR952", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1016/0167-4781(93)90285-L", "volume": "1172", "author": "C.N. Palmer", "year": "1993", "unstructured": "Palmer, C.N., T.H. Richardson, K.J. Griffin, M.H. Hsu, A.S. Muerhoff, J.E. Clark et al. (1993). Characterization of a cDNA encoding a human kidney, cytochrome P-450 4A fatty acid \u03c9-hydroxylase and the cognate enzyme expressed in Escherichia coli. Biochim. Biophys. Acta 1172, 161\u2013166.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "10_CR953", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1042/bj2940173", "volume": "294", "author": "D.R. Bell", "year": "1993", "unstructured": "Bell, D.R., N.J. Plant, C.G. Rider, L. Na, S. Brown, I. Ateitalla et al. (1993). Species-specific induction of cytochrome P-450 4A RNAs: PCR cloning of partial guinea-pig, human and mouse CYP4A cDNAs. Biochem. J. 294, 173\u2013180.", "journal-title": "Biochem. J."}, {"key": "10_CR954", "doi-asserted-by": "crossref", "first-page": "893", "DOI": "10.1089/dna.1993.12.893", "volume": "12", "author": "S. Imaoka", "year": "1993", "unstructured": "Imaoka, S., H. Ogawa, S. Kimura, and F.J. Gonzalez (1993). Complete cDNA sequence and cDNA-directed expression of CYP4A11, a fatty acid \u03c9-hydroxylase expressed in human kidney. DNA Cell Biol. 12, 893\u2013899.", "journal-title": "DNA Cell Biol."}, {"key": "10_CR955", "doi-asserted-by": "publisher", "first-page": "219", "DOI": "10.1006/abbi.1996.0501", "volume": "335", "author": "P.K. Powell", "year": "1996", "unstructured": "Powell, P.K., I. Wolf, and J.M. Lasker (1996). Identification of CYP4A11 as the major lauric acid \u03c9-hydroxylase in human liver microsomes. Arch. Biochem. Biophys. 335, 219\u2013226.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR956", "doi-asserted-by": "publisher", "first-page": "221", "DOI": "10.1016/S0003-9861(02)00545-3", "volume": "409", "author": "A. Bellamine", "year": "2003", "unstructured": "Bellamine, A., Y. Wang, M.R. Waterman, J.V. Gainer, III, E.P. Dawson, N.J. Brown et al. (2003). Characterization of the CYP4A11 gene, a second CYP4A gene in humans. Arch. Biochem. Biophys. 409, 221\u2013227.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR957", "first-page": "1331", "volume": "243", "author": "A.Y.H. Lu", "year": "1968", "unstructured": "Lu, A.Y.H. and M.J. Coon (1968). Role of hemoprotein P-450 in fatty acid \u03c9-hydroxylation in a soluble enzyme system from liver microsomes. J. Biol. Chem. 243, 1331\u20131332.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR958", "doi-asserted-by": "publisher", "first-page": "749", "DOI": "10.1046/j.1365-2133.2001.04490.x", "volume": "145", "author": "M.C. Gonzalez", "year": "2001", "unstructured": "Gonzalez, M.C., C. Marteau, J. Franchi, and D. Migliore-Samour (2001). Cytochrome P450 4A11 expression in human keratinocytes: Effects of ultraviolet irradiation. Br. J. Dermatol. 145, 749\u2013757.", "journal-title": "Br. J. Dermatol."}, {"key": "10_CR959", "first-page": "677", "volume": "293", "author": "B.S. Cummings", "year": "2000", "unstructured": "Cummings, B.S., J.M. Lasker, and L.H. Lash (2000). Expression of glutathione-dependent enzymes and cytochrome P450s in freshly isolated and primary cultures of proximal tubular cells from human kidney. J. Pharmacol. Exp. Ther. 293, 677\u2013685.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR960", "doi-asserted-by": "publisher", "first-page": "212", "DOI": "10.1016/S0003-9861(02)00499-X", "volume": "409", "author": "Savas", "year": "2003", "unstructured": "Savas, \u00dc., M.H. Hsu, and E.F. Johnson (2003). Differential regulation of human CYP4A genes by peroxisome proliferators and dexamethasone. Arch. Biochem. Biophys. 409, 212\u2013220.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR961", "doi-asserted-by": "publisher", "first-page": "333", "DOI": "10.1006/abbi.2000.1831", "volume": "378", "author": "H. Kawashima", "year": "2000", "unstructured": "Kawashima, H., T. Naganuma, E. Kusunose, T. Kono, R. Yasumoto, K. Sugimura et al. (2000). Human fatty acid \u03c9-hydroxylase. CYP4A11: Determination of complete genomic sequence and characterization of purified recombinant protein. Arch. Biochem. Biophys. 378, 333\u2013339.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR962", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1006/rtph.1997.1163", "volume": "27", "author": "R.C. Cattley", "year": "1998", "unstructured": "Cattley, R.C., J. DeLuca, C. Elcombe, P. Fenner-Crisp, B.G. Lake, D.S. Marsman et al. (1998). Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?. Regul. Toxicol. Pharmacol. 27, 47\u201360.", "journal-title": "Regul. Toxicol. Pharmacol."}, {"key": "10_CR963", "doi-asserted-by": "publisher", "first-page": "23055", "DOI": "10.1074/jbc.273.36.23055", "volume": "273", "author": "E.A. Dierks", "year": "1998", "unstructured": "Dierks, E.A., Z. Zhang, E.F. Johnson, and P.R. Ortiz de Montellano (1998). The catalytic site of cytochrome P4504A11 (CYP4A11) and its L131F mutant. J. Biol. Chem. 273, 23055\u201323061.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR964", "doi-asserted-by": "publisher", "first-page": "63", "DOI": "10.1006/abbi.1999.1504", "volume": "373", "author": "U. Hoch", "year": "2000", "unstructured": "Hoch, U., Z. Zhang, D.L. Kroetz, and P.R. Ortiz de Montellano (2000). Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid \u03c9-hydroxylases. Arch. Biochem. Biophys. 373, 63\u201371.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR965", "first-page": "1327", "volume": "285", "author": "P.K. Powell", "year": "1998", "unstructured": "Powell, P.K., I. Wolf, R. Jin, and J.M. Lasker (1998). Metabolism of arachidonic acid to 20-hydroxy-5,8,11,14-eicosatetraenoic acid by P450 enzymes in human liver: Involvement of CYP4F2 and CYP4A11. J. Pharmacol. Exp. Ther. 285, 1327\u20131336.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR966", "doi-asserted-by": "publisher", "first-page": "4118", "DOI": "10.1074/jbc.275.6.4118", "volume": "275", "author": "J.M. Lasker", "year": "2000", "unstructured": "Lasker, J.M., W.B. Chen, I. Wolf, B.P. Bloswick, P.D. Wilson, and P.K. Powell (2000). Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. J. Biol. Chem. 275, 4118\u20134126.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR967", "doi-asserted-by": "publisher", "first-page": "407", "DOI": "10.1016/S0006-2952(01)00683-9", "volume": "62", "author": "E.H. Oliw", "year": "2001", "unstructured": "Oliw, E.H., K. Stark, and J. Bylund (2001). Oxidation of prostaglandin H2 and prostaglandin H2 analogues by human cytochromes P450: Analysis of \u03c9-side chain hydroxy metabolites and four steroisomers of 5-hydroxyprostaglandin I1 by mass spectrometry. Biochem. Pharmacol. 62, 407\u2013415.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR968", "doi-asserted-by": "publisher", "first-page": "403", "DOI": "10.1002/(SICI)1097-0134(19990215)34:3<403::AID-PROT12>3.0.CO;2-D", "volume": "34", "author": "Y.T. Chang", "year": "1999", "unstructured": "Chang, Y.T. and G.H. Loew (1999). Homology modeling and substrate binding study of human CYP4A11 enzyme. Proteins 34, 403\u2013415.", "journal-title": "Proteins"}, {"key": "10_CR969", "doi-asserted-by": "publisher", "first-page": "12755", "DOI": "10.1074/jbc.M112155200", "volume": "277", "author": "L.A. LeBrun", "year": "2002", "unstructured": "LeBrun, L.A., U. Hoch, and P. R. Ortiz de Montellano (2002). Autocatalytic mechanism and consequences of covalent heme attachment in the cytochrome P4504A family. J. Biol. Chem. 277, 12755\u201312761.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR970", "doi-asserted-by": "publisher", "first-page": "8060", "DOI": "10.1021/bi00446a014", "volume": "28", "author": "P.T. Nhamburo", "year": "1989", "unstructured": "Nhamburo, P.T., F.J. Gonzalez, O.W. McBride, H.V. Gelboin, and S. Kimura (1989). Identification of a new P450 expressed in human lung: Complete cDNA sequence, cDNA-directed expression, and chromosome mapping. Biochemistry 28, 8060\u20138066.", "journal-title": "Biochemistry"}, {"key": "10_CR971", "doi-asserted-by": "publisher", "first-page": "776", "DOI": "10.1006/bbrc.2000.3740", "volume": "277", "author": "S. Imaoka", "year": "2000", "unstructured": "Imaoka, S., Y. Yoneda, T. Sugimoto, T. Hiroi, K. Yamamoto, T. Nakatani et al. (2000). CYP4B1 is a possible risk factor for bladder cancer in humans. Biochem. Biophys. Res. Commun. 277, 776\u2013780.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR972", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1023/A:1012526406741", "volume": "70", "author": "M. Iscan", "year": "2001", "unstructured": "Iscan, M., T. Klaavuniemi, T. Coban, N. Kapucuoglu, O. Pelkonen, and H. Raunio (2001). The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue. Breast Cancer Res. Treat. 70, 47\u201354.", "journal-title": "Breast Cancer Res. Treat."}, {"key": "10_CR973", "doi-asserted-by": "publisher", "first-page": "880", "DOI": "10.1046/j.1365-2362.2001.00893.x", "volume": "31", "author": "N. Finnstrom", "year": "2001", "unstructured": "Finnstrom, N., C. Bjelfman, T.G. Soderstrom, G. Smith, L. Egevad, B.J. Norlen et al. (2001). Detection of cytochrome P450 mRNA transcripts in prostate samples by RT-PCR. Eur. J. Clin. Invest. 31, 880\u2013886.", "journal-title": "Eur. J. Clin. Invest."}, {"key": "10_CR974", "doi-asserted-by": "publisher", "first-page": "367", "DOI": "10.1097/00008571-200207000-00004", "volume": "12", "author": "J.M. Lo-Guidice", "year": "2002", "unstructured": "Lo-Guidice, J.M., D. Allorge, C. Cauffiez, D. Chevalier, J.J. Lafitte, M. Lhermitte et al. (2002). Genetic polymorphism of the human cytochrome P450 CYP4B1: Evidence for a non-functional allelic variant. Pharmacogenetics 12, 367\u2013374.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR975", "doi-asserted-by": "publisher", "first-page": "12847", "DOI": "10.1021/bi981280m", "volume": "37", "author": "Y.-M. Zheng", "year": "1998", "unstructured": "Zheng, Y.-M., M.B. Fisher, N. Yokotani, Y. Fujii-Kuriyama, and A.E. Rettie (1998). Identification of a meander region proline residue critical for heme binding to cytochrome P450: Implications for the catalytic function of human CYP4B1. Biochemistry 37, 12847\u201312851.", "journal-title": "Biochemistry"}, {"key": "10_CR976", "doi-asserted-by": "publisher", "first-page": "757", "DOI": "10.1006/bbrc.2001.5055", "volume": "284", "author": "S. Imaoka", "year": "2001", "unstructured": "Imaoka, S., K. Hayashi, T. Hiroi, Y. Yabusaki, T. Kamataki, and Y. Funae (2001). A transgenic mouse expressing human CYP4B1 in the liver. Biochem. Biophys. Res. Commun. 284, 757\u2013762.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR977", "doi-asserted-by": "publisher", "first-page": "8597", "DOI": "10.1021/bi010395e", "volume": "40", "author": "K.R. Henne", "year": "2001", "unstructured": "Henne, K.R., M.B. Fisher, K.R. Iyer, D.H. Lang, W.F. Trager, and A.E. Rettie (2001). Active site characteristics of CYP4B1 probed with aromatic ligands. Biochemistry 40, 8597\u20138605.", "journal-title": "Biochemistry"}, {"key": "10_CR978", "doi-asserted-by": "publisher", "first-page": "12925", "DOI": "10.1021/bi011171z", "volume": "40", "author": "K.R. Henne", "year": "2001", "unstructured": "Henne, K.R., K.L. Kunze, Y.M. Zheng, P. Christmas, R.J. Soberman, and A.E. Rettie (2001). Covalent linkage of prosthetic heme to CYP4 family P450 enzymes. Biochemistry 40, 12925\u201312931.", "journal-title": "Biochemistry"}, {"key": "10_CR979", "doi-asserted-by": "publisher", "first-page": "11339", "DOI": "10.1074/jbc.M009969200", "volume": "276", "author": "U. Hoch", "year": "2001", "unstructured": "Hoch, U. and P.R. Ortiz de Montellano (2001). Covalently linked heme in cytochrome P4504A fatty acid hydroxylases. J. Biol. Chem. 276, 11339\u201311346.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR980", "doi-asserted-by": "publisher", "first-page": "178", "DOI": "10.1038/sj.cgt.7700422", "volume": "9", "author": "S. Frank", "year": "2002", "unstructured": "Frank, S., S. Steffens, U. Fischer, A. Tlolko, N.G. Rainov, and C.M. Kramm (2002). Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: Implications for pharmacogene therapy. Cancer Gene Ther. 9, 178\u2013188.", "journal-title": "Cancer Gene Ther."}, {"key": "10_CR981", "doi-asserted-by": "publisher", "first-page": "70", "DOI": "10.1016/0014-5793(94)00587-7", "volume": "348", "author": "Y. Kikuta", "year": "1994", "unstructured": "Kikuta, Y., E. Kusunose, T. Kondo, S. Yamamoto, H. Kinoshita, and M. Kusunose (1994). Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. FEBS Lett. 348, 70\u201374.", "journal-title": "FEBS Lett."}, {"key": "10_CR982", "doi-asserted-by": "publisher", "first-page": "345", "DOI": "10.1016/S0090-6980(02)00039-4", "volume": "68\u201369", "author": "Y. Kikuta", "year": "2002", "unstructured": "Kikuta, Y., E. Kusunose, and M. Kusunose (2002). Prostaglandin and leukotriene \u03c9-hydroxylases. Prostaglandins Other Lipid Mediat. 68\u201369, 345\u2013362.", "journal-title": "Prostaglandins Other Lipid Mediat."}, {"key": "10_CR983", "doi-asserted-by": "publisher", "first-page": "89", "DOI": "10.1006/abbi.1998.0880", "volume": "359", "author": "R. Jin", "year": "1998", "unstructured": "Jin, R., D.R. Koop, J.L. Raucy, and J.M. Lasker (1998). Role of human CYP4F2 in hepatic catabolism of the proinflammatory agent leukotriene B4. Arch. Biochem. Biophys. 359, 89\u201398.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR984", "doi-asserted-by": "publisher", "first-page": "723", "DOI": "10.1089/104454999315006", "volume": "18", "author": "Y. Kikuta", "year": "1999", "unstructured": "Kikuta, Y., Y. Miyauchi, E. Kusunose, and M. Kusunose (1999). Expression and molecular cloning of human liver leukotriene B4 \u03c9-hydroxylase (CYP4F2) gene. DNA Cell Biol. 18, 723\u2013730.", "journal-title": "DNA Cell Biol."}, {"key": "10_CR985", "doi-asserted-by": "crossref", "first-page": "1047", "DOI": "10.1093/oxfordjournals.jbchem.a022696", "volume": "127", "author": "Y. Kikuta", "year": "2000", "unstructured": "Kikuta, Y., E. Kusunose, and M. Kusunose (2000). Characterization of human liver leukotriene B4 \u03c9-hydroxylase P450 (CYP4F2). J. Biochem. (Tokyo) 127, 1047\u20131052.", "journal-title": "J. Biochem. (Tokyo)"}, {"key": "10_CR986", "first-page": "9376", "volume": "268", "author": "Y. Kikuta", "year": "1993", "unstructured": "Kikuta, Y., E. Kusunose, K. Endo, S. Yamamoto, K. Sogawa, Y. Fujii-Kuriyama et al. (1993). A novel form of cytochrome P-450 family 4 in human polymorphonuclear leukocytes: cDNA cloning and expression of leukotriene B4 \u03c9-hydroxylase. J. Biol. Chem. 268, 9376\u20139380.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR987", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1089/dna.1998.17.221", "volume": "17", "author": "Y. Kikuta", "year": "1998", "unstructured": "Kikuta, Y., M. Kato, Y. Yamashita, Y. Miyauchi, K. Tanaka, N. Kamada et al. (1998). Human leukotriene B4 \u03c9-hydroxylase (CYP4F3) gene: Molecular cloning and chromosomal localization. DNA Cell Biol. 17, 221\u2013230.", "journal-title": "DNA Cell Biol."}, {"key": "10_CR988", "doi-asserted-by": "publisher", "first-page": "21191", "DOI": "10.1074/jbc.274.30.21191", "volume": "274", "author": "P. Christmas", "year": "1999", "unstructured": "Christmas, P., S.R. Ursino, J.W. Fox, and R.J. Soberman (1999). Expressio of the CYP4F3 gene. J. Biol. Chem. 274, 21191\u201321199.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR989", "first-page": "38166", "volume": "276", "author": "P. Christmas", "year": "2001", "unstructured": "Christmas, P., J.P. Jones, C.J. Patten, D.A. Rock, Y. Zheng, S.M. Cheng et al. (2001). Alternative splicing determines the function of CYP4F3 by switching substrate specificity. J. Biol. Chem. 276, 38166\u201338172.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR990", "doi-asserted-by": "publisher", "first-page": "169", "DOI": "10.1006/bbrc.1999.1011", "volume": "261", "author": "J. Bylund", "year": "1999", "unstructured": "Bylund, J., N. Finnstrom, and E.H. Oliw (1999). Gene expression of a novel cytochrome P450 of the CYP4F subfamily in human seminal vesicles. Biochem. Biophys. Res. Commun. 261, 169\u2013174.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR991", "doi-asserted-by": "publisher", "first-page": "21844", "DOI": "10.1074/jbc.M001712200", "volume": "275", "author": "J. Bylund", "year": "2000", "unstructured": "Bylund, J., M. Hidestrand, M. Ingelman-Sundberg, and E.H. Oliw (2000). Identification of CYP4F8 in human seminal vesicles as a prominent 19-hydroxylase of prostaglandin endoperoxides. J. Biol. Chem. 275, 21844\u201321849.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR992", "doi-asserted-by": "publisher", "first-page": "188", "DOI": "10.1016/S0003-9861(02)00511-8", "volume": "409", "author": "K. Stark", "year": "2003", "unstructured": "Stark, K., H. Torma, M. Cristea, and E.H. Oliw (2003). Expression of CYP4F8 (prostaglandin H 19-hydroxylase) in human epithelia and prominent induction in epidermis of psoriatic lesions. Arch. Biochem. Biophys. 409, 188\u2013196.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR993", "doi-asserted-by": "publisher", "first-page": "161", "DOI": "10.1006/geno.2000.6276", "volume": "68", "author": "X. Cui", "year": "2000", "unstructured": "Cui, X., D.R. Nelson, and H.W. Strobel (2000). A novel human cytochrome P450 4F isoform (CYP4F11): cDNA cloning, expression, and genomic structural characterization. Genomics 68, 161\u2013166.", "journal-title": "Genomics"}, {"key": "10_CR994", "doi-asserted-by": "publisher", "first-page": "892", "DOI": "10.1006/bbrc.2000.4191", "volume": "280", "author": "J. Bylund", "year": "2001", "unstructured": "Bylund, J., M. Bylund, and E.H. Oliw (2001). cDNA cloning and expression of CYP4F12, a novel human cytochrome P450. Biochem. Biophys. Res. Commun. 280, 892\u2013897.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR995", "doi-asserted-by": "publisher", "first-page": "1135", "DOI": "10.1006/bbrc.2000.4238", "volume": "280", "author": "T. Hashizume", "year": "2001", "unstructured": "Hashizume, T., S. Imaoka, T. Hiroi, Y. Terauchi, T. Fujii, H. Miyazaki et al. (2001). cDNA cloning and expression of a novel cytochrome P450 (CYP4F12) from human small intestine. Biochem. Biophys. Res. Commun. 280, 1135\u20131141.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR996", "doi-asserted-by": "publisher", "first-page": "298", "DOI": "10.1124/jpet.300.1.298", "volume": "300", "author": "T. Hashizume", "year": "2002", "unstructured": "Hashizume, T., S. Imaoka, M. Mise, Y. Terauchi, T. Fujii, H. Miyazaki et al. (2002). Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes. J. Pharmacol. Exp. Ther. 300, 298\u2013304.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR997", "doi-asserted-by": "publisher", "first-page": "677", "DOI": "10.1016/S0006-291X(02)00918-X", "volume": "296", "author": "J. Bylund", "year": "2002", "unstructured": "Bylund, J., C. Zhang, and D.R. Harder (2002). Identification of a novel cytochrome P450, CYP4X1, with unique localization specific to the brain. Biochem. Biophys. Res. Commun. 296, 677\u2013684.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR998", "doi-asserted-by": "publisher", "first-page": "45", "DOI": "10.1016/S0003-9861(02)00410-1", "volume": "409", "author": "V. Ullrich", "year": "2003", "unstructured": "Ullrich, V. (2003). Thoughts on thiolate tethering. Tribute and thanks to a teacher. Arch. Biochem. Biophys. 409, 45\u201351.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR999", "doi-asserted-by": "publisher", "first-page": "1479", "DOI": "10.1016/0006-291X(91)91060-P", "volume": "178", "author": "C. Yokoyama", "year": "1991", "unstructured": "Yokoyama, C., A. Miyata, H. Ihara, V. Ullrich, and T. Tanabe (1991). Molecular cloning of human platelet thromboxane A synthase. Biochem. Biophys. Res. Commun. 178, 1479\u20131484.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1000", "doi-asserted-by": "publisher", "first-page": "131", "DOI": "10.1111/j.1432-1033.1992.tb16910.x", "volume": "206", "author": "R. Nusing", "year": "1992", "unstructured": "Nusing, R. and V. Ullrich (1992). Regulation of cyclooxygenase and thromboxane synthase in human monocytes. Eur. J. Biochem. 206, 131\u2013136.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR1001", "doi-asserted-by": "publisher", "first-page": "869", "DOI": "10.1093/rheumatology/41.8.869", "volume": "41", "author": "V. Young", "year": "2002", "unstructured": "Young, V., M. Ho, H. Vosper, J.J. Belch, and C.N. Palmer (2002). Elevated expression of the genes encoding TNF-\u03b1 and thromboxane synthase in leucocytes from patients with systemic sclerosis. Rheumatology 41, 869\u2013875.", "journal-title": "Rheumatology"}, {"key": "10_CR1002", "doi-asserted-by": "publisher", "first-page": "69", "DOI": "10.1007/BF00197395", "volume": "424", "author": "R. Nusing", "year": "1994", "unstructured": "Nusing, R., P.M. Fehr, F. Gudat, E. Kemeny, M.J. Mihatsch, and V. Ullrich (1994). The localization of thromboxane synthase in normal and pathological human kidney tissue using a monoclonal antibody Tu 300. Virchows Arch. 424, 69\u201374.", "journal-title": "Virchows Arch."}, {"key": "10_CR1003", "doi-asserted-by": "publisher", "first-page": "161", "DOI": "10.1016/0014-5793(92)80990-X", "volume": "306", "author": "H. Ihara", "year": "1992", "unstructured": "Ihara, H., C. Yokoyama, A. Miyata, T. Kosaka, R. Nusing, V. Ullrich et al. (1992). Induction of thromboxane synthase and prostaglandin endoperoxide synthase mRNAs in human erythroleukemia cells by phorbol ester. FEBS Lett. 306, 161\u2013164.", "journal-title": "FEBS Lett."}, {"key": "10_CR1004", "doi-asserted-by": "publisher", "first-page": "22497", "DOI": "10.1074/jbc.M111058200", "volume": "277", "author": "M. Yaekashiwa", "year": "2002", "unstructured": "Yaekashiwa, M. and L.H. Wang (2002). Transcriptional control of the human thromboxane synthase gene in vivo and in vitro. J. Biol. Chem. 277, 22497\u201322508.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1005", "first-page": "61", "volume": "432", "author": "D. Chevalier", "year": "2001", "unstructured": "Chevalier, D., J.M. Lo-Guidice, E. Sergent, D. Allorge, H. Debuysere, N. Ferrari et al. (2001). Identification of genetic variants in the human thromboxane synthase gene (CYP5A1). Mutat. Res. 432, 61\u201367.", "journal-title": "Mutat. Res."}, {"key": "10_CR1006", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1016/0262-1746(83)90114-2", "volume": "11", "author": "V. Ullrich", "year": "1983", "unstructured": "Ullrich, V. and M. Haurand (1983). Thromboxane synthase as a cytochrome P450 enzyme. Adv. Prostaglandin Thromboxane Leukot. Res. 11, 105\u2013110.", "journal-title": "Adv. Prostaglandin Thromboxane Leukot. Res."}, {"key": "10_CR1007", "first-page": "15059", "volume": "260", "author": "M. Haurand", "year": "1985", "unstructured": "Haurand, M. and V. Ullrich (1985). Isolation and characterization of thromboxane synthase from human platelets as a cytochrome P-450 enzyme. J. Biol. Chem. 260, 15059\u201315067.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1008", "doi-asserted-by": "publisher", "first-page": "91", "DOI": "10.1016/0014-5793(93)81335-W", "volume": "318", "author": "C. Yokoyama", "year": "1993", "unstructured": "Yokoyama, C., A. Miyata, K. Suzuki, Y. Nishikawa, T. Yoshimoto, S. Yamamoto et al. (1993). Expression of human thromboxane synthase using a baculovirus system. FEBS Lett. 318, 91\u201394.", "journal-title": "FEBS Lett."}, {"key": "10_CR1009", "doi-asserted-by": "publisher", "first-page": "124", "DOI": "10.1016/0003-9861(87)90088-9", "volume": "254", "author": "M. Hecker", "year": "1987", "unstructured": "Hecker, M., M. Haurand, V. Ullrich, U. Diczfalusy, and S. Hammarstrom (1987). Products, kinetics, and substrate specificity of homogeneous thromboxane synthase from human platelets: Development of a novel enzyme assay. Arch. Biochem. Biophys. 254, 124\u2013135.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1010", "doi-asserted-by": "publisher", "first-page": "563", "DOI": "10.1111/j.1432-1033.1987.tb13646.x", "volume": "169", "author": "M. Hecker", "year": "1987", "unstructured": "Hecker, M., W.J. Baader, P. Weber, and V. Ullrich (1987). Thromboxane synthase catalyses hydroxylation of prostaglandin H2 analogs in the presence of iodosylbenzene. Eur. J. Biochem. 169, 563\u2013569.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR1011", "first-page": "141", "volume": "264", "author": "M. Hecker", "year": "1989", "unstructured": "Hecker, M. and V. Ullrich (1989). On the mechanism of prostacyclin and thromboxane A2 biosynthesis. J. Biol. Chem. 264, 141\u2013150.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1012", "doi-asserted-by": "publisher", "first-page": "107", "DOI": "10.1016/0014-5793(77)80896-X", "volume": "82", "author": "U.D. Alusy", "year": "1977", "unstructured": "Alusy, U.D. and S. Hammarstrom (1977). Inhibitors of thromboxane synthase in human platelets. FEBS Lett. 82, 107\u2013110.", "journal-title": "FEBS Lett."}, {"key": "10_CR1013", "doi-asserted-by": "publisher", "first-page": "4007", "DOI": "10.1073/pnas.74.9.4007", "volume": "74", "author": "R.R. Gorman", "year": "1977", "unstructured": "Gorman, R.R., G.L. Bundy, D.C. Peterson, F.F. Sun, O.V. Miller, and F.A. Fitzpatrick (1977). Inhibition of human platelet thromboxane synthetase by 9,11-azoprosta-5,13-dienoic acid. Proc. Natl. Acad. Sci. USA 74, 4007\u20134011.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1014", "first-page": "27", "volume": "4", "author": "J.R. Vane", "year": "1978", "unstructured": "Vane, J.R. (1978). Inhibitors of prostaglandin, prostacyclin, and thromboxane synthesis. Adv. Prostaglandin Thromboxane Res. 4, 27\u201344.", "journal-title": "Adv. Prostaglandin Thromboxane Res."}, {"key": "10_CR1015", "doi-asserted-by": "publisher", "first-page": "217", "DOI": "10.1111/j.1432-1033.1986.tb09659.x", "volume": "157", "author": "M. Hecker", "year": "1986", "unstructured": "Hecker, M., M. Haurand, V. Ullrich, and S. Terao (1986). Spectral studies on structure-activity relationships of thromboxane synthase inhibitors. Eur. J. Biochem. 157, 217\u2013223.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR1016", "doi-asserted-by": "publisher", "first-page": "618", "DOI": "10.1124/jpet.301.2.618", "volume": "301", "author": "C.R. Pace-Asciak", "year": "2002", "unstructured": "Pace-Asciak, C.R., D. Reynaud, P. Demin, R. Aslam, and A. Sun (2002). A new family of thromboxane receptor antagonists with secondary thromboxane synthase inhibition. J. Pharmacol. Exp. Ther. 301, 618\u2013624.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR1017", "doi-asserted-by": "crossref", "first-page": "1087", "DOI": "10.1093/oxfordjournals.jbchem.a121973", "volume": "101", "author": "N. Miki", "year": "1987", "unstructured": "Miki, N., R. Miura, and Y. Miyake (1987). Purification and characterization of cholesterol 7\u03b1-hydroxylase cytochrome P-450 of untreated rabbit liver microsomes. J. Biochem. (Tokyo) 101, 1087\u20131094.", "journal-title": "J. Biochem. (Tokyo)"}, {"key": "10_CR1018", "first-page": "7646", "volume": "262", "author": "T. Ogishima", "year": "1987", "unstructured": "Ogishima, T., S. Deguchi, and K. Okuda (1987). Purification and characterization of cholesterol 7\u03b1-hydroxylase from rat liver microsomes. J. Biol. Chem. 262, 7646\u20137650.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1019", "first-page": "4541", "volume": "265", "author": "L.B. Nguyen", "year": "1990", "unstructured": "Nguyen, L.B., S. Shefer, G. Salen, G. Ness, R.D. Tanaka, V. Packin et al. (1990). Purification of cholesterol 7\u03b1-hydroxylase from human and rat liver and production of inhibiting polyclonal antibodies. J. Biol. Chem. 265, 4541\u20134546.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1020", "doi-asserted-by": "publisher", "first-page": "137", "DOI": "10.1016/0014-5793(90)80992-R", "volume": "268", "author": "M. Noshiro", "year": "1990", "unstructured": "Noshiro, M. and K. Okuda (1990). Molecular cloning and sequence analysis of cDNA encoding human cholesterol 7 \u03b1-hydroxylase. FEBS Lett. 268, 137\u2013140.", "journal-title": "FEBS Lett."}, {"key": "10_CR1021", "first-page": "12012", "volume": "265", "author": "Y.C. Li", "year": "1990", "unstructured": "Li, Y.C., D.P. Wang, and J.Y.L. Chiang (1990). Regulation of cholesterol 7\u03b1-hydroxylase in the liver: Cloning, sequencing, and regulation of cholesterol 7\u03b1-hydroxylase mRNA. J. Biol. Chem. 265, 12012\u201312019.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1022", "first-page": "8190", "volume": "265", "author": "D.F. Jelinek", "year": "1990", "unstructured": "Jelinek, D.F., S. Andersson, C.A. Slaughter, and D.W. Russell (1990). Cloning and regulation of cholesterol 7\u03b1-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis. J. Biol. Chem. 265, 8190\u20138197.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1023", "doi-asserted-by": "publisher", "first-page": "153", "DOI": "10.1016/S0888-7543(05)80298-8", "volume": "14", "author": "J.C. Cohen", "year": "1992", "unstructured": "Cohen, J.C., J.J. Cali, D.F. Jelinek, M. Mehrabian, R.S. Sparkes, A.J. Lusis et al. (1992). Cloning of the human cholesterol 7\u03b1-hydroxylase gene (CYP7) and localization to chromosome 8q11\u2013q12. Genomics 14, 153\u2013161.", "journal-title": "Genomics"}, {"key": "10_CR1024", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1016/0167-4781(93)90281-H", "volume": "1172", "author": "M. Nishimoto", "year": "1993", "unstructured": "Nishimoto, M., M. Noshiro, and K. Okuda (1993). Structure of the gene encoding human liver cholesterol 7\u03b1-hydroxylase. Biochim. Biophys. Acta 1172, 147\u2013150.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "10_CR1025", "doi-asserted-by": "publisher", "first-page": "320", "DOI": "10.1006/geno.1994.1177", "volume": "20", "author": "D.P. Wang", "year": "1994", "unstructured": "Wang, D.P. and J.Y. Chiang (1994). Structure and nucleotide sequences of the human cholesterol 7\u03b1-hydroxylase gene (CYP7). Genomics 20, 320\u2013323.", "journal-title": "Genomics"}, {"key": "10_CR1026", "doi-asserted-by": "crossref", "first-page": "1497", "DOI": "10.1172/JCI117821", "volume": "95", "author": "G. Xu", "year": "1995", "unstructured": "Xu, G., G. Salen, S. Shefer, G.C. Ness, L.B. Nguyen, T.S. Parker et al. (1995). Unexpected inhibition of cholesterol 7\u03b1-hydroxylase by cholesterol in New Zealand white and Watanabe heritable hyperlipidemic rabbits. J. Clin. Invest. 95, 1497\u20131504.", "journal-title": "J. Clin. Invest."}, {"key": "10_CR1027", "doi-asserted-by": "publisher", "first-page": "705", "DOI": "10.1111/j.1432-1033.1993.tb18082.x", "volume": "215", "author": "O. Breuer", "year": "1993", "unstructured": "Breuer, O., E. Sudjana-Sugiaman, G. Eggertsen, J.Y. Chiang, and I. Bj\u00f6rkhem (1993). Cholesterol 7\u03b1-hydroxylase is up-regulated by the competitive inhibitor 7-oxocholesterol in rat liver. Eur. J. Biochem. 215, 705\u2013710.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR1028", "doi-asserted-by": "publisher", "first-page": "1085", "DOI": "10.1093/carcin/15.6.1085", "volume": "15", "author": "A. Shibata", "year": "1994", "unstructured": "Shibata, A., P.F. Ohneseit, Y.C. Tsai, C.H. Spruck, III, P.W. Nichols, H.S. Chiang et al. (1994). Mutational spectrum in the p53 gene in bladder tumors from the endemic area of black foot disease in Taiwan. Carcinogenesis 15, 1085\u20131087.", "journal-title": "Carcinogenesis"}, {"key": "10_CR1029", "doi-asserted-by": "publisher", "first-page": "18024", "DOI": "10.1074/jbc.271.30.18024", "volume": "271", "author": "M. Schwarz", "year": "1996", "unstructured": "Schwarz, M., E.G. Lund, K.D. Setchell, H.J. Kayden, J.E. Zerwekh, I. Bjorkhem et al. (1996). Disruption of cholesterol 7\u03b1-hydroxylase gene in mice. II. Bile acid deficiency is overcome by induction of oxysterol 7\u03b1-hydroxylase. J. Biol. Chem. 271, 18024\u201318031.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1030", "doi-asserted-by": "publisher", "first-page": "3137", "DOI": "10.1074/jbc.272.6.3137", "volume": "272", "author": "J.M. Lehmann", "year": "1997", "unstructured": "Lehmann, J.M., S.A. Kliewer, L.B. Moore, T.A. Smith-Oliver, B.B. Oliver, J.L. Su et al. (1997). Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272, 3137\u20133140.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1031", "doi-asserted-by": "publisher", "first-page": "693", "DOI": "10.1016/S0092-8674(00)81432-4", "volume": "93", "author": "D.J. Peet", "year": "1998", "unstructured": "Peet, D.J., S.D. Turley, W. Ma, B.A. Janowski, J.M. Lobaccaro, R.E. Hammer et al. (1998). Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR\u03b1. Cell 93, 693\u2013704.", "journal-title": "Cell"}, {"key": "10_CR1032", "doi-asserted-by": "publisher", "first-page": "539", "DOI": "10.1016/S0092-8674(00)80763-1", "volume": "97", "author": "D.W. Russell", "year": "1999", "unstructured": "Russell, D.W. (1999). Nuclear orphan receptors control cholesterol catabolism. Cell 97, 539\u2013542.", "journal-title": "Cell"}, {"key": "10_CR1033", "doi-asserted-by": "publisher", "first-page": "1362", "DOI": "10.1126/science.284.5418.1362", "volume": "284", "author": "M. Makishima", "year": "1999", "unstructured": "Makishima, M., A.Y. Okamoto, J.J. Repa, H. Tu, R.M. Learned, A. Luk et al. (1999). Identification of a nuclear receptor for bile acids. Science 284, 1362\u20131365.", "journal-title": "Science"}, {"key": "10_CR1034", "doi-asserted-by": "publisher", "first-page": "6669", "DOI": "10.1073/pnas.96.12.6660", "volume": "96", "author": "M. Nitta", "year": "1999", "unstructured": "Nitta, M., S. Ku, C. Brown, A.Y. Okamoto, and B. Shan (1999). CPF: An orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7\u03b1-hydroxylase gene. Proc. Natl. Acad. Sci. USA 96, 6669\u20136665.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1035", "doi-asserted-by": "publisher", "first-page": "10918", "DOI": "10.1074/jbc.275.15.10918", "volume": "275", "author": "J.Y. Chiang", "year": "2000", "unstructured": "Chiang, J.Y., R. Kimmel, C. Weinberger, and D. Stroup (2000). Farnesoid X receptor responds to bile acids and represses cholesterol 7\u03b1-hydroxylase gene (CYP7A1) transcription. J. Biol. Chem. 275, 10918\u201310924.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1036", "doi-asserted-by": "publisher", "first-page": "3369", "DOI": "10.1073/pnas.051551698", "volume": "98", "author": "J.L. Staudinger", "year": "2001", "unstructured": "Staudinger, J.L., B. Goodwin, S.A. Jones, D. Hawkins-Brown, K.I. MacKenzie, A. LaTour et al. (2001). The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl. Acad. Sci. USA 98, 3369\u20133374.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1037", "doi-asserted-by": "publisher", "first-page": "338", "DOI": "10.1016/S0006-291X(02)00229-2", "volume": "293", "author": "S. Gupta", "year": "2002", "unstructured": "Gupta, S., W.M. Pandak, and P.B. Hylemon (2002). LXR\u03b1 is the dominant regulator of CYP7A1 transcription. Biochem. Biophys. Res. Commun. 293, 338\u2013343.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1038", "doi-asserted-by": "publisher", "first-page": "747", "DOI": "10.1042/0264-6021:3510747", "volume": "351", "author": "D.D. Patel", "year": "2000", "unstructured": "Patel, D.D., B.L. Knight, A.K. Soutar, G.F. Gibbons, and D.P. Wade (2000). The effect of peroxisome-proliferator-activated receptor-\u03b1 on the activity of the cholesterol 7\u03b1-hydroxylase gene. Biochem. J. 351, 747\u2013753.", "journal-title": "Biochem. J."}, {"key": "10_CR1039", "doi-asserted-by": "publisher", "first-page": "12530", "DOI": "10.1074/jbc.275.17.12530", "volume": "275", "author": "S.K. Cheema", "year": "2000", "unstructured": "Cheema, S.K. and L.B. Agellon (2000). The murine and human cholesterol 7\u03b1-hydroxylase gene promoters are differentially responsive to regulation by fatty acids mediated via peroxisome proliferator-activated receptor \u03b1. J. Biol. Chem. 275, 12530\u201312536.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1040", "doi-asserted-by": "crossref", "first-page": "14", "DOI": "10.1124/mol.53.1.14", "volume": "53", "author": "C.N.a. Palmer", "year": "1998", "unstructured": "Palmer, C.N.a., M.H. Hsu, K.J. Griffin, J.L. Raucy, and E.F. Johnson (1998). Peroxisome proliferator activated receptor-\u03b1 expression in human liver. Mol. Pharmacol. 53, 14\u201322.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR1041", "first-page": "514", "volume": "41", "author": "M. Marrapodi", "year": "2000", "unstructured": "Marrapodi, M. and J.Y. Chiang (2000). Peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1) and agonist inhibit cholesterol 7\u03b1-hydroxylase gene (CYP7A1) transcription. J. Lipid Res. 41, 514\u2013520.", "journal-title": "J. Lipid Res."}, {"key": "10_CR1042", "doi-asserted-by": "publisher", "first-page": "30708", "DOI": "10.1074/jbc.M103270200", "volume": "276", "author": "E. Fabiani De", "year": "2001", "unstructured": "De Fabiani, E., N. Mitro, A.C. Anzulovich, A. Pinelli, G. Galli, and M. Crestani (2001). The negative effects of bile acids and tumor necrosis factor-\u03b1 on the transcription of cholesterol 7\u03b1-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4: A novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. J. Biol. Chem. 276, 30708\u201330716.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1043", "first-page": "223", "volume": "37", "author": "K.R. Feingold", "year": "1996", "unstructured": "Feingold, K.R., D.K. Spady, A.S. Pollock, A.H. Moser, and C. Grunfeld (1996). Endotoxin, TNF, and IL-1 decrease cholesterol 7\u03b1-hydroxylase mRNA levels and activity. J. Lipid Res. 37, 223\u2013228.", "journal-title": "J. Lipid Res."}, {"key": "10_CR1044", "doi-asserted-by": "publisher", "first-page": "14", "DOI": "10.1210/me.16.1.14", "volume": "16", "author": "V.A. Drover", "year": "2002", "unstructured": "Drover, V.A., N.C. Wong, and L.B. Agellon (2002). A distinct thyroid hormone response element mediates repression of the human cholesterol 7\u03b1-hydroxylase (CYP7A1) gene promoter. Mol. Endocrinol., 16 14\u201323.", "journal-title": "Mol. Endocrinol."}, {"key": "10_CR1045", "doi-asserted-by": "publisher", "first-page": "26804", "DOI": "10.1074/jbc.M202343200", "volume": "277", "author": "I. Bj\u00f6rkhem", "year": "2002", "unstructured": "Bj\u00f6rkhem, I., Z. Araya, M. Rudling, B. Angelin, C. Einarsson, and K. Wikvall (2002). Differences in the regulation of the classical and the alternative pathway for bile acid synthesis in human liver. No coordinate regulation of CYP7A1 and CYP27A1. J. Biol. Chem. 277, 26804\u201326807.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1046", "first-page": "1831", "volume": "37", "author": "D. Wang", "year": "1996", "unstructured": "Wang, D., D. Stroup, M. Marrapodi, M. Crestani, G. Galli, and J.Y.L. Chiang (1996). Transcriptional regulation of the human cholesterol 7\u03b1-hydroxylase gene (CYP7A) in HepG2 cells. J. Lipid Res. 37, 1831\u20131841.", "journal-title": "J. Lipid Res."}, {"key": "10_CR1047", "doi-asserted-by": "crossref", "first-page": "300", "DOI": "10.1016/0005-2760(91)90072-P", "volume": "1084", "author": "R.S. Kushwaha", "year": "1991", "unstructured": "Kushwaha, R.S. and K.M. Born (1991). Effect of estrogen and progesterone on the hepatic cholesterol 7\u03b1-hydroxylase activity in ovariectomized baboons. Biochim. Biophys. Acta 1084, 300\u2013302.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "10_CR1048", "doi-asserted-by": "publisher", "first-page": "585", "DOI": "10.1006/bbrc.1996.1215", "volume": "225", "author": "M. Crestani", "year": "1996", "unstructured": "Crestani, M., A. Sadeghpour, D. Stroup, G. Galli, and J.Y. Chiang (1996). The opposing effects of retinoic acid and phorbol esters converge to a common response element in the promoter of the rat cholesterol 7\u03b1-hydroxylase gene (CYP7A). Biochem. Biophys. Res. Commun. 225, 585\u2013592.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1049", "doi-asserted-by": "publisher", "first-page": "454", "DOI": "10.1006/bbrc.1999.1799", "volume": "266", "author": "S.A. Goodart", "year": "1999", "unstructured": "Goodart, S.A., C. Huynh, W. Chen, A.D. Cooper, and B. Levy-Wilson (1999). Expression of the human cholesterol 7\u03b1-hydroxylase gene in transgenic mice. Biochem. Biophys. Res. Commun. 266, 454\u2013459.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1050", "doi-asserted-by": "publisher", "first-page": "42588", "DOI": "10.1074/jbc.M205117200", "volume": "277", "author": "J.Y. Chen", "year": "2002", "unstructured": "Chen, J.Y., B. Levy-Wilson, S. Goodart, and A.D. Cooper (2002). Mice expressing the human CYP7A1 gene in the mouse CYP7A1 knock-out background lack induction of CYP7A1 expression by cholesterol feeding and have increased hypercholesterolemia when fed a high fat diet. J. Biol. Chem. 277, 42588\u201342595.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1051", "doi-asserted-by": "crossref", "first-page": "1498", "DOI": "10.1016/0016-5085(89)90395-8", "volume": "97", "author": "E. Reihner", "year": "1989", "unstructured": "Reihner, E., I. Bj\u00f6rkhem, B. Angelin, S. Ewerth, and K. Einarsson (1989). Bile acid synthesis in humans: Regulation of hepatic microsomal cholesterol 7\u03b1-hydroxylase activity. Gastroenterology 97, 1498\u20131505.", "journal-title": "Gastroenterology"}, {"key": "10_CR1052", "doi-asserted-by": "publisher", "first-page": "267", "DOI": "10.1007/BF00340534", "volume": "36", "author": "D. Mayer", "year": "1976", "unstructured": "Mayer, D. (1976). The circadian rhythm of synthesis and catabolism of cholesterol. Arch. Toxicol. 36, 267\u2013276.", "journal-title": "Arch. Toxicol."}, {"key": "10_CR1053", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1111/j.1432-1033.1975.tb02136.x", "volume": "55", "author": "J. Gielen", "year": "1975", "unstructured": "Gielen, J., J. Van Cantfort, B. Robaye, and J. Renson (1975). Rat-liver cholesterol 7\u03b1-hydroxylase. 3. New results about its circadian rhythm. Eur. J. Biochem. 55, 41\u201348.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR1054", "doi-asserted-by": "publisher", "first-page": "46", "DOI": "10.1016/0006-291X(81)91658-2", "volume": "103", "author": "H. Danielsson", "year": "1981", "unstructured": "Danielsson, H. and K. Wikvall (1981). Evidence for a specific cytochrome P-450 with short half-life catalyzing 7\u03b1-hydroxylation of cholesterol. Biochem. Biophys. Res. Commun. 103, 46\u201351.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1055", "doi-asserted-by": "crossref", "first-page": "409", "DOI": "10.1016/0005-2760(78)90085-1", "volume": "529", "author": "F.H. Hulcher", "year": "1978", "unstructured": "Hulcher, F.H., R.D. Margolis, and D.J. Bowman (1978). Circadian rhythm of cholesterol-7\u03b1-hydroxylase and cortisol in the African green monkey (Cercopithecus aethiops). Biochim. Biophys. Acta 529, 409\u2013418.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "10_CR1056", "first-page": "3889", "volume": "265", "author": "J.Y. Chiang", "year": "1990", "unstructured": "Chiang, J.Y., W.F. Miller, and G.M. Lin (1990). Regulation of cholesterol 7 alpha-hydroxylase in the liver. Purification of cholesterol 7\u03b1-hydroxylase and the immunochemical evidence for the induction of cholesterol 7\u03b1-hydroxylase by cholestyramine and circadian rhythm. J. Biol. Chem. 265, 3889\u20133897.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1057", "doi-asserted-by": "publisher", "first-page": "377", "DOI": "10.1016/S0960-0760(02)00071-7", "volume": "81", "author": "M. Kinowaki", "year": "2002", "unstructured": "Kinowaki, M., S. Tanaka, Y. Maeda, S. Higashi, K. Okuda, and T. Setoguchi (2002). Half-life of cholesterol 7\u03b1-hydroxylase activity and enzyme mass differ in animals and humans when determined by a monoclonal antibody against human cholesterol 7\u03b1-hydroxylase. J. Steroid Biochem. Mol. Biol. 81, 377\u2013380.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10_CR1058", "first-page": "10036", "volume": "265", "author": "M. Noshiro", "year": "1990", "unstructured": "Noshiro, M., M. Nishimoto, and K. Okuda (1990). Rat liver cholesterol 7\u03b1-hydroxylase: Pretranslational regulation for circadian rhythm. J. Biol. Chem. 265, 10036\u201310041.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1059", "doi-asserted-by": "publisher", "first-page": "886", "DOI": "10.1016/0006-291X(81)90893-7", "volume": "103", "author": "A. Sanghvi", "year": "1981", "unstructured": "Sanghvi, A., E. Grassi, V. Warty, W. Diven, C. Wight, and R. Lester (1981). Reversible activation-inactivation of cholesterol 7\u03b1-hydroxylase possibly due to phosphorylation-dephosphorylation. Biochem. Biophys. Res. Commun. 103, 886\u2013892.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1060", "first-page": "4469", "volume": "257", "author": "C.D. Goodwin", "year": "1982", "unstructured": "Goodwin, C.D., B.W. Cooper, and S. Margolis (1982). Rat liver cholesterol 7\u03b1-hydroxylase: Modulation of enzyme activity by changes in phosphorylation state. J. Biol. Chem. 257, 4469\u20134472.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1061", "doi-asserted-by": "publisher", "first-page": "543", "DOI": "10.1016/0003-9861(87)90612-6", "volume": "256", "author": "E.J. Holsztynska", "year": "1987", "unstructured": "Holsztynska, E.J. and D.J. Waxman (1987). Cytochrome P-450 cholesterol 7\u03b1-hydroxylase: Inhibition of enzyme deactivation by structurally diverse calmodulin antagonists and phosphatase inhibitors. Arch. Biochem. Biophys. 256, 543\u2013559.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1062", "first-page": "1468", "volume": "24", "author": "L.B. Nguyen", "year": "1996", "unstructured": "Nguyen, L.B., S. Shefer, G. Salen, J.Y. Chiang, and M. Patel (1996). Cholesterol 7\u03b1-hydroxylase activities from human and rat liver are modulated in vitro posttranslationally by phosphorylation/dephosphorylation. Hepatology 24, 1468\u20131474.", "journal-title": "Hepatology"}, {"key": "10_CR1063", "doi-asserted-by": "publisher", "first-page": "588", "DOI": "10.1016/0006-291X(92)91665-D", "volume": "185", "author": "W.G. Karam", "year": "1992", "unstructured": "Karam, W.G. and J.Y.L. Chiang (1992). Plymorphisms of human cholesterol 7\u03b1-hydroxylase. Biochem. Biophys. Res. Commun. 185, 588\u2013595.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1064", "doi-asserted-by": "crossref", "first-page": "1690", "DOI": "10.1172/JCI2962", "volume": "102", "author": "K.D. Setchell", "year": "1998", "unstructured": "Setchell, K.D., M. Schwarz, N.C. O\u2019Connell, E.G. Lund, D.L. Davis, R. Lathe et al. (1998). Identification of a new inborn error in bile acid synthesis: Mutation of the oxysterol 7\u03b1-hydroxylase gene causes severe neonatal liver disease. J. Clin. Invest. 102, 1690\u20131703.", "journal-title": "J. Clin. Invest."}, {"key": "10_CR1065", "doi-asserted-by": "publisher", "first-page": "579", "DOI": "10.1016/S0021-9150(00)00419-6", "volume": "154", "author": "R.A. Hegele", "year": "2001", "unstructured": "Hegele, R.A., J. Wang, S.B. Harris, J.H. Brunt, T.K. Young, A.J. Hanley et al. (2001). Variable association between genetic variation in the CYP7 gene promoter and plasma lipoproteins in three Canadian populations. Atherosclerosis 154, 579\u2013587.", "journal-title": "Atherosclerosis"}, {"key": "10_CR1066", "doi-asserted-by": "crossref", "first-page": "172", "DOI": "10.1016/0005-2760(75)90180-0", "volume": "398", "author": "S. Balasubramaniam", "year": "1975", "unstructured": "Balasubramaniam, S., K.A. Mitropoulos, and N.B. Myant (1975). The substrate for cholesterol 7\u03b1-hydroxylase. Biochim. Biophys. Acta 398, 172\u2013177.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "10_CR1067", "first-page": "1629", "volume": "41", "author": "M. Norlin", "year": "2000", "unstructured": "Norlin, M., A. Toll, I. Bj\u00f6rkhem, and K. Wikvall (2000). 24-hydroxycholesterol is a substrate for hepatic cholesterol 7\u03b1-hydroxylase (CYP7A). J. Lipid Res. 41, 1629\u20131639.", "journal-title": "J. Lipid Res."}, {"key": "10_CR1068", "doi-asserted-by": "publisher", "first-page": "34046", "DOI": "10.1074/jbc.M002663200", "volume": "275", "author": "M. Norlin", "year": "2000", "unstructured": "Norlin, M., U. Andersson, I. Bj\u00f6rkhem, and K. Wikvall (2000). Oxysterol 7\u03b1-hydroxylase activity by cholesterol 7\u03b1-hydroxylase (CYP7A). J. Biol. Chem. 275, 34046\u201334053.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1069", "doi-asserted-by": "publisher", "first-page": "967", "DOI": "10.1016/S0039-128X(02)00044-2", "volume": "67", "author": "R. Lathe", "year": "2002", "unstructured": "Lathe, R. (2002). Steroid and sterol 7-hydroxylation: Ancient pathways. Steroids 67, 967\u2013977.", "journal-title": "Steroids"}, {"key": "10_CR1070", "doi-asserted-by": "publisher", "first-page": "31459", "DOI": "10.1074/jbc.M103943200", "volume": "276", "author": "K. Nakayama", "year": "2001", "unstructured": "Nakayama, K., A. Puchkaev, and I.A. Pikuleva (2001). Membrane binding and substrate access merge in cytochrome P450 7A1, a key enzyme in degradation of cholesterol. J. Biol. Chem. 276, 31459\u201331465.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1071", "doi-asserted-by": "publisher", "first-page": "1447", "DOI": "10.1002/hep.510250623", "volume": "25", "author": "D. Stahlberg", "year": "1997", "unstructured": "Stahlberg, D., M. Rudling, B. Angelin, I. Bj\u00f6rkhem, P. Forsell, K. Nilsell et al. (1997). Hepatic cholesterol metabolism in human obesity. Hepatology 25, 1447\u20131450.", "journal-title": "Hepatology"}, {"key": "10_CR1072", "doi-asserted-by": "crossref", "first-page": "3064", "DOI": "10.1161/01.ATV.17.11.3064", "volume": "17", "author": "S.M. Post", "year": "1997", "unstructured": "Post, S.M., E.C. de Wit, and H.M. Princen (1997). Cafestol, the cholesterol-raising factor in boiled coffee, suppresses bile acid synthesis by downregulation of cholesterol 7\u03b1-hydroxylase and sterol 27-hydroxylase in rat hepatocytes. Arterioscler. Thromb. Vasc. Biol. 17, 3064\u20133070.", "journal-title": "Arterioscler. Thromb. Vasc. Biol."}, {"key": "10_CR1073", "doi-asserted-by": "crossref", "first-page": "G878", "DOI": "10.1152/ajpgi.2001.281.4.G878", "volume": "281", "author": "W.M. Pandak", "year": "2001", "unstructured": "Pandak, W.M., C. Schwarz, P.B. Hylemon, D. Mallonee, K. Valerie, D.M. Heuman et al. (2001). Effects of CYP7A1 overexpression on cholesterol and bile acid homeostasis. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G878\u2013G889.", "journal-title": "Am. J. Physiol. Gastrointest. Liver Physiol."}, {"key": "10_CR1074", "doi-asserted-by": "crossref", "first-page": "176", "DOI": "10.1055/s-2007-979016", "volume": "29", "author": "G. Sauter", "year": "1997", "unstructured": "Sauter, G., M. Weiss, and R. Hoermann (1997). Cholesterol 7\u03b1-hydroxylase activity in hypothyroidism and hyperthyroidism in humans. Horm. Metab. Res. 29, 176\u2013179.", "journal-title": "Horm. Metab. Res."}, {"key": "10_CR1075", "doi-asserted-by": "publisher", "first-page": "109", "DOI": "10.1172/JCI200215387", "volume": "110", "author": "C.R. Pullinger", "year": "2002", "unstructured": "Pullinger, C.R., C. Eng, G. Salen, S. Shefer, A.K. Batta, S.K. Erickson et al. (2002). Human cholesterol 7\u03b1-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J. Clin. Invest. 110, 109\u2013117.", "journal-title": "J. Clin. Invest."}, {"key": "10_CR1076", "doi-asserted-by": "publisher", "first-page": "29", "DOI": "10.1172/JCI200216076", "volume": "110", "author": "A. Beigneux", "year": "2002", "unstructured": "Beigneux, A., A.F. Hofmann, and S.G. Young (2002). Human CYP7A1 deficiency: Progress and enigmas. J. Clin. Invest. 110, 29\u201331.", "journal-title": "J. Clin. Invest."}, {"key": "10_CR1077", "doi-asserted-by": "publisher", "first-page": "29739", "DOI": "10.1074/jbc.270.50.29739", "volume": "270", "author": "G. Stapleton", "year": "1995", "unstructured": "Stapleton, G., M. Steel, M. Richardson, J.O. Mason, K.A. Rose, R.G.M. Morris et al. (1995). A novel cytochrome P450 expressed primarily in brain. J. Biol. Chem. 270, 29739\u201329745.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1078", "doi-asserted-by": "publisher", "first-page": "4925", "DOI": "10.1073/pnas.94.10.4925", "volume": "94", "author": "K.A. Rose", "year": "1997", "unstructured": "Rose, K.A., G. Stapleton, K. Dott, M.P. Kieny, R. Best, M. Schwarz et al. (1997). Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7\u03b1-hydroxy dehydroepiandrosterone and 7\u03b1-hydroxy pregnenolone. Proc. Natl. Acad. Sci. USA 94, 4925\u20134930.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1079", "doi-asserted-by": "publisher", "first-page": "23937", "DOI": "10.1074/jbc.M011564200", "volume": "276", "author": "K. Rose", "year": "2001", "unstructured": "Rose, K., A. Allan, S. Gauldie, G. Stapleton, L. Dobbie, K. Dott et al. (2001). Neurosteroid hydroxylase CYP7B: Vivid reporter activity in dentate gyrus of gene-targeted mice and abolition of a widespread pathway of steroid and oxysterol hydroxylation. J. Biol. Chem. 276, 23937\u201323944.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1080", "doi-asserted-by": "crossref", "first-page": "271", "DOI": "10.1093/oxfordjournals.bmb.a071832", "volume": "39", "author": "S. Bunting", "year": "1983", "unstructured": "Bunting, S., S. Moncada, and J.R. Vane (1983). The prostacyclin-thromboxane A2 balance: Pathophysiological and therapeutic implications. Br. Med. Bull. 39, 271\u2013276.", "journal-title": "Br. Med. Bull."}, {"key": "10_CR1081", "doi-asserted-by": "publisher", "first-page": "1728", "DOI": "10.1006/bbrc.1994.1652", "volume": "200", "author": "A. Miyata", "year": "1994", "unstructured": "Miyata, A., S. Hara, C. Yokoyama, H. Inoue, V. Ullrich, and T. Tanabe (1994). Molecular cloning and expression of human prostacyclin synthase. Biochem. Biophys. Res. Commun. 200, 1728\u20131734.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1082", "doi-asserted-by": "publisher", "first-page": "2033", "DOI": "10.1016/0006-2952(81)90218-5", "volume": "30", "author": "V. Ullrich", "year": "1981", "unstructured": "Ullrich, V., L. Castle, and P. Weber (1981). Spectral evidence for the cytochrome P450 nature of prostacyclin synthetase. Biochem. Pharmacol. 30, 2033\u20132036.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR1083", "first-page": "3285", "volume": "258", "author": "D.L. DeWitt", "year": "1983", "unstructured": "DeWitt, D.L. and W.L. Smith (1983). Purification of prostacyclin synthase from bovine aorta by immunoaffinity chromatography. Evidence that the enzyme is a hemoprotein. J. Biol. Chem. 258, 3285\u20133293.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1084", "first-page": "19897", "volume": "269", "author": "S. Hara", "year": "1994", "unstructured": "Hara, S., A. Miyata, C. Yokoyama, H. Inoue, R. Brugger, F. Lottspeich et al. (1994). Isolation and molecular cloning of prostacyclin synthase from bovine endothelial cells. J. Biol. Chem. 269, 19897\u201319903.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1085", "doi-asserted-by": "publisher", "first-page": "507", "DOI": "10.1006/excr.1995.1259", "volume": "219", "author": "E. Spisni", "year": "1995", "unstructured": "Spisni, E., G. Bartolini, M. Orlandi, B. Belletti, S. Santi, and V. Tomasi (1995). Prostacyclin (PG12) synthase is a constitutively expressed enzyme in human endothelial cells. Exp. Cell Res. 219, 507\u2013513.", "journal-title": "Exp. Cell Res."}, {"key": "10_CR1086", "doi-asserted-by": "publisher", "first-page": "187", "DOI": "10.1016/S0304-3940(99)00558-3", "volume": "271", "author": "M. Mehl", "year": "1999", "unstructured": "Mehl, M., H.J. Bidmon, H. Hilbig, K. Zilles, R. Dringen, and V. Ullrich (1999). Prostacyclin synthase is localized in rat, bovine and human neuronal brain cells. Neurosci. Lett. 271, 187\u2013190.", "journal-title": "Neurosci. Lett."}, {"key": "10_CR1087", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.1177/002215540004800507", "volume": "48", "author": "I. Siegle", "year": "2000", "unstructured": "Siegle, I., T. Klein, M.H. Zou, P. Fritz, and M. Komhoff (2000). Distribution and cellular localization of prostacyclin synthase in human brain. J. Histochem. Cytochem. 48, 631\u2013641.", "journal-title": "J. Histochem. Cytochem."}, {"key": "10_CR1088", "doi-asserted-by": "publisher", "first-page": "4361", "DOI": "10.1210/jc.2002-020199", "volume": "87", "author": "J.C. Huang", "year": "2002", "unstructured": "Huang, J.C., F. Arbab, K.J. Tumbusch, J.S. Goldsby, N. Matijevic-Aleksic, and K.K. Wu (2002). Human fallopian tubes express prostacyclin (PGI) synthase and cyclooxygenases and synthesize abundant PGI. J. Clin. Endocrinol. Metab. 87, 4361\u20134368.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1089", "doi-asserted-by": "publisher", "first-page": "296", "DOI": "10.1006/geno.1996.0465", "volume": "36", "author": "C. Yokoyama", "year": "1996", "unstructured": "Yokoyama, C., T. Yabuki, H. Inoue, Y. Tone, S. Hara, T. Hatae et al. (1996). Human gene encoding prostacyclin synthase (PTGIS): Genomic organization, chromosomal localization, and promoter activity. Genomics 36, 296\u2013304.", "journal-title": "Genomics"}, {"key": "10_CR1090", "doi-asserted-by": "publisher", "first-page": "803", "DOI": "10.1006/bbrc.1996.0677", "volume": "221", "author": "T. Nakayama", "year": "1996", "unstructured": "Nakayama, T., M. Soma, Y. Izumi, and K. Kanmatsuse (1996). Organization of the human prostacyclin synthase gene. Biochem. Biophys. Res. Commun. 221, 803\u2013806.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1091", "doi-asserted-by": "publisher", "first-page": "631", "DOI": "10.1006/bbrc.1996.1407", "volume": "226", "author": "L.H. Wang", "year": "1996", "unstructured": "Wang, L.H. and L. Chen (1996). Organization of the gene encoding human prostacyclin synthase. Biochem. Biophys. Res. Commun. 226, 631\u2013637.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1092", "doi-asserted-by": "publisher", "first-page": "148", "DOI": "10.1007/s004390000444", "volume": "108", "author": "D. Chevalier", "year": "2001", "unstructured": "Chevalier, D., C. Cauffiez, C. Bernard, J.M. Lo-Guidice, D. Allorge, F. Fazio et al. (2001). Characterization of new mutations in the coding sequence and 5\u2032-untranslated region of the human prostacylcin synthase gene (CYP8A1). Hum. Genet. 108, 148\u2013155.", "journal-title": "Hum. Genet."}, {"key": "10_CR1093", "doi-asserted-by": "publisher", "first-page": "31", "DOI": "10.1016/S0090-6980(02)00016-3", "volume": "70", "author": "D. Chevalier", "year": "2002", "unstructured": "Chevalier, D., D. Allorge, J.M. Lo-Guidice, C. Cauffiez, C. Lepetit, F. Migot-Nabias et al. (2002). Sequence analysis, frequency and ethnic distribution of VNTR polymorphism in the 5\u2032-untranslated region of the human prostacyclin synthase gene (CYP8A1). Prostaglandins Other Lipid Mediat. 70, 31\u201337.", "journal-title": "Prostaglandins Other Lipid Mediat."}, {"key": "10_CR1094", "doi-asserted-by": "publisher", "first-page": "1263", "DOI": "10.1016/S0895-7061(00)01216-4", "volume": "13", "author": "T. Nakayama", "year": "2000", "unstructured": "Nakayama, T., M. Soma, D. Rehemudula, Y. Takahashi, H. Tobe, M. Satoh et al. (2000). Association of 5\u2032 upstream promoter region of prostacyclin synthase gene variant with cerebral infarction. Am. J. Hypertens. 13, 1263\u20131267.", "journal-title": "Am. J. Hypertens."}, {"key": "10_CR1095", "doi-asserted-by": "publisher", "first-page": "797", "DOI": "10.1067/mhj.2002.122171", "volume": "143", "author": "T. Nakayama", "year": "2002", "unstructured": "Nakayama, T., M. Soma, S. Saito, J. Honye, J. Yajima, D. Rahmutula et al. (2002). Association of a novel single nucleotide polymorphism of the prostacyclin synthase gene with myocardial infarction. Am. Heart J. 143, 797\u2013801.", "journal-title": "Am. Heart J."}, {"key": "10_CR1096", "doi-asserted-by": "publisher", "first-page": "409", "DOI": "10.1016/S0895-7061(00)01256-5", "volume": "14", "author": "T. Nakayama", "year": "2001", "unstructured": "Nakayama, T., M. Soma, Y. Takahashi, D. Rehemudula, H. Tobe, M. Sato et al. (2001). Polymorphism of the promoter region of prostacyclin synthase gene is not related to essential hypertension. Am. J. Hypertens. 14, 409\u2013411.", "journal-title": "Am. J. Hypertens."}, {"key": "10_CR1097", "doi-asserted-by": "publisher", "first-page": "65", "DOI": "10.1291/hypres.25.65", "volume": "25", "author": "T. Nakayama", "year": "2002", "unstructured": "Nakayama, T., M. Soma, D. Rahmutula, H. Tobe, M. Sato, J. Uwabo et al. (2002). Association study between a novel single nucleotide polymorphism of the promoter region of the prostacyclin synthase gene and essential hypertension. Hypertens. Res. 25, 65\u201368.", "journal-title": "Hypertens. Res."}, {"key": "10_CR1098", "doi-asserted-by": "publisher", "first-page": "1135", "DOI": "10.1016/S0006-291X(02)02341-0", "volume": "297", "author": "T. Nakayama", "year": "2002", "unstructured": "Nakayama, T., M. Soma, Y. Watanabe, B. Hasimu, M. Sato, N. Aoi et al. (2002). Splicing mutation of the prostacyclin synthase gene in a family associated with hypertension. Biochem. Biophys. Res. Commun. 297, 1135\u20131139.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1099", "doi-asserted-by": "publisher", "first-page": "268", "DOI": "10.1016/0014-5793(96)00600-X", "volume": "389", "author": "T. Hatae", "year": "1996", "unstructured": "Hatae, T., S. Hara, C. Yokoyama, T. Yabuki, H. Inoue, V. Ullrich et al. (1996). Site-directed mutagenesis of human prostacyclin synthase: Alteration of Cys441 of the Cys-pocket, and Glu347 and Arg350 of the EXXR motif. FEBS Lett. 389, 268\u2013272.", "journal-title": "FEBS Lett."}, {"key": "10_CR1100", "doi-asserted-by": "publisher", "first-page": "3657", "DOI": "10.1074/jbc.272.6.3657", "volume": "272", "author": "S.K. Shyue", "year": "1997", "unstructured": "Shyue, S.K., K.H. Ruan, L.H. Wang, and K.K. Wu (1997). Prostacyclin synthase active sites. Identification by molecular modeling-guided site-directed mutagenesis. J. Biol. Chem. 272, 3657\u20133662.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1101", "doi-asserted-by": "publisher", "first-page": "78", "DOI": "10.1006/abbi.1998.0599", "volume": "352", "author": "Y. Lin", "year": "1998", "unstructured": "Lin, Y., K.K. Wu, and K.H. Ruan (1998). Characterization of the secondary structure and membrane interaction of the putative membrane anchor domains of prostaglandin I2 synthase and cytochrome P450 2C1. Arch. Biochem. Biophys. 352, 78\u201384.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1102", "doi-asserted-by": "publisher", "first-page": "188", "DOI": "10.1006/abbi.2000.1892", "volume": "379", "author": "Y.Z. Lin", "year": "2000", "unstructured": "Lin, Y.Z., H. Deng, and K.H. Ruan (2000). Topology of catalytic portion of prostaglandin I2 synthase: Identification by molecular modeling-guided site-specific antibodies. Arch. Biochem. Biophys. 379, 188\u2013197.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1103", "doi-asserted-by": "publisher", "first-page": "545", "DOI": "10.1042/0264-6021:3620545", "volume": "362", "author": "H. Deng", "year": "2002", "unstructured": "Deng, H., A. Huang, S.P. So, Y.Z. Lin, and K.H. Ruan (2002). Substrate access channel topology in membrane-bound prostacyclin synthase. Biochem. J. 362, 545\u2013551.", "journal-title": "Biochem. J."}, {"key": "10_CR1104", "first-page": "109", "volume": "27", "author": "G.A. Reed", "year": "1985", "unstructured": "Reed, G.A., I.O. Griffin, and T.E. Eling (1985). Inactivation of prostaglandin H synthase and prostacyclin synthase by phenylbutazone. Requirement for peroxidative metabolism. Mol. Pharmacol. 27, 109\u2013114.", "journal-title": "Mol. Pharmacol."}, {"key": "10_CR1105", "doi-asserted-by": "publisher", "first-page": "453", "DOI": "10.1006/abbi.1995.1417", "volume": "321", "author": "M.L. Wade", "year": "1995", "unstructured": "Wade, M.L., N.F. Voelkel, and F.A. Fitzpatrick (1995). \u201cSuicide\u201d inactivation of prostaglandin I2 synthase: Characterization of mechanism-based inactivation with isolated enzyme and endothelial cells. Arch. Biochem. Biophys. 321, 453\u2013458.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1106", "doi-asserted-by": "publisher", "first-page": "101", "DOI": "10.1016/0014-5793(96)00160-3", "volume": "382", "author": "M.H. Zou", "year": "1996", "unstructured": "Zou, M.H. and V. Ullrich (1996). Peroxynitrite formed by simultaneous generation of nitric oxide and superoxide selectively inhibits bovine aortic prostacyclin synthase. FEBS Lett. 382, 101\u2013104.", "journal-title": "FEBS Lett"}, {"key": "10_CR1107", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1016/S1054-3589(08)61079-0", "volume": "34", "author": "J.P. Crow", "year": "1995", "unstructured": "Crow, J.P. and J.S. Beckman (1995). Reactions between nitric oxide, superoxide, and peroxynitrite: Footprints of peroxynitrite in vivo. Adv. Pharmacol. 34, 17\u201343.", "journal-title": "Adv. Pharmacol."}, {"key": "10_CR1108", "first-page": "707", "volume": "378", "author": "M. Zou", "year": "1997", "unstructured": "Zou, M., C. Martin, and V. Ullrich (1997). Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol. Chem. 378, 707\u2013713.", "journal-title": "Biol. Chem."}, {"key": "10_CR1109", "doi-asserted-by": "publisher", "first-page": "12813", "DOI": "10.1074/jbc.M208080200", "volume": "278", "author": "P. Schmidt", "year": "2003", "unstructured": "Schmidt, P., N. Youhnovski, A. Daiber, A. Balan, M. Arsic, M. Bachschmid et al. (2003). Specific nitration at tyrosine-430 revealed by high resolution mass spectrometry as basis for redox regulation of bovine prostacyclin synthase. J. Biol. Chem. 278, 12813\u201312819.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1110", "doi-asserted-by": "crossref", "first-page": "1925", "DOI": "10.1164/ajrccm.159.6.9804054", "volume": "159", "author": "R.M. Tuder", "year": "1999", "unstructured": "Tuder, R.M., C.D. Cool, M.W. Geraci, J. Wang, S.H. Abman, L. Wright et al. (1999). Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am. J. Respir. Crit. Care Med. 159, 1925\u20131932.", "journal-title": "Am. J. Respir. Crit. Care Med."}, {"key": "10_CR1111", "doi-asserted-by": "crossref", "first-page": "2231", "DOI": "10.1161/01.CIR.100.22.2231", "volume": "100", "author": "N. Iwai", "year": "1999", "unstructured": "Iwai, N., T. Katsuya, K. Ishikawa, T. Mannami, J. Ogata, J. Higaki et al. (1999). Human prostacyclin synthase gene and hypertension: The Suita study. Circulation 100, 2231\u20132236.", "journal-title": "Circulation"}, {"key": "10_CR1112", "doi-asserted-by": "crossref", "first-page": "1509", "DOI": "10.1172/JCI5911", "volume": "103", "author": "M.W. Geraci", "year": "1999", "unstructured": "Geraci, M.W., B. Gao, D.C. Shepherd, M.D. Moore, J.Y. Westcott, K.A. Fagan et al. (1999). Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension. J. Clin. Invest. 103, 1509\u20131515.", "journal-title": "J. Clin. Invest."}, {"key": "10_CR1113", "doi-asserted-by": "crossref", "first-page": "419", "DOI": "10.1161/01.STR.30.2.419", "volume": "30", "author": "T. Todaka", "year": "1999", "unstructured": "Todaka, T., C. Yokoyama, H. Yanamoto, N. Hashimoto, I. Nagata, T. Tsukahara et al. (1999). Gene transfer of human prostacyclin synthase prevents neointimal formation after carotid balloon injury in rats. Stroke 30, 419\u2013426.", "journal-title": "Stroke"}, {"key": "10_CR1114", "first-page": "63", "volume": "62", "author": "P. Pradono", "year": "2002", "unstructured": "Pradono, P., R. Tazawa, M. Maemondo, M. Tanaka, K. Usui, Y. Saijo et al. (2002). Gene transfer of thromboxane A2 synthase and prostaglandin I2 synthase antithetically altered tumor angiogenesis and tumor growth. Cancer Res 62, 63\u201366.", "journal-title": "Cancer Res"}, {"key": "10_CR1115", "doi-asserted-by": "publisher", "first-page": "211", "DOI": "10.1097/00008571-199806000-00004", "volume": "8", "author": "J.S. Leeder", "year": "1998", "unstructured": "Leeder, J.S., X. Lu, Y. Timsit, and A. Gaedigk (1998). Non-monooxygenase cytochromes P450 as potential human auto antigens in anticonvulsant hypersensitivity reactions. Pharmacogenetics 8, 211\u2013225.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR1116", "doi-asserted-by": "publisher", "first-page": "184", "DOI": "10.1006/geno.1998.5606", "volume": "56", "author": "M. Gafvels", "year": "1999", "unstructured": "Gafvels, M., M. Olin, B.P. Chowdhary, T. Raudsepp, U. Andersson, B. Persson et al. (1999). Structure and chromosomal assignment of the sterol 12\u03b1-hydroxylase gene (CYP8B1) in human and mouse: Eukaryotic cytochrome P-450 gene devoid of introns. Genomics 56, 184\u2013196.", "journal-title": "Genomics"}, {"key": "10_CR1117", "doi-asserted-by": "publisher", "first-page": "41690", "DOI": "10.1074/jbc.M105117200", "volume": "276", "author": "M. Zhang", "year": "2001", "unstructured": "Zhang, M. and J.Y. Chiang (2001). Transcriptional regulation of the human sterol 12\u03b1-hydroxylase gene (CYP8B1): Roles of hepatocyte nuclear factor 4\u03b1 in mediating bile acid repression. J. Biol. Chem. 276, 41690\u201341699.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1118", "doi-asserted-by": "publisher", "first-page": "42973", "DOI": "10.1074/jbc.M205089200", "volume": "277", "author": "M.C. Gerbod-Giannone", "year": "2002", "unstructured": "Gerbod-Giannone, M.C., A. Del Castillo-Olivares, S. Janciauskiene, G. Gil, and P.B. Hylemon (2002). Suppression of cholesterol 7\u03b1-hydroxylase transcription and bile acid synthesis by an \u03b11-antitrypsin peptide via interaction with \u03b11-fetoprotein transcription factor. J. Biol. Chem. 277, 42973\u201342980.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1119", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1016/S1388-1981(02)00186-5", "volume": "1583", "author": "Y. Yang", "year": "2002", "unstructured": "Yang, Y., M. Zhang, G. Eggertsen, and J.Y. Chiang (2002). On the mechanism of bile acid inhibition of rat sterol 12\u03b1-hydroxylase gene (CYP8B1) transcription: Roles of \u03b1-fetoprotein transcription factor and hepatocyte nuclear factor 4\u03b1. Biochim. Biophys. Acta 1583, 63\u201373.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "10_CR1120", "first-page": "6068", "volume": "251", "author": "H.P. Wang", "year": "1976", "unstructured": "Wang, H.P. and T. Kimura (1976). Purification and characterization of adrenal cortex mitochondrial cytochrome P-450 specific for cholesterol side chain cleavage activity. J. Biol. Chem. 251, 6068\u20136074.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1121", "doi-asserted-by": "crossref", "first-page": "8879", "DOI": "10.1093/oxfordjournals.jbchem.a121955", "volume": "101", "author": "K. Morohashi", "year": "1987", "unstructured": "Morohashi, K., K. Sogawa, T. Omura, and Y. Fujii-Kuriyama (1987). Gene structure of human cytochrome P-450(SCC), cholesterol desmolase. J. Biochem. (Tokyo) 101, 8879\u20138887.", "journal-title": "J. Biochem. (Tokyo)"}, {"key": "10_CR1122", "first-page": "16122", "volume": "260", "author": "T.L. Poulos", "year": "1985", "unstructured": "Poulos, T.L., B.C. Finzel, I.C. Gunsalus, G.C. Wagner, and J. Kraut (1985). The 2.6-\u00c5 crystal structure of Pseudomonas putida cytochrome P-450. J. Biol. Chem. 260, 16122\u201316130.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1123", "doi-asserted-by": "publisher", "first-page": "283", "DOI": "10.1016/0960-0760(94)90041-8", "volume": "51", "author": "C.J. Belfiore", "year": "1994", "unstructured": "Belfiore, C.J., D.E. Hawkins, M.C. Wiltbank, and G.D. Niswender (1994). Regulation of cytochrome P450scc synthesis and activity in the ovine corpus luteum. J. Steroid Biochem. Mol. Biol. 51, 283\u2013290.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10_CR1124", "doi-asserted-by": "publisher", "first-page": "456", "DOI": "10.1016/0003-9861(86)90749-6", "volume": "250", "author": "M.F. Matocha", "year": "1986", "unstructured": "Matocha, M.F. and M.R. Waterman (1986). Import and processing of P-450scc and P-45011\u03b2 precursors by corpus luteal mitochondria: A processing pathway recognizing homologous and heterologous precursors. Arch. Biochem. Biophys. 250, 456\u2013460.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1125", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1530/jrf.0.0850163", "volume": "85", "author": "H. Sasano", "year": "1989", "unstructured": "Sasano, H., M. Okamoto, J.I. Mason, E.R. Simpson, C.R. Mendelson, N. Sasano et al. (1989). Immunolocalization of aromatase, 17\u03b1-hydroxylase and side-chain-cleavage cytochromes P-450 in the human ovary. J. Reprod. Fertil. 85, 163\u2013169.", "journal-title": "J. Reprod. Fertil."}, {"key": "10_CR1126", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.1016/S0039-128X(96)00156-0", "volume": "62", "author": "B.C. Chung", "year": "1997", "unstructured": "Chung, B.C., I.C. Guo, and S.J. Chou (1997). Transcriptional regulation of the CYP11A1 and ferredoxin genes. Steroids 62, 37\u201342.", "journal-title": "Steroids"}, {"key": "10_CR1127", "doi-asserted-by": "publisher", "first-page": "592", "DOI": "10.1016/0003-9861(87)90142-1", "volume": "254", "author": "B. Walther", "year": "1987", "unstructured": "Walther, B., J.F. Ghersi-Egea, A. Minn, and G. Siest (1987). Brain mitochondrial cytochrome P-450scc: Spectral and catalytic properties. Arch. Biochem. Biophys. 254, 592\u2013596.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1128", "doi-asserted-by": "publisher", "first-page": "224", "DOI": "10.1006/frne.1995.1008", "volume": "16", "author": "M. Warner", "year": "1995", "unstructured": "Warner, M. and J.A. Gustafsson (1995). Cytochrome P450 in the brain: Neuroendocrine functions. Front. Neuroendocrinol. 16, 224\u2013236.", "journal-title": "Front. Neuroendocrinol."}, {"key": "10_CR1129", "doi-asserted-by": "publisher", "first-page": "3067", "DOI": "10.1097/00001756-199909290-00035", "volume": "10", "author": "S. Beyenburg", "year": "1999", "unstructured": "Beyenburg, S., B. Stoffel-Wagner, M. Watzka, I. Blumcke, J. Bauer, J. Schramm et al. (1999). Expression of cytochrome P450scc mRNA in the hippocampus of patients with temporal lobe epilepsy. Neuroreport 10, 3067\u20133070.", "journal-title": "Neuroreport"}, {"key": "10_CR1130", "doi-asserted-by": "publisher", "first-page": "901", "DOI": "10.1046/j.1365-2826.1999.00407.x", "volume": "11", "author": "M. Watzka", "year": "1999", "unstructured": "Watzka, M., F. Bidlingmaier, J. Schramm, D. Klingmuller, and B. Stoffel-Wagner (1999). Sex-and age-specific differences in human brain CYP11A1 mRNA expression. J. Neuroendocrinol. 11, 901\u2013905.", "journal-title": "J. Neuroendocrinol."}, {"key": "10_CR1131", "doi-asserted-by": "publisher", "first-page": "39", "DOI": "10.1097/00006676-199907000-00006", "volume": "19", "author": "A. Morales", "year": "1999", "unstructured": "Morales, A., A. Cuellar, J. Ramirez, F. Vilchis, and V. Diaz-Sanchez (1999). Synthesis of steroids in pancreas: Evidence of cytochrome P-450scc activity. Pancreas 19, 39\u201344.", "journal-title": "Pancreas"}, {"key": "10_CR1132", "doi-asserted-by": "crossref", "first-page": "1287", "DOI": "10.1093/oxfordjournals.jbchem.a121835", "volume": "100", "author": "W. Ou", "year": "1986", "unstructured": "Ou, W., A. Ito, K. Morohashi, Y. Fujii-Kuriyama, and T. Omura (1986). Processing-independent in vitro translocation of cytochrome P-450SCC precursor across mitochondrial membranes. J. Biochem. (Tokyo) 100, 1287\u20131296.", "journal-title": "J. Biochem. (Tokyo)"}, {"key": "10_CR1133", "doi-asserted-by": "crossref", "first-page": "833", "DOI": "10.1093/oxfordjournals.jbchem.a122122", "volume": "102", "author": "T. Kumamoto", "year": "1987", "unstructured": "Kumamoto, T., K. Morohashi, A. Ito, and T. Omura (1987). Site-directed mutagenesis of basic amino acid residues in the extension peptide of P-450SCC precursor: Effects on the import of the precursor into mitochondria. J. Biochem. (Tokyo) 102, 833\u2013838.", "journal-title": "J. Biochem. (Tokyo)"}, {"key": "10_CR1134", "doi-asserted-by": "publisher", "first-page": "7247", "DOI": "10.1073/pnas.91.15.7247", "volume": "91", "author": "S.M. Black", "year": "1994", "unstructured": "Black, S.M., J.A. Harikrishna, G.D. Szklarz, and W.L. Miller (1994). The mitochondrial environment is required for activity of the cholesterol side-chain cleavage enzyme, cytochrome P450scc. Proc. Natl. Acad. Sci. USA 91, 7247\u20137251.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1135", "doi-asserted-by": "publisher", "first-page": "25402", "DOI": "10.1074/jbc.270.43.25402", "volume": "270", "author": "P. Venepally", "year": "1995", "unstructured": "Venepally, P. and M.R. Waterman (1995). Two Sp1-binding site mediate cAMP-induced transcription of the bovine CYP11A gene through the protein kinase A signaling pathway. J. Biol. Chem. 270, 25402\u201325410.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1136", "doi-asserted-by": "publisher", "first-page": "19422", "DOI": "10.1074/jbc.274.27.19422", "volume": "274", "author": "R. Ahlgren", "year": "1999", "unstructured": "Ahlgren, R., G. Suske, M.R. Waterman, and J. Lund (1999). Role of Sp1 in cAMP-dependent transcriptional regulation of the bovine CYP11A gene. J. Biol. Chem. 274, 19422\u201319428.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1137", "doi-asserted-by": "publisher", "first-page": "329", "DOI": "10.1016/S0960-0760(99)00080-1", "volume": "69", "author": "I.C. Guo", "year": "1999", "unstructured": "Guo, I.C. and B.C. Chung (1999). Cell-type specificity of human CYP11A1 TATA box. J. Steroid Biochem. Mol. Biol. 69, 329\u2013334.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10_CR1138", "doi-asserted-by": "publisher", "first-page": "205", "DOI": "10.1016/S0303-7207(01)00388-4", "volume": "175", "author": "Y. Huang", "year": "2001", "unstructured": "Huang, Y., M. Hu, N. Hsu, C.L. Wang, and B. Chung (2001). Action of hormone responsive sequence in 2.3 kb promoter of CYP11A1. Mol. Cell Endocrinol. 175, 205\u2013210.", "journal-title": "Mol. Cell Endocrinol."}, {"key": "10_CR1139", "doi-asserted-by": "publisher", "first-page": "812", "DOI": "10.1210/me.15.5.812", "volume": "15", "author": "M.C. Hu", "year": "2001", "unstructured": "Hu, M.C., N.C. Hsu, C.I. Pai, C.K. Wang, and B. Chung (2001). Functions of the upstream and proximal steroidogenic factor 1 (SF-1)-binding sites in the CYP11A1 promoter in basal transcription and hormonal response. Mol. Endocrinol. 15, 812\u2013818.", "journal-title": "Mol. Endocrinol."}, {"key": "10_CR1140", "doi-asserted-by": "publisher", "first-page": "183", "DOI": "10.1016/S0303-7207(99)00036-2", "volume": "153", "author": "Z. Liu", "year": "1999", "unstructured": "Liu, Z. and E.R. Simpson (1999). Molecular mechanism for cooperation between Sp1 and steroidogenic factor-1 (SF-1) to regulate bovine CYP11A gene expression. Mol. Cell Endocrinol. 153, 183\u2013196.", "journal-title": "Mol. Cell Endocrinol."}, {"key": "10_CR1141", "doi-asserted-by": "publisher", "first-page": "33881", "DOI": "10.1074/jbc.M100113200", "volume": "276", "author": "F. Gizard", "year": "2001", "unstructured": "Gizard, F., B. Lavallee, F. DeWitte, and D.W. Hum (2001). A novel zinc finger protein TReP-132 interacts with CBP/p300 to regulate human CYP11A1 gene expression. J. Biol. Chem. 276, 33881\u201333892.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1142", "doi-asserted-by": "publisher", "first-page": "39144", "DOI": "10.1074/jbc.M205786200", "volume": "277", "author": "F. Gizard", "year": "2002", "unstructured": "Gizard, F., B. Lavallee, F. DeWitte, E. Teissier, B. Staels, and D.W. Hum (2002). The transcriptional regulating protein of 132 kDa (TReP-132) enhances P450scc gene transcription through interaction with steroidogenic factor-1 in human adrenal cells. J. Biol. Chem. 277, 39144\u201339155.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1143", "doi-asserted-by": "publisher", "first-page": "15629", "DOI": "10.1074/jbc.M109365200", "volume": "277", "author": "J. Doi", "year": "2002", "unstructured": "Doi, J., H. Takemori, X.Z. Lin, N. Horike, Y. Katoh, and M. Okamoto (2002). Salt-inducible kinase represses cAMP-dependent protein kinase-mediated activation of human cholesterol side chain cleavage cytochrome P450 promoter through the CREB basic leucine zipper domain. J. Biol. Chem. 277, 15629\u201315637.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1144", "doi-asserted-by": "publisher", "first-page": "1864", "DOI": "10.1210/me.2002-0056", "volume": "16", "author": "M. Ben-Zimra", "year": "2002", "unstructured": "Ben-Zimra, M., M. Koler, and J. Orly (2002). Transcription of cholesterol side-chain cleavage cytochrome P450 in the placenta: Activating protein-2 assumes the role of steroidogenic factor-1 by binding to an overlapping promoter element. Mol. Endocrinol. 16, 1864\u20131880.", "journal-title": "Mol. Endocrinol."}, {"key": "10_CR1145", "doi-asserted-by": "publisher", "first-page": "3808", "DOI": "10.1210/jc.87.8.3808", "volume": "87", "author": "N. Katsumata", "year": "2002", "unstructured": "Katsumata, N., M. Ohtake, T. Hojo, E. Ogawa, T. Hara, N. Sato et al. (2002). Compound heterozygous mutations in the cholesterol side-chain cleavage enzyme gene (CYP11A) cause congenital adrenal insufficiency in humans. J. Clin. Endocrinol. Metab. 87, 3808\u20133813.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1146", "doi-asserted-by": "publisher", "first-page": "230", "DOI": "10.1016/0039-128X(93)90024-H", "volume": "58", "author": "R.C. Tuckey", "year": "1993", "unstructured": "Tuckey, R.C. and K.J. Cameron (1993). Human placental cholesterol side-chain cleavage: Enzymatic synthesis of (22R)-20\u03b1,22-dihydroxycholesterol. Steroids 58, 230\u2013233.", "journal-title": "Steroids"}, {"key": "10_CR1147", "doi-asserted-by": "publisher", "first-page": "2186", "DOI": "10.1021/ja00293a068", "volume": "107", "author": "R.I. Murray", "year": "1985", "unstructured": "Murray, R.I. and S.G. Sligar (1985). Oxidative cleavage of 1-phenyl-1,2-ethanediol by 4-cyano-N,N-dimethylaniline N-oxide and chloro (5,10,15,20-tetraphenylporphinato) chromium (III): A model for cholesterol side-chain cleavage by cytochrome P-450scc. J. Am. Chem. Soc. 107, 2186\u20132187.", "journal-title": "J. Am. Chem. Soc."}, {"key": "10_CR1148", "doi-asserted-by": "publisher", "first-page": "1187", "DOI": "10.1021/ja00212a030", "volume": "110", "author": "T. Okamoto", "year": "1988", "unstructured": "Okamoto, T., K. Sasaki, and S. Oka (1988). Biomimetic oxidation with molecular oxygen. Selective carbon-carbon bond cleavage of 1,2-diols by molecular oxygen and dihydropyridine in the presence of iron-porphyrin catalysts. J. Am. Chem. Soc. 110, 1187\u20131196.", "journal-title": "J. Am. Chem. Soc."}, {"key": "10_CR1149", "author": "P.R. Ortiz de Montellano", "first-page": "245", "year": "1995", "unstructured": "Ortiz de Montellano, P.R. (1995). Oxygen activation and reactivity. In P.R. Ortiz de Montellano (ed.), Cytochrome P450: Structure, Mechanism, and Biochemistry. Plenum Press, New York, pp. 245\u2013303.", "volume-title": "Cytochrome P450: Structure, Mechanism, and Biochemistry", "DOI": "10.1007/978-1-4757-2391-5_8", "doi-asserted-by": "crossref"}, {"key": "10_CR1150", "doi-asserted-by": "publisher", "first-page": "835", "DOI": "10.1111/j.1432-1033.1997.00835.x", "volume": "244", "author": "R.C. Tuckey", "year": "1997", "unstructured": "Tuckey, R.C., S.T. Woods, and M. Tajbakhsh (1997). Electron transfer to cytochrome P-450scc limits cholesterol-side-chain-cleavage activity in the human placenta. Eur. J. Biochem. 244, 835\u2013839.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR1151", "doi-asserted-by": "publisher", "first-page": "4883", "DOI": "10.1074/jbc.272.8.4883", "volume": "272", "author": "V. Beckert", "year": "1997", "unstructured": "Beckert, V. and R. Bernhardt (1997). Specific aspects of electron transfer from adrenodoxin to cytochromes P450scc and P45011\u03b2. J. Biol. Chem. 272, 4883\u20134888.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1152", "doi-asserted-by": "publisher", "first-page": "720", "DOI": "10.1046/j.1432-1327.1999.00414.x", "volume": "262", "author": "P. Cao", "year": "1999", "unstructured": "Cao, P. and R. Bernhardt (1999). Interaction of CYP11B1 (cytochrome P-45011\u03b2) with CYP11A1 (cytochrome P-450scc) in COS-1 cells. Eur. J. Biochem. 262, 720\u2013726.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR1153", "doi-asserted-by": "publisher", "first-page": "279", "DOI": "10.1016/0014-5793(91)80135-P", "volume": "278", "author": "S.A. Usanov", "year": "1991", "unstructured": "Usanov, S.A. and V.L. Chashchin (1991). Interaction of cytochrome P-450scc with cytochrome b 5. FEBS Lett. 278, 279\u2013282.", "journal-title": "FEBS Lett"}, {"key": "10_CR1154", "first-page": "22877", "volume": "267", "author": "A. Wada", "year": "1992", "unstructured": "Wada, A. and M.R. Waterman (1992). Identification by site-directed mutagenesis of two lysine residues in cholesterol side chain cleavage cytochrome P450 that are essential for adrenodoxin binding. J. Biol. Chem. 267, 22877\u201322882.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1155", "doi-asserted-by": "publisher", "first-page": "109", "DOI": "10.1006/abbi.1998.0621", "volume": "353", "author": "S.T. Woods", "year": "1998", "unstructured": "Woods, S.T., J. Sadleir, T. Downs, T. Triantopoulos, M.J. Headlam, and R.C. Tuckey (1998). Expression of catalytically active human cytochrome P450scc in Escherichia coli and mutagenesis of isoleucine-462. Arch. Biochem. Biophys. 353, 109\u2013115.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1156", "first-page": "3832", "volume": "258", "author": "L.E. Vickery", "year": "1983", "unstructured": "Vickery, L.E. and J.T. Kellis (1983). Inhibition of adrenocortical cytochrome P-450scc by (20R)-20-phenyl-5-pregnene-3\u03b2,20-diol: Mechanism and implications for the structure of the active site. J. Biol. Chem. 258, 3832\u20133836.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1157", "doi-asserted-by": "publisher", "first-page": "539", "DOI": "10.1016/0022-4731(88)90190-2", "volume": "29", "author": "L.E. Vickery", "year": "1988", "unstructured": "Vickery, L.E. and J. Singh (1988). 22-Thio-23,24-bisnor-5-cholen-3 \u03b2-ol: An active site-directed inhibitor of cytochrome P450scc. J. Steroid Biochem. 29, 539\u2013543.", "journal-title": "J. Steroid Biochem."}, {"key": "10_CR1158", "doi-asserted-by": "publisher", "first-page": "273", "DOI": "10.1016/0022-4731(90)90217-G", "volume": "36", "author": "O. Olakanmi", "year": "1990", "unstructured": "Olakanmi, O. and D.W. Seybert (1990). Modified acetylenic steroids as potent mechanism-based inhibitors of cytochrome P-450scc. J. Steroid Biochem. 36, 273\u2013280.", "journal-title": "J. Steroid Biochem."}, {"key": "10_CR1159", "first-page": "185", "volume": "3", "author": "M. Jarman", "year": "1988", "unstructured": "Jarman, M., S.E. Barrie, C.S. Leung, and M.G. Rowlands (1988). Selective inhibition of cholesterol side-chain cleavage by potential pro-drug forms of aminoglutethimide. Anticancer Drug Design 3, 185\u2013190.", "journal-title": "Anticancer Drug Design"}, {"key": "10_CR1160", "doi-asserted-by": "publisher", "first-page": "77", "DOI": "10.1016/S0960-0760(96)00166-5", "volume": "60", "author": "T. Ohnishi", "year": "1997", "unstructured": "Ohnishi, T. and Y. Ichikawa (1997). Direct inhibitions of the activities of steroidogenic cytochrome P-450 mono-oxygenase systems by anticonvulsants. J. Steroid Biochem. Mol. Biol. 60, 77\u201385.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10_CR1161", "doi-asserted-by": "publisher", "first-page": "1977", "DOI": "10.1210/en.132.5.1977", "volume": "132", "author": "X. Yang", "year": "1993", "unstructured": "Yang, X., K. Iwamoto, M. Wang, J. Artwohl, J.I. Mason, and S. Pang (1993). Inherited congenital adrenal hyperplasia in the rabbit is caused by a deletion in the gene encoding cytochrome P450 cholesterol side-chain cleavage enzyme. Endocrinology 132, 1977\u20131982.", "journal-title": "Endocrinology"}, {"key": "10_CR1162", "doi-asserted-by": "publisher", "first-page": "1943", "DOI": "10.1210/me.2002-0055", "volume": "16", "author": "M.C. Hu", "year": "2002", "unstructured": "Hu, M.C., N.C. Hsu, N.B. El Hadj, C.I. Pai, H.P. Chu, C.K. Wang et al. (2002). Steroid deficiency syndromes in mice with targeted disruption of Cyp11a1. Mol. Endocrinol. 16, 1943\u20131950.", "journal-title": "Mol. Endocrinol."}, {"key": "10_CR1163", "doi-asserted-by": "publisher", "first-page": "1871", "DOI": "10.1210/jc.81.5.1871", "volume": "81", "author": "S. Chen", "year": "1996", "unstructured": "Chen, S., J. Sawicka, C. Betterle, M. Powell, L. Prentice, M. Volpato et al. (1996). Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison\u2019s disease, and premature ovarian failure. J. Clin. Endocrinol. Metab. 81, 1871\u20131876.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1164", "doi-asserted-by": "crossref", "first-page": "208", "DOI": "10.1055/s-0029-1212100", "volume": "107", "author": "J. Seissler", "year": "1999", "unstructured": "Seissler, J., M. Schott, H. Steinbrenner, P. Peterson, and W.A. Scherbaum (1999). Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison\u2019s disease and autoimmune polyendocrine syndrome type II. Exp. Clin. Endocrinol. Diabetes 107, 208\u2013213.", "journal-title": "Exp. Clin. Endocrinol. Diabetes"}, {"key": "10_CR1165", "doi-asserted-by": "publisher", "first-page": "1537", "DOI": "10.1515/BC.2002.174", "volume": "383", "author": "M. Bureik", "year": "2002", "unstructured": "Bureik, M., M. Lisurek, and R. Bernhardt (2002). The human steroid hydroxylases CYP11B1 and CYP11B2. Biol. Chem. 383, 1537\u20131551.", "journal-title": "Biol. Chem."}, {"key": "10_CR1166", "doi-asserted-by": "publisher", "first-page": "127", "DOI": "10.1021/bi00594a018", "volume": "17", "author": "M. Watanuki", "year": "1978", "unstructured": "Watanuki, M., B.E. Tilley, and P.F. Hall (1978). Cytochrome P-450 for 11\u03b2-and 18-hydroxylase activities of bovine adrenocortical mitochondria: One enzyme or two?. Biochemistry 17, 127\u2013130.", "journal-title": "Biochemistry"}, {"key": "10_CR1167", "first-page": "20961", "volume": "264", "author": "E. Mornet", "year": "1989", "unstructured": "Mornet, E., J. Dupont, A. Vitek, and P.C. White (1989). Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11)\u03b2). J. Biol. Chem. 264, 20961\u201320967.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1168", "doi-asserted-by": "publisher", "first-page": "345", "DOI": "10.1016/0014-5793(90)81190-Y", "volume": "269", "author": "T. Kawamoto", "year": "1990", "unstructured": "Kawamoto, T., Y. Mitsuuchi, K. Toda, K. Miyahara, Y. Yokoyama, K. Nakao et al. (1990). Cloning of cDNA and genomic DNA for human cytochrome P-45011\u03b1. FEBS Lett. 269, 345\u2013349.", "journal-title": "FEBS Lett"}, {"key": "10_CR1169", "doi-asserted-by": "publisher", "first-page": "3254", "DOI": "10.1210/jc.81.9.3254", "volume": "81", "author": "G. Zhang", "year": "1996", "unstructured": "Zhang, G. and W.L. Miller (1996). The human genome contains only two CYP11B (P450c11) genes. J. Clin. Endocrinol. Metab. 81, 3254\u20133256.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1170", "doi-asserted-by": "publisher", "first-page": "1458", "DOI": "10.1073/pnas.89.4.1458", "volume": "89", "author": "T. Kawamoto", "year": "1992", "unstructured": "Kawamoto, T., Y. Mitsuuchi, K. Toda, Y. Yokoyama, K. Miyahara, S. Miura et al. (1992). Role of steroid 11\u03b2-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans. Proc. Natl. Acad. Sci. USA 89, 1458\u20131462.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1171", "doi-asserted-by": "publisher", "first-page": "305", "DOI": "10.1016/S1071-5576(97)00066-X", "volume": "4", "author": "W.A. Freije", "year": "1997", "unstructured": "Freije, W.A., V. Pezzi, A. Arici, B.R. Carr, and W.E. Rainey (1997). Expression of 11 beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) in the human fetal adrenal. J. Soc. Gynecol. Investig. 4, 305\u2013309.", "journal-title": "J. Soc. Gynecol. Investig."}, {"key": "10_CR1172", "doi-asserted-by": "publisher", "first-page": "1196", "DOI": "10.1210/me.7.9.1196", "volume": "7", "author": "K. Morohashi", "year": "1993", "unstructured": "Morohashi, K., U.M. Zanger, S. Honda, M. Hara, M.R. Waterman, and T. Omura (1993). Activation of CYP11A and CYP11B gene promoters by the steroidogenic cell-specific transcription factor, Ad4BP. Mol. Endocrinol. 7, 1196\u20131204.", "journal-title": "Mol. Endocrinol."}, {"key": "10_CR1173", "first-page": "7494", "volume": "268", "author": "S. Honda", "year": "1993", "unstructured": "Honda, S., K. Morohashi, M. Nomura, H. Takeya, M. Kitajima, and T. Omura (1993). Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. J. Biol. Chem. 268, 7494\u20137502.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1174", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1093/oxfordjournals.jbchem.a123941", "volume": "112", "author": "T. Hashimoto", "year": "1992", "unstructured": "Hashimoto, T., K. Morohashi, K. Takayama, S. Honda, T. Wada, H. Handa et al. (1992). Cooperative transcription activation between Ad1, a CRE-like element, and other elements in the CYP11B gene promoter. J. Biochem. (Tokyo) 112, 573\u2013575.", "journal-title": "J. Biochem. (Tokyo)"}, {"key": "10_CR1175", "doi-asserted-by": "publisher", "first-page": "190", "DOI": "10.1046/j.1432-1327.1998.2560190.x", "volume": "256", "author": "K. Mukai", "year": "1998", "unstructured": "Mukai, K., F. Mitani, R. Agake, and Y. Ishimura (1998). Adrenocorticotropic hormone stimulates CYP11B1 gene transcription through a mechanism involving AP-1 factors. Eur. J. Biochem. 256, 190\u2013200.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR1176", "doi-asserted-by": "publisher", "first-page": "3587", "DOI": "10.1210/en.141.10.3587", "volume": "141", "author": "X.L. Wang", "year": "2000", "unstructured": "Wang, X.L., M. Bassett, Y. Zhang, S. Yin, C. Clyne, P.C. White et al. (2000). Transcriptional regulation of human 11\u03b2-hydroxylase (hCYP11B1). Endocrinology 141, 3587\u20133594.", "journal-title": "Endocrinology"}, {"key": "10_CR1177", "doi-asserted-by": "publisher", "first-page": "125", "DOI": "10.1677/jme.0.0280125", "volume": "28", "author": "M.H. Bassett", "year": "2002", "unstructured": "Bassett, M.H., Y. Zhang, C. Clyne, P.C. White, and W.E. Rainey (2002). Differential regulation of aldosterone synthase and 11\u03b2-hydroxylase transcription by steroidogenic factor-1. J. Mol. Endocrinol. 28, 125\u2013135.", "journal-title": "J. Mol. Endocrinol."}, {"key": "10_CR1178", "doi-asserted-by": "publisher", "first-page": "377", "DOI": "10.1093/hmg/3.2.377", "volume": "3", "author": "C.A. Skinner", "year": "1994", "unstructured": "Skinner, C.A. and G. Rumsby (1994). Steroid 11 beta-hydroxylase deficiency caused by a five base pair duplication in the CYP11B1 gene. Hum. Mol. Genet. 3, 377\u2013378.", "journal-title": "Hum. Mol. Genet."}, {"key": "10_CR1179", "doi-asserted-by": "publisher", "first-page": "4552", "DOI": "10.1073/pnas.90.10.4552", "volume": "90", "author": "K.M. Curnow", "year": "1993", "unstructured": "Curnow, K.M., L. Slutsker, J. Vitek, T. Cole, P.W. Speiser, M.I. New et al. (1993). Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc. Natl. Acad. Sci. USA 90, 4552\u20134556.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1180", "doi-asserted-by": "publisher", "first-page": "262", "DOI": "10.1038/355262a0", "volume": "355", "author": "R.P. Lifton", "year": "1992", "unstructured": "Lifton, R.P., R.G. Dluhy, M. Powers, G.M. Rich, S. Cook, S. Ulick et al. (1992). A chimaeric 11\u03b2-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355, 262\u2013265.", "journal-title": "Nature"}, {"key": "10_CR1181", "doi-asserted-by": "publisher", "first-page": "8327", "DOI": "10.1073/pnas.89.17.8327", "volume": "89", "author": "L. Pascoe", "year": "1992", "unstructured": "Pascoe, L., K.M. Curnow, L. Slutsker, J.M. Connell, P.W. Speiser, M.I. New et al. (1992). Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2, Proc. Natl. Acad. Sci. USA 89, 8327\u20138331.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1182", "doi-asserted-by": "publisher", "first-page": "4445", "DOI": "10.1210/jc.86.9.4445", "volume": "86", "author": "M. Hampf", "year": "2001", "unstructured": "Hampf, M., N.T. Dao, N.T. Hoan, and R. Bernhardt (2001). Unequal crossing-over between aldosterone synthase and 11\u03b2-hydroxylase genes causes congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 86, 4445\u20134452.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1183", "doi-asserted-by": "publisher", "first-page": "3197", "DOI": "10.1210/jc.86.7.3197", "volume": "86", "author": "S. Portrat", "year": "2001", "unstructured": "Portrat, S., P. Mulatero, K.M. Curnow, J.L. Chaussain, Y. Morel, and L. Pascoe (2001). Deletion hybrid genes, due to unequal crossing over between CYP11B1 (11\u03b2-hydroxylase) and CYP11B2 (aldosterone synthase) cause steroid 11\u03b2-hydroxylase deficiency and congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 86, 3197\u20133201.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1184", "doi-asserted-by": "crossref", "first-page": "797", "DOI": "10.3109/07435800009048602", "volume": "26", "author": "O. Chabre", "year": "2000", "unstructured": "Chabre, O., S. Portrat-Doyen, J. Vivier, Y. Morel, and G. Defaye (2000). Two novel mutations in splice donor sites of CYP11B1 in congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency. Endocrinol. Res. 26, 797\u2013801.", "journal-title": "Endocrinol. Res."}, {"key": "10_CR1185", "doi-asserted-by": "publisher", "first-page": "3996", "DOI": "10.1210/jc.83.11.3996", "volume": "83", "author": "P. Mulatero", "year": "1998", "unstructured": "Mulatero, P., K.M. Curnow, B. Aupetit-Faisant, M. Foekling, C. Gomez-Sanchez, F. Veglio, X. Jeunemaitre et al. (1998). Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol. J. Clin. Endocrinol. Metab. 83, 3996\u20134001.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1186", "doi-asserted-by": "crossref", "first-page": "S42", "DOI": "10.1111/j.1440-1681.1998.tb02299.x", "volume": "25", "author": "A. Fisher", "year": "1998", "unstructured": "Fisher, A., E. Davies, R. Fraser, and J.M. Connell (1998). Structure-function relationships of aldosterone synthase and 11\u03b2-hydroxylase enzymes: Implications for human hypertension. Clin. Exp. Pharmacol. Physiol. Suppl. 25, S42\u2013S46.", "journal-title": "Clin. Exp. Pharmacol. Physiol. Suppl."}, {"key": "10_CR1187", "doi-asserted-by": "publisher", "first-page": "1261", "DOI": "10.1210/jc.85.3.1261", "volume": "85", "author": "A. Fisher", "year": "2000", "unstructured": "Fisher, A., R. Fraser, J. McConnell, and E. Davies (2000). Amino acid residue 147 of human aldosterone synthase and 11\u03b2-hydroxylase plays a key role in 11\u03b2-hydroxylation. J. Clin. Endocrinol. Metab. 85, 1261\u20131266.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1188", "doi-asserted-by": "publisher", "first-page": "458", "DOI": "10.1046/j.1432-1327.1998.2520458.x", "volume": "252", "author": "B. B\u00f6ttner", "year": "1998", "unstructured": "B\u00f6ttner, B., K. Denner, and R. Bernhardt (1998). Conferring aldosterone synthesis to human CYP11B1 by replacing key amino acid residues with CYP11B2-specific ones. Eur. J. Biochem. 252, 458\u2013466.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR1189", "doi-asserted-by": "publisher", "first-page": "217", "DOI": "10.1016/S0960-0760(98)00032-6", "volume": "66", "author": "D.F. Lewis", "year": "1998", "unstructured": "Lewis, D.F. and P. Lee-Robichaud (1998). Molecular modelling of steroidogenic cyto-chromes P450 from families CYP11, CYP17, CYP19 and CYP21 based on the CYP102 crystal structure. J. Steroid Biochem. Mol. Biol. 66, 217\u2013233.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10_CR1190", "doi-asserted-by": "publisher", "first-page": "197", "DOI": "10.1016/S0162-0134(01)00331-2", "volume": "87", "author": "N.V. Belkina", "year": "2001", "unstructured": "Belkina, N.V., M. Lisurek, A.S. Ivanov, and R. Bernhardt (2001). Modelling of three-dimensional structures of cytochromes P450 11B1 and 11B2. J. Inorg. Biochem. 87, 197\u2013207.", "journal-title": "J. Inorg. Biochem."}, {"key": "10_CR1191", "doi-asserted-by": "publisher", "first-page": "89", "DOI": "10.1097/00008571-199504000-00005", "volume": "5", "author": "K. Denner", "year": "1995", "unstructured": "Denner, K., R. Vogel, W. Schmalix, J. Doehmer, and R. Bernhardt (1995). Cloning and stable expression of the human mitochondrial cytochrome P45011B1 cDNA in V79 Chinese hamster cells and their application for testing of potential inhibitors. Pharmacogenetics 5, 89\u201396.", "journal-title": "Pharmacogenetics"}, {"key": "10_CR1192", "doi-asserted-by": "publisher", "first-page": "17", "DOI": "10.1016/0960-0760(94)00152-C", "volume": "52", "author": "J.O. Johnston", "year": "1995", "unstructured": "Johnston, J.O., C.L. Wright, and G.W. Holbert (1995). Enzyme-activated inhibitors of steroidal hydroxylases. J. Steroid Biochem. Mol. Biol. 52, 17\u201334.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10_CR1193", "doi-asserted-by": "publisher", "first-page": "252", "DOI": "10.1111/j.1432-1033.1997.00252.x", "volume": "248", "author": "C. Delorme", "year": "1997", "unstructured": "Delorme, C., A. Piffeteau, F. Sobrio, and A. Marquet (1997). Mechanism-based inactivation of bovine cytochrome P45011\u03b2 by 18-unsaturated progesterone derivatives. Eur. J. Biochem. 248, 252\u2013260.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR1194", "doi-asserted-by": "crossref", "first-page": "61", "DOI": "10.1016/S0889-8529(08)70019-7", "volume": "30", "author": "P.C. White", "year": "2001", "unstructured": "White, P.C. (2001). Steroid 11\u03b2-hydroxylase deficiency and related disorders. Endocrinol. Metab. Clin. North Am. 30, 61\u201379.", "journal-title": "Endocrinol. Metab. Clin. North Am."}, {"key": "10_CR1195", "doi-asserted-by": "publisher", "first-page": "211", "DOI": "10.1159/000023374", "volume": "51", "author": "M. Peter", "year": "1999", "unstructured": "Peter, M., J.M. Dubuis, and W.G. Sippell (1999). Disorders of the aldosterone synthase and steroid 11\u03b2-hydroxylase deficiencies. Horm. Res. 51, 211\u2013222.", "journal-title": "Horm. Res."}, {"key": "10_CR1196", "doi-asserted-by": "publisher", "first-page": "4996", "DOI": "10.1073/pnas.89.11.4996", "volume": "89", "author": "L. Pascoe", "year": "1992", "unstructured": "Pascoe, L., K.M. Curnow, L. Slutsker, A. R\u00f6sler, and P.C. White (1992). Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency. Proc. Natl. Acad. Sci. USA 89, 4996\u20135000.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1197", "doi-asserted-by": "publisher", "first-page": "864", "DOI": "10.1006/bbrc.1993.1128", "volume": "190", "author": "Y. Mitsuuchi", "year": "1993", "unstructured": "Mitsuuchi, Y., T. Kawamoto, K. Miyahara, S. Ulick, D.H. Morton, Y. Naiki et al. (1993). Congenitally defective aldosterone biosynthesis in humans: Inactivation of the P-450C18 gene (CYP11B2) due to nucleotide deletion in CMO I deficient patients. Biochem. Biophys. Res. Commun. 190, 864\u2013869.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1198", "doi-asserted-by": "publisher", "first-page": "309", "DOI": "10.1016/S0006-291X(05)81058-7", "volume": "173", "author": "T. Kawamoto", "year": "1990", "unstructured": "Kawamoto, T., Y. Mitsuuchi, T. Ohnishi, Y. Ichikawa, Y. Yokoyama, H. Sumimoto et al. (1990). Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism. Biochem. Biophys. Res. Commun. 173, 309\u2013316.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1199", "doi-asserted-by": "crossref", "first-page": "1513", "DOI": "10.1210/mend-5-10-1513", "volume": "5", "author": "K.M. Curnow", "year": "1991", "unstructured": "Curnow, K.M., M.T. Tusie-Luna, L. Pascoe, R. Natarajan, J.L. Gu, J.L. Nadler et al. (1991). The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol. Endocrinol. 5, 1513\u20131522.", "journal-title": "Mol. Endocrinol."}, {"key": "10_CR1200", "doi-asserted-by": "crossref", "first-page": "885", "DOI": "10.3748/wjg.v6.i6.885", "volume": "6", "author": "X. Li", "year": "2000", "unstructured": "Li, X., Y. Meng, X.S. Yang, P.S. Wu, S.M. Li, and W.Y. Lai (2000). CYP11B2 expression in HSCs and its effect on hepatic fibrogenesis. World J. Gastroenterol. 6, 885\u2013887.", "journal-title": "World J. Gastroenterol."}, {"key": "10_CR1201", "doi-asserted-by": "crossref", "first-page": "941", "DOI": "10.3109/07435800009048620", "volume": "26", "author": "M.H. Bassett", "year": "2000", "unstructured": "Bassett, M.H., Y. Zhang, P.C. White, and W.E. Rainey (2000). Regulation of human CYP11B2 and CYP11B1: Comparing the role of the common CRE/Ad1 element. Endocrinol. Res. 26, 941\u2013951.", "journal-title": "Endocrinol. Res."}, {"key": "10_CR1202", "doi-asserted-by": "crossref", "first-page": "485", "DOI": "10.1080/07435809609043735", "volume": "22", "author": "C.D. Clyne", "year": "1996", "unstructured": "Clyne, C.D., P.C. White, and W.E. Rainey (1996). Calcium regulates human CYP11B2 transcription. Endocrinol. Res. 22, 485\u2013492.", "journal-title": "Endocrinol. Res."}, {"key": "10_CR1203", "doi-asserted-by": "publisher", "first-page": "351", "DOI": "10.1081/ERC-120016808", "volume": "28", "author": "M. Bureik", "year": "2002", "unstructured": "Bureik, M., A. Zeeh, and R. Bernhardt (2002). Modulation of steroid hydroxylase activity in stably transfected V79MZh11B1 and V79MZh11B2 cells by PKC and PKD inhibitors. Endocrinol. Res. 28, 351\u2013355.", "journal-title": "Endocrinol. Res."}, {"key": "10_CR1204", "doi-asserted-by": "crossref", "first-page": "1027", "DOI": "10.3109/07435800009048634", "volume": "26", "author": "J.G. LeHoux", "year": "2000", "unstructured": "J.G. LeHoux, G. Dupuis, and A. Lefebvre (2000). Regulation of CYP11B2 gene expression by protein kinase C. Endocrinol. Res. 26, 1027\u20131031.", "journal-title": "Endocrinol. Res."}, {"key": "10_CR1205", "doi-asserted-by": "publisher", "first-page": "131", "DOI": "10.1046/j.1365-2265.2001.01192.x", "volume": "55", "author": "T. Ise", "year": "2001", "unstructured": "Ise, T., A. Shimoda, H. Takakuwa, T. Kato, Y. Izumiya, K. Shimizu et al. (2001). A chimeric CYP11B1/CYP11B2 gene in glucocorticoid-insuppressible familial hyperaldosteronism. Clin. Endocrinol. (Oxford) 55, 131\u2013134.", "journal-title": "Clin. Endocrinol. (Oxford)"}, {"key": "10_CR1206", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1111/j.1749-6632.2002.tb04414.x", "volume": "970", "author": "R.V. Jackson", "year": "2002", "unstructured": "Jackson, R.V., A. Lafferty, D.J. Torpy, and C. Stratakis (2002). New genetic insights in familial hyperaldosteronism. Ann. N. Y. Acad. Sci. 970, 77\u201388.", "journal-title": "Ann. N. Y. Acad. Sci."}, {"key": "10_CR1207", "first-page": "1037", "volume": "57", "author": "G. Zhang", "year": "1995", "unstructured": "Zhang, G., H. Rodriguez, C.E. Fardella, D.A. Harris, and W.L. Miller (1995). Mutation T318M in the CYP11B2 gene encoding P450c11AS (aldosterone synthase) causes corticosterone methyl oxidase II deficiency. Am. J. Hum. Genet. 57, 1037\u20131043.", "journal-title": "Am. J. Hum. Genet."}, {"key": "10_CR1208", "doi-asserted-by": "crossref", "first-page": "694", "DOI": "10.1161/01.HYP.35.3.694", "volume": "35", "author": "P. Mulatero", "year": "2000", "unstructured": "Mulatero, P., D. Schiavone, F. Fallo, F. Rabbia, C. Pilon, L. Chiandussi et al. (2000). CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism. Hypertension 35, 694\u2013698.", "journal-title": "Hypertension"}, {"key": "10_CR1209", "doi-asserted-by": "publisher", "first-page": "789", "DOI": "10.1038/sj.jhh.1001484", "volume": "16", "author": "K. Tsukada", "year": "2002", "unstructured": "Tsukada, K., T. Ishimitsu, M. Teranishi, M. Saitoh, M. Yoshii, H. Inada et al. (2002). Positive association of CYP11B2 gene polymorphism with genetic predisposition to essential hypertension. J. Hum. Hypertens. 16, 789\u2013793.", "journal-title": "J. Hum. Hypertens."}, {"key": "10_CR1210", "doi-asserted-by": "publisher", "first-page": "1118", "DOI": "10.1046/j.1432-1033.2002.02729.x", "volume": "269", "author": "S. Bechtel", "year": "2002", "unstructured": "Bechtel, S., N. Belkina, and R. Bernhardt (2002). The effect of amino-acid substitutions I112P, D147E and K152N in CYP11B2 on the catalytic activities of the enzyme. Eur. J. Biochem. 269, 1118\u20131127.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR1211", "doi-asserted-by": "publisher", "first-page": "173", "DOI": "10.1016/S0960-0760(02)00056-0", "volume": "81", "author": "P.B. Ehmer", "year": "2002", "unstructured": "Ehmer, P.B., M. Bureik, R. Bernhardt, U. Muller, and R.W. Hartmann (2002). Development of a test system for inhibitors of human aldosterone synthase (CYP11B2): Screening in fission yeast and evaluation of selectivity in V79 cells. J. Steroid Biochem. Mol. Biol. 81, 173\u2013179.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10_CR1212", "doi-asserted-by": "publisher", "first-page": "83", "DOI": "10.1097/00000441-198908000-00003", "volume": "298", "author": "G.T. Griffing", "year": "1989", "unstructured": "Griffing, G.T., M. Holbrook, J.C. Melby, J. Alberta, and N.R. Orme-Johnson (1989). 19-Hydroxylase inhibition of adrenal mitochondrial P450 11\u03b2/18/19-hydroxylase by a suicide inhibitor. Am. J. Med. Sci. 298, 83\u201388.", "journal-title": "Am. J. Med. Sci."}, {"key": "10_CR1213", "doi-asserted-by": "crossref", "first-page": "703", "DOI": "10.1161/01.HYP.33.2.703", "volume": "33", "author": "E. Davies", "year": "1999", "unstructured": "Davies, E., C.D. Holloway, M.C. Ingram, G.C. Inglis, E.C. Friel, C. Morrison et al. (1999). Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension 33, 703\u2013707.", "journal-title": "Hypertension"}, {"key": "10_CR1214", "doi-asserted-by": "publisher", "first-page": "409", "DOI": "10.1016/S0960-0760(99)00071-0", "volume": "69", "author": "P.C. White", "year": "1999", "unstructured": "White, P.C., A. Hautanen, and M. Kupari (1999). Aldosterone synthase (CYP11B2) polymorphisms and cardiovascular function. J. Steroid Biochem. Mol. Biol. 69, 409\u2013412.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10_CR1215", "doi-asserted-by": "crossref", "first-page": "569", "DOI": "10.1161/01.CIR.97.6.569", "volume": "97", "author": "M. Kupari", "year": "1998", "unstructured": "Kupari, M., A. Hautanen, L. Lankinen, P. Koskinen, J. Virolainen, H. Nikkila et al. (1998). Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation 97, 569\u2013575.", "journal-title": "Circulation"}, {"key": "10_CR1216", "doi-asserted-by": "crossref", "first-page": "381", "DOI": "10.1042/cs1020381", "volume": "102", "author": "M. Satoh", "year": "2002", "unstructured": "Satoh, M., M. Nakamura, H. Saitoh, H. Satoh, T. Akatsu, J. Iwasaka et al. (2002). Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart. Clin. Sci. (London) 102, 381\u2013386.", "journal-title": "Clin. Sci. (London)"}, {"key": "10_CR1217", "doi-asserted-by": "publisher", "first-page": "1785", "DOI": "10.1097/00004872-200209000-00023", "volume": "20", "author": "P. Russo", "year": "2002", "unstructured": "Russo, P., A. Siani, A. Venezia, R. Iacone, O. Russo, G. Barba et al. (2002). Interaction between the C(-344)T polymorphism of CYP11B2 and age in the regulation of blood pressure and plasma aldosterone levels: Cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. J. Hypertens. 20, 1785\u20131792.", "journal-title": "J. Hypertens."}, {"key": "10_CR1218", "doi-asserted-by": "publisher", "first-page": "4398", "DOI": "10.1210/jc.2001-012070", "volume": "87", "author": "P.O. Lim", "year": "2002", "unstructured": "Lim, P.O., T.M. Macdonald, C. Holloway, E. Friel, N.H. Anderson, E. Dow et al. (2002). Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio. J. Clin. Endocrinol. Metab. 87, 4398\u20134402.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1219", "doi-asserted-by": "publisher", "first-page": "105", "DOI": "10.1291/hypres.24.105", "volume": "24", "author": "Y. Tsujita", "year": "2001", "unstructured": "Tsujita, Y., N. Iwai, T. Katsuya, J. Higaki, T. Ogihara, S. Tamaki et al. (2001). Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: The Suita Study. Hypertens. Res. 24, 105\u2013109.", "journal-title": "Hypertens. Res."}, {"key": "10_CR1220", "doi-asserted-by": "publisher", "first-page": "407", "DOI": "10.1073/pnas.84.2.407", "volume": "84", "author": "B. Chung", "year": "1987", "unstructured": "Chung, B., J. Picado-Leonard, M. Haniu, M. Bienkowski, P.F. Hall, J.E. Shively et al. (1987). Cytochrome P450c17 (steroid 17\u03b1-hydroxylase/17, 20 lyase): Cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc. Natl. Acad. Sci. USA 84, 407\u2013411.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1221", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1089/dna.1987.6.439", "volume": "6", "author": "J. Picado-Leonard", "year": "1987", "unstructured": "Picado-Leonard, J. and W.L. Miller (1987). Cloning and sequence of the human gene for P450c17 (steroid 17 \u03b1-hydroxylase/17, 20 lyase): Similarity with the gene for P450c21. DNA 6, 439\u2013448.", "journal-title": "DNA"}, {"key": "10_CR1222", "doi-asserted-by": "publisher", "first-page": "4037", "DOI": "10.1021/bi00517a014", "volume": "20", "author": "S. Nakajin", "year": "1981", "unstructured": "Nakajin, S., J.E. Shively, P.M. Yuan, and P.F. Hall (1981). Microsomal cytochrome P-450 from neonatal pig testis: Two enzymatic activities (17\u03b1-hydroxylase and C17,20-lyase) associated with one protein. Biochemistry 20, 4037\u20134042.", "journal-title": "Biochemistry"}, {"key": "10_CR1223", "doi-asserted-by": "publisher", "first-page": "379", "DOI": "10.1016/0006-291X(82)91877-0", "volume": "108", "author": "M. Katagiri", "year": "1982", "unstructured": "Katagiri, M., K. Suhara, M. Shiroo, and Y. Fujimura (1982). Role of cytochrome b 5 in the cytochrome P-450-mediated C21-steroid 17,20-lyase reaction. Biochem. Biophys. Res. Commun. 108, 379\u2013384.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1224", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1016/0005-2760(85)90263-2", "volume": "833", "author": "K. Shinzawa", "year": "1985", "unstructured": "Shinzawa, K., S. Kominami, and S. Takemori (1985). Studies on cytochrome P-450 (P-45017\u03b1, lyase) from guinea pig adrenal microsomes. Dual function of a single enzyme and effect of cytochrome b 5. Biochim. Biophys. Acta 833, 151\u2013160.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "10_CR1225", "doi-asserted-by": "publisher", "first-page": "91", "DOI": "10.1016/0039-128X(82)90115-5", "volume": "40", "author": "M.L. Casey", "year": "1982", "unstructured": "Casey, M.L. and P.C. MacDonald (1982). Demonstration of steroid 17\u03b1-hydroxylase activity in human fetal kidney, thymus, and spleen. Steroids 40, 91\u201397.", "journal-title": "Steroids"}, {"key": "10_CR1226", "doi-asserted-by": "publisher", "first-page": "2519", "DOI": "10.1210/jc.85.7.2519", "volume": "85", "author": "K.M. Kayes-Wandover", "year": "2000", "unstructured": "Kayes-Wandover, K.M. and P.C. White (2000). Steroidogenic enzyme gene expression in the human heart. J. Clin. Endocrinol. Metab. 85, 2519\u20132525.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1227", "doi-asserted-by": "publisher", "first-page": "223", "DOI": "10.1530/eje.0.1460223", "volume": "146", "author": "C. Puche", "year": "2002", "unstructured": "Puche, C., M. Jose, A. Cabero, and A. Meseguer (2002). Expression and enzymatic activity of the P450c17 gene in human adipose tissue. Eur. J. Endorinol. 146, 223\u2013229.", "journal-title": "Eur. J. Endorinol."}, {"key": "10_CR1228", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1093/oxfordjournals.jbchem.a002853", "volume": "129", "author": "K. Kusano", "year": "2001", "unstructured": "Kusano, K., M. Sakaguchi, N. Kagawa, M.R. Waterman, and T. Omura (2001). Microsomal P450s use specific proline-rich sequences for efficient folding, but not for maintenance of the folded structure. J. Biochem. (Tokyo) 129, 259\u2013269.", "journal-title": "J. Biochem. (Tokyo)"}, {"key": "10_CR1229", "first-page": "11200", "volume": "262", "author": "D.B. Hales", "year": "1987", "unstructured": "Hales, D.B., L.L. Sha, and A.H. Payne (1987). Testosterone inhibits cAMP-induced de novo synthesis of Leydig cell cytochrome P-450(17\u03b1) by an androgen receptor-mediated mechanism. J. Biol. Chem. 262, 11200\u201311206.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1230", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1016/0167-4781(96)00016-4", "volume": "1307", "author": "P. Zhang", "year": "1996", "unstructured": "Zhang, P., X.G. Han, S.H. Mellon, and P.F. Hall (1996). Expression of the gene for cytochrome P-450 17\u03b1-hydroxylase/C17-20 lyase (CYP17) in porcine Leydig cells: Identification of a DNA sequence that mediates cAMP response. Biochim. Biophys. Acta 1307, 73\u201382.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "10_CR1231", "doi-asserted-by": "publisher", "first-page": "226", "DOI": "10.1006/abbi.1997.0372", "volume": "348", "author": "A. Ogo", "year": "1997", "unstructured": "Ogo, A., M.R. Waterman, J.M. McAllister, and N. Kagawa (1997). The homeodomain protein Pbx1 is involved in cAMP-dependent transcription of human CYP17. Arch. Biochem. Biophys. 348, 226\u2013231.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1232", "doi-asserted-by": "crossref", "first-page": "489", "DOI": "10.3109/07435809809032637", "volume": "24", "author": "L.J. Bischof", "year": "1998", "unstructured": "Bischof, L.J., N. Kagawa, and M.R. Waterman (1998). The bovine CYP17 promoter contains a transcriptional regulatory element cooperatively bound by tale homeodomain proteins. Endocrinol. Res. 24, 489\u2013495.", "journal-title": "Endocrinol. Res."}, {"key": "10_CR1233", "doi-asserted-by": "publisher", "first-page": "1277", "DOI": "10.1210/me.15.8.1277", "volume": "15", "author": "C.J. Lin", "year": "2001", "unstructured": "Lin, C.J., J.W. Martens, and W.L. Miller (2001). NF-1C, Sp1, and Sp3 are essential for transcription of the human gene for P450c17 (steroid 17\u03b1-hydroxylase/17, 20 lyase) in human adrenal NCI-H295A cells. Mol. Endocrinol. 15, 1277\u20131293.", "journal-title": "Mol. Endocrinol."}, {"key": "10_CR1234", "doi-asserted-by": "publisher", "first-page": "1280", "DOI": "10.1210/en.143.4.1280", "volume": "143", "author": "M.B. Sewer", "year": "2002", "unstructured": "Sewer, M.B., V.Q. Nguyen, C.J. Huang, P.W. Tucker, N. Kagawa, and M.R. Waterman (2002). Transcriptional activation of human CYP17 in H295R adrenocortical cells depends on complex formation among p54nrb/NonO, protein-associated splicing factor, and SF-1, a complex that also participates in repression of transcription. Endocrinology 143, 1280\u20131290.", "journal-title": "Endocrinology"}, {"key": "10_CR1235", "doi-asserted-by": "publisher", "first-page": "1769", "DOI": "10.1210/en.143.5.1769", "volume": "143", "author": "M.B. Sewer", "year": "2002", "unstructured": "Sewer, M.B. and M.R. Waterman (2002). Adrenocorticotropin/cyclic adenosine 3\u2032,5\u2032-monophosphate-mediated transcription of the human CYP17 gene in the adrenal cortex is dependent on phosphatase activity. Endocrinology 143, 1769\u20131777.", "journal-title": "Endocrinology"}, {"key": "10_CR1236", "doi-asserted-by": "publisher", "first-page": "163", "DOI": "10.1677/jme.0.0290163", "volume": "29", "author": "M.B. Sewer", "year": "2002", "unstructured": "Sewer, M.B. and M.R. Waterman (2002). cAMP-dependent transcription of steroidogenic genes in the human adrenal cortex requires a dual-specificity phosphatase in addition to protein kinase A. J. Mol. Endocrinol. 29, 163\u2013174.", "journal-title": "J. Mol. Endocrinol."}, {"key": "10_CR1237", "doi-asserted-by": "publisher", "first-page": "8106", "DOI": "10.1074/jbc.M210264200", "volume": "278", "author": "M.B. Sewer", "year": "2003", "unstructured": "Sewer, M.B. and M.R. Waterman (2003). cAMP-dependent protein kinase enhances CYP17 transcription via MKP-1 activation in H295R human adrenocortical cells. J. Biol. Chem. 278, 8106\u20138111.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1238", "doi-asserted-by": "publisher", "first-page": "153", "DOI": "10.1016/0960-0760(95)00029-Y", "volume": "53", "author": "T. Yanase", "year": "1995", "unstructured": "Yanase, T. (1995). 17\u03b1-Hydroxylase/17,20-lyase defects. J. Steroid Biochem. Mol. Biol. 53, 153\u2013157.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10_CR1239", "doi-asserted-by": "publisher", "first-page": "160", "DOI": "10.1210/jc.79.1.160", "volume": "79", "author": "C.E. Fardella", "year": "1994", "unstructured": "Fardella, C.E., D.W. Hum, J. Homoki, and W.L. Miller (1994). Point mutation of Arg440 to His in cytochrome P450c17 causes severe 17\u03b1-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 79, 160\u2013164.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1240", "first-page": "19681", "volume": "268", "author": "T. Imai", "year": "1993", "unstructured": "Imai, T., H. Globerman, J.M. Gertner, N. Kagawa, and M.R. Waterman (1993). Expression and purification of functional human 17\u03b1-hydroxylase/17,20-lyase (P450c17) in Escherichia coli. Use of this system for study of a novel form of combined 17\u03b1-hydroxylase/17,20-lyase deficiency. J. Biol. Chem. 268, 19681\u201319689.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1241", "doi-asserted-by": "publisher", "first-page": "275", "DOI": "10.1017/S0003480097006180", "volume": "61", "author": "S. Monno", "year": "1997", "unstructured": "Monno, S., Y. Mizushima, N. Toyoda, T. Kashii, and M. Kobayashi (1997). A new variant of the cytochrome P450c17 (CYP17) gene mutation in three patients with 17\u03b1-hydroxylase deficiency. Ann. Hum. Genet. 61, 275\u2013279.", "journal-title": "Ann. Hum. Genet."}, {"key": "10_CR1242", "doi-asserted-by": "publisher", "first-page": "285", "DOI": "10.1007/BF00291172", "volume": "82", "author": "K. Kagimoto", "year": "1989", "unstructured": "Kagimoto, K., M.R. Waterman, M. Kagimoto, P. Ferreira, E.R. Simpson, and J.S. Winter (1989). Identification of a common molecular basis for combined 17\u03b1-hydroxylase/17,20-lyase deficiency in two Mennonite families. Hum. Genet. 82, 285\u2013286.", "journal-title": "Hum. Genet."}, {"key": "10_CR1243", "doi-asserted-by": "publisher", "first-page": "1934", "DOI": "10.1210/jc.82.6.1934", "volume": "82", "author": "H. Yamaguchi", "year": "1997", "unstructured": "Yamaguchi, H., M. Nakazato, M. Miyazato, K. Kangawa, and S. Matsukura (1997). A 5\u2032-splice site mutation in the cytochrome P450 steroid 17\u03b1-hydroxylase gene in 17\u03b1-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 82, 1934\u20131938.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1244", "doi-asserted-by": "publisher", "first-page": "201", "DOI": "10.1038/ng1097-201", "volume": "17", "author": "D.H. Geller", "year": "1997", "unstructured": "Geller, D.H., R.J. Auchus, B.B. Mendon\u00e7a, and W.L. Miller (1997). The genetic and functional basis of isolated 17,20-lyase deficiency. Nat. Genet. 17, 201\u2013205.", "journal-title": "Nat. Genet."}, {"key": "10_CR1245", "doi-asserted-by": "crossref", "first-page": "817", "DOI": "10.3109/07435809809032692", "volume": "24", "author": "W.L. Miller", "year": "1998", "unstructured": "Miller, W.L., D.H. Geller, and R.J. Auchus (1998). The molecular basis of isolated 17, 20 lyase deficiency. Endocrinol. Res. 24, 817\u2013825.", "journal-title": "Endocrinol. Res."}, {"key": "10_CR1246", "doi-asserted-by": "publisher", "first-page": "443", "DOI": "10.1081/ERC-120016821", "volume": "28", "author": "R.J. Auchus", "year": "2002", "unstructured": "Auchus, R.J. and M.K. Gupta (2002). Towards a unifying mechanism for CYP17 mutations that cause isolated 17,20-lyase deficiency. Endocrinol. Res. 28, 443\u2013447.", "journal-title": "Endocrinol. Res."}, {"key": "10_CR1247", "doi-asserted-by": "crossref", "first-page": "419", "DOI": "10.1007/978-1-4757-2391-5_12", "volume-title": "Cytochrome P450-Structure, Mechanism, and Biochemistry", "author": "N. Kagawa", "year": "1995", "unstructured": "Kagawa, N. and M.R. Waterman (1995). Regulation of steroidogenic and related P450s. In P.R. Ortiz de Montellano (ed.), Cytochrome P450-Structure, Mechanism, and Biochemistry, 2nd edn. Plenum Press, New York, pp. 419\u2013442.", "edition": "2nd edn."}, {"key": "10_CR1248", "doi-asserted-by": "publisher", "first-page": "14104", "DOI": "10.1021/bi00043a015", "volume": "34", "author": "P. Lee-Robichaud", "year": "1995", "unstructured": "P. Lee-Robichaud, A.Z. Shyadehi, J.N. Wright, M.E. Akhtar, and M. Akhtar (1995). Mechanistic kinship between hydroxylation and desaturation reactions: Acyl-carbon bond cleavage promoted by pig and human CYP17 (P-45017a; 17\u03b1-hydroxylase-17,20-lyase). Biochemistry 34, 14104\u201314113.", "journal-title": "Biochemistry"}, {"key": "10_CR1249", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.1016/S0960-0760(01)00105-4", "volume": "78", "author": "S. Lieberman", "year": "2001", "unstructured": "Lieberman, S. and P.A. Warne (2001). 17-Hydroxylase: An evaluation of the present view of its catalytic role in steroidogenesis. J. Steroid Biochem. Mol. Biol. 78, 299\u2013312.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10_CR1250", "doi-asserted-by": "publisher", "first-page": "1349", "DOI": "10.1046/j.1432-1033.2003.03508.x", "volume": "270", "author": "P. Soucy", "year": "2003", "unstructured": "Soucy, P., L. Lacoste, and V. Luu-The (2003). Assessment of porcine and human 16-enesynthase, a third activity of P450c17, in the formation of an androstenol precursor. Eur. J. Biochem. 270, 1349\u20131355.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR1251", "doi-asserted-by": "publisher", "first-page": "343", "DOI": "10.1006/abbi.1995.1173", "volume": "317", "author": "M. Katagiri", "year": "1995", "unstructured": "Katagiri, M., N. Kagawa, and M.R. Waterman (1995). The role of cytochrome b 5 in the biosynthesis of androgens by human P450c17. Arch. Biochem. Biophys. 317, 343\u2013347.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1252", "doi-asserted-by": "publisher", "first-page": "133", "DOI": "10.1016/S0039-128X(96)00172-9", "volume": "62", "author": "W.L. Miller", "year": "1997", "unstructured": "Miller, W.L., R.J. Auchus, and D.H. Geller (1997). The regulation of 17, 20 lyase activity. Steroids 62, 133\u2013142.", "journal-title": "Steroids"}, {"key": "10_CR1253", "doi-asserted-by": "publisher", "first-page": "1226", "DOI": "10.1210/jc.85.3.1226", "volume": "85", "author": "A. Biason-Lauber", "year": "2000", "unstructured": "Biason-Lauber, A., B. Kempken, E. Werder, M.G. Forest, S. Einaudi, M.B. Ranke et al. (2000). 17\u03b1-hydroxylase/17,20-lyase deficiency as a model to study enzymatic activity regulation: Role of phosphorylation. J. Clin. Endocrinol. Metab. 85, 1226\u20131231.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1254", "doi-asserted-by": "publisher", "first-page": "71", "DOI": "10.1016/S0960-0760(01)00171-6", "volume": "80", "author": "P. Soucy", "year": "2002", "unstructured": "Soucy, P. and V. Luu-The (2002). Assessment of the ability of type 2 cytochrome b 5 to modulate 17,20-lyase activity of human P450c17. J. Steroid Biochem. Mol. Biol. 80, 71\u201375.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10_CR1255", "doi-asserted-by": "publisher", "first-page": "1598", "DOI": "10.1021/bi9821059", "volume": "38", "author": "B.J. Brock", "year": "1999", "unstructured": "Brock, B.J. and M.R. Waterman (1999). Biochemical differences between rat and human cytochrome P450c17 support the different steroidogenic needs of these two species. Biochemistry 38, 1598\u20131606.", "journal-title": "Biochemistry"}, {"key": "10_CR1256", "doi-asserted-by": "publisher", "first-page": "2800", "DOI": "10.1021/bi9715066", "volume": "37", "author": "T. Yamazaki", "year": "1998", "unstructured": "Yamazaki, T., T. Ohno, T. Sakaki, M. Akiyoshi-Shibata, Y. Yabusaki, T. Imai et al. (1998). Kinetic analysis of successive reactions catalyzed by bovine cytochrome P45017\u03b1,lyase. Biochemistry 37, 2800\u20132806.", "journal-title": "Biochemistry"}, {"key": "10_CR1257", "doi-asserted-by": "publisher", "first-page": "3243", "DOI": "10.1046/j.1432-1327.2000.01349.x", "volume": "267", "author": "P. Soucy", "year": "2000", "unstructured": "Soucy, P. and V. Luu-The (2000). Conversion of pregnenolone to DHEA by human 17\u03b1-hydroxylase/17,20-lyase (P450c17). Evidence that DHEA is produced from the released intermediate, 17\u03b1-hydroxypregnenolone. Eur. J. Biochem. 267, 3243\u20133247.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR1258", "first-page": "25811", "volume": "268", "author": "S. Monno", "year": "1993", "unstructured": "Monno, S., H. Ogawa, T. Date, M. Fujioka, W.L. Miller, and M. Kobayashi (1993). Mutation of histidine 373 to leucine in cytochrome P450c17 causes 17\u03b1-hydroxylase deficiency. J. Biol. Chem. 268, 25811\u201325817.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1259", "doi-asserted-by": "publisher", "first-page": "254", "DOI": "10.1006/mgme.2000.3134", "volume": "72", "author": "C.W. Lam", "year": "2001", "unstructured": "Lam, C.W., W. Arlt, C.K. Chan, J.W. Honour, C.J. Lin, S.F. Tong et al. (2001). Mutation of proline 409 to arginine in the meander region of cytochrome p450c17 causes severe 17\u03b1-hydroxylase deficiency. Mol. Genet. Metab. 72, 254\u2013259.", "journal-title": "Mol. Genet. Metab."}, {"key": "10_CR1260", "doi-asserted-by": "crossref", "first-page": "967", "DOI": "10.1042/bj3300967", "volume": "330", "author": "P. Lee-Robichaud", "year": "1998", "unstructured": "Lee-Robichaud, P., M.E. Akhtar, and M. Akhtar (1998). An analysis of the role of active site protic residues of cytochrome P-450s: Mechanistic and mutational studies on 17\u03b1-hydroxylase-17,20-lyase (P-45017\u03b1 also CYP17). Biochem. J. 330, 967\u2013974.", "journal-title": "Biochem. J."}, {"key": "10_CR1261", "doi-asserted-by": "crossref", "first-page": "1373", "DOI": "10.1210/mend-5-10-1373", "volume": "5", "author": "M. Kitamura", "year": "1991", "unstructured": "Kitamura, M., E. Buczko, and M.L. Dufau (1991). Dissociation of hydroxylase and lyase activities by site-directed mutagenesis of the rat P45017\u03b1. Mol. Endocrinol. 5, 1373\u20131380.", "journal-title": "Mol. Endocrinol."}, {"key": "10_CR1262", "doi-asserted-by": "publisher", "first-page": "3807", "DOI": "10.1210/jc.82.11.3807", "volume": "82", "author": "A. Biason-Lauber", "year": "1997", "unstructured": "Biason-Lauber, A., E. Leiberman, and M. Zachmann (1997). A single amino acid substitution in the putative redox partner-binding site of P450c17 as cause of iolated 17,20-lyase deficiency. J. Clin. Endocrinol. Metab. 82, 3807\u20133812.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1263", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1042/bj3320293", "volume": "332", "author": "P. Lee-Robichaud", "year": "1998", "unstructured": "Lee-Robichaud, P., M.E. Akhtar, and M. Akhtar (1998). Control of androgen biosynthesis in the human through the interaction of Arg347 and Arg358 of CYP17 with cytochrome b 5. Biochem. J. 332, 293\u2013296.", "journal-title": "Biochem. J."}, {"key": "10_CR1264", "doi-asserted-by": "publisher", "first-page": "309", "DOI": "10.1042/0264-6021:3420309", "volume": "342", "author": "P. LeeRobichaud", "year": "1999", "unstructured": "LeeRobichaud, P., M.E. Akhtar, and M. Akhtar (1999). Lysine mutagenesis identifies cationic charges of human CYP17 that interact with cytochrome b 5 to promote male sex-hormone biosynthesis. Biochem. J. 342, 309\u2013312.", "journal-title": "Biochem. J."}, {"key": "10_CR1265", "doi-asserted-by": "crossref", "first-page": "695", "DOI": "10.3109/07435800009048589", "volume": "26", "author": "R.J. Auchus", "year": "2000", "unstructured": "Auchus, R.J., K. Worthy, D.H. Geller, and W.L. Miller (2000). Probing structural and functional domains of human P450c17. Endocrinol. Res. 26, 695\u2013703.", "journal-title": "Endocrinol. Res."}, {"key": "10_CR1266", "doi-asserted-by": "publisher", "first-page": "4416", "DOI": "10.1210/jc.86.9.4416", "volume": "86", "author": "M.K. Gupta", "year": "2001", "unstructured": "Gupta, M.K., D.H. Geller, and R.J. Auchus (2001). Pitfalls in characterizing P450c17 mutations associated with isolated 17,20-lyase deficiency. J. Clin. Endocrinol. Metab. 86, 4416\u20134423.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1267", "doi-asserted-by": "publisher", "first-page": "898", "DOI": "10.1210/jc.87.2.898", "volume": "87", "author": "A. Cerbo Di", "year": "2002", "unstructured": "Di Cerbo, A., A. Biason-Lauber, M. Savino, M.R. Piemontese, A. Di Giorgio, M. Perona et al. (2002). Combined 17\u03b1-hydroxylase/17,20-lyase deficiency caused by Phe93Cys mutation in the CYP17 gene. J. Clin. Endocrinol. Metab. 87, 898\u2013905.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1268", "doi-asserted-by": "publisher", "first-page": "141", "DOI": "10.1159/000049986", "volume": "55", "author": "N. Katsumata", "year": "2001", "unstructured": "Katsumata, N., M. Satoh, A. Mikami, S. Mikami, A. Nagashima-Miyokawa, N. Sato et al. (2001). New compound heterozygous mutation in the CYP17 gene in a 46,XY girl with 17\u03b1-hydroxylase/17,20-lyase deficiency. Horm. Res. 55, 141\u2013146.", "journal-title": "Horm. Res."}, {"key": "10_CR1269", "doi-asserted-by": "publisher", "first-page": "401", "DOI": "10.1006/abbi.1999.1557", "volume": "373", "author": "B.J. Brock", "year": "2000", "unstructured": "Brock, B.J. and M.R. Waterman (2000). The use of random chimeragenesis to study structure/function properties of rat and human P450c17. Arch. Biochem. Biophys. 373, 401\u2013408.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1270", "doi-asserted-by": "publisher", "first-page": "99", "DOI": "10.1016/S0960-0760(01)00172-8", "volume": "80", "author": "A.P. Mathieu", "year": "2002", "unstructured": "Mathieu, A.P., R.J. Auchus, and J.G. LeHoux (2002). Comparison of the hamster and human adrenal P450c17 (17\u03b1-hydroxylase/17,20-lyase) using site-directed mutagenesis and molecular modeling. J. Steroid Biochem. Mol. Biol. 80, 99\u2013107.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10_CR1271", "doi-asserted-by": "publisher", "first-page": "392", "DOI": "10.1210/me.8.3.392", "volume": "8", "author": "D. Lin", "year": "1994", "unstructured": "Lin, D., L.H. Zhang, E. Chiao, and W.L. Miller (1994). Modeling and mutagenesis of the active site of human P450c17. Mol. Endocrinol. 8, 392\u2013402.", "journal-title": "Mol. Endocrinol."}, {"key": "10_CR1272", "first-page": "113", "volume": "12", "author": "D.F. Burke", "year": "1997", "unstructured": "Burke, D.F., C.A. Laughton, and S. Neidle (1997). Homology modelling of the enzyme P450 17\u03b1-hydroxylase/17,20-lyase\u2014a target for prostate cancer chemotherapy\u2014from the crystal structure of P450BM-3. Anticancer Drug Des. 12, 113\u2013123.", "journal-title": "Anticancer Drug Des"}, {"key": "10_CR1273", "doi-asserted-by": "publisher", "first-page": "1169", "DOI": "10.1210/me.13.7.1169", "volume": "13", "author": "R.J. Auchus", "year": "1999", "unstructured": "Auchus, R.J. and W.L. Miller (1999). Molecular modeling of human P450c17 (17\u03b1-hydroxylase/17,20-lyase): Insights into reaction mechanisms and effects of mutations. Mol. Endocrinol. 13, 1169\u20131182.", "journal-title": "Mol. Endocrinol."}, {"key": "10_CR1274", "doi-asserted-by": "publisher", "first-page": "1487", "DOI": "10.1016/S0968-0896(99)00077-2", "volume": "7", "author": "S. Ahmed", "year": "1999", "unstructured": "Ahmed, S. (1999). A novel molecular modelling study of inhibitors of the 17\u03b1-hydroxylase component of the enzyme system 17\u03b1-hydroxylase/17,20-lyase (P-45017\u03b1). Bioorg. Med. Chem. 7, 1487\u20131496.", "journal-title": "Bioorg. Med. Chem."}, {"key": "10_CR1275", "first-page": "435", "volume": "56", "author": "A. Schappach", "year": "2001", "unstructured": "Schappach, A. and H.D. Holtje (2001). Molecular modelling of 17\u03b1-hydroxylase-17,20-lyase. Pharmazie 56, 435\u2013442.", "journal-title": "Pharmazie"}, {"key": "10_CR1276", "doi-asserted-by": "publisher", "first-page": "1023", "DOI": "10.1016/0022-4731(85)90062-7", "volume": "23", "author": "P.B. Kan", "year": "1985", "unstructured": "Kan, P.B., M.A. Hirst, and D. Feldman (1985). Inhibition of steroidogenic cytochrome P-450 enzymes in rat testis by ketoconazole and related imidazole anti-fungal drugs. J. Steroid Biochem. 23, 1023\u20131029.", "journal-title": "J. Steroid Biochem."}, {"key": "10_CR1277", "doi-asserted-by": "publisher", "first-page": "421", "DOI": "10.1016/0960-0760(92)90147-B", "volume": "42", "author": "D.C. Kossor", "year": "1992", "unstructured": "Kossor, D.C., S. Kominami, S. Takemori, and H.D. Colby (1992). Destruction of testicular cytochrome P-450 by 7\u03b1-thiospironolactone is catalyzed by the 17\u03b1-hydroxylase. J. Steroid Biochem. Mol. Biol. 42, 421\u2013424.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10_CR1278", "doi-asserted-by": "publisher", "first-page": "2463", "DOI": "10.1021/jm00013a022", "volume": "38", "author": "G.A. Potter", "year": "1995", "unstructured": "Potter, G.A., S.E. Barrie, M. Jarman, and M.G. Rowlands (1995). Novel steroidal inhibitors of human cytochrome P45017\u03b1 (17\u03b1-hydroxylase-C17,20-lyase): Potential agents for the treatment of prostatic cancer. J. Med. Chem. 38, 2463\u20132471.", "journal-title": "J. Med. Chem."}, {"key": "10_CR1279", "doi-asserted-by": "publisher", "first-page": "4335", "DOI": "10.1021/jm960245f", "volume": "39", "author": "J.S. Li", "year": "1996", "unstructured": "Li, J.S., Y. Li, C. Son, and A.M. Brodie (1996). Synthesis and evaluation of pregnane derivatives as inhibitors of human testicular 17\u03b1-hydroxylase/C17,20-lyase. J. Med. Chem. 39, 4335\u20134339.", "journal-title": "J. Med. Chem."}, {"key": "10_CR1280", "first-page": "163", "volume": "5", "author": "V.C. Njar", "year": "1999", "unstructured": "Njar, V.C. and A.M. Brodie (1999). Inhibitors of 17\u03b1-hydroxylase/17,20-lyase (CYP17): Potential agents for the treatment of prostate cancer. Curr. Pharm. Des. 5, 163\u2013180.", "journal-title": "Curr. Pharm. Des."}, {"key": "10_CR1281", "doi-asserted-by": "publisher", "first-page": "4437", "DOI": "10.1021/jm991070n", "volume": "43", "author": "R.W. Hartmann", "year": "2000", "unstructured": "Hartmann, R.W., M. Hector, B.G. Wachall, A. Palusczak, M. Palzer, V. Huch et al. (2000). Synthesis and evaluation of 17-aliphatic heterocycle-substituted steroidal inhibitors of 17\u03b1-hydroxylase/C17-20-lyase (P450 17). J. Med. Chem. 43, 4437\u20134445.", "journal-title": "J. Med. Chem."}, {"key": "10_CR1282", "doi-asserted-by": "publisher", "first-page": "929", "DOI": "10.1016/S0968-0896(01)00354-6", "volume": "10", "author": "J.P. Burkhart", "year": "2002", "unstructured": "Burkhart, J.P., P.M. Weintraub, C.A. Gates, R.J. Resvick, R.J. Vaz, D. Friedrich et al. (2002). Novel steroidal vinyl fluorides as inhibitors of steroid C17 (20) lyase. Bioorg. Med. Chem. 10, 929\u2013934.", "journal-title": "Bioorg. Med. Chem."}, {"key": "10_CR1283", "doi-asserted-by": "publisher", "first-page": "134", "DOI": "10.1016/S0003-9861(02)00491-5", "volume": "409", "author": "R.J. Auchus", "year": "2003", "unstructured": "Auchus, R.J., A. Sampath Kumar, C. Andrew Boswell, M.K. Gupta, K. Bruce, N.P. Rath et al. (2003). The enantiomer of progesterone (ent-progesterone) is a competitive inhibitor of human cytochromes P450c17 and P450c21. Arch. Biochem. Biophys. 409, 134\u2013144.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1284", "doi-asserted-by": "publisher", "first-page": "427", "DOI": "10.1211/0022357991772637", "volume": "51", "author": "C.P. Owen", "year": "1999", "unstructured": "Owen, C.P., P.J. Nicholls, H.J. Smith, and R. Whomsley (1999). Inhibition of aromatase (P450Arom) by some 1-(benzofuran-2-ylmethyl) imidazoles. J. Pharm. Pharmacol. 51, 427\u2013433.", "journal-title": "J. Pharm. Pharmacol."}, {"key": "10_CR1285", "doi-asserted-by": "publisher", "first-page": "672", "DOI": "10.1021/jm000955s", "volume": "44", "author": "M. Recanatini", "year": "2001", "unstructured": "Recanatini, M., A. Bisi, A. Cavalli, F. Belluti, S. Gobbi, A. Rampa et al. (2001). A new class of nonsteroidal aromatase inhibitors: Design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17\u03b1-hydroxylase/C17,20-lyase. J. Med. Chem. 44, 672\u2013680.", "journal-title": "J. Med. Chem."}, {"key": "10_CR1286", "doi-asserted-by": "publisher", "first-page": "251", "DOI": "10.1021/jm015567k", "volume": "45", "author": "A. Cavalli", "year": "2002", "unstructured": "Cavalli, A. and M. Recanatini (2002). Looking for selectivity among cytochrome P450 inhibitors. J. Med. Chem. 45, 251\u2013254.", "journal-title": "J. Med. Chem."}, {"key": "10_CR1287", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1016/S0960-0760(00)00137-0", "volume": "75", "author": "P.B. Ehmer", "year": "2000", "unstructured": "Ehmer, P.B., J. Jose, and R.W. Hartmann (2000). Development of a simple and rapid assay for the evaluation of inhibitors of human 17\u03b1-hydroxylase-C17,20-lyase (P450c17) by coexpression of P450c17 with NADPH-cytochrome-P450-reductase in Escherichia coli. J. Steroid Biochem. Mol. Biol. 75, 57\u201363.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10_CR1288", "doi-asserted-by": "publisher", "first-page": "319", "DOI": "10.1006/abio.1998.2993", "volume": "267", "author": "D.N. Grigoryev", "year": "1999", "unstructured": "Grigoryev, D.N., K. Kato, V.C. Njar, B.J. Long, Y.Z. Ling, X. Wang et al. (1999). Cytochrome P450c17-expressing Escherichia coli as a first-step screening system for 17\u03b1-hydroxylase-C17,20-lyase inhibitors. Anal. Biochem. 267, 319\u2013330.", "journal-title": "Anal. Biochem."}, {"key": "10_CR1289", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1016/S0889-8529(08)70021-5", "volume": "30", "author": "R.J. Auchus", "year": "2001", "unstructured": "Auchus, R.J. (2001). The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol. Metab. Clin. North Am. 30, 101\u2013119, vii.", "journal-title": "Endocrinol. Metab. Clin. North Am."}, {"key": "10_CR1290", "doi-asserted-by": "crossref", "first-page": "32", "DOI": "10.1210/jcem-57-1-32", "volume": "57", "author": "F.R. Kaufman", "year": "1983", "unstructured": "Kaufman, F.R., G. Costin, U. Goebelsmann, F.Z. Stanczyk, and M. Zachmann (1983). Male pseudohermaphroditism due to 17,20-desmolase deficiency. J. Clin. Endocrinol. Metab. 57, 32\u201336.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1291", "first-page": "721", "volume": "17", "author": "J. Huang", "year": "1999", "unstructured": "Huang, J., T. Ushiyama, K. Inoue, K. Mori, and S. Hukuda (1999). Possible association of CYP17 gene polymorphisms with the onset of rheumatoid arthritis. Clin. Exp. Rheumatol. 17, 721\u2013724.", "journal-title": "Clin. Exp. Rheumatol."}, {"key": "10_CR1292", "doi-asserted-by": "publisher", "first-page": "449", "DOI": "10.1006/mgme.2001.3260", "volume": "74", "author": "J. Lai", "year": "2001", "unstructured": "Lai, J., D. Vesprini, W. Chu, H. Jernstrom, and S.A. Narod (2001). CYP gene polymorphisms and early menarche. Mol. Genet. Metab. 74, 449\u2013457.", "journal-title": "Mol. Genet. Metab."}, {"key": "10_CR1293", "first-page": "3908", "volume": "59", "author": "H.S. Feigelson", "year": "1999", "unstructured": "Feigelson, H.S., R. McKean-Cowdin, M.C. Pike, G.A. Coetzee, L.N. Kolonel, A.M. Nomura et al. (1999). Cytochrome P450c17alpha gene (CYP17) polymorphism predicts use of hormone replacement therapy. Cancer Res 59, 3908\u20133910.", "journal-title": "Cancer Res"}, {"key": "10_CR1294", "first-page": "123", "volume": "15", "author": "B. Marszalek", "year": "2001", "unstructured": "Marszalek, B., M. Lacinski, N. Babych, E. Capla, J. Biernacka-Lukanty, A. Warenik-Szymankiewicz et al. (2001). Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5\u2032-UTR in patients with polycystic ovarian syndrome. Gynecol. Endocrinol. 15, 123\u2013128.", "journal-title": "Gynecol. Endocrinol."}, {"key": "10_CR1295", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1016/S0027-5107(01)00212-3", "volume": "482", "author": "V.N. Kristensen", "year": "2001", "unstructured": "Kristensen, V.N., E.H. Kure, B. Erikstein, N. Harada, and A. Borresen-Dale (2001). Genetic susceptibility and environmental estrogen-like compounds. Mutat. Res. 482, 77\u201382.", "journal-title": "Mutat. Res."}, {"key": "10_CR1296", "first-page": "1063", "volume": "57", "author": "H.S. Feigelson", "year": "1997", "unstructured": "Feigelson, H.S., G.A. Coetzee, L.N. Kolonel, R.K. Ross, and B.E. Henderson (1997). A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res. 57, 1063\u20131065.", "journal-title": "Cancer Res"}, {"key": "10_CR1297", "first-page": "785", "volume": "61", "author": "H.S. Feigelson", "year": "2001", "unstructured": "Feigelson, H.S., R. McKean-Cowdin, G.A. Coetzee, D.O. Stram, L.N. Kolonel, and B.E. Henderson (2001). Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates. Cancer Res. 61, 785\u2013789.", "journal-title": "Cancer Res"}, {"key": "10_CR1298", "unstructured": "Thompson, P.A. and C. Ambrosone (2000). Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J. Natl. Cancer Inst. Monogr., 125\u2013134.", "DOI": "10.1093/oxfordjournals.jncimonographs.a024235", "doi-asserted-by": "crossref"}, {"key": "10_CR1299", "first-page": "1343", "volume": "9", "author": "K. Mitrunen", "year": "2000", "unstructured": "Mitrunen, K., N. Jourenkova, V. Kataja, M. Eskelinen, V.M. Kosma, S. Benhamou et al. (2000). Steroid metabolism gene CYP17 polymorphism and the development of breast cancer. Cancer Epidemiol. Biomarkers Prev. 9, 1343\u20131348.", "journal-title": "Cancer Epidemiol. Biomarkers Prev."}, {"key": "10_CR1300", "doi-asserted-by": "publisher", "first-page": "119", "DOI": "10.1093/mutage/17.2.119", "volume": "17", "author": "Z. Ye", "year": "2002", "unstructured": "Ye, Z. and J.M. Parry (2002). The CYP17 MspA1 polymorphism and breast cancer risk: A metanalysis. Mutagenesis 17, 119\u2013126.", "journal-title": "Mutagenesis"}, {"key": "10_CR1301", "doi-asserted-by": "publisher", "first-page": "445", "DOI": "10.1093/mutage/17.5.445", "volume": "17", "author": "H.S. Feigelson", "year": "2002", "unstructured": "Feigelson, H.S., R. McKean-Cowdin, and B.E. Henderson (2002). Concerning the CYP17 MspA1 polymorphism and breast cancer risk: A meta-analysis. Mutagenesis 17, 445\u2013446.", "journal-title": "Mutagenesis"}, {"key": "10_CR1302", "doi-asserted-by": "publisher", "first-page": "R45", "DOI": "10.1186/bcr570", "volume": "5", "author": "C.B. Ambrosone", "year": "2003", "unstructured": "Ambrosone, C.B., K.B. Moysich, H. Furberg, J.L. Freudenheim, E.D. Bowman, S. Ahmed et al. (2003). CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors. Breast Cancer Res. 5, R45\u201351.", "journal-title": "Breast Cancer Res"}, {"key": "10_CR1303", "first-page": "243", "volume": "11", "author": "J.L. Stanford", "year": "2002", "unstructured": "Stanford, J.L., E.A. Noonan, L. Iwasaki, S. Kolb, R.B. Chadwick, Z. Feng et al. (2002). A polymorphism in the CYP17 gene and risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 11, 243\u2013247.", "journal-title": "Cancer Epidemiol. Biomarkers Prev."}, {"key": "10_CR1304", "first-page": "743", "volume": "10", "author": "C.A. Haiman", "year": "2001", "unstructured": "Haiman, C.A., M.J. Stampfer, E. Giovannucci, J. Ma, N.E. Decalo, P.W. Kantoff et al. (2001). The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer. Cancer Epidemiol. Biomarkers Prev. 10, 743\u2013748.", "journal-title": "Cancer Epidemiol. Biomarkers Prev."}, {"key": "10_CR1305", "first-page": "848", "volume": "61", "author": "R. McKean-Cowdin", "year": "2001", "unstructured": "McKean-Cowdin, R., H.S. Feigelson, M.C. Pike, G.A. Coetzee, L.N. Kolonel, and B.E. Henderson (2001). Risk of endometrial cancer and estrogen replacement therapy history by CYP17 genotype. Cancer Res. 61, 848\u2013849.", "journal-title": "Cancer Res"}, {"key": "10_CR1306", "doi-asserted-by": "publisher", "first-page": "187", "DOI": "10.1530/eje.0.1420187", "volume": "142", "author": "R. Carmo Silva de", "year": "2000", "unstructured": "de Carmo Silva, R., C.E. Kater, S.A. Dib, S. Laureti, F. Forini, A. Cosentino et al. (2000). Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, sidechain cleavage and 17\u03b1-hydroxylase in Addison\u2019s disease and autoimmune polyendocrine syndrome type III. Eur. J. Endocrinol. 142, 187\u2013194.", "journal-title": "Eur. J. Endocrinol."}, {"key": "10_CR1307", "doi-asserted-by": "publisher", "first-page": "93", "DOI": "10.1146/annurev.physiol.64.081601.142703", "volume": "64", "author": "E.R. Simpson", "year": "2002", "unstructured": "Simpson, E.R., C. Clyne, G. Rubin, W.C. Boon, K. Robertson, K. Britt et al. (2002). Aromatase\u2014a brief overview. Annu. Rev. Physiol. 64, 93\u2013127.", "journal-title": "Annu. Rev. Physiol."}, {"key": "10_CR1308", "doi-asserted-by": "publisher", "first-page": "247", "DOI": "10.1016/S0960-0760(01)00141-8", "volume": "79", "author": "C.E. Roselli", "year": "2001", "unstructured": "Roselli, C.E. and J.A. Resko (2001). Cytochrome P450 aromatase (CYP19) in the non-human primate brain: Distribution, regulation, and functional significance. J. Steroid Biochem. Mol. Biol. 79, 247\u2013253.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10_CR1309", "doi-asserted-by": "publisher", "first-page": "1001", "DOI": "10.1016/0006-291X(92)92303-F", "volume": "189", "author": "N. Harada", "year": "1992", "unstructured": "Harada, N. (1992). A unique aromatase (P-450AROM) mRNA formed by alternative use of tissue-specific exons 1 in human skin fibroblasts. Biochem. Biophys. Res. Commun. 189, 1001\u20131007.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1310", "doi-asserted-by": "publisher", "first-page": "193", "DOI": "10.1016/S0960-0760(01)00157-1", "volume": "79", "author": "M.M. Hinshelwood", "year": "2001", "unstructured": "Hinshelwood, M.M. and C.R. Mendelson (2001). Tissue-specific expression of the human CYP19 (aromatase) gene in ovary and adipose tissue of transgenic mice. J. Steroid Biochem. Mol. Biol. 79, 193\u2013201.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10_CR1311", "doi-asserted-by": "publisher", "first-page": "2540", "DOI": "10.1210/jc.87.6.2540", "volume": "87", "author": "M. Shozu", "year": "2002", "unstructured": "Shozu, M., H. Sumitani, T. Segawa, H.J. Yang, K. Murakami, T. Kasai et al. (2002). Over-expression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19). J. Clin. Endocrinol. Metab. 87, 2540\u20132548.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1312", "doi-asserted-by": "publisher", "first-page": "2863", "DOI": "10.1210/en.143.8.2863", "volume": "143", "author": "G.L. Rubin", "year": "2002", "unstructured": "Rubin, G.L., J.H. Duong, C.D. Clyne, C.J. Speed, Y. Murata, C. Gong et al. (2002). Ligands for the peroxisomal proliferator-activated receptor gamma and the retinoid X receptor inhibit aromatase cytochrome P450 (CYP19) expression mediated by promoter II in human breast adipose. Endocrinology 143, 2863\u20132871.", "journal-title": "Endocrinology"}, {"key": "10_CR1313", "doi-asserted-by": "publisher", "first-page": "20591", "DOI": "10.1074/jbc.M201117200", "volume": "277", "author": "C.D. Clyne", "year": "2002", "unstructured": "Clyne, C.D., C.J. Speed, J. Zhou, and E.R. Simpson (2002). Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes. J. Biol. Chem. 277, 20591\u201320597.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1314", "doi-asserted-by": "publisher", "first-page": "173", "DOI": "10.1016/S0960-0760(01)00156-X", "volume": "79", "author": "A. Kamat", "year": "2001", "unstructured": "Kamat, A. and C.R. Mendelson (2001). Identification of the regulatory regions of the human aromatase P450 (CYP19) gene involved in placenta-specific expression. J. Steroid Biochem. Mol. Biol. 79, 173\u2013180.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10_CR1315", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1023/A:1021112121782", "volume": "77", "author": "C.A. Haiman", "year": "2003", "unstructured": "Haiman, C.A., S.E. Hankinson, I. De Vivo, C. Guillemette, N. Ishibe, D.J. Hunter et al. (2003). Polymorphisms in steroid hormone pathway genes and mammographic density. Breast Cancer Res. Treat. 77, 27\u201336.", "journal-title": "Breast Cancer Res. Treat."}, {"key": "10_CR1316", "doi-asserted-by": "publisher", "first-page": "1284", "DOI": "10.1021/ja00212a043", "volume": "110", "author": "P.A. Cole", "year": "1988", "unstructured": "Cole, P.A. and C.H. Robinson (1988). A peroxide model reaction for placental aromatase. J. Am. Chem. Soc. 110, 1284\u20131285.", "journal-title": "J. Am. Chem. Soc."}, {"key": "10_CR1317", "doi-asserted-by": "publisher", "first-page": "4410", "DOI": "10.1021/bi00180a039", "volume": "33", "author": "M. Akhtar", "year": "1994", "unstructured": "Akhtar, M., D. Corina, S. Miller, A.Z. Shyadehi, and J.N. Wright (1994). Mechanism of the acyl-carbon cleavage and related reactions catalyzed by multifunctional P-450s: Studies on cytochrome P45017\u03b1. Biochemistry 33, 4410\u20134418.", "journal-title": "Biochemistry"}, {"key": "10_CR1318", "doi-asserted-by": "publisher", "first-page": "8963", "DOI": "10.1073/pnas.88.20.8963", "volume": "88", "author": "E.S. Roberts", "year": "1991", "unstructured": "Roberts, E.S., A.D.N. Vaz, and M.J. Coon (1991). Catalysis by cytochrome P-450 of an oxidative reaction in xenobiotic aldehyde metabolism: Deformylation with olefin formation. Proc. Natl. Acad. Sci. USA 88, 8963\u20138966.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1319", "doi-asserted-by": "publisher", "first-page": "1107", "DOI": "10.1016/S0047-6374(01)00394-3", "volume": "123", "author": "R. Takayanagi", "year": "2002", "unstructured": "Takayanagi, R., K. Goto, S. Suzuki, S. Tanaka, S. Shimoda, and H. Nawata (2002). Dehydroepiandrosterone (DHEA) as a possible source for estrogen formation in bone cells: Correlation between bone mineral density and serum DHEA-sulfate concentration in postmenopausal women, and the presence of aromatase to be enhanced by 1,25-dihydroxyvitamin D3 in human osteoblasts. Mech. Ageing Dev. 123, 1107\u20131114.", "journal-title": "Mech. Ageing Dev."}, {"key": "10_CR1320", "doi-asserted-by": "publisher", "first-page": "1317", "DOI": "10.1016/S0006-2952(02)01361-8", "volume": "64", "author": "F. Zhang", "year": "2002", "unstructured": "Zhang, F., D. Zhou, Y.C. Kao, J. Ye, and S. Chen (2002). Expression and purification of a recombinant form of human aromatase from Escherichia coli. Biochem. Pharmacol. 64, 1317\u20131324.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR1321", "doi-asserted-by": "publisher", "first-page": "205", "DOI": "10.1016/S0039-128X(02)00168-X", "volume": "68", "author": "N. Kagawa", "year": "2003", "unstructured": "Kagawa, N., Q. Cao, and K. Kusano (2003). Expression of human aromatase (CYP19) in Escherichia coli by N-terminal replacement and induction of cold stress response. Steroids 68, 205\u2013209.", "journal-title": "Steroids"}, {"key": "10_CR1322", "first-page": "11939", "volume": "266", "author": "S. Graham-Lorence", "year": "1991", "unstructured": "Graham-Lorence, S., M.W. Khalil, M.C. Lorence, C.R. Mendelson, and E.R. Simpson (1991). Structure-function relationships of human aromatase cytochrome P-450 using molecular modeling and site-directed mutagenesis. J. Biol. Chem. 266, 11939\u201311946.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1323", "doi-asserted-by": "publisher", "first-page": "1456", "DOI": "10.1210/me.16.7.1456", "volume": "16", "author": "A. Conley", "year": "2002", "unstructured": "Conley, A., S. Mapes, C.J. Corbin, D. Greger, and S. Graham (2002). Structural determinants of aromatase cytochrome P450 inhibition in substrate recognition site-1. Mol. Endocrinol. 16, 1456\u20131468.", "journal-title": "Mol. Endocrinol."}, {"key": "10_CR1324", "first-page": "3322s", "volume": "42", "author": "P.A. Marcotte", "year": "1982", "unstructured": "Marcotte, P.A. and C.H. Robinson (1982). Design of mechanism-based inactivators of human placental aromatase. Cancer Res. 42, 3322s\u20133326s.", "journal-title": "Cancer Res"}, {"key": "10_CR1325", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.1586/14737140.2.2.181", "volume": "2", "author": "R.W. Brueggemeier", "year": "2002", "unstructured": "Brueggemeier, R.W. (2002). Aromatase inhibitors in breast cancer therapy. Expert Rev. Anticancer Ther. 2, 181\u2013191.", "journal-title": "Expert Rev. Anticancer Ther."}, {"key": "10_CR1326", "doi-asserted-by": "crossref", "first-page": "326", "DOI": "10.1016/S0925-4439(02)00096-0", "volume": "1587", "author": "P. Lombardi", "year": "2002", "unstructured": "Lombardi, P. (2002). Exemestane, a new steroidal aromatase inhibitor of clinical relevance. Biochim. Biophys. Acta 1587, 326\u2013337.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "10_CR1327", "doi-asserted-by": "publisher", "first-page": "265", "DOI": "10.1007/s101470200038", "volume": "7", "author": "P.E. Lonning", "year": "2002", "unstructured": "Lonning, P.E. (2002). The role of aromatase inactivators in the treatment of breast cancer. Int. J. Clin. Oncol. 7, 265\u2013270.", "journal-title": "Int. J. Clin. Oncol."}, {"issue": "Suppl 6", "key": "10_CR1328", "doi-asserted-by": "publisher", "first-page": "S47", "DOI": "10.1016/S0959-8049(02)00283-6", "volume": "38", "author": "P.E. Lonning", "year": "2002", "unstructured": "Lonning, P.E. (2002). Aromatase inhibitors and inactivators for breast cancer treatment. Eur. J. Cancer 38(Suppl 6), S47\u2013S48.", "journal-title": "Eur. J. Cancer"}, {"key": "10_CR1329", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.3816/CBC.2000.n.017", "volume": "1", "author": "S.A. Jones", "year": "2000", "unstructured": "Jones, S.A. and S.E. Jones (2000). Exemestane: A novel aromatase inactivator for breast cancer. Clin. Breast Cancer 1, 211\u2013216.", "journal-title": "Clin. Breast Cancer"}, {"key": "10_CR1330", "doi-asserted-by": "publisher", "first-page": "600", "DOI": "10.1002/ijc.10878", "volume": "103", "author": "G. Winnett", "year": "2003", "unstructured": "Winnett, G., D. van Hagen, and M. Schrey (2003). Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: Potential implications for breast cancer therapy. Int. J. Cancer 103, 600\u2013605.", "journal-title": "Int. J. Cancer"}, {"key": "10_CR1331", "doi-asserted-by": "publisher", "first-page": "2859", "DOI": "10.1016/S0960-894X(02)00565-6", "volume": "12", "author": "C. Pouget", "year": "2002", "unstructured": "Pouget, C., C. Fagnere, J.P. Basly, G. Habrioux, and A.J. Chulia (2002). Design, synthesis and evaluation of 4-imidazolylflavans as new leads for aromatase inhibition. Bioorg. Med. Chem. Lett. 12, 2859\u20132861.", "journal-title": "Bioorg. Med. Chem. Lett."}, {"key": "10_CR1332", "doi-asserted-by": "publisher", "first-page": "1864", "DOI": "10.1002/cncr.10844", "volume": "95", "author": "M.R. Smith", "year": "2002", "unstructured": "Smith, M.R., D. Kaufman, D. George, W.K. Oh, M. Kazanis, J. Manola et al. (2002). Selective aromatase inhibition for patients with androgen-independent prostate carcinoma. Cancer 95, 1864\u20131868.", "journal-title": "Cancer"}, {"key": "10_CR1333", "doi-asserted-by": "publisher", "first-page": "7", "DOI": "10.1016/S0303-7207(02)00090-4", "volume": "193", "author": "Y. Murata", "year": "2002", "unstructured": "Murata, Y., K.M. Robertson, M.E. Jones, and E.R. Simpson (2002). Effect of estrogen deficiency in the male: The ArKO mouse model. Mol. Cell Endocrinol. 193, 7\u201312.", "journal-title": "Mol. Cell Endocrinol."}, {"key": "10_CR1334", "doi-asserted-by": "publisher", "first-page": "5476", "DOI": "10.1210/jc.2002-020498", "volume": "87", "author": "B.L. Herrmann", "year": "2002", "unstructured": "Herrmann, B.L., B. Saller, O.E. Janssen, P. Gocke, A. Bockisch, H. Sperling et al. (2002). Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. J. Clin. Endocrinol. Metab. 87, 5476\u20135484.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1335", "doi-asserted-by": "publisher", "first-page": "145", "DOI": "10.1159/000058374", "volume": "57", "author": "U. Meinhardt", "year": "2002", "unstructured": "Meinhardt, U. and P.E. Mullis (2002). The aromatase cytochrome P-450 and its clinical impact. Horm. Res. 57, 145\u2013152.", "journal-title": "Horm. Res."}, {"key": "10_CR1336", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.1016/S0960-0760(01)00158-3", "volume": "79", "author": "K.L. Britt", "year": "2001", "unstructured": "Britt, K.L., A.E. Drummond, M. Dyson, N.G. Wreford, M.E. Jones, E.R. Simpson et al. (2001). The ovarian phenotype of the aromatase knockout (ArKO) mouse. J. Steroid Biochem. Mol. Biol. 79, 181\u2013185.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10_CR1337", "doi-asserted-by": "crossref", "first-page": "9104", "DOI": "10.1523/JNEUROSCI.22-20-09104.2002", "volume": "22", "author": "J. Bakker", "year": "2002", "unstructured": "Bakker, J., S. Honda, N. Harada, and J. Balthazart (2002). The aromatase knock-out mouse provides new evidence that estradiol is required during development in the female for the expression of sociosexual behaviors in adulthood. J. Neurosci. 22, 9104\u20139112.", "journal-title": "J. Neurosci."}, {"key": "10_CR1338", "first-page": "4423s", "volume": "7", "author": "P.E. Lonning", "year": "2001", "unstructured": "Lonning, P.E., L.E. Kragh, B. Erikstein, A. Hagen, T. Risberg, E. Schlichting et al. (2001). The potential for aromatase inhibition in breast cancer prevention. Clin. Cancer Res. 7, 4423s\u20134428s; discussion 4411s\u20134412s.", "journal-title": "Clin. Cancer Res."}, {"key": "10_CR1339", "doi-asserted-by": "publisher", "first-page": "1911", "DOI": "10.1016/S0959-8049(02)00149-1", "volume": "38", "author": "E.N. Suspitsin", "year": "2002", "unstructured": "Suspitsin, E.N., M.Y. Grigoriev, A.V. Togo, E.S. Kuligina, E.V. Belogubova, K.M. Pozharisski et al. (2002). Distinct prevalence of the CYP19 \u03943 (TTTA)7 allele in premenopausal versus postmenopausal breast cancer patients, but not in control individuals. Eur. J. Cancer 38, 1911\u20131916.", "journal-title": "Eur. J. Cancer"}, {"key": "10_CR1340", "doi-asserted-by": "publisher", "first-page": "897", "DOI": "10.1093/humrep/17.4.897", "volume": "17", "author": "N. Kado", "year": "2002", "unstructured": "Kado, N., J. Kitawaki, H. Obayashi, H. Ishihara, H. Koshiba, I. Kusuki et al. (2002). Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women. Hum. Reprod. 17, 897\u2013902.", "journal-title": "Hum. Reprod."}, {"key": "10_CR1341", "doi-asserted-by": "publisher", "first-page": "185", "DOI": "10.1016/0039-128X(74)90151-2", "volume": "23", "author": "G.T. Bryan", "year": "1974", "unstructured": "Bryan, G.T., A.M. Lewis, J.B. Harkins, S.F. Micheletti, and G.S. Boyd (1974). Cytochrome P450 and steroid 21-hydroxylation in microsomes from beef adrenal cortex. Steroids 23, 185\u2013201.", "journal-title": "Steroids"}, {"key": "10_CR1342", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1016/S0303-7207(96)03997-4", "volume": "127", "author": "Z. Zhou", "year": "1997", "unstructured": "Zhou, Z., V.R. Agarwal, N. Dixit, P. White, and P.W. Speiser (1997). Steroid 21-hydroxylase expression and activity in human lymphocytes. Mol. Cell Endocrinol. 127, 11\u201318.", "journal-title": "Mol. Cell Endocrinol."}, {"key": "10_CR1343", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.1016/S0303-7207(02)00041-2", "volume": "190", "author": "L. Yu", "year": "2002", "unstructured": "Yu, L., D.G. Romero, C.E. Gomez-Sanchez, and E.P. Gomez-Sanchez (2002). Steroidogenic enzyme gene expression in the human brain. Mol. Cell Endocrinol. 190, 9\u201317.", "journal-title": "Mol. Cell Endocrinol."}, {"key": "10_CR1344", "doi-asserted-by": "crossref", "first-page": "719", "DOI": "10.1096/fasebj.6.2.1311271", "volume": "6", "author": "U.M. Zanger", "year": "1992", "unstructured": "Zanger, U.M., N. Kagawa, J. Lund, and M.R. Waterman (1992). Distinct biochemical mechanisms for cAMP-dependent transcription of CYP17 and CYP21. FASEB J. 6, 719\u2013723.", "journal-title": "FASEB J"}, {"key": "10_CR1345", "doi-asserted-by": "publisher", "first-page": "521", "DOI": "10.1111/j.1432-1033.1993.tb17950.x", "volume": "214", "author": "N. Watanabe", "year": "1993", "unstructured": "Watanabe, N., M. Kitazume, J. Fujisawa, M. Yoshida, and Y. Fujii-Kuriyama (1993). A novel cAMP-dependent regulatory region including a sequence like the cAMP-responsive element, far upstream of the human CYP21A2 gene. Eur. J. Biochem. 214, 521\u2013531.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR1346", "doi-asserted-by": "publisher", "first-page": "1330", "DOI": "10.1210/me.9.10.1330", "volume": "9", "author": "S.F. Chang", "year": "1995", "unstructured": "Chang, S.F. and B.C. Chung (1995). Difference in transcriptional activity of two homologous CYP21A genes. Mol. Endocrinol. 9, 1330\u20131336.", "journal-title": "Mol. Endocrinol."}, {"key": "10_CR1347", "doi-asserted-by": "publisher", "first-page": "1592", "DOI": "10.1210/jc.83.5.1592", "volume": "83", "author": "I.M. Bird", "year": "1998", "unstructured": "Bird, I.M., J.I. Mason, and W.E. Rainey (1998). Protein kinase A, protein kinase C, and Ca2+-regulated expression of 21-hydroxylase cytochrome P450 in H295R human adrenocortical cells. J. Clin. Endocrinol. Metab. 83, 1592\u20131597.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1348", "doi-asserted-by": "publisher", "first-page": "38097", "DOI": "10.1074/jbc.274.53.38097", "volume": "274", "author": "S.D. Wijesuriya", "year": "1999", "unstructured": "Wijesuriya, S.D., G. Zhang, A. Dardis, and W.L. Miller (1999). Transcriptional regulatory elements of the human gene for cytochrome P450c21 (steroid 21-hydroxylase) lie within intron 35 of the linked C4B gene. J. Biol. Chem. 274, 38097\u201338106.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1349", "doi-asserted-by": "publisher", "first-page": "373", "DOI": "10.1002/humu.1380030408", "volume": "3", "author": "P.C. White", "year": "1994", "unstructured": "White, P.C., M.T. Tusie-Luna, M.I. New, and P.W. Speiser (1994). Mutations in steroid 21-hydroxylase (CYP21). Hum. Mutat. 3, 373\u2013378.", "journal-title": "Hum. Mutat."}, {"key": "10_CR1350", "doi-asserted-by": "crossref", "first-page": "685", "DOI": "10.1210/mend-5-5-685", "volume": "5", "author": "M.T. Tusie-Luna", "year": "1991", "unstructured": "M.T. Tusie-Luna, P.W. Speiser, M. Dumic, M.I. New, and P.C. White (1991). A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele. Mol. Endocrinol. 5, 685\u2013692.", "journal-title": "Mol. Endocrinol."}, {"key": "10_CR1351", "doi-asserted-by": "publisher", "first-page": "1600", "DOI": "10.1073/pnas.85.5.1600", "volume": "85", "author": "M. Amor", "year": "1988", "unstructured": "Amor, M., K.L. Parker, H. Globerman, M.I. New, and P.C. White (1988). Mutation in the CYP21B gene (Ile-172\u2192Asn) causes steroid 21-hydroxylase deficiency. Proc. Natl. Acad. Sci. USA 85, 1600\u20131604.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1352", "doi-asserted-by": "publisher", "first-page": "1211", "DOI": "10.1210/me.6.8.1211", "volume": "6", "author": "D. Owerbach", "year": "1992", "unstructured": "Owerbach, D., L. Sherman, A.L. Ballard, and R. Azziz (1992). Pro-453 to Ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency. Mol. Endocrinol. 6, 1211\u20131215.", "journal-title": "Mol. Endocrinol."}, {"key": "10_CR1353", "doi-asserted-by": "publisher", "first-page": "481", "DOI": "10.1002/(SICI)1098-1004(200005)15:5<481::AID-HUMU14>3.0.CO;2-A", "volume": "15", "author": "A. Bobba", "year": "2000", "unstructured": "Bobba, A., E. Marra, P. Lattanzio, A. Iolascon, and S. Giannattasio (2000). Characterization of the CYP21 gene 5\u2032 flanking region in patients affected by 21-OH deficiency. Hum. Mutat. 15, 481.", "journal-title": "Hum. Mutat."}, {"key": "10_CR1354", "doi-asserted-by": "publisher", "first-page": "245", "DOI": "10.1210/er.21.3.245", "volume": "21", "author": "P.C. White", "year": "2000", "unstructured": "White, P.C. and P.W. Speiser (2000). Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrinol. Rev. 21, 245\u2013291.", "journal-title": "Endocrinol. Rev."}, {"key": "10_CR1355", "doi-asserted-by": "publisher", "first-page": "293", "DOI": "10.1034/j.1399-0004.2001.590501.x", "volume": "59", "author": "H. Lee", "year": "2001", "unstructured": "Lee, H. (2001). CYP21 mutations and congenital adrenal hyperplasia. Clin. Genet. 59, 293\u2013301.", "journal-title": "Clin. Genet."}, {"key": "10_CR1356", "doi-asserted-by": "publisher", "first-page": "1059", "DOI": "10.1210/jc.85.3.1059", "volume": "85", "author": "N. Krone", "year": "2000", "unstructured": "Krone, N., A. Braun, A.A. Roscher, D. Knorr, and H.P. Schwarz (2000). Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J. Clin. Endocrinol. Metab. 85, 1059\u20131065.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1357", "doi-asserted-by": "publisher", "first-page": "885", "DOI": "10.1002/pd.167", "volume": "21", "author": "A. Levo", "year": "2001", "unstructured": "Levo, A. and J. Partanen (2001). Novel mutations in the human CYP21 gene. Prenat. Diagn. 21, 885\u2013889.", "journal-title": "Prenat. Diagn."}, {"key": "10_CR1358", "doi-asserted-by": "publisher", "first-page": "2668", "DOI": "10.1210/jc.87.6.2668", "volume": "87", "author": "S. Koyama", "year": "2002", "unstructured": "Koyama, S., T. Toyoura, S. Saisho, K. Shimozawa, and J. Yata (2002). Genetic analysis of Japanese patients with 21-hydroxylase deficiency: Identification of a patient with a new mutation of a homozygous deletion of adenine at codon 246 and patients without demonstrable mutations within the structural gene for CYP21. J. Clin. Endocrinol. Metab. 87, 2668\u20132673.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1359", "doi-asserted-by": "publisher", "first-page": "517", "DOI": "10.1007/s100380200077", "volume": "47", "author": "H.H. Lee", "year": "2002", "unstructured": "Lee, H.H., D.M. Niu, R.W. Lin, P. Chan, and C.Y. Lin (2002). Structural analysis of the chimeric CYP21P/CYP21 gene in steroid 21-hydroxylase deficiency. J. Hum. Genet. 47, 517\u2013522.", "journal-title": "J. Hum. Genet."}, {"key": "10_CR1360", "doi-asserted-by": "publisher", "first-page": "405", "DOI": "10.1007/s00439-002-0810-7", "volume": "111", "author": "P.F. Koppens", "year": "2002", "unstructured": "Koppens, P.F., T. Hoogenboezem, and H.J. Degenhart (2002). Duplication of the CYP21A2 gene complicates mutation analysis of steroid 21-hydroxylase deficiency: Characteristics of three unusual haplotypes. Hum. Genet. 111, 405\u2013410.", "journal-title": "Hum. Genet."}, {"key": "10_CR1361", "doi-asserted-by": "publisher", "first-page": "239", "DOI": "10.1046/j.0300-0664.2001.01419.x", "volume": "56", "author": "L.B. Dain", "year": "2002", "unstructured": "Dain, L.B., N.D. Buzzalino, A. Oneto, S. Belli, M. Stivel, T. Pasqualini et al. (2002). Classical and nonclassical 21-hydroxylase deficiency: A molecular study of Argentine patients. Clin. Endocrinol. (Oxford) 56, 239\u2013245.", "journal-title": "Clin. Endocrinol. (Oxford)"}, {"key": "10_CR1362", "doi-asserted-by": "publisher", "first-page": "330", "DOI": "10.1007/s004390051046", "volume": "106", "author": "E. Mornet", "year": "2000", "unstructured": "Mornet, E. and J.F. Gibrat (2000). A 3D model of human P450c21: Study of the putative effects of steroid 21-hydroxylase gene mutations. Hum. Genet. 106, 330\u2013339.", "journal-title": "Hum. Genet."}, {"key": "10_CR1363", "doi-asserted-by": "publisher", "first-page": "395", "DOI": "10.1016/0003-9861(76)90277-0", "volume": "173", "author": "R.H. Menard", "year": "1976", "unstructured": "Menard, R.H., F.C. Bartter, and J.R. Gillette (1976). Spironolactone and cytochrome P-450: Impairment of steroid 21-hydroxylation in the adrenal cortex. Arch. Biochem. Biophys. 173, 395\u2013402.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1364", "doi-asserted-by": "publisher", "first-page": "1898", "DOI": "10.1038/sj.gt.3301018", "volume": "6", "author": "T. Tajima", "year": "1999", "unstructured": "Tajima, T., T. Okada, X.M. Ma, W. Ramsey, S. Bornstein, and G. Aguilera (1999). Restoration of adrenal steroidogenesis by adenovirus-mediated transfer of human cytochrome P450 21-hydroxylase into the adrenal gland of 21-hydroxylase-deficient mice. Gene Ther. 6, 1898\u20131903.", "journal-title": "Gene Ther"}, {"key": "10_CR1365", "first-page": "742", "volume": "258", "author": "J.I. Pedersen", "year": "1983", "unstructured": "Pedersen, J.I., H.H. Shobaki, I. Holmberg, S. Bergseth, and I. Bj\u00f6rkhem (1983). 25-Hydroxyvitamin D3-24-hydroxylase in rat kidney mitochondria. J. Biol. Chem. 258, 742\u2013746.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1366", "doi-asserted-by": "publisher", "first-page": "405", "DOI": "10.1016/0014-5793(89)81133-0", "volume": "255", "author": "Y. Ohyama", "year": "1989", "unstructured": "Ohyama, Y., S. Hayashi, and K. Okuda (1989). Purification of 25-hydroxyvitamin D3 24-hydroxylase from rat kidney mitochondria. FEBS Lett. 255, 405\u2013408.", "journal-title": "FEBS Lett"}, {"key": "10_CR1367", "first-page": "176", "volume": "269", "author": "R.A. Ettinger", "year": "1994", "unstructured": "Ettinger, R.A., R. Ismail, and H.F. DeLuca (1994). cDNA cloning and characterization of a vitamin D3 hydroxylase-associated protein. J. Biol. Chem. 269, 176\u2013182.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1368", "doi-asserted-by": "publisher", "first-page": "4543", "DOI": "10.1073/pnas.90.10.4543", "volume": "90", "author": "K.S. Chen", "year": "1993", "unstructured": "Chen, K.S., J.M. Prahl, and H.F. DeLuca (1993). Isolation and expression of human 1,25-dihydroxyvitamin D3 24-hydroxylase cDNA. Proc. Natl. Acad. Sci. USA 90, 4543\u20134547.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1369", "doi-asserted-by": "crossref", "first-page": "E793", "DOI": "10.1152/ajpcell.1999.276.1.C76", "volume": "276", "author": "W. Yang", "year": "1999", "unstructured": "Yang, W., P.A. Friedman, R. Kumar, J.L. Omdahl, B.K. May, M.L. SiuCaldera et al. (1999). Expression of 25 (OH)D3 24-hydroxylase in distal nephron: Coordinate regulation by 1, 25 (OH)2D3 and cAMP or PTH. Am. J. Physiol. 276, E793\u2013E805.", "journal-title": "Am. J. Physiol."}, {"key": "10_CR1370", "doi-asserted-by": "publisher", "first-page": "3303", "DOI": "10.1210/en.140.7.3303", "volume": "140", "author": "G. Jones", "year": "1999", "unstructured": "Jones, G., H. Ramshaw, A. Zhang, R. Cook, V. Byford, J. White et al. (1999). Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1\u03b1 and CYP24) in human nonsmall cell lung carcinomas. Endocrinology 140, 3303\u20133310.", "journal-title": "Endocrinology"}, {"key": "10_CR1371", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.3181/00379727-207-43791", "volume": "207", "author": "M.L. Chen", "year": "1994", "unstructured": "Chen, M.L., G. Heinrich, Y.I. Ohyama, K. Okuda, J.L. Omdahl, T.C. Chen et al. (1994). Expression of 25-hydroxyvitamin D3-24-hydroxylase mRNA in cultured human keratinocytes. Proc. Soc. Exp. Biol. Med. 207, 57\u201361.", "journal-title": "Proc. Soc. Exp. Biol. Med."}, {"key": "10_CR1372", "doi-asserted-by": "publisher", "first-page": "451", "DOI": "10.1016/S0039-128X(00)00166-5", "volume": "66", "author": "I. Schuster", "year": "2001", "unstructured": "Schuster, I., H. Egger, N. Astecker, G. Herzig, M. Schussler, and G. Vorisek (2001). Selective inhibitors of CYP24: Mechanistic tools to explore vitamin D metabolism in human keratinocytes. Steroids 66, 451\u2013462.", "journal-title": "Steroids"}, {"key": "10_CR1373", "doi-asserted-by": "publisher", "first-page": "320", "DOI": "10.1006/excr.2002.5528", "volume": "276", "author": "P. Bareis", "year": "2002", "unstructured": "Bareis, P., E. Kallay, M.G. Bischof, G. Bises, H. Hofer, C. Potzi et al. (2002). Clonal differences in expression of 25-hydroxyvitamin D3-1\u03b1-hydroxylase, of 25-hydroxyvitamin D3-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: Effects of epidermal growth factor and 1\u03b1,25-dihydroxyvitamin D3. Exp. Cell Res. 276, 320\u2013327.", "journal-title": "Exp. Cell Res."}, {"key": "10_CR1374", "doi-asserted-by": "crossref", "first-page": "459", "DOI": "10.1111/j.1749-6632.2002.tb04683.x", "volume": "973", "author": "H. Farhan", "year": "2002", "unstructured": "Farhan, H. and H.S. Cross (2002). Transcriptional inhibition of CYP24 by genistein. Ann. N. Y. Acad. Sci. 973, 459\u2013462.", "journal-title": "Ann. N. Y. Acad. Sci."}, {"key": "10_CR1375", "doi-asserted-by": "publisher", "first-page": "900", "DOI": "10.1073/pnas.91.3.900", "volume": "91", "author": "C. Zierold", "year": "1994", "unstructured": "Zierold, C., H.M. Darwish, and H.F. DeLuca (1994). Identification of a vitamin D-response element in the rat calcidiol (25-hydroxyvitamin D3) 24-hydroxylase gene. Proc. Natl. Acad. Sci. USA 91, 900\u2013902.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1376", "first-page": "10545", "volume": "269", "author": "Y. Ohyama", "year": "1994", "unstructured": "Ohyama, Y., K. Ozono, M. Uchida, T. Shinki, S. Kato, T. Suda et al. (1994). Identification of a vitamin D-responsive element in the 5\u2032-flanking region of the rat 25-hydroxyvitamin D3 24-hydroxylase gene. J. Biol. Chem. 269, 10545\u201310550.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1377", "doi-asserted-by": "publisher", "first-page": "29715", "DOI": "10.1074/jbc.271.47.29715", "volume": "271", "author": "D.M. Kerry", "year": "1996", "unstructured": "Kerry, D.M., P.P. Dwivedi, C.N. Hahn, H.A. Morris, J.L. Omdahl, and B.K. May (1996). Transcriptional synergism between vitamin D-responsive elements in the rat 25-hydroxyvitamin D3 24-hydroxylase (CYP24) promoter. J. Biol. Chem. 271, 29715\u201329721.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1378", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1074/jbc.275.1.47", "volume": "275", "author": "P.P. Dwivedi", "year": "2000", "unstructured": "Dwivedi, P.P., J.L. Omdahl, I. Kola, D.K. Hume, and B.K. May (2000). Regulation of rat cytochrome P450C24 (CYP24) gene expression. Evidence for functional cooperation of Ras-activated Ets transcription factors with the vitamin D receptor in 1,25-dihydroxyvitamin D3-mediated induction. J. Biol. Chem. 275, 47\u201355.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1379", "doi-asserted-by": "publisher", "first-page": "1035", "DOI": "10.1210/me.15.6.1035", "volume": "15", "author": "M. Raval-Pandya", "year": "2001", "unstructured": "Raval-Pandya, M., P. Dhawan, F. Barletta, and S. Christakos (2001). YY1 represses vitamin D receptor-mediated 25-hydroxyvitamin D3 24-hydroxylase transcription: Relief of repression by CREB-binding protein. Mol. Endocrinol. 15, 1035\u20131046.", "journal-title": "Mol. Endocrinol."}, {"key": "10_CR1380", "doi-asserted-by": "publisher", "first-page": "29643", "DOI": "10.1074/jbc.M204561200", "volume": "277", "author": "P.P. Dwivedi", "year": "2002", "unstructured": "Dwivedi, P.P., C.S. Hii, A. Ferrante, J. Tan, C.J. Der, J.L. Omdahl et al. (2002). Role of MAP kinases in the 1,25-dihydroxyvitamin D3-induced transactivation of the rat cytochrome P450C24 (CYP24) promoter. Specific functions for ERK1/ERK2 and ERK5. J. Biol. Chem. 277, 29643\u201329653.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1381", "doi-asserted-by": "publisher", "first-page": "179", "DOI": "10.1359/jbmr.2002.17.1.179", "volume": "17", "author": "G. Jones", "year": "2002", "unstructured": "Jones, G. and H.S. Tenenhouse (2002). 1,25(OH)2D, the preferred substrate for CYP24. J. Bone Miner. Res. 17, 179\u2013181.", "journal-title": "J. Bone Miner. Res."}, {"key": "10_CR1382", "doi-asserted-by": "publisher", "first-page": "6158", "DOI": "10.1046/j.1432-1327.2000.01680.x", "volume": "267", "author": "T. Sakaki", "year": "2000", "unstructured": "Sakaki, T., N. Sawada, K. Komai, S. Shiozawa, S. Yamada, K. Yamamoto et al. (2000). Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24. Eur. J. Biochem. 267, 6158\u20136165.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR1383", "doi-asserted-by": "publisher", "first-page": "8465", "DOI": "10.1021/bi960658i", "volume": "35", "author": "M.J. Beckman", "year": "1996", "unstructured": "Beckman, M.J., P. Tadikonda, E. Werner, J. Prahl, S. Yamada, and H.F. DeLuca (1996). Human 25-hydroxyvitamin D3-24-hydroxylase, a multicatalytic enzyme. Biochemistry 35, 8465\u20138472.", "journal-title": "Biochemistry"}, {"key": "10_CR1384", "doi-asserted-by": "publisher", "first-page": "14115", "DOI": "10.1074/jbc.272.22.14115", "volume": "272", "author": "Y. Miyamoto", "year": "1997", "unstructured": "Miyamoto, Y., T. Shinki, K. Yamamoto, Y. Ohyama, H. Iwasaki, R. Hosotani et al. (1997). 1\u03b1,25-dihydroxyvitamin D3-24-hydroxylase (CYP24) hydroxylates the carbon at the end of the side chain (C-26) of the C-24-fluorinated analog of 1\u03b1,25-dihydroxyvitamin D3. J. Biol. Chem. 272, 14115\u201314119.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1385", "doi-asserted-by": "publisher", "first-page": "457", "DOI": "10.1080/004982598239380", "volume": "28", "author": "K. Hayashi", "year": "1998", "unstructured": "Hayashi, K., M. Akiyoshi-Shibata, T. Sakaki, and Y. Tabusaki (1998). Rat CYP24 catalyses 23S-hydroxylation of 26,26,26,27,27,27-hexafluorocalcitriol in vitro. Xenobiotica 28, 457\u2013463.", "journal-title": "Xenobiotica"}, {"key": "10_CR1386", "doi-asserted-by": "publisher", "first-page": "43", "DOI": "10.1046/j.1432-1327.1999.00375.x", "volume": "262", "author": "T. Sakaki", "year": "1999", "unstructured": "Sakaki, T., N. Sawada, Y. Nonaka, Y. Ohyama, and K. Inouye (1999). Metabolic studies using recombinant Escherichia coli cells producing rat mitochondrial CYP24. CYP24 can convert 1\u03b1,25-dihydroxyvitamin D3 to calcitroic acid. Eur. J. Biochem. 262, 43\u201348.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR1387", "doi-asserted-by": "crossref", "first-page": "179", "DOI": "10.1016/S1387-2656(01)07037-5", "volume": "7", "author": "K. Inouye", "year": "2001", "unstructured": "Inouye, K. and T. Sakaki (2001). Enzymatic studies on the key enzymes of vitamin D metabolism; 1\u03b1-hydroxylase (CYP27B1) and 24-hydroxylase (CYP24). Biotechnol. Annu. Rev. 7, 179\u2013194.", "journal-title": "Biotechnol. Annu. Rev."}, {"key": "10_CR1388", "doi-asserted-by": "publisher", "first-page": "356", "DOI": "10.1002/jcb.10366", "volume": "88", "author": "J.L. Omdahl", "year": "2003", "unstructured": "Omdahl, J.L., E.V. Bobrovnikova, A. Annalora, P. Chen, and R. Serda (2003). Expression, structure-function, and molecular modeling of vitamin D P450s. J. Cell. Biochem. 88, 356\u2013362.", "journal-title": "J. Cell. Biochem."}, {"key": "10_CR1389", "doi-asserted-by": "publisher", "first-page": "16766", "DOI": "10.1074/jbc.270.28.16766", "volume": "270", "author": "F.J. Dilworth", "year": "1995", "unstructured": "Dilworth, F.J., I. Scott, A. Green, S. Strugnell, Y.D. Guo, E.A. Roberts et al. (1995). Different mechanisms of hydroxylation site selection by liver and kidney cytochrome P450 species (CYP27 and CYP24) involved in vitamin D metabolism. J. Biol. Chem. 270, 16766\u201316774.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1390", "doi-asserted-by": "publisher", "first-page": "372", "DOI": "10.1002/jcb.10365", "volume": "88", "author": "I. Schuster", "year": "2003", "unstructured": "Schuster, I., H. Egger, P. Nussbaumer, and R.T. Kroemer (2003). Inhibitors of vitamin D hydroxylases: Structure-activity relationships. J. Cell. Biochem. 88, 372\u2013380.", "journal-title": "J. Cell. Biochem."}, {"key": "10_CR1391", "doi-asserted-by": "publisher", "first-page": "409", "DOI": "10.1016/S0039-128X(00)00159-8", "volume": "66", "author": "I. Schuster", "year": "2001", "unstructured": "Schuster, I., H. Egger, D. Bikle, G. Herzig, G.S. Reddy, A. Stuetz et al. (2001). Selective inhibition of vitamin D hydroxylases in human keratinocytes. Steroids 66, 409\u2013422.", "journal-title": "Steroids"}, {"key": "10_CR1392", "doi-asserted-by": "publisher", "first-page": "391", "DOI": "10.1016/S0039-128X(00)00158-6", "volume": "66", "author": "H.L. Henry", "year": "2001", "unstructured": "Henry, H.L. (2001). The 25(OH)D3/1\u03b1,25(OH)2D3-24R-hydroxylase: A catabolic or biosynthetic enzyme? Steroids 66, 391\u2013398.", "journal-title": "Steroids"}, {"key": "10_CR1393", "doi-asserted-by": "publisher", "first-page": "1332", "DOI": "10.1016/S0006-291X(02)02254-4", "volume": "297", "author": "H. Kasuga", "year": "2002", "unstructured": "Kasuga, H., N. Hosogane, K. Matsuoka, I. Mori, Y. Sakura, K. Shimakawa et al. (2002). Characterization of transgenic rats constitutively expressing vitamin D-24-hydroxylase gene. Biochem. Biophys. Res. Commun. 297, 1332\u20131338.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1394", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1006/abbi.1993.1255", "volume": "303", "author": "R. Martini", "year": "1993", "unstructured": "Martini, R. and M. Murray (1993). Participation of P450 3A enzymes in rat hepatic microsomal retinoic acid 4-hydroxylation. Arch. Biochem. Biophys. 303, 57\u201366.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1395", "first-page": "18539", "volume": "272", "author": "J.A. White", "year": "1997", "unstructured": "White, J.A., B. Beckett-Jones, Y.D. Guo, F.J. Dilworth, J. Bonasoro, G. Jones et al. (1997). cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450 (CYP26). J. Biol. Chem. 272, 18539\u201318541.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1396", "doi-asserted-by": "publisher", "first-page": "6403", "DOI": "10.1073/pnas.120161397", "volume": "97", "author": "J.A. White", "year": "2000", "unstructured": "White, J.A., H. Ramshaw, M. Taimi, W. Stangle, A. Zhang, S. Everingham et al. (2000). Identification of the human cytochrome P450, P450RAI-2, which is predominantly expressed in the adult cerebellum and is responsible for all-trans-retinoic acid metabolism. Proc. Natl. Acad. Sci. USA 97, 6403\u20136408.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1397", "doi-asserted-by": "publisher", "first-page": "487", "DOI": "10.1006/bbrc.1998.9659", "volume": "252", "author": "M.E. Trofimova-Griffin", "year": "1998", "unstructured": "Trofimova-Griffin, M.E. and M.R. Juchau (1998). Expression of cytochrome P450RAI (CYP26) in human fetal hepatic and cephalic tissues. Biochem. Biophys. Res. Commun. 252, 487\u2013491.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1398", "doi-asserted-by": "publisher", "first-page": "345", "DOI": "10.1006/abbi.1999.1438", "volume": "371", "author": "D.R. Nelson", "year": "1999", "unstructured": "Nelson, D.R. (1999). A second CYP26 P450 in humans and zebrafish: CYP26B1. Arch. Biochem. Biophys. 371, 345\u2013347.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1399", "doi-asserted-by": "publisher", "first-page": "173", "DOI": "10.1016/S0925-4773(01)00572-X", "volume": "110", "author": "S. Abu-Abed", "year": "2002", "unstructured": "Abu-Abed, S., G. MacLean, V. Fraulob, P. Chambon, M. Petkovich, and P. Dolle (2002). Differential expression of the retinoic acid-metabolizing enzymes CYP26A1 and CYP26B1 during murine organogenesis. Mech. Dev. 110, 173\u2013177.", "journal-title": "Mech. Dev."}, {"key": "10_CR1400", "doi-asserted-by": "publisher", "first-page": "175", "DOI": "10.1016/S0165-3806(02)00305-X", "volume": "136", "author": "M.E. Trofimova-Griffin", "year": "2002", "unstructured": "Trofimova-Griffin, M.E. and M.R. Juchau (2002). Developmental expression of cytochrome CYP26B1 (P450RAI-2) in human cephalic tissues. Brain. Res. Develop. Brain Res. 136, 175\u2013178.", "journal-title": "Brain. Res. Develop. Brain Res."}, {"key": "10_CR1401", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1016/S0925-4439(02)00157-6", "volume": "1588", "author": "Y. Matsuzaki", "year": "2002", "unstructured": "Matsuzaki, Y., B. Bouscarel, T. Ikegami, A. Honda, M. Doy, S. Ceryak et al. (2002). Selective inhibition of CYP27A1 and of chenodeoxycholic acid synthesis in cholestatic hamster liver. Biochim. Biophys. Acta 1588, 139\u2013148.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "10_CR1402", "doi-asserted-by": "publisher", "first-page": "491", "DOI": "10.1006/bbrc.1997.7551", "volume": "241", "author": "H. Postlind", "year": "1997", "unstructured": "Postlind, H., E. Ax\u00e9n, T. Bergman, and K. Wikvall (1997). Cloning, structure, and expression of a cDNA encoding vitamin D3 25-hydroxylase. Biochem. Biophys. Res. Commun. 241, 491\u2013497.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1403", "doi-asserted-by": "publisher", "first-page": "994", "DOI": "10.1016/0006-291X(84)90775-7", "volume": "121", "author": "S. Hayashi", "year": "1984", "unstructured": "Hayashi, S., M. Noshiro, and K. Okuda (1984). Purification of cytochrome P-450 catalyzing 25-hydroxylation of vitamin D3 from rat liver microsomes. Biochem. Biophys. Res. Commun. 121, 994\u20131000.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1404", "first-page": "177", "volume": "840", "author": "K. Saarem", "year": "1985", "unstructured": "Saarem, K. and J.I. Pedersen (1985). 25-Hydroxylation of 1\u03b1-hydroxyvitamin D3 in rat and human liver. Biochim. Biophys. Acta 840, 177\u2013126.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "10_CR1405", "doi-asserted-by": "publisher", "first-page": "367", "DOI": "10.1016/0014-5793(91)80333-X", "volume": "280", "author": "M. Akiyoshi-Shibata", "year": "1991", "unstructured": "Akiyoshi-Shibata, M., E. Usui, T. Sakaki, Y. Yabusaki, M. Noshiro, K. Okuda et al. (1991). Expression of rat liver vitamin D3 25-hydroxylase cDNA in Saccharomyces cerevisiae. FEBS Lett. 280, 367\u2013370.", "journal-title": "FEBS Lett."}, {"key": "10_CR1406", "doi-asserted-by": "publisher", "first-page": "8668", "DOI": "10.1073/pnas.90.18.8668", "volume": "90", "author": "Y.D. Guo", "year": "1993", "unstructured": "Guo, Y.D., S. Strugnell, D.W. Back, and G. Jones (1993). Transfected human liver cytochrome P-450 hydroxylates vitamin D analogs at different side-chain positions. Proc. Natl. Acad. Sci. USA 90, 8668\u20138672.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1407", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1136/jnnp.67.5.675", "volume": "67", "author": "K. Shiga", "year": "1999", "unstructured": "Shiga, K., R. Fukuyama, S. Kimura, K. Nakajima, and S. Fushiki (1999). Mutation of the sterol 27-hydroxylase gene (CYP27) results in truncation of mRNA expressed in leucocytes in a Japanese family with cerebrotendinous xanthomatosis. J. Neurol. Neurosurg. Psychiatr. 67, 675\u2013677.", "journal-title": "J. Neurol. Neurosurg. Psychiatr."}, {"key": "10_CR1408", "first-page": "2322", "volume": "38", "author": "R. Garuti", "year": "1997", "unstructured": "Garuti, R., M.A. Croce, R. Tiozzo, M.T. Dotti, A. Federico, S. Bertolini et al. (1997). Four novel mutations of sterol 27-hydroxylase gene in Italian patients with cerebrotendinous xanthomatosis. J. Lipid Res. 38, 2322\u20132334.", "journal-title": "J. Lipid Res."}, {"key": "10_CR1409", "doi-asserted-by": "publisher", "first-page": "107", "DOI": "10.1046/j.1365-2265.2001.01160.x", "volume": "54", "author": "M. Gascon-Barre", "year": "2001", "unstructured": "Gascon-Barre, M., C. Demers, O. Ghrab, C. Theodoropoulos, R. Lapointe, G. Jones et al. (2001). Expression of CYP27A, a gene encoding a vitamin D-25 hydroxylase in human liver and kidney. Clin. Endocrinol. (Oxford) 54, 107\u2013115.", "journal-title": "Clin. Endocrinol. (Oxford)"}, {"key": "10_CR1410", "doi-asserted-by": "publisher", "first-page": "269", "DOI": "10.1016/S0021-9150(00)00473-1", "volume": "154", "author": "C.M. Shanahan", "year": "2001", "unstructured": "Shanahan, C.M., K.L. Carpenter, and N.R. Cary (2001). A potential role for sterol 27-hydroxylase in atherogenesis. Atherosclerosis 154, 269\u2013276.", "journal-title": "Atherosclerosis"}, {"key": "10_CR1411", "doi-asserted-by": "publisher", "first-page": "1311", "DOI": "10.1007/s00415-002-0762-9", "volume": "249", "author": "M.J. Lee", "year": "2002", "unstructured": "Lee, M.J., Y.C. Huang, M.G. Sweeney, N.W. Wood, M.M. Reilly, and P.K. Yip (2002). Mutation of the sterol 27-hydroxylase gene (CYP27A1) in a Taiwanese family with cerebrotendinous xanthomatosis. J. Neurol. 249, 1311\u20131312.", "journal-title": "J. Neurol."}, {"key": "10_CR1412", "doi-asserted-by": "publisher", "first-page": "15050", "DOI": "10.1021/bi9807660", "volume": "37", "author": "W. Chen", "year": "1998", "unstructured": "Chen, W., S. Kubota, H. Ujike, T. Ishihara, and Y. Seyama (1998). A novel Arg362Ser mutation in the sterol 27-hydroxylase gene (CYP27): Its effects on pre-mRNA splicing and enzyme activity. Biochemistry 37, 15050\u201315056.", "journal-title": "Biochemistry"}, {"key": "10_CR1413", "doi-asserted-by": "crossref", "first-page": "657", "DOI": "10.1089/dna.1990.9.657", "volume": "9", "author": "P. Su", "year": "1990", "unstructured": "Su, P., H. Rennert, R.M. Shayiq, R. Yamamoto, Y. Zheng, S. Addya et al. (1990). A cDNA encoding a rat mitochondrial cytochrome P450 catalyzing both the 26-hydroxylation of cholesterol and 25-hydroxylation of vitamin D3: Gonadotropic regulation of the cognate mRNA in ovaries. DNA Cell Biol. 9, 657\u2013665.", "journal-title": "DNA Cell Biol."}, {"key": "10_CR1414", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1007/s008940100035", "volume": "7", "author": "K. Wikvall", "year": "2001", "unstructured": "Wikvall, K. (2001). Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form (review). Int. J. Mol. Med. 7, 201\u2013209.", "journal-title": "Int. J. Mol. Med."}, {"key": "10_CR1415", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1006/abbi.1997.0142", "volume": "343", "author": "I.A. Pikuleva", "year": "1997", "unstructured": "Pikuleva, I.A., I. Bj\u00f6rkhelm, and M.R. Waterman (1997). Expression, purification, and enzymatic properties of recombinant human cytochrome P450c27 (CYP27). Arch. Biochem. Biophys. 343, 123\u2013130.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1416", "doi-asserted-by": "publisher", "first-page": "18153", "DOI": "10.1074/jbc.273.29.18153", "volume": "273", "author": "I.A. Pikuleva", "year": "1998", "unstructured": "Pikuleva, I.A., A. Babiker, M.R. Waterman, and I. Bj\u00f6rkhem (1998). Activities of recombinant human cytochrome P450c27 (CYP27) which produce intermediates of alternative bile acid biosynthetic pathways. J. Biol. Chem. 273, 18153\u201318160.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1417", "doi-asserted-by": "publisher", "first-page": "977", "DOI": "10.1006/bbrc.2000.3050", "volume": "273", "author": "N. Sawada", "year": "2000", "unstructured": "Sawada, N., T. Sakaki, M. Ohta, and K. Inouye (2000). Metabolism of vitamin D3 by human CYP27A1. Biochem. Biophys. Res. Commun. 273, 977\u2013984.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1418", "doi-asserted-by": "publisher", "first-page": "6607", "DOI": "10.1046/j.0014-2956.2001.02615.x", "volume": "268", "author": "N. Sawada", "year": "2001", "unstructured": "Sawada, N., T. Sakaki, S. Kitanaka, S. Kato, and K. Inouye (2001). Structure-function analysis of CYP27B1 and CYP27A1\u2014Studies on mutants from patients with vitamin D-dependent rickets type I (VDDR-I) and cerebrotendinous xanthomatosis (CTX). Eur. J. Biochem. 268, 6607\u20136615.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR1419", "doi-asserted-by": "crossref", "first-page": "7621", "DOI": "10.1021/bi010193i", "volume": "40", "author": "I.A. Pikuleva", "year": "2001", "unstructured": "Pikuleva, I.A., A. Puchkaev, and I. Bjorkhem (2001). Putative helix F contributes to regioselectivity of hydroxylation in mitochondrial cytochrome P450 27A1. Biochemistry 40, 7621\u20137629.", "journal-title": "Biochemistry"}, {"key": "10_CR1420", "doi-asserted-by": "publisher", "first-page": "37582", "DOI": "10.1074/jbc.M204909200", "volume": "277", "author": "D. Murtazina", "year": "2002", "unstructured": "Murtazina, D., A.V. Puchkaev, C.H. Schein, N. Oezguen, W. Braun, A. Nanavati et al. (2002). Membrane-protein interactions contribute to efficient 27-hydroxylation of cholesterol by mitochondrial cytochrome P450 27A1. J. Biol. Chem. 277, 37582\u201337589.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1421", "doi-asserted-by": "publisher", "first-page": "1059", "DOI": "10.1006/bbrc.2001.5879", "volume": "288", "author": "F. Hosseinpour", "year": "2001", "unstructured": "Hosseinpour, F., M. Hidestrand, M. Ingelman-Sundberg, and K. Wikvall (2001). The importance of residues in substrate recognition site 3 for the catalytic function of CYP2D25 (vitamin D 25-hydroxylase). Biochem. Biophys. Res. Commun. 288, 1059\u20131063.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1422", "first-page": "189", "volume": "14", "author": "M.R. Wills", "year": "1984", "unstructured": "Wills, M.R. and J. Savory (1984). Vitamin D metabolism and chronic liver disease. Ann. Clin. Lab. Sci. 14, 189\u2013197.", "journal-title": "Ann. Clin. Lab. Sci."}, {"key": "10_CR1423", "doi-asserted-by": "publisher", "first-page": "379", "DOI": "10.1023/A:1010564920930", "volume": "24", "author": "S. Sugama", "year": "2001", "unstructured": "Sugama, S., A. Kimura, W. Chen, S. Kubota, Y. Seyama, N. Taira et al. (2001). Frontal lobe dementia with abnormal cholesterol metabolism and heterozygous mutation in sterol 27-hydroxylase gene (CYP27). J. Inherit. Metab. Dis. 24, 379\u2013392.", "journal-title": "J. Inherit. Metab. Dis."}, {"key": "10_CR1424", "doi-asserted-by": "publisher", "first-page": "725", "DOI": "10.1172/JCI200216388", "volume": "110", "author": "I. Bj\u00f6rkhem", "year": "2002", "unstructured": "Bj\u00f6rkhem, I. (2002). Do oxysterols control cholesterol homeostasis?. J. Clin. Invest. 110, 725\u2013730.", "journal-title": "J. Clin. Invest."}, {"key": "10_CR1425", "doi-asserted-by": "publisher", "first-page": "14805", "DOI": "10.1074/jbc.273.24.14805", "volume": "273", "author": "H. Rosen", "year": "1998", "unstructured": "Rosen, H., A. Reshef, N. Maeda, A. Lippoldt, S. Shpizen, L. Triger et al. (1998). Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene. J. Biol. Chem. 273, 14805\u201314812.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1426", "first-page": "1913", "volume": "42", "author": "A.B. Reiss", "year": "2001", "unstructured": "Reiss, A.B., N.W. Awadallah, S. Malhotra, M.C. Montesinos, E.S. Chan, N.B. Javitt et al. (2001). Immune complexes and IFN-\u03b3 decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages. J. Lipid Res. 42, 1913\u20131922.", "journal-title": "J. Lipid Res."}, {"key": "10_CR1427", "doi-asserted-by": "publisher", "first-page": "223", "DOI": "10.1073/pnas.0237082100", "volume": "100", "author": "B. Goodwin", "year": "2003", "unstructured": "Goodwin, B., K.C. Gauthier, M. Umetani, M.A. Watson, M.I. Lochansky, J.L. Collins et al. (2003). Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proc. Natl. Acad. Sci. USA 100, 223\u2013228.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1428", "doi-asserted-by": "publisher", "first-page": "11015", "DOI": "10.1074/jbc.M212780200", "volume": "278", "author": "G. Escher", "year": "2003", "unstructured": "Escher, G., Z. Krozowski, K.D. Croft, and D. Sviridov (2003). Expression of sterol 27-hydroxylase (CYP27A1) enhances cholesterol efflux. J. Biol. Chem. 278, 11015\u201311019.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1429", "doi-asserted-by": "publisher", "first-page": "38378", "DOI": "10.1074/jbc.M105805200", "volume": "276", "author": "X. Fu", "year": "2001", "unstructured": "Fu, X., J.G. Menke, Y. Chen, G. Zhou, K.L. MacNaul, S.D. Wright et al. (2001). 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J. Biol. Chem. 276, 38378\u201338387.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1430", "doi-asserted-by": "publisher", "first-page": "563", "DOI": "10.1016/0006-2952(77)90025-9", "volume": "26", "author": "H.F. DeLuca", "year": "1977", "unstructured": "H.F. DeLuca (1977). Vitamin D as a prohormone. Biochem. Pharmacol. 26, 563\u2013566.", "journal-title": "Biochem. Pharmacol."}, {"key": "10_CR1431", "first-page": "11488", "volume": "260", "author": "S.K. Paulson", "year": "1985", "unstructured": "Paulson, S.K. and H.F. DeLuca (1985). Subcellular location and properties of rat renal 25-hydroxyvitamin D3-1\u03b1-hydroxylase. J. Biol. Chem. 260, 11488\u201311492.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1432", "first-page": "3498", "volume": "267", "author": "M. Burgos-Trinidad", "year": "1992", "unstructured": "M. Burgos-Trinidad, R. Ismail, R.A. Ettinger, J.M. Prahl, and H.F. DeLuca (1992). Immunopurified 25-hydroxyvitamin D 1\u03b1-hydroxylase and 1,25-dihydroxyvitamin D 24-hydroxylase are closely related but distinct enzymes. J. Biol. Chem. 267, 3498\u20133505.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1433", "doi-asserted-by": "publisher", "first-page": "513", "DOI": "10.1016/0960-0760(93)90167-U", "volume": "45", "author": "A. Arabian", "year": "1993", "unstructured": "Arabian, A., J. Grover, M.G. Barre, and E.E. Delvin (1993). Rat kidney 25-hydroxyvitamin D3 1\u03b1-and 24-hydroxylases: Evidence for two distinct gene products. J. Steroid Biochem. Mol. Biol. 45, 513\u2013516.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10_CR1434", "doi-asserted-by": "publisher", "first-page": "10014", "DOI": "10.1073/pnas.91.21.10014", "volume": "91", "author": "E. Ax\u00e9n", "year": "1994", "unstructured": "Ax\u00e9n, E., H. Postlind, H. Sj\u00f6berg, and K. Wikvall (1994). Liver mitochondrial cytochrome P450 CYP27 and recombinant expressed human CYP27 catalyze 1\u03b1-hydroxylation of 25-hydroxyvitamin D3. Proc. Natl. Acad. Sci. USA 91, 10014\u201310018.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1435", "doi-asserted-by": "publisher", "first-page": "527", "DOI": "10.1006/bbrc.1997.7508", "volume": "239", "author": "T. Monkawa", "year": "1997", "unstructured": "Monkawa, T., T. Yoshida, S. Wakino, T. Shinki, H. Anazawa, H.F. DeLuca et al. (1997). Molecular cloning of cDNA and genomic DNA for human 25-hydroxyvitamin D3 1\u03b1-hydroxylase. Biochem. Biophys. Res. Commun. 239, 527\u2013533.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1436", "doi-asserted-by": "crossref", "first-page": "1499", "DOI": "10.1089/dna.1997.16.1499", "volume": "16", "author": "G.K. Fu", "year": "1997", "unstructured": "Fu, G.K., A.A. Portale, and W.L. Miller (1997). Complete structure of the human gene for the vitamin D 1\u03b1-hydroxylase, P450c1\u03b1. DNA Cell Biol. 16, 1499\u20131507.", "journal-title": "DNA Cell Biol"}, {"key": "10_CR1437", "first-page": "2465", "volume": "10", "author": "D. Zehnder", "year": "1999", "unstructured": "Zehnder, D., R. Bland, E.A. Walker, A.R. Bradwell, A.J. Howie, M. Hewison et al. (1999). Expression of 25-hydroxyvitamin D3-1\u03b1-hydroxylase in the human kidney. J. Am. Soc. Nephrol. 10, 2465\u20132473.", "journal-title": "J. Am. Soc. Nephrol."}, {"key": "10_CR1438", "doi-asserted-by": "publisher", "first-page": "888", "DOI": "10.1210/jc.86.2.888", "volume": "86", "author": "D. Zehnder", "year": "2001", "unstructured": "Zehnder, D., R. Bland, M.C. Williams, R.W. McNinch, A.J. Howie, P.M. Stewart et al. (2001). Extrarenal expression of 25-hydroxyvitamin D3-1\u03b1-hydroxylase. J. Clin. Endocrinol. Metab. 86, 888\u2013894.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1439", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1016/S0002-9440(10)64162-4", "volume": "161", "author": "D. Zehnder", "year": "2002", "unstructured": "Zehnder, D., K.N. Evans, M.D. Kilby, J.N. Bulmer, B.A. Innes, P.M. Stewart et al. (2002). The ontogeny of 25-hydroxyvitamin D3 1\u03b1-hydroxylase expression in human placenta and decidua. Am. J. Pathol. 161, 105\u2013114.", "journal-title": "Am. J. Pathol."}, {"key": "10_CR1440", "doi-asserted-by": "publisher", "first-page": "3876", "DOI": "10.1210/jc.87.8.3876", "volume": "87", "author": "L. Diaz", "year": "2002", "unstructured": "Diaz, L., C. Arranz, E. Avila, A. Halhali, F. Vilchis, and F. Larrea (2002). Expression and activity of 25-hydroxyvitamin D-1\u03b1-hydroxylase are restricted in cultures of human syncytiotrophoblast cells from preeclamptic pregnancies. J. Clin. Endocrinol. Metab. 87, 3876\u20133882.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1441", "first-page": "183", "volume": "22", "author": "M. Friedrich", "year": "2002", "unstructured": "Friedrich, M., C. Villena-Heinsen, R. Axt-Fliedner, R. Meyberg, W. Tilgen, W. Schmidt et al. (2002). Analysis of 25-hydroxyvitamin D3-1\u03b1-hydroxylase in cervical tissue. Anticancer Res. 22, 183\u2013186.", "journal-title": "Anticancer Res"}, {"key": "10_CR1442", "doi-asserted-by": "publisher", "first-page": "2967", "DOI": "10.1210/jc.87.6.2967", "volume": "87", "author": "U. Segersten", "year": "2002", "unstructured": "Segersten, U., P. Correa, M. Hewison, P. Hellman, H. Dralle, T. Carling et al. (2002). 25-hydroxyvitamin D3-1\u03b1-hydroxylase expression in normal and pathological parathyroid glands. J. Clin. Endocrinol. Metab. 87, 2967\u20132972.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1443", "doi-asserted-by": "publisher", "first-page": "121", "DOI": "10.1006/abbi.2001.2279", "volume": "388", "author": "H.L. Brenza", "year": "2001", "unstructured": "Brenza, H.L. and H.F. DeLuca (2001). Analysis of basal regulatory elements in the 25-hydroxyvitamin D3 1\u03b1-hydroxylase gene promoter. Arch. Biochem. Biophys. 388, 121\u2013126.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1444", "first-page": "3158", "volume": "251", "author": "L.A. Baxter", "year": "1976", "unstructured": "Baxter, L.A. and H.F. DeLuca (1976). Stimulation of 25-hydroxyvitamin D3-1\u03b1-hydroxylase by phosphate depletion. J. Biol. Chem. 251, 3158\u20133161.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1445", "doi-asserted-by": "publisher", "first-page": "1720", "DOI": "10.1210/en.142.5.1720", "volume": "142", "author": "T. Yoshida", "year": "2001", "unstructured": "Yoshida, T., N. Yoshida, T. Monkawa, M. Hayashi, and T. Saruta (2001). Dietary phosphorus deprivation induces 25-hydroxyvitamin D3 1\u03b1-hydroxylase gene expression. Endocrinology 142, 1720\u20131726.", "journal-title": "Endocrinology"}, {"key": "10_CR1446", "doi-asserted-by": "publisher", "first-page": "587", "DOI": "10.1210/en.143.2.587", "volume": "143", "author": "M.Y. Zhang", "year": "2002", "unstructured": "Zhang, M.Y., X. Wang, J.T. Wang, N.A. Compagnone, S.H. Mellon, J.L. Olson et al. (2002). Dietary phosphorus transcriptionally regulates 25-hydroxyvitamin D-1\u03b1-hydroxylase gene expression in the proximal renal tubule. Endocrinology 143, 587\u2013595.", "journal-title": "Endocrinology"}, {"key": "10_CR1447", "doi-asserted-by": "publisher", "first-page": "2027", "DOI": "10.1210/en.140.5.2027", "volume": "140", "author": "R. Bland", "year": "1999", "unstructured": "Bland, R., E.A. Walker, S.V. Hughes, P.M. Stewart, and M. Hewison (1999). Constitutive expression of 25-hydroxyvitamin D3-1\u03b1-hydroxylase in a transformed human proximal tubule cell line: Evidence for direct regulation of vitamin D metabolism by calcium. Endocrinology 140, 2027\u20132034.", "journal-title": "Endocrinology"}, {"key": "10_CR1448", "doi-asserted-by": "publisher", "first-page": "1827", "DOI": "10.1126/science.277.5333.1827", "volume": "277", "author": "K. Takeyama", "year": "1997", "unstructured": "Takeyama, K., S. Kitanaka, T. Sato, M. Kobori, J. Yanagisawa, and S. Kato (1997). 25-Hydroxyvitamin D3 1\u03b1-hydroxylase and vitamin D synthesis. Science 277, 1827\u20131830.", "journal-title": "Science"}, {"key": "10_CR1449", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1006/bbrc.1998.9098", "volume": "249", "author": "A. Murayama", "year": "1998", "unstructured": "Murayama, A., K. Takeyama, S. Kitanaka, Y. Kodera, T. Hosoya, and S. Kato (1998). The promoter of the human 25-hydroxyvitamin D3 1\u03b1-hydroxylase gene confers positive and negative responsiveness to PTH, calcitonin, and 1\u03b1,25(OH)2D3. Biochem. Biophys. Res. Commun. 249, 11\u201316.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1450", "doi-asserted-by": "publisher", "first-page": "6988", "DOI": "10.1073/pnas.96.12.6988", "volume": "96", "author": "X.F. Kong", "year": "1999", "unstructured": "Kong, X.F., X.H. Zhu, Y.L. Pei, D.M. Jackson, and M.F. Holick (1999). Molecular cloning, characterization, and promoter analysis of the human 25-hydroxyvitamin D3-1\u03b1-hydroxylase gene. Proc. Natl. Acad. Sci. USA 96, 6988\u20136993.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1451", "doi-asserted-by": "publisher", "first-page": "921", "DOI": "10.1016/S1357-2725(01)00165-0", "volume": "34", "author": "X.H. Gao", "year": "2002", "unstructured": "Gao, X.H., P.P. Dwivedi, S. Choe, F. Alba, H.A. Morris, J.L. Omdahl et al. (2002). Basal and parathyroid hormone induced expression of the human 25-hydroxyvitamin D 1\u03b1-hydroxylase gene promoter in kidney AOK-B50 cells: Role of Sp1, Ets and CCAAT box protein binding sites. Int. J. Biochem. Cell Biol. 34, 921\u2013930.", "journal-title": "Int. J. Biochem. Cell Biol."}, {"key": "10_CR1452", "doi-asserted-by": "publisher", "first-page": "249", "DOI": "10.1677/joe.0.1710249", "volume": "171", "author": "T. Michigami", "year": "2001", "unstructured": "Michigami, T., H. Yamato, H. Suzuki, Y. Nagai-Itagaki, K. Sato, and K. Ozono (2001). Conflicting actions of parathyroid hormone-related protein and serum calcium as regulators of 25-hydroxyvitamin D3-1\u03b1-hydroxylase expression in a nude rat model of humoral hypercalcemia of malignancy. J. Endocrinol. 171, 249\u2013257.", "journal-title": "J. Endocrinol."}, {"key": "10_CR1453", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1159/000057955", "volume": "57", "author": "S. Kato", "year": "2002", "unstructured": "Kato, S., T. Yoshizazawa, S. Kitanaka, A. Murayama, and K. Takeyama (2002). Molecular genetics of vitamin D-dependent hereditary rickets. Horm. Res. 57, 73\u201378.", "journal-title": "Horm. Res."}, {"key": "10_CR1454", "doi-asserted-by": "publisher", "first-page": "1694", "DOI": "10.1086/302156", "volume": "63", "author": "J.T. Wang", "year": "1998", "unstructured": "Wang, J.T., C.J. Lin, S.M. Burridge, G.K. Fu, M. Labuda, A.A. Portale et al. (1998). Genetics of vitamin D 1\u03b1-hydroxylase deficiency in 17 families. Am. J. Hum. Genet. 63, 1694\u20131702.", "journal-title": "Am. J. Hum. Genet."}, {"key": "10_CR1455", "doi-asserted-by": "crossref", "first-page": "620", "DOI": "10.1007/PL00009639", "volume": "14", "author": "A.A. Portale", "year": "2000", "unstructured": "Portale, A.A. and W.L. Miller (2000). Human 25-hydroxyvitamin D-1\u03b1-hydroxylase: Cloning, mutations, and gene expression. Pediatr. Nephrol. 14, 620\u2013625.", "journal-title": "Pediatr. Nephrol."}, {"key": "10_CR1456", "doi-asserted-by": "crossref", "first-page": "557", "DOI": "10.1007/BF03345500", "volume": "25", "author": "L. Porcu", "year": "2002", "unstructured": "Porcu, L., A. Meloni, L. Casula, I. Asunis, M.G. Marini, A. Cao et al. (2002). A novel splicing defect (IVS6 + 1G>T) in a patient with pseudovitamin D deficiency rickets. J. Endocrinol. Invest. 25, 557\u2013560.", "journal-title": "J. Endocrinol. Invest."}, {"key": "10_CR1457", "doi-asserted-by": "publisher", "first-page": "653", "DOI": "10.1056/NEJM199803053381004", "volume": "338", "author": "S. Kitanaka", "year": "1998", "unstructured": "Kitanaka, S., K. Takeyama, A. Murayama, T. Sato, K. Okumura, M. Nogami et al. (1998). Inactivating mutations in the 25-hydroxyvitamin D3 1\u03b1-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N. Engl. J. Med. 338, 653\u2013661.", "journal-title": "N. Engl. J. Med."}, {"key": "10_CR1458", "doi-asserted-by": "publisher", "first-page": "730", "DOI": "10.1359/jbmr.1999.14.5.730", "volume": "14", "author": "S.J. Smith", "year": "1999", "unstructured": "Smith, S.J., A.K. Rucka, J.L. Berry, M. Davies, S. Mylchreest, C.R. Paterson et al. (1999). Novel mutations in the 1\u03b1-hydroxylase (P450c1) gene in three families with pseudovitamin D-deficiency rickets resulting in loss of functional enzyme activity in blood-derived macrophages. J. Bone Miner. Res. 14, 730\u2013739.", "journal-title": "J. Bone Miner. Res."}, {"key": "10_CR1459", "doi-asserted-by": "publisher", "first-page": "950", "DOI": "10.1046/j.1432-1327.1999.00794.x", "volume": "265", "author": "N. Sawada", "year": "1999", "unstructured": "Sawada, N., T. Sakaki, S. Kitanaka, K. Takeyama, S. Kato, and K. Inouye (1999). Enzymatic properties of human 25-hydroxyvitamin D3 1\u03b1-hydroxylase coexpression with adrenodoxin and NADPH-adrenodoxin reductase in Escherichia coli. Eur. J. Biochem. 265, 950\u2013956.", "journal-title": "Eur. J. Biochem."}, {"key": "10_CR1460", "doi-asserted-by": "publisher", "first-page": "2424", "DOI": "10.1210/jc.87.6.2424", "volume": "87", "author": "X. Wang", "year": "2002", "unstructured": "Wang, X., M.Y. Zhang, W.L. Miller, and A.A. Portale (2002). Novel gene mutations in patients with 1\u03b1-hydroxylase deficiency that confer partial enzyme activity in vitro. J. Clin. Endocrinol. Metab. 87, 2424\u20132430.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1461", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1016/S0960-0760(97)00015-0", "volume": "62", "author": "K.R. Muralidharan", "year": "1997", "unstructured": "Muralidharan, K.R., M. Rowland-Goldsmith, A.S. Lee, G. Park, A.W. Norman, H.L. Henry et al. (1997). Inhibitors of 25-hydroxyvitamin D3-1\u03b1-hydroxylase: Thiavitamin D analogs and biological evaluation. J. Steroid Biochem. 62, 73\u201378.", "journal-title": "J. Steroid Biochem."}, {"key": "10_CR1462", "doi-asserted-by": "publisher", "first-page": "141", "DOI": "10.1677/jme.0.0250141", "volume": "25", "author": "M. Hewison", "year": "2000", "unstructured": "Hewison, M., D. Zehnder, R. Bland, and P.M. Stewart (2000). 1\u03b1-Hydroxylase and the action of vitamin D. J. Mol. Endocrinol. 25, 141\u2013148.", "journal-title": "J. Mol. Endocrinol."}, {"key": "10_CR1463", "first-page": "427", "volume": "48", "author": "S. Kitanaka", "year": "2001", "unstructured": "Kitanaka, S., K. Takeyama, A. Murayama, and S. Kato (2001). The molecular basis of vitamin D-dependent rickets type I. Endocrinol. J. 48, 427\u2013432.", "journal-title": "Endocrinol. J."}, {"key": "10_CR1464", "doi-asserted-by": "crossref", "first-page": "620", "DOI": "10.1007/PL00009639", "volume": "14", "author": "A.A. Portale", "year": "2000", "unstructured": "Portale, A.A. and W.L. Miller (2000). Human 25-hydroxyvitamin D-1\u03b1-hydroxylase: Cloning, mutations, and gene expression. Pediatr. Nephrol. 14, 620\u2013625.", "journal-title": "Pediatr. Nephrol."}, {"key": "10_CR1465", "doi-asserted-by": "publisher", "first-page": "4111", "DOI": "10.1210/jc.84.11.4111", "volume": "84", "author": "S. Kitanaka", "year": "1999", "unstructured": "Kitanaka, S., A. Murayama, T. Sakaki, K. Inouye, Y. Seino, S. Fukumoto et al. (1999). No enzyme activity of 25-hydroxyvitamin D3 1\u03b1-hydroxylase gene product in pseudovitamin D deficiency rickets, including that with mild clinical manifestation. J. Clin. Endocrinol. Metab. 84, 4111\u20134117.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1466", "doi-asserted-by": "publisher", "first-page": "3135", "DOI": "10.1210/en.142.7.3135", "volume": "142", "author": "O. Dardenne", "year": "2001", "unstructured": "Dardenne, O., J. Prud\u2019homme, A. Arabian, F.H. Glorieux, and R. St-Arnaud (2001). Targeted inactivation of the 25-hydroxyvitamin D3-1\u03b1-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 142, 3135\u20133141.", "journal-title": "Endocrinology"}, {"key": "10_CR1467", "doi-asserted-by": "publisher", "first-page": "7498", "DOI": "10.1073/pnas.131029498", "volume": "98", "author": "D.K. Panda", "year": "2001", "unstructured": "Panda, D.K., D. Miao, M.L. Tremblay, J. Sirois, R. Farookhi, G.N. Hendy et al. (2001). Targeted ablation of the 25-hydroxyvitamin D 1\u03b1-hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction. Proc. Natl. Acad. Sci. USA 98, 7498\u20137503.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1468", "doi-asserted-by": "publisher", "first-page": "245", "DOI": "10.1002/jcb.10348", "volume": "88", "author": "R. St-Arnaud", "year": "2003", "unstructured": "St-Arnaud, R., O. Dardenne, J. Prud\u2019homme, S.A. Hacking, and F.H. Glorieux (2003). Conventional and tissue-specific inactivation of the 25-hydroxyvitamin D-1\u03b1-hydroxylase (CYP27B1). J. Cell. Biochem. 88, 245\u2013251.", "journal-title": "J. Cell. Biochem."}, {"key": "10_CR1469", "doi-asserted-by": "crossref", "first-page": "712", "DOI": "10.1038/ki.1988.237", "volume": "34", "author": "K. Satomura", "year": "1988", "unstructured": "Satomura, K., Y. Seino, K. Yamaoka, Y. Tanaka, M. Ishida, H. Yabuuchi et al. (1988). Renal 25-hydroxyvitamin D3-1-hydroxylase in patients with renal disease. Kidney Int. 34, 712\u2013716.", "journal-title": "Kidney Int"}, {"key": "10_CR1470", "doi-asserted-by": "publisher", "first-page": "5826", "DOI": "10.1210/jc.2002-021356", "volume": "87", "author": "P. Correa", "year": "2002", "unstructured": "Correa, P., U. Segersten, P. Hellman, G. Akerstrom, and G. Westin (2002). Increased 25-hydroxyvitamin D3 1\u03b1-hydroxylase and reduced 25-hydroxyvitamin D3 24-hydroxylase expression in parathyroid tumors\u2014new prospects for treatment of hyperparathyroidism with vitamin D. J. Clin. Endocrinol. Metab. 87, 5826\u20135829.", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10_CR1471", "first-page": "868", "volume": "7", "author": "R.M. Maas", "year": "2001", "unstructured": "Maas, R.M., K. Reus, B. Diesel, W.I. Steudel, W. Feiden, U. Fischer et al. (2001). Amplification and expression of splice variants of the gene encoding the P450 cytochrome 25-hydroxyvitamin D3 1,\u03b1-hydroxylase (CYP 27B1) in human malignant glioma. Clin. Cancer Res. 7, 868\u2013875.", "journal-title": "Clin. Cancer Res."}, {"key": "10_CR1472", "doi-asserted-by": "publisher", "first-page": "1673", "DOI": "10.1016/S0140-6736(00)04831-5", "volume": "357", "author": "V. Tangpricha", "year": "2001", "unstructured": "Tangpricha, V., J.N. Flanagan, L.W. Whitlatch, C.C. Tseng, T.C. Chen, P.R. Holt et al. (2001). 25-hydroxyvitamin D-1\u03b1-hydroxylase in normal and malignant colon tissue. Lancet 357, 1673\u20131674.", "journal-title": "Lancet"}, {"key": "10_CR1473", "doi-asserted-by": "publisher", "first-page": "287", "DOI": "10.1016/S0039-128X(00)00153-7", "volume": "66", "author": "H.S. Cross", "year": "2001", "unstructured": "Cross, H.S., P. Bareis, H. Hofer, M.G. Bischof, E. Bajna, S. Kriwanek et al. (2001). 25-Hydroxyvitamin D3-1\u03b1-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66, 287\u2013292.", "journal-title": "Steroids"}, {"key": "10_CR1474", "doi-asserted-by": "publisher", "first-page": "1831", "DOI": "10.1016/S0140-6736(02)08680-4", "volume": "359", "author": "B.W. Ogunkolade", "year": "2002", "unstructured": "Ogunkolade, B.W., B.J. Boucher, P.D. Fairclough, G.A. Hitman, S. Dorudi, P.J. Jenkins et al. (2002). Expression of 25-hydroxyvitamin D-1-\u03b1-hydroxylase mRNA in individuals with colorectal cancer. Lancet 359, 1831\u20131832.", "journal-title": "Lancet"}, {"key": "10_CR1475", "first-page": "2852", "volume": "61", "author": "J.Y. Hsu", "year": "2001", "unstructured": "Hsu, J.Y., D. Feldman, J.E. McNeal, and D.M. Peehl (2001). Reduced 1\u03b1-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition. Cancer Res. 61, 2852\u20132856.", "journal-title": "Cancer Res"}, {"key": "10_CR1476", "doi-asserted-by": "publisher", "first-page": "135", "DOI": "10.1016/S0960-0760(02)00053-5", "volume": "81", "author": "L.W. Whitlatch", "year": "2002", "unstructured": "Whitlatch, L.W., M.V. Young, G.G. Schwartz, J.N. Flanagan, K.L. Burnstein et al. (2002). 25-Hydroxyvitamin D-1\u03b1-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. J. Steroid Biochem. Mol. Biol. 81, 135\u2013140.", "journal-title": "J. Steroid Biochem. Mol. Biol."}, {"key": "10_CR1477", "doi-asserted-by": "publisher", "first-page": "910", "DOI": "10.1046/j.1523-1747.2001.01360.x", "volume": "116", "author": "J.N. Flanagan", "year": "2001", "unstructured": "Flanagan, J.N., L.W. Whitlatch, T.C. Chen, X.H. Zhu, M.T. Holick, X.F. Kong et al. (2001). Enhancing 1\u03b1-hydroxylase activity with the 25-hydroxyvitamin D-1\u03b1-hydroxylase gene in cultured human keratinocytes and mouse skin. J. Invest. Dermatol. 116, 910\u2013914.", "journal-title": "J. Invest. Dermatol."}, {"key": "10_CR1478", "doi-asserted-by": "publisher", "first-page": "16543", "DOI": "10.1074/jbc.M001810200", "volume": "275", "author": "J. Li-Hawkins", "year": "2000", "unstructured": "Li-Hawkins, J., E.G. Lund, A.D. Bronson, and D.W. Russell (2000). Expression cloning of an oxysterol 7\u03b1-hydroxylase selective for 24-hydroxycholesterol. J. Biol. Chem. 275, 16543\u201316549.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1479", "doi-asserted-by": "publisher", "first-page": "7238", "DOI": "10.1073/pnas.96.13.7238", "volume": "96", "author": "E.G. Lund", "year": "1999", "unstructured": "Lund, E.G., J.M. Guileyardo, and D.W. Russell (1999). cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. USA 96, 7238\u20137243.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1480", "doi-asserted-by": "crossref", "first-page": "126", "DOI": "10.1016/S1388-1981(00)00142-6", "volume": "1529", "author": "D.W. Russell", "year": "2000", "unstructured": "Russell, D.W. (2000). Oxysterol biosynthetic enzymes. Biochim. Biophys. Acta 1529, 126\u2013135.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "10_CR1481", "doi-asserted-by": "publisher", "first-page": "45", "DOI": "10.1016/S0304-3940(01)02277-7", "volume": "314", "author": "N. Bogdanovic", "year": "2001", "unstructured": "Bogdanovic, N., L. Bretillon, E.G. Lund, U. Diczfalusy, L. Lannfelt, B. Winblad et al. (2001). On the turnover of brain cholesterol in patients with Alzheimer\u2019s disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells. Neurosci. Lett. 314, 45\u201348.", "journal-title": "Neurosci. Lett."}, {"key": "10_CR1482", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1016/S0022-3956(01)00050-4", "volume": "36", "author": "A. Papassotiropoulos", "year": "2002", "unstructured": "Papassotiropoulos, A., D. Lutjohann, M. Bagli, S. Locatelli, F. Jessen, R. Buschfort et al. (2002). 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J. Psychiatr. Res. 36, 27\u201332.", "journal-title": "J. Psychiatr. Res."}, {"key": "10_CR1483", "doi-asserted-by": "publisher", "first-page": "899", "DOI": "10.1038/sj.mp.4001109", "volume": "7", "author": "H. Kolsch", "year": "2002", "unstructured": "Kolsch, H., D. Lutjohann, M. Ludwig, A. Schulte, U. Ptok, F. Jessen et al. (2002). Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer\u2019s disease. Mol. Psychiatry 7, 899\u2013902.", "journal-title": "Mol. Psychiatry"}, {"key": "10_CR1484", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.1016/S0304-3940(02)00443-3", "volume": "328", "author": "P. Desai", "year": "2002", "unstructured": "Desai, P., S.T. DeKosky, and M.I. Kamboh (2002). Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer\u2019s disease. Neurosci. Lett. 328, 9\u201312.", "journal-title": "Neurosci. Lett."}, {"key": "10_CR1485", "doi-asserted-by": "publisher", "first-page": "14284", "DOI": "10.1021/bi035512f", "volume": "42", "author": "N. Mast", "year": "2003", "unstructured": "Mast, N., R. Norcross, U. Andersson, M. Shou, K. Nakayama, I. Bjorkhem, and I.A. Pikuleva (2003). Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain. Biochemistry 42, 14284\u201314292.", "journal-title": "Biochemistry"}, {"key": "10_CR1486", "doi-asserted-by": "publisher", "first-page": "1320", "DOI": "10.1006/bbrc.1994.1848", "volume": "201", "author": "Y. Aoyama", "year": "1994", "unstructured": "Aoyama, Y., Y. Funae, M. Noshiro, T. Horiuchi, and Y. Yoshida (1994). Occurrence of a P450 showing high homology to yeast lanosterol 14-demethylase (P45014DM) in rat liver. Biochem. Biophys. Res. Commun. 201, 1320\u20131326.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1487", "doi-asserted-by": "crossref", "first-page": "982", "DOI": "10.1093/oxfordjournals.jbchem.a021516", "volume": "120", "author": "Y. Aoyama", "year": "1996", "unstructured": "Aoyama, Y., T. Horiuchi, and Y. Yoshida (1996). Lanosterol 14-demethylase activity expressed in rat brain microsomes. J. Biochem. (Tokyo) 120, 982\u2013986.", "journal-title": "J. Biochem."}, {"key": "10_CR1488", "doi-asserted-by": "publisher", "first-page": "466", "DOI": "10.1006/abbi.1996.0416", "volume": "333", "author": "D. Rozman", "year": "1996", "unstructured": "Rozman, D., M. Str\u00f6mstedt, and M.R. Waterman (1996). The three human cytochrome P450 lanosterol 14\u03b1-demethylase (CYP51) genes reside on chromosomes 3, 7, and 13: Structure of the two retrotransposed pseudogenes, association with a line-1 element, and evolution of the human CYP51 family. Arch. Biochem. Biophys. 333, 466\u2013474.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1489", "doi-asserted-by": "publisher", "first-page": "R167", "DOI": "10.1007/s004240100011", "volume": "442", "author": "M. Cotman", "year": "2001", "unstructured": "Cotman, M., D. Rozma, L. Banek, and D. Jezek (2001). Localisation of lanosterol 14\u03b1-demethylase in round and elongated spermatids of the mouse testis: An immunoelectron microscopic and stereological study. Pflugers Arch. 442, R167\u2013R168.", "journal-title": "Pflugers Arch"}, {"key": "10_CR1490", "doi-asserted-by": "publisher", "first-page": "R56", "DOI": "10.1007/s004240000090", "volume": "439", "author": "D. Rozman", "year": "2000", "unstructured": "Rozman, D. (2000). Lanosterol 14\u03b1-demethylase (CYP51)\u2014a cholesterol biosynthetic enzyme involved in production of meiosis activating sterols in oocytes and testis\u2014a minireview. Pflugers Arch. 439, R56\u2013R57.", "journal-title": "Pflugers Arch"}, {"key": "10_CR1491", "doi-asserted-by": "publisher", "first-page": "95", "DOI": "10.1002/ajmg.10510", "volume": "110", "author": "R.I. Kelley", "year": "2002", "unstructured": "Kelley, R.I., L.E. Kratz, R.L. Glaser, M.L. Netzloff, L.M. Wolf, and E.W. Jabs (2002). Abnormal sterol metabolism in a patient with Antley-Bixler syndrome and ambiguous genitalia. Am. J. Med. Genet. 110, 95\u2013102.", "journal-title": "Am. J. Med. Genet."}, {"key": "10_CR1492", "doi-asserted-by": "publisher", "first-page": "159", "DOI": "10.1016/S0003-9861(02)00418-6", "volume": "409", "author": "N. Debeljak", "year": "2003", "unstructured": "Debeljak, N., M. Fink, and D. Rozman (2003). Many facets of mammalian lanosterol 14\u03b1-demethylase from the evolutionarily conserved cytochrome P450 family CYP51. Arch. Biochem. Biophys. 409, 159\u2013171.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1493", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1006/abbi.1996.0193", "volume": "329", "author": "M. Str\u00f6mstedt", "year": "1996", "unstructured": "Str\u00f6mstedt, M., D. Rozman, and M.R. Waterman (1996). The ubiquitously expressed human CYP51 cDNA encodes lanosterol 14\u03b1-demethylase, a cytochrome P450 whose expression is regulated by oxysterols. Arch. Biochem. Biophys. 329, 73\u201381.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1494", "doi-asserted-by": "publisher", "first-page": "1951", "DOI": "10.1210/me.13.11.1951", "volume": "13", "author": "D. Rozman", "year": "1999", "unstructured": "Rozman, D., M. Fink, G.M. Fimia, P. Sassone-Corsi, and M.R. Waterman (1999). Cyclic adenosine 3\u2032,5\u2032-monophosphate(cAMP)/ cAMP-responsive element modulator (CREM)-dependent regulation of cholesterogenic lanosterol 14\u03b1-demethylase (CYP51) in spermatids. Mol. Endocrinol. 13, 1951\u20131962.", "journal-title": "Mol. Endocrinol."}, {"key": "10_CR1495", "doi-asserted-by": "publisher", "first-page": "1853", "DOI": "10.1210/me.2001-0262", "volume": "16", "author": "S.K. Halder", "year": "2002", "unstructured": "Halder, S.K., M. Fink, M.R. Waterman, and D. Rozman (2002). A cAMP-responsive element binding site is essential for sterol regulation of the human lanosterol 14\u03b1-demethylase gene (CYP51). Mol. Endocrinol. 16, 1853\u20131863.", "journal-title": "Mol. Endocrinol."}, {"key": "10_CR1496", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1093/oxfordjournals.jbchem.a022734", "volume": "128", "author": "C. Yamashita", "year": "2000", "unstructured": "Yamashita, C., M. Kudo, H. Ishida, M. Noshiro, Y. Aoyama, and Y. Yoshida (2000). Insulin is the essential factor maintaining the constitutive expression of hepatic sterol 14-demethylase P450 (CYP51). J. Biochem. (Tokyo) 128, 93\u201399.", "journal-title": "J. Biochem."}, {"key": "10_CR1497", "doi-asserted-by": "crossref", "first-page": "268", "DOI": "10.1161/01.RES.88.3.268", "volume": "88", "author": "C. Rodriguez", "year": "2001", "unstructured": "Rodriguez, C., J. Martinez-Gonzalez, S. Sanchez-Gomez, and L. Badimon (2001). LDL downregulates CYP51 in porcine vascular endothelial cells and in the arterial wall through a sterol regulatory element binding protein-2-dependent mechanism. Circ. Res. 88, 268\u2013274.", "journal-title": "Circ. Res."}, {"key": "10_CR1498", "doi-asserted-by": "publisher", "first-page": "78", "DOI": "10.1006/abbi.2001.2566", "volume": "395", "author": "D.C. Lamb", "year": "2001", "unstructured": "Lamb, D.C., N.N. Kaderbhai, K. Venkateswarlu, D.E. Kelly, S.L. Kelly, and M.A. Kaderbhai (2001). Human sterol 14\u03b1-demethylase activity is enhanced by the membrane-bound state of cytochrome b 5. Arch. Biochem. Biophys. 395, 78\u201384.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "10_CR1499", "doi-asserted-by": "publisher", "first-page": "263", "DOI": "10.1016/S0014-5793(98)00247-6", "volume": "425", "author": "D.C. Lamb", "year": "1998", "unstructured": "Lamb, D.C., D.E. Kelly, and S.L. Kelly (1998). Molecular diversity of sterol 14\u03b1-demethylase substrates in plants, fungi and humans. FEBS Lett. 425, 263\u2013265.", "journal-title": "FEBS Lett"}, {"key": "10_CR1500", "doi-asserted-by": "publisher", "first-page": "3068", "DOI": "10.1073/pnas.061562898", "volume": "98", "author": "L.M. Podust", "year": "2001", "unstructured": "Podust, L.M., T.L. Poulos, and M.R. Waterman (2001). Crystal structure of cytochrome P450 14\u03b1-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc. Natl. Acad. Sci. USA 98, 3068\u20133073.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1501", "doi-asserted-by": "publisher", "first-page": "227", "DOI": "10.1016/S0162-0134(01)00388-9", "volume": "87", "author": "L.M. Podust", "year": "2001", "unstructured": "Podust, L.M., J. Stojan, T.L. Poulos, and M.R. Waterman (2001). Substrate recognition sites in 14 \u03b1-sterol demethylase from comparative analysis of amino acid sequences and X-ray structure of Mycobacterium tuberculosis CYP51. J. Inorg. Biochem. 87, 227\u2013235.", "journal-title": "J. Inorg. Biochem."}, {"key": "10_CR1502", "doi-asserted-by": "crossref", "first-page": "2701", "DOI": "10.1099/00221287-145-10-2701", "volume": "145", "author": "P. Marichal", "year": "1999", "unstructured": "Marichal, P., L. Koymans, S. Willemsens, D. Bellens, P. Verhasselt, W. Luyten et al. (1999). Contribution of mutations in the cytochrome P450 14\u03b1-demethylase (Erg11p, CYP51p) to azole resistance in Candida albicans. Microbiology 145, 2701\u20132713.", "journal-title": "Microbiology"}, {"key": "10_CR1503", "doi-asserted-by": "publisher", "first-page": "28413", "DOI": "10.1074/jbc.M102767200", "volume": "276", "author": "G.I. Lepesheva", "year": "2001", "unstructured": "Lepesheva, G.I., L.M. Podust, A. Bellamine, and M.R. Waterman (2001). Folding requirements are different between sterol 14\u03b1-demethylase (CYP51) from Mycobacterium tuberculosis and human or fungal orthologs. J. Biol. Chem. 276, 28413\u201328420.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1504", "doi-asserted-by": "publisher", "first-page": "755", "DOI": "10.1002/(SICI)1097-0061(19990630)15:9<755::AID-YEA417>3.0.CO;2-8", "volume": "15", "author": "D.C. Lamb", "year": "1999", "unstructured": "Lamb, D.C., D.E. Kelly, M.R. Waterman, M. Stromstedt, D. Rozman, and S.L. Kelly (1999). Characteristics of the heterologously expressed human lanosterol 14\u03b1-demethylase (other names: P45014DM, CYP51, P45051) and inhibition of the purified human and Candida albicans CYP51 with azole antifungal agents. Yeast 15, 755\u2013763.", "journal-title": "Yeast"}, {"key": "10_CR1505", "first-page": "1199", "volume": "26", "author": "D. Rozman", "year": "1998", "unstructured": "Rozman, D. and M.R. Waterman (1998). Lanosterol 14\u03b1-demethylase (CYP51) and spermatogenesis. Drug Metab. Dispos. 26, 1199\u20131201.", "journal-title": "Drug Metab. Dispos."}, {"key": "10_CR1506", "doi-asserted-by": "publisher", "first-page": "463", "DOI": "10.1677/joe.0.1660463", "volume": "166", "author": "G. Majdic", "year": "2000", "unstructured": "Majdic, G., M. Parvinen, A. Bellamine, H.J. Harwood, Jr., W.W. Ku, M.R. Waterman, and D. Rozman (2000). Lanosterol 14\u03b1-demethylase (CYP51), NADPH-cytochrome P450 reductase and squalene synthase in spermatogenesis: Late spermatids of the rat express proteins needed to synthesize follicular fluid meiosis activating sterol. J. Endocrinol. 166, 463\u2013474.", "journal-title": "J. Endocrinol."}, {"key": "10_CR1507", "doi-asserted-by": "crossref", "first-page": "849", "DOI": "10.1093/oxfordjournals.jbchem.a003057", "volume": "130", "author": "C. Yamashita", "year": "2001", "unstructured": "Yamashita, C., Y. Aoyama, M. Noshiro, and Y. Yoshida (2001). Gonadotropin-dependent expression of sterol 14-demethylase P450 (CYP51) in rat ovaries and its contribution to the production of a meiosis-activating steroid. J. Biochem. (Tokyo) 130, 849\u2013856.", "journal-title": "J. Biochem."}, {"key": "10_CR1508", "doi-asserted-by": "publisher", "first-page": "179", "DOI": "10.1016/S0303-7207(01)00693-1", "volume": "187", "author": "D. Rozman", "year": "2002", "unstructured": "Rozman, D., M. Cotman, and R. Frangez (2002). Lanosterol 14\u03b1-demethylase and MAS sterols in mammalian gametogenesis. Mol. Cell Endocrinol. 187, 179\u2013187.", "journal-title": "Mol. Cell Endocrinol."}, {"key": "10_CR1509", "doi-asserted-by": "publisher", "first-page": "716", "DOI": "10.1073/pnas.86.2.716", "volume": "86", "author": "H. Kodaira", "year": "1989", "unstructured": "Kodaira, H., C.A. Lisek, A. Arimura, I. Jardine, and S. Spector (1989). Identification of the convulsant opiate thebaine in mammalian brain. Proc. Natl. Acad. Sci. USA 86, 716\u2013719.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1510", "doi-asserted-by": "publisher", "first-page": "1267", "DOI": "10.1073/pnas.85.4.1267", "volume": "85", "author": "H. Kodaira", "year": "1988", "unstructured": "Kodaira, H. and S. Spector (1988). Transformation of thebaine to oripavine, codeine, and morphine by rat liver, kidney, and brain microsomes. Proc. Natl. Acad. Sci. USA 85, 1267\u20131271.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "10_CR1511", "doi-asserted-by": "publisher", "first-page": "411", "DOI": "10.1016/S0006-291X(88)80729-0", "volume": "152", "author": "P. Dayer", "year": "1988", "unstructured": "Dayer, P., J. Desmeules, T. Leemann, and R. Striberni (1988). Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation. Biochem. Biophys. Res. Commun. 152, 411\u2013416.", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "10_CR1512", "first-page": "546", "volume": "268", "author": "G. Mikus", "year": "1994", "unstructured": "Mikus, G., F. Bochner, M. Eichelbaum, P. Horak, A.A. Somogyi, and S. Spector (1994). Endogenous codeine and morphine in poor and extensive metabolisers of the CYP2D6 (debrisoquine/sparteine) polymorphism. J. Pharmacol. Exp. Ther. 268, 546\u2013551.", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "10_CR1513", "doi-asserted-by": "publisher", "first-page": "174", "DOI": "10.1038/nature00908", "volume": "12", "author": "S.C. Trewick", "year": "2002", "unstructured": "Trewick, S.C., T.F. Henshaw, R.P. Hausinger, T. Lindahl, and B. Sedgwick (2002). Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage. Nature 12, 174\u2013178.", "journal-title": "Nature"}, {"key": "10_CR1514", "doi-asserted-by": "publisher", "first-page": "10157", "DOI": "10.1074/jbc.M211058200", "volume": "278", "author": "R.W. Welford", "year": "2003", "unstructured": "Welford, R.W., I. Schlemminger, L.A. McNeill, K.S. Hewitson, and C.J. Schofield (2003). The selectivity and inhibition of AlkB. J. Biol. Chem. 278, 10157\u201310161.", "journal-title": "J. Biol. Chem."}, {"key": "10_CR1515", "unstructured": "Pai, H.V., R.P. Kommaddi, S.J. Chinta, T. Mori, M.R. Boyd, and V. Ravindranath (2004, in press). A frame shift mutation and alternate splicing in human brain generates a functional form of the pseudogene, cytochrome P4502D7 that demethylates codeine to morphine. J. Biol. Chem. 39774.", "DOI": "10.1074/jbc.M402337200", "doi-asserted-by": "crossref"}], "container-title": ["Cytochrome P450"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/0-387-27447-2_10", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 24]], "date-time": "2019-04-24T05:08:49Z", "timestamp": 1556082529000}, "score": 30.167105, "issued": {"date-parts": [[null]]}, "ISBN": ["9780306483240"], "references-count": 1515, "URL": "http://dx.doi.org/10.1007/0-387-27447-2_10", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T15:57:05Z", "timestamp": 1574524625229}, "publisher-location": "Boston, MA", "reference-count": 472, "publisher": "Springer US", "isbn-type": [{"value": "9781441932488", "type": "print"}, {"value": "9781475723915", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1995]]}, "DOI": "10.1007/978-1-4757-2391-5_14", "type": "book-chapter", "created": {"date-parts": [[2012, 12, 28]], "date-time": "2012-12-28T04:10:20Z", "timestamp": 1356667820000}, "page": "473-535", "source": "Crossref", "is-referenced-by-count": 190, "title": ["Human Cytochrome P450 Enzymes"], "prefix": "10.1007", "author": [{"given": "F. Peter", "family": "Guengerich", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "14_CR1", "doi-asserted-by": "publisher", "first-page": "206", "DOI": "10.1016/0003-9861(80)90274-X", "volume": "199", "author": "P Wang", "year": "1980", "unstructured": "Wang, P., Mason, P. S., and Guengerich, F. P., 1980, Purification of human liver cytochrome P-450 and comparison to the enzyme isolated from rat liver, Arch. Biochem. Biophys. 199: 206\u2013219.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR2", "doi-asserted-by": "publisher", "first-page": "826", "DOI": "10.1016/0006-291X(79)91482-7", "volume": "88", "author": "P Beaune", "year": "1979", "unstructured": "Beaune, P., Dansette, P., Flinois, J. P., Columelli, S., Mansuy, D., and Leroux, J. P., 1979, Partial purification of human liver cytochrome P-450, Biochem. Biophys. Res. Commun. 88: 826\u2013832.", "journal-title": "Biochem. Biophys. Res. Commun"}, {"key": "14_CR3", "doi-asserted-by": "publisher", "first-page": "793", "DOI": "10.1016/0006-2952(79)90360-5", "volume": "28", "author": "M Kitada", "year": "1979", "unstructured": "Kitada, M., and Kamataki, T., 1979, Partial purification and properties of cytochrome P450 from homogenates of human fetal livers, Biochem. Pharmacol. 28: 793\u2013797.", "journal-title": "Biochem. Pharmacol"}, {"key": "14_CR4", "doi-asserted-by": "publisher", "first-page": "5375", "DOI": "10.1021/bi00292a019", "volume": "22", "author": "PP Wang", "year": "1983", "unstructured": "Wang, P. P., Beaune, P., Kaminsky, L. S., Dannan, G. A., Kadlubar, F. F., Larrey, D., and Guengerich, F. P., 1983, Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes, Biochemistry\n                        22: 5375\u20135383.", "journal-title": "Biochemistry"}, {"key": "14_CR5", "doi-asserted-by": "crossref", "first-page": "943", "DOI": "10.1016/S0140-6736(78)90724-9", "volume": "1", "author": "R. L. Smith", "year": "1978", "unstructured": "Smith, R. L., Idle, J. R., Mahgoub, A. A., Sloan, T. P., and Lancaster, R.,1978, Genetically determined defects of oxidation at carbon centres of drugs, Lancet\n                        1: 943\u2013944.", "journal-title": "Lancet"}, {"key": "14_CR6", "first-page": "856", "volume": "41", "author": "T Shimada", "year": "1992", "unstructured": "Shimada, T., Yun, C.-H., Yamazaki, H., Gautier, J.-C., Beaune, P. H., and Guengerich, F. P., 1992, Characterization of human lung microsomal cytochrome P-450 1Al and its role in the oxidation of chemical carcinogens, Mol. Pharmacal. 41: 856\u2013864.", "journal-title": "Mol. Pharmacal"}, {"key": "14_CR7", "first-page": "9057", "volume": "260", "author": "LM Distlerath", "year": "1985", "unstructured": "Distlerath, L. M., Reilly, P. E. B., Martin, M. V., Davis, G. G., Wilkinson, G. R., and Guengerich, F. P., 1985, Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism, J. Biol. Chem. 260: 9057\u20139067.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR8", "first-page": "679", "volume": "40", "author": "C-H Yun", "year": "1991", "unstructured": "Yun, C.-H., Shimada, T., and Guengerich, F. P., 1991, Purification and characterization of human liver microsomal cytochrome P-450 2A6, Mol. Pharmacol. 40: 679\u2013685.", "journal-title": "Mol. Pharmacol"}, {"key": "14_CR9", "doi-asserted-by": "publisher", "first-page": "6929", "DOI": "10.1021/bi00418a039", "volume": "27", "author": "C Ged", "year": "1988", "unstructured": "Ged, C., Umbenhauer, D. R., Bellew, T. M., Bork, R. W., Srivastava, P. K., Shinriki, N., Lloyd, R. S., and Guengerich, F. P., 1988, Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4\u2019-hydroxylase, Biochemistry\n                        27: 6929\u20136940.", "journal-title": "Biochemistry"}, {"key": "14_CR10", "first-page": "909", "volume": "261", "author": "T Shimada", "year": "1986", "unstructured": "Shimada, T., Misono, K. S., and Guengerich, F. P., 1986, Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction, J. Biol. Chem. 261: 909\u2013921.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR11", "first-page": "11734", "volume": "261", "author": "J Gut", "year": "1986", "unstructured": "Gut, J., Catin, T., Dayer, P., Kronbach, T., Zanger, U., and Meyer, U.A., 1986, Debrisoquine/sparteine-type polymorphism of drug oxidation: Purification and characterization of two functionally different human liver cytochrome P-450 isozymes involved in impaired hydroxylation of the prototype substrate bufuralol, J. Biol. Chem. 261: 11734\u201311743.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR12", "doi-asserted-by": "publisher", "first-page": "3165", "DOI": "10.1016/0006-2952(86)90403-X", "volume": "35", "author": "C Birgersson", "year": "1986", "unstructured": "Birgersson, C., Morgan, E. T., J\u00f6mvall, H., and von Bahr, C., 1986, Purification of a desmethylimipramine and debrisoquine hydroxylating cytochrome P-450 from human liver, Biochem. Pharmacol. 35: 3165\u20133166.", "journal-title": "Biochem. Pharmacol"}, {"key": "14_CR13", "doi-asserted-by": "publisher", "first-page": "292", "DOI": "10.1016/0003-9861(87)90347-X", "volume": "258", "author": "SA Wrighton", "year": "1987", "unstructured": "Wrighton, S. A., Thomas, P. E., Ryan, D. E., and Levin, W., 1987, Purification and characterization of ethanol-inducible human hepatic cytochrome P-450HLj, Arch. Biochem. Biophys. 258: 292\u2013297.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR14", "doi-asserted-by": "publisher", "first-page": "168", "DOI": "10.1021/tx00020a008", "volume": "4", "author": "FP Guengerich", "year": "1991", "unstructured": "Guengerich, F. P., Kim, D.-H., and Iwasaki, M., 1991, Role of human cytochrome P-450 IIE1 in the oxidation of several low molecular weight cancer suspects, Chem. Res. Toxicol. 4: 168\u2013179.", "journal-title": "Chem. Res. Toxicol"}, {"key": "14_CR15", "first-page": "5051", "volume": "261", "author": "FR Guengerich", "year": "1986", "unstructured": "Guengerich, F. R, Martin, M. V., Beaune, P. H., Kremers, P., Wolff, T., and Waxman, D. J., 1986, Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism, J. Biol. Chem. 261: 5051\u20135060.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR16", "doi-asserted-by": "publisher", "first-page": "144", "DOI": "10.1016/0003-9861(89)90575-4", "volume": "268", "author": "SA Wrighton", "year": "1989", "unstructured": "Wrighton, S.A., and VandenBranden, M., 1989, Isolation and characterization of human fetal liver cytochrome P450HLp2: A third member of the P450III gene family, Arch. Biochem. Biophys. 268: 144\u2013151.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR17", "doi-asserted-by": "publisher", "first-page": "156", "DOI": "10.1016/0005-2760(92)90106-6", "volume": "1123", "author": "H Kawashima", "year": "1992", "unstructured": "Kawashima, H., Kusunose, E., Kubota, I., Maekawa, M., and Kusunose, M., 1992, Purification and NHs-terminal amino acid sequences of human and rat kidney fatty acid tu-hydroxylases, Biochim. Biophys. Acta\n                        1123: 156\u2013162.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "14_CR18", "doi-asserted-by": "publisher", "first-page": "92", "DOI": "10.1016/0005-2760(93)90179-D", "volume": "1170", "author": "Y Sonoda", "year": "1993", "unstructured": "Sonoda, Y., Endo, M., Ishida, K., Sato, Y., Fukusen, N., and Fukuhara, M., 1993, Purification of a human P-450 isozyme catalyzing lanosterol 14a-demethylation, Biochim. Biophys. Acta\n                        1170: 92\u201397.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "14_CR19", "doi-asserted-by": "publisher", "first-page": "6310", "DOI": "10.1073/pnas.82.18.6310", "volume": "82", "author": "PB Watkins", "year": "1985", "unstructured": "Watkins, P. B., Wrighton, S. A., Maurel, P., Schuetz, E. G., Mendez-Picon, G., Parker, G. A., and Guzelian, P. S., 1985, Identification of an inducible form of cytochrome P-450 in human liver, Proc. Natl. Acad. Sci. USA\n                        82: 6310\u20136314.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "14_CR20", "first-page": "1048", "volume": "21", "author": "M Mimura", "year": "1993", "unstructured": "Mimura, M., Baba, T., Yamazaki, Y., Ohmori, S., Inui, Y., Gonzalez, F. J., Guengerich, F. R, and Shimada, T., 1993, Characterization of cytochrome P450 2B6 in human liver microsomes, Drug Metab. Dispos\n                        21: 1048\u20131056.", "journal-title": "Drug Metab. Dispos"}, {"key": "14_CR21", "first-page": "243", "volume": "40", "author": "FJ Gonzalez", "year": "1989", "unstructured": "Gonzalez, F. J., 1989, The molecular biology of cytochrome P450s, Pharmacol. Rev. 40: 243\u2013288.", "journal-title": "Pharmacol. Rev"}, {"key": "14_CR22", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1089/dna.1993.12.1", "volume": "12", "author": "DR Nelson", "year": "1993", "unstructured": "Nelson, D. R., Kamataki, T., Waxman, D. J., Guengerich, F. R, Estabrook, R. W., Feyereisen, R., Gonzalez, F. J., Coon, M. J., Gunsalus, I. C., Gotoh, O., Okuda, K., and Nebert, D. W., 1993, The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature, DNA Cell Biol. 12: 1\u201351.", "journal-title": "DNA Cell Biol"}, {"key": "14_CR23", "author": "T Tateishi", "year": "1994", "unstructured": "Tateishi, T., Krivoruk, Y., Wood, A. J. J., Guengerich, F. R, and Wood, M., 1994, Identification of human liver P450 3A4 as the enzyme responsible for sulfentanil N-dealkylation, in: Abstracts, 12th Int. Congr. Pharmacol. (July 24\u201329, Montreal).", "volume-title": "Montreal)"}, {"key": "14_CR24", "first-page": "414", "volume": "270", "author": "T Shimada", "year": "1994", "unstructured": "Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., and Guengerich, F. R, 1994, Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians, J. Pharmacol. Exp. Ther. 270: 414\u2013423.", "journal-title": "J. Pharmacol. Exp. Ther"}, {"key": "14_CR25", "first-page": "2370", "volume": "239", "author": "T Omura", "year": "1964", "unstructured": "Omura, T., and Sato, R., 1964, The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature, J. Biol. Chem. 239: 2370\u20132378.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR26", "doi-asserted-by": "publisher", "first-page": "402", "DOI": "10.1038/clpt.1985.194", "volume": "38", "author": "K Nakamura", "year": "1985", "unstructured": "Nakamura, K., Goto, E, Ray, W. A., McAllister, C. B., Jacqz, E., Wilkinson, G. R., and Branch, R. A., 1985, Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations, Clin. Pharmacol. Thee. 38: 402\u2013408.", "journal-title": "Clin. Pharmacol. Thee"}, {"key": "14_CR27", "doi-asserted-by": "publisher", "first-page": "308", "DOI": "10.1038/clpt.1991.141", "volume": "50", "author": "MV Relling", "year": "1991", "unstructured": "Relling, M. V., Cherrie, J., Schell, M. J., Petros, W. P., Meyer, W. H., and Evans, W. E., 1991, Lower prevalence of the debrisoquin oxidative poor metabolizer phenotype in American black versus white subjects, Clin. Pharmacol. Ther. 50: 308\u2013313.", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "14_CR28", "doi-asserted-by": "publisher", "first-page": "301", "DOI": "10.1016/0163-7258(93)90026-A", "volume": "58", "author": "DS Keeney", "year": "1993", "unstructured": "Keeney, D.S., and Waterman, M. R., 1993, Regulation of steroid hydroxylase gene expression: Importance to physiology and disease, Pharmacol. Ther. 58: 301\u2013317.", "journal-title": "Pharmacol. Ther"}, {"key": "14_CR29", "doi-asserted-by": "publisher", "first-page": "391", "DOI": "10.1021/tx00022a001", "volume": "4", "author": "FP Guengerich", "year": "1991", "unstructured": "Guengerich, F. P., and Shimada, T., 1991, Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes, Chem. Res. Toxicol. 4: 391\u2013407.", "journal-title": "Chem. Res. Toxicol"}, {"key": "14_CR30", "doi-asserted-by": "publisher", "first-page": "651", "DOI": "10.1111/j.1365-2125.1990.tb03686.x", "volume": "29", "author": "D Sesardic", "year": "1990", "unstructured": "Sesardic, D., Boobis, A., Murray, B., Murray, S., Segura, J., De La Torre, R., and Davies, D., 1990, Furafylline is a potent and selective inhibitor of cytochrome P450 lA2 in man, Br. J. Clin. Pharmacol. 29: 651\u2013663.", "journal-title": "Br. J. Clin. Pharmacol"}, {"key": "14_CR31", "doi-asserted-by": "publisher", "first-page": "649", "DOI": "10.1021/tx00035a009", "volume": "6", "author": "KL Kunze", "year": "1993", "unstructured": "Kunze, K. L., and Trager, W. F., 1993, Isoform-selective mechanism-based inhibition of human cytochrome-P450 1A2 by furafylline, Chem. Res. Toxicol. 6: 649\u2013656.", "journal-title": "Chem. Res. Toxicol"}, {"key": "14_CR32", "first-page": "101", "volume": "54", "author": "EP Gallagher", "year": "1994", "unstructured": "Gallagher, E. P., Wienkers, L. C., Stapleton, P. L., Kunze, K. L., and Eaton, D. L., 1994, Role of human microsomal and human complementary DNA-expressed cytochrome-P4501A2 and cytochromeP4503A4 in the bioactivation of aflatoxin Bt, Cancer Res. 54: 101\u2013108.", "journal-title": "Cancer Res"}, {"key": "14_CR33", "first-page": "A1381", "volume": "8", "author": "GJ Hammons", "year": "1994", "unstructured": "Hammons, G. J., Milton, D., Guengerich, F. P., Tukey, R. H., and Kadlubar, E F., 1994, Human cytochrome P450 1A2-catalyzed N-hydroxylation of carcinogenic heterocyclic amines, FASEB J. 8: A1381.", "journal-title": "FASEB J"}, {"key": "14_CR34", "doi-asserted-by": "publisher", "first-page": "1698", "DOI": "10.1021/bi00536a035", "volume": "21", "author": "EP Guengerich", "year": "1982", "unstructured": "Guengerich, E P., Wang, P., and Davidson, N. K., 1982, Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis, Biochemistry\n                        21: 1698\u20131706.", "journal-title": "Biochemistry"}, {"key": "14_CR35", "first-page": "437", "volume": "14", "author": "P Beaune", "year": "1986", "unstructured": "Beaune, P., Kremers, P. G., Kaminsky, L. S., de Graeve, J., and Guengerich, E R, 1986, Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes, Drug Metab. Dispos. 14: 437\u2013442.", "journal-title": "Drug Metab. Dispos"}, {"key": "14_CR36", "doi-asserted-by": "publisher", "first-page": "11748", "DOI": "10.1073/pnas.90.24.11748", "volume": "90", "author": "MS Shet", "year": "1993", "unstructured": "Shet, M. S., Fisher, C. W., Holmans, P. L., and Estabrook, R. W., 1993, Human cytochrome P450 3A4: Enzymatic properties of a purified recombinant fusion protein containing NADPH-P450 reductase, Proc. Natl. Acad. Sci. USA\n                        90: 11748\u201311752.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "14_CR37", "doi-asserted-by": "publisher", "first-page": "355", "DOI": "10.1016/0003-9861(91)90551-S", "volume": "290", "author": "RW Wang", "year": "1991", "unstructured": "Wang, R. W., Kari, P. H., Lu, A.Y.H., Thomas, P. E., Guengerich, F. R, and Vyas, K. R, 1991, Biotransformation of lovastatin. IV. Identification of cytochrome P-450 3A proteins as the major enzymes responsible for the oxidative metabolism of lovastatin in rat and human liver microsomes, Arch. Biochem. Biophys. 290: 355\u2013361.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR38", "doi-asserted-by": "publisher", "first-page": "363", "DOI": "10.1021/tx00016a015", "volume": "3", "author": "FR Guengerich", "year": "1990", "unstructured": "Guengerich, F. R, 1990, Mechanism-based inactivation of human liver cytochrome P-450 IIIA4 by gestodene, Chem. Res. Toxicol. 3: 363\u2013371.", "journal-title": "Chem. Res. Toxicol"}, {"key": "14_CR39", "doi-asserted-by": "publisher", "first-page": "7348", "DOI": "10.1073/pnas.81.23.7348", "volume": "81", "author": "LM Distlerath", "year": "1984", "unstructured": "Distlerath, L. M., and Guengerich, F. P., 1984, Characterization of a human liver cytochrome P-450 involved in the oxidation of debrisoquine and other drugs using antibodies raised to the analogous rat enzyme, Proc. Natl. Acad. Sci. USA\n                        81: 7348\u20137352.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "14_CR40", "unstructured": "Guo, Z., Gillam, E.M.J., Ohmori, S., Tukey, R. H., and Guengerich, F. R, 1995, Expression of modified human cytochrome P450 1A1 in Escherichia coli. Effects of 5\u2019 substitution, purification, spectral characterization, reconstitution conditions and catalytic properties, Arch. Biochem. Biophys. 317: 374384.", "DOI": "10.1006/abbi.1994.1330", "doi-asserted-by": "crossref"}, {"key": "14_CR41", "doi-asserted-by": "publisher", "first-page": "3735", "DOI": "10.1016/0006-2952(88)90408-X", "volume": "37", "author": "RJ Edwards", "year": "1988", "unstructured": "Edwards, R. J., Singleton, A. M., Sesardic, D., Boobis, A. R., and Davies, D. S., 1988, Antibodies to a synthetic peptide that react specifically with a common surface region on two hydrocarbon-inducible isoenzymes of cytochrome P-450 in the rat, Biochem. Pharmacol. 37: 3735\u20133741.", "journal-title": "Biochem. Pharmacol"}, {"key": "14_CR42", "doi-asserted-by": "publisher", "first-page": "3682", "DOI": "10.1073/pnas.79.12.3682", "volume": "79", "author": "T Fujino", "year": "1982", "unstructured": "Fujino, T., Park, S. S., West, D., and Gelboin, H. V., 1982, Phenotyping of cytochromes P-450 in human tissues with monoclonal antibodies, Proc. Natl. Acad. Sci. USA\n                        79: 3682\u20133686.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "14_CR43", "author": "LM Reik", "year": "1985", "unstructured": "Reik, L. M., Levin, W., Ryan, D. E., Maines, S. L., and Thomas, R E., 1985, Monoclonal antibodies distinguish among isozymes of the cytochrome P-450b subfamily, Arch. Biochem. Biophys. 242:365-382.", "volume-title": "242:365-382"}, {"key": "14_CR44", "doi-asserted-by": "publisher", "first-page": "2225", "DOI": "10.1016/0006-2952(85)90776-2", "volume": "34", "author": "HV Gelboin", "year": "1985", "unstructured": "Gelboin, H. V., and Friedman, F. K., 1985, Monoclonal antibodies for studies on xenobiotic and endobiotic metabolism, Biochem. Pharmacol. 34: 2225\u20132234.", "journal-title": "Biochem. Pharmacol"}, {"key": "14_CR45", "doi-asserted-by": "publisher", "first-page": "787", "DOI": "10.1016/0006-2952(93)90485-F", "volume": "46", "author": "I Goldfarb", "year": "1993", "unstructured": "Goldfarb, I., Korzekwa, K., Krausz, K. W., Gonzalez, F., and Gelboin, H. V., 1993, Cross-reactivity of thirteen monoclonal antibodies with ten vaccinia cDNA expressed rat, mouse and human cytochrome P450s, Biochem. Pharmacol. 46: 787\u2013790.", "journal-title": "Biochem. Pharmacol"}, {"key": "14_CR46", "first-page": "76", "volume": "41", "author": "SA Wrighton", "year": "1992", "unstructured": "Wrighton, S. A., VandenBranden, M., Becker, G. W., Black, S. D., and Thomas, P. E., 1992, Two monoclonal antibodies recognizing different epitomes on rat cytochrome P450 IIB1 react with human IIE!, Mol. Pharmacol. 41: 76\u201382.", "journal-title": "Mol. Pharmacol"}, {"key": "14_CR47", "doi-asserted-by": "publisher", "first-page": "240", "DOI": "10.1006/abbi.1993.1506", "volume": "306", "author": "SA Wrighton", "year": "1993", "unstructured": "Wrighton, S. A., Stevens, J. C., Becker, G. W., and VandenBranden, M., 1993, Isolation and characterization of human liver cytochrome P450 2C19: Correlation between 2C19 and 5-mephenytoin 4\u2019-hydroxylation, Arch. Biochem. Biophys. 306: 240\u2013245.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR48", "author": "P Soucek", "year": "1994", "unstructured": "Soucek, P., Guo, Z., Sandhu, P., Martin, M. V., and Guengerich, F. P., 1994, Immunochemical cross-reactivity of human cytochrome P450 enzymes analyzed with recombinant proteins, FASEB J. 8:Al248.", "volume-title": "8:Al248"}, {"key": "14_CR49", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.3109/10408449209145319", "volume": "22", "author": "SA Wrighton", "year": "1992", "unstructured": "Wrighton, S. A., and Stevens, J. C., 1992, The human hepatic cytochromes P450 involved in drug metabolism, Crit. Rev. Toxicol. 22: 1\u201321.", "journal-title": "Crit. Rev. Toxicol"}, {"key": "14_CR50", "doi-asserted-by": "publisher", "first-page": "203", "DOI": "10.1089/dna.1985.4.203", "volume": "4", "author": "K Oeda", "year": "1985", "unstructured": "Oeda, K., Sakaki, T., and Ohkawa, H., 1985, Expression of rat liver cytochrome P-450MC cDNA in Saccharomyces cerevisiae, DNA 4: 203\u2013210.", "journal-title": "Dna"}, {"key": "14_CR51", "doi-asserted-by": "publisher", "first-page": "1258", "DOI": "10.1126/science.3535074", "volume": "234", "author": "MX Zuber", "year": "1986", "unstructured": "Zuber, M. X., Simpson, E. R., and Waterman, M. R., 1986, Expression of bovine 17a-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells, Science\n                        234: 1258\u20131261.", "journal-title": "Science"}, {"key": "14_CR52", "doi-asserted-by": "publisher", "first-page": "93", "DOI": "10.1016/0076-6879(91)06080-M", "volume": "206", "author": "FJ Gonzalez", "year": "1991", "unstructured": "Gonzalez, F. J., Kimura, S., Tamura, S., and Gelboin, H. V., 1991, Expression of mammalian cytochrome P450 using baculovirus, Methods Enzymol. 206: 93\u201399.", "journal-title": "Methods Enzymol"}, {"key": "14_CR53", "doi-asserted-by": "publisher", "first-page": "130", "DOI": "10.1016/0076-6879(91)06085-H", "volume": "206", "author": "FP Guengerich", "year": "1991", "unstructured": "Guengerich, F. P., Brian, W. R., Sari, M.-A., and Ross, J.-T., 1991, Expression of mammalian cytochrome P450 enzymes using yeast-based vectors, Methods Enzymol. 206: 130\u2013145.", "journal-title": "Methods Enzymol"}, {"key": "14_CR54", "doi-asserted-by": "publisher", "first-page": "85", "DOI": "10.1016/0076-6879(91)06079-I", "volume": "206", "author": "FJ Gonzalez", "year": "1991", "unstructured": "Gonzalez, F. J., Aoyama, T., and Gelboin, H. V., 1991, Expression of mammalian cytochrome P450 using vaccinia virus, Methods Enzymol. 206: 85\u201392.", "journal-title": "Methods Enzymol"}, {"key": "14_CR55", "doi-asserted-by": "publisher", "first-page": "100", "DOI": "10.1016/0076-6879(91)06081-D", "volume": "206", "author": "BJ Clark", "year": "1991", "unstructured": "Clark, B. J., and Waterman, M. R., 1991, Heterologous expression of mammalian P450 in COS cells, Methods Enzymol. 206: 100\u2013108.", "journal-title": "Methods Enzymol"}, {"key": "14_CR56", "doi-asserted-by": "publisher", "first-page": "108", "DOI": "10.1016/0076-6879(91)06082-E", "volume": "206", "author": "TD Porter", "year": "1991", "unstructured": "Porter, T. D., and Larson, J. R., 1991, Expression of mammalian P450s in Escherichia coli, Methods Enzymol. 206: 108\u2013116.", "journal-title": "Methods Enzymol"}, {"key": "14_CR57", "doi-asserted-by": "publisher", "first-page": "117", "DOI": "10.1016/0076-6879(91)06083-F", "volume": "206", "author": "J Doehmer", "year": "1991", "unstructured": "Doehmer, J., and Oesch, F., 1991, V79 Chinese hamster cells genetically engineered for stable expression of cytochromes P450, Methods Enzymol. 206: 117\u2013123.", "journal-title": "Methods Enzymol"}, {"key": "14_CR58", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1016/0076-6879(91)06084-G", "volume": "206", "author": "CL Crespi", "year": "1991", "unstructured": "Crespi, C. L., 1991, Expression of cytochrome P450 cDNAs in human B lymphoblastoid cells: Applications to toxicology and metabolite analysis, Methods Enzymol. 206: 123\u2013129.", "journal-title": "Methods Enzymol"}, {"key": "14_CR59", "doi-asserted-by": "publisher", "first-page": "717", "DOI": "10.1016/0006-291X(89)92780-0", "volume": "158", "author": "Y Imai", "year": "1989", "unstructured": "Imai, Y., and Nakamura, M., 1989, Point mutations at threonine-301 modify substrate specificity of rabbit liver microsomal cytochromes P-450 (laurate (w-1)-hydroxylase and testosterone 16a-hydroxylase), Biochem. Biophys. Res. Commun. 158: 717\u2013722.", "journal-title": "Biochem. Biophys. Res. Commun"}, {"key": "14_CR60", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1006/abbi.1993.1401", "volume": "305", "author": "EMJ Gillam", "year": "1993", "unstructured": "Gill am, E. M. J., Baba, T., Kim, B.-R., Ohmori, S., and Guengerich, E R, 1993, Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme, Arch. Biochem. Biophys. 305: 123\u2013131.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR61", "doi-asserted-by": "publisher", "first-page": "443", "DOI": "10.1006/abbi.1993.1536", "volume": "306", "author": "R Sandhu", "year": "1993", "unstructured": "Sandhu, R, Baba, T., and Guengerich, F. P., 1993, Expression of modified cytochrome P450 2C10 in Escherichia coli, purification, and reconstitution of catalytic activity, Arch. Biochem. Biophys. 306: 443\u2013450.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR62", "doi-asserted-by": "publisher", "first-page": "168", "DOI": "10.1006/abbi.1994.1099", "volume": "309", "author": "P Sandhu", "year": "1994", "unstructured": "Sandhu, P., Guo, Z., Baba, T., Martin, M. V., Tukey, R. H., and Guengerich, E R, 1994, Expression of modified human cytochrome P450 1A2 in Escherichia coli. Stabilization, purification, characterization, and catalytic activities of the enzyme, Arch. Biochem. Biophys. 309: 168\u2013177.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR63", "doi-asserted-by": "publisher", "first-page": "59", "DOI": "10.1006/abbi.1994.1280", "volume": "312", "author": "EMJ Gillam", "year": "1994", "unstructured": "Gillam, E.M.J., Guo, Z., and Guengerich, F R, 1994, Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties, Arch. Biochem. Biophys. 312: 59\u201366.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR64", "doi-asserted-by": "crossref", "first-page": "741", "DOI": "10.1093/oxfordjournals.jbchem.a135533", "volume": "99", "author": "T Sakaki", "year": "1986", "unstructured": "Sakaki, T., Oeda, K., Yabusaki, Y., and Ohkawa, H., 1986, Monooxygenase activity of Saccharomyces cerevisiae cells transformed with expression plasmids carrying rat cytochrome P-450MC cDNA, J. Biochem. 99: 741\u2013749.", "journal-title": "J. Biochem"}, {"key": "14_CR65", "first-page": "608", "volume": "37", "author": "S Dogra", "year": "1990", "unstructured": "Dogra, S., Doehmer, J., Glatt, H., Molders, H., Siegert, P., Friedberg, T., Seidel, A., and Oesch, F., 1990, Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing, Mol. Pharmacol. 37: 608\u2013613.", "journal-title": "Mol. Pharmacol"}, {"key": "14_CR66", "doi-asserted-by": "publisher", "first-page": "10817", "DOI": "10.1073/pnas.89.22.10817", "volume": "89", "author": "CW Fisher", "year": "1992", "unstructured": "Fisher, C. W., Shet, M. S., Caudle, D. L., Martin-Wixtrom, C.A., and Estabrook, R. W., 1992, High-level expression in Escherichia coli of enzymatically active fusion proteins containing the domains of mammalian cytochromes P450 and NADPH-P450 reductase flavoprotein, Proc. Natl. Acad. Sci. USA\n                        89: 10817\u201310821.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "14_CR67", "doi-asserted-by": "publisher", "first-page": "437", "DOI": "10.1111/j.1432-1033.1990.tb19140.x", "volume": "191", "author": "F Morel", "year": "1990", "unstructured": "Morel, F., Beaune, P. H., Ratanasavanh, D., Flinois, J.-P., Yang, C.-S., Guengerich, F. P., and Guillouzo, A., 1990, Expression of cytochrome P-450 enzymes in cultured human hepatocytes, Eur. J. Biochem. 191: 437\u2013444.", "journal-title": "Eur. J. Biochem"}, {"key": "14_CR68", "doi-asserted-by": "publisher", "first-page": "1327", "DOI": "10.1073/pnas.81.5.1327", "volume": "81", "author": "DC Dahlin", "year": "1984", "unstructured": "Dahlin, D. C., Miwa, G. T., Lu, A.Y. H., and Nelson, S. D., 1984, N-Acetyl-p-benzoquinone imine: A cytochrome P-450-mediated oxidation product of acetaminophen, Proc. Natl. Acad. Sci. USA\n                        81: 1327\u20131331.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "14_CR69", "doi-asserted-by": "crossref", "first-page": "638", "DOI": "10.1093/oxfordjournals.jbchem.a123433", "volume": "109", "author": "Y Higashi", "year": "1991", "unstructured": "Higashi, Y., Hiromasa, T., Tanae, A., Miki, T., Nakura, J., Kondo, T., Ohura, T., Ogawa, E., Nakayama, K., and Fujii-Kuriyama, Y., 1991, Effects of individual mutations in the P-450n (C21) pseudogene on the P-450 (C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency, J. Biochem. 109: 638\u2013644.", "journal-title": "J. Biochem"}, {"key": "14_CR70", "doi-asserted-by": "publisher", "first-page": "371", "DOI": "10.1146/annurev.ge.23.120189.002103", "volume": "23", "author": "WL Miller", "year": "1989", "unstructured": "Miller, W.L., and Morel, Y., 1989, The molecular genetics of 21-hydroxylase deficiency, Annu. Rev. Genet. 23: 371\u2013393.", "journal-title": "Annu. Rev. Genet"}, {"key": "14_CR71", "doi-asserted-by": "publisher", "first-page": "1664", "DOI": "10.1172/JCI115182", "volume": "87", "author": "PC White", "year": "1991", "unstructured": "White, P. C., Dupont, J., New, M. I., Leiberman, E., Hochberg, Z., and R\u00f6sler, A., 1991, A mutation in CYP11Ba (Arg 448-H is) associated with steroid 11(3-hydroxylase deficiency in Jews of Moroccan origin, J. Clin. Invest. 87: 1664\u20131667.", "journal-title": "J. Clin. Invest"}, {"key": "14_CR72", "author": "LM Distlerath", "first-page": "133", "year": "1987", "unstructured": "Distlerath, L. M., and Guengerich, E P., 1987, Enzymology of human liver cytochromes P-450, in: Mammalian Cytochromes P-450, Vol. 1 ( F. P. Guengerich, ed.), CRC Press, Boca Raton, FL, pp. 133\u2013198.", "volume-title": "Mammalian Cytochromes P-450, Vol. 1"}, {"key": "14_CR73", "doi-asserted-by": "publisher", "first-page": "951", "DOI": "10.1016/0006-2952(87)90190-0", "volume": "36", "author": "M Tinel", "year": "1987", "unstructured": "Tinel, M., Belghiti, J., Descatoire, V., Amouyal, G., Letteron, P., Geneve, J., Larrey, D., and Pessayre, D., 1987, Inactivation of human liver cytochrome P-450 by the drug methoxsalen and other psoralen derivatives, Biochem. Pharmacol. 36: 951\u2013955.", "journal-title": "Biochem. Pharmacol"}, {"key": "14_CR74", "doi-asserted-by": "publisher", "first-page": "481", "DOI": "10.1146/annurev.pa.23.040183.002405", "volume": "23", "author": "PR Montellano", "year": "1983", "unstructured": "Ortiz de Montellano, P. R., and Correia, M. A., 1983, Suicidal destruction of cytochrome P-450 during oxidative drug metabolism, Annu. Rev. Pharmacol. Toxicol. 23: 481\u2013503.", "journal-title": "Annu. Rev. Pharmacol. Toxicol"}, {"key": "14_CR75", "doi-asserted-by": "publisher", "first-page": "268", "DOI": "10.1016/0140-6736(91)90872-M", "volume": "337", "author": "DG Bailey", "year": "1991", "unstructured": "Bailey, D. G., Spence, J. D., Munoz, C., and Arnold, J. M. O., 1991, Interaction of citrus juices with felodipine and nifedipine, Lancet\n                        337: 268\u2013269.", "journal-title": "Lancet"}, {"key": "14_CR76", "doi-asserted-by": "crossref", "first-page": "36", "DOI": "10.1017/S0317167100026147", "volume": "14", "author": "A Barbeau", "year": "1987", "unstructured": "Barbeau, A., Roy, M., Bernier, G., Campanella, G., and Paris, S., 1987, Ecogenetics of Parkinson\u2019s disease: Prevalence and environmental aspects in rural areas, Can. J. Neurol. Sci. 14: 36\u201341.", "journal-title": "Can. J. Neurol. Sci"}, {"key": "14_CR77", "doi-asserted-by": "publisher", "first-page": "1213", "DOI": "10.1016/S0140-6736(85)90743-3", "volume": "11", "author": "A. Barbeau", "year": "1985", "unstructured": "Barbeau, A., Roy, M., Paris, S., Cloutier, T., Plasse, L., and Poirier, J.,1985, Ecogenetics of Parkinson\u2019s disease: 4-Hydroxylation of debrisoquine, Lancet\n                        11: 1213\u20131215.", "journal-title": "Lancet"}, {"key": "14_CR78", "doi-asserted-by": "publisher", "first-page": "1017", "DOI": "10.1016/0140-6736(92)90537-D", "volume": "339", "author": "M Armstrong", "year": "1992", "unstructured": "Armstrong, M., Daly, A. K., Cholerton, S., Bateman, D. N., and Idle, J. R., 1992, Mutant debrisoquine hydroxylation genes in Parkinson\u2019s disease, Lancet\n                        339: 1017\u20131018.", "journal-title": "Lancet"}, {"key": "14_CR79", "doi-asserted-by": "crossref", "first-page": "1144", "DOI": "10.1016/S0006-291X(87)80252-8", "volume": "148", "author": "R. Fonne-Pfister", "year": "1987", "unstructured": "Fonne-Pfister, R., Bargetzi, M. J., and Meyer, U. A., 1987, MPTP, the neurotoxin inducing Parkinson\u2019s disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufl, P450dbl) catalyzing debrisoquine 4-hydroxylation, Biochem. Biophys. Res. Commun. 148: 1144 1150.", "journal-title": "Biochem. Biophys. Res. Commun"}, {"key": "14_CR80", "doi-asserted-by": "publisher", "first-page": "169", "DOI": "10.1038/312169a0", "volume": "312", "author": "R Ayesh", "year": "1984", "unstructured": "Ayesh, R., Idle, J. R., Ritchie, J. C., Crothers, M. J., and Hetzel, M. R., 1984, Metabolic oxidation phenotypes as markers for susceptibility to lung cancer, Nature\n                        312: 169\u2013170.", "journal-title": "Nature"}, {"key": "14_CR81", "doi-asserted-by": "publisher", "first-page": "246", "DOI": "10.1097/00008571-199212000-00002", "volume": "2", "author": "JR Idle", "year": "1992", "unstructured": "Idle, J. R., Armstrong, M., Boddy, A. V., Boustead, C., Cholerton, S., Cooper, J., Daly, A. K., Ellis, J., Gregory, W., Hadidi, H., H\u00f6fer, C., Holt, J., Leathart, J., McCracken, N., Monkman, S. C., Painter, J. E., Taber, H., Walker, D., and Yule, M., 1992, The pharmacogenetics of chemical carcinogenesis, Pharmacogenetics\n                        2: 246\u2013258.", "journal-title": "Pharmacogenetics"}, {"key": "14_CR82", "doi-asserted-by": "publisher", "first-page": "1527", "DOI": "10.1093/carcin/11.9.1527", "volume": "11", "author": "H Sugimura", "year": "1990", "unstructured": "Sugimura, H., Caporaso, N. E., Shaw, G. L., Modali, R. V., Gonzalez, F. J., Hoover, R. N., Resau, J. H., Trump, B. F., Weston, A., and Harris, C. C., 1990, Human debrisoquine hydroxylase gene polymorphisms in cancer patients and controls, Carcinogenesis\n                        11: 1527\u20131530.", "journal-title": "Carcinogenesis"}, {"key": "14_CR83", "first-page": "5488", "volume": "47", "author": "A. Kaisary", "year": "1987", "unstructured": "Kaisary, A., Smith, P., Jaczq, E., McAllister, C. B., Wilkinson, G. R, Ray, W. A., and Branch, R. A., 1987, Genetic predisposition to bladder cancer: Ability to hydroxylate debrisoquine and mephenytoin as risk factors, Cancer Res. 47: 5488\u20135493.", "journal-title": "Cancer Res"}, {"key": "14_CR84", "doi-asserted-by": "publisher", "first-page": "686", "DOI": "10.1038/bjc.1989.142", "volume": "54", "author": "MR Law", "year": "1989", "unstructured": "Law, M. R., Hetzel, M. R., and Idle, J. R., 1989, Debrisoquine metabolism and genetic predisposition to lung cancer, Br. J Cancer\n                        54: 686\u2013687.", "journal-title": "Br. J Cancer"}, {"key": "14_CR85", "doi-asserted-by": "publisher", "first-page": "1264", "DOI": "10.1093/jnci/82.15.1264", "volume": "82", "author": "NE Caporaso", "year": "1990", "unstructured": "Caporaso, N. E., Tucker, M. A., Hoover, R. N., Hayes, R. B., Pickle, L. W., Issaq, H. J., Muschik, G. M., Green-Gallo, L., Buivys, D., Aisner, S., Resau, J. H., Trump, B. F., Tollerud, D., Weston, A., and Harris, C. C., 1990, Lung cancer and the debrisoquine metabolic phenotype, J. Natl. Cancer Inst. 82: 1264\u20131271.", "journal-title": "J. Natl. Cancer Inst"}, {"key": "14_CR86", "first-page": "2116", "volume": "45", "author": "T Wolff", "year": "1985", "unstructured": "Wolff, T., Distlerath, L. M., Worthington, M. T., Groopman, J. D., Hammons, G. J., Kadlubar, F. F., Prough, R. A., Martin, M. V., and Guengerich, F. P., 1985, Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling, Cancer Res. 45: 2116\u20132122.", "journal-title": "Cancer Res"}, {"key": "14_CR87", "first-page": "5284", "volume": "51", "author": "T Shimada", "year": "1991", "unstructured": "Shimada, T., and Guengerich, F. P., 1991, Activation of amino-a-carboline, 2-amino-1-methyl-6phenylimidazo[4,5-b]pyridine, and a copper phthalocyanine cellulose extract of cigarette smoke condensate by cytochrome P450 enzymes in rat and human liver microsomes, Cancer Res. 51: 5284\u20135291.", "journal-title": "Cancer Res"}, {"key": "14_CR88", "author": "I Roots", "year": "1993", "unstructured": "Roots, I., Drakoulis, N., and Brockm\u00f6ller, J., 1993, Still an open question: Does active CYP2D6 predispose to lung cancer? in: 8th International Conference on Cytochrome P450: Biochemistry, Biophysics, and Molecular Biology (October 24\u201328, Lisbon), p. 159.", "volume-title": "Still 59"}, {"issue": "5", "key": "14_CR89", "first-page": "221", "volume": "59", "author": "J Ritter", "year": "1986", "unstructured": "Ritter, J., Somasundaram, R., Heinemeyer, G., and Roots, I., 1986, The debrisoquine hydroxylation phenotype and the acetylator phenotype as genetic risk factors for the occurrence of larynx and pharynx carcinoma, Acta Pharmacol. Toxicol. 59 (Suppl. 5): 221.", "journal-title": "Acta Pharmacol. Toxicol"}, {"issue": "5", "key": "14_CR90", "first-page": "220", "volume": "59", "author": "N Drakoulis", "year": "1986", "unstructured": "Drakoulis, N., Minks, T., Ploch, M., Otte, F., Heinemeyer, G., Kampf, D., Loddenkemper, R., and Roots, I., 1986, Questionable association of debrisoquine hydroxylator phenotype and risk for bronchial carcinoma, Acta Pharmacol. Toxicol. 59 (Suppl. 5): 220.", "journal-title": "Acta Pharmacol. Toxicol"}, {"key": "14_CR91", "doi-asserted-by": "publisher", "first-page": "101", "DOI": "10.1111/j.1365-2125.1990.tb03608.x", "volume": "29", "author": "CJ Speirs", "year": "1990", "unstructured": "Speirs, C. J., Murray, S., Davies, D. S., Mabadeje, A. E B., and Boobis, A. R., 1990, Debrisoquine oxidation phenotype and susceptibility to lung cancer, Br. J. Clin. Pharmacol. 29: 101\u2013109.", "journal-title": "Br. J. Clin. Pharmacol"}, {"key": "14_CR92", "doi-asserted-by": "publisher", "first-page": "525", "DOI": "10.1007/BF00315234", "volume": "40", "author": "JM Ladero", "year": "1991", "unstructured": "Ladero, J. M., Benitez, J., Gonzalez, J. E, Vargas, E., and D\u00edaz-Rubio, M., 1991, Oxidative polymorphism of debrisoquine is not related to human colo-rectal cancer, Eur. J. Clin. Pharmacol. 40: 525\u2013527.", "journal-title": "Eur. J. Clin. Pharmacol"}, {"key": "14_CR93", "doi-asserted-by": "publisher", "first-page": "101", "DOI": "10.1289/ehp.9298101", "volume": "98", "author": "NE Caporaso", "year": "1992", "unstructured": "Caporaso, N. E., Shields, P. G., Landi, M. T., Shaw, G. L., Tucker, M. A., Hoover, M., Sugimura, H., Weston, A., and Harris, C. C., 1992, The debrisoquine metabolic phenotype and DNA-based assays: Implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotype, Environ. Health Perspect. 98: 101\u2013105.", "journal-title": "Environ. Health Perspect"}, {"key": "14_CR94", "doi-asserted-by": "publisher", "first-page": "951", "DOI": "10.1111/j.1365-2125.1984.tb02569.x", "volume": "18", "author": "DG Waller", "year": "1984", "unstructured": "Waller, D. G., Renwick, A. G., Gruchy, B. S., and George, C. F., 1984, The first pass metabolism of nifedipine in man, Br. J. Clin. Pharmacol. 18: 951\u2013954.", "journal-title": "Br. J. Clin. Pharmacol"}, {"key": "14_CR95", "doi-asserted-by": "publisher", "first-page": "407", "DOI": "10.3109/10408449209089881", "volume": "21", "author": "LS Kaminsky", "year": "1992", "unstructured": "Kaminsky, L.S., and Fasco, M. J., 1992, Small intestinal cytochromes P450, Crit. Rev. Toxicol. 21: 407\u2013422.", "journal-title": "Crit. Rev. Toxicol"}, {"key": "14_CR96", "doi-asserted-by": "crossref", "first-page": "1871", "DOI": "10.1172/JCI116064", "volume": "90", "author": "J. C. Kolars", "year": "1992", "unstructured": "Kolars, J. C., Schmiedlin-Ren, P., Schuetz, J. D., Fang, C., and Watkins, P. B., 1992, Identification of rifampin-inducible P450II1A4 (CYP3A4) in human small bowel enterocytes, J. Clin. Invest. 90: 1871\u20131878.", "journal-title": "J. Clin. Invest"}, {"key": "14_CR97", "doi-asserted-by": "publisher", "first-page": "R13", "DOI": "10.1016/0006-2952(91)90579-T", "volume": "42", "author": "CO Meese", "year": "1991", "unstructured": "Meese, C. O., Fischer, C., Kupfer, A., Wisser, H., and Eichelbaum, M., 1991, Identification of the \u201cmajor\u201d polymorphic carbocysteine metabolite as S-(carboxymethylthio)-L-cysteine, Biochem. Pharmacol. 42: R13 - R16.", "journal-title": "Biochem. Pharmacol"}, {"key": "14_CR98", "doi-asserted-by": "publisher", "first-page": "471", "DOI": "10.1038/clpt.1992.174", "volume": "52", "author": "DK Tlrgeon", "year": "1992", "unstructured": "TLrgeon, D. K., Normolle, D. P., Leichtman, A. B., Annesley, T. M., Smith, D. E., and Watkins, P. B., 1992, Erythromycin breath test predicts oral clearance of cyclosporine in kidney transplant recipients, Clin. Pharmacol. Ther. 52: 471\u2013478.", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "14_CR99", "author": "T Cresteil", "first-page": "51", "year": "1988", "unstructured": "Cresteil, T., and Eisen, H.J., 1988, Regulation of human cytochrome P1\u2013450 gene, in: Liver Cells and Drugs, Colloque INSERM ( A. Guillouzo, ed.), INSERM/John Libbey Erotext Ltd., London, pp. 51\u201358.", "volume-title": "Liver Cells and Drugs, Colloque INSERM"}, {"key": "14_CR100", "doi-asserted-by": "publisher", "first-page": "239", "DOI": "10.1097/00008571-199310000-00003", "volume": "3", "author": "H Schweikl", "year": "1993", "unstructured": "Schweikl, H., Taylor, J. A., Kitareewan, S., Linko, P., Nagorney, D., and Goldstein, J. A., 1993, Expression of CYPIAJ and CYPIA2 genes in human liver, Pharmacogenetics\n                        3: 239\u2013249.", "journal-title": "Pharmacogenetics"}, {"key": "14_CR101", "first-page": "327", "volume": "25", "author": "G Kellerman", "year": "1973", "unstructured": "Kellerman, G., Luyten-Kellerman, M., and Shaw, C. R., 1973, Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes, Am. J. Hum. Genet. 25: 327\u2013331.", "journal-title": "Am. J. Hum. Genet"}, {"key": "14_CR102", "doi-asserted-by": "publisher", "first-page": "934", "DOI": "10.1056/NEJM197311012891802", "volume": "298", "author": "G Kellerman", "year": "1973", "unstructured": "Kellerman, G., Shaw, C. R., and Luyten-Kellerman, M., 1973, Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma, N. Engl. J Med. 298: 934\u2013937.", "journal-title": "N. Engl. J Med"}, {"key": "14_CR103", "first-page": "2757", "volume": "41", "author": "B Paigen", "year": "1981", "unstructured": "Paigen, B., Ward, E., Reilly, A., Houten, L., Gurtoo, H. L., Minowada, J., Steenland, K., Havens, M. B., and Sartori, P., 1981, Seasonal variation of aryl hydrocarbon hydroxylase activity in human lymphocytes, Cancer Res. 41: 2757\u20132761.", "journal-title": "Cancer Res"}, {"key": "14_CR104", "doi-asserted-by": "publisher", "first-page": "348", "DOI": "10.1016/0005-2744(81)90305-3", "volume": "658", "author": "R Leboeuf", "year": "1981", "unstructured": "Leboeuf, R., Havens, M., Tabron, D., and Paigen, B., 1981, Arylhydrocarbon hydroxylase activity and cytochrome P-450 in human tissues, Biochim. Biophys. Acta\n                        658: 348\u2013355.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "14_CR105", "doi-asserted-by": "publisher", "first-page": "44", "DOI": "10.1177/019262338401200107", "volume": "12", "author": "RE Kouri", "year": "1984", "unstructured": "Kouri, R. E., McKinney, C. E., Levine, A. S., Edwards, B. K., Vesell, E. S., Nebert, D. W., and McLemore, T. L., 1984, Variations in aryl hydrocarbon hydroxylase activities in mitogen-activated human and nonhuman primate lymphocytes, Toxicol. Pathol. 12: 44\u201348.", "journal-title": "Toxicol. Pathol"}, {"key": "14_CR106", "first-page": "5030", "volume": "42", "author": "RE Kouri", "year": "1982", "unstructured": "Kouri, R. E., McKinney, C. E., Slomiany, D. J., Snodgrass, D. R., Wray, N. P., and McLemore, T. L., 1982, Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes, Cancer Res. 42: 5030\u20135037.", "journal-title": "Cancer Res"}, {"key": "14_CR107", "doi-asserted-by": "publisher", "first-page": "1333", "DOI": "10.1093/jnci/82.16.1333", "volume": "82", "author": "TL Mclemore", "year": "1990", "unstructured": "McLemore, T. L., Adelberg, S., Liu, M. C., McMahon, N. A., Yu, S. J., Hubbard, W.C., Czerwinski, M., Wood, T. G., Storeng, R., Lubet, R. A., Eggleston, J. C., Boyd, M.R., and Hines, R. N., 1990, Expression of CYP1A1 gene in patients with lung cancer: Evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas, J. Natl. Cancer Inst. 82: 1333\u20131339.", "journal-title": "J. Natl. Cancer Inst"}, {"key": "14_CR108", "doi-asserted-by": "crossref", "first-page": "407", "DOI": "10.1093/oxfordjournals.jbchem.a123594", "volume": "110", "author": "S Hayashi", "year": "1991", "unstructured": "Hayashi, S., Watanabe, J., Nakachi, K., and Kawajiri, K., 1991, Genetic linkage of lung cancer-associated Mspl polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene, J. Biochem. 110: 407\u2013411.", "journal-title": "J. Biochem"}, {"key": "14_CR109", "doi-asserted-by": "publisher", "first-page": "20", "DOI": "10.1097/00008571-199110000-00004", "volume": "1", "author": "T Tefre", "year": "1991", "unstructured": "Tefre, T., Ryberg, D., Haugen, A., Nebert, D. W., Skaug, V., Brogger, A., and Borresen, A. L., 1991, Human CYP1A\n                        1(cytochrome P1450) gene: Lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population, Pharmacogenetics\n                        1: 20\u201325.", "journal-title": "Pharmacogenetics"}, {"key": "14_CR110", "first-page": "485", "volume": "1", "author": "A Hirvonen", "year": "1992", "unstructured": "Hirvonen, A., Husgafvel-Pursiainen, K., Karjalainen, A., Anttila, S., and Vainio, H., 1992, Point-mutational Mspl and Ile-Val polymorphisms closely linked in the CYP1A1 gene: Lack of association with susceptibility to lung cancer in a Finnish study population, Cancer Epidemiol. Biomarkers Prey. 1: 485\u2013489.", "journal-title": "Cancer Epidemiol. Biomarkers Prey"}, {"key": "14_CR111", "doi-asserted-by": "publisher", "first-page": "4797", "DOI": "10.1093/nar/19.17.4797", "volume": "19", "author": "SI Hayashi", "year": "1991", "unstructured": "Hayashi, S. I., Watanabe, J., Nakachi, K., and Kawajiri, K., 1991, PCR detection of an A/G polymorphism within exon 7 of the CYPIA1 gene, Nucl. Acids Res. 19: 4797.", "journal-title": "Nucl. Acids Res"}, {"key": "14_CR112", "author": "N Drakoulis", "first-page": "204", "year": "1993", "unstructured": "Drakoulis, N., Cascorbi, I., Brockm\u00f6ller, J., Gross, C. R., and Roots, I., 1993, Exon-7 point mutation (M2; 4889A>G) in human CYP1A1 gene as susceptibility factor for lung cancer, in: 8th International Conference on Cytochrome P450: Biochemistry, Biophysics, and Molecular Biology (October 24\u201328, Lisbon, Portugal ), p. 204.", "volume-title": "and Molecular Biology (October"}, {"key": "14_CR113", "doi-asserted-by": "publisher", "first-page": "21", "DOI": "10.1097/00008571-199402000-00003", "volume": "4", "author": "RJ Wedlund", "year": "1994", "unstructured": "Wedlund, R. J., Kimura, S., Gonzalez, F. J., and Nebert, D. W., 1994, I462V mutation in the human CYP1A1 gene: Lack of correlation with either the Msp I 1.9 kb (M2) allele or CYPIA1 inducibility in a three-generation family of East Mediterranean descent, Pharmacogenetics\n                        4: 21\u201326.", "journal-title": "Pharmacogenetics"}, {"key": "14_CR114", "doi-asserted-by": "publisher", "first-page": "1729", "DOI": "10.1093/carcin/14.9.1729", "volume": "14", "author": "F Crofts", "year": "1993", "unstructured": "Crofts, F., Cosma, G. N., Currie, D., Taioli, E., Toniolo, R, and Garte, S. J., 1993, A novel CYP1A1 gene polymorphism in African-Americans, Carcinogenesis\n                        14: 1729\u20131731.", "journal-title": "Carcinogenesis"}, {"key": "14_CR115", "doi-asserted-by": "publisher", "first-page": "1373", "DOI": "10.1006/bbrc.1993.1568", "volume": "192", "author": "SJ Roberts-Thomson", "year": "1993", "unstructured": "Roberts-Thomson, S. J., McManus, M. E., Tukey, R. H., Gonzalez, F. J., and Holder, G. M., 1993, The catalytic activity of four expressed human cytochrome P450s towards benzo[a]pyrene and the isomers of its proximate carcinogen, Biochem. Biophys. Res. Commun. 192: 1373\u20131379.", "journal-title": "Biochem. Biophys. Res. Commun"}, {"key": "14_CR116", "first-page": "6304", "volume": "49", "author": "T Shimada", "year": "1989", "unstructured": "Shimada, T., Martin, M. V., Pruess-Schwartz, D., Marnett, L. J., and Guengerich, F. R, 1989, Roles of individual human cytochrome P450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycydic aromatic hydrocarbons, Cancer Res. 49: 6304\u20136312.", "journal-title": "Cancer Res"}, {"key": "14_CR117", "first-page": "1868", "volume": "52", "author": "C-H Yun", "year": "1992", "unstructured": "Yun, C.-H., Shimada, T., and Guengerich, F. P., 1992, Roles of human liver cytochrome P-4502C and 3A enzymes in the 3-hydroxylation of benzo(a)pyrene, Cancer Res. 52: 1868\u20131874.", "journal-title": "Cancer Res"}, {"key": "14_CR118", "first-page": "3367", "volume": "50", "author": "ME Mcmanus", "year": "1990", "unstructured": "McManus, M. E., Burgess, W. M., Veronese, M. E., Huggett, A., Quattrochi, L. C., and Tukey, R. H., 1990, Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450, Cancer Res. 50: 3367\u20133376.", "journal-title": "Cancer Res"}, {"key": "14_CR119", "doi-asserted-by": "publisher", "first-page": "737", "DOI": "10.1016/0006-291X(90)90736-7", "volume": "172", "author": "HP Eugster", "year": "1990", "unstructured": "Eugster, H. P., Sengstag, C., Meyer, U. A., Hinnen, A., and Wiirgler, F. E., 1990, Constitutive and inducible expression of human cytochrome P450IA1 in yeast Saccharomyces cerevisiae: An alternative enzyme source for in vitro studies, Biochem. Biophys. Res. Commun. 172: 737\u2013744.", "journal-title": "Biochem. Biophys. Res. Commun"}, {"key": "14_CR120", "doi-asserted-by": "publisher", "first-page": "753", "DOI": "10.1016/0006-2952(91)90032-Z", "volume": "42", "author": "MS Ching", "year": "1991", "unstructured": "Ching, M. S., Lennard, M. S., Tucker, G. T., Woods, H. E, Kelly, D. E., and Kelly, S. L., 1991, The expression of human cytochrome P450IA1 in the yeast Saccharomyces cerevisiae, Biochem. Pharmacol. 42: 753\u2013758.", "journal-title": "Biochem. Pharmacol"}, {"key": "14_CR121", "doi-asserted-by": "publisher", "first-page": "39", "DOI": "10.1016/0300-483X(93)90058-Z", "volume": "182", "author": "JP Renaud", "year": "1993", "unstructured": "Renaud, J. P., Peyronneau, M. A., Urban, P., Truan, G., Cullin, C., Pompon, D., Beaune, P., and Mansuy, D., 1993, Recombinant yeast in drug metabolism, Toxicology\n                        182: 39\u201352.", "journal-title": "Toxicology"}, {"key": "14_CR122", "author": "I Simon", "first-page": "44", "year": "1993", "unstructured": "Simon, I., Berthou, F., Riche, C., Beaune, P., and Ratanasavanh, D., 1993, Both cytochrome P4501A and 3A4 are involved in the N-demethylation of tamoxifen, in: Abstracts, 5th Europenn ISSX Meeting (September 26\u201329, Tours), Vol. 3, p. 44.", "volume-title": "Abstracts, 5th Europenn ISSX Meeting (September 26-29, Tours)"}, {"key": "14_CR123", "author": "E Berthou", "first-page": "116", "year": "1993", "unstructured": "Berthou, E, Carriere, V., Ratanasavanh, D., Goasduff, T., Morel, F., Gautier, J. C., Guillouzo, A., and Beaune, P., 1993, On the specificity of chlorzoxazone as drug probe of cytochrome P4502E1, in: Abstracts, 5th European ISSX Meeting (September 26\u201329, Tours), Vol. 3, p. 116.", "volume-title": "Abstracts, 5th European ISSX Meeting (September 26-29, Tours)"}, {"key": "14_CR124", "doi-asserted-by": "publisher", "first-page": "317", "DOI": "10.1080/15287399309531797", "volume": "40", "author": "FM Farin", "year": "1993", "unstructured": "Farin, F. M., and Omiecinski, C. J., 1993, Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue, J. Toxicol. Environ. Health\n                        40: 317\u2013335.", "journal-title": "J. Toxicol. Environ. Health"}, {"key": "14_CR125", "doi-asserted-by": "publisher", "first-page": "754", "DOI": "10.1021/tx00036a003", "volume": "6", "author": "JP Whitlock Jr", "year": "1993", "unstructured": "Whitlock, J. P., Jr., 1993, Mechanistic aspects of dioxin action, Chem. Res. Toxicol. 6: 754\u2013763.", "journal-title": "Chem. Res. Toxicol"}, {"key": "14_CR126", "first-page": "6949", "volume": "269", "author": "LC Quattrochi", "year": "1994", "unstructured": "Quattrochi, L. C., Vu, T., and Tukey, R. H., 1994, The human CYP1A2 gene and induction by 3-methylcholanthrene. A region of DNA that supports Ah-receptor binding and promoter-specific induction, J. Biol. Chem. 269: 6949\u20136954.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR127", "doi-asserted-by": "publisher", "first-page": "7696", "DOI": "10.1073/pnas.86.20.7696", "volume": "86", "author": "MA Butler", "year": "1989", "unstructured": "Butler, M. A., Iwasaki, M., Guengerich, F. P., and Kadlubar, F. F., 1989, Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines, Proc. Natl. Acad. Sci. USA\n                        86: 7696\u20137700.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "14_CR128", "doi-asserted-by": "publisher", "first-page": "116", "DOI": "10.1097/00008571-199206000-00003", "volume": "2", "author": "MA Butler", "year": "1992", "unstructured": "Butler, M. A., Lang, N. P., Young, J. F., Caporaso, N. E., Vineis, P., Hayes, R. B., Teitel, C. H., Massengill, J. P., Lawsen, M. F., and Kadlubar, E F., 1992, Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites, Pharmacogenetics\n                        2: 116\u2013127.", "journal-title": "Pharmacogenetics"}, {"key": "14_CR129", "first-page": "2342", "volume": "43", "author": "ES Vesell", "year": "1984", "unstructured": "Vesell, E.S., and Penno, M. B., 1984, A new polymorphism of hepatic drug oxidation in humans: Family studies of antipyrine metabolites, Fed. Proc. 43: 2342\u20132347.", "journal-title": "Fed. Proc"}, {"key": "14_CR130", "unstructured": "Engel, G., Knebel, N. G., Hofmann, U., and Eichelbaum, M., 1992, In vitro characterization of human cytochrome P450-enzymes involved in antipyrine metabolism, in: Abstracts, 23rd European Workshop on Drug Metabolism (September 21\u201325, Bergamo)."}, {"key": "14_CR131", "first-page": "675", "volume": "3", "author": "NP Lang", "year": "1994", "unstructured": "Lang, N. P., Butler, M. A., Massengill, J., Lawson, M., Stotts, R. C., Hauer-Jensen, M., and Kadlubar, F. E, 1994, Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increases the risk for colorectal cancer or polyps, Cancer Epidemiol. Biomarkers Prey. 3: 675\u2013682.", "journal-title": "Cancer Epidemiol. Biomarkers Prey"}, {"key": "14_CR132", "doi-asserted-by": "publisher", "first-page": "503", "DOI": "10.1038/clpt.1993.63", "volume": "53", "author": "W Kalow", "year": "1993", "unstructured": "Kalow, W., and Tang, B. K., 1993, The use of caffeine for enzyme assays: A critical appraisal, Clin. Pharmacol. Ther. 53: 503\u2013514.", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "14_CR133", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1097/00008571-199204000-00004", "volume": "2", "author": "L Gu", "year": "1992", "unstructured": "Gu, L., Gonzalez, F. J., Kalow, W., and Tang, B. K., 1992, Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E 1, Pharmacogenetics\n                        2: 73\u201377.", "journal-title": "Pharmacogenetics"}, {"key": "14_CR134", "doi-asserted-by": "publisher", "first-page": "293", "DOI": "10.1111/j.1365-2125.1987.tb03172.x", "volume": "24", "author": "RA Robson", "year": "1987", "unstructured": "Robson, R. A., Matthews, A. R, Miners, J. O., McManus, M. E., Meyer, U. A., Hall, R. de la M., and Birken, D. J., 1987, Characterisation of theophylline metabolism in human liver microsomes, Br. J. Clin. Pharmacol. 24: 293\u2013300.", "journal-title": "Br. J. Clin. Pharmacol"}, {"key": "14_CR135", "doi-asserted-by": "publisher", "first-page": "511", "DOI": "10.1021/tx00034a019", "volume": "6", "author": "C Patten", "year": "1993", "unstructured": "Patten, C., Thomas, P. E., Guy, R., Lee, M., Gonzalez, F. J., Guengerich, F. P., and Yang, C. S., 1993, Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics, Chem. Res. Toxicol. 6: 511\u2013518.", "journal-title": "Chem. Res. Toxicol"}, {"key": "14_CR136", "doi-asserted-by": "publisher", "first-page": "815", "DOI": "10.1038/clpt.1984.118", "volume": "35", "author": "R Dahlqvist", "year": "1984", "unstructured": "Dahlqvist, R., Bertilsson, L., Birkett, D. J., Eichelbaum, M., S\u00e4we, J., and Sj\u00f6qvist, P., 1984, Theophylline metabolism in relation to antipyrine, debrisoquine, and sparteine metabolism, Clin. Pharmacol. Titer. 35: 815\u2013821.", "journal-title": "Clin. Pharmacol. Titer"}, {"key": "14_CR137", "first-page": "568", "volume": "46", "author": "H Yamazaki", "year": "1994", "unstructured": "Yamazaki, H., Guo, Z., Mimura, M., Gonzalez, F. J., Sugahara, C., Guengerich, E P., and Shimada, T., 1994, Bufuralol hydroxylation by cytochrome P450 2D6, 1A1, and 1A2 enzymes in human liver microsomes, Mol. Pharmacol. 46: 568\u2013577.", "journal-title": "Mol. Pharmacol"}, {"key": "14_CR138", "author": "TF Woolf", "first-page": "139", "year": "1993", "unstructured": "Woolf, T. F., Pool, W. F., Kukan, M., Bezek, S., Kunze, K., and Trager, W. F., 1993, Characterization of tacrine metabolism and bioactivation using heterologous expression systems and inhibition studies: Evidence for CYP 1 A2 involvement, in: Abstracts, 5th North American ISSX Meeting (October 17\u201321, Tucson), Vol. 4, p. 139.", "volume-title": "Abstracts, 5th North American ISSX Meeting (October 17-21, Tucson)"}, {"key": "14_CR139", "author": "KL Kunze", "first-page": "138", "year": "1993", "unstructured": "Kunze, K. L., Wienkers, L. C., Thutmnel, K. E., and Trager, W. F., 1993, The use of furafylline together with li ver screening techniques and enzyme kinetics to evaluate the role of P450 1 A2 in the metabolism of theophylline at therapeutic concentrations in human liver, in: Abstracts, 5th North American ISSX Meeting (October 17\u201321, Tucson), Vol. 4, p. 138.", "volume-title": "Abstracts, 5th North American ISSX Meeting (October 17-21, Tucson)"}, {"key": "14_CR140", "doi-asserted-by": "publisher", "first-page": "54", "DOI": "10.1021/tx00025a009", "volume": "5", "author": "AE Rettie", "year": "1992", "unstructured": "Rettie, A. E., Korzekwa, K. R., Kunze, K. L., Lawrence, R. E, Eddy, A. C., Aoyama, T., Gelboin, H. V., Gonzalez, F. J., and Trager, W. F., 1992, Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: A role for P-4502C9 in the etiology of (S)-warfarin drug interactions, Chem. Res. Toxicol. 5: 54\u201359.", "journal-title": "Chem. Res. Toxicol"}, {"key": "14_CR141", "first-page": "956", "volume": "66", "author": "CH Feldman", "year": "1980", "unstructured": "Feldman, C. H., Hutchinson, V. E., Pippenger, C. E., Blemenfeld, T. A., Feldman, B. R., and Davis, W. J., 1980, Effect of dietary protein and carbohydrate on theophylline metabolism in children, Pediatrics\n                        66: 956\u2013962.", "journal-title": "Pediatrics"}, {"key": "14_CR142", "doi-asserted-by": "crossref", "first-page": "737", "DOI": "10.1016/0016-5085(90)90963-2", "volume": "99", "author": "D Diaz", "year": "1990", "unstructured": "Diaz, D., Fabre, I., Daujat, M., Saintaubert, B., Bories, P., Michel, H., and Maurel, P., 1990, Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome-P450, Gastroenterology\n                        99: 737\u2013747.", "journal-title": "Gastroenterology"}, {"key": "14_CR143", "first-page": "504", "volume": "43", "author": "LC Quattrochi", "year": "1993", "unstructured": "Quattrochi, L. C., and Tukey, R. H., 1993, Nuclear uptake of the Ah (dionan) receptor in response to omeprazole: Transcriptional activation of the human CYP1A1 gene, Mol. Pharmacol. 43: 504\u2013508.", "journal-title": "Mol. Pharmacol"}, {"key": "14_CR144", "author": "KL Rost", "year": "1993", "unstructured": "Rost, K. L., and Roots, I., 1993, Accelerated caffeine metabolism after omeprazole treatment in breath, plasma, and urine, in: 8th International Conference on Cytochrome P450: Biochemistry, Biophysics, and Molecular Biology (October 24\u201328, Lisbon), p. 203.", "volume-title": "Accelerated 203"}, {"key": "14_CR145", "doi-asserted-by": "crossref", "first-page": "759", "DOI": "10.1096/fasebj.6.2.1537466", "volume": "6", "author": "CW Fisher", "year": "1992", "unstructured": "Fisher, C. W., Caudle, D. L., Martin-Wixtrom, C., Quattrochi, L. C., Tukey, R. H., Waterman, M. R., and Estabrook, R. W., 1992, High-level expression of functional cytochrome P450 1A2 in Escherichia coli, FASEB J. 6: 759\u2013764.", "journal-title": "FASEB J"}, {"key": "14_CR146", "author": "PF Kadlubar", "first-page": "81", "year": "1987", "unstructured": "Kadlubar, P. F., and Hammons, G. J., 1987, The role of cytochrome P-450 in the metabolism of chemical carcinogens, in: Mammalian Cytochromes P-450, Vol. 2 (F. P. Guengerich, ed.), CRC Press, Boca Raton, FL, pp. 81\u2013130.", "volume-title": "The role of cytochrome P-450 in the metabolism of chemical carcinogens, in: Mammalian Cytochromes P-450, Vol. 2 (F. P. Guengerich, ed.)"}, {"key": "14_CR147", "doi-asserted-by": "publisher", "first-page": "603", "DOI": "10.1126/science.1411570", "volume": "258", "author": "T Sugimura", "year": "1992", "unstructured": "Sugimura, T., 1992, Multistep carcinogenesis: A 1992 perspective, Science\n                        258: 603\u2013607.", "journal-title": "Science"}, {"key": "14_CR148", "doi-asserted-by": "publisher", "first-page": "5", "DOI": "10.1002/mc.2940030104", "volume": "3", "author": "CL Crespi", "year": "1990", "unstructured": "Crespi, C. L., Steimel, D. T., Aoyama, T., Gelboin, H. V., and Gonzalez, F. J., 1990, Stable expression of human cytochrome P450IA2 cDNA in a human lymphoblastoid cell line: Role of the enzyme in the metabolic activation of aflatoxin Bi, Mol. Carcinog. 3: 5\u20138.", "journal-title": "Mol. Carcinog"}, {"key": "14_CR149", "author": "HR Glatt", "first-page": "1167", "year": "1993", "unstructured": "Glatt, H. R., Pauly, K., W\u00f6lfel, C., Dogra, S., Seidel, A., Lee, H., Harvey, R. G., Oesch, F., and Doehmer, J., 1993, Stable expression of heterologous cytochromes P450 in V79 cells: Mutagenicity studies with polycyclic aromatic hydrocarbons, in: Polycyclic Aromatic Compounds: Synthesis, Properties, Analytical Measurements, Occurrence and Biological Effects. (Proceedings of the Thirteenth International Symposium on Polynuclear Aromatic Hydrocarbons, October\n                        1\u20134, 1991, Bordeaux, France) ( P. Garrigues and M. Lamotte, eds.) Gordon and Breach, New York pp. 1167\u20131174.", "volume-title": "Polycyclic Aromatic Compounds: Synthesis Properties Analytical Measurements Occurrence and Biological Effects. (Proceedings of the Thirteenth International Symposium on Polynuclear Aromatic Hydrocarbons"}, {"key": "14_CR150", "first-page": "14905", "volume": "264", "author": "U Savas", "year": "1994", "unstructured": "Savas, U., Bhattacharyya, K. K., Christou, M., Alexander, D. L., and Jefcoate, C. R., 1994, Mouse cytochrome P450EF, representative of a new 1B subfamily of cytochrome P450s. Cloning, sequence determination, and tissue expression, J. Biol. Chem. 264: 14905\u201314911.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR151", "first-page": "1309213099", "volume": "269", "author": "T. R Sutter", "year": "1994", "unstructured": "Sutter, T. R, Tang, Y. M., Hayes, C. L., Wo, Y-Y. P., Jabs, E. W., Li, X., Yin, H., Cody, C. S., and Greenlee, W. F., 1994, Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2, J. Biol. Chem. 269: 1309213099.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR152", "doi-asserted-by": "publisher", "first-page": "1322", "DOI": "10.1021/bi00457a031", "volume": "29", "author": "S Yamano", "year": "1990", "unstructured": "Yamano, S., Tatsuno, J., and Gonzalez, F. J., 1990, The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes, Biochemistry\n                        29: 1322\u20131329.", "journal-title": "Biochemistry"}, {"key": "14_CR153", "doi-asserted-by": "crossref", "first-page": "365", "DOI": "10.1042/bj2670365", "volume": "267", "author": "JS Miles", "year": "1990", "unstructured": "Miles, J. S., McLaren, A. W., Forrester, L. M., Glancey, M. J., Lang, M. A., and Wolf, C. R., 1990, Identification of the human liver cytochrome P450 responsible for coumarin 7-hydroxylase activity, Biochem. J. 267: 365\u2013371.", "journal-title": "Biochem. J"}, {"key": "14_CR154", "doi-asserted-by": "publisher", "first-page": "129", "DOI": "10.1016/0163-7258(93)90053-G", "volume": "57", "author": "AK Daly", "year": "1993", "unstructured": "Daly, A. K., Cholerton, S., Gregory, W., and Idle, J. R., 1993, Metabolic polymorphisms, Pharmacol. Ther. 57: 129\u2013160.", "journal-title": "Pharmacol. Ther"}, {"key": "14_CR155", "doi-asserted-by": "publisher", "first-page": "325", "DOI": "10.1016/0378-4347(92)80166-N", "volume": "575", "author": "S Cholerton", "year": "1992", "unstructured": "Cholerton, S., Idle, M. E., Vas, A., Gonzalez, F. J., and Idle, J. R., 1992, Comparison of a novel thin-layer chromatographic\u2014fluorescence detection method with a spectrofluorometric method for the determination of 7-hydroxycoumarin in human urine, J. Chromatogr. 575: 325\u2013330.", "journal-title": "J. Chromatogr"}, {"key": "14_CR156", "doi-asserted-by": "publisher", "first-page": "55", "DOI": "10.1289/ehp.94102s955", "volume": "102", "author": "AK Daly", "year": "1994", "unstructured": "Daly, A. K., Cholerton, S., Armstrong, M., and Idle, J. R., 1994, Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility, Environ. Health Perspect. 102: 55\u201361.", "journal-title": "Environ. Health Perspect"}, {"key": "14_CR157", "unstructured": "Rautio, A., Kraul, H., Kojo, A., Salmela, E., and Pelkonen, 0., 1992, Interindividual variability of coumarin 7-hydroxylation in healthy volunteers, Pharmacogenetics\n                        2: 227\u2013233.", "DOI": "10.1097/00008571-199210000-00005", "doi-asserted-by": "crossref"}, {"key": "14_CR158", "doi-asserted-by": "publisher", "first-page": "355", "DOI": "10.1093/carcin/12.2.355", "volume": "12", "author": "CL Crespi", "year": "1991", "unstructured": "Crespi, C. L., Penman, B. W., Steimel, D. T., Gelboin, H. V., and Gonzalez, F. J., 1991, The development of a human cell line stably expressing human CYP3A4: Role in the metabolic activation of aflatoxin Bi and comparison to CYPIA2 and CYP2A3, Carcinogenesis\n                        12: 355\u2013359.", "journal-title": "Carcinogenesis"}, {"key": "14_CR159", "doi-asserted-by": "publisher", "first-page": "1293", "DOI": "10.1093/carcin/11.8.1293", "volume": "11", "author": "CL Crespi", "year": "1990", "unstructured": "Crespi, C. L., Penman, B. W., Leakey, J.A.E., Arlotto, M. P., Stark, A., Parkinson, A., Turner, T., Steimel, D. T., Rudo, K., Davies, R. L., and Langenbach, R., 1990, Human cytochrome P4501IA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1, Carcinogenesis\n                        11: 1293\u20131300.", "journal-title": "Carcinogenesis"}, {"key": "14_CR160", "doi-asserted-by": "publisher", "first-page": "1789", "DOI": "10.1093/carcin/13.10.1789", "volume": "13", "author": "H Yamazaki", "year": "1992", "unstructured": "Yamazaki, H., Inui, Y., Yun, C. H., Mimura, M., Guengerich, E P., and Shimada, T., 1992, Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes, Carcinogenesis\n                        13: 1789\u20131794.", "journal-title": "Carcinogenesis"}, {"key": "14_CR161", "first-page": "1757", "volume": "52", "author": "TJ Smith", "year": "1992", "unstructured": "Smith, T. J., Guo, Z., Gonzalez, P. J., Guengerich, E P., Stoner, G. D., and Yang, C. S., 1992, Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells, Cancer Res. 52: 1757\u20131763.", "journal-title": "Cancer Res"}, {"key": "14_CR162", "author": "CL Crespi", "year": "1991", "unstructured": "Crespi, C. L., Penman, B. W., Gelboin, H. V., and Gonzalez, F. J., 1991, A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6, Carcinogenesis\n                        12:1197-1201.", "volume-title": "Carcinogenesis 12:1197-1201"}, {"key": "14_CR163", "doi-asserted-by": "publisher", "first-page": "2141", "DOI": "10.1093/carcin/13.11.2141", "volume": "13", "author": "JY Hong", "year": "1992", "unstructured": "Hong, J. Y., Ding, X., Smith, T. J., Coon, M. J., and Yang, C. S., 1992, Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific carcinogen, by rabbit nasal microsomes and cytochrome P405s NMa and NMb, Carcinogenesis\n                        13: 2141\u20132144.", "journal-title": "Carcinogenesis"}, {"key": "14_CR164", "first-page": "3567", "volume": "250", "author": "DA Haugen", "year": "1975", "unstructured": "Haugen, D. A., van der Hoeven, T. A., and Coon, M. J., 1975, Purified liver microsomal cytochrome P-450: Separation and characterization of multiple forms, J. Biol. Chem. 250: 3567\u20133570.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR165", "doi-asserted-by": "publisher", "first-page": "814", "DOI": "10.1016/0006-291X(74)90164-8", "volume": "60", "author": "Y Imai", "year": "1974", "unstructured": "Imai, Y., and Sato, R., 1974, A gel-electrophoretically homogeneous preparation of cytochrome P-450 from liver microsomes of phenobarbital-pretreated rabbits, Biochem. Biophys. Res. Commun. 60: 814.", "journal-title": "Biochem. Biophys. Res. Commun"}, {"key": "14_CR166", "first-page": "7931", "volume": "253", "author": "FP Guengerich", "year": "1978", "unstructured": "Guengerich, F. P., 1978, Separation and purification of multiple forms of microsomal cytochrome P-450. Partial characterization of three apparently homogeneous cytochromes P-450 prepared from livers of phenobarbital-and 3-methylcholanthrene-treated rats, J. Biol. Chem. 253: 7931\u20137939.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR167", "first-page": "1365", "volume": "254", "author": "DE Ryan", "year": "1979", "unstructured": "Ryan, D. E., Thomas, P. E., Korzeniowski, D., and Levin, W., 1979, Separation and characterization of highly purified forms of liver microsomal cytochrome P-450 from rats treated with polychlorinated biphenyls, phenobarbital, and 3-methylcholanthrene, J. Biol. Chem. 254: 1365\u20131374.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR168", "doi-asserted-by": "crossref", "first-page": "7340", "DOI": "10.1021/bi00444a029", "volume": "28", "author": "S. Yamano", "year": "1989", "unstructured": "Yamano, S., Nhamburo, P. T., Aoyama, T., Meyer, U. A., Inaba, T., Kalow, W., Gelboin, H. V., McBride, 0. W., and Gonzalez, F. J., 1989, cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: Identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver, Biochemistry\n                        28:7340\u20137348.", "journal-title": "Biochemistry"}, {"key": "14_CR169", "first-page": "1", "volume": "8", "author": "AM Flammang", "year": "1992", "unstructured": "Flammang, A. M., Gelboin, H. V., Aoyama, T., Gonzalez, F. J., and McCoy, G. D., 1992, Nicotine metabolism by cDNA-expressed human cytochrome P-450s, Biochem. Arch. 8: 1\u20138.", "journal-title": "Biochem. Arch"}, {"key": "14_CR170", "doi-asserted-by": "publisher", "first-page": "305", "DOI": "10.1016/0003-9861(89)90112-4", "volume": "269", "author": "MA Leo", "year": "1989", "unstructured": "Leo, M. A., Lasker, J. M., Raucy, J. L., Kim, C. I., Black, M., and Lieber, C. S., 1989, Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8, A rch. Biochem. Biophys. 269: 305\u2013312.", "journal-title": "rch. Biochem. Biophys"}, {"key": "14_CR171", "doi-asserted-by": "publisher", "first-page": "1017", "DOI": "10.1172/JCI113154", "volume": "80", "author": "SA Wrighton", "year": "1987", "unstructured": "Wrighton, S. A., Thomas, P. E., Willis, P., Maines, S. L., Watkins, R. B., Levin, W., and Guzelian, P. S., 1987, Purification of a human liver cytochrome P-450 immunochemically related to several cytochromes P-450 purified from untreated rats, J. Clin. Invest. 80: 1017\u20131022.", "journal-title": "J. Clin. Invest"}, {"key": "14_CR172", "first-page": "16072", "volume": "262", "author": "ST Okino", "year": "1987", "unstructured": "Okino, S. T., Quattrochi, L. C., Pendurthi, U. R., McBride, O. W., and Tukey, R. H., 1987, Characterization of multiple human cytochrome P450 1 cDNAs, J. Biol. Chem. 262: 16072\u201316079.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR173", "doi-asserted-by": "crossref", "first-page": "10053", "DOI": "10.1093/nar/15.23.10053", "volume": "15", "author": "S. Kimura", "year": "1987", "unstructured": "Kimura, S., Pastewka, J., Gelboin, H. V., and Gonzalez, F. J., 1987, cDNA and amino acid sequences of two members of the human P450I1C gene subfamily, Nucl. Acids Res. 15: 10053", "journal-title": "Nucl. Acids Res"}, {"key": "14_CR174", "first-page": "4026", "volume": "54", "author": "JW Harris", "year": "1994", "unstructured": "Harris, J. W., Rahman, A., Kim, B.-R., Guengerich, F. R. and Collins, J. M., 1994, Metabolism of taxol by human hepatic microsomes and liver slices: Participation of cytochrome P450 3A4 and of an unknown P450 enzyme, Cancer Res. 54: 4026\u20134035.", "journal-title": "Cancer Res"}, {"key": "14_CR175", "author": "J Cosme", "year": "1994", "unstructured": "Cosme, J., Maurel, R, Soucek, R, Guengerich, F. R, and Beaune, R. H., 1994, Cloning, expression and characterization of human cytochrome P-450 2C8 in heterologous systems, Abstracts, 14th European Drug Metabolism Workshop (July 3\u20138, Paris).", "volume-title": "Paris)"}, {"key": "14_CR176", "doi-asserted-by": "publisher", "first-page": "3247", "DOI": "10.1021/bi00227a012", "volume": "30", "author": "M Romkes", "year": "1991", "unstructured": "Romkes, M., Faletto, M. B., Blaisdell, J. A., Raucy, J. L., and Goldstein, J. A., 1991, Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily, Biochemistry\n                        30: 3247\u20133255.", "journal-title": "Biochemistry"}, {"key": "14_CR177", "doi-asserted-by": "crossref", "first-page": "4993", "DOI": "10.1021/bi00438a014", "volume": "28", "author": "WR Brian", "year": "1989", "unstructured": "Brian, W. R., Srivastava, P. K., Umbenhauer, D. R., Lloyd, R. S., and Guengerich, F. R, 1989, Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae, Biochemistry\n                        28: 4993\u20134999.", "journal-title": "Saccharomyces cerevisiae, Biochemistry"}, {"key": "14_CR178", "first-page": "442", "volume": "252", "author": "MV Relling", "year": "1990", "unstructured": "Relling, M. V., Aoyama, T., Gonzalez, F. J., and Meyer, U. A., 1990, Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily, J. Pharmacol. Exp. Ther. 252: 442\u2013447.", "journal-title": "J. Pharmacol. Exp. Ther"}, {"key": "14_CR179", "doi-asserted-by": "publisher", "first-page": "223", "DOI": "10.1111/j.1432-1033.1993.tb17752.x", "volume": "213", "author": "MR Lopezrcia", "year": "1993", "unstructured": "Lopez Garcia, M. R, Dansette, R. M., Valadon, R, Amar, C., Beaune, P. H., Guengerich, F. R, and Mansuy, D., 1993, Human liver P450s expressed in yeast as tools for reactive metabolite formation studies: Oxidative activation of tienilic acid by P450 2C9 and P450 2C10, Eur. J. Biochem. 213: 223\u2013232.", "journal-title": "Eur. J. Biochem"}, {"key": "14_CR180", "doi-asserted-by": "publisher", "first-page": "1112", "DOI": "10.1016/0006-291X(91)91680-B", "volume": "175", "author": "ME Veronese", "year": "1991", "unstructured": "Veronese, M. E., Mackenzie, R. I., Doecke, C. J., McManus, M. E., Miners, J. O., and Birken, D. J., 1991, Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9, Biochem. Biophys. Res. Commun. 175: 1112\u20131118.", "journal-title": "Biochem. Biophys. Res. Commun"}, {"key": "14_CR181", "doi-asserted-by": "publisher", "first-page": "287", "DOI": "10.1007/BF00607679", "volume": "11", "author": "W Zilly", "year": "1977", "unstructured": "Zilly, W., Breimer, D. D., and Richter, E., 1977, Stimulation of drug metabolism by rifampicin in patients with cirrhosis or cholestasis measured by increased hexobarbital and tolbutamide clearance, Eur. J. Clin. Pharmacol. 11: 287\u2013293.", "journal-title": "Eur. J. Clin. Pharmacol"}, {"key": "14_CR182", "doi-asserted-by": "publisher", "first-page": "96", "DOI": "10.1038/clpt.1980.15", "volume": "27", "author": "MR Vasko", "year": "1980", "unstructured": "Vasko, M. R., Bell, R. D., Daly, D. D., and Pippenger, C. E., 1980, Inheritance of phenytoin hypometabolism: A kinetic study of one family, Clin. Pharmacol. Ther. 27: 96\u2013103.", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "14_CR183", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.2337/diabetes.28.1.41", "volume": "28", "author": "J Scott", "year": "1978", "unstructured": "Scott, J., and Poffenbarger, R. L., 1978, Pharmacogenetics of tolbutamide metabolism in humans, Diabetes\n                        28: 41\u201351.", "journal-title": "Diabetes"}, {"key": "14_CR184", "doi-asserted-by": "publisher", "first-page": "1094", "DOI": "10.1021/bi00378a016", "volume": "26", "author": "DR Umbenhauer", "year": "1987", "unstructured": "Umbenhauer, D. R., Martin, M. V., Lloyd, R. S., and Guengerich, F. P., 1987, Cloning and sequence determination of a complementary DNA related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylase, Biochemistry\n                        26: 1094\u20131099.", "journal-title": "Biochemistry"}, {"key": "14_CR185", "first-page": "69", "volume": "40", "author": "PK Srivastava", "year": "1991", "unstructured": "Srivastava, P. K., Yun, C.-H., Beaune, R H., Ged, C., and Guengerich, F. R, 1991, Separation of human liver tolbutamine hydroxylase and (S)-mephenytoin 4\u2019-hydroxylase cytochrome P-450 enzymes, Mol. Pharmacol. 40: 69\u201379.", "journal-title": "Mol. Pharmacol"}, {"key": "14_CR186", "author": "R Kato", "year": "1993", "unstructured": "Kato, R., Yasumori, T., Nagata, K., Yang, S. K., Chen, L. S., Murayama, N., and Yamazoe, Y., 1993, Oxidative metabolism of diazepam in human liver: Differential role of CYP2C and CYP3A depending on substrate concentration, in: 8th International Conference on Cytochrome P450: Biochemistry, Biophysics, and Molecular Biology (October 24\u201328, Lisbon), p. 241.", "volume-title": "Oxidative 241"}, {"key": "14_CR187", "doi-asserted-by": "publisher", "first-page": "291", "DOI": "10.1097/00008571-199312000-00003", "volume": "3", "author": "T Yasumori", "year": "1993", "unstructured": "Yasumori, T., Nagata, K., Yang, S. K., Chen, L.-S., Murayama, N., Yamazoe, Y., and Kato, R., 1993, Cytochrome P450 mediated metabolism of diazepam in human and rat: Involvement of human CYP2C in N-demethylation in the substrate concentration-dependent manner, Pharmacogenetics\n                        3: 291\u2013301.", "journal-title": "Pharmacogenetics"}, {"key": "14_CR188", "doi-asserted-by": "publisher", "first-page": "29", "DOI": "10.1016/0024-3205(93)90285-B", "volume": "52", "author": "T Leeman", "year": "1993", "unstructured": "Leeman, T., Transon, C., and Dayer, P., 1993, Cytochrome P450TB (CYP2C): A major monooxygenase catalyzing diclofenac 4\u2019-hydroxylation in human liver, Life Sci. 52: 29\u201334.", "journal-title": "Life Sci"}, {"key": "14_CR189", "first-page": "845", "volume": "245", "author": "RG Knodell", "year": "1988", "unstructured": "Knodell, R. G., Dubey, R. K., Wilkinson, G. R., and Guengerich, F. P., 1988, Oxidative metabolism of hexobarbital in human liver: Relationship to polymorphic S-mephenytoin 4-hydroxylation, J. Pharmacol. Exp. Ther. 245: 845\u2013849.", "journal-title": "J. Pharmacol. Exp. Ther"}, {"key": "14_CR190", "first-page": "189", "volume": "19", "author": "TD Leeman", "year": "1993", "unstructured": "Leeman, T. D., Transon, C., Bonnabry, P., and Dayer, P., 1993, A major role for cytochrome P450m (CYP2C subfamily) in the actions of non-steroidal antiinflammatory drugs, Drugs Exp. Clin. Res. 19: 189\u2013195.", "journal-title": "Drugs Exp. Clin. Res"}, {"key": "14_CR191", "author": "RA Stearns", "first-page": "238", "year": "1993", "unstructured": "Stearns, R. A., Chakravarty, P. K., Chen, R., and Chiu, S.H.L., 1993, Investigations into the mechanism of oxidation of losartan, an alcohol, to its active metabolite, a carboxylic acid derivative, in: Abstracts, 5th North American ISSX Meeting (October 17\u201321, Tucson), Vol. 4, p. 238.", "volume-title": "Abstracts, 5th North American ISSX Meeting (October 17-21, Tucson)"}, {"key": "14_CR192", "doi-asserted-by": "publisher", "first-page": "414", "DOI": "10.1038/clpt.1985.196", "volume": "38", "author": "A Kupfer", "year": "1985", "unstructured": "Kupfer, A., and Branch, R. A., 1985, Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylation, Clin. Pharmacol. Ther. 38: 414\u2013418.", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "14_CR193", "first-page": "216", "volume": "240", "author": "SD Hall", "year": "1987", "unstructured": "Hall, S. D., Guengerich, F. P., Branch, R. A., and Wilkinson, G. R., 1987, Characterization and inhibition of mephenytoin 4-hydroxylase activity in human liver microsomes, J. Pharmacol. Exp. Ther. 240: 216\u2013222.", "journal-title": "J. Pharmacol. Exp. Ther"}, {"key": "14_CR194", "doi-asserted-by": "publisher", "first-page": "415", "DOI": "10.1097/00007691-199007000-00020", "volume": "12", "author": "T Andersson", "year": "1990", "unstructured": "Andersson, T., Reg\u00e2rdh, C. G., Dahl-Puustinen, M. L., and Bertilsson, L., 1990, Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators, Ther. Drug Monitoring\n                        12: 415\u2013416.", "journal-title": "Ther. Drug Monitoring"}, {"key": "14_CR195", "author": "R Curi-Pedrosa", "first-page": "46", "year": "1993", "unstructured": "Curi-Pedrosa, R., Pichard, L., Bonfils, C., Jacqz-Aigrain, E., Guengerich, F. R, and Maurel, P., 1993, Major implication of cytochrome P450 3A4 in the oxidative metabolism of antisecretory drugs omeprazole and lansoprazole in human liver microsomes and hepatocytes, in: Abstracts, 5th European ISSX Meeting (September 26\u201329, Tours), Vol. 3, p. 46.", "volume-title": "Abstracts, 5th European ISSX Meeting (September 26-29, Tours)"}, {"key": "14_CR196", "first-page": "1112", "volume": "241", "author": "RG Knodell", "year": "1987", "unstructured": "Knodell, R. G., Hall, S. D., Wilkinson, G. R., and Guengerich, F. R, 1987, Hepatic metabolism of tolbutamide: Characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition, J. Pharmacol. Exp. Ther. 241: 1112\u20131119.", "journal-title": "J. Pharmacol. Exp. Ther"}, {"key": "14_CR197", "first-page": "247", "volume": "47", "author": "M Nakamura", "year": "1994", "unstructured": "Nakamura, M., Tanaka, E., Misawa, S., Shimada, T., Imaoka, S., and Funae, Y., 1994, Trimethadione metabolism, a useful indicator for assessing hepatic drug-oxidizing capacity, Biochem. Pharmacol. 47: 247\u2013251.", "journal-title": "Biochem. Pharmacol"}, {"key": "14_CR198", "first-page": "375", "volume": "40", "author": "H Furuya", "year": "1991", "unstructured": "Furuya, H., Meyer, U. A., Gelboin, H. V., and Gonzalez, F. J., 1991, Polymerase chain reaction-directed identification, cloning, and quantification of human CYP2C18 mRNA, Mol. Pharmacol. 40: 375\u2013382.", "journal-title": "Mol. Pharmacol"}, {"key": "14_CR199", "first-page": "443", "volume": "35", "author": "T Yasumori", "year": "1989", "unstructured": "Yasumori, T., Murayama, N., Yamazoe, Y., Nogi, Y., Fukasawa, T., and Kato, R., 1989, Expression of a human P-4501\u00edC gene in yeast cells using galactose-inducible expression system, Mol. Pharmacol. 35: 443\u2013449.", "journal-title": "Mol. Pharmacol"}, {"key": "14_CR200", "doi-asserted-by": "publisher", "first-page": "1743", "DOI": "10.1021/bi00173a017", "volume": "33", "author": "JA Goldstein", "year": "1994", "unstructured": "Goldstein, J. A., Faletto, M. B., Romkessparks, M., Sullivan, T., Kitareewan, S., Raucy, J. L., Lasker, J. M., and Ghanayem, B. I., 1994, Evidence that CYP2C19 is the major (S)-mephenytoin 4\u2019hydroxylase in humans, Biochemistry\n                        33: 1743\u20131752.", "journal-title": "Biochemistry"}, {"key": "14_CR201", "doi-asserted-by": "publisher", "first-page": "773", "DOI": "10.1038/clpt.1984.256", "volume": "36", "author": "RJ Wedlund", "year": "1984", "unstructured": "Wedlund, R. J., Aslanian, W. S., McAllister, C. B., Wilkinson, G. R., and Branch, R. A., 1984, Mephenytoin hydroxylation deficiency in Caucasians: Frequency of a new oxidative drug metabolism polymorphism, Clin. Pharmacol. Ther. 36: 773\u2013780.", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "14_CR202", "doi-asserted-by": "publisher", "first-page": "753", "DOI": "10.1007/BF00541938", "volume": "26", "author": "A Kupfer", "year": "1984", "unstructured": "Kupfer, A., and Preisig, R., 1984, Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in man, Eur. J. Clin. Phnrmacol. 26: 753\u2013759.", "journal-title": "Eur. J. Clin. Phnrmacol"}, {"key": "14_CR203", "doi-asserted-by": "publisher", "first-page": "1137", "DOI": "10.1016/0006-2952(88)90522-9", "volume": "37", "author": "JO Miners", "year": "1988", "unstructured": "Miners, J. O., Smith, K. J., Robson, R. A., McManus, M. E., Veronese, M. E., and Birkett, D. J., 1988, Tolbutamide hydroxylation by human liver microsomes: Kinetic characterisation and relationship to other cytochrome P-450 dependent xenobiotic oxidations, Biochem. Pharmacol. 37: 1137\u20131144.", "journal-title": "Biochem. Pharmacol"}, {"key": "14_CR204", "doi-asserted-by": "publisher", "first-page": "442", "DOI": "10.1038/331442a0", "volume": "331", "author": "EJ Gonzalez", "year": "1988", "unstructured": "Gonzalez, E J., Skoda, R. C., Kimura, S., Umeno, M., Zanger, U. M., Neben, D. W., Gelboin, H. V., Hardwick, J. P., and Meyer, U. A., 1988, Characterization of the common genetic defect in humans deficient in debrisoquine metabolism, Nature\n                        331: 442\u2013446.", "journal-title": "Nature"}, {"key": "14_CR205", "first-page": "889", "volume": "45", "author": "S. Kimura", "year": "1989", "unstructured": "Kimura, S., Umeno, M., Skoda, R. C., Meyer, U. A., and Gonzalez, F. J.,1989, The human debrisoquine 4-hydroxylase (CYP2D) locus: Sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene, Am. J. Hum. Genet. 45: 889\u2013904.", "journal-title": "Am. J. Hum. Genet"}, {"key": "14_CR206", "doi-asserted-by": "publisher", "first-page": "979", "DOI": "10.1016/0024-3205(78)90363-6", "volume": "22", "author": "JR Idle", "year": "1978", "unstructured": "Idle, J. R., Mahgoub, A., Lancaster, R., and Smith, R. L., 1978, Hypotensive response to debrisoquine and hydroxylation phenotype, Life Sci. 22: 979\u2013984.", "journal-title": "Life Sci"}, {"key": "14_CR207", "doi-asserted-by": "publisher", "first-page": "183", "DOI": "10.1007/BF00562059", "volume": "16", "author": "M Eichelbaum", "year": "1979", "unstructured": "Eichelbaum, M., Spannbrucker, N., Steincke, B., and Dengler, H. J., 1979, Defective N-oxidation of sparteine in man: A new pharmacogenetic defect, Eur. J. Clin. Pharmacol. 16: 183\u2013187.", "journal-title": "Eur. J. Clin. Pharmacol"}, {"key": "14_CR208", "first-page": "572P", "volume": "16", "author": "MS Lennard", "year": "1982", "unstructured": "Lennard, M. S., Silas, J. H., Freestone, S., Tucker, G. T., Ramsay, L. E., and Woods, H. F., 1982, Impaired metabolism of metoprolol in poor hydroxylators of debrisoquine, Br. J. Pharmscol. 16: 572P - 573 P.", "journal-title": "Br. J. Pharmscol"}, {"key": "14_CR209", "doi-asserted-by": "publisher", "first-page": "1673", "DOI": "10.1016/0024-3205(80)90642-6", "volume": "27", "author": "L Bertilsson", "year": "1980", "unstructured": "Bertilsson, L., Eichelbaum, M., Mellstr\u00f6m, B., S\u00e4we, J., Schulz, H. U., and Sj\u00f6gvist, E, 1980, Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man, Life Sci. 27: 1673\u20131677.", "journal-title": "Life Sci"}, {"key": "14_CR210", "doi-asserted-by": "publisher", "first-page": "2787", "DOI": "10.1021/bi00307a039", "volume": "23", "author": "D Larrey", "year": "1984", "unstructured": "Larrey, D., Distlerath, L. M., Dannan, G. A., Wilkinson, G. R., and Guengerich, F. P., 1984, Purification and characterization of the rat liver microsomal cytochrome P-450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism, Biochemistry\n                        23: 2787\u20132795.", "journal-title": "Biochemistry"}, {"key": "14_CR211", "doi-asserted-by": "publisher", "first-page": "149", "DOI": "10.1089/dna.1987.6.149", "volume": "6", "author": "EJ Gonzalez", "year": "1987", "unstructured": "Gonzalez, E J., Matsunaga, T., Nagata, K., Meyer, U. A., Nebert, D. W., Pastewka, J., Kozak, C. A., Gillette, J., Gelboin, H. V., and Hardwick, J. P., 1987, Debrisoquine 4-hydroxylase: Characterization of a new P450 gene subfamily, regulation, chromosomal mapping, and molecular analysis of the DA rat polymorphism, DNA\n                        6: 149\u2013161.", "journal-title": "Dna"}, {"key": "14_CR212", "doi-asserted-by": "publisher", "first-page": "7349", "DOI": "10.1021/bi00444a030", "volume": "28", "author": "E Matsunaga", "year": "1989", "unstructured": "Matsunaga, E., Zanger, U. M., Hardwick, J. P., Gelboin, H. V., Meyer, U. A., and Gonzalez, F. J., 1989, The CYP2D gene subfamily: Analysis of the molecular basis of the debrisoquine 4-hydroxylase deficiency in DA rats, Biochemistry\n                        28: 7349\u20137355.", "journal-title": "Biochemistry"}, {"key": "14_CR213", "doi-asserted-by": "publisher", "first-page": "287", "DOI": "10.1016/0014-5793(84)80792-9", "volume": "173", "author": "J Gut", "year": "1984", "unstructured": "Gut, J., Gasser, R., Dayer, P., Kronbach, T., Catin, T., and Meyer, U. A., 1984, Debrisoquine-type polymorphism of drug oxidation: Purification from human liver of a cytochrome P450 isozyme with high activity for bufuralol hydroxylation, FEBS Lett. 173: 287\u2013290.", "journal-title": "FEBS Lett"}, {"key": "14_CR214", "doi-asserted-by": "publisher", "first-page": "5240", "DOI": "10.1073/pnas.85.14.5240", "volume": "85", "author": "RC Skoda", "year": "1988", "unstructured": "Skoda, R. C., Gonzalez, F. J., Demierre, A., and Meyer, U. A., 1988, Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs, Proc. Natl. Acad. Sci. USA\n                        85: 5240\u20135243.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "14_CR215", "doi-asserted-by": "publisher", "first-page": "26", "DOI": "10.1097/00008571-199110000-00005", "volume": "1", "author": "R Tyndale", "year": "1991", "unstructured": "Tyndale, R., Aoyama, T., Broly, F., Matsunaga, T., Inaba, T., Kalow, W., Gelboin, H. V., Meyer, U. A., and Gonzalez, F. J., 1991, Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: Possible association with the poor metabolizer phenotype, Pharmacogenetics\n                        1: 26\u201332.", "journal-title": "Pharmacogenetics"}, {"key": "14_CR216", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1097/00008571-199404000-00004", "volume": "4", "author": "M Armstrong", "year": "1994", "unstructured": "Armstrong, M., Fairbrother, K., Idle, J. R., and Daly, A. K., 1994, The cytochrome P450 CYP2D6 allelic variant CYPD6J and related polymorphisms in a European population, Pharmacogenetics\n                        4 73\u201381.", "journal-title": "Pharmacogenetics"}, {"key": "14_CR217", "doi-asserted-by": "publisher", "first-page": "616", "DOI": "10.1007/BF00205091", "volume": "91", "author": "M Armstrong", "year": "1993", "unstructured": "Armstrong, M., Idle, J. R., and Daly, A. K., 1993, A polymorphic CfoI site in exon 6 of the human cytochrome P50 CYP2D6 gene detected by the polymerase chain reaction, Hum. Genet. 91: 616\u2013617.", "journal-title": "Hum. Genet"}, {"key": "14_CR218", "doi-asserted-by": "publisher", "first-page": "233", "DOI": "10.1038/clpt.1991.131", "volume": "50", "author": "FJ Gonzalez", "year": "1991", "unstructured": "Gonzalez, F. J., and Meyer, U. A., 1991, Molecular genetics of the debrisoquin-sparteine polymorphism, Clin. Pharmacol. Ther. 50: 233\u2013238.", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "14_CR219", "doi-asserted-by": "publisher", "first-page": "773", "DOI": "10.1038/347773a0", "volume": "347", "author": "AC Gough", "year": "1990", "unstructured": "Gough, A. C., Miles, J. S., Spurr, N. K., Moss, J. E., Gaedigk, A., Eichelbaum, M., and Wolf, C. R., 1990, Identification of the primary gene defect at the cytochrome P450 CYP2D locus, Nature\n                        347: 773\u2013776.", "journal-title": "Nature"}, {"key": "14_CR220", "doi-asserted-by": "publisher", "first-page": "529", "DOI": "10.1016/0140-6736(90)92086-W", "volume": "336", "author": "M Heim", "year": "1990", "unstructured": "Heim, M., and Meyer, U. A., 1990, Genotyping of poor metabolizers of debrisoquine by allele-specific PCR amplification, Lancet\n                        336: 529\u2013532.", "journal-title": "Lancet"}, {"key": "14_CR221", "doi-asserted-by": "publisher", "first-page": "33", "DOI": "10.1097/00008571-199110000-00006", "volume": "1", "author": "AK Daly", "year": "1991", "unstructured": "Daly, A. K., Armstrong, M., Monkman, S. C., Idle, M. E., and Idle, J. R., 1991, Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypes, Pharmacogenetics 1: 33\u201341.", "journal-title": "Pharmacogenetics"}, {"key": "14_CR222", "doi-asserted-by": "publisher", "first-page": "2150", "DOI": "10.1172/JCI116441", "volume": "91", "author": "WE Evans", "year": "1993", "unstructured": "Evans, W. E., Relling, M. V., Rahman, A., McLeod, H. L., Scott, E. P., and Lin, J. S., 1993, Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in black Americans, J. Clin. Invest. 91: 2150\u20132154.", "journal-title": "J. Clin. Invest"}, {"key": "14_CR223", "doi-asserted-by": "publisher", "first-page": "11825", "DOI": "10.1073/pnas.90.24.11825", "volume": "90", "author": "I Johansson", "year": "1993", "unstructured": "Johansson, I., Lundqvist, E., Bertilsson, L., Dahl, M. L., Sjoqvist, F., and Ingelman-Sundberg, M. 1993, Inherited amplification of an active gene in the cytochrome-P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine, Proc. Natl. Acad. Sci. USA. 90: 11825\u201311829.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "14_CR224", "first-page": "17197", "volume": "265", "author": "E Matsunaga", "year": "1990", "unstructured": "Matsunaga, E., Zeugin, T., Zanger, U. M., Aoyama, T., Meyer, U. A., and Gonzalez, F. J., 1990, Setuence requirements for cytochrome P-450IID1 catalytic activity: A single amino acid change (Ile-80 Phe) specifically decreases V. of the enzyme for bufuralol but not debrisoquine hydroxylation, J. Biol. Chem. 265: 17197\u201317201.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR225", "doi-asserted-by": "publisher", "first-page": "309", "DOI": "10.1007/BF03190117", "volume": "14", "author": "C K\u00f6ppel", "year": "1989", "unstructured": "K\u00f6ppel, C., Tenczer, J., and Arndt, I., 1989, Metabolic disposition of ajmaline, Eur. J. Drug Metab. Pharmacokin. 14: 309\u2013316.", "journal-title": "Eur. J. Drug Metab. Pharmacokin"}, {"key": "14_CR226", "doi-asserted-by": "publisher", "first-page": "515", "DOI": "10.1038/clpt.1984.212", "volume": "36", "author": "G Alvan", "year": "1984", "unstructured": "Alvan, G., Grind, M., Graffner, C., and Sj\u00f6qvist, F., 1984, Relationship of N-demethylation of amiflamine and its metabolite to debrisoquine hydroxylation polymorphism, Clin. Pharmacol. Ther. 36: 515\u2013519.", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "14_CR227", "doi-asserted-by": "publisher", "first-page": "369", "DOI": "10.1038/clpt.1986.56", "volume": "39", "author": "B Mellstr\u00f6m", "year": "1986", "unstructured": "Mellstr\u00f6m, B., S\u00e4we, J., Bertilsson, L., and Sj\u00f6qvist, F., 1986, Amitriptyline metabolism: Association with debrisoquin hydroxylation in nonsmokers, Clin. Pharmacol. Ther. 39: 369\u2013371.", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "14_CR228", "doi-asserted-by": "publisher", "first-page": "426", "DOI": "10.1111/j.1365-2125.1993.tb04161.x", "volume": "35", "author": "T Ebner", "year": "1993", "unstructured": "Ebner, T., and Eichelbaum, M., 1993, The metabolism of apridine in relation to the sparteine/debrisoquine polymorphism, Br. J. Clin. Pharmacol. 35: 426\u2013430.", "journal-title": "Br. J. Clin. Pharmacol"}, {"key": "14_CR229", "doi-asserted-by": "publisher", "first-page": "317", "DOI": "10.1007/BF00543330", "volume": "28", "author": "P Dayer", "year": "1985", "unstructured": "Dayer, P., Balant, L., Kupfer, A., Striberni, R., and Leemann, T., 1985, Effect of oxidative polymorphism (debrisoquine/sparteine type) on hepatic first-pass metabolism of bufuralol, Eur. J. Clin. Pharmacol. 28: 317\u2013320.", "journal-title": "Eur. J. Clin. Pharmacol"}, {"key": "14_CR230", "doi-asserted-by": "publisher", "first-page": "261", "DOI": "10.1007/BF00315393", "volume": "45", "author": "J Pressacco", "year": "1993", "unstructured": "Pressacco, J., Muller, R., and Kalow, W., 1993, Interactions of bupranolol with the polymorphic debrisoquine/spearteine monooxygenase (CYP2D6), Eur J, Clin. Pharmacol. 45: 261\u2013264.", "journal-title": "Eur J, Clin. Pharmacol"}, {"key": "14_CR231", "doi-asserted-by": "publisher", "first-page": "81", "DOI": "10.1111/j.1365-2125.1985.tb02802.x", "volume": "20", "author": "CH Gleiter", "year": "1985", "unstructured": "Gleiter, C. H., Aichele, G., Nilsson, E., Hengen, N., Antonin, K. H., and Bieck, P. R., 1985, Discovery of altered pharmacokinetics of CGP 15 210 G in poor hydroxylators of debrisoquine during early drug development, Br. J. Clin. Pharmacol. 20: 81\u201384.", "journal-title": "Br. J. Clin. Pharmacol"}, {"key": "14_CR232", "doi-asserted-by": "publisher", "first-page": "449", "DOI": "10.1007/BF00613523", "volume": "31", "author": "AE Balant-Gorgia", "year": "1986", "unstructured": "Balant-Gorgia, A. E., Balant, L. P., Genet, C., Dayer, P., Aeschlimann, J. M., and Garrone, G., 1986, Importance of oxidative polymorphism and levomepromazine treatment on the steady-state blood concentrations of clomipramine and its major metabolites, Eue J. Clin. Pharmacol. 31: 449\u2013455.", "journal-title": "Eue J. Clin. Pharmacol"}, {"key": "14_CR233", "first-page": "1355", "volume": "260", "author": "V Fischer", "year": "1992", "unstructured": "Fischer, V., Vogels, B., Maurer, G., and Tynes, R. E., 1992, The anti psychotic clozapine is metabolized by the polymorphic human microsomal and recombinant cytochrome P450 2D6, J. Pharmacol. Exp. Ther. 260: 1355\u20131360.", "journal-title": "J. Pharmacol. Exp. Ther"}, {"key": "14_CR234", "doi-asserted-by": "publisher", "first-page": "411", "DOI": "10.1016/S0006-291X(88)80729-0", "volume": "152", "author": "P Dayer", "year": "1988", "unstructured": "Dayer, P., Desmeules, J., Leemann, T., and Striberni, R., 1988, Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation, Biochem. Biophys. Res. Commun. 152: 411\u2013416.", "journal-title": "Biochem. Biophys. Res. Commun"}, {"key": "14_CR235", "doi-asserted-by": "publisher", "first-page": "718", "DOI": "10.1016/S0140-6736(77)90527-X", "volume": "11", "author": "GT Tucker", "year": "1977", "unstructured": "Tucker, G. T., Silas, J. H., Iyun, A. O., Lennard, M. S., and Smith, A. J., 1977, Polymorphic hydroxylation of debrisoquine, Lancet. 11: 718.", "journal-title": "Lancet"}, {"key": "14_CR236", "doi-asserted-by": "publisher", "first-page": "321", "DOI": "10.1136/jmg.20.5.321", "volume": "20", "author": "DAP Evans", "year": "1983", "unstructured": "Evans, D.A.P., Harmer, D., Downham, D. Y., Whibley, E. J., Idle, J. R, Ritchie, J., and Smith, R. L., 1983, The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions, J. Med. Genet. 20: 321\u2013329.", "journal-title": "J. Med. Genet"}, {"key": "14_CR237", "doi-asserted-by": "publisher", "first-page": "584", "DOI": "10.1016/S0140-6736(77)91430-1", "volume": "11", "author": "A Mahgoub", "year": "1977", "unstructured": "Mahgoub, A., Idle, J. R., Dring, L. G., Lancaster, R., and Smith, R. L., 1977, Polymorphic hydroxylation of debrisoquine in man, Lancet\n                        11: 584\u2013586.", "journal-title": "Lancet"}, {"key": "14_CR238", "doi-asserted-by": "publisher", "first-page": "545", "DOI": "10.1089/dna.1991.10.545", "volume": "10", "author": "F Broly", "year": "1991", "unstructured": "Broly, F., Gaedigk, A., Heim, M., Eichelbaum, M., Morike, K., and Meyer, U. A., 1991, Debrisoquine/sparteine hydroxylation genotype and phenotype: Analysis of common mutations and alleles of CYP2D6 in a European population, DNA Cell Biol. 10: 545\u2013558.", "journal-title": "DNA Cell Biol"}, {"key": "14_CR239", "doi-asserted-by": "publisher", "first-page": "286", "DOI": "10.1021/tx00039a003", "volume": "7", "author": "JM Grace", "year": "1994", "unstructured": "Grace, J. M., Kinter, M. T., and Macdonald, T.L., 1994, Atypical metabolism of deprenyl and its enantiomer, (S)-(+)N,a-dimethyl-N-propynylphenethylamine, by cytochrome P450 2D6, Chem. Res. Toxicol. 7: 286\u2013290.", "journal-title": "Chem. Res. Toxicol"}, {"key": "14_CR240", "doi-asserted-by": "publisher", "first-page": "314", "DOI": "10.1038/clpt.1987.33", "volume": "41", "author": "E Spina", "year": "1987", "unstructured": "Spina, E., Steiner, E., Ericsson, \u00d6., and Sj\u00f6qvist, F., 1987, Hydroxylation of desmethylimipramine: Dependence on the debrisoquin hydroxylation phenotype, Clin. Pharmacol. Ther. 41: 314\u2013319.", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "14_CR241", "author": "C Coulter", "first-page": "183", "year": "1993", "unstructured": "Coulter, C., Sanzgiri, U., and Parkinson, A., 1993, Evidence for the involvement of CYP3A enzymes in the N-demethylation of dextromethorphan, in: Abstracts, 5th North American ISSX Meeting (October 17\u201321, Tucson), Vol. 4, p. 183.", "volume-title": "Abstracts, 5th North American ISSX Meeting (October 17-21, Tucson)"}, {"key": "14_CR242", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1111/j.1365-2125.1989.tb05354.x", "volume": "27", "author": "O. Mortimer", "year": "1989", "unstructured": "Mortimer, O., Lindstr\u00f6m, B., Laurell, H., Bergman, U., and Rane, A., 1989, Dextromethorphan: Polymorphic serum pattern of the 0-demethylated and didemethylated metabolites in man, Br. J. Clin. Pharmacol. 27: 223\u2013227.", "journal-title": "Br. J. Clin. Pharmacol"}, {"key": "14_CR243", "doi-asserted-by": "publisher", "first-page": "517", "DOI": "10.1016/S0140-6736(84)92591-1", "volume": "11", "author": "A K\u00fcpfer", "year": "1984", "unstructured": "K\u00fcpfer, A., Schmid, B., Preisig, R., and Pfaff, G., 1984, Dextromethorphan as a safe probe for debrisoquine hydroxylation polymorphism, Lancet 11: 517\u2013518.", "journal-title": "Lancet"}, {"key": "14_CR244", "doi-asserted-by": "publisher", "first-page": "282", "DOI": "10.1038/clpt.1986.40", "volume": "39", "author": "RL Woosley", "year": "1986", "unstructured": "Woosley, R. L., Roden, D. M., Dai, G., Wang, T., Altenbern, D., Oates, J., and Wilkinson, G. R., 1986, Co-inheritance of the polymorphic metabolism of encainide and debrisoquin, Clin. Pharmacol. Ther. 39: 282\u2013287.", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "14_CR245", "doi-asserted-by": "publisher", "first-page": "555", "DOI": "10.1111/j.1365-2125.1989.tb03542.x", "volume": "28", "author": "AS Gross", "year": "1989", "unstructured": "Gross, A. S., Mikus, G., Fischer, C., Hertrampf, R, Gundert-Remy, U., and Eichelbaum, M., 1989, Stereoselective disposition of flecainide in relation to the sparteine debrisoquine metaboliser phenotype, Br. J. Clin. Pharmacol. 28: 555\u2013566.", "journal-title": "Br. J. Clin. Pharmacol"}, {"key": "14_CR246", "doi-asserted-by": "publisher", "first-page": "655", "DOI": "10.1136/bmj.2.6138.655", "volume": "2", "author": "P Sloan", "year": "1978", "unstructured": "Sloan, P., Mahgoub, A., Lancaster, R., Idle, J. R., and Smith, R. L., 1978, Polymorphism of carbon oxidation of drugs and clinical implications, Br. Med. J. 2: 655\u2013657.", "journal-title": "Br. Med. J"}, {"key": "14_CR247", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1021/tx00019a017", "volume": "4", "author": "B Subramanyam", "year": "1991", "unstructured": "Subramanyam, B., Woolf, T., and Castagnoli, N., Jr., 1991, Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metabolite, Chem. Res. Toxicol. 4: 123\u2013128.", "journal-title": "Chem. Res. Toxicol"}, {"key": "14_CR248", "doi-asserted-by": "publisher", "first-page": "463", "DOI": "10.1038/clpt.1993.177", "volume": "54", "author": "SV Otton", "year": "1993", "unstructured": "Otton, S. V., Schadel, M., Cheung, S. W., Kaplan, H. L., Busto, U. E., and Sellers, E. M., 1993, CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone, Clin. Pharmacol. Ther. 54: 463\u2013472.", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "14_CR249", "first-page": "827", "volume": "43", "author": "A Lemoine", "year": "1993", "unstructured": "Lemoine, A., Gautier, J. C., Azoulay, D., Guengerich, F. P., Beaune, P., Maurel, P., and Leroux, J. P., 1993, The major pathway of imipramine metabolism is catalyzed by cytochrome P-450 1 A2 and P-450 3A4 in human liver, Mol. Pharmacol. 43: 827\u2013832.", "journal-title": "Mol. Pharmacol"}, {"key": "14_CR250", "doi-asserted-by": "publisher", "first-page": "1357", "DOI": "10.3109/00498259009046634", "volume": "20", "author": "DM Pierce", "year": "1990", "unstructured": "Pierce, D. M., 1990, A review of the clinical pharmacokinetics and metabolism of the alpha 1-adrenoceptor antagonist indoramin, Xenobiotica\n                        20: 1357\u20131367.", "journal-title": "Xenobiotica"}, {"key": "14_CR251", "unstructured": "Dow, J. D., Laucher-Harsany, V., and Haegele, K. D., 1993, In vitro studies on the metabolism of the putative anxiolytic MDL 73005 using human liver microsomes and microsomes prepared from cells expressing a single human cytochrome P-450 isozyme, in: Abstracts, 5th European ISSX Meeting (September 26\u201329, Tours), Vol. 3, p. 48."}, {"key": "14_CR252", "doi-asserted-by": "publisher", "first-page": "397", "DOI": "10.3109/00498257909038744", "volume": "9", "author": "I Kitchen", "year": "1979", "unstructured": "Kitchen, I., Tremblay, J., Andre, J., Dring, L. G., Idle, J. R., Smith, R. L., and Williams, R. T., 1979, Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamine, Xenobiotica\n                        9: 397\u2013404.", "journal-title": "Xenobiotica"}, {"key": "14_CR253", "doi-asserted-by": "publisher", "first-page": "128", "DOI": "10.1038/clpt.1985.148", "volume": "38", "author": "SD Roy", "year": "1985", "unstructured": "Roy, S. D., Hawes, E. M., McKay, G., Korchinski, E. D., and Midha, K. K., 1985, Metabolism of methoxyphenamine in extensive and poor metabolizers of debrisoquin, Clin. Pharmacol. Ther. 38: 128\u2013133.", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "14_CR254", "doi-asserted-by": "publisher", "first-page": "617", "DOI": "10.1016/0006-2952(92)90394-X", "volume": "44", "author": "SW Ellis", "year": "1992", "unstructured": "Ellis, S. W., Ching, M. S., Watson, P. F., Henderson, C. J., Simula, A. P., Lennard, M. S., Tucker, G. T., and Woods, H. F., 1992, Catalytic activities of human debrisoquine 4-hydroxylase cytochrome P450 (CYP2D6) expressed in yeast, Biochem. Pharmacol. 44: 617\u2013620.", "journal-title": "Biochem. Pharmacol"}, {"key": "14_CR255", "doi-asserted-by": "publisher", "first-page": "1558", "DOI": "10.1056/NEJM198212163072505", "volume": "307", "author": "MS Lennard", "year": "1982", "unstructured": "Lennard, M. S., Silas, J. H., Freestone, S., Ramsay, L. E., Tucker, G. T., and Woods, H. F., 1982, Oxidation phenotype\u2014A major determinant of metoprolol metabolism and response, N. Engl. J. Med. 307: 1558\u20131560.", "journal-title": "N. Engl. J. Med"}, {"key": "14_CR256", "first-page": "789", "volume": "259", "author": "J Turgeon", "year": "1991", "unstructured": "Turgeon, J., Fiset, C., Gigu\u00e8re, R., Gilbert, M., Moerike, K., Rouleau, J. R., Kroemer, H. K., Eichelbaum, M., Grech-B\u00e9langer, O., and B\u00e9langer, P. M., 1991, Influence of debrisoquine phenotype and of quinidine on mexiletine disposition in man, J. Pharmacol. Exp. Ther. 259: 789\u2013798.", "journal-title": "J. Pharmacol. Exp. Ther"}, {"key": "14_CR257", "first-page": "316", "volume": "20", "author": "T Marre", "year": "1992", "unstructured": "Marre, T., Fabre, G., Lacarelle, B., Bourrie, M., Catalin, J., Berger, Y., Rahmani, R., and Cano, J. P., 1992, Involvement of the cytochrome P-450IID subfamily in minaprine 4-hydroxylation by human microsomes, Drug Metab. Dispos. 20: 316\u2013321.", "journal-title": "Drug Metab. Dispos"}, {"key": "14_CR258", "first-page": "560", "volume": "11", "author": "L Bertilsson", "year": "1981", "unstructured": "Bertilsson, L., Mellstr\u00f6m, B., Sj\u00f6qvist, F., M$rtensson, B., and Asberg, M., 1981, Slow hydroxylation of nortriptyline and concomitant poor debrisoquine hydroxylation: Clinical implications, Lancet\n                        11: 560\u2013561.", "journal-title": "Slow hydroxylation of nortriptyline and concomitant poor debrisoquine hydroxylation: Clinical implications, Lancet"}, {"key": "14_CR259", "doi-asserted-by": "publisher", "first-page": "521", "DOI": "10.1111/j.1365-2125.1992.tb04082.x", "volume": "33", "author": "JC Bloomer", "year": "1992", "unstructured": "Bloomer, J. C., Woods, P. R., Haddock, R. E., Lennard, M. S., and Tucker, G. T., 1992, The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes, Br. J. Clin. Pharmacol. 33: 521\u2013523.", "journal-title": "Br. J. Clin. Pharmacol"}, {"key": "14_CR260", "doi-asserted-by": "publisher", "first-page": "295", "DOI": "10.1136/bmj.284.6312.295", "volume": "284", "author": "RR Shah", "year": "1982", "unstructured": "Shah, R. R., Oates, N. S., Idle, J. R., Smith, R. L., and Lockhart, J.D.F., 1982, Impaired oxidation of debrisoquine in patients with perhexiline neuropathy, Br. Med. J. 284: 295\u2013299.", "journal-title": "Br. Med. J"}, {"key": "14_CR261", "doi-asserted-by": "publisher", "first-page": "78", "DOI": "10.1038/clpt.1989.109", "volume": "46", "author": "ML Dahl-Puustinen", "year": "1989", "unstructured": "Dahl-Puustinen, M. L., Lid\u00e9n, A., Alm, C., Nordin, C., and Bertilsson, L., 1989, Disposition of perphenazine is related to polymorphic debrisoquin hydroxylation in human beings, Clin. Pharmacol. Ther. 46: 78\u201381.", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "14_CR262", "author": "NS Oates", "year": "1981", "unstructured": "Oates, N. S., Shah, R. R., Idle, J. R., and Smith, R. L., 1981, Phenforn\u00fan-induced lactic acidosis associated with impaired debrisoquine hydroxylation, Lancet i:837\u2013838.", "volume-title": "Lancet i:837-838"}, {"key": "14_CR263", "first-page": "135", "volume": "40", "author": "HK Kroemer", "year": "1991", "unstructured": "Kroemer, H. K., Fischer, C., Meese, C. O., and Eichelbaum, M., 1991, Enantiomer\u2013enantiomer interaction of (S)- and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: In vitro evaluation of the mechanism, Mol. Pharmacol. 40: 135\u2013142.", "journal-title": "Mol. Pharmacol"}, {"key": "14_CR264", "doi-asserted-by": "publisher", "first-page": "1764", "DOI": "10.1056/NEJM199006213222502", "volume": "322", "author": "JT Lee", "year": "1990", "unstructured": "Lee, J. T., Kroemer, H. K., Silberstein, D. J., Funck-Brentano, C., Lineberry, M. D., Wood, A. J. J., Roden, D. M., and Woosley, R. L., 1990, The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone, N. Engl. J. Med. 322: 1764\u20131768.", "journal-title": "N. Engl. J. Med"}, {"key": "14_CR265", "doi-asserted-by": "publisher", "first-page": "1180", "DOI": "10.1007/BF01740595", "volume": "63", "author": "C Zekorn", "year": "1985", "unstructured": "Zekorn, C., Achtert, G., Hausleiter, H. J., Moon, C. H., and Eichelbaum, M., 1985, Pharmacokinetics of N-propylajmaline in relation to polymorphic sparteine oxidation, K(in. Wochenschr. 63: 1180\u20131186.", "journal-title": "K(in. Wochenschr"}, {"key": "14_CR266", "doi-asserted-by": "publisher", "first-page": "2283", "DOI": "10.1016/0006-2952(87)90592-2", "volume": "36", "author": "L Shaw", "year": "1987", "unstructured": "Shaw, L., Lennard, M. S., Tucker, G. T., Bax, N.D.S., and Woods, H. E, 1987, Irreversible binding and metabolism of propranolol by human liver microsomes\u2014relationship to polymorphic oxidation, Biochem. Pharmacol. 36: 2283\u20132288.", "journal-title": "Biochem. Pharmacol"}, {"key": "14_CR267", "doi-asserted-by": "publisher", "first-page": "320", "DOI": "10.1038/clpt.1987.34", "volume": "41", "author": "B Osikowska-Evers", "year": "1987", "unstructured": "Osikowska-Evers, B., Dayer, P., Meyer, U. A., Robertz, G. E, and Eichelbaum, M., 1987, Evidence for altered catalytic properties of the cytochrome P-450 involved in sparteine oxidation in poor metabolizers, Clin. Pharmacol. Ther. 41: 320\u2013325.", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "14_CR268", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1097/00007691-199202000-00001", "volume": "14", "author": "P Baumann", "year": "1992", "unstructured": "Baumann, P., Meyer, J. W., Amey, M., Baettig, D., Bryois, C., Jonzier-Perey, M., Koeb, L., Monney, C., and Woggon, B., 1992, Dextromethorphan and mephenytoin phenotyping of patients treated with thioridazine or amitriptyline, Ther. Drug Monitor. 14: 1\u20138.", "journal-title": "Ther. Drug Monitor"}, {"key": "14_CR269", "doi-asserted-by": "publisher", "first-page": "409", "DOI": "10.1038/clpt.1985.195", "volume": "38", "author": "JC Mcgourty", "year": "1985", "unstructured": "McGourty, J. C., Silas, J. H., Fleming, J. J., McBurney, A., and Ward, J. W., 1985, Pharmacokinetics and beta-blocking effects of timolol in poor and extensive metabolizers of debrisoquin, Clin. Pharmacol. Ther. 38: 409\u2013413.", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "14_CR270", "doi-asserted-by": "publisher", "first-page": "329", "DOI": "10.1111/j.1365-2125.1985.tb02651.x", "volume": "19", "author": "RV Lewis", "year": "1985", "unstructured": "Lewis, R. V., Lennard, M. S., Jackson, P. R., Tucker, G. T., Ramsay, L. E., and Woods, H. E, 1985, Timolol and atenolol: Relationships between oxidation phenotype, pharmacokinetics and pharmacodynamics, Br. J. Clin. Pharmacol. 19: 329\u2013333.", "journal-title": "Br. J. Clin. Pharmacol"}, {"key": "14_CR271", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1016/0024-3205(84)90332-1", "volume": "34", "author": "SV Otton", "year": "1984", "unstructured": "Otton, S. V., Inaba, T., and Kalow, W., 1984, Competitive inhibition of sparteine oxidation in human liver by (3-adrenoceptor antagonists and other cardiovascular drugs, Life Sci. 34: 73\u201380.", "journal-title": "Life Sci"}, {"key": "14_CR272", "doi-asserted-by": "publisher", "first-page": "3829", "DOI": "10.1016/0006-2952(88)90063-9", "volume": "37", "author": "R Fonne-Pfister", "year": "1988", "unstructured": "Fonne-Pfister, R., and Meyer, U. A., 1988, Xenobiotic and endobiotic inhibitors of cytochrome P-450db1 function, the target of the debrisoquine/sparteine type polymorphism, Biochem. Pharmacol. 37: 3829\u20133835.", "journal-title": "Biochem. Pharmacol"}, {"key": "14_CR273", "doi-asserted-by": "publisher", "first-page": "1136", "DOI": "10.1021/jm00061a004", "volume": "36", "author": "GR Strobl", "year": "1993", "unstructured": "Strobl, G. R., von Kruedener, S., St\u00f6ckigt, J., Guengerich, F. P., and Wolff, T., 1993, Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: Molecular modeling and inhibition studies, J. Med. Chem. 36: 1136\u20131145.", "journal-title": "J. Med. Chem"}, {"key": "14_CR274", "doi-asserted-by": "publisher", "first-page": "199", "DOI": "10.1111/j.1365-2125.1986.tb05251.x", "volume": "22", "author": "T Inaba", "year": "1986", "unstructured": "Inaba, T., Tyndale, R. E., and Mahon, W. A., 1986, Quinidine: Potent inhibition of sparteine and debrisoquine oxidation in vivo, Br. J. Clin. Pharmacol. 22: 199\u2013200.", "journal-title": "Br. J. Clin. Pharmacol"}, {"key": "14_CR275", "doi-asserted-by": "publisher", "first-page": "739", "DOI": "10.1007/BF00615971", "volume": "29", "author": "T Leemann", "year": "1986", "unstructured": "Leemann, T., Dayer, P., and Meyer, U. A., 1986, Single-dose quinidine treatment inhibits metoprolol oxidation in extensive metabolizers, Eur. J. Clin. Pharmacol. 29: 739\u2013741.", "journal-title": "Eur. J. Clin. Pharmacol"}, {"key": "14_CR276", "first-page": "546", "volume": "268", "author": "G Mikus", "year": "1994", "unstructured": "Mikus, G., Bochner, F., Eichelbaum, M., Horak, P., Somogyi, A. A., and Spector, S., 1994, Endogenous codeine and morphine in poor and extensive metabolisers of the YP2D6 (debrisoquine/sparteine) polymorphism, J. Pharmacol. Exp. Ther. 268: 546\u2013551.", "journal-title": "J. Pharmacol. Exp. Ther"}, {"key": "14_CR277", "doi-asserted-by": "publisher", "first-page": "2211", "DOI": "10.1093/carcin/12.12.2211", "volume": "12", "author": "SA Islam", "year": "1991", "unstructured": "Islam, S. A., Wolf, C. R., Lennard, M. S., and Sternberg, M.J.E., 1991, A three-dimensional molecular template for substrates of human cytochrome P450 involved in debrisoquine 4-hydroxylation, Carcinogenesis\n                        12: 2211\u20132219.", "journal-title": "Carcinogenesis"}, {"key": "14_CR278", "doi-asserted-by": "publisher", "first-page": "211", "DOI": "10.1021/tx00026a010", "volume": "5", "author": "L Koymans", "year": "1992", "unstructured": "Koymans, L., Vermeulen, N.P.E., van Acker, S.A.B.E., te Koppele, J. M., Heykants, J.J.P., Lavrijsen, K., Meuldermans, W., and Donn\u00e9-Op den Kelder, G. M., 1992, A predictive model for substrates of cytochrome P450-debrisoquine (2D6), Chem. Res. Toxicol. 5: 211\u2013219.", "journal-title": "Chem. Res. Toxicol"}, {"key": "14_CR279", "first-page": "287", "volume": "30", "author": "FP Guengerich", "year": "1986", "unstructured": "Guengerich, F. P., M\u00fcller-Enoch, D., and Blair, I. A., 1986, Oxidation of quinidine by human liver cytochrome P-450, Mol. Pharmacol. 30: 287\u2013295.", "journal-title": "Mol. Pharmacol"}, {"key": "14_CR280", "doi-asserted-by": "publisher", "first-page": "2071", "DOI": "10.1021/bi00431a016", "volume": "28", "author": "TL Macdonald", "year": "1989", "unstructured": "Macdonald, T. L., Gutheim, W.G., Martin, R. B., and Guengerich, F. P., 1989, Oxidation of substituted N,N-dimethylanilines by cytochrome P-450: Estimation of the effective oxidation\u2014reduction potential of cytochrome P-450, Biochemistry\n                        28: 2071\u20132077.", "journal-title": "Biochemistry"}, {"key": "14_CR281", "doi-asserted-by": "publisher", "first-page": "424", "DOI": "10.1016/0003-9861(90)90741-G", "volume": "276", "author": "HB Niznik", "year": "1990", "unstructured": "Niznik, H. B., Tyndale, R. F., Sallee, E R., Gonzalez, F. J., Hardwick, J. P., Inaba, T., and Kalow, W., 1990, The dopamine transporter and cytochrome P450I1D1 (debrisoquine 4-hydroxylase) in brain: Resolution and identification of two distinct [1H]GBR-12935 binding proteins, Arch. Biochem. Biophys. 276: 424\u2013432.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR282", "first-page": "164", "volume": "66", "author": "FJ Gonzalez", "year": "1990", "unstructured": "Gonzalez, F. J., and Nebert, D. W., 1990, Evolution of the P450 gene superfamily: Animal\u2014plant `warfare,\u2019 molecular drive and human genetic differences in drug oxidation, Trends Genet. 66: 164\u2013168.", "journal-title": "Trends Genet"}, {"key": "14_CR283", "doi-asserted-by": "publisher", "first-page": "331", "DOI": "10.1016/0304-3835(81)90099-9", "volume": "11", "author": "JR Idle", "year": "1981", "unstructured": "Idle, J. R., Mahgoub, A., Sloan, T. P., Smith, R. L., Mbanefo, C. O., andBababunmi, E. A., 1981, Some observations on the oxidation phenotype status of Nigerian patients presenting with cancer, Cancer Lett. 11: 331\u2013338.", "journal-title": "cancer, Cancer Lett"}, {"key": "14_CR284", "doi-asserted-by": "publisher", "first-page": "1213", "DOI": "10.1016/S0140-6736(85)90743-3", "volume": "11", "author": "A Barbeau", "year": "1985", "unstructured": "Barbeau, A., Roy, M., Paris, S., Cloutier, T., Plasse, L., and Poirier, J., 1985, Ecogenetics of Parkinson\u2019s disease: 4-Hydroxylation of debrisoquine, Lancet 11: 1213\u20131215.", "journal-title": "Lancet"}, {"key": "14_CR285", "doi-asserted-by": "publisher", "first-page": "653", "DOI": "10.1111/j.1365-2125.1990.tb03832.x", "volume": "30", "author": "AR Boobis", "year": "1990", "unstructured": "Boobis, A. R., and Davies, D. S., 1990, Debrisoquine oxidation phenotype and susceptibility to lung cancer, Br. J. Clin. Pharmacol. 30: 653\u2013656.", "journal-title": "Br. J. Clin. Pharmacol"}, {"key": "14_CR286", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.1016/0140-6736(92)93266-P", "volume": "340", "author": "H Vallada", "year": "1992", "unstructured": "Vallada, H., Collier, D., Dawson, E., Owen, M., Nanko, S., Murray, R, and Gill, M., 1992, Debrisoquine 4-hydroxylase (CYP2D) locus and possible susceptibility to schizophrenia, Lancet\n                        340: 181\u2013182.", "journal-title": "Lancet"}, {"key": "14_CR287", "doi-asserted-by": "publisher", "first-page": "270", "DOI": "10.1016/0003-9861(91)90134-5", "volume": "291", "author": "X Ding", "year": "1991", "unstructured": "Ding, X., Pemecky, S. J., and Coon, M. J., 1991, Purification and characterization of cytochrome P450 2E2 from hepatic microsomes of neonatal rabbits, Arch. Biochem. Biophys. 291: 270\u2013276.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR288", "doi-asserted-by": "crossref", "first-page": "724", "DOI": "10.1096/fasebj.6.2.1537462", "volume": "6", "author": "DR Koop", "year": "1992", "unstructured": "Koop, D. R., 1992, Oxidative and reductive metabolism by cytochrome P450 2E1, FASEB J. 6: 724\u2013730.", "journal-title": "FASEB J"}, {"key": "14_CR289", "doi-asserted-by": "publisher", "first-page": "147", "DOI": "10.3109/03602539009041082", "volume": "22", "author": "CS Yang", "year": "1990", "unstructured": "Yang, C. S., Yoo, J.S.H., Ishizaki, H., and Hong, J., 1990, Cytochrome P4501IE1: Roles in nitrosamine metabolism and mechanisms of regulation, Drug Metab. Rev. 22: 147\u2013159.", "journal-title": "Drug Metab. Rev"}, {"key": "14_CR290", "doi-asserted-by": "publisher", "first-page": "113", "DOI": "10.1620/tjem.168.113", "volume": "168", "author": "F Uematsu", "year": "1992", "unstructured": "Uematsu, F., Kikuchi, H., Motomiya, M., Abe, T., Ishioka, C., Kanamaru, R, Sagami, I., and Watanabe, M., 1992, Human cytochrome P450I1E1 gene: Dral polymorphism and susceptibility to cancer, Tohoku J. Exp. Med. 168: 113\u2013117.", "journal-title": "Tohoku J. Exp. Med"}, {"key": "14_CR291", "doi-asserted-by": "publisher", "first-page": "566", "DOI": "10.1021/tx00018a012", "volume": "3", "author": "R Peter", "year": "1990", "unstructured": "Peter, R., B\u00f6cker, R. G., Beaune, P. H., Iwasaki, M., Guengerich, F. P., and Yang, C.-S., 1990, Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450 IIEi, Chem. Res. Toxicol. 3: 566\u2013573.", "journal-title": "Chem. Res. Toxicol"}, {"key": "14_CR292", "first-page": "1189", "volume": "256", "author": "FP Guengerich", "year": "1991", "unstructured": "Guengerich, F. P., and Turvy, C. G., 1991, Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples, J. Pharmacol. Exp. Ther. 256: 1189\u20131194.", "journal-title": "J. Pharmacol. Exp. Ther"}, {"key": "14_CR293", "doi-asserted-by": "publisher", "first-page": "132", "DOI": "10.1016/0003-9861(90)90422-U", "volume": "281", "author": "JY Hong", "year": "1990", "unstructured": "Hong, J. Y., Ning, S. M., Ma, B. L., Lee, M. J., Pan, J., and Yang, C. S., 1990, Roles of pituitary hormones in the regulation of hepatic cytochrome P45011E1 in rats and mice, Arch. Biochem. Biophys. 281: 132\u2013138.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR294", "doi-asserted-by": "publisher", "first-page": "110", "DOI": "10.1016/0003-9861(92)90251-Q", "volume": "299", "author": "J Pan", "year": "1992", "unstructured": "Pan, J., Hong, J. Y., and Yang, C. S., 1992, Post-transcriptional regulation of mouse renal cytochrome P450 2E1 by testosterone, Arch. Biochem. Biophys. 299: 110\u2013115", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR295", "doi-asserted-by": "publisher", "first-page": "383", "DOI": "10.1111/j.1432-1033.1991.tb16026.x", "volume": "198", "author": "MJJ Ronis", "year": "1991", "unstructured": "Ronis, M.J.J., Johansson, I., Hultenby, K., Lagercrantz, J., Glaumann, H., and Ingelman-Sundberg, M., 1991, Acetone-regulated synthesis and degradation of cytochrome P4502E and cytochrome P4502B1 in rat liver, Eur. J. Biochem. 198: 383\u2013389.", "journal-title": "Eur. J. Biochem"}, {"key": "14_CR296", "doi-asserted-by": "publisher", "first-page": "375", "DOI": "10.1016/0006-291X(84)91563-8", "volume": "124", "author": "M Ingelman-Sundberg", "year": "1984", "unstructured": "Ingelman-Sundberg, M., and J\u00f6rnvall, H., 1984, Induction of the ethanol-inducible form of rabbit liver microsomal cytochrome P450 by inhibitors of alcohol dehydrogenase, Biochem. Biophys. Res. Commun. 124: 375\u2013382.", "journal-title": "Biochem. Biophys. Res. Commun"}, {"key": "14_CR297", "first-page": "10667", "volume": "261", "author": "FJ Gonzalez", "year": "1986", "unstructured": "Gonzalez, F. J., Kimura, S., Song, B. J., Pastewka, J., Gelboin, H. V., and Hardwick, J. P., 1986, Sequence of two related P450 mRNAs transcriptionally increased during rat development, J. Biol. Chem. 261: 10667\u201310672.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR298", "first-page": "3568", "volume": "264", "author": "BJ Song", "year": "1989", "unstructured": "Song, B. J., Veech, R. L., Park, S. S., Gelboin, H. V., and Gonzalez, E. J., 1989, Induction of rat hepatic N-nitrosodimethylamine demethylase by acetone is due to protein stabilization, J. Biol. Chem. 264: 3568\u20133572.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR299", "doi-asserted-by": "publisher", "first-page": "549", "DOI": "10.1111/j.1365-2362.1989.tb00273.x", "volume": "19", "author": "N Perrot", "year": "1989", "unstructured": "Perrot, N., Nalpas, B., Yang, C. S., and Beaune, R H., 1989, Modulation of cytochrome P450 isozymes in human liver, by ethanol and drug intake, Eur. J. Clin. Invest. 19: 549\u2013555.", "journal-title": "Eur. J. Clin. Invest"}, {"key": "14_CR300", "doi-asserted-by": "crossref", "first-page": "559", "DOI": "10.1093/oxfordjournals.jbchem.a123619", "volume": "110", "author": "S Hayashi", "year": "1991", "unstructured": "Hayashi, S., Watanabe, J., and Kawajiri, K., 1991, Genetic polymorphisms in the 5\u2019-flanking region change transcriptional regulation of the human P450IIE1 gene, J. Biochem. 110: 559\u2013565.", "journal-title": "J. Biochem"}, {"key": "14_CR301", "doi-asserted-by": "publisher", "first-page": "163", "DOI": "10.1016/0003-9861(92)90258-X", "volume": "299", "author": "CJ Patten", "year": "1992", "unstructured": "Patten, C. J., Ishizaki, H., Aoyama, T., Lee, M., Ning, S. M., Huang, W., Gonzalez, F. J., and Yang, C. S., 1992, Catalytic properties of the human cytochrome P450 2E1 produced by cDNA expression in mammalian cells, Arch. Biochem. Biophys. 299: 163\u2013171.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR302", "doi-asserted-by": "publisher", "first-page": "735", "DOI": "10.1111/j.1432-1033.1993.tb17975.x", "volume": "214", "author": "J Mapoles", "year": "1993", "unstructured": "Mapoles, J., Berthou, F., Alexander, A., Simon, F., and M\u00e9nez, J.-F., 1993, Mammalian PC-12 cell genetically engineered for human cytochrome P450 2E1 expression, Eur. J. Biochem. 214: 735\u2013745.", "journal-title": "Eur. J. Biochem"}, {"key": "14_CR303", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1016/0304-4165(92)90093-A", "volume": "1156", "author": "DK Winters", "year": "1992", "unstructured": "Winters, D. K., and Cederbaum, A. I., 1992, Expression of a catalytically active human cytochrome P-4502E1 in Escherichia coli, Biochem. Biophys. Acta\n                        1156: 43\u201349.", "journal-title": "Escherichia coli, Biochem. Biophys. Acta"}, {"key": "14_CR304", "first-page": "3373", "volume": "47", "author": "D Wade", "year": "1987", "unstructured": "Wade, D., Yang, C. S., Metral, C. J., Roman, J. M., Hrabie, J. A., Riggs, C. W., Anjo, T., Keefer, L. K., and Mico, B. A., 1987, Deuterium isotope effect on denitrosation and demethylation of N-nitrosodimethylamine by rat liver microsomes, Cancer Res. 47: 3373\u20133377.", "journal-title": "Cancer Res"}, {"key": "14_CR305", "doi-asserted-by": "publisher", "first-page": "408", "DOI": "10.1021/tx00022a002", "volume": "4", "author": "CS Yang", "year": "1991", "unstructured": "Yang, C. S., Ishizaki, H., Lee, M., Wade, D., and Fadel, A., 1991, Deuterium isotope effect in the interaction of N-nitrosodimethylamine, ethanol, and related compounds with cytochrome P-450IIE1, Chem. Res. Toxicol. 4: 408\u2013413.", "journal-title": "Chem. Res. Toxicol"}, {"key": "14_CR306", "doi-asserted-by": "publisher", "first-page": "158", "DOI": "10.1006/taap.1994.1193", "volume": "128", "author": "ME Andersen", "year": "1993", "unstructured": "Andersen, M. E., Clewell, H. J., III, Mahle, D. A., and Gearhart, J. M., 1993, Deuterium isotope effects of dichloromethane in vivo and the mechanism of substrate oxidation by cytochrome P450 2E1, Toxicol. Appl. Pharmacol. 128: 158\u2013165.", "journal-title": "Toxicol. Appl. Pharmacol"}, {"key": "14_CR307", "author": "ED Kharasch", "first-page": "143", "year": "1993", "unstructured": "Kharasch, E. D., Thummel, K. E., and Mautz, D., 1993, Human enflurane metabolism in vivo by cytochrome P450 2E1, in: Abstracts, 5th North American ISSX Meeting (October 17\u201321, Tucson), Vol. 4, p. 143.", "volume-title": "Abstracts, 5th North American ISSX Meeting (October 17-21, Tucson)"}, {"key": "14_CR308", "first-page": "359", "volume": "56", "author": "D O\u2019Shea", "year": "1994", "unstructured": "O\u2019Shea, D., Davis, S. N., Kim, R. B., and Wilkinson, G. R., 1994, Effect of fasting and obesity in humans on the 6-hydroxylation of chloroxazone\u2014A putative probe of CYP2E1 activity, Clin. Pliarrnacol. The,. 56: 359\u2013367.", "journal-title": "Clin. Pliarrnacol. The"}, {"key": "14_CR309", "author": "DM Ziegler", "year": "1988", "unstructured": "Ziegler, D. M., 1988, Flavin-containing monooxygenases: Catalytic mechanism and substrate specificities, Drug Metab. Rev. 19:1\u201332.", "volume-title": "Flavi 19:1-32"}, {"key": "14_CR310", "first-page": "21569", "volume": "268", "author": "SK Lee", "year": "1993", "unstructured": "Lee, S. K., Nesheim, J. C., and Lipscomb, J. D., 1993, Transient intermediates of the methane monooxygenase catalytic cycle, J. Biol. Chem. 268: 21569\u201321577.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR311", "doi-asserted-by": "publisher", "first-page": "1293", "DOI": "10.1093/carcin/11.8.1293", "volume": "11", "author": "CL Crespi", "year": "1990", "unstructured": "Crespi, C. L., Penman, B. W., Leakey, J. A., Arlotto, M. R, Stark, A., Parkinson, A., Turner, T., Steimel, D. T., Rudo, K., Davies, R. L., and Langenbach, R., 1990, Human cytochrome P4501IA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P4501IE1, Carcinogenesis\n                        11: 1293\u20131300.", "journal-title": "Carcinogenesis"}, {"key": "14_CR312", "doi-asserted-by": "publisher", "first-page": "5491", "DOI": "10.1021/bi00475a012", "volume": "29", "author": "PT Nhamburo", "year": "1990", "unstructured": "Nhamburo, P. T., Kimura, S., McBride, O. W., Kozak, C. A., Gelboin, H. V., and Gonzalez, F. J., 1990, The human CYP2F gene subfamily: Identification of a cDNA encoding a new cytochrome P450, cDNA-directed expression, and chromosome mapping, Biochemistry\n                        29: 5491\u20135499.", "journal-title": "Biochemistry"}, {"key": "14_CR313", "doi-asserted-by": "publisher", "first-page": "289", "DOI": "10.1080/15287399309531795", "volume": "40", "author": "FJ Gonzalez", "year": "1993", "unstructured": "Gonzalez, F. J., and Gelboin, H. V., 1993, Role of human cytochrome P-450s in risk assessment and susceptibility to environmentally based disease, J. Toxicol. Environ. Health\n                        40: 289\u2013308.", "journal-title": "J. Toxicol. Environ. Health"}, {"key": "14_CR314", "author": "FP Guengerich", "year": "1994", "unstructured": "Guengerich, F. P., Gillam, E. M. J., Martin, M. V., Baba, T., Kim, B. R., Shimada, T., Raney, K. D., and Yun, C. H., 1994, The importance of cytochrome P450 3A enzymes in drug metabolism, in: Schering Foundation Workshop, Assessment of the Use of Single Cytochrome P450 Enzymes in Drug Research (March 23\u201325, Springer-Verlag Berlin), pp 161\u2013186.", "volume-title": "The importance pp 161-186"}, {"key": "14_CR315", "doi-asserted-by": "publisher", "first-page": "467", "DOI": "10.1097/00000542-199209000-00011", "volume": "77", "author": "C-H Yun", "year": "1992", "unstructured": "Yun, C.-H., Wood, M., Wood, A. J. J., and Guengerich, F. P., 1992, Identification of the pharmacogenetic determinants of alfentanil metabolism: Cytochrome P-450 3A4. An explanation of the variable elimination clearance, Anesthesiology\n                        77: 467\u2013474.", "journal-title": "Anesthesiology"}, {"key": "14_CR316", "author": "G Gillet", "first-page": "47", "year": "1993", "unstructured": "Gillet, G., Pichard, L., Filali-Ansary, A., Th\u00e9not, J. P., and Maurel, P., 1993, Identification of the major cytochromes P450 involved in the formation of plasma metabolites of alpidem in man, in: Abstracts, 5th European ISSX Meeting (September 26\u201329, Tours) Vol. 3, p. 47.", "volume-title": "Abstracts, 5th European ISSX Meeting (September 26-29, Tours)"}, {"key": "14_CR317", "first-page": "978", "volume": "21", "author": "G Fabre", "year": "1993", "unstructured": "Fabre, G., Julian, B., Saint-Aubert, B., Joyeux, H., and Berger, Y., 1993, Evidence for CYP3A-mediated N-deethylation of aminodarone in human liver microsomal fractions, Drug Metab. Dispos. 21: 978\u2013985.", "journal-title": "Drug Metab. Dispos"}, {"key": "14_CR318", "doi-asserted-by": "publisher", "first-page": "1838", "DOI": "10.1021/jm00110a012", "volume": "34", "author": "ER Guengerich", "year": "1991", "unstructured": "Guengerich, E R, Brian, W. R., Iwasaki, M., Sari, M.-A., B\u00e4\u00e4rnhielm, C., and Berntsson, R, 1991, Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 II1A4, J. Med. Chem. 34: 1838\u20131844.", "journal-title": "J. Med. Chem"}, {"key": "14_CR319", "author": "R Andersson", "first-page": "236", "year": "1993", "unstructured": "Andersson, R, and J\u00f6nsson, G., 1993, The metabolism of budesonide in human liver is catalysed by cytochrome P450 3A isoenzymes, in: Abstracts, 5th North American ISSX Meeting (October 17\u201321, Tucson), Vol. 4, p. 236.", "volume-title": "Abstracts, 5th North American ISSX Meeting (October 17-21, Tucson)"}, {"key": "14_CR320", "author": "G J\u00f6nsson", "year": "1993", "unstructured": "J\u00f6nsson, G., Andersson, P., and \u00c4str\u00f6m, A., 1993, Budesonide is metabolised by cytochrome P4503A isoenzymes in human liver, in: 8th International Conference on Cytochrome P450: Biochemistry, Biophysics, and Molecular Biology (October 24\u201328, Lisbon), p. 242.", "volume-title": "Budesonide 242"}, {"key": "14_CR321", "doi-asserted-by": "publisher", "first-page": "35", "DOI": "10.1016/0926-6917(94)90078-7", "volume": "270", "author": "R Pellinen", "year": "1994", "unstructured": "Pellinen, R, Honkakoski, P., Stenb\u00e4ck, F., Niemitz, M., Alhava, E., Pelkonen, O., Lang, M., and Pasanen, M., 1994, Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitors, Eur. J. Pharmacol. Environ. Toxicol. Pharmacol. Sect. 270: 35\u201343.", "journal-title": "Eur. J. Pharmacol. Environ. Toxicol. Pharmacol. Sect"}, {"key": "14_CR322", "first-page": "373", "volume": "28", "author": "C Ged", "year": "1989", "unstructured": "Ged, C., Rouillon, J. M., Pichard, L., Combalbert, J., Bressot, N., Bories, R. Michel, H., Beaune, R, and Maurel, R, 1989, The increase in urinary excretion of 6\u00df-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction, Br. J. Clin. Pharmacol. 28: 373\u2013387.", "journal-title": "The increase in urinary excretion of 6\u00df-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction, Br. J. Clin. Pharmacol"}, {"key": "14_CR323", "doi-asserted-by": "crossref", "first-page": "11280", "DOI": "10.1021/bi00503a018", "volume": "29", "author": "WR Brian", "year": "1990", "unstructured": "Brian, W. R., Sari, M.-A., Iwasaki, M., Shimada, T., Kaminsky, L. S., and Guengerich, F. R, 1990, Catalytic activities of human liver cytochrome P-450 111A4 expressed in Saccharomyces cerevisiae, Biochemistry\n                        29: 11280\u201311292.", "journal-title": "Saccharomyces cerevisiae, Biochemistry"}, {"key": "14_CR324", "author": "DJ Waxman", "year": "1993", "unstructured": "Waxman, D. J., Chang, T.K.H., and Chen, G., 1993, Role of individual human liver P450s and other enzymes in anti-cancer drug metabolism: Drug activation and drug resistance mechanisms, in: 8th International Conference on Cytochrome P450: Biochemistry, Biophysics, and Molecular Biology (October 24\u201328, Lisbon), p. 71.", "volume-title": "Role of individual 71"}, {"key": "14_CR325", "first-page": "197", "volume": "17", "author": "J Combalbert", "year": "1989", "unstructured": "Combalbert, J., Fabre, I., Fabre, G., Dalet, I., Derancourt, J., Cano, J. R, and Maurel, P., 1989, Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily, Drug Metab. Dispos. 17: 197\u2013207.", "journal-title": "Drug Metab. Dispos"}, {"key": "14_CR326", "doi-asserted-by": "publisher", "first-page": "630", "DOI": "10.1038/clpt.1988.87", "volume": "43", "author": "T Kronbach", "year": "1988", "unstructured": "Kronbach, T., Fischer, V., and Meyer, U. A., 1988, Cyclosporine metabolism in human liver: Identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs, Clin. Pharmacol. Ther. 43: 630\u2013635.", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "14_CR327", "first-page": "975", "volume": "41", "author": "CM Fleming", "year": "1992", "unstructured": "Fleming, C. M., Branch, R. A., Wilkinson, G. R., and Guengerich, F. R, 1992, Human liver microsomal N-hydroxylation of dapsone by cytochrome P450 3A4, Mol. Pharmacol. 41: 975\u2013980.", "journal-title": "Mol. Pharmacol"}, {"key": "14_CR328", "doi-asserted-by": "publisher", "first-page": "5901", "DOI": "10.1016/S0040-4039(00)97989-9", "volume": "31", "author": "MA Chauncey", "year": "1990", "unstructured": "Chauncey, M. A., and Ninomiya, S., 1990, Metabolic studies with model cytochrome P-450 systems, Tetrahedron Lett. 31: 5901\u20135904.", "journal-title": "Tetrahedron Lett"}, {"key": "14_CR329", "author": "JC Stevens", "first-page": "66", "year": "1993", "unstructured": "Stevens, J. C., Berger, R. L., and Bordeaux, K. G., 1993, Metabolism of ebastine by human liver microsomes and cDNA-expressed cytochrome P450 forms, in: Abstracts, 5th European ISSX Meeting (September 26\u201329, Tours), Vol. 3, p. 66.", "volume-title": "Abstracts, 5th European ISSX Meeting (September 26-29, Tours)"}, {"key": "14_CR330", "first-page": "56", "volume": "20", "author": "SE Ball", "year": "1992", "unstructured": "Ball, S. E., Maurer, G., Zollinger, M., Ladona, M., and Vickers, A. E. M., 1992, Characterization of the cytochrome P-450 gene family responsible for the N-dealkylation of the ergot alkaloid CQA 206\u2013291 in humans, Drug Metab. Dispos. 20: 56\u201363.", "journal-title": "Drug Metab. Dispos"}, {"key": "14_CR331", "doi-asserted-by": "publisher", "first-page": "1745", "DOI": "10.1016/0006-2952(92)90068-T", "volume": "44", "author": "V Kerlan", "year": "1992", "unstructured": "Kerlan, V., Dreano, Y., Bercovici, J. R, Beaune, P. H., Foch, H. H., and Berthou, F., 1992, Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes, Biochem. Pharmacol. 44: 1745\u20131756.", "journal-title": "Biochem. Pharmacol"}, {"key": "14_CR332", "doi-asserted-by": "publisher", "first-page": "160", "DOI": "10.1016/0003-9861(91)90602-F", "volume": "290", "author": "DJ Waxman", "year": "1991", "unstructured": "Waxman, D. J., Lapenson, D. P., Aoyama, T., Gelboin, H. V., Gonzalez, F. J., and Korzekwa, K., 1991, Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s, Arch. Biochem. Biophys. 290: 160\u2013166.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR333", "first-page": "500", "volume": "33", "author": "FR Guengerich", "year": "1988", "unstructured": "Guengerich, F. R, 1988, Oxidation of 17a-ethynylestradiol by human liver cytochrome P-450, Mol. Pharmscol. 33: 500\u2013508.", "journal-title": "Pharmscol"}, {"key": "14_CR334", "first-page": "753", "volume": "20", "author": "M Sattler", "year": "1992", "unstructured": "Sattler, M., Guengerich, F. R, Yun, C.-H., Christians, U., and Sewing, K. F., 1992, Human and rat liver microsomal cytochrome P450 3A enzymes are involved in biotransformation of FK506 and rapamyein, Drug Metab. Dispos. 20: 753\u2013761.", "journal-title": "Drug Metab. Dispos"}, {"key": "14_CR335", "doi-asserted-by": "publisher", "first-page": "454", "DOI": "10.1016/0003-9861(92)90711-5", "volume": "294", "author": "SH Vincent", "year": "1992", "unstructured": "Vincent, S. H., Karanam, B. V., Painter, S. K., and Chiu, S.H.L., 1992, In vitro metabolism of FK-506 in rat, rabbit, and human liver microsomes: Identification of a major metabolite and of cytochrome P450 3A as the major enzymes responsible for its metabolism, Arch. Biochem. Biophys. 294: 454\u2013460.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR336", "first-page": "421", "volume": "46", "author": "MJ Bargetzi", "year": "1989", "unstructured": "Bargetzi, M. J., Aoyama, T., Gonzalez, F. J., and Meyer, U. A., 1989, Lidocaine metabolism in human liver microsomes by cytochrome P450II1A4, Clin. Pharniacol. Ther. 46: 421\u2013427.", "journal-title": "Clin. Pharniacol. Ther"}, {"key": "14_CR337", "first-page": "1385", "volume": "255", "author": "S Imaoka", "year": "1990", "unstructured": "Imaoka, S., Enomoto, K., Oda, Y., Asada, A., Fujimori, M., Shimada, T., Fujita, S., Guengerich, F. R, and Funae, Y., 1990, Lidocaine metabolism by human cytochrome P-450s purified from hepatic microsomes: Comparison of those with rat hepatic cytochrome P-450s, J. Pharmacol. Exp. Ther. 255: 1385\u20131391.", "journal-title": "J. Pharmacol. Exp. Ther"}, {"key": "14_CR338", "author": "KP Vyas", "first-page": "35", "year": "1993", "unstructured": "Vyas, K. P., Kari, R. H., Pitzenberger, S. M., Wang, R. W., and Lu, A. Y. H., 1993, Identification of 3\u2019,5\u2019-dihydro-3\u2019,5\u2019-diol-A4-lovastatin as a new cytochrome P450 3A catalyzed metabolite of lovastatin in rat and human liver microsomes, in: Abstracts, 5th North American ISSX Meeting (October 17\u201321, Tucson), Vol. 4, p. 35.", "volume-title": "Abstracts, 5th North American ISSX Meeting (October 17-21, Tucson)"}, {"key": "14_CR339", "first-page": "89", "volume": "36", "author": "T Kronbach", "year": "1989", "unstructured": "Kronbach, T., Mathys, D., Umeno, M., Gonzalez, F. J., and Meyer, U. A., 1989, Oxidation of midazolam and triazolam by human liver cytochrome P450111A4, Mol. Pharmacol. 36: 89\u201396.", "journal-title": "Mol. Pharmacol"}, {"key": "14_CR340", "doi-asserted-by": "publisher", "first-page": "1596", "DOI": "10.1021/jm00159a007", "volume": "29", "author": "RH B\u00f6cker", "year": "1986", "unstructured": "B\u00f6cker, R. H., and Guengerich, F. R, 1986, Oxidation of 4-aryl-and 4-alkyl-substituted 2,6-dimethyl3,5-bis(alkoxycarbonyl)-1,4-dihydropyridines by human liver microsomes and immunochemical evidence for the involvement of a form of cytochrome P-450, J. Med. Chem. 29: 1596\u20131603.", "journal-title": "J. Med. Chem"}, {"key": "14_CR341", "author": "T Andersson", "first-page": "45", "year": "1993", "unstructured": "Andersson, T., Miners, J. O., Veronese, M. E., and Birkett, D. J., 1993, Primary and secondary metabolism of omeprazole in human liver microsomes, in: Abstracts, 5th European ISSX Meeting (September 26\u201329, Tours), Vol. 3, p. 45.", "volume-title": "Abstracts, 5th European ISSX Meeting (September 26-29, Tours)"}, {"key": "14_CR342", "doi-asserted-by": "publisher", "first-page": "424", "DOI": "10.1016/0003-9861(88)90655-8", "volume": "263", "author": "DJ Waxman", "year": "1988", "unstructured": "Waxman, D. J., Attisano, C., Guengerich, E R, and Lapenson, D. R, 1988, Cytochrome P-450 steroid hormone metabolism catalyzed by human liver microsomes, Arch. Biochem. Biophys. 263: 424\u2013436.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR343", "author": "DJ Mulford", "first-page": "147", "year": "1993", "unstructured": "Mulford, D. J., Rodrigues, A. D., and Bopp, B. A., 1993, Identification of the human cytochrome P450 enzymes involved in the N-dealkylation of [14C]sertindole, in: Abstracts, 5th North American ISSX Meeting (October 17\u201321, Tucson), Vol. 4, p. 147.", "volume-title": "Abstracts, 5th North American ISSX Meeting (October 17-21, Tucson)"}, {"key": "14_CR344", "author": "AK Mitra", "first-page": "148", "year": "1993", "unstructured": "Mitra, A. K., Kalhorn, T. F., Thummel, K. E., Unadkat, J. D., and Slattery, J. T., 1993, Metabolism of arylamines by human liver microsomal cytochrome P450(s), in: Abstracts, 5th North American ISSX Meeting (October 17\u201321, Tucson), Vol. 4, p. 148.", "volume-title": "Abstracts, 5th North American ISSX Meeting (October 17-21, Tucson)"}, {"key": "14_CR345", "doi-asserted-by": "publisher", "first-page": "1911", "DOI": "10.1016/0006-2952(91)90131-N", "volume": "41", "author": "F Jacolot", "year": "1991", "unstructured": "Jacolot, F., Simon, I., Dreano, Y., Beaune, P., Riche, C., and Berthou, F., 1991, Identification of the cytochrome P450111A family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes, Biochem. Pharmacol. 41: 1911\u20131919.", "journal-title": "Biochem. Pharmacol"}, {"key": "14_CR346", "author": "GN Kumar", "first-page": "145", "year": "1993", "unstructured": "Kumar, G. N., Thornburg, K. R., Walle, U. K., and Walle, T., 1993, Evidence for human liver microsomal CYP 3A mediated hydroxylation of taxol, in: Abstracts, 5th North American ISSX Meeting (October, Tucson), Vol. 4, p 145.", "volume-title": "Abstracts, 5th North American ISSX Meeting (October, Tucson)"}, {"key": "14_CR347", "first-page": "403", "volume": "21", "author": "CH Yun", "year": "1993", "unstructured": "Yun, C. H., Okerholm, R. A., and Guengerich, F. R, 1993, Oxidation of the antihistaminic drug terfenadine in human liver microsomes: Role of cytochrome P450 3A(4) in N-dealkylation and C-hydroxylation, Drug Metab. Dispos. 21: 403\u2013409.", "journal-title": "Drug Metab. Dispos"}, {"key": "14_CR348", "first-page": "10388", "volume": "264", "author": "T Aoyama", "year": "1989", "unstructured": "Aoyama, T., Yamano, S., Waxman, D. J., Lapenson, D. R, Meyer, U. A., Fischer, V., Tyndale, R, Inaba, T., Kalow, W., Gelboin, H. V., and Gonzalez, E J., 1989, Cytochrome P-450 hPCN3, a novel cytochrome P450 IIIA gene product that is differentially expressed in adult human liver, J. Biol. Chem. 264: 10388\u201310395.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR349", "doi-asserted-by": "publisher", "first-page": "889", "DOI": "10.1111/j.1432-1033.1990.tb19483.x", "volume": "194", "author": "JP Renaud", "year": "1990", "unstructured": "Renaud, J. P., Cullin, C., Pompon, D., Beaune, P., and Mansuy, D., 1990, Expression of human liver cytochrome P450 IIIA4 in yeast: A functional model for the hepatic enzyme, Eur. J. Biochem. 194: 889\u2013896.", "journal-title": "Eur. J. Biochem"}, {"key": "14_CR350", "doi-asserted-by": "crossref", "first-page": "332", "DOI": "10.1007/BF00169164", "volume": "348", "author": "HK Kroemer", "year": "1993", "unstructured": "Kroemer, H. K., Gautier, J.-C., Beaune, P., Henderson, C., and Wolf, C. R., 1993, Identification of P450 enzymes involved in metabolism of verapamil in humans, Naunyn-Schmiedebergs Arch. Pharmacol. 348: 332\u2013337.", "journal-title": "Naunyn-Schmiedebergs Arch. Pharmacol"}, {"key": "14_CR351", "author": "BJ Ring", "first-page": "36", "year": "1993", "unstructured": "Ring, B. J., Parli, C. J., George, M. C., and Wrighton, S. A., 1993, Interspecies comparison and role of CYP3A in zatosetron metabolism, in: Abstracts, 5th North American ISSX Meeting (October 17\u201321, Tucson), Vol. 4, p. 36.", "volume-title": "Abstracts, 5th North American ISSX Meeting (October 17-21, Tucson)"}, {"key": "14_CR352", "first-page": "777", "volume": "21", "author": "H Nakasa", "year": "1993", "unstructured": "Nakasa, H., Komiya, M., Ohmori, S., Rikihisa, T., and Kitada, M., 1993, Rat liver microsomal cytochrome P-450 responsible for reductive metabolism of zonisamide, Drug Metab. Dispos. 21: 777\u2013781.", "journal-title": "Drug Metab. Dispos"}, {"key": "14_CR353", "doi-asserted-by": "publisher", "first-page": "8064", "DOI": "10.1073/pnas.83.21.8064", "volume": "83", "author": "PH Beaune", "year": "1986", "unstructured": "Beaune, P. H., Umbenhauer, D. R., Bork, R. W., Lloyd, R. S., and Guengerich, E. P., 1986, Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase, Proc. Natl. Acad. Sci. USA\n                        83: 8064\u20138068.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "14_CR354", "first-page": "1279", "volume": "255", "author": "NA Elshourbagy", "year": "1980", "unstructured": "Elshourbagy, N. A., and Guzelian, P. S., 1980, Separation, purification, and characterization of a novel form of hepatic cytochrome P450 from rats treated with pregnenolone-l6a-carboni tri le, J. Biol. Chem. 255: 1279\u20131285.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR355", "doi-asserted-by": "publisher", "first-page": "5311", "DOI": "10.1073/pnas.83.14.5311", "volume": "83", "author": "DT Molowa", "year": "1986", "unstructured": "Molowa, D. T., Schuetz, E.G., Wrighton, S. A., Watkins, P. B., Kremers, P., Mendez-Picon, G., Parker, G. A., and Guzelian, P. S., 1986, Complete eDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver, Proc. Natl. Acad. Sci. USA\n                        83: 5311\u20135315.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "14_CR356", "first-page": "910", "volume": "264", "author": "RW Bork", "year": "1989", "unstructured": "Bork, R. W., Muto, T., Beaune, P. H., Srivastava, P. K., Lloyd, R. S., and Guengerich, F. P., 1989, Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity, J. Biol. Chem. 264: 910\u2013919.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR357", "first-page": "A2242", "volume": "4", "author": "J Kolars", "year": "1990", "unstructured": "Kolars, J., Schmiedelin-Ren, P., Dobbins, W., Merion, R., Wrighton, S., and Watkins, P., 1990, Heterogeneity of P-450 ILIA expression in human gut epithelia, FASEB J. 4: A2242.", "journal-title": "FASEB J"}, {"key": "14_CR358", "unstructured": "Daujat, M., Pichard, L., Fabre, I., Diaz, D., Maurice, M., Pineau, T., Blanc, P., Fabre, G., Fabre, J. M., Saint Aubert, B., and Maurel, P., 1990, Human P450IA and IIIA subfamilies: Regulation of expression and inducibility in primary cultures of human hepatocytes, in: Drug Metabolizing Enzymes: Genetics, Regulation and Toxicology, Proceedings of the Eighth International Symposium on Microsomes and Drug Oxidations (Stockholm, June 25\u201329) (M. Ingelman-Sundberg, J.-A. Gustafsson, and S. Orrenius, eds.), p. 16."}, {"key": "14_CR359", "doi-asserted-by": "publisher", "first-page": "355", "DOI": "10.1016/0003-9861(89)90449-9", "volume": "274", "author": "JD Schuetz", "year": "1989", "unstructured": "Schuetz, J. D., Molowa, D. T., and Guzelian, P. S., 1989, Characterization of a eDNA encoding a new member of the glucocorticoid-responsive cytochromes P450 in human liver, Arch. Biochem. Biophys. 274: 355\u2013365.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR360", "first-page": "97", "volume": "86", "author": "SA Wrighton", "year": "1989", "unstructured": "Wrighton, S. A., Ring, B. J., Watkins, P. B., and VandenBranden, M., 1989, Identification of a polymorphically expressed member of the human cytochrome P-450III family, Mol. Pharmacol. 86: 97\u2013105.", "journal-title": "Mol. Pharmacol"}, {"key": "14_CR361", "first-page": "207", "volume": "38", "author": "SA Wrighton", "year": "1990", "unstructured": "Wrighton, S. A., Brian, W. R., Sari, M. A., Iwasaki, M., Guengerich, E P., Raucy, J. L., Molowa, D. T., and VandenBranden, M., 1990, Studies on the expression and metabolic capabilities of human liver cytochrome P4501IIA5 (HLp3), Mol. Pharmacol. 38: 207\u2013213.", "journal-title": "Mol. Pharmacol"}, {"key": "14_CR362", "doi-asserted-by": "publisher", "first-page": "275", "DOI": "10.1016/0003-9861(85)90383-2", "volume": "241", "author": "M Kitada", "year": "1985", "unstructured": "Kitada, M., Kamataki, T., Itahashi, K., Rikihisa, T., Kato, R., and Kanakubo, Y., 1985, Purification and properties of cytochrome P-450 from homogenates of human fetal livers, Arch. Biochem. Biophys. 241: 275\u2013280.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR363", "doi-asserted-by": "publisher", "first-page": "4430", "DOI": "10.1021/bi00470a024", "volume": "29", "author": "M Komori", "year": "1990", "unstructured": "Komori, M., Nishio, K., Kitada, M., Shiramatsu, K., Muroya, K., Soma, M., Nagashima, K., and Kamataki, T., 1990, Fetus-specific expression of a form of cytochrome P-450 in human livers, Biochemistry\n                        29: 4430\u20134433.", "journal-title": "Biochemistry"}, {"key": "14_CR364", "doi-asserted-by": "publisher", "first-page": "1018", "DOI": "10.1172/JCI116607", "volume": "92", "author": "JD Schuetz", "year": "1993", "unstructured": "Schuetz, J. D., Kauma, S., and Guzelian, P. S., 1993, Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta, J. Clin. Invest. 92: 1018\u20131024.", "journal-title": "J. Clin. Invest"}, {"key": "14_CR365", "doi-asserted-by": "publisher", "first-page": "6", "DOI": "10.1016/0306-9877(92)90003-U", "volume": "37", "author": "RL Hancock", "year": "1992", "unstructured": "Hancock, R. L., 1992, Theoretical mechanisms for synthesis of carcinogen-induced embryonic proteins: XXVII. Intermediate generalizations (Part B), Med. Hypoth. 37: 6\u20131 I.", "journal-title": "Med. Hypoth"}, {"key": "14_CR366", "doi-asserted-by": "publisher", "first-page": "585", "DOI": "10.1111/j.1432-1033.1993.tb18412.x", "volume": "218", "author": "H Hashimoto", "year": "1993", "unstructured": "Hashimoto, H., Toide, K., Kitamura, R., Fujita, M., Tagawa, S., Itoh, S., and Kamataki, T., 1993, Gene structure of CYP3A4, an adult-specific form of cytochrome-P450 in human livers, and its transcriptional control, Eur. J. Biochem. 218: 585\u2013595.", "journal-title": "Eur. J. Biochem"}, {"key": "14_CR367", "unstructured": "Kelly, J. D.,Eaton, D. L., Guengerich, F. P., and Coulombe, R. A., Jr., 1995, Aflatoxin B1 activation in human lung: Role of cytochrome P450 3A, Carcinogenesis, in press."}, {"key": "14_CR368", "doi-asserted-by": "publisher", "first-page": "1488", "DOI": "10.1016/0140-6736(91)92302-I", "volume": "338", "author": "JC Kolars", "year": "1991", "unstructured": "Kolars, J. C., Awni, W. M., Merion, R. M., and Watkins, P. B., 1991, First-pass metabolism of cyclosporin by the gut, Lancet\n                        338: 1488\u20131490.", "journal-title": "Lancet"}, {"key": "14_CR369", "first-page": "493499", "volume": "33", "author": "G. E. Schwab", "year": "1988", "unstructured": "Schwab, G. E., Raney, J. L., and Johnson, E. F., 1988, Modulation of rabbit and human hepatic cytochrome P-450-catalyzed steroid hydroxylations by a-naphthoflavone, Mol. Pharmacol. 33: 493499.", "journal-title": "Mol. Pharmacol"}, {"key": "14_CR370", "doi-asserted-by": "publisher", "first-page": "6063", "DOI": "10.1021/bi00141a015", "volume": "31", "author": "S Imaoka", "year": "1992", "unstructured": "Imaoka, S., Lmai, Y., Shimada, T., and Funae, Y., 1992, Role of phospholipids in reconstituted cytochrome P450 3A forms and mechanism of their activation of catalytic activity, Biochemistry 31: 6063\u20136069.", "journal-title": "Biochemistry"}, {"key": "14_CR371", "doi-asserted-by": "publisher", "first-page": "109", "DOI": "10.1111/j.1432-1033.1992.tb17027.x", "volume": "207", "author": "MA Peyronneau", "year": "1992", "unstructured": "Peyronneau, M. A., Renaud, J. P., Truan, G., Urban, P., Pompon, D., and Mansuy, D., 1992, Optimization of yeast-expressed human liver cytochrome-P450 3A4 catalytic activities by coexpressing NADPH-cytochrome P450 reductase and cytochrome b5, Eur. J. Biochem. 207: 109\u2013116.", "journal-title": "b5, Eur. J. Biochem"}, {"key": "14_CR372", "author": "FP Guengerich", "first-page": "179", "year": "1995", "unstructured": "Guengerich, F. P., 1995, Cytochrome P450s of human liver. Classification and activity profile of the major enzymes, in: Advances in Drug Metabolism in Man ( G. M. Pacifici and G. N. Fracchia, eds.), Medical Research Commission, European Communities, Brussels, pp. 179\u2013231.", "volume-title": "Advances in Drug Metabolism in Man"}, {"key": "14_CR373", "doi-asserted-by": "crossref", "first-page": "348", "DOI": "10.1016/0006-291X(78)90616-2", "volume": "82", "author": "M. K. Buening", "year": "1978", "unstructured": "Buening, M. K., Fortner, J. G., Kappas, A., and Conney, A. H., 1978, 7,8-Benzoflavone stimulates the metabolic activation of aflatoxin Bi to mutagens by human liver, Biochem. Biophys. Res. Commun. 82: 348\u2013355.", "journal-title": "Biochem. Biophys. Res. Commun"}, {"key": "14_CR374", "first-page": "67", "volume": "41", "author": "MK Buening", "year": "1981", "unstructured": "Buening, M. K., Chang, R. L., Huang, M. R., Former, J. G., Wood, A. W., and Conney, A. H., 1981, Activation and inhibition of benzo(a)pyrene and aflatoxin Bi metabolism in human liver microsomes by naturally occurring flavonoids, Cancer Res. 41: 67\u201372.", "journal-title": "Cancer Res"}, {"key": "14_CR375", "doi-asserted-by": "publisher", "first-page": "462", "DOI": "10.1073/pnas.86.2.462", "volume": "86", "author": "T Shimada", "year": "1989", "unstructured": "Shimada, T., and Guengerich, F. P., 1989, Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver, Proc. Natl. Acad. Sci. USA\n                        86: 462\u2013465.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "14_CR376", "first-page": "3218", "volume": "49", "author": "T Shimada", "year": "1989", "unstructured": "Shimada, T., Iwasaki, M., Martin, M. V., and Guengerich, F. P., 1989, Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by mu gene response in Salmonella typhimurium TA1535/pSK1002, Cancer Res. 49: 3218\u20133228.", "journal-title": "Cancer Res"}, {"key": "14_CR377", "doi-asserted-by": "publisher", "first-page": "202", "DOI": "10.1021/tx00026a009", "volume": "5", "author": "KD Raney", "year": "1992", "unstructured": "Raney, K. D., Shimada, T., Kim, D.-H., Groopman, J. D., Harris, T. M., and Guengerich, F. P., 1992, Oxidation of aflatoxin Bi and related dihydrofurans by human liver microsomes: Significance of aflatoxin QI as a detoxication product, Chem. Res. Toxicol. 5: 202\u2013210.", "journal-title": "Chem. Res. Toxicol"}, {"key": "14_CR378", "author": "FP Guengerich", "first-page": "97", "year": "1994", "unstructured": "Guengerich, F. P., Kim, B.-R., Gillam, E. M. J., and Shimada, T., 1994, Mechanisms of enhancement and inhibition of cytochrome P450 catalytic activity, in: Proceedings, 8th Int. Conf. on Cytochrome P450: Biochemistry, Biophysics, and Molecular Biology, ( M. C. Lechner, ed.) John Libbey Eurotext, Chichester, U.K., pp. 97\u2013101.", "volume-title": "Proceedings, 8th Int. Conf. on Cytochrome P450: Biochemistry, Biophysics, and Molecular Biology"}, {"key": "14_CR379", "first-page": "10897", "volume": "256", "author": "MT Huang", "year": "1981", "unstructured": "Huang, M. T., Johnson, E. F., Muller-Eberhard, U., Koop, D. R., Coon, M. J., and Conney, A. H., 1981, Specificity in the activation and inhibition by flavonoids of benzo[a)pyrene hydroxylation by cytochrome P-450 isozymes from rabbit liver microsomes, J. Biol. Chem. 256: 10897\u201310901.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR380", "first-page": "17672", "volume": "263", "author": "EF Johnson", "year": "1988", "unstructured": "Johnson, E. F., Schwab, G. E., and Vickery, L. E., 1988, Positive effectors of the binding of an active site-directed amino steroid to rabbit cytochrome P-450 3c, J. Biol. Chem. 263: 17672\u201317677.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR381", "doi-asserted-by": "publisher", "first-page": "205", "DOI": "10.1289/ehp.9193205", "volume": "93", "author": "MS Rao", "year": "1991", "unstructured": "Rao, M. S., and Reddy, J. K., 1991, An overview of peroxisome proliferator-induced hepatocarcinogenesis, Environ. Health Perspect. 93: 205\u2013209.", "journal-title": "Environ. Health Perspect"}, {"key": "14_CR382", "doi-asserted-by": "publisher", "first-page": "193", "DOI": "10.1016/0378-4274(93)90130-P", "volume": "68", "author": "GG Gibson", "year": "1993", "unstructured": "Gibson, G. G., 1993, Peroxisome proliferators: Paradigms and prospects, Toxicol. Lett. 68: 193\u2013201.", "journal-title": "Toxicol. Lett"}, {"key": "14_CR383", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1006/abbi.1993.1560", "volume": "307", "author": "LJ Roman", "year": "1993", "unstructured": "Roman, L. J., Palmer, C.N.A., Clark, J. E., Muerhoff, A. S., Griffin, K. J., Johnson, E. F., and Masters, B.S.S., 1993, Expression of rabbit cytochromes P4504A which catalyze the to-hydroxylation of arachidonic acid, fatty acids, and prostaglandins, Arch. Biochem. Biophys. 307: 57\u201365.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR384", "doi-asserted-by": "publisher", "first-page": "8060", "DOI": "10.1021/bi00446a014", "volume": "28", "author": "PT Nhamburo", "year": "1989", "unstructured": "Nhamburo, P. T., Gonzalez, F. J., McBride, O. W., Gelboin, H. V., and Kimura, S., 1989, Identification of a new P450 expressed in human lung: Complete cDNA sequence, cDNA-directed expression, and chromosome mapping, Biochemistry\n                        28: 8060\u20138066.", "journal-title": "Biochemistry"}, {"key": "14_CR385", "first-page": "15059", "volume": "260", "author": "M Haurand", "year": "1985", "unstructured": "Haurand, M., and Ullrich, V., 1985, Isolation and characterization of thromboxane synthase from human platelets as a cytochrome P450 enzyme, J. Biol. Chem. 260: 15059\u201315067.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR386", "doi-asserted-by": "publisher", "first-page": "325", "DOI": "10.1016/0003-9861(90)90337-X", "volume": "280", "author": "R N\u00fcsing", "year": "1990", "unstructured": "N\u00fcsing, R., Schneider-Voss, S., and Ullrich, V., 1990, Immunoaffinity purification of human thromboxane synthase, Arch. Biochem. Biophys. 280: 325\u2013330.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR387", "doi-asserted-by": "publisher", "first-page": "487", "DOI": "10.1002/anie.198304871", "volume": "22", "author": "H Graf", "year": "1983", "unstructured": "Graf, H., Ruf, H. H., and Ullrich, V., 1983, Prostacyclin synthase, a cytochrome P450 enzyme, Angew. Chem. Int. Ed. Engl. 22: 487\u2013488.", "journal-title": "Angew. Chem. Int. Ed. Engl"}, {"key": "14_CR388", "doi-asserted-by": "publisher", "first-page": "352", "DOI": "10.1016/0165-6147(84)90467-X", "volume": "5", "author": "V Ullrich", "year": "1984", "unstructured": "Ullrich, V., and Graf, H., 1984, Prostacyclin and thromboxane synthase as P-450 enzymes, Trends Pharmacol. Sci. 5: 352\u2013355.", "journal-title": "Trends Pharmacol. Sci"}, {"key": "14_CR389", "first-page": "141", "volume": "264", "author": "M Hecker", "year": "1989", "unstructured": "Hecker, M., and Ullrich, V., 1989, On the mechanism of prostacyclin and thromboxane A2 biosynthesis, J. Biol. Chem. 264: 141\u2013150.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR390", "doi-asserted-by": "publisher", "first-page": "217", "DOI": "10.1111/j.1432-1033.1986.tb09659.x", "volume": "157", "author": "M Hecker", "year": "1986", "unstructured": "Hecker, M., Haurand, M., Ullrich, V., and Terao, S., 1986, Spectral studies on structure\u2014activity relationships of thromboxane synthase inhibitors, Eur. J Biochem. 157: 217\u2013223.", "journal-title": "Eur. J Biochem"}, {"key": "14_CR391", "doi-asserted-by": "publisher", "first-page": "233", "DOI": "10.1146/annurev.bi.44.070175.001313", "volume": "44", "author": "H Danielsson", "year": "1975", "unstructured": "Danielsson, H., and Sj\u00f6vall, J., 1975, Bile acid metabolism, Annu Rev. Biochem. 44: 233\u2013253.", "journal-title": "Annu Rev. Biochem"}, {"key": "14_CR392", "first-page": "12012", "volume": "265", "author": "YC Li", "year": "1990", "unstructured": "Li, Y. C., Wang, D. P., and Chiang, J. Y. L., 1990, Regulation of cholesterol 7a-hydroxylase in the liver: Cloning, sequencing, and regulation of cholesterol 7a-hydroxylase mRNA, J. Biol. Chem. 265: 12012\u201312019.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR393", "first-page": "34163421", "volume": "266", "author": "W. M. Pendak", "year": "1991", "unstructured": "Pendak, W. M., Li, Y. C., Chiang, J. Y. L., Studer, E. J., Gurley, E. C., Heuman, D. M., Vlahcevic, Z. R., and Hylemon, R. B., 1991, Regulation of cholesterol 7a-hydroxylase mRNA and transcriptional activity by taurocholate and cholesterol in the chronic biliary diverted rat, J. Biol. Chem. 266: 34163421.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR394", "doi-asserted-by": "publisher", "first-page": "147", "DOI": "10.1016/0167-4781(93)90281-H", "volume": "1172", "author": "M Nishimoto", "year": "1993", "unstructured": "Nishimoto, M., Noshiro, M., and Okuda, K., 1993, Structure of the gene encoding human liver cholesterol 7a-hydroxylase, Biochim. Biophys. Acta\n                        1172: 147\u2013150.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "14_CR395", "doi-asserted-by": "crossref", "first-page": "879", "DOI": "10.1093/oxfordjournals.jbchem.a121955", "volume": "101", "author": "K Morohashi", "year": "1987", "unstructured": "Morohashi, K., Sogawa, K., Omura, T., and Fujii-Kuriyama, Y., 1987, Gene structure of human cytochrome P-450(SCC), cholesterol desmolase, J. Biochem. 101: 879\u2013887.", "journal-title": "J. Biochem"}, {"key": "14_CR396", "doi-asserted-by": "publisher", "first-page": "1955", "DOI": "10.1172/JCI115520", "volume": "88", "author": "D Lin", "year": "1991", "unstructured": "Lin, D., Gitelman, S. E., Saenger, P., and Miller, W. L., 1991, Normal genes for the cholesterol side chain cleavage enzyme, P450., in congenital lipoid adrenal hyperplasia, J Clin. Invest. 88: 1955\u20131962.", "journal-title": "J Clin. Invest"}, {"key": "14_CR397", "doi-asserted-by": "publisher", "first-page": "693", "DOI": "10.1016/0022-4731(87)91041-7", "volume": "26", "author": "M Lauber", "year": "1987", "unstructured": "Lauber, M., Sugano, S., Ohnishi, T., Okamoto, M., and M\u00fcller, J., 1987, Aldosterone biosynthesis and cytochrome P4504: Evidence for two different forms of the enzyme in rats, J. Steroid Biochem. 26: 693\u2013698.", "journal-title": "J. Steroid Biochem"}, {"key": "14_CR398", "doi-asserted-by": "publisher", "first-page": "9819", "DOI": "10.1021/bi00494a010", "volume": "29", "author": "MC Lorence", "year": "1990", "unstructured": "Lorence, M. C., Trant, J. M., Clark, B. J., Khyatt, B., Mason, J. I., Estabrook, R. W., and Waterman, M. R., 1990, Construction and expression of human/bovine P45017a chimeric proteins: Evidence for distinct tertiary structures in the same P450 from two different species, Biochemistry\n                        29: 9819\u20139824.", "journal-title": "Biochemistry"}, {"key": "14_CR399", "doi-asserted-by": "publisher", "first-page": "98", "DOI": "10.1210/jc.77.1.98", "volume": "77", "author": "P Swart", "year": "1993", "unstructured": "Swart, P., Swart, A. C., Waterman, M. R., Estabrook, R. W., and Mason, J. I., 1993, Progesterone 16a-hydroxylase activity is catalyzed by human cytochrome P450 17a-hydroxylase, J. Clin. Endocrinol. Metab. 77: 98\u2013102.", "journal-title": "J. Clin. Endocrinol. Metab"}, {"key": "14_CR400", "doi-asserted-by": "publisher", "first-page": "249", "DOI": "10.1016/0303-7207(88)90110-4", "volume": "59", "author": "T Yanase", "year": "1988", "unstructured": "Yanase, T., Kagimoto, M., Matsui, N., Simpson, E. R., and Waterman, M. R., 1988, Combined 17a-hydroxylase/17,20-lyase deficiency due to a stop codon in the N-terminal region of 17a-hydroxylase cytochrome P-450, Mol. Cell. Endocrino!. 59: 249\u2013253.", "journal-title": "Mol. Cell. Endocrino!"}, {"key": "14_CR401", "doi-asserted-by": "publisher", "first-page": "564", "DOI": "10.1210/mend-2-6-564", "volume": "2", "author": "M Kagimoto", "year": "1988", "unstructured": "Kagimoto, M., Winter, J.S.D., Kagimoto, K., Simpson, E. R., and Waterman, M. R., 1988, Structural characterization of normal and mutant human steroid 17a-hydroxylase genes: Molecular basis of one example of combined 17a-hydroxylase/17,20 lyase deficiency, Mol. Endocrinol. 2: 564\u2013570.", "journal-title": "Mol. Endocrinol"}, {"key": "14_CR402", "author": "T Yanase", "year": "1989", "unstructured": "Yanase, T., Kagimoto, M., Suzuki, S., Hashiba, K., Simpson, E. R., and Waterman, M. R., 1989, Deletion of a phenylalanine in the N-terminal region of human cytochrome P-45017a results in partial combined 17a-hydroxylase/17,20-lyase deficiency, J. Biol. Chem. 264:18076\u201318082.", "volume-title": "Deletion 264:18076-18082"}, {"key": "14_CR403", "doi-asserted-by": "publisher", "first-page": "973", "DOI": "10.1016/0960-0760(92)90325-D", "volume": "43", "author": "T Yanase", "year": "1992", "unstructured": "Yanase, T., Imai, T., Simpson, E. R., and Waterman, M. R., 1992, Molecular basis of 17a-hydroxylase/17,20-lyase deficiency, J. Steroid Biochem. Mol. Biol. 43: 973\u2013979.", "journal-title": "J. Steroid Biochem. Mol. Biol"}, {"key": "14_CR404", "doi-asserted-by": "publisher", "first-page": "658", "DOI": "10.1016/0006-3002(58)90408-6", "volume": "27", "author": "KJ Ryan", "year": "1958", "unstructured": "Ryan, K. J., 1958, Conversion of androstenedione to estrone by placental microsomes, Biochim. Biophys. Acta\n                        27: 658\u2013662.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "14_CR405", "unstructured": "Brodie, A. M. H., 1987, Aromatase inhibitors: Applications of inhibitors of estrogen biosynthesis, IS/ Atlas of Science: Pharmacology 266\u2013269."}, {"key": "14_CR406", "first-page": "4413", "volume": "262", "author": "JT Kellis", "year": "1987", "unstructured": "Kellis, J. T., Jr.., and Vickery, L. E., 1987, Purification and characterization of human placental aromatase cytochrome P-450, J. Biol. Chem. 262: 4413\u20134420.", "journal-title": "Purification and characterization of human placental aromatase cytochrome P-450, J. Biol. Chem"}, {"key": "14_CR407", "doi-asserted-by": "publisher", "first-page": "511", "DOI": "10.3109/03602538909103557", "volume": "20", "author": "S Chen", "year": "1989", "unstructured": "Chen, S., Besman, M. J., Shively, J. E., Yanagibashi, K., and Hall, P. F., 1989, Human aromatase, Drug Metab. Rev. 20: 511\u2013517.", "journal-title": "Drug Metab. Rev"}, {"key": "14_CR408", "doi-asserted-by": "publisher", "first-page": "389", "DOI": "10.1016/0960-0760(93)90242-O", "volume": "44", "author": "SS Oh", "year": "1993", "unstructured": "Oh, S.S., and Robinson, C. H., 1993, Mechanism of human placental aromatase: A new active site model, J. Steroid Biochem. Mol. Biol. 44: 389\u2013397.", "journal-title": "J. Steroid Biochem. Mol. Biol"}, {"key": "14_CR409", "doi-asserted-by": "publisher", "first-page": "243", "DOI": "10.1111/j.1432-1033.1986.tb09574.x", "volume": "157", "author": "L Tan", "year": "1986", "unstructured": "Tan, L., and Muto, N., 1986, Purification and reconstitution properties of human placental aromatase: A cytochrome P450-type monooxygenase, Eur. J. Biochem. 157: 243\u2013250.", "journal-title": "Eur. J. Biochem"}, {"key": "14_CR410", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.1016/0039-128X(83)90060-0", "volume": "50", "author": "PF Hall", "year": "1987", "unstructured": "Hall, P. F., Chen, S., Nakajin, S., Shinoda, M., and Shively, J. E., 1987, Purification and characterization of aromatase from human placenta, Steroids\n                        50: 37\u201350.", "journal-title": "Steroids"}, {"key": "14_CR411", "doi-asserted-by": "publisher", "first-page": "713", "DOI": "10.1016/0006-291X(86)90987-3", "volume": "135", "author": "S Chen", "year": "1986", "unstructured": "Chen, S., Shively, J. E., Nakajin, S., Shinoda, M., and Hall, P. F., 1986, Amino terminal sequence analysis of human placenta aromatase, Biochem. Biophys. Res. Commun. 135: 713\u2013179.", "journal-title": "Biochem. Biophys. Res. Commun"}, {"key": "14_CR412", "doi-asserted-by": "publisher", "first-page": "480", "DOI": "10.1016/0003-9861(85)90525-9", "volume": "243", "author": "CR Mendelson", "year": "1985", "unstructured": "Mendelson, C. R., Wright, E. E., Evans, C. T., Porter, J. C., and Simpson, E. R., 1985, Preparation and characterization of polyclonal and monoclonal antibodies against human aromatase cytochrome P-450 (P-450arom), and their use in its purification, Arch. Biochem. Biophys. 243: 480\u2013491.", "journal-title": "Arch. Biochem. Biophys"}, {"key": "14_CR413", "doi-asserted-by": "publisher", "first-page": "3003", "DOI": "10.1021/bi00226a004", "volume": "30", "author": "N Yoshida", "year": "1991", "unstructured": "Yoshida, N., and Osawa, Y., 1991, Purification of human placental aromatase cytochrome P-450 with monoclonal antibody and its characterization, Biochemistry\n                        30: 3003\u20133010.", "journal-title": "Biochemistry"}, {"key": "14_CR414", "doi-asserted-by": "publisher", "first-page": "8948", "DOI": "10.1073/pnas.85.23.8948", "volume": "85", "author": "CJ Corbin", "year": "1988", "unstructured": "Corbin, C. J., Graham-Lorence, S., McPhaul, M., Mason, J. I., Mendelson, C. R., and Simpson, E. R., 1988, Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in nonsteroidogenic cells, Proc. Natl. Acad. Sci. USA\n                        85: 8948\u20138952.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "14_CR415", "doi-asserted-by": "publisher", "first-page": "559", "DOI": "10.1111/j.1432-1033.1990.tb19372.x", "volume": "193", "author": "K Toda", "year": "1990", "unstructured": "Toda, K., Terashima, M., Kawamoto, T., Sumimoto, H., Yokoyama, Y., Kuribayashi, I., Mitsuuchi, Y., Maeda, T., Yamamoto, Y., Sagara, Y., Ikeda, H., and Shizuta, Y., 1990, Structural and functional characterization of human aromatase P-450 gene, Eur. J. Biochem. 193: 559\u2013565.", "journal-title": "Eur. J. Biochem"}, {"key": "14_CR416", "first-page": "8099", "volume": "269", "author": "K Toda", "year": "1994", "unstructured": "Toda, K., and Shizuta, Y., 1994, Identification and characterization of cis-acting regulatory elements for the expression of the human aromatase cytochrome P-450 gene, J. Biol. Chem. 269: 8099\u20138107.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR417", "doi-asserted-by": "publisher", "first-page": "383", "DOI": "10.1111/j.1432-1033.1993.tb17772.x", "volume": "213", "author": "K Toda", "year": "1993", "unstructured": "Toda, K., and Shizuta, Y., 1993, Molecular cloning of a cDNA showing alternative splicing of the 5\u2019-untranslated sequence of mRNA for human aromatase P-450, Eur. J. Biochem. 213: 383\u2013389.", "journal-title": "Eur. J. Biochem"}, {"key": "14_CR418", "doi-asserted-by": "publisher", "first-page": "1001", "DOI": "10.1016/0006-291X(92)92303-F", "volume": "189", "author": "N Harada", "year": "1992", "unstructured": "Harada, N., 1992, A unique aromatase (P-450AROm) mRNA formed by alternative use of tissue-specific exons 1 in human skin fibroblasts, Biochem. Biophys. Res. Commun. 189: 1001\u20131007.", "journal-title": "Biochem. Biophys. Res. Commun"}, {"key": "14_CR419", "doi-asserted-by": "publisher", "first-page": "11312", "DOI": "10.1073/pnas.90.23.11312", "volume": "90", "author": "N Harada", "year": "1993", "unstructured": "Harada, N., Utsumi, T., and Takagi, Y., 1993, Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis, Proc. Natl. Acad. Sci. USA\n                        90: 11312\u201311316.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "14_CR420", "author": "FP Guengerich", "first-page": "191", "year": "1993", "unstructured": "Guengerich, F. P., and Macdonald, T. L., 1993, Sequential electron transfer oxidation reactions catalyzed by cytochrome P-450 enzymes, in: Advances in Electron Transfer Chemistry, Vol. 3 (P. S. Mariano, ed.), JAI Press, Greenwich, CT, pp. 191\u2013241.", "volume-title": "Advances in Electron Transfer Chemistry", "DOI": "10.1016/B978-1-4831-0093-7.50008-5", "doi-asserted-by": "crossref"}, {"key": "14_CR421", "author": "PR Montellano", "first-page": "217", "year": "1986", "unstructured": "Ortiz de Montellano, P. R., 1986, Oxygen activation and transfer, in: Cytochrome P-450 ( P. R. Ortiz de Montellano, ed.), Plenum Press, New York, pp. 217\u2013271.", "volume-title": "Cytochrome P-450", "DOI": "10.1007/978-1-4757-9939-2_7", "doi-asserted-by": "crossref"}, {"key": "14_CR422", "doi-asserted-by": "publisher", "first-page": "1284", "DOI": "10.1021/ja00212a043", "volume": "110", "author": "PA Cole", "year": "1988", "unstructured": "Cole, P. A., and Robinson, C. H., 1988, A peroxide model reaction for placental aromatase, J. Am. Chem. Soc. 110: 1284\u20131285.", "journal-title": "J. Am. Chem. Soc"}, {"key": "14_CR423", "unstructured": "Akhtar, M., Calder, M. R., Corina, D. L., and Wright, J. N., 982, Mechanistic studies on C-19 demethylation in oestrogen biosynthesis, Biochem. J. 201: 569\u2013580.", "DOI": "10.1042/bj2010569", "doi-asserted-by": "crossref"}, {"key": "14_CR424", "doi-asserted-by": "publisher", "first-page": "2933", "DOI": "10.1021/jm00173a001", "volume": "33", "author": "PA Cole", "year": "1990", "unstructured": "Cole, P. A., and Robinson, C. H., 1990, Mechanism and inhibition of cytochrome P-450 aromatase, J. Med. Chem. 33: 2933\u20132942.", "journal-title": "J. Med. Chem"}, {"key": "14_CR425", "doi-asserted-by": "publisher", "first-page": "8130", "DOI": "10.1021/ja00021a044", "volume": "113", "author": "RA Cole", "year": "1991", "unstructured": "Cole, R A., and Robinson, C. H., 1991, Mechanistic studies on a placental aromatase model reaction, J. Am. Chem. Soc. 113: 8130\u20138137.", "journal-title": "J. Am. Chem. Soc"}, {"key": "14_CR426", "doi-asserted-by": "publisher", "first-page": "5886", "DOI": "10.1021/ja00015a066", "volume": "113", "author": "ADN Vaz", "year": "1991", "unstructured": "Vaz, A. D. N., Roberts, E. S., and Coon, M. J., 1991, Olefin formation in the oxidative deformylation of aldehydes by cytochrome P-450. Mechanistic implications for catalysis by oxygen-derived peroxide, J. Am. Chem. Soc. 113: 5886\u20135887.", "journal-title": "J. Am. Chem. Soc"}, {"key": "14_CR427", "doi-asserted-by": "publisher", "first-page": "327", "DOI": "10.1016/0960-0760(90)90481-Y", "volume": "37", "author": "AMH Brodie", "year": "1990", "unstructured": "Brodie, A. M. H., Banks, P. K., Inskster, S. E., Dowsett, M., and Coombes, R. C., 1990, Aromatase inhibitors and hormone-dependent cancers, J. Steroid Biochem. Mol. Biol. 37: 327\u2013333.", "journal-title": "J. Steroid Biochem. Mol. Biol"}, {"key": "14_CR428", "unstructured": "Bhamagar, A. S., H\u00e4usler, A., Schieweck, K., Browne, L. J., Bowman, R., and Steele, R. E., 990, Novel aromatase inhibitors, J. Steroid Biochem. Mol. Biol. 37: 363\u2013367.", "DOI": "10.1016/0960-0760(90)90485-4", "doi-asserted-by": "crossref"}, {"key": "14_CR429", "author": "JT Kellis Jr.", "year": "1984", "unstructured": "Kellis, J. T., Jr., and Vickery, L. E., 1984, Inhibition of human estrogen synthetase (aromatase) by flavones, Science\n                        225:1032\u20131034.", "volume-title": "Science 225:1032-1034"}, {"key": "14_CR430", "doi-asserted-by": "publisher", "first-page": "2887", "DOI": "10.1016/0006-2952(86)90481-8", "volume": "35", "author": "JT Kellis Jr.", "year": "1986", "unstructured": "Kellis, J. T., Jr., Nesnow, S., and Vickery, L. E., 1986, Inhibition of aromatase cytochrome P-450 (estrogen synthetase) by derivatives of a-naphthoflavone, Biochem. Pharmacol. 35: 2887\u20132891.", "journal-title": "Biochem. Pharmacol"}, {"key": "14_CR431", "first-page": "21399", "volume": "268", "author": "O Shimozawa", "year": "1993", "unstructured": "Shimozawa, O., Sakaguchi, M., Ogawa, H., Harada, N., Mihara, K., and Omura, T., 1993, Core glycosylation of cytochrome P-405(arom): Evidence for localization of N terminus of microsomal cytochrome P-450 in the lumen, J. Biol. Chem. 268: 21399\u201321402.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR432", "doi-asserted-by": "publisher", "first-page": "347", "DOI": "10.1016/0960-0760(93)90238-R", "volume": "44", "author": "S Chen", "year": "1993", "unstructured": "Chen, S., Zhou, D., Swiderek, K. M., Kadohama, N., Osawa, Y., and Hall, P. F., 1993, Structure-function studies of human aromatase, J. Steroid Biochem. Mol. Biol. 44: 347\u2013356.", "journal-title": "J. Steroid Biochem. Mol. Biol"}, {"key": "14_CR433", "doi-asserted-by": "publisher", "first-page": "410", "DOI": "10.1073/pnas.88.2.410", "volume": "88", "author": "D Zhou", "year": "1991", "unstructured": "Zhou, D., Pompon, D., and Chen, S., 1991, Structure-function studies of human aromatase by site-directed mutagenesis: Kinetic properties of mutants Pro-308 Phe, Tyr-361 Phe, Tyr-361 Leu, and Phe-406 Arg, Proc. Natl. Acad. Sci. USA\n                        88: 410\u2013414.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "14_CR434", "first-page": "11939", "volume": "266", "author": "S Graham-Lorence", "year": "1991", "unstructured": "Graham-Lorence, S., Khalil, M. W., Lorence, M. C., Mendelson, C. R., and Simpson, E. R., 1991, Structure-function relationships of human aromatase cytochrome P-450 using molecular modeling and site-directed mutagenesis, J. Biol. Chem. 266: 11939\u201311946.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR435", "first-page": "22587", "volume": "267", "author": "S Chen", "year": "1992", "unstructured": "Chen, S., and Zhou, D., 1992, Functional domains for aromatase cytochrome P450 inferred from comparative analyses of amino acid sequences and substantiated by site-directed mutagenesis experiments, J. Biol. Chem. 267: 22587\u201322594.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR436", "doi-asserted-by": "publisher", "first-page": "399", "DOI": "10.1016/0960-0760(93)90243-P", "volume": "44", "author": "CA Laughton", "year": "1993", "unstructured": "Laughton, C. A., 1993, A detailed molecular model for human aromatase, J. Steroid Biochem. Mol. Biol. 44: 399\u2013407.", "journal-title": "J. Steroid Biochem. Mol. Biol"}, {"key": "14_CR437", "first-page": "11199", "volume": "266", "author": "N Kagawa", "year": "1991", "unstructured": "Kagawa, N., and Waterman, M. R., 1991, Evidence that an adrenal-specific nuclear protein regulates the cAMP responsiveness of the human CYP21B (P450C21) gene, J. Biol. Chem. 266: 11199\u201311204.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR438", "doi-asserted-by": "publisher", "first-page": "2841", "DOI": "10.1073/pnas.83.9.2841", "volume": "83", "author": "Y Higashi", "year": "1986", "unstructured": "Higashi, Y., Yoshioka, H., Yamane, M., Gotoh, O., and Fujii-Kuriyama, Y., 1986, Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: A pseudo-gene and a genuine gene, Proc. Natl. Acad. Sci. USA\n                        83: 2841\u20132845.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "14_CR439", "doi-asserted-by": "crossref", "first-page": "2124", "DOI": "10.1128/MCB.12.5.2124", "volume": "12", "author": "SE Gitelman", "year": "1992", "unstructured": "Gitelman, S. E., Bristow, J., and Miller, W. L., 1992, Mechanism and consequences of the duplication of the human C4/P450c21/gene X locus, Mol. Cell. Biol. 12: 2124\u20132134.", "journal-title": "Mol. Cell. Biol"}, {"key": "14_CR440", "first-page": "17", "volume": "42", "author": "Y Higashi", "year": "1988", "unstructured": "Higashi, Y., Tanae, A., Inoue, H., and Fujii-Kuriyama, Y., 1988, Evidence for frequent gene conversion in the steroid 21-hydroxylase P-450(C21) gene: Implications for steroid 21-hydroxylase deficiency, Am. J. Hum. Genet. 42: 17\u201325.", "journal-title": "Am. J. Hum. Genet"}, {"key": "14_CR441", "doi-asserted-by": "publisher", "first-page": "359", "DOI": "10.1089/dna.1992.11.359", "volume": "11", "author": "A Helmberg", "year": "1992", "unstructured": "Helmberg, A., Tabarelli, M., Fuchs, M. A., Keller, E., Dobler, G., Schnegg, I., Knorr, D., Albert, E., and Kofler, R., 1992, Identification of molecular defects causing congenital adrenal hyperplasia by cloning and differential hybridization of polymerase chain reaction-amplified 21-hydroxylase (CYP21) genes, DNA Cell Biol. 11: 359\u2013368.", "journal-title": "DNA Cell Biol"}, {"key": "14_CR442", "first-page": "3549", "volume": "265", "author": "SH Chiou", "year": "1990", "unstructured": "Chiou, S. H., Hu, M. C., and Chung, B., 1990, A missense mutation at Ile 172-Asn or Arg356-*Trp causes steroid 21-hydroxylase deficiency, J. Biol. Chem. 265: 3549\u20133552.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR443", "unstructured": "New, M. I., 1994, 21-Hydroxylase deficiency congenital adrenal hyperplasia, J. Steroid Biochem. Mol. Biol. 48: 15\u201322.", "DOI": "10.1016/0960-0760(94)90246-1", "doi-asserted-by": "crossref"}, {"key": "14_CR444", "first-page": "7774", "volume": "266", "author": "JJ Cali", "year": "1991", "unstructured": "Cali, J. J., and Russell, D. W., 1991, Characterization of human sterol 27-hydroxylase: Amitochondrial cytochrome P-450 that catalyzes multiple oxidation reactions in bile acid biosynthesis, J. Biol. Chem. 266: 7774\u20137778.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR445", "first-page": "7779", "volume": "266", "author": "JJ Cali", "year": "1991", "unstructured": "Cali, J. J., Hsieh, C. L., Francke, U., and Russell, D. W., 1991, Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis, J. Biol. Chem. 266: 7779\u20137783.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR446", "doi-asserted-by": "publisher", "first-page": "317", "DOI": "10.1016/S0006-291X(88)81087-8", "volume": "155", "author": "N Ishida", "year": "1988", "unstructured": "Ishida, N., Aoyama, Y., Hatanaka, R., Oyama, Y., Imajo, S., Ishiguro, M., Oshima, T., Nakazato, H., Noguchi, T., Maitra, U.S., Mohan, V. P., Sprinson, D. B., and Yoshida, Y., 1988, A single amino acid substitution converts cytochrome P45014DM to an inactive form, cytochrome P450SG1: Complete primary structures deduced from cloned DNAs, Biochem. Biophys. Res. Commun. 155: 317\u2013323.", "journal-title": "Biochem. Biophys. Res. Commun"}, {"key": "14_CR447", "first-page": "14260", "volume": "262", "author": "Y Aoyama", "year": "1987", "unstructured": "Aoyama, Y., Yoshida, Y., Nishino, T., Katsuki, H., Maitra, U. S., Mohan, V. P., and Sprinson, D. B., 1987, Isolation and characterization of an altered cytochrome P-450 from a yeast mutant defective in lanosterol 14a-demethylation, J. Biol. Chem. 262: 14260\u201314264.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR448", "doi-asserted-by": "publisher", "first-page": "79", "DOI": "10.1093/carcin/1.1.79", "volume": "1", "author": "BE Coles", "year": "1980", "unstructured": "Coles, B. E, Welch, A. M., Hertzog, P. J., Lindsay Smith, J. R., and Garner, R. C., 1980, Biological and chemical studies on 8,9-dihydroxy-8,9-dihydro-aflatoxin B1 and some of its esters, Carcinogenesis\n                        1: 79\u201390.", "journal-title": "Carcinogenesis"}, {"key": "14_CR449", "doi-asserted-by": "publisher", "first-page": "687", "DOI": "10.1016/0022-2836(87)90190-2", "volume": "195", "author": "TL Poulos", "year": "1987", "unstructured": "Poulos, T. L., Finzel, B. C., and Howard, A. J., 1987, High-resolution crystal structure of cytochrome P450cam, J. Mol. Biol. 195: 687\u2013700.", "journal-title": "J. Mol. Biol"}, {"key": "14_CR450", "doi-asserted-by": "publisher", "first-page": "731", "DOI": "10.1126/science.8342039", "volume": "261", "author": "KG Ravichandran", "year": "1993", "unstructured": "Ravichandran, K. G., Boddupalli, S. S., Hasemann, C. A., Peterson, J. A., and Deisenhofer, J., 1993, Crystal structure of hemoprotein domain of P450 BM-3, a prototype for microsomal P450\u2019s, Science\n                        261: 731\u2013736.", "journal-title": "Science"}, {"key": "14_CR451", "doi-asserted-by": "publisher", "first-page": "1169", "DOI": "10.1016/0022-2836(94)90019-1", "volume": "236", "author": "CA Hasemann", "year": "1994", "unstructured": "Hasemann, C. A., Ravichandran, K. G., Peterson, J. A., and Deisenhofer, J., 1994, Crystal structure and refinement of cytochrome P450(terp) at 2.3 angstrom resolution, J. Mol. Biol. 236: 1169\u20131185.", "journal-title": "J. Mol. Biol"}, {"key": "14_CR452", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1016/0076-6879(91)06073-C", "volume": "206", "author": "TL Poulos", "year": "1991", "unstructured": "Poulos, T. L., 1991, Modeling of mammalian P450s on basis of P450cam X-ray structure, Methods Enzymol. 206: 11\u201330.", "journal-title": "Methods Enzymol"}, {"key": "14_CR453", "doi-asserted-by": "publisher", "first-page": "89", "DOI": "10.1016/0300-483X(93)90062-W", "volume": "82", "author": "CL Crespi", "year": "1993", "unstructured": "Crespi, C. L., Langenbach, R., and Penman, B. W., 1993, Human cell lines, derived from AHH-1 TK+/\u2014 human lymphoblasts, genetically engineered for expression of cytochromes P450, Toxicology\n                        82: 89\u2013104.", "journal-title": "Toxicology"}, {"key": "14_CR454", "first-page": "251", "volume": "248", "author": "WA Schmalix", "year": "1994", "unstructured": "Schmalix, W. A., M\u00e4ser, H., Kiefer, F., Reen, R., Wiebel, F. J., Gonzalez, F., Seidel, A., Glatt, H., Greiff\u2019, H., and Doehmer, J., 1994, Stable expression of human cytochrome P450 lAl cDNA in V79 Chinese hamster cells and metabolic activation of benzo[a]pyrene, Eur. J. Pharmacol. 248: 251\u2013261.", "journal-title": "Eur. J. Pharmacol"}, {"key": "14_CR455", "first-page": "7321", "volume": "266", "author": "JR Larson", "year": "1991", "unstructured": "Larson, J. R., Coon, M. J., and Porter, T. D., 1991, Alcohol-inducible cytochrome P-45011E1 lacking the hydrophobic NH2-terminal segment retains catalytic activity and is membrane-bound when expressed in Escherichia coli, J. Biol. Chem. 266: 7321\u20137324.", "journal-title": "Escherichia coli, J. Biol. Chem"}, {"key": "14_CR456", "doi-asserted-by": "publisher", "first-page": "5597", "DOI": "10.1073/pnas.88.13.5597", "volume": "88", "author": "HJ Barnes", "year": "1991", "unstructured": "Barnes, H. J., Arlotto, M. P., and Waterman, M. R., 1991, Expression and enzymatic activity of recombinant cytochrome P450 17a-hydroxylase in Escherichia coli, Proc. Natl. Acad. Sci. USA\n                        88: 5597\u20135601.", "journal-title": "Escherichia coli, Proc. Natl. Acad. Sci. USA"}, {"key": "14_CR457", "doi-asserted-by": "publisher", "first-page": "621", "DOI": "10.1038/clpt.1993.199", "volume": "54", "author": "MT Kinirons", "year": "1993", "unstructured": "Kinirons, M. T., Oshea, D., Downing, T. E., Fitzwilliam, A. T., Joellenbeck, L., Groopman, J. D., Wilkinson, G. R., and Wood, A. J. J., 1993, Absence of correlations among 3 putative in vivo probes of human cytochrome-P4503A activity in young healthy men, Clin. Pharmacol. Ther. 54: 621\u2013629.", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "14_CR458", "first-page": "579", "volume": "202", "author": "GC Mueller", "year": "1953", "unstructured": "Mueller, G. C., and Miller, J. A., 1953, The metabolism of methylated aminoazo dyes. II. Oxidative demethylation by rat liver homogenates, J. Biol. Chem. 202: 579\u2013587.", "journal-title": "J. Biol. Chem"}, {"key": "14_CR459", "first-page": "356", "volume": "12", "author": "HL Richardson", "year": "1952", "unstructured": "Richardson, H. L., Stier, A. R., and Borsos-Nachtnebel, E., 1952, Liver tumor inhibition and adrenal histologic responses in rats to which 3\u2019-methyl-4-dimethylaminoazobenzene and 20-methylcholan-threne were simultaneously administered, Cancer Res. 12: 356\u2013361.", "journal-title": "Cancer Res"}, {"key": "14_CR460", "first-page": "32", "volume": "1", "author": "EC Miller", "year": "1954", "unstructured": "Miller, E. C., Miller, J. A., and Conney, A. H., 1954, On the mechanism of the methylcholanthrene inhibition of carcinogenesis by 3\u2019-methyl-4-dimethylaminoazobenzene, Proc. Am. Assoc. Cancer Res. 1: 32.", "journal-title": "Proc. Am. Assoc. Cancer Res"}, {"key": "14_CR461", "first-page": "469", "volume": "18", "author": "EC Miller", "year": "1958", "unstructured": "Miller, E. C., Miller, J. A., Brown, R. R., and MacDonald, J. C., 1958, On the protective action of certain polycyclic aromatic hydrocarbons against carcinogenesis by aminoazo dyes and 2-acetylaminofluorene, Cancer Res. 18: 469\u2013477.", "journal-title": "Cancer Res"}, {"key": "14_CR462", "first-page": "450", "volume": "16", "author": "AH Conney", "year": "1956", "unstructured": "Conney, A. H., Miller, E. C., and Miller, J. A., 1956, The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene, Cancer Res. 16: 450\u2013459.", "journal-title": "Cancer Res"}, {"key": "14_CR463", "doi-asserted-by": "publisher", "first-page": "1019", "DOI": "10.1016/S0300-9084(78)80589-6", "volume": "60", "author": "DW Nebert", "year": "1978", "unstructured": "Nebert, D. W., 1978, Genetic control of carcinogen metabolism leading to individual differences in cancer risk, Biochimie\n                        60: 1019\u20131029.", "journal-title": "Biochimie"}, {"key": "14_CR464", "doi-asserted-by": "publisher", "first-page": "153", "DOI": "10.3109/10408448909017908", "volume": "20", "author": "DW Nebert", "year": "1989", "unstructured": "Nebert, D. W., 1989, The Ah locus: Genetic differences in toxicity, cancer, mutation, and birth defects, Crit. Rev. Toxicol. 20: 153\u2013174.", "journal-title": "Crit. Rev. Toxicol"}, {"key": "14_CR465", "first-page": "2946", "volume": "48", "author": "FP Guengerich", "year": "1988", "unstructured": "Guengerich, F. P., 1988, Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy, Cancer Res. 48: 2946\u20132954.", "journal-title": "Cancer Res"}, {"key": "14_CR466", "first-page": "327", "volume": "5", "author": "EP Guengerich", "year": "1990", "unstructured": "Guengerich, E. P., 1990, Characterization of roles of human cytochrome P450 enzymes in carcinogen metabolism, Asia Pac. J. Pharmacol. 5: 327\u2013345.", "journal-title": "Asia Pac. J. Pharmacol"}, {"key": "14_CR467", "doi-asserted-by": "publisher", "first-page": "17", "DOI": "10.1016/0163-7258(92)90050-A", "volume": "54", "author": "FP Guengerich", "year": "1992", "unstructured": "Guengerich, F. P., 1992, Metabolic activation of carcinogens, Pharmacol. Ther. 54: 17\u201361.", "journal-title": "Pharmacol. Ther"}, {"key": "14_CR468", "first-page": "1", "volume": "21", "author": "FP Guengerich", "year": "1992", "unstructured": "Guengerich, F. P., 1993, The 1992 Bernard B. Brodie Award Lecture. Bioactivation and detoxication of toxic and carcinogenic chemicals, Drug Metab. Dispos. 21: 1\u20136.", "journal-title": "Drug Metab. Dispos"}, {"key": "14_CR469", "doi-asserted-by": "publisher", "first-page": "1271", "DOI": "10.1093/carcin/14.7.1271", "volume": "14", "author": "H Yamazaki", "year": "1993", "unstructured": "Yamazaki, H., Mimura, M., Oda, Y., Inui, Y., Shiraga, T., Iwasaki, K., Guengerich, P. R, and Shimada, T., 1993, Roles of different forms of cytochrome P450 in the activation of the promutagen 6-aminochrysene to genotoxic metabolites in human liver microsomes, Carcinogenesis\n                        14: 1271\u20131278.", "journal-title": "Carcinogenesis"}, {"key": "14_CR470", "doi-asserted-by": "publisher", "first-page": "101", "DOI": "10.1289/ehp.9298101", "volume": "98", "author": "NE Caporaso", "year": "1992", "unstructured": "Caporaso, N. E., Shields, P. G., Landi, M. T., Shaw, G. L., Tucker, M. A., Hoover, M., Sugimura, H., Weston, A., and Harris, C. C., 1992, The debrisoquine metabolic phenotype and DNA-based assays: Implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotype, Environ. Health Perspect. 98: 101\u2013105.", "journal-title": "Environ. Health Perspect"}, {"key": "14_CR471", "doi-asserted-by": "publisher", "first-page": "254", "DOI": "10.1111/j.1349-7006.1991.tb01838.x", "volume": "82", "author": "F Uematsu", "year": "1991", "unstructured": "Uematsu, F., Kikuchi, H., Motomiya, M., Abe, T., Sagami, I., Ohmachi, T., Wakui, A., Kanamaru, and Watanabe, M., 1991, Association between restriction fragment length polymorphism of the human cytochrome P4501IE1 gene and susceptibility to lung cancer, Jpn. J Cancer Res. 82: 254\u2013256.", "journal-title": "Jpn. J Cancer Res"}, {"key": "14_CR472", "doi-asserted-by": "publisher", "first-page": "2613", "DOI": "10.1093/carcin/14.12.2613", "volume": "14", "author": "GM Kirby", "year": "1993", "unstructured": "Kirby, G. M., Wolf, C. R, Neal, G. E., Judah, D. J., Henderson, C. J., Srivatanakul, P., and Wild, C. P., 1993, In vitro metabolism of aflatoxin Bt by normal and tumorous liver tissue from Thailand, Carcinogenesis\n                        14: 2613\u20132620.", "journal-title": "Carcinogenesis"}], "container-title": ["Cytochrome P450"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-4757-2391-5_14", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 10]], "date-time": "2019-05-10T02:09:56Z", "timestamp": 1557454196000}, "score": 30.167105, "issued": {"date-parts": [[1995]]}, "ISBN": ["9781441932488", "9781475723915"], "references-count": 472, "URL": "http://dx.doi.org/10.1007/978-1-4757-2391-5_14", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T09:39:48Z", "timestamp": 1574588388321}, "publisher-location": "Cham", "reference-count": 2769, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319121079", "type": "print"}, {"value": "9783319121086", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2015]]}, "DOI": "10.1007/978-3-319-12108-6_9", "type": "book-chapter", "created": {"date-parts": [[2015, 3, 13]], "date-time": "2015-03-13T10:31:24Z", "timestamp": 1426242684000}, "page": "523-785", "source": "Crossref", "is-referenced-by-count": 39, "title": ["Human Cytochrome P450 Enzymes"], "prefix": "10.1007", "author": [{"given": "F. Peter", "family": "Guengerich", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 3, 14]]}, "reference": [{"key": "9_CR1", "first-page": "450", "volume": "16", "author": "AH Conney", "year": "1956", "unstructured": "Conney AH, Miller EC, Miller JA (1956) The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. Cancer Res 16:450\u2013459", "journal-title": "Cancer Res"}, {"key": "9_CR2", "first-page": "296", "volume": "237", "author": "H Remmer", "year": "1957", "unstructured": "Remmer H (1957) The acceleration of evipan oxidation and the demethylation of methylaminopyrine by barbiturates. Naunyn Schmiedeberg\u2019s Arch Exp Pathol Pharmakol 237:296\u2013307", "journal-title": "Naunyn Schmiedeberg\u2019s Arch Exp Pathol Pharmakol"}, {"key": "9_CR3", "first-page": "317", "volume": "19", "author": "AH Conney", "year": "1967", "unstructured": "Conney AH (1967) Pharmacological implications of microsomal enzyme induction. Pharmacol Rev 19:317\u2013366", "journal-title": "Pharmacol Rev"}, {"key": "9_CR4", "doi-asserted-by": "crossref", "first-page": "72", "DOI": "10.1126/science.161.3836.72", "volume": "161", "author": "ES Vesell", "year": "1968", "unstructured": "Vesell ES, Page JG (1968) Genetic control of drug levels in man: antipyrine. Science 161:72\u201373", "journal-title": "Science"}, {"key": "9_CR5", "first-page": "4206", "volume": "39", "author": "E Dybing", "year": "1979", "unstructured": "Dybing E, von Bahr C, Aune T, Glaumann H, Levitt DS, Thorgeirsson SS (1979) In vitro metabolism and activation of carcinogenic aromatic amines by subcellular fractions of human liver. Cancer Res 39:4206\u20134211", "journal-title": "Cancer Res"}, {"key": "9_CR6", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1016/0006-2952(75)90293-2", "volume": "24", "author": "RM Kaschnitz", "year": "1975", "unstructured": "Kaschnitz RM, Coon MJ (1975) Drug and fatty acid hydroxylation by solubilized human liver microsomal cytochrome P-450: phospholipid requirement. Biochem Pharmacol 24:295\u2013297", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR7", "doi-asserted-by": "crossref", "first-page": "826", "DOI": "10.1016/0006-291X(79)91482-7", "volume": "88", "author": "P Beaune", "year": "1979", "unstructured": "Beaune P, Dansette P, Flinois JP, Columelli S, Mansuy D, Leroux JP (1979) Partial purification of human liver cytochrome P-450. Biochem Biophys Res Commun 88:826\u2013832", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR8", "doi-asserted-by": "crossref", "first-page": "1993", "DOI": "10.1016/0006-2952(79)90214-4", "volume": "28", "author": "T Kamataki", "year": "1979", "unstructured": "Kamataki T, Sugiura M, Yamazoe Y, Kato R (1979) Purification and properties of cytochrome P-450 and NADPH-cytochrome c (P-450) reductase from human liver microsomes. Biochem Pharmacol 28:1993\u20132000", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR9", "doi-asserted-by": "crossref", "first-page": "206", "DOI": "10.1016/0003-9861(80)90274-X", "volume": "199", "author": "P Wang", "year": "1980", "unstructured": "Wang P, Mason PS, Guengerich FP (1980) Purification of human liver cytochrome P-450 and comparison to the enzyme isolated from rat liver. Arch Biochem Biophys 199:206\u2013219", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR10", "doi-asserted-by": "crossref", "first-page": "5375", "DOI": "10.1021/bi00292a019", "volume": "22", "author": "PP Wang", "year": "1983", "unstructured": "Wang PP, Beaune P, Kaminsky LS, Dannan GA, Kadlubar FF, Larrey D, Guengerich FP (1983) Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes. Biochemistry 22:5375\u20135383", "journal-title": "Biochemistry"}, {"key": "9_CR11", "doi-asserted-by": "crossref", "first-page": "584", "DOI": "10.1016/S0140-6736(77)91430-1", "volume": "ii", "author": "A Mahgoub", "year": "1977", "unstructured": "Mahgoub A, Idle JR, Dring LG, Lancaster R, Smith RL (1977) Polymorphic hydroxylation of debrisoquine in man. Lancet ii:584\u2013586", "journal-title": "Lancet"}, {"key": "9_CR12", "doi-asserted-by": "crossref", "first-page": "718", "DOI": "10.1016/S0140-6736(77)90527-X", "volume": "ii", "author": "GT Tucker", "year": "1977", "unstructured": "Tucker GT, Silas JH, Iyun AO, Lennard MS, Smith AJ (1977) Polymorphic hydroxylation of debrisoquine. Lancet ii:718", "journal-title": "Lancet"}, {"key": "9_CR13", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1007/BF00562059", "volume": "16", "author": "M Eichelbaum", "year": "1979", "unstructured": "Eichelbaum M, Spannbrucker N, Steincke B, Dengler HJ (1979) Defective N-oxidation of sparteine in man: a new pharmacogenetic defect. Eur J Clin Pharmacol 16:183\u2013187", "journal-title": "Euro J Clin Pharmacol"}, {"key": "9_CR14", "first-page": "9057", "volume": "260", "author": "LM Distlerath", "year": "1985", "unstructured": "Distlerath LM, Reilly PE, Martin MV, Davis GG, Wilkinson GR, Guengerich FP (1985) Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism. J Biol Chem 260:9057\u20139067", "journal-title": "J Biol Chem"}, {"key": "9_CR15", "first-page": "909", "volume": "261", "author": "T Shimada", "year": "1986", "unstructured": "Shimada T, Misono KS, Guengerich FP (1986) Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. J Biol Chem 261:909\u2013921", "journal-title": "J Biol Chem"}, {"key": "9_CR16", "first-page": "5051", "volume": "261", "author": "FP Guengerich", "year": "1986", "unstructured": "Guengerich FP, Martin MV, Beaune PH, Kremers P, Wolff T, Waxman DJ (1986) Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J Biol Chem 261:5051\u20135060", "journal-title": "J Biol Chem"}, {"key": "9_CR17", "first-page": "679", "volume": "40", "author": "CH Yun", "year": "1991", "unstructured": "Yun CH, Shimada T, Guengerich FP (1991) Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol Pharmacol 40:679\u2013685", "journal-title": "Mol Pharmacol"}, {"key": "9_CR18", "first-page": "856", "volume": "41", "author": "T Shimada", "year": "1992", "unstructured": "Shimada T, Yun CH, Yamazaki H, Gautier JC, Beaune PH, Guengerich FP (1992) Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol Pharmacol 41:856\u2013864", "journal-title": "Mol Pharmacol"}, {"key": "9_CR19", "first-page": "11734", "volume": "261", "author": "J Gut", "year": "1986", "unstructured": "Gut J, Catin T, Dayer P, Kronbach T, Zanger U, Meyer UA (1986) Debrisoquine/sparteine-type polymorphism of drug oxidation: purification and characterization of two functionally different human liver cytochrome P-450 isozymes involved in impaired hydroxylation of the prototype substrate bufuralol. J Biol Chem 261:11734\u201311743", "journal-title": "J Biol Chem"}, {"key": "9_CR20", "first-page": "197", "volume": "17", "author": "J Combalbert", "year": "1989", "unstructured": "Combalbert J, Fabre I, Fabre G, Dalet I, Derancourt J, Cano JP, Maurel P (1989) Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily. Drug Metab Dispos 17:197\u2013207", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR21", "doi-asserted-by": "crossref", "first-page": "3165", "DOI": "10.1016/0006-2952(86)90403-X", "volume": "35", "author": "C Birgersson", "year": "1986", "unstructured": "Birgersson C, Morgan ET, J\u00f6rnvall H, von Bahr C (1986) Purification of a desmethylimipramine and debrisoquine hydroxylating cytochrome P-450 from human liver. Biochem Pharmacol 35:3165\u20133166", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR22", "doi-asserted-by": "crossref", "first-page": "1743", "DOI": "10.1021/bi00173a017", "volume": "33", "author": "JA Goldstein", "year": "1994", "unstructured": "Goldstein JA, Faletto MB, Romkes-Sparks M, Sullivan T, Kitareewan S, Raucy JL, Lasker JM, Ghanayem BI (1994) Evidence that CYP2C19 is the major (S)-mephenytoin 4\u2032-hydroxylase in humans. Biochemistry 33:1743\u20131752", "journal-title": "Biochemistry"}, {"key": "9_CR23", "doi-asserted-by": "crossref", "first-page": "292", "DOI": "10.1016/0003-9861(87)90347-X", "volume": "258", "author": "SA Wrighton", "year": "1987", "unstructured": "Wrighton SA, Thomas PE, Ryan DE, Levin W (1987) Purification and characterization of ethanol-inducible human hepatic cytochrome P-450HLj. Arch Biochem Biophys 258:292\u2013297", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR24", "doi-asserted-by": "crossref", "first-page": "275", "DOI": "10.1016/0003-9861(85)90383-2", "volume": "241", "author": "M Kitada", "year": "1985", "unstructured": "Kitada M, Kamataki T, Itahashi K, Rikihisa T, Kato R, Kanakubo Y (1985) Purification and properties of cytochrome P-450 from homogenates of human fetal livers. Arch Biochem Biophys 241:275\u2013280", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR25", "first-page": "437", "volume": "14", "author": "P Beaune", "year": "1986", "unstructured": "Beaune P, Kremers PG, Kaminsky LS, de Graeve J, Guengerich FP (1986) Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes. Drug Metab Dispos 14:437\u2013442", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR26", "first-page": "500", "volume": "33", "author": "FP Guengerich", "year": "1988", "unstructured": "Guengerich FP (1988) Oxidation of 17\u03b1-ethynylestradiol by human liver cytochrome P-450. Mol Pharmacol 33:500\u2013508", "journal-title": "Mol Pharmacol"}, {"key": "9_CR27", "doi-asserted-by": "crossref", "first-page": "7348", "DOI": "10.1073/pnas.81.23.7348", "volume": "81", "author": "LM Distlerath", "year": "1984", "unstructured": "Distlerath LM, Guengerich FP (1984) Characterization of a human liver cytochrome P-450 involved in the oxidation of debrisoquine and other drugs by using antibodies raised to the analogous rat enzyme. Proc Natl Acad Sci U S A 81:7348\u20137352", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR28", "author": "LM Distlerath", "year": "1987", "unstructured": "Distlerath LM, Guengerich FP (1987) Enzymology of human liver cytochromes P-450. In: Guengerich FP (ed) Mammalian cytochromes P-450, vol\u00a01. CRC Press, Boca Raton", "volume-title": "Mammalian cytochromes P-450"}, {"key": "9_CR29", "doi-asserted-by": "crossref", "first-page": "462", "DOI": "10.1073/pnas.86.2.462", "volume": "86", "author": "T Shimada", "year": "1989", "unstructured": "Shimada T, Guengerich FP (1989) Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc Natl Acad Sci U S A 86:462\u2013465", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR30", "doi-asserted-by": "crossref", "first-page": "391", "DOI": "10.1021/tx00022a001", "volume": "4", "author": "FP Guengerich", "year": "1991", "unstructured": "Guengerich FP, Shimada T (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 4:391\u2013407", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR31", "first-page": "3218", "volume": "49", "author": "T Shimada", "year": "1989", "unstructured": "Shimada T, Iwasaki M, Martin MV, Guengerich FP (1989) Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA1535/pSK1002. Cancer Res 49:3218\u20133228", "journal-title": "Cancer Res"}, {"key": "9_CR32", "doi-asserted-by": "crossref", "first-page": "2793", "DOI": "10.1073/pnas.79.9.2793", "volume": "79", "author": "Y Fujii-Kuriyama", "year": "1982", "unstructured": "Fujii-Kuriyama Y, Mizukami Y, Kawajiri K, Sogawa K, Muramatsu M (1982) Primary structure of a cytochrome P-450: coding nucleotide sequence of phenobarbital-inducible cytochrome P-450 cDNA from rat liver. Proc Natl Acad Sci U S A 79:2793\u20132797", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR33", "first-page": "243", "volume": "40", "author": "FJ Gonzalez", "year": "1989", "unstructured": "Gonzalez FJ (1989) The molecular biology of cytochrome P450s. Pharmacol Rev 40:243\u2013288", "journal-title": "Pharmacol Rev"}, {"key": "9_CR34", "doi-asserted-by": "crossref", "first-page": "442", "DOI": "10.1038/331442a0", "volume": "331", "author": "FJ Gonzalez", "year": "1988", "unstructured": "Gonzalez FJ, Skoda RC, Kimura S, Umeno M, Zanger UM, Nebert DW, Gelboin HV, Hardwick JP, Meyer UA (1988) Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 331:442\u2013446", "journal-title": "Nature"}, {"key": "9_CR35", "doi-asserted-by": "crossref", "first-page": "1258", "DOI": "10.1126/science.3535074", "volume": "234", "author": "MX Zuber", "year": "1986", "unstructured": "Zuber MX, Simpson ER, Waterman MR (1986) Expression of bovine 17\u03b1-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells. Science 234:1258\u20131261", "journal-title": "Science"}, {"key": "9_CR36", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1093/oxfordjournals.jbchem.a135255", "volume": "98", "author": "T Sakaki", "year": "1985", "unstructured": "Sakaki T, Oeda K, Miyoshi M, Ohkawa H (1985) Characterization of rat cytochrome P-450MC synthesized in Saccharomyces cerevisiae. J Biochem (Tokyo) 98:167\u2013175", "journal-title": "J Biochem (Tokyo)"}, {"key": "9_CR37", "first-page": "19186", "volume": "266", "author": "YC Li", "year": "1991", "unstructured": "Li YC, Chiang JYL (1991) The expression of a catalytically active cholesterol 7\u03b1-hydroxylase cytochrome P-450 in Escherichia coli. J Biol Chem 266:19186\u201319191", "journal-title": "J Biol Chem"}, {"key": "9_CR38", "first-page": "7321", "volume": "266", "author": "JR Larson", "year": "1991", "unstructured": "Larson JR, Coon MJ, Porter TD (1991) Alcohol-inducible cytochrome P-450IIE1 lacking the hydrophobic NH2-terminal segment retains catalytic activity and is membrane-bound when expressed in Escherichia coli. J Biol Chem 266:7321\u20137324", "journal-title": "J Biol Chem"}, {"key": "9_CR39", "doi-asserted-by": "crossref", "first-page": "5597", "DOI": "10.1073/pnas.88.13.5597", "volume": "88", "author": "HJ Barnes", "year": "1991", "unstructured": "Barnes HJ, Arlotto MP, Waterman MR (1991) Expression and enzymatic activity of recombinant cytochrome P450 17\u03b1-hydroxylase in Escherichia coli. Proc Natl Acad Sci U S A 88:5597\u20135601", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR40", "doi-asserted-by": "crossref", "first-page": "121", "DOI": "10.1016/S1097-2765(00)80408-6", "volume": "5", "author": "PA Williams", "year": "2000", "unstructured": "Williams PA, Cosme J, Sridhar V, Johnson EF, McRee DE (2000) Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. Mol Cell 5:121\u2013131", "journal-title": "Mol Cell"}, {"key": "9_CR41", "doi-asserted-by": "crossref", "first-page": "464", "DOI": "10.1038/nature01862", "volume": "424", "author": "PA Williams", "year": "2003", "unstructured": "Williams PA, Cosme J, Ward A, Angove HC, Matak Vinkovic D, Jhoti H (2003) Crystal structure of human cytochrome P450 2C9 with bound warfarin. Nature 424:464\u2013468", "journal-title": "Nature"}, {"key": "9_CR42", "doi-asserted-by": "crossref", "first-page": "10613", "DOI": "10.1074/jbc.M111.323501", "volume": "287", "author": "B Zhao", "year": "2012", "unstructured": "Zhao B, Lei L, Kagawa N, Sundaramoorthy M, Banerjee S, Nagy LD, Guengerich FP, Waterman MR (2012) Three-dimensional structure of steroid 21-hydroxylase (cytochrome P450 21A2) with two substrates reveals locations of disease-associated variants. J Biol Chem 287:10613\u201310622", "journal-title": "J Biol Chem"}, {"key": "9_CR43", "doi-asserted-by": "crossref", "first-page": "441", "DOI": "10.1016/j.jmb.2009.11.057", "volume": "396", "author": "AJ Annalora", "year": "2010", "unstructured": "Annalora AJ, Goodin DB, Hong WX, Zhang Q, Johnson EF, Stout CD (2010) Crystal structure of CYP24A1, a mitochondrial cytochrome P450 involved in vitamin D metabolism. J Mol Biol 396:441\u2013451", "journal-title": "J Mol Biol"}, {"key": "9_CR44", "author": "W Kalow", "year": "1962", "unstructured": "Kalow W (1962) Pharmacogenetics. W. B. Saunders, Philadelphia", "volume-title": "Pharmacogenetics"}, {"key": "9_CR45", "author": "DV Parke", "first-page": "244", "year": "1979", "unstructured": "Parke DV (1979) IV. The drug metabolizing enzyme system. Discussion. In: Estabrook RW, Lindenlaub EF (eds) The induction of drug metabolism. K. Schattauer Verlag, Stuttgart, pp\u00a0244\u2013250", "volume-title": "The induction of drug metabolism"}, {"key": "9_CR46", "first-page": "12068", "volume": "256", "author": "MA Lang", "year": "1981", "unstructured": "Lang MA, Gielen JE, Nebert DW (1981) Genetic evidence for many unique liver microsomal P-450-mediated monooxygenase activities in heterogeneic stock mice. J Biol Chem 256:12068\u201312075", "journal-title": "J Biol Chem"}, {"key": "9_CR47", "doi-asserted-by": "crossref", "first-page": "1155", "DOI": "10.1016/S0140-6736(02)11203-7", "volume": "360", "author": "DW Nebert", "year": "2002", "unstructured": "Nebert DW, Russell DW (2002) Clinical importance of the cytochromes P450. Lancet 360:1155\u20131162", "journal-title": "Lancet"}, {"key": "9_CR48", "doi-asserted-by": "crossref", "first-page": "17091", "DOI": "10.1074/jbc.R112.431916", "volume": "288", "author": "IA Pikuleva", "year": "2013", "unstructured": "Pikuleva IA, Waterman MR (2013) Cytochromes P450: roles in diseases. J Biol Chem 288:17091\u201317098", "journal-title": "J Biol Chem"}, {"key": "9_CR49", "doi-asserted-by": "crossref", "first-page": "1201", "DOI": "10.1124/dmd.104.000794", "volume": "32", "author": "JA Williams", "year": "2004", "unstructured": "Williams JA, Hyland R, Jones BC, Smith DA, Hurst S, Goosen TC, Peterkin V, Koup JR, Ball SE (2004) Drug-drug interactions for UDP-glucuronosyltransferasesubstrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Drug Metab Dispos 32:1201\u20131208", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR50", "doi-asserted-by": "crossref", "first-page": "825", "DOI": "10.1038/nrd1851", "volume": "4", "author": "LC Wienkers", "year": "2005", "unstructured": "Wienkers LC, Heath TG (2005) Predicting in vivo drug interactions from in vitro drug discovery data. Nat Rev Drug Discov 4:825\u2013833", "journal-title": "Nat Rev Drug Discov"}, {"key": "9_CR51", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1081/DMR-120001392", "volume": "34", "author": "S Rendic", "year": "2002", "unstructured": "Rendic S (2002) Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev 34:83\u2013448", "journal-title": "Drug Metab Rev"}, {"key": "9_CR52", "first-page": "414", "volume": "270", "author": "T Shimada", "year": "1994", "unstructured": "Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414\u2013423", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR53", "first-page": "2370", "volume": "239", "author": "T Omura", "year": "1964", "unstructured": "Omura T, Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370\u20132378", "journal-title": "J Biol Chem"}, {"key": "9_CR54", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.1002/jps.22255", "volume": "100", "author": "H Kawakami", "year": "2011", "unstructured": "Kawakami H, Ohtsuki S, Kamiie J, Suzuki T, Abe T, Terasaki T (2011) Simultaneous absolute quantification of 11 cytochrome P450 isoforms in human liver microsomes by liquid chromatography tandem mass spectrometry with in silico target peptide selection. J Pharm Sci 100:341\u2013352", "journal-title": "J Pharm Sci"}, {"key": "9_CR55", "doi-asserted-by": "crossref", "first-page": "500", "DOI": "10.1124/dmd.113.055632", "volume": "42", "author": "B Achour", "year": "2014", "unstructured": "Achour B, Russell MR, Barber J, Rostami-Hodjegan A (2014) Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics. Drug Metab Dispos 42:500\u2013510", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR56", "doi-asserted-by": "crossref", "first-page": "880", "DOI": "10.1124/dmd.105.008672", "volume": "34", "author": "MF Paine", "year": "2006", "unstructured": "Paine MF, Hart HL, Ludington SS, Haining RL, Rettie AE, Zeldin DC (2006) The human intestinal cytochrome P450 \u201cpie\u201d. Drug Metab Dispos 34:880\u2013886", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR57", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1146/annurev.pharmtox.43.100901.140233", "volume": "43", "author": "M Schwab", "year": "2003", "unstructured": "Schwab M, Eichelbaum M, Fromm MF (2003) Genetic polymorphisms of the human MDR1 drug transporter. Annu Rev Pharmacol Toxicol 43:285\u2013307", "journal-title": "Annu Rev Pharmacol Toxicol"}, {"key": "9_CR58", "author": "RH Ho", "first-page": "519", "year": "2010", "unstructured": "Ho RH, Kim RB (2010) Uptake transporters. In: Guengerich FP (ed) Biotransfomration, vol\u00a04 of comprehensive toxciology, 2nd edn., (McQueen, C.A., series ed.). Elsevier, Oxford, pp\u00a0519\u2013555", "volume-title": "Biotransfomration, vol\u00a04 of comprehensive toxciology, 2nd edn., (McQueen, C.A., series ed.)"}, {"key": "9_CR59", "author": "P Jugsuwadee", "first-page": "557", "year": "2010", "unstructured": "Jugsuwadee P, Vore ME (2010) Efflux transporters. In: Guengerich FP (ed) Biotransfomration, vol\u00a04 of comprehensive toxciology, 2nd edn., (McQueen, C.A., series ed.). Elsevier, Oxford, pp\u00a0557\u2013601", "volume-title": "Biotransfomration, vol\u00a04 of comprehensive toxciology, 2nd edn., (McQueen, C.A., series ed.)"}, {"key": "9_CR60", "doi-asserted-by": "crossref", "first-page": "7696", "DOI": "10.1073/pnas.86.20.7696", "volume": "86", "author": "MA Butler", "year": "1989", "unstructured": "Butler MA, Iwasaki M, Guengerich FP, Kadlubar FF (1989) Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci U S A 86:7696\u20137700", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR61", "doi-asserted-by": "crossref", "first-page": "116", "DOI": "10.1097/00008571-199206000-00003", "volume": "2", "author": "MA Butler", "year": "1992", "unstructured": "Butler MA, Lang NP, Young JF, Caporaso NE, Vineis P, Hayes RB, Teitel CH, Massengill JP, Lawsen MF, Kadlubar FF (1992) Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics 2:116\u2013127", "journal-title": "Pharmacogenetics"}, {"key": "9_CR62", "doi-asserted-by": "crossref", "first-page": "584", "DOI": "10.1002/cpt1979265584", "volume": "26", "author": "NM Woolhouse", "year": "1979", "unstructured": "Woolhouse NM, Andoh B, Mahgoub A, Sloan TP, Idle JR, Smith RL (1979) Debrisoquin hydroxylation polymorphism among Ghanaians and Caucasians. Clin Pharmacol Ther 26:584\u2013591", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR63", "doi-asserted-by": "crossref", "first-page": "11825", "DOI": "10.1073/pnas.90.24.11825", "volume": "90", "author": "I Johansson", "year": "1993", "unstructured": "Johansson I, Lundqvist E, Bertilsson L, Dahl ML, Sj\u00f6qvist F, Ingelman-Sundberg M (1993) Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine. Proc Natl Acad Sci U S A 90:11825\u201311829", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR64", "doi-asserted-by": "crossref", "first-page": "1020", "DOI": "10.1101/gr.103341.109", "volume": "20", "author": "X Yang", "year": "2010", "unstructured": "Yang X, Zhang B, Molony C, Chudin E, Hao K, Zhu J, Gaedigk A, Suver C, Zhong H, Leeder JS, Guengerich FP, Strom SC, Schuetz E, Rushmore TH, Ulrich RG, Slatter JG, Schadt EE, Kasarskis A, Lum PY (2010) Systematic genetic and genomicanalysis of cytochrome P450 enzyme activities in human liver. Genome Res 20:1020\u20131036", "journal-title": "Genome Res"}, {"key": "9_CR65", "doi-asserted-by": "crossref", "first-page": "443", "DOI": "10.2217/14622416.8.5.443", "volume": "8", "author": "M Schirmer", "year": "2007", "unstructured": "Schirmer M, Rosenberger A, Klein K, Kulle B, Toliat MR, Nurnberg P, Zanger UM, Wojnowski L (2007) Sex-dependent genetic markers of CYP3A4 expression and activity in human liver microsomes. Pharmacogenomics 8:443\u2013453", "journal-title": "Pharmacogenomics"}, {"key": "9_CR66", "doi-asserted-by": "crossref", "first-page": "474", "DOI": "10.1067/mcp.2002.128388", "volume": "72", "author": "CL Cummins", "year": "2002", "unstructured": "Cummins CL, Wu CY, Benet LZ (2002) Sex-related differences in the clearance of cytochrome P450 3A4 substrates may be caused by P-glycoprotein. Clin Pharmacol Ther 72:474\u2013489", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR67", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1046/j.1472-8206.2003.00119.x", "volume": "17", "author": "AK Daly", "year": "2003", "unstructured": "Daly AK (2003) Pharmacogenetics of the major polymorphic metabolizing enzymes. Fundam Clin Pharmacol 17:27\u201341", "journal-title": "Fundam Clin Pharmacol"}, {"key": "9_CR68", "doi-asserted-by": "crossref", "first-page": "399", "DOI": "10.1111/j.1365-2125.1991.tb05552.x", "volume": "31", "author": "CH Ahsan", "year": "1991", "unstructured": "Ahsan CH, Renwick AG, Macklin B, Challenor VF, Waller DG, George CF (1991) Ethnic differences in the pharmacokinetics of oral nifedipine. Br J Clin Pharmacol 31:399\u2013403", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR69", "first-page": "4", "volume": "279", "author": "RB Kim", "year": "1996", "unstructured": "Kim RB, Yamazaki H, Chiba K, O\u2019Shea D, Mimura M, Guengerich FP, Ishizaki T, Shimada T, Wilkinson GR (1996) In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians. J Pharmacol Exp Ther 279:4\u201311", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR70", "first-page": "4875", "volume": "42", "author": "AH Conney", "year": "1982", "unstructured": "Conney AH (1982) Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes memorial lecture. Cancer Res 42:4875\u20134917", "journal-title": "Cancer Res"}, {"key": "9_CR71", "doi-asserted-by": "crossref", "first-page": "415", "DOI": "10.1126/science.1925598", "volume": "254", "author": "TR Sutter", "year": "1991", "unstructured": "Sutter TR, Guzman K, Dold KM, Greenlee WF (1991) Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1\u03b2. Science 254:415\u2013418", "journal-title": "Science"}, {"key": "9_CR72", "doi-asserted-by": "crossref", "first-page": "255", "DOI": "10.1124/mol.61.2.255", "volume": "61", "author": "SP Rivera", "year": "2002", "unstructured": "Rivera SP, Saarikoski ST, Hankinson O (2002) Identification of a novel dioxin-inducible cytochrome P450. Mol Pharmacol 61:255\u2013259", "journal-title": "Mol Pharmacol"}, {"key": "9_CR73", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1016/0165-6147(90)90245-4", "volume": "11", "author": "DD Breimer", "year": "1990", "unstructured": "Breimer DD, Schellens JH (1990) A \u2018cocktail\u2019 strategy to assess in vivo oxidative drug metabolism in humans. Trends Pharmacol Sci 11:223\u2013225", "journal-title": "Trends Pharmacol Sci"}, {"key": "9_CR74", "author": "DD Breimer", "year": "1994", "unstructured": "Breimer DD (1994) Genetic polymorphisms in drug metabolism; clinical implications and consequences in ADME studies. In: Walker S, Lumley C, McAuslane N (eds) The relevance of ethnic factors in the clinical evaluation of medicines. Kluwer Academic Publishers, Dordrecht", "volume-title": "The relevance of ethnic factors in the clinical evaluation of medicines"}, {"key": "9_CR75", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1136/bmj.284.6312.295", "volume": "284", "author": "RR Shah", "year": "1982", "unstructured": "Shah RR, Oates NS, Idle JR, Smith RL, Lockhart JDF (1982) Impaired oxidation of debrisoquine in patients with perhexiline neuropathy. Br Med J 284:295\u2013299", "journal-title": "Br Med J"}, {"key": "9_CR76", "doi-asserted-by": "crossref", "first-page": "361", "DOI": "10.1097/00008571-199710000-00004", "volume": "7", "author": "DJ Steward", "year": "1997", "unstructured": "Steward DJ, Haining RL, Henne KR, Davis G, Rushmore TH, Trager WF, Rettie AE (1997) Genetic association between sensitivity to warfarin and expression of CYP2C9*3. Pharmacogenetics 7:361\u2013367", "journal-title": "Pharmacogenetics"}, {"key": "9_CR77", "doi-asserted-by": "crossref", "first-page": "717", "DOI": "10.1016/S0140-6736(98)04474-2", "volume": "353", "author": "GP Aithal", "year": "1999", "unstructured": "Aithal GP, Day CP, Kesteven PJ, Daly AK (1999) Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet 353:717\u2013719", "journal-title": "Lancet"}, {"key": "9_CR78", "doi-asserted-by": "crossref", "first-page": "408", "DOI": "10.1046/j.1365-2125.2002.01572_6.x", "volume": "53", "author": "AK Daly", "year": "2002", "unstructured": "Daly AK, Day CP, Aithal GP (2002) CYP2C9 polymorphism and warfarin dose requirements. Br J Clin Pharmacol 53:408\u2013409", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR79", "first-page": "52", "volume": "266", "author": "K Chiba", "year": "1993", "unstructured": "Chiba K, Kobayashi K, Manabe K, Tani M, Kamataki T, Ishizaki T (1993) Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4-hydroxylation. J Pharmacol Exp Ther 266:52\u201359", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR80", "first-page": "1081", "volume": "24", "author": "WG Karam", "year": "1996", "unstructured": "Karam WG, Goldstein JA, Lasker JM, Ghanayem BI (1996) Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes. Drug Metab Dispos 24:1081\u20131087", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR81", "doi-asserted-by": "crossref", "first-page": "2827", "DOI": "10.1056/NEJMoa041888", "volume": "351", "author": "Y Gasche", "year": "2004", "unstructured": "Gasche Y, Daali Y, Fathi M, Chiappe A, Cottini S, Dayer P, Desmeules J (2004) Codeine intoxication associated with ultrarapid CYP2D6 metabolism. New Engl J Med 351:2827\u20132831", "journal-title": "New Engl J Med"}, {"key": "9_CR82", "doi-asserted-by": "crossref", "first-page": "189", "DOI": "10.1530/acta.0.0850189", "volume": "85", "author": "HM Bolt", "year": "1977", "unstructured": "Bolt HM, Bolt M, Kappus H (1977) Interaction of rifampicin treatment with pharmacokinetics and metabolism of ethinyloestradiol in man. Acta Endocrinol 85:189\u2013197", "journal-title": "Acta Endocrinol"}, {"key": "9_CR83", "doi-asserted-by": "crossref", "first-page": "112", "DOI": "10.1046/j.1365-2125.2003.01716.x", "volume": "55", "author": "UI Schwarz", "year": "2003", "unstructured": "Schwarz UI, Buschel B, Kirch W (2003) Unwanted pregnancyon self-medication with St John\u2019s wort despite hormonal contraception. Br J Clin Pharmacol 55:112\u2013113", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR84", "author": "FP Guengerich", "first-page": "203", "year": "1999", "unstructured": "Guengerich FP (1999) Inhibition of drug metabolizing enzymes: molecular and biochemical aspects. In: Woolf TF (ed) Handbook of drug metabolism. Marcel Dekker, New York, pp\u00a0203\u2013227", "volume-title": "Handbook of drug metabolism", "DOI": "10.1201/b13995-9", "doi-asserted-by": "crossref"}, {"key": "9_CR85", "unstructured": "Hollenberg PF, Correia MA, Zhang H (2014) Inhibition of P450 enzymes, Chap.\u00a05 (this book)"}, {"key": "9_CR86", "first-page": "357", "volume": "12", "author": "DG Bailey", "year": "1990", "unstructured": "Bailey DG, Spence JD, Edgar B, Bayliff CD, Arnold JMO (1990) Ethanol enhances the hemodynamic effects of felodipine. Invest Med 12:357\u2013362", "journal-title": "Invest Med"}, {"key": "9_CR87", "first-page": "181", "volume": "47", "author": "B Edgar", "year": "1990", "unstructured": "Edgar B, Bailey DG, Bergstrand R, Johnsson G, Lurje L (1990) Formulation dependent interaction between felodipine and grapefruit juice. Clin Pharmacol Ther 47:181", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR88", "doi-asserted-by": "crossref", "first-page": "252", "DOI": "10.1021/tx970192k", "volume": "11", "author": "K He", "year": "1998", "unstructured": "He K, Iyer R, Hayes RN, Sinz MW, Woolf TF, Hollenberg PF (1998) Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem Res Toxicol 11:252\u2013259", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR89", "first-page": "1228", "volume": "25", "author": "P Schmiedlin-Ren", "year": "1997", "unstructured": "Schmiedlin-Ren P, Edwards DJ, Fitzsimmons ME, He K, Lown KS, Woster PM, Rahman A, Thummel KE, Fisher JM, Hollenberg PF, Watkins PB (1997) Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Drug Metab Dispos 25:1228\u20131233", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR90", "first-page": "255", "volume": "25", "author": "D Reimers", "year": "1971", "unstructured": "Reimers D, Jezek A (1971) Rifampicin und andere Antituberkulotika bei gleichzeitiger oraler Kontrazeption. Przx Pneumolonol 25:255\u2013262", "journal-title": "Przx Pneumolonol"}, {"key": "9_CR91", "doi-asserted-by": "crossref", "first-page": "1521", "DOI": "10.1055/s-0028-1107071", "volume": "98", "author": "L Nocke-Finck", "year": "1973", "unstructured": "Nocke-Finck L, Brewer H, Reimers D (1973) Wirkung van Rifampicin auf den Menstrationszylkus und die \u00d6strogenausscheidung bei Einnahme oraler Kontrazeptive. Dtsch Med Wochenschr 98:1521\u20131523", "journal-title": "Dtsch Med Wochenschr"}, {"key": "9_CR92", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.2165/00003088-199427010-00001", "volume": "27", "author": "KT Kivist\u00f6", "year": "1994", "unstructured": "Kivist\u00f6 KT, Neuvonen PJ, Klotz U (1994) Inhibition of terfenadine metabolism: pharmacokinetic and pharmacodynamic consequences. Clin Pharmacokinet 27:1\u20135", "journal-title": "Clin Pharmacokinet"}, {"key": "9_CR93", "first-page": "403", "volume": "21", "author": "CH Yun", "year": "1993", "unstructured": "Yun CH, Okerholm RA, Guengerich FP (1993) Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation. Drug Metab Dispos 21:403\u2013409", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR94", "author": "FP Guengerich", "first-page": "523", "year": "2014", "unstructured": "Guengerich FP (2014) Cytochrome P450-mediated drug interactions and cardiovascular toxicity: the Seldane to Allegra transformation. In: Wang J, Urban L (eds) Predictive ADMET: integrated approaches in drug discovery and development. Wiley, New York, pp\u00a0523\u2013534", "volume-title": "Predictive ADMET: integrated approaches in drug discovery and development", "DOI": "10.1002/9781118783344.ch23", "doi-asserted-by": "crossref"}, {"key": "9_CR95", "doi-asserted-by": "crossref", "first-page": "1339", "DOI": "10.1001/jama.1996.03530410053033", "volume": "275", "author": "D Thompson", "year": "1996", "unstructured": "Thompson D, Oster G (1996) Use of terfenadine and contraindicated drugs. J Am Med Assoc 275:1339\u20131341", "journal-title": "J Am Med Assoc"}, {"key": "9_CR96", "doi-asserted-by": "crossref", "first-page": "149", "DOI": "10.3109/00498258509045345", "volume": "15", "author": "T Fischbach", "year": "1985", "unstructured": "Fischbach T, Lenk W (1985) Additional routes in the metabolism of phenacetin. Xenobiotica 15:149\u2013164", "journal-title": "Xenobiotica"}, {"key": "9_CR97", "first-page": "287", "volume": "30", "author": "FP Guengerich", "year": "1986", "unstructured": "Guengerich FP, M\u00fcller-Enoch D, Blair IA (1986) Oxidation of quinidine by human liver cytochrome P-450. Mol Pharmacol 30:287\u2013295", "journal-title": "Mol Pharmacol"}, {"key": "9_CR98", "first-page": "535", "volume": "176", "author": "GC Mueller", "year": "1948", "unstructured": "Mueller GC, Miller JA (1948) The metabolism of 4-dimethylaminoazobenzene by rat liver homogenates. J Biol Chem 176:535\u2013544", "journal-title": "J Biol Chem"}, {"key": "9_CR99", "doi-asserted-by": "crossref", "first-page": "1316", "DOI": "10.1021/tx300132k", "volume": "25", "author": "S Rendic", "year": "2012", "unstructured": "Rendic S, Guengerich FP (2012) Contributions of human enzymes in carcinogen metabolism. Chem Res Toxicol 25:1316\u20131383", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR100", "first-page": "195", "volume": "187", "author": "DJ Jollow", "year": "1973", "unstructured": "Jollow DJ, Mitchell JR, Potter WZ, Davis DC, Gillette JR, Brodie BB (1973) Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther 187:195\u2013202", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR101", "doi-asserted-by": "crossref", "first-page": "321", "DOI": "10.1146/annurev.pa.22.040182.001541", "volume": "22", "author": "RA Neal", "year": "1982", "unstructured": "Neal RA, Halpert J (1982) Toxicology of thiono-sulfur compounds. Annu Rev Pharmacol Toxicol 22:321\u2013339", "journal-title": "Annu Rev Pharmacol Toxicol"}, {"key": "9_CR102", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1126/science.6849116", "volume": "219", "author": "KD Wing", "year": "1983", "unstructured": "Wing KD, Glickman AH, Casida JE (1983) Oxidative bioactivation of S-alkyl phosphorothiolate pesticides: stereospecificity of profenofos insecticide activation. Science 219:63\u201365", "journal-title": "Science"}, {"key": "9_CR103", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.3109/10408448909017908", "volume": "20", "author": "DW Nebert", "year": "1989", "unstructured": "Nebert DW (1989) The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. Crit Rev Toxicol 20:153\u2013174", "journal-title": "Crit Rev Toxicol"}, {"key": "9_CR104", "doi-asserted-by": "crossref", "first-page": "12063", "DOI": "10.1074/jbc.271.20.12063", "volume": "271", "author": "SST Lee", "year": "1996", "unstructured": "Lee SST, Buters JTM, Pineau T, Fernandez-Salguero P, Gonzalez FJ (1996) Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem 271:12063\u201312067", "journal-title": "J Biol Chem"}, {"key": "9_CR105", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1006/taap.1998.8501", "volume": "152", "author": "H Zaher", "year": "1998", "unstructured": "Zaher H, Buters JT, Ward JM, Bruno MK, Lucas AM, Stern ST, Cohen SD, Gonzalez FJ (1998) Protection against acetaminophen toxicityin CYP1A2 and CYP2E1 double-null mice. Toxicol Appl Pharmacol 152:193\u2013199", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "9_CR106", "doi-asserted-by": "crossref", "first-page": "1977", "DOI": "10.1073/pnas.96.5.1977", "volume": "96", "author": "JTM Buters", "year": "1999", "unstructured": "Buters JTM, Sakai S, Richter T, Pineau T, Alexander DL, Savas U, Doehmer J, Ward JM, Jefcoate CR, Gonzalez FJ (1999) Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas. Proc Natl Acad Sci U S A 96:1977\u20131982", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR107", "first-page": "6242", "volume": "243", "author": "DW Nebert", "year": "1968", "unstructured": "Nebert DW, Gelboin HV (1968) Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture: assay and properties of induced enzyme. J Biol Chem 243:6242\u20136249", "journal-title": "J Biol Chem"}, {"key": "9_CR108", "first-page": "327", "volume": "25", "author": "G Kellerman", "year": "1973", "unstructured": "Kellerman G, Luyten-Kellerman M, Shaw CR (1973) Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes. Am J Hum Genet 25:327\u2013331", "journal-title": "Am J Hum Genet"}, {"key": "9_CR109", "doi-asserted-by": "crossref", "first-page": "934", "DOI": "10.1056/NEJM197311012891802", "volume": "298", "author": "G Kellerman", "year": "1973", "unstructured": "Kellerman G, Shaw CR, Luyten-Kellerman M (1973) Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. New Engl J Med 298:934\u2013937", "journal-title": "New Engl J Med"}, {"key": "9_CR110", "first-page": "2757", "volume": "41", "author": "B Paigen", "year": "1981", "unstructured": "Paigen B, Ward E, Reilly A, Houten L, Gurtoo HL, Minowada J, Steenland K, Havens MB, Sartori P (1981) Seasonal variation of aryl hydrocarbon hydroxylase activity in human lymphocytes. Cancer Res 41:2757\u20132761", "journal-title": "Cancer Res"}, {"key": "9_CR111", "first-page": "5030", "volume": "42", "author": "RE Kouri", "year": "1982", "unstructured": "Kouri RE, McKinney CE, Slomiany DJ, Snodgrass DR, Wray NP, McLemore TL (1982) Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res 42:5030\u20135037", "journal-title": "Cancer Res"}, {"key": "9_CR112", "doi-asserted-by": "crossref", "first-page": "312", "DOI": "10.1097/00008571-199312000-00005", "volume": "3", "author": "C Chang", "year": "1993", "unstructured": "Chang C, Smith DR, Prasad VS, Sidman CL, Nebert DW, Puga A (1993) Ten nucleotide differences, five of which cause amino acid changes, are associated with the Ah receptor locus polymorphism of C57BL/6 and DBA/2 mice. Pharmacogenetics 3:312\u2013321", "journal-title": "Pharmacogenetics"}, {"key": "9_CR113", "first-page": "911", "volume": "44", "author": "KM Dolwick", "year": "1993", "unstructured": "Dolwick KM, Schmidt JV, Carver LA, Swanson HI, Bradfield CA (1993) Cloning and expression of a human Ah receptor cDNA. Mol Pharmacol 44:911\u2013917", "journal-title": "Mol Pharmacol"}, {"key": "9_CR114", "doi-asserted-by": "crossref", "first-page": "S149", "DOI": "10.1097/00008571-199512001-00018", "volume": "5", "author": "Y Fujii-Kuriyama", "year": "1995", "unstructured": "Fujii-Kuriyama Y, Ema M, Mimura J, Matsushita N, Sogawa K (1995) Polymorphic forms of the Ah receptor and induction of the CYP1A1 gene. Pharmacogenetics 5:S149\u2013S153", "journal-title": "Pharmacogenetics"}, {"key": "9_CR115", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1097/00008571-199506000-00003", "volume": "5", "author": "K Kawajiri", "year": "1995", "unstructured": "Kawajiri K, Watanabe J, Eguchi H, Nakachi K, Kiyohara C, Hayashi S (1995) Polymorphisms of human Ah receptor gene are not involved in lung cancer. Pharmacogenetics 5:151\u2013158", "journal-title": "Pharmacogenetics"}, {"key": "9_CR116", "doi-asserted-by": "crossref", "first-page": "407", "DOI": "10.1093/oxfordjournals.jbchem.a123594", "volume": "110", "author": "S Hayashi", "year": "1991", "unstructured": "Hayashi S, Watanabe J, Nakachi K, Kawajiri K (1991) Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem (Tokyo) 110:407\u2013411", "journal-title": "J Biochem (Tokyo)"}, {"key": "9_CR117", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1097/00008571-199110000-00004", "volume": "1", "author": "T Tefre", "year": "1991", "unstructured": "Tefre T, Ryberg D, Haugen A, Nebert DW, Skaug V, Brogger A, Borresen AL (1991) Human CYP1A1 (cytochrome P1450) gene: lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics 1:20\u201325", "journal-title": "Pharmacogenetics"}, {"key": "9_CR118", "first-page": "485", "volume": "1", "author": "A Hirvonen", "year": "1992", "unstructured": "Hirvonen A, Husgafvel-Pursiainen K, Karjalainen A, Anttila S, Vainio H (1992) Point-mutational Msp1 and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol Biomarkers Prev 1:485\u2013489", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9_CR119", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1097/00008571-199402000-00003", "volume": "4", "author": "PJ Wedlund", "year": "1994", "unstructured": "Wedlund PJ, Kimura S, Gonzalez FJ, Nebert DW (1994) I462V mutation in the human CYP1A1 gene: lack of correlation with either the Msp I 1.9\u00a0kb (M2) allele or CYP1A1 inducibility in a three-generation family of East Mediterranean descent. Pharmacogenetics 4:21\u201326", "journal-title": "Pharmacogenetics"}, {"key": "9_CR120", "first-page": "3926", "volume": "56", "author": "ZY Zhang", "year": "1996", "unstructured": "Zhang ZY, Fasco MJ, Huang L, Guengerich FP, Kaminsky LS (1996) Characterization of purified human recombinant cytochrome P4501A1-Ile462 and -Val462: assessment of a role for the rare allele in carcinogenesis. Cancer Res 56:3926\u20133933", "journal-title": "Cancer Res"}, {"key": "9_CR121", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1006/bbrc.1997.6051", "volume": "231", "author": "I Persson", "year": "1997", "unstructured": "Persson I, Johansson I, Ingelman-Sundberg M (1997) In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility. Biochem Biophys Res Commun 231:227\u2013230", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR122", "first-page": "219", "volume": "12", "author": "K Toide", "year": "2003", "unstructured": "Toide K, Yamazaki H, Nagashima R, Itoh K, Iwano S, Takahashi Y, Watanabe S, Kamataki T (2003) Aryl hydrocarbon hydroxylase represents CYP1B1, and not CYP1A1, in human freshly isolated white cells: Trimodal distribution of Japanese population according to induction of CYP1B1 mRNA by environmental dioxins. Cancer Epidemiol Biomarkers Prev 12:219\u2013222", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9_CR123", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1038/312169a0", "volume": "312", "author": "R Ayesh", "year": "1984", "unstructured": "Ayesh R, Idle JR, Ritchie JC, Crothers MJ, Hetzel MR (1984) Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature 312:169\u2013170", "journal-title": "Nature"}, {"key": "9_CR124", "doi-asserted-by": "crossref", "first-page": "149", "DOI": "10.3109/13547509609079352", "volume": "1", "author": "A d\u2019Errico", "year": "1996", "unstructured": "d\u2019Errico A, Taioli E, Chen X, Vineis P (1996) Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers 1:149\u2013173", "journal-title": "Biomarkers"}, {"key": "9_CR125", "first-page": "5284", "volume": "51", "author": "T Shimada", "year": "1991", "unstructured": "Shimada T, Guengerich FP (1991) Activation of amino-\u03b1-carboline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and a copper phthalocyanine cellulose extract of cigarette smoke condensate by cytochrome P-450 enzymes in rat and human liver microsomes. Cancer Res 51:5284\u20135291", "journal-title": "Cancer Res"}, {"key": "9_CR126", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1016/S0300-483X(02)00450-X", "volume": "181", "author": "P Vineis", "year": "2002", "unstructured": "Vineis P (2002) The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicology 181:457\u2013462", "journal-title": "Toxicology"}, {"key": "9_CR127", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1086/301764", "volume": "62", "author": "I Stoilov", "year": "1998", "unstructured": "Stoilov I, Akarsu AN, Alozie I, Child A, Barsoum-Homsy M, Turacli ME, Or M, Lewis RA, Ozdemir N, Brice G, Aktan SG, Chevrette L, Coca-Prados M, Sarfarazi M (1998) Sequence analysis and homology modelingsuggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P450 1B1. Am J Hum Genet 62:573\u2013584", "journal-title": "Am J Hum Genet"}, {"key": "9_CR128", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1016/S0003-9861(02)00364-8", "volume": "409", "author": "FJ Gonzalez", "year": "2003", "unstructured": "Gonzalez FJ, Kimura S (2003) Study of P450 function using gene knockout and transgenic mice. Arch Biochem Biophys 409:153\u2013158", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR129", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1080/00498250110043490", "volume": "31", "author": "T Shimada", "year": "2001", "unstructured": "Shimada T, Watanabe J, Inoue K, Guengerich FP, Gillam EM (2001) Specificity of 17\u03b2-oestradiol and benzo[a]pyrene oxidation by polymorphic human cytochrome P4501B1 variants substituted at residues 48, 119 and 432. Xenobiotica 31:163\u2013176", "journal-title": "Xenobiotica"}, {"key": "9_CR130", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1097/00008571-200002000-00004", "volume": "10", "author": "J Watanabe", "year": "2000", "unstructured": "Watanabe J, Shimada T, Gillam EMJ, Ikuta T, Suemasu K, Higashi Y, Osamu G, Kawajiri K (2000) Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics 10:25\u201333", "journal-title": "Pharmacogenetics"}, {"key": "9_CR131", "first-page": "147", "volume": "V9", "author": "W Zheng", "year": "2000", "unstructured": "Zheng W, Xie DW, Jin F, Cheng JR, Dai Q, Wen WQ, Shu XO, Gao YT (2000) Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev V9:147\u2013150", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9_CR132", "first-page": "675", "volume": "3", "author": "NP Lang", "year": "1994", "unstructured": "Lang NP, Butler MA, Massengill J, Lawson M, Stotts RC, Maurer-Jensen M, Kadlubar FF (1994) Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol Biomarkers Prev 3:675\u2013682", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9_CR133", "first-page": "890", "volume": "11", "author": "N Ariyoshi", "year": "2002", "unstructured": "Ariyoshi N, Miyamoto M, Umetsu Y, Kunitoh H, Dosaka-Akita H, Sawamura Y, Yokota J, Nemoto N, Sato K, Kamataki T (2002) Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers. Cancer Epidemiol Biomarkers Prev 11:890\u2013894", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9_CR134", "doi-asserted-by": "crossref", "first-page": "750", "DOI": "10.1038/31623", "volume": "393", "author": "ML Pianezza", "year": "1998", "unstructured": "Pianezza ML, Sellers EM, Tyndale RF (1998) Nicotine metabolism defect reduces smoking. Nature 393:750", "journal-title": "Nature"}, {"key": "9_CR135", "first-page": "162", "volume": "4", "author": "RB Kim", "year": "1994", "unstructured": "Kim RB, O\u2019Shea D, Wilkinson GR (1994) Relationship in healthy subjects between CYP2E1 genetic polymorphism and the 6-hydroxylation of chlorzoxazone: a putative measure of CYP2E1 activity. Pharmacogenetics 4:162\u2013165", "journal-title": "Pharmacogenetics"}, {"key": "9_CR136", "doi-asserted-by": "crossref", "first-page": "485", "DOI": "10.3109/03602539308993983", "volume": "25", "author": "C Ioannides", "year": "1993", "unstructured": "Ioannides C, Parke DV (1993) Induction of cytochrome P4501 as an indicator of potential chemical carcinogenesis. Drug Metab Rev 25:485\u2013501", "journal-title": "Drug Metab Rev"}, {"key": "9_CR137", "unstructured": "Rice JM, Diwan BA, Ward JM, Nims RW, Lubet RA (1992) Phenobarbital and related compounds: approaches to interspecies extrapolation. In: Relevance of animal studies to the evaluation of human cancer risk. Wiley, New York, pp\u00a0231\u2013249"}, {"key": "9_CR138", "doi-asserted-by": "crossref", "first-page": "803", "DOI": "10.1093/jnci/81.10.803", "volume": "81", "author": "JH Olsen", "year": "1989", "unstructured": "Olsen JH, Boice JD Jr, Jensen JPA, Fraumeni JF Jr (1989) Cancer among epileptic patients exposed to anticonvulsant drugs. J Natl Cancer Inst 81:803\u2013808", "journal-title": "J Natl Cancer Inst"}, {"key": "9_CR139", "doi-asserted-by": "crossref", "first-page": "170", "DOI": "10.1006/rtph.1994.1068", "volume": "20", "author": "WM Kluwe", "year": "1994", "unstructured": "Kluwe WM (1994) The relevance of hepatic peroxisome proliferation in rats to assessment of human carcinogenic risk for pharmaceuticals. Regul Toxicol Pharmacol 20:170\u2013186", "journal-title": "Regul Toxicol Pharmacol"}, {"key": "9_CR140", "doi-asserted-by": "crossref", "first-page": "1189", "DOI": "10.1124/mol.60.6.1189", "volume": "60", "author": "RS Thomas", "year": "2001", "unstructured": "Thomas RS, Rank DR, Penn SG, Zastrow GM, Hayes KR, Pande K, Glover E, Silander T, Craven MW, Reddy JK, Jovanovich SB, Bradfield CA (2001) Identification of toxicologically predictive gene sets using cDNA microarrays. Mol Pharmacol 60:1189\u20131194", "journal-title": "Mol Pharmacol"}, {"key": "9_CR141", "doi-asserted-by": "crossref", "first-page": "5652", "DOI": "10.1073/pnas.1037886100", "volume": "100", "author": "T Moriguchi", "year": "2003", "unstructured": "Moriguchi T, Motohashi H, Hosoya T, Nakajima O, Takahashi S, Ohsako S, Aoki Y, Nishimura N, Tohyama C, Fujii-Kuriyama Y, Yamamoto M (2003) Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse. Proc Natl Acad Sci U S A 100:5652\u20135657", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR142", "doi-asserted-by": "crossref", "first-page": "132", "DOI": "10.1093/toxsci/kfm206", "volume": "101", "author": "Q Yang", "year": "2008", "unstructured": "Yang Q, Nagano T, Shah Y, Cheung C, Ito S, Gonzalez FJ (2008) The PPAR\u03b1-humanized mouse: a model to investigate species differences in liver toxicitymediated by PPAR\u03b1. Toxicol Sci 101:132\u2013139", "journal-title": "Toxicol Sci"}, {"key": "9_CR143", "doi-asserted-by": "crossref", "first-page": "658", "DOI": "10.1016/0006-3002(58)90408-6", "volume": "27", "author": "KJ Ryan", "year": "1958", "unstructured": "Ryan KJ (1958) Conversion of androstenedione to estrone by placental microsomes. Biochim Biophys Acta 27:658\u2013662", "journal-title": "Biochim Biophys Acta"}, {"key": "9_CR144", "doi-asserted-by": "crossref", "first-page": "5933", "DOI": "10.1021/ja01143a033", "volume": "74", "author": "DH Peterson", "year": "1952", "unstructured": "Peterson DH (1952) Microbial transformations of steroids. I. Introduction of oxygen at carbon-11 of progesterone. J Am Chem Soc 74:5933\u20135936", "journal-title": "J Am Chem Soc"}, {"key": "9_CR145", "unstructured": "Miller WA, Auchus RJ (2014) P450 enzymes in steroid processing, Chap.\u00a011 (this book)", "DOI": "10.1007/978-3-319-12108-6_12", "doi-asserted-by": "crossref"}, {"key": "9_CR146", "doi-asserted-by": "crossref", "first-page": "3213", "DOI": "10.1016/0006-2952(85)90337-5", "volume": "34", "author": "AMH Brodie", "year": "1985", "unstructured": "Brodie AMH (1985) Aromatase inhibition and its pharmacologic implications. Biochem Pharmacol 34:3213\u20133219", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR147", "doi-asserted-by": "crossref", "first-page": "5009", "DOI": "10.1021/jm800355c", "volume": "51", "author": "MA Pinto-Bazurco Mendieta", "year": "2008", "unstructured": "Pinto-Bazurco Mendieta MA, Negri M, Jagusch C, Muller-Vieira U, Lauterbach T, Hartmann RW (2008) Synthesis, biological evaluation, and molecular modeling of abirateroneanalogues: novel CYP17 inhibitors for the treatment of prostate cancer. J Med Chem 51:5009\u20135018", "journal-title": "J Med Chem"}, {"key": "9_CR148", "doi-asserted-by": "crossref", "first-page": "473", "DOI": "10.1007/978-1-4757-2391-5_14", "volume-title": "Cytochrome P450: structure, mechanism, and biochemistry", "author": "FP Guengerich", "year": "1995", "unstructured": "Guengerich FP (1995) Human cytochrome P450 enzymes. In: Ortiz de Montellano PR (ed) Cytochrome P450: structure, mechanism, and biochemistry, 2nd edn. Plenum Press, New York, pp\u00a0473\u2013535", "edition": "2"}, {"key": "9_CR149", "unstructured": "Guengerich FP (2005) Human cytochrome P450 enzymes. In: Ortiz de Montellano PR (ed) Cytochrome P450: structure, mechanism, and biochemistry, 3rd edn. Kluwer Academic/Plenum Press, New York, pp\u00a0377\u2013530", "DOI": "10.1007/0-387-27447-2_10", "doi-asserted-by": "crossref"}, {"key": "9_CR150", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1124/dmd.31.4.345", "volume": "31", "author": "AYH Lu", "year": "2003", "unstructured": "Lu AYH, Wang RW, Lin JH (2003) Cytochrome P450 in vitro reaction phenotyping: a re-evaluation of approaches used for P450 isoform identification. Drug Metab Dispos 31:345\u2013350", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR151", "doi-asserted-by": "crossref", "first-page": "247", "DOI": "10.1007/0-387-27447-2_7", "volume-title": "Cytochrome P450: structure, mechanism, and biochemistry", "author": "MA Correia", "year": "2005", "unstructured": "Correia MA, Ortiz de Montellano PR (2005) Inhibition of cytochrome P450 enzymes. In: Ortiz de Montellano PR (ed) Cytochrome P450: structure, mechanism, and biochemistry, 3rd edn. Kluwer Academic/Plenum Press, New York, pp\u00a0247\u2013322", "edition": "3"}, {"key": "9_CR152", "first-page": "4026", "volume": "54", "author": "JW Harris", "year": "1994", "unstructured": "Harris JW, Rahman A, Kim BR, Guengerich FP, Collins JM (1994) Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme. Cancer Res 54:4026\u20134035", "journal-title": "Cancer Res"}, {"key": "9_CR153", "doi-asserted-by": "crossref", "first-page": "1441", "DOI": "10.1124/dmd.30.12.1441", "volume": "30", "author": "TH Tran", "year": "2002", "unstructured": "Tran TH, Von Moltke LL, Venkatakrishnan K, Granda BW, Gibbs MA, Obach RS, Harmatz JS, Greenblatt DJ (2002) Microsomal protein concentration modifies the apparent inhibitory potency of CYP3A inhibitors. Drug Metab Dispos 30:1441\u20131445", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR154", "doi-asserted-by": "crossref", "first-page": "1497", "DOI": "10.1124/dmd.30.12.1497", "volume": "30", "author": "RP Austin", "year": "2002", "unstructured": "Austin RP, Barton P, Cockroft SL, Wenlock MC, Riley RJ (2002) The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties. Drug Metab Dispos 30:1497\u20131503", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR155", "first-page": "3378", "volume": "47", "author": "JSH Yoo", "year": "1987", "unstructured": "Yoo JSH, Cheung RJ, Patten CJ, Wade D, Yang CS (1987) Nature of N-nitrosodimethylamine demethylase and its inhibitors. Cancer Res 47:3378\u20133383", "journal-title": "Cancer Res"}, {"key": "9_CR156", "first-page": "1", "volume": "26", "author": "N Chauret", "year": "1998", "unstructured": "Chauret N, Gauthier A, Nicoll-Griffith DA (1998) Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes. Drug Metab Dispos 26:1\u20134", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR157", "doi-asserted-by": "crossref", "first-page": "18426", "DOI": "10.1074/jbc.M111.240457", "volume": "286", "author": "R Shinkyo", "year": "2011", "unstructured": "Shinkyo R, Guengerich FP (2011) Inhibition of human cytochrome P450 3A4 by cholesterol. J Biol Chem 286:18426\u201318433", "journal-title": "J Biol Chem"}, {"key": "9_CR158", "doi-asserted-by": "crossref", "first-page": "1311", "DOI": "10.1124/dmd.30.12.1311", "volume": "30", "author": "R Yuan", "year": "2002", "unstructured": "Yuan R, Madani S, Wei XX, Reynolds K, Huang SM (2002) Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions. Drug Metab Dispos 30:1311\u20131319", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR159", "first-page": "619", "volume-title": "Cytochrome P450: structure, mechanism, and biochemistry", "author": "MA Correia", "year": "2005", "unstructured": "Correia MA (2005) Isoform functional markers, isoform substrate specificities, and fluorescent substrate assays. In: Ortiz de Montellano PR (ed) Cytochrome P450: structure, mechanism, and biochemistry, 3rd edn. Kluwer ACademic/Plenum Press, New York, pp\u00a0619\u2013657", "edition": "3"}, {"key": "9_CR160", "doi-asserted-by": "crossref", "first-page": "16013", "DOI": "10.1021/bi00049a015", "volume": "34", "author": "P Soucek", "year": "1995", "unstructured": "Soucek P, Martin MV, Ueng YF, Guengerich FP (1995) Identification of a common cytochrome P450 epitope near the conserved heme-binding petide with antibodies raised against recombinant cytochrome P450 family 2 proteins. Biochemistry 34:16013\u201316021", "journal-title": "Biochemistry"}, {"key": "9_CR161", "doi-asserted-by": "crossref", "first-page": "524", "DOI": "10.1016/0003-9861(79)90122-X", "volume": "192", "author": "PE Thomas", "year": "1979", "unstructured": "Thomas PE, Koreniowski D, Ryan D, Levin W (1979) Preparation of monospecific antibodies against two forms of rat liver cytochrome P-450 and quantitation of these antigens in microsomes. Arch Biochem Biophys 192:524\u2013532", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR162", "doi-asserted-by": "crossref", "first-page": "1689", "DOI": "10.1007/s13361-012-0423-x", "volume": "23", "author": "G Thiery", "year": "2012", "unstructured": "Thiery G, Mernaugh RL, Yan H, Spraggins JM, Yang J, Parl FF, Caprioli RM (2012) Targeted multiplex imaging mass spectrometry with single chain fragment variable (SCFV) recombinant antibodies. J Am Soc Mass Spectrom 23:1689\u20131696", "journal-title": "J Am Soc Mass Spectrom"}, {"key": "9_CR163", "doi-asserted-by": "crossref", "first-page": "567", "DOI": "10.1080/00498250600761662", "volume": "36", "author": "MR Shiran", "year": "2006", "unstructured": "Shiran MR, Proctor NJ, Howgate EM, Rowland-Yeo K, Tucker GT, Rostami-Hodjegan A (2006) Prediction of metabolic drug clearance in humans: in vitro-in vivo extrapolation vs allometric scaling. Xenobiotica 36:567\u2013580", "journal-title": "Xenobiotica"}, {"key": "9_CR164", "doi-asserted-by": "crossref", "first-page": "835", "DOI": "10.1001/jama.1957.72980250010016", "volume": "165", "author": "AG Motulsky", "year": "1957", "unstructured": "Motulsky AG (1957) Drug reactions, enzymes and biochemical genetics. J Am Med Assoc 165:835\u2013837", "journal-title": "J Am Med Assoc"}, {"key": "9_CR165", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1016/0163-7258(93)90026-A", "volume": "58", "author": "DS Keeney", "year": "1993", "unstructured": "Keeney DS, Waterman MR (1993) Regulation of steroid hydroxylase gene expression: importance to physiology and disease. Pharmacol Ther 58:301\u2013317", "journal-title": "Pharmacol Ther"}, {"key": "9_CR166", "doi-asserted-by": "crossref", "first-page": "943", "DOI": "10.1016/S0140-6736(78)90724-9", "volume": "i", "author": "RL Smith", "year": "1978", "unstructured": "Smith RL, Idle JR, Mahgoub AA, Sloan TP, Lancaster R (1978) Genetically determined defects of oxidation at carbon centres of drugs. Lancet i:943\u2013944", "journal-title": "Lancet"}, {"key": "9_CR167", "doi-asserted-by": "crossref", "first-page": "402", "DOI": "10.1038/clpt.1985.194", "volume": "38", "author": "K Nakamura", "year": "1985", "unstructured": "Nakamura K, Goto F, Ray WA, McAllister CB, Jacqz E, Wilkinson GR, Branch RA (1985) Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations. Clin Pharmacol Ther 38:402\u2013408", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR168", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.2133/dmpk.17.167", "volume": "17", "author": "K Nagata", "year": "2002", "unstructured": "Nagata K, Yamazoe Y (2002) Genetic polymorphism of human cytochrome P450 involved in drug metabolism. Drug Metab Pharmacokinet 17:167\u2013189", "journal-title": "Drug Metab Pharmacokinet"}, {"key": "9_CR169", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1097/00008571-199606000-00001", "volume": "6", "author": "AK Daly", "year": "1996", "unstructured": "Daly AK, Brockm\u00f6ller J, Broly F, Eichelbaum M, Evans WE, Gonzalez FJ, Huang JD, Idle JR, Ingelman-Sundberg M, Ishizaki T, Jacqz-Algrain E, Meyer UA, Steen VM, Wolf CR, Zanger UM (1996) Nomenclature for human CYP2D6 alleles. Pharmacogenetics 6:193\u2013201", "journal-title": "Pharmacogenetics"}, {"key": "9_CR170", "first-page": "943", "volume": "48", "author": "A Gaedigk", "year": "1991", "unstructured": "Gaedigk A, Blum M, Gaedigk R, Eichelbaum M, Meyer UA (1991) Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism. Am J Hum Genet 48:943\u2013950", "journal-title": "Am J Hum Genet"}, {"key": "9_CR171", "doi-asserted-by": "crossref", "first-page": "1260", "DOI": "10.1124/mol.60.6.1260", "volume": "60", "author": "J Corchero", "year": "2001", "unstructured": "Corchero J, Granvil CP, Akiyama TE, Hayhurst GP, Pimprale S, Feigenbaum L, Idle JR, Gonzalez FJ (2001) The CYP2D6 humanized mouse: effect of the human CYP2D6 transgene and HNF4\u03b1 on the disposition of debrisoquine in the mouse. Mol Pharmacol 60:1260\u20131267", "journal-title": "Mol Pharmacol"}, {"key": "9_CR172", "first-page": "188", "volume": "57", "author": "EG Schuetz", "year": "2000", "unstructured": "Schuetz EG, Umbenhauer DR, Yasuda K, Brimer C, Nguyen L, Relling MV, Schuetz JD, Schinkel AH (2000) Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes. Mol Pharmacol 57:188\u2013197", "journal-title": "Mol Pharmacol"}, {"key": "9_CR173", "doi-asserted-by": "crossref", "first-page": "661", "DOI": "10.1016/0378-4274(92)90245-F", "volume": "64/65", "author": "R Kato", "year": "1992", "unstructured": "Kato R, Yamazoe Y (1992) Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity. Toxicol Lett 64/65:661\u2013667", "journal-title": "Toxicol Lett"}, {"key": "9_CR174", "doi-asserted-by": "crossref", "first-page": "4430", "DOI": "10.1021/bi00470a024", "volume": "29", "author": "M Komori", "year": "1990", "unstructured": "Komori M, Nishio K, Kitada M, Shiramatsu K, Muroya K, Soma M, Nagashima K, Kamataki T (1990) Fetus-specific expression of a form of cytochrome P-450 in human livers. Biochemistry 29:4430\u20134433", "journal-title": "Biochemistry"}, {"key": "9_CR175", "doi-asserted-by": "crossref", "first-page": "625", "DOI": "10.1111/j.1432-1033.1997.00625.x", "volume": "247", "author": "D Lacroix", "year": "1997", "unstructured": "Lacroix D, Sonnier M, Moncion A, Cheron G, Cresteil T (1997) Expression of CYP3A in the human liver: evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 247:625\u2013634", "journal-title": "Eur J Biochem"}, {"key": "9_CR176", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1016/0163-7258(88)90115-5", "volume": "36", "author": "CM Loi", "year": "1988", "unstructured": "Loi CM, Vestal RE (1988) Drug metabolism in the elderly. Pharmacol Ther 36:131\u2013149", "journal-title": "Pharmacol Ther"}, {"key": "9_CR177", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.2165/00003088-199019050-00002", "volume": "19", "author": "C Durnas", "year": "1990", "unstructured": "Durnas C, Loi CM, Cusack BJ (1990) Hepatic drug metabolism and aging. Clin Pharmacokinet 19:359\u2013389", "journal-title": "Clin Pharmacokinet"}, {"key": "9_CR178", "doi-asserted-by": "crossref", "first-page": "727", "DOI": "10.1016/0006-2952(95)00192-3", "volume": "50", "author": "J George", "year": "1995", "unstructured": "George J, Byth K, Farrell GC (1995) Age but not gender selectively affects expression of individual cytochrome P450 proteins in human liver. Biochem Pharmacol 50:727\u2013730", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR179", "doi-asserted-by": "crossref", "first-page": "ra31", "DOI": "10.1126/scisignal.2003705", "volume": "6", "author": "S Mutoh", "year": "2013", "unstructured": "Mutoh S, Sobhany M, Moore R, Perera L, Pedersen L, Sueyoshi T, Negishi M (2013) Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling. Sci Signal 6:ra31", "journal-title": "Sci Signal"}, {"key": "9_CR180", "doi-asserted-by": "crossref", "first-page": "377", "DOI": "10.1016/j.abb.2005.02.022", "volume": "436", "author": "U Savas", "year": "2005", "unstructured": "Savas U, Hsu MH, Griffin KJ, Bell DR, Johnson EF (2005) Conditional regulation of the human CYP4X1 and CYP4Z1 genes. Arch Biochem Biophys 436:377\u2013385", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR181", "doi-asserted-by": "crossref", "first-page": "8106", "DOI": "10.1074/jbc.M210264200", "volume": "278", "author": "MB Sewer", "year": "2003", "unstructured": "Sewer MB, Waterman MR (2003) cAMP-dependent protein kinase enhances CYP17 transcription via MKP-1 activation in H295R human adrenocortical cells. J Biol Chem 278:8106\u20138111", "journal-title": "J Biol Chem"}, {"key": "9_CR182", "doi-asserted-by": "crossref", "first-page": "180", "DOI": "10.1006/abbi.2000.1704", "volume": "376", "author": "TA Kocarek", "year": "2000", "unstructured": "Kocarek TA, Zangar RC, Novak RF (2000) Post-transcriptional regulation of rat CYP2E1 expression: role of CYP2E1 mRNA untranslated regions in control of translational efficiency and message stability. Arch Biochem Biophys 376:180\u2013190", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR183", "doi-asserted-by": "crossref", "first-page": "4495", "DOI": "10.1128/MCB.10.9.4495", "volume": "10", "author": "T Ueno", "year": "1990", "unstructured": "Ueno T, Gonzalez FJ (1990) Transcriptional control of the rat hepatic CYP2E1 gene. Mol Cell Biol 10:4495\u20134505", "journal-title": "Mol Cell Biol"}, {"key": "9_CR184", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1124/dmd.106.012492", "volume": "35", "author": "FJ Gonzalez", "year": "2007", "unstructured": "Gonzalez FJ (2007) The 2006 Bernard B. Brodie award lecture. Cyp2e1. Drug Metab Dispos 35:1\u20138", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR185", "first-page": "40", "volume": "37", "author": "A Gomez", "year": "2005", "unstructured": "Gomez A, Rodriquez-Antona C, Mkrtchian S, Karlgren M, Ingelman-Sundberg M (2005) DNA methylation governs the expression of CYP2W1. Drug Metab Rev 37:40", "journal-title": "Drug Metab Rev"}, {"key": "9_CR186", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1007/s00439-009-0748-0", "volume": "127", "author": "C Rodriguez-Antona", "year": "2010", "unstructured": "Rodriguez-Antona C, Gomez A, Karlgren M, Sim SC, Ingelman-Sundberg M (2010) Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment. Hum Genet 127:1\u201317", "journal-title": "Hum Genet"}, {"key": "9_CR187", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.2133/dmpk.DMPK-13-PF-900", "volume": "28", "author": "T Yokoi", "year": "2013", "unstructured": "Yokoi T (2013) A new era in the study of individual differences in drug metabolism and pharmacokinetics. Drug Metab Pharmacokinet 28:1\u20132", "journal-title": "Drug Metab Pharmacokinet"}, {"key": "9_CR188", "doi-asserted-by": "crossref", "first-page": "1725", "DOI": "10.1124/dmd.113.053157", "volume": "41", "author": "M Ingelman-Sundberg", "year": "2013", "unstructured": "Ingelman-Sundberg M, Zhong XB, Hankinson O, Beedanagari S, Yu AM, Peng L, Osawa Y (2013) Potential role of epigenetic mechanisms in the regulation of drug metabolism and transport. Drug Metab Dispos 41:1725\u20131731", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR189", "doi-asserted-by": "crossref", "first-page": "777", "DOI": "10.1139/y90-119", "volume": "68", "author": "KW Renton", "year": "1990", "unstructured": "Renton KW, Knickle LC (1990) Regulation of hepatic cytochrome P-450 during infectious disease. Can J Physiol Pharmacol 68:777\u2013781", "journal-title": "Can J Physiol Pharmacol"}, {"key": "9_CR190", "doi-asserted-by": "crossref", "first-page": "6019", "DOI": "10.1021/bi00266a045", "volume": "21", "author": "FP Guengerich", "year": "1982", "unstructured": "Guengerich FP, Dannan GA, Wright ST, Martin MV, Kaminsky LS (1982) Purification and characterization of liver microsomal cytochromes P-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbitalor \u03b2-naphthoflavone. Biochemistry 21:6019\u20136030", "journal-title": "Biochemistry"}, {"key": "9_CR191", "doi-asserted-by": "crossref", "first-page": "1803", "DOI": "10.1124/dmd.108.020966", "volume": "36", "author": "RM Sawaya", "year": "2008", "unstructured": "Sawaya RM, Riddick DS (2008) Cytochrome P450 2C11 5\u2032-flanking region and promoter mediate in vivo suppression by 3-methylcholanthrene. Drug Metab Dispos 36:1803\u20131811", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR192", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.3109/00498251003592683", "volume": "40", "author": "DK Sevior", "year": "2010", "unstructured": "Sevior DK, Hokkanen J, Tolonen A, Abass K, Tursas L, Pelkonen O, Ahokas JT (2010) Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktail. Xenobiotica 40:245\u2013254", "journal-title": "Xenobiotica"}, {"key": "9_CR193", "author": "M Dixon", "year": "1964", "unstructured": "Dixon M, Webb EC (1964) Enzymes. Longmans, Green, and Co. Ltd., London", "volume-title": "Enzymes"}, {"key": "9_CR194", "doi-asserted-by": "crossref", "first-page": "2359", "DOI": "10.1021/ja953069t", "volume": "118", "author": "HG Bull", "year": "1996", "unstructured": "Bull HG, Garcia-Calvo M, Andersson S, Baginsky WF, Chan HK, Ellsworth DE, Miller RR, Stearns RA, Bakshi RK, Rasmusson GH, Tolman RL, Myers RW, Kozarich JW, Harris GS (1996) Mechanism-based inhibition of human steroid 5\u03b1-reductase by finasteride: enzyme-catalyzed formation of NADP\u2013dihydrofinasteride, a potent bisubstrate analog inhibitor. J Am Chem Soc 118:2359\u20132365", "journal-title": "J Am Chem Soc"}, {"key": "9_CR195", "doi-asserted-by": "crossref", "first-page": "2561", "DOI": "10.1016/S0040-4039(01)90520-9", "volume": "22", "author": "M Lange", "year": "1981", "unstructured": "Lange M, Mansuy D (1981) N-substituted porphyrins formation from carbene iron-porphyrin complexes: a possible pathway for cytochrome P450 heme destruction. Tet Lett 22:2561\u20132564", "journal-title": "Tet Lett"}, {"key": "9_CR196", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1111/j.1432-1033.1978.tb12341.x", "volume": "86", "author": "D Mansuy", "year": "1978", "unstructured": "Mansuy D, Beaune P, Cresteil T, Bacot C, Chottard JC, Gans P (1978) Formation of complexes between microsomal cytochrome P-450-Fe(II) and nitrosoarenes obtained by oxidation of arylhydroxylamines or reduction of nitroarenes in situ. Eur J Biochem 86:573\u2013579", "journal-title": "Eur J Biochem"}, {"key": "9_CR197", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1016/0006-291X(86)90265-2", "volume": "138", "author": "FP Guengerich", "year": "1986", "unstructured": "Guengerich FP (1986) Covalent binding to apoprotein is a major fate of heme in a variety of reactions in which cytochrome P-450 is destroyed. Biochem Biophys Res Commun 138:193\u2013198", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR198", "doi-asserted-by": "crossref", "first-page": "3203", "DOI": "10.1016/0006-2952(85)90172-8", "volume": "34", "author": "HW Davies", "year": "1985", "unstructured": "Davies HW, Satoh H, Schulick RD, Pohl LR (1985) Immunochemical identification of an irreversibly bound heme-derived adduct to cytochrome P-450 following CCl4 treatment of rats. Biochem Pharmacol 34:3203\u20133206", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR199", "doi-asserted-by": "crossref", "first-page": "481", "DOI": "10.1146/annurev.pa.23.040183.002405", "volume": "23", "author": "PR Ortiz de Montellano", "year": "1983", "unstructured": "Ortiz de Montellano PR, Correia MA (1983) Suicidal destruction of cytochrome P-450 during oxidative drug metabolism. Annu Rev Pharmacol Toxicol 23:481\u2013503", "journal-title": "Annu Rev Pharmacol Toxicol"}, {"key": "9_CR200", "author": "SA Kuby", "year": "1991", "unstructured": "Kuby SA (1991) A study of enzymes, vol\u00a0I, Enzyme catalysis, kinetics, and substrate binding. CRC Press, Boca Raton", "volume-title": "A study of enzymes, vol\u00a0I, enzyme catalysis, kinetics, and substrate binding"}, {"key": "9_CR201", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.1016/0003-9861(71)90456-5", "volume": "144", "author": "FJ Wiebel", "year": "1971", "unstructured": "Wiebel FJ, Leutz JC, Diamond L, Gelboin HV (1971) Aryl hydrocarbon (benzo[a]pyrene) hydroxylase in microsomes from rat tissues: differential inhibitionand stimulation by benzoflavones and organic solvents. Arch Biochem Biophys 144:78\u201386", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR202", "doi-asserted-by": "crossref", "first-page": "1419", "DOI": "10.1126/science.7089530", "volume": "216", "author": "JM Lasker", "year": "1982", "unstructured": "Lasker JM, Huang M-T, Conney AH (1982) In vivo activation of zoxazolamine metabolism by flavone. Science 216:1419\u20131421", "journal-title": "Science"}, {"key": "9_CR203", "doi-asserted-by": "crossref", "first-page": "475", "DOI": "10.1002/cpt1977224475", "volume": "22", "author": "J Kapitulnik", "year": "1977", "unstructured": "Kapitulnik J, Poppers PJ, Buening MK, Fortner JG, Conney AH (1977) Activation of monooxygenases in human liver by 7,8-benzoflavone. Clin Pharmacol Ther 22:475\u2013485", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR204", "author": "FP Guengerich", "first-page": "97", "year": "1994", "unstructured": "Guengerich FP, Kim B-R, Gillam EMJ, Shimada T (1994) Mechanisms of enhancement and inhibition of cytochrome P450 catalytic activity. In: Lechner MC (ed) Proceedings, 8th international conference on cytochrome P450: biochemistry, biophysics, and molecular biology. John Libbey Eurotext, Paris, pp\u00a097\u2013101", "volume-title": "Proceedings, 8th international conference on cytochrome P450: biochemistry, biophysics, and molecular biology"}, {"key": "9_CR205", "doi-asserted-by": "crossref", "first-page": "6450", "DOI": "10.1021/bi00187a009", "volume": "33", "author": "M Shou", "year": "1994", "unstructured": "Shou M, Grogan J, Mancewicz JA, Krausz KW, Gonzalez FJ, Gelboin HV, Korzekwa KR (1994) Activation of CYP3A4: evidence for the simultaneous binding of two substrates in a cytochrome P450 active site. Biochemistry 33:6450\u20136455", "journal-title": "Biochemistry"}, {"key": "9_CR206", "first-page": "58", "volume": "290", "author": "LE Witherow", "year": "1999", "unstructured": "Witherow LE, Houston JB (1999) Sigmoidal kinetics of CYP3Asubstrates: an approach for scaling dextromethorphan metabolism in hepatic microsomes and isolated hepatocytes to predict in vivo clearance in rat. J Pharmacol Exp Ther 290:58\u201365", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR207", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.2174/1389200013338658", "volume": "2", "author": "W Tang", "year": "2001", "unstructured": "Tang W, Stearns RA (2001) Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions. Curr Drug Metab 2:185\u2013198", "journal-title": "Curr Drug Metab"}, {"key": "9_CR208", "first-page": "287", "volume": "277", "author": "CA Lee", "year": "1996", "unstructured": "Lee CA, Lillibridge JH, Nelson SD, Slattery JT (1996) Effects of caffeine and theophylline on acetaminophen pharmacokinetics: P450 inhibition and activation. J Pharmacol Exp Ther 277:287\u2013291", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR209", "first-page": "1043", "volume": "28", "author": "JS Ngui", "year": "2000", "unstructured": "Ngui JS, Tang W, Stearns RA, Shou MG, Miller RR, Zhang Y, Lin JH, Baillie TA (2000) Cytochrome P450 3A4-mediated interaction of diclofenac and quinidine. Drug Metab Dispos 28:1043\u20131050", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR210", "doi-asserted-by": "crossref", "first-page": "841", "DOI": "10.1046/j.1432-1327.1999.00098.x", "volume": "259", "author": "AB Shapiro", "year": "1999", "unstructured": "Shapiro AB, Fox K, Lam P, Ling V (1999) Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Eur J Biochem 259:841\u2013850", "journal-title": "Eur J Biochem"}, {"key": "9_CR211", "doi-asserted-by": "crossref", "first-page": "5929", "DOI": "10.1021/bi992765t", "volume": "39", "author": "NA Hosea", "year": "2000", "unstructured": "Hosea NA, Miller GP, Guengerich FP (2000) Elucidation of distinct ligand binding sites for cytochrome P450 3A4. Biochemistry 39:5929\u20135939", "journal-title": "Biochemistry"}, {"key": "9_CR212", "doi-asserted-by": "crossref", "first-page": "6636", "DOI": "10.1073/pnas.95.12.6636", "volume": "95", "author": "GR Harlow", "year": "1998", "unstructured": "Harlow GR, Halpert JR (1998) Analysis of human cytochrome P450 3A4 cooperativity: construction and characterization of a site-directed mutant that displays hyperbolic steroid hydroxylation kinetics. Proc Natl Acad Sci U S A 95:6636\u20136641", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR213", "doi-asserted-by": "crossref", "first-page": "13682", "DOI": "10.1073/pnas.0603236103", "volume": "103", "author": "M Ekroos", "year": "2006", "unstructured": "Ekroos M, Sjogren T (2006) Structural basis for ligand promiscuity in cytochrome P450 3A4. Proc Natl Acad Sci U S A 103:13682\u201313687", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR214", "doi-asserted-by": "crossref", "first-page": "7293", "DOI": "10.1074/jbc.M709783200", "volume": "283", "author": "CD Sohl", "year": "2008", "unstructured": "Sohl CD, Isin EM, Eoff RL, Marsch GA, Stec DF, Guengerich FP (2008) Cooperativity in oxidation reactions catalyzed by cytochrome P450 1A2: highly cooperative pyrene hydroxylation and multiphasic kinetics of ligand binding. J Biol Chem 283:7293\u20137308", "journal-title": "J Biol Chem"}, {"key": "9_CR215", "doi-asserted-by": "crossref", "first-page": "683", "DOI": "10.1126/science.1099736", "volume": "305", "author": "PA Williams", "year": "2004", "unstructured": "Williams PA, Cosme J, Vinkovic DM, Ward A, Angove HC, Day PJ, Vonrhein C, Tickle IJ, Jhoti H (2004) Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone. Science 305:683\u2013686", "journal-title": "Science"}, {"key": "9_CR216", "unstructured": "He Y-A, Gajiwala KS, Wu M, Parge H, Burke B, Lee CA, Wester MR (2006) The crystal structure of human CYP3A4 in complex with testosterone. Abstracts, 16th international symposium on microsomes and drug oxidations (MDO 2006). Budapest, Hungary, 3\u20137 Sept"}, {"key": "9_CR217", "doi-asserted-by": "crossref", "first-page": "9127", "DOI": "10.1074/jbc.M511375200", "volume": "281", "author": "EM Isin", "year": "2006", "unstructured": "Isin EM, Guengerich FP (2006) Kinetics and thermodynamics of ligand binding by cytochrome P450 3A4. J Biol Chem 281:9127\u20139136", "journal-title": "J Biol Chem"}, {"key": "9_CR218", "doi-asserted-by": "crossref", "first-page": "6863", "DOI": "10.1074/jbc.M610346200", "volume": "282", "author": "EM Isin", "year": "2007", "unstructured": "Isin EM, Guengerich FP (2007) Multiple sequential steps involved in the binding of inhibitors to cytochrome P450 3A4. J Biol Chem 282:6863\u20136874", "journal-title": "J Biol Chem"}, {"key": "9_CR219", "doi-asserted-by": "crossref", "first-page": "3510", "DOI": "10.1074/jbc.M111.317081", "volume": "287", "author": "IF Sevrioukova", "year": "2012", "unstructured": "Sevrioukova IF, Poulos TL (2012) Structural and mechanistic insights into the interaction of cytochrome P450 3A4 with bromoergocryptine, a type I ligand. J Biol Chem 287:3510\u20133517", "journal-title": "J Biol Chem"}, {"key": "9_CR220", "doi-asserted-by": "crossref", "first-page": "17734", "DOI": "10.1074/jbc.M110.123711", "volume": "285", "author": "CD Sohl", "year": "2010", "unstructured": "Sohl CD, Guengerich FP (2010) Kinetic analysis of the three-step steroid aromatase reaction of human cytochrome P450 19A1. J Biol Chem 285:17734\u201317743", "journal-title": "J Biol Chem"}, {"key": "9_CR221", "doi-asserted-by": "crossref", "first-page": "3050", "DOI": "10.1073/pnas.97.7.3050", "volume": "97", "author": "J Cupp-Vickery", "year": "2000", "unstructured": "Cupp-Vickery J, Anderson R, Hatziris Z (2000) Crystal structures of ligand complexes of P450eryF exhibiting homotropic cooperativity. Proc Natl Acad Sci U S A 97:3050\u20133055", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR222", "doi-asserted-by": "crossref", "first-page": "11599", "DOI": "10.1074/jbc.M410933200", "volume": "280", "author": "B Zhao", "year": "2005", "unstructured": "Zhao B, Guengerich FP, Bellamine A, Lamb DC, Izumikawa M, Lei L, Podust LM, Sundaramoorthy M, Kalaitzis JA, Reddy LM, Kelly SL, Moore BS, Stec D, Voehler M, Falck JR, Shimada T, Waterman MR (2005) Binding of two flaviolin substrate molecules, oxidative coupling, and crystal structure of Streptomyces coelicolor A3(2) cytochrome P450 158A2. J Biol Chem 280:11599\u201311607", "journal-title": "J Biol Chem"}, {"key": "9_CR223", "doi-asserted-by": "crossref", "first-page": "17227", "DOI": "10.1074/jbc.M802180200", "volume": "283", "author": "GA Schoch", "year": "2008", "unstructured": "Schoch GA, Yano JK, Sansen S, Dansette PM, Stout CD, Johnson EF (2008) Determinants of cytochrome P450 2C8 substrate binding: structures of complexes with montelukast, troglitazone, felodipine, and 9-cis-retinoic acid. J Biol Chem 283:17227\u201317237", "journal-title": "J Biol Chem"}, {"key": "9_CR224", "first-page": "4315", "volume": "50", "author": "CJ Omiecinski", "year": "1990", "unstructured": "Omiecinski CJ, Redlich CA, Costa P (1990) Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues: detection by the polymerase chain reaction. Cancer Res 50:4315\u20134321", "journal-title": "Cancer Res"}, {"key": "9_CR225", "doi-asserted-by": "crossref", "first-page": "426", "DOI": "10.1111/j.1349-7006.1991.tb01866.x", "volume": "82", "author": "M Kitada", "year": "1991", "unstructured": "Kitada M, Taneda M, Itahashi K, Kamataki T (1991) Four forms of cytochrome P-450 in human fetal liver: purification and their capacity to activate promutagens. Jpn J Cancer Res 82:426\u2013432", "journal-title": "Jpn J Cancer Res"}, {"key": "9_CR226", "doi-asserted-by": "crossref", "first-page": "305", "DOI": "10.3109/03602539409029800", "volume": "26", "author": "M Kitada", "year": "1994", "unstructured": "Kitada M, Kamataki T (1994) Cytochrome P450 in human fetal liver: significance and fetal-specific expression. Drug Metab Rev 26:305\u2013323", "journal-title": "Drug Metab Rev"}, {"key": "9_CR227", "doi-asserted-by": "crossref", "first-page": "130", "DOI": "10.1006/abbi.2001.2323", "volume": "389", "author": "N Liu", "year": "2001", "unstructured": "Liu N, Zhang QY, Vakharia D, Dunbar D, Kaminsky LS (2001) Induction of CYP1A by benzo[k]fluoranthene in human hepatocytes: CYP1A1 or CYP1A2? Arch Biochem Biophys 389:130\u2013134", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR228", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1016/0003-9861(86)90116-5", "volume": "244", "author": "JB Fagan", "year": "1986", "unstructured": "Fagan JB, Pastewka JV, Chalberg SC, Gozukara E, Guengerich FP, Gelboin HV (1986) Noncoordinate regulation of the mRNAs encoding cytochromes P-450BNF/MC-B and P-450ISF/BNF-G. Arch Biochem Biophys 244:261\u2013272", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR229", "doi-asserted-by": "crossref", "first-page": "210", "DOI": "10.1016/j.taap.2003.11.015", "volume": "199", "author": "JH Kim", "year": "2004", "unstructured": "Kim JH, Sherman ME, Curriero FC, Guengerich FP, Strickland PT, Sutter TR (2004) Expression of cytochromes P450 1A1and 1B1 in human lung from smokers, non-smokers, and ex-smokers. Toxicol Appl Pharmacol 199:210\u2013219", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "9_CR230", "doi-asserted-by": "crossref", "first-page": "1629", "DOI": "10.1016/0024-3205(77)90241-7", "volume": "21", "author": "RA Prough", "year": "1977", "unstructured": "Prough RA, S\u00edpal Z, Jakobsson SW (1977) Metabolism of benzo(a)pyrene by human lung microsomal fractions. Life Sci 21:1629\u20131636", "journal-title": "Life Sci"}, {"key": "9_CR231", "first-page": "3916", "volume": "44", "author": "T Fujino", "year": "1984", "unstructured": "Fujino T, Gottlieb K, Manchester DK, Park SS, West D, Gurtoo HL, Tarone RE, Gelboin HV (1984) Monoclonal antibodyphenotyping of interindividual differences in cytochrome P-450-dependent reactions of single and twin human placenta. Cancer Res 44:3916\u20133923", "journal-title": "Cancer Res"}, {"key": "9_CR232", "doi-asserted-by": "crossref", "first-page": "1031", "DOI": "10.1126/science.7375915", "volume": "208", "author": "K Robie-Suh", "year": "1980", "unstructured": "Robie-Suh K, Robinson R, Gelboin HV, Guengerich FP (1980) Aryl hydrocarbon hydroxylase is inhibited by antibodyto rat liver cytochrome P-450. Science 208:1031\u20131033", "journal-title": "Science"}, {"key": "9_CR233", "first-page": "515", "volume": "24", "author": "T Shimada", "year": "1996", "unstructured": "Shimada T, Yamazaki H, Mimura M, Wakamiya N, Ueng YF, Guengerich FP, Inui Y (1996) Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs. Drug Metab Dispos 24:515\u2013522", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR234", "doi-asserted-by": "crossref", "first-page": "1231", "DOI": "10.1517/17425255.2010.503955", "volume": "6", "author": "MC Sangar", "year": "2010", "unstructured": "Sangar MC, Bansal S, Avadhani NG (2010) Bimodal targeting of microsomal cytochrome P450s to mitochondria: implications in drug metabolism and toxicity. Exp Opin Drug Metab Toxicol 6:1231\u20131251", "journal-title": "Exp Opin Drug Metab Toxicol"}, {"key": "9_CR235", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1007/0-387-27447-2_8", "volume-title": "Cytochrome P450: structure, mechanism, and biochemistry", "author": "SN Williams", "year": "2005", "unstructured": "Williams SN, Dunham E, Bradfield CA (2005) Induction of cytochrome P450 enzymes. In: Ortiz de Montellano PR (ed) Cytochrome P450: structure, mechanism, and biochemistry, 3rd edn. Kluwer Academic/Plenum Press, New York, pp\u00a0323\u2013346", "edition": "3"}, {"key": "9_CR236", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1289/ehp.877679", "volume": "76", "author": "GW Lucier", "year": "1987", "unstructured": "Lucier GW, Nelson KG, Everson RB, Wong TK, Philpot RM, Tiernan T, Taylor M, Sunahara GI (1987) Placental markers of human exposure to polychlorinated biphenyls and polychlorinated dibenzofurans. Environ Health Perspect 76:79\u201387", "journal-title": "Environ Health Perspect"}, {"key": "9_CR237", "doi-asserted-by": "crossref", "first-page": "737", "DOI": "10.1016/0016-5085(90)90963-2", "volume": "99", "author": "D Diaz", "year": "1990", "unstructured": "Diaz D, Fabre I, Daujat M, Saintaubert B, Bories P, Michel H, Maurel P (1990) Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome-P450. Gastroenterology 99:737\u2013747", "journal-title": "Gastroenterology"}, {"key": "9_CR238", "doi-asserted-by": "crossref", "first-page": "1254", "DOI": "10.1124/dmd.105.004655", "volume": "33", "author": "S Koyano", "year": "2005", "unstructured": "Koyano S, Saito Y, Fukushima-Uesaka H, Ishida S, Ozawa S, Kamatani N, Minami H, Ohtsu A, Hamaguchi T, Shirao K, Yoshida T, Saijo N, Jinno H, Sawada J (2005) Functional analysis of six human aryl hydrocarbon receptor variants in a Japanese population. Drug Metab Dispos 33:1254\u20131260", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR239", "doi-asserted-by": "crossref", "first-page": "769", "DOI": "10.1124/mol.107.043125", "volume": "73", "author": "P Monteiro", "year": "2008", "unstructured": "Monteiro P, Gilot D, Le Ferrec E, Rauch C, Lagadic-Gossmann D, Fardel O (2008) Dioxin-mediated up-regulation of aryl hydrocarbon receptor target genes is dependent on the calcium/calmodulin/CaMKI\u03b1 pathway. Mol Pharmacol 73:769\u2013777", "journal-title": "Mol Pharmacol"}, {"key": "9_CR240", "doi-asserted-by": "crossref", "first-page": "116", "DOI": "10.1124/mi.9.3.4", "volume": "9", "author": "O Hankinson", "year": "2009", "unstructured": "Hankinson O (2009) Repression of aryl hydrocarbon receptor transcriptional activity by epidermal growth factor. Mol Interv 9:116\u2013118", "journal-title": "Mol Interv"}, {"key": "9_CR241", "doi-asserted-by": "crossref", "first-page": "4266", "DOI": "10.1073/pnas.0900874106", "volume": "106", "author": "CH Sutter", "year": "2009", "unstructured": "Sutter CH, Yin H, Li Y, Mammen JS, Bodreddigari S, Stevens G, Cole JA, Sutter TR (2009) EGF receptor signalingblocks aryl hydrocarbon receptor-mediated transcription and cell differentiation in human epidermal keratinocytes. Proc Natl Acad Sci U S A 106:4266\u20134271", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR242", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1016/j.bcp.2009.08.008", "volume": "79", "author": "K Yoshinari", "year": "2010", "unstructured": "Yoshinari K, Yoda N, Toriyabe T, Yamazoe Y (2010) Constitutive androstane receptor transcriptionally activates human CYP1A1 and CYP1A2 genes through a common regulatory element in the 5\u2032-flanking region. Biochem Pharmacol 79:261\u2013269", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR243", "doi-asserted-by": "crossref", "first-page": "451", "DOI": "10.2133/dmpk.DMPK-11-RG-030", "volume": "26", "author": "N Shibahara", "year": "2011", "unstructured": "Shibahara N, Masunaga Y, Iwano S, Yamazaki H, Kiyotani K, Kamataki T (2011) Human cytochrome P450 1A1 is a novel target gene of liver X receptor \u03b1. Drug Metab Pharmacokinet 26:451\u2013457", "journal-title": "Drug Metab Pharmacokinet"}, {"key": "9_CR244", "doi-asserted-by": "crossref", "first-page": "466", "DOI": "10.1016/j.cbi.2010.01.038", "volume": "184", "author": "S Luecke", "year": "2010", "unstructured": "Luecke S, Wincent E, Backlund M, Rannug U, Rannug A (2010) Cytochrome P450 1A1 gene regulation by UVB involves crosstalk between the aryl hydrocarbon receptor and nuclear factor kB. Chem Biol Interact 184:466\u2013473", "journal-title": "Chem Biol Interact"}, {"key": "9_CR245", "doi-asserted-by": "crossref", "first-page": "1866", "DOI": "10.1074/jbc.M113.505578", "volume": "289", "author": "CF Vogel", "year": "2014", "unstructured": "Vogel CF, Khan EM, Leung PS, Gershwin ME, Chang WL, Wu D, Haarmann-Stemmann T, Hoffmann A, Denison MS (2014) Cross-talk between aryl hydrocarbon receptor and the inflammatory response: a role for nuclear factor-kB. J Biol Chem 289:1866\u20131875", "journal-title": "J Biol Chem"}, {"key": "9_CR246", "doi-asserted-by": "crossref", "first-page": "4479", "DOI": "10.1073/pnas.1118467109", "volume": "109", "author": "E Wincent", "year": "2012", "unstructured": "Wincent E, Bengtsson J, Mohammadi Bardbori A, Alsberg T, Luecke S, Rannug U, Rannug A (2012) Inhibition of cytochrome P450 1-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A 109:4479\u20134484", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR247", "doi-asserted-by": "crossref", "first-page": "1412", "DOI": "10.1073/pnas.0607296104", "volume": "104", "author": "BJ McMillan", "year": "2007", "unstructured": "McMillan BJ, Bradfield CA (2007) The aryl hydrocarbon receptor is activated by modified low-density lipoprotein. Proc Natl Acad Sci U S A 104:1412\u20131417", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR248", "doi-asserted-by": "crossref", "first-page": "1938", "DOI": "10.1021/tx900241g", "volume": "22", "author": "WC Chu", "year": "2009", "unstructured": "Chu WC, Hong WF, Huang MC, Chen FY, Lin SC, Liao PJ, Su JG (2009) 1-Nitropyrene stabilizes the mRNA of cytochrome P450 1a1, a carcinogen-metabolizing enzyme, via the Akt pathway. Chem Res Toxicol 22:1938\u20131947", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR249", "doi-asserted-by": "crossref", "first-page": "1333", "DOI": "10.1093/jnci/82.16.1333", "volume": "82", "author": "TL McLemore", "year": "1990", "unstructured": "McLemore TL, Adelberg S, Liu MC, McMahon NA, Yu SJ, Hubbard WC, Czerwinski M, Wood TG, Storeng R, Lubet RA, Eggleston JC, Boyd MR, Hines RN (1990) Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst 82:1333\u20131339", "journal-title": "J Natl Cancer Inst"}, {"key": "9_CR250", "doi-asserted-by": "crossref", "first-page": "741", "DOI": "10.1097/00008571-200011000-00008", "volume": "10", "author": "S Anttila", "year": "2000", "unstructured": "Anttila S, Lei XD, Elovaara E, Karjalainen A, Sun WM, Vainio H, Hankinson O (2000) An uncommon phenotype of poor inducibility of CYP1A1 in human lung is not ascribable to polymorphisms in the AHR, ARNT, or CYP1A1 genes. Pharmacogenetics 10:741\u2013751", "journal-title": "Pharmacogenetics"}, {"key": "9_CR251", "doi-asserted-by": "crossref", "first-page": "501", "DOI": "10.1097/00008571-200108000-00005", "volume": "11", "author": "S Anttila", "year": "2001", "unstructured": "Anttila S, Tuominen P, Hirvonen A, Nurminen M, Karjalainen A, Hankinson O, Elovaara E (2001) CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptor. Pharmacogenetics 11:501\u2013509", "journal-title": "Pharmacogenetics"}, {"key": "9_CR252", "first-page": "1868", "volume": "52", "author": "CH Yun", "year": "1992", "unstructured": "Yun CH, Shimada T, Guengerich FP (1992) Roles of human liver cytochrome P450 2C and 3A enzymes in the 3-hydroxylation of benzo[a]pyrene. Cancer Res 52:1868\u20131874", "journal-title": "Cancer Res"}, {"key": "9_CR253", "doi-asserted-by": "crossref", "first-page": "372", "DOI": "10.1016/S0076-6879(78)52041-7", "volume": "52", "author": "RA Prough", "year": "1978", "unstructured": "Prough RA, Burke MD, Mayer RT (1978) Direct fluorometric methods for measuring mixed-function oxidase activity. Methods Enzymol 52:372\u2013377", "journal-title": "Methods Enzymol"}, {"key": "9_CR254", "doi-asserted-by": "crossref", "first-page": "436", "DOI": "10.1006/abbi.1994.1330", "volume": "312", "author": "Z Guo", "year": "1994", "unstructured": "Guo Z, Gillam EM, Ohmori S, Tukey RH, Guengerich FP (1994) Expression of modified human cytochrome P450 1A1in Escherichia coli: effects of 5\u2032 substitution, stabilization, purification, spectral characterization, and catalytic properties. Arch Biochem Biophys 312:436\u2013446", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR255", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1002/mc.2940100307", "volume": "10", "author": "M Shou", "year": "1994", "unstructured": "Shou M, Korzekwa KR, Crespi CL, Gonzalez FJ, Gelboin HV (1994) The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8-dihydrodiol. Mol Carcinogen 10:159\u2013168", "journal-title": "Mol Carcinogen"}, {"key": "9_CR256", "doi-asserted-by": "crossref", "first-page": "136", "DOI": "10.1021/tx00043a018", "volume": "8", "author": "E Bauer", "year": "1995", "unstructured": "Bauer E, Guo Z, Ueng YF, Bell LC, Zeldin D, Guengerich FP (1995) Oxidation of benzo[a]pyrene by recombinant human cytochrome P450 enzymes. Chem Res Toxicol 8:136\u2013142", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR257", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1006/abbi.1996.0161", "volume": "328", "author": "M Shou", "year": "1996", "unstructured": "Shou M, Krausz KW, Gonzalez FJ, Gelboin HV (1996) Metabolic activation of the ptotent carcinogen dibenzo[a, h]anthracene by cDNA-expressed human cytochromes P450. Arch Biochem Biophys 328:201\u2013207", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR258", "doi-asserted-by": "crossref", "first-page": "2429", "DOI": "10.1093/carcin/17.11.2429", "volume": "17", "author": "M Shou", "year": "1996", "unstructured": "Shou M, Krausz KW, Gonzalez FJ, Gelboin HV (1996) Metabolic activation of the potent carcinogen dibenzo[a, l]pyrene by human recombinant cytochromes P450, lung and liver microsomes. Carcinogenesis 17:2429\u20132433", "journal-title": "Carcinogenesis"}, {"key": "9_CR259", "first-page": "2979", "volume": "56", "author": "T Shimada", "year": "1996", "unstructured": "Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, Sutter TR (1996) Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res 56:2979\u20132984", "journal-title": "Cancer Res"}, {"key": "9_CR260", "doi-asserted-by": "crossref", "first-page": "411", "DOI": "10.1093/mutage/gel047", "volume": "21", "author": "Y Oda", "year": "2006", "unstructured": "Oda Y, Totsuka Y, Wakabayashi K, Guengerich FP, Shimada T (2006) Activation of aminophenylnorharman, aminomethylnorharman, and aminophenylharman to genotoxic metabolites by human N, O-acetyltransferases and cytochrome P450 enzymes expressed in Salmonella typhimurium umu tester strains. Mutagenesis 21:411\u2013416", "journal-title": "Mutagenesis"}, {"key": "9_CR261", "first-page": "733", "volume": "29", "author": "J Sistkova", "year": "2008", "unstructured": "Sistkova J, Hudecek J, Hodek P, Frei E, Schmeiser HH, Stiborova M (2008) Human cytochromes P450 1A1 and 1A2 participate in detoxication of carcinogenic aristolochic acid. Neuro Endocrinol Lett 29:733\u2013737", "journal-title": "Neuro Endocrinol Lett"}, {"key": "9_CR262", "doi-asserted-by": "crossref", "first-page": "1238", "DOI": "10.1124/dmd.109.030361", "volume": "38", "author": "X Li", "year": "2010", "unstructured": "Li X, Kamenecka TM, Cameron MD (2010) Cytochrome P450-mediated bioactivation of the epidermal growth factor receptor inhibitor erlotinib to a reactive electrophile. Drug Metab Dispos 38:1238\u20131245", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR263", "doi-asserted-by": "crossref", "first-page": "993", "DOI": "10.1021/tx400139p", "volume": "26", "author": "K Wang", "year": "2013", "unstructured": "Wang K, Guengerich FP (2013) Reduction of aromatic and heterocyclic aromatic N-hydroxylamines by human cytochrome P450 2S1. Chem Res Toxicol 26:993\u20131004", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR264", "doi-asserted-by": "crossref", "first-page": "511", "DOI": "10.1016/S0006-291X(03)01439-6", "volume": "308", "author": "R Shinkyo", "year": "2003", "unstructured": "Shinkyo R, Sakaki T, Takita T, Ohta M, Inouye K (2003) Generation of 2,3,7,8-TCDD-metabolizing enzyme by modifying rat CYP1A1 through site-directed mutagenesis. Biochem Biophys Res Commun 308:511\u2013517", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR265", "doi-asserted-by": "crossref", "first-page": "2167", "DOI": "10.1021/tx200309p", "volume": "24", "author": "JG Su", "year": "2011", "unstructured": "Su JG, Huang MC, Chen FY (2011) 2,3,7,8-Tetrachlorodibenzo-p-dioxin\u2019s suppression of 1-nitropyrene-induced p53 expression is mediated by cytochrome P450 1A1. Chem Res Toxicol 24:2167\u20132175", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR266", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1006/abbi.1997.0125", "volume": "342", "author": "H Yamazaki", "year": "1997", "unstructured": "Yamazaki H, Gillam EM, Dong MS, Johnson WW, Guengerich FP, Shimada T (1997) Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450-P450 and cytochrome P450-b 5 interactions. Arch Biochem Biophys 342:329\u2013337", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR267", "doi-asserted-by": "crossref", "first-page": "669", "DOI": "10.1016/j.bcp.2011.06.003", "volume": "82", "author": "V Kotrbova", "year": "2011", "unstructured": "Kotrbova V, Mrazova B, Moserova M, Martinek V, Hodek P, Hudecek J, Frei E, Stiborova M (2011) Cytochrome b 5 shifts oxidation of the anticancer drug ellipticine by cytochromes P450 1A1 and 1A2 from its detoxication to activation, thereby modulating its pharmacological efficacy. Biochem Pharmacol 82:669\u2013680", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR268", "doi-asserted-by": "crossref", "first-page": "610", "DOI": "10.1016/0006-291X(85)90460-7", "volume": "130", "author": "SK Balani", "year": "1985", "unstructured": "Balani SK, Yeh HJC, Ryan DE, Thomas PE, Levin W, Jerina DM (1985) Absolute configuration of the 5,6-oxide formed from 7,12-dimethylbenz[a]anthracene by cytochrome P450c. Biochem Biophys Res Commun 130:610\u2013616", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR269", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1016/S0300-483X(99)00098-0", "volume": "139", "author": "DF Lewis", "year": "1999", "unstructured": "Lewis DF, Lake BG, George SG, Dickins M, Eddershaw PJ, Tarbit MH, Beresford AP, Goldfarb PS, Guengerich FP (1999) Molecular modelling of CYP1 family enzymes CYP1A1, CYP1A2, CYP1A6 and CYP1B1 based on sequence homology with CYP102. Toxicology 139:53\u201379", "journal-title": "Toxicology"}, {"key": "9_CR270", "doi-asserted-by": "crossref", "first-page": "12932", "DOI": "10.1074/jbc.M113.452953", "volume": "288", "author": "AA Walsh", "year": "2013", "unstructured": "Walsh AA, Szklarz GD, Scott EE (2013) Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism. J Biol Chem 288:12932\u201312943", "journal-title": "J Biol Chem"}, {"key": "9_CR271", "doi-asserted-by": "crossref", "first-page": "14348", "DOI": "10.1074/jbc.M611692200", "volume": "282", "author": "S Sansen", "year": "2007", "unstructured": "Sansen S, Yano JK, Reynald RL, Schoch GA, Griffin KJ, Stout CD, Johnson EF (2007) Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2. J Biol Chem 282:14348\u201314355", "journal-title": "J Biol Chem"}, {"key": "9_CR272", "doi-asserted-by": "crossref", "first-page": "5736", "DOI": "10.1074/jbc.M110.204420", "volume": "286", "author": "A Wang", "year": "2011", "unstructured": "Wang A, Savas U, Stout CD, Johnson EF (2011) Structural characterization of the complex between \u03b1-naphthoflavone and human cytochrome P450 1B1. J Biol Chem 286:5736\u20135743", "journal-title": "J Biol Chem"}, {"key": "9_CR273", "doi-asserted-by": "crossref", "first-page": "446", "DOI": "10.1016/j.bbagen.2006.08.005", "volume": "1770", "author": "V Taly", "year": "2007", "unstructured": "Taly V, Urban P, Truan G, Pompon D (2007) A combinatorial approach to substrate discrimination in the P450 CYP1A subfamily. Biochim Biophys Acta 1770:446\u2013457", "journal-title": "Biochim Biophys Acta"}, {"key": "9_CR274", "doi-asserted-by": "crossref", "first-page": "1048", "DOI": "10.1021/tx980090+", "volume": "11", "author": "T Shimada", "year": "1998", "unstructured": "Shimada T, Yamazaki H, Foroozesh M, Hopkins NE, Alworth WL, Guengerich FP (1998) Selectivity of polycyclic inhibitorsfor human cytochrome P450s 1A1, 1A2, and 1B1. Chem Res Toxicol 11:1048\u20131056", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR275", "first-page": "3367", "volume": "50", "author": "ME McManus", "year": "1990", "unstructured": "McManus ME, Burgess WM, Veronese ME, Huggett A, Quattrochi LC, Tukey RH (1990) Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. Cancer Res 50:3367\u20133376", "journal-title": "Cancer Res"}, {"key": "9_CR276", "doi-asserted-by": "crossref", "first-page": "6273", "DOI": "10.1021/jm4000209", "volume": "56", "author": "HM Sheldrake", "year": "2013", "unstructured": "Sheldrake HM, Travica S, Johansson I, Loadman PM, Sutherland M, Elsalem L, Illingworth N, Cresswell AJ, Reuillon T, Snyder SD, Mkrtchian S, Searcey M, Ingelman-Sundberg M, Patterson LH, Pors K (2013) Re-engineering of the duocarmycin structural architecture enables bioprecursor development targeting CYP1A1 and CYP2W1 for biological activity. J Med Chem 56:6273\u20136277", "journal-title": "J Med Chem"}, {"key": "9_CR277", "doi-asserted-by": "crossref", "first-page": "1327", "DOI": "10.1021/tx200218u", "volume": "24", "author": "T Shimada", "year": "2011", "unstructured": "Shimada T, Murayama N, Tanaka K, Takenaka S, Guengerich FP, Yamazaki H, Komori M (2011) Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds. Chem Res Toxicol 24:1327\u20131337", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR278", "doi-asserted-by": "crossref", "first-page": "1921", "DOI": "10.1021/tx100286d", "volume": "23", "author": "T Shimada", "year": "2010", "unstructured": "Shimada T, Tanaka K, Takenaka S, Murayama N, Martin MV, Foroozesh MK, Yamazaki H, Guengerich FP, Komori M (2010) Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives. Chem Res Toxicol 23:1921\u20131935", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR279", "first-page": "8164", "volume": "61", "author": "Y-J Chun", "year": "2001", "unstructured": "Chun Y-J, Kim S, Kim D, Lee SK, Guengerich FP (2001) A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis. Cancer Res 61:8164\u20138170", "journal-title": "Cancer Res"}, {"key": "9_CR280", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.2133/dmpk.DMPK-12-RG-113", "volume": "28", "author": "Y-F Ueng", "year": "2013", "unstructured": "Ueng Y-F, Chen CC, Yamazaki H, Kiyotani K, Chang YP, Lo WS, Li DT, Tsai PL (2013) Mechanism-based inhibition of CYP1A1 and CYP3A4 by the furanocoumarinchalepensin. Drug Metab Pharmacokinet 28:229\u2013238", "journal-title": "Drug Metab Pharmacokinet"}, {"key": "9_CR281", "doi-asserted-by": "crossref", "first-page": "e85166", "DOI": "10.1371/journal.pone.0085166", "volume": "8", "author": "B Wu", "year": "2013", "unstructured": "Wu B, Liu K, Huang H, Yuan J, Yuan W, Wang S, Chen T, Zhao H, Yin C (2013) MspI and Ile462Val polymorphisms in CYP1A1 and overall cancer risk: a meta-analysis. PLoS One 8:e85166", "journal-title": "PLoS One"}, {"key": "9_CR282", "doi-asserted-by": "crossref", "first-page": "602", "DOI": "10.1158/1055-9965.EPI-05-0853", "volume": "15", "author": "PD Terry", "year": "2006", "unstructured": "Terry PD, Goodman M (2006) Is the association between cigarette smoking and breast cancer modified by genotype? A review of epidemiologic studies and meta-analysis. Cancer Epidemiol Biomarkers Prev 15:602\u2013611", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9_CR283", "doi-asserted-by": "crossref", "first-page": "3533", "DOI": "10.1007/s11033-011-1126-2", "volume": "39", "author": "Y Zheng", "year": "2012", "unstructured": "Zheng Y, Wang JJ, Sun L, Li HL (2012) Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis. Mol Biol Rep 39:3533\u20133540", "journal-title": "Mol Biol Rep"}, {"key": "9_CR284", "doi-asserted-by": "crossref", "first-page": "324", "DOI": "10.1016/j.cyto.2012.04.027", "volume": "59", "author": "YN Ji", "year": "2012", "unstructured": "Ji YN, Wang Q, Lin XQ, Suo LJ (2012) CYP1A1 MspI polymorphisms and lung cancer risk: an updated meta-analysis involving 20,209 subjects. Cytokine 59:324\u2013334", "journal-title": "Cytokine"}, {"key": "9_CR285", "doi-asserted-by": "crossref", "first-page": "2079", "DOI": "10.1007/s13277-012-0467-3", "volume": "33", "author": "X Zhuo", "year": "2012", "unstructured": "Zhuo X, Zhao H, Chang A, Ye H, Zhou Y, Song Y, Tan Y (2012) Cytochrome P450 1A1Ile462Val polymorphism and oral carcinoma risk: an updated meta-analysis including 1515 cases and 2233 controls. Tumour Biol 33:2079\u20132089", "journal-title": "Tumour Biol"}, {"key": "9_CR286", "doi-asserted-by": "crossref", "first-page": "3717", "DOI": "10.7314/APJCP.2012.13.8.3717", "volume": "13", "author": "XW Wang", "year": "2012", "unstructured": "Wang XW, Zhong TY, Xiong YH, Lin HB, Liu QY (2012) Lack of association between the CYP1A1 Ile462Val polymorphism and endometrial cancer risk: a meta-analysis. Asian Pac J Cancer Prev 13:3717\u20133721", "journal-title": "Asian Pac J Cancer Prev"}, {"key": "9_CR287", "doi-asserted-by": "crossref", "first-page": "350", "DOI": "10.1006/bbrc.1995.1668", "volume": "210", "author": "MG Mercurio", "year": "1995", "unstructured": "Mercurio MG, Shiff SJ, Galbraith RA, Sassa S (1995) Expression of cytochrome P450 mRNAs in the colon and the rectum in normal human subjects. Biochem Biophys Res Commun 210:350\u2013355", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR288", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1002/cpt19741519", "volume": "15", "author": "EJ Pantuck", "year": "1974", "unstructured": "Pantuck EJ, Hsiao, K-C, Maggio A, Nakamura K, Kuntzman R, Conney AH (1974) Effect of cigarette smoking on phenacetin metabolism. Clin Pharmacol Ther 15:9\u201317", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR289", "doi-asserted-by": "crossref", "first-page": "473", "DOI": "10.1097/00008571-200208000-00008", "volume": "12", "author": "BB Rasmussen", "year": "2002", "unstructured": "Rasmussen BB, Brix TH, Kyvik KO, Br\u00f8sen K (2002) The interindividual differences in the 3-demethylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharmacogenetics 12:473\u2013478", "journal-title": "Pharmacogenetics"}, {"key": "9_CR290", "first-page": "6949", "volume": "269", "author": "LC Quattrochi", "year": "1994", "unstructured": "Quattrochi LC, Vu T, Tukey RH (1994) The human CYP1A2 gene and inductionby 3-methylcholanthrene: a region of DNA that supports Ah-receptor binding and promoter-specific induction. J Biol Chem 269:6949\u20136954", "journal-title": "J Biol Chem"}, {"key": "9_CR291", "doi-asserted-by": "crossref", "first-page": "945", "DOI": "10.1124/jpet.102.039982", "volume": "303", "author": "SR Kondraganti", "year": "2002", "unstructured": "Kondraganti SR, Jiang WW, Moorthy B (2002) Differential regulation of expression of hepatic and pulmonary cytochrome P4501A enzymes by 3-methylcholanthrene in mice lacking the CYP1A2 gene. J Pharmacol Exp Ther 303:945\u2013951", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR292", "first-page": "4388", "volume": "256", "author": "GJ Fisher", "year": "1981", "unstructured": "Fisher GJ, Fukushima H, Gaylor JL (1981) Isolation, purification, and properties of a unique form of cytochrome P-450 in microsomes of isosafrole-treated rats. J Biol Chem 256:4388\u20134394", "journal-title": "J Biol Chem"}, {"key": "9_CR293", "doi-asserted-by": "crossref", "first-page": "1561", "DOI": "10.1093/carcin/13.9.1561", "volume": "13", "author": "K Vistisen", "year": "1992", "unstructured": "Vistisen K, Poulsen HE, Loft S (1992) Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine. Carcinogenesis 13:1561\u20131568", "journal-title": "Carcinogenesis"}, {"key": "9_CR294", "doi-asserted-by": "crossref", "first-page": "170", "DOI": "10.1038/clpt.1992.126", "volume": "52", "author": "KL Rost", "year": "1992", "unstructured": "Rost KL, Br\u00f6sicke H, Brockm\u00f6ller J, Scheffler M, Helg H, Roots I (1992) Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin. Clin Pharmacol Ther 52:170\u2013180", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR295", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.1016/j.toxlet.2012.09.021", "volume": "215", "author": "K Araki", "year": "2012", "unstructured": "Araki K, Watanabe K, Yamazoe Y, Yoshinari K (2012) Liver X receptor a bidirectionally transactivates human CYP1A1 and CYP1A2 through two cis-elements common to both genes. Toxicol Lett 215:16\u201324", "journal-title": "Toxicol Lett"}, {"key": "9_CR296", "doi-asserted-by": "crossref", "first-page": "597", "DOI": "10.1016/j.cbi.2013.04.002", "volume": "203", "author": "A Belic", "year": "2013", "unstructured": "Belic A, Toth K, Vrzal R, Temesvari M, Porrogi P, Orban E, Rozman D, Dvorak Z, Monostory K (2013) Dehydroepiandrosterone post-transcriptionally modifies CYP1A2 induction involving androgen receptor. Chem Biol Interact 203:597\u2013603", "journal-title": "Chem Biol Interact"}, {"key": "9_CR297", "doi-asserted-by": "crossref", "first-page": "4678", "DOI": "10.1021/pr800231w", "volume": "7", "author": "G Redlich", "year": "2008", "unstructured": "Redlich G, Zanger UM, Riedmaier S, Bache N, Giessing AB, Eisenacher M, Stephan C, Meyer HE, Jensen ON, Marcus K (2008) Distinction between human cytochrome P450 (CYP) isoforms and identification of new phosphorylation sites by mass spectrometry. J Proteome Res 7:4678\u20134688", "journal-title": "J Proteome Res"}, {"key": "9_CR298", "doi-asserted-by": "crossref", "first-page": "69", "DOI": "10.1289/ehp.929869", "volume": "98", "author": "FF Kadlubar", "year": "1992", "unstructured": "Kadlubar FF, Butler MA, Kaderlik KR, Chou HC, Lang NP (1992) Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environ Health Perspect 98:69\u201374", "journal-title": "Environ Health Perspect"}, {"key": "9_CR299", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1016/j.abb.2003.11.019", "volume": "422", "author": "H Zhou", "year": "2004", "unstructured": "Zhou H, Josephy PD, Kim D, Guengerich FP (2004) Functional characterization of four allelic variants of human cytochrome P450 1A2. Arch Biochem Biophys 422:23\u201330", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR300", "doi-asserted-by": "crossref", "first-page": "647", "DOI": "10.1097/FPC.0b013e32833e90eb", "volume": "20", "author": "SL Browning", "year": "2010", "unstructured": "Browning SL, Tarekegn A, Bekele E, Bradman N, Thomas MG (2010) CYP1A2 is more variable than previously thought: a genomic biography of the gene behind the human drug-metabolizing enzyme. Pharmacogenet Genomics 20:647\u2013664", "journal-title": "Pharmacogenet Genomics"}, {"key": "9_CR301", "doi-asserted-by": "crossref", "first-page": "697", "DOI": "10.1007/s00228-010-0823-4", "volume": "66", "author": "N Djordjevic", "year": "2010", "unstructured": "Djordjevic N, Ghotbi R, Jankovic S, Aklillu E (2010) Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2\u2013163C> A polymorphism. Eur J Clin Pharmacol 66:697\u2013703", "journal-title": "Eur J Clin Pharmacol"}, {"key": "9_CR302", "doi-asserted-by": "crossref", "first-page": "e1002033", "DOI": "10.1371/journal.pgen.1002033", "volume": "7", "author": "MC Cornelis", "year": "2011", "unstructured": "Cornelis MC, Monda KL, Yu K, Paynter N, Azzato EM, Bennett SN, Berndt SI, Boerwinkle E, Chanock S, Chatterjee N, Couper D, Curhan G, Heiss G, Hu FB, Hunter DJ, Jacobs K, Jensen MK, Kraft P, Landi MT, Nettleton JA, Purdue MP, Rajaraman P, Rimm EB, Rose LM, Rothman N, Silverman D, Stolzenberg-Solomon R, Subar A, Yeager M, Chasman DI, van Dam RM, Caporaso NE (2011) Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLoS Genet 7:e1002033", "journal-title": "PLoS Genet"}, {"key": "9_CR303", "doi-asserted-by": "crossref", "first-page": "2071", "DOI": "10.1093/hmg/ddr086", "volume": "20", "author": "P Sulem", "year": "2011", "unstructured": "Sulem P, Gudbjartsson DF, Geller F, Prokopenko I, Feenstra B, Aben KK, Franke B, den Heijer M, Kovacs P, Stumvoll M, Magi R, Yanek LR, Becker LC, Boyd HA, Stacey SN, Walters GB, Jonasdottir A, Thorleifsson G, Holm H, Gudjonsson SA, Rafnar T, Bjornsdottir G, Becker DM, Melbye M, Kong A, Tonjes A, Thorgeirsson T, Thorsteinsdottir U, Kiemeney LA, Stefansson K (2011) Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption. Hum Mol Genet 20:2071\u20132077", "journal-title": "Hum Mol Genet"}, {"key": "9_CR304", "doi-asserted-by": "crossref", "first-page": "511", "DOI": "10.1021/tx00034a019", "volume": "6", "author": "CJ Patten", "year": "1993", "unstructured": "Patten CJ, Thomas PE, Guy RL, Lee M, Gonzalez FJ, Guengerich FP, Yang CS (1993) Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol 6:511\u2013518", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR305", "doi-asserted-by": "crossref", "first-page": "613", "DOI": "10.1016/S0009-9236(96)90001-6", "volume": "59", "author": "G Engel", "year": "1996", "unstructured": "Engel G, Hofmann U, Heidemann H, Cosme J, Eichelbaum M (1996) Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation. Clin Pharmacol Ther 59:613\u2013623", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR306", "first-page": "568", "volume": "46", "author": "H Yamazaki", "year": "1994", "unstructured": "Yamazaki H, Guo Z, Persmark M, Mimura M, Inoue K, Guengerich FP, Shimada T (1994) Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes. Mol Pharmacol 46:568\u2013577", "journal-title": "Mol Pharmacol"}, {"key": "9_CR307", "first-page": "1225", "volume": "23", "author": "CM Dixon", "year": "1995", "unstructured": "Dixon CM, Colthup PV, Serabjit-Singh CJ, Kerr BM, Boehlert CC, Park GR, Tarbit MH (1995) Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans. Drug Metab Dispos 23:1225\u20131230", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR308", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1097/00008571-199804000-00002", "volume": "8", "author": "L Becquemont", "year": "1998", "unstructured": "Becquemont L, Le Bot MA, Riche C, Funck-Brentano C, Jaillon P, Beaune P (1998) Use of heterologously expressed human cytochrome P450 1A2 to predict tacrine-fluvoxamine drug interaction in man. Pharmacogenetics 8:101\u2013108", "journal-title": "Pharmacogenetics"}, {"key": "9_CR309", "doi-asserted-by": "crossref", "first-page": "423", "DOI": "10.1016/S0006-2952(96)00713-7", "volume": "53", "author": "GG Benoit", "year": "1997", "unstructured": "Benoit GG, Naud CF, Simard MA, Astier AL (1997) Noninterference of cytochrome P4501A2 in the cytotoxicity of tacrine using genetically engineered V79 Chinese hamster cells for stable expression of the human or rat isoform and two human hepatocyte cell lines. Biochem Pharmacol 53:423\u2013427", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR310", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1016/0006-2952(95)00120-O", "volume": "50", "author": "ZY Zhang", "year": "1995", "unstructured": "Zhang ZY, Kaminsky LS (1995) Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation. Biochem Pharmacol 50:205\u2013211", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR311", "doi-asserted-by": "crossref", "first-page": "659", "DOI": "10.1021/tx970217f", "volume": "11", "author": "H Yamazaki", "year": "1998", "unstructured": "Yamazaki H, Shaw PM, Guengerich FP, Shimada T (1998) Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Chem Res Toxicol 11:659\u2013665", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR312", "doi-asserted-by": "crossref", "first-page": "1305", "DOI": "10.1056/NEJM198611203152101", "volume": "315", "author": "JJ Michnovicz", "year": "1986", "unstructured": "Michnovicz JJ, Hershcopr RJ, Naganuma H, Bradlow HL, Fishman J (1986) Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. New Engl J Med 315:1305\u20131309", "journal-title": "New Engl J Med"}, {"key": "9_CR313", "doi-asserted-by": "crossref", "first-page": "6295", "DOI": "10.1073/pnas.82.18.6295", "volume": "82", "author": "HL Bradlow", "year": "1985", "unstructured": "Bradlow HL, Hershcopf RJ, Martucci CP, Fishman J (1985) Estradiol 16\u03b1-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. Proc Natl Acad Sci U S A 82:6295\u20136299", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR314", "doi-asserted-by": "crossref", "first-page": "979", "DOI": "10.1093/carcin/13.6.979", "volume": "13", "author": "H Yamazaki", "year": "1992", "unstructured": "Yamazaki H, Oda Y, Funae Y, Imaoka S, Inui Y, Guengerich FP, Shimada T (1992) Participation of rat liver cytochrome P450 2E1 in the activation of N-nitrosodimethylamine and N-nitrosodiethylamine to products genotoxic in an acetyltransferase-overexpressing Salmonella typhimurium strain (NM2009). Carcinogenesis 13:979\u2013985", "journal-title": "Carcinogenesis"}, {"key": "9_CR315", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1093/toxsci/kfr306", "volume": "125", "author": "M Stiborova", "year": "2012", "unstructured": "Stiborova M, Levova K, Barta F, Shi Z, Frei E, Schmeiser HH, Nebert DW, Phillips DH, Arlt VM (2012) Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2. Toxicol Sci 125:345\u2013358", "journal-title": "Toxicol Sci"}, {"key": "9_CR316", "unstructured": "Ortiz de Montellano PR (2014) Substrate oxidation, Chap.\u00a04 (this book)"}, {"key": "9_CR317", "first-page": "9986", "volume": "268", "author": "Y Seto", "year": "1993", "unstructured": "Seto Y, Guengerich FP (1993) Partitioning between N-dealkylation and N-oxygenation in the oxidation of N, N-dialkylarylamines catalyzed by cytochrome P450 2B1. J Biol Chem 268:9986\u20139997", "journal-title": "J Biol Chem"}, {"key": "9_CR318", "doi-asserted-by": "crossref", "first-page": "2549", "DOI": "10.1021/ja00294a057", "volume": "107", "author": "LT Burka", "year": "1985", "unstructured": "Burka LT, Guengerich FP, Willard RJ, Macdonald TL (1985) Mechanism of cytochrome P-450 catalysis. Mechanism of N-dealkylation and amine oxide deoxygenation. J Am Chem Soc 107:2549\u20132551", "journal-title": "J Am Chem Soc"}, {"key": "9_CR319", "first-page": "1546", "volume": "268", "author": "O Okazaki", "year": "1993", "unstructured": "Okazaki O, Guengerich FP (1993) Evidence for specific base catalysis in N-dealkylation reactions catalyzed by cytochrome P450 and chloroperoxidase. Differences in rates of deprotonation of aminium radicals as an explanation for high kinetic hydrogen isotope effects observed with peroxidases. J Biol Chem 268:1546\u20131552", "journal-title": "J Biol Chem"}, {"key": "9_CR320", "doi-asserted-by": "crossref", "first-page": "451", "DOI": "10.1081/DMR-120005646", "volume": "34", "author": "P Hlavica", "year": "2002", "unstructured": "Hlavica P (2002) N-Oxidative transformation of free and N-substituted amine functions by cytochrome P450 as means of bioactivation and detoxication. Drug Metab Rev 34:451\u2013477", "journal-title": "Drug Metab Rev"}, {"key": "9_CR321", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1021/tx400376u", "volume": "27", "author": "L Ripa", "year": "2014", "unstructured": "Ripa L, Mee C, Sjo P, Shamovsky I (2014) Theoretical studies of the mechanism of N-hydroxylation of primary aromatic amines by cytochrome P450 1A2: radicaloid or anionic? Chem Res Toxicol 27:265\u2013278", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR322", "doi-asserted-by": "crossref", "first-page": "1017", "DOI": "10.1124/dmd.108.025700", "volume": "37", "author": "M Turpeinen", "year": "2009", "unstructured": "Turpeinen M, Hofmann U, Klein K, Murdter T, Schwab M, Zanger UM (2009) A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes. Drug Metab Dispos 37:1017\u20131024", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR323", "doi-asserted-by": "crossref", "first-page": "10834", "DOI": "10.1074/jbc.M111.307918", "volume": "287", "author": "A Wang", "year": "2012", "unstructured": "Wang A, Savas U, Hsu MH, Stout CD, Johnson EF (2012) Crystal structure of human cytochrome P450 2D6 with prinomastat bound. J Biol Chem 287:10834\u201310843", "journal-title": "J Biol Chem"}, {"key": "9_CR324", "doi-asserted-by": "crossref", "first-page": "7262", "DOI": "10.1021/bi010402z", "volume": "40", "author": "GP Miller", "year": "2001", "unstructured": "Miller GP, Guengerich FP (2001) Binding and oxidation of alkyl 4-nitrophenyl ethers by rabbit cytochrome P450 1A2: evidence for two binding sites. Biochemistry 40:7262\u20137272", "journal-title": "Biochemistry"}, {"key": "9_CR325", "doi-asserted-by": "crossref", "first-page": "69", "DOI": "10.1016/j.abb.2008.02.033", "volume": "473", "author": "EM Isin", "year": "2008", "unstructured": "Isin EM, Sohl CD, Eoff RL, Guengerich FP (2008) Cooperativity of cytochrome P450 1A2: interactions of 1,4-phenylene diisocyanide and 1-isopropoxy-4-nitrobenzene. Arch Biochem Biophys 473:69\u201375", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR326", "doi-asserted-by": "crossref", "first-page": "7407", "DOI": "10.1021/bi973011m", "volume": "37", "author": "JK Racha", "year": "1998", "unstructured": "Racha JK, Rettie AE, Kunze KL (1998) Mechanism-based inactivation of human cytochrome P450 1A2 by furafylline: detection of a 1:1 adduct to protein and evidence for the formation of a novel imidazomethide intermediate. Biochemistry 37:7407\u20137419", "journal-title": "Biochemistry"}, {"key": "9_CR327", "doi-asserted-by": "crossref", "first-page": "69", "DOI": "10.1016/0041-008X(87)90307-3", "volume": "90", "author": "R Voorman", "year": "1987", "unstructured": "Voorman R, Aust SD (1987) Specific binding of polyhalogenated aromatic hydrocarbon inducers of cytochrome P-450d to the cytochrome and inhibition of its estradiol 2-hydroxylase activity. Toxicol Appl Pharmacol 90:69\u201378", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "9_CR328", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1016/j.bcp.2014.01.016", "volume": "88", "author": "R Gu", "year": "2014", "unstructured": "Gu R, Hibbs DE, Ong JA, Edwards RJ, Murray M (2014) The multikinase inhibitor axitinib is a potent inhibitor of human CYP1A2. Biochem Pharmacol 88:245\u2013252", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR329", "doi-asserted-by": "crossref", "first-page": "1047", "DOI": "10.1021/tx300023p", "volume": "25", "author": "J Liu", "year": "2012", "unstructured": "Liu J, Nguyen TT, Dupart PS, Sridhar J, Zhang X, Zhu N, Stevens CL, Foroozesh M (2012) 7-Ethynylcoumarins: selective inhibitors of human cytochrome P450s 1A1 and 1A2. Chem Res Toxicol 25:1047\u20131057", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR330", "doi-asserted-by": "crossref", "first-page": "651", "DOI": "10.1111/j.1365-2125.1990.tb03686.x", "volume": "29", "author": "D Sesardic", "year": "1990", "unstructured": "Sesardic D, Boobis A, Murray B, Murray S, Segura J, De La Torre R, Davies D (1990) Furafylline is a potent and selective inhibitor of cytochrome P450 1A2 in man. Br J Clin Pharmacol 29:651\u2013663", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR331", "doi-asserted-by": "crossref", "first-page": "445", "DOI": "10.1002/cpt1978234445", "volume": "3", "author": "A Kappas", "year": "1978", "unstructured": "Kappas A, Alvares AP, Anderson KE, Pantuck EJ, Pantuck CB, Chang R, Conney AH (1978) Effect of charcoal-broiled beef on antipyrine and theophylline metabolism. Clin Pharmacol Ther 3:445\u2013450", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR332", "first-page": "956", "volume": "66", "author": "CH Feldman", "year": "1980", "unstructured": "Feldman CH, Hutchinson VE, Pippenger CE, Blemenfeld TA, Feldman BR, Davis WJ (1980) Effect of dietary protein and carbohydrate on theophylline metabolism in children. Pediatrics 66:956\u2013962", "journal-title": "Pediatrics"}, {"key": "9_CR333", "doi-asserted-by": "crossref", "first-page": "278", "DOI": "10.1016/j.cancergen.2012.02.004", "volume": "205", "author": "S Pavanello", "year": "2012", "unstructured": "Pavanello S, Fedeli U, Mastrangelo G, Rota F, Overvad K, Raaschou-Nielsen O, Tjonneland A, Vogel U (2012) Role of CYP1A2 polymorphisms on lung cancer risk in a prospective study. Cancer Genet 205:278\u2013284", "journal-title": "Cancer Genet"}, {"key": "9_CR334", "doi-asserted-by": "crossref", "first-page": "4979", "DOI": "10.3748/wjg.v17.i45.4979", "volume": "17", "author": "A Kasicka-Jonderko", "year": "2011", "unstructured": "Kasicka-Jonderko A, Nita A, Jonderko K, Kaminska M, Blonska-Fajfrowska B (2011) C-methacetin breath test reproducibility study reveals persistent CYP1A2 stimulation on repeat examinations. World J Gastroenterol 17:4979\u20134986", "journal-title": "World J Gastroenterol"}, {"key": "9_CR335", "doi-asserted-by": "crossref", "first-page": "970", "DOI": "10.1210/endo-129-2-970", "volume": "129", "author": "S Otto", "year": "1991", "unstructured": "Otto S, Marcus C, Pidgeon C, Jefcoate C (1991) A novel adrenocorticotropin-inducible cytochrome P450 from rat adrenalmicrosomes catalyzes polycyclic aromatic hydrocarbon metabolism. Endocrinology 129:970\u2013982", "journal-title": "Endocrinology"}, {"key": "9_CR336", "doi-asserted-by": "crossref", "first-page": "106", "DOI": "10.1006/abbi.2001.2482", "volume": "393", "author": "BP Murray", "year": "2001", "unstructured": "Murray BP, Correia MA (2001) Ubiquitin-dependent 26S proteasomal pathway: a role in the degradation of native human liver CYP3A4 expressed in Saccharomyces cerevisiae? Arch Biochem Biophys 393:106\u2013116", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR337", "first-page": "3026", "volume": "57", "author": "GI Murray", "year": "1997", "unstructured": "Murray GI, Taylor MC, McFadyen MC, McKay JA, Greenlee WF, Burke MD, Melvin WT (1997) Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res 57:3026\u20133031", "journal-title": "Cancer Res"}, {"key": "9_CR338", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1093/toxsci/71.1.11", "volume": "71", "author": "TKH Chang", "year": "2003", "unstructured": "Chang TKH, Chen J, Pillay V, Ho, J-Y, Bandiera SM (2003) Real-time polymerase chain reaction analysis of CYP1B1 gene expression in human liver. Toxicol Sci 71:11\u201319", "journal-title": "Toxicol Sci"}, {"key": "9_CR339", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1146/annurev.pharmtox.48.061807.154729", "volume": "48", "author": "V Vasiliou", "year": "2008", "unstructured": "Vasiliou V, Gonzalez FJ (2008) Role of CYP1B1 in glaucoma. Annu Rev Pharmacol Toxicol 48:333\u2013358", "journal-title": "Annu Rev Pharmacol Toxicol"}, {"key": "9_CR340", "doi-asserted-by": "crossref", "first-page": "9936", "DOI": "10.1074/jbc.M113.525659", "volume": "289", "author": "S Bansal", "year": "2014", "unstructured": "Bansal S, Leu A, Gonzalez FJ, Guengerich FP, Roy Chowdhury A, Anandathheerthavarada HK, Avadhani NG (2014) Mitochondrial targeting of cytochrome P450 (CYP) 1B1 and its role in polycyclic aromatic hydrocarbon-induced mitochondrial dysfunction. J Biol Chem 289:9936\u20139951", "journal-title": "J Biol Chem"}, {"key": "9_CR341", "doi-asserted-by": "crossref", "first-page": "3119", "DOI": "10.1158/0008-5472.CAN-04-0166", "volume": "64", "author": "Y Tsuchiya", "year": "2004", "unstructured": "Tsuchiya Y, Nakajima M, Kyo S, Kanaya T, Inoue M, Yokoi T (2004) Human CYP1B1 is regulated by estradiolvia estrogenreceptor. Cancer Res 64:3119\u20133125", "journal-title": "Cancer Res"}, {"key": "9_CR342", "doi-asserted-by": "crossref", "first-page": "9090", "DOI": "10.1158/0008-5472.CAN-06-1403", "volume": "66", "author": "Y Tsuchiya", "year": "2006", "unstructured": "Tsuchiya Y, Nakajima M, Takagi S, Taniya T, Yokoi T (2006) MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Res 66:9090\u20139098", "journal-title": "Cancer Res"}, {"key": "9_CR343", "doi-asserted-by": "crossref", "first-page": "641", "DOI": "10.1093/hmg/6.4.641", "volume": "6", "author": "I Stoilov", "year": "1997", "unstructured": "Stoilov I, Akarsu AN, Sarfarazi M (1997) Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum Mol Genet 6:641\u2013647", "journal-title": "Hum Mol Genet"}, {"key": "9_CR344", "first-page": "1176", "volume": "29", "author": "T Shimada", "year": "2001", "unstructured": "Shimada T, Oda Y, Gillam EM, Guengerich FP, Inoue K (2001) Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009. Drug Metab Dispos 29:1176\u20131182", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR345", "first-page": "617", "volume": "25", "author": "T Shimada", "year": "1997", "unstructured": "Shimada T, Gillam EM, Sutter TR, Strickland PT, Guengerich FP, Yamazaki H (1997) Oxidation of xenobiotics by recombinant human cytochrome P450 1B1. Drug Metab Dispos 25:617\u2013622", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR346", "doi-asserted-by": "crossref", "first-page": "129", "DOI": "10.1016/S1383-5718(00)00138-8", "volume": "472", "author": "H Yamazaki", "year": "2000", "unstructured": "Yamazaki H, Hatanaka N, Kizu R, Hayakawa K, Shimada N, Guengerich FP, Nakajima M, Yokoi T (2000) Bioactivation of diesel exhaust particle extracts and their major nitrated polycyclic aromatic hydrocarbon components, 1-nitropyrene and dinitropyrenes, by human cytochromes P450 1A1, 1A2, and 1B1. Mutat Res 472:129\u2013138", "journal-title": "Mutat Res"}, {"key": "9_CR347", "doi-asserted-by": "crossref", "first-page": "9776", "DOI": "10.1073/pnas.93.18.9776", "volume": "93", "author": "CL Hayes", "year": "1996", "unstructured": "Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, Sutter TR (1996) 17\u03b2-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci U S A 93:9776\u20139781", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR348", "doi-asserted-by": "crossref", "first-page": "1607", "DOI": "10.1093/carcin/20.8.1607", "volume": "20", "author": "T Shimada", "year": "1999", "unstructured": "Shimada T, Watanabe J, Kawajiri K, Sutter TR, Guengerich FP, Gillam EM, Inoue K (1999) Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis 20:1607\u20131613", "journal-title": "Carcinogenesis"}, {"key": "9_CR349", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1146/annurev.pharmtox.45.120403.100010", "volume": "45", "author": "D Kim", "year": "2005", "unstructured": "Kim D, Guengerich FP (2005) Cytochrome P450 activation of arylamines and heterocyclic amines. Annu Rev Pharmacol Toxicol 45:27\u201349", "journal-title": "Annu Rev Pharmacol Toxicol"}, {"key": "9_CR350", "doi-asserted-by": "crossref", "first-page": "2007", "DOI": "10.1124/mol.106.023648", "volume": "69", "author": "ZL Wu", "year": "2006", "unstructured": "Wu ZL, Sohl CD, Shimada T, Guengerich FP (2006) Recombinant enzymes overexpressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1. Mol Pharmacol 69:2007\u20132014", "journal-title": "Mol Pharmacol"}, {"key": "9_CR351", "doi-asserted-by": "crossref", "first-page": "529", "DOI": "10.1021/tx3004906", "volume": "26", "author": "T Shimada", "year": "2013", "unstructured": "Shimada T, Murayama N, Yamazaki H, Tanaka K, Takenaka S, Komori M, Kim D, Guengerich FP (2013) Metabolic activation of polycyclic aromatic hydrocarbons and aryl and heterocyclic amines by human cytochromes P450 2A13 and 2A6. Chem Res Toxicol 26:529\u2013537", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR352", "doi-asserted-by": "crossref", "first-page": "623", "DOI": "10.1021/tx990028s", "volume": "12", "author": "T Shimada", "year": "1999", "unstructured": "Shimada T, Gillam EM, Oda Y, Tsumura F, Sutter TR, Guengerich FP, Inoue K (1999) Metabolism of benzo[a]pyrene to trans-7,8-dihydroxy-7, 8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1and purified liver epoxide hydrolase. Chem Res Toxicol 12:623\u2013629", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR353", "doi-asserted-by": "crossref", "first-page": "451", "DOI": "10.1124/mol.113.087700", "volume": "84", "author": "CR Nishida", "year": "2013", "unstructured": "Nishida CR, Everett S, Ortiz de Montellano PR (2013) Specificity determinants of CYP1B1 estradiol hydroxylation. Mol Pharmacol 84:451\u2013458", "journal-title": "Mol"}, {"key": "9_CR354", "first-page": "3440", "volume": "60", "author": "IH Hanna", "year": "2000", "unstructured": "Hanna IH, Dawling S, Roodi N, Guengerich FP, Parl FF (2000) Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res 60:3440\u20133444", "journal-title": "Cancer Res"}, {"key": "9_CR355", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1093/carcin/18.1.207", "volume": "18", "author": "M Shou", "year": "1997", "unstructured": "Shou M, Korzekwa KR, Brooks EN, Krausz KW, Gonzalez FJ, Gelboin HV (1997) Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone. Carcinogenesis 18:207\u2013214", "journal-title": "Carcinogenesis"}, {"key": "9_CR356", "doi-asserted-by": "crossref", "first-page": "1113", "DOI": "10.1021/tx9801007", "volume": "11", "author": "JL Bolton", "year": "1998", "unstructured": "Bolton JL, Pisha E, Zhang F, Qiu S (1998) Role of quinoids in estrogen carcinogenesis. Chem Res Toxicol 11:1113\u20131127", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR357", "doi-asserted-by": "crossref", "first-page": "9220", "DOI": "10.1073/pnas.92.20.9220", "volume": "92", "author": "JG Liehr", "year": "1995", "unstructured": "Liehr JG, Ricci MJ, Jefcoate CR, Hannigan EV, Hokanson JA, Zhu BT (1995) 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. Proc Natl Acad Sci U S A 92:9220\u20139224", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR358", "doi-asserted-by": "crossref", "first-page": "451", "DOI": "10.1124/mol.113.087700", "volume": "84", "author": "CR Nishida", "year": "2013", "unstructured": "Nishida CR, Everett S, Ortiz de Montellano PR (2013) Specificity determinants of CYP1B1 estradiol hydroxylation. Mol Pharmacol 84:451\u2013458", "journal-title": "Mol Pharmacol"}, {"key": "9_CR359", "doi-asserted-by": "crossref", "first-page": "218", "DOI": "10.1126/science.275.5297.218", "volume": "275", "author": "M Jang", "year": "1997", "unstructured": "Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218\u2013220", "journal-title": "Science"}, {"key": "9_CR360", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1006/bbrc.1999.1152", "volume": "262", "author": "Y-J Chun", "year": "1999", "unstructured": "Chun Y-J, Kim MY, Guengerich FP (1999) Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem Biophys Res Commun 262:20\u201324", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR361", "doi-asserted-by": "crossref", "first-page": "774", "DOI": "10.1038/sj.bjc.6600197", "volume": "86", "author": "GA Potter", "year": "2002", "unstructured": "Potter GA, Patterson LH, Wanogho E, Perry PJ, Butler PC, Ijaz T, Ruparelia KC, Lamb JH, Farmer PB, Stanley LA, Burke MD (2002) The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br J Cancer 86:774\u2013778", "journal-title": "Br J Cancer"}, {"key": "9_CR362", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1016/S0027-5107(02)00333-0", "volume": "523\u2013524", "author": "FP Guengerich", "year": "2003", "unstructured": "Guengerich FP, Chun Y-J, Kim D, Gillam EMJ, Shimada T (2003) Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies. Mutat Res 523\u2013524:173\u2013182", "journal-title": "Mutat Res"}, {"key": "9_CR363", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1517/14796694.1.2.259", "volume": "1", "author": "MC McFadyen", "year": "2005", "unstructured": "McFadyen MC, Murray GI (2005) Cytochrome P450 1B1: a novel anticancer therapeutic target. Future Oncol 1:259\u2013263", "journal-title": "Future Oncol"}, {"key": "9_CR364", "doi-asserted-by": "crossref", "first-page": "84", "DOI": "10.1016/j.toxlet.2009.05.005", "volume": "189", "author": "Y-J Chun", "year": "2009", "unstructured": "Chun Y-J, Oh YK, Kim BJ, Kim D, Kim SS, Choi HK, Kim MY (2009) Potent inhibition of human cytochrome P450 1B1 by tetramethoxystilbene. Toxicol Lett 189:84\u201389", "journal-title": "Toxicol Lett"}, {"key": "9_CR365", "doi-asserted-by": "crossref", "first-page": "1325", "DOI": "10.1021/tx900127s", "volume": "22", "author": "T Shimada", "year": "2009", "unstructured": "Shimada T, Tanaka K, Takenaka S, Foroozesh MK, Murayama N, Yamazaki H, Guengerich FP, Komori M (2009) Reverse type I binding spectra of human cytochrome P450 1B1 induced by flavonoid, stilbene, pyrene, naphthalene, phenanthrene, and biphenyl derivatives that inhibit catalytic activity: a structure-function relationship study. Chem Res Toxicol 22:1325\u20131333", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR366", "first-page": "630", "volume": "195", "author": "A Lacassagne", "year": "1932", "unstructured": "Lacassagne A (1932) Apparition de cancers de la mamelle chez la souris male, soumise a des injections de folliculine. Compt Rend Acad Sci 195:630\u2013632", "journal-title": "Compt Rend Acad Sci"}, {"key": "9_CR367", "doi-asserted-by": "crossref", "first-page": "11126", "DOI": "10.1021/ja971396q", "volume": "119", "author": "L Shen", "year": "1997", "unstructured": "Shen L, Qiu S, van Breemen RB, Zhang F, Chen Y, Bolton JL (1997) Reaction of the premarin metabolite 4-hydroxyequilenin semiquinone radical with 2\u2032-deoxyguanosine: formation of unusual cyclic adducts. J Am Chem Soc 119:11126\u201311127", "journal-title": "J Am Chem Soc"}, {"key": "9_CR368", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.1517/17425255.1.2.187", "volume": "1", "author": "PH Roos", "year": "2005", "unstructured": "Roos PH, Bolt HM (2005) Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1. Exp Opin Drug Metab Toxicol 1:187\u2013202", "journal-title": "Exp Opin Drug Metab Toxicol"}, {"key": "9_CR369", "doi-asserted-by": "crossref", "first-page": "1533", "DOI": "10.1093/carcin/bgg114", "volume": "24", "author": "T Rylander-Rudqvist", "year": "2003", "unstructured": "Rylander-Rudqvist T, Wedren S, Granath F, Humphreys K, Ahlberg S, Weiderpass E, Oscarson M, Ingelman-Sundberg M, Persson I (2003) Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk. Carcinogenesis 24:1533\u20131539", "journal-title": "Carcinogenesis"}, {"key": "9_CR370", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1016/j.mrfmmm.2007.10.007", "volume": "639", "author": "AP Singh", "year": "2008", "unstructured": "Singh AP, Shah PP, Mathur N, Buters JT, Pant MC, Parmar D (2008) Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer. Mutat Res 639:11\u201319", "journal-title": "Mutat Res"}, {"key": "9_CR371", "doi-asserted-by": "crossref", "first-page": "7038", "DOI": "10.1158/0008-5472.CAN-09-1691", "volume": "69", "author": "S Saini", "year": "2009", "unstructured": "Saini S, Hirata H, Majid S, Dahiya R (2009) Functional significance of cytochrome P450 1B1 in endometrial carcinogenesis. Cancer Res 69:7038\u20137045", "journal-title": "Cancer Res"}, {"key": "9_CR372", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.4149/neo_2010_01_015", "volume": "57", "author": "D Vrana", "year": "2010", "unstructured": "Vrana D, Novotny J, Holcatova I, Hlavata I, Soucek P (2010) CYP1B1 gene polymorphism modifies pancreatic cancer risk but not survival. Neoplasma 57:15\u201319", "journal-title": "Neoplasma"}, {"key": "9_CR373", "doi-asserted-by": "crossref", "first-page": "809", "DOI": "10.1007/s13277-011-0298-7", "volume": "33", "author": "Y Xie", "year": "2012", "unstructured": "Xie Y, Liu GQ, Miao XY, Liu Y, Zhou W, Zhong DW (2012) CYP1B1 Leu432Val polymorphism and colorectal cancer risk among Caucasians: a meta-analysis. Tumour Biol 33:809\u2013816", "journal-title": "Tumour Biol"}, {"key": "9_CR374", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1016/j.canlet.2012.04.021", "volume": "324", "author": "K Gajjar", "year": "2012", "unstructured": "Gajjar K, Martin-Hirsch PL, Martin FL (2012) CYP1B1 and hormone-induced cancer. Cancer Lett 324:13\u201330", "journal-title": "Cancer Lett"}, {"key": "9_CR375", "doi-asserted-by": "crossref", "first-page": "e68634", "DOI": "10.1371/journal.pone.0068634", "volume": "8", "author": "H Zhang", "year": "2013", "unstructured": "Zhang H, Li L, Xu Y (2013) CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis. PLoS One 8:e68634", "journal-title": "PLoS One"}, {"key": "9_CR376", "doi-asserted-by": "crossref", "first-page": "11115", "DOI": "10.1073/pnas.1220919110", "volume": "110", "author": "J Iqbal", "year": "2013", "unstructured": "Iqbal J, Sun L, Cao J, Yuen T, Lu P, Bab I, Leu NA, Srinivasan S, Wagage S, Hunter CA, Nebert DW, Zaidi M, Avadhani NG (2013) Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes. Proc Natl Acad Sci U S A 110:11115\u201311120", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR377", "doi-asserted-by": "crossref", "first-page": "1087", "DOI": "10.1161/CIRCULATIONAHA.111.062927", "volume": "126", "author": "K White", "year": "2012", "unstructured": "White K, Johansen AK, Nilsen M, Ciuclan L, Wallace E, Paton L, Campbell A, Morecroft I, Loughlin L, McClure JD, Thomas M, Mair KM, MacLean MR (2012) Activity of the estrogen-metabolizing enzyme cytochrome P450 1B1 influences the development of pulmonary arterial hypertension. Circulation 126:1087\u20131098", "journal-title": "Circulation"}, {"key": "9_CR378", "doi-asserted-by": "crossref", "first-page": "1510", "DOI": "10.1161/HYPERTENSIONAHA.112.202606", "volume": "60", "author": "BL Jennings", "year": "2012", "unstructured": "Jennings BL, Estes AM, Anderson LJ, Fang XR, Yaghini FA, Fan Z, Gonzalez FJ, Campbell WB, Malik KU (2012) Cytochrome P450 1B1 gene disruption minimizes deoxycorticosterone acetate-salt-induced hypertension and associated cardiac dysfunction and renal damage in mice. Hypertension 60:1510\u20131516", "journal-title": "Hypertension"}, {"key": "9_CR379", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1089/dna.1993.12.1", "volume": "12", "author": "DR Nelson", "year": "1993", "unstructured": "Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Gotoh O et\u00a0al (1993) The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 12:1\u201351", "journal-title": "DNA Cell Biol"}, {"key": "9_CR380", "doi-asserted-by": "crossref", "first-page": "1322", "DOI": "10.1021/bi00457a031", "volume": "29", "author": "S Yamano", "year": "1990", "unstructured": "Yamano S, Tatsuno J, Gonzalez FJ (1990) The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry 29:1322\u20131329", "journal-title": "Biochemistry"}, {"key": "9_CR381", "doi-asserted-by": "crossref", "first-page": "403", "DOI": "10.1016/0006-2952(95)02184-1", "volume": "51", "author": "J Hakkola", "year": "1996", "unstructured": "Hakkola J, Pasanen M, Hukkanen J, Pelkonen O, M\u00e4enp\u00e4\u00e4 J, Edwards RJ, Boobis AR, Raunio H (1996) Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta. Biochem Pharmacol 51:403\u2013411", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR382", "doi-asserted-by": "crossref", "first-page": "149", "DOI": "10.1146/annurev.pharmtox.43.100901.140251", "volume": "43", "author": "X Ding", "year": "2003", "unstructured": "Ding X, Kaminsky LS (2003) Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 43:149\u2013173", "journal-title": "Annu Rev Pharmacol Toxicol"}, {"key": "9_CR383", "doi-asserted-by": "crossref", "first-page": "611", "DOI": "10.1093/carcin/23.4.611", "volume": "23", "author": "W Godoy", "year": "2002", "unstructured": "Godoy W, Albano RM, Moraes EG, Pinho PR, Nunes RA, Saito EH, Higa C, Filho IM, Kruel CD, Schirmer CC, Gurski R, Lang MA, Pinto LF (2002) CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism. Carcinogenesis 23:611\u2013616", "journal-title": "Carcinogenesis"}, {"key": "9_CR384", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.1002/hep.510270217", "volume": "27", "author": "H Raunio", "year": "1998", "unstructured": "Raunio H, Juvonen R, Pasanen M, Pelkonen O, Paakko P, Soini Y (1998) Cytochrome P4502A6 (CYP2A6) expression in human hepatocellular carcinoma. Hepatology 27:427\u2013432", "journal-title": "Hepatology"}, {"key": "9_CR385", "first-page": "53", "volume": "18", "author": "Y Matsuda", "year": "2007", "unstructured": "Matsuda Y, Yamakawa K, Saoo K, Hosokawa K, Yokohira M, Kuno T, Iwai J, Shirai T, Obika K, Kamataki T, Imaida K (2007) CYP2A6 overexpression in human lung cancers correlates with a high malignant status. Oncol Rep 18:53\u201357", "journal-title": "Oncol Rep"}, {"key": "9_CR386", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1159/000339591", "volume": "84", "author": "HC Chiang", "year": "2012", "unstructured": "Chiang HC, Wang CK, Tsou TC (2012) Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract. Respiration 84:319\u2013326", "journal-title": "Respiration"}, {"key": "9_CR387", "first-page": "849", "volume": "299", "author": "JM Rae", "year": "2001", "unstructured": "Rae JM, Johnson MD, Lippman ME, Flockhart DA (2001) Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays. J Pharmacol Exp Ther 299:849\u2013857", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR388", "first-page": "1321", "volume": "28", "author": "MT Donato", "year": "2000", "unstructured": "Donato MT, Viitala P, Rodriguez-Antona C, Lindfors A, Castell JV, Raunio H, Gomez-Lechon MJ, Pelkonen O (2000) CYP2A5/CYP2A6 expression in mouse and human hepatocytes treated with various in vivo inducers. Drug Metab Dispos 28:1321\u20131326", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR389", "doi-asserted-by": "crossref", "first-page": "668", "DOI": "10.1053/jhep.2001.22176", "volume": "33", "author": "R Jover", "year": "2001", "unstructured": "Jover R, Bort R, Gomez-Lechon MJ, Castell JV (2001) Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting. Hepatology 33:668\u2013675", "journal-title": "Hepatology"}, {"key": "9_CR390", "doi-asserted-by": "crossref", "first-page": "814", "DOI": "10.1124/jpet.104.081570", "volume": "313", "author": "M Pitarque", "year": "2005", "unstructured": "Pitarque M, Rodriguez-Antona C, Oscarson M, Ingelman-Sundberg M (2005) Transcriptional regulation of the human CYP2A6 gene. J Pharmacol Exp Ther 313:814\u2013822", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR391", "doi-asserted-by": "crossref", "first-page": "693", "DOI": "10.1124/jpet.106.107573", "volume": "319", "author": "M Itoh", "year": "2006", "unstructured": "Itoh M, Nakajima M, Higashi E, Yoshida R, Nagata K, Yamazoe Y, Yokoi T (2006) Induction of human CYP2A6 is mediated by the pregnane X receptor with peroxisome proliferator-activated receptor-\u03b3 coactivator 1\u03b1. J Pharmacol Exp Ther 319:693\u2013702", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR392", "doi-asserted-by": "crossref", "first-page": "1935", "DOI": "10.1124/dmd.107.016568", "volume": "35", "author": "E Higashi", "year": "2007", "unstructured": "Higashi E, Fukami T, Itoh M, Kyo S, Inoue M, Yokoi T, Nakajima M (2007) Human CYP2A6 is induced by estrogen via estrogen receptor. Drug Metab Dispos 35:1935\u20131941", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR393", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1016/j.clpt.2004.10.012", "volume": "77", "author": "J Hukkanen", "year": "2005", "unstructured": "Hukkanen J, Gourlay SG, Kenkare S, Benowitz NL (2005) Influence of menstrual cycle on cytochrome P450 2A6 activity and cardiovascular effects of nicotine. Clin Pharmacol Ther 77:159\u2013169", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR394", "doi-asserted-by": "crossref", "first-page": "172", "DOI": "10.1016/j.clpt.2003.10.008", "volume": "75", "author": "O von Richter", "year": "2004", "unstructured": "von Richter O, Burk O, Fromm MF, Thon KP, Eichelbaum M, Kivisto KT (2004) Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens. Clin Pharmacol Ther 75:172\u2013183", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR395", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.1016/j.bcp.2010.09.020", "volume": "81", "author": "S Yokota", "year": "2011", "unstructured": "Yokota S, Higashi E, Fukami T, Yokoi T, Nakajima M (2011) Human CYP2A6 is regulated by nuclear factor-erythroid 2 related factor 2. Biochem Pharmacol 81:289\u2013294", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR396", "doi-asserted-by": "crossref", "first-page": "1405", "DOI": "10.1124/mol.65.6.1405", "volume": "65", "author": "K Christian", "year": "2004", "unstructured": "Christian K, Lang M, Maurel P, Raffalli-Mathieu F (2004) Interaction of heterogeneous nuclear ribonucleoprotein A1 with cytochrome P450 2A6 mRNA: implications for post-transcriptional regulation of the CYP2A6 gene. Mol Pharmacol 65:1405\u20131414", "journal-title": "Mol Pharmacol"}, {"key": "9_CR397", "doi-asserted-by": "crossref", "first-page": "491", "DOI": "10.1016/j.bbrc.2005.12.035", "volume": "340", "author": "J Wang", "year": "2006", "unstructured": "Wang J, Pitarque M, Ingelman-Sundberg M (2006) 3\u2032-UTR polymorphism in the human CYP2A6 gene affects mRNA stability and enzyme expression. Biochem Biophys Res Commun 340:491\u2013497", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR398", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1042/bj3060161", "volume": "306", "author": "S Ding", "year": "1995", "unstructured": "Ding S, Lake BG, Friedberg T, Wolf CR (1995) Expression and alternative splicing of the cytochrome P-450 CYP2A7. Biochem J 306:161\u2013166", "journal-title": "Biochem J"}, {"key": "9_CR399", "doi-asserted-by": "crossref", "first-page": "275", "DOI": "10.1002/humu.10126", "volume": "20", "author": "M Oscarson", "year": "2002", "unstructured": "Oscarson M, McLellan RA, Asp V, Ledesma M, Ruiz ML, Sinues B, Rautio A, Ingelman-Sundberg M (2002) Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity. Hum Mutat 20:275\u2013283", "journal-title": "Hum Mutat"}, {"key": "9_CR400", "doi-asserted-by": "crossref", "first-page": "458", "DOI": "10.3109/00498251003786749", "volume": "40", "author": "KH Tiong", "year": "2010", "unstructured": "Tiong KH, Yiap BC, Tan EL, Ismail R, Ong CE (2010) In vitro modulation of naturally occurring flavonoids on cytochrome P450 2A6 (CYP2A6) activity. Xenobiotica 40:458\u2013466", "journal-title": "Xenobiotica"}, {"key": "9_CR401", "doi-asserted-by": "crossref", "first-page": "903", "DOI": "10.1016/S0278-6915(97)00066-5", "volume": "35", "author": "H Hadidi", "year": "1997", "unstructured": "Hadidi H, Zahlsen K, Idle JR, Cholerton S (1997) A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin. Food Chem Toxicol 35:903\u2013907", "journal-title": "Food Chem Toxicol"}, {"key": "9_CR402", "doi-asserted-by": "crossref", "first-page": "258", "DOI": "10.1002/humu.20002", "volume": "23", "author": "M Pitarque", "year": "2004", "unstructured": "Pitarque M, von Richter O, Rodriguez-Antona C, Wang J, Oscarson M, Ingelman-Sundberg M (2004) A nicotine C-oxidase gene (CYP2A6) polymorphism important for promoter activity. Hum Mutat 23:258\u2013266", "journal-title": "Hum Mutat"}, {"key": "9_CR403", "doi-asserted-by": "crossref", "first-page": "72", "DOI": "10.1067/mcp.2001.112688", "volume": "69", "author": "M Nakajima", "year": "2001", "unstructured": "Nakajima M, Kwon J-T, Tanaka N, Zenta T, Yamamoto Y, Yamamoto H, Yamazaki H, Yamamoto T, Kuroiwa Y, Yokoi T (2001) Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans. Clin Pharmacol Ther 69:72\u201378", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR404", "first-page": "548", "volume": "29", "author": "RF Tyndale", "year": "2001", "unstructured": "Tyndale RF, Sellers EM (2001) Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk. Drug Metab Dispos 29:548\u2013552", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR405", "doi-asserted-by": "crossref", "first-page": "511", "DOI": "10.1046/j.1365-2125.2002.01667.x", "volume": "54", "author": "R Yoshida", "year": "2002", "unstructured": "Yoshida R, Nakajima M, Watanabe Y, Kwon JT, Yokoi T (2002) Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism. Br J Clin Pharmacol 54:511\u2013517", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR406", "doi-asserted-by": "crossref", "first-page": "383", "DOI": "10.1046/j.1469-1809.2000.6450383.x", "volume": "64", "author": "DF Gu", "year": "2000", "unstructured": "Gu DF, Hinks LJ, Morton NE, Day IN (2000) The use of long PCR to confirm three common alleles at the CYP2A6 locus and the relationship between genotype and smoking habit. Ann Hum Genet 64:383\u2013390", "journal-title": "Ann Hum Genet"}, {"key": "9_CR407", "doi-asserted-by": "crossref", "first-page": "747", "DOI": "10.1124/mol.58.4.747", "volume": "58", "author": "Y Rao", "year": "2000", "unstructured": "Rao Y, Hoffmann E, Zia M, Bodin L, Zeman M, Sellers EM, Tyndale RF (2000) Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking. Mol Pharmacol 58:747\u2013755", "journal-title": "Mol Pharmacol"}, {"key": "9_CR408", "doi-asserted-by": "crossref", "first-page": "1245", "DOI": "10.1016/S0169-409X(02)00065-0", "volume": "54", "author": "C Xu", "year": "2002", "unstructured": "Xu C, Goodz S, Sellers EM, Tyndale RF (2002) CYP2A6 genetic variation and potential consequences. Adv Drug Deliv Rev 54:1245\u20131256", "journal-title": "Adv Drug Deliv Rev"}, {"key": "9_CR409", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1097/00007691-200202000-00026", "volume": "24", "author": "RF Tyndale", "year": "2002", "unstructured": "Tyndale RF, Sellers EM (2002) Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior. Ther Drug Monit 24:163\u2013171", "journal-title": "Ther Drug Monit"}, {"key": "9_CR410", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1016/S1383-5742(99)00040-X", "volume": "428", "author": "T Kamataki", "year": "1999", "unstructured": "Kamataki T, Nunoya K, Sakai Y, Kushida H, Fujita K (1999) Genetic polymorphism of CYP2A6 in relation to cancer. Mutat Res 428:125\u2013130", "journal-title": "Mutat Res"}, {"key": "9_CR411", "doi-asserted-by": "crossref", "first-page": "658", "DOI": "10.1006/bbrc.1999.1089", "volume": "261", "author": "M Miyamoto", "year": "1999", "unstructured": "Miyamoto M, Umetsu Y, Dosaka-Akita H, Sawamura Y, Yokota J, Kunitoh H, Nemoto N, Sato K, Ariyoshi N, Kamataki T (1999) CYP2A6 gene deletion reduces susceptibility to lung cancer. Biochem Biophys Res Commun 261:658\u2013660", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR412", "doi-asserted-by": "crossref", "first-page": "898", "DOI": "10.1016/S0140-6736(98)04984-8", "volume": "353", "author": "SJ London", "year": "1999", "unstructured": "London SJ, Idle JR, Daly AK, Coetzee GA (1999) Genetic variation of CYP2A6, smoking, and risk of cancer. Lancet 353:898\u2013899", "journal-title": "Lancet"}, {"key": "9_CR413", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1007/978-1-4615-0667-6_29", "volume": "500", "author": "TG Schulz", "year": "2001", "unstructured": "Schulz TG, Ruhnau P, Hallier E (2001) Lack of correlation between CYP2A6 genotype and smoking habits. Adv Exp Med Biol 500:213\u2013215", "journal-title": "Adv Exp Med Biol"}, {"key": "9_CR414", "doi-asserted-by": "crossref", "first-page": "357", "DOI": "10.1046/j.0306-5251.2001.01500.x", "volume": "52", "author": "H Raunio", "year": "2001", "unstructured": "Raunio H, Rautio A, Gullsten H, Pelkonen O (2001) Polymorphisms of CYP2A6 and its practical consequences. Br J Clin Pharmacol 52:357\u2013363", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR415", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1016/S0300-483X(02)00513-9", "volume": "183", "author": "AR Tricker", "year": "2003", "unstructured": "Tricker AR (2003) Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour. Toxicology 183:151\u2013173", "journal-title": "Toxicology"}, {"key": "9_CR416", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1097/00008571-200102000-00005", "volume": "11", "author": "MA Loriot", "year": "2001", "unstructured": "Loriot MA, Rebuissou S, Oscarson M, Cenee S, Miyamoto M, Ariyoshi N, Kamataki T, Hemon D, Beaune P, Stucker I (2001) Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population. Pharmacogenetics 11:39\u201344", "journal-title": "Pharmacogenetics"}, {"key": "9_CR417", "first-page": "486", "volume": "36", "author": "X Zhang", "year": "2001", "unstructured": "Zhang X, Amemo K, Ameno S, Iwahashi K, Kinoshita H, Kubota T, Mostofa J, Ijiri I (2001) Lack of association between smoking and CYP2A6 gene polymorphisms in a Japanese population. Nihon Arukoru Yakubutsu Igakkai Zasshi 36:486\u2013490", "journal-title": "Nihon Arukoru Yakubutsu Igakkai Zasshi"}, {"key": "9_CR418", "first-page": "91", "volume": "29", "author": "M Oscarson", "year": "2001", "unstructured": "Oscarson M (2001) Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: implications for interindividual differences in nicotine metabolism. Drug Metab Dispos 29:91\u201395", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR419", "doi-asserted-by": "crossref", "first-page": "865", "DOI": "10.1081/DMR-120015696", "volume": "34", "author": "M Nakajima", "year": "2002", "unstructured": "Nakajima M, Kuroiwa Y, Yokoi T (2002) Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6. Drug Metab Rev 34:865\u2013877", "journal-title": "Drug Metab Rev"}, {"key": "9_CR420", "doi-asserted-by": "crossref", "first-page": "129", "DOI": "10.1016/0163-7258(93)90053-G", "volume": "57", "author": "AK Daly", "year": "1993", "unstructured": "Daly AK, Cholerton S, Gregory W, Idle JR (1993) Metabolic polymorphisms. Pharmacol Ther 57:129\u2013160", "journal-title": "Pharmacol Ther"}, {"key": "9_CR421", "doi-asserted-by": "crossref", "first-page": "325", "DOI": "10.1016/0378-4347(92)80166-N", "volume": "575", "author": "S Cholerton", "year": "1992", "unstructured": "Cholerton S, Idle ME, Vas A, Gonzalez FJ, Idle JR (1992) Comparison of a novel thin-layer chromatographic-fluorescence detection method with a spectrofluorometric method for the determination of 7-hydroxycoumarin in human urine. J Chromatogr 575:325\u2013330", "journal-title": "J Chromatogr"}, {"key": "9_CR422", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1097/00008571-199210000-00005", "volume": "2", "author": "A Rautio", "year": "1992", "unstructured": "Rautio A, Kraul H, Kojo A, Salmela E, Pelkonen O (1992) Interindividual variability of coumarin 7-hydroxylation in healthy volunteers. Pharmacogenetics 2:227\u2013233", "journal-title": "Pharmacogenetics"}, {"key": "9_CR423", "doi-asserted-by": "crossref", "first-page": "190", "DOI": "10.1006/abbi.1999.1388", "volume": "370", "author": "P Soucek", "year": "1999", "unstructured": "Soucek P (1999) Expression of cytochrome P450 2A6 in Escherichia coli: purification, spectral and catalytic characterization, and preparation of polyclonal antibodies. Arch Biochem Biophys 370:190\u2013200", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR424", "first-page": "377", "volume": "11", "author": "S Nowell", "year": "2002", "unstructured": "Nowell S, Sweeney C, Hammons G, Kadlubar FF, Ln NP (2002) CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 11:377\u2013383", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9_CR425", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1016/S0378-4274(00)00286-1", "volume": "124", "author": "A Le Gal", "year": "2001", "unstructured": "Le Gal A, Dreano Y, Gervasi PG, Berthou F (2001) Human cytochrome P450 2A6 is the major enzyme involved in the metabolism of three alkoxyethers used as oxyfuels. Toxicol Lett 124:47\u201358", "journal-title": "Toxicol Lett"}, {"key": "9_CR426", "doi-asserted-by": "crossref", "first-page": "342", "DOI": "10.1006/abbi.1994.1246", "volume": "311", "author": "RJ Duescher", "year": "1994", "unstructured": "Duescher RJ, Elfarra AA (1994) Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochrome P450 2A6 and 2E1. Arch Biochem Biophys 311:342\u2013349", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR427", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1097/00008571-199806000-00006", "volume": "8", "author": "K Nunoya", "year": "1998", "unstructured": "Nunoya K, Yokoi T, Kimura K, Inoue K, Kodama T, Funayama M, Nagashima K, Funae Y, Green C, Kinoshita M, Kamataki T (1998) A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502). Pharmacogenetics 8:239\u2013249", "journal-title": "Pharmacogenetics"}, {"key": "9_CR428", "first-page": "437", "volume": "289", "author": "KI Nunoya", "year": "1999", "unstructured": "Nunoya KI, Yokoi T, Kimura K, Kainuma T, Satoh K, Kinoshita M, Kamataki T (1999) A new CYP2A6 gene deletion responsible for the in vivo polymorphic metabolism of (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride in humans. J Pharmacol Exp Ther 289:437\u2013442", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR429", "first-page": "1457", "volume": "28", "author": "T Komatsu", "year": "2000", "unstructured": "Komatsu T, Yamazaki H, Shimada N, Nakajima M, Yokoi T (2000) Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes. Drug Metab Dispos 28:1457\u20131463", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR430", "first-page": "4409", "volume": "6", "author": "K Ikeda", "year": "2000", "unstructured": "Ikeda K, Yoshisue K, Matsushima E, Nagayama S, Kobayashi K, Tyson CA, Chiba K, Kawaguchi Y (2000) Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro. Clin Cancer Res 6:4409\u20134415", "journal-title": "Clin Cancer Res"}, {"key": "9_CR431", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1097/00000542-200108000-00037", "volume": "95", "author": "Y Minoda", "year": "2001", "unstructured": "Minoda Y, Kharasch ED (2001) Halothane-dependent lipid peroxidation in human liver microsomes is catalyzed by cytochrome P4502A6 (CYP2A6). Anesthesiology 95:509\u2013514", "journal-title": "Anesthesiology"}, {"key": "9_CR432", "doi-asserted-by": "crossref", "first-page": "1293", "DOI": "10.1093/carcin/11.8.1293", "volume": "11", "author": "CL Crespi", "year": "1990", "unstructured": "Crespi CL, Penman BW, Leakey JA, Arlotto MP, Stark A, Parkinson A, Turner T, Steimel DT, Rudo K, Davies RL, Langenbach R (1990) Human cytochrome P450IIA3:cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1. Carcinogenesis 11:1293\u20131300", "journal-title": "Carcinogenesis"}, {"key": "9_CR433", "doi-asserted-by": "crossref", "first-page": "1789", "DOI": "10.1093/carcin/13.10.1789", "volume": "13", "author": "H Yamazaki", "year": "1992", "unstructured": "Yamazaki H, Inui Y, Yun CH, Guengerich FP, Shimada T (1992) Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis 13:1789\u20131794", "journal-title": "Carcinogenesis"}, {"key": "9_CR434", "first-page": "1757", "volume": "52", "author": "TJ Smith", "year": "1992", "unstructured": "Smith TJ, Guo Z, Gonzalez FJ, Guengerich FP, Stoner GD, Yang CS (1992) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells. Cancer Res 52:1757\u20131763", "journal-title": "Cancer Res"}, {"key": "9_CR435", "doi-asserted-by": "crossref", "first-page": "1197", "DOI": "10.1093/carcin/12.7.1197", "volume": "12", "author": "CL Crespi", "year": "1991", "unstructured": "Crespi CL, Penman BW, Gelboin HV, Gonzalez FJ (1991) A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. Carcinogenesis 12:1197\u20131201", "journal-title": "Carcinogenesis"}, {"key": "9_CR436", "doi-asserted-by": "crossref", "first-page": "2859", "DOI": "10.1093/carcin/15.12.2859", "volume": "15", "author": "HF Tiano", "year": "1994", "unstructured": "Tiano HF, Wang RL, Hosokawa M, Crespi C, Tindall KR, Langenbach R (1994) Human CYP2A6 activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): mutational specificityin the gpt gene of AS52 cells. Carcinogenesis 15:2859\u20132866", "journal-title": "Carcinogenesis"}, {"key": "9_CR437", "doi-asserted-by": "crossref", "first-page": "1254", "DOI": "10.1021/tx990128y", "volume": "12", "author": "LB von Weymarn", "year": "1999", "unstructured": "von Weymarn LB, Felicia ND, Ding X, Murphy SE (1999) N-nitrosobenzylmethylamine hydroxylation and coumarin 7-hydroxylation: catalysis by rat esophageal microsomes and cytochrome P450 2A3 and 2A6 enzymes. Chem Res Toxicol 12:1254\u20131261", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR438", "first-page": "1227", "volume": "21", "author": "H Kushida", "year": "2000", "unstructured": "Kushida H, Fujita K, Suzuki A, Yamada M, Endo T, Nohmi T, Kamataki T (2000) Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase. Carcinogenesis 21:1227\u20131232", "journal-title": "Carcinogenesis"}, {"key": "9_CR439", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.1002/em.10036", "volume": "38", "author": "K Fujita", "year": "2001", "unstructured": "Fujita K, Kamataki T (2001) Predicting the mutagenicity of tobacco-related N-nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH-cytochrome P450 reductase. Environ Mol Mutagen 38:339\u2013346", "journal-title": "Environ Mol Mutagen"}, {"key": "9_CR440", "first-page": "1212", "volume": "24", "author": "M Nakajima", "year": "1996", "unstructured": "Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, Kuroiwa Y (1996) Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos 24:1212\u20131217", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR441", "first-page": "1608", "volume": "282", "author": "ES Messina", "year": "1997", "unstructured": "Messina ES, Tyndale RF, Sellers EM (1997) A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther 282:1608\u20131614", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR442", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1007/s002040050588", "volume": "73", "author": "H Yamazaki", "year": "1999", "unstructured": "Yamazaki H, Inoue K, Hashimoto M, Shimada T (1999) Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes. Arch Toxicol 73:65\u201370", "journal-title": "Arch Toxicol"}, {"key": "9_CR443", "first-page": "1010", "volume": "277", "author": "M Nakajima", "year": "1996", "unstructured": "Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, Kuroiwa Y (1996) Characterization of CYP2A6 involved in 3-hydroxylation of cotinine in human liver microsomes. J Pharmacol Exp Ther 277:1010\u20131015", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR444", "doi-asserted-by": "crossref", "first-page": "12493", "DOI": "10.1073/pnas.220207697", "volume": "97", "author": "SS Hecht", "year": "2000", "unstructured": "Hecht SS, Hochalter JB, Villalta PW, Murphy SE (2000) 2\u2032-Hydroxylation of nicotine by cytochrome P450 2A6 and human liver microsomes: formation of a lung carcinogen precursor. Proc Natl Acad Sci U S A 97:12493\u201312497", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR445", "first-page": "5074", "volume": "60", "author": "T Su", "year": "2000", "unstructured": "Su T, Bao ZP, Zhang QY, Smith TJ, Hong JY, Ding XX (2000) Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res 60:5074\u20135079", "journal-title": "Cancer Res"}, {"key": "9_CR446", "doi-asserted-by": "crossref", "first-page": "13817", "DOI": "10.1021/bi001229u", "volume": "39", "author": "EM Gillam", "year": "2000", "unstructured": "Gillam EM, Notley LM, Cai H, De Voss JJ, Guengerich FP (2000) Oxidation of indole by cytochrome P450 enzymes. Biochemistry 39:13817\u201313824", "journal-title": "Biochemistry"}, {"key": "9_CR447", "doi-asserted-by": "crossref", "first-page": "280", "DOI": "10.1006/abio.2001.5098", "volume": "292", "author": "K Nakamura", "year": "2001", "unstructured": "Nakamura K, Hanna IH, Cai H, Nishimura Y, Williams KM, Guengerich FP (2001) Coumarin substrates for cytochrome P450 2D6 fluorescence assays. Anal Biochem 292:280\u2013286", "journal-title": "Anal Biochem"}, {"key": "9_CR448", "doi-asserted-by": "crossref", "first-page": "1361", "DOI": "10.1124/dmd.105.004796", "volume": "33", "author": "M Kimura", "year": "2005", "unstructured": "Kimura M, Yamazaki H, Fujieda M, Kiyotani K, Honda G, Saruwatari J, Nakagawa K, Ishizaki T, Kamataki T (2005) CYP2A6 is a principal enzyme involved in hydroxylation of 1,7-dimethylxanthine, a main caffeine metabolite, in humans. Drug Metab Dispos 33:1361\u20131366", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR449", "doi-asserted-by": "crossref", "first-page": "476", "DOI": "10.1124/dmd.106.013425", "volume": "35", "author": "T Endo", "year": "2007", "unstructured": "Endo T, Ban M, Hirata K, Yamamoto A, Hara Y, Momose Y (2007) Involvement of CYP2A6 in the formation of a novel metabolite, 3-hydroxypilocarpine, from pilocarpine in human liver microsomes. Drug Metab Dispos 35:476\u2013483", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR450", "doi-asserted-by": "crossref", "first-page": "50", "DOI": "10.1016/j.taap.2012.03.010", "volume": "261", "author": "Ae Abu-Bakar", "year": "2012", "unstructured": "Abu-Bakar Ae, Arthur DM, Wikman AS, Rahnasto M, Juvonen RO, Vepsalainen J, Raunio H, Ng JC, Lang MA (2012), Metabolism of bilirubin by human cytochrome P450 2A6. Toxicol Appl Pharmacol 261:50\u201358", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "9_CR451", "doi-asserted-by": "crossref", "first-page": "1686", "DOI": "10.1124/dmd.113.052548", "volume": "41", "author": "RE Pearce", "year": "2013", "unstructured": "Pearce RE, Cohen-Wolkowiez M, Sampson MR, Kearns GL (2013) The role of human cytochrome P450 enzymes in the formation of 2-hydroxymetronidazole: CYP2A6 is the high affinity (low K m) catalyst. Drug Metab Dispos 41:1686\u20131694", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR452", "doi-asserted-by": "crossref", "first-page": "12279", "DOI": "10.1074/jbc.M411019200", "volume": "280", "author": "CH Yun", "year": "2005", "unstructured": "Yun CH, Kim KH, Calcutt MW, Guengerich FP (2005) Kinetic analysis of oxidation of coumarins by human cytochrome P450 2A6. J Biol Chem 280:12279\u201312291", "journal-title": "J Biol Chem"}, {"key": "9_CR453", "doi-asserted-by": "crossref", "first-page": "822", "DOI": "10.1038/nsmb971", "volume": "12", "author": "JK Yano", "year": "2005", "unstructured": "Yano JK, Hsu MH, Griffin KJ, Stout CD, Johnson EF (2005) Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen. Nat Struct Biol 12:822\u2013823", "journal-title": "Nat Struct Biol"}, {"key": "9_CR454", "doi-asserted-by": "crossref", "first-page": "6987", "DOI": "10.1021/jm060519r", "volume": "49", "author": "JK Yano", "year": "2006", "unstructured": "Yano JK, Denton TT, Cerny MA, Zhang X, Johnson EF, Cashman JR (2006) Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization. J Med Chem 49:6987\u20137001", "journal-title": "J Med Chem"}, {"key": "9_CR455", "doi-asserted-by": "crossref", "first-page": "197", "DOI": "10.1016/j.abb.2007.04.028", "volume": "464", "author": "S Sansen", "year": "2007", "unstructured": "Sansen S, Hsu MH, Stout CD, Johnson EF (2007) Structural insight into the altered substrate specificity of human cytochrome P450 2A6 mutants. Arch Biochem Biophys 464:197\u2013206", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR456", "doi-asserted-by": "crossref", "first-page": "1621", "DOI": "10.1111/j.1742-4658.2011.08412.x", "volume": "279", "author": "NM DeVore", "year": "2012", "unstructured": "DeVore NM, Meneely KM, Bart AG, Stephens ES, Battaile KP, Scott EE (2012) Structural comparison of cytochromes P450 2A6, 2A13, and 2E1 with pilocarpine. FEBS J 279:1621\u20131631", "journal-title": "FEBS J"}, {"key": "9_CR457", "doi-asserted-by": "crossref", "first-page": "1319", "DOI": "10.1124/dmd.109.026765", "volume": "37", "author": "NM DeVore", "year": "2009", "unstructured": "DeVore NM, Smith BD, Wang JL, Lushington GH, Scott EE (2009) Key residues controlling binding of diverse ligands to human cytochrome P450 2A enzymes. Drug Metab Dispos 37:1319\u20131327", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR458", "doi-asserted-by": "crossref", "first-page": "40319", "DOI": "10.1074/jbc.M508171200", "volume": "280", "author": "D Kim", "year": "2005", "unstructured": "Kim D, Wu ZL, Guengerich FP (2005) Analysis of coumarin 7-hydroxylation activity of cytochrome P450 2A6 using random mutagenesis. J Biol Chem 280:40319\u201340327", "journal-title": "J Biol Chem"}, {"key": "9_CR459", "doi-asserted-by": "crossref", "first-page": "41090", "DOI": "10.1074/jbc.M508182200", "volume": "280", "author": "ZL Wu", "year": "2005", "unstructured": "Wu ZL, Podust LM, Guengerich FP (2005) Expansion of substrate specificity of cytochrome P450 2A6 by random and site-directed mutagenesis. J Biol Chem 280:41090\u201341100", "journal-title": "J Biol Chem"}, {"key": "9_CR460", "first-page": "29", "volume": "19", "author": "DF Lewis", "year": "2002", "unstructured": "Lewis DF, Gorrod JW (2002) Molecular orbital calculations and nicotine metabolism: a rationale for experimentally observed metabolite ratios. Drug Metab Drug Interact 19:29\u201339", "journal-title": "Drug Metab Drug Interact"}, {"key": "9_CR461", "doi-asserted-by": "crossref", "first-page": "168", "DOI": "10.1021/tx00020a008", "volume": "4", "author": "FP Guengerich", "year": "1991", "unstructured": "Guengerich FP, Kim DH, Iwasaki M (1991) Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4:168\u2013179", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR462", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1016/S0009-9236(98)90020-0", "volume": "64", "author": "ED Kharasch", "year": "1998", "unstructured": "Kharasch ED, Hankins DC, Baxter PJ, Thummel KE (1998) Single-dose disulfiram does not inhibit CYP2A6 activity. Clin Pharmacol Ther 64:39\u201345", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR463", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1006/abbi.1997.9964", "volume": "341", "author": "AJ Draper", "year": "1997", "unstructured": "Draper AJ, Madan A, Parkinson A (1997) Inhibition of coumarin 7-hydroxylase activity in human liver microsomes. Arch Biochem Biophys 341:47\u201361", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR464", "first-page": "897", "volume": "26", "author": "WJ Zhang", "year": "2001", "unstructured": "Zhang WJ, Kilicarslan T, Tyndale RF, Sellers EM (2001) Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro. Drug Metab Dispos 26:897\u2013902", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR465", "first-page": "217", "volume": "29", "author": "P Taavitsainen", "year": "2001", "unstructured": "Taavitsainen P, Juvonen R, Pelkonen O (2001) In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene. Drug Metab Dispos 29:217\u2013222", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR466", "first-page": "1407", "volume": "25", "author": "LL Koenigs", "year": "1997", "unstructured": "Koenigs LL, Peter RM, Thompson SJ, Rettie AE, Trager WF (1997) Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen. Drug Metab Dispos 25:1407\u20131415", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR467", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1067/mcp.2000.107651", "volume": "68", "author": "EM Sellers", "year": "2000", "unstructured": "Sellers EM, Kaplan HL, Tyndale RF (2000) Inhibition of cytochrome P450 2A6 increases nicotine\u2019s oral bioavailability and decreases smoking. Clin Pharmacol Ther 68:35\u201343", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR468", "doi-asserted-by": "crossref", "first-page": "10047", "DOI": "10.1021/bi980003c", "volume": "37", "author": "LL Koenigs", "year": "1998", "unstructured": "Koenigs LL, Trager WF (1998) Mechanism-based inactivation of P450 2A6 by furanocoumarins. Biochemistry 37:10047\u201310061", "journal-title": "Biochemistry"}, {"key": "9_CR469", "first-page": "701", "volume": "26", "author": "SC Khojasteh-Bakht", "year": "1998", "unstructured": "Khojasteh-Bakht SC, Koenigs LL, Peter RM, Trager WF, Nelson SD (1998) (R)-(+)-Menthofuran is a potent, mechanism-based inactivator of human liver cytochrome P450 2A6. Drug Metab Dispos 26:701\u2013704", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR470", "doi-asserted-by": "crossref", "first-page": "799", "DOI": "10.1007/s00228-001-0396-3", "volume": "57", "author": "X Wen", "year": "2002", "unstructured": "Wen X, Wang JS, Neuvonen PJ, Backman JT (2002) Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes. Eur J Clin Pharmacol 57:799\u2013804", "journal-title": "Eur J Clin Pharmacol"}, {"key": "9_CR471", "doi-asserted-by": "crossref", "first-page": "1562", "DOI": "10.1002/cbic.200800712", "volume": "10", "author": "A Chougnet", "year": "2009", "unstructured": "Chougnet A, Woggon WD, Locher E, Schilling B (2009) Synthesis and in vitro activity of heterocyclic inhibitors of CYP2A6 and CYP2A13, two cytochrome P450 enzymes present in the respiratory tract. Chembiochem 10:1562\u20131567", "journal-title": "Chembiochem"}, {"key": "9_CR472", "doi-asserted-by": "crossref", "first-page": "1797", "DOI": "10.1124/dmd.112.045161", "volume": "40", "author": "ES Stephens", "year": "2012", "unstructured": "Stephens ES, Walsh AA, Scott EE (2012) Evaluation of Inhibition selectivity for human cytochrome P450 2A enzymes. Drug Metab Dispos 40:1797\u20131802", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR473", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1007/s13318-011-0024-2", "volume": "36", "author": "SC Khojasteh", "year": "2011", "unstructured": "Khojasteh SC, Prabhu S, Kenny JR, Halladay JS, Lu AY (2011) Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity. Eur J Drug Metab Pharmacokinet 36:1\u201316", "journal-title": "Eur J Drug Metab Pharmacokinet"}, {"key": "9_CR474", "doi-asserted-by": "crossref", "first-page": "1250", "DOI": "10.1111/j.1476-5381.2011.01341.x", "volume": "163", "author": "YF Ueng", "year": "2011", "unstructured": "Ueng YF, Chen CC, Chung YT, Liu TY, Chang YP, Lo WS, Murayama N, Yamazaki H, Soucek P, Chau GY, Chi CW, Chen RM, Li DT (2011) Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo. Br J Pharmacol 163:1250\u20131262", "journal-title": "Br J Pharmacol"}, {"key": "9_CR475", "doi-asserted-by": "crossref", "first-page": "224", "DOI": "10.1021/jm049696n", "volume": "48", "author": "TT Denton", "year": "2005", "unstructured": "Denton TT, Zhang X, Cashman JR (2005) 5-Substituted, 6-substituted, and unsubstituted 3-heteroaromatic pyridine analogues of nicotine as selective inhibitors of cytochrome P-450 2A6. J Med Chem 48:224\u2013239", "journal-title": "J Med Chem"}, {"key": "9_CR476", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1124/jpet.105.091306", "volume": "316", "author": "LB von Weymarn", "year": "2006", "unstructured": "von Weymarn LB, Brown KM, Murphy SE (2006) Inactivation of CYP2A6 and CYP2A13 during nicotine metabolism. J Pharmacol Exp Ther 316:295\u2013303", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR477", "doi-asserted-by": "crossref", "first-page": "517", "DOI": "10.1021/tx300492j", "volume": "26", "author": "T Shimada", "year": "2013", "unstructured": "Shimada T, Kim D, Murayama N, Tanaka K, Takenaka S, Nagy LD, Folkman LM, Foroozesh MK, Komori M, Yamazaki H, Guengerich FP (2013) Binding of diverse environmental chemicals with human cytochromes P450 2A13, 2A6, and 1B1 and enzyme inhibition. Chem Res Toxicol 26:517\u2013528", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR478", "first-page": "7581", "volume": "63", "author": "H Takeuchi", "year": "2003", "unstructured": "Takeuchi H, Saoo K, Yokohira M, Ikeda M, Maeta H, Miyazaki M, Yamazaki H, Kamataki T, Imaida K (2003) Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice. Cancer Res 63:7581\u20137583", "journal-title": "Cancer Res"}, {"key": "9_CR479", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1517/14622416.3.2.185", "volume": "3", "author": "LA Howard", "year": "2002", "unstructured": "Howard LA, Sellers EM, Tyndale RF (2002) The role of pharmacogenetically-variable cytochrome P450 enzymes in drug abuse and dependence. Pharmacogenomics 3:185\u2013199", "journal-title": "Pharmacogenomics"}, {"key": "9_CR480", "doi-asserted-by": "crossref", "first-page": "96", "DOI": "10.1002/1097-0215(20010320)95:2<96::AID-IJC1017>3.0.CO;2-2", "volume": "95", "author": "W Tan", "year": "2001", "unstructured": "Tan W, Chen GF, Xing DY, Song CY, Kadlubar FF, Lin DX (2001) Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population. Int J Cancer 95:96\u2013101", "journal-title": "Int J Cancer"}, {"key": "9_CR481", "first-page": "795", "volume": "5", "author": "S Satarug", "year": "1996", "unstructured": "Satarug S, Lang MA, Yongvanit P, Sithithaworn P, Mairiang E, Mairiang P, Pelkonen P, Bartsch H, Haswell-Elkins MR (1996) Induction of cytochrome P450 2A6 expression in humans by the carcinogenic parasite infection, opisthorchiasis viverrini. Cancer Epidemiol Biomarkers Prev 5:795\u2013800", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9_CR482", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1016/S0300-483X(97)00119-4", "volume": "123", "author": "M Pasanen", "year": "1997", "unstructured": "Pasanen M, Rannala Z, Tooming A, Sotaniemi EA, Pelkonen O, Rautio A (1997) Hepatitis A impairs the function of human hepatic CYP2A6 in vivo. Toxicology 123:177\u2013184", "journal-title": "Toxicology"}, {"key": "9_CR483", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1016/j.clpt.2006.08.011", "volume": "80", "author": "NL Benowitz", "year": "2006", "unstructured": "Benowitz NL, Swan GE, Jacob P 3rd, Lessov-Schlaggar CN, Tyndale RF (2006) CYP2A6 genotype and the metabolism and disposition kinetics of nicotine. Clin Pharmacol Ther 80:457\u2013467", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR484", "doi-asserted-by": "crossref", "first-page": "232", "DOI": "10.1097/FPC.0b013e32835f834d", "volume": "23", "author": "MJ Chenoweth", "year": "2013", "unstructured": "Chenoweth MJ, O\u2019Loughlin J, Sylvestre MP, Tyndale RF (2013) CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers. Pharmacogenet Genomics 23:232\u2013235", "journal-title": "Pharmacogenet Genomics"}, {"key": "9_CR485", "doi-asserted-by": "crossref", "first-page": "555", "DOI": "10.1093/hmg/ddt432", "volume": "23", "author": "AJ Bloom", "year": "2014", "unstructured": "Bloom AJ, Baker TB, Chen LS, Breslau N, Hatsukami D, Bierut LJ, Goate A (2014) Variants in two adjacent genes, EGLN2 and CYP2A6, influence smoking behavior related to disease risk via different mechanisms. Hum Mol Genet 23:555\u2013561", "journal-title": "Hum Mol Genet"}, {"key": "9_CR486", "doi-asserted-by": "crossref", "first-page": "118", "DOI": "10.1097/FPC.0000000000000026", "volume": "24", "author": "M Piliguian", "year": "2014", "unstructured": "Piliguian M, Zhu AZ, Zhou Q, Benowitz NL, Ahluwalia JS, Sanderson Cox L, Tyndale RF (2014) Novel CYP2A6 variants identified in African Americans are associated with slow nicotine metabolism in vitro and in vivo. Pharmacogenet Genomics 24:118\u2013128", "journal-title": "Pharmacogenet Genomics"}, {"key": "9_CR487", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1016/j.canlet.2005.10.026", "volume": "241", "author": "D Tiwawech", "year": "2006", "unstructured": "Tiwawech D, Srivatanakul P, Karalak A, Ishida T (2006) Cytochrome P450 2A6 polymorphism in nasopharyngeal carcinoma. Cancer Lett 241:135\u2013141", "journal-title": "Cancer Lett"}, {"key": "9_CR488", "doi-asserted-by": "crossref", "first-page": "1737", "DOI": "10.2217/14622416.9.11.1737", "volume": "9", "author": "A Rossini", "year": "2008", "unstructured": "Rossini A, de Almeida Simao T, Albano RM, Pinto LF (2008) CYP2A6 polymorphisms and risk for tobacco-related cancers. Pharmacogenomics 9:1737\u20131752", "journal-title": "Pharmacogenomics"}, {"key": "9_CR489", "doi-asserted-by": "crossref", "first-page": "e59556", "DOI": "10.1371/journal.pone.0059556", "volume": "8", "author": "L Wang", "year": "2013", "unstructured": "Wang L, Zang W, Liu J, Xie D, Ji W, Pan Y, Li Z, Shen J, Shi Y (2013) Association of CYP2A6*4 with susceptibility of lung cancer: a meta-analysis. PLoS One 8:e59556", "journal-title": "PLoS One"}, {"key": "9_CR490", "doi-asserted-by": "crossref", "first-page": "5255", "DOI": "10.1007/s11033-013-2625-0", "volume": "40", "author": "ZB Liu", "year": "2013", "unstructured": "Liu ZB, Shu J, Wang LP, Jin C, Lou ZX (2013) Cytochrome P450 2A6 deletion polymorphism and risk of lung cancer: a meta-analysis. Mol Biol Rep 40:5255\u20135259", "journal-title": "Mol Biol Rep"}, {"key": "9_CR491", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.2217/14622416.8.2.151", "volume": "8", "author": "N Farinola", "year": "2007", "unstructured": "Farinola N, Piller NB (2007) CYP2A6 polymorphisms: is there a role for pharmacogenomics in preventing coumarin-induced hepatotoxicity in lymphedema patients? Pharmacogenomics 8:151\u2013158", "journal-title": "Pharmacogenomics"}, {"key": "9_CR492", "first-page": "263", "volume": "10", "author": "S Kadlubar", "year": "2009", "unstructured": "Kadlubar S, Anderson JP, Sweeney C, Gross MD, Lang NP, Kadlubar FF, Anderson KE (2009) Phenotypic CYP2A6 variation and the risk of pancreatic cancer. J Pancreas 10:263\u2013270", "journal-title": "J Pancreas"}, {"key": "9_CR493", "doi-asserted-by": "crossref", "first-page": "1407", "DOI": "10.1016/S0006-2952(99)00015-5", "volume": "57", "author": "S Koskela", "year": "1999", "unstructured": "Koskela S, Hakkola J, Hukkanen J, Pelkonen O, Sorri M, Saranen A, Anttila S, Fernandez-Salguero P, Gonzalez F, Raunio H (1999) Expression of CYP2A genes in human liver and extrahepatic tisssues. Biochem Pharmacol 57:1407\u20131413", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR494", "doi-asserted-by": "crossref", "first-page": "321", "DOI": "10.1016/S0014-5793(99)01364-2", "volume": "460", "author": "M Oscarson", "year": "1999", "unstructured": "Oscarson M, McLellan RA, Gullsten H, Agundez JAG, Benitez J, Rautio A, Raunio H, Pelkonen O, Ingelman-Sundberg M (1999) Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism. FEBS Lett 460:321\u2013327", "journal-title": "FEBS Lett"}, {"key": "9_CR495", "unstructured": "Fukami T, Nakajima M, Sakai H, McLeod HL, Yokoi T, CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele. Pharmacogenomics 6:401\u2013412", "DOI": "10.1038/sj.tpj.6500390", "doi-asserted-by": "crossref"}, {"key": "9_CR496", "first-page": "5074", "volume": "60", "author": "T Su", "year": "2000", "unstructured": "Su T, Bao Z, Zhang QY, Smith TJ, Hong JY, Ding X (2000) Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res 60:5074\u20135079", "journal-title": "Cancer Res"}, {"key": "9_CR497", "doi-asserted-by": "crossref", "first-page": "1672", "DOI": "10.1124/dmd.106.011049", "volume": "34", "author": "LR Zhu", "year": "2006", "unstructured": "Zhu LR, Thomas PE, Lu G, Reuhl KR, Yang GY, Wang LD, Wang SL, Yang CS, He XY, Hong JY (2006) CYP2A13 in human respiratory tissues and lung cancers: an immunohistochemical study with a new peptide-specific antibody. Drug Metab Dispos 34:1672\u20131676", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR498", "doi-asserted-by": "crossref", "first-page": "2520", "DOI": "10.1002/ijc.22136", "volume": "119", "author": "M Nakajima", "year": "2006", "unstructured": "Nakajima M, Itoh M, Sakai H, Fukami T, Katoh M, Yamazaki H, Kadlubar FF, Imaoka S, Funae Y, Yokoi T (2006) CYP2A13 expressed in human bladder metabolically activates 4-aminobiphenyl. Int J Cancer 119:2520\u20132526", "journal-title": "Int J Cancer"}, {"key": "9_CR499", "doi-asserted-by": "crossref", "first-page": "1878", "DOI": "10.1124/dmd.112.046359", "volume": "40", "author": "Y Guo", "year": "2012", "unstructured": "Guo Y, Zhu LR, Lu G, Wang H, Hong JY (2012) Selective expression of CYP2A13 in human pancreatic alpha-islet cells. Drug Metab Dispos 40:1878\u20131882", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR500", "doi-asserted-by": "crossref", "first-page": "1024", "DOI": "10.1111/j.1349-7006.2009.01482.x", "volume": "101", "author": "T Fukami", "year": "2010", "unstructured": "Fukami T, Nakajima M, Matsumoto I, Zen Y, Oda M, Yokoi T (2010) Immunohistochemical analysis of CYP2A13 in various types of human lung cancers. Cancer Sci 101:1024\u20131028", "journal-title": "Cancer Sci"}, {"key": "9_CR501", "first-page": "202", "volume": "27", "author": "L Sun", "year": "2013", "unstructured": "Sun L, Fan X (2013) Expression of cytochrome P450 2A13 in human non-small cell lung cancer and its clinical significance. J Biomed Res 27:202\u2013207", "journal-title": "J Biomed Res"}, {"key": "9_CR502", "doi-asserted-by": "crossref", "first-page": "807", "DOI": "10.1124/mol.106.031104", "volume": "71", "author": "G Ling", "year": "2007", "unstructured": "Ling G, Wei Y, Ding X (2007) Transcriptional regulation of human CYP2A13 expression in the respiratory tract by CCAAT/enhancer binding protein and epigenetic modulation. Mol Pharmacol 71:807\u2013816", "journal-title": "Mol Pharmacol"}, {"key": "9_CR503", "doi-asserted-by": "crossref", "first-page": "668", "DOI": "10.1111/j.1601-0825.2010.01676.x", "volume": "16", "author": "R Sharma", "year": "2010", "unstructured": "Sharma R, Panda NK, Khullar M (2010) Hypermethylation of carcinogen metabolism genes, CYP1A1, CYP2A13 and GSTM1 genes in head and neck cancer. Oral Dis 16:668\u2013673", "journal-title": "Oral Dis"}, {"key": "9_CR504", "doi-asserted-by": "crossref", "first-page": "1081", "DOI": "10.1124/dmd.31.9.1081", "volume": "31", "author": "X Zhang", "year": "2003", "unstructured": "Zhang X, Chen Y, Liu Y, Ren X, Zhang QY, Caggana M, Ding X (2003) Single nucleotide polymorphisms of the human CYP2A13 gene: evidence for a null allele. Drug Metab Dispos 31:1081\u20131085", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR505", "first-page": "8057", "volume": "63", "author": "H Wang", "year": "2003", "unstructured": "Wang H, Tan W, Hao B, Miao X, Zhou G, He F, Lin D (2003) Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK. Cancer Res 63:8057\u20138061", "journal-title": "Cancer Res"}, {"key": "9_CR506", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1124/jpet.104.069872", "volume": "311", "author": "X Zhang", "year": "2004", "unstructured": "Zhang X, Caggana M, Cutler TL, Ding X (2004) Development of a real-time polymerase chain reaction-based method for the measurement of relative allelic expression and identification of CYP2A13 alleles with decreased expression in human lung. J Pharmacol Exp Ther 311:373\u2013381", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR507", "doi-asserted-by": "crossref", "first-page": "38", "DOI": "10.1093/toxsci/kfl081", "volume": "94", "author": "SL Wang", "year": "2006", "unstructured": "Wang SL, He XY, Shen J, Wang JS, Hong JY (2006) The missense genetic polymorphisms of human CYP2A13: functional significance in carcinogen activation and identification of a null allelic variant. Toxicol Sci 94:38\u201345", "journal-title": "Toxicol Sci"}, {"key": "9_CR508", "doi-asserted-by": "crossref", "first-page": "1439", "DOI": "10.1080/00498250701666265", "volume": "37", "author": "KE Schlicht", "year": "2007", "unstructured": "Schlicht KE, Michno N, Smith BD, Scott EE, Murphy SE (2007) Functional characterization of CYP2A13 polymorphisms. Xenobiotica 37:1439\u20131449", "journal-title": "Xenobiotica"}, {"key": "9_CR509", "doi-asserted-by": "crossref", "first-page": "661", "DOI": "10.1080/00498250500202171", "volume": "35", "author": "C Cauffiez", "year": "2005", "unstructured": "Cauffiez C, Pottier N, Tournel G, Lo-Guidice JM, Allorge D, Chevalier D, Migot-Nabias F, Kenani A, Broly F (2005) CYP2A13 genetic polymorphism in French Caucasian, Gabonese and Tunisian populations. Xenobiotica 35:661\u2013669", "journal-title": "Xenobiotica"}, {"key": "9_CR510", "doi-asserted-by": "crossref", "first-page": "86", "DOI": "10.2133/dmpk.18.86", "volume": "18", "author": "M Fujieda", "year": "2003", "unstructured": "Fujieda M, Yamazaki H, Kiyotani K, Muroi A, Kunitoh H, Dosaka-Akita H, Sawamura Y, Kamataki T (2003) Eighteen novel polymorphisms of the CYP2A13 gene in Japanese. Drug Metab Pharmacokinet 18:86\u201390", "journal-title": "Drug Metab Pharmacokinet"}, {"key": "9_CR511", "doi-asserted-by": "crossref", "first-page": "544", "DOI": "10.2133/dmpk.DMPK-11-SC-033", "volume": "26", "author": "Y Tamaki", "year": "2011", "unstructured": "Tamaki Y, Honda M, Muroi Y, Arai T, Sugimura H, Matsubara Y, Kanno S, Ishikawa M, Hirasawa N, Hiratsuka M (2011) Novel single nucleotide polymorphism of the CYP2A13 gene in Japanese individuals. Drug Metab Pharmacokinet 26:544\u2013547", "journal-title": "Drug Metab Pharmacokinet"}, {"key": "9_CR512", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1080/0049825021000022302", "volume": "33", "author": "LB Von Weymarn", "year": "2003", "unstructured": "Von Weymarn LB, Murphy SE (2003) CYP2A13-catalysed coumarin metabolism: comparison with CYP2A5 and CYP2A6. Xenobiotica 33:73\u201381", "journal-title": "Xenobiotica"}, {"key": "9_CR513", "doi-asserted-by": "crossref", "first-page": "1199", "DOI": "10.1124/dmd.31.10.1199", "volume": "31", "author": "JR Jalas", "year": "2003", "unstructured": "Jalas JR, Ding X, Murphy SE (2003) Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13. Drug Metab Dispos 31:1199\u20131202", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR514", "doi-asserted-by": "crossref", "first-page": "258", "DOI": "10.1124/dmd.104.002105", "volume": "33", "author": "Z Bao", "year": "2005", "unstructured": "Bao Z, He XY, Ding X, Prabhu S, Hong JY (2005) Metabolism of nicotine and cotinine by human cytochrome P450 2A13. Drug Metab Dispos 33:258\u2013261", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR515", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1124/jpet.112.195255", "volume": "343", "author": "LB von Weymarn", "year": "2012", "unstructured": "von Weymarn LB, Retzlaff C, Murphy SE (2012) CYP2A6-and CYP2A13-catalyzed metabolism of the nicotine \u03945(1\u02b9) iminium ion. J Pharmacol Exp Ther 343:307\u2013315", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR516", "doi-asserted-by": "crossref", "first-page": "2665", "DOI": "10.1002/ijc.21665", "volume": "118", "author": "XY He", "year": "2006", "unstructured": "He XY, Tang L, Wang SL, Cai QS, Wang JS, Hong JY (2006) Efficient activation of aflatoxin B1 by cytochrome P450 2A13, an enzyme predominantly expressed in human respiratory tract. Int J Cancer 118:2665\u20132671", "journal-title": "Int J Cancer"}, {"key": "9_CR517", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1016/j.tox.2012.06.010", "volume": "300", "author": "XJ Yang", "year": "2012", "unstructured": "Yang XJ, Lu HY, Li ZY, Bian Q, Qiu LL, Li Z, Liu Q, Li J, Wang X, Wang SL (2012) Cytochrome P450 2A13 mediates aflatoxin B1-induced cytotoxicity and apoptosisin human bronchial epithelial cells. Toxicology 300:138\u2013148", "journal-title": "Toxicology"}, {"key": "9_CR518", "doi-asserted-by": "crossref", "first-page": "335", "DOI": "10.1124/dmd.106.011064", "volume": "35", "author": "T Fukami", "year": "2007", "unstructured": "Fukami T, Nakajima M, Sakai H, Katoh M, Yokoi T (2007) CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophylline. Drug Metab Dispos 35:335\u2013339", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR519", "doi-asserted-by": "crossref", "first-page": "2110", "DOI": "10.1124/dmd.110.034553", "volume": "38", "author": "T Goto", "year": "2010", "unstructured": "Goto T, Moriuchi H, Fu X, Ikegawa T, Matsubara T, Chang G, Uno T, Morigaki K, Isshiki K, Imaishi H (2010) The effects of single nucleotide polymorphisms in CYP2A13 on metabolism of 5-methoxypsoralen. Drug Metab Dispos 38:2110\u20132116", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR520", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1093/carcin/bgt269", "volume": "35", "author": "V Megaraj", "year": "2014", "unstructured": "Megaraj V, Zhou X, Xie F, Liu Z, Yang W, Ding X (2014) Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: in vivo studies using a CYP2A13-humanized mouse model. Carcinogenesis 35:131\u2013137", "journal-title": "Carcinogenesis"}, {"key": "9_CR521", "doi-asserted-by": "crossref", "first-page": "1516", "DOI": "10.1124/dmd.104.001370", "volume": "32", "author": "XY He", "year": "2004", "unstructured": "He XY, Shen J, Ding X, Lu AY, Hong JY (2004) Identification of critical amino acid residues of human CYP2A13 for the metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen. Drug Metab Dispos 32:1516\u20131521", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR522", "doi-asserted-by": "crossref", "first-page": "17306", "DOI": "10.1074/jbc.M702361200", "volume": "282", "author": "BD Smith", "year": "2007", "unstructured": "Smith BD, Sanders JL, Porubsky PR, Lushington GH, Stout CD, Scott EE (2007) Structure of the human lung cytochrome P450 2A13. J Biol Chem 282:17306\u201317313", "journal-title": "J Biol Chem"}, {"key": "9_CR523", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.jmgm.2011.05.002", "volume": "30", "author": "Y Xu", "year": "2011", "unstructured": "Xu Y, Shen Z, Shen J, Liu G, Li W, Tang Y (2011) Computational insights into the different catalytic activities of CYP2A13 and CYP2A6 on NNK. J Mol Graph Model 30:1\u20139", "journal-title": "J Mol Graph Model"}, {"key": "9_CR524", "doi-asserted-by": "crossref", "first-page": "782", "DOI": "10.1093/carcin/bgi301", "volume": "27", "author": "LB von Weymarn", "year": "2006", "unstructured": "von Weymarn LB, Chun JA, Hollenberg PF (2006) Effects of benzyl and phenethyl isothiocyanate on P450s 2A6 and 2A13: potential for chemoprevention in smokers. Carcinogenesis 27:782\u2013790", "journal-title": "Carcinogenesis"}, {"key": "9_CR525", "doi-asserted-by": "crossref", "first-page": "1252", "DOI": "10.1021/tx700078v", "volume": "20", "author": "LB von Weymarn", "year": "2007", "unstructured": "von Weymarn LB, Chun JA, Knudsen GA, Hollenberg PF (2007) Effects of eleven isothiocyanates on P450 2A6- and 2A13-catalyzed coumarin 7-hydroxylation. Chem Res Toxicol 20:1252\u20131259", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR526", "doi-asserted-by": "crossref", "first-page": "2290", "DOI": "10.1007/s11095-013-1054-z", "volume": "30", "author": "LC Blake", "year": "2013", "unstructured": "Blake LC, Roy A, Neul D, Schoenen FJ, Aube J, Scott EE (2013) Benzylmorpholine analogs as selective inhibitors of lung cytochrome P450 2A13 for the chemoprevention of lung cancer in tobacco users. Pharm Res 30:2290\u20132302", "journal-title": "Pharm Res"}, {"key": "9_CR527", "doi-asserted-by": "crossref", "first-page": "621", "DOI": "10.1093/carcin/bgh348", "volume": "26", "author": "LB von Weymarn", "year": "2005", "unstructured": "von Weymarn LB, Zhang QY, Ding X, Hollenberg PF (2005) Effects of 8-methoxypsoralen on cytochrome P450 2A13. Carcinogenesis 26:621\u2013629", "journal-title": "Carcinogenesis"}, {"key": "9_CR528", "doi-asserted-by": "crossref", "first-page": "87", "DOI": "10.1016/j.cbi.2012.03.009", "volume": "197", "author": "VM Kramlinger", "year": "2012", "unstructured": "Kramlinger VM, von Weymarn LB, Murphy SE (2012) Inhibition and inactivation of cytochrome P450 2A6 and cytochrome P450 2A13 by menthofuran, beta-nicotyrine and menthol. Chem Biol Interact 197:87\u201392", "journal-title": "Chem Biol Interact"}, {"key": "9_CR529", "doi-asserted-by": "crossref", "first-page": "662", "DOI": "10.1016/j.bbrc.2004.03.092", "volume": "317", "author": "C Cauffiez", "year": "2004", "unstructured": "Cauffiez C, Lo-Guidice JM, Quaranta S, Allorge D, Chevalier D, Cenee S, Hamdan R, Lhermitte M, Lafitte JJ, Libersa C, Colombel JF, Stucker I, Broly F (2004) Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility. Biochem Biophys Res Commun 317:662\u2013669", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR530", "doi-asserted-by": "crossref", "first-page": "24", "DOI": "10.1186/1479-5876-2-24", "volume": "2", "author": "JH Jiang", "year": "2004", "unstructured": "Jiang JH, Jia WH, Chen HK, Feng BJ, Qin HD, Pan ZG, Shen GP, Huang LX, Feng QS, Chen LZ, Lin DX, Zeng YX (2004) Genetic polymorphisms of CYP2A13 and its relationship to nasopharyngeal carcinoma in the Cantonese population. J Translat Med 2:24", "journal-title": "J Translat Med"}, {"key": "9_CR531", "doi-asserted-by": "crossref", "first-page": "570", "DOI": "10.1124/jpet.107.127068", "volume": "323", "author": "X Zhang", "year": "2007", "unstructured": "Zhang X, D\u2019Agostino J, Wu H, Zhang QY, von Weymarn L, Murphy SE, Ding X (2007) CYP2A13: variable expression and role in human lung microsomal metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. J Pharmacol Exp Ther 323:570\u2013578", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR532", "doi-asserted-by": "crossref", "first-page": "144", "DOI": "10.1097/MPA.0b013e3181bab6c2", "volume": "39", "author": "B Mohelnikova-Duchonova", "year": "2010", "unstructured": "Mohelnikova-Duchonova B, Vrana D, Holcatova I, Ryska M, Smerhovsky Z, Soucek P (2010) CYP2A13, ADH1B, and ADH1C gene polymorphisms and pancreatic cancer risk. Pancreas 39:144\u2013148", "journal-title": "Pancreas"}, {"key": "9_CR533", "doi-asserted-by": "crossref", "first-page": "653", "DOI": "10.1016/j.canep.2013.04.010", "volume": "37", "author": "HC Chiang", "year": "2013", "unstructured": "Chiang HC, Lee H, Chao HR, Chiou YH, Tsou TC (2013) Pulmonary CYP2A13 levels are associated with early occurrence of lung cancer-Its implication in mutagenesis of non-small cell lung carcinoma. Cancer Epidemiol 37:653\u2013659", "journal-title": "Cancer Epidemiol"}, {"key": "9_CR534", "first-page": "1048", "volume": "21", "author": "M Mimura", "year": "1993", "unstructured": "Mimura M, Baba T, Yamazaki H, Ohmori S, Inui Y, Gonzalez FJ, Guengerich FP, Shimada T (1993) Characterization of cytochrome P-450 2B6 in human liver microsomes. Drug Metab Disp 21:1048\u20131056", "journal-title": "Drug Metab Disp"}, {"key": "9_CR535", "doi-asserted-by": "crossref", "first-page": "391", "DOI": "10.1080/20024091064273", "volume": "32", "author": "J Hukkanen", "year": "2002", "unstructured": "Hukkanen J, Pelkonen A, Hakkola J, Raunio H (2002) Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit Rev Toxicol 32:391\u2013411", "journal-title": "Crit Rev Toxicol"}, {"key": "9_CR536", "doi-asserted-by": "crossref", "first-page": "569", "DOI": "10.1016/0006-291X(74)90278-2", "volume": "60", "author": "TA van der Hoeven", "year": "1974", "unstructured": "van der Hoeven TA, Haugen DA, Coon MJ (1974) Cytochrome P-450 purified to apparent homogeneity from phenobarbital-induced rabbit liver microsomes: catalytic activity and other properties. Biochem Biophys Res Commun 60:569\u2013575", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR537", "doi-asserted-by": "crossref", "first-page": "8", "DOI": "10.1016/0006-291X(74)90164-8", "volume": "60", "author": "Y Imai", "year": "1974", "unstructured": "Imai Y, Sato R (1974) A gel-electrophoretically homogeneous preparation of cytochrome P-450 from liver microsomes of phenobarbital-pretreated rabbits. Biochem Biophys Res Commun 60:8\u201314", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR538", "doi-asserted-by": "crossref", "first-page": "983", "DOI": "10.1073/pnas.82.4.983", "volume": "82", "author": "IR Phillips", "year": "1985", "unstructured": "Phillips IR, Shephard EA, Ashworth A, Rabin BR (1985) Isolation and sequence of a human cytochrome P-450 cDNA clone. Proc Natl Acad Sci U S A 82:983\u2013987", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR539", "first-page": "517", "volume": "27", "author": "DM Stresser", "year": "1999", "unstructured": "Stresser DM, Kupfer D (1999) Monospecific antipeptide antibodyto cytochrome P-450 2B6. Drug Metab Dispos 27:517\u2013525", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR540", "first-page": "985", "volume": "25", "author": "EL Code", "year": "1997", "unstructured": "Code EL, Crespi CL, Penman BW, Gonzalez FJ, Chang TKH, Waxman DJ (1997) Human cytochrome P450 2B1. Interindividual hepatic expression, substrate specificity, and role in procarcinogen activation. Drug Metab Dispos 25:985\u2013993", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR541", "first-page": "1253", "volume": "286", "author": "S Ekins", "year": "1998", "unstructured": "Ekins S, VandenBranden M, Ring BJ, Gillespie JS, Yang TJ, Gelboin HV, Wrighton SA (1998) Further characterization of the expression in liver and catalytic activity of CYP2B6. J Pharmacol Exp Ther 286:1253\u20131259", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR542", "doi-asserted-by": "crossref", "first-page": "1041", "DOI": "10.1016/0006-2952(96)00052-4", "volume": "51", "author": "S Imaoka", "year": "1996", "unstructured": "Imaoka S, Yamada T, Hiroi T, Hayashi K, Sakaki T, Yabusaki Y, Funae Y (1996) Multiple forms of human P450 expressed in Saccharomyces cerevisiae: systematic characterization and comparison with those of the rat. Biochem Pharmacol 51:1041\u20131050", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR543", "first-page": "655", "volume": "27", "author": "P Roy", "year": "1999", "unstructured": "Roy P, Yu LJ, Crespi CL, Waxman DJ (1999) Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles. Drug Metab Dispos 27:655\u2013666", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR544", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1097/00008571-199906000-00004", "volume": "9", "author": "L Gervot", "year": "1999", "unstructured": "Gervot L, Rochat B, Gautier JC, Bohnenstengel F, Kroemer H, de Berardinis V, Martin H, Beaune P, de Waziers I (1999) Human CYP2B6: expression, inducibility and catalytic activities. Pharmacogenetics 9:295\u2013306", "journal-title": "Pharmacogenetics"}, {"key": "9_CR545", "doi-asserted-by": "crossref", "first-page": "206", "DOI": "10.1006/abbi.2000.1708", "volume": "376", "author": "IH Hanna", "year": "2000", "unstructured": "Hanna IH, Reed JR, Guengerich FP, Hollenberg PF (2000) Expression of human cytochrome P450 2B6 in Escherichia coli: characterization of catalytic activity and expression levels in human liver. Arch Biochem Biophys 376:206\u2013216", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR546", "doi-asserted-by": "crossref", "first-page": "6043", "DOI": "10.1074/jbc.274.10.6043", "volume": "274", "author": "T Sueyoshi", "year": "1999", "unstructured": "Sueyoshi T, Kawamoto T, Zelko I, Honkakoski P, Neigishi M (1999) The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J Biol Chem 274:6043\u20136046", "journal-title": "J Biol Chem"}, {"key": "9_CR547", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1016/S0014-5793(98)00746-7", "volume": "431", "author": "R Jover", "year": "1998", "unstructured": "Jover R, Bort R, Gomezlechon MJ, Castell JV (1998) Re-expression of C/EBP\u03b1 induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells. FEBS Lett 431:227\u2013230", "journal-title": "FEBS Lett"}, {"key": "9_CR548", "first-page": "427", "volume": "60", "author": "B Goodwin", "year": "2001", "unstructured": "Goodwin B, Moore LB, Stoltz CM, McKee DD, Kliewer SA (2001) Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor. Mol Pharmacol 60:427\u2013431", "journal-title": "Mol Pharmacol"}, {"key": "9_CR549", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1038/nrd753", "volume": "1", "author": "TM Willson", "year": "2002", "unstructured": "Willson TM, Kliewer SA (2002) PXR, CAR and drug metabolism. Nat Rev Drug Discov 1:259\u2013266", "journal-title": "Nat Rev Drug Discov"}, {"key": "9_CR550", "doi-asserted-by": "crossref", "first-page": "366", "DOI": "10.1124/mol.62.2.366", "volume": "62", "author": "J Makinen", "year": "2002", "unstructured": "Makinen J, Frank C, Jyrkkarinne J, Gynther J, Carlberg C, Honkakoski P (2002) Modulation of mouse and human phenobarbital-responsive enhancer module by nuclear receptors. Mol Pharmacol 62:366\u2013378", "journal-title": "Mol Pharmacol"}, {"key": "9_CR551", "doi-asserted-by": "crossref", "first-page": "25125", "DOI": "10.1074/jbc.M201323200", "volume": "277", "author": "L Drocourt", "year": "2002", "unstructured": "Drocourt L, Ourlin JC, Pascussi JM, Maurel P, Vilarem MJ (2002) Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J Biol Chem 277:25125\u201325132", "journal-title": "J Biol Chem"}, {"key": "9_CR552", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1124/dmd.31.1.7", "volume": "31", "author": "TK Chang", "year": "2003", "unstructured": "Chang TK, Bandiera SM, Chen J (2003) Constitutive androstane receptor and pregnane X receptor gene expression in human liver: interindividual variability and correlation with CYP2B6 mRNA levels. Drug Metab Dispos 31:7\u201310", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR553", "doi-asserted-by": "crossref", "first-page": "17277", "DOI": "10.1074/jbc.M300138200", "volume": "278", "author": "JM Maglich", "year": "2003", "unstructured": "Maglich JM, Parks DJ, Moore LB, Collins JL, Goodwin B, Billin AN, Stoltz CA, Kliewer SA, Lambert MH, Willson TM, Moore JT (2003) Identification of a novel human CAR agonist and its use in the identification of CAR target genes. J Biol Chem 278:17277\u201312783", "journal-title": "J Biol Chem"}, {"key": "9_CR554", "doi-asserted-by": "crossref", "first-page": "14146", "DOI": "10.1074/jbc.M212482200", "volume": "278", "author": "H Wang", "year": "2003", "unstructured": "Wang H, Faucette S, Sueyoshi T, Moore R, Ferguson S, Negishi M, LeCluyse EL (2003) A novel distal enhancer module regulated by PXR/CAR is essential for the maximal induction of CYP2B6 gene expression. J Biol Chem 278:14146\u201314152", "journal-title": "J Biol Chem"}, {"key": "9_CR555", "doi-asserted-by": "crossref", "first-page": "515", "DOI": "10.2174/1389200033489262", "volume": "4", "author": "H Wang", "year": "2003", "unstructured": "Wang H, Negishi M (2003) Transcriptional regulation of cytochrome P450 2B genes by nuclear receptors. Curr Drug Metab 4:515\u2013525", "journal-title": "Curr Drug Metab"}, {"key": "9_CR556", "doi-asserted-by": "crossref", "first-page": "1331", "DOI": "10.2165/00003088-200342150-00003", "volume": "42", "author": "H Wang", "year": "2003", "unstructured": "Wang H, LeCluyse EL (2003) Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes. Clin Pharmacokinet 42:1331\u20131357", "journal-title": "Clin Pharmacokinet"}, {"key": "9_CR557", "doi-asserted-by": "crossref", "first-page": "348", "DOI": "10.1124/dmd.32.3.348", "volume": "32", "author": "SR Faucette", "year": "2004", "unstructured": "Faucette SR, Wang H, Hamilton GA, Jolley SL, Gilbert D, Lindley C, Yan B, Negishi M, LeCluyse EL (2004) Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers. Drug Metab Dispos 32:348\u2013358", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR558", "doi-asserted-by": "crossref", "first-page": "3458", "DOI": "10.1074/jbc.M411318200", "volume": "280", "author": "K Swales", "year": "2005", "unstructured": "Swales K, Kakizaki S, Yamamoto Y, Inoue K, Kobayashi K, Negishi M (2005) Novel CAR-mediated mechanism for synergistic activation of two distinct elements within the human cytochrome P450 2B6 gene in HepG2 cells. J Biol Chem 280:3458\u20133466", "journal-title": "J Biol Chem"}, {"key": "9_CR559", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1016/j.taap.2003.12.027", "volume": "199", "author": "V Lamba", "year": "2004", "unstructured": "Lamba V, Yasuda K, Lamba JK, Assem M, Davila J, Strom S, Schuetz EG (2004) PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators. Toxicol Appl Pharmacol 199:251\u2013265", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "9_CR560", "doi-asserted-by": "crossref", "first-page": "72", "DOI": "10.1124/jpet.106.112136", "volume": "320", "author": "SR Faucette", "year": "2007", "unstructured": "Faucette SR, Zhang TC, Moore R, Sueyoshi T, Omiecinski CJ, LeCluyse EL, Negishi M, Wang H (2007) Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers. J Pharmacol Exp Ther 320:72\u201380", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR561", "doi-asserted-by": "crossref", "first-page": "10425", "DOI": "10.1074/jbc.M800729200", "volume": "283", "author": "K Inoue", "year": "2008", "unstructured": "Inoue K, Negishi M (2008) Nuclear receptor CAR requires early growth response 1 to activate the human cytochrome P450 2B6gene. J Biol Chem 283:10425\u201310432", "journal-title": "J Biol Chem"}, {"key": "9_CR562", "doi-asserted-by": "crossref", "first-page": "1716", "DOI": "10.1124/dmd.108.020867", "volume": "36", "author": "MD Merrell", "year": "2008", "unstructured": "Merrell MD, Jackson JP, Augustine LM, Fisher CD, Slitt AL, Maher JM, Huang W, Moore DD, Zhang Y, Klaassen CD, Cherrington NJ (2008) The Nrf2 activator oltipraz also activates the constitutive androstane receptor. Drug Metab Dispos 36:1716\u20131721", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR563", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1124/mol.113.089763", "volume": "85", "author": "H Yang", "year": "2014", "unstructured": "Yang H, Garzel B, Heyward S, Moeller T, Shapiro P, Wang H (2014) Metformin represses drug-induced expression of CYP2B6 by modulating the constitutive androstane receptor signaling. Mol Pharmacol 85:249\u2013260", "journal-title": "Mol Pharmacol"}, {"key": "9_CR564", "doi-asserted-by": "crossref", "first-page": "885", "DOI": "10.1097/FPC.0b013e3282ef5cd1", "volume": "17", "author": "M Rotger", "year": "2007", "unstructured": "Rotger M, Saumoy M, Zhang K, Flepp M, Sahli R, Decosterd L, Telenti A (2007) Partial deletion of CYP2B6 owing to unequal crossover with CYP2B7. Pharmacogenet Genomics 17:885\u2013890", "journal-title": "Pharmacogenet Genomics"}, {"key": "9_CR565", "doi-asserted-by": "crossref", "first-page": "743", "DOI": "10.2217/14622416.8.7.743", "volume": "8", "author": "UM Zanger", "year": "2007", "unstructured": "Zanger UM, Klein K, Saussele T, Blievernicht J, Hofmann MH, Schwab M (2007) Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance. Pharmacogenomics 8:743\u2013759", "journal-title": "Pharmacogenomics"}, {"key": "9_CR566", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.2174/138920008784746346", "volume": "9", "author": "S Ekins", "year": "2008", "unstructured": "Ekins S, Iyer M, Krasowski MD, Kharasch ED (2008) Molecular characterization of CYP2B6 substrates. Curr Drug Metab 9:363\u2013373", "journal-title": "Curr Drug Metab"}, {"key": "9_CR567", "doi-asserted-by": "crossref", "first-page": "598", "DOI": "10.2174/138920008785821710", "volume": "9", "author": "H Wang", "year": "2008", "unstructured": "Wang H, Tompkins LM (2008) CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme. Curr Drug Metab 9:598\u2013610", "journal-title": "Curr Drug Metab"}, {"key": "9_CR568", "doi-asserted-by": "crossref", "first-page": "E18", "DOI": "10.1208/ps050218", "volume": "5", "author": "BD Marks", "year": "2003", "unstructured": "Marks BD, Goossens TA, Braun HA, Ozers MS, Smith RW, Lebakken C, Trubetskoy OV (2003) High-throughput screening assays for CYP2B6 metabolism and inhibition using fluorogenic vivid substrates. AAPS PharmSci 5:E18", "journal-title": "AAPS PharmSci"}, {"key": "9_CR569", "doi-asserted-by": "crossref", "first-page": "287", "DOI": "10.1124/jpet.103.049601", "volume": "306", "author": "BA Ward", "year": "2003", "unstructured": "Ward BA, Gorski JC, Jones DR, Hall SD, Flockhart DA, Desta Z (2003) The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity. J Pharmacol Exp Ther 306:287\u2013300", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR570", "doi-asserted-by": "crossref", "first-page": "520", "DOI": "10.2133/dmpk.DMPK-12-RG-014", "volume": "27", "author": "K Kozakai", "year": "2012", "unstructured": "Kozakai K, Yamada Y, Oshikata M, Kawase T, Suzuki E, Haramaki Y, Taniguchi H (2012) Reliable high-throughput method for inhibition assay of 8 cytochrome P450 isoforms using cocktail of probe substrates and stable isotope-labeled internal standards. Drug Metab Pharmacokinet 27:520\u2013529", "journal-title": "Drug Metab Pharmacokinet"}, {"key": "9_CR571", "doi-asserted-by": "crossref", "first-page": "320", "DOI": "10.3109/00498254.2012.719088", "volume": "43", "author": "B Gerin", "year": "2013", "unstructured": "Gerin B, Dell\u2019Aiera S, Richert L, Smith S, Chanteux H (2013) Assessment of cytochrome P450 (1A2, 2B6, 2C9 and 3A4) induction in cryopreserved human hepatocytes cultured in 48-well plates using the cocktail strategy. Xenobiotica 43:320\u2013335", "journal-title": "Xenobiotica"}, {"key": "9_CR572", "doi-asserted-by": "crossref", "first-page": "271", "DOI": "10.1007/s40262-013-0115-0", "volume": "53", "author": "M Donzelli", "year": "2013", "unstructured": "Donzelli M, Derungs A, Serratore MG, Noppen C, Nezic L, Krahenbuhl S, Haschke M (2013) The Basel cocktail for simultaneous phenotyping of human cytochrome P450 isoforms in plasma, saliva and dried blood spots. Clin Pharmacokinet 53:271\u2013282", "journal-title": "Clin Pharmacokinet"}, {"key": "9_CR573", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1002/bdd.665", "volume": "30", "author": "S Asimus", "year": "2009", "unstructured": "Asimus S, Ashton M (2009) Artemisinin\u2014a possible CYP2B6 probe substrate? Biopharm Drug Dispos 30:265\u2013275", "journal-title": "Biopharm Drug Dispos"}, {"key": "9_CR574", "doi-asserted-by": "crossref", "first-page": "305", "DOI": "10.1002/jcph.1", "volume": "53", "author": "ED Kharasch", "year": "2013", "unstructured": "Kharasch ED, Stubbert K (2013) Role of cytochrome P4502B6 in methadone metabolism and clearance. J Clin Pharmacol 53:305\u2013313", "journal-title": "J Clin Pharmacol"}, {"key": "9_CR575", "doi-asserted-by": "crossref", "first-page": "420", "DOI": "10.1016/j.pharmthera.2006.10.002", "volume": "113", "author": "E Hodgson", "year": "2007", "unstructured": "Hodgson E, Rose RL (2007) The importance of cytochrome P450 2B6 in the human metabolism of environmental chemicals. Pharmacol Ther 113:420\u2013428", "journal-title": "Pharmacol Ther"}, {"key": "9_CR576", "first-page": "1141", "volume": "290", "author": "TL Domanski", "year": "1999", "unstructured": "Domanski TL, Schultz KM, Roussel F, Stevens JC, Halpert JR (1999) Structure-function analysis of human cytochrome P450 2B6 using a novel substrate, site-directed mutagenesis, and molecular modeling. J Pharmacol Exp Ther 290:1141\u20131147", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR577", "doi-asserted-by": "crossref", "first-page": "8709", "DOI": "10.1021/bi100914z", "volume": "49", "author": "SC Gay", "year": "2010", "unstructured": "Gay SC, Roberts AG, Maekawa K, Talakad JC, Hong WX, Zhang Q, Stout CD, Halpert JR (2010) Structures of cytochrome P450 2B4 complexed with the antiplatelet drugs ticlopidine and clopidogrel. Biochemistry 49:8709\u20138720", "journal-title": "Biochemistry"}, {"key": "9_CR578", "doi-asserted-by": "crossref", "first-page": "529", "DOI": "10.1124/mol.109.062570", "volume": "77", "author": "SC Gay", "year": "2010", "unstructured": "Gay SC, Shah MB, Talakad JC, Maekawa K, Roberts AG, Wilderman PR, Sun L, Yang JY, Huelga SC, Hong WX, Zhang Q, Stout CD, Halpert JR (2010) Crystal structure of a cytochrome P450 2B6 genetic variant in complex with the inhibitor 4-(4-chlorophenyl)imidazole at 2.0-\u00c5 resolution. Mol Pharmacol 77:529\u2013538", "journal-title": "Mol Pharmacol"}, {"key": "9_CR579", "doi-asserted-by": "crossref", "first-page": "1047", "DOI": "10.1124/mol.111.074427", "volume": "80", "author": "MB Shah", "year": "2011", "unstructured": "Shah MB, Pascual J, Zhang Q, Stout CD, Halpert JR (2011) Structures of cytochrome P450 2B6 bound to 4-benzylpyridine and 4-(4-nitrobenzyl)pyridine: insight into inhibitor binding and rearrangement of active siteside chains. Mol Pharmacol 80:1047\u20131055", "journal-title": "Mol Pharmacol"}, {"key": "9_CR580", "doi-asserted-by": "crossref", "first-page": "7225", "DOI": "10.1021/bi300894z", "volume": "51", "author": "MB Shah", "year": "2012", "unstructured": "Shah MB, Wilderman PR, Pascual J, Zhang Q, Stout CD, Halpert JR (2012) Conformational adaptation of human cytochrome P450 2B6 and rabbit cytochrome P450 2B4 revealed upon binding multiple amlodipine molecules. Biochemistry 51:7225\u20137238", "journal-title": "Biochemistry"}, {"key": "9_CR581", "doi-asserted-by": "crossref", "first-page": "361", "DOI": "10.1080/004982599238560", "volume": "29", "author": "DFV Lewis", "year": "1999", "unstructured": "Lewis DFV, Lake BG, Dickins M, Eddershaw PJ, Tarbit MH, Goldfarb PS (1999) Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b 5 binding site and comparisons with CYP2B1 and CYP2B4. Xenobiotica 29:361\u2013393", "journal-title": "Xenobiotica"}, {"key": "9_CR582", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1515/DMDI.2001.18.3-4.221", "volume": "18", "author": "DF Lewis", "year": "2001", "unstructured": "Lewis DF, Modi S, Dickins M (2001) Quantitative structure-activity relationships (QSARs) within substrates of human cytochromes P450 involved in drug metabolism. Drug Metab Drug Interact 18:221\u2013242", "journal-title": "Drug Metab Drug Interact"}, {"key": "9_CR583", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1007/s00894-002-0104-y", "volume": "8", "author": "C Bathelt", "year": "2002", "unstructured": "Bathelt C, Schmid RD, Pleiss J (2002) Regioselectivity of CYP2B6: homology modeling, molecular dynamics simulation, docking. J Mol Model 8:327\u2013335", "journal-title": "J Mol Model"}, {"key": "9_CR584", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.2133/dmpk.DMPK-10-RG-097", "volume": "26", "author": "N Koyama", "year": "2011", "unstructured": "Koyama N, Yamazoe Y (2011) Development of two-dimensional template system for the prediction of CYP2B6-mediated reaction sites. Drug Metab Pharmacokinet 26:309\u2013330", "journal-title": "Drug Metab Pharmacokinet"}, {"key": "9_CR585", "doi-asserted-by": "crossref", "first-page": "1899", "DOI": "10.1002/jcc.21190", "volume": "30", "author": "MK Leong", "year": "2009", "unstructured": "Leong MK, Chen YM, Chen TH (2009) Prediction of human cytochrome P450 2B6-substrate interactions using hierarchical support vector regression approach. J Comput Chem 30:1899\u20131909", "journal-title": "J Comput Chem"}, {"key": "9_CR586", "first-page": "390", "volume": "25", "author": "Z Guo", "year": "1997", "unstructured": "Guo Z, Raeissi S, White RB, Stevens JC (1997) Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes. Drug Metab Dispos 25:390\u2013393", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR587", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.1097/00008571-199706000-00001", "volume": "7", "author": "S Ekins", "year": "1997", "unstructured": "Ekins S, VandenBranden M, Ring BJ, Wrighton SA (1997) Examination of purported probes of human CYP2B6. Pharmacogenetics 7:165\u2013179", "journal-title": "Pharmacogenetics"}, {"key": "9_CR588", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1016/S0003-9861(02)00259-X", "volume": "403", "author": "M Stiborova", "year": "2002", "unstructured": "Stiborova M, Borek-Dohalska L, Hodek P, Mraz J, Frei E (2002) New selective inhibitors of cytochromes P450 2B and their application to antimutagenesis of tamoxifen. Arch Biochem Biophys 403:41\u201349", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR589", "doi-asserted-by": "crossref", "first-page": "525", "DOI": "10.1124/dmd.30.5.525", "volume": "30", "author": "JM Rae", "year": "2002", "unstructured": "Rae JM, Soukhova NV, Flockhart DA, Desta Z (2002) Triethylenethiophosphoramide is a specific inhibitor of cytochrome P4502B6: implications for cyclophosphamide metabolism. Drug Metab Dispos 30:525\u2013530", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR590", "doi-asserted-by": "crossref", "first-page": "932", "DOI": "10.1038/sj.bjp.0707173", "volume": "150", "author": "LE Korhonen", "year": "2007", "unstructured": "Korhonen LE, Turpeinen M, Rahnasto M, Wittekindt C, Poso A, Pelkonen O, Raunio H, Juvonen RO (2007) New potent and selective cytochrome P450 2B6 (CYP2B6) inhibitors based on three-dimensional quantitative structure-activity relationship (3D-QSAR) analysis. Br J Pharmacol 150:932\u2013942", "journal-title": "Br J Pharmacol"}, {"key": "9_CR591", "doi-asserted-by": "crossref", "first-page": "644", "DOI": "10.1124/dmd.108.023655", "volume": "37", "author": "JC Talakad", "year": "2009", "unstructured": "Talakad JC, Kumar S, Halpert JR (2009) Decreased susceptibility of the cytochrome P450 2B6 variant K262R to inhibition by several clinically important drugs. Drug Metab Dispos 37:644\u2013650", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR592", "doi-asserted-by": "crossref", "first-page": "2431", "DOI": "10.1124/dmd.111.042176", "volume": "39", "author": "HL Lin", "year": "2011", "unstructured": "Lin HL, Zhang H, Pratt-Hyatt MJ, Hollenberg PF (2011) Thr302 is the site for the covalent modification of human cytochrome P450 2B6 leading to mechanism-based inactivation by tert-butylphenylacetylene. Drug Metab Dispos 39:2431\u20132439", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR593", "doi-asserted-by": "crossref", "first-page": "549", "DOI": "10.1124/jpet.300.2.549", "volume": "300", "author": "UM Kent", "year": "2002", "unstructured": "Kent UM, Mills DE, Rajnarayanan RV, Alworth WL, Hollenberg PF (2002) Effect of 17\u03b1-ethynylestradiol on activities of cytochrome P450 2B (P450 2B) enzymes: characterization of inactivation of P450s 2B1 and 2B6 and identification of metabolites. J Pharmacol Exp Ther 300:549\u2013558", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR594", "doi-asserted-by": "crossref", "first-page": "314", "DOI": "10.1016/j.toxlet.2011.07.019", "volume": "206", "author": "CY Chan", "year": "2011", "unstructured": "Chan CY, New LS, Ho HK, Chan EC (2011) Reversible time-dependent inhibition of cytochrome P450 enzymes by duloxetine and inertness of its thiophene ring towards bioactivation. Toxicol Lett 206:314\u2013324", "journal-title": "Toxicol Lett"}, {"key": "9_CR595", "doi-asserted-by": "crossref", "first-page": "28", "DOI": "10.1124/dmd.31.1.28", "volume": "31", "author": "PW Fan", "year": "2003", "unstructured": "Fan PW, Gu C, Marsh SA, Stevens JC (2003) Mechanism-based inactivation of cytochrome P450 2B6 by a novel terminal acetylene inhibitor. Drug Metab Dispos 31:28\u201336", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR596", "doi-asserted-by": "crossref", "first-page": "189", "DOI": "10.1124/jpet.103.056127", "volume": "308", "author": "T Richter", "year": "2004", "unstructured": "Richter T, Murdter TE, Heinkele G, Pleiss J, Tatzel S, Schwab M, Eichelbaum M, Zanger UM (2004) Potent mechanism-based inhibition of human CYP2B6 by clopidogreland ticlopidine. J Pharmacol Exp Ther 308:189\u2013197", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR597", "doi-asserted-by": "crossref", "first-page": "589", "DOI": "10.1124/dmd.108.022988", "volume": "37", "author": "Y Nishiya", "year": "2009", "unstructured": "Nishiya Y, Hagihara K, Ito T, Tajima M, Miura S, Kurihara A, Farid NA, Ikeda T (2009) Mechanism-based inhibition of human cytochrome P450 2B6 by ticlopidine, clopidogrel, and the thiolactone metabolite of prasugrel. Drug Metab Dispos 37:589\u2013593", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR598", "doi-asserted-by": "crossref", "first-page": "1523", "DOI": "10.1124/dmd.106.010579", "volume": "34", "author": "MI Jushchyshyn", "year": "2006", "unstructured": "Jushchyshyn MI, Wahlstrom JL, Hollenberg PF, Wienkers LC (2006) Mechanism of inactivation of human cytochrome P450 2B6 by phencyclidine. Drug Metab Dispos 34:1523\u20131529", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR599", "doi-asserted-by": "crossref", "first-page": "1849", "DOI": "10.1124/dmd.106.010082", "volume": "34", "author": "C Sridar", "year": "2006", "unstructured": "Sridar C, Kobayashi Y, Brevig H, Kent UM, Puppali SG, Rimoldi JM, Hollenberg PF (2006) Synthesis of substituted phenyl diaziridines and characterization as mechanism-based inactivators of human cytochrome P450 2B6. Drug Metab Dispos 34:1849\u20131855", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR600", "doi-asserted-by": "crossref", "first-page": "1612", "DOI": "10.1021/tx700220e", "volume": "20", "author": "HL Lin", "year": "2007", "unstructured": "Lin HL, Myshkin E, Waskell L, Hollenberg PF (2007) Peroxynitrite inactivation of human cytochrome P450s 2B6 and 2E1: heme modification and site-specific nitrotyrosine formation. Chem Res Toxicol 20:1612\u20131622", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR601", "doi-asserted-by": "crossref", "first-page": "1956", "DOI": "10.1021/tx800138v", "volume": "21", "author": "UM Kent", "year": "2008", "unstructured": "Kent UM, Sridar C, Spahlinger G, Hollenberg PF (2008) Modification of serine 360 by a reactive intermediate of 17\u03b1-ethynylestradiol results in mechanism-based inactivation of cytochrome P450s 2B1 and 2B6. Chem Res Toxicol 21:1956\u20131963", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR602", "doi-asserted-by": "crossref", "first-page": "1765", "DOI": "10.1124/dmd.112.045971", "volume": "40", "author": "HT Amunugama", "year": "2012", "unstructured": "Amunugama HT, Zhang H, Hollenberg PF (2012) Mechanism-based inactivation of cytochrome P450 2B6 by methadone through destruction of prosthetic heme. Drug Metab Dispos 40:1765\u20131770", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR603", "doi-asserted-by": "crossref", "first-page": "2256", "DOI": "10.1124/dmd.112.046979", "volume": "40", "author": "C Sridar", "year": "2012", "unstructured": "Sridar C, Kenaan C, Hollenberg PF (2012) Inhibition of bupropion metabolism by selegiline: mechanism-based inactivation of human CYP2B6 and characterization of glutathione and peptide adducts. Drug Metab Dispos 40:2256\u20132266", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR604", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1016/j.cbi.2013.06.006", "volume": "205", "author": "SH Bae", "year": "2013", "unstructured": "Bae SH, Kwon MJ, Choi EJ, Zheng YF, Yoon KD, Liu KH, Bae SK (2013) Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes. Chem Biol Interact 205:11\u201319", "journal-title": "Chem Biol Interact"}, {"key": "9_CR605", "doi-asserted-by": "crossref", "first-page": "1813", "DOI": "10.1124/dmd.113.053108", "volume": "41", "author": "HL Lin", "year": "2013", "unstructured": "Lin HL, D\u2019Agostino J, Kenaan C, Calinski D, Hollenberg PF (2013) The effect of ritonaviron human CYP2B6 catalytic activity: heme modification contributes to the mechanism-based inactivation of CYP2B6 and CYP3A4 by ritonavir. Drug Metab Dispos 41:1813\u20131824", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR606", "doi-asserted-by": "crossref", "first-page": "154", "DOI": "10.1124/jpet.104.079608", "volume": "313", "author": "HL Lin", "year": "2005", "unstructured": "Lin HL, Kent UM, Hollenberg PF (2005) The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent bindingto protein in P450s 2B6 and 3A5. J Pharmacol Exp Ther 313:154\u2013164", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR607", "doi-asserted-by": "crossref", "first-page": "24", "DOI": "10.3389/fgene.2013.00024", "volume": "4", "author": "UM Zanger", "year": "2013", "unstructured": "Zanger UM, Klein K (2013) Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance. Front Genet 4:24", "journal-title": "Front Genet"}, {"key": "9_CR608", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1258/095646207781439810", "volume": "18", "author": "O Usami", "year": "2007", "unstructured": "Usami O, Ashino Y, Komaki Y, Tomaki M, Irokawa T, Tamada T, Hayashida T, Teruya K, Hattori T (2007) Efavirenz-induced neurological symptoms in rare homozygote CYP2B6 *2/*2 (C64T). Int J STD AIDS 18:575\u2013576", "journal-title": "Int J STD AIDS"}, {"key": "9_CR609", "doi-asserted-by": "crossref", "first-page": "1453", "DOI": "10.1093/infdis/jis508", "volume": "206", "author": "M Gandhi", "year": "2012", "unstructured": "Gandhi M, Greenblatt RM, Bacchetti P, Jin C, Huang Y, Anastos K, Cohen M, Dehovitz JA, Sharp GB, Gange SJ, Liu C, Hanson SC, Aouizerat B (2012) A single-nucleotide polymorphism in CYP2B6 leads to > 3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women. J Infect Dis 206:1453\u20131461", "journal-title": "J Infect Dis"}, {"key": "9_CR610", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1016/j.jcv.2013.05.003", "volume": "58", "author": "AM Elsharkawy", "year": "2013", "unstructured": "Elsharkawy AM, Schwab U, McCarron B, Burt AD, Daly AK, Hudson M, Masson S (2013) Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser. J Clin Virol 58:331\u2013333", "journal-title": "J Clin Virol"}, {"key": "9_CR611", "first-page": "S0", "volume": "pii", "author": "C Sukasem", "year": "2013", "unstructured": "Sukasem C, Manosuthi W, Koomdee N, Santon S, Jantararoungtong T, Prommas S, Chamnanphol M, Puangpetch A, Sungkanuparph S (2013) Low level of efavirenz in HIV-1-infected Thai adults is associated with the CYP2B6 polymorphism. Infection pii:S0924\u2013S8579", "journal-title": "Infection"}, {"key": "9_CR612", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1124/dmd.112.048108", "volume": "41", "author": "K Ilic", "year": "2013", "unstructured": "Ilic K, Hawke RL, Thirumaran RK, Schuetz EG, Hull JH, Kashuba AD, Stewart PW, Lindley CM, Chen ML (2013) The influence of sex, ethnicity, and CYP2B6 genotype on bupropion metabolism as an index of hepatic CYP2B6 activity in humans. Drug Metab Dispos 41:575\u2013581", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR613", "doi-asserted-by": "crossref", "first-page": "e79700", "DOI": "10.1371/journal.pone.0079700", "volume": "8", "author": "AJ Bloom", "year": "2013", "unstructured": "Bloom AJ, Martinez M, Chen LS, Bierut LJ, Murphy SE, Goate A (2013) CYP2B6 non-coding variation associated with smoking cessation is also associated with differences in allelic expression, splicing, and nicotine metabolism independent of common amino-acid changes. PLoS One 8:e79700", "journal-title": "PLoS One"}, {"key": "9_CR614", "doi-asserted-by": "crossref", "first-page": "513", "DOI": "10.1097/QAI.0b013e318183a425", "volume": "49", "author": "SM Robertson", "year": "2008", "unstructured": "Robertson SM, Maldarelli F, Natarajan V, Formentini E, Alfaro RM, Penzak SR (2008) Efavirenz induces CYP2B6-mediated hydroxylation of bupropion in healthy subjects. J Acquir Immune Defic Syndr 49:513\u2013519", "journal-title": "J Acquir Immune Defic Syndr"}, {"key": "9_CR615", "doi-asserted-by": "crossref", "first-page": "1312", "DOI": "10.1158/1055-9965.EPI-07-0188", "volume": "16", "author": "AM Lee", "year": "2007", "unstructured": "Lee AM, Jepson C, Shields PG, Benowitz N, Lerman C, Tyndale RF (2007) CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev 16:1312\u20131314", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9_CR616", "doi-asserted-by": "crossref", "first-page": "381", "DOI": "10.3109/00498251003713958", "volume": "40", "author": "N Al Koudsi", "year": "2010", "unstructured": "Al Koudsi N, Tyndale RF (2010) Hepatic CYP2B6 is altered by genetic, physiologic, and environmental factors but plays little role in nicotine metabolism. Xenobiotica 40:381\u2013392", "journal-title": "Xenobiotica"}, {"key": "9_CR617", "doi-asserted-by": "crossref", "first-page": "383", "DOI": "10.1002/ajh.21987", "volume": "86", "author": "N Helsby", "year": "2011", "unstructured": "Helsby N, Tingle M (2011) The importance of correct assignment of CYP2B6 genetic variants with respect to cyclophosphamide metabolizer status. Am J Hematol 86:383\u2013384", "journal-title": "Am J Hematol"}, {"key": "9_CR618", "doi-asserted-by": "crossref", "first-page": "635", "DOI": "10.1124/dmd.111.043646", "volume": "40", "author": "NA Helsby", "year": "2012", "unstructured": "Helsby NA, Tingle MD (2012) Which CYP2B6 variants have functional consequences for cyclophosphamide bioactivation? Drug Metab Dispos 40:635\u2013637", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR619", "doi-asserted-by": "crossref", "first-page": "4253", "DOI": "10.1182/blood-2013-07-516666", "volume": "122", "author": "GG Johnson", "year": "2013", "unstructured": "Johnson GG, Lin K, Cox TF, Oates M, Sibson DR, Eccles R, Lloyd B, Gardiner LJ, Carr DF, Pirmohamed M, Strefford JC, Oscier DG, Gonzalez de Castro D, Else M, Catovsky D, Pettitt AR (2013) CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia. Blood 122:4253\u20134258", "journal-title": "Blood"}, {"key": "9_CR620", "doi-asserted-by": "crossref", "first-page": "709", "DOI": "10.1111/j.1369-1600.2011.00349.x", "volume": "18", "author": "O Levran", "year": "2013", "unstructured": "Levran O, Peles E, Hamon S, Randesi M Adelson M, Kreek MJ (2013) CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction. Addict Biol 18:709\u2013716", "journal-title": "Addict Biol"}, {"key": "9_CR621", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1016/j.cca.2013.11.007", "volume": "428", "author": "IC Hwang", "year": "2014", "unstructured": "Hwang IC, Park JY, Ahn HY, Kim KK, Suh HS, Ko KD, Kim KA (2014) Effects of CYP3A5, CYP2C19, and CYP2B6 on the clinical efficacy and adverse outcomes of sibutramine therapy: a crucial role for the CYP2B6*6 allele. Clin Chim Acta 428:77\u201381", "journal-title": "Clin Chim Acta"}, {"key": "9_CR622", "doi-asserted-by": "crossref", "first-page": "782", "DOI": "10.1007/s12032-013-0782-6", "volume": "31", "author": "Y Kassogue", "year": "2014", "unstructured": "Kassogue Y, Quachouh M, Dehbi H, Quessar A, Benchekroun S, Nadifi S (2014) Functional polymorphism of CYP2B6 G15631T is associated with hematologic and cytogenetic response in chronic myeloid leukemia patients treated with imatinib. Med Oncol 31:782", "journal-title": "Med Oncol"}, {"key": "9_CR623", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1016/j.tox.2012.01.006", "volume": "293", "author": "AL Crane", "year": "2012", "unstructured": "Crane AL, Klein K, Zanger UM, Olson JR (2012) Effect of CYP2B6*6 and CYP2C19*2 genotype on chlorpyrifos metabolism. Toxicology 293:115\u2013122", "journal-title": "Toxicology"}, {"key": "9_CR624", "doi-asserted-by": "crossref", "first-page": "753", "DOI": "10.1007/BF00541938", "volume": "26", "author": "A K\u00fcpfer", "year": "1984", "unstructured": "K\u00fcpfer A, Preisig R (1984) Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man. Eur J Clin Pharmacol 26:753\u2013759", "journal-title": "Eur J Clin Pharmacol"}, {"key": "9_CR625", "doi-asserted-by": "crossref", "first-page": "773", "DOI": "10.1038/clpt.1984.256", "volume": "36", "author": "PJ Wedlund", "year": "1984", "unstructured": "Wedlund PJ, Aslanian WS, McAllister CB, Wilkinson GR, Branch RA (1984) Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism. Clin Pharmacol Ther 36:773\u2013780", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR626", "first-page": "1112", "volume": "241", "author": "RG Knodell", "year": "1987", "unstructured": "Knodell RG, Hall SD, Wilkinson GR, Guengerich FP (1987) Hepatic metabolism of tolbutamide: characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition. J Pharmacol Exp Ther 241:1112\u20131119", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR627", "doi-asserted-by": "crossref", "first-page": "4993", "DOI": "10.1021/bi00438a014", "volume": "28", "author": "WR Brian", "year": "1989", "unstructured": "Brian WR, Srivastava PK, Umbenhauer DR, Lloyd RS, Guengerich FP (1989) Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae. Biochemistry 28:4993\u20134999", "journal-title": "Biochemistry"}, {"key": "9_CR628", "doi-asserted-by": "crossref", "first-page": "6929", "DOI": "10.1021/bi00418a039", "volume": "27", "author": "C Ged", "year": "1988", "unstructured": "Ged C, Umbenhauer DR, Bellew TM, Bork RW, Srivastava PK, Shinriki N, Lloyd RS, Guengerich FP (1988) Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4\u2032-hydroxylase. Biochemistry 27:6929\u20136940", "journal-title": "Biochemistry"}, {"key": "9_CR629", "doi-asserted-by": "crossref", "first-page": "3247", "DOI": "10.1021/bi00227a012", "volume": "30", "author": "M Romkes", "year": "1991", "unstructured": "Romkes M, Faletto MB, Blaisdell JA, Raucy JL, Goldstein JA (1991) Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry 30:3247\u20133255", "journal-title": "Biochemistry"}, {"key": "9_CR630", "doi-asserted-by": "crossref", "first-page": "240", "DOI": "10.1006/abbi.1993.1506", "volume": "306", "author": "SA Wrighton", "year": "1993", "unstructured": "Wrighton SA, Stevens JC, Becker GW, VandenBranden M (1993) Isolation and characterization of human liver cytochrome P450 2C19: correlation between 2C19 and S-mephenytoin 4\u2032-hydroxylation. Arch Biochem Biophys 306:240\u2013245", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR631", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1097/00008571-199602000-00002", "volume": "6", "author": "DR Nelson", "year": "1996", "unstructured": "Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers, and nomenclature. Pharmacogenetics 6:1\u201342", "journal-title": "Pharmacogenetics"}, {"key": "9_CR632", "doi-asserted-by": "crossref", "first-page": "597", "DOI": "10.1097/00008571-200110000-00006", "volume": "11", "author": "D Dai", "year": "2001", "unstructured": "Dai D, Zeldin DC, Blaisdell JA, Chanas B, Coulter SJ, Ghanayem BI, Goldstein JA (2001) Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid. Pharmacogenetics 11:597\u2013607", "journal-title": "Pharmacogenetics"}, {"key": "9_CR633", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.1002/(SICI)1099-0461(1999)13:6<289::AID-JBT1>3.0.CO;2-N", "volume": "13", "author": "TS Klose", "year": "1999", "unstructured": "Klose TS, Blaisdell JA, Goldstein JA (1999) Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs. J Biochem Mol Toxicol 13:289\u2013295", "journal-title": "J Biochem Mol Toxicol"}, {"key": "9_CR634", "doi-asserted-by": "crossref", "first-page": "682", "DOI": "10.1124/dmd.106.012823", "volume": "35", "author": "TC Delozier", "year": "2007", "unstructured": "Delozier TC, Kissling GE, Coulter SJ, Dai D, Foley JF, Bradbury JA, Murphy E, Steenbergen C, Zeldin DC, Goldstein JA (2007) Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues. Drug Metab Dispos 35:682\u2013688", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR635", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1016/j.taap.2012.12.008", "volume": "267", "author": "K Shrivas", "year": "2013", "unstructured": "Shrivas K, Mindaye ST, Getie-Kebtie M, Alterman MA (2013) Mass spectrometry-based proteomic analysis of human liver cytochrome(s) P450. Toxicol Appl Pharmacol 267:125\u2013136", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "9_CR636", "doi-asserted-by": "crossref", "first-page": "889", "DOI": "10.1124/dmd.109.031542", "volume": "38", "author": "SB Naraharisetti", "year": "2010", "unstructured": "Naraharisetti SB, Lin YS, Rieder MJ, Marciante KD, Psaty BM, Thummel KE, Totah RA (2010) Human liver expression of CYP2C8: gender, age, and genotype effects. Drug Metab Dispos 38:889\u2013893", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR637", "doi-asserted-by": "crossref", "first-page": "1976", "DOI": "10.1124/dmd.110.034942", "volume": "38", "author": "G Hu", "year": "2010", "unstructured": "Hu G, Johnson EF, Kemper B (2010) CYP2C8 exists as a dimer in natural membranes. Drug Metab Dispos 38:1976\u20131983", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR638", "doi-asserted-by": "crossref", "first-page": "29614", "DOI": "10.1074/jbc.M114.583062", "volume": "289", "author": "P Bajpai", "year": "2014", "unstructured": "Bajpai P, Srinivasan S, Ghosh J, Nagy LD, Wei S, Guengerich FP, Avadhani NG (2014) Targeting of spice variants of human cytochrome P450 2C8 (CYP2C8) to mitochondria and their role in arachidonic acid metabolism and respiratory dysfunction. J Biol Chem 289:29614\u201329630", "journal-title": "J Biol Chem"}, {"key": "9_CR639", "doi-asserted-by": "crossref", "first-page": "1579", "DOI": "10.1016/S0006-2952(02)01354-0", "volume": "64", "author": "N Bahadur", "year": "2002", "unstructured": "Bahadur N, Leathart JB, Mutch E, Steimel-Crespi D, Dunn SA, Gilissen R, Houdt JV, Hendrickx J, Mannens G, Bohets H, Williams FM, Armstrong M, Crespi CL, Daly AK (2002) CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6\u03b1-hydroxylase activity in human liver microsomes. Biochem Pharmacol 64:1579\u20131589", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR640", "first-page": "242", "volume": "29", "author": "S Gerbal-Chaloin", "year": "2001", "unstructured": "Gerbal-Chaloin S, Pascussi JM, Pichard-Garcia L, Daujat M, Waechter F, Fabre JM, Carrere N, Maurel P (2001) Induction of CYP2C genes in human hepatocytes in primary culture. Drug Metab Dispos 29:242\u2013251", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR641", "doi-asserted-by": "crossref", "first-page": "747", "DOI": "10.1124/mol.105.013169", "volume": "68", "author": "SS Ferguson", "year": "2005", "unstructured": "Ferguson SS, Chen Y, LeCluyse EL, Negishi M, Goldstein JA (2005) Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoidreceptor, and hepatic nuclear factor 4\u03b1. Mol Pharmacol 68:747\u2013757", "journal-title": "Mol Pharmacol"}, {"key": "9_CR642", "doi-asserted-by": "crossref", "first-page": "529", "DOI": "10.1124/mol.112.078386", "volume": "82", "author": "SY Zhang", "year": "2012", "unstructured": "Zhang SY, Surapureddi S, Coulter S, Ferguson SS, Goldstein JA (2012) Human CYP2C8 is post-transcriptionally regulated by microRNAs 103 and 107 in human liver. Mol Pharmacol 82:529\u2013540", "journal-title": "Mol Pharmacol"}, {"key": "9_CR643", "doi-asserted-by": "crossref", "first-page": "2359", "DOI": "10.1124/dmd.109.029728", "volume": "37", "author": "JT Backman", "year": "2009", "unstructured": "Backman JT, Honkalammi J, Neuvonen M, Kurkinen KJ, Tornio A, Niemi M, Neuvonen PJ (2009) CYP2C8 activity recovers within 96 hours after gemfibrozil dosing: estimation of CYP2C8 half-life using repaglinide as an in vivo probe. Drug Metab Dispos 37:2359\u20132366", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR644", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.1016/j.clpt.2004.12.267", "volume": "77", "author": "RA Totah", "year": "2005", "unstructured": "Totah RA, Rettie AE (2005) Cytochrome P450 2C8: substrates, inhibitors, pharmacogenetics, and clinical relevance. Clin Pharmacol Ther 77:341\u2013352", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR645", "doi-asserted-by": "crossref", "first-page": "630", "DOI": "10.1124/dmd.105.003830", "volume": "33", "author": "H Hichiya", "year": "2005", "unstructured": "Hichiya H, Tanaka-Kagawa T, Soyama A, Jinno H, Koyano S, Katori N, Matsushima E, Uchiyama S, Tokunaga H, Kimura H, Minami N, Katoh M, Sugai K, Goto Y, Tamura T, Yamamoto N, Ohe Y, Kunitoh H, Nokihara H, Yoshida T, Minami H, Saijo N, Ando M, Ozawa S, Saito Y, Sawada J (2005) Functional characterization of five novel CYP2C8 variants, G171S, R186X, R186G, K247R, and K383N, found in a Japanese population. Drug Metab Dispos 33:630\u2013636", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR646", "doi-asserted-by": "crossref", "first-page": "467", "DOI": "10.3109/00498254.2010.487163", "volume": "40", "author": "Y Gao", "year": "2010", "unstructured": "Gao Y, Liu D, Wang H, Zhu J, Chen C (2010) Functional characterization of five CYP2C8 variants and prediction of CYP2C8 genotype-dependent effects on in vitro and in vivo drug-drug interactions. Xenobiotica 40:467\u2013475", "journal-title": "Xenobiotica"}, {"key": "9_CR647", "doi-asserted-by": "crossref", "first-page": "1427", "DOI": "10.1248/bpb.24.1427", "volume": "24", "author": "A Soyama", "year": "2001", "unstructured": "Soyama A, Saito Y, Hanioka N, Murayama N, Nakajima O, Katori N, Ishida S, Sai K, Ozawa S, Sawada JI (2001) Non-synonymous single nucleotide alterations found in the CYP2C8 gene result in reduced in vitro paclitaxel metabolism. Biol Pharm Bull 24:1427\u20131430", "journal-title": "Biol Pharm Bull"}, {"key": "9_CR648", "doi-asserted-by": "crossref", "first-page": "1489", "DOI": "10.2217/pgs.09.82", "volume": "10", "author": "EB Daily", "year": "2009", "unstructured": "Daily EB, Aquilante CL (2009) Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies. Pharmacogenomics 10:1489\u20131510", "journal-title": "Pharmacogenomics"}, {"key": "9_CR649", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1186/1475-2875-11-125", "volume": "11", "author": "GM Paganotti", "year": "2012", "unstructured": "Paganotti GM, Gramolelli S, Tabacchi F, Russo G, Modiano D, Coluzzi M, Romano R (2012) Distribution of human CYP2C8*2 allele in three different African populations. Malaria J 11:125", "journal-title": "Malaria J"}, {"key": "9_CR650", "doi-asserted-by": "crossref", "first-page": "657", "DOI": "10.1016/j.clpt.2006.09.008", "volume": "80", "author": "J Kirchheiner", "year": "2006", "unstructured": "Kirchheiner J, Thomas S, Bauer S, Tomalik-Scharte D, Hering U, Doroshyenko O, Jetter A, Stehle S, Tsahuridu M, Meineke I, Brockmoller J, Fuhr U (2006) Pharmacokinetics and pharmacodynamics of rosiglitazone in relation to CYP2C8 genotype. Clin Pharmacol Ther 80:657\u2013667", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR651", "doi-asserted-by": "crossref", "first-page": "711", "DOI": "10.1124/dmd.110.035899", "volume": "39", "author": "CW Yeo", "year": "2011", "unstructured": "Yeo CW, Lee SJ, Lee SS, Bae SK, Kim EY, Shon JH, Rhee BD, Shin JG (2011) Discovery of a novel allelic variant of CYP2C8, CYP2C8*11, in Asian populations and its clinical effect on the rosiglitazone disposition in vivo. Drug Metab Dispos 39:711\u2013716", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR652", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.1111/j.1742-7843.2010.00669.x", "volume": "108", "author": "N Hanioka", "year": "2011", "unstructured": "Hanioka N, Matsumoto K, Saito Y, Narimatsu S (2011) Influence of CYP2C8*13 and CYP2C8*14 alleles on amiodarone N-deethylation. Basic Clin Pharmacol Toxicol 108:359\u2013362", "journal-title": "Basic Clin Pharmacol Toxicol"}, {"key": "9_CR653", "doi-asserted-by": "crossref", "first-page": "174", "DOI": "10.1034/j.1600-0773.2002.910404.x", "volume": "91", "author": "A Soyama", "year": "2002", "unstructured": "Soyama A, Hanioka N, Saito Y, Murayama N, Ando M, Ozawa S, Sawada J (2002) Amiodarone N-deethylation by CYP2C8 and its variants, CYP2C8*3 and CYP2C8 P404A. Pharmacol Toxicol 91:174\u2013178", "journal-title": "Pharmacol Toxicol"}, {"key": "9_CR654", "doi-asserted-by": "crossref", "first-page": "1261", "DOI": "10.1124/dmd.109.030866", "volume": "38", "author": "SE Rowbotham", "year": "2010", "unstructured": "Rowbotham SE, Boddy AV, Redfern CP, Veal GJ, Daly AK (2010) Relevance of nonsynonymous CYP2C8 polymorphisms to 13-cis retinoic acid and paclitaxel hydroxylation. Drug Metab Dispos 38:1261\u20131266", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR655", "first-page": "5543", "volume": "54", "author": "A Rahman", "year": "1994", "unstructured": "Rahman A, Korzekwa KR, Grogan J, Gonzalez FJ, Harris JW (1994) Selective biotransformation of taxol to 6\u03b1-hydroxytaxol by human cytochrome P450 2C8. Cancer Res 54:5543\u20135546", "journal-title": "Cancer Res"}, {"key": "9_CR656", "doi-asserted-by": "crossref", "first-page": "305", "DOI": "10.1016/0003-9861(89)90112-4", "volume": "269", "author": "MA Leo", "year": "1989", "unstructured": "Leo MA, Lasker JM, Raucy JL, Kim CI, Black M, Lieber CS (1989) Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8. Arch Biochem Biophys 269:305\u2013312", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR657", "first-page": "1260", "volume": "27", "author": "H Yamazaki", "year": "1999", "unstructured": "Yamazaki H, Shibata A, Suzuki M, Nakajima M, Shimada N, Guengerich FP, Yokoi T (1999) Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes. Drug Metab Dispos 27:1260\u20131266", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR658", "doi-asserted-by": "crossref", "first-page": "6363", "DOI": "10.1021/bi027391+", "volume": "42", "author": "C Marques-Soares", "year": "2003", "unstructured": "Marques-Soares C, Dijols S, Macherey A-C, Wester MR, Johnson EF, Dansette PM, Mansuy D (2003) Sulfaphenazole derivatives as tools for comparing cytochrome P450 2C5 and human cytochrome P450 2Cs: identification of a new high affinity subwstrate common to those CYP 2C enzymes. Biochemistry 42:6363\u20136369", "journal-title": "Biochemistry"}, {"key": "9_CR659", "doi-asserted-by": "crossref", "first-page": "189", "DOI": "10.1006/abbi.2001.2511", "volume": "394", "author": "NT Ha-Duong", "year": "2001", "unstructured": "Ha-Duong NT, Marques-Soares C, Dijols S, Sari MA, Dansette PM, Mansuy D (2001) Interaction of new sulfaphenazole derivatives with human liver cytochrome P4502Cs: structural determinants required for selective recognition by CYP2C9 and for inhibition of human CYP2Cs. Arch Biochem Biophys 394:189\u2013200", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR660", "doi-asserted-by": "crossref", "first-page": "1145", "DOI": "10.2174/138920012802850092", "volume": "13", "author": "T Niwa", "year": "2012", "unstructured": "Niwa T, Yamazaki H (2012) Comparison of cytochrome P450 2C subfamily members in terms of drug oxidation rates and substrate inhibition. Curr Drug Metab 13:1145\u20131159", "journal-title": "Curr Drug Metab"}, {"key": "9_CR661", "doi-asserted-by": "crossref", "first-page": "374", "DOI": "10.1111/j.1742-7843.2009.00457.x", "volume": "105", "author": "E Muschler", "year": "2009", "unstructured": "Muschler E, Lal J, Jetter A, Rattay A, Zanger U, Zadoyan G, Fuhr U, Kirchheiner J (2009) The role of human CYP2C8 and CYP2C9 variants in pioglitazone metabolism in vitro. Basic Clin Pharmacol Toxicol 105:374\u2013379", "journal-title": "Basic Clin Pharmacol Toxicol"}, {"key": "9_CR662", "doi-asserted-by": "crossref", "first-page": "231", "DOI": "10.1016/j.clpt.2005.11.002", "volume": "79", "author": "LI Kajosaari", "year": "2006", "unstructured": "Kajosaari LI, Niemi M, Backman JT, Neuvonen PJ (2006) Telithromycin, but not montelukast, increases the plasma concentrations and effects of the cytochrome P450 3A4 and 2C8 substrate repaglinide. Clin Pharmacol Ther 79:231\u2013242", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR663", "doi-asserted-by": "crossref", "first-page": "1546", "DOI": "10.1124/dmd.111.039065", "volume": "39", "author": "BM VandenBrink", "year": "2011", "unstructured": "VandenBrink BM, Foti RS, Rock DA, Wienkers LC, Wahlstrom JL (2011) Evaluation of CYP2C8 inhibition in vitro: utility of montelukast as a selective CYP2C8 probe substrate. Drug Metab Dispos 39:1546\u20131554", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR664", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1111/j.1365-2125.2011.04086.x", "volume": "73", "author": "T Karonen", "year": "2012", "unstructured": "Karonen T, Neuvonen PJ, Backman JT (2012) CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukast. Br J Clin Pharmacol 73:257\u2013267", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR665", "doi-asserted-by": "crossref", "first-page": "473", "DOI": "10.1124/dmd.32.5.473", "volume": "32", "author": "B Ma", "year": "2004", "unstructured": "Ma B, Subramanian R, Schrag ML, Rodrigues AD, Tang C (2004) Cytochrome P450 2C8 (CYP2C8)-mediated hydroxylation of an endothelin ETA receptor antagonistin human liver microsomes. Drug Metab Dispos 32:473\u2013478", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR666", "doi-asserted-by": "crossref", "first-page": "50", "DOI": "10.1124/dmd.112.048017", "volume": "41", "author": "AM Filppula", "year": "2013", "unstructured": "Filppula AM, Neuvonen M, Laitila J, Neuvonen PJ, Backman JT (2013) Autoinhibition of CYP3A4 leads to important role of CYP2C8 in imatinib metabolism: variability in CYP2C8 activity may alter plasma concentrations and response. Drug Metab Dispos 41:50\u201359", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR667", "doi-asserted-by": "crossref", "first-page": "42223", "DOI": "10.1074/jbc.M112.404475", "volume": "287", "author": "JA Shimshoni", "year": "2012", "unstructured": "Shimshoni JA, Roberts AG, Scian M, Topletz AR, Blankert SA, Halpert JR, Nelson WL, Isoherranen N (2012) Stereoselective formation and metabolism of 4-hydroxy-retinoic acid enantiomers by cytochrome P450 enzymes. J Biol Chem 287:42223\u201342232", "journal-title": "J Biol Chem"}, {"key": "9_CR668", "doi-asserted-by": "crossref", "first-page": "681", "DOI": "10.1016/j.bcp.2011.06.027", "volume": "82", "author": "R Kaspera", "year": "2011", "unstructured": "Kaspera R, Naraharisetti SB, Evangelista EA, Marciante KD, Psaty BM, Totah RA (2011) Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b 5. Biochem Pharmacol 82:681\u2013691", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR669", "doi-asserted-by": "crossref", "first-page": "9497", "DOI": "10.1074/jbc.M312516200", "volume": "279", "author": "GA Schoch", "year": "2004", "unstructured": "Schoch GA, Yano JK, Wester MR, Griffin KJ, Stout CD, Johnson EF (2004) Structure of human microsomal cytochrome P450 2C8: evidence for a peripheral fatty acid binding site. J Biol Chem 279:9497\u20139503", "journal-title": "J Biol Chem"}, {"key": "9_CR670", "doi-asserted-by": "crossref", "first-page": "282", "DOI": "10.1016/j.jsb.2010.09.026", "volume": "173", "author": "A Zawaira", "year": "2011", "unstructured": "Zawaira A, Coulson L, Gallotta M, Karimanzira O, Blackburn J (2011) On the deduction and analysis of singlet and two-state gating-models from the static structures of mammalian CYP450. J Struct Biol 173:282\u2013293", "journal-title": "J Struct Biol"}, {"key": "9_CR671", "doi-asserted-by": "crossref", "first-page": "3622", "DOI": "10.1021/jm010861y", "volume": "44", "author": "NT Ha-Duong", "year": "2001", "unstructured": "Ha-Duong NT, Dijols S, Marques-Soares C, Minoletti C, Dansette PM, Mansuy D (2001) Synthesis of sulfaphenazole derivatives and their use as inhibitors and tools for comparing the active sites of human liver cytochromes P450 of the 2C subfamily. J Med Chem 44:3622\u20133631", "journal-title": "J Med Chem"}, {"key": "9_CR672", "doi-asserted-by": "crossref", "first-page": "189", "DOI": "10.1006/abbi.2001.2511", "volume": "394", "author": "NT Ha-Duong", "year": "2001", "unstructured": "Ha-Duong NT, Marques-Soares C, Dijols S, Sari MA, Dansette PM, Mansuy D (2001) Interaction of new sulfaphenazole derivatives with human liver cytochrome P4502Cs: structural determinants required for selective recognition by CYP2C9 and for inhibition of human CYP2Cs. Arch Biochem Biophys 394:189\u2013200", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR673", "doi-asserted-by": "crossref", "first-page": "68", "DOI": "10.1177/0091270004270642", "volume": "45", "author": "RL Walsky", "year": "2005", "unstructured": "Walsky RL, Gaman EA, Obach RS (2005) Examination of 209 drugs for inhibition of cytochrome P450 2C8. J Clin Pharmacol 45:68\u201378", "journal-title": "J Clin Pharmacol"}, {"key": "9_CR674", "doi-asserted-by": "crossref", "first-page": "413", "DOI": "10.1124/dmd.104.002766", "volume": "33", "author": "RL Walsky", "year": "2005", "unstructured": "Walsky RL, Obach RS, Gaman EA, Gleeson JP, Proctor WR (2005) Selective inhibition of human cytochrome P4502C8 by montelukast. Drug Metab Dispos 33:413\u2013418", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR675", "doi-asserted-by": "crossref", "first-page": "462", "DOI": "10.2133/dmpk.DMPK-13-RG-019", "volume": "28", "author": "MJ Kim", "year": "2013", "unstructured": "Kim MJ, Lee JW, Oh KS, Choi CS, Kim KH, Han WS, Yoon CN, Chung ES, Kim DH, Shin JG (2013) The tyrosine kinase inhibitor nilotinib selectively inhibits CYP2C8 activities in human liver microsomes. Drug Metab Pharmacokinet 28:462\u2013467", "journal-title": "Drug Metab Pharmacokinet"}, {"key": "9_CR676", "doi-asserted-by": "crossref", "first-page": "1298", "DOI": "10.1021/tx900105n", "volume": "22", "author": "BR Baer", "year": "2009", "unstructured": "Baer BR, DeLisle RK, Allen A (2009) Benzylic oxidation of gemfibrozil-1-O-\u03b2-glucuronide by P450 2C8 leads to heme alkylation and irreversible inhibition. Chem Res Toxicol 22:1298\u20131309", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR677", "doi-asserted-by": "crossref", "first-page": "846", "DOI": "10.1038/clpt.2011.313", "volume": "91", "author": "J Honkalammi", "year": "2012", "unstructured": "Honkalammi J, Niemi M, Neuvonen PJ, Backman JT (2012) Gemfibrozil is a strong inactivator of CYP2C8 in very small multiple doses. Clin Pharmacol Ther 91:846\u2013855", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR678", "doi-asserted-by": "crossref", "first-page": "383", "DOI": "10.1038/clpt.2013.92", "volume": "94", "author": "AM Filppula", "year": "2013", "unstructured": "Filppula AM, Tornio A, Niemi M, Neuvonen PJ, Backman JT (2013) Gemfibrozil impairs imatinib absorption and inhibits the CYP2C8-mediated formation of its main metabolite. Clin Pharmacol Ther 94:383\u2013393", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR679", "doi-asserted-by": "crossref", "first-page": "1454", "DOI": "10.2174/1568026611313120007", "volume": "13", "author": "C Chen", "year": "2013", "unstructured": "Chen C, Wang DW (2013) CYP epoxygenase derived EETs: from cardiovascular protection to human cancer therapy. Curr Topics Med Chem 13:1454\u20131469", "journal-title": "Curr Topics Med Chem"}, {"key": "9_CR680", "doi-asserted-by": "crossref", "first-page": "1352", "DOI": "10.1124/dmd.30.12.1352", "volume": "30", "author": "JS Wang", "year": "2002", "unstructured": "Wang JS, Neuvonen M, Wen X, Backman JT, Neuvonen PJ (2002) Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomes. Drug Metab Dispos 30:1352\u20131356", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR681", "doi-asserted-by": "crossref", "first-page": "582", "DOI": "10.1007/s10038-004-0188-6", "volume": "49", "author": "C Ishikawa", "year": "2004", "unstructured": "Ishikawa C, Ozaki H, Nakajima T, Ishii T, Kanai S, Anjo S, Shirai K, Inoue I (2004) A frameshift variant of CYP2C8 was identified in a patient who suffered from rhabdomyolysis after administration of cerivastatin. J Hum Genet 49:582\u2013585", "journal-title": "J Hum Genet"}, {"key": "9_CR682", "doi-asserted-by": "crossref", "first-page": "619", "DOI": "10.1097/FPC.0b013e32833ecace", "volume": "20", "author": "R Kaspera", "year": "2010", "unstructured": "Kaspera R, Naraharisetti SB, Tamraz B, Sahele T, Cheesman MJ, Kwok PY, Marciante K, Heckbert SR, Psaty BM, Totah RA (2010) Cerivastatin in vitro metabolism by CYP2C8 variants found in patients experiencing rhabdomyolysis. Pharmacogenet Genomics 20:619\u2013629", "journal-title": "Pharmacogenet Genomics"}, {"key": "9_CR683", "doi-asserted-by": "crossref", "first-page": "280", "DOI": "10.1097/FPC.0b013e328343dd7d", "volume": "21", "author": "KD Marciante", "year": "2011", "unstructured": "Marciante KD, Durda JP, Heckbert SR, Lumley T, Rice K, McKnight B, Totah RA, Tamraz B, Kroetz DL, Fukushima H, Kaspera R, Bis JC, Glazer NL, Li G, Austin TR, Taylor KD, Rotter JI, Jaquish CE, Kwok PY, Tracy RP, Psaty BM (2011) Cerivastatin, genetic variants, and the risk of rhabdomyolysis. Pharmacogenet Genomics 21:280\u2013288", "journal-title": "Pharmacogenet Genomics"}, {"key": "9_CR684", "doi-asserted-by": "crossref", "first-page": "197", "DOI": "10.1038/sj.clpt.6100122", "volume": "82", "author": "S Parikh", "year": "2007", "unstructured": "Parikh S, Ouedraogo JB, Goldstein JA, Rosenthal PJ, Kroetz DL (2007) Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa. Clin Pharmacol Ther 82:197\u2013203", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR685", "doi-asserted-by": "crossref", "first-page": "401", "DOI": "10.1007/s10549-012-2054-0", "volume": "134", "author": "DL Hertz", "year": "2012", "unstructured": "Hertz DL, Motsinger-Reif AA, Drobish A, Winham SJ, McLeod HL, Carey LA, Dees EC (2012) CYP2C8*3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxel. Breast Cancer Res Treat 134:401\u2013410", "journal-title": "Breast Cancer Res Treat"}, {"key": "9_CR686", "doi-asserted-by": "crossref", "first-page": "1000", "DOI": "10.1002/phar.1292", "volume": "33", "author": "CL Aquilante", "year": "2013", "unstructured": "Aquilante CL, Wempe MF, Spencer SH, Kosmiski LA, Predhomme JA, Sidhom MS (2013) Influence of CYP2C8*2 on the pharmacokinetics of pioglitazone in healthy African-American volunteers. Pharmacotherapy 33:1000\u20131007", "journal-title": "Pharmacotherapy"}, {"key": "9_CR687", "doi-asserted-by": "crossref", "first-page": "1261", "DOI": "10.1002/jcph.169", "volume": "53", "author": "R Prieto-Perez", "year": "2013", "unstructured": "Prieto-Perez R, Ochoa D, Cabaleiro T, Roman M, Sanchez-Rojas SD, Talegon M, Abad-Santos F (2013) Evaluation of the relationship between polymorphisms in CYP2C8 and CYP2C9 and the pharmacokinetics of celecoxib. J Clin Pharmacol 53:1261\u20131267", "journal-title": "J Clin Pharmacol"}, {"key": "9_CR688", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1007/BF00614021", "volume": "9", "author": "W Zilly", "year": "1975", "unstructured": "Zilly W, Breimer DD, Richter E (1975) Induction of drug metabolismin man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance. Eur J Clin Pharmacol 9:219\u2013227", "journal-title": "Eur J Clin Pharmacol"}, {"key": "9_CR689", "doi-asserted-by": "crossref", "first-page": "1094", "DOI": "10.1021/bi00378a016", "volume": "26", "author": "DR Umbenhauer", "year": "1987", "unstructured": "Umbenhauer DR, Martin MV, Lloyd RS, Guengerich FP (1987) Cloning and sequence determination of a complementary DNA related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylase. Biochemistry 26:1094\u20131099", "journal-title": "Biochemistry"}, {"key": "9_CR690", "first-page": "845", "volume": "245", "author": "RG Knodell", "year": "1988", "unstructured": "Knodell RG, Dubey RK, Wilkinson GR, Guengerich FP (1988) Oxidative metabolism of hexobarbital in human liver: relationship to polymorphic S-mephenytoin 4-hydroxylation. J Pharmacol Exp Ther 245:845\u2013849", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR691", "first-page": "443", "volume": "35", "author": "T Yasumori", "year": "1989", "unstructured": "Yasumori T, Murayama N, Yamazoe Y, Abe A, Nogi Y, Fukasawa T, Kato R (1989) Expression of a human P-450IIC gene in yeast cells using galactose-inducible expression system. Mol Pharmacol 35:443\u2013449", "journal-title": "Mol Pharmacol"}, {"key": "9_CR692", "first-page": "69", "volume": "40", "author": "PK Srivastava", "year": "1991", "unstructured": "Srivastava PK, Yun CH, Beaune PH, Ged C, Guengerich FP (1991) Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4\u2032-hydroxylase cytochrome P-450 enzymes. Mol Pharmacol 40:69\u201379", "journal-title": "Mol Pharmacol"}, {"key": "9_CR693", "doi-asserted-by": "crossref", "first-page": "441", "DOI": "10.1097/00008571-199712000-00002", "volume": "7", "author": "JM Treluyer", "year": "1997", "unstructured": "Treluyer JM, Gueret G, Cheron G, Sonnier M, Cresteil T (1997) Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in-vivo/in-vitro correlation and inducibility. Pharmacogenetics 7:441\u2013452", "journal-title": "Pharmacogenetics"}, {"key": "9_CR694", "doi-asserted-by": "crossref", "first-page": "965", "DOI": "10.1124/jpet.103.060137", "volume": "308", "author": "SB Koukouritaki", "year": "2004", "unstructured": "Koukouritaki SB, Manro JR, Marsh SA, Stevens JC, Rettie AE, McCarver DG, Hines RN (2004) Developmental expression of human hepatic CYP2C9 and CYP2C19. J Pharmacol Exp Ther 308:965\u2013974", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR695", "doi-asserted-by": "crossref", "first-page": "283", "DOI": "10.2165/00003088-200342030-00003", "volume": "42", "author": "SS Brenner", "year": "2003", "unstructured": "Brenner SS, Herrlinger C, Dilger K, Murdter TE, Hofmann U, Marx C, Klotz U (2003) Influence of age and cytochrome P450 2C9 genotype on the steady-state disposition of diclofenac and celecoxib. Clin Pharmacokinet 42:283\u2013292", "journal-title": "Clin Pharmacokinet"}, {"key": "9_CR696", "first-page": "347", "volume": "29", "author": "RS Obach", "year": "2001", "unstructured": "Obach RS, Zhang QY, Dunbar D, Kaminsky LS (2001) Metabolic characterization of the major human small intestinal cytochrome p450s. Drug Metab Dispos 29:347\u2013352", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR697", "doi-asserted-by": "crossref", "first-page": "437", "DOI": "10.1111/j.1432-1033.1990.tb19140.x", "volume": "191", "author": "F Morel", "year": "1990", "unstructured": "Morel F, Beaune PH, Ratanasavanh D, Flinois JP, Yang CS, Guengerich FP, Guillouzo A (1990) Expression of cytochrome P-450 enzymes in cultured human hepatocytes. Eur J Biochem 191:437\u2013444", "journal-title": "Eur J Biochem"}, {"key": "9_CR698", "doi-asserted-by": "crossref", "first-page": "475", "DOI": "10.1124/jpet.102.033837", "volume": "302", "author": "JL Raucy", "year": "2002", "unstructured": "Raucy JL, Mueller L, Duan K, Allen SW, Strom S, Lasker JM (2002) Expression and induction of CYP2C P450 enzymes in primary cultures of human hepatocytes. J Pharmacol Exp Ther 302:475\u2013482", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR699", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1074/jbc.M107228200", "volume": "277", "author": "S Gerbal-Chaloin", "year": "2002", "unstructured": "Gerbal-Chaloin S, Daujat M, Pascussi JM, Pichard-Garcia L, Vilarem MJ, Maurel P (2002) Transcriptional regulation of CYP2C9 gene. Role of glucocorticoid receptor and constitutive androstane receptor. J Biol Chem 277:209\u2013217", "journal-title": "J Biol Chem"}, {"key": "9_CR700", "doi-asserted-by": "crossref", "first-page": "737", "DOI": "10.1124/mol.62.3.737", "volume": "62", "author": "SS Ferguson", "year": "2002", "unstructured": "Ferguson SS, LeCluyse EL, Negishi M, Goldstein JA (2002) Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site. Mol Pharmacol 62:737\u2013746", "journal-title": "Mol Pharmacol"}, {"key": "9_CR701", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1016/S0304-4165(02)00483-X", "volume": "1619", "author": "JM Pascussi", "year": "2003", "unstructured": "Pascussi JM, Gerbal-Chaloin S, Drocourt L, Maurel P, Vilarem MJ (2003) The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim Biophys Acta 1619:243\u2013253", "journal-title": "Biochim Biophys Acta"}, {"key": "9_CR702", "doi-asserted-by": "crossref", "first-page": "8028", "DOI": "10.1021/bi00025a008", "volume": "34", "author": "GC Ibeanu", "year": "1995", "unstructured": "Ibeanu GC, Goldstein JA (1995) Transcriptional regulation of human CYP2C genes: functional comparison of CYP2C9 and CYP2C18 promoter regions. Biochemistry 34:8028\u20138036", "journal-title": "Biochemistry"}, {"key": "9_CR703", "first-page": "277", "volume": "20", "author": "D Van Booven", "year": "2010", "unstructured": "Van Booven D, Marsh S, McLeod H, Carrillo MW, Sangkuhl K, Klein TE, Altman RB (2010) Cytochrome P450 2C9-CYP2C9. Pharmacogenet Genomics 20:277\u2013281", "journal-title": "Pharmacogenet Genomics"}, {"key": "9_CR704", "doi-asserted-by": "crossref", "first-page": "1125", "DOI": "10.1124/jpet.105.087072", "volume": "314", "author": "Y Chen", "year": "2005", "unstructured": "Chen Y, Kissling G, Negishi M, Goldstein JA (2005) The nuclear receptors constitutive androstane receptor and pregnane X receptor cross-talk with hepatic nuclear factor 4\u03b1 to synergistically activate the human CYP2C9 promoter. J Pharmacol Exp Ther 314:1125\u20131133", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR705", "doi-asserted-by": "crossref", "first-page": "415", "DOI": "10.1124/dmd.109.029405", "volume": "38", "author": "J Mwinyi", "year": "2010", "unstructured": "Mwinyi J, Nekvindova J, Cavaco I, Hofmann Y, Pedersen RS, Landman E, Mkrtchian S, Ingelman-Sundberg M (2010) New insights into the regulation of CYP2C9 gene expression: the role of the transcription factor GATA-4. Drug Metab Dispos 38:415\u2013421", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR706", "doi-asserted-by": "crossref", "first-page": "302", "DOI": "10.1124/jpet.110.175075", "volume": "338", "author": "J Mwinyi", "year": "2011", "unstructured": "Mwinyi J, Cavaco I, Yurdakok B, Mkrtchian S, Ingelman-Sundberg M (2011) The ligands of estrogenreceptor \u03b1 regulate cytochrome P4502C9 (CYP2C9) expression. J Pharmacol Exp Ther 338:302\u2013309", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR707", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.2337/diab.28.1.41", "volume": "28", "author": "J Scott", "year": "1978", "unstructured": "Scott J, Poffenbarger PL (1978) Pharmacogenetics of tolbutamide metabolism in humans. Diabetes 28:41\u201351", "journal-title": "Diabetes"}, {"key": "9_CR708", "doi-asserted-by": "crossref", "first-page": "599", "DOI": "10.1124/jpet.109.161026", "volume": "332", "author": "AS Chaudhry", "year": "2010", "unstructured": "Chaudhry AS, Urban TJ, Lamba JK, Birnbaum AK, Remmel RP, Subramanian M, Strom S, You JH, Kasperaviciute D, Catarino CB, Radtke RA, Sisodiya SM, Goldstein DB, Schuetz EG (2010) CYP2C9*1B promoter polymorphisms, in linkage with CYP2C19*2, affect phenytoin autoinduction of clearance and maintenance dose. J Pharmacol Exp Ther 332:599\u2013611", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR709", "first-page": "1073", "volume": "27", "author": "S Ohgiya", "year": "1992", "unstructured": "Ohgiya S, Komori M, Ohi H, Shiramatsu K, Shinriki N, Kamataki T (1992) Six-base deletion occurring in messages of human cytochrome P-450 in the CYP2C subfamily results in reduction of tolbutamide hydroxylase activity. Biochem Int 27:1073\u20131081", "journal-title": "Biochem Int"}, {"key": "9_CR710", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1097/00008571-199412000-00001", "volume": "4", "author": "JA Goldstein", "year": "1994", "unstructured": "Goldstein JA, Demorais SMF (1994) Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics 4:285\u2013299", "journal-title": "Pharmacogenetics"}, {"key": "9_CR711", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1097/00008571-199704000-00003", "volume": "7", "author": "K Inoue", "year": "1997", "unstructured": "Inoue K, Yamazaki H, Imiya K, Akasaka S, Guengerich FP, Shimada T (1997) Relationship between CYP2C9 and 2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4-hydroxylation activities in livers of Japanese and Caucasian populations. Pharmacogenetics 7:103\u2013113", "journal-title": "Pharmacogenetics"}, {"key": "9_CR712", "doi-asserted-by": "crossref", "first-page": "382", "DOI": "10.1124/mol.60.2.382", "volume": "60", "author": "LJ Dickmann", "year": "2001", "unstructured": "Dickmann LJ, Rettie AE, Kneller MB, Kim RB, Wood AJ, Stein CM, Wilkinson GR, Schwarz UI (2001) Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans. Mol Pharmacol 60:382\u2013387", "journal-title": "Mol Pharmacol"}, {"key": "9_CR713", "doi-asserted-by": "crossref", "first-page": "175", "DOI": "10.1067/mcp.2001.117367", "volume": "70", "author": "M Shintani", "year": "2001", "unstructured": "Shintani M, Ieiri I, Inoue K, Mamiya K, Ninomiya H, Tashiro N, Higuchi S, Otsubo K (2001) Genetic polymorphisms and functional characterization of the 5\u2032-flanking region of the human CYP2C9 gene: in vitro and in vivo studies. Clin Pharmacol Ther 70:175\u2013182", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR714", "doi-asserted-by": "crossref", "first-page": "1841", "DOI": "10.1093/oxfordjournals.molbev.a003726", "volume": "18", "author": "SC Warner", "year": "2001", "unstructured": "Warner SC, Finta C, Zaphiropoulos PG (2001) Intergenic transcripts containing a novel human cytochrome P450 2C exon 1 spliced to sequences from the CYP2C9 gene. Mol Biol Evol 18:1841\u20131848", "journal-title": "Mol Biol Evol"}, {"key": "9_CR715", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1016/S0006-291X(02)02592-5", "volume": "299", "author": "U Yasar", "year": "2002", "unstructured": "Yasar U, Lundgren S, Eliasson E, Bennet A, Wiman B, de Faire U, Rane A (2002) Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms. Biochem Biophys Res Commun 299:25\u201328", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR716", "doi-asserted-by": "crossref", "first-page": "270", "DOI": "10.3109/00498254.2013.820007", "volume": "44", "author": "YH Wang", "year": "2013", "unstructured": "Wang YH, Pan PP, Dai DP, Wang SH, Geng PW, Cai JP, Hu GX (2013) Effect of 36 CYP2C9 variants found in the Chinese population on losartan metabolism in vitro. Xenobiotica 44:270\u2013275", "journal-title": "Xenobiotica"}, {"key": "9_CR717", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1038/tpj.2013.22", "volume": "14", "author": "Y Niinuma", "year": "2014", "unstructured": "Niinuma Y, Saito T, Takahashi M, Tsukada C, Ito M, Hirasawa N, Hiratsuka M (2014) Functional characterization of 32 CYP2C9 allelic variants. Pharmacogenomics J 14:107\u2013114", "journal-title": "Pharmacogenomics J"}, {"key": "9_CR718", "doi-asserted-by": "crossref", "first-page": "1895", "DOI": "10.1124/dmd.109.027003", "volume": "37", "author": "K Maekawa", "year": "2009", "unstructured": "Maekawa K, Harakawa N, Sugiyama E, Tohkin M, Kim SR, Kaniwa N, Katori N, Hasegawa R, Yasuda K, Kamide K, Miyata T, Saito Y, Sawada J (2009) Substrate-dependent functional alterations of seven CYP2C9 variants found in Japanese subjects. Drug Metab Dispos 37:1895\u20131903", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR719", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.2133/dmpk.22.187", "volume": "22", "author": "N Ariyoshi", "year": "2007", "unstructured": "Ariyoshi N, Shimizu Y, Kobayashi Y, Nakamura H, Nakasa H, Nakazawa K, Ishii I, Kitada M (2007) Identification and partial characterization of a novel CYP2C9 splicing variant encoding a protein lacking eight amino acid residues. Drug Metab Pharmacokinet 22:187\u2013194", "journal-title": "Drug Metab Pharmacokinet"}, {"key": "9_CR720", "doi-asserted-by": "crossref", "first-page": "1280", "DOI": "10.1124/mol.107.036178", "volume": "72", "author": "L Wei", "year": "2007", "unstructured": "Wei L, Locuson CW, Tracy TS (2007) Polymorphic variants of CYP2C9: mechanisms involved in reduced catalytic activity. Mol Pharmacol 72:1280\u20131288", "journal-title": "Mol Pharmacol"}, {"key": "9_CR721", "unstructured": "Gangadhariah MH, Guengerich FP, Pozzi A (2015) Arachidonic acid metabolism by major variants of human cytochrome P450 2C9. J Biol Chem 289 (in preparation)"}, {"key": "9_CR722", "doi-asserted-by": "crossref", "first-page": "525", "DOI": "10.1046/j.1365-2125.1998.00721.x", "volume": "45", "author": "JO Miners", "year": "1998", "unstructured": "Miners JO, Birkett DJ (1998) Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. Br J Clin Pharmacol 45:525\u2013538", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR723", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1007/s002280100268", "volume": "57", "author": "GM Giancarlo", "year": "2001", "unstructured": "Giancarlo GM, Venkatakrishnan K, Granda BW, von Moltke LL, Greenblatt DJ (2001) Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidine. Eur J Clin Pharmacol 57:31\u201336", "journal-title": "Eur J Clin Pharmacol"}, {"key": "9_CR724", "doi-asserted-by": "crossref", "first-page": "199", "DOI": "10.1006/abbi.2000.1705", "volume": "376", "author": "AJ Draper", "year": "2000", "unstructured": "Draper AJ, Hammock BD (2000) Identification of CYP2C9 as a human liver microsomal linoleic acid epoxygenase. Arch Biochem Biophys 376:199\u2013205", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR725", "doi-asserted-by": "crossref", "first-page": "517", "DOI": "10.1016/S0006-2952(00)00356-7", "volume": "60", "author": "LC McSorley", "year": "2000", "unstructured": "McSorley LC, Daly AK (2000) Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylation. Biochem Pharmacol 60:517\u2013526", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR726", "doi-asserted-by": "crossref", "first-page": "3071", "DOI": "10.1021/ac900021a", "volume": "81", "author": "Z Tang", "year": "2009", "unstructured": "Tang Z, Martin MV, Guengerich FP (2009) Elucidation of functions of human cytochrome P450 enzymes: identification of endogenous substrates in tissue extracts using metabolomic and isotopic labeling approaches. Anal Chem 81:3071\u20133078", "journal-title": "Anal Chem"}, {"key": "9_CR727", "doi-asserted-by": "crossref", "first-page": "770", "DOI": "10.1096/fj.02-0640fje", "volume": "17", "author": "UR Michaelis", "year": "2003", "unstructured": "Michaelis UR, Fisslthaler B, Medhora M, Harder D, Fleming I, Busse R (2003) Cytochrome P450 2C9-derived epoxyeicosatrienoic acids induce angiogenesis via cross-talk with the epidermal growth factor receptor (EGFR). FASEB J 17:770\u2013772", "journal-title": "FASEB J"}, {"key": "9_CR728", "doi-asserted-by": "crossref", "first-page": "5223", "DOI": "10.1074/jbc.M112.407981", "volume": "288", "author": "N Pidkovka", "year": "2013", "unstructured": "Pidkovka N, Rao R, Mei S Gong Y, Harris RC, Wang WH, Capdevila JH (2013) Epoxyeicosatrienoic acids (EETs) regulate epithelial sodium channel activity by extracellular signal-regulated kinase 1/2 (ERK1/2)-mediated phosphorylation. J Biol Chem 288:5223\u20135231", "journal-title": "J Biol Chem"}, {"key": "9_CR729", "doi-asserted-by": "crossref", "first-page": "5069", "DOI": "10.1021/jm900634w", "volume": "52", "author": "JR Falck", "year": "2009", "unstructured": "Falck JR, Kodela R, Manne R, Atcha KR, Puli N, Dubasi N, Manthati VL, Capdevila JH, Yi XY, Goldman DH, Morisseau C Hammock BD, Campbell WB (2009) 14,15-Epoxyeicosa-5,8,11-trienoic acid (14,15-EET) surrogates containing epoxide bioisosteres: influence upon vascular relaxation and soluble epoxide hydrolase inhibition. J Med Chem 52:5069\u20135075", "journal-title": "J Med Chem"}, {"key": "9_CR730", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1097/MNH.0b013e32835d911e", "volume": "22", "author": "J Capdevila", "year": "2013", "unstructured": "Capdevila J, Wang W (2013) Role of cytochrome P450 epoxygenase in regulating renal membrane transport and hypertension. Curr Opin Nephrol Hypertens 22:163\u2013169", "journal-title": "Curr Opin Nephrol Hypertens"}, {"key": "9_CR731", "doi-asserted-by": "crossref", "first-page": "1680", "DOI": "10.1152/ajprenal.00409.2013", "volume": "305", "author": "M Zhang", "year": "2013", "unstructured": "Zhang M, Wang Y, Wei S, Capdevila JH, Harris RC (2013) Role of epoxyeicosatrienoic acids (EETs) in mediating dopamine effects in the kidney. Am J Physiol Renal Physiol 305:1680\u20131686", "journal-title": "Am J Physiol Renal Physiol"}, {"key": "9_CR732", "doi-asserted-by": "crossref", "first-page": "84", "DOI": "10.1177/0091270002239710", "volume": "43", "author": "CR Lee", "year": "2003", "unstructured": "Lee CR, Pieper JA, Frye RF, Hinderliter AL, Blaisdell JA, Goldstein JA (2003) Tolbutamide, flurbiprofen, and losartan as probes of CYP2C9 activity in humans. J Clin Pharmacol 43:84\u201391", "journal-title": "J Clin Pharmacol"}, {"key": "9_CR733", "doi-asserted-by": "crossref", "first-page": "423", "DOI": "10.1046/j.1365-2125.2002.01660.x", "volume": "54", "author": "M Sandberg", "year": "2002", "unstructured": "Sandberg M, Yasar U, Stromberg P, Hoog JO, Eliasson E (2002) Oxidation of celecoxib by polymorphic cytochrome P450 2C9 and alcohol dehydrogenase. Br J Clin Pharmacol 54:423\u2013429", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR734", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1097/00008571-200104000-00006", "volume": "11", "author": "C Tang", "year": "2001", "unstructured": "Tang C, Shou M, Rushmore TH, Mei Q, Sandhu P, Woolf EJ, Rose MJ, Gelmann A, Greenberg HE, De Lepeleire I, Van Hecken A, De Schepper PJ, Ebel DL, Schwartz JI, Rodrigues AD (2001) In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics. Pharmacogenetics 11:223\u2013235", "journal-title": "Pharmacogenetics"}, {"key": "9_CR735", "first-page": "567", "volume": "28", "author": "CY Tang", "year": "2000", "unstructured": "Tang CY, Shou MG, Rodrigues AD (2000) Substrate-dependent effect of acetonitrile on human liver microsomal cytochrome P4502C9 (CYP2C9) activity. Drug Metab Dispos 28:567\u2013572", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR736", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1006/prep.2001.1578", "volume": "24", "author": "H Yamazaki", "year": "2002", "unstructured": "Yamazaki H, Nakamura M, Komatsu T, Ohyama K, Hatanaka N, Asahi S, Shimada N, Guengerich FP, Shimada T, Nakajima M, Yokoi T (2002) Roles of NADPH-P450 reductase and apo- and holo-cytochrome b 5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli. Protein Expr Purif 24:329\u2013337", "journal-title": "Protein Expr Purif"}, {"key": "9_CR737", "doi-asserted-by": "crossref", "first-page": "12852", "DOI": "10.1021/bi980674a", "volume": "37", "author": "WL Backes", "year": "1998", "unstructured": "Backes WL, Batie CJ, Cawley GF (1998) Interactions among P450 enzymes when combined in reconstituted systems: formation of a 2B4\u20131A2 complex with a high affinity for NADPH-cytochrome P450 reductase. Biochemistry 37:12852\u201312859", "journal-title": "Biochemistry"}, {"key": "9_CR738", "doi-asserted-by": "crossref", "first-page": "1194", "DOI": "10.1124/dmd.30.11.1194", "volume": "30", "author": "JM Hutzler", "year": "2002", "unstructured": "Hutzler JM, Kolwankar D, Hummel MA, Tracy TS (2002) Activation of CYP2C9-mediated metabolism by a series of dapsone analogs: kinetics and structural requirements. Drug Metab Dispos 30:1194\u20131200", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR739", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.1016/S0003-9861(02)00665-3", "volume": "410", "author": "JM Hutzler", "year": "2003", "unstructured": "Hutzler JM, Wienkers LC, Wahlstrom JL, Carlson TJ, Tracy TS (2003) Activation of cytochrome P450 2C9-mediated metabolism: mechanistic evidence in support of kinetic observations. Arch Biochem Biophys 410:16\u201324", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR740", "doi-asserted-by": "crossref", "first-page": "370", "DOI": "10.1021/bi962359z", "volume": "36", "author": "Y-F Ueng", "year": "1997", "unstructured": "Ueng Y-F, Kuwabara T, Chun YJ, Guengerich FP (1997) Cooperativity in oxidations catalyzed by cytochrome P450 3A4. Biochemistry 36:370\u2013381", "journal-title": "Biochemistry"}, {"key": "9_CR741", "doi-asserted-by": "crossref", "first-page": "667", "DOI": "10.2174/092986711794480131", "volume": "18", "author": "SM He", "year": "2011", "unstructured": "He SM, Zhou ZW, Li XT, Zhou SF (2011) Clinical drugs undergoing polymorphic metabolism by human cytochrome P450 2C9 and the implication in drug development. Curr Med Chem 18:667\u2013713", "journal-title": "Curr Med Chem"}, {"key": "9_CR742", "doi-asserted-by": "crossref", "first-page": "647", "DOI": "10.1124/dmd.32.6.647", "volume": "32", "author": "RL Walsky", "year": "2004", "unstructured": "Walsky RL, Obach RS (2004) Validated assays for human cytochrome P450 activities. Drug Metab Dispos 32:647\u2013660", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR743", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.1007/s00228-004-0754-z", "volume": "60", "author": "A Jetter", "year": "2004", "unstructured": "Jetter A, Kinzig-Schippers M, Skott A, Lazar A, Tomalik-Scharte D, Kirchheiner J, Walchner-Bonjean M, Hering U, Jakob V, Rodamer M, Jabrane W, Kasel D, Brockmoller J, Fuhr U, Sorgel F (2004) Cytochrome P450 2C9 phenotyping using low-dose tolbutamide. Eur J Clin Pharmacol 60:165\u2013171", "journal-title": "Eur J Clin Pharmacol"}, {"key": "9_CR744", "doi-asserted-by": "crossref", "first-page": "1209", "DOI": "10.1124/dmd.104.000182", "volume": "32", "author": "B Wang", "year": "2004", "unstructured": "Wang B, Sanchez RI, Franklin RB, Evans DC, Huskey SE (2004) The involvement of CYP3A4 and CYP2C9 in the metabolism of 17\u03b1-ethinylestradiol. Drug Metab Dispos 32:1209\u20131212", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR745", "doi-asserted-by": "crossref", "first-page": "734", "DOI": "10.1248/bpb.34.734", "volume": "34", "author": "K Matsumoto", "year": "2011", "unstructured": "Matsumoto K, Nemoto E, Hasegawa T, Akimoto M, Sugibayashi K (2011) In vitro characterization of the cytochrome P450 isoforms involved in the metabolism of 6-methoxy-2-napthylacetic acid, an active metabolite of the prodrug nabumetone. Biolog Pharm Bull 34:734\u2013739", "journal-title": "Biolog Pharm Bull"}, {"key": "9_CR746", "doi-asserted-by": "crossref", "first-page": "1245", "DOI": "10.1021/tx040001v", "volume": "17", "author": "SM Jeurissen", "year": "2004", "unstructured": "Jeurissen SM, Bogaards JJ, Awad HM, Boersma MG, Brand W, Fiamegos YC, van Beek TA, Alink GM, Sudholter EJ, Cnubben NH, Rietjens IM (2004) Human cytochrome P450 enzyme specificity for bioactivation of safrole to the proximate carcinogen 1\u2032-hydroxysafrole. Chem Res Toxicol 17:1245\u20131250", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR747", "doi-asserted-by": "crossref", "first-page": "895", "DOI": "10.1021/tx200519d", "volume": "25", "author": "PM Rademacher", "year": "2012", "unstructured": "Rademacher PM, Woods CM, Huang Q, Szklarz GD, Nelson SD (2012) Differential oxidation of two thiophene-containing regioisomers to reactive metabolites by cytochrome P450 2C9. Chem Res Toxicol 25:895\u2013903", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR748", "doi-asserted-by": "crossref", "first-page": "35630", "DOI": "10.1074/jbc.M405427200", "volume": "279", "author": "MR Wester", "year": "2004", "unstructured": "Wester MR, Yano JK, Schoch GA, Yang C, Griffin KJ, Stout CD, Johnson EF (2004) The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0-\u00c5 resolution. J Biol Chem 279:35630\u201335637", "journal-title": "J Biol Chem"}, {"key": "9_CR749", "doi-asserted-by": "crossref", "first-page": "44581", "DOI": "10.1074/jbc.M112.424895", "volume": "287", "author": "RL Reynald", "year": "2012", "unstructured": "Reynald RL, Sansen S, Stout CD, Johnson EF (2012) Structural caharacterization of human P450 2C19: active site differences between P450s 2C8, 2C9, and 2C19. J Biol Chem 287:44581\u201344591", "journal-title": "J Biol Chem"}, {"key": "9_CR750", "doi-asserted-by": "crossref", "first-page": "1992", "DOI": "10.1124/dmd.108.022186", "volume": "36", "author": "G Tai", "year": "2008", "unstructured": "Tai G, Dickmann LJ, Matovic N, DeVoss JJ, Gillam EM, Rettie AE (2008) Re-engineering of CYP2C9 to probe acid-base substrate selectivity. Drug Metab Dispos 36:1992\u20131997", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR751", "doi-asserted-by": "crossref", "first-page": "938", "DOI": "10.1124/jpet.109.150706", "volume": "329", "author": "CM Mosher", "year": "2009", "unstructured": "Mosher CM, Tai G, Rettie AE (2009) CYP2C9 amino acid residues influencing phenytoin turnover and metabolite regio- and stereochemistry. J Pharmacol Exp Ther 329:938\u2013944", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR752", "doi-asserted-by": "crossref", "first-page": "e1002152", "DOI": "10.1371/journal.pcbi.1002152", "volume": "7", "author": "V Cojocaru", "year": "2011", "unstructured": "Cojocaru V, Balali-Mood K, Sansom MS, Wade RC (2011) Structure and dynamics of the membrane-bound cytochrome P450 2C9. PLoS Computat Biol 7:e1002152", "journal-title": "PLoS Computat Biol"}, {"key": "9_CR753", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.2174/138920012798918462", "volume": "13", "author": "V Cojocaru", "year": "2012", "unstructured": "Cojocaru V, Winn PJ, Wade RC (2012) Multiple, ligand-dependent routes from the active site of cytochrome P450 2C9. Curr Drug Metab 13:143\u2013154", "journal-title": "Curr Drug Metab"}, {"key": "9_CR754", "doi-asserted-by": "crossref", "first-page": "780", "DOI": "10.1021/jm7009793", "volume": "51", "author": "MJ Sykes", "year": "2008", "unstructured": "Sykes MJ, McKinnon RA, Miners JO (2008) Prediction of metabolism by cytochrome P450 2C9: alignment and docking studies of a validated database of substrates. J Med Chem 51:780\u2013791", "journal-title": "J Med Chem"}, {"key": "9_CR755", "doi-asserted-by": "crossref", "first-page": "399", "DOI": "10.1007/s10822-010-9347-3", "volume": "24", "author": "A Tarcsay", "year": "2010", "unstructured": "Tarcsay A, Kiss R, Keseru GM (2010) Site of metabolism prediction on cytochrome P450 2C9: a knowledge-based docking approach. J Comput Aided Mol Des 24:399\u2013408", "journal-title": "J Comput Aided Mol Des"}, {"key": "9_CR756", "doi-asserted-by": "crossref", "first-page": "1328", "DOI": "10.1021/ci200558e", "volume": "52", "author": "MA Lardy", "year": "2012", "unstructured": "Lardy MA, Lebrun L, Bullard D, Kissinger C, Gobbi A (2012) Building a three-dimensional model of CYP2C9 inhibition using the autocorrelator: an autonomous model generator. J Chem Inf Model 52:1328\u20131336", "journal-title": "J Chem Inf Model"}, {"key": "9_CR757", "doi-asserted-by": "crossref", "first-page": "1202", "DOI": "10.1002/cmdc.201200160", "volume": "7", "author": "P Rydberg", "year": "2012", "unstructured": "Rydberg P, Olsen L (2012) Predicting drug metabolismby cytochrome P450 2C9: comparison with the 2D6 and 3A4 isoforms. ChemMedChem 7:1202\u20131209", "journal-title": "ChemMedChem"}, {"key": "9_CR758", "doi-asserted-by": "crossref", "first-page": "8001", "DOI": "10.1021/ja402016p", "volume": "135", "author": "R Lonsdale", "year": "2013", "unstructured": "Lonsdale R, Houghton KT, Zurek J, Bathelt CM, Foloppe N, de Groot MJ, Harvey JN, Mulholland AJ (2013) Quantum mechanics/molecular mechanics modeling of regioselectivity of drug metabolismin cytochrome P450 2C9. J Am Chem Soc 135:8001\u20138015", "journal-title": "J Am Chem Soc"}, {"key": "9_CR759", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.1097/00008571-200003000-00001", "volume": "10", "author": "K Takanashi", "year": "2000", "unstructured": "Takanashi K, Tainaka H, Kobayashi K, Yasumori T, Hosakawa M, Chiba K (2000) CYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates. Pharmacogenetics 10:95\u2013104", "journal-title": "Pharmacogenetics"}, {"key": "9_CR760", "doi-asserted-by": "crossref", "first-page": "729", "DOI": "10.1007/s00228-001-0376-7", "volume": "57", "author": "U Yasar", "year": "2001", "unstructured": "Yasar U, Eliasson E, Forslund-Bergengren C, Tybring G, Gadd M, Sjoqvist F, Dahl ML (2001) The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro. Eur J Clin Pharmacol 57:729\u2013735", "journal-title": "Eur J Clin Pharmacol"}, {"key": "9_CR761", "doi-asserted-by": "crossref", "first-page": "983", "DOI": "10.1006/bbrc.2000.2538", "volume": "270", "author": "M Ridderstrom", "year": "2000", "unstructured": "Ridderstrom M, Masimirembwa C, Trump-Kallmeyer S, Ahlefelt M, Otter C, Andersson TB (2000) Arginines 97 and 108 in CYP2C9 are important determinants of the catalytic function. Biochem Biophys Res Commun 270:983\u2013987", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR762", "doi-asserted-by": "crossref", "first-page": "921", "DOI": "10.1042/bj20021841", "volume": "370", "author": "JU Flanagan", "year": "2003", "unstructured": "Flanagan JU, McLaughlin LA, Paine MJ, Sutcliffe MJ, Roberts GC, Wolf CR (2003) Role of conserved Asp293 of cytochrome P450 2C9in substrate recognition and catalytic activity. Biochem J 370:921\u2013926", "journal-title": "Biochem J"}, {"key": "9_CR763", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.1006/abbi.1999.1468", "volume": "372", "author": "M He", "year": "1999", "unstructured": "He M, Korzekwa KR, Jones JP, Rettie AE, Trager WF (1999) Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9. Arch Biochem Biophys 372:16\u201328", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR764", "doi-asserted-by": "crossref", "first-page": "16205", "DOI": "10.1021/bi961950t", "volume": "35", "author": "A Mancy", "year": "1996", "unstructured": "Mancy A, Dijols S, Poli S, Guengerich P, Mansuy D (1996) Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9. Biochemistry 35:16205\u201316212", "journal-title": "Biochemistry"}, {"key": "9_CR765", "doi-asserted-by": "crossref", "first-page": "10365", "DOI": "10.1021/bi00033a007", "volume": "34", "author": "A Mancy", "year": "1995", "unstructured": "Mancy A, Broto P, Dijols S, Dansette PM, Mansuy D (1995) The substrate binding site of human liver cytochrome P450 2C9: an approach using designed tienilic acidderivatives and molecular modeling. Biochemistry 34:10365\u201310375", "journal-title": "Biochemistry"}, {"key": "9_CR766", "doi-asserted-by": "crossref", "first-page": "16270", "DOI": "10.1021/bi981704c", "volume": "37", "author": "F Jung", "year": "1998", "unstructured": "Jung F, Griffin KJ, Richardson TH, Yang M, Johnson EF (1998) Identification of amino acid substitutions that confer a high affinity for sulphaphenazole binding and a high catalytic efficiency for warfarin metabolism to P450 2C19. Biochemistry 37:16270\u201316279", "journal-title": "Biochemistry"}, {"key": "9_CR767", "doi-asserted-by": "crossref", "first-page": "80", "DOI": "10.1016/S0003-9861(02)00548-9", "volume": "409", "author": "A Melet", "year": "2003", "unstructured": "Melet A, Assrir N, Jean P, Pilar Lopez-Garcia M, Marques-Soares C, Jaouen M, Dansette PM, Sari MA, Mansuy D (2003) Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid. Arch Biochem Biophys 409:80\u201391", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR768", "doi-asserted-by": "crossref", "first-page": "403", "DOI": "10.1038/clpt.1990.46", "volume": "47", "author": "ME Veronese", "year": "1990", "unstructured": "Veronese ME, Miners JO, Randles D, Gregov D, Birkett DJ (1990) Validation of the tolbutamide metabolic ratio for population screening with use of sulfaphenazole to produce model phenotypic poor metabolizers. Clin Pharmacol Ther 47:403\u2013411", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR769", "doi-asserted-by": "crossref", "first-page": "6370", "DOI": "10.1021/bi0273922", "volume": "42", "author": "MR Wester", "year": "2003", "unstructured": "Wester MR, Johnson EF, Marques-Soares C, Dansette P, Mansuy D, Stout CD (2003) Structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3\u00a0\u00c5 resolution: evidence for multiple substrate binding modes. Biochemistry 42:6370\u20136379", "journal-title": "Biochemistry"}, {"key": "9_CR770", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.1124/dmd.30.6.631", "volume": "30", "author": "X Wen", "year": "2002", "unstructured": "Wen X, Wang JS, Backman JT, Laitila J, Neuvonen PJ (2002) Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively. Drug Metab Dispos 30:631\u2013635", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR771", "doi-asserted-by": "crossref", "first-page": "547", "DOI": "10.1046/j.0306-5251.2001.01474.x", "volume": "52", "author": "X Wen", "year": "2001", "unstructured": "Wen X, Wang JS, Kivisto KT, Neuvonen PJ, Backman JT (2001) In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9). Br J Clin Pharmacol 52:547\u2013553", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR772", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.1016/S0049-3848(97)00270-3", "volume": "88", "author": "ZY Zhang", "year": "1997", "unstructured": "Zhang ZY, Kerr J, Wexler RS, Li HY, Robinson AJ, Harlow PP, Kaminsky LS (1997) Warfarin analog inhibition of human CYP2C9-catalyzed S-warfarin 7-hydroxylation. Thromb Res 88:389\u2013398", "journal-title": "Thromb Res"}, {"key": "9_CR773", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1007/s00228-003-0603-5", "volume": "59", "author": "T Hanatani", "year": "2003", "unstructured": "Hanatani T, Fukuda T, Onishi S, Funae Y, Azuma J (2003) No major difference in inhibitory susceptibility between CYP2C9.1 and CYP2C9.3. Eur J Clin Pharmacol 59:233\u2013235", "journal-title": "Eur J Clin Pharmacol"}, {"key": "9_CR774", "doi-asserted-by": "crossref", "first-page": "551", "DOI": "10.1073/pnas.84.2.551", "volume": "84", "author": "P Beaune", "year": "1987", "unstructured": "Beaune P, Dansette PM, Mansuy D, Kiffel L, Finck M, Amar C, Leroux JP, Homberg JC (1987) Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc Natl Acad Sci U S A 84:551\u2013555", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR775", "doi-asserted-by": "crossref", "first-page": "1624", "DOI": "10.1016/S0006-291X(05)81594-3", "volume": "186", "author": "PM Dansette", "year": "1992", "unstructured": "Dansette PM, Thang DC, El Amri H, Mansuy D (1992) Evidence for thiophene-S-oxide as a primary reactive metabolite of thiophene in vivo: formation of a dihydrothiophene sulfoxide mercapturic acid. Biochem Biophys Res Commun 186:1624\u20131630", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR776", "doi-asserted-by": "crossref", "first-page": "199", "DOI": "10.1016/S1054-3589(08)60175-1", "volume": "30", "author": "P Beaune", "year": "1994", "unstructured": "Beaune P, Pessayre D, Dansette P, Mansuy D, Manns M (1994) Autoantibodies against cytochromes P450: role in human diseases. Adv Pharmacol 30:199\u2013245", "journal-title": "Adv Pharmacol"}, {"key": "9_CR777", "doi-asserted-by": "crossref", "first-page": "8000", "DOI": "10.1021/jm8011257", "volume": "51", "author": "CC Peng", "year": "2008", "unstructured": "Peng CC, Cape JL, Rushmore T, Crouch GJ, Jones JP (2008) Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues. J Med Chem 51:8000\u20138011", "journal-title": "J Med Chem"}, {"key": "9_CR778", "doi-asserted-by": "crossref", "first-page": "553", "DOI": "10.1016/0006-2952(91)90627-H", "volume": "41", "author": "PM Dansette", "year": "1991", "unstructured": "Dansette PM, Amar C, Valadon P, Pons C, Beaune PH, Mansuy D (1991) Hydroxylation and formation of electrophilic metabolites of tienilic acidand its isomer by human liver microsomes: catalysis by a cytochrome P450 IIC different from that responsible for mephenytoin hydroxylation. Biochem Pharmacol 41:553\u2013560", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR779", "doi-asserted-by": "crossref", "first-page": "59", "DOI": "10.1124/dmd.108.023358", "volume": "37", "author": "JM Hutzler", "year": "2009", "unstructured": "Hutzler JM, Balogh LM, Zientek M, Kumar V, Tracy TS (2009) Mechanism-based inactivation of cytochrome P450 2C9 by tienilic acidand (+/\u2212)-suprofen: a comparison of kinetics and probe substrate selection. Drug Metab Dispos 37:59\u201365", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR780", "doi-asserted-by": "crossref", "first-page": "939", "DOI": "10.1021/tx1000283", "volume": "23", "author": "DR Jones", "year": "2010", "unstructured": "Jones DR, Kim SY, Guderyon M, Yun CH, Moran JH, Miller GP (2010) Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin. Chem Res Toxicol 23:939\u2013945", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR781", "doi-asserted-by": "crossref", "first-page": "1690", "DOI": "10.1001/jama.287.13.1690", "volume": "287", "author": "MK Higashi", "year": "2002", "unstructured": "Higashi MK, Veenstra DL, Kondo LM, Wittkowsky AK, Srinouanprachanh SL, Farin FM, Rettie AE (2002) Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy. J Am Med Assoc 287:1690\u20131698", "journal-title": "J Am Med Assoc"}, {"key": "9_CR782", "doi-asserted-by": "crossref", "first-page": "2273", "DOI": "10.1056/NEJMp1314529", "volume": "369", "author": "I Zineh", "year": "2013", "unstructured": "Zineh I, Pacanowski M, Woodcock J (2013) Pharmacogenetics and coumarin dosing\u2014recalibrating expectations. New Engl J Med 369:2273\u20132275", "journal-title": "New Engl J Med"}, {"key": "9_CR783", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1592/phco.28.2.141", "volume": "28", "author": "HI Bussey", "year": "2008", "unstructured": "Bussey HI, Wittkowsky AK, Hylek EM, Walker MB (2008) Genetic testing for warfarin dosing? Not yet ready for prime time. Pharmacotherapy 28:141\u2013143", "journal-title": "Pharmacotherapy"}, {"key": "9_CR784", "doi-asserted-by": "crossref", "first-page": "290", "DOI": "10.1177/1358863X13503193", "volume": "18", "author": "DL Kadian-Dodov", "year": "2013", "unstructured": "Kadian-Dodov DL, van der Zee SA, Scott SA, Peter I, Martis S, Doheny DO, Rothlauf EB, Lubitz SA, Desnick RJ, Halperin JL (2013) Warfarin pharmacogenetics: a controlled dose-response study in healthy subjects. Vasc Med 18:290\u2013297", "journal-title": "Vasc Med"}, {"key": "9_CR785", "doi-asserted-by": "crossref", "first-page": "2294", "DOI": "10.1056/NEJMoa1311386", "volume": "369", "author": "M Pirmohamed", "year": "2013", "unstructured": "Pirmohamed M, Burnside G, Eriksson N, Jorgensen AL, Toh CH, Nicholson T, Kesteven P, Christersson C, Wahlstrom B, Stafberg C, Zhang JE, Leathart JB, Kohnke H, Maitland-van der Zee AH, Williamson PR, Daly AK, Avery P, Kamali F, Wadelius M (2013) A randomized trial of genotype-guided dosing of warfarin. New Engl J Med 369:2294\u20132303", "journal-title": "New Engl J Med"}, {"key": "9_CR786", "unstructured": "Shaw K, Amstutz U, Hildebrand C, Rassekh SR, Hosking M, Neville K, Leeder JS, Hayden MR, Ross CJ, Carleton BC (2014) VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children. Pediatr Blood Cancer. doi:10.1002/pbc.24932 (in press)", "DOI": "10.1002/pbc.24932", "doi-asserted-by": "crossref"}, {"key": "9_CR787", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1097/FPC.0000000000000025", "volume": "24", "author": "HI Lee", "year": "2014", "unstructured": "Lee HI, Bae JW, Choi CI, Lee YJ, Byeon JY, Jang CG, Lee SY (2014) Strongly increased exposure of meloxicam in CYP2C9*3/*3 individuals. Pharmacogenet Genomics 24:113\u2013117", "journal-title": "Pharmacogenet Genomics"}, {"key": "9_CR788", "doi-asserted-by": "crossref", "first-page": "287", "DOI": "10.1016/j.clpt.2005.11.007", "volume": "79", "author": "MS Lundblad", "year": "2006", "unstructured": "Lundblad MS, Ohlsson S, Johansson P, Lafolie P, Eliasson E (2006) Accumulation of celecoxib with a 7-fold higher drug exposure in individuals homozygous for CYP2C9*3. Clin Pharmacol Ther 79:287\u2013288", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR789", "doi-asserted-by": "crossref", "first-page": "2127", "DOI": "10.1053/j.gastro.2009.02.045", "volume": "136", "author": "AT Chan", "year": "2009", "unstructured": "Chan AT, Zauber AG, Hsu M, Breazna A, Hunter DJ, Rosenstein RB, Eagle CJ, Hawk ET, Bertagnolli MM (2009) Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma. Gastroenterology 136:2127\u20132136 e2121", "journal-title": "Gastroenterology"}, {"key": "9_CR790", "doi-asserted-by": "crossref", "first-page": "678", "DOI": "10.1038/clpt.2013.143", "volume": "94", "author": "SM Markova", "year": "2013", "unstructured": "Markova SM, De Marco T, Bendjilali N, Kobashigawa EA, Mefford J, Sodhi J, Le H, Zhang C, Halladay J, Rettie AE, Khojasteh C, McGlothlin D, Wu AH, Hsueh WC, Witte JS, Schwartz JB, Kroetz DL (2013) Association of CYP2C9*2 with bosentan-induced liver injury. Clin Pharmacol Ther 94:678\u2013686", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR791", "doi-asserted-by": "crossref", "first-page": "629", "DOI": "10.1038/clpt.2013.182", "volume": "94", "author": "PB Watkins", "year": "2013", "unstructured": "Watkins PB (2013) Managing the risk of drug-induced liver injury. Clin Pharmacol Ther 94:629\u2013631", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR792", "doi-asserted-by": "crossref", "first-page": "60", "DOI": "10.1055/s-0033-1361097", "volume": "122", "author": "G Ragia", "year": "2014", "unstructured": "Ragia G, Tavridou A, Elens L, Van Schaik RH, Manolopoulos VG (2014) CYP2C9*2 Allele increases risk for hypoglycemia in POR*1/*1 type 2 diabetic patients treated with sulfonylureas. Exp Clin Endocrinol Diabetes 122:60\u201363", "journal-title": "Exp Clin Endocrinol Diabetes"}, {"key": "9_CR793", "doi-asserted-by": "crossref", "first-page": "1716", "DOI": "10.1373/clinchem.2005.050807", "volume": "51", "author": "M Funk", "year": "2005", "unstructured": "Funk M, Freitag R, Endler G, Lalouschek W, Lang W, Mannhalter C, Sunder-Plassmann R (2005) Influence of cytochrome P450 2C9*2 and 2C9*3 variants on the risk of ischemic stroke: a cross-sectional case-control study. Clin Chem 51:1716\u20131718", "journal-title": "Clin Chem"}, {"key": "9_CR794", "doi-asserted-by": "crossref", "first-page": "e49134", "DOI": "10.1371/journal.pone.0049134", "volume": "7", "author": "S Liang", "year": "2012", "unstructured": "Liang S, Hu J, Cao W, Cai S (2012) Meta-analysis of cytochrome P-450 2C9 polymorphism and colorectal cancer risk. PLoS One 7:e49134", "journal-title": "PLoS One"}, {"key": "9_CR795", "doi-asserted-by": "crossref", "first-page": "7828", "DOI": "10.1021/bi9903289", "volume": "38", "author": "C Minoletti", "year": "1999", "unstructured": "Minoletti C, Dijols S, Dansette PM, Mansuy D (1999) Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18. Biochemistry 38:7828\u20137836", "journal-title": "Biochemistry"}, {"key": "9_CR796", "doi-asserted-by": "crossref", "first-page": "565", "DOI": "10.1097/00008571-200309000-00005", "volume": "13", "author": "F Lapple", "year": "2003", "unstructured": "Lapple F, von Richter O, Fromm MF, Richter T, Thon KP, Wisser H, Griese EU, Eichelbaum M, Kivisto KT (2003) Differential expression and function of CYP2C isoforms in human intestine and liver. Pharmacogenetics 13:565\u2013575", "journal-title": "Pharmacogenetics"}, {"key": "9_CR797", "doi-asserted-by": "crossref", "first-page": "157", "DOI": "10.1006/abbi.1996.9817", "volume": "338", "author": "TH Richardson", "year": "1997", "unstructured": "Richardson TH, Griffin KJ, Jung F, Raucy JL, Johnson EF (1997) Targeted antipeptide antibodies to cytochrome P450 2C18 based on epitopemapping of an inhibitory monoclonal antibody to P450 2C5. Arch Biochem Biophys 338:157\u2013164", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR798", "doi-asserted-by": "crossref", "first-page": "2985", "DOI": "10.1128/MCB.17.6.2985", "volume": "17", "author": "PG Zaphiropoulos", "year": "1997", "unstructured": "Zaphiropoulos PG (1997) Exon skipping and circular RNA formation in transcripts of the human cytochrome P-450 2C18 gene in epidermis and of the rat androgen binding protein gene in testis. Mol Cell Biol 17:2985\u20132993", "journal-title": "Mol Cell Biol"}, {"key": "9_CR799", "doi-asserted-by": "crossref", "first-page": "914", "DOI": "10.1016/S0959-8049(98)00034-3", "volume": "34", "author": "K Mace", "year": "1998", "unstructured": "Mace K, Bowman ED, Vautravers P, Shields PG, Harris CC, Pfeifer AM (1998) Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues. Eur J Cancer 34:914\u2013920", "journal-title": "Eur J Cancer"}, {"key": "9_CR800", "doi-asserted-by": "crossref", "first-page": "1868", "DOI": "10.1021/tx050181o", "volume": "18", "author": "RT Kinobe", "year": "2005", "unstructured": "Kinobe RT, Parkinson OT, Mitchell DJ, Gillam EMJ (2005) P450 2C18 catalyzes the metabolic bioactivation of phenytoin. Chem Res Toxicol 18:1868\u20131875", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR801", "doi-asserted-by": "crossref", "first-page": "1505", "DOI": "10.1124/dmd.109.026963", "volume": "37", "author": "S Lofgren", "year": "2009", "unstructured": "Lofgren S, Baldwin RM, Carleros M, Terelius Y, Fransson-Steen R, Mwinyi J, Waxman DJ, Ingelman-Sundberg M (2009) Regulation of human CYP2C18 and CYP2C19 in transgenic mice: influence of castration, testosterone, and growth hormone. Drug Metab Dispos 37:1505\u20131512", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR802", "doi-asserted-by": "crossref", "first-page": "199", "DOI": "10.1211/0022357001773850", "volume": "52", "author": "M Mizugaki", "year": "2000", "unstructured": "Mizugaki M, Hiratsuka M, Agatsuma Y, Matsubara Y, Fujii K, Kure S, Narisawa K (2000) Rapid detection of CYP2C18 genotypes by real-time fluorescence polymerase chain reaction. J Pharm Pharmacol 52:199\u2013205", "journal-title": "J Pharm Pharmacol"}, {"key": "9_CR803", "doi-asserted-by": "crossref", "first-page": "888", "DOI": "10.3748/wjg.v8.i5.888", "volume": "8", "author": "J Zhu-Ge", "year": "2002", "unstructured": "Zhu-Ge J, Yu YN, Qian YL, Li X (2002) Establishment of a transgenic cell line stably expressing human cytochrome P450 2C18 and identification of a CYP2C18 clone with exon 5 missing. World J Gastroenterol 8:888\u2013892", "journal-title": "World J Gastroenterol"}, {"key": "9_CR804", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1021/tx4004215", "volume": "27", "author": "G Chowdhury", "year": "2014", "unstructured": "Chowdhury G, Shibata N, Yamazaki H, Guengerich FP (2014) Human cytochrome P450 oxidation of 5-hydroxythalidomide and pomalidomide, an amino analogue of thalidomide. Chem Res Toxicol 27:147\u2013156", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR805", "doi-asserted-by": "crossref", "first-page": "9335", "DOI": "10.1021/bi034556l", "volume": "42", "author": "MR Wester", "year": "2003", "unstructured": "Wester MR, Johnson EF, Marques-Soares C, Dijols S, Dansette PM, Mansuy D, Stout CD (2003) Structure of mammalian cytochrome P450 2C5 complexed with diclofenac at 2.1\u00a0\u00c5 resolution: evidence for an induced fit model of substrate binding. Biochemistry 42:9335\u20139345", "journal-title": "Biochemistry"}, {"key": "9_CR806", "doi-asserted-by": "crossref", "first-page": "204", "DOI": "10.1002/(SICI)1097-0134(19991101)37:2<204::AID-PROT6>3.0.CO;2-O", "volume": "37", "author": "VA Payne", "year": "1999", "unstructured": "Payne VA, Chang YT, Loew GH (1999) Homology modeling and substrate binding study of human CYP2C18 and CYP2C19 enzymes. Proteins 37:204\u2013217", "journal-title": "Proteins"}, {"key": "9_CR807", "doi-asserted-by": "crossref", "first-page": "8466", "DOI": "10.1021/bi00399a065", "volume": "26", "author": "UT Meier", "year": "1987", "unstructured": "Meier UT, Meyer UA (1987) Genetic polymorphism of human cytochrome P-450 (S)-mephenytoin 4-hydroxylase. Studies with human autoantibodies suggest a functionally altered cytochrome P-450 isozyme as cause of the genetic deficiency. Biochemistry 26:8466\u20138474", "journal-title": "Biochemistry"}, {"key": "9_CR808", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1016/0163-7258(89)90047-8", "volume": "43", "author": "GR Wilkinson", "year": "1989", "unstructured": "Wilkinson GR, Guengerich FP, Branch RA (1989) Genetic polymorphism of S-mephenytoin hydroxylation. Pharmacol Ther 43:53\u201376", "journal-title": "Pharmacol Ther"}, {"key": "9_CR809", "doi-asserted-by": "crossref", "first-page": "313", "DOI": "10.1038/clpt.1990.34", "volume": "47", "author": "T Yasumori", "year": "1990", "unstructured": "Yasumori T, Murayama N, Yamazoe Y, Kato R (1990) Polymorphism in hydroxylation of mephenytoin and hexobarbital stereoisomers in relation to hepatic P-450 human-2. Clin Pharmacol Ther 47:313\u2013322", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR810", "doi-asserted-by": "crossref", "first-page": "192", "DOI": "10.1067/mcp.2002.126174", "volume": "72", "author": "MJ Kim", "year": "2002", "unstructured": "Kim MJ, Bertino JS Jr, Gaedigk A, Zhang Y, Sellers EM, Nafziger AN (2002) Effect of sex and menstrual cycle phase on cytochrome P450 2C19 activity with omeprazole used as a biomarker. Clin Pharmacol Ther 72:192\u2013199", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR811", "doi-asserted-by": "crossref", "first-page": "471", "DOI": "10.1111/j.1365-2125.1990.tb03799.x", "volume": "30", "author": "HH Zhou", "year": "1990", "unstructured": "Zhou HH, Anthony LB, Wood AJ, Wilkinson GR (1990) Induction of polymorphic 4\u2032-hydroxylation of S-mephenytoin by rifampicin. Br J Clin Pharmacol 30:471\u2013475", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR812", "doi-asserted-by": "crossref", "first-page": "1196", "DOI": "10.2174/138920012802850146", "volume": "13", "author": "CR Uppugunduri", "year": "2012", "unstructured": "Uppugunduri CR, Daali Y, Desmeules J, Dayer P, Krajinovic M, Ansari M (2012) Transcriptional regulation of CYP2C19 and its role in altered enzyme activity. Curr Drug Metab 13:1196\u20131204", "journal-title": "Curr Drug Metab"}, {"key": "9_CR813", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1515/dmdi-2012-0038", "volume": "28", "author": "JC Sanford", "year": "2013", "unstructured": "Sanford JC, Guo Y, Sadee W, Wang D (2013) Regulatory polymorphisms in CYP2C19 affecting hepatic expression. Drug Metab Drug Interact 28:23\u201330", "journal-title": "Drug Metab Drug Interact"}, {"key": "9_CR814", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1038/clpt.2012.215", "volume": "93", "author": "CO Musumba", "year": "2013", "unstructured": "Musumba CO, Jorgensen A, Sutton L, Van Eker D, Zhang E, O\u2019Hara N, Carr DF, Pritchard DM, Pirmohamed M (2013) CYP2C19*17 gain-of-function polymorphism is associated with peptic ulcer disease. Clin Pharmacol Ther 93:195\u2013203", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR815", "doi-asserted-by": "crossref", "first-page": "703", "DOI": "10.1097/00008571-200212000-00004", "volume": "12", "author": "J Blaisdell", "year": "2002", "unstructured": "Blaisdell J, Mohrenweiser H, Jackson J, Ferguson S, Coulter S, Chanas B, Xi T, Ghanayem B, Goldstein JA (2002) Identification and functional characterization of new potentially defective alleles of human CYP2C19. Pharmacogenetics 12:703\u2013711", "journal-title": "Pharmacogenetics"}, {"key": "9_CR816", "doi-asserted-by": "crossref", "first-page": "913", "DOI": "10.2165/00003088-200241120-00002", "volume": "41", "author": "Z Desta", "year": "2002", "unstructured": "Desta Z, Zhao X, Shin JG, Flockhart DA (2002) Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Clin Pharmacokinet 41:913\u2013958", "journal-title": "Clin Pharmacokinet"}, {"key": "9_CR817", "doi-asserted-by": "crossref", "first-page": "286", "DOI": "10.2133/dmpk.21.286", "volume": "21", "author": "W Tassaneeyakul", "year": "2006", "unstructured": "Tassaneeyakul W, Mahatthanatrakul W, Niwatananun K, Na-Bangchang K, Tawalee A, Krikreangsak N, Cykleng U, Tassaneeyakul W (2006) CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations. Drug Metab Pharmacokinet 21:286\u2013290", "journal-title": "Drug Metab Pharmacokinet"}, {"key": "9_CR818", "first-page": "15419", "volume": "269", "author": "SMF de Morais", "year": "1994", "unstructured": "de Morais SMF, Wilkinson GR, Blaisdell J, Nakamura K, Meyer UA, Goldstein JA (1994) The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem 269:15419\u201315422", "journal-title": "J Biol Chem"}, {"key": "9_CR819", "first-page": "356", "volume": "284", "author": "RJ Ferguson", "year": "1998", "unstructured": "Ferguson RJ, De Morais SM, Benhamou S, Bouchardy C, Blaisdell J, Ibeanu G, Wilkinson GR, Sarich TC, Wright JM, Dayer P, Goldstein JA (1998) A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin. J Pharmacol Exp Ther 284:356\u2013361", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR820", "first-page": "354", "volume": "28", "author": "MR Wester", "year": "2000", "unstructured": "Wester MR, Lasker JM, Johnson EF, Raucy JL (2000) CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes. Drug Metab Dispos 28:354\u2013359", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR821", "first-page": "470", "volume": "12", "author": "LS Kaminsky", "year": "1984", "unstructured": "Kaminsky LS, Dunbar DA, Wang PP, Beaune P, Larrey D, Guengerich FP, Schnellmann RG, Sipes IG (1984) Human hepatic cytochrome P-450 composition as probed by in vitro microsomal metabolism of warfarin. Drug Metab Dispos 12:470\u2013477", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR822", "first-page": "610", "volume": "24", "author": "LC Wienkers", "year": "1996", "unstructured": "Wienkers LC, Wurden CJ, Storch E, Kunze KL, Rettie AE, Trager WF (1996) Formation of (R)-8-hydroxywarfarin in human liver microsomes: a new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19. Drug Metab Dispos 24:610\u2013614", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR823", "doi-asserted-by": "crossref", "first-page": "663", "DOI": "10.1124/dmd.30.6.663", "volume": "30", "author": "W Zhang", "year": "2002", "unstructured": "Zhang W, Ramamoorthy Y, Tyndale RF, Glick SD, Maisonneuve IM, Kuehne ME, Sellers EM (2002) Metabolism of 18-methoxycoronaridine, an ibogaine analog, to 18-hydroxycoronaridine by genetically variable CYP2C19. Drug Metab Dispos 30:663\u2013669", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR824", "first-page": "1964", "volume": "8", "author": "Y Ando", "year": "2002", "unstructured": "Ando Y, Fuse E, Figg WD (2002) Thalidomide metabolism by the CYP2C subfamily. Clin Cancer Res 8:1964\u20131973", "journal-title": "Clin Cancer Res"}, {"key": "9_CR825", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1006/abbi.1997.0302", "volume": "346", "author": "H Yamazaki", "year": "1997", "unstructured": "Yamazaki H, Shimada T (1997) Progesterone and testosteronehydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Arch Biochem Biophys 346:161\u2013169", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR826", "doi-asserted-by": "crossref", "first-page": "68", "DOI": "10.1006/taap.2001.9294", "volume": "177", "author": "WA Kappers", "year": "2001", "unstructured": "Kappers WA, Edwards RJ, Murray S, Boobis AR (2001) Diazinon is activated by CYP2C19 in human liver. Toxicol Appl Pharmacol 177:68\u201376", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "9_CR827", "doi-asserted-by": "crossref", "first-page": "92", "DOI": "10.1124/dmd.109.029132", "volume": "38", "author": "M Kazui", "year": "2010", "unstructured": "Kazui M, Nishiya Y, Ishizuka T, Hagihara K, Farid NA, Okazaki O, Ikeda T, Kurihara A (2010) Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite. Drug Metab Dispos 38:92\u201399", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR828", "doi-asserted-by": "crossref", "first-page": "540", "DOI": "10.1124/dmd.31.5.540", "volume": "31", "author": "R Hyland", "year": "2003", "unstructured": "Hyland R, Jones BC, Smith DA (2003) Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole. Drug Metab Dispos 31:540\u2013547", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR829", "doi-asserted-by": "crossref", "first-page": "196", "DOI": "10.1177/0091270008327537", "volume": "49", "author": "J Weiss", "year": "2009", "unstructured": "Weiss J, Ten Hoevel MM, Burhenne J, Walter-Sack I, Hoffmann MM, Rengelshausen J, Haefeli WE, Mikus G (2009) CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole. J Clin Pharmacol 49:196\u2013204", "journal-title": "J Clin Pharmacol"}, {"key": "9_CR830", "first-page": "1279", "volume": "32", "author": "C Giraud", "year": "2004", "unstructured": "Giraud C, Tran A, Rey E, Vincent J, Treluyer JM, Pons G (2004) In vitro characterization of clobazam metabolism by recombinant cytochrome P450 enzymes: importance of CYP2C19. Drug Metab Dispos 32:1279\u20131286", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR831", "doi-asserted-by": "crossref", "first-page": "527", "DOI": "10.2217/14622416.9.5.527", "volume": "9", "author": "T Seo", "year": "2008", "unstructured": "Seo T, Nagata R, Ishitsu T, Murata T, Takaishi C, Hori M, Nakagawa K (2008) Impact of CYP2C19 polymorphisms on the efficacy of clobazam therapy. Pharmacogenomics 9:527\u2013537", "journal-title": "Pharmacogenomics"}, {"key": "9_CR832", "doi-asserted-by": "crossref", "first-page": "322", "DOI": "10.1038/sj.clpt.6100291", "volume": "83", "author": "I Rudberg", "year": "2008", "unstructured": "Rudberg I, Mohebi B, Hermann M, Refsum H, Molden E (2008) Impact of the ultrarapid CYP2C19*17 allele on serum concentration of escitalopram in psychiatric patients. Clin Pharmacol Ther 83:322\u2013327", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR833", "doi-asserted-by": "crossref", "first-page": "5448", "DOI": "10.1128/AAC.00843-13", "volume": "57", "author": "Z Wu", "year": "2013", "unstructured": "Wu Z, Lee D, Joo J, Shin JH, Kang W, Oh S, Lee do Y, Lee SJ, Yea SS, Lee HS, Lee T, Liu KH (2013) CYP2J2 and CYP2C19 are the major enzymes responsible for metabolism of albendazole and fenbendazole in human liver microsomes and recombinant P450 assay systems. Antimicrob Agents Chemother 57:5448\u20135456", "journal-title": "Antimicrob Agents Chemother"}, {"key": "9_CR834", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1002/hon.992", "volume": "30", "author": "Y Li", "year": "2012", "unstructured": "Li Y, Jiang Z, Xiao Y, Li L, Gao Y (2012) Metabolism of thalidomide by human liver microsome cytochrome CYP2C19 is required for its antimyeloma and antiangiogenic activities in vitro. Hematolog Oncol 30:13\u201321", "journal-title": "Hematolog Oncol"}, {"key": "9_CR835", "doi-asserted-by": "crossref", "first-page": "38", "DOI": "10.2133/dmpk.DMPK-12-RV-089", "volume": "28", "author": "K Nakamura", "year": "2013", "unstructured": "Nakamura K, Matsuzawa N, Ohmori S, Ando Y, Yamazaki H, Matsunaga T (2013) Clinical evidence of pharmacokinetic changes in thalidomide therapy. Drug Metab Pharmacokinet 28:38\u201343", "journal-title": "Drug Metab Pharmacokinet"}, {"key": "9_CR836", "doi-asserted-by": "crossref", "first-page": "12496", "DOI": "10.1074/jbc.271.21.12496", "volume": "271", "author": "GC Ibeanu", "year": "1996", "unstructured": "Ibeanu GC, Ghanayem BI, Linko P, Li L, Pedersen LG, Goldstein JA (1996) Identification of residues 99, 220, and 221 of human cytochrome P450 2C19 as key determinants of omeprazole hydroxylase activity. J Biol Chem 271:12496\u201312501", "journal-title": "J Biol Chem"}, {"key": "9_CR837", "doi-asserted-by": "crossref", "first-page": "1937", "DOI": "10.1021/bi001678u", "volume": "40", "author": "CC Tsao", "year": "2001", "unstructured": "Tsao CC, Wester MR, Ghanayem B, Coulter SJ, Chanas B, Johnson EF, Goldstein JA (2001) Identification of human CYP2C19 residues that confer S-mephenytoin 4\u2032-hydroxylation activity to CYP2C9. Biochemistry 40:1937\u20131944", "journal-title": "Biochemistry"}, {"key": "9_CR838", "doi-asserted-by": "crossref", "first-page": "343", "DOI": "10.1124/dmd.31.3.343", "volume": "31", "author": "RL Walsky", "year": "2003", "unstructured": "Walsky RL, Obach RS (2003) Verification of the selectivity of (+)N-3-benzylnirvanol as a CYP2C19 inhibitor. Drug Metab Dispos 31:343", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR839", "doi-asserted-by": "crossref", "first-page": "584", "DOI": "10.1124/dmd.32.6.584", "volume": "32", "author": "X Cai", "year": "2004", "unstructured": "Cai X, Wang RW, Edom RW, Evans DC, Shou M, Rodrigues AD, Liu W, Dean DC, Baillie TA (2004) Validation of (\u2212)-N-3-benzyl-phenobarbital as a selective inhibitor of CYP2C19 in human liver microsomes. Drug Metab Dispos 32:584\u2013586", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR840", "doi-asserted-by": "crossref", "first-page": "523", "DOI": "10.1124/dmd.107.019265", "volume": "36", "author": "RS Foti", "year": "2008", "unstructured": "Foti RS, Wahlstrom JL (2008) CYP2C19 inhibition: the impact of substrate probe selection on in vitro inhibition profiles. Drug Metab Dispos 36:523\u2013528", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR841", "doi-asserted-by": "crossref", "first-page": "332", "DOI": "10.2133/dmpk.DMPK-12-RG-129", "volume": "28", "author": "R Jiang", "year": "2013", "unstructured": "Jiang R, Yamaori S, Okamoto Y, Yamamoto I, Watanabe K (2013) Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19. Drug Metab Pharmacokinet 28:332\u2013338", "journal-title": "Drug Metab Pharmacokinet"}, {"key": "9_CR842", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1038/clpt.2013.192", "volume": "95", "author": "MT Holmberg", "year": "2013", "unstructured": "Holmberg MT, Tornio A, Neuvonen M, Neuvonen PJ, Backman JT, Niemi M (2013) Grapefruit juice inhibits the metabolic activation of clopidogrel. Clin Pharmacol Ther 95:307\u2013313", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR843", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.1097/00008571-200106000-00009", "volume": "11", "author": "T Furuta", "year": "2001", "unstructured": "Furuta T, Shirai N, Takashima M, Xiao F, Hanai H, Nakagawa K, Sugimura H, Ohashi K, Ishizaki T (2001) Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin. Pharmacogenetics 11:341\u2013348", "journal-title": "Pharmacogenetics"}, {"key": "9_CR844", "doi-asserted-by": "crossref", "first-page": "453", "DOI": "10.1067/mcp.2002.127637", "volume": "72", "author": "T Furuta", "year": "2002", "unstructured": "Furuta T, Shirai N, Watanabe F, Honda S, Takeuchi K, Iida T, Sato Y, Kajimura M, Futami H, Takayanagi S, Yamada M, Ohashi K, Ishizaki T, Hanai H (2002) Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole. Clin Pharmacol Ther 72:453\u2013460", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR845", "doi-asserted-by": "crossref", "first-page": "923", "DOI": "10.1248/bpb.25.923", "volume": "25", "author": "T Kita", "year": "2002", "unstructured": "Kita T, Sakaeda T, Aoyama N, Sakai T, Kawahara Y, Kasuga M, Okumura K (2002) Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerations. Biolog Pharm Bull 25:923\u2013927", "journal-title": "Biolog Pharm Bull"}, {"key": "9_CR846", "doi-asserted-by": "crossref", "first-page": "386", "DOI": "10.1248/bpb.26.386", "volume": "26", "author": "T Kita", "year": "2003", "unstructured": "Kita T, Sakaeda T, Baba T, Aoyama N, Kakumoto M, Kurimoto Y, Kawahara Y, Okamura N, Kirita S, Kasuga M, Okumura K (2003) Different contribution of CYP2C19 in the in vitro metabolism of three proton pump inhibitors. Biolog Pharm Bull 26:386\u2013390", "journal-title": "Biolog Pharm Bull"}, {"key": "9_CR847", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.5414/CPP44297", "volume": "44", "author": "U Klotz", "year": "2006", "unstructured": "Klotz U (2006) Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem. Int J Clin Pharmacol Ther 44:297\u2013302", "journal-title": "Int J Clin Pharmacol Ther"}, {"key": "9_CR848", "doi-asserted-by": "crossref", "first-page": "659", "DOI": "10.1373/clinchem.2010.158709", "volume": "57", "author": "CP Cannon", "year": "2011", "unstructured": "Cannon CP (2011) Clopidogrel: to test or not to test? That is the question\u2014still. Clin Chem 57:659\u2013661", "journal-title": "Clin Chem"}, {"key": "9_CR849", "doi-asserted-by": "crossref", "first-page": "1821", "DOI": "10.1001/jama.2010.1543", "volume": "304", "author": "JL Mega", "year": "2010", "unstructured": "Mega JL, Simon T, Collet JP, Anderson JL, Antman EM, Bliden K, Cannon CP, Danchin N, Giusti B, Gurbel P, Horne BD, Hulot JS, Kastrati A, Montalescot G, Neumann FJ, Shen L, Sibbing D, Steg PG, Trenk D, Wiviott SD, Sabatine MS (2010) Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. J Am Med Assoc 304:1821\u20131830", "journal-title": "J Am Med Assoc"}, {"key": "9_CR850", "doi-asserted-by": "crossref", "first-page": "849", "DOI": "10.1001/jama.2009.1232", "volume": "302", "author": "AR Shuldiner", "year": "2009", "unstructured": "Shuldiner AR, O\u2019Connell JR, Bliden KP, Gandhi A, Ryan K, Horenstein RB, Damcott CM, Pakyz R, Tantry US, Gibson Q, Pollin TI, Post W, Parsa A, Mitchell BD, Faraday N, Herzog W, Gurbel PA (2009) Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. J Am Med Assoc 302:849\u2013857", "journal-title": "J Am Med Assoc"}, {"key": "9_CR851", "doi-asserted-by": "crossref", "first-page": "774", "DOI": "10.1038/clpt.2012.21", "volume": "91", "author": "JA Johnson", "year": "2012", "unstructured": "Johnson JA, Roden DM, Lesko LJ, Ashley E, Klein TE, Shuldiner AR (2012) Clopidogrel: a case for indication-specific pharmacogenetics. Clin Pharmacol Ther 91:774\u2013776", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR852", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1007/s10549-009-0695-4", "volume": "122", "author": "C Mao", "year": "2010", "unstructured": "Mao C, Wang XW, He BF, Qiu LX, Liao RY, Luo RC, Chen Q (2010) Lack of association between CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis of 22,090 cases and 28,498 controls. Breast Cancer Res Treat 122:259\u2013265", "journal-title": "Breast Cancer Res Treat"}, {"key": "9_CR853", "doi-asserted-by": "crossref", "first-page": "1239", "DOI": "10.1136/hrt.2010.220509", "volume": "97", "author": "HJ Bouman", "year": "2011", "unstructured": "Bouman HJ, Harmsze AM, van Werkum JW., Breet NJ, Bergmeijer TO, Ten Cate H, Hackeng CM, Deneer VH, Ten Berg JM (2011) Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting. Heart 97:1239\u20131244", "journal-title": "Heart"}, {"key": "9_CR854", "doi-asserted-by": "crossref", "first-page": "2013", "DOI": "10.2217/pgs.13.164", "volume": "14", "author": "MJ Sorich", "year": "2013", "unstructured": "Sorich MJ, Horowitz JD, Sorich W, Wiese MD, Pekarsky B, Karnon JD (2013) Cost-effectiveness of using CYP2C19 genotype to guide selection of clopidogrel or ticagrelor in Australia. Pharmacogenomics 14:2013\u20132021", "journal-title": "Pharmacogenomics"}, {"key": "9_CR855", "doi-asserted-by": "crossref", "first-page": "2803", "DOI": "10.1038/bjc.2013.588", "volume": "109", "author": "N Yamamoto", "year": "2013", "unstructured": "Yamamoto N, Murakami H, Hayashi H, Fujisaka Y, Hirashima T, Takeda K, Satouchi M, Miyoshi K, Akinaga S, Takahashi T, Nakagawa K (2013) CYP2C19 genotype-based phase I studies of a c-Met inhibitor tivantinib in combination with erlotinib, in advanced/metastatic non-small cell lung cancer. Br J Cancer 109:2803\u20132809", "journal-title": "Br J Cancer"}, {"key": "9_CR856", "doi-asserted-by": "crossref", "first-page": "1719", "DOI": "10.1016/S0024-3205(00)00757-8", "volume": "67", "author": "TK Chau", "year": "2000", "unstructured": "Chau TK, Marakami S, Kawai B, Nasu K, Kubota T, Ohnishi A (2000) Genotype analysis of the CYP2C19 gene in HCV-seropositive patients with cirrhosis and hepatocellular carcinoma. Life Sci 67:1719\u20131724", "journal-title": "Life Sci"}, {"key": "9_CR857", "doi-asserted-by": "crossref", "first-page": "605", "DOI": "10.1097/00008571-200010000-00004", "volume": "10", "author": "PL Roddam", "year": "2000", "unstructured": "Roddam PL, Rollinson S, Kane E, Roman E, Moorman A, Cartwright R, Morgan GJ (2000) Poor metabolizers at the cytochrome P450 2D6and 2C19 loci are at increased risk of developing adult acute leukaemia. Pharmacogenetics 10:605\u2013615", "journal-title": "Pharmacogenetics"}, {"key": "9_CR858", "doi-asserted-by": "crossref", "first-page": "5358", "DOI": "10.1002/cncr.25508", "volume": "116", "author": "C Justenhoven", "year": "2010", "unstructured": "Justenhoven C, Winter S, Hamann U, Haas S, Fischer HP, Pesch B, Bruning T, Ko YD, Brauch H (2010) The frameshift polymorphism CYP3A43_74_delA is associated with poor differentiation of breast tumors. Cancer 116:5358\u20135364", "journal-title": "Cancer"}, {"key": "9_CR859", "doi-asserted-by": "crossref", "first-page": "1045", "DOI": "10.1007/s00535-010-0246-0", "volume": "45", "author": "Y Isomura", "year": "2010", "unstructured": "Isomura Y, Yamaji Y, Ohta M, Seto M, Asaoka Y, Tanaka Y, Sasaki T, Nakai Y, Sasahira N, Isayama H, Tada M, Yoshida H, Kawabe T, Omata M, Koike K (2010) A genetic polymorphism of CYP2C19 is associated with susceptibility to biliary tract cancer. J Gastroenterol 45:1045\u20131052", "journal-title": "J Gastroenterol"}, {"key": "9_CR860", "doi-asserted-by": "crossref", "first-page": "e66865", "DOI": "10.1371/journal.pone.0066865", "volume": "8", "author": "B Zhou", "year": "2013", "unstructured": "Zhou B, Song Z, Qian M, Li L, Gong J, Zou S (2013) Functional polymorphisms in the CYP2C19 gene contribute to digestive system cancer risk: evidence from 11,042 subjects. PLoS One 8:e66865", "journal-title": "PLoS One"}, {"key": "9_CR861", "doi-asserted-by": "crossref", "first-page": "2236", "DOI": "10.1016/j.fertnstert.2011.03.062", "volume": "95", "author": "JN Painter", "year": "2011", "unstructured": "Painter JN, Nyholt DR, Morris A, Zhao ZZ, Henders AK, Lambert A, Wallace L, Martin NG, Kennedy SH, Treloar SA, Zondervan KT, Montgomery GW (2011) High-density fine-mapping of a chromosome 10q26 linkage peak suggests association between endometriosis and variants close to CYP2C19. Fertil Steril 95:2236\u20132240", "journal-title": "Fertil Steril"}, {"key": "9_CR862", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1159/000095702", "volume": "56", "author": "H Alonso-Navarro", "year": "2006", "unstructured": "Alonso-Navarro H, Martinez C, Garcia-Martin E, Benito-Leon J, Garcia-Ferrer I, Vazquez-Torres P, Puertas I, Lopez-Alburquerque T, Agundez JA, Jimenez-Jimenez FJ (2006) CYP2C19 polymorphism and risk for essential tremor. Eur Neurol 56:119\u2013123", "journal-title": "Eur Neurol"}, {"key": "9_CR863", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1159/000320093", "volume": "117", "author": "LA Malek", "year": "2010", "unstructured": "Malek LA, Przyluski J, Spiewak M, Klopotowski M, Kostrzewa G, Kruk M, Ploski R, Witkowski A, Ruzyllo W (2010) Cytochrome P450 2C19 polymorphism, suboptimal reperfusion and all-cause mortality in patients with acute myocardial infarction. Cardiology 117:81\u201387", "journal-title": "Cardiology"}, {"key": "9_CR864", "doi-asserted-by": "crossref", "first-page": "1587", "DOI": "10.1124/dmd.108.021873", "volume": "36", "author": "JC Stevens", "year": "2008", "unstructured": "Stevens JC, Marsh SA, Zaya MJ, Regina KJ, Divakaran K, Le M, Hines RN (2008) Developmental changes in human liver CYP2D6 expression. Drug Metab Dispos 36:1587\u20131593", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR865", "doi-asserted-by": "crossref", "first-page": "2313", "DOI": "10.1002/pmic.200800680", "volume": "9", "author": "E Langenfeld", "year": "2009", "unstructured": "Langenfeld E, Zanger UM, Jung K, Meyer HE, Marcus K (2009) Mass spectrometry-based absolute quantification of microsomal cytochrome P450 2D6 in human liver. Proteomics 9:2313\u20132323", "journal-title": "Proteomics"}, {"key": "9_CR866", "doi-asserted-by": "crossref", "first-page": "583", "DOI": "10.1111/j.1432-1033.1991.tb16411.x", "volume": "202", "author": "JM Treluyer", "year": "1991", "unstructured": "Treluyer JM, Jacqz-Aigrain E, Alvarez F, Cresteil T (1991) Expression of CYP2D6 in developing human liver. Eur J Biochem 202:583\u2013588", "journal-title": "Eur J Biochem"}, {"key": "9_CR867", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1006/bbrc.1997.7775", "volume": "241", "author": "JM Lo Guidice", "year": "1997", "unstructured": "Lo Guidice JM, Marez D, Sabbagh N, LegrandAndreoletti M, Spire C, Alca\u00efde E, Lafitte JJ, Broly F (1997) Evidence for CYP2D6 expression in human lung. Biochem Biophys Res Commun 241:79\u201385", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR868", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1097/00008571-200104000-00007", "volume": "11", "author": "I Siegle", "year": "2001", "unstructured": "Siegle I, Fritz P, Eckhardt K, Zanger UM, Eichelbaum M (2001) Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain. Pharmacogenetics 11:237\u2013245", "journal-title": "Pharmacogenetics"}, {"key": "9_CR869", "doi-asserted-by": "crossref", "first-page": "1376", "DOI": "10.1046/j.1471-4159.2002.01069.x", "volume": "82", "author": "S Miksys", "year": "2002", "unstructured": "Miksys S, Rao Y, Hoffmann E, Mash DC, Tyndale RF (2002) Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics. J Neurochem 82:1376\u20131387", "journal-title": "J Neurochem"}, {"key": "9_CR870", "doi-asserted-by": "crossref", "first-page": "973", "DOI": "10.3109/00498254.2013.791410", "volume": "43", "author": "J Cheng", "year": "2013", "unstructured": "Cheng J, Zhen Y, Miksys S, Beyoglu D, Krausz KW, Tyndale RF, Yu A, Idle JR, Gonzalez FJ (2013) Potential role of CYP2D6 in the central nervous system. Xenobiotica 43:973\u2013984", "journal-title": "Xenobiotica"}, {"key": "9_CR871", "doi-asserted-by": "crossref", "first-page": "3440", "DOI": "10.1111/j.1742-4658.2009.07067.x", "volume": "276", "author": "MC Sangar", "year": "2009", "unstructured": "Sangar MC, Anandatheerthavarada HK, Tang W, Prabu SK, Martin MV, Dostalek M, Guengerich FP, Avadhani NG (2009) Human liver mitochondrial cytochrome P450 2D6\u2014individual variations and implications in drug metabolism. FEBS J 276:3440\u20133453", "journal-title": "FEBS J"}, {"key": "9_CR872", "doi-asserted-by": "crossref", "first-page": "90", "DOI": "10.1016/j.ymgme.2009.08.009", "volume": "99", "author": "MC Sangar", "year": "2010", "unstructured": "Sangar MC, Anandatheerthavarada HK, Martin MV, Guengerich FP, Avadhani NG (2010) Identification of genetic variants of human cytochrome P450 2D6 with impaired mitochondrial targeting. Mol Genet Metab 99:90\u201397", "journal-title": "Mol Genet Metab"}, {"key": "9_CR873", "doi-asserted-by": "crossref", "first-page": "4436", "DOI": "10.1074/jbc.M112.402123", "volume": "288", "author": "P Bajpai", "year": "2013", "unstructured": "Bajpai P, Sangar MC, Singh S, Tang W, Bansal S, Chowdhury G, Cheng Q, Fang JK, Martin MV, Guengerich FP, Avadhani NG (2013) Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by mitochondrion-targeted cytochrome P450 2D6: implications in Parkinsons disease. J Biol Chem 288:4436\u20134451", "journal-title": "J Biol Chem"}, {"key": "9_CR874", "doi-asserted-by": "crossref", "first-page": "979", "DOI": "10.1016/0024-3205(78)90363-6", "volume": "22", "author": "JR Idle", "year": "1978", "unstructured": "Idle JR, Mahgoub A, Lancaster R, Smith RL (1978) Hypotensive response to debrisoquine and hydroxylation phenotype. Life Sci 22:979\u2013984", "journal-title": "Life Sci"}, {"key": "9_CR875", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1016/S0140-6736(82)91583-5", "volume": "1", "author": "G Alvan", "year": "1982", "unstructured": "Alvan G, von Bahr C, Seideman P, Sjoqvist F (1982) High plasma concentrations of \u03b2-receptor blocking drugs and deficient debrisoquine hydroxylation. Lancet 1:333", "journal-title": "Lancet"}, {"key": "9_CR876", "doi-asserted-by": "crossref", "first-page": "321", "DOI": "10.1136/jmg.20.5.321", "volume": "20", "author": "DAP Evans", "year": "1983", "unstructured": "Evans DAP, Harmer D, Downham DY, Whibley EJ, Idle JR, Ritchie J, Smith RL (1983) The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions. J Med Genet 20:321\u2013329", "journal-title": "J Med Genet"}, {"key": "9_CR877", "doi-asserted-by": "crossref", "first-page": "412", "DOI": "10.2174/138920011795495286", "volume": "12", "author": "T Niwa", "year": "2011", "unstructured": "Niwa T, Murayama N, Yamazaki H (2011) Comparison of cytochrome P450 2D6 and variants in terms of drug oxidation rates and substrate inhibition. Curr Drug Metab 12:412\u2013435", "journal-title": "Curr Drug Metab"}, {"key": "9_CR878", "doi-asserted-by": "crossref", "first-page": "405", "DOI": "10.2133/dmpk.DMPK-11-RG-078", "volume": "27", "author": "K Chiba", "year": "2012", "unstructured": "Chiba K, Kato M, Ito T, Suwa T, Sugiyama Y (2012) Inter-individual variability of in vivo CYP2D6 activity in different genotypes. Drug Metab Pharmacokinet 27:405\u2013413", "journal-title": "Drug Metab Pharmacokinet"}, {"key": "9_CR879", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1097/00008571-200110000-00004", "volume": "11", "author": "UM Zanger", "year": "2001", "unstructured": "Zanger UM, Fischer J, Raimundo S, Stuven T, Evert BO, Schwab M, Eichelbaum M (2001) Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6. Pharmacogenetics 11:573\u2013585", "journal-title": "Pharmacogenetics"}, {"key": "9_CR880", "doi-asserted-by": "crossref", "first-page": "26", "DOI": "10.1097/00008571-199110000-00005", "volume": "1", "author": "R Tyndale", "year": "1991", "unstructured": "Tyndale R, Aoyama T, Broly F, Matsunaga T, Inaba T, Kalow W, Gelboin HV, Meyer UA, Gonzalez FJ (1991) Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotype. Pharmacogenetics 1:26\u201332", "journal-title": "Pharmacogenetics"}, {"key": "9_CR881", "doi-asserted-by": "crossref", "first-page": "1291", "DOI": "10.1124/jpet.102.039891", "volume": "303", "author": "A Yu", "year": "2002", "unstructured": "Yu A, Kneller BM, Rettie AE, Haining RL (2002) Expression, purification, biochemical characterization, and comparative function of human cytochrome P450 2D6. 1, 2D6. 2, 2D6.10, and 2D6.17 allelic isoforms. J Pharmacol Exp Ther 303:1291\u20131300", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR882", "doi-asserted-by": "crossref", "first-page": "166", "DOI": "10.1016/S0888-7543(02)00031-9", "volume": "81", "author": "B Fletcher", "year": "2003", "unstructured": "Fletcher B, Goldstein DB, Bradman AL, Weale ME, Bradman N, Thomas MG (2003) High-throughput analysis of informative CYP2D6 compound haplotypes. Genomics 81:166\u2013174", "journal-title": "Genomics"}, {"key": "9_CR883", "first-page": "516", "volume": "274", "author": "ML Dahl", "year": "1995", "unstructured": "Dahl ML, Johansson I, Bertilsson L, Ingelman-Sundberg M, Sjoqvist F (1995) Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis. J Pharmacol Exp Ther 274:516\u2013520", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR884", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1016/S0378-1119(98)00567-8", "volume": "226", "author": "E Lundqvist", "year": "1999", "unstructured": "Lundqvist E, Johansson I, Ingelman-Sundberg M (1999) Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes. Gene 226:327\u2013338", "journal-title": "Gene"}, {"key": "9_CR885", "doi-asserted-by": "crossref", "first-page": "30", "DOI": "10.1016/0014-5793(96)00779-X", "volume": "392", "author": "R L\u00f8vlie", "year": "1996", "unstructured": "L\u00f8vlie R, Daly AK, Molven A, Idle JR, Steen VM (1996) Ultrarapid metabolizers of debrisoquine: characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene. FEBS Lett 392:30\u201334", "journal-title": "FEBS Lett"}, {"key": "9_CR886", "doi-asserted-by": "crossref", "first-page": "116", "DOI": "10.1055/s-2002-31517", "volume": "35", "author": "MD Kohnke", "year": "2002", "unstructured": "Kohnke MD, Griese EU, Stosser D, Gaertner I, Barth G (2002) Cytochrome P450 2D6 deficiency and its clinical relevance in a patient treated with risperidone. Pharmacopsychiatry 35:116\u2013118", "journal-title": "Pharmacopsychiatry"}, {"key": "9_CR887", "doi-asserted-by": "crossref", "first-page": "611", "DOI": "10.1021/tx0002583", "volume": "14", "author": "FP Guengerich", "year": "2001", "unstructured": "Guengerich FP (2001) Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol 14:611\u2013650", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR888", "first-page": "2116", "volume": "45", "author": "T Wolff", "year": "1985", "unstructured": "Wolff T, Distlerath LM, Worthington MT, Groopman JD, Hammons GJ, Kadlubar FF, Prough RA, Martin MV, Guengerich FP (1985) Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling. Cancer Res 45:2116\u20132122", "journal-title": "Cancer Res"}, {"key": "9_CR889", "doi-asserted-by": "crossref", "first-page": "2211", "DOI": "10.1093/carcin/12.12.2211", "volume": "12", "author": "SA Islam", "year": "1991", "unstructured": "Islam SA, Wolf CR, Lennard MS, Sternberg MJE (1991) A three-dimensional molecular template for substrates of human cytochrome P450 involved in debrisoquine 4-hydroxylation. Carcinogenesis 12:2211\u20132219", "journal-title": "Carcinogenesis"}, {"key": "9_CR890", "doi-asserted-by": "crossref", "first-page": "1136", "DOI": "10.1021/jm00061a004", "volume": "36", "author": "GR Strobl", "year": "1993", "unstructured": "Strobl GR, von Kruedener S, Stockigt J, Guengerich FP, Wolff T (1993) Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studies. J Med Chem 36:1136\u20131145", "journal-title": "J Med Chem"}, {"key": "9_CR891", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.1021/tx00026a010", "volume": "5", "author": "L Koymans", "year": "1992", "unstructured": "Koymans L, Vermeulen NPE, van Acker SABE, te Koppele JM, Heykants JJP, Lavrijsen K, Meuldermans W, Donn\u00e9-Op den Kelder GM (1992) A predictive model for substrates of cytochrome P450-debrisoquine (2D6). Chem Res Toxicol 5:211\u2013219", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR892", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1021/tx960129f", "volume": "10", "author": "MJ de Groot", "year": "1997", "unstructured": "de Groot MJ, Bijloo GJ, Martens BJ, van Acker FAA, Vermeulen NPE (1997) A refined substrate model for human cytochrome P450 2D6. Chem Res Toxicol 10:41\u201348", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR893", "first-page": "1377", "volume": "29", "author": "AL Upthagrove", "year": "2001", "unstructured": "Upthagrove AL, Nelson WL (2001) Importance of amine pKa and distribution coefficient in the metabolism of fluorinated propranolol derivatives. Preparation, identification of metabolite regioisomers, and metabolism by CYP2D6. Drug Metab Dispos 29:1377\u20131388", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR894", "doi-asserted-by": "crossref", "first-page": "14215", "DOI": "10.1021/bi0110037", "volume": "40", "author": "GP Miller", "year": "2001", "unstructured": "Miller GP, Hanna IH, Nishimura Y, Guengerich FP (2001) Oxidation of phenethylamine derivatives by cytochrome P450 2D6: the issue of substrate protonation in binding and catalysis. Biochemistry 40:14215\u201314223", "journal-title": "Biochemistry"}, {"key": "9_CR895", "doi-asserted-by": "crossref", "first-page": "286", "DOI": "10.1021/tx00039a003", "volume": "7", "author": "JM Grace", "year": "1994", "unstructured": "Grace JM, Kinter MT, Macdonald TL (1994) Atypical metabolism of deprenyl and its enantiomer, (S)-(+)-N, \u03b1-dimethyl-N-propynylphenethylamine, by cytochrome P450 2D6. Chem Res Toxicol 7:286\u2013290", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR896", "doi-asserted-by": "crossref", "first-page": "539", "DOI": "10.1080/004982598239290", "volume": "28", "author": "T Niwa", "year": "1998", "unstructured": "Niwa T, Yabusaki Y, Honma K, Matsuo N, Tatsuta K, Ishibashi F, Katagiri M (1998) Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones. Xenobiotica 28:539\u2013547", "journal-title": "Xenobiotica"}, {"key": "9_CR897", "doi-asserted-by": "crossref", "first-page": "3901", "DOI": "10.1210/endo.142.9.8363", "volume": "142", "author": "T Hiroi", "year": "2001", "unstructured": "Hiroi T, Kishimoto W, Chow T, Imaoka S, Igarashi T, Funae Y (2001) Progesterone oxidation by cytochrome P450 2D isoforms in the brain. Endocrinology 142:3901\u20133908", "journal-title": "Endocrinology"}, {"key": "9_CR898", "doi-asserted-by": "crossref", "first-page": "11025", "DOI": "10.1021/bi020341k", "volume": "41", "author": "FP Guengerich", "year": "2002", "unstructured": "Guengerich FP, Miller GP, Hanna IH, Martin MV, Leger S, Black C, Chauret N, Silva JM, Trimble LA, Yergey JA, Nicoll-Griffith DA (2002) Diversity in the oxidation of substrates by cytochrome P450 2D6: lack of an obligatory role of aspartate 301-substrate electrostatic bonding. Biochemistry 41:11025\u201311034", "journal-title": "Biochemistry"}, {"key": "9_CR899", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1097/00008571-199704000-00001", "volume": "7", "author": "C Martinez", "year": "1997", "unstructured": "Martinez C, Agundez JA, Gervasini G, Martin R, Benitez J (1997) Tryptamine: a possible endogenous substrate for CYP2D6. Pharmacogenetics 7:85\u201393", "journal-title": "Pharmacogenetics"}, {"key": "9_CR900", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1097/00008571-200306000-00002", "volume": "13", "author": "AM Yu", "year": "2003", "unstructured": "Yu AM, Idle JR, Herraiz T, K\u00fcpfer A, Gonzalez FJ (2003) Screening for endogenous substrates reveals that CYP2D6 is a 5-methoxyindolethylamine O-demethylase. Pharmacogenetics 13:307\u2013319", "journal-title": "Pharmacogenetics"}, {"key": "9_CR901", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1097/00008571-200303000-00007", "volume": "13", "author": "AM Yu", "year": "2003", "unstructured": "Yu AM, Idle JR, Byrd LG, Krausz KW, Kupfer A, Gonzalez FJ (2003) Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6. Pharmacogenetics 13:173\u2013181", "journal-title": "Pharmacogenetics"}, {"key": "9_CR902", "doi-asserted-by": "crossref", "first-page": "1611", "DOI": "10.1021/tx050140s", "volume": "18", "author": "LM Notley", "year": "2005", "unstructured": "Notley LM, Crewe KH, Taylor PJ, Lennard MS, Gillam EMJ (2005) Characterization of the human cytochrome P450 forms involved in metabolism of tamoxifen to its \u03b1-hydroxy and \u03b1,4-dihydroxy derivatives. Chem Res Toxicol 18:1611\u20131618", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR903", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1124/dmd.32.4.379", "volume": "32", "author": "RF Staack", "year": "2004", "unstructured": "Staack RF, Theobald DS, Paul LD, Springer D, Kraemer T, Maurer HH (2004) Identification of human cytochrome P450 2D6 as major enzyme involved in the O-demethylation of the designer drug p-methoxymethamphetamine. Drug Metab Dispos 32:379\u2013381", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR904", "doi-asserted-by": "crossref", "first-page": "387", "DOI": "10.1016/j.taap.2006.06.003", "volume": "216", "author": "T Herraiz", "year": "2006", "unstructured": "Herraiz T, Guillen H, Aran VJ, Idle JR, Gonzalez FJ (2006) Comparative aromatic hydroxylationand N-demethylation of MPTP neurotoxin and its analogs, N-methylated \u03b2-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6. Toxicol Appl Pharmacol 216:387\u2013398", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "9_CR905", "doi-asserted-by": "crossref", "first-page": "24425", "DOI": "10.1074/jbc.M109.011320", "volume": "284", "author": "N Grobe", "year": "2009", "unstructured": "Grobe N, Zhang B, Fisinger U, Kutchan TM, Zenk MH, Guengerich FP (2009) Mammalian cytochrome P450 enzymes catalyze the phenol-coupling step in endogenous morphine biosynthesis. J Biol Chem 284:24425\u201324431", "journal-title": "J Biol Chem"}, {"key": "9_CR906", "unstructured": "Kramlinger VM, Kanamori T, Alvardo-Rojas M, Guengerich FP (2015) O 6-Demethylation of thebaine by human cytochromes P450 3A4 and 3A5 in the biosynthesis of endogenous morphine. J Biol Chem 290 (submitted)", "DOI": "10.1074/jbc.M115.665331", "doi-asserted-by": "crossref"}, {"key": "9_CR907", "doi-asserted-by": "crossref", "first-page": "4461", "DOI": "10.1021/bi962633p", "volume": "36", "author": "S Modi", "year": "1997", "unstructured": "Modi S, Gilham DE, Sutcliffe MJ, Lian L-Y., Primrose WU, Wolf CR, Roberts GCK (1997) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine as a substrate of cytochrome P450 2D6: allosteric effects of NADPH-cytochrome P450 reductase. Biochemistry 36:4461\u20134470", "journal-title": "Biochemistry"}, {"key": "9_CR908", "doi-asserted-by": "crossref", "first-page": "39553", "DOI": "10.1074/jbc.M106841200", "volume": "276", "author": "IH Hanna", "year": "2001", "unstructured": "Hanna IH, Krauser JA, Cai H, Kim MS, Guengerich FP (2001) Diversity in mechanisms of substrate oxidation by cytochrome P450 2D6. Lack of an allosteric role of NADPH-cytochrome P450 reductase in catalytic regioselectivity. J Biol Chem 276:39553\u201339561", "journal-title": "J Biol Chem"}, {"key": "9_CR909", "doi-asserted-by": "crossref", "first-page": "33711", "DOI": "10.1074/jbc.M205146200", "volume": "277", "author": "FP Guengerich", "year": "2002", "unstructured": "Guengerich FP, Miller GP, Hanna IH, Sato H, Martin MV (2002) Oxidation of methoxyphenethylamines by cytochrome P450 2D6. Analysis of rate-limiting steps. J Biol Chem 277:33711\u201333719", "journal-title": "J Biol Chem"}, {"key": "9_CR910", "doi-asserted-by": "crossref", "first-page": "303", "DOI": "10.1006/abbi.2000.1936", "volume": "380", "author": "T Fukuda", "year": "2000", "unstructured": "Fukuda T, Nishida Y, Imaoka S, Hiroi T, Naohara M, Funae Y, Azuma J (2000) The decreased in vivo clearance of CYP2D6 substrates by CYP2D6*10 might be caused not only by the low-expression but also by low affinity of CYP2D6. Arch Biochem Biophys 380:303\u2013308", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR911", "doi-asserted-by": "crossref", "first-page": "281", "DOI": "10.1007/BF00125503", "volume": "7", "author": "L Koymans", "year": "1993", "unstructured": "Koymans L, Vermeulen NPE, Baarslag A, Donne-Op den Kelder G (1993) A preliminary 3D model for cytochrome P450 2D6 constructed by homology model building. J Comput Aided Mol Des 7:281\u2013289", "journal-title": "J Comput Aided Mol Des"}, {"key": "9_CR912", "doi-asserted-by": "crossref", "first-page": "1079", "DOI": "10.1021/tx960003i", "volume": "9", "author": "MJ de Groot", "year": "1996", "unstructured": "de Groot MJ, Vermeulen NPE, Kramer JD, van Acker FAA, Donn\u00e9-Op den Kelder GM (1996) A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structure of P450 101, P450 102, and P450 108. Chem Res Toxicol 9:1079\u20131091", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR913", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1080/004982597240497", "volume": "27", "author": "DFV Lewis", "year": "1997", "unstructured": "Lewis DFV, Eddershaw PJ, Goldfarb PS, Tarbit MH (1997) Molecular modeling of cytochrome P4502D6 (CYP2D6) based on an alignment with CYP102: structural studies on specific CYP2D6 substrate metabolism. Xenobiotica 27:319\u2013340", "journal-title": "Xenobiotica"}, {"key": "9_CR914", "doi-asserted-by": "crossref", "first-page": "4540", "DOI": "10.1021/bi952742o", "volume": "35", "author": "S Modi", "year": "1996", "unstructured": "Modi S, Paine MJ, Sutcliffe MJ, Lian LY, Primrose WU, Wolf CR, Roberts GCK. (1996) A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding. Biochemistry 35:4540\u20134550", "journal-title": "Biochemistry"}, {"key": "9_CR915", "doi-asserted-by": "crossref", "first-page": "4062", "DOI": "10.1021/jm991058v", "volume": "42", "author": "MJ de Groot", "year": "1999", "unstructured": "de Groot MJ, Ackland MJ, Horne VA, Alex AA, Jones BC (1999) A novel approach to predicting P450 mediated drug metabolism. CYP2D6 catalyzed N-dealkylation reactions and qualitative metabolite predictions using a combined protein and pharmacophore model for CYP2D6. J Med Chem 42:4062\u20134070", "journal-title": "J Med Chem"}, {"key": "9_CR916", "doi-asserted-by": "crossref", "first-page": "216", "DOI": "10.1002/prot.10192", "volume": "49", "author": "SB Kirton", "year": "2002", "unstructured": "Kirton SB, Kemp CA, Tomkinson NP, St-Gallay S, Sutcliffe MJ (2002) Impact of incorporating the 2C5 crystal structure into comparative models of cytochrome P450 2D6. Proteins 49:216\u2013231", "journal-title": "Proteins"}, {"key": "9_CR917", "doi-asserted-by": "crossref", "first-page": "74", "DOI": "10.1021/jm0209578", "volume": "46", "author": "J Venhorst", "year": "2003", "unstructured": "Venhorst J, ter Laak AM, Commandeur JN, Funae Y, Hiroi T, Vermeulen NP (2003) Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities. J Med Chem 46:74\u201386", "journal-title": "J Med Chem"}, {"key": "9_CR918", "doi-asserted-by": "crossref", "first-page": "234", "DOI": "10.1097/00008571-199508000-00007", "volume": "5", "author": "CL Crespi", "year": "1995", "unstructured": "Crespi CL, Steimel DT, Penman BW, Korzekwa KR, Fernandez-Salguero P, Buters JTM, Gelboin HV, Gonzalez FJ, Idle JR, Daly AK (1995) Comparison of substrate metabolism by wild type CYP2D6 protein and a variant containing methionine, not valine, at position 374. Pharmacogenetics 5:234\u2013243", "journal-title": "Pharmacogenetics"}, {"key": "9_CR919", "doi-asserted-by": "crossref", "first-page": "647", "DOI": "10.1042/bj3160647", "volume": "316", "author": "SW Ellis", "year": "1996", "unstructured": "Ellis SW, Rowland K, Ackland MJ, Rekka E, Simula AP, Lennard MS, Wolf CR, Tucker GT (1996) Influence of amino acid residue 374 of cytochrome P-450 2D6 (CYP2D6) on the regio- and enantio-selective metabolism of metoprolol. Biochem J 316:647\u2013654", "journal-title": "Biochem J"}, {"key": "9_CR920", "doi-asserted-by": "crossref", "first-page": "7614", "DOI": "10.1074/jbc.M511232200", "volume": "281", "author": "P Rowland", "year": "2006", "unstructured": "Rowland P, Blaney FE, Smyth MG, Jones JJ, Leydon VR, Oxbrow AK, Lewis CJ, Tennant MG, Modi S, Eggleston DS, Chenery RJ, Bridges AM (2006) Crystal structure of human cytochrome P450 2D6. J Biol Chem 281:7614\u20137622", "journal-title": "J Biol Chem"}, {"key": "9_CR921", "doi-asserted-by": "crossref", "first-page": "46", "DOI": "10.1016/j.jinorgbio.2012.02.010", "volume": "110", "author": "K Berka", "year": "2012", "unstructured": "Berka K, Anzenbacherova E, Hendrychova T, Lange R, Masek V, Anzenbacher P, Otyepka M (2012) Binding of quinidine radically increases the stability and decreases the flexibility of the cytochrome P450 2D6 active site. J Inorg Biochem 110:46\u201350", "journal-title": "J Inorg Biochem"}, {"key": "9_CR922", "doi-asserted-by": "crossref", "first-page": "1245", "DOI": "10.1021/bi027085w", "volume": "42", "author": "FP Guengerich", "year": "2003", "unstructured": "Guengerich FP, Hanna IH, Martin MV, Gillam EMJ (2003) Role of glutamic acid 216 in cytochrome P450 2D6 substrate binding and catalysis. Biochemistry 42:1245\u20131253", "journal-title": "Biochemistry"}, {"key": "9_CR923", "doi-asserted-by": "crossref", "first-page": "4021", "DOI": "10.1074/jbc.M209519200", "volume": "278", "author": "MJ Paine", "year": "2003", "unstructured": "Paine MJ, McLaughlin LA, Flanagan JU, Kemp CA, Sutcliffe MJ, Roberts GC, Wolf CR (2003) Residues glutamate 216 and aspartate 301 are key determinants of substrate specificity and product regioselectivity in cytochrome P450 2D6. J Biol Chem 278:4021\u20134027", "journal-title": "J Biol Chem"}, {"key": "9_CR924", "doi-asserted-by": "crossref", "first-page": "38617", "DOI": "10.1074/jbc.M505974200", "volume": "280", "author": "LA McLaughlin", "year": "2005", "unstructured": "McLaughlin LA, Paine MJ, Kemp CA, Marechal JD, Flanagan JU, Ward CJ, Sutcliffe MJ, Roberts GC, Wolf CR (2005) Why is quinidine an inhibitor of cytochrome P450 2D6? The role of key active-site residues in quinidine binding. J Biol Chem 280:38617\u201338624", "journal-title": "J Biol Chem"}, {"key": "9_CR925", "doi-asserted-by": "crossref", "first-page": "1938", "DOI": "10.1124/dmd.108.020776", "volume": "36", "author": "M Kotsuma", "year": "2008", "unstructured": "Kotsuma M, Hanzawa H, Iwata Y, Takahashi K, Tokui T (2008) Novel binding mode of the acidic CYP2D6 substrates pactimibe and its metabolite R-125528. Drug Metab Dispos 36:1938\u20131943", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR926", "doi-asserted-by": "crossref", "first-page": "811", "DOI": "10.2174/138620711796957170", "volume": "14", "author": "YG Shin", "year": "2011", "unstructured": "Shin YG, Le H, Khojasteh C, Hop CE (2011) Comparison of metabolic soft spot predictions of CYP3A4, CYP2C9 and CYP2D6 substrates using MetaSite and StarDrop. Comb Chem High Throughput Screen 14:811\u2013823", "journal-title": "Comb Chem High Throughput Screen"}, {"key": "9_CR927", "doi-asserted-by": "crossref", "first-page": "6098", "DOI": "10.1021/jm2006468", "volume": "54", "author": "SL Moors", "year": "2011", "unstructured": "Moors SL, Vos AM, Cummings MD, Van Vlijmen H, Ceulemans A (2011) Structure-based site of metabolism prediction for cytochrome P450 2D6. J Med Chem 54:6098\u20136105", "journal-title": "J Med Chem"}, {"key": "9_CR928", "doi-asserted-by": "crossref", "first-page": "486", "DOI": "10.1124/dmd.111.043125", "volume": "40", "author": "K Sato", "year": "2012", "unstructured": "Sato K, Yamazoe Y (2012) Unimolecular and bimolecular binding system for the prediction of CYP2D6-mediated metabolism. Drug Metab Dispos 40:486\u2013496", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR929", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1124/dmd.111.041210", "volume": "40", "author": "BM VandenBrink", "year": "2012", "unstructured": "VandenBrink BM, Foti RS, Rock DA, Wienkers LC, Wahlstrom JL (2012) Prediction of CYP2D6 drug interactions from in vitro data: evidence for substrate-dependent inhibition. Drug Metab Dispos 40:47\u201353", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR930", "doi-asserted-by": "crossref", "first-page": "450", "DOI": "10.1021/tx025674x", "volume": "16", "author": "JM Hutzler", "year": "2003", "unstructured": "Hutzler JM, Walker GS, Wienkers LC (2003) Inhibition of cytochrome P450 2D6: structure-activity studies using a series of quinidine and quinine analogues. Chem Res Toxicol 16:450\u2013459", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR931", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1016/0024-3205(84)90332-1", "volume": "34", "author": "SV Otton", "year": "1984", "unstructured": "Otton SV, Inaba T, Kalow W (1984) Competitive inhibition of sparteine oxidation in human liver by \u03b2-adrenoceptor antagonists and other cardiovascular drugs. Life Sci 34:73\u201380", "journal-title": "Life Sci"}, {"key": "9_CR932", "first-page": "863", "volume": "29", "author": "JR Palamanda", "year": "2001", "unstructured": "Palamanda JR, Casciano CN, Norton LA, Clement RP, Favreau LV, Lin CC, Nomeir AA (2001) Mechanism-based inactivation of CYP2D6 by 5-fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine. Drug Metab Dispos 29:863\u2013867", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR933", "doi-asserted-by": "crossref", "first-page": "174", "DOI": "10.1021/tx034199f", "volume": "17", "author": "JM Hutzler", "year": "2004", "unstructured": "Hutzler JM, Steenwyk RC, Smith EB, Walker GS, Wienkers LC (2004) Mechanism-based inactivation of cytochrome P450 2D6 by 1-[(2-ethyl-4-methyl-1H-imidazol-5-yl)methyl]- 4-[4-(trifluoromethyl)-2-pyridinyl]piperazine: kinetic characterization and evidence for apoprotein adduction. Chem Res Toxicol 17:174\u2013184", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR934", "doi-asserted-by": "crossref", "first-page": "974", "DOI": "10.1124/dmd.110.037630", "volume": "39", "author": "LD Nagy", "year": "2011", "unstructured": "Nagy LD, Mocny CS, Diffenderfer LE, Hsi DJ, Butler BF, Arthur EJ, Fletke KJ, Palamanda JR, Nomeir AA, Furge LL (2011) Substituted imidazole of 5-fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine inactivates cytochrome P450 2D6 by protein adduction. Drug Metab Dispos 39:974\u2013983", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR935", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.2174/187231212800229318", "volume": "6", "author": "M Livezey", "year": "2012", "unstructured": "Livezey M, Nagy LD, Diffenderfer LE, Arthur EJ, Hsi DJ, Holton JM, Furge LL (2012) Molecular analysis and modeling of inactivation of human CYP2D6 by four mechanism based inactivators. Drug Metab Lett 6:7\u201314", "journal-title": "Drug Metab Lett"}, {"key": "9_CR936", "doi-asserted-by": "crossref", "first-page": "1213", "DOI": "10.1124/dmd.104.001180", "volume": "32", "author": "A Heydari", "year": "2004", "unstructured": "Heydari A, Yeo KR, Lennard MS, Ellis SW, Tucker GT, Rostami-Hodjegan A (2004) Mechanism-based inactivation of CYP2D6 by methylenedioxymethamphetamine. Drug Metab Dispos 32:1213\u20131217", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR937", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.3109/00498254.2013.835885", "volume": "44", "author": "MR Livezey", "year": "2014", "unstructured": "Livezey MR, Briggs ED, Bolles AK, Nagy LD, Fujiwara R, Furge LL (2014) Metoclopramide is metabolized by CYP2D6 and is a reversible inhibitor, but not inactivator, of CYP2D6. Xenobiotica 44:309\u2013319", "journal-title": "Xenobiotica"}, {"key": "9_CR938", "doi-asserted-by": "crossref", "first-page": "392", "DOI": "10.1016/j.fct.2013.02.054", "volume": "56", "author": "XY Qi", "year": "2013", "unstructured": "Qi XY, Liang SC, Ge GB, Liu Y, Dong PP, Zhang JW, Wang AX, Hou J, Zhu LL, Yang L, Tu CX (2013) Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes. Food Chem Toxicol 56:392\u2013397", "journal-title": "Food Chem Toxicol"}, {"key": "9_CR939", "doi-asserted-by": "crossref", "first-page": "2049", "DOI": "10.1124/dmd.111.041384", "volume": "39", "author": "S Yamaori", "year": "2011", "unstructured": "Yamaori S, Okamoto Y, Yamamoto I, Watanabe K (2011) Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6. Drug Metab Dispos 39:2049\u20132056", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR940", "doi-asserted-by": "crossref", "first-page": "827", "DOI": "10.1038/clpt.1983.257", "volume": "34", "author": "NS Oates", "year": "1983", "unstructured": "Oates NS, Shah RR, Idle JR, Smith RL (1983) Influence of oxidation polymorphism on phenformin kinetics and dynamics. Clin Pharmacol Ther 34:827\u2013834", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR941", "first-page": "601P", "volume": "14", "author": "NS Oates", "year": "1982", "unstructured": "Oates NS, Shah RR, Drury PL, Idle JR, Smith RL (1982) Captopril-induced agranulocytosis associated with an impairment of debrisoquine hydroxylation. Br J Clin Pharmacol 14:601P", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR942", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1097/00008571-200208000-00007", "volume": "12", "author": "T Rau", "year": "2002", "unstructured": "Rau T, Heide R, Bergmann K, Wuttke H, Werner U, Feifel N, Eschenhagen T (2002) Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment. Pharmacogenetics 12:465\u2013472", "journal-title": "Pharmacogenetics"}, {"key": "9_CR943", "doi-asserted-by": "crossref", "first-page": "1633", "DOI": "10.1016/S0278-6915(02)00117-5", "volume": "40", "author": "JL Dorne", "year": "2002", "unstructured": "Dorne JL, Walton K, Slob W, Renwick AG (2002) Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate? Food Chem Toxicol 40:1633\u20131656", "journal-title": "Food Chem Toxicol"}, {"key": "9_CR944", "doi-asserted-by": "crossref", "first-page": "246", "DOI": "10.1097/00004714-200004000-00019", "volume": "20", "author": "WH Chou", "year": "2000", "unstructured": "Chou WH, Yan FX, de Leon J, Barnhill J, Rogers T, Cronin M, Pho M, Xiao V, Ryder TB, Liu WW, Teiling C, Wedlund PJ (2000) Extension of a pilot study: impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness. J Clin Psychopharmacol 20:246\u2013251", "journal-title": "J Clin Psychopharmacol"}, {"key": "9_CR945", "doi-asserted-by": "crossref", "first-page": "453", "DOI": "10.2165/00003088-200241070-00001", "volume": "41", "author": "ML Dahl", "year": "2002", "unstructured": "Dahl ML (2002) Cytochrome P450 phenotyping/genotyping in patients receiving antipsychotics: useful aid to prescribing? Clin Pharmacokinet 41:453\u2013470", "journal-title": "Clin Pharmacokinet"}, {"key": "9_CR946", "doi-asserted-by": "crossref", "first-page": "154", "DOI": "10.1016/S0006-3223(01)01353-1", "volume": "52", "author": "EM Scolnick", "year": "2002", "unstructured": "Scolnick EM (2002) Discovery and development of antidepressants: a perspective from a pharmaceutical discovery company. Biol Psychiatry 52:154\u2013156", "journal-title": "Biol Psychiatry"}, {"key": "9_CR947", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.2217/pgs.11.137", "volume": "13", "author": "W Zhang", "year": "2012", "unstructured": "Zhang W, Roederer MW, Chen WQ, Fan L, Zhou HH (2012) Pharmacogenetics of drugs withdrawn from the market. Pharmacogenomics 13:223\u2013231", "journal-title": "Pharmacogenomics"}, {"key": "9_CR948", "doi-asserted-by": "crossref", "first-page": "1025", "DOI": "10.4088/JCP.13lr08555", "volume": "74", "author": "EJ Berm", "year": "2013", "unstructured": "Berm EJ, Risselada AJ, Mulder H, Hak E, Wilffert B (2013) Phenoconversion of cytochrome P450 2D6: the need for identifying the intermediate metabolizer genotype. J Clin Psychiatry 74:1025", "journal-title": "J Clin Psychiatry"}, {"key": "9_CR949", "doi-asserted-by": "crossref", "first-page": "679", "DOI": "10.2174/1389200211209050679", "volume": "13", "author": "JL Pilgrim", "year": "2012", "unstructured": "Pilgrim JL, Ruiz Y, Gesteira A, Cruz R, Gerostamoulos D, Carracedo A, Drummer OH (2012) Characterization of single nucleotide polymorphisms of cytochrome P450 in an Australian deceased sample. Curr Drug Metab 13:679\u2013692", "journal-title": "Curr Drug Metab"}, {"key": "9_CR950", "doi-asserted-by": "crossref", "first-page": "855", "DOI": "10.1007/s00228-011-1080-x", "volume": "67", "author": "A Elkalioubie", "year": "2011", "unstructured": "Elkalioubie A, Allorge D, Robriquet L, Wiart JF, Garat A, Broly F, Fourrier F (2011) Near-fatal tramadol cardiotoxicity in a CYP2D6 ultrarapid metabolizer. Eur J Clin Pharmacol 67:855\u2013858", "journal-title": "Eur J Clin Pharmacol"}, {"key": "9_CR951", "doi-asserted-by": "crossref", "first-page": "1267", "DOI": "10.1093/jnci/djt221", "volume": "105", "author": "D Berry", "year": "2013", "unstructured": "Berry D (2013) CYP2D6 genotyping and the use of tamoxifen in breast cancer. J Natl Cancer Inst 105:1267\u20131269", "journal-title": "J Natl Cancer Inst"}, {"key": "9_CR952", "doi-asserted-by": "crossref", "first-page": "216", "DOI": "10.1038/clpt.2013.186", "volume": "95", "author": "MA Province", "year": "2014", "unstructured": "Province MA, Goetz MP, Brauch H, Flockhart DA, Hebert JM, Whaley R, Suman VJ, Schroth W, Winter S, Zembutsu H, Mushiroda T, Newman WG, Lee MT, Ambrosone CB, Beckmann MW, Choi JY, Dieudonne AS, Fasching PA, Ferraldeschi R, Gong L, Haschke-Becher E, Howell A, Jordan LB, Hamann U, Kiyotani K, Krippl P, Lambrechts D, Latif A, Langsenlehner U, Lorizio W, Neven P, Nguyen AT, Park BW, Purdie CA, Quinlan P, Renner W, Schmidt M, Schwab M, Shin JG, Stingl JC, Wegman P, Wingren S, Wu AH, Ziv E, Zirpoli G, Thompson AM, Jordan VC, Nakamura Y, Altman RB, Ames MM, Weinshilboum RM, Eichelbaum M, Ingle JN, Klein TE (2014) CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations. Clin Pharmacol Ther 95:216\u2013227", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR953", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1016/j.jns.2013.10.030", "volume": "336", "author": "Y Lu", "year": "2014", "unstructured": "Lu Y, Peng Q, Zeng Z, Wang J, Deng Y, Xie L, Mo C, Zeng J, Qin X, Li S (2014) CYP2D6 phenotypes and Parkinson\u2019s disease risk: a meta-analysis. J Neurol Sci 336:161\u2013168", "journal-title": "J Neurol Sci"}, {"key": "9_CR954", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.2217/pgs.13.221", "volume": "15", "author": "JA Jung", "year": "2014", "unstructured": "Jung JA, Lim HS (2014) Association between CYP2D6 genotypes and the clinical outcomes of adjuvant tamoxifen for breast cancer: a meta-analysis. Pharmacogenomics 15:49\u201360", "journal-title": "Pharmacogenomics"}, {"key": "9_CR955", "first-page": "3675", "volume": "49", "author": "N Caporaso", "year": "1989", "unstructured": "Caporaso N, Hayes RB, Dosemeci M, Hoover R, Ayesh R, Hetzel M, Idle J (1989) Lung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype. Cancer Res 49:3675\u20133679", "journal-title": "Cancer Res"}, {"key": "9_CR956", "first-page": "251", "volume": "56", "author": "C Bouchardy", "year": "1996", "unstructured": "Bouchardy C, Benhamou S, Dayer P (1996) The effect of tobacco on lung cancer risk depends on CYP2D6 activity. Cancer Res 56:251\u2013253", "journal-title": "Cancer Res"}, {"key": "9_CR957", "first-page": "215", "volume": "7", "author": "GL Shaw", "year": "1998", "unstructured": "Shaw GL, Falk RT, Frame JN, Weiffenbach B, Nesbitt JV, Pass HI, Caporaso NE, Moir DT, Tucker MA (1998) Genetic polymorphism of CYP2D6 and lung cancer risk. Cancer Epidemiol Biomarkers Prev 7:215\u2013219", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9_CR958", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1097/00008571-199806000-00005", "volume": "8", "author": "A Rostami-Hodjegan", "year": "1998", "unstructured": "Rostami-Hodjegan A, Lennard MS, Woods HF, Tucker GT (1998) Meta-analysis of studies of the CYP2D6 polymorphism in relation to lung cancer and Parkinson\u2019s disease. Pharmacogenetics 8:227\u2013238", "journal-title": "Pharmacogenetics"}, {"key": "9_CR959", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1097/00008571-199802000-00002", "volume": "8", "author": "M LegrandAndreoletti", "year": "1998", "unstructured": "LegrandAndreoletti M, Stucker I, Marez D, Galais P, Cosme J, Sabbagh N, Spire C, Cenee S, Lafitte JJ, Beaune P, Broly F (1998) Cytochrome P450 CYP2D6 gene polymorphism and lung cancer susceptibility in Caucasians. Pharmacogenetics 8:7\u201314", "journal-title": "Pharmacogenetics"}, {"key": "9_CR960", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.1007/s002280050219", "volume": "51", "author": "PM Christensen", "year": "1997", "unstructured": "Christensen PM, G*tzsche PC, Br\u00f8sen K (1997) The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of lung cancer: a meta-analysis. Eur J Clin Pharmacol 51:389\u2013393", "journal-title": "Eur J Clin Pharmacol"}, {"key": "9_CR961", "doi-asserted-by": "crossref", "first-page": "128", "DOI": "10.1097/00008571-199206000-00004", "volume": "2", "author": "CM Fleming", "year": "1992", "unstructured": "Fleming CM, Kaisary A, Wilkinson GR, Smith P, Branch RA (1992) The ability to 4-hydroxylate debrisoquine is related to recurrence of bladder cancer. Pharmacogenetics 2:128\u2013134", "journal-title": "Pharmacogenetics"}, {"key": "9_CR962", "doi-asserted-by": "crossref", "first-page": "433", "DOI": "10.1097/00008571-199810000-00008", "volume": "8", "author": "SF Worrall", "year": "1998", "unstructured": "Worrall SF, Corrigan M, High A, Starr D, Matthias C, Wolf CR, Jones PW, Hand P, Gilford J, Farrell WE, Hoban P, Fryer AA, Strange RC (1998) Susceptibility and outcome in oral cancer: preliminary data showing an association with polymorphism in cytochrome P450 CYP2D6. Pharmacogenetics 8:433\u2013439", "journal-title": "Pharmacogenetics"}, {"key": "9_CR963", "doi-asserted-by": "crossref", "first-page": "1213", "DOI": "10.1016/S0140-6736(85)90743-3", "volume": "ii", "author": "A Barbeau", "year": "1985", "unstructured": "Barbeau A, Roy M, Paris S, Cloutier T, Plasse L, Poirier J (1985) Ecogenetics of Parkinson\u2019s disease: 4-hydroxylation of debrisoquine. Lancet ii:1213\u20131215", "journal-title": "Lancet"}, {"key": "9_CR964", "doi-asserted-by": "crossref", "first-page": "1017", "DOI": "10.1016/0140-6736(92)90537-D", "volume": "339", "author": "M Armstrong", "year": "1992", "unstructured": "Armstrong M, Daly AK, Cholerton S, Bateman DN, Idle JR (1992) Mutant debrisoquine hydroxylation genes in Parkinson\u2019s disease. Lancet 339:1017\u20131018", "journal-title": "Lancet"}, {"key": "9_CR965", "doi-asserted-by": "crossref", "first-page": "290", "DOI": "10.1002/mds.1041", "volume": "16", "author": "BS Harhangi", "year": "2001", "unstructured": "Harhangi BS, Oostra BA, Heutink P, van Duijn CM, Hofman A, Breteler MM (2001) CYP2D6 polymorphism in Parkinson\u2019s disease: the Rotterdam study. Mov Disord 16:290\u2013293", "journal-title": "Mov Disord"}, {"key": "9_CR966", "doi-asserted-by": "crossref", "first-page": "851", "DOI": "10.1080/00207450290025860", "volume": "112", "author": "MF Allam", "year": "2002", "unstructured": "Allam MF, Serrano del Castillo A, Fernandez-Crehuet Navajas R (2002) Smoking and Parkinson\u2019s disease: explanatory hypothesis. Int J Neurosci 112:851\u2013854", "journal-title": "Int J Neurosci"}, {"key": "9_CR967", "doi-asserted-by": "crossref", "first-page": "8256", "DOI": "10.1073/pnas.85.21.8256", "volume": "85", "author": "UM Zanger", "year": "1988", "unstructured": "Zanger UM, Hauri HP, Loeper J, Homberg JC, Meyer UA (1988) Antibodies against human cytochrome P-450dbl in autoimmune hepatitis type II. Proc Natl Acad Sci U S A 85:8256\u20132860", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR968", "doi-asserted-by": "crossref", "first-page": "503", "DOI": "10.1007/BF02919749", "volume": "10", "author": "MP Manns", "year": "1991", "unstructured": "Manns MP (1991) Cytochrome P450 enzymes as human autoantigens. Immunol Res 10:503\u2013507", "journal-title": "Immunol Res"}, {"key": "9_CR969", "doi-asserted-by": "crossref", "first-page": "1370", "DOI": "10.1172/JCI115443", "volume": "88", "author": "MP Manns", "year": "1991", "unstructured": "Manns MP, Griffin KJ, Sullivan KF, Johnson EF (1991) LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest 88:1370\u20131378", "journal-title": "J Clin Invest"}, {"key": "9_CR970", "doi-asserted-by": "crossref", "first-page": "203", "DOI": "10.1016/0016-5085(93)90853-5", "volume": "104", "author": "J Loeper", "year": "1993", "unstructured": "Loeper J, Descatoire V, Maurice M, Beaune P, Belghiti J, Houssin D, Ballet F, Feldmann G, Guengerich FP, Pessayre D (1993) Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies. Gastroenterology 104:203\u2013216", "journal-title": "Gastroenterology"}, {"key": "9_CR971", "doi-asserted-by": "crossref", "first-page": "449", "DOI": "10.1136/gut.46.4.449", "volume": "46", "author": "D Vergani", "year": "2000", "unstructured": "Vergani D (2000) LKM antibody: getting in some target practice. Gut 46:449\u2013450", "journal-title": "Gut"}, {"key": "9_CR972", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1016/S0022-1759(02)00016-9", "volume": "262", "author": "S Vitozzi", "year": "2002", "unstructured": "Vitozzi S, Lapierre P, Djilali-Saiah I, Alvarez F (2002) Autoantibody detection in type 2 autoimmune hepatitis using a chimerarecombinant protein. J Immunol Methods 262:103\u2013110", "journal-title": "J Immunol Methods"}, {"key": "9_CR973", "doi-asserted-by": "crossref", "first-page": "734", "DOI": "10.1016/0168-8278(95)80041-7", "volume": "23", "author": "W Nolte", "year": "1995", "unstructured": "Nolte W, Polzien F, Sattler B, Ramadori G, Hartmann H (1995) Recurrent episodes of acute hepatitis associated with LKM-1 (cytochrome P450 2D6) antibodies in identical twin brothers. J Hepatol 23:734\u2013739", "journal-title": "J Hepatol"}, {"key": "9_CR974", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1016/j.eurpsy.2013.10.002", "volume": "29", "author": "A Sicras-Mainar", "year": "2014", "unstructured": "Sicras-Mainar A, Guijarro P, Armada B, Blanca-Tamayo M, Navarro-Artieda R (2014) Influence of combinations of drugs that act on the CYP2D6 metabolic pathway in the treatment of major depressive disorder: a population-based study. Eur Psychiatry 29:331\u2013337. doi:10.1016/j.eurpsy.2013.10.002", "journal-title": "Eur Psychiatry"}, {"key": "9_CR975", "doi-asserted-by": "crossref", "first-page": "304", "DOI": "10.1038/clpt.2010.144", "volume": "88", "author": "L Bertilsson", "year": "2010", "unstructured": "Bertilsson L (2010) CYP2D6, serotonin, and suicide\u2014a relationship? Clin Pharmacol Ther 88:304\u2013305", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR976", "doi-asserted-by": "crossref", "first-page": "785", "DOI": "10.1111/j.1365-2125.2004.02076.x", "volume": "57", "author": "SH Gan", "year": "2004", "unstructured": "Gan SH, Ismail R, Wan Adnan WA, Zulmi W, Kumaraswamy N, Larmie ET (2004) Relationship between type A and B personality and debrisoquine hydroxylation capacity. Br J Clin Pharmacol 57:785\u2013789", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR977", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.1016/0006-291X(65)90429-8", "volume": "21", "author": "WH Orme-Johnson", "year": "1965", "unstructured": "Orme-Johnson WH, Ziegler DM (1965) Alcohol mixed function oxidase activity of mammalian liver micoromes. Biochem Biophys Res Commun 21:78\u201382", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR978", "first-page": "2505", "volume": "245", "author": "CS Lieber", "year": "1970", "unstructured": "Lieber CS, DeCarli LM (1970) Hepatic microsomal ethanol oxidizing system: In vitro chracteristics and adaptive properties in vivo. J Biol Chem 245:2505\u20132512", "journal-title": "J Biol Chem"}, {"key": "9_CR979", "doi-asserted-by": "crossref", "first-page": "404", "DOI": "10.1016/0003-9861(74)90492-5", "volume": "163", "author": "R Teschke", "year": "1974", "unstructured": "Teschke R, Hasumura Y, Lieber CS (1974) Hepatic microsomal ethanol-oxidizing system: solubilization, isolation and characterization. Arch Biochem Biophys 163:404\u2013415", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR980", "first-page": "6385", "volume": "260", "author": "DE Ryan", "year": "1985", "unstructured": "Ryan DE, Ramanathan L, Iida S, Thomas PE, Haniu M, Shively JE, Lieber CS, Levin W (1985) Characterization of a major form of rat hepatic microsomal cytochrome P-450 induced by isoniazid. J Biol Chem 260:6385\u20136393", "journal-title": "J Biol Chem"}, {"key": "9_CR981", "doi-asserted-by": "crossref", "first-page": "9006", "DOI": "10.1021/bi00425a019", "volume": "27", "author": "M Umeno", "year": "1988", "unstructured": "Umeno M, McBride OW, Yang C-S, Gelboin HV, Gonzalez FJ (1988) Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosomemapping, and cDNA-directed expression. Biochemistry 27:9006\u20139013", "journal-title": "Biochemistry"}, {"key": "9_CR982", "doi-asserted-by": "crossref", "first-page": "1672", "DOI": "10.1021/pr800795r", "volume": "8", "author": "C Seibert", "year": "2009", "unstructured": "Seibert C, Davidson BR, Fuller BJ, Patterson LH, Griffiths WJ, Wang Y (2009) Multiple-approaches to the identification and quantification of cytochromes P450 in human liver tissue by mass spectrometry. J Proteome Res 8:1672\u20131681", "journal-title": "J Proteome Res"}, {"key": "9_CR983", "first-page": "1189", "volume": "256", "author": "FP Guengerich", "year": "1991", "unstructured": "Guengerich FP, Turvy CG (1991) Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolasein normal and disease states using immunochemical analysis of surgical liver samples. J Pharmacol Exp Ther 256:1189\u20131194", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR984", "doi-asserted-by": "crossref", "first-page": "476", "DOI": "10.1111/j.1432-1033.1996.0476z.x", "volume": "238", "author": "I Vieira", "year": "1996", "unstructured": "Vieira I, Sonnier M, Cresteil T (1996) Developmental expression of CYP2E1 in the human liver: hypermethylation control of gene expression during the neonatal period. Eur J Biochem 238:476\u2013483", "journal-title": "Eur J Biochem"}, {"key": "9_CR985", "doi-asserted-by": "crossref", "first-page": "402", "DOI": "10.1124/jpet.102.053124", "volume": "307", "author": "EK Johnsrud", "year": "2003", "unstructured": "Johnsrud EK, Koukouritaki SB, Divakaran K, Brunengraber LL, Hines RN, McCarver DG (2003) Human hepatic CYP2E1 expression during development. J Pharmacol Exp Ther 307:402\u2013407", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR986", "doi-asserted-by": "crossref", "first-page": "1019", "DOI": "10.1073/pnas.91.3.1019", "volume": "91", "author": "M Warner", "year": "1994", "unstructured": "Warner M, Gustafsson JA (1994) Effect of ethanol on cytochrome P450 in the rat brain. Proc Natl Acad Sci U S A 91:1019\u20131023", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR987", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1006/abbi.1999.1477", "volume": "373", "author": "SC Upadhya", "year": "2000", "unstructured": "Upadhya SC, Tirumalai PS, Boyd MR, Mori T, Ravindranath V (2000) Cytochrome P4502E (CYP2E) in brain: constitutive expression, induction by ethanol and localization by fluorescence in Situ hybridization. Arch Biochem Biophys 373:23\u201334", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR988", "doi-asserted-by": "crossref", "first-page": "179", "DOI": "10.1016/0964-1955(94)90088-4", "volume": "30B", "author": "K Kazakoff", "year": "1994", "unstructured": "Kazakoff K, Iversen P, Lawson T, Baron J, Guengerich FP, Pour PM (1994) Involvement of cytochrome P450 2E1-like isoform in the activation of N-nitrosobis(2-oxopropyl)amine in the rat nasal mucosa. Eur J Cancer B Oral Oncol 30B:179\u2013185", "journal-title": "Eur J Cancer B Oral Oncol"}, {"key": "9_CR989", "doi-asserted-by": "crossref", "first-page": "426", "DOI": "10.1136/gut.42.3.426", "volume": "42", "author": "ID Norton", "year": "1998", "unstructured": "Norton ID, Apte MV, Haber PS, McCaughan GW, Pirola RC, Wilson JS (1998) Cytochrome P4502E1 is present in rat pancreas and is induced by chronic ethanol administration. Gut 42:426\u2013430", "journal-title": "Gut"}, {"key": "9_CR990", "doi-asserted-by": "crossref", "first-page": "9141", "DOI": "10.1073/pnas.88.20.9141", "volume": "88", "author": "JR Larson", "year": "1991", "unstructured": "Larson JR, Coon MJ, Porter TD (1991) Purification and properties of a shortened form of cytochrome P-450 2E1: deletion of the NH2-terminal membrane-insertion signal peptide does not alter the catalytic activities. Proc Natl Acad Sci U S A 88:9141\u20139145", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR991", "doi-asserted-by": "crossref", "first-page": "59", "DOI": "10.1006/abbi.1994.1280", "volume": "312", "author": "EMJ Gillam", "year": "1994", "unstructured": "Gillam EMJ, Guo Z, Guengerich FP (1994) Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties. Arch Biochem Biophys 312:59\u201366", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR992", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1016/S0014-5793(99)01361-7", "volume": "460", "author": "EPA Neve", "year": "1999", "unstructured": "Neve EPA, Ingelman-Sundberg M (1999) A soluble NH2-terminally truncated catalytically active form of rat cytochrome P450 2E1 targeted to liver mitochondria. FEBS Lett 460:309\u2013314", "journal-title": "FEBS Lett"}, {"key": "9_CR993", "doi-asserted-by": "crossref", "first-page": "24680", "DOI": "10.1074/jbc.M100363200", "volume": "276", "author": "MA Robin", "year": "2001", "unstructured": "Robin MA, Anandatheerthavarada HK, Fang JK, Cudic M, Otvos L, Avadhani NG (2001) Mitochondrial targeted cytochrome P450 2E1 (P450 MT5) contains an intact N-terminus and requires mitochondrial specific electron transferproteins for activity. J Biol Chem 276:24680\u201324689", "journal-title": "J Biol Chem"}, {"key": "9_CR994", "doi-asserted-by": "crossref", "first-page": "40583", "DOI": "10.1074/jbc.M203292200", "volume": "277", "author": "MA Robin", "year": "2002", "unstructured": "Robin MA, Anandatheerthavarada HK, Biswas G, Sepuri NB, Gordon DM, Pain D, Avadhani NG (2002) Bimodal targeting of microsomal CYP2E1 to mitochondria through activation of an N-terminal chimeric signal by cAMP-mediated phosphorylation. J Biol Chem 277:40583\u201340593", "journal-title": "J Biol Chem"}, {"key": "9_CR995", "doi-asserted-by": "crossref", "first-page": "17130", "DOI": "10.1074/jbc.M000957200", "volume": "275", "author": "EP Neve", "year": "2000", "unstructured": "Neve EP, Ingelman-Sundberg M (2000) Molecular basis for the transport of cytochrome P450 2E1 to the plasma membrane. J Biol Chem 275:17130\u201317135", "journal-title": "J Biol Chem"}, {"key": "9_CR996", "doi-asserted-by": "crossref", "first-page": "4252", "DOI": "10.1111/j.1742-4658.2011.08357.x", "volume": "278", "author": "L Knockaert", "year": "2011", "unstructured": "Knockaert L, Fromenty B, Robin MA (2011) Mechanisms of mitochondrial targeting of cytochrome P450 2E1: physiopathological role in liver injury and obesity. FEBS J 278:4252\u20134260", "journal-title": "FEBS J"}, {"key": "9_CR997", "doi-asserted-by": "crossref", "first-page": "12627", "DOI": "10.1074/jbc.M113.452367", "volume": "288", "author": "S Bansal", "year": "2013", "unstructured": "Bansal S, Anandatheerthavarada HK, Prabu GK, Milne GL, Martin MV, Guengerich FP, Avadhani NG (2013) Human cytochrome P450 2E1 mutations that alter mitochondrial targeting efficiency and susceptibility to ethanol-induced toxicity in cellular models. J Biol Chem 288:12627\u201312644", "journal-title": "J Biol Chem"}, {"key": "9_CR998", "doi-asserted-by": "crossref", "first-page": "2280", "DOI": "10.1021/bi00382a031", "volume": "26", "author": "PE Thomas", "year": "1987", "unstructured": "Thomas PE, Bandiera S, Maines SL, Ryan DE, Levin W (1987) Regulation of cytochrome P-450j, a high-affinity N-nitrosodimethylamine demethylase, in rat hepatic microsomes. Biochemistry 26:2280\u20132289", "journal-title": "Biochemistry"}, {"key": "9_CR999", "doi-asserted-by": "crossref", "first-page": "429", "DOI": "10.1002/bies.950120906", "volume": "12", "author": "DR Koop", "year": "1990", "unstructured": "Koop DR, Tierney DJ (1990) Multiple mechanisms in the regulation of ethanol-inducible cytochrome P450IIE1. Bioessays 12:429\u2013435", "journal-title": "Bioessays"}, {"key": "9_CR1000", "doi-asserted-by": "crossref", "first-page": "304", "DOI": "10.1006/bbrc.1999.1817", "volume": "266", "author": "KJ Woodcroft", "year": "1999", "unstructured": "Woodcroft KJ, Novak RF (1999) The role of phosphatidylinositol 3-kinase, Src kinase, and protein kinase A signaling pathways in insulin and glucagon regulation of CYP2E1 expression. Biochem Biophys Res Commun 266:304\u2013307", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1001", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1053/jhep.2000.8532", "volume": "32", "author": "E Siewert", "year": "2000", "unstructured": "Siewert E, Bort R, Kluge R, Heinrich PC, Castell J, Jover R (2000) Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent. Hepatology 32:49\u201355", "journal-title": "Hepatology"}, {"key": "9_CR1002", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1023/A:1007625925095", "volume": "16", "author": "D Lagadic-Gossmann", "year": "2000", "unstructured": "Lagadic-Gossmann D, Lerche C, Rissel M, Joannard F, Galisteo M, Guillouzo A, Corcos L (2000) The induction of the human hepatic CYP2E1 gene by interleukin 4 is transcriptional and regulated by protein kinase C. Cell Biol Toxicol 16:221\u2013233", "journal-title": "Cell Biol Toxicol"}, {"key": "9_CR1003", "doi-asserted-by": "crossref", "first-page": "1048", "DOI": "10.1124/jpet.102.041582", "volume": "304", "author": "J Hakkola", "year": "2003", "unstructured": "Hakkola J, Hu Y, Ingelman-Sundberg M (2003) Mechanisms of down-regulation of CYP2E1 expression by inflammatory cytokines in rat hepatoma cells. J Pharmacol Exp Ther 304:1048\u20131054", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1004", "doi-asserted-by": "crossref", "first-page": "1072", "DOI": "10.1016/0006-291X(90)90976-T", "volume": "166", "author": "SG Kim", "year": "1990", "unstructured": "Kim SG, Novak RF (1990) Induction of rat hepatic P450IIE1 (CYP 2E1) by pyridine: evidence for a role of protein synthesis in the absence of transcriptional activation. Biochem Biophys Res Commun 166:1072\u20131079", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1005", "doi-asserted-by": "crossref", "first-page": "29632", "DOI": "10.1074/jbc.270.50.29632", "volume": "270", "author": "BJ Roberts", "year": "1995", "unstructured": "Roberts BJ, Song BJ, Soh Y, Park SS, Shoaf SE (1995) Ethanol induces CYP2E1 by protein stabilization: role of ubiquitin conjugation in the rapid degradation of CYP2E1. J Biol Chem 270:29632\u201329635", "journal-title": "J Biol Chem"}, {"key": "9_CR1006", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1006/abbi.1997.9907", "volume": "341", "author": "MX Yang", "year": "1997", "unstructured": "Yang MX, Cederbaum AI (1997) Characterization of cytochrome P4502E1 turnover in transfected HepG2 cells expressing human CYP2E1. Arch Biochem Biophys 341:25\u201333", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1007", "first-page": "213", "volume": "291", "author": "MG Emery", "year": "1999", "unstructured": "Emery MG, Jubert C, Thummel KE, Kharasch ED (1999) Duration of cytochrome P-450 2E1 (CYP2E1) inhibition and estimation of functional CYP2E1 enzyme half-life after single-dose disulfiram administration in humans. J Pharmacol Exp Ther 291:213\u2013219", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1008", "doi-asserted-by": "crossref", "first-page": "1045", "DOI": "10.1016/j.bcp.2009.11.015", "volume": "79", "author": "T Mohri", "year": "2010", "unstructured": "Mohri T, Nakajima M, Fukami T, Takamiya M, Aoki Y, Yokoi T (2010) Human CYP2E1 is regulated by miR-378. Biochem Pharmacol 79:1045\u20131052", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR1009", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1016/B978-0-12-398339-8.00004-5", "volume": "63", "author": "AK Daly", "year": "2012", "unstructured": "Daly AK (2012) Genetic polymorphisms affecting drug metabolism: recent advances and clinical aspects. Adv Pharmacol 63:137\u2013167", "journal-title": "Adv Pharmacol"}, {"key": "9_CR1010", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1080/0049825031000086400", "volume": "33", "author": "N Hanioka", "year": "2003", "unstructured": "Hanioka N, Tanaka-Kagawa T, Miyata Y, Matsushima E, Makino Y, Ohno A, Yoda R, Jinno H, Ando M (2003) Functional characterization of three human cytochrome P450 2E1 variants with amino acid substitutions. Xenobiotica 33:575\u2013586", "journal-title": "Xenobiotica"}, {"key": "9_CR1011", "doi-asserted-by": "crossref", "first-page": "321", "DOI": "10.1093/oxfordjournals.jbchem.a124526", "volume": "116", "author": "J Watanabe", "year": "1994", "unstructured": "Watanabe J, Hayashi S, Kawajiri K (1994) Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5\u2032-flanking region. J Biochem (Tokyo) 116:321\u2013326", "journal-title": "J Biochem (Tokyo)"}, {"key": "9_CR1012", "doi-asserted-by": "crossref", "first-page": "543", "DOI": "10.1097/00008571-199812000-00011", "volume": "8", "author": "KS Fairbrother", "year": "1998", "unstructured": "Fairbrother KS, Grove J, de Waziers I, Steimel DT, Day CP, Crespi CL, Daly AK (1998) Detection and characterization of novel polymorphisms in the CYP2E1 gene. Pharmacogenetics 8:543\u2013552", "journal-title": "Pharmacogenetics"}, {"key": "9_CR1013", "first-page": "1", "volume": "432", "author": "E Fritsche", "year": "2000", "unstructured": "Fritsche E, Pittman GS, Bell DA (2000) Localization, sequence analysis, and ethnic distribution of a 96-bp insertion in the promoter of the human CYP2E1 gene. Mutat Res 432:1\u20135", "journal-title": "Mutat Res"}, {"key": "9_CR1014", "doi-asserted-by": "crossref", "first-page": "411", "DOI": "10.1097/00008571-199810000-00006", "volume": "8", "author": "H Powell", "year": "1998", "unstructured": "Powell H, Kitteringham NR, Pirmohamed M, Smith DA, Park BK (1998) Expression of cytochrome P4502E1 in human liver: assessment by mRNA, genotype and phenotype. Pharmacogenetics 8:411\u2013421", "journal-title": "Pharmacogenetics"}, {"key": "9_CR1015", "doi-asserted-by": "crossref", "first-page": "372", "DOI": "10.1007/s002040000151", "volume": "74", "author": "K Inoue", "year": "2000", "unstructured": "Inoue K, Yamazaki H, Shimada T (2000) Characterization of liver microsomal 7-ethoxycoumarin O-deethylation and chlorzoxazone 6-hydroxylation activities in Japanese and Caucasian subjects genotyped for CYP2E1 gene. Arch Toxicol 74:372\u2013378", "journal-title": "Arch Toxicol"}, {"key": "9_CR1016", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.1038/clpt.1994.150", "volume": "56", "author": "D O\u2019Shea", "year": "1994", "unstructured": "O\u2019Shea D, Davis SN, Kim RB, Wilkinson GR (1994) Effect of fasting and obesity in humans on the 6-hydroxylation of chloroxazone: a putative probe of CYP2E1 activity. Clin Pharmacol Ther 56:359\u2013367", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR1017", "first-page": "13607", "volume": "260", "author": "DR Koop", "year": "1985", "unstructured": "Koop DR, Casazza JP (1985) Identification of ethanol-inducible P-450 isozyme 3a as the acetone and acetol monooxygenase of rabbit microsomes. J Biol Chem 260:13607\u201313612", "journal-title": "J Biol Chem"}, {"key": "9_CR1018", "first-page": "83", "volume": "105", "author": "FY Bondoc", "year": "1999", "unstructured": "Bondoc FY, Bao Z, Hu WY, Gonzalez FJ, Wang Y, Yang CS, Hong JY (1999) Acetone catabolism by cytochrome P450 2E1: studies with CYP2E1-null mice. Biochem Pharmacol 105:83\u201388", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR1019", "first-page": "438", "volume": "21", "author": "T Kashiwagi", "year": "1982", "unstructured": "Kashiwagi T, Ji S, Lemasters JJ, Thurman RG (1982) Rates of alcohol dehydrogenase-dependent ethanol metabolism in periportal and pericentral regions of the perfused rat liver. Mol Pharmacol 21:438\u2013443", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1020", "doi-asserted-by": "crossref", "first-page": "4", "DOI": "10.1002/9780470511848.ch2", "volume": "285", "author": "DW Crabb", "year": "2007", "unstructured": "Crabb DW, Liangpunsakul S (2007) Acetaldehyde generating enzyme systems: roles of alcohol dehydrogenase, CYP2E1 and catalase, and speculations on the role of other enzymes and processes. Novartis Found Sympos 285:4\u201316", "journal-title": "Novartis Found Sympos"}, {"key": "9_CR1021", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1016/j.toxlet.2006.09.011", "volume": "167", "author": "S Hamitouche", "year": "2006", "unstructured": "Hamitouche S, Poupon J, Dreano Y, Amet Y, Lucas D (2006) Ethanol oxidation into acetaldehyde by 16 recombinant human cytochrome P450 isoforms: role of CYP2C isoforms in human liver microsomes. Toxicol Lett 167:221\u2013230", "journal-title": "Toxicol Lett"}, {"key": "9_CR1022", "first-page": "G1259", "volume": "277", "author": "H Kono", "year": "1999", "unstructured": "Kono H, Bradford BU, Yin M, Sulik KK, Koop DR, Peters JM, Gonzalez FJ, McDonald T, Dikalova A, Kadiiska MB, Mason RP, Thurman RG (1999) CYP2E1 is not involved in early alcohol-induced liver injury. Am J Physiol 277:G1259\u2013G1267", "journal-title": "Am J Physiol"}, {"key": "9_CR1023", "doi-asserted-by": "crossref", "first-page": "689", "DOI": "10.1016/0006-291X(91)91427-E", "volume": "179", "author": "Y Terelius", "year": "1991", "unstructured": "Terelius Y, Norsten-H\u00f6\u00f6g C, Cronholm T, Ingelman-Sundberg M (1991) Acetaldehyde as a substrate for ethanol-inducible cytochrome P450 (CYP2E1). Biochem Biophys Res Commun 179:689\u2013694", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1024", "first-page": "527", "volume": "280", "author": "S Kunitoh", "year": "1997", "unstructured": "Kunitoh S, Imaoka S, Hiroi T, Yabusaki Y, Monna T, Funae Y (1997) Acetaldehyde as well as ethanol is metabolized by human CYP2E1. J Pharmacol Exp Ther 280:527\u2013532", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1025", "doi-asserted-by": "crossref", "first-page": "23833", "DOI": "10.1074/jbc.274.34.23833", "volume": "274", "author": "LC Bell-Parikh", "year": "1999", "unstructured": "Bell-Parikh LC, Guengerich FP (1999) Kinetics of cytochrome P450 2E1-catalyzed oxidation of ethanol to acetic acid via acetaldehyde. J Biol Chem 274:23833\u201323840", "journal-title": "J Biol Chem"}, {"key": "9_CR1026", "doi-asserted-by": "crossref", "first-page": "1975", "DOI": "10.1016/0006-2952(93)90639-E", "volume": "46", "author": "W Tassaneeyakul", "year": "1993", "unstructured": "Tassaneeyakul W, Veronese ME, Birkett DJ, Gonzalez FJ, Miners JO (1993) Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques. Biochem Pharmacol 46:1975\u20131981", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR1027", "doi-asserted-by": "crossref", "first-page": "566", "DOI": "10.1021/tx00018a012", "volume": "3", "author": "R Peter", "year": "1990", "unstructured": "Peter R, Bocker R, Beaune PH, Iwasaki M, Guengerich FP, Yang CS (1990) Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem Res Toxicol 3:566\u2013573", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR1028", "first-page": "438", "volume": "23", "author": "H Yamazaki", "year": "1995", "unstructured": "Yamazaki H, Guo Z, Guengerich FP (1995) Selectivity of cytochrome P4502E1 in chlorzoxazone 6-hydroxylation. Drug Metab Dispos 23:438\u2013440", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1029", "unstructured": "Preussmann R, Stewart BW (1984) N-Nitroso carcinogens. In: Searle CE (ed) Chemical carcinogens, vol\u00a02, 2nd edn. American Chemical Society, Washington, DC, pp\u00a0643\u2013828"}, {"key": "9_CR1030", "doi-asserted-by": "crossref", "first-page": "127", "DOI": "10.1016/0009-2797(76)90002-8", "volume": "13", "author": "MF Argus", "year": "1976", "unstructured": "Argus MF, Arcos JC, Pastor KM, Wu BC, Venkatesan N (1976) Dimethylnitrosamine-demethylase: absence of increased enzyme catabolism and multiplicity of effector sites in repression. Hemoprotein involvement. Chem-Biol Interact 13:127\u2013140", "journal-title": "Chem-Biol Interact"}, {"key": "9_CR1031", "doi-asserted-by": "crossref", "first-page": "610", "DOI": "10.1042/bst0020610", "volume": "2", "author": "BG Lake", "year": "1974", "unstructured": "Lake BG, Heading CE, Phillips JC, Gangolli SD, Lloyd AG (1974) Some studies on the metabolism in vitro of dimethylnitrosamine by rat liver. Biochem Soc Trans 2:610\u2013612", "journal-title": "Biochem Soc Trans"}, {"key": "9_CR1032", "doi-asserted-by": "crossref", "first-page": "158", "DOI": "10.1016/0003-9861(86)90412-1", "volume": "248", "author": "W Levin", "year": "1986", "unstructured": "Levin W, Thomas PE, Oldfield N, Ryan DE (1986) N-Demethylation of N-nitrosodimethylamine catalyzed by purified rat hepatic microsomal cytochrome P-450: isozyme specificityand role of cytochrome b 5. Arch Biochem Biophys 248:158\u2013165", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1033", "doi-asserted-by": "crossref", "first-page": "6731", "DOI": "10.1021/bi00370a001", "volume": "25", "author": "SA Wrighton", "year": "1986", "unstructured": "Wrighton SA, Thomas PE, Molowa DT, Haniu M, Shively JE, Maines SL, Watkins PB, Parker G, Mendez-Picon G, Levin W, Guzelian PS (1986) Characterization of ethanol-inducible human liver N-nitrosodimethylamine demethylase. Biochemistry 25:6731\u20136735", "journal-title": "Biochemistry"}, {"key": "9_CR1034", "doi-asserted-by": "crossref", "first-page": "756", "DOI": "10.1139/y98-087", "volume": "76", "author": "MC Bastien", "year": "1998", "unstructured": "Bastien MC, Villeneuve JP (1998) Characterization of cytochrome P450 2E1 activity by the [14C]nitrosodimethylamine breath test. Can J Physiol Pharmacol 76:756\u2013763", "journal-title": "Can J Physiol Pharmacol"}, {"key": "9_CR1035", "doi-asserted-by": "crossref", "first-page": "9995", "DOI": "10.1021/bi301092c", "volume": "51", "author": "G Chowdhury", "year": "2012", "unstructured": "Chowdhury G, Calcutt MW, Nagy LD, Guengerich FP (2012) Oxidation of methyl and ethyl nitrosamines by cytochrome P450 2E1 and 2B1. Biochemistry 51:9995\u201310007", "journal-title": "Biochemistry"}, {"key": "9_CR1036", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.3109/10408449309104072", "volume": "23", "author": "JL Raucy", "year": "1993", "unstructured": "Raucy JL, Kraner JC, Lasker JM (1993) Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. CRC Crit Rev Toxicol 23:1\u201320", "journal-title": "CRC Crit Rev Toxicol"}, {"key": "9_CR1037", "doi-asserted-by": "crossref", "first-page": "266", "DOI": "10.1007/s002040050386", "volume": "71", "author": "JY Hong", "year": "1997", "unstructured": "Hong JY, Yang CS, Lee M, Wang YY, Huang W, Tan Y, Patten CJ, Bondoc FY (1997) Role of cytochromes P450 in the metabolism of methyl tert-butyl ether in human livers. Arch Toxicol 71:266\u2013269", "journal-title": "Arch Toxicol"}, {"key": "9_CR1038", "doi-asserted-by": "crossref", "first-page": "911", "DOI": "10.1124/dmd.30.8.911", "volume": "30", "author": "H Wang", "year": "2002", "unstructured": "Wang H, Chanas B, Ghanayem BI (2002) Cytochrome P450 2E1 (CYP2E1) is essential for acrylonitrile metabolism to cyanide: comparative studies using CYP2E1-null and wild-type mice. Drug Metab Dispos 30:911\u2013917", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1039", "doi-asserted-by": "crossref", "first-page": "557", "DOI": "10.1124/jpet.103.049072", "volume": "305", "author": "U Hoffler", "year": "2003", "unstructured": "Hoffler U, El-Masri HA, Ghanayem BI (2003) Cytochrome P450 2E1 (CYP2E1) is the principal enzyme responsible for urethane metabolism: comparative studies using CYP2E1-null and wild-type mice. J Pharmacol Exp Ther 305:557\u2013564", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1040", "doi-asserted-by": "crossref", "first-page": "836", "DOI": "10.1021/tx00042a018", "volume": "7", "author": "SE Clarke", "year": "1994", "unstructured": "Clarke SE, Baldwin SJ, Bloomer JC, Ayrton AD, Sozio RS, Chenery RJ (1994) Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomes. Chem Res Toxicol 7:836\u2013842", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR1041", "first-page": "1037", "volume": "23", "author": "PJ Castle", "year": "1995", "unstructured": "Castle PJ, Merdink JL, Okita JR, Wrighton SA, Okita RT (1995) Human liver lauric acid hydroxylase activities. Drug Metab Dispos 23:1037\u20131043", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1042", "doi-asserted-by": "crossref", "first-page": "469", "DOI": "10.1006/bbrc.1999.1702", "volume": "265", "author": "EMJ Gillam", "year": "1999", "unstructured": "Gillam EMJ, Aguinaldo AM, Notley LM, Kim D, Mundkowski RG, Volkov AA, Arnold FH, Soucek P, DeVoss JJ, Guengerich FP (1999) Formation of indigo by recombinant mammalian cytochrome P450. Biochem Biophys Res Commun 265:469\u2013472", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1043", "doi-asserted-by": "crossref", "first-page": "31475", "DOI": "10.1074/jbc.C100238200", "volume": "276", "author": "J Adachi", "year": "2001", "unstructured": "Adachi J, Mori Y, Matsui S, Takigami H, Fujino J, Kitagawa H, Miller CA III, Kato T, Saeki K, Matsuda T (2001) Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J Biol Chem 276:31475\u201331478", "journal-title": "J Biol Chem"}, {"key": "9_CR1044", "first-page": "400", "volume": "281", "author": "DK Spracklin", "year": "1997", "unstructured": "Spracklin DK, Hankins DC, Fisher JM, Thummel KE, Kharasch ED (1997) Cytochrome P450 2E1is the principal catalyst of human oxidative halothane metabolism in vitro. J Pharmacol Exp Ther 281:400\u2013411", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1045", "doi-asserted-by": "crossref", "first-page": "766", "DOI": "10.1097/00000542-199903000-00019", "volume": "90", "author": "ED Kharasch", "year": "1999", "unstructured": "Kharasch ED, Hankins DC, Cox K (1999) Clinical isoflurane metabolism by cytochrome P450 2E1. Anesthesiology 90:766\u2013771", "journal-title": "Anesthesiology"}, {"key": "9_CR1046", "doi-asserted-by": "crossref", "first-page": "550", "DOI": "10.1124/dmd.112.049734", "volume": "41", "author": "AM Real", "year": "2013", "unstructured": "Real AM, Hong S, Pissios P (2013) Nicotinamide N-oxidation by CYP2E1 in human liver microsomes. Drug Metab Dispos 41:550\u2013553", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1047", "doi-asserted-by": "crossref", "first-page": "29643", "DOI": "10.1074/jbc.272.47.29643", "volume": "272", "author": "LC Bell", "year": "1997", "unstructured": "Bell LC, Guengerich FP (1997) Oxidation kinetics of ethanol by human cytochrome P450 2E1. Rate-limiting product release accounts for effects of isotopic hydrogen substitution and cytochrome b 5 on steady-state kinetics. J Biol Chem 272:29643\u201329651", "journal-title": "J Biol Chem"}, {"key": "9_CR1048", "doi-asserted-by": "crossref", "first-page": "8031", "DOI": "10.1074/jbc.M109.088039", "volume": "285", "author": "G Chowdhury", "year": "2010", "unstructured": "Chowdhury G, Calcutt MW, Guengerich FP (2010) Oxidation of N-nitrosoalkylamines by human cytochrome P450 2A6: sequential oxidation to aldehydes and carboxylic acids and analysis of reaction steps. J Biol Chem 285:8031\u20138044", "journal-title": "J Biol Chem"}, {"key": "9_CR1049", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1016/0300-9084(96)88173-9", "volume": "77", "author": "FP Guengerich", "year": "1995", "unstructured": "Guengerich FP, Bell LC, Okazaki O (1995) Interpretations of cytochrome P450 mechanisms from kinetic studies. Biochimie 77:573\u2013580", "journal-title": "Biochimie"}, {"key": "9_CR1050", "doi-asserted-by": "crossref", "first-page": "126", "DOI": "10.1016/j.abb.2010.08.017", "volume": "507", "author": "FP Guengerich", "year": "2011", "unstructured": "Guengerich FP, Sohl CD, Chowdhury G (2011) Multi-step oxidations catalyzed by cytochrome P450 enzymes: processive vs. distributive kinetics and the issue of carbonyl oxidation in chemical mechanisms. Arch Biochem Biophys 507:126\u2013134", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1051", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1016/0006-2952(96)00208-0", "volume": "52", "author": "H Yamazaki", "year": "1996", "unstructured": "Yamazaki H, Nakano M, Gillam EM, Bell LC, Guengerich FP, Shimada T (1996) Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes. Biochem Pharmacol 52:301\u2013309", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR1052", "doi-asserted-by": "crossref", "first-page": "61", "DOI": "10.1016/S0027-5107(01)00236-6", "volume": "484", "author": "MT Cooper", "year": "2001", "unstructured": "Cooper MT, Porter TD (2001) Cytochrome b5 coexpression increases the CYP2E1-dependent mutagenicity of dialkylnitrosamines in methyltransferase-deficient strains of Salmonella typhimurium. Mutat Res 484:61\u201368", "journal-title": "Mutat Res"}, {"key": "9_CR1053", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1016/S0163-7258(02)00327-3", "volume": "97", "author": "JB Schenkman", "year": "2003", "unstructured": "Schenkman JB, Jansson I (2003) The many roles of cytochrome b 5. Pharmacol Ther 97:139\u2013152", "journal-title": "Pharmacol Ther"}, {"key": "9_CR1054", "doi-asserted-by": "crossref", "first-page": "3487", "DOI": "10.1074/jbc.M707630200", "volume": "283", "author": "SL Collom", "year": "2008", "unstructured": "Collom SL, Laddusaw RM, Burch AM, Kuzmic P, Perry MD Jr, Miller GP (2008) CYP2E1 substrate inhibition. Mechanistic interpretation through an effector site for monocyclic compounds. J Biol Chem 283:3487\u20133496", "journal-title": "J Biol Chem"}, {"key": "9_CR1055", "doi-asserted-by": "crossref", "first-page": "11076", "DOI": "10.1073/pnas.92.24.11076", "volume": "92", "author": "H Yin", "year": "1995", "unstructured": "Yin H, Anders MW, Korzekwa KR, Higgins L, Thummel KE, Kharasch ED, Jones JP (1995) Designing safer chemicals: predicting the rates of metabolism of halogenated alkanes. Proc Natl Acad Sci U S A 92:11076\u201311080", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR1056", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1002/jbt.10055", "volume": "17", "author": "DF Lewis", "year": "2003", "unstructured": "Lewis DF, Sams C, Loizou GD (2003) A quantitative structure-activity relationship analysis on a series of alkyl benzenes metabolized by human cytochrome P450 2E1. J Biochem Mol Toxicol 17:47\u201352", "journal-title": "J Biochem Mol Toxicol"}, {"key": "9_CR1057", "doi-asserted-by": "crossref", "first-page": "33698", "DOI": "10.1074/jbc.M805999200", "volume": "283", "author": "PR Porubsky", "year": "2008", "unstructured": "Porubsky PR, Meneely KM, Scott EE (2008) Structures of human cytochrome P-450 2E1. Insights into the binding of inhibitors and both small molecular weight and fatty acid substrates. J Biol Chem 283:33698\u201333707", "journal-title": "J Biol Chem"}, {"key": "9_CR1058", "doi-asserted-by": "crossref", "first-page": "22282", "DOI": "10.1074/jbc.M110.109017", "volume": "285", "author": "PR Porubsky", "year": "2010", "unstructured": "Porubsky PR, Battaile KP, Scott EE (2010) Human cytochrome P450 2E1 structures with fatty acid analogs reveal a previously unobserved binding mode. J Biol Chem 285:22282\u201322290", "journal-title": "J Biol Chem"}, {"key": "9_CR1059", "doi-asserted-by": "crossref", "first-page": "409", "DOI": "10.3109/03602532.2011.624103", "volume": "43", "author": "Y Yamazoe", "year": "2011", "unstructured": "Yamazoe Y, Ito K, Yoshinari K (2011) Construction of a CYP2E1-template system for prediction of the metabolism on both site and preference order. Drug Metab Rev 43:409\u2013439", "journal-title": "Drug Metab Rev"}, {"key": "9_CR1060", "doi-asserted-by": "crossref", "first-page": "5731", "DOI": "10.1021/bi000129l", "volume": "39", "author": "SV Smith", "year": "2000", "unstructured": "Smith SV, Koley AP, Dai R, Robinson RC, Leong H, Markowitz A, Friedman FK (2000) Conformational modulation of human cytochrome P450 2E1 by ethanol and other substrates: a CO flash photolysis study. Biochemistry 39:5731\u20135737", "journal-title": "Biochemistry"}, {"key": "9_CR1061", "doi-asserted-by": "crossref", "first-page": "230", "DOI": "10.1016/0041-008X(89)90328-1", "volume": "97", "author": "RH Reitz", "year": "1989", "unstructured": "Reitz RH, Mendrala AL, Guengerich FP (1989) In vitro metabolism of methylene chloride in human and animal tissues: use in physiologically based pharmacokinetic models. Toxicol Appl Pharmacol 97:230\u2013246", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "9_CR1062", "unstructured": "Pernecky SJ, Porter TD, Coon MJ (1990) Expression of rabbit cytochrome P-450IIE2 in yeast and stabilization of the enzyme by 4-methylpyrazole. Biochem Biophys Res Commun 172:1331\u20131337", "DOI": "10.1016/0006-291X(90)91595-J", "doi-asserted-by": "crossref"}, {"key": "9_CR1063", "doi-asserted-by": "crossref", "first-page": "377", "DOI": "10.1021/tx00016a017", "volume": "3", "author": "DR Koop", "year": "1990", "unstructured": "Koop DR (1990) Inhibition of ethanol-inducible cytochrome P450IIE1 by 3-amino-1,2,4-triazole. Chem Res Toxicol 3:377\u2013383", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR1064", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/0009-2797(79)90064-4", "volume": "25", "author": "D Hultmark", "year": "1979", "unstructured": "Hultmark D, Sundh K, Johansson L, Arrhenius E (1979) Ethanol inhibition of vinyl chloride metabolism in isolated rat hepatocytes. Chem Biol Interact 25:1\u20136", "journal-title": "Chem Biol Interact"}, {"key": "9_CR1065", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1016/0041-008X(82)90036-9", "volume": "63", "author": "LCK Wong", "year": "1982", "unstructured": "Wong LCK, Winston JM, Hong CB, Plotnick H (1982) Carcinogenicity and toxicity of 1,2-dibromoethane in the rat. Toxicol Appl Pharmacol 63:155\u2013165", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "9_CR1066", "doi-asserted-by": "crossref", "first-page": "531", "DOI": "10.1016/0006-2952(94)90185-6", "volume": "47", "author": "MK Kwak", "year": "1994", "unstructured": "Kwak MK, Kim SG, Kwak JY, Novak RF, Kim ND (1994) Inhibition of cytochrome P450 2E1 expression by organosulfur compounds allylsulfide, allylmercaptan and allylmethylsulfide in rats. Biochem Pharmacol 47:531\u2013539", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR1067", "first-page": "1110", "volume": "29", "author": "M Nakajima", "year": "2001", "unstructured": "Nakajima M, Yoshida R, Shimada N, Yamazaki H, Yokoi T (2001) Inhibition and inactivation of human cytochrome P450 isoforms by phenethyl isothiocyanate. Drug Metab Dispos 29:1110\u20131113", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1068", "doi-asserted-by": "crossref", "first-page": "2286", "DOI": "10.1124/dmd.110.034710", "volume": "38", "author": "M Pratt-Hyatt", "year": "2010", "unstructured": "Pratt-Hyatt M, Lin HL, Hollenberg PF (2010) Mechanism-based inactivation of human CYP2E1 by diethyldithocarbamate. Drug Metab Dispos 38:2286\u20132292", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1069", "doi-asserted-by": "crossref", "first-page": "1460", "DOI": "10.1124/dmd.112.045492", "volume": "40", "author": "JP Harrelson", "year": "2012", "unstructured": "Harrelson JP, Stamper BD, Chapman JD, Goodlett DR, Nelson SD (2012) Covalent modification and time-dependent inhibition of human CYP2E1 by the meta-isomer of acetaminophen. Drug Metab Dispos 40:1460\u20131465", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1070", "doi-asserted-by": "crossref", "first-page": "858", "DOI": "10.1124/dmd.112.050609", "volume": "41", "author": "Y Yoshigae", "year": "2013", "unstructured": "Yoshigae Y, Sridar C, Kent UM, Hollenberg PF (2013) The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation. Drug Metab Dispos 41:858\u2013869", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1071", "doi-asserted-by": "crossref", "first-page": "553", "DOI": "10.1111/j.1472-8206.1998.tb00985.x", "volume": "12", "author": "D Lucas", "year": "1998", "unstructured": "Lucas D, Farez C, Bardou LG, Vaisse J, Attali JR, Valensi P (1998) Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation. Fundam Clin Pharmacol 12:553\u2013558", "journal-title": "Fundam Clin Pharmacol"}, {"key": "9_CR1072", "first-page": "495", "volume": "8", "author": "L Le Marchand", "year": "1999", "unstructured": "Le Marchand L, Wilkinson GR, Wilkens LR (1999) Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chlorzoxazone. Cancer Epidemiol Biomarkers Prev 8:495\u2013500", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9_CR1073", "doi-asserted-by": "crossref", "first-page": "459", "DOI": "10.1016/0741-8329(93)90065-V", "volume": "10", "author": "M Morimoto", "year": "1993", "unstructured": "Morimoto M, Hagbjork AL, Nanji AA, Ingelman-Sundberg M, Lindros KO, Fu PC, Albano E, French SW (1993) Role of cytochrome P450 2E1 in alcoholic liver disease pathogenesis. Alcohol 10:459\u2013464", "journal-title": "Alcohol"}, {"key": "9_CR1074", "doi-asserted-by": "crossref", "first-page": "122", "DOI": "10.1053/jhep.2002.33720", "volume": "36", "author": "K Morgan", "year": "2002", "unstructured": "Morgan K, French SW, Morgan TR (2002) Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology 36:122\u2013134", "journal-title": "Hepatology"}, {"key": "9_CR1075", "doi-asserted-by": "crossref", "first-page": "944", "DOI": "10.1124/mol.51.6.944", "volume": "51", "author": "DR Koop", "year": "1997", "unstructured": "Koop DR, Klopfenstein B, Iimuro Y, Thurman RG (1997) Gadolinium chloride blocks alcohol-dependent liver toxicityin rats treated chronically with intragastric alcohol despite the induction of CYP2E1. Mol Pharmacol 51:944\u2013950", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1076", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1124/mol.55.2.223", "volume": "55", "author": "SD Lytton", "year": "1999", "unstructured": "Lytton SD, Helander A, Zhang-Gouillon ZQ, Stokkeland K, Bordone R, Aric\u00f3 S, Albano E, French SW, Ingelman-Sundberg M (1999) Autoantibodies against cytochromes P-450 2E1 and P-450 3A in alcoholics. Mol Pharmacol 55:223\u2013233", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1077", "doi-asserted-by": "crossref", "first-page": "206", "DOI": "10.1053/gast.1996.v111.pm8698201", "volume": "111", "author": "P Clot", "year": "1996", "unstructured": "Clot P, Albano E, Eliasson E, Tabone M, Arico S, Israel Y, Moncada C, Ingelman-Sundberg M (1996) Cytochrome P450 2E1 hydroxyethyl radical adducts as the major antigen in autoantibody formation among alcoholics. Gastroenterology 111:206\u2013216", "journal-title": "Gastroenterology"}, {"key": "9_CR1078", "doi-asserted-by": "crossref", "first-page": "1159", "DOI": "10.1021/tx960083q", "volume": "9", "author": "M Bourdi", "year": "1996", "unstructured": "Bourdi M, Chen W, Peter RM, Martin JL, Buters JTM, Nelson SD, Pohl LR (1996) Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis. Chem Res Toxicol 9:1159\u20131166", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR1079", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1097/00008571-199212000-00003", "volume": "2", "author": "A Hirvonen", "year": "1992", "unstructured": "Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Karjalainen A, Sorsa M, Vainio H (1992) Metabolic cytochrome P450 genotypes and assessment of individual susceptibility to lung cancer. Pharmacogenetics 2:259\u2013263", "journal-title": "Pharmacogenetics"}, {"key": "9_CR1080", "doi-asserted-by": "crossref", "first-page": "264", "DOI": "10.1097/00008571-199212000-00004", "volume": "2", "author": "M Ingelman-Sundberg", "year": "1992", "unstructured": "Ingelman-Sundberg M, Johansson I, Persson I, Yue QY, Dahl ML, Bertilsson L, Sjoqvist F (1992) Genetic polymorphism of cytochromes P450: interethnic differences and relationship to incidence of lung cancer. Pharmacogenetics 2:264\u2013271", "journal-title": "Pharmacogenetics"}, {"key": "9_CR1081", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1016/0014-5793(93)80547-8", "volume": "319", "author": "I Persson", "year": "1993", "unstructured": "Persson I, Johansson I, Bergling H, Dahl ML, Seideg\u00e5rd J, Rylander R, Rannug A, H\u00f6gberg J, Ingelman-Sundberg M (1993) Genetic polymorphism of cytochrome P450 2E1 in a Swedish population: relationship to incidence of lung cancer. FEBS Lett 319:207\u2013211", "journal-title": "FEBS Lett"}, {"key": "9_CR1082", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1097/00008571-199604000-00002", "volume": "6", "author": "SJ London", "year": "1996", "unstructured": "London SJ, Daly AK, Cooper J, Carpenter CL, Navidi WC, Ding L, Idle JR (1996) Lung cancer risk in relation to the CYP2E1 RsaI genetic polymorphism among African-Americans and Caucasians in Los Angeles County. Pharmacogenetics 6:151\u2013158", "journal-title": "Pharmacogenetics"}, {"key": "9_CR1083", "first-page": "515", "volume": "3", "author": "PG Shields", "year": "1994", "unstructured": "Kato S, Shields PG, Caporaso NE, Sugimura H, Trivers GE, Tucker MA, Trump BF, Weston A, Harris CC (1994) Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer. Cancer Epidemiol Biomarkers Prev 3:515\u2013518", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9_CR1084", "doi-asserted-by": "crossref", "first-page": "15S", "DOI": "10.1111/j.1530-0277.2002.tb02696.x", "volume": "26", "author": "S Itoga", "year": "2002", "unstructured": "Itoga S, Nomura F, Makino Y, Tomonaga T, Shimada H, Ochiai T, Iizasa T, Baba M, Fujisawa T, Harada S (2002) Tandem repeat polymorphism of the CYP2E1 gene: an association study with esophageal cancer and lung cancer. Alcohol Clin Exp Res 26:15S\u201319S", "journal-title": "Alcohol Clin Exp Res"}, {"key": "9_CR1085", "doi-asserted-by": "crossref", "first-page": "734", "DOI": "10.1002/1097-0215(20000901)87:5<734::AID-IJC17>3.0.CO;2-E", "volume": "87", "author": "C Bouchardy", "year": "2000", "unstructured": "Bouchardy C, Hirvonen A, Coutelle C, Ward PJ, Dayer P, Benhamou S (2000) Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract. Int J Cancer 87:734\u2013740", "journal-title": "Int J Cancer"}, {"key": "9_CR1086", "doi-asserted-by": "crossref", "first-page": "437", "DOI": "10.1016/S1368-8375(00)00099-3", "volume": "37", "author": "S Liu", "year": "2001", "unstructured": "Liu S, Park JY, Schantz SP, Stern JC, Lazarus P (2001) Elucidation of CYP2E1 5\u2032 regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer. Oral Oncol 37:437\u2013445", "journal-title": "Oral Oncol"}, {"key": "9_CR1087", "doi-asserted-by": "crossref", "first-page": "S141", "DOI": "10.1097/00008571-199512001-00016", "volume": "5", "author": "S Kato", "year": "1995", "unstructured": "Kato S, Onda M, Matsukura N, Tokunaga A, Tajiri T, Kim DY, Tsuruta H, Matsuda N, Yamashita K, Shields PG (1995) Cytochrome P4502E1 (CYP2E1) genetic polymorphism in a case-control study of gastric cancer and liver disease. Pharmacogenetics 5:S141\u2013S144", "journal-title": "Pharmacogenetics"}, {"key": "9_CR1088", "first-page": "475", "volume": "11", "author": "RH Wong", "year": "2002", "unstructured": "Wong RH, Du CL, Wang JD, Chan CC, Luo JC, Cheng TJ (2002) XRCC1 and CYP2E1 polymorphisms as susceptibility factors of plasma mutant p53 protein and anti-p53 antibody expression in vinyl chloride monomer-exposed polyvinyl chloride workers. Cancer Epidemiol Biomarkers Prev 11:475\u2013482", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9_CR1089", "first-page": "174", "volume": "76", "author": "HM Bolt", "year": "2003", "unstructured": "Bolt HM, Roos PH, Thier R (2003) The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine. Int Arch Occup Environ Health 76:174\u2013185", "journal-title": "Int Arch Occup Environ Health"}, {"key": "9_CR1090", "doi-asserted-by": "crossref", "first-page": "34", "DOI": "10.1016/j.tox.2007.06.089", "volume": "239", "author": "HI Hsieh", "year": "2007", "unstructured": "Hsieh HI, Chen PC, Wong RH, Wang JD, Yang PM, Cheng TJ (2007) Effect of the CYP2E1 genotype on vinyl chloride monomer-induced liver fibrosis among polyvinyl chloride workers. Toxicology 239:34\u201344", "journal-title": "Toxicology"}, {"key": "9_CR1091", "doi-asserted-by": "crossref", "first-page": "364", "DOI": "10.1016/j.yrtph.2011.01.013", "volume": "59", "author": "HR Pohl", "year": "2011", "unstructured": "Pohl HR, Scinicariello F (2011) The impact of CYP2E1 genetic variability on risk assessment of VOC mixtures. Regul Toxicol Pharmacol 59:364\u2013374", "journal-title": "Regul Toxicol Pharmacol"}, {"key": "9_CR1092", "doi-asserted-by": "crossref", "first-page": "1221", "DOI": "10.1111/j.0272-4332.2003.00397.x", "volume": "23", "author": "JC Lipscomb", "year": "2003", "unstructured": "Lipscomb JC, Teuschler LK, Swartout J, Popken D, Cox T, Kedderis GL (2003) The impact of cytochrome P450 2E1-dependent metabolic variance on a risk-relevant pharmacokinetic outcome in humans. Risk Anal 23:1221\u20131238", "journal-title": "Risk Anal"}, {"key": "9_CR1093", "doi-asserted-by": "crossref", "first-page": "758", "DOI": "10.1016/j.ejca.2009.12.010", "volume": "46", "author": "Y Wang", "year": "2010", "unstructured": "Wang Y, Yang H, Li L, Wang H, Zhang C, Yin G, Zhu B (2010) Association between CYP2E1 genetic polymorphisms and lung cancer risk: a meta-analysis. Eur J Cancer 46:758\u2013764", "journal-title": "Eur J Cancer"}, {"key": "9_CR1094", "doi-asserted-by": "crossref", "first-page": "2409", "DOI": "10.1007/s11033-010-0375-9", "volume": "38", "author": "D Lu", "year": "2011", "unstructured": "Lu D, Yu X, Du Y (2011) Meta-analyses of the effect of cytochrome P450 2E1 gene polymorphism on the risk of head and neck cancer. Mol Biol Rep 38:2409\u20132416", "journal-title": "Mol Biol Rep"}, {"key": "9_CR1095", "doi-asserted-by": "crossref", "first-page": "e44478", "DOI": "10.1371/journal.pone.0044478", "volume": "7", "author": "J Feng", "year": "2012", "unstructured": "Feng J, Pan X, Yu J, Chen Z, Xu H, El-Rifai W, Zhang G, Xu Z (2012) Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer. PLoS One 7:e44478", "journal-title": "PLoS One"}, {"key": "9_CR1096", "doi-asserted-by": "crossref", "first-page": "e48265", "DOI": "10.1371/journal.pone.0048265", "volume": "7", "author": "W Zhuo", "year": "2012", "unstructured": "Zhuo W, Zhang L, Wang Y, Ling J, Zhu B, Chen Z (2012) CYP2E1 RsaI/PstI polymorphism and gastric cancer susceptibility: meta-analyses based on 24 case-control studies. PLoS One 7:e48265", "journal-title": "PLoS One"}, {"key": "9_CR1097", "doi-asserted-by": "crossref", "first-page": "2225", "DOI": "10.1007/s13277-013-0762-7", "volume": "34", "author": "J Qian", "year": "2013", "unstructured": "Qian J, Song Z, Lv Y, Huang X (2013) CYP2E1 T7632A and 9-bp insertion polymorphisms and colorectal cancer risk: a meta-analysis based on 4592 cases and 5918 controls. Tumour Biol 34:2225\u20132231", "journal-title": "Tumour Biol"}, {"key": "9_CR1098", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1517/17425250903540238", "volume": "6", "author": "DT Trafalis", "year": "2010", "unstructured": "Trafalis DT, Panteli ES, Grivas A, Tsigris C, Karamanakos PN (2010) CYP2E1 and risk of chemically mediated cancers. Expert Opin Drug Metab Toxicol 6:307\u2013319", "journal-title": "Expert Opin Drug Metab Toxicol"}, {"key": "9_CR1099", "doi-asserted-by": "crossref", "first-page": "605", "DOI": "10.1016/j.jhep.2006.11.009", "volume": "46", "author": "M Vidali", "year": "2007", "unstructured": "Vidali M, Occhino G, Ivaldi A, Serino R, Moia S, Alchera E, Carini R, Rigamonti C, Sartori M, Albano E (2007) Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C. J Hepatol 46:605\u2013612", "journal-title": "J Hepatol"}, {"key": "9_CR1100", "doi-asserted-by": "crossref", "first-page": "601", "DOI": "10.1111/j.1600-6143.2008.02520.x", "volume": "9", "author": "C Rigamonti", "year": "2009", "unstructured": "Rigamonti C, Vidali M, Donato MF, Sutti S, Occhino G, Ivaldi A, Arosio E, Agnelli F, Rossi G, Colombo M, Albano E (2009) Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C. Am J Transplant 9:601\u2013609", "journal-title": "Am J Transplant"}, {"key": "9_CR1101", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1016/j.taap.2005.01.057", "volume": "207", "author": "D Wu", "year": "2005", "unstructured": "Wu D, Cederbaum AI (2005) Oxidative stress mediated toxicity exerted by ethanol-inducible CYP2E1. Toxicol Appl Pharmacol 207:70\u201376", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "9_CR1102", "doi-asserted-by": "crossref", "first-page": "1223", "DOI": "10.1517/17425250903143769", "volume": "5", "author": "A Cederbaum", "year": "2009", "unstructured": "Cederbaum A (2009) Nrf2 and antioxidant defense against CYP2E1 toxicity. Expert Opin Drug Metab Toxicol 5:1223\u20131244", "journal-title": "Expert Opin Drug Metab Toxicol"}, {"key": "9_CR1103", "doi-asserted-by": "crossref", "first-page": "802", "DOI": "10.1159/000324289", "volume": "28", "author": "AI Cederbaum", "year": "2010", "unstructured": "Cederbaum AI (2010) Role of CYP2E1 in ethanol-induced oxidant stress, fatty liver and hepatotoxicity. Dig Dis 28:802\u2013811", "journal-title": "Dig Dis"}, {"key": "9_CR1104", "doi-asserted-by": "crossref", "first-page": "175", "DOI": "10.1016/j.freeradbiomed.2013.05.009", "volume": "63", "author": "X Wang", "year": "2013", "unstructured": "Wang X, Wu D, Yang L, Gan L, Cederbaum AI (2013) Cytochrome P450 2E1potentiates ethanol induction of hypoxia and HIF-1\u03b1 in vivo. Free Radic Biol Med 63:175\u2013186", "journal-title": "Free Radic Biol Med"}, {"key": "9_CR1105", "doi-asserted-by": "crossref", "first-page": "1313", "DOI": "10.1016/0006-2952(89)90338-9", "volume": "38", "author": "G Ekstr\u00f6m", "year": "1989", "unstructured": "Ekstr\u00f6m G, Ingelman-Sundberg M (1989) Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol 38:1313\u20131319", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR1106", "doi-asserted-by": "crossref", "first-page": "987", "DOI": "10.1002/hep.510300433", "volume": "30", "author": "N Nieto", "year": "1999", "unstructured": "Nieto N, Friedman SL, Greenwel P, Cederbaum AI (1999) CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells. Hepatology 30:987\u2013996", "journal-title": "Hepatology"}, {"key": "9_CR1107", "doi-asserted-by": "crossref", "first-page": "1539", "DOI": "10.1016/S0891-5849(01)00743-2", "volume": "31", "author": "AI Cederbaum", "year": "2001", "unstructured": "Cederbaum AI, Wu D, Mari M, Bai J (2001) CYP2E1-dependent toxicity and oxidative stress in HepG2 cells. Free Radic Biol Med 31:1539\u20131543", "journal-title": "Free Radic Biol Med"}, {"key": "9_CR1108", "doi-asserted-by": "crossref", "first-page": "1484", "DOI": "10.1111/j.1742-4658.2011.08063.x", "volume": "278", "author": "W Zhang", "year": "2011", "unstructured": "Zhang W, Lu D, Dong W, Zhang L, Zhang X, Quan X, Ma C, Lian H, Zhang L (2011) Expression of CYP2E1 increases oxidative stress and induces apoptosis of cardiomyocytes in transgenic mice. FEBS J 278:1484\u20131492", "journal-title": "FEBS J"}, {"key": "9_CR1109", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1161/HYPERTENSIONAHA.112.191478", "volume": "60", "author": "D Lu", "year": "2012", "unstructured": "Lu D, Ma Y, Zhang W, Bao D, Dong W, Lian H, Huang L, Zhang L (2012) Knockdown of cytochrome P450 2E1 inhibits oxidative stress and apoptosis in the cTnT(R141W) dilated cardiomyopathy transgenic mice. Hypertension 60:81\u201389", "journal-title": "Hypertension"}, {"key": "9_CR1110", "doi-asserted-by": "crossref", "first-page": "711", "DOI": "10.1016/j.freeradbiomed.2004.10.024", "volume": "38", "author": "MB Kadiiska", "year": "2005", "unstructured": "Kadiiska MB, Gladen BC, Baird DD, Graham LB, Parker CE, Ames BN, Basu S, Fitzgerald GA, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts LJ 2nd, Rokach J, Shigenaga MK, Sun J, Walter PB, Tomer KB, Barrett JC, Mason RP (2005) Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med 38:711\u2013718", "journal-title": "Free Radic Biol Med"}, {"key": "9_CR1111", "doi-asserted-by": "crossref", "first-page": "1419", "DOI": "10.1124/mol.107.040238", "volume": "72", "author": "M Dostalek", "year": "2007", "unstructured": "Dostalek M, Brooks JD, Hardy KD, Milne GL, Moore MM, Sharma S, Morrow JD, Guengerich FP (2007) In vivo oxidative damage in rats is associated with barbiturate response but not other cytochrome P450 inducers. Mol Pharmacol 72:1419\u20131424", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1112", "doi-asserted-by": "crossref", "first-page": "17147", "DOI": "10.1074/jbc.M802447200", "volume": "283", "author": "M Dostalek", "year": "2008", "unstructured": "Dostalek M, Hardy KD, Milne GL, Morrow JD, Chen C, Gonzalez FJ, Gu J, Ding X, Johnson DA, Johnson JA, Martin MV, Guengerich FP (2008) Development of oxidative stress by cytochrome P450 induction in rodents is selective for barbiturates and related to loss of pyridine nucleotide-dependent protective systems. J Biol Chem 283:17147\u201317157", "journal-title": "J Biol Chem"}, {"key": "9_CR1113", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.1007/978-94-007-5881-0_5", "volume": "67", "author": "AK Daly", "year": "2013", "unstructured": "Daly AK (2013) Relevance of CYP2E1 to non-alcoholic fatty liver disease. Subcell Biochem 67:165\u2013175", "journal-title": "Subcell Biochem"}, {"key": "9_CR1114", "doi-asserted-by": "crossref", "first-page": "5491", "DOI": "10.1021/bi00475a012", "volume": "29", "author": "PT Nhamburo", "year": "1990", "unstructured": "Nhamburo PT, Kimura S, McBride OW, Kozak CA, Gelboin HV, Gonzalez FJ (1990) The human CYP2F gene subfamily: identification of a cDNA encoding a new cytochrome P450, cDNA-directed expression, and chromosomemapping. Biochemistry 29:5491\u20135499", "journal-title": "Biochemistry"}, {"key": "9_CR1115", "doi-asserted-by": "crossref", "first-page": "1423", "DOI": "10.1124/dmd.105.005769", "volume": "33", "author": "X Zhang", "year": "2005", "unstructured": "Zhang X, Zhang QY, Liu D, Su T, Weng Y, Ling G, Chen Y, Gu J, Schilling B, Ding X (2005) Expression of cytochrome P450 and other biotransformation genes in fetal and adult human nasal mucosa. Drug Metab Dispos 33:1423\u20131428", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1116", "doi-asserted-by": "crossref", "first-page": "15473", "DOI": "10.1074/jbc.M300319200", "volume": "278", "author": "BA Carr", "year": "2003", "unstructured": "Carr BA, Wan J, Hines RN, Yost GS (2003) Characterization of the human lung CYP2F1 gene and identification of a novel lung-specific binding motif. J Biol Chem 278:15473\u201315483", "journal-title": "J Biol Chem"}, {"key": "9_CR1117", "doi-asserted-by": "crossref", "first-page": "1244", "DOI": "10.1124/dmd.105.004069", "volume": "33", "author": "J Wan", "year": "2005", "unstructured": "Wan J, Carr BA, Cutler NS, Lanza DL, Hines RN, Yost GS (2005) Sp1 and Sp3 regulate basal transcription of the human CYP2F1 gene. Drug Metab Dispos 33:1244\u20131253", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1118", "doi-asserted-by": "crossref", "first-page": "696", "DOI": "10.1021/tx9004506", "volume": "23", "author": "JM Weems", "year": "2010", "unstructured": "Weems JM, Yost GS (2010) 3-Methylindole metabolites induce lung CYP1A1 and CYP2F1 enzymes by AhR and non-AhR mechanisms, respectively. Chem Res Toxicol 23:696\u2013704", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR1119", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1016/j.mrfmmm.2007.01.007", "volume": "617", "author": "G Tournel", "year": "2007", "unstructured": "Tournel G, Cauffiez C, Billaut-Laden I, Allorge D, Chevalier D, Bonnifet F, Mensier E, Lafitte JJ, Lhermitte M, Broly F, Lo-Guidice JM (2007) Molecular analysis of the CYP2F1 gene: identification of a frequent non-functional allelic variant. Mutat Res 617:79\u201389", "journal-title": "Mutat Res"}, {"key": "9_CR1120", "doi-asserted-by": "crossref", "first-page": "1433", "DOI": "10.1080/00498250701644403", "volume": "37", "author": "G Tournel", "year": "2007", "unstructured": "Tournel G, Cauffiez C, Leclerc J, Billaut-Laden I, Allorge D, Chevalier D, Migot-Nabias F, Kenani A, Broly F, Lo-Guidice J (2007) CYP2F1 genetic polymorphism: identification of interethnic variations. Xenobiotica 37:1433\u20131438", "journal-title": "Xenobiotica"}, {"key": "9_CR1121", "first-page": "4636", "volume": "51", "author": "M Czerwinski", "year": "1991", "unstructured": "Czerwinski M, McLemore TL, Philpot RM, Nhamburo PT, Korzekwa K, Gelboin HV, Gonzalez FJ (1991) Metabolic activation of 4-ipomeanol by complementary DNA-expressed human cytochromes P-450: evidence for species-specific metabolism. Cancer Res 51:4636\u20134638", "journal-title": "Cancer Res"}, {"key": "9_CR1122", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1016/S0006-291X(05)81387-7", "volume": "181", "author": "JR Thornton-Manning", "year": "1991", "unstructured": "Thornton-Manning JR, Ruangyuttikarn W, Gonzalez FJ, Yost GS (1991) Metabolic activation of the pneumotoxin, 3-methylindole, by vaccinia-expressed cytochrome P450s. Biochem Biophys Res Commun 181:100\u2013107", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1123", "first-page": "21", "volume": "276", "author": "J Thornton-Manning", "year": "1996", "unstructured": "Thornton-Manning J, Appleton ML, Gonzalez FJ, Yost GS (1996) Metabolism of 3-methylindole by vaccinia-expressed P450 enzymes: correlation of 3-methyleneindolenine formation and protein-binding. J Pharmacol Exp Ther 276:21\u201329", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1124", "doi-asserted-by": "crossref", "first-page": "891", "DOI": "10.1021/tx00042a026", "volume": "7", "author": "T Nakajima", "year": "1994", "unstructured": "Nakajima T, Elovaara E, Gonzalez FJ, Gelboin HV, Raunio H, Pelkonen O, Vainio H, Aoyama T (1994) Styrene metabolism by cDNA-expressed human hepatic and pulmonary cytochromes P450. Chem Res Toxicol 7:891\u2013896", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR1125", "first-page": "798", "volume": "27", "author": "DL Lanza", "year": "1999", "unstructured": "Lanza DL, Code E, Crespi CL, Gonzalez FJ, Yost GS (1999) Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells. Drug Metab Dispos 27:798\u2013803", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1126", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1515/DMDI.2009.24.2-4.229", "volume": "24", "author": "DF Lewis", "year": "2009", "unstructured": "Lewis DF, Ito Y, Lake BG (2009) Molecular modelling of CYP2F substrates: comparison of naphthalene metabolism by human, rat and mouse CYP2F subfamily enzymes. Drug Metab Drug Interact 24:229\u2013257", "journal-title": "Drug Metab Drug Interact"}, {"key": "9_CR1127", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1124/dmd.107.017897", "volume": "36", "author": "JS Kartha", "year": "2008", "unstructured": "Kartha JS, Yost GS (2008) Mechanism-based inactivation of lung-selective cytochrome P450 CYP2F enzymes. Drug Metab Dispos 36:155\u2013162", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1128", "doi-asserted-by": "crossref", "first-page": "3460", "DOI": "10.1074/jbc.271.7.3460", "volume": "271", "author": "S Wu", "year": "1996", "unstructured": "Wu S, Moomaw CR, Tomer KB, Falck JR, Zeldin DC (1996) Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem 271:3460\u20133468", "journal-title": "J Biol Chem"}, {"key": "9_CR1129", "doi-asserted-by": "crossref", "first-page": "2087", "DOI": "10.1124/dmd.113.053389", "volume": "41", "author": "EA Evangelista", "year": "2013", "unstructured": "Evangelista EA, Kaspera R, Mokadam NA, Jones JP 3rd, Totah RA (2013) Activity, inhibition, and induction of cytochrome P450 2J2 in adult human primary cardiomyocytes. Drug Metab Dispos 41:2087\u20132094", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1130", "doi-asserted-by": "crossref", "first-page": "311", "DOI": "10.3109/03602532.2013.806537", "volume": "45", "author": "M Xu", "year": "2013", "unstructured": "Xu M, Ju W, Hao H, Wang G, Li P (2013) Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance. Drug Metab Rev 45:311\u2013352", "journal-title": "Drug Metab Rev"}, {"key": "9_CR1131", "first-page": "1111", "volume": "50", "author": "DC Zeldin", "year": "1996", "unstructured": "Zeldin DC, Foley J, Ma J, Boyle JE, Pascual JM, Moomaw CR, Tomer KB, Steenbergen C, Wu S (1996) CYP2J subfamily P450s in the lung: expression, localization, and potential functional significance. Mol Pharmacol 50:1111\u20131117", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1132", "doi-asserted-by": "crossref", "first-page": "931", "DOI": "10.1124/mol.51.6.931", "volume": "51", "author": "DC Zeldin", "year": "1997", "unstructured": "Zeldin DC, Foley J, Goldsworthy SM, Cook ME, Boyle JE, Ma J, Moomaw CR, Tomer KB, Steenbergen C, Wu S (1997) CYP2J subfamily cytochrome P450s in the gastrointestinal tract: expression, localization, and potential functional significance. Mol Pharmacol 51:931\u2013943", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1133", "doi-asserted-by": "crossref", "first-page": "1338", "DOI": "10.1210/endo.138.3.4970", "volume": "138", "author": "DC Zeldin", "year": "1997", "unstructured": "Zeldin DC, Foley J, Boyle JE, Moomaw CR, Tomer KB, Parker C, Steenbergen C, Wu S (1997) Predominant expression of an arachidonate epoxygenase in islets of Langerhans cells in human and rat pancreas. Endocrinology 138:1338\u20131346", "journal-title": "Endocrinology"}, {"key": "9_CR1134", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1006/bbrc.1999.1011", "volume": "261", "author": "J Bylund", "year": "1999", "unstructured": "Bylund J, Finnstrom N, Oliw EH (1999) Gene expression of a novel cytochrome P450 of the CYP4F subfamily in human seminal vesicles. Biochem Biophys Res Commun 261:169\u2013174", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1135", "unstructured": "Hukkanen J, Pelkonen O, Hakkola J, Raunio H (2002) Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit Rev Toxicol 32:391\u2013411", "DOI": "10.1080/20024091064273", "doi-asserted-by": "crossref"}, {"key": "9_CR1136", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.1016/j.lfs.2008.06.026", "volume": "83", "author": "K Nakayama", "year": "2008", "unstructured": "Nakayama K, Nitto T, Inoue T, Node K (2008) Expression of the cytochrome P450 epoxygenase CYP2J2 in human monocytic leukocytes. Life Sci 83:339\u2013345", "journal-title": "Life Sci"}, {"key": "9_CR1137", "doi-asserted-by": "crossref", "first-page": "523", "DOI": "10.1124/jpet.106.109215", "volume": "319", "author": "A Gaedigk", "year": "2006", "unstructured": "Gaedigk A, Baker DW, Totah RA, Gaedigk R, Pearce RE, Vyhlidal CA, Zeldin DC, Leeder JS (2006) Variability of CYP2J2 expression in human fetal tissues. J Pharmacol Exp Ther 319:523\u2013532", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1138", "doi-asserted-by": "crossref", "first-page": "987", "DOI": "10.1124/mol.109.062729", "volume": "77", "author": "AC Lee", "year": "2010", "unstructured": "Lee AC, Murray M (2010) Up-regulation of human CYP2J2 in HepG2 cells by butylated hydroxyanisole is mediated by c-Jun and Nrf2. Mol Pharmacol 77:987\u2013994", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1139", "doi-asserted-by": "crossref", "first-page": "e39197", "DOI": "10.1371/journal.pone.0039197", "volume": "7", "author": "F Chen", "year": "2012", "unstructured": "Chen F, Chen C, Yang S, Gong W, Wang Y, Cianflone K, Tang J, Wang DW (2012) Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2. PLoS One 7:e39197", "journal-title": "PLoS One"}, {"key": "9_CR1140", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.1042/BJ20050798", "volume": "391", "author": "NY Marden", "year": "2005", "unstructured": "Marden NY, Murray M (2005) Characterization of a c-Jun-responsive module in the 5\u2032-flank of the human CYP2J2 gene that regulates transactivation. Biochem J 391:631\u2013640", "journal-title": "Biochem J"}, {"key": "9_CR1141", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1097/01213011-200502000-00006", "volume": "15", "author": "SS Lee", "year": "2005", "unstructured": "Lee SS, Jeong HE, Liu KH, Ryu JY, Moon T, Yoon CN, Oh SJ, Yun CH, Shin JG (2005) Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity. Pharmacogenet Genomics 15:105\u2013113", "journal-title": "Pharmacogenet Genomics"}, {"key": "9_CR1142", "doi-asserted-by": "crossref", "first-page": "1201", "DOI": "10.1080/00498250600944318", "volume": "36", "author": "H Yamazaki", "year": "2006", "unstructured": "Yamazaki H, Okayama A, Imai N, Guengerich FP, Shimizu M (2006) Inter-individual variation of cytochrome P4502J2 expression and catalytic activities in liver microsomes from Japanese and Caucasian populations. Xenobiotica 36:1201\u20131209", "journal-title": "Xenobiotica"}, {"key": "9_CR1143", "doi-asserted-by": "crossref", "first-page": "355", "DOI": "10.2165/00129785-200303050-00006", "volume": "3", "author": "L Pucci", "year": "2003", "unstructured": "Pucci L, Lucchesi D, Chirulli V, Penno G, Johansson I, Gervasi P, Del Prato S, Longo V (2003) Cytochrome P450 2J2 polymorphism in healthy Caucasians and those with diabetesmellitus. Am J Pharmacogenom 3:355\u2013358", "journal-title": "Am J Pharmacogenom"}, {"key": "9_CR1144", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1097/01213011-200501000-00002", "volume": "15", "author": "LM King", "year": "2005", "unstructured": "King LM, Gainer JV, David GL, Dai D, Goldstein JA, Brown NJ, Zeldin DC (2005) Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension. Pharmacogenet Genomics 15:7\u201313", "journal-title": "Pharmacogenet Genomics"}, {"key": "9_CR1145", "doi-asserted-by": "crossref", "first-page": "1276", "DOI": "10.1016/j.amjhyper.2005.04.019", "volume": "18", "author": "AW Dreisbach", "year": "2005", "unstructured": "Dreisbach AW, Japa S, Sigel A, Parenti MB, Hess AE, Srinouanprachanh SL, Rettie AE, Kim H, Farin FM, Hamm LL, Lertora JJ (2005) The prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension. Am J Hypertens 18:1276\u20131281", "journal-title": "Am J Hypertens"}, {"key": "9_CR1146", "doi-asserted-by": "crossref", "first-page": "294", "DOI": "10.1097/HJH.0b013e328333097e", "volume": "28", "author": "C Fava", "year": "2010", "unstructured": "Fava C, Montagnana M, Almgren P, Hedblad B, Engstrom G, Berglund G, Minuz P, Melander O (2010) The common functional polymorphism \u2212 50G > T of the CYP2J2 gene is not associated with ischemic coronary and cerebrovascular events in an urban-based sample of Swedes. J Hypertens 28:294\u2013299", "journal-title": "J Hypertens"}, {"key": "9_CR1147", "doi-asserted-by": "crossref", "first-page": "435", "DOI": "10.1002/cbf.1661", "volume": "28", "author": "Z Jie", "year": "2010", "unstructured": "Jie Z, Hong K, Jianhong T, Biao C, Yongmei Z, Jingchuan L (2010) Haplotype analysis of the CYP2J2 gene associated with myocardial infarction in a Chinese Han population. Cell Biochem Funct 28:435\u2013439", "journal-title": "Cell Biochem Funct"}, {"key": "9_CR1148", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1124/dmd.109.030270", "volume": "38", "author": "CA Lee", "year": "2010", "unstructured": "Lee CA, Neul D, Clouser-Roche A, Dalvie D, Wester MR, Jiang Y, Jones JP 3rd, Freiwald S, Zientek M, Totah RA (2010) Identification of novel substrates for human cytochrome P450 2J2. Drug Metab Dispos 38:347\u2013356", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1149", "doi-asserted-by": "crossref", "first-page": "298", "DOI": "10.1124/jpet.300.1.298", "volume": "300", "author": "T Hashizume", "year": "2002", "unstructured": "Hashizume T, Imaoka S, Mise M, Terauchi Y, Fujii T, Miyazaki H, Kamataki T, Funae Y (2002) Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes. J Pharmacol Exp Ther 300:298\u2013304", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1150", "doi-asserted-by": "crossref", "first-page": "1240", "DOI": "10.1124/dmd.30.11.1240", "volume": "30", "author": "S Matsumoto", "year": "2002", "unstructured": "Matsumoto S, Hirama T, Matsubara T, Nagata K, Yamazoe Y (2002) Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole. Drug Metab Dispos 30:1240\u20131245", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1151", "doi-asserted-by": "crossref", "first-page": "615", "DOI": "10.1080/0049825031000105778", "volume": "33", "author": "S Matsumoto", "year": "2003", "unstructured": "Matsumoto S, Hirama T, Kim HJ, Nagata K, Yamazoe Y (2003) In vitro inhibition of human small intestinal and liver microsomal astemizole O-demethylation: different contribution of CYP2J2 in the small intestine and liver. Xenobiotica 33:615\u2013623", "journal-title": "Xenobiotica"}, {"key": "9_CR1152", "doi-asserted-by": "crossref", "first-page": "1793", "DOI": "10.1124/dmd.106.010488", "volume": "34", "author": "KH Liu", "year": "2006", "unstructured": "Liu KH, Kim MG, Lee DJ, Yoon YJ, Kim MJ, Shon JH, Choi CS, Choi YK, Desta Z, Shin JG (2006) Characterization of ebastine, hydroxyebastine, and carebastine metabolism by human liver microsomes and expressed cytochrome P450 enzymes: major roles for CYP2J2 and CYP3A. Drug Metab Dispos 34:1793\u20131797", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1153", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1080/00498250802509448", "volume": "39", "author": "HH Yoo", "year": "2009", "unstructured": "Yoo HH, Kim NS, Lee J, Sohn DR, Jin C, Kim DH (2009) Characterization of human cytochrome P450 enzymes involved in the biotransformation of eperisone. Xenobiotica 39:1\u201310", "journal-title": "Xenobiotica"}, {"key": "9_CR1154", "doi-asserted-by": "crossref", "first-page": "30", "DOI": "10.1124/dmd.110.035493", "volume": "39", "author": "A Ghosal", "year": "2011", "unstructured": "Ghosal A, Lu X, Penner N, Gao L, Ramanathan R, Chowdhury SK, Kishnani NS, Alton KB (2011) Identification of human liver cytochrome P450 enzymes involved in the metabolism of SCH 530348 (Vorapaxar), a potent oral thrombin protease-activated receptor 1 antagonist. Drug Metab Dispos 39:30\u201338", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1155", "doi-asserted-by": "crossref", "first-page": "943", "DOI": "10.1124/dmd.111.043505", "volume": "40", "author": "CA Lee", "year": "2012", "unstructured": "Lee CA, Jones JP, Katayama J, Kaspera R, Jiang Y, Freiwald S, Smith E, Walker GS, Totah RA (2012) Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity. Drug Metab Dispos 40:943\u2013951", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1156", "doi-asserted-by": "crossref", "first-page": "448", "DOI": "10.1124/dmd.109.029694", "volume": "38", "author": "L Wang", "year": "2010", "unstructured": "Wang L, Zhang D, Raghavan N, Yao M, Ma L, Frost CE, Maxwell BD, Chen SY, He K, Goosen TC, Humphreys WG, Grossman SJ (2010) In vitro assessment of metabolic drug-drug interaction potential of apixaban through cytochrome P450 phenotyping, inhibition, and induction studies. Drug Metab Dispos 38:448\u2013458", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1157", "doi-asserted-by": "crossref", "first-page": "2777", "DOI": "10.1016/j.bmcl.2006.02.004", "volume": "16", "author": "P Lafite", "year": "2006", "unstructured": "Lafite P, Dijols S, Buisson D, Macherey AC, Zeldin DC, Dansette PM, Mansuy D (2006) Design and synthesis of selective, high-affinity inhibitors of human cytochrome P450 2J2. Bioorg Med Chem Lett 16:2777\u20132780", "journal-title": "Bioorg Med Chem Lett"}, {"key": "9_CR1158", "doi-asserted-by": "crossref", "first-page": "1350", "DOI": "10.1021/ci400003p", "volume": "53", "author": "S Cong", "year": "2013", "unstructured": "Cong S, Ma XT, Li YX, Wang JF (2013) Structural basis for the mutation-induced dysfunction of human CYP2J2: a computational study. J Chem Inf Model 53:1350\u20131357", "journal-title": "J Chem Inf Model"}, {"key": "9_CR1159", "doi-asserted-by": "crossref", "first-page": "908", "DOI": "10.1124/jpet.109.152017", "volume": "329", "author": "C Chen", "year": "2009", "unstructured": "Chen C, Li G, Liao W, Wu J, Liu L, Ma D, Zhou J, Elbekai RH, Edin ML, Zeldin DC, Wang DW (2009) Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo. J Pharmacol Exp Ther 329:908\u2013918", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1160", "doi-asserted-by": "crossref", "first-page": "60", "DOI": "10.1124/dmd.112.048264", "volume": "41", "author": "S Ren", "year": "2013", "unstructured": "Ren S, Zeng J, Mei Y, Zhang JZ, Yan SF, Fei J, Chen L (2013) Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors. Drug Metab Dispos 41:60\u201371", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1161", "doi-asserted-by": "crossref", "first-page": "310", "DOI": "10.1124/mol.60.2.310", "volume": "60", "author": "B Yang", "year": "2001", "unstructured": "Yang B, Graham L, Dikalov S, Mason RP, Falck JR, Liao JK, Zeldin DC (2001) Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells. Mol Pharmacol 60:310\u2013320", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1162", "first-page": "H3", "volume": "297", "author": "Y Zhang", "year": "2009", "unstructured": "Zhang Y, El-Sikhry H, Chaudhary KR, Batchu SN, Shayeganpour A, Jukar TO, Bradbury JA, Graves JP, DeGraff LM, Myers P, Rouse DC, Foley J, Nyska A, Zeldin DC, Seubert JM (2009) Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity. Am J Physiol Heart Circul Physiol 297:H37\u201346", "journal-title": "Am J Physiol Heart Circul Physiol"}, {"key": "9_CR1163", "doi-asserted-by": "crossref", "first-page": "1607", "DOI": "10.1124/mol.104.004150", "volume": "66", "author": "YF Xiao", "year": "2004", "unstructured": "Xiao YF, Ke Q, Seubert JM, Bradbury JA, Graves J, Degraff LM, Falck JR, Krausz K, Gelboin HV, Morgan JP, Zeldin DC (2004) Enhancement of cardiac L-type Ca2 + currents in transgenic mice with cardiac-specific overexpression of CYP2J2. Mol Pharmacol 66:1607\u20131616", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1164", "doi-asserted-by": "crossref", "first-page": "2132", "DOI": "10.1161/01.CIR.0000143832.91812.60", "volume": "110", "author": "M Spiecker", "year": "2004", "unstructured": "Spiecker M, Darius H, Hankeln T, Soufi M, Sattler AM, Schaefer JR, Node K, Borgel J, Mugge A, Lindpaintner K, Huesing A, Maisch B, Zeldin DC, Liao JK (2004) Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. Circulation 110:2132\u20132136", "journal-title": "Circulation"}, {"key": "9_CR1165", "doi-asserted-by": "crossref", "first-page": "204", "DOI": "10.1016/j.tcm.2006.04.001", "volume": "16", "author": "M Spiecker", "year": "2006", "unstructured": "Spiecker M, Liao J (2006) Cytochrome P450 epoxygenase CYP2J2 and the risk of coronary artery disease. Trends Cardiovasc Med 16:204\u2013208", "journal-title": "Trends Cardiovasc Med"}, {"key": "9_CR1166", "doi-asserted-by": "crossref", "first-page": "539", "DOI": "10.1373/clinchem.2006.084756", "volume": "53", "author": "MM Hoffmann", "year": "2007", "unstructured": "Hoffmann MM, Bugert P, Seelhorst U, Wellnitz B, Winkelmann BR, Boehm BO, Marz W (2007) The \u2212 50G > T polymorphism in the promoter of the CYP2J2 gene in coronary heart disease: the Ludwigshafen risk and cardiovascular health study. Clin Chem 53:539\u2013540", "journal-title": "Clin Chem"}, {"key": "9_CR1167", "doi-asserted-by": "crossref", "first-page": "1047", "DOI": "10.1016/j.clinbiochem.2013.05.003", "volume": "46", "author": "Q Zhu", "year": "2013", "unstructured": "Zhu Q, Fu Z, Ma Y, Yang H, Huang D, Xie X, Liu F, Zheng Y, Cha E (2013) A novel polymorphism of the CYP2J2 gene is associated with coronary artery disease in Uygur population in China. Clin Biochem 46:1047\u20131054", "journal-title": "Clin Biochem"}, {"key": "9_CR1168", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1186/1471-2261-8-41", "volume": "8", "author": "J Borgel", "year": "2008", "unstructured": "Borgel J, Bulut D, Hanefeld C, Neubauer H, Mugge A, Epplen JT, Holland-Letz T, Spiecker M (2008) The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile. BMC Cardiovasc Disord 8:41", "journal-title": "BMC Cardiovasc Disord"}, {"key": "9_CR1169", "doi-asserted-by": "crossref", "first-page": "68", "DOI": "10.1016/j.prostaglandins.2012.09.004", "volume": "99", "author": "R Li", "year": "2012", "unstructured": "Li R, Xu X, Chen C, Yu X, Edin ML, Degraff LM, Lee CR, Zeldin DC, Wang DW (2012) Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic mice. Prostaglandins Other Lipid Mediat 99:68\u201378", "journal-title": "Prostaglandins Other Lipid Mediat"}, {"key": "9_CR1170", "doi-asserted-by": "crossref", "first-page": "535", "DOI": "10.1097/FPC.0b013e3282fd1287", "volume": "18", "author": "KD Marciante", "year": "2008", "unstructured": "Marciante KD, Totah RA, Heckbert SR, Smith NL, Lemaitre RN, Lumley T, Rice KM, Hindorff LA, Bis JC, Hartman B, Psaty BM (2008) Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke. Pharmacogenet Genomics 18:535\u2013543", "journal-title": "Pharmacogenet Genomics"}, {"key": "9_CR1171", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1097/FPC.0b013e32809913ea", "volume": "17", "author": "CR Lee", "year": "2007", "unstructured": "Lee CR, North KE, Bray MS, Couper DJ, Heiss G, Zeldin DC (2007) CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study. Pharmacogenet Genomics 17:349\u2013358", "journal-title": "Pharmacogenet Genomics"}, {"key": "9_CR1172", "doi-asserted-by": "crossref", "first-page": "1027", "DOI": "10.1089/gtmb.2012.0006", "volume": "16", "author": "A Alghasham", "year": "2012", "unstructured": "Alghasham A, Ali A, Ismail H, Dowaidar M, Settin AA (2012) CYP2J2 \u2212 50 G/T and ADRB2 G46A gene polymorphisms in Saudi subjects with hypertension. Genet Test Mol Biomarkers 16:1027\u20131031", "journal-title": "Genet Test Mol Biomarkers"}, {"key": "9_CR1173", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1111/j.1469-1809.2007.00346.x", "volume": "71", "author": "SN Wu", "year": "2007", "unstructured": "Wu SN, Zhang Y, Gardner CO, Chen Q, Li Y, Wang GL, Gao PJ, Zhu DL (2007) Evidence for association of polymorphisms in CYP2J2 and susceptibility to essential hypertension. Ann Hum Genet 71:519\u2013525", "journal-title": "Ann Hum Genet"}, {"key": "9_CR1174", "doi-asserted-by": "crossref", "first-page": "120", "DOI": "10.1378/chest.07-0371", "volume": "132", "author": "AV Polonikov", "year": "2007", "unstructured": "Polonikov AV, Ivanov VP, Solodilova MA, Khoroshaya IV, Kozhuhov MA, Panfilov VI (2007) Promoter polymorphism G-50T of a human CYP2J2 epoxygenase gene is associated with common susceptibility to asthma. Chest 132:120\u2013126", "journal-title": "Chest"}, {"key": "9_CR1175", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1097/FPC.0b013e3282f313e8", "volume": "18", "author": "L Zhang", "year": "2008", "unstructured": "Zhang L, Ding H, Yan J, Hui R, Wang W, Kissling GE, Zeldin DC, Wang DW (2008) Genetic variation in cytochrome P450 2J2 and soluble epoxide hydrolase and risk of ischemic stroke in a Chinese population. Pharmacogenet Genomics 18:45\u201351", "journal-title": "Pharmacogenet Genomics"}, {"key": "9_CR1176", "doi-asserted-by": "crossref", "first-page": "771", "DOI": "10.1002/jcp.21356", "volume": "215", "author": "KS Moshal", "year": "2008", "unstructured": "Moshal KS, Zeldin DC, Sithu SD, Sen U, Tyagi N, Kumar M, Hughes WM Jr, Metreveli N, Rosenberger DS, Singh M, Vacek TP, Rodriguez WE, Ayotunde A, Tyagi SC (2008) Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kB in hyperhomocysteinemia. J Cell Physiol 215:771\u2013781", "journal-title": "J Cell Physiol"}, {"key": "9_CR1177", "doi-asserted-by": "crossref", "first-page": "346", "DOI": "10.1055/s-0029-1243604", "volume": "118", "author": "CP Wang", "year": "2010", "unstructured": "Wang CP, Hung WC, Yu TH, Chiu CA, Lu LF, Chung FM, Hung CH, Shin SJ, Chen HJ, Lee YJ (2010) Genetic variation in the G-50T polymorphism of the cytochrome P450 epoxygenase CYP2J2 gene and the risk of younger onset type 2 diabetesamong Chinese population: potential interaction with body mass index and family history. Exp Clin Endocrinol Diabetes 118:346\u2013352", "journal-title": "Exp Clin Endocrinol Diabetes"}, {"key": "9_CR1178", "doi-asserted-by": "crossref", "first-page": "2990", "DOI": "10.1161/CIRCULATIONAHA.112.127340", "volume": "126", "author": "F Herse", "year": "2012", "unstructured": "Herse F, Lamarca B, Hubel CA, Kaartokallio T, Lokki AI, Ekholm E, Laivuori H, Gauster M, Huppertz B, Sugulle M, Ryan MJ, Novotny S, Brewer J, Park JK, Kacik M, Hoyer J, Verlohren S, Wallukat G, Rothe M, Luft FC, Muller DN, Schunck WH, Staff AC, Dechend R (2012) Cytochrome P450 subfamily 2J polypeptide 2 expression and circulating epoxyeicosatrienoic metabolites in preeclampsia. Circulation 126:2990\u20132999", "journal-title": "Circulation"}, {"key": "9_CR1179", "doi-asserted-by": "crossref", "first-page": "e75107", "DOI": "10.1371/journal.pone.0075107", "volume": "8", "author": "J Bystrom", "year": "2013", "unstructured": "Bystrom J, Thomson SJ, Johansson J, Edin ML, Zeldin DC, Gilroy DW, Smith AM, Bishop-Bailey D (2013) Inducible CYP2J2 and its product 11,12-EET promotes bacterial phagocytosis: a role for CYP2J2 deficiency in the pathogenesis of Crohn\u2019s disease? PLoS One 8:e75107", "journal-title": "PLoS One"}, {"key": "9_CR1180", "doi-asserted-by": "crossref", "first-page": "56", "DOI": "10.1016/j.prostaglandins.2013.02.003", "volume": "107", "author": "A Askari", "year": "2013", "unstructured": "Askari A, Thomson SJ, Edin ML, Zeldin DC, Bishop-Bailey D (2013) Roles of the epoxygenase CYP2J2 in the endothelium. Prostaglandins Other Lipid Mediat 107:56\u201363", "journal-title": "Prostaglandins Other Lipid Mediat"}, {"key": "9_CR1181", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1124/mol.113.087122", "volume": "85", "author": "X Wang", "year": "2014", "unstructured": "Wang X, Ni L, Yang L, Duan Q, Chen C, Edin ML, Zeldin DC, Wang DW (2014) CYP2J2-derived epoxyeicosatrienoic acids suppress endoplasmic reticulum stress in heart failure. Mol Pharmacol 85:105\u2013115", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1182", "doi-asserted-by": "crossref", "first-page": "e73490", "DOI": "10.1371/journal.pone.0073490", "volume": "8", "author": "C Westphal", "year": "2013", "unstructured": "Westphal C, Spallek B, Konkel A, Marko L, Qadri F, DeGraff LM, Schubert C, Bradbury JA, Regitz-Zagrosek V, Falck JR, Zeldin DC, Muller DN, Schunck WH, Fischer R (2013) CYP2J2 overexpression protects against arrhythmia susceptibility in cardiac hypertrophy. PLoS One 8:e73490", "journal-title": "PLoS One"}, {"key": "9_CR1183", "doi-asserted-by": "crossref", "first-page": "38084", "DOI": "10.1074/jbc.M307028200", "volume": "278", "author": "JB Cheng", "year": "2003", "unstructured": "Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW (2003) De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxylase. J Biol Chem 278:38084\u201338093", "journal-title": "J Biol Chem"}, {"key": "9_CR1184", "doi-asserted-by": "crossref", "first-page": "15650", "DOI": "10.1073/pnas.1315006110", "volume": "110", "author": "JG Zhu", "year": "2013", "unstructured": "Zhu JG, Ochalek JT, Kaufmann M, Jones G, DeLuca HF (2013) CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo. Proc Natl Acad Sci U S A 110:15650\u201315655", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR1185", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.1016/j.jmb.2008.03.065", "volume": "380", "author": "N Strushkevich", "year": "2008", "unstructured": "Strushkevich N, Usanov SA, Plotnikov AN, Jones G, Park HW (2008) Structural analysis of CYP2R1 in complex with vitamin D3. J Mol Biol 380:95\u2013106", "journal-title": "J Mol Biol"}, {"key": "9_CR1186", "doi-asserted-by": "crossref", "first-page": "50", "DOI": "10.1016/j.abb.2005.02.001", "volume": "436", "author": "D Choudhary", "year": "2005", "unstructured": "Choudhary D, Jansson I, Stoilov I, Sarfarazi M, Schenkman JB (2005) Expression patterns of mouse and human CYP orthologs (families 1\u20134) during development and in different adult tissues. Arch Biochem Biophys 436:50\u201361", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1187", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1016/j.jsbmb.2013.10.004", "volume": "144", "author": "Y Zhou", "year": "2014", "unstructured": "Zhou Y, Zhao LJ, Xu X, Ye A, Travers-Gustafson D, Zhou B, Wang HW, Zhang W, Lee Hamm L, Deng HW, Recker RR, Lappe JM (2014) DNA methylation levels of CYP2R1 and CYP24A1 predict vitamin D response variation. J Steroid Biochem Mol Biol 144:207\u2013214. doi:10.1016/j.jsbmb.2013.10.004", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR1188", "doi-asserted-by": "crossref", "first-page": "1392", "DOI": "10.1124/mol.108.053660", "volume": "75", "author": "M Ellfolk", "year": "2009", "unstructured": "Ellfolk M, Norlin M, Gyllensten K, Wikvall K (2009) Regulation of human vitamin D3 25-hydroxylases in dermal fibroblasts and prostate cancer LNCaP cells. Mol Pharmacol 75:1392\u20131399", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1189", "doi-asserted-by": "crossref", "first-page": "7711", "DOI": "10.1073/pnas.0402490101", "volume": "101", "author": "JB Cheng", "year": "2004", "unstructured": "Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW (2004) Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci U S A 101:7711\u20137715", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR1190", "doi-asserted-by": "crossref", "first-page": "2739", "DOI": "10.1093/hmg/ddq155", "volume": "19", "author": "J Ahn", "year": "2010", "unstructured": "Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, Jacobs EJ, Ascherio A, Helzlsouer K, Jacobs KB, Li Q, Weinstein SJ, Purdue M, Virtamo J, Horst R, Wheeler W, Chanock S, Hunter DJ, Hayes RB, Kraft P, Albanes D (2010) Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 19:2739\u20132745", "journal-title": "Hum Mol Genet"}, {"key": "9_CR1191", "doi-asserted-by": "crossref", "first-page": "451", "DOI": "10.1016/j.bbrc.2004.09.073", "volume": "324", "author": "R Shinkyo", "year": "2004", "unstructured": "Shinkyo R, Sakaki T, Kamakura M, Ohta M, Inouye K (2004) Metabolism of vitamin D by human microsomal CYP2R1. Biochem Biophys Res Commun 324:451\u2013457", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1192", "doi-asserted-by": "crossref", "first-page": "30", "DOI": "10.1016/j.abb.2012.01.013", "volume": "523", "author": "J Zhu", "year": "2012", "unstructured": "Zhu J, DeLuca HF (2012) Vitamin D 25-hydroxylase\u2014four decades of searching, are we there yet? Arch Biochem Biophys 523:30\u201336", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1193", "doi-asserted-by": "crossref", "first-page": "60", "DOI": "10.1186/1465-9921-7-60", "volume": "7", "author": "M Wjst", "year": "2006", "unstructured": "Wjst M, Altmuller J, Faus-Kessler T, Braig C, Bahnweg M, Andre E (2006) Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway. Respir Res 7:60", "journal-title": "Respir Res"}, {"key": "9_CR1194", "doi-asserted-by": "crossref", "first-page": "1495", "DOI": "10.1007/s00439-012-1185-z", "volume": "131", "author": "J Lasky-Su", "year": "2012", "unstructured": "Lasky-Su J, Lange N, Brehm JM, Damask A, Soto-Quiros M, Avila L, Celedon JC, Canino G, Cloutier MM, Hollis BW, Weiss ST, Litonjua AA (2012) Genome-wide association analysis of circulating vitamin D levels in children with asthma. Hum Genet 131:1495\u20131505", "journal-title": "Hum Genet"}, {"key": "9_CR1195", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.1002/dmrr.719", "volume": "23", "author": "E Ramos-Lopez", "year": "2007", "unstructured": "Ramos-Lopez E, Bruck P, Jansen T, Herwig J, Badenhoop K (2007) CYP2R1 (vitamin D 25-hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans. Diabetes Metab Res Rev 23:631\u2013636", "journal-title": "Diabetes Metab Res Rev"}, {"key": "9_CR1196", "doi-asserted-by": "crossref", "first-page": "1676", "DOI": "10.1007/s00415-011-6001-5", "volume": "258", "author": "KC Simon", "year": "2011", "unstructured": "Simon KC, Munger KL, Kraft P, Hunter DJ, De Jager PL, Ascherio A (2011) Genetic predictors of 25-hydroxy vitamin D levels and risk of multiple sclerosis. J Neurol 258:1676\u20131682", "journal-title": "J Neurol"}, {"key": "9_CR1197", "doi-asserted-by": "crossref", "first-page": "709", "DOI": "10.1089/thy.2011.0330", "volume": "22", "author": "M Penna-Martinez", "year": "2012", "unstructured": "Penna-Martinez M, Ramos-Lopez E, Stern J, Kahles H, Hinsch N, Hansmann ML, Selkinski I, Grunwald F, Vorlander C, Bechstein WO, Zeuzem S, Holzer K, Badenhoop K (2012) Impaired vitamin D activation and association with CYP24A1 haplotypes in differentiated thyroid carcinoma. Thyroid 22:709\u2013716", "journal-title": "Thyroid"}, {"key": "9_CR1198", "doi-asserted-by": "crossref", "first-page": "e66768", "DOI": "10.1371/journal.pone.0066768", "volume": "8", "author": "LN Anderson", "year": "2013", "unstructured": "Anderson LN, Cotterchio M, Knight JA, Borgida A, Gallinger S, Cleary SP (2013) Genetic variants in vitamin D pathway genes and risk of pancreas cancer; results from a population-based case-control study in Ontario, Canada. PLoS One 8:e66768", "journal-title": "PLoS One"}, {"key": "9_CR1199", "doi-asserted-by": "crossref", "first-page": "529", "DOI": "10.1006/bbrc.2001.4390", "volume": "281", "author": "T Rylander", "year": "2001", "unstructured": "Rylander T, Neve EPA, Ingelman-Sundberg M, Oscarson M (2001) Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1). Biochem Biophys Res Commun 281:529\u2013535", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1200", "doi-asserted-by": "crossref", "first-page": "781", "DOI": "10.1016/j.febslet.2007.01.056", "volume": "581", "author": "CJ Marek", "year": "2007", "unstructured": "Marek CJ, Tucker SJ, Koruth M, Wallace K, Wright MC (2007) Expression of CYP2S1 in human hepatic stellate cells. FEBS Lett 581:781\u2013786", "journal-title": "FEBS Lett"}, {"key": "9_CR1201", "doi-asserted-by": "crossref", "first-page": "549", "DOI": "10.1369/jhc.4C6576.2005", "volume": "53", "author": "ST Saarikoski", "year": "2005", "unstructured": "Saarikoski ST, Wikman HA, Smith G, Wolff CH, Husgafvel-Pursiainen K (2005) Localization of cytochrome P450 CYP2S1 expression in human tissues by in situ hybridization and immunohistochemistry. J Histochem Cytochem 53:549\u2013556", "journal-title": "J Histochem Cytochem"}, {"key": "9_CR1202", "doi-asserted-by": "crossref", "first-page": "1031", "DOI": "10.3109/00498254.2011.603763", "volume": "41", "author": "B Wang", "year": "2011", "unstructured": "Wang B, Robertson LW, Wang K, Ludewig G (2011) Species difference in the regulation of cytochrome P450 2S1: lack of induction in rats by the aryl hydrocarbon receptor agonist PCB126. Xenobiotica 41:1031\u20131043", "journal-title": "Xenobiotica"}, {"key": "9_CR1203", "doi-asserted-by": "crossref", "first-page": "30", "DOI": "10.1016/j.toxlet.2011.11.020", "volume": "209", "author": "IG Bebenek", "year": "2012", "unstructured": "Bebenek IG, Solaimani P, Bui P, Hankinson O (2012) CYP2S1 is negatively regulated by corticosteroids in human cell lines. Toxicol Lett 209:30\u201334", "journal-title": "Toxicol Lett"}, {"key": "9_CR1204", "doi-asserted-by": "crossref", "first-page": "267", "DOI": "10.1016/j.mrfmmm.2004.05.007", "volume": "554", "author": "ST Saarikoski", "year": "2004", "unstructured": "Saarikoski ST, Suitiala T, Holmila R, Impivaara O, Jarvisalo J, Hirvonen A, Husgafvel-Pursiainen K (2004) Identification of genetic polymorphisms of CYP2S1 in a Finnish Caucasian population. Mutat Res 554:267\u2013277", "journal-title": "Mutat Res"}, {"key": "9_CR1205", "doi-asserted-by": "crossref", "first-page": "292", "DOI": "10.1097/FTD.0b013e318058a4e0", "volume": "29", "author": "YJ Jang", "year": "2007", "unstructured": "Jang YJ, Cha EY, Kim WY, Park SW, Shon JH, Lee SS, Shin JG (2007) CYP2S1 gene polymorphisms in a Korean population. Ther Drug Monit 29:292\u2013298", "journal-title": "Ther Drug Monit"}, {"key": "9_CR1206", "doi-asserted-by": "crossref", "first-page": "1336", "DOI": "10.1016/S0140-6736(03)13081-4", "volume": "361", "author": "G Smith", "year": "2003", "unstructured": "Smith G, Wolf CR, Deeni YY, Dawe RS, Evans AT, Comrie MM, Ferguson J, Ibbotson SH (2003) Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases. Lancet 361:1336\u20131343", "journal-title": "Lancet"}, {"key": "9_CR1207", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1016/j.taap.2004.12.022", "volume": "207", "author": "M Karlgren", "year": "2005", "unstructured": "Karlgren M, Miura S, Ingelman-Sundberg M (2005) Novel extrahepatic cytochrome P450s. Toxicol Appl Pharmacol 207:57\u201361", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "9_CR1208", "doi-asserted-by": "crossref", "first-page": "497", "DOI": "10.1124/mol.110.065045", "volume": "78", "author": "CR Nishida", "year": "2010", "unstructured": "Nishida CR, Lee M, de Montellano PR (2010) Efficient hypoxic activation of the anticancer agent AQ4N by CYP2S1 and CYP2W1. Mol Pharmacol 78:497\u2013502", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1209", "doi-asserted-by": "crossref", "first-page": "1031", "DOI": "10.1124/mol.109.057752", "volume": "76", "author": "PH Bui", "year": "2009", "unstructured": "Bui PH, Hankinson O (2009) Functional characterization of human cytochrome P450 2S1 using a synthetic gene-expressed protein in Escherichia coli. Mol Pharmacol 76:1031\u20131043", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1210", "doi-asserted-by": "crossref", "first-page": "944", "DOI": "10.1124/dmd.111.039321", "volume": "39", "author": "Y Xiao", "year": "2011", "unstructured": "Xiao Y, Shinkyo R, Guengerich FP (2011) Cytochrome P450 2S1 is reduced by NADPH-cytochrome P450 reductase. Drug Metab Dispos 39:944\u2013946", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1211", "doi-asserted-by": "crossref", "first-page": "1255", "DOI": "10.1016/0006-291X(73)91122-4", "volume": "54", "author": "FF Kadlubar", "year": "1973", "unstructured": "Kadlubar FF, Morton KC, Ziegler DM (1973) Microsomal-catalyzed hydroperoxide-dependent C-oxidation of amines. Biochem Biophys Res Commun 54:1255\u20131261", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1212", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1016/0003-9861(73)90383-4", "volume": "157", "author": "EG Hrycay", "year": "1973", "unstructured": "Hrycay EG, O\u2019Brien PJ (1973) Microsomal electron transport. I. Reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase and cytochrome P-450 as electron carriers in microsomal NADPH-peroxidase activity. Arch Biochem Biophys 157:7\u201322", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1213", "doi-asserted-by": "crossref", "first-page": "1044", "DOI": "10.1124/mol.109.057760", "volume": "76", "author": "PH Bui", "year": "2009", "unstructured": "Bui PH, Hsu EL, Hankinson O (2009) Fatty acid hydroperoxides support cytochrome P450 2S1-mediated bioactivation of benzo[a]pyrene-7,8-dihydrodiol. Mol Pharmacol 76:1044\u20131052", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1214", "doi-asserted-by": "crossref", "first-page": "1740", "DOI": "10.1021/tx3001994", "volume": "25", "author": "K Wang", "year": "2012", "unstructured": "Wang K, Guengerich FP (2012) Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1. Chem Res Toxicol 25:1740\u20131751", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR1215", "doi-asserted-by": "crossref", "first-page": "62", "DOI": "10.1016/j.taap.2004.12.027", "volume": "207", "author": "ST Saarikoski", "year": "2005", "unstructured": "Saarikoski ST, Rivera SP, Hankinson O, Husgafvel-Pursiainen K (2005) CYP2S1: a short review. Toxicol Appl Pharmacol 207:62\u201369", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "9_CR1216", "first-page": "1402", "volume": "47", "author": "LA Akhmadishina", "year": "2011", "unstructured": "Akhmadishina LA, Korytina GF, Victorova TV (2011) Polymorphic markers of the CYP1B1 (4326C > G), CYP2F1 (c.14_15insC), CYP2J2 (\u2212 76G > T), and CYP2S1 (13106C > T and 13255A > G) genes and genetic predisposition to chronic respiratory diseases induced by smoking and occupational factors. Genetika 47:1402\u20131410", "journal-title": "Genetika"}, {"key": "9_CR1217", "doi-asserted-by": "crossref", "first-page": "6305", "DOI": "10.1074/jbc.M311830200", "volume": "279", "author": "SS Chuang", "year": "2004", "unstructured": "Chuang SS, Helvig C, Taimi M, Ramshaw HA, Collop AH, Amad M, White JA, Petkovich M, Jones G, Korczak B (2004) CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes \u03c9- and (\u03c9-1)-hydroxylation of fatty acids. J Biol Chem 279:6305\u20136314", "journal-title": "J Biol Chem"}, {"key": "9_CR1218", "doi-asserted-by": "crossref", "first-page": "679", "DOI": "10.1016/j.bbrc.2004.01.110", "volume": "315", "author": "M Karlgren", "year": "2004", "unstructured": "Karlgren M, Backlund M, Johansson I, Oscarson M, Ingelman-Sundberg M (2004) Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1. Biochem Biophys Res Commun 315:679\u2013685", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1219", "doi-asserted-by": "crossref", "first-page": "1528", "DOI": "10.1124/dmd.109.027011", "volume": "37", "author": "F Dutheil", "year": "2009", "unstructured": "Dutheil F, Dauchy S, Diry M, Sazdovitch V, Cloarec O, Mellottee L, Bieche I, Ingelman-Sundberg M, Flinois JP, de Waziers I, Beaune P, Decleves X, Duyckaerts C, Loriot MA (2009) Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function. Drug Metab Dispos 37:1528\u20131538", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1220", "doi-asserted-by": "crossref", "first-page": "679", "DOI": "10.1124/dmd.109.029249", "volume": "38", "author": "S Ellero", "year": "2010", "unstructured": "Ellero S, Chakhtoura G, Barreau C, Langouet S, Benelli C, Penicaud L, Beaune P, de Waziers I (2010) Xenobiotic-metabolizing cytochromes P450 in human white adipose tissue: expression and induction. Drug Metab Dispos 38:679\u2013686", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1221", "doi-asserted-by": "crossref", "first-page": "278", "DOI": "10.1016/j.taap.2003.09.020", "volume": "195", "author": "L Du", "year": "2004", "unstructured": "Du L, Hoffman SM, Keeney DS (2004) Epidermal CYP2 family cytochromes P450. Toxicol Appl Pharmacol 195:278\u2013287", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "9_CR1222", "doi-asserted-by": "crossref", "first-page": "182", "DOI": "10.1097/SHK.0b013e31829de02f", "volume": "40", "author": "HM Brandfellner", "year": "2013", "unstructured": "Brandfellner HM, Ruparel SB, Gelfond JA, Hargreaves KM (2013) Major blunt trauma evokes selective upregulation of oxidative enzymes in circulating leukocytes. Shock 40:182\u2013187", "journal-title": "Shock"}, {"key": "9_CR1223", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1016/j.plefa.2010.06.005", "volume": "83", "author": "A Devos", "year": "2010", "unstructured": "Devos A, Lino Cardenas CL, Glowacki F, Engels A, Lo-Guidice JM, Chevalier D, Allorge D, Broly F, Cauffiez C (2010) Genetic polymorphism of CYP2U1, a cytochrome P450 involved in fatty acidshydroxylation. Prostaglandins Leukot Essent Fatty Acids 83:105\u2013110", "journal-title": "Prostaglandins Leukot Essent Fatty Acids"}, {"key": "9_CR1224", "doi-asserted-by": "crossref", "first-page": "10476", "DOI": "10.1074/jbc.M114.550004", "volume": "289", "author": "M Siller", "year": "2013", "unstructured": "Siller M, Goyal S, Xiao Y, Yoshimoto FK, Guengerich FP (2013) Oxidation of endogenous N-arachidonylserotonin by human cytochrome P450 2U1. J Biol Chem 289:10476\u201310487", "journal-title": "J Biol Chem"}, {"key": "9_CR1225", "doi-asserted-by": "crossref", "first-page": "634", "DOI": "10.1046/j.1432-1327.1998.2540634.x", "volume": "254", "author": "T Bisogno", "year": "1998", "unstructured": "Bisogno T, Katayama K, Melck D, Ueda N, De Petrocellis L, Yamamoto S, Di Marzo V (1998) Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells\u2014implications for cell proliferation and differentiation. Eur J Biochem 254:634\u2013642", "journal-title": "Eur J Biochem"}, {"key": "9_CR1226", "doi-asserted-by": "crossref", "first-page": "202", "DOI": "10.1111/j.1365-2559.2010.03606.x", "volume": "57", "author": "GI Murray", "year": "2010", "unstructured": "Murray GI, Patimalla S, Stewart KN, Miller ID, Heys SD (2010) Profiling the expression of cytochrome P450 in breast cancer. Histopathology 57:202\u2013211", "journal-title": "Histopathology"}, {"key": "9_CR1227", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1007/s00415-013-7206-6", "volume": "261", "author": "A Citterio", "year": "2014", "unstructured": "Citterio A, Arnoldi A, Panzeri E, D\u2019Angelo MG, Filosto M, Dilena R, Arrigoni F, Castelli M, Maghini C, Germiniasi C, Menni F, Martinuzzi A, Bresolin N, Bassi MT (2014) Mutations in CYP2U1, DDHD2 and GBA2 genes are rare causes of complicated forms of hereditary spastic paraparesis. J Neurol 261:373\u2013381", "journal-title": "J Neurol"}, {"key": "9_CR1228", "doi-asserted-by": "crossref", "first-page": "451", "DOI": "10.1016/j.bbrc.2005.12.200", "volume": "341", "author": "M Karlgren", "year": "2006", "unstructured": "Karlgren M, Gomez A, Stark K, Svard J, Rodriguez-Antona C, Oliw E, Bernal ML, SR YC, Johansson I, Ingelman-Sundberg M (2006) Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1. Biochem Biophys Res Commun 341:451\u2013458", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1229", "doi-asserted-by": "crossref", "first-page": "1615", "DOI": "10.2217/pgs.13.136", "volume": "14", "author": "K Stenstedt", "year": "2013", "unstructured": "Stenstedt K, Travica S, Guo J, Barragan I, Pors K, Patterson L, Edler D, Mkrtchian S, Johansson I, Ingelman-Sundberg M (2013) CYP2W1 polymorphism: functional aspects and relation to risk for colorectal cancer. Pharmacogenomics 14:1615\u20131622", "journal-title": "Pharmacogenomics"}, {"key": "9_CR1230", "doi-asserted-by": "crossref", "first-page": "837", "DOI": "10.7314/APJCP.2012.13.3.837", "volume": "13", "author": "N Cardenas-Rodriguez", "year": "2012", "unstructured": "Cardenas-Rodriguez N, Lara-Padilla E, Bandala C, Lopez-Cruz J, Uscanga-Carmona C, Lucio-Monter PF, Floriano-Sanchez E (2012) CYP2W1, CYP4F11 and CYP8A1 polymorphisms and interaction of CYP2W1 genotypes with risk factors in Mexican women with breast cancer. Asian Pac J Cancer Prev 13:837\u2013846", "journal-title": "Asian Pac J Cancer Prev"}, {"key": "9_CR1231", "doi-asserted-by": "crossref", "first-page": "919", "DOI": "10.2217/pgs.10.66", "volume": "11", "author": "G Gervasini", "year": "2010", "unstructured": "Gervasini G, de Murillo SG, Ladero JM, Agundez JA (2010) CYP2W1 variant alleles in Caucasians and association of the CYP2W1 G541A (Ala181Thr) polymorphism with increased colorectal cancer risk. Pharmacogenomics 11:919\u2013925", "journal-title": "Pharmacogenomics"}, {"key": "9_CR1232", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1124/dmd.107.019141", "volume": "36", "author": "Y Hanzawa", "year": "2008", "unstructured": "Hanzawa Y, Sasaki T, Mizugaki M, Ishikawa M, Hiratsuka M (2008) Genetic polymorphisms and haplotype structures of the human CYP2W1 gene in a Japanese population. Drug Metab Dispos 36:349\u2013352", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1233", "doi-asserted-by": "crossref", "first-page": "171", "DOI": "10.5487/TR.2010.26.3.171", "volume": "26", "author": "CY Eun", "year": "2010", "unstructured": "Eun CY, Han S, Lim YR, Park HG, Han JS, Cho KS, Chun YJ, Kim D (2010) Bioactivation of aromatic amines by human CYP2W1, an orphan cytochrome P450 enzyme. Toxicol Res 26:171\u2013175", "journal-title": "Toxicol Res"}, {"key": "9_CR1234", "doi-asserted-by": "crossref", "first-page": "1982", "DOI": "10.1158/1535-7163.MCT-11-0391", "volume": "10", "author": "BS Tan", "year": "2011", "unstructured": "Tan BS, Tiong KH, Muruhadas A, Randhawa N, Choo HL, Bradshaw TD, Stevens MF, Leong CO (2011) CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW-610, NSC 721648) sensitivity in breast and colorectal cancer cells. Mol Cancer Ther 10:1982\u20131992", "journal-title": "Mol Cancer Ther"}, {"key": "9_CR1235", "doi-asserted-by": "crossref", "first-page": "2952", "DOI": "10.1158/1078-0432.CCR-13-0238", "volume": "19", "author": "S Travica", "year": "2013", "unstructured": "Travica S, Pors K, Loadman PM, Shnyder SD, Johansson I, Alandas MN, Sheldrake HM, Mkrtchian S, Patterson LH, Ingelman-Sundberg M (2013) Colon cancer-specific cytochrome P450 2W1 converts duocarmycin analogues into potent tumor cytotoxins. Clin Cancer Res 19:2952\u20132961", "journal-title": "Clin Cancer Res"}, {"key": "9_CR1236", "doi-asserted-by": "crossref", "first-page": "1610", "DOI": "10.1194/jlr.M027185", "volume": "53", "author": "Y Xiao", "year": "2012", "unstructured": "Xiao Y, Guengerich FP (2012) Metabolomic analysis and identification of a role for the orphan human cytochrome P450 2W1 in selective oxidation of lysophospholipids. J Lipid Res 53:1610\u20131617", "journal-title": "J Lipid Res"}, {"key": "9_CR1237", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1016/j.bbrc.2006.04.080", "volume": "345", "author": "H Yoshioka", "year": "2006", "unstructured": "Yoshioka H, Kasai N, Ikushiro S, Shinkyo R, Kamakura M, Ohta M, Inouye K, Sakaki T (2006) Enzymatic properties of human CYP2W1 expressed in Escherichia coli. Biochem Biophys Res Commun 345:169\u2013174", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1238", "doi-asserted-by": "crossref", "first-page": "170", "DOI": "10.1016/j.jmgm.2009.06.002", "volume": "28", "author": "W Li", "year": "2009", "unstructured": "Li W, Tang Y, Hoshino T, Neya S (2009) Molecular modeling of human cytochrome P450 2W1 and its interactions with substrates. J Mol Graph Model 28:170\u2013176", "journal-title": "J Mol Graph Model"}, {"key": "9_CR1239", "first-page": "3869", "volume": "32", "author": "K Stenstedt", "year": "2012", "unstructured": "Stenstedt K, Hallstrom M, Johansson I, Ingelman-Sundberg M, Ragnhammar P, Edler D (2012) The expression of CYP2W1: a prognostic marker in colon cancer. Anticancer Res 32:3869\u20133874", "journal-title": "Anticancer Res"}, {"key": "9_CR1240", "doi-asserted-by": "crossref", "first-page": "2647", "DOI": "10.7314/APJCP.2012.13.6.2647", "volume": "13", "author": "C Bandala", "year": "2012", "unstructured": "Bandala C, Floriano-Sanchez E, Cardenas-Rodriguez N, Lopez-Cruz J, Lara-Padilla E (2012) RNA expression of cytochrome P450 in Mexican women with breast cancer. Asian Pac J Cancer Prev 13:2647\u20132653", "journal-title": "Asian Pac J Cancer Prev"}, {"key": "9_CR1241", "doi-asserted-by": "crossref", "first-page": "6310", "DOI": "10.1073/pnas.82.18.6310", "volume": "82", "author": "PB Watkins", "year": "1985", "unstructured": "Watkins PB, Wrighton SA, Maurel P, Schuetz EG, Mendez-Picon G, Parker GA, Guzelian PS (1985) Identification of an inducible form of cytochrome P-450 in human liver. Proc Natl Acad Sci U S A 82:6310\u20136314", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR1242", "doi-asserted-by": "crossref", "first-page": "5311", "DOI": "10.1073/pnas.83.14.5311", "volume": "83", "author": "DT Molowa", "year": "1986", "unstructured": "Molowa DT, Schuetz EG, Wrighton SA, Watkins PB, Kremers P, Mendez-Picon G, Parker GA, Guzelian PS (1986) Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. Proc Natl Acad Sci U S A 83:5311\u20135315", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR1243", "doi-asserted-by": "crossref", "first-page": "8064", "DOI": "10.1073/pnas.83.21.8064", "volume": "83", "author": "PH Beaune", "year": "1986", "unstructured": "Beaune PH, Umbenhauer DR, Bork RW, Lloyd RS, Guengerich FP (1986) Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase. Proc Natl Acad Sci U S A 83:8064\u20138068", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR1244", "first-page": "910", "volume": "264", "author": "RW Bork", "year": "1989", "unstructured": "Bork RW, Muto T, Beaune PH, Srivastava PK, Lloyd RS, Guengerich FP (1989) Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity. J Biol Chem 264:910\u2013919", "journal-title": "J Biol Chem"}, {"key": "9_CR1245", "first-page": "A2242", "volume": "4", "author": "J Kolars", "year": "1990", "unstructured": "Kolars J, Schmiedelin-Ren P Dobbins W, Merion R, Wrighton S, Watkins P (1990) Heterogeneity of P-450 IIIA expression in human gut epithelia. FASEB J 4:A2242", "journal-title": "FASEB J"}, {"key": "9_CR1246", "doi-asserted-by": "crossref", "first-page": "1871", "DOI": "10.1172/JCI116064", "volume": "90", "author": "JC Kolars", "year": "1992", "unstructured": "Kolars JC, Schmiedlin-Ren P, Schuetz JD, Fang C, Watkins PB (1992) Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J Clin Invest 90:1871\u20131878", "journal-title": "J Clin Invest"}, {"key": "9_CR1247", "doi-asserted-by": "crossref", "first-page": "1596", "DOI": "10.1021/jm00159a007", "volume": "29", "author": "RH B\u00f6cker", "year": "1986", "unstructured": "B\u00f6cker RH, Guengerich FP (1986) Oxidation of 4-aryl- and 4-alkyl-substituted 2,6-dimethyl-3,5-bis(alkoxycarbonyl)-1,4-dihydropyridines by human liver microsomes and immunochemical evidence for the involvement of a form of cytochrome P-450. J Med Chem 29:1596\u20131603", "journal-title": "J Med Chem"}, {"key": "9_CR1248", "doi-asserted-by": "crossref", "first-page": "424", "DOI": "10.1016/0003-9861(88)90655-8", "volume": "263", "author": "DJ Waxman", "year": "1988", "unstructured": "Waxman DJ, Attisano C, Guengerich FP, Lapenson DP (1988) Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6\u03b2-hydroxylase cytochrome P-450 enzyme. Arch Biochem Biophys 263:424\u2013436", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1249", "doi-asserted-by": "crossref", "first-page": "11280", "DOI": "10.1021/bi00503a018", "volume": "29", "author": "WR Brian", "year": "1990", "unstructured": "Brian WR, Sari M-A, Iwasaki M, Shimada T, Kaminsky LS, Guengerich FP (1990) Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae. Biochemistry 29:11280\u201311292", "journal-title": "Biochemistry"}, {"key": "9_CR1250", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1021/tx00016a015", "volume": "3", "author": "FP Guengerich", "year": "1990", "unstructured": "Guengerich FP (1990) Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene. Chem Res Toxicol 3:363\u2013371", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR1251", "doi-asserted-by": "crossref", "first-page": "88", "DOI": "10.1006/taap.1997.8117", "volume": "144", "author": "JD Kelly", "year": "1997", "unstructured": "Kelly JD, Eaton DL, Guengerich FP, Coulombe RA Jr (1997) Aflatoxin B1 activation in human lung. Toxicol Appl Pharmacol 144:88\u201395", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "9_CR1252", "doi-asserted-by": "crossref", "first-page": "1187", "DOI": "10.1124/dmd.113.051359", "volume": "41", "author": "IM Booth Depaz", "year": "2013", "unstructured": "Booth Depaz IM, Toselli F, Wilce PA, Gillam EM (2013) Differential expression of human cytochrome P450 enzymes from the CYP3A subfamily in the brains of alcoholic subjects and drug-free controls. Drug Metab Dispos 41:1187\u20131194", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1253", "doi-asserted-by": "crossref", "first-page": "1108", "DOI": "10.1124/dmd.30.10.1108", "volume": "30", "author": "I Koch", "year": "2002", "unstructured": "Koch I, Weil R, Wolbold R, Brockmoller J, Hustert E, Burk O, Nuessler A, Neuhaus P, Eichelbaum M, Zanger U, Wojnowski L (2002) Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA. Drug Metab Dispos 30:1108\u20131114", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1254", "doi-asserted-by": "crossref", "first-page": "e2337", "DOI": "10.1371/journal.pone.0002337", "volume": "3", "author": "V Agarwal", "year": "2008", "unstructured": "Agarwal V, Kommaddi RP, Valli K, Ryder D, Hyde TM, Kleinman JE, Strobel HW, Ravindranath V (2008) Drug metabolism in human brain: high levels of cytochrome P4503A43 in brain and metabolism of anti-anxiety drug alprazolam to its active metabolite. PLoS One 3:e2337", "journal-title": "PLoS One"}, {"key": "9_CR1255", "doi-asserted-by": "crossref", "first-page": "562", "DOI": "10.1111/j.1528-1167.2010.02956.x", "volume": "52", "author": "C Ghosh", "year": "2011", "unstructured": "Ghosh C, Marchi N, Desai NK, Puvenna V, Hossain M, Gonzalez-Martinez J, Alexopoulos AV, Janigro D (2011) Cellular localization and functional significance of CYP3A4 in the human epileptic brain. Epilepsia 52:562\u2013571", "journal-title": "Epilepsia"}, {"key": "9_CR1256", "doi-asserted-by": "crossref", "first-page": "571", "DOI": "10.1097/00008571-200008000-00011", "volume": "10", "author": "T Nakamoto", "year": "2000", "unstructured": "Nakamoto T, Hase I, Imaoka S, Hiroi T, Oda Y, Asada A, Funae Y (2000) Quantitative RT-PCR for CYP3A4 mRNA in human peripheral lymphocytes: induction of CYP3A4 in lymphocytes and in liver by rifampicin. Pharmacogenetics 10:571\u2013575", "journal-title": "Pharmacogenetics"}, {"key": "9_CR1257", "first-page": "460", "volume": "47", "author": "M El Mouelhi", "year": "1987", "unstructured": "El Mouelhi M, Didolkar MS, Elias EG, Guengerich FP, Kauffman FC (1987) Hepatic drug-metabolizing enzymes in primary and secondary tumors of human liver. Cancer Res 47:460\u2013466", "journal-title": "Cancer Res"}, {"key": "9_CR1258", "doi-asserted-by": "crossref", "first-page": "42", "DOI": "10.1007/s002800100291", "volume": "48", "author": "K Fujitaka", "year": "2001", "unstructured": "Fujitaka K, Oguri T, Isobe T, Fujiwara Y, Kohno N (2001) Induction of cytochrome P450 3A4 by docetaxel in peripheral mononuclear cells and its expression in lung cancer. Cancer Chemother Pharmacol 48:42\u201346", "journal-title": "Cancer Chemother Pharmacol"}, {"key": "9_CR1259", "doi-asserted-by": "crossref", "first-page": "145", "DOI": "10.1038/sj.neo.7900017", "volume": "1", "author": "SJ Hughes", "year": "1999", "unstructured": "Hughes SJ, Morse MA, Weghorst CM, Kim H, Watkins PB, Guengerich FP, Orringer MB, Beer DG (1999) Cytochromes P450 are expressed in proliferating cells in Barrett\u2019s metaplasia. Neoplasia 1:145\u2013153", "journal-title": "Neoplasia"}, {"key": "9_CR1260", "doi-asserted-by": "crossref", "first-page": "485", "DOI": "10.2165/00003088-199937060-00004", "volume": "37", "author": "SN de Wildt", "year": "1999", "unstructured": "de Wildt SN, Kearns GL, Leeder JS, van den Anker JN (1999) Cytochrome P450 3A. Ontogeny and drug disposition. Clin Pharmacokinet 37:485\u2013505", "journal-title": "Clin Pharmacokinet"}, {"key": "9_CR1261", "doi-asserted-by": "crossref", "first-page": "670", "DOI": "10.1038/sj.clpt.6100327", "volume": "83", "author": "TN Johnson", "year": "2008", "unstructured": "Johnson TN, Tucker GT, Rostami-Hodjegan A (2008) Development of CYP2D6 and CYP3A4 in the first year of life. Clin Pharmacol Ther 83:670\u2013671", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR1262", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1007/BF01899734", "volume": "37", "author": "K Inoue", "year": "1992", "unstructured": "Inoue K, Inazawa J, Nakagawa H, Shimada T, Yamazaki H, Guengerich FP, Abe T (1992) Assignment of the human cytochrome P-450 nifedipine oxidase gene (CYP3A4) to chromosome 7 at band q22.1 by fluorescence in situ hybridization. Jpn J Hum Genet 37:133\u2013138", "journal-title": "Jpn J Hum Genet"}, {"key": "9_CR1263", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1016/0003-9861(72)90239-1", "volume": "152", "author": "AYH Lu", "year": "1972", "unstructured": "Lu AYH, Somogyi A, West S, Kuntzman R, Conney AH (1972) Pregnenolone-16\u03b1-carbonitrile: a new type of inducer of drug-metabolizing enzymes. Arch Biochem Biophys 152:457\u2013462", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1264", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1146/annurev.pharmtox.39.1.1", "volume": "39", "author": "FP Guengerich", "year": "1999", "unstructured": "Guengerich FP (1999) Cytochrome P-450 3A4: regulationand role in drug metabolism. Annu Rev Pharmacol Toxicol 39:1\u201317", "journal-title": "Annu Rev Pharmacol Toxicol"}, {"key": "9_CR1265", "first-page": "10", "volume": "50", "author": "JL Barwick", "year": "1996", "unstructured": "Barwick JL, Quattrochi LC, Mills AS, Potenza C, Tukey RH, Guzelian PS (1996) Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes. Mol Pharmacol 50:10\u201316", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1266", "first-page": "2007", "volume": "259", "author": "EG Schuetz", "year": "1984", "unstructured": "Schuetz EG, Guzelian PS (1984) Induction of cytochrome P-450 by glucocorticoids in rat liver: II. Evidence that glucocorticoids regulate induction of cytochrome P-450 by a nonclassical receptor mechanism. J Biol Chem 259:2007\u20132012", "journal-title": "J Biol Chem"}, {"key": "9_CR1267", "doi-asserted-by": "crossref", "first-page": "92", "DOI": "10.1038/nm0198-092", "volume": "4", "author": "C Calleja", "year": "1998", "unstructured": "Calleja C, Pascussi JM, Mani JC, Maurel P, Vilarem MJ (1998) The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor. Nat Med 4:92\u201396", "journal-title": "Nat Med"}, {"key": "9_CR1268", "first-page": "1090", "volume": "4", "author": "DW Ray", "year": "1998", "unstructured": "Ray DW, Lovering AM, Davis JR, White A (1998) Rifampicin: a glucocorticoid receptor ligand? Nat Med 4:1090\u20131091", "journal-title": "Nat Med"}, {"key": "9_CR1269", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1016/S0092-8674(00)80900-9", "volume": "92", "author": "SA Kliewer", "year": "1998", "unstructured": "Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, McKee DD, Oliver BB, Wilson TM, Zetterst\u00f6rm RH, Perlmann T, Lehmann JM (1998) An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92:73\u201382", "journal-title": "Cell"}, {"key": "9_CR1270", "doi-asserted-by": "crossref", "first-page": "1016", "DOI": "10.1172/JCI3703", "volume": "102", "author": "JM Lehmann", "year": "1998", "unstructured": "Lehmann JM, McKee DD, Watson MA, Wilson TM, Moore JT, Kliewer SA (1998) The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102:1016\u20131023", "journal-title": "J Clin Invest"}, {"key": "9_CR1271", "doi-asserted-by": "crossref", "first-page": "1513", "DOI": "10.1016/S0006-2952(02)01298-4", "volume": "64", "author": "X Coumoul", "year": "2002", "unstructured": "Coumoul X, Diry M, Barouki R (2002) PXR-dependent induction of human CYP3A4 gene expression by organochlorine pesticides. Biochem Pharmacol 64:1513\u20131519", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR1272", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1016/S0076-6879(02)57675-8", "volume": "357", "author": "SA Jones", "year": "2002", "unstructured": "Jones SA, Moore LB, Wisely GB, Kliewer SA (2002) Use of in vitro pregnane X receptor assays to assess CYP3A4 induction potential of drug candidates. Methods Enzymol 357:161\u2013170", "journal-title": "Methods Enzymol"}, {"key": "9_CR1273", "doi-asserted-by": "crossref", "first-page": "412", "DOI": "10.1124/jpet.102.038653", "volume": "303", "author": "J Raucy", "year": "2002", "unstructured": "Raucy J, Warfe L, Yueh MF, Allen SW (2002) A cell-based reporter gene assay for determining induction of CYP3A4 in a high-volume system. J Pharmacol Exp Ther 303:412\u2013423", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1274", "doi-asserted-by": "crossref", "first-page": "795", "DOI": "10.1124/dmd.30.7.795", "volume": "30", "author": "G Luo", "year": "2002", "unstructured": "Luo G, Cunningham M, Kim S, Burn T, Lin J, Sinz M, Hamilton G, Rizzo C, Jolley S, Gilbert D, Downey A, Mudra D, Graham R, Carroll K, Xie J, Madan A, Parkinson A, Christ D, Selling B, LeCluyse E, Gan LS (2002) CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes. Drug Metab Dispos 30:795\u2013804", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1275", "doi-asserted-by": "crossref", "first-page": "555", "DOI": "10.1097/00008571-200110000-00003", "volume": "11", "author": "J Zhang", "year": "2001", "unstructured": "Zhang J, Kuehl P, Green ED, Touchman JW, Watkins PB, Daly A, Hall SD, Maurel P, Relling M, Brimer C, Yasuda K, Wrighton SA, Hancock M, Kim RB, Strom S, Thummel K, Russell CG, Hudson JR Jr, Schuetz EG, Boguski MS (2001) The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics 11:555\u2013572", "journal-title": "Pharmacogenetics"}, {"key": "9_CR1276", "doi-asserted-by": "crossref", "first-page": "1329", "DOI": "10.1124/mol.56.6.1329", "volume": "56", "author": "B Goodwin", "year": "1999", "unstructured": "Goodwin B, Hodgson E, Liddle C (1999) The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol Pharmacol 56:1329\u20131339", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1277", "doi-asserted-by": "crossref", "first-page": "1029", "DOI": "10.1124/dmd.30.9.1029", "volume": "30", "author": "W El-Sankary", "year": "2002", "unstructured": "El-Sankary W, Bombail V, Gibson GG, Plant N (2002) Glucocorticoid-mediated induction of CYP3A4 is decreased by disruption of a protein: DNA interaction distinct from the pregnane X receptor response element. Drug Metab Dispos 30:1029\u20131034", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1278", "doi-asserted-by": "crossref", "first-page": "32453", "DOI": "10.1074/jbc.M111245200", "volume": "277", "author": "A Takeshita", "year": "2002", "unstructured": "Takeshita A, Taguchi M, Koibuchi N, Ozawa Y (2002) Putative role of the orphan nuclear receptor SXR (steroid and xenobiotic receptor) in the mechanism of CYP3A4 inhibition by xenobiotics. J Biol Chem 277:32453\u201332458", "journal-title": "J Biol Chem"}, {"key": "9_CR1279", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.1124/mol.62.2.359", "volume": "62", "author": "B Goodwin", "year": "2002", "unstructured": "Goodwin B, Hodgson E, D\u2019Costa DJ, Robertson GR, Liddle C (2002) Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. Mol Pharmacol 62:359\u2013365", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1280", "doi-asserted-by": "crossref", "first-page": "1399", "DOI": "10.1124/mol.60.6.1399", "volume": "60", "author": "KE Thummel", "year": "2001", "unstructured": "Thummel KE, Brimer C, Yasuda K, Thottassery J, Senn T, Lin Y, Ishizuka H, Kharasch E, Schuetz J, Schuetz E (2001) Transcriptional control of intestinal cytochrome P-4503A by 1\u03b1,25-dihydroxy vitamin D3. Mol Pharmacol 60:1399\u20131406", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1281", "doi-asserted-by": "crossref", "first-page": "182", "DOI": "10.1016/S0006-291X(02)00860-4", "volume": "296", "author": "H Hara", "year": "2002", "unstructured": "Hara H, Yasunami Y, Adachi T (2002) Alteration of cellular phosphorylationstate affects vitamin D receptor-mediated CYP3A4 mRNA induction in Caco-2 cells. Biochem Biophys Res Commun 296:182\u2013188", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1282", "doi-asserted-by": "crossref", "first-page": "54", "DOI": "10.1016/S0168-8278(97)80497-7", "volume": "26", "author": "JC Ourlin", "year": "1997", "unstructured": "Ourlin JC, Jounaidi Y, Maurel P, Vilarem MJ (1997) Role of the liver-enriched transcription factors C/EBP\u03b1 and DBP in the expression of human CYP3A4 and CYP3A7. J Hepatol 26:54\u201362", "journal-title": "J Hepatol"}, {"key": "9_CR1283", "doi-asserted-by": "crossref", "first-page": "220", "DOI": "10.1038/nm815", "volume": "9", "author": "RG Tirona", "year": "2003", "unstructured": "Tirona RG, Lee W, Leake BF, Lan LB, Cline CB, Lamba V, Parviz F, Duncan SA, Inoue Y, Gonzalez FJ, Schuetz EG, Kim RB (2003) The orphan nuclear receptor HNF4\u03b1 determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat Med 9:220\u2013224", "journal-title": "Nat Med"}, {"key": "9_CR1284", "doi-asserted-by": "crossref", "first-page": "1799", "DOI": "10.1096/fj.02-0195fje", "volume": "16", "author": "R Jover", "year": "2002", "unstructured": "Jover R, Bort R, Gomez-Lechon MJ, Castell JV (2002) Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: molecular mechanism and transcription factors involved. FASEB J 16:1799\u20131801", "journal-title": "FASEB J"}, {"key": "9_CR1285", "doi-asserted-by": "crossref", "first-page": "e107", "DOI": "10.1371/journal.pbio.0060107", "volume": "6", "author": "EE Schadt", "year": "2008", "unstructured": "Schadt EE, Molony C, Chudin E, Hao K, Yang X, Lum PY, Kasarskis A, Zhang B, Wang S, Suver C, Zhu J, Millstein J, Sieberts S, Lamb J, GuhaThakurta D, Derry J, Storey JD, Avila-Campillo I, Kruger MJ, Johnson JM, Rohl CA, van Nas A, Mehrabian M, Drake TA, Lusis AJ, Smith RC, Guengerich FP, Strom SC, Schuetz E, Rushmore TH, Ulrich R (2008) Mapping the genetic architecture of gene expression in human liver. PLoS Biol 6:e107", "journal-title": "PLoS Biol"}, {"key": "9_CR1286", "doi-asserted-by": "crossref", "first-page": "279", "DOI": "10.1124/mol.65.2.279", "volume": "65", "author": "EG Schuetz", "year": "2004", "unstructured": "Schuetz EG (2004) Lessons from the CYP3A4 promoter. Mol Pharmacol 65:279\u2013281", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1287", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1097/FPC.0b013e328336bbeb", "volume": "20", "author": "H Qiu", "year": "2010", "unstructured": "Qiu H, Mathas M, Nestler S, Bengel C, Nem D, Godtel-Armbrust U, Lang T, Taudien S, Burk O, Wojnowski L (2010) The unique complexity of the CYP3A4 upstream region suggests a nongenetic explanation of its expression variability. Pharmacogenet Genomics 20:167\u2013178", "journal-title": "Pharmacogenet Genomics"}, {"key": "9_CR1288", "doi-asserted-by": "crossref", "first-page": "326", "DOI": "10.1124/mol.65.2.326", "volume": "65", "author": "K Matsumura", "year": "2004", "unstructured": "Matsumura K, Saito T, Takahashi Y, Ozeki T, Kiyotani K, Fujieda M, Yamazaki H, Kunitoh H, Kamataki T (2004) Identification of a novel polymorphic enhancer of the human CYP3A4 gene. Mol Pharmacol 65:326\u2013334", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1289", "doi-asserted-by": "crossref", "first-page": "220", "DOI": "10.1038/nm815", "volume": "9", "author": "RG Tirona", "year": "2003", "unstructured": "Tirona RG, Lee W, Leake BF, Lan LB, Cline CB, Lamba V, Parviz F, Duncan SA, Inoue Y, Gonzalez FJ, Schuetz EG, Kim RB (2003) The orphan nuclear receptor HNF4\u03b1 determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat Med 9:220\u2013224", "journal-title": "Nat Med"}, {"key": "9_CR1290", "doi-asserted-by": "crossref", "first-page": "688", "DOI": "10.1016/j.bbrc.2010.02.058", "volume": "393", "author": "MA Istrate", "year": "2010", "unstructured": "Istrate MA, Nussler AK, Eichelbaum M, Burk O (2010) Regulation of CYP3A4 by pregnane X receptor: the role of nuclear receptors competing for response element binding. Biochem Biophys Res Commun 393:688\u2013693", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1291", "doi-asserted-by": "crossref", "first-page": "709", "DOI": "10.1124/mol.112.082503", "volume": "83", "author": "M Thomas", "year": "2013", "unstructured": "Thomas M, Burk O, Klumpp B, Kandel BA, Damm G, Weiss TS, Klein K, Schwab M, Zanger UM (2013) Direct transcriptional regulation of human hepatic cytochrome P450 3A4 (CYP3A4) by peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1). Mol Pharmacol 83:709\u2013718", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1292", "doi-asserted-by": "crossref", "first-page": "728", "DOI": "10.1124/jpet.104.068908", "volume": "311", "author": "ET Williams", "year": "2004", "unstructured": "Williams ET, Leyk M, Wrighton SA, Davies PJ, Loose DS, Shipley GL, Strobel HW (2004) Estrogen regulation of the cytochrome P450 3A subfamily in humans. J Pharmacol Exp Ther 311:728\u2013735", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1293", "doi-asserted-by": "crossref", "first-page": "978", "DOI": "10.1002/hep.1840380424", "volume": "38", "author": "R Wolbold", "year": "2003", "unstructured": "Wolbold R, Klein K, Burk O, Nussler AK, Neuhaus P, Eichelbaum M, Schwab M, Zanger UM (2003) Sex is a major determinant of CYP3A4 expression in human liver. Hepatology 38:978\u2013988", "journal-title": "Hepatology"}, {"key": "9_CR1294", "first-page": "509", "volume": "218", "author": "G Danan", "year": "1981", "unstructured": "Danan G, Descatoire V, Pessayre D (1981) Self-induction by erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. J Pharmacol Exp Ther 218:509\u2013514", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1295", "doi-asserted-by": "crossref", "first-page": "591", "DOI": "10.1016/0006-2952(94)00477-4", "volume": "49", "author": "C Bensoussan", "year": "1995", "unstructured": "Bensoussan C, Delaforge M, Mansuy D (1995) Particular ability of cytochromes P450 3A to form inhibitory P450-iron-metabolite complexes upon metabolic oxidation of amino drugs. Biochem Pharmacol 49:591\u2013602", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR1296", "doi-asserted-by": "crossref", "first-page": "11318", "DOI": "10.1021/bi010690z", "volume": "40", "author": "XY Wang", "year": "2001", "unstructured": "Wang XY, Medzihradszky KF, Maltby D, Correia MA (2001) Phosphorylation of native and heme-modified CYP3A4 by protein kinase C: a mass spectrometric characterization of the phosphorylated peptides. Biochemistry 40:11318\u201311326", "journal-title": "Biochemistry"}, {"key": "9_CR1297", "doi-asserted-by": "crossref", "first-page": "5671", "DOI": "10.1074/jbc.M806104200", "volume": "284", "author": "Y Wang", "year": "2009", "unstructured": "Wang Y, Liao M, Hoe N, Acharya P, Deng C, Krutchinsky AN, Correia MA (2009) A role for protein phosphorylationin cytochrome P450 3A4 ubiquitin-dependent proteasomal degradation. J Biol Chem 284:5671\u20135684", "journal-title": "J Biol Chem"}, {"key": "9_CR1298", "doi-asserted-by": "crossref", "first-page": "66", "DOI": "10.1016/j.abb.2008.12.001", "volume": "483", "author": "MK Pabarcus", "year": "2009", "unstructured": "Pabarcus MK, Hoe N, Sadeghi S, Patterson C, Wiertz E, Correia MA (2009) CYP3A4 ubiquitination by gp78 (the tumor autocrine motility factor receptor, AMFR) and CHIP E3 ligases. Arch Biochem Biophys 483:66\u201374", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1299", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.1002/iub.1247", "volume": "66", "author": "MA Correia", "year": "2014", "unstructured": "Correia MA, Wang Y, Kim SM, Guan S (2014) Hepatic cytochrome P450 ubiquitination: conformational phosphodegrons for E2/E3 recognition? IUBMB Life 66:78\u201388", "journal-title": "IUBMB Life"}, {"key": "9_CR1300", "doi-asserted-by": "crossref", "first-page": "1652", "DOI": "10.1124/mol.107.043976", "volume": "73", "author": "RC Zangar", "year": "2008", "unstructured": "Zangar RC, Bollinger N, Verma S, Karin NJ, Lu Y (2008) The nuclear factor-kappa B pathway regulates cytochrome P450 3A4 protein stability. Mol Pharmacol 73:1652\u20131658", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1301", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1016/j.cmet.2006.12.009", "volume": "5", "author": "AL Hughes", "year": "2007", "unstructured": "Hughes AL, Powell DW, Bard M, Eckstein J, Barbuch R, Link AJ, Espenshade PJ (2007) Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes. Cell Metab 5:143\u2013149", "journal-title": "Cell Metab"}, {"key": "9_CR1302", "doi-asserted-by": "crossref", "first-page": "340", "DOI": "10.1124/mol.110.068478", "volume": "79", "author": "E Szczesna-Skorupa", "year": "2011", "unstructured": "Szczesna-Skorupa E, Kemper B (2011) Progesterone receptor membrane component 1 inhibits the activity of drug-metabolizing cytochromes P450 and binds to cytochrome P450 reductase. Mol Pharmacol 79:340\u2013350", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1303", "doi-asserted-by": "crossref", "first-page": "357", "DOI": "10.1007/s00228-002-0487-9", "volume": "58", "author": "SK Sy", "year": "2002", "unstructured": "Sy SK, Ciaccia A, Li W, Roberts EA, Okey A, Kalow W, Tang BK (2002) Modeling of human hepatic CYP3A4 enzyme kinetics, protein, and mRNA indicates deviation from log-normal distribution in CYP3A4 gene expression. Eur J Clin Pharmacol 58:357\u2013365", "journal-title": "Eur J Clin Pharmacol"}, {"key": "9_CR1304", "doi-asserted-by": "crossref", "first-page": "288", "DOI": "10.1016/S0009-9236(99)70037-8", "volume": "66", "author": "SE Ball", "year": "1999", "unstructured": "Ball SE, Scatina J, Kao J, Ferron GM, Fruncillo R, Mayer P, Weinryb I, Guida M, Hopkins PJ, Warner N, Hall J (1999) Population distribution and effects on drug metabolism of a genetic variant in the 5\u2032 promotor region of CYP3A4. Clin Pharmacol Ther 66:288\u2013294", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR1305", "doi-asserted-by": "crossref", "first-page": "355", "DOI": "10.1097/00008571-200207000-00003", "volume": "12", "author": "AB Spurdle", "year": "2002", "unstructured": "Spurdle AB, Goodwin B, Hodgson E, Hopper JL, Chen X, Purdie DM, McCredie MR, Giles GG, Chenevix-Trench G, Liddle C (2002) The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer. Pharmacogenetics 12:355\u2013366", "journal-title": "Pharmacogenetics"}, {"key": "9_CR1306", "doi-asserted-by": "crossref", "first-page": "447", "DOI": "10.1097/00008571-200107000-00008", "volume": "11", "author": "R Eiselt", "year": "2001", "unstructured": "Eiselt R, Domanski TL, Zibat A, Mueller R, Presecan-Siedel E, Hustert E, Zanger UM, Brockmoller J, Klenk HP, Meyer UA, Khan KK, He YA, Halpert JR, Wojnowski L (2001) Identification and functional characterization of eight CYP3A4 protein variants. Pharmacogenetics 11:447\u2013458", "journal-title": "Pharmacogenetics"}, {"key": "9_CR1307", "doi-asserted-by": "crossref", "first-page": "196", "DOI": "10.1067/mcp.2002.121371", "volume": "71", "author": "E Garcia-Martin", "year": "2002", "unstructured": "Garcia-Martin E, Martinez C, Pizarro RM, Garcia-Gamito FJ, Gullsten H, Raunio H, Agundez JA (2002) CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity. Clin Pharmacol Ther 71:196\u2013204", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR1308", "doi-asserted-by": "crossref", "first-page": "121", "DOI": "10.1097/00008571-200203000-00006", "volume": "12", "author": "JK Lamba", "year": "2002", "unstructured": "Lamba JK, Lin YS, Thummel K, Daly A, Watkins PB, Strom S, Zhang J, Schuetz EG (2002) Common allelic variants of cytochrome P4503A4 and their prevalence in different populations. Pharmacogenetics 12:121\u2013132", "journal-title": "Pharmacogenetics"}, {"key": "9_CR1309", "first-page": "825", "volume": "299", "author": "D Dai", "year": "2001", "unstructured": "Dai D, Tang J, Rose R, Hodgson E, Bienstock RJ, Mohrenweiser HW, Goldstein JA (2001) Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos. J Pharmacol Exp Ther 299:825\u2013831", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1310", "doi-asserted-by": "crossref", "first-page": "1271", "DOI": "10.1016/S0169-409X(02)00066-2", "volume": "54", "author": "JK Lamba", "year": "2002", "unstructured": "Lamba JK, Lin YS, Schuetz EG, Thummel KE (2002) Genetic contribution to variable human CYP3A-mediated metabolism. Adv Drug Deliv Rev 54:1271\u20131294", "journal-title": "Adv Drug Deliv Rev"}, {"key": "9_CR1311", "doi-asserted-by": "crossref", "first-page": "150", "DOI": "10.2133/dmpk.17.150", "volume": "17", "author": "N Murayama", "year": "2002", "unstructured": "Murayama N, Nakamura T, Saeki M, Soyama A, Saito Y, Sai K, Ishida S, Nakajima O, Itoda M, Ohno Y, Ozawa S, Sawada J (2002) CYP3A4 gene polymorphisms influence testosterone 6\u03b2-hydroxylation. Drug Metab Pharmacokinet 17:150\u2013156", "journal-title": "Drug Metab Pharmacokinet"}, {"key": "9_CR1312", "doi-asserted-by": "crossref", "first-page": "2287", "DOI": "10.1124/dmd.108.021816", "volume": "36", "author": "M Miyazaki", "year": "2008", "unstructured": "Miyazaki M, Nakamura K, Fujita Y, Guengerich FP, Horiuchi R, Yamamoto K (2008) Defective activity of recombinant cytochromes P450 3A4.2 and 3A4.16 in oxidation of midazolam, nifedipine, and testosterone. Drug Metab Dispos 36:2287\u20132291", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1313", "doi-asserted-by": "crossref", "first-page": "302", "DOI": "10.1124/jpet.104.078758", "volume": "313", "author": "SJ Lee", "year": "2005", "unstructured": "Lee SJ, Bell DA, Coulter SJ, Ghanayem B, Goldstein JA (2005) Recombinant CYP3A4*17 is defective in metabolizing the hypertensive drug nifedipine, and the CYP3A4*17 allele may occur on the same chromosomeas CYP3A5*3, representing a new putative defective CYP3A haplotype. J Pharmacol Exp Ther 313:302\u2013309", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1314", "doi-asserted-by": "crossref", "first-page": "1088", "DOI": "10.1124/jpet.109.160804", "volume": "332", "author": "V Lamba", "year": "2010", "unstructured": "Lamba V, Panetta JC, Strom S, Schuetz EG (2010) Genetic predictors of interindividual variability in hepatic CYP3A4 expression. J Pharmacol Exp Ther 332:1088\u20131099", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1315", "doi-asserted-by": "crossref", "first-page": "12", "DOI": "10.3389/fgene.2013.00012", "volume": "4", "author": "K Klein", "year": "2013", "unstructured": "Klein K, Zanger UM (2013) Pharmacogenomics of cytochrome P450 3A4: recent progress toward the \u201cmissing heritability\u201d problem. Front Genet 4:12", "journal-title": "Front Genet"}, {"key": "9_CR1316", "doi-asserted-by": "crossref", "first-page": "883", "DOI": "10.1124/dmd.30.8.883", "volume": "30", "author": "JA Williams", "year": "2002", "unstructured": "Williams JA, Ring BJ, Cantrell VE, Jones DR, Eckstein J, Ruterbories K, Hamman MA, Hall SD, Wrighton SA (2002) Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7. Drug Metab Dispos 30:883\u2013891", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1317", "doi-asserted-by": "crossref", "first-page": "355", "DOI": "10.1016/0003-9861(91)90551-S", "volume": "290", "author": "RW Wang", "year": "1991", "unstructured": "Wang RW, Kari PH, Lu AY, Thomas PE, Guengerich FP, Vyas KP (1991) Biotransformation of lovastatin. IV. Identification of cytochrome P450 3A proteins as the major enzymes responsible for the oxidative metabolism of lovastatin in rat and human liver microsomes. Arch Biochem Biophys 290:355\u2013361", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1318", "first-page": "1126", "volume": "23", "author": "SEW Huskey", "year": "1995", "unstructured": "Huskey SEW, Dean DC, Miller RR, Rasmusson GH, Chiu SHL (1995) Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride. Drug Metab Dispos 23:1126\u20131135", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1319", "doi-asserted-by": "crossref", "first-page": "630", "DOI": "10.1038/clpt.1988.87", "volume": "43", "author": "T Kronbach", "year": "1988", "unstructured": "Kronbach T, Fischer V, Meyer UA (1988) Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharmacol Ther 43:630\u2013635", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR1320", "first-page": "552", "volume": "26", "author": "T Koudriakova", "year": "1998", "unstructured": "Koudriakova T, Iatsimirskaia E, Utkin I, Gangl E, Vouros P, Storozhuk E, Orza D, Marinina J, Gerber N (1998) Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: mechanism-based inactivation of cytochrome P4503A by ritonavir. Drug Metab Dispos 26:552\u2013561", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1321", "first-page": "392", "volume": "28", "author": "JS Warrington", "year": "2000", "unstructured": "Warrington JS, Shader RI, von Moltke LL, Greenblatt DJ (2000) In vitro biotransformation of sildenafil (Viagra): identification of human cytochromes and potential drug interactions. Drug Metab Dispos 28:392\u2013397", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1322", "first-page": "303", "volume": "27", "author": "S Kudo", "year": "1999", "unstructured": "Kudo S, Okumura MG, Ishizaki T (1999) Cytochrome P-450 isoforms involved in carboxylic acid ester cleavage of Hantzsch pyridine ester of pranidipine. Drug Metab Dispos 27:303\u2013308", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1323", "doi-asserted-by": "crossref", "first-page": "2712", "DOI": "10.1021/bi0119971", "volume": "41", "author": "Z Zhang", "year": "2002", "unstructured": "Zhang Z, Li Y, Stearns RA, Ortiz de Montellano PR, Baillie TA, Tang W (2002) Cytochrome P450 3A4-mediated oxidative conversion of a cyano to an amide group in the metabolism of pinacidil. Biochemistry 41:2712\u20132718", "journal-title": "Biochemistry"}, {"key": "9_CR1324", "doi-asserted-by": "crossref", "first-page": "365", "DOI": "10.1006/abbi.1998.0659", "volume": "353", "author": "NA Hosea", "year": "1998", "unstructured": "Hosea NA, Guengerich FP (1998) Oxidation of nonionic detergents by cytochrome P450 enzymes. Arch Biochem Biophys 353:365\u2013373", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1325", "doi-asserted-by": "crossref", "first-page": "38685", "DOI": "10.1074/jbc.M105127200", "volume": "276", "author": "K Bodin", "year": "2001", "unstructured": "Bodin K, Bretillon L, Aden Y, Bertilsson L, Broome U, Einarsson C, Diczfalusy U (2001) Antiepileptic drugs increase plasma levels of 4\u03b2-hydroxycholesterol in humans: evidence for involvement of cytochrome P450 3A4. J Biol Chem 276:38685\u201338689", "journal-title": "J Biol Chem"}, {"key": "9_CR1326", "doi-asserted-by": "crossref", "first-page": "31534", "DOI": "10.1074/jbc.M201712200", "volume": "277", "author": "K Bodin", "year": "2002", "unstructured": "Bodin K, Andersson U, Rystedt E, Ellis E, Norlin M, Pikuleva I, Eggertsen G, Bj\u00f6rkhem I, Diczfalusy U (2002) Metabolism of 4\u03b2-hydroxycholesterol in humans. J Biol Chem 277:31534\u201331540", "journal-title": "J Biol Chem"}, {"key": "9_CR1327", "doi-asserted-by": "crossref", "first-page": "46", "DOI": "10.1016/S0005-2760(98)00175-1", "volume": "1437", "author": "C Furster", "year": "1999", "unstructured": "Furster C, Wikvall K (1999) Identification of CYP3A4 as the major enzyme responsible for 25-hydroxylation of 5\u03b2-cholestane-3\u03b1,7\u03b1,12\u03b1-triol in human liver microsomes. Biochim Biophys Acta 1437:46\u201352", "journal-title": "Biochim Biophys Acta"}, {"key": "9_CR1328", "doi-asserted-by": "crossref", "first-page": "34579", "DOI": "10.1074/jbc.M103025200", "volume": "276", "author": "A Honda", "year": "2001", "unstructured": "Honda A, Salen G, Matsuzaki Y, Batta AK, Xu G, Leitersdorf E, Tint GS, Erickson SK, Tanaka N, Shefer S (2001) Side chain hydroxylations in bile acid biosynthesis catalyzed by CYP3A are markedly up-regulated in Cyp27 \u2212/\u2212 mice but not in cerebrotendinous xanthomatosis. J Biol Chem 276:34579\u201334585", "journal-title": "J Biol Chem"}, {"key": "9_CR1329", "doi-asserted-by": "crossref", "first-page": "833", "DOI": "10.1073/pnas.0336235100", "volume": "100", "author": "I Dussault", "year": "2003", "unstructured": "Dussault I, Yoo HD, Lin M, Wang E, Fan M, Batta AK, Salen G, Erickson SK, Forman BM (2003) Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance. Proc Natl Acad Sci U S A 100:833\u2013838", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR1330", "doi-asserted-by": "crossref", "first-page": "1897", "DOI": "10.1093/carcin/23.11.1897", "volume": "23", "author": "DJ Boocock", "year": "2002", "unstructured": "Boocock DJ, Brown K, Gibbs AH, Sanchez E, Turteltaub KW, White IN (2002) Identification of human CYP forms involved in the activation of tamoxifen and irreversible binding to DNA. Carcinogenesis 23:1897\u20131901", "journal-title": "Carcinogenesis"}, {"key": "9_CR1331", "doi-asserted-by": "crossref", "first-page": "218", "DOI": "10.1021/tx00044a006", "volume": "8", "author": "Y-F Ueng", "year": "1995", "unstructured": "Ueng Y-F, Shimada T, Yamazaki H, Guengerich FP (1995) Oxidation of aflatoxin B1 by bacterial recombinant human cytochrome P450 enzymes. Chem Res Toxicol 8:218\u2013225", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR1332", "doi-asserted-by": "crossref", "first-page": "1603", "DOI": "10.1021/ja00084a001", "volume": "116", "author": "R Iyer", "year": "1994", "unstructured": "Iyer R, Coles B, Raney KD, Thier R, Guengerich FP, Harris TM (1994) DNA adduction by the potent carcinogen aflatoxin B1: mechanistic studies. J Am Chem Soc 116:1603\u20131609", "journal-title": "J Am Chem Soc"}, {"key": "9_CR1333", "doi-asserted-by": "crossref", "first-page": "188", "DOI": "10.1006/abio.1997.2145", "volume": "248", "author": "CL Crespi", "year": "1997", "unstructured": "Crespi CL, Miller VP, Penman BW (1997) Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Anal Biochem 248:188\u2013190", "journal-title": "Anal Biochem"}, {"key": "9_CR1334", "doi-asserted-by": "crossref", "first-page": "845", "DOI": "10.1124/dmd.30.7.845", "volume": "30", "author": "DM Stresser", "year": "2002", "unstructured": "Stresser DM, Turner SD, Blanchard AP, Miller VP, Crespi CL (2002) Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4. Drug Metab Dispos 30:845\u2013852", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1335", "doi-asserted-by": "crossref", "first-page": "215", "DOI": "10.1006/abio.1999.4348", "volume": "276", "author": "N Chauret", "year": "1999", "unstructured": "Chauret N, Tremblay N, Lackman RL, Gauthier J-Y, Silva JM, Marois J, Yergey JA, Nicoll-Griffith DA (1999) Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a selective fluorescent probe. Anal Biochem 276:215\u2013226", "journal-title": "Anal Biochem"}, {"key": "9_CR1336", "doi-asserted-by": "crossref", "first-page": "716", "DOI": "10.1046/j.1365-2125.1999.00073.x", "volume": "48", "author": "KE Kenworthy", "year": "1999", "unstructured": "Kenworthy KE, Bloomer JC, Clarke SE, Houston JB (1999) CYP3A4 drug interactions: correlation of 10 in vitro probe substrates. Br J Clin Pharmacol 48:716\u2013727", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR1337", "doi-asserted-by": "crossref", "first-page": "2507", "DOI": "10.1016/0006-2952(88)90238-9", "volume": "37", "author": "JHM Schellens", "year": "1988", "unstructured": "Schellens JHM, Soons PA, Breimer DD (1988) Lack of bimodality in nifedipine plasma kinetics in a large population of healthy subjects. Biochem Pharmacol 37:2507\u20132510", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR1338", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1038/clpt.1992.17", "volume": "51", "author": "K Lown", "year": "1992", "unstructured": "Lown K, Kolars J, Turgeon K, Merion R, Wrighton SA, Watkins PB (1992) The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease. Clin Pharmacol Ther 51:229\u2013238", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR1339", "doi-asserted-by": "crossref", "first-page": "565", "DOI": "10.1002/hep.1840120319", "volume": "12", "author": "DA Gremse", "year": "1990", "unstructured": "Gremse DA, A-Kader HH, Schroeder TJ, Balistreri WF (1990) Assessment of lidocaine metabolite formation as a quantitative liver function test in children. Hepatology 12:565\u2013569", "journal-title": "Hepatology"}, {"key": "9_CR1340", "doi-asserted-by": "crossref", "first-page": "492", "DOI": "10.1038/clpt.1994.62", "volume": "55", "author": "DG May", "year": "1994", "unstructured": "May DG, Porter J, Wilkinson GR, Branch RA (1994) Frequency distribution of dapsone N-hydroxylase, a putative probe for P450 3A4 activity, in a white population. Clin Pharmacol Ther 55:492\u2013500", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR1341", "first-page": "549", "volume": "271", "author": "KE Thummel", "year": "1994", "unstructured": "Thummel KE, Shen DD, Podoll TD, Kunze KL, Trager WF, Hartwell PS, Raisys VA, Marsh CL, McVicar JP, Barr DM, Perkins JD, Carithers RL Jr (1994) Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients. J Pharmacol Exp Ther 271:549\u2013556", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1342", "doi-asserted-by": "crossref", "first-page": "643", "DOI": "10.1046/j.1365-2125.2002.01687.x", "volume": "54", "author": "S Wanwimolruk", "year": "2002", "unstructured": "Wanwimolruk S, Paine MF, Pusek SN, Watkins PB (2002) Is quinine a suitable probe to assess the hepatic drug-metabolizing enzyme CYP3A4? Br J Clin Pharmacol 54:643\u2013651", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR1343", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1111/j.1365-2125.1989.tb03516.x", "volume": "28", "author": "C Ged", "year": "1989", "unstructured": "Ged C, Rouillon JM, Pichard L, Combalbert J, Bressot N, Bories P, Michel H, Beaune P, Maurel P (1989) The increase in urinary excretion of 6\u03b2-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction. Br J Clin Pharmacol 28:373\u2013387", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR1344", "first-page": "120", "volume": "48", "author": "PB Watkins", "year": "1990", "unstructured": "Watkins PB, Hamilton TA, Annesley TM, Ellis CN, Kolars JC, Voorhees JJ (1990) The erythromycin breath test as a predictor of cyclosporine blood levels. Clin Pharmacol Ther 48:120\u2013129", "journal-title": "Clin"}, {"key": "9_CR1345", "doi-asserted-by": "crossref", "first-page": "621", "DOI": "10.1038/clpt.1993.199", "volume": "54", "author": "MT Kinirons", "year": "1993", "unstructured": "Kinirons MT, Oshea D, Downing TE, Fitzwilliam AT, Joellenbeck L, Groopman JD, Wilkinson GR, Wood AJJ (1993) Absence of correlations among 3 putative in vivo probes of human cytochrome P4503A activity in young healthy men. Clin Pharmacol Ther 54:621\u2013629", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR1346", "doi-asserted-by": "crossref", "first-page": "608", "DOI": "10.1038/clpt.1994.185", "volume": "56", "author": "Y Krivoruk", "year": "1994", "unstructured": "Krivoruk Y, Kinirons MT, Wood AJJ, Wood M (1994) Metabolism of cytochrome P4503A substrates in vivo administered by the same route: lack of correlation between alfentanil clearance and erythromycin breath test. Clin Pharmacol Ther 56:608\u2013614", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR1347", "doi-asserted-by": "crossref", "first-page": "40S", "DOI": "10.1177/009127009703700121", "volume": "37", "author": "KT Kivisto", "year": "1997", "unstructured": "Kivisto KT, Kroemer HK (1997) Use of probe drugs as predictors of drug metabolism in humans. J Clin Pharmacol 37:40S\u201348S", "journal-title": "J Clin Pharmacol"}, {"key": "9_CR1348", "doi-asserted-by": "crossref", "first-page": "491", "DOI": "10.1016/S0009-9236(96)90177-0", "volume": "59", "author": "KE Thummel", "year": "1996", "unstructured": "Thummel KE, O\u2019Shea D, Paine MF, Shen DD, Kunze KL, Perkins JD, Wilkinson GR (1996) Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism. Clin Pharmacol Ther 59:491\u2013502", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR1349", "doi-asserted-by": "crossref", "first-page": "524", "DOI": "10.1067/mcp.2002.128387", "volume": "72", "author": "MF Paine", "year": "2002", "unstructured": "Paine MF, Wagner DA, Hoffmaster KA, Watkins PB (2002) Cytochrome P450 3A4 and P-glycoprotein mediate the interaction between an oral erythromycin breath test and rifampin. Clin Pharmacol Ther 72:524\u2013535", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR1350", "first-page": "311", "volume": "49", "author": "EG Schuetz", "year": "1996", "unstructured": "Schuetz EG, Beck WT, Schuetz JD (1996) Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol Pharmacol 49:311\u2013318", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1351", "doi-asserted-by": "crossref", "first-page": "1983", "DOI": "10.1124/dmd.108.022194", "volume": "36", "author": "AK Deo", "year": "2008", "unstructured": "Deo AK, Bandiera SM (2008) Identification of human hepatic cytochrome P450 enzymes involved in the biotransformation of cholic and chenodeoxycholic acid. Drug Metab Dispos 36:1983\u20131991", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1352", "doi-asserted-by": "crossref", "first-page": "38", "DOI": "10.1111/j.1365-2125.2008.03309.x", "volume": "67", "author": "U Diczfalusy", "year": "2009", "unstructured": "Diczfalusy U, Kanebratt KP, Bredberg E, Andersson TB, Bottiger Y, Bertilsson L (2009) 4\u03b2-Hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half-life of elimination after inductionwith rifampicin. Br J Clin Pharmacol 67:38\u201343", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR1353", "doi-asserted-by": "crossref", "first-page": "888", "DOI": "10.1038/clpt.2011.53", "volume": "89", "author": "CC Peng", "year": "2011", "unstructured": "Peng CC, Templeton I, Thummel KE, Davis C, Kunze KL, Isoherranen N (2011) Evaluation of 6\u03b2-hydroxycortisol, \u03b2-hydroxycortisone, and a combination of the two as endogenous probes for inhibition of CYP3A4 in vivo. Clin Pharmacol Ther 89:888\u2013895", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR1354", "doi-asserted-by": "crossref", "first-page": "1536", "DOI": "10.1111/bcp.12016", "volume": "75", "author": "Y Marde Arrhen", "year": "2013", "unstructured": "Marde Arrhen Y, Nylen H, Lovgren-Sandblom A, Kanebratt KP, Wide K, Diczfalusy U (2013) A comparison of 4\u03b2-hydroxycholesterol: cholesterol and 6\u03b2-hydroxycortisol: cortisolas markers of CYP3A4 induction. Br J Clin Pharmacol 75:1536\u20131540", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR1355", "doi-asserted-by": "crossref", "first-page": "1509", "DOI": "10.1194/jlr.M014084", "volume": "52", "author": "A Honda", "year": "2011", "unstructured": "Honda A, Miyazaki T, Ikegami T, Iwamoto J, Maeda T, Hirayama T, Saito Y, Teramoto T, Matsuzaki Y (2011) Cholesterol 25-hydroxylation activity of CYP3A. J Lipid Res 52:1509\u20131516", "journal-title": "J Lipid Res"}, {"key": "9_CR1356", "doi-asserted-by": "crossref", "first-page": "455", "DOI": "10.1016/j.biochi.2012.06.016", "volume": "95", "author": "U Diczfalusy", "year": "2013", "unstructured": "Diczfalusy U (2013) On the formation and possible biological role of 25-hydroxycholesterol. Biochimie 95:455\u2013460", "journal-title": "Biochimie"}, {"key": "9_CR1357", "doi-asserted-by": "crossref", "first-page": "3962", "DOI": "10.1111/j.1432-1033.2004.04339.x", "volume": "271", "author": "JA Krauser", "year": "2004", "unstructured": "Krauser JA, Voehler M, Tseng LH, Schefer AB, Godejohann M, Guengerich FP (2004) Testosterone 1\u03b2-hydroxylation by human cytochrome P450 3A4. Eur J Biochem 271:3962\u20133969", "journal-title": "Eur J Biochem"}, {"key": "9_CR1358", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1210/jc.2008-1174", "volume": "94", "author": "LG Gomes", "year": "2009", "unstructured": "Gomes LG, Huang N, Agrawal V, Mendonca BB, Bachega TA, Miller WL (2009) Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency. J Clin Endocrinol Metab 94:89\u201395", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR1359", "doi-asserted-by": "crossref", "first-page": "2911", "DOI": "10.1210/en.2004-1248", "volume": "146", "author": "AM Yu", "year": "2005", "unstructured": "Yu AM, Fukamachi K, Krausz KW, Cheung C, Gonzalez FJ (2005) Potential role for human cytochrome P450 3A4 in estradiolhomeostasis. Endocrinology 146:2911\u20132919", "journal-title": "Endocrinology"}, {"key": "9_CR1360", "doi-asserted-by": "crossref", "first-page": "1018", "DOI": "10.1021/tx900367p", "volume": "23", "author": "G Chowdhury", "year": "2010", "unstructured": "Chowdhury G, Murayama N, Okada Y, Uno Y, Shimizu M, Shibata N, Guengerich FP, Yamazaki H (2010) Human liver microsomal cytochrome P450 3A enzymes involved in thalidomide 5-hydroxylation and formation of a glutathioneconjugate. Chem Res Toxicol 23:1018\u20131024", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR1361", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.1016/j.lfs.2011.05.018", "volume": "89", "author": "R Jiang", "year": "2011", "unstructured": "Jiang R, Yamaori S, Takeda S, Yamamoto I, Watanabe K (2011) Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes. Life Sci 89:165\u2013170", "journal-title": "Life Sci"}, {"key": "9_CR1362", "doi-asserted-by": "crossref", "first-page": "1138", "DOI": "10.1021/tx0300131", "volume": "16", "author": "SY Kim", "year": "2003", "unstructured": "Kim SY, Suzuki N, Santosh Laxmi YR, Rieger R, Shibutani S (2003) \u03b1-Hydroxylation of tamoxifen and toremifene by human and rat cytochrome P450 3A subfamily enzymes. Chem Res Toxicol 16:1138\u20131144", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR1363", "doi-asserted-by": "crossref", "first-page": "13778", "DOI": "10.1021/ja074864x", "volume": "129", "author": "A Das", "year": "2007", "unstructured": "Das A, Grinkova YV, Sligar SG (2007) Redox potential control by drug binding to cytochrome P 450 3A4. J Am Chem Soc 129:13778\u201313779", "journal-title": "J Am Chem Soc"}, {"key": "9_CR1364", "doi-asserted-by": "crossref", "first-page": "14741", "DOI": "10.1021/bi9719399", "volume": "36", "author": "FP Guengerich", "year": "1997", "unstructured": "Guengerich FP, Johnson WW (1997) Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems. Biochemistry 36:14741\u201314750", "journal-title": "Biochemistry"}, {"key": "9_CR1365", "doi-asserted-by": "crossref", "first-page": "8380", "DOI": "10.1021/bi00026a020", "volume": "34", "author": "H Yamazaki", "year": "1995", "unstructured": "Yamazaki H, Ueng YF, Shimada T, Guengerich FP (1995) Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of NADPH-cytochrome P450 reductase with other flavoproteins, ferredoxin, and oxygen surrogates. Biochemistry 34:8380\u20138389", "journal-title": "Biochemistry"}, {"key": "9_CR1366", "doi-asserted-by": "crossref", "first-page": "23313", "DOI": "10.1074/jbc.M605511200", "volume": "281", "author": "IG Denisov", "year": "2006", "unstructured": "Denisov IG, Grinkova YV, Baas BJ, Sligar SG (2006) The ferrous-dioxygen intermediate in human cytochrome P450 3A4. Substrate dependence of formation and decay kinetics. J Biol Chem 281:23313\u201323318", "journal-title": "J Biol Chem"}, {"key": "9_CR1367", "doi-asserted-by": "crossref", "first-page": "26865", "DOI": "10.1074/jbc.M704747200", "volume": "282", "author": "IG Denisov", "year": "2007", "unstructured": "Denisov IG, Grinkova YV, McLean MA, Sligar SG (2007) The one-electron autoxidation of human cytochrome P450 3A4. J Biol Chem 282:26865\u201326873", "journal-title": "J Biol Chem"}, {"key": "9_CR1368", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1016/j.abb.2013.11.001", "volume": "541", "author": "HM Peng", "year": "2014", "unstructured": "Peng HM, Auchus RJ (2014) Two surfaces of cytochrome b 5 with major and minor contributions to CYP3A4-catalyzed steroid and nifedipine oxygenation chemistries. Arch Biochem Biophys 541:53\u201360", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1369", "doi-asserted-by": "crossref", "first-page": "30885", "DOI": "10.1074/jbc.M105011200", "volume": "276", "author": "H Yamazaki", "year": "2001", "unstructured": "Yamazaki H, Shimada T, Martin MV, Guengerich FP (2001) Stimulation of cytochrome P450 reactions by apo-cytochrome b 5: evidence against transfer of heme from cytochrome P450 3A4 to apo-cytochrome b 5 or heme oxygenase. J Biol Chem 276:30885\u201330891", "journal-title": "J Biol Chem"}, {"key": "9_CR1370", "doi-asserted-by": "crossref", "first-page": "27438", "DOI": "10.1074/jbc.271.44.27438", "volume": "271", "author": "H Yamazaki", "year": "1996", "unstructured": "Yamazaki H, Johnson WW, Ueng YF, Shimada T, Guengerich FP (1996) Lack of electron transferfrom cytochrome b 5 in stimulation of catalytic activities of cytochrome P450 3A4. Characterization of a reconstituted cytochrome P450 3A4/NADPH-cytochrome P450 reductase system and studies with apo-cytochrome b 5. J Biol Chem 271:27438\u201327444", "journal-title": "J Biol Chem"}, {"key": "9_CR1371", "doi-asserted-by": "crossref", "first-page": "40750", "DOI": "10.1074/jbc.M111.300871", "volume": "286", "author": "WA Johnston", "year": "2011", "unstructured": "Johnston WA, Hunter DJ, Noble CJ, Hanson GR, Stok JE, Hayes MA, De Voss JJ, Gillam EMJ (2011) Cytochrome P450 is present in both ferrous and ferric forms in the resting state within intact Escherichia coli and hepatocytes. J Biol Chem 286:40750\u201340759", "journal-title": "J Biol Chem"}, {"key": "9_CR1372", "doi-asserted-by": "crossref", "first-page": "19496", "DOI": "10.1074/jbc.M501854200", "volume": "280", "author": "JA Krauser", "year": "2005", "unstructured": "Krauser JA, Guengerich FP (2005) Cytochrome P450 3A4-catalyzed testosterone 6\u03b2-hydroxylation stereochemistry, kinetic deuterium isotope effects, and rate-limiting steps. J Biol Chem 280:19496\u201319506", "journal-title": "J Biol Chem"}, {"key": "9_CR1373", "doi-asserted-by": "crossref", "first-page": "29554", "DOI": "10.1074/jbc.M112.390047", "volume": "287", "author": "Q Cheng", "year": "2012", "unstructured": "Cheng Q, Sohl CD, Yoshimoto FK, Guengerich FP (2012) Oxidation of dihydrotestosterone by human cytochromes P450 19A1 and 3A4. J Biol Chem 287:29554\u201329567", "journal-title": "J Biol Chem"}, {"key": "9_CR1374", "doi-asserted-by": "crossref", "first-page": "385", "DOI": "10.1038/clpt.2011.182", "volume": "91", "author": "RS Obach", "year": "2012", "unstructured": "Obach RS (2012) Heterotropic effects on drug-metabolizing enzyme activities: in vitro curiosity emerges as a clinically meaningful phenomenon (perhaps?). Clin Pharmacol Ther 91:385\u2013387", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR1375", "doi-asserted-by": "crossref", "first-page": "453", "DOI": "10.2174/138920008784746364", "volume": "9", "author": "T Niwa", "year": "2008", "unstructured": "Niwa T, Murayama N, Yamazaki H (2008) Heterotropic cooperativity in oxidation mediated by cytochrome P450. Curr Drug Metab 9:453\u2013462", "journal-title": "Curr Drug Metab"}, {"key": "9_CR1376", "doi-asserted-by": "crossref", "first-page": "3116", "DOI": "10.1039/C2DT31833D", "volume": "42", "author": "IF Sevrioukova", "year": "2013", "unstructured": "Sevrioukova IF, Poulos TL (2013) Understanding the mechanism of cytochrome P450 3A4: recent advances and remaining problems. Dalton Trans 42:3116\u20133126", "journal-title": "Dalton Trans"}, {"key": "9_CR1377", "doi-asserted-by": "crossref", "first-page": "486", "DOI": "10.1021/tx400008g", "volume": "26", "author": "H Yamazaki", "year": "2013", "unstructured": "Yamazaki H, Suemizu H, Murayama N, Utoh M, Shibata N, Nakamura M, Guengerich FP (2013) In vivo drug interactions of the teratogen thalidomide with midazolam: heterotropic cooperativity of human cytochrome P450 in humanized TK-NOG mice. Chem Res Toxicol 26:486\u2013489", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR1378", "doi-asserted-by": "crossref", "first-page": "2066", "DOI": "10.1124/dmd.113.052662", "volume": "41", "author": "AL Blobaum", "year": "2013", "unstructured": "Blobaum AL, Bridges TM, Byers FW, Turlington ML, Mattmann ME, Morrison RD, Mackie C, Lavreysen H, Bartolome JM, Macdonald GJ, Steckler T, Jones CK, Niswender CM, Conn PJ, Lindsley CW, Stauffer SR, Daniels JS (2013) Heterotropic activation of the midazolam hydroxylase activity of CYP3A by a positive allosteric modulator of mGlu5: in vitro to in vivo translation and potential impact on clinically relevant drug-drug interactions. Drug Metab Dispos 41:2066\u20132075", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1379", "doi-asserted-by": "crossref", "first-page": "351", "DOI": "10.1016/j.abb.2004.09.010", "volume": "433", "author": "JB Houston", "year": "2005", "unstructured": "Houston JB, Galetin A (2005) Modelling atypical CYP3A4 kinetics: principles and pragmatism. Arch Biochem Biophys 433:351\u2013360", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1380", "doi-asserted-by": "crossref", "first-page": "4199", "DOI": "10.1021/bi052491b", "volume": "45", "author": "H Fernando", "year": "2006", "unstructured": "Fernando H, Halpert JR, Davydov DR (2006) Resolution of multiple substrate binding sites in cytochrome P450 3A4: the stoichiometry of the enzyme-substrate complexes probed by FRET and Job\u2019s titration. Biochemistry 45:4199\u20134209", "journal-title": "Biochemistry"}, {"key": "9_CR1381", "doi-asserted-by": "crossref", "first-page": "2136", "DOI": "10.1124/dmd.108.021733", "volume": "36", "author": "Y Kapelyukh", "year": "2008", "unstructured": "Kapelyukh Y, Paine MJ, Marechal JD, Sutcliffe MJ, Wolf CR, Roberts GC (2008) Multiple substrate binding by cytochrome P450 3A4: estimation of the number of bound substrate molecules. Drug Metab Dispos 36:2136\u20132144", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1382", "doi-asserted-by": "crossref", "first-page": "146", "DOI": "10.1016/j.abb.2009.06.013", "volume": "488", "author": "DJ Frank", "year": "2009", "unstructured": "Frank DJ, Denisov IG, Sligar SG (2009) Mixing apples and oranges: analysis of heterotropic cooperativity in cytochrome P450 3A4. Arch Biochem Biophys 488:146\u2013152", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1383", "doi-asserted-by": "crossref", "first-page": "5540", "DOI": "10.1074/jbc.M110.182055", "volume": "286", "author": "DJ Frank", "year": "2011", "unstructured": "Frank DJ, Denisov IG, Sligar SG (2011) Analysis of heterotropic cooperativity in cytochrome P450 3A4 using \u03b1-naphthoflavone and testosterone. J Biol Chem 286:5540\u20135545", "journal-title": "J Biol Chem"}, {"key": "9_CR1384", "doi-asserted-by": "crossref", "first-page": "10041", "DOI": "10.1021/bi2013454", "volume": "50", "author": "CM Woods", "year": "2011", "unstructured": "Woods CM, Fernandez C, Kunze KL, Atkins WM (2011) Allosteric activation of cytochrome P450 3A4 by \u03b1-naphthoflavone: branch point regulation revealed by isotope dilution analysis. Biochemistry 50:10041\u201310051", "journal-title": "Biochemistry"}, {"key": "9_CR1385", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1016/j.abb.2005.02.027", "volume": "438", "author": "MI Jushchyshyn", "year": "2005", "unstructured": "Jushchyshyn MI, Hutzler JM, Schrag ML, Wienkers LC (2005) Catalytic turnover of pyrene by CYP3A4: evidence that cytochrome b 5 directly induces positive cooperativity. Arch Biochem Biophys 438:21\u201328", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1386", "doi-asserted-by": "crossref", "first-page": "7853", "DOI": "10.1021/ja200551y", "volume": "133", "author": "AT Larsen", "year": "2011", "unstructured": "Larsen AT, May EM, Auclair K (2011) Predictable stereoselective and chemoselective hydroxylations and epoxidations with P450 3A4. J Am Chem Soc 133:7853\u20137858", "journal-title": "J Am Chem Soc"}, {"key": "9_CR1387", "doi-asserted-by": "crossref", "first-page": "3510", "DOI": "10.1074/jbc.M111.317081", "volume": "287", "author": "IF Sevrioukova", "year": "2012", "unstructured": "Sevrioukova IF, Poulos TL (2012) Structural and mechanistic insights into the interaction of cytochrome P450 3A4 with bromoergocryptine, a type I ligand. J Biol Chem 287:3510\u20133517", "journal-title": "J Biol Chem"}, {"key": "9_CR1388", "doi-asserted-by": "crossref", "first-page": "14143", "DOI": "10.1021/bi051689t", "volume": "44", "author": "MD Cameron", "year": "2005", "unstructured": "Cameron MD, Wen B, Allen KE, Roberts AG, Schuman JT, Campbell AP, Kunze KL, Nelson SD (2005) Cooperative binding of midazolam with testosteroneand \u03b1-naphthoflavone within the CYP3A4 active site: a NMR T1 paramagnetic relaxation study. Biochemistry 44:14143\u201314151", "journal-title": "Biochemistry"}, {"key": "9_CR1389", "doi-asserted-by": "crossref", "first-page": "15746", "DOI": "10.1021/ja805772r", "volume": "130", "author": "A Nath", "year": "2008", "unstructured": "Nath A, Koo PK, Rhoades E, Atkins WM (2008) Allosteric effects on substrate dissociation from cytochrome P450 3A4 in nanodiscs observed by ensemble and single-molecule fluorescence spectroscopy. J Am Chem Soc 130:15746\u201315747", "journal-title": "J Am Chem Soc"}, {"key": "9_CR1390", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1021/bi7013807", "volume": "47", "author": "JN Lampe", "year": "2008", "unstructured": "Lampe JN, Fernandez C, Nath A, Atkins WM (2008) Nile Red is a fluorescent allosteric substrate of cytochrome P450 3A4. Biochemistry 47:509\u2013516", "journal-title": "Biochemistry"}, {"key": "9_CR1391", "doi-asserted-by": "crossref", "first-page": "198", "DOI": "10.1016/j.abb.2008.03.017", "volume": "474", "author": "A Nath", "year": "2008", "unstructured": "Nath A, Fernandez C, Lampe JN, Atkins WM (2008) Spectral resolution of a second binding site for Nile Red on cytochrome P450 3A4. Arch Biochem Biophys 474:198\u2013204", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1392", "doi-asserted-by": "crossref", "first-page": "5014", "DOI": "10.1074/jbc.270.10.5014", "volume": "270", "author": "AP Koley", "year": "1995", "unstructured": "Koley AP, Buters JTM, Robinson RC, Markowitz A, Friedman FK (1995) CO binding kinetics of human cytochrome P450 3A4: specific interaction of substrates with kinetically distinguishable conformers. J Biol Chem 270:5014\u20135018", "journal-title": "J Biol Chem"}, {"key": "9_CR1393", "doi-asserted-by": "crossref", "first-page": "3149", "DOI": "10.1074/jbc.272.6.3149", "volume": "272", "author": "AP Koley", "year": "1997", "unstructured": "Koley AP, Buters JTM, Robinson RC, Markowitz A, Friedman FK (1997) Differential mechanisms of cytochrome P450 inhibition and activation by \u03b1-naphthoflavone. J Biol Chem 272:3149\u20133152", "journal-title": "J Biol Chem"}, {"key": "9_CR1394", "doi-asserted-by": "crossref", "first-page": "706", "DOI": "10.1016/S0300-9084(97)82528-X", "volume": "78", "author": "AP Koley", "year": "1996", "unstructured": "Koley AP, Robinson RC, Friedman FK (1996) Cytochrome P450 conformation and substrate interactions as probed by CO binding kinetics. Biochimie 78:706\u2013713", "journal-title": "Biochimie"}, {"key": "9_CR1395", "first-page": "455", "volume": "53", "author": "AP Koley", "year": "1997", "unstructured": "Koley AP, Robinson RC, Markowitz A, Friedman FK (1997) Drug-drug interactions: effect of quinidine on nifedipine binding to human cytochrome P450 3A4. Biochem Pharmacol 53:455\u2013460", "journal-title": "Biochem"}, {"key": "9_CR1396", "doi-asserted-by": "crossref", "first-page": "2916", "DOI": "10.1046/j.1432-1327.2000.01305.x", "volume": "267", "author": "E Anzenbacherova", "year": "2000", "unstructured": "Anzenbacherova E, Bec N, Anzenbacher P, Hudecek J, Soucek P, Jung C, Munro AW, Lange R (2000) Flexibility and stability of the structure of cytochromes P450 3A4 and BM-3. Eur J Biochem 267:2916\u20132920", "journal-title": "Eur J Biochem"}, {"key": "9_CR1397", "doi-asserted-by": "crossref", "first-page": "184", "DOI": "10.1110/ps.21302", "volume": "11", "author": "B Ma", "year": "2002", "unstructured": "Ma B, Shatsky M, Wolfson HJ, Nussinov R (2002) Multiple diverse ligands binding at a single protein site: a matter of pre-existing populations. Protein Sci 11:184\u2013197", "journal-title": "Protein Sci"}, {"key": "9_CR1398", "doi-asserted-by": "crossref", "first-page": "447", "DOI": "10.1016/S1367-5931(02)00341-1", "volume": "6", "author": "HA Carlson", "year": "2002", "unstructured": "Carlson HA (2002) Protein flexibility and drug design: how to hit a moving target. Curr Opin Chem Biol 6:447\u2013452", "journal-title": "Curr Opin Chem Biol"}, {"key": "9_CR1399", "doi-asserted-by": "crossref", "first-page": "1571", "DOI": "10.2174/1381612023394232", "volume": "8", "author": "HA Carlson", "year": "2002", "unstructured": "Carlson HA (2002) Protein flexibility is an important component of structure-based drug discovery. Curr Pharm Des 8:1571\u20131578", "journal-title": "Curr Pharm Des"}, {"key": "9_CR1400", "doi-asserted-by": "crossref", "first-page": "1615", "DOI": "10.1126/science.287.5458.1615", "volume": "287", "author": "I Schlichting", "year": "2000", "unstructured": "Schlichting I, Berendzen J, Chu K, Stock AM, Maves SA, Benson DE, Sweet BM, Ringe D, Petsko GA, Sligar SG (2000) The catalytic pathway of cytochrome P450cam at atomic resolution. Science 287:1615\u20131622", "journal-title": "Science"}, {"key": "9_CR1401", "doi-asserted-by": "crossref", "first-page": "338", "DOI": "10.1021/tx0002132", "volume": "14", "author": "WM Atkins", "year": "2001", "unstructured": "Atkins WM, Wang RW, Lu AYH (2001) Allosteric behavior in cytochrome P450-dependent in vitro drug-drug interactions: a prospective based on conformational dynamics. Chem Res Toxicol 14:338\u2013347", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR1402", "author": "IH Segel", "year": "1975", "unstructured": "Segel IH (1975) Enzyme kinetics. Behavior and analysis of rapid equilibrium and steady-state enzyme systems. Wiley, New York", "volume-title": "Enzyme kinetics. Behavior and analysis of rapid equilibrium and steady-state enzyme systems"}, {"key": "9_CR1403", "doi-asserted-by": "crossref", "first-page": "348", "DOI": "10.1016/0006-291X(78)90616-2", "volume": "82", "author": "MK Buening", "year": "1978", "unstructured": "Buening MK, Fortner JG, Kappas A, Conney AH (1978) 7,8-Benzoflavone stimulates the metabolic activation of aflatoxin B1 to mutagens by human liver. Biochem Biophys Res Commun 82:348\u2013355", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1404", "first-page": "585", "volume": "293", "author": "TL Domanski", "year": "2000", "unstructured": "Domanski TL, He YA, Harlow GR, Halpert JR (2000) Dual role of human cytochrome P450 3A4 residue Phe-304 in substrate specificityand cooperativity. J Pharmacol Exp Ther 293:585\u2013591", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1405", "doi-asserted-by": "crossref", "first-page": "4406", "DOI": "10.1021/bi992372u", "volume": "39", "author": "SM Fowler", "year": "2000", "unstructured": "Fowler SM, Riley RJ, Pritchard MP, Sutcliffe MJ, Friedberg T, Wolf CR (2000) Amino acid 305 determines catalytic center accessibility in CYP3A4. Biochemistry 39:4406\u20134414", "journal-title": "Biochemistry"}, {"key": "9_CR1406", "doi-asserted-by": "crossref", "first-page": "483", "DOI": "10.1021/tx000218z", "volume": "14", "author": "L Xue", "year": "2001", "unstructured": "Xue L, Wang HF, Wang Q, Szklarz GD, Domanski TL, Halpert JR, Correia MA (2001) Influence of P450 3A4 SRS-2 residues on cooperativity and/or regioselectivity of aflatoxin B1 oxidation. Chem Res Toxicol 14:483\u2013491", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR1407", "doi-asserted-by": "crossref", "first-page": "452", "DOI": "10.1124/dmd.30.4.452", "volume": "30", "author": "SM Fowler", "year": "2002", "unstructured": "Fowler SM, Taylor JM, Friedberg T, Wolf CR, Riley RJ (2002) CYP3A4 active site volume modification by mutagenesis of leucine 211. Drug Metab Dispos 30:452\u2013456", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1408", "doi-asserted-by": "crossref", "first-page": "38091", "DOI": "10.1074/jbc.C400293200", "volume": "279", "author": "JK Yano", "year": "2004", "unstructured": "Yano JK, Wester MR, Schoch GA, Griffin KJ, Stout CD, Johnson EF (2004) The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05\u00a0\u00c5 resolution. J Biol Chem 279:38091\u201338094", "journal-title": "J Biol Chem"}, {"key": "9_CR1409", "doi-asserted-by": "crossref", "first-page": "4474", "DOI": "10.1021/bi4005396", "volume": "52", "author": "IF Sevrioukova", "year": "2013", "unstructured": "Sevrioukova IF, Poulos TL (2013) Dissecting cytochrome P450 3A4-ligand interactions using ritonavir analogues. Biochemistry 52:4474\u20134481", "journal-title": "Biochemistry"}, {"key": "9_CR1410", "doi-asserted-by": "crossref", "first-page": "108", "DOI": "10.1016/j.abb.2012.02.018", "volume": "520", "author": "IF Sevrioukova", "year": "2012", "unstructured": "Sevrioukova IF, Poulos TL (2012) Interaction of human cytochrome P450 3A4 with ritonavir analogs. Arch Biochem Biophys 520:108\u2013116", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1411", "doi-asserted-by": "crossref", "first-page": "13565", "DOI": "10.1073/pnas.0606333103", "volume": "103", "author": "FP Guengerich", "year": "2006", "unstructured": "Guengerich FP (2006) A malleable catalyst dominates the metabolism of drugs. Proc Natl Acad Sci U S A 103:13565\u201313566", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR1412", "doi-asserted-by": "crossref", "first-page": "8165", "DOI": "10.1021/jp800311c", "volume": "112", "author": "J Skopalik", "year": "2008", "unstructured": "Skopalik J, Anzenbacher P, Otyepka M (2008) Flexibility of human cytochromes P450: molecular dynamics reveals differences between CYPs 3A4, 2C9, and 2A6, which correlate with their substrate preferences. J Phys Chem B 112:8165\u20138173", "journal-title": "J Phys Chem B"}, {"key": "9_CR1413", "doi-asserted-by": "crossref", "first-page": "6797", "DOI": "10.1074/jbc.M111.325654", "volume": "287", "author": "DR Davydov", "year": "2012", "unstructured": "Davydov DR, Rumfeldt JA, Sineva EV, Fernando H, Davydova NY, Halpert JR (2012) Peripheral ligand-binding site in cytochrome P450 3A4 located with fluorescence resonance energy transfer (FRET). J Biol Chem 287:6797\u20136809", "journal-title": "J Biol Chem"}, {"key": "9_CR1414", "doi-asserted-by": "crossref", "first-page": "9488", "DOI": "10.1021/bi301069r", "volume": "51", "author": "C Zhao", "year": "2012", "unstructured": "Zhao C, Gao Q, Roberts AG, Shaffer SA, Doneanu CE, Xue S, Goodlett DR, Nelson SD, Atkins WM (2012) Cross-linking mass spectrometry and mutagenesis confirm the functional importance of surface interactions between CYP3A4 and holo/apo cytochrome b 5. Biochemistry 51:9488\u20139500", "journal-title": "Biochemistry"}, {"key": "9_CR1415", "doi-asserted-by": "crossref", "first-page": "990", "DOI": "10.2174/138161208784139738", "volume": "14", "author": "SF Zhou", "year": "2008", "unstructured": "Zhou SF (2008) Potential strategies for minimizing mechanism-based inhibition of cytochrome P450 3A4. Curr Pharm Des 14:990\u20131000", "journal-title": "Curr Pharm Des"}, {"key": "9_CR1416", "doi-asserted-by": "crossref", "first-page": "279", "DOI": "10.2165/00003088-200544030-00005", "volume": "44", "author": "S Zhou", "year": "2005", "unstructured": "Zhou S, Yung Chan S, Cher Goh B, Chan E, Duan W, Huang M, McLeod HL (2005) Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs. Clin Pharmacokinet 44:279\u2013304", "journal-title": "Clin Pharmacokinet"}, {"key": "9_CR1417", "doi-asserted-by": "crossref", "first-page": "724", "DOI": "10.1124/dmd.110.036780", "volume": "39", "author": "T Akiyoshi", "year": "2011", "unstructured": "Akiyoshi T, Saito T, Murase S, Miyazaki M, Murayama N, Yamazaki H, Guengerich FP, Nakamura K, Yamamoto K, Ohtani H (2011) Comparison of the inhibitory profiles of itraconazole and cimetidine in cytochrome P450 3A4 genetic variants. Drug Metab Dispos 39:724\u2013728", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1418", "doi-asserted-by": "crossref", "first-page": "2309", "DOI": "10.1016/0006-2952(83)90178-8", "volume": "32", "author": "M Delaforge", "year": "1983", "unstructured": "Delaforge M, Jaouen M, Mansuy D (1983) Dual effects of macrolide antibiotics on rat liver cytochrome P-450: inductionand formation of metabolite-complexes: a structure-activity relationship. Biochem Pharmacol 32:2309\u20132318", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR1419", "first-page": "180", "volume": "47", "author": "DG Bailey", "year": "1990", "unstructured": "Bailey DG, Edgar B, Spence JD, Munzo C, Arnold JMO (1990) Felodipine and nifedipine interactions with grapefruit juice. Clin Pharmacol Ther 47:180", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR1420", "doi-asserted-by": "crossref", "first-page": "357", "DOI": "10.1097/00004714-200108000-00001", "volume": "21", "author": "DJ Greenblatt", "year": "2001", "unstructured": "Greenblatt DJ, Patki KC, von Moltke LL, Shader RI (2001) Drug interactions with grapefruit juice: an update. J Clin Psychopharmacol 21:357\u2013359", "journal-title": "J Clin Psychopharmacol"}, {"key": "9_CR1421", "doi-asserted-by": "crossref", "first-page": "2275", "DOI": "10.1093/carcin/11.12.2275", "volume": "11", "author": "FP Guengerich", "year": "1990", "unstructured": "Guengerich FP, Kim DH (1990) In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis 11:2275\u20132279", "journal-title": "Carcinogenesis"}, {"key": "9_CR1422", "doi-asserted-by": "crossref", "first-page": "106", "DOI": "10.1002/j.1552-4604.1998.tb04398.x", "volume": "38", "author": "LL von Moltke", "year": "1998", "unstructured": "von Moltke LL, Greenblatt DJ, Grassi JM, Granda BW, Duan SX, Fogelman SM, Daily JP, Harmatz JS, Shader RI (1998) Protease inhibitorsas inhibitors of human cytochromes P450: high risk associated with ritonavir. J Clin Pharmacol 38:106\u2013111", "journal-title": "J Clin Pharmacol"}, {"key": "9_CR1423", "doi-asserted-by": "crossref", "first-page": "1055", "DOI": "10.1055/s-2002-36360", "volume": "68", "author": "M Unger", "year": "2002", "unstructured": "Unger M, Holzgrabe U, Jacobsen W, Cummins C, Benet LZ (2002) Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (kava-kava). Planta Med 68:1055\u20131058", "journal-title": "Planta Med"}, {"key": "9_CR1424", "doi-asserted-by": "crossref", "first-page": "160", "DOI": "10.1124/jpet.301.1.160", "volume": "301", "author": "HL Lin", "year": "2002", "unstructured": "Lin HL, Kent UM, Hollenberg PF (2002) Mechanism-based inactivation of cytochrome P450 3A4 by 17\u03b1-ethynylestradiol: evidence for heme destruction and covalent binding to protein. J Pharmacol Exp Ther 301:160\u2013167", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1425", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1046/j.1365-2125.2000.00271.x", "volume": "50", "author": "S Palovaara", "year": "2000", "unstructured": "Palovaara S, Kivisto KT, Tapanainen P, Manninen P, Neuvonen PJ, Laine K (2000) Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1-hydroxylation. Br J Clin Pharmacol 50:333\u2013337", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR1426", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1016/0010-7824(88)90088-1", "volume": "38", "author": "H Kuhl", "year": "1988", "unstructured": "Kuhl H, Jung-Hoffmann C, Heidt F (1988) Alterations in the serum levels of gestodene and SHBG during 12 cycles of treatment with 30\u00a0\u00b5g ethinylestradiol and 75\u00a0\u00b5g gestodene. Contraception 38:477\u2013486", "journal-title": "Contraception"}, {"key": "9_CR1427", "doi-asserted-by": "crossref", "first-page": "729", "DOI": "10.1007/s002280050543", "volume": "54", "author": "A Balogh", "year": "1998", "unstructured": "Balogh A, Gessinger S, Svarovsky U, Hippius M, Mellinger U, Klinger G, Hoffmann A, Oettel M (1998) Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans? Eur J Clin Pharmacol 54:729\u2013734", "journal-title": "Eur J Clin Pharmacol"}, {"key": "9_CR1428", "doi-asserted-by": "crossref", "first-page": "17448", "DOI": "10.1021/bi9808464", "volume": "37", "author": "K He", "year": "1998", "unstructured": "He K, Bornheim LM, Falick AM, Maltby D, Yin H, Correia MA (1998) Identification of the heme-modified peptides from cumene hydroperoxide-inactivated cytochrome P450 3A4. Biochemistry 37:17448\u201317457", "journal-title": "Biochemistry"}, {"key": "9_CR1429", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1124/dmd.32.1.105", "volume": "32", "author": "DM Stresser", "year": "2004", "unstructured": "Stresser DM, Broudy MI, Ho T, Cargill CE, Blanchard AP, Sharma R, Dandeneau AA, Goodwin JJ, Turner SD, Erve JC, Patten CJ, Dehal SS, Crespi CL (2004) Highly selective inhibition of human CYP3A in vitro by azamulin and evidence that inhibition is irreversible. Drug Metab Dispos 32:105\u2013112", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1430", "doi-asserted-by": "crossref", "first-page": "1686", "DOI": "10.1124/dmd.112.045302", "volume": "40", "author": "RL Walsky", "year": "2012", "unstructured": "Walsky RL, Obach RS, Hyland R, Kang P, Zhou S, West M, Geoghegan KF, Helal CJ, Walker GS, Goosen TC, Zientek MA (2012) Selective mechanism-based inactivation of CYP3A4 by CYP3cide (PF-04981517) and its utility as an in vitro tool for delineating the relative roles of CYP3A4 versus CYP3A5 in the metabolism of drugs. Drug Metab Dispos 40:1686\u20131697", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1431", "unstructured": "Cameron M, Kamenecka T, Madoux F, Chase P, Roush W, Hodder P, Griffin PR (2010) ML368. Identification of imidazopyridines as selective inhibitors of the cytochrome P450 enzyme CYP3A4. In: (ed) Probe Reports from the NIH Molecular Libraries Program, National Center for Biotechnology Information (US), Bethesda (MD)"}, {"key": "9_CR1432", "doi-asserted-by": "crossref", "first-page": "1803", "DOI": "10.1124/dmd.112.046144", "volume": "40", "author": "X Li", "year": "2012", "unstructured": "Li X, Song X, Kamenecka TM, Cameron MD (2012) Discovery of a highly selective CYP3A4 inhibitor suitable for reaction phenotyping studies and differentiation of CYP3A4 and CYP3A5. Drug Metab Dispos 40:1803\u20131809", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1433", "doi-asserted-by": "crossref", "first-page": "3733", "DOI": "10.1021/jm400288z", "volume": "56", "author": "IF Sevrioukova", "year": "2013", "unstructured": "Sevrioukova IF, Poulos TL (2013) Pyridine-substituted desoxyritonavir is a more potent inhibitor of cytochrome P450 3A4 than ritonavir. J Med Chem 56:3733\u20133741", "journal-title": "J Med Chem"}, {"key": "9_CR1434", "doi-asserted-by": "crossref", "first-page": "732", "DOI": "10.1021/tx700363s", "volume": "21", "author": "Q Zhou", "year": "2008", "unstructured": "Zhou Q, Zhang L, Zuniga MA, Tombes RM, Stewart JK (2008) Mixed inhibition of P450 3A4 as a chemoprotective mechanism against aflatoxin B1-induced cytotoxicity with cis-terpenones. Chem Res Toxicol 21:732\u2013738", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR1435", "doi-asserted-by": "crossref", "first-page": "150", "DOI": "10.1021/tx034143l", "volume": "17", "author": "TM Alvarez-Diez", "year": "2004", "unstructured": "Alvarez-Diez TM, Zheng J (2004) Mechanism-based inactivation of cytochrome P450 3A4 by 4-ipomeanol. Chem Res Toxicol 17:150\u2013157", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR1436", "doi-asserted-by": "crossref", "first-page": "1373", "DOI": "10.1021/tx700165q", "volume": "20", "author": "H Yukinaga", "year": "2007", "unstructured": "Yukinaga H, Takami T, Shioyama SH, Tozuka Z, Masumoto H, Okazaki O, Sudo K (2007) Identification of cytochrome P450 3A4 modification site with reactive metabolite using linear ion trap-fourier transform mass spectrometry. Chem Res Toxicol 20:1373\u20131378", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR1437", "doi-asserted-by": "crossref", "first-page": "998", "DOI": "10.1124/dmd.112.044560", "volume": "40", "author": "HL Lin", "year": "2012", "unstructured": "Lin HL, Kenaan C, Hollenberg PF (2012) Identification of the residue in human CYP3A4 that is covalently modified by bergamottin and the reactive intermediate that contributes to the grapefruit juice effect. Drug Metab Dispos 40:998\u20131006", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1438", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1016/S1056-8719(01)00121-6", "volume": "45", "author": "LC Wienkers", "year": "2001", "unstructured": "Wienkers LC (2001) Problems associated with in vitro assessment of drug inhibition of CYP3A4 and other P-450 enzymes and its impact on drug discovery. J Pharmacol Toxicol Methods 45:79\u201384", "journal-title": "J Pharmacol Toxicol Methods"}, {"key": "9_CR1439", "first-page": "50", "volume": "6", "author": "NJ Plant", "year": "2003", "unstructured": "Plant NJ, Gibson GG (2003) Evaluation of the toxicological relevance of CYP3A4 induction. Curr Opin Drug Discov Devel 6:50\u201356", "journal-title": "Curr Opin Drug Discov Devel"}, {"key": "9_CR1440", "doi-asserted-by": "crossref", "first-page": "87", "DOI": "10.2133/dmpk.23.87", "volume": "23", "author": "M Kato", "year": "2008", "unstructured": "Kato M (2008) Intestinal first-pass metabolism of CYP3A4 substrates. Drug Metab Pharmacokinet 23:87\u201394", "journal-title": "Drug Metab Pharmacokinet"}, {"key": "9_CR1441", "doi-asserted-by": "crossref", "first-page": "300", "DOI": "10.1186/1479-7364-1-4-300", "volume": "1", "author": "FJ Gonzalez", "year": "2004", "unstructured": "Gonzalez FJ (2004) Cytochrome P450 humanised mice. Hum Genomics 1:300\u2013306", "journal-title": "Hum Genomics"}, {"key": "9_CR1442", "doi-asserted-by": "crossref", "first-page": "518", "DOI": "10.1124/mol.111.071845", "volume": "80", "author": "M Hasegawa", "year": "2011", "unstructured": "Hasegawa M, Kapelyukh Y, Tahara H, Seibler J, Rode A, Krueger S, Lee DN, Wolf CR, Scheer N (2011) Quantitative prediction of human pregnane X receptor and cytochrome P450 3A4 mediated drug-drug interaction in a novel multiple humanized mouse line. Mol Pharmacol 80:518\u2013528", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1443", "first-page": "1277", "volume": "64", "author": "GC Yee", "year": "1984", "unstructured": "Yee GC, Kennedy MS, Storb R, Thomas ED (1984) Effect of hepatic dysfunction on oral cyclosporine pharmacokinetics in marrow transplant patients. Blood 64:1277\u20131279", "journal-title": "Blood"}, {"key": "9_CR1444", "doi-asserted-by": "crossref", "first-page": "1222", "DOI": "10.1002/j.1552-4604.1994.tb04735.x", "volume": "34", "author": "LL von Moltke", "year": "1994", "unstructured": "von Moltke LL, Greenblatt DJ, Duan SX, Harmatz JS, Shader RI (1994) In vitro prediction of the terfenadine-ketoconazole pharmacokinetic interaction. J Clin Pharmacol 34:1222\u20131227", "journal-title": "J Clin Pharmacol"}, {"key": "9_CR1445", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1016/S0278-6915(02)00209-0", "volume": "41", "author": "JL Dorne", "year": "2003", "unstructured": "Dorne JL, Walton K, Renwick AG (2003) Human variability in CYP3A4 metabolism and CYP3A4-related uncertainty factors for risk assessment. Food Chem Toxicol 41:201\u2013224", "journal-title": "Food Chem Toxicol"}, {"key": "9_CR1446", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.3748/wjg.v9.i2.359", "volume": "9", "author": "LQ Yang", "year": "2003", "unstructured": "Yang LQ, Li SJ, Cao YF, Man XB, Yu WF, Wang HY, Wu MC (2003) Different alterations of cytochrome P450 3A4 isoform and its gene expression in livers of patients with chronic liver diseases. World J Gastroenterol 9:359\u2013363", "journal-title": "World J Gastroenterol"}, {"key": "9_CR1447", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1016/S0009-9236(96)90022-3", "volume": "59", "author": "CC Lang", "year": "1996", "unstructured": "Lang CC, Brown RM, Kinirons MT, Deathridge MA, Guengerich FP, Kelleher D, O\u2019Briain DS, Ghishan FK, Wood AJ (1996) Decreased intestinal CYP3A in celiac disease: reversal after successful gluten-free diet: a potential source of interindividual variability in first-pass drug metabolism. Clin Pharmacol Ther 59:41\u201346", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR1448", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1081/DMR-120018248", "volume": "35", "author": "S Zhou", "year": "2003", "unstructured": "Zhou S, Gao Y, Jiang W, Huang M, Xu A, Paxton JW (2003) Interactions of herbs with cytochrome P450. Drug Metab Rev 35:35\u201398", "journal-title": "Drug Metab Rev"}, {"key": "9_CR1449", "doi-asserted-by": "crossref", "first-page": "7500", "DOI": "10.1073/pnas.130155097", "volume": "97", "author": "LB Moore", "year": "2000", "unstructured": "Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, Collins JL, Kliewer SA (2000) St. John\u2019s wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci U S A 97:7500\u20137502", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR1450", "doi-asserted-by": "crossref", "first-page": "1430", "DOI": "10.1021/bi0268753", "volume": "42", "author": "RE Watkins", "year": "2003", "unstructured": "Watkins RE, Maglich JM, Moore LB, Wisely GB, Noble SM, Davis-Searles PR, Lambert MH, Kliewer SA, Redinbo MR (2003) 2.1 A crystal structure of human PXR in complex with the St. John\u2019s wort compound hyperforin. Biochemistry 42:1430\u20131438", "journal-title": "Biochemistry"}, {"key": "9_CR1451", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1046/j.1365-2125.2002.01683.x", "volume": "54", "author": "L Henderson", "year": "2002", "unstructured": "Henderson L, Yue QY, Bergquist C, Gerden B, Arlett P (2002) St John\u2019s wort (Hypericum perforatum): drug interactions and clinical outcomes. Br J Clin Pharmacol 54:349\u2013356", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR1452", "doi-asserted-by": "crossref", "first-page": "433", "DOI": "10.1016/0016-5085(94)90602-5", "volume": "106", "author": "JC Kolars", "year": "1994", "unstructured": "Kolars JC, Benedict P, Schmiedlin-Ren P, Watkins PB (1994) Aflatoxin B1-adduct formation in rat and human small bowel enterocytes. Gastroenterology 106:433\u2013439", "journal-title": "Gastroenterology"}, {"key": "9_CR1453", "doi-asserted-by": "crossref", "first-page": "13176", "DOI": "10.1073/pnas.95.22.13176", "volume": "95", "author": "CA Felix", "year": "1998", "unstructured": "Felix CA, Walker AH, Lange BJ, Williams TM, Winick NJ, Cheung N-KV, Lovett BD, Nowell PC, Blair IA, Rebbeck TR (1998) Association of CYP3A4 genotype with treatment-related leukemia. Proc Natl Acad Sci U S A 95:13176\u201313181", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR1454", "doi-asserted-by": "crossref", "first-page": "129", "DOI": "10.1002/ijc.1568", "volume": "97", "author": "Y Miyoshi", "year": "2002", "unstructured": "Miyoshi Y, Ando A, Takamura Y, Taguchi T, Tamaki Y, Noguchi S (2002) Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues. Int J Cancer 97:129\u2013132", "journal-title": "Int J Cancer"}, {"key": "9_CR1455", "doi-asserted-by": "crossref", "first-page": "605", "DOI": "10.1097/00008571-200211000-00004", "volume": "12", "author": "JG Blanco", "year": "2002", "unstructured": "Blanco JG, Edick MJ, Hancock ML, Winick NJ, Dervieux T, Amylon MD, Bash RO, Behm FG, Camitta BM, Pui CH, Raimondi SC, Relling MV (2002) Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies. Pharmacogenetics 12:605\u2013611", "journal-title": "Pharmacogenetics"}, {"key": "9_CR1456", "doi-asserted-by": "crossref", "first-page": "1225", "DOI": "10.1093/jnci/90.16.1225", "volume": "90", "author": "TR Rebbeck", "year": "1998", "unstructured": "Rebbeck TR, Jaffe JM, Walker AH, Wein AJ, Malkowicz SB (1998) Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J Natl Cancer Inst 90:1225\u20131228", "journal-title": "J Natl Cancer Inst"}, {"key": "9_CR1457", "first-page": "653", "volume": "9", "author": "MT Tayeb", "year": "2002", "unstructured": "Tayeb MT, Clark C, Sharp L, Haites NE, Rooney PH, Murray GI, Payne SN, McLeod HL (2002) CYP3A4 promoter variant is associated with prostate cancer risk in men with benign prostate hyperplasia. Oncol Rep 9:653\u2013655", "journal-title": "Oncol Rep"}, {"key": "9_CR1458", "doi-asserted-by": "crossref", "first-page": "928", "DOI": "10.1038/sj.bjc.6600825", "volume": "88", "author": "MT Tayeb", "year": "2003", "unstructured": "Tayeb MT, Clark C, Haites NE, Sharp L, Murray GI, McLeod HL (2003) CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia. Br J Cancer 88:928\u2013932", "journal-title": "Br J Cancer"}, {"key": "9_CR1459", "doi-asserted-by": "crossref", "first-page": "1587", "DOI": "10.1093/jnci/91.18.1587", "volume": "91", "author": "Y Ando", "year": "1999", "unstructured": "Ando Y, Tateishi T, Sekido Y, Yamamoto T, Satoh T, Hasegawa Y, Kobayashi S, Katsumata Y, Shimokata K, Saito H (1999) Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J Natl Cancer Inst 91:1587\u20131588", "journal-title": "J Natl Cancer Inst"}, {"key": "9_CR1460", "doi-asserted-by": "crossref", "first-page": "553", "DOI": "10.1007/s00439-002-0731-5", "volume": "110", "author": "RA Kittles", "year": "2002", "unstructured": "Kittles RA, Chen W, Panguluri RK, Ahaghotu C, Jackson A, Adebamowo CA, Griffin R, Williams T, Ukoli F, Adams-Campbell L, Kwagyan J, Isaacs W, Freeman V, Dunston GM (2002) CYP3A4-V and prostate cancer in African Americans: causal or confounding association because of population stratification? Hum Genet 110:553\u2013560", "journal-title": "Hum Genet"}, {"key": "9_CR1461", "unstructured": "Wojnowski L, Hustert E, Klein K, Goldammer M, Haberl M, Kirchheiner J, Koch I, Klattig J, Zanger U, Brockm\u00f6ller J (2002) Re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J Natl Cancer Inst 94:630\u2013631", "DOI": "10.1093/jnci/94.8.630", "doi-asserted-by": "crossref"}, {"key": "9_CR1462", "first-page": "97", "volume": "86", "author": "SA Wrighton", "year": "1989", "unstructured": "Wrighton SA, Ring BJ, Watkins PB, VandenBranden M (1989) Identification of a polymorphically expressed member of the human cytochrome P-450III family. Mol Pharmacol 86:97\u2013105", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1463", "first-page": "10388", "volume": "264", "author": "T Aoyama", "year": "1989", "unstructured": "Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV, Gonzalez FJ (1989) Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. J Biol Chem 264:10388\u201310395", "journal-title": "J Biol Chem"}, {"key": "9_CR1464", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1016/0014-5793(95)00367-I", "volume": "364", "author": "GI Murray", "year": "1995", "unstructured": "Murray GI, Pritchard S, Melvin WT, Burke MD (1995) Cytochrome P450 CYP3A5 in the human anterior pituitary gland. FEBS Lett 364:79\u201382", "journal-title": "FEBS Lett"}, {"key": "9_CR1465", "doi-asserted-by": "crossref", "first-page": "676", "DOI": "10.1006/bbrc.1999.0960", "volume": "260", "author": "Y Yamakoshi", "year": "1999", "unstructured": "Yamakoshi Y, Kishimoto T, Sugimura K, Kawashima H (1999) Human prostate CYP3A5: identification of a unique 5-untranslated sequence and characterization of purified recombinant protein. Biochem Biophys Res Commun 260:676\u2013681", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1466", "doi-asserted-by": "crossref", "first-page": "745", "DOI": "10.1124/jpet.102.038208", "volume": "304", "author": "J Hukkanen", "year": "2003", "unstructured": "Hukkanen J, Vaisanen T, Lassila A, Piipari R, Anttila S, Pelkonen O, Raunio H, Hakkola J (2003) Regulation of CYP3A5 by glucocorticoids and cigarette smoke in human lung-derived cells. J Pharmacol Exp Ther 304:745\u2013752", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1467", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1097/00008571-199610000-00001", "volume": "6", "author": "SK Janardan", "year": "1996", "unstructured": "Janardan SK, Lown KS, Schmiedlin-Ren P, Thummel KE, Watkins PB (1996) Selective expression of CYP3A5 and not CYP3A4 in human blood. Pharmacogenetics 6:379\u2013385", "journal-title": "Pharmacogenetics"}, {"key": "9_CR1468", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1159/000047142", "volume": "80", "author": "J Hakkola", "year": "2001", "unstructured": "Hakkola J, Raunio H, Purkunen R, Saarikoski S, Vahakangas K, Pelkonen O, Edwards RJ, Boobis AR, Pasanen M (2001) Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers. Biol Neonate 80:193\u2013201", "journal-title": "Biol Neonate"}, {"key": "9_CR1469", "doi-asserted-by": "crossref", "first-page": "1741", "DOI": "10.1006/bbrc.1994.2870", "volume": "205", "author": "Y Jouna\u00efdi", "year": "1994", "unstructured": "Jouna\u00efdi Y, Guzelian PS, Vilarem MJ (1994) Sequence of the 5\u2032-flanking region of CYP3A5: comparative analysis with CYP3A4 and CYP3A7. Biochem Biophys Res Commun 205:1741\u20131747", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1470", "first-page": "63", "volume": "49", "author": "JD Schuetz", "year": "1996", "unstructured": "Schuetz JD, Schuetz EG, Thottassery JV, Guzelian PS, Strom S, Sun D (1996) Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells. Mol Pharmacol 49:63\u201372", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1471", "doi-asserted-by": "crossref", "first-page": "162", "DOI": "10.1124/mol.62.1.162", "volume": "62", "author": "YS Lin", "year": "2002", "unstructured": "Lin YS, Dowling AL, Quigley SD, Farin FM, Zhang J, Lamba J, Schuetz EG, Thummel KE (2002) Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism. Mol Pharmacol 62:162\u2013172", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1472", "first-page": "67", "volume": "35", "author": "SJ Lee", "year": "2007", "unstructured": "Lee SJ, van der Heiden IP, Goldstein JA, van Schaik RH (2007) A new CYP3A5 variant, CYP3A5*11, is shown to be defective in nifedipine metabolism in a recombinant cDNA expression system. Drug Metab Dispos 35:67\u201371", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1473", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.2165/00003088-200645010-00002", "volume": "45", "author": "AK Daly", "year": "2006", "unstructured": "Daly AK (2006) Significance of the minor cytochrome P450 3A isoforms. Clin Pharmacokinet 45:13\u201331", "journal-title": "Clin Pharmacokinet"}, {"key": "9_CR1474", "doi-asserted-by": "crossref", "first-page": "383", "DOI": "10.1038/86882", "volume": "27", "author": "P Kuehl", "year": "2001", "unstructured": "Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, Watkins PB, Daly A, Wrighton SA, Hall SD, Maurel P, Relling M, Brimer C, Yasuda K, Venkataramanan R, Strom S, Thummel K, Boguski MS, Schuetz E (2001) Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 27:383\u2013391", "journal-title": "Nat Genet"}, {"key": "9_CR1475", "doi-asserted-by": "crossref", "first-page": "415", "DOI": "10.1097/00008571-200007000-00005", "volume": "10", "author": "A Paulussen", "year": "2000", "unstructured": "Paulussen A, Lavrijsen K, Bohets H, Hendrickx J, Verhasselt P, Luyten W, Konings F, Armstrong M (2000) Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans. Pharmacogenetics 10:415\u2013424", "journal-title": "Pharmacogenetics"}, {"key": "9_CR1476", "doi-asserted-by": "crossref", "first-page": "1491", "DOI": "10.1124/dmd.30.12.1491", "volume": "30", "author": "PS Shih", "year": "2002", "unstructured": "Shih PS, Huang JD (2002) Pharmacokinetics of midazolam and 1\u2032-hydroxymidazolam in Chinese with different CYP3A5 genotypes. Drug Metab Dispos 30:1491\u20131496", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1477", "first-page": "207", "volume": "38", "author": "SA Wrighton", "year": "1990", "unstructured": "Wrighton SA, Brian WR, Sari MA, Iwasaki M, Guengerich FP, Raucy JL, Molowa DT, Vandenbranden M (1990) Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol Pharmacol 38:207\u2013213", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1478", "doi-asserted-by": "crossref", "first-page": "374", "DOI": "10.1006/abbi.1995.1177", "volume": "317", "author": "EM Gillam", "year": "1995", "unstructured": "Gillam EM, Guo Z, Ueng YF, Yamazaki H, Cock I, Reilly PE, Hooper WD, Guengerich FP (1995) Expression of cytochrome P450 3A5 in Escherichia coli: effects of 5\u2032 modification, purification, spectral characterization, reconstitution conditions, and catalytic activities. Arch Biochem Biophys 317:374\u2013384", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1479", "doi-asserted-by": "crossref", "first-page": "663", "DOI": "10.2133/dmpk.DMPK-12-SH-030", "volume": "27", "author": "SJ Lee", "year": "2012", "unstructured": "Lee SJ, Goldstein JA (2012) Comparison of CYP3A4 and CYP3A5: the effects of cytochrome b 5 and NADPH-cytochrome P450 reductase on testosterone hydroxylation activities. Drug Metab Pharmacokinet 27:663\u2013667", "journal-title": "Drug Metab Pharmacokinet"}, {"key": "9_CR1480", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1124/dmd.113.055400", "volume": "42", "author": "Y Zhu", "year": "2014", "unstructured": "Zhu Y, Wang F, Li Q, Zhu M, Du A, Tang W, Chen W (2014) Amlodipine metabolism in human liver microsomes and roles of CYP3A4/5 in the dihydropyridine dehydrogenation. Drug Metab Dispos 42:245\u2013249", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1481", "doi-asserted-by": "crossref", "first-page": "162", "DOI": "10.1124/dmd.113.054817", "volume": "42", "author": "KD Hardy", "year": "2014", "unstructured": "Hardy KD, Wahlin MD, Papageorgiou I, Unadkat JD, Rettie AE, Nelson SD (2014) Studies on the role of metabolic activation in tyrosine kinase inhibitor-dependent hepatotoxicity: induction of CYP3A4 enhances the cytotoxicity of lapatinib in HepaRG cells. Drug Metab Dispos 42:162\u2013171", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1482", "doi-asserted-by": "crossref", "first-page": "18", "DOI": "10.1124/dmd.108.024679", "volume": "37", "author": "Y Okada", "year": "2009", "unstructured": "Okada Y, Murayama N, Yanagida C, Shimizu M, Guengerich FP, Yamazaki H (2009) Drug interactions of thalidomide with midazolam and cyclosporine A: jeterotropic cooperativity of human cytochrome P450 3A5. Drug Metab Dispos 37:18\u201323", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1483", "first-page": "180", "volume": "27", "author": "MA Gibbs", "year": "1999", "unstructured": "Gibbs MA, Thummel KE, Shen DD, Kunze KL (1999) Inhibition of cytochrome P-450 3A(CYP3A) in human intestinal and liver microsomes: comparison of K i values and impact of CYP3A5 expression. Drug Metab Dispos 27:180\u2013187", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1484", "doi-asserted-by": "crossref", "first-page": "1033", "DOI": "10.1007/s00228-008-0503-9", "volume": "64", "author": "D Tomalik-Scharte", "year": "2008", "unstructured": "Tomalik-Scharte D, Doroshyenko O, Kirchheiner J, Jetter A, Lazar A, Klaassen T, Frank D, Wyen C, Fatkenheuer G, Fuhr U (2008) No role for the CYP3A5*3 polymorphism in intestinal and hepatic metabolism of midazolam. Eur J Clin Pharmacol 64:1033\u20131035", "journal-title": "Eur J Clin Pharmacol"}, {"key": "9_CR1485", "doi-asserted-by": "crossref", "first-page": "1240", "DOI": "10.1080/00498250802334391", "volume": "38", "author": "JE Park", "year": "2008", "unstructured": "Park JE, Kim KB, Bae SK, Moon BS, Liu KH, Shin JG (2008) Contribution of cytochrome P450 3A4 and 3A5 to the metabolism of atorvastatin. Xenobiotica 38:1240\u20131251", "journal-title": "Xenobiotica"}, {"key": "9_CR1486", "first-page": "753", "volume": "20", "author": "M Sattler", "year": "1992", "unstructured": "Sattler M, Guengerich FP, Yun CH, Christians U, Sewing KF (1992) Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. Drug Metab Dispos 20:753\u2013761", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1487", "first-page": "1315", "volume": "23", "author": "A Lampen", "year": "1995", "unstructured": "Lampen A, Christians U, Guengerich FP, Watkins PB, Kolars JC, Bader A, Gonschior AK, Dralle H, Hackbarth I, Sewing KF (1995) Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability. Drug Metab Dispos 23:1315\u20131324", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1488", "doi-asserted-by": "crossref", "first-page": "1198", "DOI": "10.1111/tri.12194", "volume": "26", "author": "A Asberg", "year": "2013", "unstructured": "Asberg A, Midtvedt K, van Guilder M, Storset E, Bremer S, Bergan S, Jelliffe R, Hartmann A, Neely MN (2013) Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation. Transplant Int 26:1198\u20131207", "journal-title": "Transplant Int"}, {"key": "9_CR1489", "doi-asserted-by": "crossref", "first-page": "179", "DOI": "10.2217/pgs.13.199", "volume": "15", "author": "M Kurzawski", "year": "2014", "unstructured": "Kurzawski M, Dabrowska J, Dziewanowski K, Domanski L, Peruzynska M, Drozdzik M (2014) CYP3A5 and CYP3A4, but not ABCB1 polymorphisms affect tacrolimus dose-adjusted trough concentrations in kidney transplant recipients. Pharmacogenomics 15:179\u2013188", "journal-title": "Pharmacogenomics"}, {"key": "9_CR1490", "doi-asserted-by": "crossref", "first-page": "369", "DOI": "10.1097/FTD.0b013e31821a7aa3", "volume": "33", "author": "N Pashaee", "year": "2011", "unstructured": "Pashaee N, Bouamar R, Hesselink DA, Roodnat JI, van Schaik RH, Weimar W, van Gelder T (2011) CYP3A5 genotype is not related to the intrapatient variability of tacrolimus clearance. Ther Drug Monit 33:369\u2013371", "journal-title": "Ther Drug Monit"}, {"key": "9_CR1491", "doi-asserted-by": "crossref", "first-page": "328", "DOI": "10.1097/FTD.0b013e318289644d", "volume": "35", "author": "N Spierings", "year": "2013", "unstructured": "Spierings N, Holt DW, MacPhee IA (2013) CYP3A5 genotype had no impact on intrapatient variability of tacrolimus clearance in renal transplant recipients. Ther Drug Monit 35:328\u2013331", "journal-title": "Ther Drug Monit"}, {"key": "9_CR1492", "doi-asserted-by": "crossref", "first-page": "1154", "DOI": "10.1016/0006-291X(85)90211-6", "volume": "131", "author": "M Kitada", "year": "1985", "unstructured": "Kitada M, Kamataki T, Itahashi K, Rikihisa T, Kato R, Kanakubo Y (1985) Immunochemical examinations of cytochrome P-450 in various tissues of human fetuses using antibodies to human fetal cytochrome P-450, P-450 HFLa. Biochem Biophys Res Commun 131:1154\u20131159", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1493", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1111/j.1447-0756.1993.tb00392.x", "volume": "19", "author": "Y Okajima", "year": "1993", "unstructured": "Okajima Y, Inaba N, Fukazawa I, Ota Y, Hirai Y, Sato N, Yamamoto G, Itahashi K, Kitada M, Kamataki T (1993) Immunohistochemical and immunoelectron microscopic study of cytochrome P-450 of human fetal livers (P-450HFLa): implications for an onco-feto-placental enzyme. Asia Oceania J Obstet Gynaecol 19:329\u2013341", "journal-title": "Asia Oceania J Obstet Gynaecol"}, {"key": "9_CR1494", "doi-asserted-by": "crossref", "first-page": "1018", "DOI": "10.1172/JCI116607", "volume": "92", "author": "JD Schuetz", "year": "1993", "unstructured": "Schuetz JD, Kauma S, Guzelian PS (1993) Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta. J Clin Invest 92:1018\u20131024", "journal-title": "J Clin Invest"}, {"key": "9_CR1495", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1124/dmd.31.1.1", "volume": "31", "author": "MA Sarkar", "year": "2003", "unstructured": "Sarkar MA, Vadlamuri V, Ghosh S, Glover DD (2003) Expression and cyclic variability of CYP3A4 and CYP3A7 isoforms in human endometrium and cervix during the menstrual cycle. Drug Metab Dispos 31:1\u20136", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1496", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1016/0006-2952(96)00216-X", "volume": "52", "author": "J Hakkola", "year": "1996", "unstructured": "Hakkola J, Raunio H, Purkunen R, Pelkonen O, Saarikoski S, Cresteil T, Pasanen M (1996) Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem Pharmacol 52:379\u2013383", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR1497", "first-page": "922", "volume": "46", "author": "HYL Yang", "year": "1994", "unstructured": "Yang HYL, Lee QP, Rettie AE, Juchau MR (1994) Functional cytochrome P4503A isoforms in human embryonic tissues: expression during organogenesis. Mol Pharmacol 46:922\u2013928", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1498", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1097/00008571-199402000-00002", "volume": "4", "author": "JD Schuetz", "year": "1994", "unstructured": "Schuetz JD, Beach DL, Guzelian PS (1994) Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 4:11\u201320", "journal-title": "Pharmacogenetics"}, {"key": "9_CR1499", "doi-asserted-by": "crossref", "first-page": "2567", "DOI": "10.1016/S0024-3205(97)01011-4", "volume": "61", "author": "T Tateishi", "year": "1997", "unstructured": "Tateishi T, Nakura H, Asoh M, Watanabe M, Tanaka M, Kumai T, Takashima S, Imaoka S, Funae Y, Yabusaki Y, Kamataki T, Kobayashi S (1997) A comparison of hepatic cytochrome P450 protein expression between infancy and postinfancy. Life Sci 61:2567\u20132574", "journal-title": "Life Sci"}, {"key": "9_CR1500", "doi-asserted-by": "crossref", "first-page": "1453", "DOI": "10.1210/en.2011-1020", "volume": "153", "author": "XY Pang", "year": "2012", "unstructured": "Pang XY, Cheng J, Kim JH, Matsubara T, Krausz KW, Gonzalez FJ (2012) Expression and regulation of human fetal-specific CYP3A7 in mice. Endocrinology 153:1453\u20131463", "journal-title": "Endocrinology"}, {"key": "9_CR1501", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1093/oxfordjournals.jbchem.a122632", "volume": "106", "author": "M Komori", "year": "1989", "unstructured": "Komori M, Nishio K, Ohi H, Kitada M, Kamataki T (1989) Molecular cloning and sequence analysis of cDNA containing entire coding region for human fetal liver cytochrome P-450. J Biochem (Tokyo) 106:161\u2013163", "journal-title": "J Biochem (Tokyo)"}, {"key": "9_CR1502", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1016/0167-4781(92)90520-A", "volume": "1130", "author": "S Itoh", "year": "1992", "unstructured": "Itoh S, Yanagimoto T, Tagawa S, Hashimoto H, Kitamura R, Nakajima Y, Okochi T, Fujimoto S, Uchino J, Kamataki T (1992) Genomic organization of human fetal specific P-450IIIA7 (cytochrome P-450HFLa)-related gene(s) and interaction of transcriptional regulatory factor with its DNA element in the 5\u2032 flanking region. Biochim Biophys Acta 1130:133\u2013138", "journal-title": "Biochim Biophys Acta"}, {"key": "9_CR1503", "doi-asserted-by": "crossref", "first-page": "689", "DOI": "10.1006/bbrc.1996.1231", "volume": "225", "author": "J Greuet", "year": "1996", "unstructured": "Greuet J, Pichard L, Bonfils C, Domergue J, Maurel P (1996) The fetal specific gene CYP3A7 is inducible by rifampicin in adult human hepatocytes in primary culture. Biochem Biophys Res Commun 225:689\u2013694", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1504", "doi-asserted-by": "crossref", "first-page": "377", "DOI": "10.1006/bbrc.1999.0745", "volume": "260", "author": "JM Pascussi", "year": "1999", "unstructured": "Pascussi JM, Jounaidi Y, Drocourt L, Domergue J, Balabaud C, Maurel P, Vilarem MJ (1999) Evidence for the presence of a functional pregnane X receptor response element in the CYP3A7 promoter gene. Biochem Biophys Res Commun 260:377\u2013381", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1505", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1006/bbrc.2000.4066", "volume": "280", "author": "G Bertilsson", "year": "2001", "unstructured": "Bertilsson G, Berkenstam A, Blomquist P (2001) Functionally conserved xenobiotic responsive enhancer in cytochrome P450 3A7. Biochem Biophys Res Commun 280:139\u2013144", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1506", "first-page": "38010", "volume": "276", "author": "T Saito", "year": "2001", "unstructured": "Saito T, Takahashi Y, Hashimoto H, Kamataki T (2001) Novel transcriptional regulation of the human CYP3A7 gene by Sp1 and Sp3 through nuclear factor kB-like element. J Biol Chem 276:38010\u201338022", "journal-title": "J Biol Chem"}, {"key": "9_CR1507", "doi-asserted-by": "crossref", "first-page": "428", "DOI": "10.1016/j.bbrc.2004.04.041", "volume": "318", "author": "T Matsunaga", "year": "2004", "unstructured": "Matsunaga T, Maruyama M, Harada E, Katsuyama Y, Sugihara N, Ise H, Negishi N, Ikeda U, Ohmori S (2004) Expression and induction of CYP3As in human fetal hepatocytes. Biochem Biophys Res Commun 318:428\u2013434", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1508", "doi-asserted-by": "crossref", "first-page": "585", "DOI": "10.1111/j.1432-1033.1993.tb18412.x", "volume": "218", "author": "H Hashimoto", "year": "1993", "unstructured": "Hashimoto H, Toide K, Kitamura R, Fujita M, Tagawa S, Itoh S, Kamataki T (1993) Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control. Eur J Biochem 218:585\u2013595", "journal-title": "Eur J Biochem"}, {"key": "9_CR1509", "doi-asserted-by": "crossref", "first-page": "625", "DOI": "10.1097/01.fpc.0000171516.84139.89", "volume": "15", "author": "SC Sim", "year": "2005", "unstructured": "Sim SC, Edwards RJ, Boobis AR, Ingelman-Sundberg M (2005) CYP3A7 protein expression is high in a fraction of adult human livers and partially associated with the CYP3A7*1C allele. Pharmacogenet Genomics 15:625\u2013631", "journal-title": "Pharmacogenet Genomics"}, {"key": "9_CR1510", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1007/s11033-009-9608-1", "volume": "37", "author": "SS Lee", "year": "2010", "unstructured": "Lee SS, Jung HJ, Park JS, Cha IJ, Cho DY, Shin JG (2010) Identification of a null allele of cytochrome P450 3A7: CYP3A7 polymorphism in a Korean population. Mol Biol Rep 37:213\u2013217", "journal-title": "Mol Biol Rep"}, {"key": "9_CR1511", "doi-asserted-by": "crossref", "first-page": "5313", "DOI": "10.1210/jc.2005-0307", "volume": "90", "author": "P Smit", "year": "2005", "unstructured": "Smit P, van Schaik RH, van der Werf M, van den Beld AW, Koper JW, Lindemans J, Pols HA, Brinkmann AO, de Jong FH, Lamberts SW (2005) A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels. J Clin Endocrinol Metab 90:5313\u20135316", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR1512", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1016/S0378-1119(00)00470-4", "volume": "260", "author": "C Finta", "year": "2000", "unstructured": "Finta C, Zaphiropoulos PG (2000) The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons. Gene 260:13\u201323", "journal-title": "Gene"}, {"key": "9_CR1513", "doi-asserted-by": "crossref", "first-page": "24280", "DOI": "10.1074/jbc.M202345200", "volume": "277", "author": "O Burk", "year": "2002", "unstructured": "Burk O, Tegude H, Koch I, Hustert E, Wolbold R, Glaeser H, Klein K, Fromm MF, Nuessler AK, Neuhaus P, Zanger UM, Eichelbaum M, Wojnowski L (2002) Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine. J Biol Chem 277:24280\u201324288", "journal-title": "J Biol Chem"}, {"key": "9_CR1514", "doi-asserted-by": "crossref", "first-page": "626", "DOI": "10.1124/jpet.105.086504", "volume": "314", "author": "JS Leeder", "year": "2005", "unstructured": "Leeder JS, Gaedigk R, Marcucci KA, Gaedigk A, Vyhlidal CA, Schindel BP, Pearce RE (2005) Variability of CYP3A7 expression in human fetal liver. J Pharmacol Exp Ther 314:626\u2013635", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1515", "doi-asserted-by": "crossref", "first-page": "453", "DOI": "10.1016/0006-2952(87)90350-9", "volume": "36", "author": "M Kitada", "year": "1987", "unstructured": "Kitada M, Kamataki T, Itahashi K, Rikihisa T, Kanakubo Y (1987) Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidations. Biochem Pharmacol 36:453\u2013456", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR1516", "first-page": "13534", "volume": "262", "author": "M Kitada", "year": "1987", "unstructured": "Kitada M, Kamataki T, Itahashi K, Rikihisa T, Kanakubo Y (1987) P-450 HFLa, a form of cytochrome P-450 purified from human fetal livers, is the 16\u03b1-hydroxylase of dehydroepiandrosterone 3-sulfate. J Biol Chem 262:13534\u201313537", "journal-title": "J Biol Chem"}, {"key": "9_CR1517", "first-page": "15", "volume": "100", "author": "S Ohmori", "year": "1998", "unstructured": "Ohmori S, Fujiki N, Nakasa H, Nakamura H, Ishii I, Itahashi K, Kitada M (1998) Steroid hydroxylation by human fetal CYP3A7 and human NADPH-cytochrome P450 reductase coexpressed in insect cells using baculovirus. Res Commun Mol Pathol Pharmacol 100:15\u201328", "journal-title": "Res Commun Mol Pathol Pharmacol"}, {"key": "9_CR1518", "doi-asserted-by": "crossref", "first-page": "1643", "DOI": "10.1016/0006-2952(94)90543-6", "volume": "47", "author": "JC Gorski", "year": "1994", "unstructured": "Gorski JC, Hall SD, Jones DR, VandenBranden M, Wrighton SA (1994) Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily. Biochem Pharmacol 47:1643\u20131653", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR1519", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1006/abbi.1997.0286", "volume": "346", "author": "EMJ Gillam", "year": "1997", "unstructured": "Gillam EMJ, Wunsch RM, Ueng YF, Shimada T, Reilly PE, Kamataki T, Guengerich FP (1997) Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5\u2032 modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase. Arch Biochem Biophys 346:81\u201390", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1520", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1016/0003-9861(95)90016-0", "volume": "320", "author": "H Hashimoto", "year": "1995", "unstructured": "Hashimoto H, Yanagawa Y, Sawada M, Itoh S, Deguchi T, Kamataki T (1995) Simultaneous expression of human CYP3A7 and N-acetyltransferase in Chinese hamster CHL cells results in high cytotoxicity for carcinogenic heterocyclic amines. Arch Biochem Biophys 320:323\u2013329", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1521", "first-page": "641", "volume": "57", "author": "Y Li", "year": "1997", "unstructured": "Li Y, Yokoi T, Katsuki M, Wang JS, Groopman JD, Kamataki T (1997) In vivo activation of aflatoxin B1 in C57BL/6N mice carrying a human fetus-specific CYP3A7 gene. Cancer Res 57:641\u2013645", "journal-title": "Cancer Res"}, {"key": "9_CR1522", "doi-asserted-by": "crossref", "first-page": "150", "DOI": "10.1006/bbrc.1998.9202", "volume": "250", "author": "A Yamada", "year": "1998", "unstructured": "Yamada A, Fujita K, Yokoi T, Muto S, Suzuki A, Gondo Y, Katsuki M, Kamataki T (1998) In vivo detection of mutations induced by aflatoxin B1 using human CYP3A7/HITEC hybrid mice. Biochem Biophys Res Commun 250:150\u2013153", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1523", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1006/abbi.1996.0214", "volume": "329", "author": "Y Li", "year": "1996", "unstructured": "Li Y, Yokoi T, Kitamura R, Sasaki M, Gunji M, Katsuki M, Kamataki T (1996) Establishment of transgenic mice carrying human fetus-specific CYP3A7. Arch Biochem Biophys 329:235\u2013240", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1524", "first-page": "1051", "volume": "28", "author": "H Chen", "year": "2000", "unstructured": "Chen H, Fantel AG, Juchau MR (2000) Catalysis of the 4-hydroxylation of retinoic acids by CYP3A7 in human fetal hepatic tissues. Drug Metab Dispos 28:1051\u20131057", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1525", "first-page": "6532", "volume": "63", "author": "AJ Lee", "year": "2003", "unstructured": "Lee AJ, Conney AH, Zhu BT (2003) Human cytochrome P450 3A7 has a distinct high catalytic activity for the 16\u03b1-hydroxylation of estrone but not 17\u03b2-estradiol. Cancer Res 63:6532\u20136536", "journal-title": "Cancer Res"}, {"key": "9_CR1526", "doi-asserted-by": "crossref", "first-page": "623", "DOI": "10.1006/bbrc.2000.2340", "volume": "269", "author": "E Inoue", "year": "2000", "unstructured": "Inoue E, Takahashi Y, Imai Y, Kamataki T (2000) Development of bacterial expression system with high yield of CYP3A7, a human fetus-specific form of cytochrome P450. Biochem Biophys Res Commun 269:623\u2013627", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1527", "doi-asserted-by": "crossref", "first-page": "250", "DOI": "10.1016/j.pharmthera.2008.02.005", "volume": "118", "author": "RN Hines", "year": "2008", "unstructured": "Hines RN (2008) The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol Ther 118:250\u2013267", "journal-title": "Pharmacol Ther"}, {"key": "9_CR1528", "doi-asserted-by": "crossref", "first-page": "440", "DOI": "10.1016/j.drudis.2006.03.002", "volume": "11", "author": "JC Stevens", "year": "2006", "unstructured": "Stevens JC (2006) New perspectives on the impact of cytochrome P450 3A expression for pediatric pharmacology. Drug Discov Today 11:440\u2013445", "journal-title": "Drug Discov Today"}, {"key": "9_CR1529", "first-page": "4990", "volume": "59", "author": "N Kondoh", "year": "1999", "unstructured": "Kondoh N, Wakatsuki T, Ryo A, Hada A, Aihara T, Horiuchi S, Goseki N, Matsubara O, Takenaka K, Shichita M, Tanaka K, Shuda M, Yamamoto M (1999) Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res 59:4990\u20134996", "journal-title": "Cancer Res"}, {"key": "9_CR1530", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1097/00008571-200103000-00002", "volume": "11", "author": "K Gellner", "year": "2001", "unstructured": "Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, Deglmann CJ, Burk O, Buntefuss D, Escher S, Bishop C, Koebe HG, Brinkmann U, Klenk HP, Kleine K, Meyer UA, Wojnowski L (2001) Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics 11:111\u2013121", "journal-title": "Pharmacogenetics"}, {"key": "9_CR1531", "doi-asserted-by": "crossref", "first-page": "386", "DOI": "10.1124/mol.59.2.386", "volume": "59", "author": "TL Domanski", "year": "2001", "unstructured": "Domanski TL, Finta C, Halpert JR, Zaphiropoulos PG (2001) cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450. Mol Pharmacol 59:386\u2013392", "journal-title": "Mol"}, {"key": "9_CR1532", "doi-asserted-by": "crossref", "first-page": "1349", "DOI": "10.1006/bbrc.2001.4505", "volume": "281", "author": "A Westlind", "year": "2001", "unstructured": "Westlind A, Malmebo S, Johansson I, Otter C, Andersson TB, Ingelman-Sundberg M, Oscarson M (2001) Cloning and tissue distribution of a novel human cytochrome P450 of the CYP3A subfamily, CYP3A43. Biochem Biophys Res Commun 281:1349\u20131355", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1533", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1002/humu.9211", "volume": "23", "author": "C Cauffiez", "year": "2004", "unstructured": "Cauffiez C, Lo-Guidice JM, Chevalier D, Allorge D, Hamdan R, Lhermitte M, Lafitte JJ, Colombel JF, Libersa C, Broly F (2004) First report of a genetic polymorphism of the cytochrome P450 3A43 (CYP3A43) gene: identification of a loss-of-function variant. Hum Mutat 23:101", "journal-title": "Hum Mutat"}, {"key": "9_CR1534", "doi-asserted-by": "crossref", "first-page": "620", "DOI": "10.1038/mp.2011.38", "volume": "16", "author": "KL Bigos", "year": "2011", "unstructured": "Bigos KL, Bies RR, Pollock BG, Lowy JJ, Zhang F, Weinberger DR (2011) Genetic variation in CYP3A43 explains racial difference in olanzapine clearance. Mol Psychiatry 16:620\u2013625", "journal-title": "Mol Psychiatry"}, {"key": "9_CR1535", "first-page": "658", "volume": "276", "author": "BJ Ring", "year": "1996", "unstructured": "Ring BJ, Catlow J, Lindsay TJ, Gillespie T, Roskos LK, Cerimele BJ, Swanson SP, Hamman MA, Wrighton SA (1996) Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine. J Pharmacol Exp Ther 276:658\u2013666", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1536", "doi-asserted-by": "crossref", "first-page": "893", "DOI": "10.1089/dna.1993.12.893", "volume": "12", "author": "S Imaoka", "year": "1993", "unstructured": "Imaoka S, Ogawa H, Kimura S, Gonzalez FJ (1993) Complete cDNA sequence and cDNA-directed expression of CYP4A11, a fatty acid \u03c9-hydroxylase expressed in human kidney. DNA Cell Biol 12:893\u2013899", "journal-title": "DNA Cell Biol"}, {"key": "9_CR1537", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1006/abbi.1996.0501", "volume": "335", "author": "PK Powell", "year": "1996", "unstructured": "Powell PK, Wolf I, Lasker JM (1996) Identification of CYP4A11 as the major lauric acid \u03c9-hydroxylase in human liver microsomes. Arch Biochem Biophys 335:219\u2013226", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1538", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1016/S0003-9861(02)00545-3", "volume": "409", "author": "A Bellamine", "year": "2003", "unstructured": "Bellamine A, Wang Y, Waterman MR, Gainer JV III, Dawson EP, Brown NJ, Capdevila JH (2003) Characterization of the CYP4A11 gene, a second CYP4A gene in humans. Arch Biochem Biophys 409:221\u2013227", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1539", "doi-asserted-by": "crossref", "first-page": "212", "DOI": "10.1016/S0003-9861(02)00499-X", "volume": "409", "author": "U Savas", "year": "2003", "unstructured": "Savas U, Hsu MH, Johnson EF (2003) Differential regulation of human CYP4A genes by peroxisome proliferators and dexamethasone. Arch Biochem Biophys 409:212\u2013220", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1540", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1093/toxsci/kfh126", "volume": "79", "author": "JL Raucy", "year": "2004", "unstructured": "Raucy JL, Lasker J, Ozaki K, Zoleta V (2004) Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes. Toxicol Sci 79:233\u2013241", "journal-title": "Toxicol Sci"}, {"key": "9_CR1541", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1007/s10038-005-0245-9", "volume": "50", "author": "BH Cho", "year": "2005", "unstructured": "Cho BH, Park BL, Kim LH, Chung HS, Shin HD (2005) Highly polymorphic human CYP4A11 gene. J Hum Genet 50:259\u2013263", "journal-title": "J Hum Genet"}, {"key": "9_CR1542", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1161/01.CIR.0000151309.82473.59", "volume": "111", "author": "JV Gainer", "year": "2005", "unstructured": "Gainer JV, Bellamine A, Dawson EP, Womble KE, Grant SW, Wang Y, Cupples LA, Guo CY, Demissie S, O\u2019Donnell CJ, Brown NJ, Waterman MR, Capdevila JH (2005) Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Circulation 111:63\u201369", "journal-title": "Circulation"}, {"key": "9_CR1543", "first-page": "1327", "volume": "285", "author": "PK Powell", "year": "1998", "unstructured": "Powell PK, Wolf I, Jin R, Lasker JM (1998) Metabolism of arachidonic acid to 20-hydroxy-5,8,11,14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11. J Pharmacol Exp Ther 285:1327\u20131336", "journal-title": "J Pharmacol Exp Ther"}, {"key": "9_CR1544", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1006/abbi.1999.1504", "volume": "373", "author": "U Hoch", "year": "2000", "unstructured": "Hoch U, Zhang Z, Kroetz DL, Ortiz de Montellano PR (2000) Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid omega-hydroxylases. Arch Biochem Biophys 373:63\u201371", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1545", "doi-asserted-by": "crossref", "first-page": "4118", "DOI": "10.1074/jbc.275.6.4118", "volume": "275", "author": "JM Lasker", "year": "2000", "unstructured": "Lasker JM, Chen WB, Wolf I, Bloswick BP, Wilson PD, Powell PK (2000) Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of CYP4F2 and CYP4A11. J Biol Chem 275:4118\u20134126", "journal-title": "J Biol Chem"}, {"key": "9_CR1546", "doi-asserted-by": "crossref", "first-page": "12755", "DOI": "10.1074/jbc.M112155200", "volume": "277", "author": "LA LeBrun", "year": "2002", "unstructured": "LeBrun LA, Hoch U, Ortiz de Montellano PR (2002) Autocatalytic mechanism and consequences of covalent heme attachment in the cytochrome P4504A family. J Biol Chem 277:12755\u201312761", "journal-title": "J Biol Chem"}, {"key": "9_CR1547", "doi-asserted-by": "crossref", "first-page": "23055", "DOI": "10.1074/jbc.273.36.23055", "volume": "273", "author": "EA Dierks", "year": "1998", "unstructured": "Dierks EA, Zhang Z, Johnson EF, Ortiz de Montellano PR (1998) The catalytic site of cytochrome P4504A11 (CYP4A11) and its L131F mutant. J Biol Chem 273:23055\u201323061", "journal-title": "J Biol Chem"}, {"key": "9_CR1548", "doi-asserted-by": "crossref", "first-page": "6161", "DOI": "10.1021/bi500710e", "volume": "53", "author": "G-S Cha", "year": "2014", "unstructured": "Cha G-S, Kim D, Nagy LD, Kramlinger VM, Guengerich FP, Yun C-H (2014) Kinetic analysis of lauric acid hydroxylation by human cytochrome P450 4A11. Biochemistry 53:6161\u20136172", "journal-title": "Biochemistry"}, {"key": "9_CR1549", "unstructured": "Albertolle MW, Kim D, Nagy LD, Wei S, Guengerich FP (2015) Catalytic activity of human cytochrome P450 4A11 is dependent on the oxidation states of cysteine residues. J Biol Chem 290 (in preparation)"}, {"key": "9_CR1550", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1081/DMR-120001390", "volume": "34", "author": "DF Lewis", "year": "2002", "unstructured": "Lewis DF (2002) Molecular modeling of human cytochrome P450-substrate interactions. Drug Metab Rev 34:55\u201367", "journal-title": "Drug Metab Rev"}, {"key": "9_CR1551", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1016/j.gene.2011.07.015", "volume": "487", "author": "CL Lino Cardenas", "year": "2011", "unstructured": "Lino Cardenas CL, Renault N, Farce A, Cauffiez C, Allorge D, Lo-Guidice JM, Lhermitte M, Chavatte P, Broly F, Chevalier D (2011) Genetic polymorphism of CYP4A11 and CYP4A22 genes and in silico insights from comparative 3D modelling in a French population. Gene 487:10\u201320", "journal-title": "Gene"}, {"key": "9_CR1552", "doi-asserted-by": "crossref", "first-page": "325", "DOI": "10.1038/sj.bjp.0704101", "volume": "133", "author": "N Miyata", "year": "2001", "unstructured": "Miyata N, Taniguchi K, Seki T, Ishimoto T, Sato-Watanabe M, Yasuda Y, Doi M, Kametani S, Tomishima Y, Ueki T, Sato M, Kameo K (2001) HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme. Br J Clin Pharmacol 133:325\u2013329", "journal-title": "Br J Clin Pharmacol"}, {"key": "9_CR1553", "doi-asserted-by": "crossref", "first-page": "766", "DOI": "10.1161/01.HYP.0000182658.04299.15", "volume": "46", "author": "B Mayer", "year": "2005", "unstructured": "Mayer B, Lieb W, Gotz A, Konig IR, Aherrahrou Z, Thiemig A, Holmer S, Hengstenberg C, Doering A, Loewel H, Hense HW, Schunkert H, Erdmann J (2005) Association of the T8590C polymorphism of CYP4A11 with hypertensionin the MONICA Augsburg echocardiographic substudy. Hypertension 46:766\u2013771", "journal-title": "Hypertension"}, {"key": "9_CR1554", "doi-asserted-by": "crossref", "first-page": "1965", "DOI": "10.1097/01.hjh.0000244944.34546.8e", "volume": "24", "author": "B Mayer", "year": "2006", "unstructured": "Mayer B, Lieb W, Gotz A, Konig IR, Kauschen LF, Linsel-Nitschke P, Pomarino A, Holmer S, Hengstenberg C, Doering A, Loewel H, Hense HW, Ziegler A, Erdmann J, Schunkert H (2006) Association of a functional polymorphism in the CYP4A11 gene with systolic blood pressure in survivors of myocardial infarction. J Hypertens 24:1965\u20131970", "journal-title": "J Hypertens"}, {"key": "9_CR1555", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1097/MNH.0b013e32827ab48c", "volume": "16", "author": "JH Capdevila", "year": "2007", "unstructured": "Capdevila JH (2007) Regulation of ion transport and blood pressure by cytochrome P450 monooxygenases. Curr Opin Nephrol Hypertens 16:465\u2013470", "journal-title": "Curr Opin Nephrol Hypertens"}, {"key": "9_CR1556", "doi-asserted-by": "crossref", "first-page": "767", "DOI": "10.1161/HYPERTENSIONAHA.107.102921", "volume": "51", "author": "CL Laffer", "year": "2008", "unstructured": "Laffer CL, Gainer JV, Waterman MR, Capdevila JH, Laniado-Schwartzman M, Nasjletti A, Brown NJ, Elijovich F (2008) The T8590C polymorphism of CYP4A11 and 20-hydroxyeicosatetraenoic acid in essential hypertension. Hypertension 51:767\u2013772", "journal-title": "Hypertension"}, {"key": "9_CR1557", "doi-asserted-by": "crossref", "first-page": "453", "DOI": "10.1097/HJH.0b013e3282f2f10c", "volume": "26", "author": "Z Fu", "year": "2008", "unstructured": "Fu Z, Nakayama T, Sato N, Izumi Y, Kasamaki Y, Shindo A, Ohta M, Soma M, Aoi N, Sato M, Ozawa Y, Ma Y (2008) A haplotype of the CYP4A11 gene associated with essential hypertension in Japanese men. J Hypertens 26:453\u2013461", "journal-title": "J Hypertens"}, {"key": "9_CR1558", "doi-asserted-by": "crossref", "first-page": "1606", "DOI": "10.1681/ASN.2008010063", "volume": "19", "author": "JV Gainer", "year": "2008", "unstructured": "Gainer JV, Lipkowitz MS, Yu C, Waterman MR, Dawson EP, Capdevila JH, Brown NJ (2008) Association of a CYP4A11 variant and blood pressure in black men. J Am Soc Nephrol 19:1606\u20131612", "journal-title": "J Am Soc Nephrol"}, {"key": "9_CR1559", "doi-asserted-by": "crossref", "first-page": "215", "DOI": "10.1007/s12020-008-9078-6", "volume": "33", "author": "Z Fu", "year": "2008", "unstructured": "Fu Z, Nakayama T, Sato N, Izumi Y, Kasamaki Y, Shindo A, Ohta M, Soma M, Aoi N, Sato M, Matsumoto K, Ozawa Y, Ma Y (2008) Haplotype-based case study of human CYP4A11 gene and cerebral infarction in Japanese subject. Endocrine 33:215\u2013222", "journal-title": "Endocrine"}, {"key": "9_CR1560", "doi-asserted-by": "crossref", "first-page": "1712", "DOI": "10.1097/HJH.0b013e3283000504", "volume": "26", "author": "F Elijovich", "year": "2008", "unstructured": "Elijovich F, Laffer CL (2008) The relationship between CYP4A11 and human hypertension. J Hypertens 26:1712\u20131714", "journal-title": "J Hypertens"}, {"key": "9_CR1561", "doi-asserted-by": "crossref", "first-page": "1142", "DOI": "10.1161/HYPERTENSIONAHA.108.114082", "volume": "52", "author": "K Sugimoto", "year": "2008", "unstructured": "Sugimoto K, Akasaka H, Katsuya T, Node K, Fujisawa T, Shimaoka I, Yasuda O, Ohishi M, Ogihara T, Shimamoto K, Rakugi H (2008) A polymorphism regulates CYP4A11 transcriptional activity and is associated with hypertension in a Japanese population. Hypertension 52:1142\u20131148", "journal-title": "Hypertension"}, {"key": "9_CR1562", "doi-asserted-by": "crossref", "first-page": "446", "DOI": "10.1016/j.pharmthera.2009.12.002", "volume": "125", "author": "BN Zordoky", "year": "2010", "unstructured": "Zordoky BN, El-Kadi AO (2010) Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases. Pharmacol Ther 125:446\u2013463", "journal-title": "Pharmacol Ther"}, {"key": "9_CR1563", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.1097/FPC.0b013e328336eefe", "volume": "20", "author": "H Ding", "year": "2010", "unstructured": "Ding H, Cui G, Zhang L, Xu Y, Bao X, Tu Y, Wu B, Wang Q, Hui R, Wang W, Dackor RT, Kissling GE, Zeldin DC, Wang DW (2010) Association of common variants of CYP4A11 and CYP4F2 with stroke in the Han Chinese population. Pharmacogenet Genomics 20:187\u2013194", "journal-title": "Pharmacogenet Genomics"}, {"key": "9_CR1564", "doi-asserted-by": "crossref", "first-page": "645", "DOI": "10.1038/hr.2011.8", "volume": "34", "author": "R Zhang", "year": "2011", "unstructured": "Zhang R, Lu J, Hu C, Wang C, Yu W, Ma X, Bao Y, Xiang K, Guan Y, Jia W (2011) A common polymorphism of CYP4A11 is associated with blood pressure in a Chinese population. Hypertens Res 34:645\u2013648", "journal-title": "Hypertens Res"}, {"key": "9_CR1565", "doi-asserted-by": "crossref", "first-page": "1913", "DOI": "10.1097/HJH.0b013e32834aa786", "volume": "29", "author": "JS Williams", "year": "2011", "unstructured": "Williams JS, Hopkins PN, Jeunemaitre X, Brown NJ (2011) CYP4A11 T8590C polymorphism, salt-sensitive hypertension, and renal blood flow. J Hypertens 29:1913\u20131918", "journal-title": "J Hypertens"}, {"key": "9_CR1566", "doi-asserted-by": "crossref", "first-page": "44", "DOI": "10.1038/tpj.2011.40", "volume": "13", "author": "CC White", "year": "2013", "unstructured": "White CC, Feng Q, Cupples LA, Gainer JV, Dawson EP, Wilke RA, Brown NJ (2013) CYP4A11 variant is associated with high-density lipoprotein cholesterol in women. Pharmacogenomics J 13:44\u201351", "journal-title": "Pharmacogenomics J"}, {"key": "9_CR1567", "doi-asserted-by": "crossref", "first-page": "60", "DOI": "10.1177/1076029611436197", "volume": "19", "author": "Z Fu", "year": "2013", "unstructured": "Fu Z, Ma Y, Xie X, Huang D, Yang H, Nakayama T, Sato N (2013) A novel polymorphism of the CYP4A11 gene is associated with coronary artery disease. Clin Appl Thromb Hemost 19:60\u201365", "journal-title": "Clin Appl Thromb Hemost"}, {"key": "9_CR1568", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1111/j.1601-5223.2012.02247.x", "volume": "149", "author": "Z Fu", "year": "2012", "unstructured": "Fu Z, Nakayama T, Sato N, Izumi Y, Kasamaki Y, Shindo A, Ohta M, Soma M, Aoi N, Sato M, Ozawa Y, Ma Y (2012) Haplotype-based case-control study of CYP4A11 gene and myocardial infarction. Hereditas 149:91\u201398", "journal-title": "Hereditas"}, {"key": "9_CR1569", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1097/CRD.0b013e3182961659", "volume": "22", "author": "CC Wu", "year": "2014", "unstructured": "Wu CC, Gupta T, Garcia V, Ding Y, Schwartzman ML (2014) 20-HETE and blood pressure regulation: clinical implications. Cardiol Rev 22:1\u201312", "journal-title": "Cardiol Rev"}, {"key": "9_CR1570", "unstructured": "Yang H, Fu Z, Ma Y, Huang D, Zhu Q, Erdenbat C, Xie X, Liu F, Zheng Y (2014) CYP4A11 gene T8590C polymorphism is associated with essential hypertension in the male western Chinese Han population. Clin Exp Hypertens, 36:398\u2013403", "DOI": "10.3109/10641963.2013.846353", "doi-asserted-by": "crossref"}, {"key": "9_CR1571", "doi-asserted-by": "crossref", "first-page": "e80072", "DOI": "10.1371/journal.pone.0080072", "volume": "8", "author": "HC Yan", "year": "2013", "unstructured": "Yan HC, Liu JH, Li J, He BX, Yang L, Qiu J, Li L, Ding DP, Shi L, Zhao SJ (2013) Association between the CYP4A11 T8590C variant and essential hypertension: new data from Han Chinese and a meta-analysis. PLoS One 8:e80072", "journal-title": "PLoS One"}, {"key": "9_CR1572", "doi-asserted-by": "crossref", "first-page": "1393", "DOI": "10.1161/HYPERTENSIONAHA.107.104463", "volume": "51", "author": "NC Ward", "year": "2008", "unstructured": "Ward NC, Tsai IJ, Barden A, van Bockxmeer FM, Puddey IB, Hodgson JM, Croft KD (2008) A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure. Hypertension 51:1393\u20131398", "journal-title": "Hypertension"}, {"key": "9_CR1573", "doi-asserted-by": "crossref", "first-page": "1696", "DOI": "10.1172/JCI27546", "volume": "116", "author": "K Nakagawa", "year": "2006", "unstructured": "Nakagawa K, Holla VR, Wei Y, Wang WH, Gatica A, Wei S, Mei S, Miller CM, Cha DR, Price E Jr, Zent R, Pozzi A, Breyer MD, Guan Y, Falck JR, Waterman MR, Capdevila JH (2006) Salt-sensitive hypertensionis associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel. J Clin Invest 116:1696\u20131702", "journal-title": "J Clin Invest"}, {"key": "9_CR1574", "doi-asserted-by": "crossref", "first-page": "p", "DOI": "10.1159/000235774", "volume": "113", "author": "R Quigley", "year": "2009", "unstructured": "Quigley R, Chakravarty S, Zhao X, Imig JD, Capdevila JH (2009) Increased renal proximal convoluted tubule transport contributes to hypertensionin Cyp4a14 knockout mice. Nephron Physiol 113:p23\u201328", "journal-title": "Nephron Physiol"}, {"key": "9_CR1575", "doi-asserted-by": "crossref", "first-page": "1288", "DOI": "10.1681/ASN.2012070714", "volume": "24", "author": "CC Wu", "year": "2013", "unstructured": "Wu CC, Mei S, Cheng J, Ding Y, Weidenhammer A, Garcia V, Zhang F, Gotlinger K, Manthati VL, Falck JR, Capdevila JH, Schwartzman ML (2013) Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase. J Am Soc Nephrol 24:1288\u20131296", "journal-title": "J Am Soc Nephrol"}, {"key": "9_CR1576", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.1161/HYPERTENSIONAHA.111.178475", "volume": "59", "author": "P Sun", "year": "2012", "unstructured": "Sun P, Antoun J, Lin DH, Yue P, Gotlinger KH, Capdevila J, Wang WH (2012) Cyp2c44 epoxygenase is essential for preventing the renal sodium absorption during increasing dietary potassium intake. Hypertension 59:339\u2013347", "journal-title": "Hypertension"}, {"key": "9_CR1577", "doi-asserted-by": "crossref", "first-page": "16541", "DOI": "10.1074/jbc.M902074200", "volume": "284", "author": "U S\u00e4vas", "year": "2009", "unstructured": "S\u00e4vas U, Machemer DE, Hsu MH, Gaynor P, Lasker JM, Tukey RH, Johnson EF (2009) Opposing roles of peroxisome proliferator-activated receptor \u03b1 and growth hormone in the regulation of CYP4A11 expression in a transgenic mouse model. J Biol Chem 284:16541\u201316552", "journal-title": "J Biol Chem"}, {"key": "9_CR1578", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1006/abbi.2000.1831", "volume": "378", "author": "H Kawashima", "year": "2000", "unstructured": "Kawashima H, Naganuma T, Kusunose E, Kono T, Yasumoto R, Sugimura K, Kishimoto T (2000) Human fatty acid \u03c9-hydroxylase, CYP4A11: determination of complete genomic sequence and characterization of purified recombinant protein. Arch Biochem Biophys 378:333\u2013339", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1579", "doi-asserted-by": "crossref", "first-page": "98", "DOI": "10.1016/j.mrfmmm.2006.02.008", "volume": "599", "author": "M Hiratsuka", "year": "2006", "unstructured": "Hiratsuka M, Nozawa H, Katsumoto Y, Moteki T, Sasaki T, Konno Y, Mizugaki M (2006) Genetic polymorphisms and haplotype structures of the CYP4A22 gene in a Japanese population. Mutat Res 599:98\u2013104", "journal-title": "Mutat Res"}, {"key": "9_CR1580", "doi-asserted-by": "crossref", "first-page": "524", "DOI": "10.1016/j.jmgm.2009.11.010", "volume": "28", "author": "P Gajendrarao", "year": "2010", "unstructured": "Gajendrarao P, Krishnamoorthy N, Sakkiah S, Lazar P, Lee KW (2010) Molecular modeling study on orphan human protein CYP4A22 for identification of potential ligand binding site. J Mol Graph Model 28:524\u2013532", "journal-title": "J Mol Graph Model"}, {"key": "9_CR1581", "doi-asserted-by": "crossref", "first-page": "8060", "DOI": "10.1021/bi00446a014", "volume": "28", "author": "PT Nhamburo", "year": "1989", "unstructured": "Nhamburo PT, Gonzalez FJ, McBride OW, Gelboin HV, Kimura S (1989) Identification of a new P450 expressed in human lung: complete cDNA sequence, cDNA-directed expression, and chromosome mapping. Biochemistry 28:8060\u20138066", "journal-title": "Biochemistry"}, {"key": "9_CR1582", "doi-asserted-by": "crossref", "first-page": "776", "DOI": "10.1006/bbrc.2000.3740", "volume": "277", "author": "S Imaoka", "year": "2000", "unstructured": "Imaoka S, Yoneda Y, Sugimoto T, Hiroi T, Yamamoto K, Nakatani T, Funae Y (2000) CYP4B1 is a possible risk factor for bladder cancer in humans. Biochem Biophys Res Commun 277:776\u2013780", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1583", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1023/A:1012526406741", "volume": "70", "author": "M Iscan", "year": "2001", "unstructured": "Iscan M, Klaavuniemi T, Coban T, Kapucuoglu N, Pelkonen O, Raunio H (2001) The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue. Breast Cancer Res Treat 70:47\u201354", "journal-title": "Breast Cancer Res Treat"}, {"key": "9_CR1584", "doi-asserted-by": "crossref", "first-page": "880", "DOI": "10.1046/j.1365-2362.2001.00893.x", "volume": "31", "author": "N Finnstrom", "year": "2001", "unstructured": "Finnstrom N, Bjelfman C, Soderstrom TG, Smith G, Egevad L, Norlen BJ, Wolf CR, Rane A (2001) Detection of cytochrome P450 mRNA transcripts in prostate samples by RT-PCR. Eur J Clin Invest 31:880\u2013886", "journal-title": "Eur J Clin Invest"}, {"key": "9_CR1585", "first-page": "1085", "volume": "54", "author": "M Czerwinski", "year": "1994", "unstructured": "Czerwinski M, McLemore TL, Gelboin HV, Gonzalez FJ (1994) Quantification of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors. Cancer Res 54:1085\u20131091", "journal-title": "Cancer Res"}, {"key": "9_CR1586", "doi-asserted-by": "crossref", "first-page": "451", "DOI": "10.1080/03602530600688503", "volume": "38", "author": "BR Baer", "year": "2006", "unstructured": "Baer BR, Rettie AE (2006) CYP4B1: an enigmatic P450 at the interface between xenobiotic and endobiotic metabolism. Drug Metab Rev 38:451\u2013476", "journal-title": "Drug Metab Rev"}, {"key": "9_CR1587", "doi-asserted-by": "crossref", "first-page": "1174", "DOI": "10.1124/dmd.105.004523", "volume": "33", "author": "MT Poch", "year": "2005", "unstructured": "Poch MT, Cutler NS, Yost GS, Hines RN (2005) Molecular mechanisms regulating human CYP4B1 lung-selective expression. Drug Metab Dispos 33:1174\u20131184", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1588", "doi-asserted-by": "crossref", "first-page": "367", "DOI": "10.1097/00008571-200207000-00004", "volume": "12", "author": "JM Lo-Guidice", "year": "2002", "unstructured": "Lo-Guidice JM, Allorge D, Cauffiez C, Chevalier D, Lafitte JJ, Lhermitte M, Broly F (2002) Genetic polymorphism of the human cytochrome P450 CYP4B1: evidence for a non-functional allelic variant. Pharmacogenetics 12:367\u2013374", "journal-title": "Pharmacogenetics"}, {"key": "9_CR1589", "doi-asserted-by": "crossref", "first-page": "634", "DOI": "10.1093/jjco/hyn081", "volume": "38", "author": "T Sasaki", "year": "2008", "unstructured": "Sasaki T, Horikawa M, Orikasa K, Sato M, Arai Y, Mitachi Y, Mizugaki M, Ishikawa M, Hiratsuka M (2008) Possible relationship between the risk of Japanese bladder cancer cases and the CYP4B1 genotype. Jpn J Clin Oncol 38:634\u2013640", "journal-title": "Jpn J Clin Oncol"}, {"key": "9_CR1590", "doi-asserted-by": "crossref", "first-page": "757", "DOI": "10.1006/bbrc.2001.5055", "volume": "284", "author": "S Imaoka", "year": "2001", "unstructured": "Imaoka S, Hayashi K, Hiroi T, Yabusaki Y, Kamataki T, Funae Y (2001) A transgenic mouse expressing human CYP4B1 in the liver. Biochem Biophys Res Commun 284:757\u2013762", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1591", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1093/toxsci/kft123", "volume": "134", "author": "OT Parkinson", "year": "2013", "unstructured": "Parkinson OT, Liggitt HD, Rettie AE, Kelly EJ (2013) Generation and characterization of a Cyp4b1 null mouse and the role of CYP4B1 in the activation and toxicity of ipomeanol. Toxicol Sci 134:243\u2013250", "journal-title": "Toxicol Sci"}, {"key": "9_CR1592", "doi-asserted-by": "crossref", "first-page": "11598", "DOI": "10.1021/bi701064b", "volume": "46", "author": "BR Baer", "year": "2007", "unstructured": "Baer BR, Kunze KL, Rettie AE (2007) Mechanism of formation of the ester linkage between heme and Glu310 of CYP4B1: 18O protein labeling studies. Biochemistry 46:11598\u201311605", "journal-title": "Biochemistry"}, {"key": "9_CR1593", "doi-asserted-by": "crossref", "first-page": "1261", "DOI": "10.1089/hum.1998.9.9-1261", "volume": "9", "author": "NG Rainov", "year": "1998", "unstructured": "Rainov NG, Dobberstein KU, Sena-Esteves M, Herrlinger U, Kramm CM, Philpot RM, Hilton J, Chiocca EA, Breakefield XO (1998) New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol. Hum Gene Ther 9:1261\u20131273", "journal-title": "Hum Gene Ther"}, {"key": "9_CR1594", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1016/0014-5793(94)00587-7", "volume": "348", "author": "Y Kikuta", "year": "1994", "unstructured": "Kikuta Y, Kusunose E, Kondo T, Yamamoto S, Kinoshita H, Kusunose M (1994) Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. FEBS Lett 348:70\u201374", "journal-title": "FEBS Lett"}, {"key": "9_CR1595", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1016/S0090-6980(02)00039-4", "volume": "68\u201369", "author": "Y Kikuta", "year": "2002", "unstructured": "Kikuta Y, Kusunose E, Kusunose M (2002) Prostaglandin and leukotriene omega-hydroxylases. Prostaglandins Other Lipid Mediat 68\u201369:345\u2013362", "journal-title": "Prostaglandins Other Lipid Mediat"}, {"key": "9_CR1596", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1006/abbi.1998.0880", "volume": "359", "author": "R Jin", "year": "1998", "unstructured": "Jin R, Koop DR, Raucy JL, Lasker JM (1998) Role of human CYP4F2 in hepatic catabolism of the proinflammatory agent leukotriene B4. Arch Biochem Biophys 359:89\u201398", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1597", "doi-asserted-by": "crossref", "first-page": "5225", "DOI": "10.1074/jbc.M608176200", "volume": "282", "author": "MH Hsu", "year": "2007", "unstructured": "Hsu MH, S\u00e4vas U, Griffin KJ, Johnson EF (2007) Regulation of human cytochrome P450 4F2 expression by sterol regulatory element-binding protein and lovastatin. J Biol Chem 282:5225\u20135236", "journal-title": "J Biol Chem"}, {"key": "9_CR1598", "doi-asserted-by": "crossref", "first-page": "74", "DOI": "10.1152/physiolgenomics.00003.2007", "volume": "30", "author": "DE Stec", "year": "2007", "unstructured": "Stec DE, Roman RJ, Flasch A, Rieder MJ (2007) Functional polymorphism in human CYP4F2 decreases 20-HETE production. Physiol Genomics 30:74\u201381", "journal-title": "Physiol Genomics"}, {"key": "9_CR1599", "doi-asserted-by": "crossref", "first-page": "4106", "DOI": "10.1182/blood-2007-11-122010", "volume": "111", "author": "MD Caldwell", "year": "2008", "unstructured": "Caldwell MD, Awad T, Johnson JA, Gage BF, Falkowski M, Gardina P, Hubbard J, Turpaz Y, Langaee TY, Eby C, King CR, Brower A, Schmelzer JR, Glurich I, Vidaillet HJ, Yale SH, Qi Zhang K, Berg RL, Burmester JK (2008) CYP4F2 genetic variant alters required warfarin dose. Blood 111:4106\u20134112", "journal-title": "Blood"}, {"key": "9_CR1600", "doi-asserted-by": "crossref", "first-page": "8276", "DOI": "10.1021/bi401208m", "volume": "52", "author": "KZ Edson", "year": "2013", "unstructured": "Edson KZ, Prasad B, Unadkat JD, Suhara Y, Okano T, Guengerich FP, Rettie AE (2013) Cytochrome P450-dependent catabolism of vitamin K: \u03c9-hydroxylation catalyzed by human CYP4F2 and CYP4F11. Biochemistry 52:8276\u20138285", "journal-title": "Biochemistry"}, {"key": "9_CR1601", "doi-asserted-by": "crossref", "first-page": "723", "DOI": "10.1089/104454999315006", "volume": "18", "author": "Y Kikuta", "year": "1999", "unstructured": "Kikuta Y, Miyauchi Y, Kusunose E, Kusunose M (1999) Expression and molecular cloning of human liver leukotriene B4 \u03c9-hydroxylase (CYP4F2) gene. DNA Cell Biol 18:723\u2013730", "journal-title": "DNA Cell Biol"}, {"key": "9_CR1602", "doi-asserted-by": "crossref", "first-page": "1047", "DOI": "10.1093/oxfordjournals.jbchem.a022696", "volume": "127", "author": "Y Kikuta", "year": "2000", "unstructured": "Kikuta Y, Kusunose E, Kusunose M (2000) Characterization of human liver leukotriene B4 \u03c9-hydroxylase P450 (CYP4F2). J Biochem (Tokyo) 127:1047\u20131052", "journal-title": "J Biochem (Tokyo)"}, {"key": "9_CR1603", "doi-asserted-by": "crossref", "first-page": "1985", "DOI": "10.1124/dmd.106.010587", "volume": "34", "author": "MZ Wang", "year": "2006", "unstructured": "Wang MZ, Saulter JY, Usuki E, Cheung YL, Hall M, Bridges AS, Loewen G, Parkinson OT, Stephens CE, Allen JL, Zeldin DC, Boykin DW, Tidwell RR, Parkinson A, Paine MF, Hall JE (2006) CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime]. Drug Metab Dispos 34:1985\u20131994", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1604", "doi-asserted-by": "crossref", "first-page": "191", "DOI": "10.1124/dmd.110.035378", "volume": "39", "author": "Y Jin", "year": "2011", "unstructured": "Jin Y, Zollinger M, Borell H, Zimmerlin A, Patten CJ (2011) CYP4F enzymes are responsible for the elimination of fingolimod (FTY720), a novel treatment of relapsing multiple sclerosis. Drug Metab Dispos 39:191\u2013198", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1605", "doi-asserted-by": "crossref", "first-page": "1337", "DOI": "10.1124/mol.109.054833", "volume": "75", "author": "MG McDonald", "year": "2009", "unstructured": "McDonald MG, Rieder MJ, Nakano M, Hsia CK, Rettie AE (2009) CYP4F2 is a vitamin K1 oxidase: an explanation for altered warfarin dose in carriers of the V433M variant. Mol Pharmacol 75:1337\u20131346", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1606", "doi-asserted-by": "crossref", "first-page": "1901", "DOI": "10.3945/jn.110.128579", "volume": "140", "author": "SA Bardowell", "year": "2010", "unstructured": "Bardowell SA, Stec DE, Parker RS (2010) Common variants of cytochrome P450 4F2 exhibit altered vitamin E-\u03c9-hydroxylase specific activity. J Nutr 140:1901\u20131906", "journal-title": "J Nutr"}, {"key": "9_CR1607", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1007/s11239-013-0940-x", "volume": "37", "author": "V Tatarunas", "year": "2014", "unstructured": "Tatarunas V, Lesauskaite V, Veikutiene A, Grybauskas P, Jakuska P, Jankauskiene L, Bartuseviciute R, Benetis R (2014) The effect of CYP2C9, VKORC1 and CYP4F2 polymorphism and of clinical factors on warfarin dosage during initiation and long-term treatment after heart valve surgery. J Thromb Thrombolysis 37:177\u2013185", "journal-title": "J Thromb Thrombolysis"}, {"key": "9_CR1608", "doi-asserted-by": "crossref", "first-page": "407", "DOI": "10.1007/s00204-013-1013-9", "volume": "87", "author": "AK Daly", "year": "2013", "unstructured": "Daly AK (2013) Optimal dosing of warfarin and other coumarin anticoagulants: the role of genetic polymorphisms. Arch Toxicol 87:407\u2013420", "journal-title": "Arch Toxicol"}, {"key": "9_CR1609", "doi-asserted-by": "crossref", "first-page": "746", "DOI": "10.1038/clpt.2012.184", "volume": "92", "author": "E Danese", "year": "2012", "unstructured": "Danese E, Montagnana M, Johnson JA, Rettie AE, Zambon CF, Lubitz SA, Suarez-Kurtz G, Cavallari LH, Zhao L, Huang M, Nakamura Y, Mushiroda T, Kringen MK, Borgiani P, Ciccacci C, Au NT, Langaee T, Siguret V, Loriot MA, Sagreiya H, Altman RB, Shahin MH, Scott SA, Khalifa SI, Chowbay B, Suriapranata IM, Teichert M, Stricker BH, Taljaard M, Botton MR, Zhang JE, Pirmohamed M, Zhang X, Carlquist JF, Horne BD, Lee MT, Pengo V, Guidi GC, Minuz P, Fava C (2012) Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis. Clin Pharmacol Ther 92:746\u2013756", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR1610", "doi-asserted-by": "crossref", "first-page": "38", "DOI": "10.1016/j.thromres.2011.11.043", "volume": "130", "author": "R Liang", "year": "2012", "unstructured": "Liang R, Wang C, Zhao H, Huang J, Hu D, Sun Y (2012) Influence of CYP4F2 genotype on warfarin dose requirement-a systematic review and meta-analysis. Thromb Res 130:38\u201344", "journal-title": "Thromb Res"}, {"key": "9_CR1611", "first-page": "9376", "volume": "268", "author": "Y Kikuta", "year": "1993", "unstructured": "Kikuta Y, Kusunose E, Endo K, Yamamoto S, Sogawa K, Fujii-Kuriyama Y, Kusunose M (1993) A novel form of cytochrome P-450 family 4 in human polymorphonuclear leukocytes: cDNA cloning and expression of leukotriene B4 \u03c9-hydroxylase. J Biol Chem 268:9376\u20139380", "journal-title": "J Biol Chem"}, {"key": "9_CR1612", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1515/dmdi-2011-0037", "volume": "27", "author": "L Corcos", "year": "2012", "unstructured": "Corcos L, Lucas D, Le Jossic-Corcos C, Dreano Y, Simon B, Plee-Gautier E, Amet Y, Salaun JP (2012) Human cytochrome P450 4F3: structure, functions, and prospects. Drug Metab Drug Interact 27:63\u201371", "journal-title": "Drug Metab Drug Interact"}, {"key": "9_CR1613", "doi-asserted-by": "crossref", "first-page": "21191", "DOI": "10.1074/jbc.274.30.21191", "volume": "274", "author": "P Christmas", "year": "1999", "unstructured": "Christmas P, Ursino SR, Fox JW, Soberman RJ (1999) Expression of the CYP4F3 gene. J Biol Chem 274:21191\u201321199", "journal-title": "J Biol Chem"}, {"key": "9_CR1614", "first-page": "38166", "volume": "276", "author": "P Christmas", "year": "2001", "unstructured": "Christmas P, Jones JP, Patten CJ, Rock DA, Zheng Y, Cheng SM, Weber BM, Carlesso N, Scadden DT, Rettie AE, Soberman RJ (2001) Alternative splicing determines the function of CYP4F3 by switching substrate specificity. J Biol Chem 276:38166\u201338172", "journal-title": "J Biol Chem"}, {"key": "9_CR1615", "doi-asserted-by": "crossref", "first-page": "2135", "DOI": "10.1194/jlr.M800043-JLR200", "volume": "49", "author": "J Antoun", "year": "2008", "unstructured": "Antoun J, Goulitquer S, Amet Y, Dreano Y, Salaun JP, Corcos L, Plee-Gautier E (2008) CYP4F3B is induced by PGA1 in human liver cells: a regulation of the 20-HETE synthesis. J Lipid Res 49:2135\u20132141", "journal-title": "J Lipid Res"}, {"key": "9_CR1616", "doi-asserted-by": "crossref", "first-page": "282", "DOI": "10.1124/dmd.108.023192", "volume": "37", "author": "Z Zhao", "year": "2009", "unstructured": "Zhao Z, He X, Bi Y, Xia Y, Tao N, Li L, Ma Q (2009) Induction of CYP4F3 by benzene metabolites in human white blood cells in vivo in human promyelocytic leukemic cell lines and ex vivo in human blood neutrophils. Drug Metab Dispos 37:282\u2013291", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1617", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1016/j.cbi.2009.12.024", "volume": "184", "author": "Y Bi", "year": "2010", "unstructured": "Bi Y, Li Y, Kong M, Xiao X, Zhao Z, He X, Ma Q (2010) Gene expression in benzene-exposed workers by microarray analysis of peripheral mononuclear blood cells: induction and silencing of CYP4F3A and regulation of DNA-dependent protein kinase catalytic subunit in DNA double strand break repair. Chem Biol Interact 184:207\u2013211", "journal-title": "Chem Biol Interact"}, {"key": "9_CR1618", "doi-asserted-by": "crossref", "first-page": "1987", "DOI": "10.1124/dmd.110.036848", "volume": "39", "author": "S Madec", "year": "2011", "unstructured": "Madec S, Cerec V, Plee-Gautier E, Antoun J, Glaise D, Salaun JP, Guguen-Guillouzo C, Corlu A (2011) CYP4F3B expression is associated with differentiation of HepaRG human hepatocytes and unaffected by fatty acid overload. Drug Metab Dispos 39:1987\u20131996", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1619", "doi-asserted-by": "crossref", "first-page": "571", "DOI": "10.1016/j.bcp.2012.05.012", "volume": "84", "author": "E Plee-Gautier", "year": "2012", "unstructured": "Plee-Gautier E, Antoun J, Goulitquer S, Le Jossic-Corcos C, Simon B, Amet Y, Salaun JP, Corcos L (2012) Statins increase cytochrome P450 4F3-mediated eicosanoids production in human liver cells: a PXR dependent mechanism. Biochem Pharmacol 84:571\u2013579", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR1620", "doi-asserted-by": "crossref", "first-page": "104", "DOI": "10.1016/j.bbrc.2003.12.062", "volume": "314", "author": "Y Mizukami", "year": "2004", "unstructured": "Mizukami Y, Sumimoto H, Takeshige K (2004) Induction of cytochrome CYP4F3A in all-trans-retinoic acid-treated HL60 cells. Biochem Biophys Res Commun 314:104\u2013109", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1621", "doi-asserted-by": "crossref", "first-page": "e15672", "DOI": "10.1371/journal.pone.0015672", "volume": "5", "author": "I Costea", "year": "2010", "unstructured": "Costea I, Mack DR, Israel D, Morgan K, Krupoves A, Seidman E, Deslandres C, Lambrette P, Grimard G, Levy E, Amre DK (2010) Genes involved in the metabolism of poly-unsaturated fattyacids (PUFA) and risk for Crohn\u2019s disease in children & young adults. PLoS One 5:e15672", "journal-title": "PLoS One"}, {"key": "9_CR1622", "doi-asserted-by": "crossref", "first-page": "12925", "DOI": "10.1021/bi011171z", "volume": "40", "author": "KR Henne", "year": "2001", "unstructured": "Henne KR, Kunze KL, Zheng YM, Christmas P, Soberman RJ, Rettie AE (2001) Covalent linkage of prosthetic heme to CYP4 family P450 enzymes. Biochemistry 40:12925\u201312931", "journal-title": "Biochemistry"}, {"key": "9_CR1623", "doi-asserted-by": "crossref", "first-page": "188", "DOI": "10.1016/S0003-9861(02)00511-8", "volume": "409", "author": "K Stark", "year": "2003", "unstructured": "Stark K, Torma H, Cristea M, E HO (2003) Expression of CYP4F8 (prostaglandin H 19-hydroxylase) in human epithelia and prominent induction in epidermis of psoriatic lesions. Arch Biochem Biophys 409:188\u2013196", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1624", "doi-asserted-by": "crossref", "first-page": "114", "DOI": "10.1016/j.prostaglandins.2005.12.003", "volume": "79", "author": "K Stark", "year": "2006", "unstructured": "Stark K, Torma H, Oliw EH (2006) Co-localization of COX-2, CYP4F8, and mPGES-1 in epidermis with prominent expression of CYP4F8 mRNA in psoriatic lesions. Prostaglandins Other Lipid Mediat 79:114\u2013125", "journal-title": "Prostaglandins Other Lipid Mediat"}, {"key": "9_CR1625", "doi-asserted-by": "crossref", "first-page": "191", "DOI": "10.1097/FPC.0b013e32834fdd41", "volume": "22", "author": "S Aslibekyan", "year": "2012", "unstructured": "Aslibekyan S, Kabagambe EK, Irvin MR, Straka RJ, Borecki IB, Tiwari HK, Tsai MY, Hopkins PN, Shen J, Lai CQ, Ordovas JM, Arnett DK (2012) A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the genetics of lipid lowering drug and diet network. Pharmacogenet Genomics 22:191\u2013197", "journal-title": "Pharmacogenet Genomics"}, {"key": "9_CR1626", "doi-asserted-by": "crossref", "first-page": "21844", "DOI": "10.1074/jbc.M001712200", "volume": "275", "author": "J Bylund", "year": "2000", "unstructured": "Bylund J, Hidestrand M, Ingelman-Sundberg M, Oliw EH (2000) Identification of CYP4F8 in human seminal vesicles as a prominent 19-hydroxylase of prostaglandin endoperoxides. J Biol Chem 275:21844\u201321849", "journal-title": "J Biol Chem"}, {"key": "9_CR1627", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1016/j.abb.2009.11.013", "volume": "494", "author": "T Nilsson", "year": "2010", "unstructured": "Nilsson T, Ivanov IV, Oliw EH (2010) LC-MS/MS analysis of epoxyalcohols and epoxides of arachidonic acid and their oxygenation by recombinant CYP4F8 and CYP4F22. Arch Biochem Biophys 494:64\u201371", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1628", "doi-asserted-by": "crossref", "first-page": "525", "DOI": "10.1016/j.ajpath.2010.10.002", "volume": "178", "author": "P Vainio", "year": "2011", "unstructured": "Vainio P, Gupta S, Ketola K, Mirtti T, Mpindi JP, Kohonen P, Fey V, Perala M, Smit F, Verhaegh G, Schalken J, Alanen KA, Kallioniemi O, Iljin K (2011) Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer. Am J Pathol 178:525\u2013536", "journal-title": "Am J Pathol"}, {"key": "9_CR1629", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1006/geno.2000.6276", "volume": "68", "author": "X Cui", "year": "2000", "unstructured": "Cui X, Nelson DR, Strobel HW (2000) A novel human cytochrome P450 4F isoform (CYP4F11): cDNA cloning, expression, and genomic structural characterization. Genomics 68:161\u2013166", "journal-title": "Genomics"}, {"key": "9_CR1630", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1124/dmd.109.029025", "volume": "38", "author": "Y Wang", "year": "2010", "unstructured": "Wang Y, Bell JC, Keeney DS, Strobel HW (2010) Gene regulation of CYP4F11 in human keratinocyte HaCaT cells. Drug Metab Dispos 38:100\u2013107", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1631", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1124/dmd.111.041178", "volume": "40", "author": "JC Bell", "year": "2012", "unstructured": "Bell JC, Strobel HW (2012) Regulation of cytochrome P450 4F11 by nuclear transcription factor-kB. Drug Metab Dispos 40:205\u2013211", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1632", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1016/j.taap.2003.12.033", "volume": "199", "author": "A Kalsotra", "year": "2004", "unstructured": "Kalsotra A, Turman CM, Kikuta Y, Strobel HW (2004) Expression and characterization of human cytochrome P450 4F11: putative role in the metabolism of therapeutic drugs and eicosanoids. Toxicol Appl Pharmacol 199:295\u2013304", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "9_CR1633", "doi-asserted-by": "crossref", "first-page": "612", "DOI": "10.1194/jlr.M700450-JLR200", "volume": "49", "author": "M Dhar", "year": "2008", "unstructured": "Dhar M, Sepkovic DW, Hirani V, Magnusson RP, Lasker JM (2008) Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. J Lipid Res 49:612\u2013624", "journal-title": "J Lipid Res"}, {"key": "9_CR1634", "doi-asserted-by": "crossref", "first-page": "86", "DOI": "10.1016/j.abb.2009.11.017", "volume": "494", "author": "Z Tang", "year": "2010", "unstructured": "Tang Z, Salamanca-Pinzon SG, Wu ZL, Xiao Y, Guengerich FP (2010) Human cytochrome P450 4F11: heterologous expression in bacteria, purification, and characterization of catalytic function. Arch Biochem Biophys 494:86\u201393", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1635", "unstructured": "Parker RS, Xiao Y, Guengerich FP (2015) \u03c9-Oxidation of vitamin E by P450s 4F2 and 4F11. Drug Metab Dispos (in preparation)"}, {"key": "9_CR1636", "doi-asserted-by": "crossref", "first-page": "892", "DOI": "10.1006/bbrc.2000.4191", "volume": "280", "author": "J Bylund", "year": "2001", "unstructured": "Bylund J, Bylund M, Oliw EH (2001) cDNA cloning and expression of CYP4F12, a novel human cytochrome P450. Biochem Biophys Res Commun 280:892\u2013897", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1637", "doi-asserted-by": "crossref", "first-page": "1135", "DOI": "10.1006/bbrc.2000.4238", "volume": "280", "author": "T Hashizume", "year": "2001", "unstructured": "Hashizume T, Imaoka S, Hiroi T, Terauchi Y, Fujii T, Miyazaki H, Kamataki T, Funae Y (2001) cDNA cloning and expression of a novel cytochrome P450 (CYP4F12) from human small intestine. Biochem Biophys Res Commun 280:1135\u20131141", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1638", "first-page": "798", "volume": "29", "author": "T Hashizume", "year": "2001", "unstructured": "Hashizume T, Mise M, Matsumoto S, Terauchi Y, Fujii T, Imaoka S, Funae Y, Kamataki T, Miyazaki H (2001) A novel cytochrome P450 enzyme responsible for the metabolism of ebastine in monkey small intestine. Drug Metab Dispos 29:798\u2013805", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1639", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1111/j.1742-7843.2004.pto940404.x", "volume": "94", "author": "K Stark", "year": "2004", "unstructured": "Stark K, Schauer L, Sahlen GE, Ronquist G, Oliw EH (2004) Expression of CYP4F12 in gastrointestinal and urogenital epithelia. Basic Clin Pharmacol Toxicol 94:177\u2013183", "journal-title": "Basic Clin Pharmacol Toxicol"}, {"key": "9_CR1640", "doi-asserted-by": "crossref", "first-page": "1160", "DOI": "10.1093/nar/gkn1047", "volume": "37", "author": "N Hariparsad", "year": "2009", "unstructured": "Hariparsad N, Chu X, Yabut J, Labhart P, Hartley DP, Dai X, Evers R (2009) Identification of pregnane-X receptor target genes and coactivator and corepressor binding to promoter elements in human hepatocytes. Nucleic Acids Res 37:1160\u20131173", "journal-title": "Nucleic Acids Res"}, {"key": "9_CR1641", "doi-asserted-by": "crossref", "first-page": "2417", "DOI": "10.1016/j.bcp.2004.08.025", "volume": "68", "author": "C Cauffiez", "year": "2004", "unstructured": "Cauffiez C, Klinzig F, Rat E, Tournel G, Allorge D, Chevalier D, Pottier N, Lovecchio T, Colombel JF, Lhermitte M, Lo-Guidice JM, Broly F (2004) Human CYP4F12 genetic polymorphism: identification and functional characterization of seven variant allozymes. Biochem Pharmacol 68:2417\u20132425", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR1642", "doi-asserted-by": "crossref", "first-page": "174", "DOI": "10.1016/j.abb.2005.07.003", "volume": "441", "author": "K Stark", "year": "2005", "unstructured": "Stark K, Wongsud B, Burman R, Oliw EH (2005) Oxygenation of polyunsaturated long chain fatty acidsby recombinant CYP4F8 and CYP4F12 and catalytic importance of Tyr-125 and Gly-328 of CYP4F8. Arch Biochem Biophys 441:174\u2013181", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1643", "doi-asserted-by": "crossref", "first-page": "124", "DOI": "10.1124/mi.11.2.10", "volume": "11", "author": "EJ Kelly", "year": "2011", "unstructured": "Kelly EJ, Nakano M, Rohatgi P, Yarov-Yarovoy V, Rettie AE (2011) Finding homes for orphan cytochrome P450s: CYP4V2 and CYP4F22 in disease states. Mol Interv 11:124\u2013132", "journal-title": "Mol Interv"}, {"key": "9_CR1644", "doi-asserted-by": "crossref", "first-page": "156", "DOI": "10.1016/j.jdermsci.2011.12.006", "volume": "65", "author": "K Sasaki", "year": "2012", "unstructured": "Sasaki K, Akiyama M, Yanagi T, Sakai K, Miyamura Y, Sato M, Shimizu H (2012) CYP4F22 is highly expressed at the site and timing of onset of keratinization during skin development. J Dermatol Sci 65:156\u2013158", "journal-title": "J Dermatol Sci"}, {"key": "9_CR1645", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1016/j.jdermsci.2013.06.008", "volume": "72", "author": "K Sugiura", "year": "2013", "unstructured": "Sugiura K, Takeichi T, Tanahashi K, Ito Y, Kosho T, Saida K, Uhara H, Okuyama R, Akiyama M (2013) Lamellar ichthyosis in a collodion baby caused by CYP4F22 mutations in a non-consanguineous family outside the Mediterranean. J Dermatol Sci 72:193\u2013195", "journal-title": "J Dermatol Sci"}, {"key": "9_CR1646", "doi-asserted-by": "crossref", "first-page": "911", "DOI": "10.1111/ced.12148", "volume": "38", "author": "S Israeli", "year": "2013", "unstructured": "Israeli S, Goldberg I, Fuchs-Telem D, Bergman R, Indelman M, Bitterman-Deutsch O, Harel A, Mashiach Y, Sarig O, Sprecher E (2013) Non-syndromic autosomal recessive congenital ichthyosis in the Israeli population. Clin Exp Dermatol 38:911\u2013916", "journal-title": "Clin Exp Dermatol"}, {"key": "9_CR1647", "doi-asserted-by": "crossref", "first-page": "270", "DOI": "10.1016/j.ad.2011.11.015", "volume": "104", "author": "L Rodriguez-Pazos", "year": "2013", "unstructured": "Rodriguez-Pazos L, Ginarte M, Vega A, Toribio J (2013) Autosomal recessive congenital ichthyosis. Actas Dermosifiliogr 104:270\u2013284", "journal-title": "Actas Dermosifiliogr"}, {"key": "9_CR1648", "doi-asserted-by": "crossref", "first-page": "3493", "DOI": "10.1111/j.1742-4658.2007.05908.x", "volume": "274", "author": "S Nigam", "year": "2007", "unstructured": "Nigam S (2007) Hepoxilins: novel enzymatic pathways and clinical significance. FEBS J 274:3493", "journal-title": "FEBS J"}, {"key": "9_CR1649", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.6026/97320630007207", "volume": "7", "author": "S Kumar", "year": "2011", "unstructured": "Kumar S (2011) Molecular modeling and identification of substrate binding site of orphan human cytochrome P450 4F22. Bioinformation 7:207\u2013210", "journal-title": "Bioinformation"}, {"key": "9_CR1650", "doi-asserted-by": "crossref", "first-page": "906", "DOI": "10.1111/j.1365-2133.2011.10454.x", "volume": "165", "author": "L Rodriguez-Pazos", "year": "2011", "unstructured": "Rodriguez-Pazos L, Ginarte M, Fachal L, Toribio J, Carracedo A, Vega A (2011) Analysis of TGM1, ALOX12B, ALOXE3, NIPAL4 and CYP4F22 in autosomal recessive congenital ichthyosis from Galicia (NW Spain): evidence of founder effects. Br J Dermatol 165:906\u2013911", "journal-title": "Br J Dermatol"}, {"key": "9_CR1651", "doi-asserted-by": "crossref", "first-page": "817", "DOI": "10.1086/383228", "volume": "74", "author": "A Li", "year": "2004", "unstructured": "Li A, Jiao X, Munier FL, Schorderet DF, Yao W, Iwata F, Hayakawa M, Kanai A, Shy Chen M, Alan Lewis R, Heckenlively J, Weleber RG, Traboulsi EI, Zhang Q, Xiao X, Kaiser-Kupfer M, Sergeev YV, Hejtmancik JF (2004) Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. Am J Hum Genet 74:817\u2013826", "journal-title": "Am J Hum Genet"}, {"key": "9_CR1652", "doi-asserted-by": "crossref", "first-page": "679", "DOI": "10.1124/mol.112.080085", "volume": "82", "author": "M Nakano", "year": "2012", "unstructured": "Nakano M, Kelly EJ, Wiek C, Hanenberg H, Rettie AE (2012) CYP4V2 in Bietti\u2019s crystalline dystrophy: ocular localization, metabolism of \u03c9-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant. Mol Pharmacol 82:679\u2013686", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1653", "doi-asserted-by": "crossref", "first-page": "1002", "DOI": "10.1097/ICO.0b013e31828a27bc", "volume": "32", "author": "GP Garcia-Garcia", "year": "2013", "unstructured": "Garcia-Garcia GP, Lopez-Garrido MP, Martinez-Rubio M, Moya-Moya MA, Belmonte-Martinez J, Escribano J (2013) Genotype-phenotype analysis of Bietti crystalline dystrophy in a family with the CYP4V2 Ile111Thr mutation. Cornea 32:1002\u20131008", "journal-title": "Cornea"}, {"key": "9_CR1654", "doi-asserted-by": "crossref", "first-page": "2119", "DOI": "10.1124/dmd.109.028530", "volume": "37", "author": "M Nakano", "year": "2009", "unstructured": "Nakano M, Kelly EJ, Rettie AE (2009) Expression and characterization of CYP4V2 as a fatty acid \u03c9-hydroxylase. Drug Metab Dispos 37:2119\u20132122", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1655", "doi-asserted-by": "crossref", "first-page": "360", "DOI": "10.6026/97320630007360", "volume": "7", "author": "S Kumar", "year": "2011", "unstructured": "Kumar S (2011) Comparative modeling and molecular docking of orphan human CYP4V2 protein with fatty acid substrates: insights into substrate specificity. Bioinformation 7:360\u2013365", "journal-title": "Bioinformation"}, {"key": "9_CR1656", "doi-asserted-by": "crossref", "first-page": "3706", "DOI": "10.1111/j.1742-4658.2008.06518.x", "volume": "275", "author": "K Stark", "year": "2008", "unstructured": "Stark K, Dostalek M, Guengerich FP (2008) Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide. FEBS J 275:3706\u20133717", "journal-title": "FEBS J"}, {"key": "9_CR1657", "doi-asserted-by": "crossref", "first-page": "2357", "DOI": "10.1158/0008-5472.CAN-03-0849", "volume": "64", "author": "MA Rieger", "year": "2004", "unstructured": "Rieger MA, Ebner R, Bell DR, Kiessling A, Rohayem J, Schmitz M, Temme A, Rieber EP, Weigle B (2004) Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma. Cancer Res 64:2357\u20132364", "journal-title": "Cancer Res"}, {"key": "9_CR1658", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1016/j.taap.2012.07.019", "volume": "264", "author": "W Yu", "year": "2012", "unstructured": "Yu W, Chai H, Li Y, Zhao H, Xie X, Zheng H, Wang C, Wang X, Yang G, Cai X, Falck JR, Yang J (2012) Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer. Toxicol Appl Pharmacol 264:73\u201383", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "9_CR1659", "doi-asserted-by": "crossref", "first-page": "918", "DOI": "10.1309/AJCPF3QWIG8FWXIH", "volume": "137", "author": "A Tradonsky", "year": "2012", "unstructured": "Tradonsky A, Rubin T, Beck R, Ring B, Seitz R, Mair S (2012) A search for reliable molecular markers of prognosis in prostate cancer: a study of 240 cases. Am J Clin Pathol 137:918\u2013930", "journal-title": "Am J Clin Pathol"}, {"key": "9_CR1660", "doi-asserted-by": "crossref", "first-page": "7369", "DOI": "10.1158/1078-0432.CCR-05-0466", "volume": "11", "author": "D Downie", "year": "2005", "unstructured": "Downie D, McFadyen MC, Rooney PH, Cruickshank ME, Parkin DE, Miller ID, Telfer C, Melvin WT, Murray GI (2005) Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Clin Cancer Res 11:7369\u20137375", "journal-title": "Clin Cancer Res"}, {"key": "9_CR1661", "doi-asserted-by": "crossref", "first-page": "313", "DOI": "10.1515/BC.2009.030", "volume": "390", "author": "A Z\u00f6llner", "year": "2009", "unstructured": "Z\u00f6llner A, Dragan CA, Pistorius D, Muller R, Bode HB, Peters FT, Maurer HH, Bureik M (2009) Human CYP4Z1 catalyzes the in-chain hydroxylation of lauric acid and myristic acid. Biol Chem 390:313\u2013317", "journal-title": "Biol Chem"}, {"key": "9_CR1662", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1016/S0003-9861(02)00410-1", "volume": "409", "author": "V Ullrich", "year": "2003", "unstructured": "Ullrich V (2003) Thoughts on thiolate tethering. Tribute and thanks to a teacher. Arch Biochem Biophys 409:45\u201351", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1663", "doi-asserted-by": "crossref", "first-page": "1479", "DOI": "10.1016/0006-291X(91)91060-P", "volume": "178", "author": "C Yokoyama", "year": "1991", "unstructured": "Yokoyama C, Miyata A, Ihara H, Ullrich V, Tanabe T (1991) Molecular cloning of human platelet thromboxane A synthase. Biochem Biophys Res Commun 178:1479\u20131484", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1664", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1111/j.1432-1033.1992.tb16910.x", "volume": "206", "author": "R Nusing", "year": "1992", "unstructured": "Nusing R, Ullrich V (1992) Regulation of cyclooxygenase and thromboxane synthase in human monocytes. Eur J Biochem 206:131\u2013136", "journal-title": "Eur J Biochem"}, {"key": "9_CR1665", "doi-asserted-by": "crossref", "first-page": "869", "DOI": "10.1093/rheumatology/41.8.869", "volume": "41", "author": "V Young", "year": "2002", "unstructured": "Young V, Ho M, Vosper H, Belch JJ, Palmer CN (2002) Elevated expression of the genes encoding TNF-\u03b1 and thromboxane synthase in leucocytes from patients with systemic sclerosis. Rheumatology 41:869\u2013875", "journal-title": "Rheumatology"}, {"key": "9_CR1666", "doi-asserted-by": "crossref", "first-page": "69", "DOI": "10.1007/BF00197395", "volume": "424", "author": "R Nusing", "year": "1994", "unstructured": "Nusing R, Fehr PM, Gudat F, Kemeny E, Mihatsch MJ, Ullrich V (1994) The localization of thromboxane synthase in normal and pathological human kidney tissue using a monoclonal antibody Tu 300. Virchows Arch 424:69\u201374", "journal-title": "Virchows Arch"}, {"key": "9_CR1667", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1016/0014-5793(92)80990-X", "volume": "306", "author": "H Ihara", "year": "1992", "unstructured": "Ihara H, Yokoyama C, Miyata A, Kosaka T, Nusing R, Ullrich V, Tanabe T (1992) Induction of thromboxane synthase and prostaglandin endoperoxide synthase mRNAs in human erythroleukemia cells by phorbol ester. FEBS Lett 306:161\u2013164", "journal-title": "FEBS Lett"}, {"key": "9_CR1668", "doi-asserted-by": "crossref", "first-page": "22497", "DOI": "10.1074/jbc.M111058200", "volume": "277", "author": "M Yaekashiwa", "year": "2002", "unstructured": "Yaekashiwa M, Wang LH (2002) Transcriptional control of the human thromboxane synthase gene in vivo and in vitro. J Biol Chem 277:22497\u201322508", "journal-title": "J Biol Chem"}, {"key": "9_CR1669", "doi-asserted-by": "crossref", "first-page": "479", "DOI": "10.1089/10445490360708883", "volume": "22", "author": "M Yaekashiwa", "year": "2003", "unstructured": "Yaekashiwa M, Wang LH (2003) Nrf2 regulates thromboxane synthase gene expression in human lung cells. DNA Cell Biol 22:479\u2013487", "journal-title": "DNA Cell Biol"}, {"key": "9_CR1670", "doi-asserted-by": "crossref", "first-page": "1249", "DOI": "10.1161/HYPERTENSIONAHA.111.188730", "volume": "59", "author": "AA Mousa", "year": "2012", "unstructured": "Mousa AA, Strauss JF 3rd, Walsh SW (2012) Reduced methylation of the thromboxane synthase gene is correlated with its increased vascular expression in preeclampsia. Hypertension 59:1249\u20131255", "journal-title": "Hypertension"}, {"key": "9_CR1671", "first-page": "61", "volume": "432", "author": "D Chevalier", "year": "2001", "unstructured": "Chevalier D, Lo-Guidice JM, Sergent E, Allorge D, Debuysere H, Ferrari N, Libersa C, Lhermitte M, Broly F (2001) Identification of genetic variants in the human thromboxane synthase gene (CYP5A1). Mutat Res 432:61\u201367", "journal-title": "Mutat Res"}, {"key": "9_CR1672", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1016/S0090-6980(02)00016-3", "volume": "70", "author": "D Chevalier", "year": "2002", "unstructured": "Chevalier D, Allorge D, Lo-Guidice JM, Cauffiez C, Lepetit C, Migot-Nabias F, Kenani A, Lhermitte M, Broly F (2002) Sequence analysis, frequency and ethnic distribution of VNTR polymorphism in the 5\u2032-untranslated region of the human prostacyclin synthase gene (CYP8A1). Prostaglandins Other Lipid Mediat 70:31\u201337", "journal-title": "Prostaglandins Other Lipid Mediat"}, {"key": "9_CR1673", "doi-asserted-by": "crossref", "first-page": "394", "DOI": "10.1002/humu.9371", "volume": "26", "author": "CM Ulrich", "year": "2005", "unstructured": "Ulrich CM, Carlson CS, Sibert J, Poole EM, Yu JH, Wang LH, Sparks R, Potter JD, Bigler J (2005) Thromboxane synthase (TBXAS1) polymorphisms in African-American and Caucasian populations: evidence for selective pressure. Hum Mutat 26:394\u2013395", "journal-title": "Hum Mutat"}, {"key": "9_CR1674", "doi-asserted-by": "crossref", "first-page": "653", "DOI": "10.1097/FPC.0b013e3283562d82", "volume": "22", "author": "CY Chen", "year": "2012", "unstructured": "Chen CY, Poole EM, Ulrich CM, Kulmacz RJ, Wang LH (2012) Functional analysis of human thromboxane synthase polymorphic variants. Pharmacogenet Genomics 22:653\u2013658", "journal-title": "Pharmacogenet Genomics"}, {"key": "9_CR1675", "doi-asserted-by": "crossref", "first-page": "200", "DOI": "10.5483/BMBRep.2009.42.4.200", "volume": "42", "author": "SA Park", "year": "2009", "unstructured": "Park SA, Park BL, Park JH, Lee TK, Sung KB, Lee YK, Chang HS, Park CS, Shin HD (2009) Association of polymorphisms in thromboxane A2 receptor and thromboxane A synthase 1 with cerebral infarction in a Korean population. BMB Rep 42:200\u2013205", "journal-title": "BMB Rep"}, {"key": "9_CR1676", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1016/0262-1746(83)90114-2", "volume": "11", "author": "V Ullrich", "year": "1983", "unstructured": "Ullrich V, Haurand M (1983) Thromboxane synthase as a cytochrome P450 enzyme. Adv Prostaglandin Thromboxane Leukot Res 11:105\u2013110", "journal-title": "Adv Prostaglandin Thromboxane Leukot Res"}, {"key": "9_CR1677", "first-page": "15059", "volume": "260", "author": "M Haurand", "year": "1985", "unstructured": "Haurand M, Ullrich V (1985) Isolation and characterization of thromboxane synthase from human platelets as a cytochrome P-450 enzyme. J Biol Chem 260:15059\u201315067", "journal-title": "J Biol Chem"}, {"key": "9_CR1678", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1016/0014-5793(93)81335-W", "volume": "318", "author": "C Yokoyama", "year": "1993", "unstructured": "Yokoyama C, Miyata A, Suzuki K, Nishikawa Y, Yoshimoto T, Yamamoto S, N\u00fcsing R, Ullrich V, Tanabe T (1993) Expression of human thromboxane synthase using a baculovirus system. FEBS Lett 318:91\u201394", "journal-title": "FEBS Lett"}, {"key": "9_CR1679", "doi-asserted-by": "crossref", "first-page": "124", "DOI": "10.1016/0003-9861(87)90088-9", "volume": "254", "author": "M Hecker", "year": "1987", "unstructured": "Hecker M, Haurand M, Ullrich V, Diczfalusy U, Hammarstrom S (1987) Products, kinetics, and substrate specificity of homogeneous thromboxane synthase from human platelets: development of a novel enzyme assay. Arch Biochem Biophys 254:124\u2013135", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1680", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1016/j.abb.2007.03.012", "volume": "461", "author": "HC Yeh", "year": "2007", "unstructured": "Yeh HC, Tsai AL, Wang LH (2007) Reaction mechanisms of 15-hydroperoxyeicosatetraenoic acid catalyzed by human prostacyclin and thromboxane synthases. Arch Biochem Biophys 461:159\u2013168", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1681", "doi-asserted-by": "crossref", "first-page": "563", "DOI": "10.1111/j.1432-1033.1987.tb13646.x", "volume": "169", "author": "M Hecker", "year": "1987", "unstructured": "Hecker M, Baader WJ, Weber P, Ullrich V (1987) Thromboxane synthase catalyses hydroxylation of prostaglandin H2 analogs in the presence of iodosylbenzene. Eur J Biochem 169:563\u2013569", "journal-title": "Eur J Biochem"}, {"key": "9_CR1682", "first-page": "141", "volume": "264", "author": "M Hecker", "year": "1989", "unstructured": "Hecker M, Ullrich V (1989) On the mechanism of prostacyclin and thromboxane A2 biosynthesis. J Biol Chem 264:141\u2013150", "journal-title": "J Biol Chem"}, {"key": "9_CR1683", "doi-asserted-by": "crossref", "first-page": "38", "DOI": "10.1016/S0003-9861(03)00287-X", "volume": "416", "author": "PY Hsu", "year": "2003", "unstructured": "Hsu PY, Wang LH (2003) Protein engineering of thromboxane synthase: conversion of membrane-bound to soluble form. Arch Biochem Biophys 416:38\u201346", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1684", "doi-asserted-by": "crossref", "first-page": "2542", "DOI": "10.1021/bi027206s", "volume": "42", "author": "Z Chen", "year": "2003", "unstructured": "Chen Z, Wang LH, Schelvis JP (2003) Resonance Raman investigation of the interaction of thromboxane synthase with substrate analogues. Biochemistry 42:2542\u20132551", "journal-title": "Biochemistry"}, {"key": "9_CR1685", "doi-asserted-by": "crossref", "first-page": "1113", "DOI": "10.1021/bi301400t", "volume": "52", "author": "WC Chao", "year": "2013", "unstructured": "Chao WC, Lu JF, Wang JS, Yang HC, Pan TA, Chou SC, Wang LH, Chou PT (2013) Probing ligand binding to thromboxane synthase. Biochemistry 52:1113\u20131121", "journal-title": "Biochemistry"}, {"key": "9_CR1686", "unstructured": "Sathler PC, Santana M, Lourenco AL, Rodrigues CR, Abreu P, Cabral LM, Castro HC (2014) Human thromboxane synthase: comparative modeling and docking evaluation with the competitive inhibitors dazoxiben and ozagrel. J Enzyme Inhib Med Chem, PMID:23914925 (in press)"}, {"key": "9_CR1687", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1016/0014-5793(77)80896-X", "volume": "82", "author": "UD Alusy", "year": "1977", "unstructured": "Alusy UD, Hammarstrom S (1977) Inhibitors of thromboxane synthase in human platelets. FEBS Lett 82:107\u2013110", "journal-title": "FEBS Lett"}, {"key": "9_CR1688", "doi-asserted-by": "crossref", "first-page": "4007", "DOI": "10.1073/pnas.74.9.4007", "volume": "74", "author": "RR Gorman", "year": "1977", "unstructured": "Gorman RR, Bundy GL, Peterson DC, Sun FF, Miller OV, Fitzpatrick FA (1977) Inhibition of human platelet thromboxane synthetase by 9,11-azoprosta-5,13-dienoic acid. Proc Natl Acad Sci U S A 74:4007\u20134011", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR1689", "first-page": "27", "volume": "4", "author": "JR Vane", "year": "1978", "unstructured": "Vane JR (1978) Inhibitors of prostaglandin, prostacyclin, and thromboxane synthesis. Adv Prostaglandin Thromboxane Res 4:27\u201344", "journal-title": "Adv Prostaglandin Thromboxane Res"}, {"key": "9_CR1690", "doi-asserted-by": "crossref", "first-page": "217", "DOI": "10.1111/j.1432-1033.1986.tb09659.x", "volume": "157", "author": "M Hecker", "year": "1986", "unstructured": "Hecker M, Haurand M, Ullrich V, Terao S (1986) Spectral studies on structure-activity relationships of thromboxane synthase inhibitors. Eur J Biochem 157:217\u2013223", "journal-title": "Eur J Biochem"}, {"key": "9_CR1691", "unstructured": "Davi G, Santilli F, Vazzana N (2012) Thromboxane receptors antagonists and/or synthase inhibitors. Handbook Exp Pharmacol 261\u2013286", "DOI": "10.1007/978-3-642-29423-5_11", "doi-asserted-by": "crossref"}, {"key": "9_CR1692", "doi-asserted-by": "crossref", "first-page": "3162", "DOI": "10.2174/092986710792231978", "volume": "17", "author": "C Kontogiorgis", "year": "2010", "unstructured": "Kontogiorgis C, Hadjipavlou-Litina D (2010) Thromboxane synthase inhibitors and thromboxane A2 receptor antagonists: a quantitative structure activity relationships (QSARs) analysis. Curr Med Chem 17:3162\u20133214", "journal-title": "Curr Med Chem"}, {"key": "9_CR1693", "unstructured": "Fontana P, Alberts P, Sakariassen KS, Bounameaux H, Meyer JP, Santana Sorensen A (2011) The dual thromboxane receptor antagonistand thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin. J Thromb Haemost 9:2109\u20132111", "DOI": "10.1111/j.1538-7836.2011.04446.x", "doi-asserted-by": "crossref"}, {"key": "9_CR1694", "doi-asserted-by": "crossref", "first-page": "124", "DOI": "10.1016/j.prostaglandins.2011.03.001", "volume": "94", "author": "C Cherdon", "year": "2011", "unstructured": "Cherdon C, Rolin S, Hanson J, Ooms A, de Leval L, Drion P, Michiels C, Pirotte B, Masereel B, Sakalihassan N, Defraigne JO, Dogne JM (2011) BM-573 inhibits the development of early atherosclerotic lesions in Apo E deficient mice by blocking TP receptors and thromboxane synthase. Prostaglandins Other Lipid Mediat 94:124\u2013132", "journal-title": "Prostaglandins Other Lipid Mediat"}, {"key": "9_CR1695", "doi-asserted-by": "crossref", "first-page": "1255", "DOI": "10.1517/13543784.16.8.1255", "volume": "16", "author": "LG Howes", "year": "2007", "unstructured": "Howes LG, James MJ, Florin T, Walker C (2007) Nv-52: a novel thromboxane synthase inhibitor for the treatment of inflammatory bowel disease. Expert Opin Investig Drugs 16:1255\u20131266", "journal-title": "Expert Opin Investig Drugs"}, {"key": "9_CR1696", "doi-asserted-by": "crossref", "first-page": "2974", "DOI": "10.1016/j.yexcr.2009.06.025", "volume": "315", "author": "KC Leung", "year": "2009", "unstructured": "Leung KC, Hsin MK, Chan JS, Yip JH, Li M, Leung BC, Mok TS, Warner TD, Underwood MJ, Chen GG (2009) Inhibition of thromboxane synthase induces lung cancer cell death via increasing the nuclear p27. Exp Cell Res 315:2974\u20132981", "journal-title": "Exp Cell Res"}, {"key": "9_CR1697", "doi-asserted-by": "crossref", "first-page": "658", "DOI": "10.1053/j.gastro.2013.05.014", "volume": "145", "author": "Y Abe", "year": "2013", "unstructured": "Abe Y, Aly HH, Hiraga N, Imamura M, Wakita T, Shimotohno K, Chayama K, Hijikata M (2013) Thromboxane A2 synthase inhibitors prevent production of infectious hepatitis C virus in mice with humanized livers. Gastroenterology 145:658\u2013667e611", "journal-title": "Gastroenterology"}, {"key": "9_CR1698", "doi-asserted-by": "crossref", "first-page": "351", "DOI": "10.2217/pgs.10.181", "volume": "12", "author": "SH Oh", "year": "2011", "unstructured": "Oh SH, Kim YH, Park SM, Cho SH, Park JS, Jang AS, Park SW, Uh ST, Lee YM, Kim MK, Choi IS, Cho SH, Hong CS, Lee YW, Lee JY, Choi BW, Park BL, Shin HD, Park CS (2011) Association analysis of thromboxane A synthase 1 gene polymorphisms with aspirin intolerance in asthmatic patients. Pharmacogenomics 12:351\u2013363", "journal-title": "Pharmacogenomics"}, {"key": "9_CR1699", "doi-asserted-by": "crossref", "first-page": "989", "DOI": "10.1016/j.jaci.2013.04.045", "volume": "132", "author": "C Vidal", "year": "2013", "unstructured": "Vidal C, Porras-Hurtado L, Cruz R, Quiralte J, Cardona V, Colas C, Castillo LF, Marcos C, Soto T, Lopez-Abad R, Hernandez D, Audicana MT, Armisen M, Rodriguez V, Perez-Carral C, Moreno E, Cabanes R, Corominas M, Parra A, Lobera T, Quinones D, Ojeda P, Luna I, Torres M, Carracedo A (2013) Association of thromboxane A1 synthase (TBXAS1) gene polymorphism with acute urticaria induced by nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 132:989\u2013991", "journal-title": "J Allergy Clin Immunol"}, {"key": "9_CR1700", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1186/1476-4598-10-25", "volume": "10", "author": "MC Cathcart", "year": "2011", "unstructured": "Cathcart MC, Gately K, Cummins R, Kay E, O\u2019Byrne KJ, Pidgeon GP (2011) Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer. Mol Cancer 10:25", "journal-title": "Mol Cancer"}, {"key": "9_CR1701", "doi-asserted-by": "crossref", "first-page": "397", "DOI": "10.1007/s10555-011-9297-9", "volume": "30", "author": "P Ekambaram", "year": "2011", "unstructured": "Ekambaram P, Lambiv W, Cazzolli R, Ashton AW, Honn KV (2011) The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis. Cancer Metastasis Rev 30:397\u2013408", "journal-title": "Cancer Metastasis Rev"}, {"key": "9_CR1702", "first-page": "1087", "volume": "101", "author": "N Miki", "year": "1987", "unstructured": "Miki N, Miura R, Miyake Y (1987) Purification and characterization of cholesterol 7\u03b1-hydroxylase cytochrome P-450 of untreated rabbit liver microsomes. J Biochem (Tokyo) 101:1087\u20131094", "journal-title": "J"}, {"key": "9_CR1703", "first-page": "7646", "volume": "262", "author": "T Ogishima", "year": "1987", "unstructured": "Ogishima T, Deguchi S, Okuda K (1987) Purification and characterization of cholesterol 7\u03b1-hydroxylase from rat liver microsomes. J Biol Chem 262:7646\u20137650", "journal-title": "J Biol Chem"}, {"key": "9_CR1704", "first-page": "4541", "volume": "265", "author": "LB Nguyen", "year": "1990", "unstructured": "Nguyen LB, Shefer S, Salen G, Ness G, Tanaka RD, Packin V, Thomas P, Shore V, Batta A (1990) Purification of cholesterol 7\u03b1-hydroxylase from human and rat liver and production of inhibiting polyclonal antibodies. J Biol Chem 265:4541\u20134546", "journal-title": "J Biol Chem"}, {"key": "9_CR1705", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1016/0014-5793(90)80992-R", "volume": "268", "author": "M Noshiro", "year": "1990", "unstructured": "Noshiro M, Okuda K (1990) Molecular cloning and sequence analysis of cDNA encoding human cholesterol 7\u03b1-hydroxylase. FEBS Lett 268:137\u2013140", "journal-title": "FEBS Lett"}, {"key": "9_CR1706", "first-page": "12012", "volume": "265", "author": "YC Li", "year": "1990", "unstructured": "Li YC, Wang DP, Chiang JYL (1990) Regulation of cholesterol 7\u03b1-hydroxylase in the liver: cloning, sequencing, and regulation of cholesterol 7\u03b1-hydroxylase mRNA. J Biol Chem 265:12012\u201312019", "journal-title": "J Biol Chem"}, {"key": "9_CR1707", "first-page": "8190", "volume": "265", "author": "DF Jelinek", "year": "1990", "unstructured": "Jelinek DF, Andersson S, Slaughter CA, Russell DW (1990) Cloning and regulation of cholesterol 7\u03b1-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis. J Biol Chem 265:8190\u20138197", "journal-title": "J Biol Chem"}, {"key": "9_CR1708", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1016/S0888-7543(05)80298-8", "volume": "14", "author": "JC Cohen", "year": "1992", "unstructured": "Cohen JC, Cali JJ, Jelinek DF, Mehrabian M, Sparkes RS, Lusis AJ, Russell DW, Hobbs HH (1992) Cloning of the human cholesterol 7\u03b1 -hydroxylase gene (CYP7) and localization to chromosome 8q11\u2013q12. Genomics 14:153\u2013161", "journal-title": "Genomics"}, {"key": "9_CR1709", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1016/0167-4781(93)90281-H", "volume": "1172", "author": "M Nishimoto", "year": "1993", "unstructured": "Nishimoto M, Noshiro M, Okuda K (1993) Structure of the gene encoding human liver cholesterol 7\u03b1-hydroxylase. Biochim Biophys Acta 1172:147\u2013150", "journal-title": "Biochim Biophys Acta"}, {"key": "9_CR1710", "doi-asserted-by": "crossref", "first-page": "320", "DOI": "10.1006/geno.1994.1177", "volume": "20", "author": "DP Wang", "year": "1994", "unstructured": "Wang DP, Chiang JY (1994) Structure and nucleotide sequences of the human cholesterol 7\u03b1-hydroxylase gene (CYP7). Genomics 20:320\u2013323", "journal-title": "Genomics"}, {"key": "9_CR1711", "doi-asserted-by": "crossref", "first-page": "1497", "DOI": "10.1172/JCI117821", "volume": "95", "author": "G Xu", "year": "1995", "unstructured": "Xu G, Salen G, Shefer S, Ness GC, Nguyen LB, Parker TS, Chen TS, Zhao Z, Donnelly TM, Tint GS (1995) Unexpected inhibition of cholesterol 7\u03b1-hydroxylase by cholesterol in New Zealand white and Watanabe heritable hyperlipidemic rabbits. J Clin Invest 95:1497\u20131504", "journal-title": "J Clin Invest"}, {"key": "9_CR1712", "doi-asserted-by": "crossref", "first-page": "705", "DOI": "10.1111/j.1432-1033.1993.tb18082.x", "volume": "215", "author": "O Breuer", "year": "1993", "unstructured": "Breuer O, Sudjana-Sugiaman E, Eggertsen G, Chiang JY, Bj\u00f6rkhem I (1993) Cholesterol 7\u03b1-hydroxylase is up-regulated by the competitive inhibitor 7-oxocholesterol in rat liver. Eur J Biochem 215:705\u2013710", "journal-title": "Eur J Biochem"}, {"key": "9_CR1713", "first-page": "17502", "volume": "269", "author": "JYL Chiang", "year": "1994", "unstructured": "Chiang JYL, Stroup D (1994) Identification and characterization of a putative bile acid-responsive element in cholesterol 7\u03b1-hydroxylase gene promoter. J Biol Chem 269:17502\u201317507", "journal-title": "J Biol Chem"}, {"key": "9_CR1714", "doi-asserted-by": "crossref", "first-page": "18024", "DOI": "10.1074/jbc.271.30.18024", "volume": "271", "author": "M Schwarz", "year": "1996", "unstructured": "Schwarz M, Lund EG, Setchell KD, Kayden HJ, Zerwekh JE, Bj\u00f6rkhem I, Herz J, Russell DW (1996) Disruption of cholesterol 7\u03b1-hydroxylase gene in mice. II. Bile acid deficiency is overcome by induction of oxysterol 7\u03b1-hydroxylase. J Biol Chem 271:18024\u201318031", "journal-title": "J Biol Chem"}, {"key": "9_CR1715", "doi-asserted-by": "crossref", "first-page": "3137", "DOI": "10.1074/jbc.272.6.3137", "volume": "272", "author": "JM Lehmann", "year": "1997", "unstructured": "Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, Sundseth SS, Winegar DA, Blanchard DE, Spencer TA, Willson TM (1997) Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 272:3137\u20133140", "journal-title": "J Biol Chem"}, {"key": "9_CR1716", "doi-asserted-by": "crossref", "first-page": "693", "DOI": "10.1016/S0092-8674(00)81432-4", "volume": "93", "author": "DJ Peet", "year": "1998", "unstructured": "Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro JM, Hammer RE, Mangelsdorf DJ (1998) Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR\u03b1. Cell 93:693\u2013704", "journal-title": "Cell"}, {"key": "9_CR1717", "doi-asserted-by": "crossref", "first-page": "539", "DOI": "10.1016/S0092-8674(00)80763-1", "volume": "97", "author": "DW Russell", "year": "1999", "unstructured": "Russell DW (1999) Nuclear orphan receptors control cholesterol catabolism. Cell 97:539\u2013542", "journal-title": "Cell"}, {"key": "9_CR1718", "doi-asserted-by": "crossref", "first-page": "1362", "DOI": "10.1126/science.284.5418.1362", "volume": "284", "author": "M Makishima", "year": "1999", "unstructured": "Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B (1999) Identification of a nuclear receptor for bile acids. Science 284:1362\u20131365", "journal-title": "Science"}, {"key": "9_CR1719", "doi-asserted-by": "crossref", "first-page": "6669", "DOI": "10.1073/pnas.96.12.6660", "volume": "96", "author": "M Nitta", "year": "1999", "unstructured": "Nitta M, Ku S, Brown C, Okamoto AY, Shan B (1999) CPF: an orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7\u03b1-hydroxylase gene. Proc Natl Acad Sci U S A 96:6669\u20136665", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR1720", "doi-asserted-by": "crossref", "first-page": "10918", "DOI": "10.1074/jbc.275.15.10918", "volume": "275", "author": "JY Chiang", "year": "2000", "unstructured": "Chiang JY, Kimmel R, Weinberger C, Stroup D (2000) Farnesoid X receptor responds to bile acidsand represses cholesterol 7\u03b1-hydroxylase gene (CYP7A1) transcription. J Biol Chem 275:10918\u201310924", "journal-title": "J Biol Chem"}, {"key": "9_CR1721", "doi-asserted-by": "crossref", "first-page": "3369", "DOI": "10.1073/pnas.051551698", "volume": "98", "author": "JL Staudinger", "year": "2001", "unstructured": "Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, LaTour A, Liu Y, Klaassen CD, Brown KK, Reinhard J, Willson TM, Koller BH, Kliewer SA (2001) The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci U S A 98:3369\u20133374", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR1722", "doi-asserted-by": "crossref", "first-page": "338", "DOI": "10.1016/S0006-291X(02)00229-2", "volume": "293", "author": "S Gupta", "year": "2002", "unstructured": "Gupta S, Pandak WM, Hylemon PB (2002) LXR\u03b1 is the dominant regulator of CYP7A1 transcription. Biochem Biophys Res Commun 293:338\u2013343", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1723", "doi-asserted-by": "crossref", "first-page": "747", "DOI": "10.1042/bj3510747", "volume": "351", "author": "DD Patel", "year": "2000", "unstructured": "Patel DD, Knight BL, Soutar AK, Gibbons GF, Wade DP (2000) The effect of peroxisome-proliferator-activated receptor-\u03b1 on the activity of the cholesterol 7\u03b1-hydroxylase gene. Biochem J 351:747\u2013753", "journal-title": "Biochem J"}, {"key": "9_CR1724", "doi-asserted-by": "crossref", "first-page": "12530", "DOI": "10.1074/jbc.275.17.12530", "volume": "275", "author": "SK Cheema", "year": "2000", "unstructured": "Cheema SK, Agellon LB (2000) The murine and human cholesterol 7\u03b1-hydroxylase gene promoters are differentially responsive to regulation by fatty acids mediated via peroxisome proliferator-activated receptor \u03b1. J Biol Chem 275:12530\u201312536", "journal-title": "J Biol Chem"}, {"key": "9_CR1725", "doi-asserted-by": "crossref", "first-page": "14", "DOI": "10.1124/mol.53.1.14", "volume": "53", "author": "CNA Palmer", "year": "1998", "unstructured": "Palmer CNA, Hsu MH, Griffin KJ, Raucy JL, Johnson EF (1998) Peroxisome proliferator activated receptor-\u03b1 expression in human liver. Mol Pharmacol 53:14\u201322", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1726", "first-page": "514", "volume": "41", "author": "M Marrapodi", "year": "2000", "unstructured": "Marrapodi M, Chiang JY (2000) Peroxisome proliferator-activated receptor a (PPARa) and agonist inhibit cholesterol 7\u03b1-hydroxylase gene (CYP7A1) transcription. J Lipid Res 41:514\u2013520", "journal-title": "J Lipid Res"}, {"key": "9_CR1727", "doi-asserted-by": "crossref", "first-page": "30708", "DOI": "10.1074/jbc.M103270200", "volume": "276", "author": "E De Fabiani", "year": "2001", "unstructured": "De Fabiani E, Mitro N, Anzulovich AC, Pinelli A, Galli G, Crestani M (2001) The negative effects of bile acids and tumor necrosis factor-a on the transcription of cholesterol 7\u03b1-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4: a novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. J Biol Chem 276:30708\u201330716", "journal-title": "J Biol Chem"}, {"key": "9_CR1728", "first-page": "223", "volume": "37", "author": "KR Feingold", "year": "1996", "unstructured": "Feingold KR, Spady DK, Pollock AS, Moser AH, Grunfeld C (1996) Endotoxin, TNF, and IL-1 decrease cholesterol 7\u03b1-hydroxylase mRNA levels and activity. J Lipid Res 37:223\u2013228", "journal-title": "J Lipid Res"}, {"key": "9_CR1729", "first-page": "14", "volume": "16", "author": "VA Drover", "year": "2002", "unstructured": "Drover VA, Wong NC, Agellon LB (2002) A distinct thyroid hormone response element mediates repression of the human cholesterol 7\u03b1-hydroxylase (CYP7A1) gene promoter. Mol Endocrinol 16:14\u201323", "journal-title": "Mol Endocrinol"}, {"key": "9_CR1730", "doi-asserted-by": "crossref", "first-page": "26804", "DOI": "10.1074/jbc.M202343200", "volume": "277", "author": "I Bjorkhem", "year": "2002", "unstructured": "Bj\u00f6rkhem I, Araya Z, Rudling M, Angelin B, Einarsson C, Wikvall K (2002) Differences in the regulation of the classical and the alternative pathway for bile acid synthesis in human liver. No coordinate regulation of CYP7A1 and CYP27A1. J Biol Chem 277:26804\u201326807", "journal-title": "J Biol Chem"}, {"key": "9_CR1731", "first-page": "1831", "volume": "37", "author": "D Wang", "year": "1996", "unstructured": "Wang D, Stroup D, Marrapodi M, Crestani M, Galli G, Chiang JYL (1996) Transcriptional regulation of the human cholesterol 7\u03b1-hydroxylase gene (CYP7A) in HepG2 cells. J Lipid Res 37:1831\u20131841", "journal-title": "J Lipid Res"}, {"key": "9_CR1732", "doi-asserted-by": "crossref", "first-page": "300", "DOI": "10.1016/0005-2760(91)90072-P", "volume": "1084", "author": "RS Kushwaha", "year": "1991", "unstructured": "Kushwaha RS, Born KM (1991) Effect of estrogen and progesterone on the hepatic cholesterol 7\u03b1-hydroxylase activity in ovariectomized baboons. Biochim Biophys Acta 1084:300\u2013302", "journal-title": "Biochim Biophys Acta"}, {"key": "9_CR1733", "doi-asserted-by": "crossref", "first-page": "454", "DOI": "10.1006/bbrc.1999.1799", "volume": "266", "author": "SA Goodart", "year": "1999", "unstructured": "Goodart SA, Huynh C, Chen W, Cooper AD, Levy-Wilson B (1999) Expression of the human cholesterol 7\u03b1-hydroxylase gene in transgenic mice. Biochem Biophys Res Commun 266:454\u2013459", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1734", "doi-asserted-by": "crossref", "first-page": "42588", "DOI": "10.1074/jbc.M205117200", "volume": "277", "author": "JY Chen", "year": "2002", "unstructured": "Chen JY, Levy-Wilson B, Goodart S, Cooper AD (2002) Mice expressing the human CYP7A1 gene in the mouse CYP7A1 knock-out background lack induction of CYP7A1 expression by cholesterolfeeding and have increased hypercholesterolemia when fed a high fat diet. J Biol Chem 277:42588\u201342595", "journal-title": "J Biol Chem"}, {"key": "9_CR1735", "doi-asserted-by": "crossref", "first-page": "1498", "DOI": "10.1016/0016-5085(89)90395-8", "volume": "97", "author": "E Reihner", "year": "1989", "unstructured": "Reihner E, Bjorkhem I, Angelin B, Ewerth S, Einarsson K (1989) Bile acid synthesis in humans: regulation of hepatic microsomal cholesterol 7\u03b1-hydroxylase activity. Gastroenterology 97:1498\u20131505", "journal-title": "Gastroenterology"}, {"key": "9_CR1736", "doi-asserted-by": "crossref", "first-page": "267", "DOI": "10.1007/BF00340534", "volume": "36", "author": "D Mayer", "year": "1976", "unstructured": "Mayer D (1976) The circadian rhythm of synthesis and catabolism of cholesterol. Arch Toxicol 36:267\u2013276", "journal-title": "Arch Toxicol"}, {"key": "9_CR1737", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1111/j.1432-1033.1975.tb02136.x", "volume": "55", "author": "J Gielen", "year": "1975", "unstructured": "Gielen J, Van Cantfort J, Robaye B, Renson J (1975) Rat-liver cholesterol 7\u03b1-hydroxylase 3. New results about its circadian rhythm. Eur J Biochem 55:41\u201348", "journal-title": "Eur J Biochem"}, {"key": "9_CR1738", "doi-asserted-by": "crossref", "first-page": "46", "DOI": "10.1016/0006-291X(81)91658-2", "volume": "103", "author": "H Danielsson", "year": "1981", "unstructured": "Danielsson H, Wikvall K (1981) Evidence for a specific cytochrome P-450 with short half-life catalyzing 7\u03b1-hydroxylation of cholesterol. Biochem Biophys Res Commun 103:46\u201351", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1739", "doi-asserted-by": "crossref", "first-page": "409", "DOI": "10.1016/0005-2760(78)90085-1", "volume": "529", "author": "FH Hulcher", "year": "1978", "unstructured": "Hulcher FH, Margolis RD, Bowman DJ (1978) Circadian rhythm of cholesterol-7\u03b1-hydroxylase and cortisolin the African green monkey (Cercopithecus aethiops). Biochim Biophys Acta 529:409\u2013418", "journal-title": "Biochim Biophys Acta"}, {"key": "9_CR1740", "first-page": "3889", "volume": "265", "author": "JY Chiang", "year": "1990", "unstructured": "Chiang JY, Miller WF, Lin GM (1990) Regulation of cholesterol 7\u03b1-hydroxylase in the liver. Purification of cholesterol 7\u03b1-hydroxylase and the immunochemical evidence for the induction of cholesterol 7\u03b1-hydroxylase by cholestyramine and circadian rhythm. J Biol Chem 265:3889\u20133897", "journal-title": "J Biol Chem"}, {"key": "9_CR1741", "doi-asserted-by": "crossref", "first-page": "377", "DOI": "10.1016/S0960-0760(02)00071-7", "volume": "81", "author": "M Kinowaki", "year": "2002", "unstructured": "Kinowaki M, Tanaka S, Maeda Y, Higashi S, Okuda K, Setoguchi T (2002) Half-life of cholesterol 7\u03b1-hydroxylase activity and enzyme mass differ in animals and humans when determined by a monoclonal antibody against human cholesterol 7\u03b1-hydroxylase. J Steroid Biochem Mol Biol 81:377\u2013380", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR1742", "first-page": "10036", "volume": "265", "author": "M Noshiro", "year": "1990", "unstructured": "Noshiro M, Nishimoto M, Okuda K (1990) Rat liver cholesterol 7\u03b1-hydroxylase: pretranslational regulation for circadian rhythm. J Biol Chem 265:10036\u201310041", "journal-title": "J Biol Chem"}, {"key": "9_CR1743", "doi-asserted-by": "crossref", "first-page": "886", "DOI": "10.1016/0006-291X(81)90893-7", "volume": "103", "author": "A Sanghvi", "year": "1981", "unstructured": "Sanghvi A, Grassi E, Warty V, Diven W, Wight C, Lester R (1981) Reversible activation-inactivation of cholesterol 7\u03b1-hydroxylase possibly due to phosphorylation-dephosphorylation. Biochem Biophys Res Commun 103:886\u2013892", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1744", "first-page": "4469", "volume": "257", "author": "CD Goodwin", "year": "1982", "unstructured": "Goodwin CD, Cooper BW, Margolis S (1982) Rat liver cholesterol 7\u03b1-hydroxylase: modulation of enzyme activity by changes in phosphorylation state. J Biol Chem 257:4469\u20134472", "journal-title": "J Biol Chem"}, {"key": "9_CR1745", "doi-asserted-by": "crossref", "first-page": "543", "DOI": "10.1016/0003-9861(87)90612-6", "volume": "256", "author": "EJ Holsztynska", "year": "1987", "unstructured": "Holsztynska EJ, Waxman DJ (1987) Cytochrome P-450 cholesterol 7\u03b1-hydroxylase: inhibition of enzyme deactivation by structurally diverse calmodulin antagonists and phosphatase inhibitors. Arch Biochem Biophys 256:543\u2013559", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1746", "first-page": "1468", "volume": "24", "author": "LB Nguyen", "year": "1996", "unstructured": "Nguyen LB, Shefer S, Salen G, Chiang JY, Patel M (1996) Cholesterol 7\u03b1-hydroxylase activities from human and rat liver are modulated in vitro posttranslationally by phosphorylation/dephosphorylation. Hepatology 24:1468\u20131474", "journal-title": "Hepatology"}, {"key": "9_CR1747", "doi-asserted-by": "crossref", "first-page": "1993", "DOI": "10.1002/hep.21878", "volume": "46", "author": "KH Song", "year": "2007", "unstructured": "Song KH, Ellis E, Strom S, Chiang JY (2007) Hepatocyte growth factor signaling pathway inhibits cholesterol 7\u03b1-hydroxylase and bile acid synthesis in human hepatocytes. Hepatology 46:1993\u20132002", "journal-title": "Hepatology"}, {"key": "9_CR1748", "doi-asserted-by": "crossref", "first-page": "1113", "DOI": "10.1093/nar/gkh260", "volume": "32", "author": "GF Gbaguidi", "year": "2004", "unstructured": "Gbaguidi GF, Agellon LB (2004) The inhibition of the human cholesterol 7\u03b1-hydroxylase gene (CYP7A1) promoter by fibrates in cultured cells is mediated via the liver x receptor alpha and peroxisome proliferator-activated receptor \u03b1 heterodimer. Nucleic Acids Res 32:1113\u20131121", "journal-title": "Nucleic Acids Res"}, {"key": "9_CR1749", "doi-asserted-by": "crossref", "first-page": "386", "DOI": "10.1210/me.2002-0246", "volume": "17", "author": "B Goodwin", "year": "2003", "unstructured": "Goodwin B, Watson MA, Kim H, Miao J, Kemper JK, Kliewer SA (2003) Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-\u03b1. Mol Endocrinol 17:386\u2013394", "journal-title": "Mol Endocrinol"}, {"key": "9_CR1750", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1016/j.abb.2004.10.010", "volume": "434", "author": "C Handschin", "year": "2005", "unstructured": "Handschin C, Gnerre C, Fraser DJ, Martinez-Jimenez C, Jover R, Meyer UA (2005) Species-specific mechanisms for cholesterol 7\u03b1-hydroxylase (CYP7A1) regulation by drugs and bile acids. Arch Biochem Biophys 434:75\u201385", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1751", "doi-asserted-by": "crossref", "first-page": "832", "DOI": "10.1194/jlr.M002782", "volume": "51", "author": "T Li", "year": "2010", "unstructured": "Li T, Chanda D, Zhang Y, Choi HS, Chiang JY (2010) Glucose stimulates cholesterol 7\u03b1-hydroxylase gene transcription in human hepatocytes. J Lipid Res 51:832\u2013842", "journal-title": "J Lipid Res"}, {"key": "9_CR1752", "doi-asserted-by": "crossref", "first-page": "28745", "DOI": "10.1074/jbc.M605815200", "volume": "281", "author": "T Li", "year": "2006", "unstructured": "Li T, Kong X, Owsley E, Ellis E, Strom S, Chiang JY (2006) Insulin regulation of cholesterol 7\u03b1-hydroxylase expression in human hepatocytes: roles of forkhead box O1 and sterol regulatory element-binding protein 1c. J Biol Chem 281:28745\u201328754", "journal-title": "J Biol Chem"}, {"key": "9_CR1753", "doi-asserted-by": "crossref", "first-page": "2698", "DOI": "10.1210/me.2007-0196", "volume": "21", "author": "B Ponugoti", "year": "2007", "unstructured": "Ponugoti B, Fang S, Kemper JK (2007) Functional interaction of hepatic nuclear factor-4 and peroxisome proliferator-activated receptor-\u03b3 coactivator 1\u03b1 in CYP7A1 regulationis inhibited by a key lipogenic activator, sterol regulatory element-binding protein-1c. Mol Endocrinol 21:2698\u20132712", "journal-title": "Mol Endocrinol"}, {"key": "9_CR1754", "doi-asserted-by": "crossref", "first-page": "158", "DOI": "10.1016/j.bbrc.2004.02.029", "volume": "316", "author": "M Norlin", "year": "2004", "unstructured": "Norlin M, Chiang JY (2004) Transcriptional regulation of human oxysterol 7\u03b1-hydroxylase by sterol response element binding protein. Biochem Biophys Res Commun 316:158\u2013164", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1755", "doi-asserted-by": "crossref", "first-page": "50047", "DOI": "10.1074/jbc.M309736200", "volume": "278", "author": "DJ Shin", "year": "2003", "unstructured": "Shin DJ, Campos JA, Gil G, Osborne TF (2003) PGC-1\u03b1 activates CYP7A1 and bile acid biosynthesis. J Biol Chem 278:50047\u201350052", "journal-title": "J Biol Chem"}, {"key": "9_CR1756", "doi-asserted-by": "crossref", "first-page": "29840", "DOI": "10.1074/jbc.M604046200", "volume": "281", "author": "CP Martinez-Jimenez", "year": "2006", "unstructured": "Martinez-Jimenez CP, Gomez-Lechon MJ, Castell JV, Jover R (2006) Underexpressed coactivators PGC1alpha and SRC1 impair hepatocyte nuclear factor 4\u03b1 function and promote dedifferentiation in human hepatoma cells. J Biol Chem 281:29840\u201329849", "journal-title": "J Biol Chem"}, {"key": "9_CR1757", "doi-asserted-by": "crossref", "first-page": "2265", "DOI": "10.1194/jlr.M005546", "volume": "51", "author": "SY Cai", "year": "2010", "unstructured": "Cai SY, He H, Nguyen T, Mennone A, Boyer JL (2010) Retinoic acid represses CYP7A1 expression in human hepatocytes and HepG2 cells by FXR/RXR-dependent and independent mechanisms. J Lipid Res 51:2265\u20132274", "journal-title": "J Lipid Res"}, {"key": "9_CR1758", "doi-asserted-by": "crossref", "first-page": "656", "DOI": "10.1002/hep.23708", "volume": "52", "author": "V Triantis", "year": "2010", "unstructured": "Triantis V, Saeland E, Bijl N, Oude-Elferink RP, Jansen PL (2010) Glycosylation of fibroblast growth factor receptor 4 is a key regulator of fibroblast growth factor 19-mediated down-regulation of cytochrome P450 7A1. Hepatology 52:656\u2013666", "journal-title": "Hepatology"}, {"key": "9_CR1759", "doi-asserted-by": "crossref", "first-page": "1159", "DOI": "10.1210/me.2011-0033", "volume": "25", "author": "J Miao", "year": "2011", "unstructured": "Miao J, Choi SE, Seok SM, Yang L, Zuercher WJ, Xu Y, Willson TM, Xu HE, Kemper JK (2011) Ligand-dependent regulation of the activity of the orphan nuclear receptor, small heterodimer partner (SHP), in the repression of bile acid biosynthetic CYP7A1 and CYP8B1 genes. Mol Endocrinol 25:1159\u20131169", "journal-title": "Mol Endocrinol"}, {"key": "9_CR1760", "doi-asserted-by": "crossref", "first-page": "41334", "DOI": "10.1074/jbc.M112.421834", "volume": "287", "author": "S Kir", "year": "2012", "unstructured": "Kir S, Zhang Y, Gerard RD, Kliewer SA, Mangelsdorf DJ (2012) Nuclear receptors HNF4\u03b1 and LRH-1 cooperate in regulating Cyp7a1 in vivo. J Biol Chem 287:41334\u201341341", "journal-title": "J Biol Chem"}, {"key": "9_CR1761", "doi-asserted-by": "crossref", "first-page": "574", "DOI": "10.1210/en.2003-0993", "volume": "145", "author": "VA Drover", "year": "2004", "unstructured": "Drover VA, Agellon LB (2004) Regulation of the human cholesterol 7\u03b1-hydroxylase gene (CYP7A1) by thyroid hormone in transgenic mice. Endocrinology 145:574\u2013581", "journal-title": "Endocrinology"}, {"key": "9_CR1762", "doi-asserted-by": "crossref", "first-page": "957", "DOI": "10.1016/j.bbrc.2005.02.063", "volume": "329", "author": "D Stroup", "year": "2005", "unstructured": "Stroup D, Ramsaran JR (2005) Cholesterol 7\u03b1-hydroxylase is phosphorylated at multiple amino acids. Biochem Biophys Res Commun 329:957\u2013965", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1763", "doi-asserted-by": "crossref", "first-page": "1678", "DOI": "10.2741/1652", "volume": "10", "author": "D Stroup", "year": "2005", "unstructured": "Stroup D (2005) Kinase/phosphatase regulation of CYP7A1. Front Biosci 10:1678\u20131692", "journal-title": "Front Biosci"}, {"key": "9_CR1764", "first-page": "588", "volume": "185", "author": "WG Karam", "year": "1992", "unstructured": "Karam WG, Chiang JYL (1992) Polymorphisms of human cholesterol 7\u03b1-hydroxylase. Biochem Biophys Res Commun 185:588\u2013595", "journal-title": "Biochem"}, {"key": "9_CR1765", "doi-asserted-by": "crossref", "first-page": "1690", "DOI": "10.1172/JCI2962", "volume": "102", "author": "KD Setchell", "year": "1998", "unstructured": "Setchell KD, Schwarz M, O\u2019Connell NC, Lund EG, Davis DL, Lathe R, Thompson HR, Weslie Tyson R, Sokol RJ, Russell DW (1998) Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7\u03b1-hydroxylase gene causes severe neonatal liver disease. J Clin Invest 102:1690\u20131703", "journal-title": "J Clin Invest"}, {"key": "9_CR1766", "doi-asserted-by": "crossref", "first-page": "579", "DOI": "10.1016/S0021-9150(00)00419-6", "volume": "154", "author": "RA Hegele", "year": "2001", "unstructured": "Hegele RA, Wang J, Harris SB, Brunt JH, Young TK, Hanley AJ, Zinman B, Connelly PW, Anderson CM (2001) Variable association between genetic variation in the CYP7 gene promoter and plasma lipoproteins in three Canadian populations. Atherosclerosis 154:579\u2013587", "journal-title": "Atherosclerosis"}, {"key": "9_CR1767", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1016/j.clnu.2010.07.020", "volume": "30", "author": "I De Castro-Oros", "year": "2011", "unstructured": "De Castro-Oros I, Pampin S, Cofan M, Mozas P, Pinto X, Salas-Salvado J, Rodriguez-Rey JC, Ros E, Civeira F, Pocovi M (2011) Promoter variant \u2212 204 A > C of the cholesterol 7\u03b1-hydroxylase gene: association with response to plant sterols in humans and increased transcriptional activity in transfected HepG2 cells. Clin Nutr 30:239\u2013246", "journal-title": "Clin Nutr"}, {"key": "9_CR1768", "doi-asserted-by": "crossref", "first-page": "406", "DOI": "10.1111/j.1349-7006.2006.00182.x", "volume": "97", "author": "S Tabata", "year": "2006", "unstructured": "Tabata S, Yin G, Ogawa S, Yamaguchi K, Mineshita M, Kono S (2006) Genetic polymorphism of cholesterol 7\u03b1-hydroxylase (CYP7A1) and colorectal adenomas: self defense forces health study. Cancer Sci 97:406\u2013410", "journal-title": "Cancer Sci"}, {"key": "9_CR1769", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1016/j.ymgme.2007.11.014", "volume": "94", "author": "A Srivastava", "year": "2008", "unstructured": "Srivastava A, Pandey SN, Choudhuri G, Mittal B (2008) Role of genetic variant A-204C of cholesterol 7\u03b1 -hydroxylase (CYP7A1) in susceptibility to gallbladder cancer. Mol Genet Metab 94:83\u201389", "journal-title": "Mol Genet Metab"}, {"key": "9_CR1770", "doi-asserted-by": "crossref", "first-page": "767", "DOI": "10.1016/j.metabol.2009.09.021", "volume": "59", "author": "A Srivastava", "year": "2010", "unstructured": "Srivastava A, Choudhuri G, Mittal B (2010) CYP7A1 (\u2212 204 A > C; rs3808607 and \u2212 469 T > C; rs3824260) promoter polymorphisms and risk of gallbladder cancer in North Indian population. Metab Clin Exp 59:767\u2013773", "journal-title": "Metab Clin Exp"}, {"key": "9_CR1771", "doi-asserted-by": "crossref", "first-page": "172", "DOI": "10.1016/0005-2760(75)90180-0", "volume": "398", "author": "S Balasubramaniam", "year": "1975", "unstructured": "Balasubramaniam S, Mitropoulos KA, Myant NB (1975) The substrate for cholesterol 7\u03b1-hydroxylase. Biochim Biophys Acta 398:172\u2013177", "journal-title": "Biochim Biophys Acta"}, {"key": "9_CR1772", "first-page": "1629", "volume": "41", "author": "M Norlin", "year": "2000", "unstructured": "Norlin M, Toll A, Bj\u00f6rkhem I, Wikvall K (2000) 24-hydroxycholesterol is a substrate for hepatic cholesterol 7\u03b1-hydroxylase (CYP7A). J Lipid Res 41:1629\u20131639", "journal-title": "J Lipid Res"}, {"key": "9_CR1773", "doi-asserted-by": "crossref", "first-page": "34046", "DOI": "10.1074/jbc.M002663200", "volume": "275", "author": "M Norlin", "year": "2000", "unstructured": "Norlin M, Andersson U, Bj\u00f6rkhem I, Wikvall K (2000) Oxysterol 7\u03b1-hydroxylase activity by cholesterol 7\u03b1-hydroxylase (CYP7A). J Biol Chem 275:34046\u201334053", "journal-title": "J Biol Chem"}, {"key": "9_CR1774", "doi-asserted-by": "crossref", "first-page": "967", "DOI": "10.1016/S0039-128X(02)00044-2", "volume": "67", "author": "R Lathe", "year": "2002", "unstructured": "Lathe R (2002) Steroid and sterol 7-hydroxylation: ancient pathways. Steroids 67:967\u2013977", "journal-title": "Steroids"}, {"key": "9_CR1775", "doi-asserted-by": "crossref", "first-page": "4632", "DOI": "10.1074/jbc.M110.193409", "volume": "286", "author": "R Shinkyo", "year": "2011", "unstructured": "Shinkyo R, Guengerich FP (2011) Cytochrome P450 7A1 cholesterol 7\u03b1-hydroxylation: individual reaction steps in the catalytic cycle and rate-limiting ferric iron reduction. J Biol Chem 286:4632\u20134643", "journal-title": "J Biol Chem"}, {"key": "9_CR1776", "doi-asserted-by": "crossref", "first-page": "3259", "DOI": "10.1021/bi047566a", "volume": "44", "author": "N Mast", "year": "2005", "unstructured": "Mast N, Graham SE, Andersson U, Bj\u00f6rkhem I, Hill C, Peterson J, Pikuleva IA (2005) Cholesterol binding to cytochrome P450 7A1, a key enzyme in bile acid biosynthesis. Biochemistry 44:3259\u20133271", "journal-title": "Biochemistry"}, {"key": "9_CR1777", "doi-asserted-by": "crossref", "first-page": "33021", "DOI": "10.1074/jbc.M111.282434", "volume": "286", "author": "R Shinkyo", "year": "2011", "unstructured": "Shinkyo R, Xu L, Tallman KA, Cheng Q, Porter NA, Guengerich FP (2011) Conversion of 7-dehydrocholesterol to 7-ketocholesterol is catalyzed by human cytochrome P450 7A1 and occurs by direct oxidation without an epoxide intermediate. J Biol Chem 286:33021\u201333028", "journal-title": "J Biol Chem"}, {"key": "9_CR1778", "unstructured": "Bj\u00f6rkhem I, Diczfalusy U, L\u00f6vgren-Sandblom A, Starck L, Jonsson M, Tallman K, Schirmer H, Ousager LB, Crick PJ, Wang Y, Griffiths WJ, Guengerich FP (2014) On the formation of 7-ketocholesterol from 7-dehydrocholesterol in patients with cerebrotendinous xanthomatosis and Smith-Lemli-Opitz syndrome. J Lipid Res 35:1165\u20131172", "DOI": "10.1194/jlr.P048603", "doi-asserted-by": "crossref"}, {"key": "9_CR1779", "doi-asserted-by": "crossref", "first-page": "1700", "DOI": "10.1111/febs.12733", "volume": "281", "author": "AV Yantsevich", "year": "2014", "unstructured": "Yantsevich AV, Dichenko YV, Mackenzie F, Mukha DV, Baranovsky AV, Gilep AA, Usanov SA, Strushkevich NV (2014) Human steroid and oxysterol 7\u03b1-hydroxylase CYP7B1: substrate specificity, azolebinding and misfolding of clinically relevant mutants. FEBS J 281:1700\u20131713", "journal-title": "FEBS J"}, {"key": "9_CR1780", "doi-asserted-by": "crossref", "first-page": "31459", "DOI": "10.1074/jbc.M103943200", "volume": "276", "author": "K Nakayama", "year": "2001", "unstructured": "Nakayama K, Puchkaev A, Pikuleva IA (2001) Membrane binding and substrate accessmerge in cytochrome P450 7A1, a key enzyme in degradation of cholesterol. J Biol Chem 276:31459\u201331465", "journal-title": "J Biol Chem"}, {"key": "9_CR1781", "doi-asserted-by": "crossref", "first-page": "449", "DOI": "10.1016/j.pharmthera.2007.08.003", "volume": "116", "author": "F Gilardi", "year": "2007", "unstructured": "Gilardi F, Mitro N, Godio C, Scotti E, Caruso D, Crestani M, De Fabiani E (2007) The pharmacological exploitation of cholesterol 7\u03b1-hydroxylase, the key enzyme in bile acid synthesis: from binding resins to chromatin remodelling to reduce plasma cholesterol. Pharmacol Ther 116:449\u2013472", "journal-title": "Pharmacol Ther"}, {"key": "9_CR1782", "doi-asserted-by": "crossref", "first-page": "1447", "DOI": "10.1002/hep.510250623", "volume": "25", "author": "D Stahlberg", "year": "1997", "unstructured": "Stahlberg D, Rudling M, Angelin B, Bj\u00f6rkhem I, Forsell P, Nilsell K, Einarsson K (1997) Hepatic cholesterol metabolism in human obesity. Hepatology 25:1447\u20131450", "journal-title": "Hepatology"}, {"key": "9_CR1783", "doi-asserted-by": "crossref", "first-page": "3064", "DOI": "10.1161/01.ATV.17.11.3064", "volume": "17", "author": "SM Post", "year": "1997", "unstructured": "Post SM, de Wit EC, Princen HM (1997) Cafestol, the cholesterol-raising factor in boiled coffee, suppresses bile acid synthesis by downregulation of cholesterol 7\u03b1-hydroxylase and sterol 27-hydroxylase in rat hepatocytes. Arterioscler Thromb Vasc Biol 17:3064\u20133070", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "9_CR1784", "doi-asserted-by": "crossref", "first-page": "G8", "DOI": "10.1152/ajpgi.2001.281.4.G878", "volume": "281", "author": "WM Pandak", "year": "2001", "unstructured": "Pandak WM, Schwarz C, Hylemon PB, Mallonee D, Valerie K, Heuman DM, Fisher RA, Redford K, Vlahcevic ZR (2001) Effects of CYP7A1 overexpression on cholesteroland bile acid homeostasis. Am J Physiol Gastrointest Liver Physiol 281:G878\u2013889", "journal-title": "Am J Physiol Gastrointest Liver Physiol"}, {"key": "9_CR1785", "doi-asserted-by": "crossref", "first-page": "176", "DOI": "10.1055/s-2007-979016", "volume": "29", "author": "G Sauter", "year": "1997", "unstructured": "Sauter G, Weiss M, Hoermann R (1997) Cholesterol 7\u03b1-hydroxylase activity in hypothyroidism and hyperthyroidism in humans. Horm Metab Res 29:176\u2013179", "journal-title": "Horm Metab Res"}, {"key": "9_CR1786", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1172/JCI0215387", "volume": "110", "author": "CR Pullinger", "year": "2002", "unstructured": "Pullinger CR, Eng C, Salen G, Shefer S, Batta AK, Erickson SK, Verhagen A, Rivera CR, Mulvihill SJ, Malloy MJ, Kane JP (2002) Human cholesterol 7\u03b1-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest 110:109\u2013117", "journal-title": "J Clin Invest"}, {"key": "9_CR1787", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1172/JCI0216076", "volume": "110", "author": "A Beigneux", "year": "2002", "unstructured": "Beigneux A, Hofmann AF, Young SG (2002) Human CYP7A1 deficiency: progress and enigmas. J Clin Invest 110:29\u201331", "journal-title": "J Clin Invest"}, {"key": "9_CR1788", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1016/S0009-9120(03)00025-0", "volume": "36", "author": "JA Hubacek", "year": "2003", "unstructured": "Hubacek JA, Pitha J, Skodova Z, Poledne R, Lanska V, Waterworth DM, Humphries SE, Talmud PJ (2003) Polymorphisms in CYP-7A1, not APOE, influence the change in plasma lipids in response to population dietary change in an 8 year follow-up; results from the Czech MONICA study. Clin Biochem 36:263\u2013267", "journal-title": "Clin Biochem"}, {"key": "9_CR1789", "doi-asserted-by": "crossref", "first-page": "1508", "DOI": "10.3748/wjg.v10.i10.1508", "volume": "10", "author": "ZY Jiang", "year": "2004", "unstructured": "Jiang ZY, Han TQ, Suo GJ, Feng DX, Chen S, Cai XX, Jiang ZH, Shang J, Zhang Y, Jiang Y, Zhang SD (2004) Polymorphisms at cholesterol 7\u03b1-hydroxylase, apolipoproteins B and E and low density lipoprotein receptor genes in patients with gallbladder stone disease. World J Gastroenterol 10:1508\u20131512", "journal-title": "World J Gastroenterol"}, {"key": "9_CR1790", "doi-asserted-by": "crossref", "first-page": "935", "DOI": "10.1038/sj.ejhg.5201236", "volume": "12", "author": "MK Hofman", "year": "2004", "unstructured": "Hofman MK, Groenendijk M, Verkuijlen PJ, Jonkers IJ, Mohrschladt MF, Smelt AH, Princen HM (2004) Modulating effect of the A-278C promoter polymorphism in the cholesterol 7\u03b1-hydroxylase gene on serum lipid levels in normolipidaemic and hypertriglyceridaemic individuals. Eur J Hum Genet 12:935\u2013941", "journal-title": "Eur J Hum Genet"}, {"key": "9_CR1791", "first-page": "565", "volume": "53", "author": "J Kovar", "year": "2004", "unstructured": "Kovar J, Suchanek P, Hubacek JA, Poledne R (2004) The A-204C polymorphism in the cholesterol 7\u03b1-hydroxylase (CYP7A1) gene determines the cholesterolemia responsiveness to a high-fat diet. Physiol Res 53:565\u2013568", "journal-title": "Physiol Res"}, {"key": "9_CR1792", "doi-asserted-by": "crossref", "first-page": "2200", "DOI": "10.1093/jn/134.9.2200", "volume": "134", "author": "MK Hofman", "year": "2004", "unstructured": "Hofman MK, Weggemans RM, Zock PL, Schouten EG, Katan MB, Princen HM (2004) CYP7A1 A-278C polymorphism affects the response of plasma lipids after dietary cholesterol or cafestol interventions in humans. J Nutr 134:2200\u20132204", "journal-title": "J Nutr"}, {"key": "9_CR1793", "doi-asserted-by": "crossref", "first-page": "254", "DOI": "10.1097/FJC.0b013e31823de86b", "volume": "59", "author": "J Shen", "year": "2012", "unstructured": "Shen J, Arnett DK, Parnell LD, Lai CQ, Straka RJ, Hopkins PN, An P, Feitosa MF, Ordovas JM (2012) The effect of CYP7A1 polymorphisms on lipid responses to fenofibrate. J Cardiovasc Pharmacol 59:254\u2013259", "journal-title": "J Cardiovasc Pharmacol"}, {"key": "9_CR1794", "doi-asserted-by": "crossref", "first-page": "407", "DOI": "10.1016/j.atherosclerosis.2004.12.019", "volume": "180", "author": "K Kajinami", "year": "2005", "unstructured": "Kajinami K, Brousseau ME, Ordovas JM, Schaefer EJ (2005) A promoter polymorphism in cholesterol 7\u03b1-hydroxylase interacts with apolipoprotein E genotype in the LDL-lowering response to atorvastatin. Atherosclerosis 180:407\u2013415", "journal-title": "Atherosclerosis"}, {"key": "9_CR1795", "doi-asserted-by": "crossref", "first-page": "287", "DOI": "10.1016/j.atherosclerosis.2004.03.015", "volume": "175", "author": "K Kajinami", "year": "2004", "unstructured": "Kajinami K, Brousseau ME, Ordovas JM, Schaefer EJ (2004) Interactions between common genetic polymorphisms in ABCG5/G8 and CYP7A1 on LDL cholesterol-lowering response to atorvastatin. Atherosclerosis 175:287\u2013293", "journal-title": "Atherosclerosis"}, {"key": "9_CR1796", "doi-asserted-by": "crossref", "first-page": "719", "DOI": "10.1111/j.1365-2710.2012.01372.x", "volume": "37", "author": "XY Jiang", "year": "2012", "unstructured": "Jiang XY, Zhang Q, Chen P, Li SY, Zhang NN, Chen XD, Wang GC, Wang HB, Zhuang MQ, Lu M (2012) CYP7A1 polymorphism influences the LDL cholesterol-lowering response to atorvastatin. J Clin Pharm Ther 37:719\u2013723", "journal-title": "J Clin Pharm Ther"}, {"key": "9_CR1797", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1089/gte.2007.0067", "volume": "12", "author": "Z Juzyszyn", "year": "2008", "unstructured": "Juzyszyn Z, Kurzawski M, Lener A, Modrzejewski A, Pawlik A, Drozdzik M (2008) Cholesterol 7\u03b1-hydrolase (CYP7A1) c.\u2212 278 A > C promoter polymorphism in gallstone disease patients. Genet Test 12:97\u2013100", "journal-title": "Genet Test"}, {"key": "9_CR1798", "doi-asserted-by": "crossref", "first-page": "2664", "DOI": "10.1194/jlr.M800364-JLR200", "volume": "49", "author": "M Lenicek", "year": "2008", "unstructured": "Lenicek M, Komarek V, Zimolova M, Kovar J, Jirsa M, Lukas M, Vitek L (2008) CYP7A1 promoter polymorphism \u2212 203 A > C affects bile salt synthesis rate in patients after ileal resection. J Lipid Res 49:2664\u20132667", "journal-title": "J Lipid Res"}, {"key": "9_CR1799", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1016/j.nbd.2009.10.013", "volume": "37", "author": "HJ Kim", "year": "2010", "unstructured": "Kim HJ, Park HY, Kim E, Lee KS, Kim KK, Choi BO, Kim SM, Bae JS, Lee SO, Chun JY, Park TJ, Cheong HS, Jo I, Shin HD (2010) Common CYP7A1 promoter polymorphism associated with risk of neuromyelitis optica. Neurobiol Dis 37:349\u2013355", "journal-title": "Neurobiol Dis"}, {"key": "9_CR1800", "doi-asserted-by": "crossref", "first-page": "722", "DOI": "10.1038/hr.2011.18", "volume": "34", "author": "L Fu", "year": "2011", "unstructured": "Fu L, Zhao Y, Wu X, Liu H, Shi J, Lu J, Zhou B (2011) CYP7A1 genotypes and haplotypes associated with hypertension in an obese Han Chinese population. Hypertens Res 34:722\u2013727", "journal-title": "Hypertens Res"}, {"key": "9_CR1801", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1111/j.1432-1033.1994.00309.x", "volume": "224", "author": "A Toll", "year": "1994", "unstructured": "Toll A, Wikvall K, Sudjana-Sugiaman E, Kondo KH, Bjorkhem I (1994) 7 alpha hydroxylation of 25-hydroxycholesterol in liver microsomes. Evidence that the enzyme involved is different from cholesterol 7\u03b1-hydroxylase. Eur J Biochem 224:309\u2013316", "journal-title": "Eur J Biochem"}, {"key": "9_CR1802", "doi-asserted-by": "crossref", "first-page": "28485", "DOI": "10.1074/jbc.R109.042168", "volume": "284", "author": "AR Stiles", "year": "2009", "unstructured": "Stiles AR, McDonald JG, Bauman DR, Russell DW (2009) CYP7B1: one cytochrome P450, two human genetic diseases, and multiple physiological functions. J Biol Chem 284:28485\u201328489", "journal-title": "J Biol Chem"}, {"key": "9_CR1803", "doi-asserted-by": "crossref", "first-page": "761", "DOI": "10.1016/j.pharmthera.2006.05.014", "volume": "112", "author": "IA Pikuleva", "year": "2006", "unstructured": "Pikuleva IA (2006) Cytochrome P450s and cholesterol homeostasis. Pharmacol Ther 112:761\u2013773", "journal-title": "Pharmacol Ther"}, {"key": "9_CR1804", "doi-asserted-by": "crossref", "first-page": "513", "DOI": "10.1124/dmd.105.008789", "volume": "34", "author": "IA Pikuleva", "year": "2006", "unstructured": "Pikuleva IA (2006) Cholesterol-metabolizing cytochromes P450. Drug Metab Dispos 34:513\u2013520", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1805", "first-page": "2195", "volume": "40", "author": "Z Wu", "year": "1999", "unstructured": "Wu Z, Martin KO, Javitt NB, Chiang JY (1999) Structure and functions of human oxysterol 7\u03b1-hydroxylase cDNAs and gene CYP7B1. J Lipid Res 40:2195\u20132203", "journal-title": "J Lipid Res"}, {"key": "9_CR1806", "doi-asserted-by": "crossref", "first-page": "1439", "DOI": "10.1002/pros.20630", "volume": "67", "author": "M Olsson", "year": "2007", "unstructured": "Olsson M, Gustafsson O, Skogastierna C, Tolf A, Rietz BD, Morfin R, Rane A, Ekstrom L (2007) Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma. Prostate 67:1439\u20131446", "journal-title": "Prostate"}, {"key": "9_CR1807", "doi-asserted-by": "crossref", "first-page": "29739", "DOI": "10.1074/jbc.270.50.29739", "volume": "270", "author": "G Stapleton", "year": "1995", "unstructured": "Stapleton G, Steel M, Richardson M, Mason JO, Rose KA, Morris RGM, Lathe R (1995) A novel cytochrome P450 expressed primarily in brain. J Biol Chem 270:29739\u201329745", "journal-title": "J Biol Chem"}, {"key": "9_CR1808", "doi-asserted-by": "crossref", "first-page": "4925", "DOI": "10.1073/pnas.94.10.4925", "volume": "94", "author": "KA Rose", "year": "1997", "unstructured": "Rose KA, Stapleton G, Dott K, Kieny MP, Best R, Schwarz M, Russell DW, Bjorkhem I, Seckl J, Lathe R (1997) Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7\u03b1-hydroxydehydroepiandrosterone and 7\u03b1-hydroxypregnenolone. Proc Natl Acad Sci U S A 94:4925\u20134930", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR1809", "doi-asserted-by": "crossref", "first-page": "23995", "DOI": "10.1074/jbc.272.38.23995", "volume": "272", "author": "M Schwarz", "year": "1997", "unstructured": "Schwarz M, Lund EG, Lathe R, Bjorkhem I, Russell DW (1997) Identification and characterization of a mouse oxysterol 7\u03b1-hydroxylase cDNA. J Biol Chem 272:23995\u201324001", "journal-title": "J Biol Chem"}, {"key": "9_CR1810", "doi-asserted-by": "crossref", "first-page": "540", "DOI": "10.1016/j.bbrc.2006.03.175", "volume": "344", "author": "W Tang", "year": "2006", "unstructured": "Tang W, Norlin M (2006) Regulation of steroid hydroxylase CYP7B1 by androgens and estrogens in prostate cancer LNCaP cells. Biochem Biophys Res Commun 344:540\u2013546", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1811", "doi-asserted-by": "crossref", "first-page": "30118", "DOI": "10.1074/jbc.M102516200", "volume": "276", "author": "RA Memon", "year": "2001", "unstructured": "Memon RA, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR (2001) In vivo and in vitro regulation of sterol 27-hydroxylase in the liver during the acute phase response. Potential role of hepatocyte nuclear factor-1. J Biol Chem 276:30118\u201330126", "journal-title": "J Biol Chem"}, {"key": "9_CR1812", "doi-asserted-by": "crossref", "first-page": "191", "DOI": "10.1016/S0378-1119(01)00541-8", "volume": "272", "author": "Z Wu", "year": "2001", "unstructured": "Wu Z, Chiang JY (2001) Transcriptional regulation of human oxysterol 7\u03b1-hydroxylase gene (CYP7B1) by Sp1. Gene 272:191\u2013197", "journal-title": "Gene"}, {"key": "9_CR1813", "doi-asserted-by": "crossref", "first-page": "395", "DOI": "10.1016/j.bbrc.2005.02.170", "volume": "330", "author": "A Abrahamsson", "year": "2005", "unstructured": "Abrahamsson A, Gustafsson U, Ellis E, Nilsson LM, Sahlin S, Bjorkhem I, Einarsson C (2005) Feedback regulation of bile acid synthesis in human liver: importance of HNF-4\u03b1 for regulation of CYP7A1. Biochem Biophys Res Commun 330:395\u2013399", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1814", "doi-asserted-by": "crossref", "first-page": "1191", "DOI": "10.3181/0802-MR-50", "volume": "233", "author": "T Wada", "year": "2008", "unstructured": "Wada T, Kang HS, Jetten AM, Xie W (2008) The emerging role of nuclear receptor ROR\u03b1 and its crosstalk with LXRin xeno- and endobiotic gene regulation. Exp Biol Med 233:1191\u20131201", "journal-title": "Exp Biol Med"}, {"key": "9_CR1815", "doi-asserted-by": "crossref", "first-page": "62", "DOI": "10.1016/j.nmd.2008.10.009", "volume": "19", "author": "R Biancheri", "year": "2009", "unstructured": "Biancheri R, Ciccolella M, Rossi A, Tessa A, Cassandrini D, Minetti C, Santorelli FM (2009) White matter lesions in spastic paraplegia with mutations in SPG5/CYP7B1. Neuromusc Disord 19:62\u201365", "journal-title": "Neuromusc Disord"}, {"key": "9_CR1816", "doi-asserted-by": "crossref", "first-page": "1252", "DOI": "10.1007/s00415-009-5109-3", "volume": "256", "author": "C Criscuolo", "year": "2009", "unstructured": "Criscuolo C, Filla A, Coppola G, Rinaldi C, Carbone R, Pinto S, Wang Q, de Leva MF, Salvatore E, Banfi S, Brunetti A, Quarantelli M, Geschwind DH, Pappata S, De Michele G (2009) Two novel CYP7B1 mutations in Italian families with SPG5: a clinical and genetic study. J Neurol 256:1252\u20131257", "journal-title": "J Neurol"}, {"key": "9_CR1817", "doi-asserted-by": "crossref", "first-page": "1589", "DOI": "10.1093/brain/awp073", "volume": "132", "author": "C Goizet", "year": "2009", "unstructured": "Goizet C, Boukhris A, Durr A, Beetz C, Truchetto J, Tesson C, Tsaousidou M, Forlani S, Guyant-Marechal L, Fontaine B, Guimaraes J, Isidor B, Chazouilleres O, Wendum D, Grid D, Chevy F, Chinnery PF, Coutinho P, Azulay JP, Feki I, Mochel F, Wolf C, Mhiri C, Crosby A, Brice A, Stevanin G (2009) CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5. Brain J Neurol 132:1589\u20131600", "journal-title": "Brain J Neurol"}, {"key": "9_CR1818", "doi-asserted-by": "crossref", "first-page": "148", "DOI": "10.1111/j.1399-0004.2011.01715.x", "volume": "80", "author": "NA Schlipf", "year": "2011", "unstructured": "Schlipf NA, Schule R, Klimpe S, Karle KN, Synofzik M, Schicks J, Riess O, Schols L, Bauer P (2011) Amplicon-based high-throughput pooled sequencing identifies mutations in CYP7B1 and SPG7 in sporadic spastic paraplegia patients. Clin Genet 80:148\u2013160", "journal-title": "Clin Genet"}, {"key": "9_CR1819", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1038/sj.tpj.6500236", "volume": "4", "author": "J Jakobsson", "year": "2004", "unstructured": "Jakobsson J, Karypidis H, Johansson JE, Roh HK, Rane A, Ekstrom L (2004) A functional C-G polymorphism in the CYP7B1 promoter region and its different distribution in orientals and Caucasians. Pharmacogenomics J 4:245\u2013250", "journal-title": "Pharmacogenomics J"}, {"key": "9_CR1820", "doi-asserted-by": "crossref", "first-page": "441", "DOI": "10.1007/s00894-011-1084-6", "volume": "18", "author": "A Siam", "year": "2012", "unstructured": "Siam A, Brancale A, Simons C (2012) Comparative modeling of 25-hydroxycholesterol-7\u03b1-hydroxylase (CYP7B1): ligand binding and analysis of hereditary spastic paraplegia type 5 CYP7B1 mutations. J Mol Model 18:441\u2013453", "journal-title": "J Mol Model"}, {"key": "9_CR1821", "doi-asserted-by": "crossref", "first-page": "330", "DOI": "10.1111/ane.12188", "volume": "129", "author": "P Roos", "year": "2014", "unstructured": "Roos P, Svenstrup K, Danielsen ER, Thomsen C, Nielsen JE (2014) CYP7B1: novel mutations and magnetic resonance spectroscopy abnormalities in hereditary spastic paraplegia type 5A. Acta Neurol Scand 129:330\u2013334", "journal-title": "Acta Neurol Scand"}, {"key": "9_CR1822", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1017/S0317167100012774", "volume": "39", "author": "A Noreau", "year": "2012", "unstructured": "Noreau A, Dion PA, Szuto A, Levert A, Thibodeau P, Brais B, Dupre N, Rioux MF, Rouleau GA (2012) CYP7B1 mutations in French-Canadian hereditary spastic paraplegia subjects. Can J Neurol Sci 39:91\u201394", "journal-title": "Can J Neurol Sci"}, {"key": "9_CR1823", "doi-asserted-by": "crossref", "first-page": "1354", "DOI": "10.1002/mds.23466", "volume": "26", "author": "L Cao", "year": "2011", "unstructured": "Cao L, Fei QZ, Tang WG, Liu JR, Zheng L, Xiao Q, He SB, Fu Y, Chen SD (2011) Novel mutations in the CYP7B1 gene cause hereditary spastic paraplegia. Mov Disord 26:1354\u20131356", "journal-title": "Mov Disord"}, {"key": "9_CR1824", "doi-asserted-by": "crossref", "first-page": "150", "DOI": "10.1111/j.1399-0004.2011.01624.x", "volume": "81", "author": "A Arnoldi", "year": "2012", "unstructured": "Arnoldi A, Crimella C, Tenderini E, Martinuzzi A, D\u2019Angelo MG, Musumeci O, Toscano A, Scarlato M, Fantin M, Bresolin N, Bassi MT (2012) Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations. Clin Genet 81:150\u2013157", "journal-title": "Clin Genet"}, {"key": "9_CR1825", "doi-asserted-by": "crossref", "first-page": "819", "DOI": "10.1194/jlr.M002543", "volume": "51", "author": "R Schule", "year": "2010", "unstructured": "Schule R, Siddique T, Deng HX, Yang Y, Donkervoort S, Hansson M, Madrid RE, Siddique N, Schols L, Bj\u00f6rkhem I (2010) Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis. J Lipid Res 51:819\u2013823", "journal-title": "J Lipid Res"}, {"key": "9_CR1826", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.jns.2012.03.025", "volume": "318", "author": "J Finsterer", "year": "2012", "unstructured": "Finsterer J, Loscher W, Quasthoff S, Wanschitz J, Auer-Grumbach M, Stevanin G (2012) Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance. J Neurol Sci 318:1\u201318", "journal-title": "J Neurol Sci"}, {"key": "9_CR1827", "first-page": "1059", "volume": "17", "author": "T Mizuochi", "year": "2011", "unstructured": "Mizuochi T, Kimura A, Suzuki M, Ueki I, Takei H, Nittono H, Kakiuchi T, Shigeta T, Sakamoto S, Fukuda A, Nakazawa A, Shimizu T, Kurosawa T, Kasahara M (2011) Successful heterozygous living donor liver transplantation for an oxysterol 7\u03b1-hydroxylase deficiency in a Japanese patient. Liver Transpl 17:1059\u20131065", "journal-title": "Liver Transpl"}, {"key": "9_CR1828", "doi-asserted-by": "crossref", "first-page": "453", "DOI": "10.4103/0975-7406.84465", "volume": "3", "author": "V Dias", "year": "2011", "unstructured": "Dias V, Ribeiro V (2011) Ethnic differences in the prevalence of polymorphisms in CYP7A1, CYP7B1 and CYP27A1 enzymes involved in cholesterolmetabolism. J Pharm Bioallied Sci 3:453\u2013459", "journal-title": "J Pharm Bioallied Sci"}, {"key": "9_CR1829", "doi-asserted-by": "crossref", "first-page": "713", "DOI": "10.1046/j.1471-4159.2002.01187.x", "volume": "83", "author": "S Steckelbroeck", "year": "2002", "unstructured": "Steckelbroeck S, Watzka M, Lutjohann D, Makiola P, Nassen A, Hans VH, Clusmann H, Reissinger A, Ludwig M, Siekmann L, Klingmuller D (2002) Characterization of the dehydroepiandrosterone (DHEA) metabolism via oxysterol 7\u03b1-hydroxylase and 17-ketosteroid reductase activity in the human brain. J Neurochem 83:713\u2013726", "journal-title": "J Neurochem"}, {"key": "9_CR1830", "doi-asserted-by": "crossref", "first-page": "549", "DOI": "10.1002/chem.201202627", "volume": "19", "author": "YL Cui", "year": "2013", "unstructured": "Cui YL, Zhang JL, Zheng QC, Niu RJ, Xu Y, Zhang HX, Sun CC (2013) Structural and dynamic basis of human cytochrome P450 7B1: a survey of substrate selectivity and major active site access channels. Chemistry 19:549\u2013557", "journal-title": "Chemistry"}, {"key": "9_CR1831", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1042/bj3550509", "volume": "355", "author": "C Martin", "year": "2001", "unstructured": "Martin C, Bean R, Rose K, Habib F, Seckl J (2001) CYP7B1 catalyses the 7\u03b1-hydroxylation of dehydroepiandrosterone and 25-hydroxycholesterol in rat prostate. Biochem J 355:509\u2013515", "journal-title": "Biochem J"}, {"key": "9_CR1832", "doi-asserted-by": "crossref", "first-page": "1690", "DOI": "10.1172/JCI2962", "volume": "102", "author": "KD Setchell", "year": "1998", "unstructured": "Setchell KD, Schwarz M, O\u2019Connell NC, Lund EG, Davis DL, Lathe R, Thompson HR, Weslie Tyson R, Sokol RJ, Russell DW (1998) Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7\u03b1-hydroxylase gene causes severe neonatal liver disease. J Clin Invest 102:1690\u20131703", "journal-title": "J Clin Invest"}, {"key": "9_CR1833", "doi-asserted-by": "crossref", "first-page": "831", "DOI": "10.1016/S1089-3261(05)70144-6", "volume": "4", "author": "KE Bove", "year": "2000", "unstructured": "Bove KE (2000) Liver disease caused by disorders of bile acid synthesis. Clinics Liver Dis 4:831\u2013848", "journal-title": "Clinics Liver Dis"}, {"key": "9_CR1834", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1016/S0306-4522(03)00438-X", "volume": "121", "author": "JL Yau", "year": "2003", "unstructured": "Yau JL, Rasmuson S, Andrew R, Graham M, Noble J, Olsson T, Fuchs E, Lathe R, Seckl JR (2003) Dehydroepiandrosterone 7-hydroxylase CYP7B: predominant expression in primate hippocampus and reduced expression in Alzheimer\u2019s disease. Neuroscience 121:307\u2013314", "journal-title": "Neuroscience"}, {"key": "9_CR1835", "doi-asserted-by": "crossref", "first-page": "770", "DOI": "10.1002/art.20950", "volume": "52", "author": "J Dulos", "year": "2005", "unstructured": "Dulos J, van der Vleuten MA, Kavelaars A, Heijnen CJ, Boots AM (2005) CYP7B expression and activity in fibroblast-like synoviocytes from patients with rheumatoid arthritis: regulation by proinflammatory cytokines. Arthritis Rheum 52:770\u2013778", "journal-title": "Arthritis Rheum"}, {"key": "9_CR1836", "doi-asserted-by": "crossref", "first-page": "637", "DOI": "10.1016/j.celrep.2013.10.006", "volume": "5", "author": "Q Wu", "year": "2013", "unstructured": "Wu Q, Ishikawa T, Sirianni R, Tang H, McDonald JG, Yuhanna IS, Thompson B, Girard L, Mineo C, Brekken RA, Umetani M, Euhus DM, Xie Y, Shaul PW (2013) 27-hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth. Cell Rep 5:637\u2013645", "journal-title": "Cell Rep"}, {"key": "9_CR1837", "doi-asserted-by": "crossref", "first-page": "271", "DOI": "10.1093/oxfordjournals.bmb.a071832", "volume": "39", "author": "S Bunting", "year": "1983", "unstructured": "Bunting S, Moncada S, Vane JR (1983) The prostacyclin-thromboxane A2 balance: pathophysiological and therapeutic implications. Br Med Bull 39:271\u2013276", "journal-title": "Br Med Bull"}, {"key": "9_CR1838", "doi-asserted-by": "crossref", "first-page": "1728", "DOI": "10.1006/bbrc.1994.1652", "volume": "200", "author": "A Miyata", "year": "1994", "unstructured": "Miyata A, Hara S, Yokoyama C, Inoue H, Ullrich V, Tanabe T (1994) Molecular cloning and expression of human prostacyclin synthase. Biochem Biophys Res Commun 200:1728\u20131734", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1839", "doi-asserted-by": "crossref", "first-page": "2033", "DOI": "10.1016/0006-2952(81)90218-5", "volume": "30", "author": "V Ullrich", "year": "1981", "unstructured": "Ullrich V, Castle L, Weber P (1981) Spectral evidence for the cytochrome P450 nature of prostacyclin synthetase. Biochem Pharmacol 30:2033\u20132036", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR1840", "first-page": "3285", "volume": "258", "author": "DL DeWitt", "year": "1983", "unstructured": "DeWitt DL, Smith WL (1983) Purification of prostacyclin synthase from bovine aorta by immunoaffinity chromatography. Evidence that the enzyme is a hemoprotein. J Biol Chem 258:3285\u20133293", "journal-title": "J Biol Chem"}, {"key": "9_CR1841", "first-page": "19897", "volume": "269", "author": "S Hara", "year": "1994", "unstructured": "Hara S, Miyata A, Yokoyama C, Inoue H, Brugger R, Lottspeich F, Ullrich V, Tanabe T (1994) Isolation and molecular cloning of prostacyclin synthase from bovine endothelial cells. J Biol Chem 269:19897\u201319903", "journal-title": "J Biol Chem"}, {"key": "9_CR1842", "doi-asserted-by": "crossref", "first-page": "507", "DOI": "10.1006/excr.1995.1259", "volume": "219", "author": "E Spisni", "year": "1995", "unstructured": "Spisni E, Bartolini G, Orlandi M, Belletti B, Santi S, Tomasi V (1995) Prostacyclin (PGI2) synthase is a constitutively expressed enzyme in human endothelial cells. Exp Cell Res 219:507\u2013513", "journal-title": "Exp Cell Res"}, {"key": "9_CR1843", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.1016/S0304-3940(99)00558-3", "volume": "271", "author": "M Mehl", "year": "1999", "unstructured": "Mehl M, Bidmon HJ, Hilbig H, Zilles K, Dringen R, Ullrich V (1999) Prostacyclin synthase is localized in rat, bovine and human neuronal brain cells. Neurosci Lett 271:187\u2013190", "journal-title": "Neurosci Lett"}, {"key": "9_CR1844", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.1177/002215540004800507", "volume": "48", "author": "I Siegle", "year": "2000", "unstructured": "Siegle I, Klein T, Zou MH, Fritz P, Komhoff M (2000) Distribution and cellular localization of prostacyclin synthase in human brain. J Histochem Cytochem 48:631\u2013641", "journal-title": "J Histochem Cytochem"}, {"key": "9_CR1845", "doi-asserted-by": "crossref", "first-page": "4361", "DOI": "10.1210/jc.2002-020199", "volume": "87", "author": "JC Huang", "year": "2002", "unstructured": "Huang JC, Arbab F, Tumbusch KJ, Goldsby JS, Matijevic-Aleksic N, Wu KK (2002) Human fallopian tubes express prostacyclin (PGI) synthase and cyclooxygenases and synthesize abundant PGI. J Clin Endocrinol Metab 87:4361\u20134368", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR1846", "doi-asserted-by": "crossref", "first-page": "296", "DOI": "10.1006/geno.1996.0465", "volume": "36", "author": "C Yokoyama", "year": "1996", "unstructured": "Yokoyama C, Yabuki T, Inoue H, Tone Y, Hara S, Hatae T, Nagata M, Takahashi EI, Tanabe T (1996) Human gene encoding prostacyclin synthase (PTGIS): genomicorganization, chromosomal localization, and promoter activity. Genomics 36:296\u2013304", "journal-title": "Genomics"}, {"key": "9_CR1847", "doi-asserted-by": "crossref", "first-page": "803", "DOI": "10.1006/bbrc.1996.0677", "volume": "221", "author": "T Nakayama", "year": "1996", "unstructured": "Nakayama T, Soma M, Izumi Y, Kanmatsuse K (1996) Organization of the human prostacyclin synthase gene. Biochem Biophys Res Commun 221:803\u2013806", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1848", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.1006/bbrc.1996.1407", "volume": "226", "author": "LH Wang", "year": "1996", "unstructured": "Wang LH, Chen L (1996) Organization of the gene encoding human prostacyclin synthase. Biochem Biophys Res Commun 226:631\u2013637", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1849", "doi-asserted-by": "crossref", "first-page": "7320", "DOI": "10.1038/sj.onc.1208883", "volume": "24", "author": "J Frigola", "year": "2005", "unstructured": "Frigola J, Munoz M, Clark SJ, Moreno V, Capella G, Peinado MA (2005) Hypermethylation of the prostacyclin synthase (PTGIS) promoter is a frequent event in colorectal cancer and associated with aneuploidy. Oncogene 24:7320\u20137326", "journal-title": "Oncogene"}, {"key": "9_CR1850", "doi-asserted-by": "crossref", "first-page": "12813", "DOI": "10.1074/jbc.M208080200", "volume": "278", "author": "P Schmidt", "year": "2003", "unstructured": "Schmidt P, Youhnovski N, Daiber A, Balan A, Arsic M, Bachschmid M, Przybylski M, Ullrich V (2003) Specific nitration at tyrosine 430 revealed by high resolution mass spectrometry as basis for redox regulation of bovine prostacyclin synthase. J Biol Chem 278:12813\u201312819", "journal-title": "J Biol Chem"}, {"key": "9_CR1851", "doi-asserted-by": "crossref", "first-page": "536", "DOI": "10.1016/j.bbrc.2005.08.157", "volume": "338", "author": "M Bachschmid", "year": "2005", "unstructured": "Bachschmid M, Schildknecht S, Ullrich V (2005) Redox regulation of vascular prostanoid synthesis by the nitric oxide-superoxidesystem. Biochem Biophys Res Commun 338:536\u2013542", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1852", "doi-asserted-by": "crossref", "first-page": "2835", "DOI": "10.1016/j.ajpath.2011.08.041", "volume": "179", "author": "MH Zou", "year": "2011", "unstructured": "Zou MH, Li H, He C, Lin M, Lyons TJ, Xie Z (2011) Tyrosine nitration of prostacyclin synthase is associated with enhanced retinal cell apoptosisin diabetes. Am J Pathol 179:2835\u20132844", "journal-title": "Am J Pathol"}, {"key": "9_CR1853", "doi-asserted-by": "crossref", "first-page": "553", "DOI": "10.1291/hypres.26.553", "volume": "26", "author": "T Nakayama", "year": "2003", "unstructured": "Nakayama T, Soma M, Haketa A, Aoi N, Kosuge K, Sato M, Kanmatsuse K, Kokubun S (2003) Haplotype analysis of the prostacyclin synthase gene and essential hypertension. Hypertens Res 26:553\u2013557", "journal-title": "Hypertens Res"}, {"key": "9_CR1854", "doi-asserted-by": "crossref", "first-page": "184", "DOI": "10.1111/j.1440-1843.2004.00568.x", "volume": "9", "author": "S Amano", "year": "2004", "unstructured": "Amano S, Tatsumi K, Tanabe N, Kasahara Y, Kurosu K, Takiguchi Y, Kasuya Y, Kimura S, Kuriyama T (2004) Polymorphism of the promoter region of prostacyclin synthase gene in chronic thromboembolic pulmonary hypertension. Respirology 9:184\u2013189", "journal-title": "Respirology"}, {"key": "9_CR1855", "doi-asserted-by": "crossref", "first-page": "574", "DOI": "10.1177/1076029608329581", "volume": "15", "author": "X Xiang", "year": "2009", "unstructured": "Xiang X, Ma YT, Fu ZY, Yang YN, Xiang M, Chen BD, Wang YH, Fen L (2009) Haplotype analysis of the CYP8A1 gene associated with myocardial infarction. Clin Appl Thromb Hemost 15:574\u2013580", "journal-title": "Clin Appl Thromb Hemost"}, {"key": "9_CR1856", "doi-asserted-by": "crossref", "first-page": "461", "DOI": "10.1177/0003319711425230", "volume": "63", "author": "E Bousoula", "year": "2012", "unstructured": "Bousoula E, Kolovou V, Vasiliadis I, Karakosta A, Xanthos T, Johnson EO, Skandalakis P, Kolovou GD (2012) CYP8A1 gene polymorphisms and left main coronary artery disease. Angiology 63:461\u2013465", "journal-title": "Angiology"}, {"key": "9_CR1857", "first-page": "33", "volume": "29", "author": "T Nakayama", "year": "2010", "unstructured": "Nakayama T (2010) Genetic polymorphisms of prostacyclin synthase gene and cardiovascular disease. Int Angiol 29:33\u201342", "journal-title": "Int Angiol"}, {"key": "9_CR1858", "doi-asserted-by": "crossref", "first-page": "1263", "DOI": "10.1016/S0895-7061(00)01216-4", "volume": "13", "author": "T Nakayama", "year": "2000", "unstructured": "Nakayama T, Soma M, Rehemudula D, Takahashi Y, Tobe H, Satoh M, Uwabo J, Kunimoto M, Kanmatsuse K (2000) Association of 5 upstream promoter region of prostacyclin synthase gene variant with cerebral infarction. Am J Hypertens 13:1263\u20131267", "journal-title": "Am J Hypertens"}, {"key": "9_CR1859", "doi-asserted-by": "crossref", "first-page": "797", "DOI": "10.1067/mhj.2002.122171", "volume": "143", "author": "T Nakayama", "year": "2002", "unstructured": "Nakayama T, Soma M, Saito S, Honye J, Yajima J, Rahmutula D, Kaneko Y, Sato M, Uwabo J, Aoi N, Kosuge K, Kunimoto M, Kanmatsuse K, Kokubun S (2002) Association of a novel single nucleotide polymorphism of the prostacyclin synthase gene with myocardial infarction. Am Heart J 143:797\u2013801", "journal-title": "Am Heart J"}, {"key": "9_CR1860", "doi-asserted-by": "crossref", "first-page": "409", "DOI": "10.1016/S0895-7061(00)01256-5", "volume": "14", "author": "T Nakayama", "year": "2001", "unstructured": "Nakayama T, Soma M, Takahashi Y, Rehemudula D, Tobe H, Sato M, Uwabo J, Kunimoto M, Izumi Y, Kanmatsuse K (2001) Polymorphism of the promoter region of prostacyclin synthase gene is not related to essential hypertension. Am J Hypertens 14:409\u2013411", "journal-title": "Am J Hypertens"}, {"key": "9_CR1861", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1291/hypres.25.65", "volume": "25", "author": "T Nakayama", "year": "2002", "unstructured": "Nakayama T, Soma M, Rahmutula D, Tobe H, Sato M, Uwabo J, Aoi N, Kosuge K, Kunimoto M, Kanmatsuse K, Kokubun S (2002) Association study between a novel single nucleotide polymorphism of the promoter region of the prostacyclin synthase gene and essential hypertension. Hypertens Res 25:65\u201368", "journal-title": "Hypertens Res"}, {"key": "9_CR1862", "doi-asserted-by": "crossref", "first-page": "1135", "DOI": "10.1016/S0006-291X(02)02341-0", "volume": "297", "author": "T Nakayama", "year": "2002", "unstructured": "Nakayama T, Soma M, Watanabe Y, Hasimu B, Sato M, Aoi N, Kosuge K, Kanmatsuse K, Kokubun S, Morrow JD, Oates JA (2002) Splicing mutation of the prostacyclin synthase gene in a family associated with hypertension. Biochem Biophys Res Commun 297:1135\u20131139", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR1863", "doi-asserted-by": "crossref", "first-page": "266", "DOI": "10.1016/j.jmb.2006.09.039", "volume": "364", "author": "CW Chiang", "year": "2006", "unstructured": "Chiang CW, Yeh HC, Wang LH, Chan NL (2006) Crystal structure of the human prostacyclin synthase. J Mol Biol 364:266\u2013274", "journal-title": "J Mol Biol"}, {"key": "9_CR1864", "doi-asserted-by": "crossref", "first-page": "2917", "DOI": "10.1074/jbc.M707470200", "volume": "283", "author": "YC Li", "year": "2008", "unstructured": "Li YC, Chiang CW, Yeh HC, Hsu PY, Whitby FG, Wang LH, Chan NL (2008) Structures of prostacyclin synthase and its complexes with substrate analog and inhibitor reveal a ligand-specific heme conformation change. J Biol Chem 283:2917\u20132926", "journal-title": "J Biol Chem"}, {"key": "9_CR1865", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.1006/abbi.1998.0599", "volume": "352", "author": "Y Lin", "year": "1998", "unstructured": "Lin Y, Wu KK, Ruan KH (1998) Characterization of the secondary structure and membrane interaction of the putative membrane anchor domains of prostaglandin I2 synthase and cytochrome P450 2C1. Arch Biochem Biophys 352:78\u201384", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1866", "doi-asserted-by": "crossref", "first-page": "188", "DOI": "10.1006/abbi.2000.1892", "volume": "379", "author": "YZ Lin", "year": "2000", "unstructured": "Lin YZ, Deng H, Ruan KH (2000) Topology of catalytic portion of prostaglandin I2 synthase: identification by molecular modeling-guided site-specific antibodies. Arch Biochem Biophys 379:188\u2013197", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1867", "first-page": "109", "volume": "27", "author": "GA Reed", "year": "1985", "unstructured": "Reed GA, Griffin IO, Eling TE (1985) Inactivation of prostaglandin H synthase and prostacyclin synthase by phenylbutazone. Requirement for peroxidative metabolism. Mol Pharmacol 27:109\u2013114", "journal-title": "Mol Pharmacol"}, {"key": "9_CR1868", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1111/j.1582-4934.2007.00021.x", "volume": "11", "author": "C Griffoni", "year": "2007", "unstructured": "Griffoni C, Spisni E, Strillacci A, Toni M, Bachschmid MM, Tomasi V (2007) Selective inhibition of prostacyclin synthase activity by rofecoxib. J Cell Mol Med 11:327\u2013338", "journal-title": "J Cell Mol Med"}, {"key": "9_CR1869", "doi-asserted-by": "crossref", "first-page": "453", "DOI": "10.1006/abbi.1995.1417", "volume": "321", "author": "ML Wade", "year": "1995", "unstructured": "Wade ML, Voelkel NF, Fitzpatrick FA (1995) \u201cSuicide\u201d inactivation of prostaglandin I2 synthase: characterization of mechanism-based inactivation with isolated enzyme and endothelial cells. Arch Biochem Biophys 321:453\u2013458", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1870", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1016/0014-5793(96)00160-3", "volume": "382", "author": "MH Zou", "year": "1996", "unstructured": "Zou MH, Ullrich V (1996) Peroxynitrite formed by simultaneous generation of nitric oxide and superoxide selectively inhibits bovine aortic prostacyclin synthase. FEBS Lett 382:101\u2013104", "journal-title": "FEBS Lett"}, {"key": "9_CR1871", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1016/S1054-3589(08)61079-0", "volume": "34", "author": "JP Crow", "year": "1995", "unstructured": "Crow JP, Beckman JS (1995) Reactions between nitric oxide, superoxide, and peroxynitrite: footprints of peroxynitrite in vivo. Adv Pharmacol 34:17\u201343", "journal-title": "Adv Pharmacol"}, {"key": "9_CR1872", "first-page": "707", "volume": "378", "author": "M Zou", "year": "1997", "unstructured": "Zou M, Martin C, Ullrich V (1997) Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol Chem Hoppe-Seyler 378:707\u2013713", "journal-title": "Biol Chem Hoppe-Seyler"}, {"key": "9_CR1873", "doi-asserted-by": "crossref", "first-page": "12813", "DOI": "10.1074/jbc.M208080200", "volume": "278", "author": "P Schmidt", "year": "2003", "unstructured": "Schmidt P, Youhnovski N, Daiber A, Balan A, Arsic M, Bachschmid M, Przybylski M, Ullrich V (2003) Specific nitration at tyrosine-430 revealed by high resolution mass spectrometry as basis for redox regulation of bovine prostacyclin synthase. J Biol Chem 278:12813\u201312819", "journal-title": "J Biol Chem"}, {"key": "9_CR1874", "doi-asserted-by": "crossref", "first-page": "157", "DOI": "10.2174/1568016053544327", "volume": "3", "author": "T Nakayama", "year": "2005", "unstructured": "Nakayama T (2005) Prostacyclin synthase gene: genetic polymorphisms and prevention of some cardiovascular diseases. Curr Med Chem Cardiovasc Hematol Agents 3:157\u2013164", "journal-title": "Curr Med Chem Cardiovasc Hematol Agents"}, {"key": "9_CR1875", "doi-asserted-by": "crossref", "first-page": "1925", "DOI": "10.1164/ajrccm.159.6.9804054", "volume": "159", "author": "RM Tuder", "year": "1999", "unstructured": "Tuder RM, Cool CD, Geraci MW, Wang J, Abman SH, Wright L, Badesch D, Voelkel NF (1999) Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med 159:1925\u20131932", "journal-title": "Am J Respir Crit Care Med"}, {"key": "9_CR1876", "doi-asserted-by": "crossref", "first-page": "2231", "DOI": "10.1161/01.CIR.100.22.2231", "volume": "100", "author": "N Iwai", "year": "1999", "unstructured": "Iwai N, Katsuya T, Ishikawa K, Mannami T, Ogata J, Higaki J, Ogihara T, Tanabe T, Baba S (1999) Human prostacyclin synthase gene and hypertension: the Suita study. Circulation 100:2231\u20132236", "journal-title": "Circulation"}, {"key": "9_CR1877", "doi-asserted-by": "crossref", "first-page": "1509", "DOI": "10.1172/JCI5911", "volume": "103", "author": "MW Geraci", "year": "1999", "unstructured": "Geraci MW, Gao B, Shepherd DC, Moore MD, Westcott JY, Fagan KA, Alger LA, Tuder RM, Voelkel NF (1999) Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension. J Clin Invest 103:1509\u20131515", "journal-title": "J Clin Invest"}, {"key": "9_CR1878", "doi-asserted-by": "crossref", "first-page": "419", "DOI": "10.1161/01.STR.30.2.419", "volume": "30", "author": "T Todaka", "year": "1999", "unstructured": "Todaka T, Yokoyama C, Yanamoto H, Hashimoto N, Nagata I, Tsukahara T, Hara S, Hatae T, Morishita R, Aoki M, Ogihara T, Kaneda Y, Tanabe T (1999) Gene transfer of human prostacyclin synthase prevents neointimal formation after carotid balloon injury in rats. Stroke 30:419\u2013426", "journal-title": "Stroke"}, {"key": "9_CR1879", "first-page": "63", "volume": "62", "author": "P Pradono", "year": "2002", "unstructured": "Pradono P, Tazawa R, Maemondo M, Tanaka M, Usui K, Saijo Y, Hagiwara K, Nukiwa T (2002) Gene transfer of thromboxane A2 synthase and prostaglandin I2 synthase antithetically altered tumor angiogenesis and tumor growth. Cancer Res 62:63\u201366", "journal-title": "Cancer Res"}, {"key": "9_CR1880", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.1097/00008571-199806000-00004", "volume": "8", "author": "JS Leeder", "year": "1998", "unstructured": "Leeder JS, Lu X, Timsit Y, Gaedigk A (1998) Non-monooxygenase cytochromes P450 as potential human auto antigens in anticonvulsant hypersensitivity reactions. Pharmacogenetics 8:211\u2013225", "journal-title": "Pharmacogenetics"}, {"key": "9_CR1881", "doi-asserted-by": "crossref", "first-page": "184", "DOI": "10.1006/geno.1998.5606", "volume": "56", "author": "M Gafvels", "year": "1999", "unstructured": "Gafvels M, Olin M, Chowdhary BP, Raudsepp T, Andersson U, Persson B, Jansson M, Bj\u00f6rkhem I, Eggertsen G (1999) Structure and chromosomal assignment of the sterol 12\u03b1-hydroxylase gene (CYP8B1) in human and mouse: eukaryotic cytochrome P-450 gene devoid of introns. Genomics 56:184\u2013196", "journal-title": "Genomics"}, {"key": "9_CR1882", "doi-asserted-by": "crossref", "first-page": "41690", "DOI": "10.1074/jbc.M105117200", "volume": "276", "author": "M Zhang", "year": "2001", "unstructured": "Zhang M, Chiang JY (2001) Transcriptional regulation of the human sterol 12\u03b1-hydroxylase gene (CYP8B1): roles of heaptocyte nuclear factor 4\u03b1 in mediating bile acid repression. J Biol Chem 276:41690\u201341699", "journal-title": "J Biol Chem"}, {"key": "9_CR1883", "doi-asserted-by": "crossref", "first-page": "42973", "DOI": "10.1074/jbc.M205089200", "volume": "277", "author": "MC Gerbod-Giannone", "year": "2002", "unstructured": "Gerbod-Giannone MC, Del Castillo-Olivares A, Janciauskiene S, Gil G, Hylemon PB (2002) Suppression of cholesterol 7\u03b1-hydroxylase transcription and bile acid synthesis by an \u03b1 1-antitrypsin peptide via interaction with \u03b11-fetoprotein transcription factor. J Biol Chem 277:42973\u201342980", "journal-title": "J Biol Chem"}, {"key": "9_CR1884", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1016/S1388-1981(02)00186-5", "volume": "1583", "author": "Y Yang", "year": "2002", "unstructured": "Yang Y, Zhang M, Eggertsen G, Chiang JY (2002) On the mechanism of bile acid inhibition of rat sterol 12\u03b1-hydroxylase gene (CYP8B1) transcription: roles of \u03b1-fetoprotein transcription factor and hepatocyte nuclear factor 4\u03b1. Biochim Biophys Acta 1583:63\u201373", "journal-title": "Biochim Biophys Acta"}, {"key": "9_CR1885", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1016/j.taap.2008.11.008", "volume": "234", "author": "CB Lambert", "year": "2009", "unstructured": "Lambert CB, Spire C, Claude N, Guillouzo A (2009) Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. Toxicol Appl Pharmacol 234:345\u2013360", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "9_CR1886", "doi-asserted-by": "crossref", "first-page": "15665", "DOI": "10.1073/pnas.0706736104", "volume": "104", "author": "S Sanyal", "year": "2007", "unstructured": "Sanyal S, Bavner A, Haroniti A, Nilsson LM, Lundasen T, Rehnmark S, Witt MR, Einarsson C, Talianidis I, Gustafsson JA, Treuter E (2007) Involvement of corepressor complex subunit GPS2 in transcriptional pathways governing human bile acid biosynthesis. Proc Natl Acad Sci U S A 104:15665\u201315670", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR1887", "doi-asserted-by": "crossref", "first-page": "1705", "DOI": "10.1093/jn/137.7.1705", "volume": "137", "author": "Y Li", "year": "2007", "unstructured": "Li Y, Mezei O, Shay NF (2007) Human and murine hepatic sterol-12\u03b1-hydroxylase and other xenobiotic metabolism mRNA are upregulated by soy isoflavones. J Nutr 137:1705\u20131712", "journal-title": "J Nutr"}, {"key": "9_CR1888", "doi-asserted-by": "crossref", "first-page": "G685", "DOI": "10.1152/ajpgi.00207.2004", "volume": "288", "author": "A Jahan", "year": "2005", "unstructured": "Jahan A, Chiang JY (2005) Cytokine regulation of human sterol 12\u03b1-hydroxylase (CYP8B1) gene. Am J Physiol Gastrointest Liver Physiol 288: G685\u2013695", "journal-title": "Am J Physiol Gastrointest Liver Physiol"}, {"key": "9_CR1889", "doi-asserted-by": "crossref", "first-page": "2011", "DOI": "10.1016/S0006-2952(03)00586-0", "volume": "66", "author": "C Cheung", "year": "2003", "unstructured": "Cheung C, Akiyama TE, Kudo G, Gonzalez FJ (2003) Hepatic expression of cytochrome P450s in hepatocyte nuclear factor 1-\u03b1 (HNF1\u03b1)-deficient mice. Biochem Pharmacol 66:2011\u20132020", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR1890", "doi-asserted-by": "crossref", "first-page": "717", "DOI": "10.1111/jgh.12089", "volume": "28", "author": "J Qin", "year": "2013", "unstructured": "Qin J, Han TQ, Yuan WT, Zhang J, Fei J, Jiang ZY, Niu ZM, Zhang KY, Hua Q, Cai XX, Xu SJ, Huang W, Zhang SD (2013) Single nucleotide polymorphism rs3732860 in the 3\u2032-untranslated region of CYP8B1 gene is associated with gallstone disease in Han Chinese. J Gastroenterol Hepatol 28:717\u2013722", "journal-title": "J Gastroenterol Hepatol"}, {"key": "9_CR1891", "doi-asserted-by": "crossref", "first-page": "595", "DOI": "10.1080/00365510500333684", "volume": "65", "author": "A Abrahamsson", "year": "2005", "unstructured": "Abrahamsson A, Gafvels M, Reihner E, Bj\u00f6rkhem I, Einarsson C, Eggertsen G (2005) Polymorphism in the coding part of the sterol 12\u03b1-hydroxylase gene does not explain the marked differences in the ratio of cholic acid and chenodeoxycholic acid in human bile. Scand J Clin Lab Invest 65:595\u2013600", "journal-title": "Scand J Clin Lab Invest"}, {"key": "9_CR1892", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.7326/0003-4819-95-3-257", "volume": "95", "author": "LJ Schoenfield", "year": "1981", "unstructured": "Schoenfield LJ, Lachin JM (1981) Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the national cooperative gallstone study. A controlled trial of efficacy and safety. Ann Int Med 95:257\u2013282", "journal-title": "Ann Int Med"}, {"key": "9_CR1893", "first-page": "1591", "volume": "33", "author": "K Einarsson", "year": "1992", "unstructured": "Einarsson K, Akerlund JE, Reihner E, Bj\u00f6rkhem I (1992) 12\u03b1-hydroxylase activity in human liver and its relation to cholesterol 7\u03b1-hydroxylase activity. J Lipid Res 33:1591\u20131595", "journal-title": "J Lipid Res"}, {"key": "9_CR1894", "first-page": "6068", "volume": "251", "author": "HP Wang", "year": "1976", "unstructured": "Wang HP, Kimura T (1976) Purification and characterization of adrenal cortex mitochondrial cytochrome P-450 specific for cholesterolside chain cleavage activity. J Biol Chem 251:6068\u20136074", "journal-title": "J Biol Chem"}, {"key": "9_CR1895", "doi-asserted-by": "crossref", "first-page": "8879", "DOI": "10.1093/oxfordjournals.jbchem.a121955", "volume": "101", "author": "K Morohashi", "year": "1987", "unstructured": "Morohashi K, Sogawa K, Omura T, Fujii-Kuriyama Y (1987) Gene structure of human cytochrome P-450SCC, cholesterol desmolase. J Biochem (Tokyo) 101:8879\u20138887", "journal-title": "J Biochem (Tokyo)"}, {"key": "9_CR1896", "first-page": "16122", "volume": "260", "author": "TL Poulos", "year": "1985", "unstructured": "Poulos TL, Finzel BC, Gunsalus IC, Wagner GC, Kraut J (1985) The 2.6-\u00c5 crystal structure of Pseudomonas putida cytochrome P-450. J Biol Chem 260:16122\u201316130", "journal-title": "J Biol Chem"}, {"key": "9_CR1897", "doi-asserted-by": "crossref", "first-page": "283", "DOI": "10.1016/0960-0760(94)90041-8", "volume": "51", "author": "CJ Belfiore", "year": "1994", "unstructured": "Belfiore CJ, Hawkins DE, Wiltbank MC, Niswender GD (1994) Regulation of cytochrome P450scc synthesis and activity in the ovine corpus luteum. J Steroid Biochem Mol Biol 51:283\u2013290", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR1898", "doi-asserted-by": "crossref", "first-page": "456", "DOI": "10.1016/0003-9861(86)90749-6", "volume": "250", "author": "MF Matocha", "year": "1986", "unstructured": "Matocha MF, Waterman MR (1986) Import and processing of P-450scc and P-45011\u03b2 precursors by corpus luteal mitochondria: a processing pathway recognizing homologous and heterologous precursors. Arch Biochem Biophys 250:456\u2013460", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1899", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1530/jrf.0.0850163", "volume": "85", "author": "H Sasano", "year": "1989", "unstructured": "Sasano H, Okamoto M, Mason JI, Simpson ER, Mendelson CR, Sasano N, Silverberg SG (1989) Immunolocalization of aromatase, 17\u03b1-hydroxylase and side-chain-cleavage cytochromes P-450 in the human ovary. J Reprod Fertil 85:163\u2013169", "journal-title": "J Reprod Fertil"}, {"key": "9_CR1900", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1016/S0039-128X(96)00156-0", "volume": "62", "author": "BC Chung", "year": "1997", "unstructured": "Chung BC, Guo IC, Chou SJ (1997) Transcriptional regulation of the CYP11A1 and ferredoxin genes. Steroids 62:37\u201342", "journal-title": "Steroids"}, {"key": "9_CR1901", "doi-asserted-by": "crossref", "first-page": "592", "DOI": "10.1016/0003-9861(87)90142-1", "volume": "254", "author": "B Walther", "year": "1987", "unstructured": "Walther B, Ghersi-Egea JF, Minn A, Siest G (1987) Brain mitochondrial cytochrome P-450scc: spectral and catalytic properties. Arch Biochem Biophys 254:592\u2013596", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1902", "doi-asserted-by": "crossref", "first-page": "224", "DOI": "10.1006/frne.1995.1008", "volume": "16", "author": "M Warner", "year": "1995", "unstructured": "Warner M, Gustafsson JA (1995) Cytochrome P450 in the brain: neuroendocrine functions. Front Neuroendocrinol 16:224\u2013236", "journal-title": "Front Neuroendocrinol"}, {"key": "9_CR1903", "doi-asserted-by": "crossref", "first-page": "3067", "DOI": "10.1097/00001756-199909290-00035", "volume": "10", "author": "S Beyenburg", "year": "1999", "unstructured": "Beyenburg S, Stoffel-Wagner B, Watzka M Bumcke I, Bauer J, Schramm J, Bidlingmaier F, Elger CE (1999) Expression of cytochrome P450scc mRNA in the hippocampus of patients with temporal lobe epilepsy. Neuroreport 10:3067\u20133070", "journal-title": "Neuroreport"}, {"key": "9_CR1904", "doi-asserted-by": "crossref", "first-page": "901", "DOI": "10.1046/j.1365-2826.1999.00407.x", "volume": "11", "author": "M Watzka", "year": "1999", "unstructured": "Watzka M, Bidlingmaier F, Schramm J, Klingmuller D, Stoffel-Wagner B (1999) Sex- and age-specific differences in human brain CYP11A1 mRNA expression. J Neuroendocrinol 11:901\u2013905", "journal-title": "J Neuroendocrinol"}, {"key": "9_CR1905", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1097/00006676-199907000-00006", "volume": "19", "author": "A Morales", "year": "1999", "unstructured": "Morales A, Cuellar A, Ramirez J, Vilchis F, Diaz-Sanchez V (1999) Synthesis of steroids in pancreas: evidence of cytochrome P-450scc activity. Pancreas 19:39\u201344", "journal-title": "Pancreas"}, {"key": "9_CR1906", "doi-asserted-by": "crossref", "first-page": "1287", "DOI": "10.1093/oxfordjournals.jbchem.a121835", "volume": "100", "author": "W Ou", "year": "1986", "unstructured": "Ou W, Ito A, Morohashi K, Fujii-Kuriyama Y, Omura T (1986) Processing-independent in vitro translocation of cytochrome P-450SCC precursor across mitochondrial membranes. J Biochem (Tokyo) 100:1287\u20131296", "journal-title": "J Biochem (Tokyo)"}, {"key": "9_CR1907", "doi-asserted-by": "crossref", "first-page": "833", "DOI": "10.1093/oxfordjournals.jbchem.a122122", "volume": "102", "author": "T Kumamoto", "year": "1987", "unstructured": "Kumamoto T, Morohashi K, Ito A, Omura A (1987) Site-directed mutagenesis of basic amino acid residues in the extension peptide of P-450SCC precursor: effects on the import of the precursor into mitochondria. J Biochem (Tokyo) 102:833\u2013838", "journal-title": "J Biochem (Tokyo)"}, {"key": "9_CR1908", "doi-asserted-by": "crossref", "first-page": "7247", "DOI": "10.1073/pnas.91.15.7247", "volume": "91", "author": "SM Black", "year": "1994", "unstructured": "Black SM, Harikrishna JA, Szklarz GD, Miller WL (1994) The mitochondrial environment is required for activity of the cholesterolside-chain cleavage enzyme, cytochrome P450scc. Proc Natl Acad Sci U S A 91:7247\u20137251", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR1909", "doi-asserted-by": "crossref", "first-page": "25402", "DOI": "10.1074/jbc.270.43.25402", "volume": "270", "author": "P Venepally", "year": "1995", "unstructured": "Venepally P, Waterman MR (1995) Two Sp1-binding site mediate cAMP-induced transcription of the bovine CYP11A gene through the protein kinase A signaling pathway. J Biol Chem 270:25402\u201325410", "journal-title": "J Biol Chem"}, {"key": "9_CR1910", "doi-asserted-by": "crossref", "first-page": "19422", "DOI": "10.1074/jbc.274.27.19422", "volume": "274", "author": "R Ahlgren", "year": "1999", "unstructured": "Ahlgren R, Suske G, Waterman MR, Lund J (1999) Role of Sp1 in cAMP-dependent transcriptional regulation of the bovine CYP11A gene. J Biol Chem 274:19422\u201319428", "journal-title": "J Biol Chem"}, {"key": "9_CR1911", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1016/S0960-0760(99)00080-1", "volume": "69", "author": "IC Guo", "year": "1999", "unstructured": "Guo IC, Chung BC (1999) Cell-type specificity of human CYP11A1 TATA box. J Steroid Biochem Mol Biol 69:329\u2013334", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR1912", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1016/S0303-7207(01)00388-4", "volume": "175", "author": "Y Huang", "year": "2001", "unstructured": "Huang Y, Hu M, Hsu N, Wang CL, Chung B (2001) Action of hormone responsive sequence in 2.3 kb promoter of CYP11A1. Mol Cell Endocrinol 175:205\u2013210", "journal-title": "Mol Cell Endocrinol"}, {"key": "9_CR1913", "doi-asserted-by": "crossref", "first-page": "812", "DOI": "10.1210/mend.15.5.0636", "volume": "15", "author": "MC Hu", "year": "2001", "unstructured": "Hu MC, Hsu NC, Pai CI, Wang CK, Chung B (2001) Functions of the upstream and proximal steroidogenic factor 1 (SF-1)-binding sites in the CYP11A1 promoter in basal transcription and hormonal response. Mol Endocrinol 15:812\u2013818", "journal-title": "Mol Endocrinol"}, {"key": "9_CR1914", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1016/S0303-7207(99)00036-2", "volume": "153", "author": "Z Liu", "year": "1999", "unstructured": "Liu Z, Simpson ER (1999) Molecular mechanism for cooperation between Sp1 and steroidogenic factor-1 (SF-1) to regulate bovine CYP11A gene expression. Mol Cell Endocrinol 153:183\u2013196", "journal-title": "Mol Cell Endocrinol"}, {"key": "9_CR1915", "doi-asserted-by": "crossref", "first-page": "33881", "DOI": "10.1074/jbc.M100113200", "volume": "276", "author": "F Gizard", "year": "2001", "unstructured": "Gizard F, Lavallee B, DeWitte F, Hum DW (2001) A novel zinc finger protein TReP-132 interacts with CBP/p300 to regulate human CYP11A1 gene expression. J Biol Chem 276:33881\u201333892", "journal-title": "J Biol Chem"}, {"key": "9_CR1916", "doi-asserted-by": "crossref", "first-page": "39144", "DOI": "10.1074/jbc.M205786200", "volume": "277", "author": "F Gizard", "year": "2002", "unstructured": "Gizard F, Lavallee B, DeWitte F, Teissier E, Staels B, Hum DW (2002) The transcriptional regulating protein of 132 kDa (TReP-132) enhances P450scc gene transcription through interaction with steroidogenic factor-1 in human adrenal cells. J Biol Chem 277:39144\u201339155", "journal-title": "J Biol Chem"}, {"key": "9_CR1917", "doi-asserted-by": "crossref", "first-page": "15629", "DOI": "10.1074/jbc.M109365200", "volume": "277", "author": "J Doi", "year": "2002", "unstructured": "Doi J, Takemori H, Lin XZ, Horike N, Katoh Y, Okamoto M (2002) Salt-inducible kinase represses cAMP-dependent protein kinase-mediated activation of human cholesterolside chain cleavage cytochrome P450 promoter through the CREB basic leucine zipper domain. J Biol Chem 277:15629\u201315637", "journal-title": "J Biol Chem"}, {"key": "9_CR1918", "doi-asserted-by": "crossref", "first-page": "1864", "DOI": "10.1210/me.2002-0056", "volume": "16", "author": "M Ben-Zimra", "year": "2002", "unstructured": "Ben-Zimra M, Koler M, Orly J (2002) Transcription of cholesterolside-chain cleavage cytochrome P450 in the placenta: activating protein-2 assumes the role of steroidogenic factor-1 by binding to an overlapping promoter element. Mol Endocrinol 16:1864\u20131880", "journal-title": "Mol Endocrinol"}, {"key": "9_CR1919", "doi-asserted-by": "crossref", "first-page": "80", "DOI": "10.1016/j.mce.2010.12.017", "volume": "336", "author": "MC Shih", "year": "2011", "unstructured": "Shih MC, Chiu YN, Hu MC, Guo IC, Chung BC (2011) Regulation of steroid production: analysis of Cyp11a1 promoter. Mol Cell Endocrinol 336:80\u201384", "journal-title": "Mol Cell Endocrinol"}, {"key": "9_CR1920", "doi-asserted-by": "crossref", "first-page": "1678", "DOI": "10.1210/jc.2004-0374", "volume": "90", "author": "JW Kim", "year": "2005", "unstructured": "Kim JW, Havelock JC, Carr BR, Attia GR (2005) The orphan nuclear receptor, liver receptor homolog-1, regulates cholesterolside-chain cleavage cytochrome P450 enzyme in human granulosa cells. J Clin Endocrinol Metab 90:1678\u20131685", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR1921", "doi-asserted-by": "crossref", "first-page": "152", "DOI": "10.1016/j.placenta.2006.03.008", "volume": "28", "author": "YC Henderson", "year": "2007", "unstructured": "Henderson YC, Frederick MJ, Jayakumar A, Choi Y, Wang MT, Kang Y, Evans R, Spring PM, Uesugi M, Clayman GL (2007) Human LBP-32/MGR is a repressor of the P450scc in human choriocarcinoma cell line JEG-3. Placenta 28:152\u2013160", "journal-title": "Placenta"}, {"key": "9_CR1922", "doi-asserted-by": "crossref", "first-page": "2027", "DOI": "10.1128/MCB.02253-06", "volume": "27", "author": "HC Lan", "year": "2007", "unstructured": "Lan HC, Li HJ, Lin G, Lai PY, Chung BC (2007) Cyclic AMP stimulates SF-1-dependent CYP11A1 expression through homeodomain-interacting protein kinase 3-mediated Jun N-terminal kinase and c-Jun phosphorylation. Mol Cell Biol 27:2027\u20132036", "journal-title": "Mol Cell Biol"}, {"key": "9_CR1923", "doi-asserted-by": "crossref", "first-page": "520", "DOI": "10.1071/RD10266", "volume": "23", "author": "Y Liu", "year": "2011", "unstructured": "Liu Y, Jiang H, He LY, Huang WJ, He XY, Xing FQ (2011) Abnormal expression of uncoupling protein-2 correlates with CYP11A1 expression in polycystic ovary syndrome. Reprod Fertil Dev 23:520\u2013526", "journal-title": "Reprod Fertil Dev"}, {"key": "9_CR1924", "doi-asserted-by": "crossref", "first-page": "e48963", "DOI": "10.1371/journal.pone.0048963", "volume": "7", "author": "JK Wickenheisser", "year": "2012", "unstructured": "Wickenheisser JK, Biegler JM, Nelson-Degrave VL, Legro RS, Strauss JF 3rd, McAllister JM (2012) Cholesterol side-chain cleavage gene expression in theca cells: augmented transcriptional regulation and mRNA stability in polycystic ovarysyndrome. PLoS One 7:e48963", "journal-title": "PLoS One"}, {"key": "9_CR1925", "doi-asserted-by": "crossref", "first-page": "3808", "DOI": "10.1210/jcem.87.8.8763", "volume": "87", "author": "N Katsumata", "year": "2002", "unstructured": "Katsumata N, Ohtake M, Hojo T, Ogawa E, Hara T, Sato N, Tanaka T (2002) Compound heterozygous mutations in the cholesterolside-chain cleavage enzyme gene (CYP11A) cause congenital adrenalin sufficiency in humans. J Clin Endocrinol Metab 87:3808\u20133813", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR1926", "doi-asserted-by": "crossref", "first-page": "2408", "DOI": "10.1210/jc.2003-031640", "volume": "89", "author": "M Gaasenbeek", "year": "2004", "unstructured": "Gaasenbeek M, Powell BL, Sovio U, Haddad L, Gharani N, Bennett A, Groves CJ, Rush K, Goh MJ, Conway GS, Ruokonen A, Martikainen H, Pouta A, Taponen S, Hartikainen AL, Halford S, Jarvelin MR, Franks S, McCarthy MI (2004) Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone. J Clin Endocrinol Metab 89:2408\u20132413", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR1927", "doi-asserted-by": "crossref", "first-page": "653", "DOI": "10.1016/j.fertnstert.2008.07.016", "volume": "92", "author": "M Pusalkar", "year": "2009", "unstructured": "Pusalkar M, Meherji P, Gokral J, Chinnaraj S, Maitra A (2009) CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome. Fertil Steril 92:653\u2013659", "journal-title": "Fertil Steril"}, {"key": "9_CR1928", "first-page": "56", "volume": "30", "author": "CF Hao", "year": "2009", "unstructured": "Hao CF, Bao HC, Zhang N, Gu HF, Chen ZJ (2009) Evaluation of association between the CYP11a promoter pentannucleotide (TTTTA)n polymorphism and polycystic ovarian syndrome among Han Chinese women. Neuro Endocrinol Lett 30:56\u201360", "journal-title": "Neuro Endocrinol Lett"}, {"key": "9_CR1929", "doi-asserted-by": "crossref", "first-page": "538", "DOI": "10.1210/jc.2004-1059", "volume": "90", "author": "O Hiort", "year": "2005", "unstructured": "Hiort O, Holterhus PM, Werner R, Marschke C, Hoppe U, Partsch CJ, Riepe FG, Achermann JC, Struve D (2005) Homozygous disruption of P450 side-chain cleavage (CYP11A1) is associated with prematurity, complete 46,XY sex reversal, and severe adrenal failure. J Clin Endocrinol Metab 90:538\u2013541", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR1930", "doi-asserted-by": "crossref", "first-page": "696", "DOI": "10.1210/jc.2007-2330", "volume": "93", "author": "CJ Kim", "year": "2008", "unstructured": "Kim CJ, Lin L, Huang N, Quigley CA, AvRuskin TW, Achermann JC, Miller WL (2008) Severe combined adrenal and gonadal deficiency caused by novel mutations in the cholesterolside chain cleavage enzyme, P450scc. J Clin Endocrinol Metab 93:696\u2013702", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR1931", "doi-asserted-by": "crossref", "first-page": "E1798", "DOI": "10.1210/jc.2011-1277", "volume": "96", "author": "S Parajes", "year": "2011", "unstructured": "Parajes S, Kamrath C, Rose IT, Taylor AE, Mooij CF, Dhir V, Grotzinger J, Arlt W, Krone N (2011) A novel entity of clinically isolated adrenal insufficiency caused by a partially inactivating mutation of the gene encoding for P450 side chain cleavage enzyme (CYP11A1). J Clin Endocrinol Metab 96:E1798\u2013E1806", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR1932", "first-page": "709", "volume": "13", "author": "W Zheng", "year": "2004", "unstructured": "Zheng W, Gao YT, Shu XO, Wen W, Cai Q, Dai Q, Smith JR (2004) Population-based case-control study of CYP11A gene polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 13:709\u2013714", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9_CR1933", "doi-asserted-by": "crossref", "first-page": "5673", "DOI": "10.1158/0008-5472.CAN-07-0467", "volume": "67", "author": "BL Yaspan", "year": "2007", "unstructured": "Yaspan BL, Breyer JP, Cai Q, Dai Q, Elmore JB, Amundson I, Bradley KM, Shu XO, Gao YT, Dupont WD, Zheng W, Smith JR (2007) Haplotype analysis of CYP11A1 identifies promoter variants associated with breast cancer risk. Cancer Res 67:5673\u20135682", "journal-title": "Cancer Res"}, {"key": "9_CR1934", "doi-asserted-by": "crossref", "first-page": "255", "DOI": "10.1016/j.ygyno.2010.02.002", "volume": "117", "author": "K Terry", "year": "2010", "unstructured": "Terry K, McGrath M, Lee IM, Buring J, De Vivo I (2010) Genetic variation in CYP11A1and StAR in relation to endometrial cancer risk. Gynecol Oncol 117:255\u2013259", "journal-title": "Gynecol Oncol"}, {"key": "9_CR1935", "doi-asserted-by": "crossref", "first-page": "230", "DOI": "10.1016/0039-128X(93)90024-H", "volume": "58", "author": "RC Tuckey", "year": "1993", "unstructured": "Tuckey RC, Cameron KJ (1993) Human placental cholesterol side-chain cleavage: enzymatic synthesis of (22R)-20\u03b1,22-dihydroxy cholesterol. Steroids 58:230\u2013233", "journal-title": "Steroids"}, {"key": "9_CR1936", "doi-asserted-by": "crossref", "first-page": "2186", "DOI": "10.1021/ja00293a068", "volume": "107", "author": "RI Murray", "year": "1985", "unstructured": "Murray RI, Sligar SG (1985) Oxidative cleavage of 1-phenyl-1,2-ethanediol by 4-cyano-N, N-dimethylaniline N-oxide and chloro(5,10,15,20-tetraphenylporphinato)chromium(III): a model for cholesterolside-chain cleavage by cytochrome P-450scc. J Am Chem Soc 107:2186\u20132187", "journal-title": "J Am Chem Soc"}, {"key": "9_CR1937", "doi-asserted-by": "crossref", "first-page": "1187", "DOI": "10.1021/ja00212a030", "volume": "110", "author": "T Okamoto", "year": "1988", "unstructured": "Okamoto T, Sasaki K, Oka S (1988) Biomimetic oxidation with molecular oxygen. Selective carbon-carbon bond cleavage of 1,2-diols by molecular oxygen and dihydropyridine in the presence of iron-porphyrin catalysts. J Am Chem Soc 110:1187\u20131196", "journal-title": "J Am Chem Soc"}, {"key": "9_CR1938", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1007/978-1-4757-2391-5_8", "volume-title": "Cytochrome P450: structure, mechanism, and biochemistry", "author": "PR Ortiz de Montellano", "year": "1995", "unstructured": "Ortiz de Montellano PR (1995) Oxygen activation and reactivity. In: Ortiz de Montellano PR (ed) Cytochrome P450: structure, mechanism, and biochemistry, 2nd edn. Plenum Press, New York, pp\u00a0245\u2013303", "edition": "2"}, {"key": "9_CR1939", "doi-asserted-by": "crossref", "first-page": "835", "DOI": "10.1111/j.1432-1033.1997.00835.x", "volume": "244", "author": "RC Tuckey", "year": "1997", "unstructured": "Tuckey RC, Woods ST, Tajbakhsh M (1997) Electron transfer to cytochrome P-450scc limits cholesterol-side-chain-cleavage activity in the human placenta. Eur J Biochem 244:835\u2013839", "journal-title": "Eur J Biochem"}, {"key": "9_CR1940", "doi-asserted-by": "crossref", "first-page": "4883", "DOI": "10.1074/jbc.272.8.4883", "volume": "272", "author": "V Beckert", "year": "1997", "unstructured": "Beckert V, Bernhardt R (1997) Specific aspects of electron transfer from adrenodoxin to cytochromes P450scc and P45011b. J Biol Chem 272:4883\u20134888", "journal-title": "J Biol Chem"}, {"key": "9_CR1941", "doi-asserted-by": "crossref", "first-page": "720", "DOI": "10.1046/j.1432-1327.1999.00414.x", "volume": "262", "author": "P Cao", "year": "1999", "unstructured": "Cao P, Bernhardt R (1999) Interaction of CYP11B1 (cytochrome P-45011b ) with CYP11A1 (cytochrome P-450scc) in COS-1 cells. Eur J Biochem 262:720\u2013726", "journal-title": "Eur J Biochem"}, {"key": "9_CR1942", "doi-asserted-by": "crossref", "first-page": "279", "DOI": "10.1016/0014-5793(91)80135-P", "volume": "278", "author": "SA Usanov", "year": "1991", "unstructured": "Usanov SA, Chashchin VL (1991) Interaction of cythochrome P-450scc with cytochrome b 5. FEBS Lett 278:279\u2013282", "journal-title": "FEBS Lett"}, {"key": "9_CR1943", "doi-asserted-by": "crossref", "first-page": "14754", "DOI": "10.1073/pnas.2336107100", "volume": "100", "author": "O Guryev", "year": "2003", "unstructured": "Guryev O, Carvalho RA, Usanov S, Gilep A, Estabrook RW (2003) A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1). Proc Natl Acad Sci U S A 100:14754\u201314759", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR1944", "doi-asserted-by": "crossref", "first-page": "2585", "DOI": "10.1111/j.1742-4658.2008.06406.x", "volume": "275", "author": "RC Tuckey", "year": "2008", "unstructured": "Tuckey RC, Li W, Zjawiony JK, Zmijewski MA, Nguyen MN, Sweatman T, Miller D, Slominski A (2008) Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc. FEBS J 275:2585\u20132596", "journal-title": "FEBS J"}, {"key": "9_CR1945", "doi-asserted-by": "crossref", "first-page": "1577", "DOI": "10.1124/dmd.111.040071", "volume": "39", "author": "RC Tuckey", "year": "2011", "unstructured": "Tuckey RC, Li W, Shehabi HZ, Janjetovic Z, Nguyen MN, Kim TK, Chen J, Howell DE, Benson HA, Sweatman T, Baldisseri DM, Slominski A (2011) Production of 22-hydroxy metabolites of vitamin D3 by cytochrome p450scc (CYP11A1) and analysis of their biological activities on skin cells. Drug Metab Dispos 39:1577\u20131588", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1946", "doi-asserted-by": "crossref", "first-page": "2891", "DOI": "10.1111/j.1742-4658.2006.05302.x", "volume": "273", "author": "A Slominski", "year": "2006", "unstructured": "Slominski A, Semak I, Wortsman J, Zjawiony J, Li W, Zbytek B, Tuckey RC (2006) An alternative pathway of vitamin D metabolism. Cytochrome P450scc (CYP11A1)-mediated conversion to 20-hydroxyvitamin D2 and 17,20-dihydroxyvitamin D2. FEBS J 273:2891\u20132901", "journal-title": "FEBS J"}, {"key": "9_CR1947", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1016/j.jsbmb.2008.10.005", "volume": "112", "author": "RC Tuckey", "year": "2008", "unstructured": "Tuckey RC, Janjetovic Z, Li W, Nguyen MN, Zmijewski MA, Zjawiony J, Slominski A (2008) Metabolism of 1\u03b1-hydroxyvitamin D3 by cytochrome P450scc to biologically active 1\u03b1,20-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 112:213\u2013219", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR1948", "doi-asserted-by": "crossref", "first-page": "28", "DOI": "10.1016/j.jsbmb.2013.10.012", "volume": "144", "author": "AT Slominski", "year": "2014", "unstructured": "Slominski AT, Kim TK, Li W, Yi AK, Postlethwaite A, Tuckey RC (2014) The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions. J Steroid Biochem Mol Biol 144:28\u201329. doi:10.1016/j.jsbmb.2013.10.012", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR1949", "doi-asserted-by": "crossref", "first-page": "2003", "DOI": "10.1016/j.biocel.2012.07.027", "volume": "44", "author": "AT Slominski", "year": "2012", "unstructured": "Slominski AT, Kim TK, Chen J, Nguyen MN, Li W, Yates CR, Sweatman T, Janjetovic Z, Tuckey RC (2012) Cytochrome P450scc-dependent metabolism of 7-dehydrocholesterol in placenta and epidermal keratinocytes. Int J Biochem Cell Biol 44:2003\u20132018", "journal-title": "Int J Biochem Cell Biol"}, {"key": "9_CR1950", "doi-asserted-by": "crossref", "first-page": "436", "DOI": "10.1124/dmd.111.042515", "volume": "40", "author": "RC Tuckey", "year": "2012", "unstructured": "Tuckey RC, Nguyen MN, Chen J, Slominski AT, Baldisseri DM, Tieu EW, Zjawiony JK, Li W (2012) Human cytochrome P450scc (CYP11A1) catalyzes epoxide formation with ergosterol. Drug Metab Dispos 40:436\u2013444", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR1951", "doi-asserted-by": "crossref", "first-page": "556", "DOI": "10.1021/tx200524d", "volume": "25", "author": "D Zhang", "year": "2012", "unstructured": "Zhang D, Flint O, Wang L, Gupta A, Westhouse RA, Zhao W, Raghavan N, Caceres-Cortes J, Marathe P, Shen G, Zhang Y, Allentoff A, Josephs J, Gan J, Borzilleri R, Humphreys WG (2012) Cytochrome P450 11A1 bioactivation of a kinase inhibitor in rats: use of radioprofiling, modulation of metabolism, and adrenocortical cell lines to evaluate adrenal toxicity. Chem Res Toxicol 25:556\u2013571", "journal-title": "Chem Res Toxicol"}, {"key": "9_CR1952", "doi-asserted-by": "crossref", "first-page": "5607", "DOI": "10.1074/jbc.M110.188433", "volume": "286", "author": "N Mast", "year": "2011", "unstructured": "Mast N, Annalora AJ, Lodowski DT, Palczewski K, Stout CD, Pikuleva IA (2011) Structural basis for three-step sequential catalysis by the cholesterol side chain cleavage enzyme CYP11A1. J Biol Chem 286:5607\u20135613", "journal-title": "J Biol Chem"}, {"key": "9_CR1953", "doi-asserted-by": "crossref", "first-page": "10139", "DOI": "10.1073/pnas.1019441108", "volume": "108", "author": "N Strushkevich", "year": "2011", "unstructured": "Strushkevich N, MacKenzie F, Cherkesova T, Grabovec I, Usanov S, Park HW (2011) Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system. Proc Natl Acad Sci U S A 108:10139\u201310143", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR1954", "doi-asserted-by": "crossref", "first-page": "1127", "DOI": "10.1007/s11745-008-3234-x", "volume": "43", "author": "IA Pikuleva", "year": "2008", "unstructured": "Pikuleva IA, Mast N, Liao WL, Turko IV (2008) Studies of membrane topology of mitochondrial cholesterol hydroxylases CYPs 27A1 and 11A1. Lipids 43:1127\u20131132", "journal-title": "Lipids"}, {"key": "9_CR1955", "first-page": "22877", "volume": "267", "author": "A Wada", "year": "1992", "unstructured": "Wada A, Waterman MR (1992) Identification by site-directed mutagenesis of two lysine residues in cholesterol side chain cleavage cytochrome P450 that are essential for adrenodoxin binding. J Biol Chem 267:22877\u201322882", "journal-title": "J Biol Chem"}, {"key": "9_CR1956", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1006/abbi.1998.0621", "volume": "353", "author": "ST Woods", "year": "1998", "unstructured": "Woods ST, Sadleir J, Downs T, Triantopoulos T, Headlam MJ, Tuckey RC (1998) Expression of catalytically active human cytochrome P450scc in Escherichia coli and mutagenesis of isoleucine-462. Arch Biochem Biophys 353:109\u2013115", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR1957", "first-page": "3832", "volume": "258", "author": "LE Vickery", "year": "1983", "unstructured": "Vickery LE, Kellis JT (1983) Inhibition of adrenocortical cytochrome P-450scc by (20R)-20-phenyl-5-pregnene-3\u03b2,20-diol: mechanism and implications for the structure of the active site. J Biol Chem 258:3832\u20133836", "journal-title": "J Biol Chem"}, {"key": "9_CR1958", "doi-asserted-by": "crossref", "first-page": "539", "DOI": "10.1016/0022-4731(88)90190-2", "volume": "29", "author": "LE Vickery", "year": "1988", "unstructured": "Vickery LE, Singh J (1988) 22-Thio-23,24-bisnor-5-cholen-3\u03b2-ol: an active site-directed inhibitor of cytochrome P450scc. J Steroid Biochem 29:539\u2013543", "journal-title": "J Steroid Biochem"}, {"key": "9_CR1959", "doi-asserted-by": "crossref", "first-page": "273", "DOI": "10.1016/0022-4731(90)90217-G", "volume": "36", "author": "O Olakanmi", "year": "1990", "unstructured": "Olakanmi O, Seybert DW (1990) Modified acetylenic steroids as potent mechanism-based inhibitors of cytochrome P-450scc. J Steroid Biochem 36:273\u2013280", "journal-title": "J Steroid Biochem"}, {"key": "9_CR1960", "first-page": "185", "volume": "3", "author": "M Jarman", "year": "1988", "unstructured": "Jarman M, Barrie SE, Leung CS, Rowlands MG (1988) Selective inhibition of cholesterol side-chain cleavage by potential pro-drug forms of aminoglutethimide. Anticancer Drug Des 3:185\u2013190", "journal-title": "Anticancer Drug Des"}, {"key": "9_CR1961", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1016/S0960-0760(96)00166-5", "volume": "60", "author": "T Ohnishi", "year": "1997", "unstructured": "Ohnishi T, Ichikawa Y (1997) Direct inhibitions of the activities of steroidogenic cytochrome P-450 mono-oxygenase systems by anticonvulsants. J Steroid Biochem Mol Biol 60:77\u201385", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR1962", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1016/j.mce.2012.10.013", "volume": "371", "author": "N Mast", "year": "2013", "unstructured": "Mast N, Linger M, Pikuleva IA (2013) Inhibition and stimulation of activity of purified recombinant CYP11A1by therapeutic agents. Mol Cell Endocrinol 371:100\u2013106", "journal-title": "Mol Cell Endocrinol"}, {"key": "9_CR1963", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1210/er.2010-0013", "volume": "32", "author": "WL Miller", "year": "2011", "unstructured": "Miller WL, Auchus RJ (2011) The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 32:81\u2013151", "journal-title": "Endocr Rev"}, {"key": "9_CR1964", "doi-asserted-by": "crossref", "first-page": "792", "DOI": "10.1210/jc.2010-1828", "volume": "96", "author": "T Sahakitrungruang", "year": "2011", "unstructured": "Sahakitrungruang T, Tee MK, Blackett PR, Miller WL (2011) Partial defect in the cholesterolside-chain cleavage enzyme P450scc (CYP11A1) resembling nonclassic congenital lipoid adrenal hyperplasia. J Clin Endocrinol Metab 96:792\u2013798", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR1965", "doi-asserted-by": "crossref", "first-page": "54", "DOI": "10.1159/000321215", "volume": "20", "author": "B Hauffa", "year": "2011", "unstructured": "Hauffa B, Hiort O (2011) P450 side-chain cleavage deficiency-a rare cause of congenital adrenal hyperplasia. Endocr Dev 20:54\u201362", "journal-title": "Endocr Dev"}, {"key": "9_CR1966", "doi-asserted-by": "crossref", "first-page": "881", "DOI": "10.1530/EJE-12-0450", "volume": "167", "author": "S Parajes", "year": "2012", "unstructured": "Parajes S, Chan AO, But WM, Rose IT, Taylor AE, Dhir V, Arlt W, Krone N (2012) Delayed diagnosis of adrenal insufficiency in a patient with severe penoscrotal hypospadias due to two novel P450 side-change cleavage enzyme (CYP11A1) mutations (p.R360W; p.R405X). Eur J Endocrinol 167:881\u2013885", "journal-title": "Eur J Endocrinol"}, {"key": "9_CR1967", "doi-asserted-by": "crossref", "first-page": "1977", "DOI": "10.1210/endo.132.5.7682938", "volume": "132", "author": "X Yang", "year": "1993", "unstructured": "Yang X, Iwamoto K, Wang M, Artwohl J, Mason JI, Pang S (1993) Inherited congenital adrenal hyperplasia in the rabbit is caused by a deletion in the gene encoding cytochrome P450 cholesterolside-chain cleavage enzyme. Endocrinology 132:1977\u20131982", "journal-title": "Endocrinology"}, {"key": "9_CR1968", "doi-asserted-by": "crossref", "first-page": "1943", "DOI": "10.1210/me.2002-0055", "volume": "16", "author": "MC Hu", "year": "2002", "unstructured": "Hu MC, Hsu NC, El Hadj NB, Pai CI, Chu HP, Wang CK, Chung BC (2002) Steroid deficiency syndromes in mice with targeted disruption of Cyp11a1. Mol Endocrinol 16:1943\u20131950", "journal-title": "Mol Endocrinol"}, {"key": "9_CR1969", "first-page": "1871", "volume": "81", "author": "S Chen", "year": "1996", "unstructured": "Chen S, Sawicka J, Betterle C, Powell M, Prentice L, Volpato M, Rees Smith B, Furmaniak J (1996) Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison\u2019s disease, and premature ovarian failure. J Clin Endocrinol Metab 81:1871\u20131876", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR1970", "doi-asserted-by": "crossref", "first-page": "208", "DOI": "10.1055/s-0029-1212100", "volume": "107", "author": "J Seissler", "year": "1999", "unstructured": "Seissler J, Schott M, Steinbrenner H, Peterson P, Scherbaum WA (1999) Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison\u2019s disease and autoimmune polyendocrine syndrome type II. Exp Clin Endocrinol Diabetes 107:208\u2013213", "journal-title": "Exp Clin Endocrinol Diabetes"}, {"key": "9_CR1971", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1530/eje.0.1500049", "volume": "150", "author": "AS Boe", "year": "2004", "unstructured": "Boe AS, Bredholt G, Knappskog PM, Hjelmervik TO, Mellgren G, Winqvist O, Kampe O, Husebye ES (2004) Autoantibodies against 21-hydroxylase and side-chain cleavage enzyme in autoimmune Addison\u2019s disease are mainly immunoglobulin G1. Euro J Endocrinol 150:49\u201356", "journal-title": "Euro J Endocrinol"}, {"key": "9_CR1972", "doi-asserted-by": "crossref", "first-page": "2821", "DOI": "10.1210/jc.2005-2230", "volume": "91", "author": "H al Kandari", "year": "2006", "unstructured": "al Kandari H, Katsumata N, Alexander S, Rasoul MA (2006) Homozygous mutation of P450 side-chain cleavage enzyme gene (CYP11A1) in 46, XY patient with adrenal insufficiency, complete sex reversal, and agenesis of corpus callosum. J Clin Endocrinol Metab 91:2821\u20132826", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR1973", "doi-asserted-by": "crossref", "first-page": "702", "DOI": "10.1016/j.lfs.2006.02.023", "volume": "79", "author": "M Pena-Rico", "year": "2006", "unstructured": "Pena-Rico M, Guadalupe Ortiz-Lopez M, Camacho-Castillo L, Cardenas M, Pedraza-Chaverri J, Menjivar M (2006) Steroidogenic impairment due to reduced ovarian transcription of cytochrome P450 side-chain-cleavage (P450scc) and steroidogenic acute regulatory protein (StAR) during experimental nephrotic syndrome. Life Sci 79:702\u2013708", "journal-title": "Life Sci"}, {"key": "9_CR1974", "doi-asserted-by": "crossref", "first-page": "12019", "DOI": "10.1158/0008-5472.CAN-06-1101", "volume": "66", "author": "VW Setiawan", "year": "2006", "unstructured": "Setiawan VW, Cheng I, Stram DO, Giorgi E, Pike MC, Van Den Berg D, Pooler L, Burtt NP, Le Marchand L, Altshuler D, Hirschhorn J, Henderson BE, Haiman CA (2006) A systematic assessment of common genetic variation in CYP11A and risk of breast cancer. Cancer Res 66:12019\u201312025", "journal-title": "Cancer Res"}, {"key": "9_CR1975", "doi-asserted-by": "crossref", "first-page": "28", "DOI": "10.1016/j.cancergencyto.2008.08.003", "volume": "187", "author": "T Celhar", "year": "2008", "unstructured": "Celhar T, Gersak K, Ovcak Z, Sedmak B, Mlinaric-Rascan I (2008) The presence of the CYP11A1 (TTTTA)6 allele increases the risk of biochemical relapse in organ confined and low-grade prostate cancer. Cancer Genet Cytogenet 187:28\u201333", "journal-title": "Cancer Genet Cytogenet"}, {"key": "9_CR1976", "doi-asserted-by": "crossref", "first-page": "1537", "DOI": "10.1515/BC.2002.174", "volume": "383", "author": "M Bureik", "year": "2002", "unstructured": "Bureik M, Lisurek M, Bernhardt R (2002) The human steroid hydroxylases CYP11B1 and CYP11B2. Biol Chem 383:1537\u20131551", "journal-title": "Biol Chem"}, {"key": "9_CR1977", "doi-asserted-by": "crossref", "first-page": "127", "DOI": "10.1021/bi00594a018", "volume": "17", "author": "M Watanuki", "year": "1978", "unstructured": "Watanuki M, Tilley BE, Hall PF (1978) Cytochrome P-450 for 11\u03b2- and 18-hydroxylase activities of bovine adrenocortical mitochondria: one enzyme or two? Biochemistry 17:127\u2013130", "journal-title": "Biochemistry"}, {"key": "9_CR1978", "first-page": "20961", "volume": "264", "author": "E Mornet", "year": "1989", "unstructured": "Mornet E, Dupont J, Vitek A, White PC (1989) Characterization of two genes encoding human steroid 11\u03b2-hydroxylase P-45011\u03b2. J Biol Chem 264:20961\u201320967", "journal-title": "J Biol Chem"}, {"key": "9_CR1979", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1016/0014-5793(90)81190-Y", "volume": "269", "author": "T Kawamoto", "year": "1990", "unstructured": "Kawamoto T, Mitsuuchi Y, Toda K, Miyahara K, Yokoyama Y, Nakao K, Hosoda K, Yamamoto Y, Imura H, Shizuta Y (1990) Cloning of cDNA and genomic DNA for human cytochrome P-45011\u03b2. FEBS Lett 269:345\u2013349", "journal-title": "FEBS Lett"}, {"key": "9_CR1980", "first-page": "3254", "volume": "81", "author": "G Zhang", "year": "1996", "unstructured": "Zhang G, Miller WL (1996) The human genome contains only two CYP11B (P450c11) genes. J Clin Endocrinol Metab 81:3254\u20133256", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR1981", "doi-asserted-by": "crossref", "first-page": "1458", "DOI": "10.1073/pnas.89.4.1458", "volume": "89", "author": "T Kawamoto", "year": "1992", "unstructured": "Kawamoto T, Mitsuuchi Y, Toda K, Yokoyama Y, Miyahara K, Miura S, Ohnishi T, Ichikawa Y, Nakao K, Imura H, Ulick S, Shizuta Y (1992) Role of steroid 11b-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans. Proc Natl Acad Sci U S A 89:1458\u20131462", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR1982", "doi-asserted-by": "crossref", "first-page": "305", "DOI": "10.1177/107155769700400607", "volume": "4", "author": "WA Freije", "year": "1997", "unstructured": "Freije WA, Pezzi V, Arici A, Carr BR, Rainey WE (1997) Expression of 11\u03b2-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) in the human fetal adrenal. J Soc Gynecol Investig 4:305\u2013309", "journal-title": "J Soc Gynecol Investig"}, {"key": "9_CR1983", "first-page": "1196", "volume": "7", "author": "K Morohashi", "year": "1993", "unstructured": "Morohashi K, Zanger UM, Honda S, Hara M, Waterman MR, Omura T (1993) Activation of CYP11A and CYP11B gene promoters by the steroidogenic cell-specific transcription factor, Ad4BP. Mol Endocrinol 7:1196\u20131204", "journal-title": "Mol Endocrinol"}, {"key": "9_CR1984", "first-page": "7494", "volume": "268", "author": "S Honda", "year": "1993", "unstructured": "Honda S, Morohashi K, Nomura M, Takeya H, Kitajima M, Omura T (1993) Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. J Biol Chem 268:7494\u20137502", "journal-title": "J Biol Chem"}, {"key": "9_CR1985", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1093/oxfordjournals.jbchem.a123941", "volume": "112", "author": "T Hashimoto", "year": "1992", "unstructured": "Hashimoto T, Morohashi K, Takayama K, Honda S, Wada T, Handa H, Omura T (1992) Cooperative transcription activation between Ad1, a CRE-like element, and other elements in the CYP11B gene promoter. J Biochem (Tokyo) 112:573\u2013575", "journal-title": "J Biochem (Tokyo)"}, {"key": "9_CR1986", "doi-asserted-by": "crossref", "first-page": "190", "DOI": "10.1046/j.1432-1327.1998.2560190.x", "volume": "256", "author": "K Mukai", "year": "1998", "unstructured": "Mukai K, Mitani F, Agake R, Ishimura Y (1998) Adrenocorticotropic hormone stimulates CYP11B1 gene transcription through a mechanism involving AP-1 factors. Eur J Biochem 256:190\u2013200", "journal-title": "Eur J Biochem"}, {"key": "9_CR1987", "doi-asserted-by": "crossref", "first-page": "3587", "DOI": "10.1210/endo.141.10.7689", "volume": "141", "author": "XL Wang", "year": "2000", "unstructured": "Wang XL, Bassett M, Zhang Y, Yin S, Clyne C, White PC, Rainey WE (2000) Transcriptional regulation of human 11\u03b2-hydroxylase (hCYP11B1). Endocrinology 141:3587\u20133594", "journal-title": "Endocrinology"}, {"key": "9_CR1988", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1677/jme.0.0280125", "volume": "28", "author": "MH Bassett", "year": "2002", "unstructured": "Bassett MH, Zhang Y, Clyne C, White PC, Rainey WE (2002) Differential regulation of aldosterone synthase and 11\u03b2-hydroxylase transcription by steroidogenic factor-1. J Mol Endocrinol 28:125\u2013135", "journal-title": "J Mol Endocrinol"}, {"key": "9_CR1989", "doi-asserted-by": "crossref", "first-page": "279", "DOI": "10.1210/me.2003-0005", "volume": "18", "author": "MH Bassett", "year": "2004", "unstructured": "Bassett MH, Suzuki T, Sasano H, White PC, Rainey WE (2004) The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production. Mol Endocrinol 18:279\u2013290", "journal-title": "Mol Endocrinol"}, {"key": "9_CR1990", "doi-asserted-by": "crossref", "first-page": "691", "DOI": "10.1111/j.1442-2042.2011.02836.x", "volume": "18", "author": "C Cao", "year": "2011", "unstructured": "Cao C, Yang X, Li L, Sun R, Xian Y, Lv W, Wang J, Xu Y, Gao Y (2011) Increased expression of CYP17 and CYP11B1 in subclinical Cushing\u2019s syndrome due to adrenal adenomas. Int J Urol 18:691\u2013696", "journal-title": "Int J Urol"}, {"key": "9_CR1991", "doi-asserted-by": "crossref", "first-page": "572", "DOI": "10.1161/HYPERTENSIONAHA.113.01102", "volume": "62", "author": "S Robertson", "year": "2013", "unstructured": "Robertson S, MacKenzie SM, Alvarez-Madrazo S, Diver LA, Lin J, Stewart PM, Fraser R, Connell JM, Davies E (2013) MicroRNA-24 is a novel regulator of aldosterone and cortisol production in the human adrenal cortex. Hypertension 62:572\u2013578", "journal-title": "Hypertension"}, {"key": "9_CR1992", "doi-asserted-by": "crossref", "first-page": "1536", "DOI": "10.1210/en.2005-0823", "volume": "147", "author": "TC Lin", "year": "2006", "unstructured": "Lin TC, Chien SC, Hsu PC, Li LA (2006) Mechanistic study of polychlorinated biphenyl 126-induced CYP11B1 and CYP11B2 up-regulation. Endocrinology 147:1536\u20131544", "journal-title": "Endocrinology"}, {"key": "9_CR1993", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1002/ajmg.a.20108", "volume": "122A", "author": "YS Zhu", "year": "2003", "unstructured": "Zhu YS, Cordero JJ, Can S, Cai LQ, You X, Herrera C, DeFillo-Ricart M, Shackleton C, Imperato-McGinley J (2003) Mutations in CYP11B1 gene: phenotype-genotype correlations. Am J Med Genet A 122A:193\u2013200", "journal-title": "Am J Med Genet A"}, {"key": "9_CR1994", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1016/j.mce.2003.09.013", "volume": "211", "author": "MI New", "year": "2003", "unstructured": "New MI (2003) Inborn errors of adrenalsteroidogenesis. Mol Cell Endocrinol 211:75\u201383", "journal-title": "Mol Cell Endocrinol"}, {"key": "9_CR1995", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1016/j.mce.2003.10.056", "volume": "214", "author": "J Nicod", "year": "2004", "unstructured": "Nicod J, Dick B, Frey FJ, Ferrari P (2004) Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production. Mol Cell Endocrinol 214:167\u2013174", "journal-title": "Mol Cell Endocrinol"}, {"key": "9_CR1996", "doi-asserted-by": "crossref", "first-page": "418", "DOI": "10.1111/j.1365-2265.2005.02234.x", "volume": "62", "author": "HH Lee", "year": "2005", "unstructured": "Lee HH, Won GS, Chao HT, Lee YJ, Chung BC (2005) Novel missense mutations, GCC [Ala306]- > GTC [Val] and ACG [Thr318]- > CCG [Pro], in the CYP11B1 gene cause steroid 11\u03b2-hydroxylase deficiency in the Chinese. Clin Endocrinol 62:418\u2013422", "journal-title": "Clin Endocrinol"}, {"key": "9_CR1997", "first-page": "284", "volume": "63", "author": "I Kuribayashi", "year": "2005", "unstructured": "Kuribayashi I, Nomoto S, Massa G, Oostdijk W, Wit JM, Wolffenbuttel BH, Shizuta Y, Honke K (2005) Steroid 11-beta-hydroxylase deficiency caused by compound heterozygosity for a novel mutation pG314R, in one CYP11B1 allele, and a chimeric CYP11B2/CYP11B1 in the other allele. Horm Res 63:284\u2013293", "journal-title": "Horm Res"}, {"key": "9_CR1998", "doi-asserted-by": "crossref", "first-page": "5051", "DOI": "10.1210/jc.2006-1481", "volume": "91", "author": "H Imrie", "year": "2006", "unstructured": "Imrie H, Freel M, Mayosi BM, Davies E, Fraser R, Ingram M, Cordell HJ, Farrall M, Avery PJ, Watkins H, Keavney B, Connell JM (2006) Association between aldosterone production and variation in the 11\u03b2-hydroxylase (CYP11B1) gene. J Clin Endocrinol Metab 91:5051\u20135056", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR1999", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1161/01.HYP.0000249904.93940.7a", "volume": "49", "author": "M Barr", "year": "2007", "unstructured": "Barr M, MacKenzie SM, Friel EC, Holloway CD, Wilkinson DM, Brain NJ, Ingram MC, Fraser R, Brown M, Samani NJ, Caulfield M, Munroe PB, Farrall M, Webster J, Clayton D, Dominiczak AF, Connell JM, Davies E (2007) Polymorphic variation in the 11\u03b2-hydroxylase gene associates with reduced 11-hydroxylase efficiency. Hypertension 49:113\u2013119", "journal-title": "Hypertension"}, {"key": "9_CR2000", "doi-asserted-by": "crossref", "first-page": "816", "DOI": "10.1111/j.1365-2265.2006.02673.x", "volume": "65", "author": "M Barr", "year": "2006", "unstructured": "Barr M, MacKenzie SM, Wilkinson DM, Holloway CD, Friel EC, Miller S, MacDonald T, Fraser R, Connell JM, Davies E (2006) Functional effects of genetic variants in the 11\u03b2-hydroxylase (CYP11B1) gene. Clin Endocrinol 65:816\u2013825", "journal-title": "Clin Endocrinol"}, {"key": "9_CR2001", "doi-asserted-by": "crossref", "first-page": "891", "DOI": "10.1007/s00431-009-1110-1", "volume": "169", "author": "K Dumic", "year": "2010", "unstructured": "Dumic K, Wilson R, Thanasawat P, Grubic Z, Kusec V, Stingl K, New MI (2010) Steroid 11-beta hydroxylase deficiency caused by compound heterozygosity for a novel mutation in intron 7 (IVS 7 DS + 4A to G) in one CYP11B1 allele and R448H in exon 8 in the other. Eur J Pediatr 169:891\u2013894", "journal-title": "Eur J Pediatr"}, {"key": "9_CR2002", "doi-asserted-by": "crossref", "first-page": "779", "DOI": "10.1210/jc.2009-0651", "volume": "95", "author": "S Parajes", "year": "2010", "unstructured": "Parajes S, Loidi L, Reisch N, Dhir V, Rose IT, Hampel R, Quinkler M, Conway GS, Castro-Feijoo L, Araujo-Vilar D, Pombo M, Dominguez F, Williams EL, Cole TR, Kirk JM, Kaminsky E, Rumsby G, Arlt W, Krone N (2010) Functional consequences of seven novel mutations in the CYP11B1 gene: four mutations associated with nonclassic and three mutations causing classic 11\u03b2-hydroxylase deficiency. J Clin Endocrinol Metab 95:779\u2013788", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2003", "doi-asserted-by": "crossref", "first-page": "377", "DOI": "10.1081/ERC-120026943", "volume": "29", "author": "I Kuribayashi", "year": "2003", "unstructured": "Kuribayashi I, Massa G, van den Tooren-de Groot HK, Oostdijk W, Wit JM, Shizuta Y (2003) A novel nonsense mutation in the Cyp11B1 gene from a subject with the steroid 11\u03b2-hydroxylase form of congenital adrenalhyperplasia. Endocrine Res 29:377\u2013381", "journal-title": "Endocrine Res"}, {"key": "9_CR2004", "doi-asserted-by": "crossref", "first-page": "5769", "DOI": "10.1210/jc.2005-0379", "volume": "90", "author": "A Grigorescu Sido", "year": "2005", "unstructured": "Grigorescu Sido A, Weber MM, Grigorescu Sido P, Clausmeyer S, Heinrich U, Schulze E (2005) 21-hydroxylase and 11\u03b2-hydroxylase mutations in Romanian patients with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 90:5769\u20135773", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2005", "doi-asserted-by": "crossref", "first-page": "5463", "DOI": "10.1210/jc.2005-1145", "volume": "90", "author": "T Paperna", "year": "2005", "unstructured": "Paperna T, Gershoni-Baruch R, Badarneh K, Kasinetz L, Hochberg Z (2005) Mutations in CYP11B1 and congenital adrenalhyperplasia in Moroccan Jews. J Clin Endocrinol Metab 90:5463\u20135465", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2006", "doi-asserted-by": "crossref", "first-page": "2682", "DOI": "10.1210/jc.2006-0209", "volume": "91", "author": "N Krone", "year": "2006", "unstructured": "Krone N, Grischuk Y, Muller M, Volk RE, Grotzinger J, Holterhus PM, Sippell WG, Riepe FG (2006) Analyzing the functional and structural consequences of two point mutations (P94 L and A368D) in the CYP11B1 gene causing congenital adrenal hyperplasia resulting from 11-hydroxylase deficiency. J Clin Endocrinol Metab 91:2682\u20132688", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2007", "first-page": "189", "volume": "67", "author": "CJ Peters", "year": "2007", "unstructured": "Peters CJ, Nugent T, Perry LA, Davies K, Morel Y, Drake WM, Savage MO, Johnston LB (2007) Cosegregation of a novel homozygous CYP11B1 mutation with the phenotype of non-classical congenital adrenal hyperplasia in a consanguineous family. Horm Res 67:189\u2013193", "journal-title": "Horm Res"}, {"key": "9_CR2008", "doi-asserted-by": "crossref", "first-page": "212", "DOI": "10.1007/s12020-012-9861-2", "volume": "44", "author": "MR Abbaszadegan", "year": "2013", "unstructured": "Abbaszadegan MR, Hassani S, Vakili R, Saberi MR, Baradaran-Heravi A, A\u2019Rabi A, Hashemipour M, Razzaghi-Azar M, Moaven O, Baratian A, Ahadian M, Keify F, Meurice N (2013) Two novel mutations in CYP11B1 and modeling the consequent alterations of the translated protein in classic congenital adrenal hyperplasia patients. Endocrine 44:212\u2013219", "journal-title": "Endocrine"}, {"key": "9_CR2009", "doi-asserted-by": "crossref", "first-page": "610", "DOI": "10.1038/ejhg.2013.197", "volume": "22", "author": "S Menabo", "year": "2014", "unstructured": "Menabo S, Polat S, Baldazzi L, Kulle AE, Holterhus PM, Grotzinger J, Fanelli F, Balsamo A, Riepe FG (2014) Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: functional consequences of four CYP11B1 mutations. Eur J Hum Genet 22:610\u2013616", "journal-title": "Eur J Hum Genet"}, {"key": "9_CR2010", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.1159/000356948", "volume": "7", "author": "M Martin", "year": "2013", "unstructured": "Martin M, Najera N, Garibay N, Malanco LM, Martinez T, Rivera J, Rivera M, Queipo G (2013) New genetic abnormalities in non-21\u03b1-hydroxylase-deficiency congenital adrenal hyperplasia. Sex Dev 7:289\u2013294", "journal-title": "Sex Dev"}, {"key": "9_CR2011", "doi-asserted-by": "crossref", "first-page": "832", "DOI": "10.1111/j.1365-2265.2007.02971.x", "volume": "67", "author": "EM Freel", "year": "2007", "unstructured": "Freel EM, Ingram M, Friel EC, Fraser R, Brown M, Samani NJ, Caulfield M, Munroe P, Farrall M, Webster J, Clayton D, Dominiczak AF, Davies E, Connell JM (2007) Phenotypic consequences of variation across the aldosterone synthase and 11-\u03b2 hydroxylase locus in a hypertensive cohort: data from the MRC BRIGHT study. Clin Endocrinol 67:832\u2013838", "journal-title": "Clin Endocrinol"}, {"key": "9_CR2012", "doi-asserted-by": "crossref", "first-page": "377", "DOI": "10.1093/hmg/3.2.377", "volume": "3", "author": "CA Skinner", "year": "1994", "unstructured": "Skinner CA, Rumsby G (1994) Steroid 11\u03b2-hydroxylase deficiency caused by a five base pair duplication in the CYP11B1 gene. Hum Mol Genet 3:377\u2013378", "journal-title": "Hum Mol Genet"}, {"key": "9_CR2013", "doi-asserted-by": "crossref", "first-page": "4552", "DOI": "10.1073/pnas.90.10.4552", "volume": "90", "author": "KM Curnow", "year": "1993", "unstructured": "Curnow KM, Slutsker L, Vitek J, Cole T, Speiser PW, New MI, White PC, Pascoe L (1993) Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc Natl Acad Sci U S A 90:4552\u20134556", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR2014", "doi-asserted-by": "crossref", "first-page": "262", "DOI": "10.1038/355262a0", "volume": "355", "author": "RP Lifton", "year": "1992", "unstructured": "Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM (1992) A chimaeric 11\u03b2-hydroxylase/aldosteronesynthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262\u2013265", "journal-title": "Nature"}, {"key": "9_CR2015", "doi-asserted-by": "crossref", "first-page": "8327", "DOI": "10.1073/pnas.89.17.8327", "volume": "89", "author": "L Pascoe", "year": "1992", "unstructured": "Pascoe L, Curnow KM, Slutsker L, Connell JM, Speiser PW, New MI, White PC (1992) Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc Natl Acad Sci U S A 89:8327\u20138331", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR2016", "first-page": "4445", "volume": "86", "author": "M Hampf", "year": "2001", "unstructured": "Hampf M, Dao NT, Hoan NT, Bernhardt R (2001) Unequal crossing-over between aldosterone synthase and 11\u03b2-hydroxylase genes causes congenital adrenal hyperplasia. J Clin Endocrinol Metab 86:4445\u20134452", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2017", "first-page": "3197", "volume": "86", "author": "S Portrat", "year": "2001", "unstructured": "Portrat S, Mulatero P, Curnow KM, Chaussain JL, Morel Y, Pascoe L (2001) Deletion hybrid genes, due to unequal crossing over between CYP11B1 (11\u03b2-hydroxylase) and CYP11B2(aldosterone synthase) cause steroid 11\u03b2-hydroxylase deficiency and congenital adrenal hyperplasia. J Clin Endocrinol Metab 86:3197\u20133201", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2018", "doi-asserted-by": "crossref", "first-page": "797", "DOI": "10.3109/07435800009048602", "volume": "26", "author": "O Chabre", "year": "2000", "unstructured": "Chabre O, Portrat-Doyen S, Vivier J, Morel Y, Defaye G (2000) Two novel mutations in splice donor sites of CYP11B1 in congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency. Endocr Res 26:797\u2013801", "journal-title": "Endocr Res"}, {"key": "9_CR2019", "doi-asserted-by": "crossref", "first-page": "315", "DOI": "10.1210/me.2012-1287", "volume": "27", "author": "N Strushkevich", "year": "2013", "unstructured": "Strushkevich N, Gilep AA, Shen L, Arrowsmith CH, Edwards AM, Usanov SA, Park HW (2013) Structural insights into aldosterone synthase substrate specificity and targeted inhibition. Mol Endocrinol 27:315\u2013324", "journal-title": "Mol Endocrinol"}, {"key": "9_CR2020", "first-page": "3996", "volume": "83", "author": "P Mulatero", "year": "1998", "unstructured": "Mulatero P, Curnow KM, Aupetit-Faisant B, Foekling M, Gomez-Sanchez C, Veglio F, Jeunemaitre X, Corvol P, Pascoe L (1998) Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol. J Clin Endocrinol Metab 83:3996\u20134001", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2021", "doi-asserted-by": "crossref", "first-page": "S", "DOI": "10.1111/j.1440-1681.1998.tb02299.x", "volume": "25", "author": "A Fisher", "year": "1998", "unstructured": "Fisher A, Davies E, Fraser R, Connell JM (1998) Structure-function relationships of aldosteronesynthase and 11\u03b2-hydroxylase enzymes: implications for human hypertension. Clin Exp Pharmacol Physiol Suppl 25:S42\u201346", "journal-title": "Clin Exp Pharmacol Physiol Suppl"}, {"key": "9_CR2022", "first-page": "1261", "volume": "85", "author": "A Fisher", "year": "2000", "unstructured": "Fisher A, Fraser R, Mc Connell J, Davies E (2000) Amino acid residue 147 of human aldosterone synthase and 11\u03b2-hydroxylase plays a key role in 11\u03b2-hydroxylation. J Clin Endocrinol Metab 85:1261\u20131266", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2023", "doi-asserted-by": "crossref", "first-page": "458", "DOI": "10.1046/j.1432-1327.1998.2520458.x", "volume": "252", "author": "B B\u00f6ttner", "year": "1998", "unstructured": "B\u00f6ttner B, Denner K, Bernhardt R (1998) Conferring aldosterone synthesis to human CYP11B1 by replacing key amino acid residues with CYP11B2-specific ones. Eur J Biochem 252:458\u2013466", "journal-title": "Eur J Biochem"}, {"key": "9_CR2024", "doi-asserted-by": "crossref", "first-page": "217", "DOI": "10.1016/S0960-0760(98)00032-6", "volume": "66", "author": "DF Lewis", "year": "1998", "unstructured": "Lewis DF, Lee-Robichaud P (1998) Molecular modelling of steroidogenic cytochromes P450 from families CYP11, CYP17, CYP19and CYP21 based on the CYP102 crystal structure. J Steroid Biochem Mol Biol 66:217\u2013233", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2025", "doi-asserted-by": "crossref", "first-page": "197", "DOI": "10.1016/S0162-0134(01)00331-2", "volume": "87", "author": "NV Belkina", "year": "2001", "unstructured": "Belkina NV, Lisurek M, Ivanov AS, Bernhardt R (2001) Modelling of three-dimensional structures of cytochromes P450 11B1 and 11B2. J Inorg Biochem 87:197\u2013207", "journal-title": "J Inorg Biochem"}, {"key": "9_CR2026", "doi-asserted-by": "crossref", "first-page": "455", "DOI": "10.1007/s10822-007-9128-9", "volume": "21", "author": "L Roumen", "year": "2007", "unstructured": "Roumen L, Sanders MP, Pieterse K, Hilbers PA, Plate R, Custers E, de Gooyer M, Smits JF, Beugels I, Emmen J, Ottenheijm HC, Leysen D, Hermans JJ (2007) Construction of 3D models of the CYP11B family as a tool to predict ligand binding characteristics. J Comput Aided Mol Des 21:455\u2013471", "journal-title": "J Comput Aided Mol Des"}, {"key": "9_CR2027", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1097/00008571-199504000-00005", "volume": "5", "author": "K Denner", "year": "1995", "unstructured": "Denner K, Vogel R, Schmalix W, Doehmer J, Bernhardt R (1995) Cloning and stable expression of the human mitochondrial cytochrome P45011B1 cDNA in V79 Chinese hamster cells and their application for testing of potential inhibitors. Pharmacogenetics 5:89\u201396", "journal-title": "Pharmacogenetics"}, {"key": "9_CR2028", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1016/0960-0760(94)00152-C", "volume": "52", "author": "JO Johnston", "year": "1995", "unstructured": "Johnston JO, Wright CL, Holbert GW (1995) Enzyme-activated inhibitors of steroidal hydroxylases. J Steroid Biochem Mol Biol 52:17\u201334", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2029", "doi-asserted-by": "crossref", "first-page": "252", "DOI": "10.1111/j.1432-1033.1997.00252.x", "volume": "248", "author": "C Delorme", "year": "1997", "unstructured": "Delorme C, Piffeteau A, Sobrio F, Marquet A (1997) Mechanism-based inactivation of bovine cytochrome P45011\u03b2 by 18-unsaturated progesterone derivatives. Eur J Biochem 248:252\u2013260", "journal-title": "Eur J Biochem"}, {"key": "9_CR2030", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1016/j.mce.2003.10.027", "volume": "217", "author": "M Bureik", "year": "2004", "unstructured": "Bureik M, Hubel K, Dragan CA, Scher J, Becker H, Lenz N, Bernhardt R (2004) Development of test systems for the discovery of selective human aldosterone synthase (CYP11B2) and 11\u03b2-hydroxylase (CYP11B1) inhibitors. Discovery of a new lead compound for the therapy of congestive heart failure, myocardial fibrosis and hypertension. Mol Cell Endocrinol 217:249\u2013254", "journal-title": "Mol Cell Endocrinol"}, {"key": "9_CR2031", "doi-asserted-by": "crossref", "first-page": "267", "DOI": "10.1016/j.bmcl.2007.10.079", "volume": "18", "author": "MA Pinto-Bazurco Mendieta", "year": "2008", "unstructured": "Pinto-Bazurco Mendieta MA, Negri M, Jagusch C, Hille UE, Muller-Vieira U, Schmidt D, Hansen K, Hartmann RW (2008) Synthesis, biological evaluation and molecular modelling studies of novel ACD- and ABD-ring steroidomimetics as inhibitors of CYP17. Bioorg Med Chem Lett 18:267\u2013273", "journal-title": "Bioorg Med Chem Lett"}, {"key": "9_CR2032", "doi-asserted-by": "crossref", "first-page": "2244", "DOI": "10.1021/jm800012w", "volume": "51", "author": "IM Zolle", "year": "2008", "unstructured": "Zolle IM, Berger ML, Hammerschmidt F, Hahner S, Schirbel A, Peric-Simov B (2008) New selective inhibitors of steroid 11\u03b2-hydroxylation in the adrenal cortex. Synthesis and structure-activity relationship of potent etomidate analogues. J Med Chem 51:2244\u20132253", "journal-title": "J Med Chem"}, {"key": "9_CR2033", "doi-asserted-by": "crossref", "first-page": "5064", "DOI": "10.1021/jm800377h", "volume": "51", "author": "R Heim", "year": "2008", "unstructured": "Heim R, Lucas S, Grombein CM, Ries C, Schewe KE, Negri M, Muller-Vieira U, Birk B, Hartmann RW (2008) Overcoming undesirable CYP1A2 inhibition of pyridylnaphthalene-type aldosterone synthase inhibitors: influence of heteroaryl derivatization on potency and selectivity. J Med Chem 51:5064\u20135074", "journal-title": "J Med Chem"}, {"key": "9_CR2034", "doi-asserted-by": "crossref", "first-page": "7715", "DOI": "10.1016/j.bmc.2008.07.011", "volume": "16", "author": "Q Hu", "year": "2008", "unstructured": "Hu Q, Negri M, Jahn-Hoffmann K, Zhuang Y, Olgen S, Bartels M, Muller-Vieira U, Lauterbach T, Hartmann RW (2008) Synthesis, biological evaluation, and molecular modeling studies of methylene imidazole substituted biaryls as inhibitors of human 17\u03b1-hydroxylase-17,20-lyase (CYP17)\u2014part II: core rigidification and influence of substituents at the methylene bridge. Bioorg Med Chem 16:7715\u20137727", "journal-title": "Bioorg Med Chem"}, {"key": "9_CR2035", "doi-asserted-by": "crossref", "first-page": "2765", "DOI": "10.1016/j.ejmech.2009.01.002", "volume": "44", "author": "UE Hille", "year": "2009", "unstructured": "Hille UE, Hu Q, Vock C, Negri M, Bartels M, Muller-Vieira U, Lauterbach T, Hartmann RW (2009) Novel CYP17 inhibitors: synthesis, biological evaluation, structure-activity relationships and modelling of methoxy- and hydroxy-substituted methyleneimidazolyl biphenyls. Eur J Med Chem 44:2765\u20132775", "journal-title": "Eur J Med Chem"}, {"key": "9_CR2036", "doi-asserted-by": "crossref", "first-page": "1712", "DOI": "10.1021/jm901356d", "volume": "53", "author": "L Roumen", "year": "2010", "unstructured": "Roumen L, Peeters JW, Emmen JM, Beugels IP, Custers EM, de Gooyer M, Plate R, Pieterse K, Hilbers PA, Smits JF, Vekemans JA, Leysen D, Ottenheijm HC, Janssen HM, Hermans JJ (2010) Synthesis, biological evaluation, and molecular modeling of 1-benzyl-1H-imidazoles as selective inhibitors of aldosterone synthase (CYP11B2). J Med Chem 53:1712\u20131725", "journal-title": "J Med Chem"}, {"key": "9_CR2037", "doi-asserted-by": "crossref", "first-page": "5749", "DOI": "10.1021/jm100317b", "volume": "53", "author": "Q Hu", "year": "2010", "unstructured": "Hu Q, Jagusch C, Hille UE, Haupenthal J, Hartmann RW (2010) Replacement of imidazolyl by pyridyl in biphenylmethylenes results in selective CYP17 and dual CYP17/CYP11B1 inhibitors for the treatment of prostate cancer. J Med Chem 53:5749\u20135758", "journal-title": "J Med Chem"}, {"key": "9_CR2038", "doi-asserted-by": "crossref", "first-page": "7080", "DOI": "10.1021/jm3004637", "volume": "55", "author": "Q Hu", "year": "2012", "unstructured": "Hu Q, Yin L, Hartmann RW (2012) Selective dual inhibitors of CYP19 and CYP11B2: targeting cardiovascular diseases hiding in the shadow of breast cancer. J Med Chem 55:7080\u20137089", "journal-title": "J Med Chem"}, {"key": "9_CR2039", "doi-asserted-by": "crossref", "first-page": "6101", "DOI": "10.1021/jm400484p", "volume": "56", "author": "MA Pinto-Bazurco Mendieta", "year": "2013", "unstructured": "Pinto-Bazurco Mendieta MA, Hu Q, Engel M, Hartmann RW (2013) Highly potent and selective nonsteroidal dual inhibitors of CYP17/CYP11B2 for the treatment of prostate cancer to reduce risks of cardiovascular diseases. J Med Chem 56:6101\u20136107", "journal-title": "J Med Chem"}, {"key": "9_CR2040", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1111/ggi.12027", "volume": "13", "author": "W Ozawa", "year": "2013", "unstructured": "Ozawa W, Sato K, Miyakoshi T, Nishio S, Yamazaki M, Suzuki S, Komatsu M (2013) Case report: beneficial effect of 11\u03b2-hydroxylase inhibitor in the management of an elderly patient with an androgen-producing inoperable adrenal tumor. Geriatr Gerontol Int 13:509\u2013511", "journal-title": "Geriatr Gerontol Int"}, {"key": "9_CR2041", "doi-asserted-by": "crossref", "first-page": "61", "DOI": "10.1016/S0889-8529(08)70019-7", "volume": "30", "author": "PC White", "year": "2001", "unstructured": "White PC (2001) Steroid 11\u03b2-hydroxylase deficiency and related disorders. Endocrinol Metab Clin North Am 30:61\u201379", "journal-title": "Endocrinol Metab Clin North Am"}, {"key": "9_CR2042", "first-page": "211", "volume": "51", "author": "M Peter", "year": "1999", "unstructured": "Peter M, Dubuis JM, Sippell WG (1999) Disorders of the aldosterone synthase and steroid 11\u03b2-hydroxylase deficiencies. Horm Res 51:211\u2013222", "journal-title": "Horm Res"}, {"key": "9_CR2043", "doi-asserted-by": "crossref", "first-page": "96", "DOI": "10.1016/j.tem.2008.01.002", "volume": "19", "author": "S Nimkarn", "year": "2008", "unstructured": "Nimkarn S, New MI (2008) Steroid 11\u03b2-hydroxylase deficiency congenital adrenal hyperplasia. Trends Endocrin Metab 19:96\u201399", "journal-title": "Trends Endocrin Metab"}, {"key": "9_CR2044", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1007/978-1-4419-8002-1_2", "volume": "707", "author": "PC White", "year": "2011", "unstructured": "White PC (2011) Congenital adrenal hyperplasia owing to 11\u03b2-hydroxylase deficiency. Adv Exp Med Biol 707:7\u20138", "journal-title": "Adv Exp Med Biol"}, {"key": "9_CR2045", "doi-asserted-by": "crossref", "first-page": "3925", "DOI": "10.1074/jbc.M805081200", "volume": "284", "author": "LJ Mullins", "year": "2009", "unstructured": "Mullins LJ, Peter A, Wrobel N, McNeilly JR, McNeilly AS, Al-Dujaili EA, Brownstein DG, Mullins JJ, Kenyon CJ (2009) Cyp11b1 null mouse, a model of congenital adrenal hyperplasia. J Biol Chem 284:3925\u20133934", "journal-title": "J Biol Chem"}, {"key": "9_CR2046", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1007/BF03346295", "volume": "30", "author": "S Cingoz", "year": "2007", "unstructured": "Cingoz S, Ozkan B, Doneray H, Sakizli M (2007) Familial pericentric inversion chromosome 3 and R448C mutation of CYP11B1 gene in Turkish kindred with 11\u03b2-hydroxylase deficiency. J Endocrin Invest 30:285\u2013291", "journal-title": "J Endocrin Invest"}, {"key": "9_CR2047", "doi-asserted-by": "crossref", "first-page": "3674", "DOI": "10.1210/jc.2007-0337", "volume": "92", "author": "HL Claahsen-van der Grinten", "year": "2007", "unstructured": "Claahsen-van der Grinten HL, Otten BJ, Sweep FC, Span PN, Ross HA, Meuleman EJ, Hermus AR (2007) Testicular tumors in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency show functional features of adrenocortical tissue. J Clin Endocrinol Metab 92:3674\u20133680", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2048", "first-page": "99", "volume": "60", "author": "HL Storr", "year": "2003", "unstructured": "Storr HL, Barwick TD, Snodgrass GA, Booy R, Morel Y, Reznek RH, Savage MO (2003) Hyperplasia of adrenalrest tissue causing a retroperitoneal mass in a child with 1 \u03b2-hydroxylase deficiency. Horm Res 60:99\u2013102", "journal-title": "Horm Res"}, {"key": "9_CR2049", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1016/j.ando.2008.12.005", "volume": "70", "author": "M Kacem", "year": "2009", "unstructured": "Kacem M, Moussa A, Khochtali I, Nabouli R, Morel Y, Zakhama A (2009) Bilateral adrenalectomy for severe hypertension in congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency: long term follow-up. Ann Endocrin 70:113\u2013118", "journal-title": "Ann Endocrin"}, {"key": "9_CR2050", "first-page": "182", "volume": "27", "author": "AR Isiavwe", "year": "2008", "unstructured": "Isiavwe AR, Ekpebegh CO, Fasanmade OA, Ohwovoriole AE (2008) Steroid responsive hypertension secondary to 11\u03b2 hydroxylase deficiency\u2014a case report. West Afr J Med 27:182\u2013185", "journal-title": "West Afr J Med"}, {"key": "9_CR2051", "doi-asserted-by": "crossref", "first-page": "232", "DOI": "10.1161/HYPERTENSIONAHA.112.200741", "volume": "61", "author": "S Alvarez-Madrazo", "year": "2013", "unstructured": "Alvarez-Madrazo S, Mackenzie SM, Davies E, Fraser R, Lee WK, Brown M, Caulfield MJ, Dominiczak AF, Farrall M, Lathrop M, Hedner T, Melander O, Munroe PB, Samani N, Stewart PM, Wahlstrand B, Webster J, Palmer CN, Padmanabhan S, Connell JM (2013) Common polymorphisms in the CYP11B1 and CYP11B2 genes: evidence for a digenic influence on hypertension. Hypertension 61:232\u2013239", "journal-title": "Hypertension"}, {"key": "9_CR2052", "first-page": "93", "volume": "21", "author": "ME Atabek", "year": "2008", "unstructured": "Atabek ME, Pirgon O, Sert A (2008) Hypokalemic rhabdomyolysis in a child with 11-hydroxylase deficiency. J Pediatr Endocrinol Metab 21:93\u201396", "journal-title": "J Pediatr Endocrinol Metabo"}, {"key": "9_CR2053", "doi-asserted-by": "crossref", "first-page": "145", "DOI": "10.1159/000137659", "volume": "70", "author": "S Riedl", "year": "2008", "unstructured": "Riedl S, Nguyen HH, Clausmeyer S, Schulze E, Waldhauser F, Bernhardt R (2008) A homozygous L299P mutation in the CYP11B1 gene leads to complete virilization in 46,XX individuals with 11\u03b2-hydroxylase deficiency. Horm Res 70:145\u2013149", "journal-title": "Horm Res"}, {"key": "9_CR2054", "doi-asserted-by": "crossref", "first-page": "387", "DOI": "10.1007/BF03345731", "volume": "32", "author": "M Wasniewska", "year": "2009", "unstructured": "Wasniewska M, Arrigo T, Lombardo F, Crisafulli G, Salzano G, De Luca F (2009) 11-hydroxylase deficiency as a cause of pre-pubertal gynecomastia. J Endocrin Invest 32:387\u2013388", "journal-title": "J Endocrin Invest"}, {"key": "9_CR2055", "doi-asserted-by": "crossref", "first-page": "4996", "DOI": "10.1073/pnas.89.11.4996", "volume": "89", "author": "L Pascoe", "year": "1992", "unstructured": "Pascoe L, Curnow KM, Slutsker L, R\u00f6sler A, White PC (1992) Mutations in the human CYP11B2 (aldosteronesynthase) gene causing corticosterone methyloxidase II deficiency. Proc Natl Acad Sci U S A 89:4996\u20135000", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR2056", "doi-asserted-by": "crossref", "first-page": "864", "DOI": "10.1006/bbrc.1993.1128", "volume": "190", "author": "Y Mitsuuchi", "year": "1993", "unstructured": "Mitsuuchi Y, Kawamoto T, Miyahara K, Ulick S, Morton DH, Naiki Y, Kuribayashi I, Toda K, Hara T, Orii T, Yasuda K, Miura K, Yamamoto Y, Imura H, Shizuta Y (1993) Congenitally defective aldosteronebiosynthesis in humans: inactivation of the P-450C18 gene (CYP11B2) due to nucleotide deletion in CMO I deficient patients. Biochem Biophys Res Commun 190:864\u2013869", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR2057", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1016/S0006-291X(05)81058-7", "volume": "173", "author": "T Kawamoto", "year": "1990", "unstructured": "Kawamoto T, Mitsuuchi Y, Ohnishi T, Ichikawa Y, Yokoyama Y, Sumimoto H, Toda K, Miyahara K, Kuribayashi I, Nakao K, Hosoda K, Yamamoto Y, Imura H, Shizuta Y (1990) Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism. Biochem Biophys Res Commun 173:309\u2013316", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR2058", "doi-asserted-by": "crossref", "first-page": "1513", "DOI": "10.1210/mend-5-10-1513", "volume": "5", "author": "KM Curnow", "year": "1991", "unstructured": "Curnow KM, Tusie-Luna MT, Pascoe L, Natarajan R, Gu JL, Nadler JL, White PC (1991) The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol Endocrinol 5:1513\u20131522", "journal-title": "Mol Endocrinol"}, {"key": "9_CR2059", "doi-asserted-by": "crossref", "first-page": "885", "DOI": "10.3748/wjg.v6.i6.885", "volume": "6", "author": "X Li", "year": "2000", "unstructured": "Li X, Meng Y, Yang XS, Wu PS, Li SM, Lai WY (2000) CYP11B2 expression in HSCs and its effect on hepatic fibrogenesis. World J Gastroenterol 6:885\u2013887", "journal-title": "World J Gastroenterol"}, {"key": "9_CR2060", "doi-asserted-by": "crossref", "first-page": "941", "DOI": "10.3109/07435800009048620", "volume": "26", "author": "MH Bassett", "year": "2000", "unstructured": "Bassett MH, Zhang Y, White PC, Rainey WE (2000) Regulation of human CYP11B2 and CYP11B1: comparing the role of the common CRE/Ad1 element. Endocr Res 26:941\u2013951", "journal-title": "Endocr Res"}, {"key": "9_CR2061", "doi-asserted-by": "crossref", "first-page": "485", "DOI": "10.1080/07435809609043735", "volume": "22", "author": "CD Clyne", "year": "1996", "unstructured": "Clyne CD, White PC, Rainey WE (1996) Calcium regulates human CYP11B2 transcription. Endocr Res 22:485\u2013492", "journal-title": "Endocr Res"}, {"key": "9_CR2062", "doi-asserted-by": "crossref", "first-page": "351", "DOI": "10.1081/ERC-120016808", "volume": "28", "author": "M Bureik", "year": "2002", "unstructured": "Bureik M, Zeeh A, Bernhardt R (2002) Modulation of steroid hydroxylase activity in stably transfected V79MZh11B1 and V79MZh11B2 cells by PKC and PKD inhibitors. Endocrin Res 28:351\u2013355", "journal-title": "Endocrin Res"}, {"key": "9_CR2063", "doi-asserted-by": "crossref", "first-page": "1027", "DOI": "10.3109/07435800009048634", "volume": "26", "author": "JG LeHoux", "year": "2000", "unstructured": "LeHoux JG, Dupuis G, Lefebvre A (2000) Regulation of CYP11B2 gene expression by protein kinase C. Endocrin Res 26:1027\u20131031", "journal-title": "Endocrin Res"}, {"key": "9_CR2064", "doi-asserted-by": "crossref", "first-page": "69", "DOI": "10.1677/joe.0.1760069", "volume": "176", "author": "P Liakos", "year": "2003", "unstructured": "Liakos P, Lenz D, Bernhardt R, Feige JJ, Defaye G (2003) Transforming growth factor \u03b21 inhibits aldosterone and cortisol production in the human adrenocortical cell line NCI-H295R through inhibition of CYP11B1 and CYP11B2 expression. J Endocrinol 176:69\u201382", "journal-title": "J Endocrinol"}, {"key": "9_CR2065", "doi-asserted-by": "crossref", "first-page": "807", "DOI": "10.1081/ERC-200044048", "volume": "30", "author": "JG LeHoux", "year": "2004", "unstructured": "LeHoux JG, Lefebvre A (2004) On the control of the hCYP11B2 gene expressing cytochrome P450 aldosterone synthase. Endocrin Res 30:807\u2013812", "journal-title": "Endocrin Res"}, {"key": "9_CR2066", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1677/jme.1.01908", "volume": "36", "author": "JG LeHoux", "year": "2006", "unstructured": "LeHoux JG, Lefebvre A (2006) Novel protein kinase C-epsilon inhibits human CYP11B2 gene expression through ERK1/2 signalling pathway and JunB. J Mol Endocrinol 36:51\u201364", "journal-title": "J Mol Endocrinol"}, {"key": "9_CR2067", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1093/jb/mvq037", "volume": "148", "author": "T Yamashiro", "year": "2010", "unstructured": "Yamashiro T, Kuge H, Zhang J, Honke K (2010) Calcineurin mediates the angiotensin II-induced aldosterone synthesis in the adrenal glands by up-regulation of transcription of the CYP11B2 gene. J BIochem (Tokyo) 148:115\u2013123", "journal-title": "J BIochem (Tokyo)"}, {"key": "9_CR2068", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1016/j.steroids.2011.10.010", "volume": "77", "author": "LC Cheng", "year": "2012", "unstructured": "Cheng LC, Pai TW, Li LA (2012) Regulation of human CYP11B1 and CYP11B2 promoters by transposable elements and conserved cis elements. Steroids 77:100\u2013109", "journal-title": "Steroids"}, {"key": "9_CR2069", "doi-asserted-by": "crossref", "first-page": "530", "DOI": "10.1093/toxsci/kfi105", "volume": "85", "author": "LA Li", "year": "2005", "unstructured": "Li LA, Wang PW (2005) PCB126 induces differential changes in androgen, cortisol, and aldosterone biosynthesis in human adrenocortical H295R cells. Toxicol Sci 85:530\u2013540", "journal-title": "Toxicol Sci"}, {"key": "9_CR2070", "doi-asserted-by": "crossref", "first-page": "1122", "DOI": "10.1080/15287394.2010.484338", "volume": "73", "author": "M Kraugerud", "year": "2010", "unstructured": "Kraugerud M, Zimmer KE, Dahl E, Berg V, Olsaker I, Farstad W, Ropstad E, Verhaegen S (2010) Three structurally different polychlorinated biphenyl congeners (Pcb 118, 153, and 126) affect hormone production and gene expression in the human H295R in vitro model. J Toxicol Environ Health A 73:1122\u20131132", "journal-title": "J Toxicol Environ Health A"}, {"key": "9_CR2071", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1111/j.1365-2265.2008.03383.x", "volume": "70", "author": "CD Holloway", "year": "2009", "unstructured": "Holloway CD, MacKenzie SM, Fraser R, Miller S, Barr M, Wilkinson D, Forbes GH, Friel E, Connell JM, Davies E (2009) Effects of genetic variation in the aldosterone synthase (CYP11B2) gene on enzyme function. Clin Endocrinol 70:363\u2013371", "journal-title": "Clin Endocrinol"}, {"key": "9_CR2072", "doi-asserted-by": "crossref", "first-page": "2518", "DOI": "10.1210/jc.2003-030353", "volume": "88", "author": "FM Dunlop", "year": "2003", "unstructured": "Dunlop FM, Crock PA, Montalto J, Funder JW, Curnow KM (2003) A compound heterozygote case of type II aldosterone synthase deficiency. J Clin Endocrinol Metab 88:2518\u20132526", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2073", "doi-asserted-by": "crossref", "first-page": "357", "DOI": "10.1016/j.ymgme.2010.04.016", "volume": "100", "author": "HH Nguyen", "year": "2010", "unstructured": "Nguyen HH, Hannemann F, Hartmann MF, Malunowicz EM, Wudy SA, Bernhardt R (2010) Five novel mutations in CYP11B2 gene detected in patients with aldosterone synthase deficiency type I: functional characterization and structural analyses. Mol Genet Metab 100:357\u2013364", "journal-title": "Mol Genet Metab"}, {"key": "9_CR2074", "first-page": "255", "volume": "60", "author": "I Kuribayashi", "year": "2003", "unstructured": "Kuribayashi I, Kuge H, Santa RJ, Mutlaq AZ, Yamasaki N, Furuno T, Takahashi A, Chida S, Nakamura T, Endo F, Doi Y, Onishi S, Shizuta Y (2003) A missense mutation (GGC[435Gly]\u2014> AGC[Ser]) in exon 8 of the CYP11B2 gene inherited in Japanese patients with congenital hypoaldosteronism. Horm Res 60:255\u2013260", "journal-title": "Horm Res"}, {"key": "9_CR2075", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1111/j.1399-0004.2004.00291.x", "volume": "66", "author": "B Ezquieta", "year": "2004", "unstructured": "Ezquieta B, Luzuriaga C (2004) Neonatal salt-wasting and 11\u03b2-hydroxylase deficiency in a child carrying a homozygous deletion hybrid CYP11B2 (aldosteronesynthase)-CYP11B1 (11\u03b2-hydroxylase). Clin Genet 66:229\u2013235", "journal-title": "Clin Genet"}, {"key": "9_CR2076", "doi-asserted-by": "crossref", "first-page": "6226", "DOI": "10.1210/jc.2005-0299", "volume": "90", "author": "H Tanahashi", "year": "2005", "unstructured": "Tanahashi H, Mune T, Takahashi Y, Isaji M, Suwa T, Morita H, Yamakita N, Yasuda K, Deguchi T, White PC, Takeda J (2005) Association of Lys173Arg polymorphism with CYP11B2 expression in normal adrenal glands and aldosterone-producing adenomas. J Clin Endocrinol Metab 90:6226\u20136231", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2077", "doi-asserted-by": "crossref", "first-page": "206", "DOI": "10.1593/neo.111758", "volume": "14", "author": "CL Ronchi", "year": "2012", "unstructured": "Ronchi CL, Leich E, Sbiera S, Weismann D, Rosenwald A, Allolio B, Fassnacht M (2012) Single nucleotide polymorphism microarray analysis in cortisol-secreting adrenocortical adenomas identifies new candidate genes and pathways. Neoplasia 14:206\u2013218", "journal-title": "Neoplasia"}, {"key": "9_CR2078", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1080/00365510600548702", "volume": "66", "author": "KJ Schjoedt", "year": "2006", "unstructured": "Schjoedt KJ, Lajer M, Andersen S, Tarnow L, Rossing P, Parving HH (2006) Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy. Scand J Clin Lab Invest 66:173\u2013180", "journal-title": "Scand J Clin Lab Invest"}, {"key": "9_CR2079", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1177/1470320311430990", "volume": "13", "author": "S Srivastava", "year": "2012", "unstructured": "Srivastava S, Bhagi S, Kumari B, Chandra K, Sarkar S, Ashraf MZ (2012) Association of polymorphisms in angiotensin and aldosterone synthase genes of the renin-angiotensin-aldosterone system with high-altitude pulmonary edema. J Renin Angiotensin Aldosterone Syst 13:155\u2013160", "journal-title": "J Renin Angiotensin Aldosterone Syst"}, {"key": "9_CR2080", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1159/000336625", "volume": "84", "author": "Y Luo", "year": "2012", "unstructured": "Luo Y, Zou Y, Gao Y (2012) Gene polymorphisms and high-altitude pulmonary edema susceptibility: a 2011 update. Respiration 84:155\u2013162", "journal-title": "Respiration"}, {"key": "9_CR2081", "doi-asserted-by": "crossref", "first-page": "218", "DOI": "10.1016/j.amjhyper.2006.07.012", "volume": "20", "author": "P Russo", "year": "2007", "unstructured": "Russo P, Lauria F, Loguercio M, Barba G, Arnout J, Cappuccio FP, de Lorgeril M, Donati MB, Iacoviello L, Krogh V, van Dongen M, Siani A (2007) \u2212 344C/T variant in the promoter of the aldosterone synthase gene (CYP11B2) is associated with metabolic syndrome in men. Am J Hypertens 20:218\u2013222", "journal-title": "Am J Hypertens"}, {"key": "9_CR2082", "doi-asserted-by": "crossref", "first-page": "2495", "DOI": "10.1210/jc.2002-021598", "volume": "88", "author": "J Nicod", "year": "2003", "unstructured": "Nicod J, Bruhin D, Auer L, Vogt B, Frey FJ, Ferrari P (2003) A biallelic gene polymorphism of CYP11B2 predicts increased aldosteroneto renin ratio in selected hypertensive patients. J Clin Endocrinol Metab 88:2495\u20132500", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2083", "doi-asserted-by": "crossref", "first-page": "1331", "DOI": "10.1097/00004872-200307000-00022", "volume": "21", "author": "NN Kumar", "year": "2003", "unstructured": "Kumar NN, Benjafield AV, Lin RC, Wang WY, Stowasser M, Morris BJ (2003) Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension. J Hypertens 21:1331\u20131337", "journal-title": "J Hypertens"}, {"key": "9_CR2084", "doi-asserted-by": "crossref", "first-page": "1853", "DOI": "10.1097/00004872-200310000-00012", "volume": "21", "author": "M Castellano", "year": "2003", "unstructured": "Castellano M, Glorioso N, Cusi D, Sarzani R, Fabris B, Opocher G, Zoccali C, Golin R, Veglio F, Volpe M, Mantero F, Fallo F, Rossi GP, Barlassina C, Tizzoni L, Filigheddu F, Giacche M, Rossi F (2003) Genetic polymorphism of the renin-angiotensin-aldosterone system and arterial hypertension in the Italian population: the GENIPER project. J Hypertens 21:1853\u20131860", "journal-title": "J Hypertens"}, {"key": "9_CR2085", "doi-asserted-by": "crossref", "first-page": "901", "DOI": "10.1161/01.HYP.0000095615.83724.82", "volume": "42", "author": "N Kosachunhanun", "year": "2003", "unstructured": "Kosachunhanun N, Hunt SC, Hopkins PN, Williams RR, Jeunemaitre X, Corvol P, Ferri C, Mortensen RM, Hollenberg NK, Williams GH (2003) Genetic determinants of nonmodulating hypertension. Hypertension 42:901\u2013908", "journal-title": "Hypertension"}, {"key": "9_CR2086", "doi-asserted-by": "crossref", "first-page": "1006", "DOI": "10.1016/j.amjhyper.2003.07.010", "volume": "16", "author": "AD Tiago", "year": "2003", "unstructured": "Tiago AD, Badenhorst D, Nkeh B, Candy GP, Brooksbank R, Sareli P, Libhaber E, Samani NJ, Woodiwiss AJ, Norton GR (2003) Impact of renin-angiotensin-aldosteronesystem gene variants on the severity of hypertension in patients with newly diagnosed hypertension. Am J Hypertens 16:1006\u20131010", "journal-title": "Am J Hypertens"}, {"key": "9_CR2087", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1016/j.jacc.2003.08.034", "volume": "43", "author": "P Stella", "year": "2004", "unstructured": "Stella P, Bigatti G, Tizzoni L, Barlassina C, Lanzani C, Bianchi G, Cusi D (2004) Association between aldosterone synthase (CYP11B2) polymorphism and left ventricular mass in human essential hypertension. J Am Coll Cardiol 43:265\u2013270", "journal-title": "J Am Coll Cardiol"}, {"key": "9_CR2088", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1291/hypres.27.1", "volume": "27", "author": "M Matsubara", "year": "2004", "unstructured": "Matsubara M, Sato T, Nishimura T, Suzuki M, Kikuya M, Metoki H, Michimata M, Tsuji I, Ogihara T, Imai Y (2004) CYP11B2 polymorphisms and home blood pressure in a population-based cohort in Japanese: the Ohasama study. Hypertens Res 27:1\u20136", "journal-title": "Hypertens Res"}, {"key": "9_CR2089", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1016/j.mce.2003.10.025", "volume": "217", "author": "JM Connell", "year": "2004", "unstructured": "Connell JM, Fraser R, MacKenzie SM, Friel EC, Ingram MC, Holloway CD, Davies E (2004) The impact of polymorphisms in the gene encoding aldosterone synthase (CYP11B2) on steroid synthesis and blood pressure regulation. Mol Cell Endocrinol 217:243\u2013247", "journal-title": "Mol Cell Endocrinol"}, {"key": "9_CR2090", "doi-asserted-by": "crossref", "first-page": "409", "DOI": "10.1111/j.1399-0004.2004.00317.x", "volume": "66", "author": "D Gu", "year": "2004", "unstructured": "Gu D, Ge D, He J, Li B, Chen J, Liu D, Chen J, Chen R (2004) Haplotypic analyses of the aldosterone synthase gene CYP11B2 associated with stage-2 hypertension in northern Han Chinese. Clin Genet 66:409\u2013416", "journal-title": "Clin Genet"}, {"key": "9_CR2091", "doi-asserted-by": "crossref", "first-page": "2311", "DOI": "10.1097/00004872-200412000-00013", "volume": "22", "author": "W Wojciechowska", "year": "2004", "unstructured": "Wojciechowska W, Staessen JA, Stolarz K, Nawrot T, Filipovsky J, Ticha M, Bianchi G, Brand E, Cwynar M, Grodzicki T, Kuznetsova T, Struijker-Boudier HA, Svobodova V, Thijs L, Van Bortel LM, Kawecka-Jaszcz K (2004) Association of peripheral and central arterial wave reflections with the CYP11B2 \u2212 344C allele and sodium excretion. J Hypertens 22:2311\u20132319", "journal-title": "J Hypertens"}, {"key": "9_CR2092", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1097/00004872-200502000-00013", "volume": "23", "author": "B Fabris", "year": "2005", "unstructured": "Fabris B, Bortoletto M, Candido R, Barbone F, Cattin MR, Calci M, Scanferla F, Tizzoni L, Giacca M, Carretta R (2005) Genetic polymorphisms of the renin-angiotensin-aldosterone system and renal insufficiency in essential hypertension. J Hypertens 23:309\u2013316", "journal-title": "J Hypertens"}, {"key": "9_CR2093", "doi-asserted-by": "crossref", "first-page": "5008", "DOI": "10.1210/jc.2006-0049", "volume": "91", "author": "P Mulatero", "year": "2006", "unstructured": "Mulatero P, Veglio F, Maffei P, Bondanelli M, Bovio S, Daffara F, Leotta G, Angeli A, Calvo C, Martini C, degli Uberti EC, Terzolo M (2006) CYP11B2 \u2212 344T/C gene polymorphism and blood pressure in patients with acromegaly. J Clin Endocrinol Metab 91:5008\u20135012", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2094", "doi-asserted-by": "crossref", "first-page": "5", "DOI": "10.1097/01.hjh.0000254372.88488.a9", "volume": "25", "author": "S Sookoian", "year": "2007", "unstructured": "Sookoian S, Gianotti TF, Gonzalez CD, Pirola CJ (2007) Association of the C-344T aldosterone synthase gene variant with essential hypertension: a meta-analysis. J Hypertens 25:5\u201313", "journal-title": "J Hypertens"}, {"key": "9_CR2095", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1097/HJH.0b013e3282f25b15", "volume": "26", "author": "H Yu", "year": "2008", "unstructured": "Yu H, Lin S, Zhang Y, Liu G (2008) Intron-2 conversion polymorphism of the aldosterone synthase gene and the antihypertensive response to angiotensin-converting enzyme inhibitors. J Hypertens 26:251\u2013256", "journal-title": "J Hypertens"}, {"key": "9_CR2096", "doi-asserted-by": "crossref", "first-page": "180", "DOI": "10.1177/1470320309360816", "volume": "11", "author": "S Saidi", "year": "2010", "unstructured": "Saidi S, Mahjoub T, Almawi WY (2010) Aldosterone synthase gene (CYP11B2) promoter polymorphism as a risk factor for ischaemic stroke in Tunisian Arabs. J Renin Angiotensin Aldosterone Syst 11:180\u2013186", "journal-title": "J Renin Angiotensin Aldosterone Syst"}, {"key": "9_CR2097", "doi-asserted-by": "crossref", "first-page": "e50910", "DOI": "10.1371/journal.pone.0050910", "volume": "7", "author": "YY Li", "year": "2012", "unstructured": "Li YY, Zhou CW, Xu J, Qian Y, Wang B (2012) CYP11B2 T-344C gene polymorphism and atrial fibrillation: a meta-analysis of 2758 subjects. PLoS One 7:e50910", "journal-title": "PLoS One"}, {"key": "9_CR2098", "doi-asserted-by": "crossref", "first-page": "1249", "DOI": "10.1097/00004872-200307000-00008", "volume": "21", "author": "E Davies", "year": "2003", "unstructured": "Davies E, Kenyon CJ (2003) CYP11B2 polymorphisms and cardiovascular risk factors. J Hypertens 21:1249\u20131253", "journal-title": "J Hypertens"}, {"key": "9_CR2099", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1046/j.1365-2265.2001.01192.x", "volume": "55", "author": "T Ise", "year": "2001", "unstructured": "Ise T, Shimoda A, Takakuwa H, Kato T, Izumiya Y, Shimizu K, Suzuki T, Sasano H, Yokoyama H, Kobayashi K (2001) A chimeric CYP11B1/CYP11B2 gene in glucocorticoid-insuppressible familial hyperaldosteronism. Clin Endocrinol 55:131\u2013134", "journal-title": "Clin Endocrinol"}, {"key": "9_CR2100", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1111/j.1749-6632.2002.tb04414.x", "volume": "970", "author": "RV Jackson", "year": "2002", "unstructured": "Jackson RV, Lafferty A, Torpy DJ, Stratakis C (2002) New genetic insights in familial hyperaldosteronism. Ann N Y Acad Sci 970:77\u201388", "journal-title": "Ann N Y Acad Sci"}, {"key": "9_CR2101", "first-page": "1037", "volume": "57", "author": "G Zhang", "year": "1995", "unstructured": "Zhang G, Rodriguez H, Fardella CE, Harris DA, Miller WL (1995) Mutation T318M in the CYP11B2 gene encoding P450c11AS (aldosteronesynthase) causes corticosterone methyl oxidase II deficiency. Am J Hum Genet 57:1037\u20131043", "journal-title": "Am J Hum Genet"}, {"key": "9_CR2102", "doi-asserted-by": "crossref", "first-page": "694", "DOI": "10.1161/01.HYP.35.3.694", "volume": "35", "author": "P Mulatero", "year": "2000", "unstructured": "Mulatero P, Schiavone D, Fallo F, Rabbia F, Pilon C, Chiandussi L, Pascoe L, Veglio F (2000) CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism. Hypertension 35:694\u2013698", "journal-title": "Hypertension"}, {"key": "9_CR2103", "doi-asserted-by": "crossref", "first-page": "789", "DOI": "10.1038/sj.jhh.1001484", "volume": "16", "author": "K Tsukada", "year": "2002", "unstructured": "Tsukada K, Ishimitsu T, Teranishi M, Saitoh M, Yoshii M, Inada H, Ohta S, Akashi M, Minami J, Ono H, Ohrui M, Matsuoka H (2002) Positive association of CYP11B2 gene polymorphism with genetic predisposition to essential hypertension. J Hum Hypertens 16:789\u2013793", "journal-title": "J Hum Hypertens"}, {"key": "9_CR2104", "doi-asserted-by": "crossref", "first-page": "381", "DOI": "10.1016/j.toxlet.2012.07.020", "volume": "213", "author": "MK Parr", "year": "2012", "unstructured": "Parr MK, Zollner A, Fussholler G, Opfermann G, Schlorer N, Zorio M, Bureik M, Schanzer W (2012) Unexpected contribution of cytochrome P450 enzymes CYP11B2 and CYP21, as well as CYP3A4 in xenobiotic androgen elimination\u2014insights from metandienone metabolism. Toxicol Lett 213:381\u2013391", "journal-title": "Toxicol Lett"}, {"key": "9_CR2105", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1016/j.bmcl.2005.09.059", "volume": "16", "author": "S Ulmschneider", "year": "2006", "unstructured": "Ulmschneider S, Negri M, Voets M, Hartmann RW (2006) Development and evaluation of a pharmacophore model for inhibitors of aldosteronesynthase (CYP11B2). Bioorg Med Chem Lett 16:25\u201330", "journal-title": "Bioorg Med Chem Lett"}, {"key": "9_CR2106", "first-page": "319", "volume": "10", "author": "PM Jansen", "year": "2009", "unstructured": "Jansen PM, van den Meiracker AH, Jan Danser AH (2009) Aldosterone synthase inhibitors: pharmacological and clinical aspects. Curr Opin Invest Drugs 10:319\u2013326", "journal-title": "Curr Opin Invest Drugs"}, {"key": "9_CR2107", "doi-asserted-by": "crossref", "first-page": "1385", "DOI": "10.2174/1568026611313120003", "volume": "13", "author": "MA Cerny", "year": "2013", "unstructured": "Cerny MA (2013) Progress towards clinically useful aldosteronesynthase inhibitors. Curr Topics Med Chem 13:1385\u20131401", "journal-title": "Curr Topics Med Chem"}, {"key": "9_CR2108", "doi-asserted-by": "crossref", "first-page": "411", "DOI": "10.1002/ardp.200400872", "volume": "337", "author": "M Voets", "year": "2004", "unstructured": "Voets M, Muller-Vieira U, Marchais-Oberwinkler S, Hartmann RW (2004) Synthesis of amidinohydrazones and evaluation of their inhibitory effect towards aldosteronesynthase (CYP11B2) and the formation of selected steroids. Arch Pharm 337:411\u2013416", "journal-title": "Arch Pharm"}, {"key": "9_CR2109", "doi-asserted-by": "crossref", "first-page": "1563", "DOI": "10.1021/jm0492397", "volume": "48", "author": "S Ulmschneider", "year": "2005", "unstructured": "Ulmschneider S, Muller-Vieira U, Klein CD, Antes I, Lengauer T, Hartmann RW (2005) Synthesis and evaluation of (pyridylmethylene)tetrahydronaphthalenes/-indanes and structurally modified derivatives: potent and selective inhibitors of aldosteronesynthase. J Med Chem 48:1563\u20131575", "journal-title": "J Med Chem"}, {"key": "9_CR2110", "doi-asserted-by": "crossref", "first-page": "6138", "DOI": "10.1021/jm800683c", "volume": "51", "author": "S Lucas", "year": "2008", "unstructured": "Lucas S, Heim R, Negri M, Antes I, Ries C, Schewe KE, Bisi A, Gobbi S, Hartmann RW (2008) Novel aldosteronesynthase inhibitorswith extended carbocyclic skeleton by a combined ligand-based and structure-based drug design approach. J Med Chem 51:6138\u20136149", "journal-title": "J Med Chem"}, {"key": "9_CR2111", "doi-asserted-by": "crossref", "first-page": "8077", "DOI": "10.1021/jm800888q", "volume": "51", "author": "S Lucas", "year": "2008", "unstructured": "Lucas S, Heim R, Ries C, Schewe KE, Birk B, Hartmann RW (2008) In vivo active aldosteronesynthase inhibitors with improved selectivity: lead optimization providing a series of pyridine substituted 3,4-dihydro-1H-quinolin-2-one derivatives. J Med Chem 51:8077\u20138087", "journal-title": "J Med Chem"}, {"key": "9_CR2112", "doi-asserted-by": "crossref", "first-page": "186", "DOI": "10.1016/j.bmcl.2010.11.040", "volume": "21", "author": "C Zimmer", "year": "2011", "unstructured": "Zimmer C, Hafner M, Zender M, Ammann D, Hartmann RW, Vock CA (2011) N-(Pyridin-3-yl)benzamides as selective inhibitors of human aldosteronesynthase (CYP11B2). Bioorg Med Chem Lett 21:186\u2013190", "journal-title": "Bioorg Med Chem Lett"}, {"key": "9_CR2113", "doi-asserted-by": "crossref", "first-page": "2307", "DOI": "10.1021/jm101470k", "volume": "54", "author": "S Lucas", "year": "2011", "unstructured": "Lucas S, Negri M, Heim R, Zimmer C, Hartmann RW (2011) Fine-tuning the selectivity of aldosteronesynthase inhibitors: structure-activity and structure-selectivity insights from studies of heteroaryl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one derivatives. J Med Chem 54:2307\u20132319", "journal-title": "J Med Chem"}, {"key": "9_CR2114", "doi-asserted-by": "crossref", "first-page": "e48048", "DOI": "10.1371/journal.pone.0048048", "volume": "7", "author": "L Yin", "year": "2012", "unstructured": "Yin L, Hu Q, Hartmann RW (2012) 3-Pyridyl substituted aliphatic cycles as CYP11B2 inhibitors: aromaticity abolishment of the core significantly increased selectivity over CYP1A2. PLoS One 7:e48048", "journal-title": "PLoS One"}, {"key": "9_CR2115", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1016/S0223-5234(03)00049-7", "volume": "38", "author": "RW Hartmann", "year": "2003", "unstructured": "Hartmann RW, Muller U, Ehmer PB (2003) Discovery of selective CYP11B2 (aldosteronesynthase) inhibitorsfor the therapy of congestive heart failure and myocardial fibrosis. Eur J Med Chem 38:363\u2013366", "journal-title": "Eur J Med Chem"}, {"key": "9_CR2116", "doi-asserted-by": "crossref", "first-page": "6632", "DOI": "10.1021/jm0503704", "volume": "48", "author": "M Voets", "year": "2005", "unstructured": "Voets M, Antes I, Scherer C, Muller-Vieira U, Biemel K, Barassin C, Marchais-Oberwinkler S, Hartmann RW (2005) Heteroaryl-substituted naphthalenes and structurally modified derivatives: selective inhibitors of CYP11B2 for the treatment of congestive heart failure and myocardial fibrosis. J Med Chem 48:6632\u20136642", "journal-title": "J Med Chem"}, {"key": "9_CR2117", "doi-asserted-by": "crossref", "first-page": "2222", "DOI": "10.1021/jm060055x", "volume": "49", "author": "M Voets", "year": "2006", "unstructured": "Voets M, Antes I, Scherer C, Muller-Vieira U, Biemel K, Marchais-Oberwinkler S, Hartmann RW (2006) Synthesis and evaluation of heteroaryl-substituted dihydronaphthalenes and indenes: potent and selective inhibitors of aldosteronesynthase (CYP11B2) for the treatment of congestive heart failure and myocardial fibrosis. J Med Chem 49:2222\u20132231", "journal-title": "J Med Chem"}, {"key": "9_CR2118", "doi-asserted-by": "crossref", "first-page": "1945", "DOI": "10.1161/CIRCULATIONAHA.111.029892", "volume": "124", "author": "DA Calhoun", "year": "2011", "unstructured": "Calhoun DA, White WB, Krum H, Guo W, Bermann G, Trapani A, Lefkowitz MP, Menard J (2011) Effects of a novel aldosteronesynthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial. Circulation 124:1945\u20131955", "journal-title": "Circulation"}, {"key": "9_CR2119", "doi-asserted-by": "crossref", "first-page": "1940", "DOI": "10.1002/cncr.22634", "volume": "109", "author": "DA Ralph", "year": "2007", "unstructured": "Ralph DA, Zhao LP, Aston CE, Manjeshwar S, Pugh TW, DeFreese DC, Gramling BA, Shimasaki CD, Jupe ER (2007) Age-specific association of steroid hormone pathway gene polymorphisms with breast cancer risk. Cancer 109:1940\u20131948", "journal-title": "Cancer"}, {"key": "9_CR2120", "doi-asserted-by": "crossref", "first-page": "703", "DOI": "10.1161/01.HYP.33.2.703", "volume": "33", "author": "E Davies", "year": "1999", "unstructured": "Davies E, Holloway CD, Ingram MC, Inglis GC, Friel EC, Morrison C, Anderson NH, Fraser R, Connell JM (1999) Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosteronesynthase gene CYP11B2. Hypertension 33:703\u2013707", "journal-title": "Hypertension"}, {"key": "9_CR2121", "doi-asserted-by": "crossref", "first-page": "409", "DOI": "10.1016/S0960-0760(99)00071-0", "volume": "69", "author": "PC White", "year": "1999", "unstructured": "White PC, Hautanen A, Kupari M (1999) Aldosterone synthase (CYP11B2) polymorphisms and cardiovascular function. J Steroid Biochem Mol Biol 69:409\u2013412", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2122", "doi-asserted-by": "crossref", "first-page": "569", "DOI": "10.1161/01.CIR.97.6.569", "volume": "97", "author": "M Kupari", "year": "1998", "unstructured": "Kupari M, Hautanen A, Lankinen L, Koskinen P, Virolainen J, Nikkila H, White PC (1998) Associations between human aldosteronesynthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation 97:569\u2013575", "journal-title": "Circulation"}, {"key": "9_CR2123", "doi-asserted-by": "crossref", "first-page": "381", "DOI": "10.1042/cs1020381", "volume": "102", "author": "M Satoh", "year": "2002", "unstructured": "Satoh M, Nakamura M, Saitoh H, Satoh H, Akatsu T, Iwasaka J, Masuda T, Hiramori K (2002) Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart. Clin Sci 102:381\u2013386", "journal-title": "Clin Sci"}, {"key": "9_CR2124", "doi-asserted-by": "crossref", "first-page": "1785", "DOI": "10.1097/00004872-200209000-00023", "volume": "20", "author": "P Russo", "year": "2002", "unstructured": "Russo P, Siani A, Venezia A, Iacone R, Russo O, Barba G, D\u2019Elia L, Cappuccio FP, Strazzullo P (2002) Interaction between the C(\u2212 344)T polymorphism of CYP11B2 and age in the regulation of blood pressure and plasma aldosteronelevels: cross-sectional and longitudinal findings of the Olivetti prospective heart study. J Hypertens 20:1785\u20131792", "journal-title": "J Hypertens"}, {"key": "9_CR2125", "doi-asserted-by": "crossref", "first-page": "4398", "DOI": "10.1210/jc.2001-012070", "volume": "87", "author": "PO Lim", "year": "2002", "unstructured": "Lim PO, Macdonald TM, Holloway C, Friel E, Anderson NH, Dow E, Jung RT, Davies E, Fraser R, Connell JM (2002) Variation at the aldosteronesynthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio. J Clin Endocrinol Metab 87:4398\u20134402", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2126", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1291/hypres.24.105", "volume": "24", "author": "Y Tsujita", "year": "2001", "unstructured": "Tsujita Y, Iwai N, Katsuya T, Higaki J, Ogihara T, Tamaki S, Kinoshita M, Mannami T, Ogata J, Baba S (2001) Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the suita study. Hypertens Res 24:105\u2013109", "journal-title": "Hypertens Res"}, {"key": "9_CR2127", "doi-asserted-by": "crossref", "first-page": "407", "DOI": "10.1073/pnas.84.2.407", "volume": "84", "author": "B Chung", "year": "1987", "unstructured": "Chung B, Picado-Leonard J, Haniu M, Bienkowski M, Hall PF, Shively JE, Miller WL (1987) Cytochrome P450c17 (steroid 17\u03b1-hydroxylase/17,20 lyase): cloning of human adrenaland testis cDNAs indicates the same gene is expressed in both tissues. Proc Natl Acad Sci U S A 84:407\u2013411", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR2128", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1089/dna.1987.6.439", "volume": "6", "author": "J Picado-Leonard", "year": "1987", "unstructured": "Picado-Leonard J, Miller WL (1987) Cloning and sequence of the human gene for P450c17 (steroid 17\u03b1-hydroxylase/17,20 lyase): similarity with the gene for P450c21. DNA 6:439\u2013448", "journal-title": "DNA"}, {"key": "9_CR2129", "doi-asserted-by": "crossref", "first-page": "4037", "DOI": "10.1021/bi00517a014", "volume": "20", "author": "S Nakajin", "year": "1981", "unstructured": "Nakajin S, Shively JE, Yuan PM, Hall PF (1981) Microsomal cytochrome P-450 from neonatal pig testis: two enzymatic activities (17\u03b1-hydroxylase and C17,20-lyase) associated with one protein. Biochemistry 20:4037\u20134042", "journal-title": "Biochemistry"}, {"key": "9_CR2130", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1016/0006-291X(82)91877-0", "volume": "108", "author": "M Katagiri", "year": "1982", "unstructured": "Katagiri M, Suhara K, Shiroo M, Fujimura Y (1982) Role of cytochrome b 5 in the cytochrome P-450-mediated C21-steroid 17,20-lyasereaction. Biochem Biophys Res Commun 108:379\u2013384", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR2131", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1016/0005-2760(85)90263-2", "volume": "833", "author": "K Shinzawa", "year": "1985", "unstructured": "Shinzawa K, Kominami S, Takemori S (1985) Studies on cytochrome P-450 (P-45017\u03b1, lyase) from guinea pig adrenalmicrosomes. Dual function of a single enzyme and effect of cytochrome b 5. Biochim Biophys Acta 833:151\u2013160", "journal-title": "Biochim Biophys Acta"}, {"key": "9_CR2132", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1016/0039-128X(82)90115-5", "volume": "40", "author": "ML Casey", "year": "1982", "unstructured": "Casey ML, MacDonald PC (1982) Demonstration of steroid 17\u03b1-hydroxylase activity in human fetal kidney, thymus, and spleen. Steroids 40:91\u201397", "journal-title": "Steroids"}, {"key": "9_CR2133", "first-page": "2519", "volume": "85", "author": "KM Kayes-Wandover", "year": "2000", "unstructured": "Kayes-Wandover KM, White PC (2000) Steroidogenic enzyme gene expression in the human heart. J Clin Endocrinol Metab 85:2519\u20132525", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2134", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1530/eje.0.1460223", "volume": "146", "author": "C Puche", "year": "2002", "unstructured": "Puche C, Jose M, Cabero A, Meseguer A (2002) Expression and enzymatic activity of the P450c17 gene in human adipose tissue. Eur J Endocrinol 146:223\u2013229", "journal-title": "Eur J Endocrinol"}, {"key": "9_CR2135", "doi-asserted-by": "crossref", "first-page": "2494", "DOI": "10.1210/en.2011-1545", "volume": "153", "author": "MD Schonemann", "year": "2012", "unstructured": "Schonemann MD, Muench MO, Tee MK, Miller WL, Mellon SH (2012) Expression of P450c17 in the human fetal nervous system. Endocrinology 153:2494\u20132505", "journal-title": "Endocrinology"}, {"key": "9_CR2136", "first-page": "11200", "volume": "262", "author": "DB Hales", "year": "1987", "unstructured": "Hales DB, Sha LL, Payne AH (1987) Testosterone inhibits cAMP-induced de novo synthesis of Leydig cell cytochrome P-450 17\u03b1 by an androgen receptor-mediated mechanism. J Biol Chem 262:11200\u201311206", "journal-title": "J Biol Chem"}, {"key": "9_CR2137", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1016/0167-4781(96)00016-4", "volume": "1307", "author": "P Zhang", "year": "1996", "unstructured": "Zhang P, Han XG, Mellon SH, Hall PF (1996) Expression of the gene for cytochrome P-450 17\u03b1-hydroxylase/C17\u201320 lyase (CYP17) in porcine Leydig cells: identification of a DNA sequence that mediates cAMP response. Biochim Biophys Acta 1307:73\u201382", "journal-title": "Biochim Biophys Acta"}, {"key": "9_CR2138", "doi-asserted-by": "crossref", "first-page": "588", "DOI": "10.1210/me.2003-0090", "volume": "18", "author": "JK Wickenheisser", "year": "2004", "unstructured": "Wickenheisser JK, Nelson-DeGrave VL, Quinn PG, McAllister JM (2004) Increased cytochrome P450 17\u03b1-hydroxylase promoter function in theca cells isolated from patients with polycystic ovarysyndrome involves nuclear factor-1. Mol Endocrinol 18:588\u2013605", "journal-title": "Mol Endocrinol"}, {"key": "9_CR2139", "doi-asserted-by": "crossref", "first-page": "5249", "DOI": "10.1210/en.2006-0355", "volume": "147", "author": "AN Urs", "year": "2006", "unstructured": "Urs AN, Dammer E, Sewer MB (2006) Sphingosine regulates the transcription of CYP17 by binding to steroidogenic factor-1. Endocrinology 147:5249\u20135258", "journal-title": "Endocrinology"}, {"key": "9_CR2140", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1007/s11010-007-9585-4", "volume": "307", "author": "N Derebecka-Holysz", "year": "2008", "unstructured": "Derebecka-Holysz N, Lehmann TP, Holysz M, Trzeciak WH (2008) SMAD3 inhibits SF-1-dependent activation of the CYP17 promoter in H295R cells. Mol Cell Biochem 307:65\u201371", "journal-title": "Mol Cell Biochem"}, {"key": "9_CR2141", "doi-asserted-by": "crossref", "first-page": "68", "DOI": "10.1080/07435800903137050", "volume": "34", "author": "N Derebecka-Holysz", "year": "2009", "unstructured": "Derebecka-Holysz N, Lehmann TP, Holysz M, Trzeciak WH (2009) TGF-beta inhibits CYP17 transcription in H295R cells acting via activin receptor-like kinase 5. Endocrin Res 34:68\u201379", "journal-title": "Endocrin Res"}, {"key": "9_CR2142", "doi-asserted-by": "crossref", "first-page": "2667", "DOI": "10.1210/en.2007-1527", "volume": "149", "author": "MK Tee", "year": "2008", "unstructured": "Tee MK, Dong Q, Miller WL (2008) Pathways leading to phosphorylation of p450c17 and to the posttranslational regulation of androgen biosynthesis. Endocrinology 149:2667\u20132677", "journal-title": "Endocrinology"}, {"key": "9_CR2143", "doi-asserted-by": "crossref", "first-page": "E7", "DOI": "10.1152/ajpendo.00034.2013", "volume": "305", "author": "J Hofland", "year": "2013", "unstructured": "Hofland J, Steenbergen J, Hofland LJ, van Koetsveld PM, Eijken M, van Nederveen FH, Kazemier G, de Herder WW, Feelders RA, de Jong FH (2013) Protein kinase C-induced activin A switches adrenocortical steroidogenesis to aldosteroneby suppressing CYP17A1 expression. Am J Physiol Endocrinol Metab 305:E736\u2013744", "journal-title": "Am J Physiol Endocrinol Metab"}, {"key": "9_CR2144", "doi-asserted-by": "crossref", "first-page": "226", "DOI": "10.1006/abbi.1997.0372", "volume": "348", "author": "A Ogo", "year": "1997", "unstructured": "Ogo A, Waterman MR, McAllister JM, Kagawa N (1997) The homeodomain protein Pbx1 is involved in cAMP-dependent transcription of human CYP17. Arch Biochem Biophys 348:226\u2013231", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR2145", "doi-asserted-by": "crossref", "first-page": "489", "DOI": "10.3109/07435809809032637", "volume": "24", "author": "LJ Bischof", "year": "1998", "unstructured": "Bischof LJ, Kagawa N, Waterman MR (1998) The bovine CYP17 promoter contains a transcriptional regulatory element cooperatively bound by tale homeodomain proteins. Endocrin Res 24:489\u2013495", "journal-title": "Endocrin Res"}, {"key": "9_CR2146", "first-page": "1277", "volume": "15", "author": "CJ Lin", "year": "2001", "unstructured": "Lin CJ, Martens JW, Miller WL (2001) NF-1C, Sp1, and Sp3 are essential for transcription of the human gene for P450c17 (steroid 17\u03b1-hydroxylase/17,20 lyase) in human adrenal NCI-H295A cells. Mol Endocrinol 15:1277\u20131293", "journal-title": "Mol Endocrinol"}, {"key": "9_CR2147", "doi-asserted-by": "crossref", "first-page": "1280", "DOI": "10.1210/endo.143.4.8748", "volume": "143", "author": "MB Sewer", "year": "2002", "unstructured": "Sewer MB, Nguyen VQ, Huang CJ, Tucker PW, Kagawa N, Waterman MR (2002) Transcriptional activation of human CYP17 in H295R adrenocortical cells depends on complex formation among p54nrb/NonO, protein-associated splicing factor, and SF-1, a complex that also participates in repression of transcription. Endocrinology 143:1280\u20131290", "journal-title": "Endocrinology"}, {"key": "9_CR2148", "doi-asserted-by": "crossref", "first-page": "1769", "DOI": "10.1210/endo.143.5.8820", "volume": "143", "author": "MB Sewer", "year": "2002", "unstructured": "Sewer MB, Waterman MR (2002) Adrenocorticotropin/cyclic adenosine 3\u2032,5\u2032-monophosphate-mediated transcription of the human CYP17 gene in the adrenalcortex is dependent on phosphatase activity. Endocrinology 143:1769\u20131777", "journal-title": "Endocrinology"}, {"key": "9_CR2149", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1677/jme.0.0290163", "volume": "29", "author": "MB Sewer", "year": "2002", "unstructured": "Sewer MB, Waterman MR (2002) cAMP-dependent transcription of steroidogenic genes in the human adrenalcortex requires a dual-specificity phosphatasein addition to protein kinase A. J Mol Endocrinol 29:163\u2013174", "journal-title": "J Mol Endocrinol"}, {"key": "9_CR2150", "doi-asserted-by": "crossref", "first-page": "13265", "DOI": "10.1074/jbc.M414673200", "volume": "280", "author": "AV Pandey", "year": "2005", "unstructured": "Pandey AV, Miller WL (2005) Regulation of 17,20 lyase activity by cytochrome b 5 and by serine phosphorylation of P450c17. J Biol Chem 280:13265\u201313271", "journal-title": "J Biol Chem"}, {"key": "9_CR2151", "doi-asserted-by": "crossref", "first-page": "1677", "DOI": "10.1210/en.2009-1247", "volume": "151", "author": "YH Wang", "year": "2010", "unstructured": "Wang YH, Tee MK, Miller WL (2010) Human cytochrome p450c17: single step purification and phosphorylation of serine 258 by protein kinase A. Endocrinology 151:1677\u20131684", "journal-title": "Endocrinology"}, {"key": "9_CR2152", "doi-asserted-by": "crossref", "first-page": "23903", "DOI": "10.1074/jbc.M113.460048", "volume": "288", "author": "MK Tee", "year": "2013", "unstructured": "Tee MK, Miller WL (2013) Phosphorylation of human cytochrome P450c17 by p38\u03b1 selectively increases 17,20 lyase activity and androgen biosynthesis. J Biol Chem 288:23903\u201323913", "journal-title": "J Biol Chem"}, {"key": "9_CR2153", "doi-asserted-by": "crossref", "first-page": "116", "DOI": "10.1038/nature10743", "volume": "482", "author": "NM DeVore", "year": "2012", "unstructured": "DeVore NM, Scott EE (2012) Structures of cytochrome P450 17A1 with prostate cancer drugs abirateroneand TOK-001. Nature 482:116\u2013U149", "journal-title": "Nature"}, {"key": "9_CR2154", "doi-asserted-by": "crossref", "first-page": "419", "DOI": "10.1007/978-1-4757-2391-5_12", "volume-title": "Cytochrome P450: structure, mechanism, and biochemistry", "author": "N Kagawa", "year": "1995", "unstructured": "Kagawa N, Waterman MR (1995) Regulation of steroidogenic and related P450s. In: Ortiz de Montellano PR (ed) Cytochrome P450: structure, mechanism, and biochemistry, 2nd edn. Plenum Press, New York, pp\u00a0419\u2013442", "edition": "2"}, {"key": "9_CR2155", "doi-asserted-by": "crossref", "first-page": "817", "DOI": "10.3109/07435809809032692", "volume": "24", "author": "WL Miller", "year": "1998", "unstructured": "Miller WL, Geller DH, Auchus RJ (1998) The molecular basis of isolated 17,20 lyase deficiency. Endocrin Res 24:817\u2013825", "journal-title": "Endocrin Res"}, {"key": "9_CR2156", "doi-asserted-by": "crossref", "first-page": "14104", "DOI": "10.1021/bi00043a015", "volume": "34", "author": "P Lee-Robichaud", "year": "1995", "unstructured": "Lee-Robichaud P, Shyadehi AZ, Wright JN, Akhtar ME, Akhtar M (1995) Mechanistic kinship between hydroxylation and desaturation reactions: acyl-carbon bond cleavage promoted by pig and human CYP17 (P-45017a; 17\u03b1-hydroxylase-17,20-lyase). Biochemistry 34:14104\u201314113", "journal-title": "Biochemistry"}, {"key": "9_CR2157", "doi-asserted-by": "crossref", "first-page": "299", "DOI": "10.1016/S0960-0760(01)00105-4", "volume": "78", "author": "S Lieberman", "year": "2001", "unstructured": "Lieberman S, Warne PA (2001) 17-hydroxylase: an evaluation of the present view of its catalytic role in steroidogenesis. J Steroid Biochem Mol Biol 78:299\u2013312", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2158", "doi-asserted-by": "crossref", "first-page": "1349", "DOI": "10.1046/j.1432-1033.2003.03508.x", "volume": "270", "author": "P Soucy", "year": "2003", "unstructured": "Soucy P, Lacoste L, Luu-The V (2003) Assessment of porcine and human 16-ene-synthase, a third activity of P450c17, in the formation of an androstenol precursor. Eur J Biochem 270:1349\u20131355", "journal-title": "Eur J Biochem"}, {"key": "9_CR2159", "doi-asserted-by": "crossref", "first-page": "3762", "DOI": "10.1210/jc.2003-030143", "volume": "88", "author": "CE Fluck", "year": "2003", "unstructured": "Fluck CE, Miller WL, Auchus RJ (2003) The 17, 20-lyase activity of cytochrome P450c17 from human fetal testis favors the D5 steroidogenic pathway. J Clin Endocrinol Metab 88:3762\u20133766", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2160", "doi-asserted-by": "crossref", "first-page": "7064", "DOI": "10.1021/bi300895w", "volume": "51", "author": "FK Yoshimoto", "year": "2012", "unstructured": "Yoshimoto FK, Zhou Y, Peng HM, Stidd D, Yoshimoto JA, Sharma KK, Matthew S, Auchus RJ (2012) Minor activities and transition state properties of the human steroid hydroxylases cytochromes P450c17 and P450c21, from reactions observed with deuterium-labeled substrates. Biochemistry 51:7064\u20137077", "journal-title": "Biochemistry"}, {"key": "9_CR2161", "doi-asserted-by": "crossref", "first-page": "112", "DOI": "10.1016/j.jsbmb.2009.12.014", "volume": "119", "author": "AC Swart", "year": "2010", "unstructured": "Swart AC, Storbeck KH, Swart P (2010) A single amino acid residue, Ala 105, confers 16\u03b1-hydroxylase activity to human cytochrome P450 17\u03b1-hydroxylase/17,20 lyase. J Steroid Biochem Mol Biol 119:112\u2013120", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2162", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1039/P19940000263", "volume": "1", "author": "M Akhtar", "year": "1994", "unstructured": "Akhtar M, Corina DL, Miller SL, Shyadehi AZ, Wright JN (1994) Incorporation of label from 18O2 into acetate during side-chain cleavage catalysed by cytochrome P45017a (17\u03b1-hydroxylase-17,20-lyase). J Chem Soc Perkin Trans 1:263\u2013267", "journal-title": "J Chem Soc Perkin Trans"}, {"key": "9_CR2163", "doi-asserted-by": "crossref", "first-page": "179", "DOI": "10.1016/j.bbrc.2013.11.094", "volume": "443", "author": "Y Khatri", "year": "2014", "unstructured": "Khatri Y, Gregory MC, Grinkova YV, Denisov IG, Sligar SG (2014) Active site proton delivery and the lyase activity of human CYP17A1. Biochem Biophys Res Commun 443:179\u2013184", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR2164", "doi-asserted-by": "crossref", "first-page": "5342", "DOI": "10.1002/anie.201300760", "volume": "52", "author": "M Gregory", "year": "2013", "unstructured": "Gregory M, Mak PJ, Sligar SG, Kincaid JR (2013) Differential hydrogen bonding in human CYP17 dictates hydroxylation versus lyase chemistry. Angew Chem Int Ed Engl 52:5342\u20135345", "journal-title": "Angew Chem Int Ed Engl"}, {"key": "9_CR2165", "doi-asserted-by": "crossref", "first-page": "16245", "DOI": "10.1021/ja4086403", "volume": "135", "author": "MC Gregory", "year": "2013", "unstructured": "Gregory MC, Denisov IG, Grinkova YV, Khatri Y, Sligar SG (2013) Kinetic solvent isotope effect in human P450 CYP17A1-mediated androgen formation: evidence for a reactive peroxoanion intermediate. J Am Chem Soc 135:16245\u201316247", "journal-title": "J Am Chem Soc"}, {"key": "9_CR2166", "doi-asserted-by": "crossref", "first-page": "343", "DOI": "10.1006/abbi.1995.1173", "volume": "317", "author": "M Katagiri", "year": "1995", "unstructured": "Katagiri M, Kagawa N, Waterman MR (1995) The role of cytochrome b 5 in the biosynthesis of androgens by human P450c17. Arch Biochem Biophys 317:343\u2013347", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR2167", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1016/S0039-128X(96)00172-9", "volume": "62", "author": "WL Miller", "year": "1997", "unstructured": "Miller WL, Auchus RJ, Geller DH (1997) The regulation of 17,20 lyase activity. Steroids 62:133\u2013142", "journal-title": "Steroids"}, {"key": "9_CR2168", "first-page": "1226", "volume": "85", "author": "A Biason-Lauber", "year": "2000", "unstructured": "Biason-Lauber A, Kempken B, Werder E, Forest MG, Einaudi S, Ranke MB, Matsuo N, Brunelli V, Schonle EJ, Zachmann M (2000) 17\u03b1-Hydroxylase/17,20-lyase deficiency as a model to study enzymatic activity regulation: role of phosphorylation. J Clin Endocrinol Metab 85:1226\u20131231", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2169", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1016/S0960-0760(01)00171-6", "volume": "80", "author": "P Soucy", "year": "2002", "unstructured": "Soucy P, Luu-The V (2002) Assessment of the ability of type 2 cytochrome b 5 to modulate 17,20-lyase activity of human P450c17. J Steroid Biochem Mol Biol 80:71\u201375", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2170", "doi-asserted-by": "crossref", "first-page": "3158", "DOI": "10.1074/jbc.273.6.3158", "volume": "273", "author": "RJ Auchus", "year": "1998", "unstructured": "Auchus RJ, Lee TC, Miller WL (1998) Cytochrome b 5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer. J Biol Chem 273:3158\u20133165", "journal-title": "J Biol Chem"}, {"key": "9_CR2171", "doi-asserted-by": "crossref", "first-page": "1598", "DOI": "10.1021/bi9821059", "volume": "38", "author": "BJ Brock", "year": "1999", "unstructured": "Brock BJ, Waterman MR (1999) Biochemical differences between rat and human cytochrome P450c17 support the different steroidogenic needs of these two species. Biochemistry 38:1598\u20131606", "journal-title": "Biochemistry"}, {"key": "9_CR2172", "doi-asserted-by": "crossref", "first-page": "2800", "DOI": "10.1021/bi9715066", "volume": "37", "author": "T Yamazaki", "year": "1998", "unstructured": "Yamazaki T, Ohno T, Sakaki T, Akiyoshi-Shibata M, Yabusaki Y, Imai T, Kominami S (1998) Kinetic anaylsis of successive reactions catalyzed by bovine cytochrome P45017\u03b1,lyase. Biochemistry 37:2800\u20132806", "journal-title": "Biochemistry"}, {"key": "9_CR2173", "doi-asserted-by": "crossref", "first-page": "3243", "DOI": "10.1046/j.1432-1327.2000.01349.x", "volume": "267", "author": "P Soucy", "year": "2000", "unstructured": "Soucy P, Luu-The V (2000) Conversion of pregnenoloneto DHEA by human 17 \u03b1-hydroxylase/17,20-lyase (P450c17). Evidence that DHEA is produced from the released intermediate, 17\u03b1-hydroxypregnenolone. Eur J Biochem 267:3243\u20133247", "journal-title": "Eur J Biochem"}, {"key": "9_CR2174", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1016/j.jsbmb.2012.01.001", "volume": "129", "author": "M Yamaoka", "year": "2012", "unstructured": "Yamaoka M, Hara T, Hitaka T, Kaku T, Takeuchi T, Takahashi J, Asahi S, Miki H, Tasaka A, Kusaka M (2012) Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys. J Steroid Biochem Mol Biol 129:115\u2013128", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2175", "doi-asserted-by": "crossref", "first-page": "4282", "DOI": "10.1210/en.2007-0487", "volume": "148", "author": "LY Zhou", "year": "2007", "unstructured": "Zhou LY, Wang DS, Kobayashi T, Yano A, Paul-Prasanth B, Suzuki A, Sakai F, Nagahama Y (2007) A novel type of P450c17 lacking the lyase activity is responsible for C21-steroid biosynthesis in the fish ovary and head kidney. Endocrinology 148:4282\u20134291", "journal-title": "Endocrinology"}, {"key": "9_CR2176", "unstructured": "Pallan PS, Lei L, Nagy ND, Gonzalez E, Kramlinger VM, Azumaya CM, Guengerich FP, Egli M (2015) Structural basis of lack of steroid 17\u03b1,20-lyase activity in fish cytochrome P450 17A2 and relevance to dual oxidation activity of cytochrome P450 17A1. J Biol Chem 290, in press PMID: 25533464"}, {"key": "9_CR2177", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1016/j.jsbmb.2004.07.005", "volume": "92", "author": "P Lee-Robichaud", "year": "2004", "unstructured": "Lee-Robichaud P, Akhtar ME, Wright JN, Sheikh QI, Akhtar M (2004) The cationic charges on Arg347, Arg358 and Arg449 of human cytochrome P450c17 (CYP17) are essential for the enzyme\u2019s cytochrome b 5-dependent acyl-carbon cleavage activities. J Steroid Biochem Mol Biol 92:119\u2013130", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2178", "doi-asserted-by": "crossref", "first-page": "17008", "DOI": "10.1074/jbc.M113.468926", "volume": "288", "author": "DF Estrada", "year": "2013", "unstructured": "Estrada DF, Laurence JS, Scott EE (2013) Substrate-modulated cytochrome P450 17A1 and cytochrome b 5 interactions revealed by NMR. J Biol Chem 288:17008\u201317018", "journal-title": "J Biol Chem"}, {"key": "9_CR2179", "doi-asserted-by": "crossref", "first-page": "254", "DOI": "10.1006/mgme.2000.3134", "volume": "72", "author": "CW Lam", "year": "2001", "unstructured": "Lam CW, Arlt W, Chan CK, Honour JW, Lin CJ, Tong SF, Choy KW, Miller WL (2001) Mutation of proline 409 to arginine in the meander region of cytochrome P450c17 causes severe 17\u03b1-hydroxylase deficiency. Mol Genet Metab 72:254\u2013259", "journal-title": "Mol Genet Metab"}, {"key": "9_CR2180", "doi-asserted-by": "crossref", "first-page": "967", "DOI": "10.1042/bj3300967", "volume": "330", "author": "P Lee-Robichaud", "year": "1998", "unstructured": "Lee-Robichaud P, Akhtar ME, Akhtar M (1998) An analysis of the role of active siteprotic residues of cytochrome P-450s: mechanistic and mutational studies on 17\u03b1-hydroxylase-17,20-lyase (P-45017\u03b1, also CYP17). Biochem J 330:967\u2013974", "journal-title": "Biochem J"}, {"key": "9_CR2181", "doi-asserted-by": "crossref", "first-page": "1373", "DOI": "10.1210/mend-5-10-1373", "volume": "5", "author": "M Kitamura", "year": "1991", "unstructured": "Kitamura M, Buczko E, Dufau ML (1991) Dissociation of hydroxylase and lyase activities by site-directed mutagenesis of the rat P45017a. Mol Endocrinol 5:1373\u20131380", "journal-title": "Mol Endocrinol"}, {"key": "9_CR2182", "first-page": "3807", "volume": "82", "author": "A Biason-Lauber", "year": "1997", "unstructured": "Biason-Lauber A, Leiberman E, Zachmann M (1997) A single amino acid substitution in the putative redox partner-binding site of P450c17 as cause of isolated 17,20-lyase deficiency. J Clin Endocrinol Metab 82:3807\u20133812", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2183", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1042/bj3320293", "volume": "332", "author": "P Lee-Robichaud", "year": "1998", "unstructured": "Lee-Robichaud P, Akhtar ME, Akhtar M (1998) Control of androgen biosynthesis in the human through the interaction of Arg347 and Arg358 of CYP17 with cytochrome b 5. Biochem J 332:293\u2013296", "journal-title": "Biochem J"}, {"key": "9_CR2184", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1042/bj3420309", "volume": "342", "author": "P LeeRobichaud", "year": "1999", "unstructured": "LeeRobichaud P, Akhtar ME, Akhtar M (1999) Lysine mutagenesis identifies cationic charges of human CYP17 that interact with cytochrome b 5 to promote male sex-hormone biosynthesis. Biochem J 342:309\u2013312", "journal-title": "Biochem J"}, {"key": "9_CR2185", "doi-asserted-by": "crossref", "first-page": "695", "DOI": "10.3109/07435800009048589", "volume": "26", "author": "RJ Auchus", "year": "2000", "unstructured": "Auchus RJ, Worthy K, Geller DH, Miller WL (2000) Probing structural and functional domains of human P450c17. Endocrin Res 26:695\u2013703", "journal-title": "Endocrin Res"}, {"key": "9_CR2186", "doi-asserted-by": "crossref", "first-page": "4416", "DOI": "10.1210/jcem.86.9.7812", "volume": "86", "author": "MK Gupta", "year": "2001", "unstructured": "Gupta MK, Geller DH, Auchus RJ (2001) Pitfalls in characterizing P450c17 mutations associated with isolated 17,20-lyasedeficiency. J Clin Endocrinol Metab 86:4416\u20134423", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2187", "first-page": "898", "volume": "87", "author": "A Di Cerbo", "year": "2002", "unstructured": "Di Cerbo A, Biason-Lauber A, Savino M, Piemontese MR, Di Giorgio A, Perona M, Savoia A (2002) Combined 17\u03b1-hydroxylase/17,20-lyase deficiency caused by Phe93Cys mutation in the CYP17 gene. J Clin Endocrinol Metab 87:898\u2013905", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2188", "first-page": "141", "volume": "55", "author": "N Katsumata", "year": "2001", "unstructured": "Katsumata N, Satoh M, Mikami A, Mikami S, Nagashima-Miyokawa A, Sato N, Yokoya S, Tanaka T (2001) New compound heterozygous mutation in the CYP17 gene in a 46,XY girl with 17\u03b1-hydroxylase/17,20-lyasedeficiency. Horm Res 55:141\u2013146", "journal-title": "Horm Res"}, {"key": "9_CR2189", "doi-asserted-by": "crossref", "first-page": "401", "DOI": "10.1006/abbi.1999.1557", "volume": "373", "author": "BJ Brock", "year": "2000", "unstructured": "Brock BJ, Waterman MR (2000) The use of random chimeragenesis to study structure/function properties of rat and human P450c17. Arch Biochem Biophys 373:401\u2013408", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR2190", "doi-asserted-by": "crossref", "first-page": "99", "DOI": "10.1016/S0960-0760(01)00172-8", "volume": "80", "author": "AP Mathieu", "year": "2002", "unstructured": "Mathieu AP, Auchus RJ, LeHoux JG (2002) Comparison of the hamster and human adrenal P450c17 (17\u03b1-hydroxylase/17,20-lyase) using site-directed mutagenesis and molecular modeling. J Steroid Biochem Mol Biol 80:99\u2013107", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2191", "doi-asserted-by": "crossref", "first-page": "2345", "DOI": "10.1021/jm020576u", "volume": "46", "author": "OO Clement", "year": "2003", "unstructured": "Clement OO, Freeman CM, Hartmann RW, Handratta VD, Vasaitis TS, Brodie AM, Njar VC (2003) Three dimensional pharmacophore modeling of human CYP17 inhibitors. Potential agents for prostate cancer therapy. J Med Chem 46:2345\u20132351", "journal-title": "J Med Chem"}, {"key": "9_CR2192", "doi-asserted-by": "crossref", "first-page": "1078", "DOI": "10.1016/j.jmb.2010.05.069", "volume": "400", "author": "SM Haider", "year": "2010", "unstructured": "Haider SM, Patel JS, Poojari CS, Neidle S (2010) Molecular modeling on inhibitor complexes and active-site dynamics of cytochrome P450 C17, a target for prostate cancer therapy. J Mol Biol 400:1078\u20131098", "journal-title": "J Mol Biol"}, {"key": "9_CR2193", "first-page": "392", "volume": "8", "author": "D Lin", "year": "1994", "unstructured": "Lin D, Zhang LH, Chiao E, Miller WL (1994) Modeling and mutagenesis of the active site of human P450c17. Mol Endocrinol 8:392\u2013402", "journal-title": "Mol Endocrinol"}, {"key": "9_CR2194", "first-page": "113", "volume": "12", "author": "DF Burke", "year": "1997", "unstructured": "Burke DF, Laughton CA, Neidle S (1997) Homology modelling of the enzyme P450 17\u03b1-hydroxylase/17,20-lyase\u2014a target for prostate cancer chemotherapy\u2014from the crystal structure of P450BM-3. Anticancer Drug Des 12:113\u2013123", "journal-title": "Anticancer Drug Des"}, {"key": "9_CR2195", "first-page": "1169", "volume": "13", "author": "RJ Auchus", "year": "1999", "unstructured": "Auchus RJ, Miller WL (1999) Molecular modeling of human P450c17 (17\u03b1-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations. Mol Endocrinol 13:1169\u20131182", "journal-title": "Mol Endocrinol"}, {"key": "9_CR2196", "doi-asserted-by": "crossref", "first-page": "1487", "DOI": "10.1016/S0968-0896(99)00077-2", "volume": "7", "author": "S Ahmed", "year": "1999", "unstructured": "Ahmed S (1999) A novel molecular modelling study of inhibitors of the 17\u03b1-hydroxylase component of the enzyme system 17\u03b1-hydroxylase/17,20-lyase (P-45017a ). Bioorg Med Chem 7:1487\u20131496", "journal-title": "Bioorg Med Chem"}, {"key": "9_CR2197", "first-page": "435", "volume": "56", "author": "A Schappach", "year": "2001", "unstructured": "Schappach A, Holtje HD (2001) Molecular modelling of 17\u03b1-hydroxylase-17,20-lyase. Pharmazie 56:435\u2013442", "journal-title": "Pharmazie"}, {"key": "9_CR2198", "doi-asserted-by": "crossref", "first-page": "1023", "DOI": "10.1016/0022-4731(85)90062-7", "volume": "23", "author": "PB Kan", "year": "1985", "unstructured": "Kan PB, Hirst MA, Feldman D (1985) Inhibition of steroidogenic cytochrome P-450 enzymes in rat testisby ketoconazole and related imidazole anti-fungal drugs. J Steroid Biochem 23:1023\u20131029", "journal-title": "J Steroid Biochem"}, {"key": "9_CR2199", "doi-asserted-by": "crossref", "first-page": "421", "DOI": "10.1016/0960-0760(92)90147-B", "volume": "42", "author": "DC Kossor", "year": "1992", "unstructured": "Kossor DC, Kominami S, Takemori S, Colby HD (1992) Destruction of testicular cytochrome P-450 by 7\u03b1-thiospironolactone is catalyzed by the 17\u03b1-hydroxylase. J Steroid Biochem Mol Biol 42:421\u2013424", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2200", "doi-asserted-by": "crossref", "first-page": "2463", "DOI": "10.1021/jm00013a022", "volume": "38", "author": "GA Potter", "year": "1995", "unstructured": "Potter GA, Barrie SE, Jarman M, Rowlands MG (1995) Novel steroidal inhibitors of human cytochrome P45017\u03b1 (17\u03b1-hydroxylase-C17,20-lyase): potential agents for the treatment of prostatic cancer. J Med Chem 38:2463\u20132471", "journal-title": "J Med Chem"}, {"key": "9_CR2201", "doi-asserted-by": "crossref", "first-page": "4335", "DOI": "10.1021/jm960245f", "volume": "39", "author": "JS Li", "year": "1996", "unstructured": "Li JS, Li Y, Son C, Brodie AM (1996) Synthesis and evaluation of pregnane derivatives as inhibitors of human testicular 17\u03b1-hydroxylase/C17,20-lyase. J Med Chem 39:4335\u20134339", "journal-title": "J Med Chem"}, {"key": "9_CR2202", "first-page": "163", "volume": "5", "author": "VC Njar", "year": "1999", "unstructured": "Njar VC, Brodie AM (1999) Inhibitors of 17\u03b1-hydroxylase/17,20-lyase (CYP17): potential agents for the treatment of prostate cancer. Curr Pharm Des 5:163\u2013180", "journal-title": "Curr Pharm Des"}, {"key": "9_CR2203", "doi-asserted-by": "crossref", "first-page": "4437", "DOI": "10.1021/jm991070n", "volume": "43", "author": "RW Hartmann", "year": "2000", "unstructured": "Hartmann RW, Hector M, Wachall BG, Palusczak A, Palzer M, Huch V, Veith M (2000) Synthesis and evaluation of 17-aliphatic heterocycle-substituted steroidal inhibitors of 1\u03b1-hydroxylase/C17\u201320-lyase (P450 17). J Med Chem 43:4437\u20134445", "journal-title": "J Med Chem"}, {"key": "9_CR2204", "doi-asserted-by": "crossref", "first-page": "929", "DOI": "10.1016/S0968-0896(01)00354-6", "volume": "10", "author": "JP Burkhart", "year": "2002", "unstructured": "Burkhart JP, Weintraub PM, Gates CA, Resvick RJ, Vaz RJ, Friedrich D, Angelastro MR, Bey P, Peet NP (2002) Novel steroidal vinyl fluorides as inhibitors of steroid C17(20) lyase. Bioorg Med Chem 10:929\u2013934", "journal-title": "Bioorg Med Chem"}, {"key": "9_CR2205", "doi-asserted-by": "crossref", "first-page": "134", "DOI": "10.1016/S0003-9861(02)00491-5", "volume": "409", "author": "RJ Auchus", "year": "2003", "unstructured": "Auchus RJ, Sampath Kumar A, Andrew Boswell C, Gupta MK, Bruce K, Rath NP, Covey DF (2003) The enantiomer of progesterone (ent-progesterone) is a competitive inhibitor of human cytochromes P450c17 and P450c21. Arch Biochem Biophys 409:134\u2013144", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR2206", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.1211/0022357991772637", "volume": "51", "author": "CP Owen", "year": "1999", "unstructured": "Owen CP, Nicholls PJ, Smith HJ, Whomsley R (1999) Inhibition of aromatase (P450Arom) by some 1-(benzofuran-2-ylmethyl)imidazoles. J Pharm Pharmacol 51:427\u2013433", "journal-title": "J Pharm Pharmacol"}, {"key": "9_CR2207", "doi-asserted-by": "crossref", "first-page": "672", "DOI": "10.1021/jm000955s", "volume": "44", "author": "M Recanatini", "year": "2001", "unstructured": "Recanatini M, Bisi A, Cavalli A, Belluti F, Gobbi S, Rampa A, Valenti P, Palzer M, Palusczak A, Hartmann RW (2001) A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17\u03b1-hydroxylase/C17,20-lyase. J Med Chem 44:672\u2013680", "journal-title": "J Med Chem"}, {"key": "9_CR2208", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1021/jm015567k", "volume": "45", "author": "A Cavalli", "year": "2002", "unstructured": "Cavalli A, Recanatini M (2002) Looking for selectivity among cytochrome P450 inhibitors. J Med Chem 45:251\u2013254", "journal-title": "J Med Chem"}, {"key": "9_CR2209", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1016/S0960-0760(00)00137-0", "volume": "75", "author": "PB Ehmer", "year": "2000", "unstructured": "Ehmer PB, Jose J, Hartmann RW (2000) Development of a simple and rapid assay for the evaluation of inhibitors of human 17\u03b1-hydroxylase-C17,20-lyase (P450cl7) by coexpression of P450cl7 with NADPH-cytochrome-P450-reductase in Escherichia coli. J Steroid Biochem Mol Biol 75:57\u201363", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2210", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1006/abio.1998.2993", "volume": "267", "author": "DN Grigoryev", "year": "1999", "unstructured": "Grigoryev DN, Kato K, Njar VC, Long BJ, Ling YZ, Wang X, Mohler J, Brodie AM (1999) Cytochrome P450c17-expressing Escherichia colias a first-step screening system for 17\u03b1-hydroxylase-C17,20-lyase inhibitors. Anal Biochem 267:319\u2013330", "journal-title": "Anal Biochem"}, {"key": "9_CR2211", "doi-asserted-by": "crossref", "first-page": "555", "DOI": "10.1016/S0960-0760(03)00070-0", "volume": "84", "author": "S Haidar", "year": "2003", "unstructured": "Haidar S, Ehmer PB, Barassin S, Batzl-Hartmann C, Hartmann RW (2003) Effects of novel 17\u03b1-hydroxylase/C17,20-lyase (P450 17, CYP 17) inhibitors on androgen biosynthesis in vitro and in vivo. J Steroid Biochem Mol Biol 84:555\u2013562", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2212", "doi-asserted-by": "crossref", "first-page": "2251", "DOI": "10.1016/j.bmc.2004.02.007", "volume": "12", "author": "N Matsunaga", "year": "2004", "unstructured": "Matsunaga N, Kaku T, Itoh F, Tanaka T, Hara T, Miki H, Iwasaki M, Aono T, Yamaoka M, Kusaka M, Tasaka A (2004) C17,20-lyase inhibitors I. Structure-based de novo design and SAR study of C17,20-lyase inhibitors. Bioorg Med Chem 12:2251\u20132273", "journal-title": "Bioorg Med Chem"}, {"key": "9_CR2213", "doi-asserted-by": "crossref", "first-page": "6792", "DOI": "10.1021/jm049535j", "volume": "47", "author": "F Leonetti", "year": "2004", "unstructured": "Leonetti F, Favia A, Rao A, Aliano R, Paluszcak A, Hartmann RW, Carotti A (2004) Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors. J Med Chem 47:6792\u20136803", "journal-title": "J Med Chem"}, {"key": "9_CR2214", "doi-asserted-by": "crossref", "first-page": "597", "DOI": "10.1002/ardp.200700251", "volume": "341", "author": "MA Pinto-Bazurco Mendieta", "year": "2008", "unstructured": "Pinto-Bazurco Mendieta MA, Negri M, Hu Q, Hille UE, Jagusch C, Jahn-Hoffmann K, Muller-Vieira U, Schmidt D, Lauterbach T, Hartmann RW (2008) CYP17 inhibitors. Annulations of additional rings in methylene imidazole substituted biphenyls: synthesis, biological evaluation and molecular modelling. Arch Pharm 341:597\u2013609", "journal-title": "Arch Pharm"}, {"key": "9_CR2215", "first-page": "E9", "volume": "110", "author": "G Di Lorenzo", "year": "2012", "unstructured": "Di Lorenzo G, Ferro M, Buonerba C (2012) Sipuleucel-T (Provenge(R)) for castration-resistant prostate cancer. BJU Int 110:E99\u2013104", "journal-title": "BJU Int"}, {"key": "9_CR2216", "doi-asserted-by": "crossref", "first-page": "868", "DOI": "10.2174/092986708783955428", "volume": "15", "author": "VM Moreira", "year": "2008", "unstructured": "Moreira VM, Salvador JA, Vasaitis TS, Njar VC (2008) CYP17 inhibitors for prostate cancer treatment\u2014an update. Curr Med Chem 15:868\u2013899", "journal-title": "Curr Med Chem"}, {"key": "9_CR2217", "doi-asserted-by": "crossref", "first-page": "449", "DOI": "10.1016/j.coph.2008.06.004", "volume": "8", "author": "TA Yap", "year": "2008", "unstructured": "Yap TA, Carden CP, Attard G, de Bono JS (2008) Targeting CYP17: established and novel approaches in prostate cancer. Curr Opin Pharmacol 8:449\u2013457", "journal-title": "Curr Opin Pharmacol"}, {"key": "9_CR2218", "doi-asserted-by": "crossref", "first-page": "613", "DOI": "10.2174/187152009788680046", "volume": "9", "author": "CP Owen", "year": "2009", "unstructured": "Owen CP (2009) 17\u03b1-Hydroxylase/17,20-lyase (P450(17\u03b1)) inhibitors in the treatment of prostate cancer: a review. Anticancer Agents Med Chem 9:613\u2013626", "journal-title": "Anticancer Agents Med Chem"}, {"key": "9_CR2219", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1016/j.jsbmb.2010.11.005", "volume": "125", "author": "TS Vasaitis", "year": "2011", "unstructured": "Vasaitis TS, Bruno RD, Njar VC (2011) CYP17 inhibitors for prostate cancer therapy. J Steroid Biochem Mol Biol 125:23\u201331", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2220", "doi-asserted-by": "crossref", "first-page": "671", "DOI": "10.1038/sj.bjc.6604904", "volume": "100", "author": "JE Ang", "year": "2009", "unstructured": "Ang JE, Olmos D, de Bono JS (2009) CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer. Br J Cancer 100:671\u2013675", "journal-title": "Br J Cancer"}, {"key": "9_CR2221", "doi-asserted-by": "crossref", "first-page": "3742", "DOI": "10.1200/JCO.2008.20.0642", "volume": "27", "author": "G Attard", "year": "2009", "unstructured": "Attard G, Reid AH, A\u2019Hern R, Parker C, Oommen NB, Folkerd E, Messiou C, Molife LR, Maier G, Thompson E, Olmos D, Sinha R, Lee G, Dowsett M, Kaye SB, Dearnaley D, Kheoh T, Molina A, de Bono JS (2009) Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer. J Clin Oncol 27:3742\u20133748", "journal-title": "J Clin Oncol"}, {"key": "9_CR2222", "doi-asserted-by": "crossref", "first-page": "1489", "DOI": "10.1200/JCO.2009.24.6819", "volume": "28", "author": "AH Reid", "year": "2010", "unstructured": "Reid AH, Attard G, Danila DC, Oommen NB, Olmos D, Fong PC, Molife LR, Hunt J, Messiou C, Parker C, Dearnaley D, Swennenhuis JF, Terstappen LW, Lee G, Kheoh T, Molina A, Ryan CJ, Small E, Scher HI, de Bono JS (2010) Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate. J Clin Oncol 28:1489\u20131495", "journal-title": "J Clin Oncol"}, {"key": "9_CR2223", "doi-asserted-by": "crossref", "first-page": "563", "DOI": "10.1517/13543781003639427", "volume": "19", "author": "S Shah", "year": "2010", "unstructured": "Shah S, Ryan C (2010) Abiraterone acetate for castration resistant prostate cancer. Exp Opin Invest Drugs 19:563\u2013570", "journal-title": "Exp Opin Invest Drugs"}, {"key": "9_CR2224", "doi-asserted-by": "crossref", "first-page": "2067", "DOI": "10.2165/11208080-000000000-00000", "volume": "71", "author": "LP Yang", "year": "2011", "unstructured": "Yang LP (2011) Abiraterone acetate: in metastatic castration-resistant prostate cancer. Drugs 71:2067\u20132077", "journal-title": "Drugs"}, {"key": "9_CR2225", "unstructured": "Rehman Y, Rosenberg JE (2012) Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer. Drug Des Devel Ther 6:13\u201318", "DOI": "10.2147/DDDT.S15850", "doi-asserted-by": "crossref"}, {"key": "9_CR2226", "doi-asserted-by": "crossref", "first-page": "6383", "DOI": "10.1016/j.bmc.2011.08.066", "volume": "19", "author": "T Kaku", "year": "2011", "unstructured": "Kaku T, Hitaka T, Ojida A, Matsunaga N, Adachi M, Tanaka T, Hara T, Yamaoka M, Kusaka M, Okuda T, Asahi S, Furuya S, Tasaka A (2011) Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer. Bioorg Med Chem 19:6383\u20136399", "journal-title": "Bioorg Med Chem"}, {"key": "9_CR2227", "doi-asserted-by": "crossref", "first-page": "191", "DOI": "10.1016/j.canlet.2004.01.001", "volume": "207", "author": "LM Berstein", "year": "2004", "unstructured": "Berstein LM, Imyanitov EN, Kovalevskij AJ, Maximov SJ, Vasilyev DA, Buslov KG, Sokolenko AP, Iyevleva AG, Chekmariova EV, Thijssen JH (2004) CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity. Cancer Lett 207:191\u2013196", "journal-title": "Cancer Lett"}, {"key": "9_CR2228", "first-page": "243", "volume": "11", "author": "JL Stanford", "year": "2002", "unstructured": "Stanford JL, Noonan EA, Iwasaki L, Kolb S, Chadwick RB, Feng Z, Ostrander EA (2002) A polymorphism in the CYP17 gene and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 11:243\u2013247", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9_CR2229", "doi-asserted-by": "crossref", "first-page": "414", "DOI": "10.1007/s00345-003-0378-4", "volume": "21", "author": "A Gsur", "year": "2004", "unstructured": "Gsur A, Feik E, Madersbacher S (2004) Genetic polymorphisms and prostate cancer risk. World J Urol 21:414\u2013423", "journal-title": "World J Urol"}, {"key": "9_CR2230", "doi-asserted-by": "crossref", "first-page": "R", "DOI": "10.1186/bcr570", "volume": "5", "author": "CB Ambrosone", "year": "2003", "unstructured": "Ambrosone CB, Moysich KB, Furberg H, Freudenheim JL, Bowman ED, Ahmed S, Graham S, Vena JE, Shields PG (2003) CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors. Breast Cancer Res 5:R45\u201351", "journal-title": "Breast Cancer Res"}, {"key": "9_CR2231", "first-page": "848", "volume": "61", "author": "R McKean-Cowdin", "year": "2001", "unstructured": "McKean-Cowdin R, Feigelson HS, Pike MC, Coetzee GA, Kolonel LN, Henderson BE (2001) Risk of endometrial cancer and estrogenreplacement therapy history by CYP17 genotype. Cancer Res 61:848\u2013849", "journal-title": "Cancer Res"}, {"key": "9_CR2232", "doi-asserted-by": "crossref", "first-page": "618", "DOI": "10.1111/j.1365-2141.2005.05505.x", "volume": "129", "author": "CF Skibola", "year": "2005", "unstructured": "Skibola CF, Lightfoot T, Agana L, Smith A, Rollinson S, Kao A, Adamson P, Morgan GJ, Smith MT, Roman E (2005) Polymorphisms in cytochrome P450 17A1 and risk of non-Hodgkin lymphoma. Br J Haematol 129:618\u2013621", "journal-title": "Br J Haematol"}, {"key": "9_CR2233", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1023/A:1021206704958", "volume": "20", "author": "D Levran", "year": "2003", "unstructured": "Levran D, Ben-Shlomo I, Pariente C, Dor J, Mashiach S, Weissman A (2003) Familial partial 17,20-desmolase and 17\u03b1-hydroxylase deficiency presenting as infertility. J Assist Reprod Genet 20:21\u201328", "journal-title": "J Assist Reprod Genet"}, {"key": "9_CR2234", "doi-asserted-by": "crossref", "first-page": "725", "DOI": "10.1093/molehr/gag089", "volume": "9", "author": "F Sata", "year": "2003", "unstructured": "Sata F, Yamada H, Yamada A, Kato EH, Kataoka S, Saijo Y, Kondo T, Tamaki J, Minakami H, Kishi R (2003) A polymorphism in the CYP17 gene relates to the risk of recurrent pregnancy loss. Mol Hum Reprod 9:725\u2013728", "journal-title": "Mol Hum Reprod"}, {"key": "9_CR2235", "doi-asserted-by": "crossref", "first-page": "5383", "DOI": "10.1128/MCB.24.12.5383-5390.2004", "volume": "24", "author": "SR Bair", "year": "2004", "unstructured": "Bair SR, Mellon SH (2004) Deletion of the mouse P450c17 gene causes early embryonic lethality. Mol Cell Biol 24:5383\u20135390", "journal-title": "Mol Cell Biol"}, {"key": "9_CR2236", "doi-asserted-by": "crossref", "first-page": "231", "DOI": "10.1093/molehr/gam004", "volume": "13", "author": "M Henningson", "year": "2007", "unstructured": "Henningson M, Johansson U, Borg A, Olsson H, Jernstrom H (2007) CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women. Mol Hum Reprod 13:231\u2013236", "journal-title": "Mol Hum Reprod"}, {"key": "9_CR2237", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1111/j.1479-828X.2004.00275.x", "volume": "44", "author": "J Philip", "year": "2004", "unstructured": "Philip J, Anjali, Thomas N, Rajaratnam S, Seshadri MS (2004) 17-\u03b1 hydroxylase deficiency: an unusual cause of secondary amenorrhoea. Aust N Z J Obstet Gynaecol 44:477\u2013478", "journal-title": "Aust N Z J Obstet Gynaecol"}, {"key": "9_CR2238", "doi-asserted-by": "crossref", "first-page": "713", "DOI": "10.1016/S1472-6483(10)61114-5", "volume": "10", "author": "E Fratantonio", "year": "2005", "unstructured": "Fratantonio E, Vicari E, Pafumi C, Calogero AE (2005) Genetics of polycystic ovarian syndrome. Reprod Biomed Online 10:713\u2013720", "journal-title": "Reprod Biomed Online"}, {"key": "9_CR2239", "doi-asserted-by": "crossref", "first-page": "286", "DOI": "10.1016/j.rbmo.2009.11.007", "volume": "20", "author": "G Bozdag", "year": "2010", "unstructured": "Bozdag G, Alp A, Saribas Z, Tuncer S, Aksu T, Gurgan T (2010) CYP17 and CYP2C19 gene polymorphisms in patients with endometriosis. Reprod Biomed Online 20:286\u2013290", "journal-title": "Reprod Biomed Online"}, {"key": "9_CR2240", "doi-asserted-by": "crossref", "first-page": "338", "DOI": "10.1159/000092284", "volume": "212", "author": "L He", "year": "2006", "unstructured": "He L, Yang Z, Yu H, Cheng B, Tang W, Dong Y, Xiao C (2006) The relationship between CYP17 -34T/C polymorphism and acne in Chinese subjects revealed by sequencing. Dermatology 212:338\u2013342", "journal-title": "Dermatology"}, {"key": "9_CR2241", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1016/S0889-8529(08)70021-5", "volume": "30", "author": "RJ Auchus", "year": "2001", "unstructured": "Auchus RJ (2001) The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol Metab Clin North Am 30:101\u2013119, vii", "journal-title": "Endocrinol Metab Clin North Am"}, {"key": "9_CR2242", "doi-asserted-by": "crossref", "first-page": "32", "DOI": "10.1210/jcem-57-1-32", "volume": "57", "author": "FR Kaufman", "year": "1983", "unstructured": "Kaufman FR, Costin G, Goebelsmann U, Stanczyk FZ, Zachmann M (1983) Male pseudohermaphroditism due to 17,20-desmolase deficiency. J Clin Endocrinol Metab 57:32\u201336", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2243", "first-page": "721", "volume": "17", "author": "J Huang", "year": "1999", "unstructured": "Huang J, Ushiyama T, Inoue K, Mori K, Hukuda S (1999) Possible association of CYP17 gene polymorphisms with the onset of rheumatoid arthritis. Clin Exp Rheumatol 17:721\u2013724", "journal-title": "Clin Exp Rheumatol"}, {"key": "9_CR2244", "doi-asserted-by": "crossref", "first-page": "449", "DOI": "10.1006/mgme.2001.3260", "volume": "74", "author": "J Lai", "year": "2001", "unstructured": "Lai J, Vesprini D, Chu W, Jernstrom H, Narod SA (2001) CYP gene polymorphisms and early menarche. Mol Genet Metab 74:449\u2013457", "journal-title": "Mol Genet Metab"}, {"key": "9_CR2245", "first-page": "3908", "volume": "59", "author": "HS Feigelson", "year": "1999", "unstructured": "Feigelson HS, McKean-Cowdin R, Pike MC, Coetzee GA, Kolonel LN, Nomura AM, Le Marchand L, Henderson BE (1999) Cytochrome P450c17\u03b1 gene (CYP17) polymorphism predicts use of hormone replacement therapy. Cancer Res 59:3908\u20133910", "journal-title": "Cancer Res"}, {"key": "9_CR2246", "first-page": "123", "volume": "15", "author": "B Marszalek", "year": "2001", "unstructured": "Marszalek B, Lacinski M, Babych N, Capla E, Biernacka-Lukanty J, Warenik-Szymankiewicz A, Trzeciak WH (2001) Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5\u2032-UTR in patients with polycystic ovarian syndrome. Gynecol Endocrinol 15:123\u2013128", "journal-title": "Gynecol Endocrinol"}, {"key": "9_CR2247", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1016/S0027-5107(01)00212-3", "volume": "482", "author": "VN Kristensen", "year": "2001", "unstructured": "Kristensen VN, Kure EH, Erikstein B, Harada N, Borresen-Dale A (2001) Genetic susceptibility and environmental estrogen-like compounds. Mutat Res 482:77\u201382", "journal-title": "Mutat Res"}, {"key": "9_CR2248", "first-page": "1063", "volume": "57", "author": "HS Feigelson", "year": "1997", "unstructured": "Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE (1997) A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 57:1063\u20131065", "journal-title": "Cancer Res"}, {"key": "9_CR2249", "first-page": "785", "volume": "61", "author": "HS Feigelson", "year": "2001", "unstructured": "Feigelson HS, McKean-Cowdin R, Coetzee GA, Stram DO, Kolonel LN, Henderson BE (2001) Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates. Cancer Res 61:785\u2013789", "journal-title": "Cancer Res"}, {"key": "9_CR2250", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1093/oxfordjournals.jncimonographs.a024235", "volume": "27", "author": "PA Thompson", "year": "2000", "unstructured": "Thompson PA, Ambrosone C (2000) Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J Natl Cancer Inst Monogr 27:125\u2013134", "journal-title": "J Natl Cancer Inst Monogr"}, {"key": "9_CR2251", "first-page": "1343", "volume": "9", "author": "K Mitrunen", "year": "2000", "unstructured": "Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Vainio H, Uusitupa M, Hirvonen A (2000) Steroid metabolism gene CYP17 polymorphism and the development of breast cancer. Cancer Epidemiol Biomarkers Prev 9:1343\u20131348", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9_CR2252", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1093/mutage/17.2.119", "volume": "17", "author": "Z Ye", "year": "2002", "unstructured": "Ye Z, Parry JM (2002) The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis. Mutagenesis 17:119\u2013126", "journal-title": "Mutagenesis"}, {"key": "9_CR2253", "doi-asserted-by": "crossref", "first-page": "445", "DOI": "10.1093/mutage/17.5.445", "volume": "17", "author": "HS Feigelson", "year": "2002", "unstructured": "Feigelson HS, McKean-Cowdin R, Henderson BE (2002) Concerning the CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis. Mutagenesis 17:445\u2013446", "journal-title": "Mutagenesis"}, {"key": "9_CR2254", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.1530/eje.0.1420187", "volume": "142", "author": "R de Carmo Silva", "year": "2000", "unstructured": "de Carmo Silva R, Kater CE, Dib SA, Laureti S, Forini F, Cosentino A, Falorni A (2000) Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side-chain cleavage and 17\u03b1-hydroxylase in Addison\u2019s disease and autoimmune polyendocrine syndrome type III. Eur J Endocrinol 142:187\u2013194", "journal-title": "Eur J Endocrinol"}, {"key": "9_CR2255", "first-page": "53", "volume": "21", "author": "CN Mowa", "year": "2006", "unstructured": "Mowa CN, Jesmin S, Miyauchi T (2006) The penis: a new target and source of estrogen in male reproduction. Histol Histopathol 21:53\u201367", "journal-title": "Histol Histopathol"}, {"key": "9_CR2256", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1016/j.mce.2005.11.021", "volume": "246", "author": "S Carreau", "year": "2006", "unstructured": "Carreau S, Delalande C, Silandre D, Bourguiba S, Lambard S (2006) Aromatase and estrogen receptors in male reproduction. Mol Cell Endocrinol 246:65\u201368", "journal-title": "Mol Cell Endocrinol"}, {"key": "9_CR2257", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1146/annurev.physiol.64.081601.142703", "volume": "64", "author": "ER Simpson", "year": "2002", "unstructured": "Simpson ER, Clyne C, Rubin G, Boon WC, Robertson K, Britt K, Speed C, Jones M (2002) Aromatase\u2014a brief overview. Annu Rev Physiol 64:93\u2013127", "journal-title": "Annu Rev Physiol"}, {"key": "9_CR2258", "doi-asserted-by": "crossref", "first-page": "1094", "DOI": "10.1016/j.bbagen.2009.12.010", "volume": "1800", "author": "TD Charlier", "year": "2010", "unstructured": "Charlier TD, Cornil CA, Ball GF, Balthazart J (2010) Diversity of mechanisms involved in aromatase regulation and estrogen action in the brain. Biochim Biophys Acta 1800:1094\u20131105", "journal-title": "Biochim Biophys Acta"}, {"key": "9_CR2259", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1196/annals.1286.024", "volume": "1007", "author": "J Bakker", "year": "2003", "unstructured": "Bakker J, Honda S, Harada N, Balthazart J (2003) The aromatase knockout (ArKO) mouse provides new evidence that estrogens are required for the development of the female brain. Ann N Y Acad Sci 1007:251\u2013262", "journal-title": "Ann N Y Acad Sci"}, {"key": "9_CR2260", "doi-asserted-by": "crossref", "first-page": "247", "DOI": "10.1016/S0960-0760(01)00141-8", "volume": "79", "author": "CE Roselli", "year": "2001", "unstructured": "Roselli CE, Resko JA (2001) Cytochrome P450 aromatase (CYP19) in the non-human primate brain: distribution, regulation, and functional significance. J Steroid Biochem Mol Biol 79:247\u2013253", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2261", "doi-asserted-by": "crossref", "first-page": "485", "DOI": "10.1016/S0960-0760(03)00059-1", "volume": "84", "author": "AA Larionov", "year": "2003", "unstructured": "Larionov AA, Vasyliev DA, Mason JI, Howie AF, Berstein LM, Miller WR (2003) Aromatase in skeletal muscle. J Steroid Biochem Mol Biol 84:485\u2013492", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2262", "doi-asserted-by": "crossref", "first-page": "305", "DOI": "10.1002/cam4.85", "volume": "2", "author": "S Hata", "year": "2013", "unstructured": "Hata S, Miki Y, Saito R, Ishida K, Watanabe M, Sasano H (2013) Aromatase in human liver and its diseases. Cancer Med 2:305\u2013315", "journal-title": "Cancer Med"}, {"key": "9_CR2263", "doi-asserted-by": "crossref", "first-page": "33224", "DOI": "10.1074/jbc.M109.006064", "volume": "284", "author": "S Praporski", "year": "2009", "unstructured": "Praporski S, Ng SM, Nguyen AD, Corbin CJ, Mechler A, Zheng J, Conley AJ, Martin LL (2009) Organization of cytochrome P450 enzymes involved in sex steroid synthesis: protein-protein interactions in lipid membranes. J Biol Chem 284:33224\u201333232", "journal-title": "J Biol Chem"}, {"key": "9_CR2264", "doi-asserted-by": "crossref", "first-page": "1001", "DOI": "10.1016/0006-291X(92)92303-F", "volume": "189", "author": "N Harada", "year": "1992", "unstructured": "Harada N (1992) A unique aromatase (P-450AROM) mRNA formed by alternative use of tissue-specific exons 1 in human skin fibroblasts. Biochem Biophys Res Commun 189:1001\u20131007", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR2265", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1016/S0960-0760(03)00359-5", "volume": "86", "author": "SE Bulun", "year": "2003", "unstructured": "Bulun SE, Sebastian S, Takayama K, Suzuki T, Sasano H, Shozu M (2003) The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J Steroid Biochem Mol Biol 86:219\u2013224", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2266", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1016/S0960-0760(01)00157-1", "volume": "79", "author": "MM Hinshelwood", "year": "2001", "unstructured": "Hinshelwood MM, Mendelson CR (2001) Tissue-specific expression of the human CYP19 (aromatase) gene in ovary and adipose tissue of transgenic mice. J Steroid Biochem Mol Biol 79:193\u2013201", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2267", "doi-asserted-by": "crossref", "first-page": "2540", "DOI": "10.1210/jcem.87.6.8533", "volume": "87", "author": "M Shozu", "year": "2002", "unstructured": "Shozu M, Sumitani H, Segawa T, Yang HJ, Murakami K, Kasai T, Inoue M (2002) Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19). J Clin Endocrinol Metab 87:2540\u20132548", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2268", "doi-asserted-by": "crossref", "first-page": "2863", "DOI": "10.1210/endo.143.8.8932", "volume": "143", "author": "GL Rubin", "year": "2002", "unstructured": "Rubin GL, Duong JH, Clyne CD, Speed CJ, Murata Y, Gong C, Simpson ER (2002) Ligands for the peroxisomal proliferator-activated receptor gamma and the retinoid X receptor inhibit aromatase cytochrome P450 (CYP19) expression mediated by promoter II in human breast adipose. Endocrinology 143:2863\u20132871", "journal-title": "Endocrinology"}, {"key": "9_CR2269", "doi-asserted-by": "crossref", "first-page": "20591", "DOI": "10.1074/jbc.M201117200", "volume": "277", "author": "CD Clyne", "year": "2002", "unstructured": "Clyne CD, Speed CJ, Zhou J, Simpson ER (2002) Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes. J Biol Chem 277:20591\u201320597", "journal-title": "J Biol Chem"}, {"key": "9_CR2270", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1016/S0960-0760(01)00156-X", "volume": "79", "author": "A Kamat", "year": "2001", "unstructured": "Kamat A, Mendelson CR (2001) Identification of the regulatory regions of the human aromatase P450 (CYP19) gene involved in placenta-specific expression. J Steroid Biochem Mol Biol 79:173\u2013180", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2271", "doi-asserted-by": "crossref", "first-page": "3433", "DOI": "10.1074/jbc.M705409200", "volume": "283", "author": "K Subbaramaiah", "year": "2008", "unstructured": "Subbaramaiah K, Hudis C, Chang SH, Hla T, Dannenberg AJ (2008) EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange. J Biol Chem 283:3433\u20133444", "journal-title": "J Biol Chem"}, {"key": "9_CR2272", "doi-asserted-by": "crossref", "first-page": "4455", "DOI": "10.1158/0008-5472.CAN-07-3249", "volume": "68", "author": "I Kijima", "year": "2008", "unstructured": "Kijima I, Ye J, Glackin C, Chen S (2008) CCAAT/enhancer binding protein delta up-regulates aromatase promoters I.3/II in breast cancer epithelial cells. Cancer Res 68:4455\u20134464", "journal-title": "Cancer Res"}, {"key": "9_CR2273", "doi-asserted-by": "crossref", "first-page": "17711", "DOI": "10.1074/jbc.M109.009241", "volume": "284", "author": "H Odawara", "year": "2009", "unstructured": "Odawara H, Iwasaki T, Horiguchi J, Rokutanda N, Hirooka K, Miyazaki W, Koibuchi Y, Shimokawa N, Iino Y, Takeyoshi I, Koibuchi N (2009) Activation of aromatase expression by retinoic acid receptor-related orphan receptor (ROR\u03b1) in breast cancer cells: identification of a novel ROR response element. J Biol Chem 284:17711\u201317719", "journal-title": "J Biol Chem"}, {"key": "9_CR2274", "doi-asserted-by": "crossref", "first-page": "247", "DOI": "10.1530/JME-12-0129", "volume": "51", "author": "J Wilde", "year": "2013", "unstructured": "Wilde J, Erdmann M, Mertens M, Eiselt G, Schmidt M (2013) Aromatase activity induction in human adipose fibroblasts by retinoic acids via retinoic acid receptor alpha. J Mol Endocrinol 51:247\u2013260", "journal-title": "J Mol Endocrinol"}, {"key": "9_CR2275", "doi-asserted-by": "crossref", "first-page": "2365", "DOI": "10.1128/MCB.00672-09", "volume": "30", "author": "JH Jeong", "year": "2010", "unstructured": "Jeong JH, Jung YK, Kim HJ, Jin JS, Kim HN, Kang SM, Kim SY, van Wijnen AJ, Stein JL, Lian JB, Stein GS, Kato S, Choi JY (2010) The gene for aromatase, a rate-limiting enzyme for local estrogen biosynthesis, is a downstream target gene of Runx2 in skeletal tissues. Mol Cell Biol 30:2365\u20132375", "journal-title": "Mol Cell Biol"}, {"key": "9_CR2276", "doi-asserted-by": "crossref", "first-page": "443", "DOI": "10.1016/j.bbrc.2013.05.124", "volume": "436", "author": "M Nomura", "year": "2013", "unstructured": "Nomura M, Sakamoto R, Morinaga H, Wang L, Mukasa C, Takayanagi R (2013) Activin stimulates CYP19A gene expression in human ovarian granulosa cell-like KGN cells via the Smad2 signaling pathway. Biochem Biophys Res Commun 436:443\u2013448", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR2277", "doi-asserted-by": "crossref", "first-page": "e14389", "DOI": "10.1371/journal.pone.0014389", "volume": "5", "author": "NI Fleming", "year": "2010", "unstructured": "Fleming NI, Knower KC, Lazarus KA, Fuller PJ, Simpson ER, Clyne CD (2010) Aromatase is a direct target of FOXL2: C134W in granulosa cell tumors via a single highly conserved binding site in the ovarian specific promoter. PLoS One 5:e14389", "journal-title": "PLoS One"}, {"key": "9_CR2278", "doi-asserted-by": "crossref", "first-page": "2012", "DOI": "10.1210/en.2011-1626", "volume": "153", "author": "W Wang", "year": "2012", "unstructured": "Wang W, Li J, Ge Y, Li W, Shu Q, Guan H, Yang K, Myatt L, Sun K (2012) Cortisol induces aromatase expression in human placental syncytiotrophoblasts through the cAMP/Sp1 pathway. Endocrinology 153:2012\u20132022", "journal-title": "Endocrinology"}, {"key": "9_CR2279", "doi-asserted-by": "crossref", "first-page": "40", "DOI": "10.1016/j.bbamcr.2012.10.012", "volume": "1833", "author": "J Lundqvist", "year": "2013", "unstructured": "Lundqvist J, Hansen SK, Lykkesfeldt AE (2013) Vitamin D analog EB1089 inhibits aromatase expression by dissociation of comodulator WSTF from the CYP19A1 promoter-a new regulatory pathway for aromatase. Biochim Biophys Acta 1833:40\u201347", "journal-title": "Biochim Biophys Acta"}, {"key": "9_CR2280", "doi-asserted-by": "crossref", "first-page": "1183", "DOI": "10.1158/1940-6207.CAPR-12-0201", "volume": "5", "author": "K Subbaramaiah", "year": "2012", "unstructured": "Subbaramaiah K, Howe LR, Zhou XK, Yang P, Hudis CA, Kopelovich L, Dannenberg AJ (2012) Pioglitazone, a PPARgamma agonist, suppresses CYP19transcription: evidence for involvement of 15-hydroxyprostaglandin dehydrogenase and BRCA1. Cancer Prev Res 5:1183\u20131194", "journal-title": "Cancer Prev Res"}, {"key": "9_CR2281", "doi-asserted-by": "crossref", "first-page": "1169", "DOI": "10.1158/1940-6207.CAPR-12-0365", "volume": "5", "author": "O Margalit", "year": "2012", "unstructured": "Margalit O, Wang D, Dubois RN (2012) PPARgamma agonists target aromatase via both PGE2 and BRCA1. Cancer Prev Res 5:1169\u20131172", "journal-title": "Cancer Prev Res"}, {"key": "9_CR2282", "doi-asserted-by": "crossref", "first-page": "106", "DOI": "10.1016/j.mce.2013.05.018", "volume": "375", "author": "W Tan", "year": "2013", "unstructured": "Tan W, Wong TY, Wang Y, Huang J, Leung LK (2013) CYP19 expression is induced by 2,3,7,8-tetrachloro-dibenzo-p-dioxin in human glioma cells. Mol Cell Endocrinol 375:106\u2013112", "journal-title": "Mol Cell Endocrinol"}, {"key": "9_CR2283", "doi-asserted-by": "crossref", "first-page": "3301", "DOI": "10.1210/en.2008-1812", "volume": "150", "author": "H Wang", "year": "2009", "unstructured": "Wang H, Li R, Hu Y (2009) The alternative noncoding exons 1 of aromatase (Cyp19) gene modulate gene expression in a posttranscriptional manner. Endocrinology 150:3301\u20133307", "journal-title": "Endocrinology"}, {"key": "9_CR2284", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1016/j.fertnstert.2010.06.024", "volume": "95", "author": "M Izawa", "year": "2011", "unstructured": "Izawa M, Taniguchi F, Uegaki T, Takai E, Iwabe T, Terakawa N, Harada T (2011) Demethylation of a nonpromoter cytosine-phosphate-guanine island in the aromatase gene may cause the aberrant up-regulation in endometriotic tissues. Fertil Steril 95:33\u201339", "journal-title": "Fertil Steril"}, {"key": "9_CR2285", "doi-asserted-by": "crossref", "first-page": "87", "DOI": "10.1186/1471-2350-14-87", "volume": "14", "author": "JR Lewis", "year": "2013", "unstructured": "Lewis JR, McNab TJ, Liew LJ, Tan J, Hudson P, Wang JZ, Prince RL (2013) DNA methylation within the I.4 promoter region correlates with CYPl19A1 gene expression in human ex vivo mature omental and subcutaneous adipocytes. BMC Med Genet 14:87", "journal-title": "BMC Med Genet"}, {"key": "9_CR2286", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1023/A:1021112121782", "volume": "77", "author": "CA Haiman", "year": "2003", "unstructured": "Haiman CA, Hankinson SE, De Vivo I, Guillemette C, Ishibe N, Hunter DJ, Byrne C (2003) Polymorphisms in steroid hormone pathway genes and mammographic density. Breast Cancer Res Treat 77:27\u201336", "journal-title": "Breast Cancer Res Treat"}, {"key": "9_CR2287", "doi-asserted-by": "crossref", "first-page": "414", "DOI": "10.1038/ncpendmet0477", "volume": "3", "author": "ME Jones", "year": "2007", "unstructured": "Jones ME, Boon WC, McInnes K, Maffei L, Carani C, Simpson ER (2007) Recognizing rare disorders: aromatase deficiency. Nat Clin Pract Endocrinol Metab 3:414\u2013421", "journal-title": "Nat Clin Pract Endocrinol Metab"}, {"key": "9_CR2288", "doi-asserted-by": "crossref", "first-page": "2998", "DOI": "10.1210/jc.2008-2309", "volume": "94", "author": "EJ Payne", "year": "2009", "unstructured": "Payne EJ, Ingley E, Dick IM, Wilson SG, Bond CS, Prince RL (2009) In vitro kinetic properties of the Thr201Met variant of human aromatase gene CYP19A1: functional responses to substrate and product inhibition and enzyme inhibitors. J Clin Endocrinol Metab 94:2998\u20133002", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2289", "unstructured": "Akhtar M, Corina D, Pratt J, Smith T (1976) Studies on the removal of C-19 in oestrogen biosynthesis using 18O2. J Chem Soc Chem Commun 854\u2013856", "DOI": "10.1039/c39760000854", "doi-asserted-by": "crossref"}, {"key": "9_CR2290", "doi-asserted-by": "crossref", "first-page": "4410", "DOI": "10.1021/bi00180a039", "volume": "33", "author": "M Akhtar", "year": "1994", "unstructured": "Akhtar M, Corina D, Miller S, Shyadehi AZ, Wright JN (1994) Mechanism of the acyl-carbon cleavage and related reactions catalyzed by multifunctional P-450s: studies on cytochrome P45017\u03b1. Biochemistry 33:4410\u20134418", "journal-title": "Biochemistry"}, {"key": "9_CR2291", "doi-asserted-by": "crossref", "first-page": "1284", "DOI": "10.1021/ja00212a043", "volume": "110", "author": "PA Cole", "year": "1988", "unstructured": "Cole PA, Robinson CH (1988) A peroxide model reaction for placental aromatase. J Am Chem Soc 110:1284\u20131285", "journal-title": "J Am Chem Soc"}, {"key": "9_CR2292", "doi-asserted-by": "crossref", "first-page": "8963", "DOI": "10.1073/pnas.88.20.8963", "volume": "88", "author": "ES Roberts", "year": "1991", "unstructured": "Roberts ES, Vaz ADN, Coon MJ (1991) Catalysis by cytochrome P-450 of an oxidative reaction in xenobiotic aldehyde metabolism: deformylation with olefin formation. Proc Natl Acad Sci U S A 88:8963\u20138966", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR2293", "doi-asserted-by": "crossref", "first-page": "1107", "DOI": "10.1016/S0047-6374(01)00394-3", "volume": "123", "author": "R Takayanagi", "year": "2002", "unstructured": "Takayanagi R, Goto K, Suzuki S, Tanaka S, Shimoda S, Nawata H (2002) Dehydroepiandrosterone (DHEA) as a possible source for estrogen formation in bone cells: correlation between bone mineral density and serum DHEA-sulfate concentration in postmenopausal women, and the presence of aromatase to be enhanced by 1,25-dihydroxyvitamin D3 in human osteoblasts. Mech Ageing Dev 123:1107\u20131114", "journal-title": "Mech Ageing Dev"}, {"key": "9_CR2294", "doi-asserted-by": "crossref", "first-page": "10839", "DOI": "10.1021/bi0508744", "volume": "44", "author": "M Numazawa", "year": "2005", "unstructured": "Numazawa M, Nagaoka M, Sohtome N (2005) Aromatase reaction of 3-deoxyandrogens: steric mode of the C-19 oxygenation and cleavage of the C10-C19 bond by human placental aromatase. Biochemistry 44:10839\u201310845", "journal-title": "Biochemistry"}, {"key": "9_CR2295", "doi-asserted-by": "crossref", "first-page": "15016", "DOI": "10.1021/ja508185d", "volume": "136", "author": "FK Yoshimoto", "year": "2014", "unstructured": "Yoshimoto FK, Guengerich FP (2014) Mechanism of the third oxidative step in the conversion of androgens to estrogens by cytochrome P450 19A1 steroid aromatase, J Am Chem Soc 136:15016\u201315025", "journal-title": "J Am Chem Soc"}, {"key": "9_CR2296", "doi-asserted-by": "crossref", "first-page": "2941", "DOI": "10.1210/endo-129-6-2941", "volume": "129", "author": "WM Garrett", "year": "1991", "unstructured": "Garrett WM, Hoover DJ, Shackleton CH, Anderson LD (1991) Androgen metabolism by porcine granulosa cells during the process of luteinization in vitro: identification of 19-oic-androstenedione as a major metabolite and possible precursor for the formation of C18 neutral steroids. Endocrinology 129:2941\u20132950", "journal-title": "Endocrinology"}, {"key": "9_CR2297", "doi-asserted-by": "crossref", "first-page": "106", "DOI": "10.1093/oxfordjournals.jbchem.a122213", "volume": "103", "author": "N Harada", "year": "1988", "unstructured": "Harada N (1988) Novel properties of human placental aromatase as cytochrome P-450: purification and characterization of a unique form of aromatase. J Biochem (Tokyo) 103:106\u2013113", "journal-title": "J Biochem (Tokyo)"}, {"key": "9_CR2298", "doi-asserted-by": "crossref", "first-page": "469", "DOI": "10.1016/0960-0760(93)90252-R", "volume": "44", "author": "Y Osawa", "year": "1993", "unstructured": "Osawa Y, Higashiyama T, Shimizu Y, Yarborough C (1993) Multiple functions of aromatase and the active sitestructure; aromatase is the placental estrogen 2-hydroxylase. J Steroid Biochem Mol Biol 44:469\u2013480", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2299", "doi-asserted-by": "crossref", "first-page": "1847", "DOI": "10.1021/ja00268a023", "volume": "108", "author": "E Caspi", "year": "1986", "unstructured": "Caspi E, Arunachalam T, Nelson PA (1986) Biosynthesis of estrogens: aromatization of (19R)-, (19S)-, and (19S)-[19-3H,2H,1H]-3\u03b2-hydroxyandrost-5-en-17-ones by human placental aromatase. J Am Chem Soc 108:1847\u20131852", "journal-title": "J Am Chem Soc"}, {"key": "9_CR2300", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1016/0039-128X(83)90058-2", "volume": "50", "author": "Y Osawa", "year": "1987", "unstructured": "Osawa Y, Yoshida N, Fronckowiak M, Kitawaki J (1987) Immunoaffinity purification of aromatase cytochrome P-450 from human placental microsomes, metabolic switching from aromatization to 1\u03b2 and 2\u03b2-monohydroxylation, and recognition of aromatase isozymes. Steroids 50:11\u201328", "journal-title": "Steroids"}, {"key": "9_CR2301", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1016/j.bbrc.2008.05.011", "volume": "372", "author": "YV Grinkova", "year": "2008", "unstructured": "Grinkova YV, Denisov IG, Waterman MR, Arase M, Kagawa N, Sligar SG (2008) The ferrous-oxy complex of human aromatase. Biochem Biophys Res Commun 372:379\u2013382", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR2302", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1016/j.bbrc.2009.06.154", "volume": "387", "author": "SL Gantt", "year": "2009", "unstructured": "Gantt SL, Denisov IG, Grinkova YV, Sligar SG (2009) The critical iron-oxygen intermediate in human aromatase. Biochem Biophys Res Commun 387:169\u2013173", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR2303", "first-page": "4472", "volume": "256", "author": "J Fishman", "year": "1981", "unstructured": "Fishman J, Raju MS (1981) Mechanism of estrogen biosynthesis. Stereochemistry of C-1 hydrogen elimination in the aromatization of 2\u03b2-hydroxy-19-oxoandrostenedione. J Biol Chem 256:4472\u20134477", "journal-title": "J Biol Chem"}, {"key": "9_CR2304", "first-page": "3277s", "volume": "42", "author": "J Fishman", "year": "1982", "unstructured": "Fishman J (1982) Biochemical mechanism of aromatization. Cancer Res 42:3277s-3280s", "journal-title": "Cancer Res"}, {"key": "9_CR2305", "doi-asserted-by": "crossref", "first-page": "569", "DOI": "10.1042/bj2010569", "volume": "201", "author": "M Akhtar", "year": "1982", "unstructured": "Akhtar M, Calder MR, Corina DL, Wright JN (1982) Mechanistic studies on C-19 demethylation in oestrogen biocynthesis. Biochem J 201:569\u2013580", "journal-title": "Biochem J"}, {"key": "9_CR2306", "doi-asserted-by": "crossref", "first-page": "6987", "DOI": "10.1021/ja00361a055", "volume": "105", "author": "E Caspi", "year": "1983", "unstructured": "Caspi E, Arunachalam T, Nelson PA (1983) Biosynthesis of estrogens: the steric mode of the initial C-19 hydroxylation of androgens by human placental aromatase. J Am Chem Soc 105:6987\u20136989", "journal-title": "J Am Chem Soc"}, {"key": "9_CR2307", "doi-asserted-by": "crossref", "first-page": "2933", "DOI": "10.1021/jm00173a001", "volume": "33", "author": "PA Cole", "year": "1990", "unstructured": "Cole PA, Robinson CH (1990) Mechanism and inhibition of cytochrome P-450 aromatase. J Med Chem 33:2933\u20132942", "journal-title": "J Med Chem"}, {"key": "9_CR2308", "doi-asserted-by": "crossref", "first-page": "5224", "DOI": "10.1021/ja044716w", "volume": "127", "author": "JC Hackett", "year": "2005", "unstructured": "Hackett JC, Brueggemeier RW, Hadad CM (2005) The final catalytic step of cytochrome P450 aromatase: a density functional theory study. J Am Chem Soc 127:5224\u20135237", "journal-title": "J Am Chem Soc"}, {"key": "9_CR2309", "doi-asserted-by": "crossref", "first-page": "3039", "DOI": "10.1021/bi300017p", "volume": "51", "author": "K Sen", "year": "2012", "unstructured": "Sen K, Hackett JC (2012) Coupled electron transfer and proton hopping in the final step of CYP19-catalyzed androgen aromatization. Biochemistry 51:3039\u20133049", "journal-title": "Biochemistry"}, {"key": "9_CR2310", "doi-asserted-by": "crossref", "first-page": "7282", "DOI": "10.1021/ja00335a090", "volume": "106", "author": "E Caspi", "year": "1984", "unstructured": "Caspi E, Wicha J, Arunachalam T, Nelson P, Spiteller G (1984) Estrogen biosynthesis: concerning the obligatory intermediacy of 2\u03b2-hydroxy-10\u03b2-formyl androst-4-ene-3,17-dione. J Am Chem Soc 106:7282\u20137283", "journal-title": "J Am Chem Soc"}, {"key": "9_CR2311", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1021/bi00841a005", "volume": "7", "author": "JD Townsley", "year": "1968", "unstructured": "Townsley JD, Brodie HJ (1968) Studies on the mechanism of estrogen biosynthesis 3. The stereochemistry of aromatization of C19 and C18 steroids. Biochemistry 7:33\u201340", "journal-title": "Biochemistry"}, {"key": "9_CR2312", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1016/0039-128X(87)90025-0", "volume": "50", "author": "DF Covey", "year": "1987", "unstructured": "Covey DF, Carrell HL, Beusen DD (1987) Metabolism of 19-methyl substituted steroids and a proposal for the third aromatase monooxygenation. Steroids 50:363\u2013374", "journal-title": "Steroids"}, {"key": "9_CR2313", "doi-asserted-by": "crossref", "first-page": "2", "DOI": "10.1016/j.jsbmb.2010.11.003", "volume": "125", "author": "M Akhtar", "year": "2011", "unstructured": "Akhtar M, Wright JN, Lee-Robichaud P (2011) A review of mechanistic studies on aromatase (CYP19) and 17\u03b1-hydroxylase-17,20-lyase (CYP17). J Steroid Biochem Mol Biol 125:2\u201312", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2314", "first-page": "1689", "volume": "259", "author": "EF Hahn", "year": "1984", "unstructured": "Hahn EF, Fishman J (1984) Immunological probe of estrogenbiosynthesis. Evidence for the 2\u03b2-hydroxylative pathway in aromatization of androgens. J Biol Chem 259:1689\u20131694", "journal-title": "J Biol Chem"}, {"key": "9_CR2315", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1016/0039-128X(87)90024-9", "volume": "50", "author": "E Caspi", "year": "1987", "unstructured": "Caspi E, Njar VC (1987) Concerning the pathway from 19-oxoandrost-4-ene-3,17-dione to estrone. Steroids 50:347\u2013362", "journal-title": "Steroids"}, {"key": "9_CR2316", "doi-asserted-by": "crossref", "first-page": "7325", "DOI": "10.1021/ja00830a025", "volume": "96", "author": "H Hosoda", "year": "1974", "unstructured": "Hosoda H, Fishman J (1974) Unusually facile aromatization of 2\u03b2-hydroxy-19-oxo-4-androstene-3,17-dione to estrone. Implications in estrogen biosynthesis. J Am Chem Soc 96:7325\u20137329", "journal-title": "J Am Chem Soc"}, {"key": "9_CR2317", "doi-asserted-by": "crossref", "first-page": "635", "DOI": "10.1021/bi00674a027", "volume": "14", "author": "P Morand", "year": "1975", "unstructured": "Morand P, Williamson DG, Layne DS, Lompa-Krzymien L, Salvador J (1975) Conversion of an androgen epoxide into 17\u03b2-estradiol by human placental microsomes. Biochemistry 14:635\u2013638", "journal-title": "Biochemistry"}, {"key": "9_CR2318", "doi-asserted-by": "crossref", "first-page": "8130", "DOI": "10.1021/ja00021a044", "volume": "113", "author": "PA Cole", "year": "1991", "unstructured": "Cole PA, Robinson CH (1991) Mechanistic studies on a placental aromatase model reaction. J Am Chem Soc 113:8130\u20138137", "journal-title": "J Am Chem Soc"}, {"key": "9_CR2319", "doi-asserted-by": "crossref", "first-page": "553", "DOI": "10.1042/bj2680553", "volume": "268", "author": "PA Cole", "year": "1990", "unstructured": "Cole PA, Robinson CH (1990) Conversion of 19-oxo[2\u03b2-2H]androgens into estrogens by human placental aromatase. An unexpected stereochemical outcome. Biochem J 268:553\u2013561", "journal-title": "Biochem J"}, {"key": "9_CR2320", "doi-asserted-by": "crossref", "first-page": "13651", "DOI": "10.1021/bi00250a015", "volume": "33", "author": "ADN Vaz", "year": "1994", "unstructured": "Vaz ADN, Kessell KJ, Coon MJ (1994) Aromatization of a bicyclic steroid analog, 3-oxodecalin-4-ene-10-carboxaldehyde, by liver microsomal cytochrome P450 2B4. Biochemistry 33:13651\u201313661", "journal-title": "Biochemistry"}, {"key": "9_CR2321", "doi-asserted-by": "crossref", "first-page": "5886", "DOI": "10.1021/ja00015a066", "volume": "113", "author": "ADN Vaz", "year": "1991", "unstructured": "Vaz ADN, Roberts ES, Coon MJ (1991) Olefin formation in the oxidative deformylation of aldehydes by cytochrome P-450. Mechanistic implications for catalysis by oxygen-derived peroxide. J Am Chem Soc 113:5886\u20135887", "journal-title": "J Am Chem Soc"}, {"key": "9_CR2322", "doi-asserted-by": "crossref", "first-page": "2157", "DOI": "10.1210/en.2003-1595", "volume": "145", "author": "CJ Corbin", "year": "2004", "unstructured": "Corbin CJ, Mapes SM, Marcos J, Shackleton CH, Morrow D, Safe S, Wise T, Ford JJ, Conley AJ (2004) Paralogues of porcine aromatase cytochrome P450: a novel hydroxylase activity is associated with the survival of a duplicated gene. Endocrinology 145:2157\u20132164", "journal-title": "Endocrinology"}, {"key": "9_CR2323", "doi-asserted-by": "crossref", "first-page": "1317", "DOI": "10.1016/S0006-2952(02)01361-8", "volume": "64", "author": "F Zhang", "year": "2002", "unstructured": "Zhang F, Zhou D, Kao YC, Ye J, Chen S (2002) Expression and purification of a recombinant form of human aromatase from Escherichia coli. Biochem Pharmacol 64:1317\u20131324", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR2324", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1016/S0039-128X(02)00168-X", "volume": "68", "author": "N Kagawa", "year": "2003", "unstructured": "Kagawa N, Cao Q, Kusano K (2003) Expression of human aromatase (CYP19) in Escherichia coliby N-terminal replacement and induction of cold stress response. Steroids 68:205\u2013209", "journal-title": "Steroids"}, {"key": "9_CR2325", "doi-asserted-by": "crossref", "first-page": "5821", "DOI": "10.1021/bi400669h", "volume": "52", "author": "J Lo", "year": "2013", "unstructured": "Lo J, Di Nardo G, Griswold J, Egbuta C, Jiang W, Gilardi G, Ghosh D (2013) Structural basis for the functional roles of critical residues in human cytochrome P450 aromatase. Biochemistry 52:5821\u20135829", "journal-title": "Biochemistry"}, {"key": "9_CR2326", "first-page": "11939", "volume": "266", "author": "S Graham-Lorence", "year": "1991", "unstructured": "Graham-Lorence S, Khalil MW, Lorence MC, Mendelson CR, Simpson ER (1991) Structure-function relationships of human aromatase cytochrome P-450 using molecular modeling and site-directed mutagenesis. J Biol Chem 266:11939\u201311946", "journal-title": "J Biol Chem"}, {"key": "9_CR2327", "doi-asserted-by": "crossref", "first-page": "1456", "DOI": "10.1210/mend.16.7.0876", "volume": "16", "author": "A Conley", "year": "2002", "unstructured": "Conley A, Mapes S, Corbin CJ, Greger D, Graham S (2002) Structural determinants of aromatase cytochrome P450 inhibition in substrate recognition site-1. Mol Endocrinol 16:1456\u20131468", "journal-title": "Mol Endocrinol"}, {"key": "9_CR2328", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1038/nature07614", "volume": "457", "author": "D Ghosh", "year": "2009", "unstructured": "Ghosh D, Griswold J, Erman M, Pangborn W (2009) Structural basis for androgen specificity and oestrogen synthesis in human aromatase. Nature 457:219\u2013223", "journal-title": "Nature"}, {"key": "9_CR2329", "doi-asserted-by": "crossref", "first-page": "8464", "DOI": "10.1021/jm300930n", "volume": "55", "author": "D Ghosh", "year": "2012", "unstructured": "Ghosh D, Lo J, Morton D, Valette D, Xi J, Griswold J, Hubbell S, Egbuta C, Jiang W, An J, Davies HM (2012) Novel aromatase inhibitors by structure-guided design. J Med Chem 55:8464\u20138476", "journal-title": "J Med Chem"}, {"issue": "Suppl 2", "key": "9_CR2330", "first-page": "1", "volume": "22", "author": "T Hakulinen", "year": "2006", "unstructured": "Hakulinen T, Untch M, Farmer R (2006) What is new in breast cancer? The expanding role of aromatase inhibitors. Gynecol Endocrinol 22(Suppl 2):1\u201313", "journal-title": "Gynecol Endocrinol"}, {"key": "9_CR2331", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1196/annals.1386.022", "volume": "1089", "author": "Y Hong", "year": "2006", "unstructured": "Hong Y, Chen S (2006) Aromatase inhibitors: structural features and biochemical characterization. Ann N Y Acad Sci 1089:237\u2013251", "journal-title": "Ann N Y Acad Sci"}, {"issue": "Suppl 2", "key": "9_CR2332", "first-page": "S", "volume": "24", "author": "S Hong", "year": "2009", "unstructured": "Hong S, Didwania A, Olopade O, Ganschow P (2009) The expanding use of third-generation aromatase inhibitors: what the general internist needs to know. J Gen Int Med 24(Suppl 2):S383\u2013388", "journal-title": "J Gen Int Med"}, {"key": "9_CR2333", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1016/j.jsbmb.2009.11.009", "volume": "118", "author": "RW Brueggemeier", "year": "2010", "unstructured": "Brueggemeier RW, Su B, Darby MV, Sugimoto Y (2010) Selective regulation of aromatase expression for drug discovery. J Steroid Biochem Mol Biol 118:207\u2013210", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2334", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1016/j.urolonc.2008.07.036", "volume": "27", "author": "A Brodie", "year": "2009", "unstructured": "Brodie A, Njar V, Macedo LF, Vasaitis TS, Sabnis G (2009) The coffey lecture: steroidogenic enzyme inhibitors and hormone dependent cancer. Urol Oncol 27:53\u201363", "journal-title": "Urol Oncol"}, {"key": "9_CR2335", "doi-asserted-by": "crossref", "first-page": "343", "DOI": "10.1210/er.2008-0016", "volume": "30", "author": "RJ Santen", "year": "2009", "unstructured": "Santen RJ, Brodie H, Simpson ER, Siiteri PK, Brodie A (2009) History of aromatase: Saga of an important biological mediator and therapeutic target. Endocr Rev 30:343\u2013375", "journal-title": "Endocr Rev"}, {"key": "9_CR2336", "doi-asserted-by": "crossref", "first-page": "1864", "DOI": "10.1002/cncr.10844", "volume": "95", "author": "MR Smith", "year": "2002", "unstructured": "Smith MR, Kaufman D, George D, Oh WK, Kazanis M, Manola J, Kantoff PW (2002) Selective aromatase inhibition for patients with androgen-independent prostate carcinoma. Cancer 95:1864\u20131868", "journal-title": "Cancer"}, {"key": "9_CR2337", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.1586/14737140.2.2.181", "volume": "2", "author": "RW Brueggemeier", "year": "2002", "unstructured": "Brueggemeier RW (2002) Aromatase inhibitors in breast cancer therapy. Exp Rev Anticancer Ther 2:181\u2013191", "journal-title": "Exp Rev Anticancer Ther"}, {"key": "9_CR2338", "doi-asserted-by": "crossref", "first-page": "326", "DOI": "10.1016/S0925-4439(02)00096-0", "volume": "1587", "author": "P Lombardi", "year": "2002", "unstructured": "Lombardi P (2002) Exemestane, a new steroidal aromatase inhibitor of clinical relevance. Biochim Biophys Acta 1587:326\u2013337", "journal-title": "Biochim Biophys Acta"}, {"key": "9_CR2339", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1007/s101470200038", "volume": "7", "author": "PE Lonning", "year": "2002", "unstructured": "Lonning PE (2002) The role of aromatase inactivators in the treatment of breast cancer. Int J Clin Oncol 7:265\u2013270", "journal-title": "Int J Clin Oncol"}, {"issue": "Suppl 6", "key": "9_CR2340", "first-page": "S", "volume": "38", "author": "PE Lonning", "year": "2002", "unstructured": "Lonning PE (2002) Aromatase inhibitors and inactivators for breast cancer treatment. Eur J Cancer 38(Suppl 6):S47\u201348", "journal-title": "Eur J Cancer"}, {"key": "9_CR2341", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.3816/CBC.2000.n.017", "volume": "1", "author": "SA Jones", "year": "2000", "unstructured": "Jones SA, Jones SE (2000) Exemestane: a novel aromatase inactivator for breast cancer. Clin Breast Cancer 1:211\u2013216", "journal-title": "Clin Breast Cancer"}, {"key": "9_CR2342", "first-page": "611", "volume": "8", "author": "RJ Lee", "year": "2012", "unstructured": "Lee RJ, Armstrong AC, Wardley AM (2012) Letrozole: advancing hormone therapy in breast cancer. Womens Health 8:611\u2013618", "journal-title": "Womens Health"}, {"key": "9_CR2343", "doi-asserted-by": "crossref", "first-page": "401", "DOI": "10.1210/me.2006-0281", "volume": "21", "author": "Y Hong", "year": "2007", "unstructured": "Hong Y, Yu B, Sherman M, Yuan YC, Zhou D, Chen S (2007) Molecular basis for the aromatization reaction and exemestane-mediated irreversible inhibition of human aromatase. Mol Endocrinol 21:401\u2013414", "journal-title": "Mol Endocrinol"}, {"key": "9_CR2344", "doi-asserted-by": "crossref", "first-page": "5347", "DOI": "10.1021/jm100319h", "volume": "53", "author": "S Gobbi", "year": "2010", "unstructured": "Gobbi S, Zimmer C, Belluti F, Rampa A, Hartmann RW, Recanatini M, Bisi A (2010) Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation. J Med Chem 53:5347\u20135351", "journal-title": "J Med Chem"}, {"key": "9_CR2345", "doi-asserted-by": "crossref", "first-page": "4006", "DOI": "10.1021/jm2000689", "volume": "54", "author": "F Caporuscio", "year": "2011", "unstructured": "Caporuscio F, Rastelli G, Imbriano C, Del Rio A (2011) Structure-based design of potent aromatase inhibitorsby high-throughput docking. J Med Chem 54:4006\u20134017", "journal-title": "J Med Chem"}, {"key": "9_CR2346", "doi-asserted-by": "crossref", "first-page": "662", "DOI": "10.1016/j.steroids.2013.02.016", "volume": "78", "author": "CL Varela", "year": "2013", "unstructured": "Varela CL, Amaral C, Correia-da-Silva G, Carvalho RA, Teixeira NA, Costa SC, Roleira FM, Tavares-da-Silva EJ (2013) Design, synthesis and biochemical studies of new 7\u03b1-allylandrostanes as aromatase inhibitors. Steroids 78:662\u2013669", "journal-title": "Steroids"}, {"key": "9_CR2347", "doi-asserted-by": "crossref", "first-page": "661", "DOI": "10.1007/s11030-013-9462-x", "volume": "17", "author": "C Nantasenamat", "year": "2013", "unstructured": "Nantasenamat C, Li H, Mandi P, Worachartcheewan A, Monnor T, Isarankura-Na-Ayudhya C, Prachayasittikul V (2013) Exploring the chemical space of aromatase inhibitors. Mol Divers 17:661\u2013677", "journal-title": "Mol Divers"}, {"key": "9_CR2348", "doi-asserted-by": "crossref", "first-page": "7536", "DOI": "10.1021/jm400377z", "volume": "56", "author": "MG Ferlin", "year": "2013", "unstructured": "Ferlin MG, Carta D, Bortolozzi R, Ghodsi R, Chimento A, Pezzi V, Moro S, Hanke N, Hartmann RW, Basso G, Viola G (2013) Design, synthesis, and structure-activity relationships of azolylmethylpyrroloquinolines as nonsteroidal aromatase inhibitors. J Med Chem 56:7536\u20137551", "journal-title": "J Med Chem"}, {"key": "9_CR2349", "doi-asserted-by": "crossref", "first-page": "6060", "DOI": "10.1016/j.bmcl.2013.09.030", "volume": "23", "author": "J McNulty", "year": "2013", "unstructured": "McNulty J, Nielsen AJ, Brown CE, DiFrancesco BR, Vurgun N, Nair JJ, Crankshaw DJ, Holloway AC (2013) Investigation of aryl halides as ketone bioisosteres: refinement of potent and selective inhibitors of human cytochrome P450 19A1 (aromatase). Bioorg Med Chem Lett 23:6060\u20136063", "journal-title": "Bioorg Med Chem Lett"}, {"key": "9_CR2350", "doi-asserted-by": "crossref", "first-page": "56", "DOI": "10.1097/GCO.0b013e328334e44e", "volume": "22", "author": "JE Mortimer", "year": "2010", "unstructured": "Mortimer JE (2010) Managing the toxicities of the aromatase inhibitors. Curr Opin Obstetr Gynecol 22:56\u201360", "journal-title": "Curr Opin Obstetr Gynecol"}, {"key": "9_CR2351", "doi-asserted-by": "crossref", "first-page": "600", "DOI": "10.1002/ijc.10878", "volume": "103", "author": "G Winnett", "year": "2003", "unstructured": "Winnett G, van Hagen D, Schrey M (2003) Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy. Int J Cancer 103:600\u2013605", "journal-title": "Int J Cancer"}, {"key": "9_CR2352", "doi-asserted-by": "crossref", "first-page": "2859", "DOI": "10.1016/S0960-894X(02)00565-6", "volume": "12", "author": "C Pouget", "year": "2002", "unstructured": "Pouget C, Fagnere C, Basly JP, Habrioux G, Chulia AJ (2002) Design, synthesis and evaluation of 4-imidazolylflavans as new leads for aromatase inhibition. Bioorg Med Chem Lett 12:2859\u20132861", "journal-title": "Bioorg Med Chem Lett"}, {"key": "9_CR2353", "doi-asserted-by": "crossref", "first-page": "1191", "DOI": "10.1007/s10549-012-2010-z", "volume": "133", "author": "R Ferraldeschi", "year": "2012", "unstructured": "Ferraldeschi R, Arnedos M, Hadfield KD, A\u2019Hern R, Drury S, Wardley A, Howell A, Evans DG, Roberts SA, Smith I, Newman WG, Dowsett M (2012) Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients. Breast Cancer Res Treat 133:1191\u20131198", "journal-title": "Breast Cancer Res Treat"}, {"key": "9_CR2354", "first-page": "126", "volume": "61", "author": "I Czajka-Oraniec", "year": "2010", "unstructured": "Czajka-Oraniec I, Simpson ER (2010) Aromatase research and its clinical significance. Endokrynol Polska 61:126\u2013134", "journal-title": "Endokrynol Polska"}, {"key": "9_CR2355", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1016/S0303-7207(02)00090-4", "volume": "193", "author": "Y Murata", "year": "2002", "unstructured": "Murata Y, Robertson KM, Jones ME, Simpson ER (2002) Effect of estrogen deficiency in the male: the ArKO mouse model. Mol Cell Endocrinol 193:7\u201312", "journal-title": "Mol Cell Endocrinol"}, {"key": "9_CR2356", "doi-asserted-by": "crossref", "first-page": "129", "DOI": "10.4274/Jcrpe.970", "volume": "5", "author": "EK Baykan", "year": "2013", "unstructured": "Baykan EK, Erdogan M, Ozen S, Darcan S, Saygili LF (2013) Aromatase deficiency, a rare syndrome: case report. J Clin Res Pediatr Endocrinol 5:129\u2013132", "journal-title": "J Clin Res Pediatr Endocrinol"}, {"key": "9_CR2357", "doi-asserted-by": "crossref", "first-page": "5476", "DOI": "10.1210/jc.2002-020498", "volume": "87", "author": "BL Herrmann", "year": "2002", "unstructured": "Herrmann BL, Saller B, Janssen OE, Gocke P, Bockisch A, Sperling H, Mann K, Broecker M (2002) Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. J Clin Endocrinol Metab 87:5476\u20135484", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2358", "first-page": "145", "volume": "57", "author": "U Meinhardt", "year": "2002", "unstructured": "Meinhardt U, Mullis PE (2002) The aromatase cytochrome P-450 and its clinical impact. Horm Res 57:145\u2013152", "journal-title": "Horm Res"}, {"key": "9_CR2359", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.1016/S0960-0760(01)00158-3", "volume": "79", "author": "KL Britt", "year": "2001", "unstructured": "Britt KL, Drummond AE, Dyson M, Wreford NG, Jones ME, Simpson ER, Findlay JK (2001) The ovarian phenotype of the aromatase knockout (ArKO) mouse. J Steroid Biochem Mol Biol 79:181\u2013185", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2360", "doi-asserted-by": "crossref", "first-page": "9104", "DOI": "10.1523/JNEUROSCI.22-20-09104.2002", "volume": "22", "author": "J Bakker", "year": "2002", "unstructured": "Bakker J, Honda S, Harada N, Balthazart J (2002) The aromatase knock-out mouse provides new evidence that estradiolis required during development in the female for the expression of sociosexual behaviors in adulthood. J Neurosci 22:9104\u20139112", "journal-title": "J Neurosci"}, {"key": "9_CR2361", "doi-asserted-by": "crossref", "first-page": "E1035", "DOI": "10.1210/jc.2011-0145", "volume": "96", "author": "M Fukami", "year": "2011", "unstructured": "Fukami M, Shozu M, Soneda S, Kato F, Inagaki A, Takagi H, Hanaki K, Kanzaki S, Ohyama K, Sano T, Nishigaki T, Yokoya S, Binder G, Horikawa R, Ogata T (2011) Aromatase excess syndrome: identification of cryptic duplications and deletions leading to gain of function of CYP19A1 and assessment of phenotypic determinants. J Clin Endocrinol Metab 96:E1035\u2013E1043", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2362", "doi-asserted-by": "crossref", "first-page": "112", "DOI": "10.1007/978-0-387-78818-0_8", "volume": "630", "author": "SE Bulun", "year": "2008", "unstructured": "Bulun SE, Simpson ER (2008) Aromatase expression in women\u2019s cancers. Adv Exp Med Biol 630:112\u2013132", "journal-title": "Adv Exp Med Biol"}, {"key": "9_CR2363", "first-page": "509", "volume": "28", "author": "M Dowsett", "year": "2010", "unstructured": "Dowsett M, Cuzick J, Ingle J, Coates A, Forbes J, Bliss J, Buyse M, Baum M, Buzdar A, Colleoni M, Coombes C, Snowdon C, Gnant M, Jakesz R, Kaufmann M, Boccardo F, Godwin J, Davies C, Peto R (2010) Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol 28:509\u2013518", "journal-title": "J"}, {"key": "9_CR2364", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1586/14737175.5.1.123", "volume": "5", "author": "C Harden", "year": "2005", "unstructured": "Harden C, MacLusky NJ (2005) Aromatase inhibitors as add-on treatment for men with epilepsy. Exp Rev Neurother 5:123\u2013127", "journal-title": "Exp Rev Neurother"}, {"key": "9_CR2365", "first-page": "2", "volume": "2", "author": "J Cernich", "year": "2004", "unstructured": "Cernich J, Jacobson JD, Moore WV, Popovic J (2004) Use of aromatase inhibitors in children with short stature. Pediatr Endocrinol Rev 2:2\u20137", "journal-title": "Pediatr Endocrinol Rev"}, {"key": "9_CR2366", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1038/nrendo.2011.161", "volume": "8", "author": "JM Wit", "year": "2012", "unstructured": "Wit JM, Hero M, Nunez SB (2012) Aromatase inhibitors in pediatrics. Nat Rev Endocrinol 8:135\u2013147", "journal-title": "Nat Rev Endocrinol"}, {"key": "9_CR2367", "first-page": "1370", "volume": "98", "author": "ME Pavone", "year": "2012", "unstructured": "Pavone ME, Bulun SE (2012) Aromatase inhibitors for the treatment of endometriosis. Fertil Steril 98:1370\u20131379", "journal-title": "Fertil"}, {"key": "9_CR2368", "doi-asserted-by": "crossref", "first-page": "1359", "DOI": "10.1016/j.fertnstert.2012.10.023", "volume": "98", "author": "PN Schlegel", "year": "2012", "unstructured": "Schlegel PN (2012) Aromatase inhibitors for male infertility. Fertil Steril 98:1359\u20131362", "journal-title": "Fertil Steril"}, {"key": "9_CR2369", "doi-asserted-by": "crossref", "first-page": "1352", "DOI": "10.1016/j.fertnstert.2012.10.008", "volume": "98", "author": "RF Casper", "year": "2012", "unstructured": "Casper RF, Mitwally MF (2012) A historical perspective of aromatase inhibitors for ovulation induction. Fertil Steril 98:1352\u20131355", "journal-title": "Fertil Steril"}, {"key": "9_CR2370", "doi-asserted-by": "crossref", "first-page": "1443", "DOI": "10.1093/annonc/mdt037", "volume": "24", "author": "P Niravath", "year": "2013", "unstructured": "Niravath P (2013) Aromatase inhibitor-induced arthralgia: a review. Ann Oncol 24:1443\u20131449", "journal-title": "Ann Oncol"}, {"key": "9_CR2371", "doi-asserted-by": "crossref", "first-page": "1911", "DOI": "10.1016/S0959-8049(02)00149-1", "volume": "38", "author": "EN Suspitsin", "year": "2002", "unstructured": "Suspitsin EN, Grigoriev MY, Togo AV, Kuligina ES, Belogubova EV, Pozharisski KM, Chagunava OL, Sokolov EP, Theillet C, Berstein LM, Hanson KP, Imyanitov EN (2002) Distinct prevalence of the CYP19D3(TTTA)7 allele in premenopausal versus postmenopausal breast cancer patients, but not in control individuals. Eur J Cancer 38:1911\u20131916", "journal-title": "Eur J Cancer"}, {"key": "9_CR2372", "doi-asserted-by": "crossref", "first-page": "897", "DOI": "10.1093/humrep/17.4.897", "volume": "17", "author": "N Kado", "year": "2002", "unstructured": "Kado N, Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, Tsukamoto K, Hasegawa G, Nakamura N, Yoshikawa T, Honjo H (2002) Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women. Hum Reprod 17:897\u2013902", "journal-title": "Hum Reprod"}, {"key": "9_CR2373", "doi-asserted-by": "crossref", "first-page": "495", "DOI": "10.1007/s10549-009-0693-6", "volume": "122", "author": "X Ma", "year": "2010", "unstructured": "Ma X, Qi X, Chen C, Lin H, Xiong H, Li Y, Jiang J (2010) Association between CYP19 polymorphisms and breast cancer risk: results from 10,592 cases and 11,720 controls. Breast Cancer Res Treat 122:495\u2013501", "journal-title": "Breast Cancer Res Treat"}, {"key": "9_CR2374", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1016/j.jsbmb.2011.02.001", "volume": "125", "author": "S Chumsri", "year": "2011", "unstructured": "Chumsri S, Howes T, Bao T, Sabnis G, Brodie A (2011) Aromatase, aromatase inhibitors, and breast cancer. J Steroid Biochem Mol Biol 125:13\u201322", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2375", "doi-asserted-by": "crossref", "first-page": "e53902", "DOI": "10.1371/journal.pone.0053902", "volume": "8", "author": "B Pineda", "year": "2013", "unstructured": "Pineda B, Garcia-Perez MA, Cano A, Lluch A, Eroles P (2013) Associations between aromatase CYP19 rs10046 polymorphism and breast cancer risk: from a case-control to a meta-analysis of 20,098 subjects. PLoS One 8:e53902", "journal-title": "PLoS One"}, {"key": "9_CR2376", "doi-asserted-by": "crossref", "first-page": "T51", "DOI": "10.1530/JME-13-0217", "volume": "51", "author": "ER Simpson", "year": "2013", "unstructured": "Simpson ER, Brown KA (2013) Obesity and breast cancer: role of inflammation and aromatase. J Mol Endocrinol 51:T51\u201359", "journal-title": "J Mol Endocrinol"}, {"key": "9_CR2377", "first-page": "1", "volume": "31", "author": "SJ Ellem", "year": "2006", "unstructured": "Ellem SJ, Risbridger GP (2006) Aromatase and prostate cancer. Minerva Endocrinol 31:1\u201312", "journal-title": "Minerva Endocrinol"}, {"key": "9_CR2378", "doi-asserted-by": "crossref", "first-page": "735", "DOI": "10.1177/0300060513477291", "volume": "41", "author": "J Zhang", "year": "2013", "unstructured": "Zhang J, Yin Y, Niu XM, Liu Y, Garfield D, Chen SF, Wang R, Wang L, Chen HQ (2013) CYP19A1 gene polymorphisms and risk of lung cancer. J Int Med Res 41:735\u2013742", "journal-title": "J Int Med Res"}, {"key": "9_CR2379", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1158/0008-5472.CAN-09-3224", "volume": "70", "author": "L Wang", "year": "2010", "unstructured": "Wang L, Ellsworth KA, Moon I, Pelleymounter LL, Eckloff BW, Martin YN, Fridley BL, Jenkins GD, Batzler A, Suman VJ, Ravi S, Dixon JM, Miller WR, Wieben ED, Buzdar A, Weinshilboum RM, Ingle JN (2010) Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors. Cancer Res 70:319\u2013328", "journal-title": "Cancer Res"}, {"key": "9_CR2380", "first-page": "E", "volume": "288", "author": "IM Dick", "year": "2005", "unstructured": "Dick IM, Devine A, Prince RL (2005) Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women. Am J Physiol Endocrinol Metab 288:E989\u2013995", "journal-title": "Am J Physiol Endocrinol Metab"}, {"key": "9_CR2381", "doi-asserted-by": "crossref", "first-page": "129", "DOI": "10.1016/B978-0-12-387025-4.00006-6", "volume": "54", "author": "L Gennari", "year": "2011", "unstructured": "Gennari L, Merlotti D, Nuti R (2011) Aromatase activity and bone loss. Adv Clin Chem 54:129\u2013164", "journal-title": "Adv Clin Chem"}, {"key": "9_CR2382", "doi-asserted-by": "crossref", "first-page": "478", "DOI": "10.3109/09513590.2013.774359", "volume": "29", "author": "L Lazaros", "year": "2013", "unstructured": "Lazaros L, Xita N, Hatzi E, Takenaka A, Kaponis A, Makrydimas G, Sofikitis N, Stefos T, Zikopoulos K, Georgiou I (2013) CYP19 gene variants affect the assisted reproduction outcome of women with polycystic ovarysyndrome. Gynecol Endocrinol 29:478\u2013482", "journal-title": "Gynecol Endocrinol"}, {"key": "9_CR2383", "doi-asserted-by": "crossref", "first-page": "3129", "DOI": "10.1093/humrep/deq276", "volume": "25", "author": "N Xita", "year": "2010", "unstructured": "Xita N, Chatzikyriakidou A, Stavrou I, Zois C, Georgiou I, Tsatsoulis A (2010) The (TTTA)n polymorphism of aromatase (CYP19) gene is associated with age at menarche. Hum Reprod 25:3129\u20133133", "journal-title": "Hum Reprod"}, {"key": "9_CR2384", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.7150/ijms.5.29", "volume": "5", "author": "M Shimodaira", "year": "2008", "unstructured": "Shimodaira M, Nakayama T, Sato N, Saito K, Morita A, Sato I, Takahashi T, Soma M, Izumi Y (2008) Association study of aromatase gene (CYP19A1) in essential hypertension. Int J Med Sci 5:29\u201335", "journal-title": "Int J Med Sci"}, {"key": "9_CR2385", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1016/j.maturitas.2011.10.012", "volume": "71", "author": "A Ziv-Gal", "year": "2012", "unstructured": "Ziv-Gal A, Gallicchio L, Miller SR, Zacur HA, Flaws JA (2012) A genetic polymorphism in the CYP19A1 gene and the risk of hypertension among midlife women. Maturitas 71:70\u201375", "journal-title": "Maturitas"}, {"key": "9_CR2386", "doi-asserted-by": "crossref", "first-page": "816", "DOI": "10.1016/j.steroids.2011.02.031", "volume": "76", "author": "WC Boon", "year": "2011", "unstructured": "Boon WC, Horne MK (2011) Aromatase and its inhibition in behaviour, obsessive compulsive disorder and parkinsonism. Steroids 76:816\u2013819", "journal-title": "Steroids"}, {"key": "9_CR2387", "doi-asserted-by": "crossref", "first-page": "240", "DOI": "10.4161/spmg.1.3.18037", "volume": "1", "author": "JT Haverfield", "year": "2011", "unstructured": "Haverfield JT, Ham S, Brown KA, Simpson ER, Meachem SJ (2011) Teasing out the role of aromatase in the healthy and diseased testis. Spermatogenesis 1:240\u2013249", "journal-title": "Spermatogenesis"}, {"key": "9_CR2388", "doi-asserted-by": "crossref", "first-page": "662", "DOI": "10.1016/j.ajodo.2012.06.014", "volume": "142", "author": "S He", "year": "2012", "unstructured": "He S, Hartsfield JK Jr, Guo Y, Cao Y, Wang S, Chen S (2012) Association between CYP19A1 genotype and pubertal sagittal jaw growth. Am J Orthodon Dentofacial Orthoped 142:662\u2013670", "journal-title": "Am J Orthodon Dentofacial Orthoped"}, {"key": "9_CR2389", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1007/s10519-012-9532-3", "volume": "42", "author": "H Anthoni", "year": "2012", "unstructured": "Anthoni H, Sucheston LE, Lewis BA, Tapia-Paez I, Fan X, Zucchelli M, Taipale M, Stein CM, Hokkanen ME, Castren E, Pennington BF, Smith SD, Olson RK, Tomblin JB, Schulte-Korne G, Nothen M, Schumacher J, Muller-Myhsok B, Hoffmann P, Gilger JW, Hynd GW, Nopola-Hemmi J, Leppanen PH, Lyytinen H, Schoumans J, Nordenskjold M, Spencer J, Stanic D, Boon WC, Simpson E, Makela S, Gustafsson JA, Peyrard-Janvid M, Iyengar S, Kere J (2012) The aromatase gene CYP19A1: several genetic and functional lines of evidence supporting a role in reading, speech and language. Behav Genet 42:509\u2013527", "journal-title": "Behav Genet"}, {"key": "9_CR2390", "doi-asserted-by": "crossref", "first-page": "1930", "DOI": "10.1124/dmd.108.022020", "volume": "36", "author": "K Stark", "year": "2008", "unstructured": "Stark K, Wu ZL, Bartleson CJ, Guengerich FP (2008) mRNA distribution and heterologous expression of orphan cytochrome P450 20A1. Drug Metab Dispos 36:1930\u20131937", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR2391", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1016/0039-128X(74)90151-2", "volume": "23", "author": "GT Bryan", "year": "1974", "unstructured": "Bryan GT, Lewis AM, Harkins JB, Micheletti SF, Boyd GS (1974) Cytochrome P450 and steroid 21-hydroxylation in microsomes from beef adrenalcortex. Steroids 23:185\u2013201", "journal-title": "Steroids"}, {"key": "9_CR2392", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1016/S0303-7207(96)03997-4", "volume": "127", "author": "Z Zhou", "year": "1997", "unstructured": "Zhou Z, Agarwal VR, Dixit N, White P, Speiser PW (1997) Steroid 21-hydroxylase expression and activity in human lymphocytes. Mol Cell Endocrinol 127:11\u201318", "journal-title": "Mol Cell Endocrinol"}, {"key": "9_CR2393", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/S0303-7207(02)00041-2", "volume": "190", "author": "L Yu", "year": "2002", "unstructured": "Yu L, Romero DG, Gomez-Sanchez CE, Gomez-Sanchez EP (2002) Steroidogenic enzyme gene expression in the human brain. Mol Cell Endocrinol 190:9\u201317", "journal-title": "Mol Cell Endocrinol"}, {"key": "9_CR2394", "doi-asserted-by": "crossref", "first-page": "719", "DOI": "10.1096/fasebj.6.2.1311271", "volume": "6", "author": "UM Zanger", "year": "1992", "unstructured": "Zanger UM, Kagawa N, Lund J, Waterman MR (1992) Distinct biochemical mechanisms for cAMP-dependent transcription of CYP17 and CYP21. FASEB J 6:719\u2013723", "journal-title": "FASEB J"}, {"key": "9_CR2395", "doi-asserted-by": "crossref", "first-page": "521", "DOI": "10.1111/j.1432-1033.1993.tb17950.x", "volume": "214", "author": "N Watanabe", "year": "1993", "unstructured": "Watanabe N, Kitazume M, Fujisawa J, Yoshida M, Fujii-Kuriyama Y (1993) A novel cAMP-dependent regulatory region including a sequence like the cAMP-responsive element, far upstream of the human CYP21A2 gene. Eur J Biochem 214:521\u2013531", "journal-title": "Eur J Biochem"}, {"key": "9_CR2396", "first-page": "1330", "volume": "9", "author": "SF Chang", "year": "1995", "unstructured": "Chang SF, Chung BC (1995) Difference in transcriptional activity of two homologous CYP21A genes. Mol Endocrinol 9:1330\u20131336", "journal-title": "Mol Endocrinol"}, {"key": "9_CR2397", "first-page": "1592", "volume": "83", "author": "IM Bird", "year": "1998", "unstructured": "Bird IM, Mason JI, Rainey WE (1998) Protein kinase A, protein kinase C, and Ca2 + -regulated expression of 21-hydroxylase cytochrome P450 in H295R human adrenocortical cells. J Clin Endocrinol Metab 83:1592\u20131597", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2398", "doi-asserted-by": "crossref", "first-page": "38097", "DOI": "10.1074/jbc.274.53.38097", "volume": "274", "author": "SD Wijesuriya", "year": "1999", "unstructured": "Wijesuriya SD, Zhang G, Dardis A, Miller WL (1999) Transcriptional regulatory elements of the human gene for cytochrome P450c21 (steroid 21-hydroxylase) lie within intron 35 of the linked C4B gene. J Biol Chem 274:38097\u201338106", "journal-title": "J Biol Chem"}, {"key": "9_CR2399", "doi-asserted-by": "crossref", "first-page": "1553", "DOI": "10.1016/j.bbagen.2012.04.017", "volume": "1820", "author": "J Lundqvist", "year": "2012", "unstructured": "Lundqvist J, Wikvall K, Norlin M (2012) Vitamin D-mediated regulation of CYP21A2 transcription\u2014a novel mechanism for vitamin D action. Biochim Biophys Acta 1820:1553\u20131559", "journal-title": "Biochim Biophys Acta"}, {"key": "9_CR2400", "doi-asserted-by": "crossref", "first-page": "2605", "DOI": "10.1073/pnas.1221133110", "volume": "110", "author": "S Haider", "year": "2013", "unstructured": "Haider S, Islam B, D\u2019Atri V, Sgobba M, Poojari C, Sun L, Yuen T, Zaidi M, New MI (2013) Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenalhyperplasia. Proc Natl Acad Sci U S A 110:2605\u20132610", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR2401", "doi-asserted-by": "crossref", "first-page": "e53", "DOI": "10.1136/jmg.40.5.e53", "volume": "40", "author": "PF Koppens", "year": "2003", "unstructured": "Koppens PF, Smeets HJ, de Wijs IJ, Degenhart HJ (2003) Mapping of a de novo unequal crossover causing a deletion of the steroid 21-hydroxylase (CYP21A2) gene and a non-functional hybrid tenascin-X (TNXB) gene. J Med Genet 40:e53", "journal-title": "J Med Genet"}, {"key": "9_CR2402", "doi-asserted-by": "crossref", "first-page": "e2138", "DOI": "10.1371/journal.pone.0002138", "volume": "3", "author": "S Parajes", "year": "2008", "unstructured": "Parajes S, Quinteiro C, Dominguez F, Loidi L (2008) High frequency of copy number variations and sequence variants at CYP21A2 locus: implication for the genetic diagnosis of 21-hydroxylase deficiency. PLoS One 3:e2138", "journal-title": "PLoS One"}, {"key": "9_CR2403", "doi-asserted-by": "crossref", "first-page": "e81977", "DOI": "10.1371/journal.pone.0081977", "volume": "8", "author": "JA Szabo", "year": "2013", "unstructured": "Szabo JA, Szilagyi A, Doleschall Z, Patocs A, Farkas H, Prohaszka Z, Racz K, Fust G, Doleschall M (2013) Both positive and negative selection pressures contribute to the polymorphism pattern of the duplicated human CYP21A2 gene. PLoS One 8:e81977", "journal-title": "PLoS One"}, {"key": "9_CR2404", "doi-asserted-by": "crossref", "first-page": "414", "DOI": "10.1016/j.ymgme.2006.12.005", "volume": "90", "author": "RC Wilson", "year": "2007", "unstructured": "Wilson RC, Nimkarn S, Dumic M, Obeid J, Azar MR, Najmabadi H, Saffari F, New MI (2007) Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Mol Genet Metab 90:414\u2013421", "journal-title": "Mol Genet Metab"}, {"key": "9_CR2405", "doi-asserted-by": "crossref", "first-page": "4028", "DOI": "10.1210/jc.2006-2163", "volume": "92", "author": "RS Araujo", "year": "2007", "unstructured": "Araujo RS, Mendonca BB, Barbosa AS, Lin CJ, Marcondes JA, Billerbeck AE, Bachega TA (2007) Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency. J Clin Endocrinol Metab 92:4028\u20134034", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2406", "doi-asserted-by": "crossref", "first-page": "1057", "DOI": "10.1515/CCLM.2010.239", "volume": "48", "author": "P Concolino", "year": "2010", "unstructured": "Concolino P, Mello E, Zuppi C, Capoluongo E (2010) Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: an update of new CYP21A2 mutations. Clin Chem Lab Med 48:1057\u20131062", "journal-title": "Clin Chem Lab Med"}, {"key": "9_CR2407", "doi-asserted-by": "crossref", "first-page": "80", "DOI": "10.1159/000321223", "volume": "20", "author": "A Wedell", "year": "2011", "unstructured": "Wedell A (2011) Molecular genetics of 21-hydroxylase deficiency. Endocr Dev 20:80\u201387", "journal-title": "Endocr Dev"}, {"key": "9_CR2408", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1002/humu.1380030408", "volume": "3", "author": "PC White", "year": "1994", "unstructured": "White PC, Tusie-Luna MT, New MI, Speiser PW (1994) Mutations in steroid 21-hydroxylase (CYP21). Hum Mutat 3:373\u2013378", "journal-title": "Hum Mutat"}, {"key": "9_CR2409", "doi-asserted-by": "crossref", "first-page": "10796", "DOI": "10.1073/pnas.92.23.10796", "volume": "92", "author": "MT Tusi\u00e9-Luna", "year": "1995", "unstructured": "Tusi\u00e9-Luna MT, White PC (1995) Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21 involve different mechanisms. Proc Natl Acad Sci U S A 92:10796\u201310800", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR2410", "doi-asserted-by": "crossref", "first-page": "1600", "DOI": "10.1073/pnas.85.5.1600", "volume": "85", "author": "M Amor", "year": "1988", "unstructured": "Amor M, Parker KL, Globerman H, New MI, White PC (1988) Mutation in the CYP21B gene (Ile-172\u2013\u2013Asn) causes steroid 21-hydroxylase deficiency. Proc Natl Acad Sci U S A 85:1600\u20131604", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR2411", "first-page": "1211", "volume": "6", "author": "D Owerbach", "year": "1992", "unstructured": "Owerbach D, Sherman L, Ballard AL, Azziz R (1992) Pro-453 to Ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency. Mol Endocrinol 6:1211\u20131215", "journal-title": "Mol Endocrinol"}, {"key": "9_CR2412", "doi-asserted-by": "crossref", "first-page": "685", "DOI": "10.1210/mend-5-5-685", "volume": "5", "author": "MT Tusie-Luna", "year": "1991", "unstructured": "Tusie-Luna MT, Speiser PW, Dumic M, New MI, White PC (1991) A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele. Mol Endocrinol 5:685\u2013692", "journal-title": "Mol Endocrinol"}, {"key": "9_CR2413", "doi-asserted-by": "crossref", "first-page": "481", "DOI": "10.1002/(SICI)1098-1004(200005)15:5<481::AID-HUMU14>3.0.CO;2-A", "volume": "15", "author": "A Bobba", "year": "2000", "unstructured": "Bobba A, Marra E, Lattanzio P, Iolascon A, Giannattasio S (2000) Characterization of the CYP21 gene 5\u2032 flanking region in patients affected by 21-OH deficiency. Hum Mutat 15:481", "journal-title": "Hum Mutat"}, {"key": "9_CR2414", "first-page": "245", "volume": "21", "author": "PC White", "year": "2000", "unstructured": "White PC, Speiser PW (2000) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21:245\u2013291", "journal-title": "Endocr Rev"}, {"key": "9_CR2415", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1034/j.1399-0004.2001.590501.x", "volume": "59", "author": "H Lee", "year": "2001", "unstructured": "Lee H (2001) CYP21 mutations and congenital adrenal hyperplasia. Clin Genet 59:293\u2013301", "journal-title": "Clin Genet"}, {"key": "9_CR2416", "doi-asserted-by": "crossref", "first-page": "1059", "DOI": "10.1210/jcem.85.3.6441", "volume": "85", "author": "N Krone", "year": "2000", "unstructured": "Krone N, Braun A, Roscher AA, Knorr D, Schwarz HP (2000) Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 85:1059\u20131065", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2417", "doi-asserted-by": "crossref", "first-page": "885", "DOI": "10.1002/pd.167", "volume": "21", "author": "A Levo", "year": "2001", "unstructured": "Levo A, Partanen J (2001) Novel mutations in the human CYP21 gene. Prenat Diagn 21:885\u2013889", "journal-title": "Prenat Diagn"}, {"key": "9_CR2418", "doi-asserted-by": "crossref", "first-page": "2668", "DOI": "10.1210/jcem.87.6.8522", "volume": "87", "author": "S Koyama", "year": "2002", "unstructured": "Koyama S, Toyoura T, Saisho S, Shimozawa K, Yata J (2002) Genetic analysis of Japanese patients with 21-hydroxylase deficiency: identification of a patient with a new mutation of a homozygous deletion of adenine at codon 246 and patients without demonstrable mutations within the structural gene for CYP21. J Clin Endocrinol Metab 87:2668\u20132673", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2419", "doi-asserted-by": "crossref", "first-page": "517", "DOI": "10.1007/s100380200077", "volume": "47", "author": "HH Lee", "year": "2002", "unstructured": "Lee HH, Niu DM, Lin RW, Chan P, Lin CY (2002) Structural analysis of the chimeric CYP21P/CYP21 gene in steroid 21-hydroxylase deficiency. J Hum Genet 47:517\u2013522", "journal-title": "J Hum Genet"}, {"key": "9_CR2420", "doi-asserted-by": "crossref", "first-page": "405", "DOI": "10.1007/s00439-002-0810-7", "volume": "111", "author": "PF Koppens", "year": "2002", "unstructured": "Koppens PF, Hoogenboezem T, Degenhart HJ (2002) Duplication of the CYP21A2 gene complicates mutation analysis of steroid 21-hydroxylase deficiency: characteristics of three unusual haplotypes. Hum Genet 111:405\u2013410", "journal-title": "Hum Genet"}, {"key": "9_CR2421", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1046/j.0300-0664.2001.01419.x", "volume": "56", "author": "LB Dain", "year": "2002", "unstructured": "Dain LB, Buzzalino ND, Oneto A, Belli S, Stivel M, Pasqualini T, Minutolo C, Charreau EH, Alba LG (2002) Classical and nonclassical 21-hydroxylase deficiency: a molecular study of Argentine patients. Clin Endocrinol 56:239\u2013245", "journal-title": "Clin Endocrinol"}, {"key": "9_CR2422", "doi-asserted-by": "crossref", "first-page": "330", "DOI": "10.1007/s004390051046", "volume": "106", "author": "E Mornet", "year": "2000", "unstructured": "Mornet E, Gibrat JF (2000) A 3D model of human P450c21: study of the putative effects of steroid 21-hydroxylase gene mutations. Hum Genet 106:330\u2013339", "journal-title": "Hum Genet"}, {"key": "9_CR2423", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1530/eje.1.02172", "volume": "155", "author": "M Janner", "year": "2006", "unstructured": "Janner M, Pandey AV, Mullis PE, Fluck CE (2006) Clinical and biochemical description of a novel CYP21A2 gene mutation 962_963insA using a new 3D model for the P450c21 protein. Eur J Endocrin 155:143\u2013151", "journal-title": "Eur J Endocrin"}, {"key": "9_CR2424", "doi-asserted-by": "crossref", "first-page": "3968", "DOI": "10.1021/bi102078e", "volume": "50", "author": "D Mizrachi", "year": "2011", "unstructured": "Mizrachi D, Wang Z, Sharma KK, Gupta MK, Xu K, Dwyer CR, Auchus RJ (2011) Why human cytochrome P450c21 is a progesterone 21-hydroxylase. Biochemistry 50:3968\u20133974", "journal-title": "Biochemistry"}, {"key": "9_CR2425", "doi-asserted-by": "crossref", "first-page": "e15899", "DOI": "10.1371/journal.pone.0015899", "volume": "6", "author": "C Minutolo", "year": "2011", "unstructured": "Minutolo C, Nadra AD, Fernandez C, Taboas M, Buzzalino N, Casali B, Belli S, Charreau EH, Alba L, Dain L (2011) Structure-based analysis of five novel disease-causing mutations in 21-hydroxylase-deficient patients. PLoS One 6:e15899", "journal-title": "PLoS One"}, {"key": "9_CR2426", "doi-asserted-by": "crossref", "first-page": "726", "DOI": "10.1016/j.steroids.2013.04.002", "volume": "78", "author": "AO Chan", "year": "2013", "unstructured": "Chan AO (2013) Performance of in silico analysis in predicting the effect of non-synonymous variants in inherited steroid metabolic diseases. Steroids 78:726\u2013730", "journal-title": "Steroids"}, {"key": "9_CR2427", "doi-asserted-by": "crossref", "first-page": "395", "DOI": "10.1016/0003-9861(76)90277-0", "volume": "173", "author": "RH Menard", "year": "1976", "unstructured": "Menard RH, Bartter FC, Gillette JR (1976) Spironolactone and cytochrome P-450: impairment of steroid 21-hydroxylation in the adrenal cortex. Arch Biochem Biophys 173:395\u2013402", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR2428", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.1196/annals.1429.021", "volume": "1135", "author": "K Lin-Su", "year": "2008", "unstructured": "Lin-Su K, Nimkarn S, New MI (2008) Congenital adrenal hyperplasia in adolescents: diagnosis and management. Ann N Y Acad Sci 1135:95\u201398", "journal-title": "Ann N Y Acad Sci"}, {"key": "9_CR2429", "doi-asserted-by": "crossref", "first-page": "396", "DOI": "10.1007/s00774-003-0434-6", "volume": "21", "author": "PO de Almeida Freire", "year": "2003", "unstructured": "de Almeida Freire PO, de Lemos-Marini SH, Maciel-Guerra AT, Morcillo AM, Matias Baptista MT, de Mello MP, Guerra G Jr (2003) Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density. J Bone Miner Metab 21:396\u2013401", "journal-title": "J Bone Miner Metab"}, {"key": "9_CR2430", "doi-asserted-by": "crossref", "first-page": "615", "DOI": "10.1007/BF03346358", "volume": "30", "author": "L Barzon", "year": "2007", "unstructured": "Barzon L, Maffei P, Sonino N, Pilon C, Baldazzi L, Balsamo A, Del Maschio O, Masi G, Trevisan M, Pacenti M, Fallo F (2007) The role of 21-hydroxylase in the pathogenesis of adrenal masses: review of the literature and focus on our own experience. J Endocrin Invest 30:615\u2013623", "journal-title": "J Endocrin Invest"}, {"key": "9_CR2431", "doi-asserted-by": "crossref", "first-page": "699", "DOI": "10.1507/endocrj.K11E-097", "volume": "58", "author": "M Haase", "year": "2011", "unstructured": "Haase M, Schott M, Kaminsky E, Ludecke DK, Saeger W, Fritzen R, Schinner S, Scherbaum WA, Willenberg HS (2011) Cushing\u2019s disease in a patient with steroid 21-hydroxylase deficiency. Endocrin J 58:699\u2013706", "journal-title": "Endocrin J"}, {"key": "9_CR2432", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1530/EJE-10-0877", "volume": "164", "author": "H Falhammar", "year": "2011", "unstructured": "Falhammar H, Filipsson Nystrom H, Wedell A, Thoren M (2011) Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur J Endocrinol 164:285\u2013293", "journal-title": "Eur J Endocrinol"}, {"key": "9_CR2433", "first-page": "226", "volume": "68", "author": "RO Rocha", "year": "2008", "unstructured": "Rocha RO, Billerbeck AE, Pinto EM, Melo KF, Lin CJ, Longui CA, Mendonca BB, Bachega TA (2008) The degree of external genitalia virilization in girls with 21-hydroxylase deficiency appears to be influenced by the CAG repeats in the androgen receptor gene. Clin Endocrinol 68:226\u2013232", "journal-title": "Clin Endocrinol"}, {"key": "9_CR2434", "first-page": "77", "volume": "123", "author": "H Falhammar", "year": "2010", "unstructured": "Falhammar H (2010) Non-classic congenital adrenal hyperplasia due to 21-hydoxylase deficiency as a cause of infertility and miscarriages. N Z Med J 123:77\u201380", "journal-title": "N Z Med J"}, {"key": "9_CR2435", "doi-asserted-by": "crossref", "first-page": "1317", "DOI": "10.2169/internalmedicine.50.5083", "volume": "50", "author": "C Sumida", "year": "2011", "unstructured": "Sumida C, Kondoh N, Kurajoh M, Koyama H, Tsutsumi Z, Moriwaki Y, Yamamoto T (2011) 21-hydroxylase deficiency associated with male infertility: report of 2 cases with gene analyses. Intern Med (Tokyo) 50:1317\u20131321", "journal-title": "Intern Med (Tokyo)"}, {"key": "9_CR2436", "doi-asserted-by": "crossref", "first-page": "1570", "DOI": "10.1210/jc.2008-1582", "volume": "94", "author": "M Bidet", "year": "2009", "unstructured": "Bidet M, Bellanne-Chantelot C, Galand-Portier MB, Tardy V, Billaud L, Laborde K, Coussieu C, Morel Y, Vaury C, Golmard JL, Claustre A, Mornet E, Chakhtoura Z, Mowszowicz I, Bachelot A, Touraine P, Kuttenn F (2009) Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members. J Clin Endocrinol Metab 94:1570\u20131578", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2437", "doi-asserted-by": "crossref", "first-page": "132", "DOI": "10.1111/j.1365-2265.2005.02184.x", "volume": "62", "author": "RS Araujo", "year": "2005", "unstructured": "Araujo RS, Billerbeck AE, Madureira G, Mendonca BB, Bachega TA (2005) Substitutions in the CYP21A2 promoter explain the simple-virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation. Clin Endocrinol 62:132\u2013136", "journal-title": "Clin Endocrinol"}, {"key": "9_CR2438", "first-page": "742", "volume": "258", "author": "JI Pedersen", "year": "1983", "unstructured": "Pedersen JI, Shobaki HH, Holmberg I, Bergseth S, Bj\u00f6rkhem I (1983) 25-hydroxyvitamin D3-24-hydroxylasein rat kidney mitochondria. J Biol Chem 258:742\u2013746", "journal-title": "J Biol Chem"}, {"key": "9_CR2439", "doi-asserted-by": "crossref", "first-page": "405", "DOI": "10.1016/0014-5793(89)81133-0", "volume": "255", "author": "Y Ohyama", "year": "1989", "unstructured": "Ohyama Y, Hayashi S, Okuda K (1989) Purification of 25-hydroxyvitamin D3 24-hydroxylase from rat kidney mitochondria. FEBS Lett 255:405\u2013408", "journal-title": "FEBS Lett"}, {"key": "9_CR2440", "first-page": "176", "volume": "269", "author": "RA Ettinger", "year": "1994", "unstructured": "Ettinger RA, Ismail R, DeLuca HF (1994) cDNA cloning and characterization of a vitamin D3 hydroxylase-associated protein. J Biol Chem 269:176\u2013182", "journal-title": "J Biol Chem"}, {"key": "9_CR2441", "doi-asserted-by": "crossref", "first-page": "4543", "DOI": "10.1073/pnas.90.10.4543", "volume": "90", "author": "KS Chen", "year": "1993", "unstructured": "Chen KS, Prahl JM, DeLuca HF (1993) Isolation and expression of human 1,25-dihydroxyvitamin D3 24-hydroxylase cDNA. Proc Natl Acad Sci U S A 90:4543\u20134547", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR2442", "doi-asserted-by": "crossref", "first-page": "E", "DOI": "10.1152/ajpcell.1999.276.1.C76", "volume": "276", "author": "W Yang", "year": "1999", "unstructured": "Yang W, Friedman PA, Kumar R, Omdahl JL, May BK, Siu-Caldera ML, Reddy GS, Christakos S (1999) Expression of 25(OH)D3 24-hydroxylasein distal nephron: coordinate regulationby 1,25(OH)2D3 and cAMP or PTH. Am J Physiol 276:E793\u2013805", "journal-title": "Am J Physiol"}, {"key": "9_CR2443", "doi-asserted-by": "crossref", "first-page": "3303", "DOI": "10.1210/endo.140.7.6799", "volume": "140", "author": "G Jones", "year": "1999", "unstructured": "Jones G, Ramshaw H, Zhang A, Cook R, Byford V, White J, Petkovich M (1999) Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1\u03b1 and CYP24) in human nonsmall cell lung carcinomas. Endocrinology 140:3303\u20133310", "journal-title": "Endocrinology"}, {"key": "9_CR2444", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.3181/00379727-207-43791", "volume": "207", "author": "ML Chen", "year": "1994", "unstructured": "Chen ML, Heinrich G, Ohyama YI, Okuda K, Omdahl JL, Chen TC, Holick MF (1994) Expression of 25-hydroxyvitamin D3-24-hydroxylase mRNA in cultured human keratinocytes. Proc Soc Exp Biol Med 207:57\u201361", "journal-title": "Proc Soc Exp Biol Med"}, {"key": "9_CR2445", "doi-asserted-by": "crossref", "first-page": "451", "DOI": "10.1016/S0039-128X(00)00166-5", "volume": "66", "author": "I Schuster", "year": "2001", "unstructured": "Schuster I, Egger H, Astecker N, Herzig G, Schussler M, Vorisek G (2001) Selective inhibitors of CYP24: mechanistic tools to explore vitamin D metabolism in human keratinocytes. Steroids 66:451\u2013462", "journal-title": "Steroids"}, {"key": "9_CR2446", "doi-asserted-by": "crossref", "first-page": "320", "DOI": "10.1006/excr.2002.5528", "volume": "276", "author": "P Bareis", "year": "2002", "unstructured": "Bareis P, Kallay E, Bischof MG, Bises G, Hofer H, Potzi C, Manhardt T, Bland R, Cross HS (2002) Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3). Exp Cell Res 276:320\u2013327", "journal-title": "Exp Cell Res"}, {"key": "9_CR2447", "doi-asserted-by": "crossref", "first-page": "459", "DOI": "10.1111/j.1749-6632.2002.tb04683.x", "volume": "973", "author": "H Farhan", "year": "2002", "unstructured": "Farhan H, Cross HS (2002) Transcriptional inhibition of CYP24 by genistein. Ann N Y Acad Sci 973:459\u2013462", "journal-title": "Ann N Y Acad Sci"}, {"key": "9_CR2448", "doi-asserted-by": "crossref", "first-page": "376", "DOI": "10.1016/j.jsbmb.2010.03.069", "volume": "121", "author": "M Blomberg Jensen", "year": "2010", "unstructured": "Blomberg Jensen M, Andersen CB, Nielsen JE, Bagi P, Jorgensen A, Juul A, Leffers H (2010) Expression of the vitamin D receptor, 25-hydroxylases, 1\u03b1-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer. J Steroid Biochem Mol Biol 121:376\u2013382", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2449", "doi-asserted-by": "crossref", "first-page": "499", "DOI": "10.1111/j.1365-2605.2012.01256.x", "volume": "35", "author": "M Blomberg Jensen", "year": "2012", "unstructured": "Blomberg Jensen M, Jorgensen A, Nielsen JE, Bjerrum PJ, Skalkam M, Petersen JH, Egeberg DL, Bangsboll S, Andersen AN, Skakkebaek NE, Juul A, Rajpert-De Meyts E, Dissing S, Leffers H, Jorgensen N (2012) Expression of the vitamin D metabolizing enzyme CYP24A1 at the annulus of human spermatozoa may serve as a novel marker of semen quality. Int J Androl 35:499\u2013510", "journal-title": "Int J Androl"}, {"key": "9_CR2450", "doi-asserted-by": "crossref", "first-page": "900", "DOI": "10.1073/pnas.91.3.900", "volume": "91", "author": "C Zierold", "year": "1994", "unstructured": "Zierold C, Darwish HM, DeLuca HF (1994) Identification of a vitamin D-response element in the rat calcidiol (25-hydroxyvitamin D3) 24-hydroxylasegene. Proc Natl Acad Sci U S A 91:900\u2013902", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR2451", "first-page": "10545", "volume": "269", "author": "Y Ohyama", "year": "1994", "unstructured": "Ohyama Y, Ozono K, Uchida M, Shinki T, Kato S, Suda T, Yamamoto O, Noshiro M, Kato Y (1994) Identification of a vitamin D-responsive element in the 5\u2032-flanking region of the rat 25-hydroxyvitamin D3 24-hydroxylase gene. J Biol Chem 269:10545\u201310550", "journal-title": "J Biol Chem"}, {"key": "9_CR2452", "doi-asserted-by": "crossref", "first-page": "29715", "DOI": "10.1074/jbc.271.47.29715", "volume": "271", "author": "DM Kerry", "year": "1996", "unstructured": "Kerry DM, Dwivedi PP, Hahn CN, Morris HA, Omdahl JL, May BK (1996) Transcriptional synergism between vitamin D-responsive elements in the rat 25-hydroxyvitamin D3 24-hydroxylase (CYP24) promoter. J Biol Chem 271:29715\u201329721", "journal-title": "J Biol Chem"}, {"key": "9_CR2453", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1074/jbc.275.1.47", "volume": "275", "author": "PP Dwivedi", "year": "2000", "unstructured": "Dwivedi PP, Omdahl JL, Kola I, Hume DK, May BK (2000) Regulation of rat cytochrome P450C24 (CYP24) gene expression. Evidence for functional cooperation of Ras-activated Ets transcription factors with the vitamin D receptor in 1,25- dihydroxyvitamin D3-mediated induction. J Biol Chem 275:47\u201355", "journal-title": "J Biol Chem"}, {"key": "9_CR2454", "doi-asserted-by": "crossref", "first-page": "1035", "DOI": "10.1210/mend.15.6.0651", "volume": "15", "author": "M Raval-Pandya", "year": "2001", "unstructured": "Raval-Pandya M, Dhawan P, Barletta F, Christakos S (2001) YY1 represses vitamin Dreceptor-mediated 25-hydroxyvitamin D3 24-hydroxylase transcription: relief of repression by CREB-binding protein. Mol Endocrinol 15:1035\u20131046", "journal-title": "Mol Endocrinol"}, {"key": "9_CR2455", "doi-asserted-by": "crossref", "first-page": "29643", "DOI": "10.1074/jbc.M204561200", "volume": "277", "author": "PP Dwivedi", "year": "2002", "unstructured": "Dwivedi PP, Hii CS, Ferrante A, Tan J, Der CJ, Omdahl JL, Morris HA, May BK (2002) Role of MAP kinases in the 1,25-dihydroxyvitamin D3-induced transactivation of the rat cytochrome P450C24 (CYP24) promoter. Specific functions for ERK1/ERK2 and ERK5. J Biol Chem 277:29643\u201329653", "journal-title": "J Biol Chem"}, {"key": "9_CR2456", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1016/j.mce.2006.08.009", "volume": "263", "author": "D Lechner", "year": "2007", "unstructured": "Lechner D, Kallay E, Cross HS (2007) 1\u03b1,25-Dihydroxyvitamin D3 downregulates CYP27B1 and induces CYP24A1 in colon cells. Mol Cell Endocrinol 263:55\u201364", "journal-title": "Mol Cell Endocrinol"}, {"key": "9_CR2457", "doi-asserted-by": "crossref", "first-page": "46", "DOI": "10.1016/j.mce.2010.04.023", "volume": "325", "author": "R Kumar", "year": "2010", "unstructured": "Kumar R, Iachini DN, Neilsen PM, Kaplan J, Michalakas J, Anderson PH, May BK, Morris HA, Callen DF (2010) Systematic characterisation of the rat and human CYP24A1 promoter. Mol Cell Endocrinol 325:46\u201353", "journal-title": "Mol Cell Endocrinol"}, {"key": "9_CR2458", "doi-asserted-by": "crossref", "first-page": "15599", "DOI": "10.1074/jbc.M110.119958", "volume": "285", "author": "MB Meyer", "year": "2010", "unstructured": "Meyer MB, Goetsch PD, Pike JW (2010) A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1\u03b1,25-dihydroxyvitamin D3. J Biol Chem 285:15599\u201315610", "journal-title": "J Biol Chem"}, {"key": "9_CR2459", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1124/mol.108.051904", "volume": "75", "author": "Y Konno", "year": "2009", "unstructured": "Konno Y, Kodama S, Moore R, Kamiya N, Negishi M (2009) Nuclear xenobiotic receptor pregnane X receptor locks corepressor silencing mediator for retinoid and thyroid hormonereceptors (SMRT) onto the CYP24A1 promoter to attenuate vitamin D3 activation. Mol Pharmacol 75:265\u2013271", "journal-title": "Mol Pharmacol"}, {"key": "9_CR2460", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1016/j.jsbmb.2008.08.009", "volume": "112", "author": "A Roff", "year": "2008", "unstructured": "Roff A, Wilson RT (2008) A novel SNP in a vitamin D response element of the CYP24A1 promoter reduces protein binding, transactivation, and gene expression. J Steroid Biochem Mol Biol 112:47\u201354", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2461", "doi-asserted-by": "crossref", "first-page": "5953", "DOI": "10.1158/0008-5472.CAN-10-0617", "volume": "70", "author": "W Luo", "year": "2010", "unstructured": "Luo W, Karpf AR, Deeb KK, Muindi JR, Morrison CD, Johnson CS, Trump DL (2010) Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer. Cancer Res 70:5953\u20135962", "journal-title": "Cancer Res"}, {"key": "9_CR2462", "doi-asserted-by": "crossref", "first-page": "14838", "DOI": "10.1074/jbc.M809542200", "volume": "284", "author": "B Novakovic", "year": "2009", "unstructured": "Novakovic B, Sibson M, Ng HK, Manuelpillai U, Rakyan V, Down T, Beck S, Fournier T, Evain-Brion D, Dimitriadis E, Craig JM, Morley R, Saffery R (2009) Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. J Biol Chem 284:14838\u201314848", "journal-title": "J Biol Chem"}, {"key": "9_CR2463", "doi-asserted-by": "crossref", "first-page": "925", "DOI": "10.3892/ol_00000163", "volume": "1", "author": "Z Fang", "year": "2010", "unstructured": "Fang Z, Xiong Y, Zhang C, Li J, Liu L, Li M, Zhang W, Wan J (2010) Coexistence of copy number increases of ZNF217 and CYP24A1 in colorectal cancers in a Chinese population. Oncol Lett 1:925\u2013930", "journal-title": "Oncol Lett"}, {"key": "9_CR2464", "doi-asserted-by": "crossref", "first-page": "1380", "DOI": "10.1002/ijc.28143", "volume": "133", "author": "J Hobaus", "year": "2013", "unstructured": "Hobaus J, Hummel DM, Thiem U, Fetahu IS, Aggarwal A, Mullauer L, Heller G, Egger G, Mesteri I, Baumgartner-Parzer S, Kallay E (2013) Increased copy-number and not DNA hypomethylation causes overexpression of the candidate proto-oncogene CYP24A1 in colorectal cancer. Int J Cancer 133:1380\u20131388", "journal-title": "Int J Cancer"}, {"key": "9_CR2465", "doi-asserted-by": "crossref", "first-page": "277", "DOI": "10.1369/jhc.2009.954339", "volume": "58", "author": "HC Horvath", "year": "2010", "unstructured": "Horvath HC, Lakatos P, Kosa JP, Bacsi K, Borka K, Bises G, Nittke T, Hershberger PA, Speer G, Kallay E (2010) The candidate oncogene CYP24A1: a potential biomarker for colorectal tumorigenesis. J Histochem Cytochem 58:277\u2013285", "journal-title": "J Histochem Cytochem"}, {"key": "9_CR2466", "doi-asserted-by": "crossref", "first-page": "2563", "DOI": "10.1158/0008-5472.CAN-12-4134", "volume": "73", "author": "ET Jacobs", "year": "2013", "unstructured": "Jacobs ET, Van Pelt C, Forster RE, Zaidi W, Hibler EA, Galligan MA, Haussler MR, Jurutka PW (2013) CYP24A1 and CYP27B1 polymorphisms modulate vitamin D metabolism in colon cancer cells. Cancer Res 73:2563\u20132573", "journal-title": "Cancer Res"}, {"key": "9_CR2467", "doi-asserted-by": "crossref", "first-page": "552", "DOI": "10.1016/j.juro.2013.02.3188", "volume": "190", "author": "D Dinour", "year": "2013", "unstructured": "Dinour D, Beckerman P, Ganon L, Tordjman K, Eisenstein Z, Holtzman EJ (2013) Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis. J Urol 190:552\u2013557", "journal-title": "J Urol"}, {"key": "9_CR2468", "first-page": "E", "volume": "97", "author": "A Dauber", "year": "2012", "unstructured": "Dauber A, Nguyen TT, Sochett E, Cole DE, Horst R, Abrams SA, Carpenter TO, Hirschhorn JN (2012) Genetic defect in CYP24A1, the vitamin D 24-hydroxylasegene, in a patient with severe infantile hypercalcemia. J Clin Endocrinol Metab 97: E268\u2013274", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2469", "doi-asserted-by": "crossref", "first-page": "179", "DOI": "10.1359/jbmr.2002.17.1.179", "volume": "17", "author": "G Jones", "year": "2002", "unstructured": "Jones G, Tenenhouse HS (2002) 1,25(OH)2D, the preferred substrate for CYP24. J Bone Miner Res 17:179\u2013181", "journal-title": "J Bone Miner Res"}, {"key": "9_CR2470", "doi-asserted-by": "crossref", "first-page": "6158", "DOI": "10.1046/j.1432-1327.2000.01680.x", "volume": "267", "author": "T Sakaki", "year": "2000", "unstructured": "Sakaki T, Sawada N, Komai K, Shiozawa S, Yamada S, Yamamoto K, Ohyama Y, Inouye K (2000) Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24. Eur J Biochem 267:6158\u20136165", "journal-title": "Eur J Biochem"}, {"key": "9_CR2471", "doi-asserted-by": "crossref", "first-page": "8465", "DOI": "10.1021/bi960658i", "volume": "35", "author": "MJ Beckman", "year": "1996", "unstructured": "Beckman MJ, Tadikonda P, Werner E, Prahl J, Yamada S, DeLuca HF (1996) Human 25-hydroxyvitamin D3-24-hydroxylase, a multicatalytic enzyme. Biochemistry 35:8465\u20138472", "journal-title": "Biochemistry"}, {"key": "9_CR2472", "doi-asserted-by": "crossref", "first-page": "14115", "DOI": "10.1074/jbc.272.22.14115", "volume": "272", "author": "Y Miyamoto", "year": "1997", "unstructured": "Miyamoto Y, Shinki T, Yamamoto K, Ohyama Y, Iwasaki H, Hosotani R, Kasama T, Takayama H, Yamada S, Suda T (1997) 1\u03b1,25-Dihydroxyvitamin D3-24-hydroxylase (CYP24) hydroxylates the carbon at the end of the side chain (C-26) of the C-24-fluorinated analog of 1\u03b1,25-dihydroxyvitamin D3. J Biol Chem 272:14115\u201314119", "journal-title": "J Biol Chem"}, {"key": "9_CR2473", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1080/004982598239380", "volume": "28", "author": "K Hayashi", "year": "1998", "unstructured": "Hayashi K, Akiyoshi-Shibata M, Sakaki T, Tabusaki Y (1998) Rat CYP24 catalyses 23S-hydroxylation of 26,26,26,27,27,27-hexafluorocalcitriol in vitro. Xenobiotica 28:457\u2013463", "journal-title": "Xenobiotica"}, {"key": "9_CR2474", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1046/j.1432-1327.1999.00375.x", "volume": "262", "author": "T Sakaki", "year": "1999", "unstructured": "Sakaki T, Sawada N, Nonaka Y, Ohyama Y, Inouye K (1999) Metabolic studies using recombinant Escherichia coli cells producing rat mitochondrial CYP24. CYP24 can convert 1a,25-dihydroxyvitamin D3 to calcitroic acid. Eur J Biochem 262:43\u201348", "journal-title": "Eur J Biochem"}, {"key": "9_CR2475", "doi-asserted-by": "crossref", "first-page": "179", "DOI": "10.1016/S1387-2656(01)07037-5", "volume": "7", "author": "K Inouye", "year": "2001", "unstructured": "Inouye K, Sakaki T (2001) Enzymatic studies on the key enzymes of vitamin D metabolism; 1\u03b1-hydroxylase (CYP27B1) and 24-hydroxylase (CYP24). Biotechnol Annu Rev 7:179\u2013194", "journal-title": "Biotechnol Annu Rev"}, {"key": "9_CR2476", "doi-asserted-by": "crossref", "first-page": "356", "DOI": "10.1002/jcb.10366", "volume": "88", "author": "JL Omdahl", "year": "2003", "unstructured": "Omdahl JL, Bobrovnikova EV, Annalora A, Chen P, Serda R (2003) Expression, structure-function, and molecular modeling of vitamin D P450s. J Cell Biochem 88:356\u2013362", "journal-title": "J Cell Biochem"}, {"key": "9_CR2477", "doi-asserted-by": "crossref", "first-page": "774", "DOI": "10.1016/j.bbrc.2004.07.040", "volume": "321", "author": "T Kusudo", "year": "2004", "unstructured": "Kusudo T, Sakaki T, Abe D, Fujishima T, Kittaka A, Takayama H, Hatakeyama S, Ohta M, Inouye K (2004) Metabolism of A-ring diastereomers of 1\u03b1,25-dihydroxyvitamin D3 by CYP24A1. Biochem Biophys Res Commun 321:774\u2013782", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR2478", "doi-asserted-by": "crossref", "first-page": "778", "DOI": "10.1124/dmd.104.003038", "volume": "33", "author": "D Abe", "year": "2005", "unstructured": "Abe D, Sakaki T, Kusudo T, Kittaka A, Saito N, Suhara Y, Fujishima T, Takayama H, Hamamoto H, Kamakura M, Ohta M, Inouye K (2005) Metabolism of 2\u03b1-propoxy-1\u03b1,25-dihydroxyvitamin D3 and 2\u03b1-(3-hydroxypropoxy)-1\u03b1,25-dihydroxyvitamin D3 by human CYP27A1 and CYP24A1. Drug Metab Dispos 33:778\u2013784", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR2479", "doi-asserted-by": "crossref", "first-page": "84", "DOI": "10.1016/j.jsbmb.2012.09.006", "volume": "133", "author": "K Yasuda", "year": "2013", "unstructured": "Yasuda K, Ikushiro S, Kamakura M, Takano M, Saito N, Kittaka A, Chen TC, Ohta M, Sakaki T (2013) Human cytochrome P450-dependent differential metabolism among three 2\u03b1-substituted-1\u03b1,25-dihydroxyvitamin D3 analogs. J Steroid Biochem Mol Biol 133:84\u201392", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2480", "doi-asserted-by": "crossref", "first-page": "1482", "DOI": "10.1124/dmd.107.015602", "volume": "35", "author": "N Urushino", "year": "2007", "unstructured": "Urushino N, Nakabayashi S, Arai MA, Kittaka A, Chen TC, Yamamoto K, Hayashi K, Kato S, Ohta M, Kamakura M, Ikushiro S, Sakaki T (2007) Kinetic studies of 25-hydroxy-19-nor-vitamin D3 and 1\u03b1,25-dihydroxy-19-nor-vitamin D3 hydroxylation by CYP27B1 and CYP24A1. Drug Metab Dispos 35:1482\u20131488", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR2481", "doi-asserted-by": "crossref", "first-page": "4296", "DOI": "10.1016/j.bmc.2009.05.032", "volume": "17", "author": "N Saito", "year": "2009", "unstructured": "Saito N, Suhara Y, Abe D, Kusudo T, Ohta M, Yasuda K, Sakaki T, Honzawa S, Fujishima T, Kittaka A (2009) Synthesis of 2\u03b1-propoxy-1\u03b1,25-dihydroxyvitamin D3 and comparison of its metabolism by human CYP24A1 and rat CYP24A1. Bioorg Med Chem 17:4296\u20134301", "journal-title": "Bioorg Med Chem"}, {"key": "9_CR2482", "doi-asserted-by": "crossref", "first-page": "144", "DOI": "10.1016/j.bbrc.2009.04.075", "volume": "384", "author": "N Urushino", "year": "2009", "unstructured": "Urushino N, Yasuda K, Ikushiro S, Kamakura M, Ohta M, Sakaki T (2009) Metabolism of 1\u03b1,25-dihydroxyvitamin D2 by human CYP24A1. Biochem Biophys Res Commun 384:144\u2013148", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR2483", "doi-asserted-by": "crossref", "first-page": "12673", "DOI": "10.1073/pnas.0702093104", "volume": "104", "author": "DE Prosser", "year": "2007", "unstructured": "Prosser DE, Kaufmann M, O\u2019Leary B, Byford V, Jones G (2007) Single A326G mutation converts human CYP24A1 from 25-OH-D3-24-hydroxylase into -23-hydroxylase, generating 1alpha,25-(OH)2D3\u201326,23-lactone. Proc Natl Acad Sci U S A 104:12673\u201312678", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR2484", "doi-asserted-by": "crossref", "first-page": "28729", "DOI": "10.1074/jbc.M111.236679", "volume": "286", "author": "M Kaufmann", "year": "2011", "unstructured": "Kaufmann M, Prosser DE, Jones G (2011) Bioengineering anabolic vitamin D-25-hydroxylase activity into the human vitamin D catabolic enzyme, cytochrome P450 CYP24A1, by a V391L mutation. J Biol Chem 286:28729\u201328737", "journal-title": "J Biol Chem"}, {"key": "9_CR2485", "doi-asserted-by": "crossref", "first-page": "120", "DOI": "10.1124/mol.106.023275", "volume": "70", "author": "H Hamamoto", "year": "2006", "unstructured": "Hamamoto H, Kusudo T, Urushino N, Masuno H, Yamamoto K, Yamada S, Kamakura M, Ohta M, Inouye K, Sakaki T (2006) Structure-function analysis of vitamin D 24-hydroxylase (CYP24A1) by site-directed mutagenesis: amino acid residues responsible for species-based difference of CYP24A1 between humans and rats. Mol Pharmacol 70:120\u2013128", "journal-title": "Mol Pharmacol"}, {"key": "9_CR2486", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1016/j.abb.2006.11.030", "volume": "460", "author": "S Masuda", "year": "2007", "unstructured": "Masuda S, Prosser DE, Guo YD, Kaufmann M, Jones G (2007) Generation of a homology model for the human cytochrome P450, CYP24A1, and the testing of putative substrate binding residues by site-directed mutagenesis and enzyme activity studies. Arch Biochem Biophys 460:177\u2013191", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR2487", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1016/j.jsbmb.2006.09.041", "volume": "104", "author": "MS Gomaa", "year": "2007", "unstructured": "Gomaa MS, Simons C, Brancale A (2007) Homology model of 1a,25-dihydroxyvitamin D3 24-hydroxylase cytochrome P450 24A1 (CYP24A1): active site architecture and ligand binding. J Steroid Biochem Mol Biol 104:53\u201360", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2488", "doi-asserted-by": "crossref", "first-page": "409", "DOI": "10.1016/S0039-128X(00)00159-8", "volume": "66", "author": "I Schuster", "year": "2001", "unstructured": "Schuster I, Egger H, Bikle D, Herzig G, Reddy GS, Stuetz A, Stuetz P, Vorisek G (2001) Selective inhibition of vitamin D hydroxylases in human keratinocytes. Steroids 66:409\u2013422", "journal-title": "Steroids"}, {"key": "9_CR2489", "doi-asserted-by": "crossref", "first-page": "372", "DOI": "10.1002/jcb.10365", "volume": "88", "author": "I Schuster", "year": "2003", "unstructured": "Schuster I, Egger H, Nussbaumer P, Kroemer RT (2003) Inhibitors of vitamin D hydroxylases: structure-activity relationships. J Cell Biochem 88:372\u2013380", "journal-title": "J Cell Biochem"}, {"key": "9_CR2490", "doi-asserted-by": "crossref", "first-page": "4939", "DOI": "10.1016/j.bmc.2010.06.011", "volume": "18", "author": "AS Aboraia", "year": "2010", "unstructured": "Aboraia AS, Yee SW, Gomaa MS, Shah N, Robotham AC, Makowski B, Prosser D, Brancale A, Jones G, Simons C (2010) Synthesis and CYP24A1 inhibitory activity of N-(2-(1H-imidazol-1-yl)-2-phenylethyl)arylamides. Bioorg Med Chem 18:4939\u20134946", "journal-title": "Bioorg Med Chem"}, {"key": "9_CR2491", "doi-asserted-by": "crossref", "first-page": "4427", "DOI": "10.1016/j.ejmech.2010.07.001", "volume": "45", "author": "AS Aboraia", "year": "2010", "unstructured": "Aboraia AS, Makowski B, Bahja A, Prosser D, Brancale A, Jones G, Simons C (2010) Synthesis and CYP24A1 inhibitory activity of (E)-2-(2-substituted benzylidene)- and 2-(2-substituted benzyl)-6-methoxy-tetralones. Eur J Med Chem 45:4427\u20134434", "journal-title": "Eur J Med Chem"}, {"key": "9_CR2492", "doi-asserted-by": "crossref", "first-page": "10403", "DOI": "10.1021/bi101488p", "volume": "49", "author": "J Zhu", "year": "2010", "unstructured": "Zhu J, Barycki R, Chiellini G, DeLuca HF (2010) Screening of selective inhibitors of 1\u03b1,25-dihydroxyvitamin D3 24-hydroxylase using recombinant human enzyme expressed in Escherichia coli. Biochemistry 49:10403\u201310411", "journal-title": "Biochemistry"}, {"key": "9_CR2493", "doi-asserted-by": "crossref", "first-page": "4301", "DOI": "10.1210/en.2009-1156", "volume": "151", "author": "JR Muindi", "year": "2010", "unstructured": "Muindi JR, Yu WD, Ma Y, Engler KL, Kong RX, Trump DL, Johnson CS (2010) CYP24A1 inhibitionenhances the antitumor activity of calcitriol. Endocrinology 151:4301\u20134312", "journal-title": "Endocrinology"}, {"key": "9_CR2494", "doi-asserted-by": "crossref", "first-page": "e45063", "DOI": "10.1371/journal.pone.0045063", "volume": "7", "author": "J Garcia-Quiroz", "year": "2012", "unstructured": "Garcia-Quiroz J, Garcia-Becerra R, Barrera D, Santos N, Avila E, Ordaz-Rosado D, Rivas-Suarez M, Halhali A, Rodriguez P, Gamboa-Dominguez A, Medina-Franco H, Camacho J, Larrea F, Diaz L (2012) Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy. PLoS One 7:e45063", "journal-title": "PLoS One"}, {"key": "9_CR2495", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.2174/18715206113139990307", "volume": "14", "author": "T Sakaki", "year": "2014", "unstructured": "Sakaki T, Yasuda K, Kittaka A, Yamamoto K, Chen TC (2014) CYP24A1 as a potential target for cancer therapy. Anti-cancer Agents Med Chem 14:97\u2013108", "journal-title": "Anti-cancer Agents Med Chem"}, {"key": "9_CR2496", "doi-asserted-by": "crossref", "first-page": "391", "DOI": "10.1016/S0039-128X(00)00158-6", "volume": "66", "author": "HL Henry", "year": "2001", "unstructured": "Henry HL (2001) The 25(OH)D3/1\u03b1,25(OH)2D3\u201324R-hydroxylase: a catabolic or biosynthetic enzyme? Steroids 66:391\u2013398", "journal-title": "Steroids"}, {"key": "9_CR2497", "doi-asserted-by": "crossref", "first-page": "1332", "DOI": "10.1016/S0006-291X(02)02254-4", "volume": "297", "author": "H Kasuga", "year": "2002", "unstructured": "Kasuga H, Hosogane N, Matsuoka K, Mori I, Sakura Y, Shimakawa K, Shinki T, Suda T, Taketomi S (2002) Characterization of transgenic rats constitutively expressing vitamin D-24-hydroxylase gene. Biochem Biophys Res Commun 297:1332\u20131338", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR2498", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.2174/1871520611009030213", "volume": "10", "author": "AN King", "year": "2010", "unstructured": "King AN, Beer DG, Christensen PJ, Simpson RU, Ramnath N (2010) The vitamin D/CYP24A1 story in cancer. Anti-cancer Agents Med Chem 10:213\u2013224", "journal-title": "Anti-cancer Agents Med Chem"}, {"key": "9_CR2499", "doi-asserted-by": "crossref", "first-page": "364", "DOI": "10.1096/fj.13-236109", "volume": "28", "author": "M Tannour-Louet", "year": "2014", "unstructured": "Tannour-Louet M, Lewis SK, Louet JF, Stewart J, Addai JB, Sahin A, Vangapandu HV, Lewis AL, Dittmar K, Pautler RG, Zhang L, Smith RG, Lamb DJ (2014) Increased expression of CYP24A1 correlates with advanced stages of prostate cancer and can cause resistance to vitamin D3-based therapies. FASEB J 28:364\u2013372", "journal-title": "FASEB J"}, {"key": "9_CR2500", "doi-asserted-by": "crossref", "first-page": "252", "DOI": "10.1016/j.jsbmb.2012.09.031", "volume": "136", "author": "W Luo", "year": "2013", "unstructured": "Luo W, Hershberger PA, Trump DL, Johnson CS (2013) 24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics. J Steroid Biochem Mol Biol 136:252\u2013257", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2501", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.1097/MNH.0b013e3283477a7b", "volume": "20", "author": "M Petkovich", "year": "2011", "unstructured": "Petkovich M, Jones G (2011) CYP24A1 and kidney disease. Curr Opin Nephrol Hypertens 20:337\u2013344", "journal-title": "Curr Opin Nephrol Hypertens"}, {"key": "9_CR2502", "doi-asserted-by": "crossref", "first-page": "649", "DOI": "10.2215/CJN.05360512", "volume": "8", "author": "G Nesterova", "year": "2013", "unstructured": "Nesterova G, Malicdan MC, Yasuda K, Sakaki T, Vilboux T, Ciccone C, Horst R, Huang Y, Golas G, Introne W, Huizing M, Adams D, Boerkoel CF, Collins MT, Gahl WA (2013) 1,25-(OH)2 D-24 hydroxylase (CYP24A1) deficiency as a cause of nephrolithiasis. Clin J Am Soc Nephrol 8:649\u2013657", "journal-title": "Clin J Am Soc Nephrol"}, {"key": "9_CR2503", "doi-asserted-by": "crossref", "first-page": "410", "DOI": "10.1056/NEJMoa1103864", "volume": "365", "author": "KP Schlingmann", "year": "2011", "unstructured": "Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, Misselwitz J, Klaus G, Kuwertz-Broking E, Fehrenbach H, Wingen AM, Guran T, Hoenderop JG, Bindels RJ, Prosser DE, Jones G, Konrad M (2011) Mutations in CYP24A1 and idiopathic infantile hypercalcemia. New Engl J Med 365:410\u2013421", "journal-title": "New Engl J Med"}, {"key": "9_CR2504", "doi-asserted-by": "crossref", "first-page": "646", "DOI": "10.1093/ndt/gft460", "volume": "29", "author": "G Colussi", "year": "2014", "unstructured": "Colussi G, Ganon L, Penco S, De Ferrari ME, Ravera F, Querques M, Primignani P, Holtzman EJ, Dinour D (2014) Chronic hypercalcaemia from inactivating mutations of vitamin D 24-hydroxylase (CYP24A1): implications for mineral metabolism changes in chronic renal failure. Nephrol Dialysis Transplant 29:646\u2013643", "journal-title": "Nephrol Dialysis Transplant"}, {"key": "9_CR2505", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1152/physiolgenomics.00182.2010", "volume": "43", "author": "AC Ross", "year": "2011", "unstructured": "Ross AC, Cifelli CJ, Zolfaghari R, Li NQ (2011) Multiple cytochrome P-450 genes are concomitantly regulated by vitamin A under steady-state conditions and by retinoic acid during hepatic first-pass metabolism. Physiol Genomics 43:57\u201367", "journal-title": "Physiol Genomics"}, {"key": "9_CR2506", "doi-asserted-by": "crossref", "first-page": "149", "DOI": "10.1016/j.bcp.2011.10.007", "volume": "83", "author": "AR Topletz", "year": "2012", "unstructured": "Topletz AR, Thatcher JE, Zelter A, Lutz JD, Tay S, Nelson WL, Isoherranen N (2012) Comparison of the function and expression of CYP26A1 and CYP26B1, the two retinoic acid hydroxylases. Biochem Pharmacol 83:149\u2013163", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR2507", "doi-asserted-by": "crossref", "first-page": "218", "DOI": "10.1124/mol.109.059071", "volume": "77", "author": "S Tay", "year": "2010", "unstructured": "Tay S, Dickmann L, Dixit V, Isoherranen N (2010) A comparison of the roles of peroxisome proliferator-activated receptor and retinoic acid receptor on CYP26 regulation. Mol Pharmacol 77:218\u2013227", "journal-title": "Mol Pharmacol"}, {"key": "9_CR2508", "doi-asserted-by": "crossref", "first-page": "903", "DOI": "10.1016/j.bcp.2010.05.023", "volume": "80", "author": "JE Thatcher", "year": "2010", "unstructured": "Thatcher JE, Zelter A, Isoherranen N (2010) The relative importance of CYP26A1 in hepatic clearance of all-trans retinoic acid. Biochem Pharmacol 80:903\u2013912", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR2509", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1146/annurev-nutr-072610-145127", "volume": "31", "author": "AC Ross", "year": "2011", "unstructured": "Ross AC, Zolfaghari R (2011) Cytochrome P450s in the regulation of cellular retinoic acid metabolism. Annu Rev Nutr 31:65\u201387", "journal-title": "Annu Rev Nutr"}, {"key": "9_CR2510", "doi-asserted-by": "crossref", "first-page": "32", "DOI": "10.1016/j.gene.2010.05.004", "volume": "464", "author": "Y Zhang", "year": "2010", "unstructured": "Zhang Y, Zolfaghari R, Ross AC (2010) Multiple retinoic acid response elements cooperate to enhance the inducibility of CYP26A1 gene expression in liver. Gene 464:32\u201343", "journal-title": "Gene"}, {"key": "9_CR2511", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1097/FPC.0b013e32801152d6", "volume": "17", "author": "SJ Lee", "year": "2007", "unstructured": "Lee SJ, Perera L, Coulter SJ, Mohrenweiser HW, Jetten A, Goldstein JA (2007) The discovery of new coding alleles of human CYP26A1 that are potentially defective in the metabolism of all-trans retinoic acid and their assessment in a recombinant cDNA expression system. Pharmacogenet Genomics 17:169\u2013180", "journal-title": "Pharmacogenet Genomics"}, {"key": "9_CR2512", "doi-asserted-by": "crossref", "first-page": "1402", "DOI": "10.2174/1568026611313120004", "volume": "13", "author": "CH Nelson", "year": "2013", "unstructured": "Nelson CH, Buttrick BR, Isoherranen N (2013) Therapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobiotics. Curr Topics Med Chem 13:1402\u20131428", "journal-title": "Curr Topics Med Chem"}, {"key": "9_CR2513", "doi-asserted-by": "crossref", "first-page": "228", "DOI": "10.1124/mol.111.072413", "volume": "80", "author": "JE Thatcher", "year": "2011", "unstructured": "Thatcher JE, Buttrick B, Shaffer SA, Shimshoni JA, Goodlett DR, Nelson WL, Isoherranen N (2011) Substrate specificity and ligand interactions of CYP26A1, the human liver retinoic acid hydroxylase. Mol Pharmacol 80:228\u2013239", "journal-title": "Mol Pharmacol"}, {"key": "9_CR2514", "doi-asserted-by": "crossref", "first-page": "487", "DOI": "10.1080/14756360802218334", "volume": "24", "author": "S Pautus", "year": "2009", "unstructured": "Pautus S, Aboraia AS, Bassett CE, Brancale A, Coogan MP, Simons C (2009) Design and synthesis of substituted imidazole and triazole N-phenylbenzo[d]oxazolamine inhibitors of retinoic acid metabolizing enzyme CYP26. J Enzyme Inhib Med Chem 24:487\u2013498", "journal-title": "J Enzyme Inhib Med Chem"}, {"key": "9_CR2515", "doi-asserted-by": "crossref", "first-page": "8301", "DOI": "10.1016/j.bmc.2007.06.048", "volume": "16", "author": "MS Gomaa", "year": "2008", "unstructured": "Gomaa MS, Armstrong JL, Bobillon B, Veal GJ, Brancale A, Redfern CP, Simons C (2008) Novel azolyl-(phenylmethyl)]aryl/heteroarylamines: potent CYP26 inhibitors and enhancers of all-trans retinoic acid activity in neuroblastoma cells. Bioorg Med Chem 16:8301\u20138313", "journal-title": "Bioorg Med Chem"}, {"key": "9_CR2516", "doi-asserted-by": "crossref", "first-page": "6803", "DOI": "10.1021/jm200695m", "volume": "54", "author": "MS Gomaa", "year": "2011", "unstructured": "Gomaa MS, Bridgens CE, Veal GJ, Redfern CP, Brancale A, Armstrong JL, Simons C (2011) Synthesis and biological evaluation of 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propyl derivatives as small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26). J Med Chem 54:6803\u20136811", "journal-title": "J Med Chem"}, {"key": "9_CR2517", "doi-asserted-by": "crossref", "first-page": "388", "DOI": "10.6026/97320630007388", "volume": "7", "author": "M Yadav", "year": "2011", "unstructured": "Yadav M (2011) 2 D\u2014QSAR studies on CYP26A1 inhibitory activity of 1-[benzofuran-2-yl-(4-alkyl/aryl-phenyl)-methyl]-1H-triazoles. Bioinformation 7:388\u2013392", "journal-title": "Bioinformation"}, {"key": "9_CR2518", "doi-asserted-by": "crossref", "first-page": "4201", "DOI": "10.1016/j.bmc.2012.05.076", "volume": "20", "author": "MS Gomaa", "year": "2012", "unstructured": "Gomaa MS, Bridgens CE, Illingworth NA, Veal GJ, Redfern CP, Brancale A, Armstrong JL, Simons C (2012) Novel retinoic acid 4-hydroxylase (CYP26) inhibitorsbased on a 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(phenylamino)phenyl)propyl scaffold. Bioorg Med Chem 20:4201\u20134207", "journal-title": "Bioorg Med Chem"}, {"key": "9_CR2519", "doi-asserted-by": "crossref", "first-page": "6080", "DOI": "10.1016/j.bmc.2012.08.044", "volume": "20", "author": "MS Gomaa", "year": "2012", "unstructured": "Gomaa MS, Lim AS, Lau SC, Watts AM, Illingworth NA, Bridgens CE, Veal GJ, Redfern CP, Brancale A, Armstrong JL, Simons C (2012) Synthesis and CYP26A1 inhibitory activity of novel methyl 3-[4-(arylamino)phenyl]-3-(azole)-2,2-dimethylpropanoates. Bioorg Med Chem 20:6080\u20136088", "journal-title": "Bioorg Med Chem"}, {"key": "9_CR2520", "doi-asserted-by": "crossref", "first-page": "3256", "DOI": "10.1016/j.bmc.2013.03.044", "volume": "21", "author": "F Li", "year": "2013", "unstructured": "Li F, Zhao D, Ren J, Hao F, Liu G, Jin S, Jing Y, Cheng M (2013) 2-(2-Methylfuran-3-carboxamido)-3-phenylpropanoic acid, a potential CYP26A1 inhibitor to enhance all-trans retinoic acid-induced leukemia cell differentiation based on virtual screening and biological evaluation. Bioorg Med Chem 21:3256\u20133261", "journal-title": "Bioorg Med Chem"}, {"key": "9_CR2521", "doi-asserted-by": "crossref", "first-page": "28801", "DOI": "10.1074/jbc.M113.474254", "volume": "288", "author": "MJ Ricard", "year": "2013", "unstructured": "Ricard MJ, Gudas LJ (2013) Cytochrome P450 CYP26A1 alters spinal motor neuron subtype identity in differentiating embryonic stem cells. J Biol Chem 288:28801\u201328813", "journal-title": "J Biol Chem"}, {"key": "9_CR2522", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1016/j.ydbio.2007.12.021", "volume": "315", "author": "S Langton", "year": "2008", "unstructured": "Langton S, Gudas LJ (2008) CYP26A1 knockout embryonic stem cells exhibit reduced differentiation and growth arrest in response to retinoic acid. Dev Biol 315:331\u2013354", "journal-title": "Dev Biol"}, {"key": "9_CR2523", "first-page": "2072", "volume": "17", "author": "F Meire", "year": "2011", "unstructured": "Meire F, Delpierre I, Brachet C, Roulez F, Van Nechel C, Depasse F, Christophe C, Menten B, De Baere E (2011) Nonsyndromic bilateral and unilateral optic nerve aplasia: first familial occurrence and potential implication of CYP26A1 and CYP26C1 genes. Mol Vis 17:2072\u20132079", "journal-title": "Mol Vis"}, {"key": "9_CR2524", "doi-asserted-by": "crossref", "first-page": "491", "DOI": "10.1002/bdra.20275", "volume": "76", "author": "E Rat", "year": "2006", "unstructured": "Rat E, Billaut-Laden I, Allorge D, Lo-Guidice JM, Tellier M, Cauffiez C, Jonckheere N, van Seuningen I, Lhermitte M, Romano A, Gueant JL, Broly F (2006) Evidence for a functional genetic polymorphism of the human retinoic acid-metabolizing enzyme CYP26A1, an enzyme that may be involved in spina bifida. Birth Defects Res A Clin Mol Teratol 76:491\u2013498", "journal-title": "Birth Defects Res A Clin Mol Teratol"}, {"key": "9_CR2525", "doi-asserted-by": "crossref", "first-page": "86", "DOI": "10.1002/bdra.20225", "volume": "76", "author": "P De Marco", "year": "2006", "unstructured": "De Marco P, Merello E, Mascelli S, Raso A, Santamaria A, Ottaviano C, Calevo MG, Cama A, Capra V (2006) Mutational screening of the CYP26A1 gene in patients with caudal regression syndrome. Birth Defects Res A Clin Mol Teratol 76:86\u201395", "journal-title": "Birth Defects Res A Clin Mol Teratol"}, {"key": "9_CR2526", "doi-asserted-by": "crossref", "first-page": "2463", "DOI": "10.1002/ajmg.a.35565", "volume": "158A", "author": "ML Browne", "year": "2012", "unstructured": "Browne ML, Carter TC, Kay DM, Kuehn D, Brody LC, Romitti PA, Liu A, Caggana M, Druschel CM, Mills JL (2012) Evaluation of genes involved in limb development, angiogenesis, and coagulation as risk factors for congenital limb deficiencies. Am J Med Genet A 158A:2463\u20132472", "journal-title": "Am J Med Genet A"}, {"key": "9_CR2527", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1006/abbi.1999.1438", "volume": "371", "author": "DR Nelson", "year": "1999", "unstructured": "Nelson DR (1999) A second CYP26 P450 in humans and zebrafish: CYP26B1. Arch Biochem Biophys 371:345\u2013347", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR2528", "doi-asserted-by": "crossref", "first-page": "175", "DOI": "10.1016/S0165-3806(02)00305-X", "volume": "136", "author": "ME Trofimova-Griffin", "year": "2002", "unstructured": "Trofimova-Griffin ME, Juchau MR (2002) Developmental expression of cytochrome CYP26B1 (P450RAI-2) in human cephalic tissues. Brain Res Dev Brain Res 136:175\u2013178", "journal-title": "Brain Res Dev Brain Res"}, {"key": "9_CR2529", "doi-asserted-by": "crossref", "first-page": "3561", "DOI": "10.1096/fj.11-184333", "volume": "25", "author": "K Kashimada", "year": "2011", "unstructured": "Kashimada K, Svingen T, Feng CW, Pelosi E, Bagheri-Fam S, Harley VR, Schlessinger D, Bowles J, Koopman P (2011) Antagonistic regulation of Cyp26b1 by transcription factors SOX9/SF1 and FOXL2 during gonadal development in mice. FASEB J 25:3561\u20133569", "journal-title": "FASEB J"}, {"key": "9_CR2530", "doi-asserted-by": "crossref", "first-page": "e16089", "DOI": "10.1371/journal.pone.0016089", "volume": "6", "author": "H Takeuchi", "year": "2011", "unstructured": "Takeuchi H, Yokota A, Ohoka Y, Iwata M (2011) Cyp26b1 regulates retinoic acid-dependent signals in T cells and its expression is inhibited by transforming growth factor-beta. PLoS One 6:e16089", "journal-title": "PLoS One"}, {"key": "9_CR2531", "doi-asserted-by": "crossref", "first-page": "e72739", "DOI": "10.1371/journal.pone.0072739", "volume": "8", "author": "K Fransen", "year": "2013", "unstructured": "Fransen K, Franzen P, Magnuson A, Elmabsout AA, Nyhlin N, Wickbom A, Curman B, Torkvist L, D\u2019Amato M, Bohr J, Tysk C, Sirsjo A, Halfvarson J (2013) Polymorphism in the retinoic acid metabolizing enzyme CYP26B1 and the development of Crohn\u2019s disease. PLoS One 8:e72739", "journal-title": "PLoS One"}, {"key": "9_CR2532", "doi-asserted-by": "crossref", "first-page": "2631", "DOI": "10.1021/ci300264u", "volume": "52", "author": "P Saenz-Mendez", "year": "2012", "unstructured": "Saenz-Mendez P, Elmabsout AA, Savenstrand H, Awadalla MK, Strid A, Sirsjo A, Eriksson LA (2012) Homology models of human all-trans retinoic acid metabolizing enzymes CYP26B1 and CYP26B1 spliced variant. J Chem Inf Model 52:2631\u20132637", "journal-title": "J Chem Inf Model"}, {"key": "9_CR2533", "doi-asserted-by": "crossref", "first-page": "449", "DOI": "10.1016/S1567-133X(03)00066-8", "volume": "3", "author": "A Tahayato", "year": "2003", "unstructured": "Tahayato A, Dolle P, Petkovich M (2003) Cyp26C1 encodes a novel retinoic acid-metabolizing enzyme expressed in the hindbrain, inner ear, first branchial arch and tooth buds during murine development. Gene Expr Patterns 3:449\u2013454", "journal-title": "Gene Expr Patterns"}, {"key": "9_CR2534", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1016/j.ydbio.2004.08.032", "volume": "276", "author": "Y Sakai", "year": "2004", "unstructured": "Sakai Y, Luo T, McCaffery P, Hamada H, Drager UC (2004) CYP26A1 and CYP26C1 cooperate in degrading retinoic acid within the equatorial retina during later eye development. Dev Biol 276:143\u2013157", "journal-title": "Dev Biol"}, {"key": "9_CR2535", "doi-asserted-by": "crossref", "first-page": "438", "DOI": "10.1016/j.gep.2008.04.003", "volume": "8", "author": "J Xi", "year": "2008", "unstructured": "Xi J, Yang Z (2008) Expression of RALDHs (ALDH1As) and CYP26s in human tissues and during the neural differentiation of P19 embryonal carcinoma stem cell. Gene Expr Patterns 8:438\u2013442", "journal-title": "Gene Expr Patterns"}, {"key": "9_CR2536", "doi-asserted-by": "crossref", "first-page": "696", "DOI": "10.1093/hmg/dds477", "volume": "22", "author": "AM Slavotinek", "year": "2013", "unstructured": "Slavotinek AM, Mehrotra P, Nazarenko I, Tang PL, Lao R, Cameron D, Li B, Chu C, Chou C, Marqueling AL, Yahyavi M, Cordoro K, Frieden I, Glaser T, Prescott T, Morren MA, Devriendt K, Kwok PY, Petkovich M, Desnick RJ (2013) Focal facial dermal dysplasia, type IV, is caused by mutations in CYP26C1. Hum Mol Genet 22:696\u2013703", "journal-title": "Hum Mol Genet"}, {"key": "9_CR2537", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1074/jbc.M308337200", "volume": "279", "author": "M Taimi", "year": "2004", "unstructured": "Taimi M, Helvig C, Wisniewski J, Ramshaw H, White J, Amad M, Korczak B, Petkovich M (2004) A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid. J Biol Chem 279:77\u201385", "journal-title": "J Biol Chem"}, {"key": "9_CR2538", "doi-asserted-by": "crossref", "first-page": "426", "DOI": "10.1111/j.1365-2133.1995.tb02672.x", "volume": "133", "author": "P Dockx", "year": "1995", "unstructured": "Dockx P, Decree J, Degreef H (1995) Inhibition of the metabolism of endogenous retinoic acid as treatment for severe psoriasis: an open study with oral liarozole. Br J Dermatol 133:426\u2013432", "journal-title": "Br J Dermatol"}, {"key": "9_CR2539", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1016/S0925-4439(02)00157-6", "volume": "1588", "author": "Y Matsuzaki", "year": "2002", "unstructured": "Matsuzaki Y, Bouscarel B, Ikegami T, Honda A, Doy M, Ceryak S, Fukushima S, Yoshida S, Shoda J, Tanaka N (2002) Selective inhibition of CYP27A1 and of chenodeoxycholic acid synthesis in cholestatic hamster liver. Biochim Biophys Acta 1588:139\u2013148", "journal-title": "Biochim Biophys Acta"}, {"key": "9_CR2540", "doi-asserted-by": "crossref", "first-page": "491", "DOI": "10.1006/bbrc.1997.7551", "volume": "241", "author": "H Postlind", "year": "1997", "unstructured": "Postlind H, Ax\u00e9n E, Bergman T, Wikvall K (1997) Cloning, structure, and expression of a cDNA encoding vitamin D3 25-hydroxylase. Biochem Biophys Res Commun 241:491\u2013497", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR2541", "doi-asserted-by": "crossref", "first-page": "994", "DOI": "10.1016/0006-291X(84)90775-7", "volume": "121", "author": "S Hayashi", "year": "1984", "unstructured": "Hayashi S, Noshiro M, Okuda K (1984) Purification of cytochrome P-450 catalyzing 25-hydroxylation of vitamin D3 from rat liver microsomes. Biochem Biophys Res Commun 121:994\u20131000", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR2542", "doi-asserted-by": "crossref", "first-page": "117", "DOI": "10.1016/0304-4165(85)90168-0", "volume": "840", "author": "K Saarem", "year": "1985", "unstructured": "Saarem K, Pedersen JI (1985) 25-hydroxylation of 1\u03b1-hydroxyvitamin D3 in rat and human liver. Biochim Biophys Acta 840:117\u2013126", "journal-title": "Biochim Biophys Acta"}, {"key": "9_CR2543", "doi-asserted-by": "crossref", "first-page": "367", "DOI": "10.1016/0014-5793(91)80333-X", "volume": "280", "author": "M Akiyoshi-Shibata", "year": "1991", "unstructured": "Akiyoshi-Shibata M, Usui E, Sakaki T, Yabusaki Y, Noshiro M, Okuda K, Ohkawa H (1991) Expression of rat liver vitamin D3 25-hydroxylase cDNA in Saccharomyces cerevisiae. FEBS Lett 280:367\u2013370", "journal-title": "FEBS Lett"}, {"key": "9_CR2544", "doi-asserted-by": "crossref", "first-page": "8668", "DOI": "10.1073/pnas.90.18.8668", "volume": "90", "author": "YD Guo", "year": "1993", "unstructured": "Guo YD, Strugnell S, Back DW, Jones G (1993) Transfected human liver cytochrome P-450 hydroxylates vitamin D analogs at different side-chain positions. Proc Natl Acad Sci U S A 90:8668\u20138672", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR2545", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1136/jnnp.67.5.675", "volume": "67", "author": "K Shiga", "year": "1999", "unstructured": "Shiga K, Fukuyama R, Kimura S, Nakajima K, Fushiki S (1999) Mutation of the sterol 27-hydroxylase gene (CYP27) results in truncation of mRNA expressed in leucocytes in a Japanese family with cerebrotendinous xanthomatosis. J Neurol Neurosurg Psychiatry 67:675\u2013677", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "9_CR2546", "first-page": "2322", "volume": "38", "author": "R Garuti", "year": "1997", "unstructured": "Garuti R, Croce MA, Tiozzo R, Dotti MT, Federico A, Bertolini S, Calandra S (1997) Four novel mutations of sterol 27-hydroxylase gene in Italian patients with cerebrotendinous xanthomatosis. J Lipid Res 38:2322\u20132334", "journal-title": "J Lipid Res"}, {"key": "9_CR2547", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1046/j.1365-2265.2001.01160.x", "volume": "54", "author": "M Gascon-Barre", "year": "2001", "unstructured": "Gascon-Barre M, Demers C, Ghrab O, Theodoropoulos C, Lapointe R, Jones G, Valiquette L, Menard D (2001) Expression of CYP27A, a gene encoding a vitamin D-25 hydroxylase in human liver and kidney. Clin Endocrinol 54:107\u2013115", "journal-title": "Clin Endocrinol"}, {"key": "9_CR2548", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.1016/S0021-9150(00)00473-1", "volume": "154", "author": "CM Shanahan", "year": "2001", "unstructured": "Shanahan CM, Carpenter KL, Cary NR (2001) A potential role for sterol 27-hydroxylase in atherogenesis. Atherosclerosis 154:269\u2013276", "journal-title": "Atherosclerosis"}, {"key": "9_CR2549", "doi-asserted-by": "crossref", "first-page": "1117", "DOI": "10.1194/jlr.M014217", "volume": "52", "author": "GY Heo", "year": "2011", "unstructured": "Heo GY, Bederman I, Mast N, Liao WL, Turko IV, Pikuleva IA (2011) Conversion of 7-ketocholesterol to oxysterol metabolites by recombinant CYP27A1 and retinal pigment epithelial cells. J Lipid Res 52:1117\u20131127", "journal-title": "J Lipid Res"}, {"key": "9_CR2550", "doi-asserted-by": "crossref", "first-page": "20413", "DOI": "10.1074/jbc.M111.232546", "volume": "286", "author": "C Charvet", "year": "2011", "unstructured": "Charvet C, Liao WL, Heo GY, Laird J, Salomon RG, Turko IV, Pikuleva IA (2011) Isolevuglandins and mitochondrial enzymes in the retina: mass spectrometry detection of post-translational modification of sterol-metabolizing CYP27A1. J Biol Chem 286:20413\u201320422", "journal-title": "J Biol Chem"}, {"key": "9_CR2551", "doi-asserted-by": "crossref", "first-page": "657", "DOI": "10.1089/dna.1990.9.657", "volume": "9", "author": "P Su", "year": "1990", "unstructured": "Su P, Rennert H, Shayiq RM, Yamamoto R, Zheng Y, Addya S, Strauss JF III, Avadhani NG (1990) A cDNA encoding a rat mitochondrial cytochrome P450 catalyzing both the 26-hydroxylation of cholesteroland 25-hydroxylation of vitamin D3: gonadotropic regulation of the cognate mRNA in ovaries. DNA Cell Biol 9:657\u2013665", "journal-title": "DNA Cell Biol"}, {"key": "9_CR2552", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1016/j.abb.2007.04.001", "volume": "462", "author": "W Tang", "year": "2007", "unstructured": "Tang W, Norlin M, Wikvall K (2007) Regulation of human CYP27A1 by estrogens and androgens in HepG2 and prostate cells. Arch Biochem Biophys 462:13\u201320", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR2553", "doi-asserted-by": "crossref", "first-page": "44", "DOI": "10.1016/j.bbalip.2004.11.002", "volume": "1687", "author": "M Hansson", "year": "2005", "unstructured": "Hansson M, Wikvall K, Babiker A (2005) Regulation of sterol 27-hydroxylase in human monocyte-derived macrophages: up-regulation by transforming growth factor beta1. Biochim Biophys Acta 1687:44\u201351", "journal-title": "Biochim Biophys Acta"}, {"key": "9_CR2554", "doi-asserted-by": "crossref", "first-page": "8154", "DOI": "10.1128/MCB.24.18.8154-8166.2004", "volume": "24", "author": "A Szanto", "year": "2004", "unstructured": "Szanto A, Benko S, Szatmari I, Balint BL, Furtos I, Ruhl R, Molnar S, Csiba L, Garuti R, Calandra S, Larsson H, Diczfalusy U, Nagy L (2004) Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages. Mol Cell Biol 24:8154\u20138166", "journal-title": "Mol Cell Biol"}, {"key": "9_CR2555", "doi-asserted-by": "crossref", "first-page": "823", "DOI": "10.1042/BJ20041776", "volume": "385", "author": "CM Quinn", "year": "2005", "unstructured": "Quinn CM, Jessup W, Wong J, Kritharides L, Brown AJ (2005) Expression and regulation of sterol 27-hydroxylase (CYP27A1) in human macrophages: a role for RXR and PPAR\u03b3 ligands. Biochem J 385:823\u2013830", "journal-title": "Biochem J"}, {"key": "9_CR2556", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1194/jlr.M600282-JLR200", "volume": "48", "author": "T Li", "year": "2007", "unstructured": "Li T, Chen W, Chiang JY (2007) PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine. J Lipid Res 48:373\u2013384", "journal-title": "J Lipid Res"}, {"key": "9_CR2557", "doi-asserted-by": "crossref", "first-page": "603", "DOI": "10.1016/j.bbrc.2007.03.177", "volume": "357", "author": "F Hosseinpour", "year": "2007", "unstructured": "Hosseinpour F, Ellfolk M, Norlin M, Wikvall K (2007) Phenobarbital suppresses vitamin D3 25-hydroxylase expression: a potential new mechanism for drug-induced osteomalacia. Biochem Biophys Res Commun 357:603\u2013607", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR2558", "doi-asserted-by": "crossref", "first-page": "1311", "DOI": "10.1007/s00415-002-0762-9", "volume": "249", "author": "MJ Lee", "year": "2002", "unstructured": "Lee MJ, Huang YC, Sweeney MG, Wood NW, Reilly MM, Yip PK (2002) Mutation of the sterol 27-hydroxylase gene (CYP27A1) in a Taiwanese family with cerebrotendinous xanthomatosis. J Neurol 249:1311\u20131312", "journal-title": "J Neurol"}, {"key": "9_CR2559", "doi-asserted-by": "crossref", "first-page": "15050", "DOI": "10.1021/bi9807660", "volume": "37", "author": "W Chen", "year": "1998", "unstructured": "Chen W, Kubota S, Ujike H, Ishihara T, Seyama Y (1998) A novel Arg362Ser mutation in the sterol 27-hydroxylase gene (CYP27): its effects on pre-mRNA splicing and enzyme activity. Biochemistry 37:15050\u201315056", "journal-title": "Biochemistry"}, {"key": "9_CR2560", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1007/s10072-006-0618-7", "volume": "27", "author": "GN Gallus", "year": "2006", "unstructured": "Gallus GN, Dotti MT, Federico A (2006) Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene. Neurolog Sci 27:143\u2013149", "journal-title": "Neurolog Sci"}, {"key": "9_CR2561", "doi-asserted-by": "crossref", "first-page": "481", "DOI": "10.1097/01.MPG.0000150419.23031.2A", "volume": "40", "author": "S von Bahr", "year": "2005", "unstructured": "von Bahr S, Bjorkhem I, Van\u2019t Hooft F, Alvelius G, Nemeth A, Sjovall J, Fischler B (2005) Mutation in the sterol 27-hydroxylase gene associated with fatal cholestasis in infancy. J Pediatr Gastroenterol Nutr 40:481\u2013486", "journal-title": "J Pediatr Gastroenterol Nutr"}, {"key": "9_CR2562", "doi-asserted-by": "crossref", "first-page": "e35333", "DOI": "10.1371/journal.pone.0035333", "volume": "7", "author": "CG Saris", "year": "2012", "unstructured": "Diekstra FP, Saris CG, van Rheenen W, Franke L, Jansen RC, van Es MA, van Vught PW, Blauw HM, Groen EJ, Horvath S, Estrada K, Rivadeneira F, Hofman A, Uitterlinden AG, Robberecht W, Andersen PM, Melki J, Meininger V, Hardiman O, Landers JE, Brown RH Jr, Shatunov A, Shaw CE, Leigh PN, Al-Chalabi A, Ophoff RA, van den Berg LH, Veldink JH (2012) Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS. PLoS One 7:e35333", "journal-title": "PLoS One"}, {"key": "9_CR2563", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1007/s008940100035", "volume": "7", "author": "K Wikvall", "year": "2001", "unstructured": "Wikvall K (2001) Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form. Int J Mol Med 7:201\u2013209", "journal-title": "Int J Mol Med"}, {"key": "9_CR2564", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1006/abbi.1997.0142", "volume": "343", "author": "IA Pikuleva", "year": "1997", "unstructured": "Pikuleva IA, Bj\u00f6rkhelm I, Waterman MR (1997) Expression, purification, and enzymatic properties of recombinant human cytochrome P450c27 (CYP27). Arch Biochem Biophys 343:123\u2013130", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR2565", "doi-asserted-by": "crossref", "first-page": "18153", "DOI": "10.1074/jbc.273.29.18153", "volume": "273", "author": "IA Pikuleva", "year": "1998", "unstructured": "Pikuleva IA, Babiker A, Waterman MR, Bj\u00f6rkhem I (1998) Activities of recombinant human cytochrome P450c27 (CYP27) which produce intermediates of alternative bile acid biosynthetic pathways. J Biol Chem 273:18153\u201318160", "journal-title": "J Biol Chem"}, {"key": "9_CR2566", "doi-asserted-by": "crossref", "first-page": "16766", "DOI": "10.1074/jbc.270.28.16766", "volume": "270", "author": "FJ Dilworth", "year": "1995", "unstructured": "Dilworth FJ, Scott I, Green A, Strugnell S, Guo YD, Roberts EA, Kremer R, Calverley MJ, Makin HLJ, Jones G (1995) Different mechanisms of hydroxylation site selection by liver and kidney cytochrome P450 species (CYP27 and CYP24) involved in vitamin D metabolism. J Biol Chem 270:16766\u201316774", "journal-title": "J Biol Chem"}, {"key": "9_CR2567", "doi-asserted-by": "crossref", "first-page": "977", "DOI": "10.1006/bbrc.2000.3050", "volume": "273", "author": "N Sawada", "year": "2000", "unstructured": "Sawada N, Sakaki T, Ohta M, Inouye K (2000) Metabolism of vitamin D3 by human CYP27A1. Biochem Biophys Res Commun 273:977\u2013984", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR2568", "doi-asserted-by": "crossref", "first-page": "40", "DOI": "10.1016/S1388-1981(03)00062-3", "volume": "1632", "author": "Z Araya", "year": "2003", "unstructured": "Araya Z, Hosseinpour F, Bodin K, Wikvall K (2003) Metabolism of 25-hydroxyvitamin D3 by microsomal and mitochondrial vitamin D3 25-hydroxylases (CYP2D25 and CYP27A1): a novel reaction by CYP27A1. Biochim Biophys Acta 1632:40\u201347", "journal-title": "Biochim Biophys Acta"}, {"key": "9_CR2569", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1016/j.abb.2003.09.028", "volume": "420", "author": "I Pikuleva", "year": "2003", "unstructured": "Pikuleva I, Javitt NB (2003) Novel sterols synthesized via the CYP27A1 metabolic pathway. Arch Biochem Biophys 420:35\u201339", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR2570", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1016/j.jsbmb.2013.11.010", "volume": "140", "author": "K Endo-Umeda", "year": "2014", "unstructured": "Endo-Umeda K, Yasuda K, Sugita K, Honda A, Ohta M, Ishikawa M, Hashimoto Y, Sakaki T, Makishima M (2014) 7-Dehydrocholesterol metabolites produced by sterol 27-hydroxylase (CYP27A1) modulate liver X receptor activity. J Steroid Biochem Mol Biol 140:7\u201316", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2571", "doi-asserted-by": "crossref", "first-page": "E9", "DOI": "10.1152/ajpendo.00298.2009", "volume": "297", "author": "G Escher", "year": "2009", "unstructured": "Escher G, Vogeli I, Escher R, Tuckey RC, Erickson S, Krozowski Z, Frey FJ (2009) Role of CYP27A1 in progesterone metabolism in vitro and in vivo. Am J Physiol Endocrinol Metab 297:E949\u2013955", "journal-title": "Am J Physiol Endocrinol Metab"}, {"key": "9_CR2572", "doi-asserted-by": "crossref", "first-page": "1515", "DOI": "10.1194/jlr.M300047-JLR200", "volume": "44", "author": "M Norlin", "year": "2003", "unstructured": "Norlin M, von Bahr S, Bjorkhem I, Wikvall K (2003) On the substrate specificity of human CYP27A1: implications for bile acid and cholestanol formation. J Lipid Res 44:1515\u20131522", "journal-title": "J Lipid Res"}, {"key": "9_CR2573", "doi-asserted-by": "crossref", "first-page": "6607", "DOI": "10.1046/j.0014-2956.2001.02615.x", "volume": "268", "author": "N Sawada", "year": "2001", "unstructured": "Sawada N, Sakaki T, Kitanaka S, Kato S, Inouye K (2001) Structure-function analysis of CYP27B1 and CYP27A1\u2014studies on mutants from patients with vitamin D-dependent ricketstype I (VDDR-I) and cerebrotendinous xanthomatosis (CTX). Eur J Biochem 268:6607\u20136615", "journal-title": "Eur J Biochem"}, {"key": "9_CR2574", "doi-asserted-by": "crossref", "first-page": "7621", "DOI": "10.1021/bi010193i", "volume": "40", "author": "IA Pikuleva", "year": "2001", "unstructured": "Pikuleva IA, Puchkaev A, Bj\u00f6rkhem I (2001) Putative helix F contributes to regioselectivity of hydroxylation in mitochondrial cytochrome P450 27A1. Biochemistry 40:7621\u20137629", "journal-title": "Biochemistry"}, {"key": "9_CR2575", "doi-asserted-by": "crossref", "first-page": "37582", "DOI": "10.1074/jbc.M204909200", "volume": "277", "author": "D Murtazina", "year": "2002", "unstructured": "Murtazina D, Puchkaev AV, Schein CH, Oezguen N, Braun W, Nanavati A, Pikuleva IA (2002) Membrane-protein interactions contribute to efficient 27-hydroxylation of cholesterol by mitochondrial cytochrome P450 27A1. J Biol Chem 277:37582\u201337589", "journal-title": "J Biol Chem"}, {"key": "9_CR2576", "doi-asserted-by": "crossref", "first-page": "1059", "DOI": "10.1006/bbrc.2001.5879", "volume": "288", "author": "F Hosseinpour", "year": "2001", "unstructured": "Hosseinpour F, Hidestrand M, Ingelman-Sundberg M, Wikvall K (2001) The importance of residues in substrate recognition site 3 for the catalytic function of CYP2D25 (vitamin D 25-hydroxylase). Biochem Biophys Res Commun 288:1059\u20131063", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR2577", "doi-asserted-by": "crossref", "first-page": "4396", "DOI": "10.1021/bi052654w", "volume": "45", "author": "N Mast", "year": "2006", "unstructured": "Mast N, Murtazina D, Liu H, Graham SE, Bj\u00f6rkhem I, Halpert JR, Peterson J, Pikuleva IA (2006) Distinct binding of cholesteroland 5\u03b2-cholestane-3\u03b1,7\u03b1,12\u03b1-triol to cytochrome P450 27A1: evidence from modeling and site-directed mutagenesis studies. Biochemistry 45:4396\u20134404", "journal-title": "Biochemistry"}, {"key": "9_CR2578", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.1016/j.bbrc.2007.01.158", "volume": "355", "author": "N Sawada", "year": "2007", "unstructured": "Sawada N, Yamamoto K, Yamada S, Ikushiro S, Kamakura M, Ohta M, Inouye K, Sakaki T (2007) Role of Gln 85 of human CYP27A1 in 25-hydroxyvitamin D3-binding and protein folding. Biochem Biophys Res Commun 355:211\u2013216", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR2579", "first-page": "189", "volume": "14", "author": "MR Wills", "year": "1984", "unstructured": "Wills MR, Savory J (1984) Vitamin D metabolism and chronic liver disease. Ann Clin Lab Sci 14:189\u2013197", "journal-title": "Ann Clin Lab Sci"}, {"key": "9_CR2580", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1023/A:1010564920930", "volume": "24", "author": "S Sugama", "year": "2001", "unstructured": "Sugama S, Kimura A, Chen W, Kubota S, Seyama Y, Taira N, Eto Y (2001) Frontal lobe dementia with abnormal cholesterolmetabolism and heterozygous mutation in sterol 27-hydroxylase gene (CYP27). J Inherit Metab Dis 24:379\u2013392", "journal-title": "J Inherit Metab Dis"}, {"key": "9_CR2581", "doi-asserted-by": "crossref", "first-page": "725", "DOI": "10.1172/JCI0216388", "volume": "110", "author": "I Bj\u00f6rkhem", "year": "2002", "unstructured": "Bj\u00f6rkhem I (2002) Do oxysterols control cholesterolhomeostasis? J Clin Invest 110:725\u2013730", "journal-title": "J Clin Invest"}, {"key": "9_CR2582", "doi-asserted-by": "crossref", "first-page": "14805", "DOI": "10.1074/jbc.273.24.14805", "volume": "273", "author": "H Rosen", "year": "1998", "unstructured": "Rosen H, Reshef A, Maeda N, Lippoldt A, Shpizen S, Triger L, Eggertsen G, Bj\u00f6rkhem I, Leitersdorf E (1998) Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene. J Biol Chem 273:14805\u201314812", "journal-title": "J Biol Chem"}, {"key": "9_CR2583", "first-page": "1913", "volume": "42", "author": "AB Reiss", "year": "2001", "unstructured": "Reiss AB, Awadallah NW, Malhotra S, Montesinos MC, Chan ES, Javitt NB, Cronstein BN (2001) Immune complexes and IFN-\u03b3 decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages. J Lipid Res 42:1913\u20131922", "journal-title": "J Lipid Res"}, {"key": "9_CR2584", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1073/pnas.0237082100", "volume": "100", "author": "B Goodwin", "year": "2003", "unstructured": "Goodwin B, Gauthier KC, Umetani M, Watson MA, Lochansky MI, Collins JL, Leitersdorf E, Mangelsdorf DJ, Kliewer SA, Repa JJ (2003) Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proc Natl Acad Sci U S A 100:223\u2013228", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR2585", "doi-asserted-by": "crossref", "first-page": "1015", "DOI": "10.1074/jbc.M212780200", "volume": "278", "author": "G Escher", "year": "2003", "unstructured": "Escher G, Krozowski Z, Croft KD, Sviridov D (2003) Expression of sterol 27-hydroxylase (CYP27A1) enhances cholesterol efflux. J Biol Chem 278:1015\u20131019", "journal-title": "J Biol Chem"}, {"key": "9_CR2586", "doi-asserted-by": "crossref", "first-page": "38378", "DOI": "10.1074/jbc.M105805200", "volume": "276", "author": "X Fu", "year": "2001", "unstructured": "Fu X, Menke JG, Chen Y, Zhou G, MacNaul KL, Wright SD, Sparrow CP, Lund EG (2001) 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J Biol Chem 276:38378\u201338387", "journal-title": "J Biol Chem"}, {"key": "9_CR2587", "doi-asserted-by": "crossref", "first-page": "1399", "DOI": "10.1038/ijo.2013.6", "volume": "37", "author": "KS Vimaleswaran", "year": "2013", "unstructured": "Vimaleswaran KS, Cavadino A, Berry DJ, Whittaker JC, Power C, Jarvelin MR, Hypponen E (2013) Genetic association analysis of vitamin D pathway with obesity traits. Int J Obes 37:1399\u20131406", "journal-title": "Int J Obes"}, {"key": "9_CR2588", "doi-asserted-by": "crossref", "first-page": "655", "DOI": "10.1016/j.ejmg.2013.09.008", "volume": "56", "author": "K Inanloorahatloo", "year": "2013", "unstructured": "Inanloorahatloo K, Zand Parsa AF, Huse K, Rasooli P, Davaran S, Platzer M, Fan JB, Amini S, Steemers F, Elahi E (2013) Mutation in CYP27A1 identified in family with coronary artery disease. Eur J Med Genet 56:655\u2013660", "journal-title": "Eur J Med Genet"}, {"key": "9_CR2589", "doi-asserted-by": "crossref", "first-page": "283", "DOI": "10.1097/MOL.0b013e328362df13", "volume": "24", "author": "I Bj\u00f6rkhem", "year": "2013", "unstructured": "Bj\u00f6rkhem I (2013) Cerebrotendinous xanthomatosis. Curr Opin Lipidol 24:283\u2013287", "journal-title": "Curr Opin Lipidol"}, {"key": "9_CR2590", "doi-asserted-by": "crossref", "first-page": "1094", "DOI": "10.1126/science.1241908", "volume": "342", "author": "ER Nelson", "year": "2013", "unstructured": "Nelson ER, Wardell SE, Jasper JS, Pard S, Suchindran S, Howe MK, Carver NJ, Pillai RV, Sullivan PM, Sondhi V, Umetani M, Geradts J, McDonnell DP (2013) 27-hydroxycholesterol links hypercholesterolemia and breast cancer therapy. Science 342:1094\u20131098", "journal-title": "Science"}, {"key": "9_CR2591", "doi-asserted-by": "crossref", "first-page": "563", "DOI": "10.1016/0006-2952(77)90025-9", "volume": "26", "author": "HF DeLuca", "year": "1977", "unstructured": "DeLuca HF (1977) Vitamin D as a prohormone. Biochem Pharmacol 26:563\u2013566", "journal-title": "Biochem Pharmacol"}, {"key": "9_CR2592", "first-page": "11488", "volume": "260", "author": "SK Paulson", "year": "1985", "unstructured": "Paulson SK, DeLuca HF (1985) Subcellular location and properties of rat renal 25-hydroxyvitamin D3\u20131\u03b1-hydroxylase. J Biol Chem 260:11488\u201311492", "journal-title": "J Biol Chem"}, {"key": "9_CR2593", "first-page": "3498", "volume": "267", "author": "M Burgos-Trinidad", "year": "1992", "unstructured": "Burgos-Trinidad M, Ismail R, Ettinger RA, Prahl JM, DeLuca HF (1992) Immunopurified 25-hydroxyvitamin D 1\u03b1-hydroxylase and 1,25-dihydroxyvitamin D 24-hydroxylase are closely related but distinct enzymes. J Biol Chem 267:3498\u20133505", "journal-title": "J Biol Chem"}, {"key": "9_CR2594", "doi-asserted-by": "crossref", "first-page": "513", "DOI": "10.1016/0960-0760(93)90167-U", "volume": "45", "author": "A Arabian", "year": "1993", "unstructured": "Arabian A, Grover J, Barre MG, Delvin EE (1993) Rat kidney 25-hydroxyvitamin D3 1\u03b1- and 24-hydroxylases: evidence for two distinct gene products. J Steroid Biochem Mol Biol 45:513\u2013516", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2595", "first-page": "10014", "volume": "91", "author": "E Ax\u00e9n", "year": "1994", "unstructured": "Ax\u00e9n E, Postlind H, Sj\u00f6berg H, Wikvall K (1994) Liver mitochondrial cytochrome P450 CYP27 and recombinant expressed human CYP27 catalyze 1\u03b1-hydroxylation of 25-hydroxyvitamin D3. Proc Natl Acad Sci U S A 91:10014\u201310018", "journal-title": "Proc"}, {"key": "9_CR2596", "doi-asserted-by": "crossref", "first-page": "527", "DOI": "10.1006/bbrc.1997.7508", "volume": "239", "author": "T Monkawa", "year": "1997", "unstructured": "Monkawa T, Yoshida T, Wakino S, Shinki T, Anazawa H, DeLuca HF, Suda T, Hayashi M, Saruta T (1997) Molecular cloning of cDNA and genomicDNA for human 25-hydroxyvitamin D3 1\u03b1-hydroxylase. Biochem Biophys Res Commun 239:527\u2013533", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR2597", "first-page": "2465", "volume": "10", "author": "D Zehnder", "year": "1999", "unstructured": "Zehnder D, Bland R, Walker EA, Bradwell AR, Howie AJ, Hewison M, Stewart PM (1999) Expression of 25-hydroxyvitamin D3\u20131\u03b1-hydroxylase in the human kidney. J Am Soc Nephrol 10:2465\u20132473", "journal-title": "J Am Soc Nephrol"}, {"key": "9_CR2598", "first-page": "888", "volume": "86", "author": "D Zehnder", "year": "2001", "unstructured": "Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, Hewison M (2001) Extrarenal expression of 25-hydroxyvitamin D3\u20131\u03b1-hydroxylase. J Clin Endocrinol Metab 86:888\u2013894", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2599", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1016/S0002-9440(10)64162-4", "volume": "161", "author": "D Zehnder", "year": "2002", "unstructured": "Zehnder D, Evans KN, Kilby MD, Bulmer JN, Innes BA, Stewart PM, Hewison M (2002) The ontogeny of 25-hydroxyvitamin D3 1\u03b1-hydroxylase expression in human placenta and decidua. Am J Pathol 161:105\u2013114", "journal-title": "Am J Pathol"}, {"key": "9_CR2600", "first-page": "3876", "volume": "87", "author": "L Diaz", "year": "2002", "unstructured": "Diaz L, Arranz C, Avila E, Halhali A, Vilchis F, Larrea F (2002) Expression and activity of 25-hydroxyvitamin D-1\u03b1-hydroxylase are restricted in cultures of human syncytiotrophoblast cells from preeclamptic pregnancies. J Clin Endocrinol Metab 87:3876\u20133882", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2601", "first-page": "183", "volume": "22", "author": "M Friedrich", "year": "2002", "unstructured": "Friedrich M, Villena-Heinsen C, Axt-Fliedner R, Meyberg R, Tilgen W, Schmidt W, Reichrath J (2002) Analysis of 25-hydroxyvitamin D3\u20131\u03b1-hydroxylase in cervical tissue. Anticancer Res 22:183\u2013186", "journal-title": "Anticancer Res"}, {"key": "9_CR2602", "first-page": "2967", "volume": "87", "author": "U Segersten", "year": "2002", "unstructured": "Segersten U, Correa P, Hewison M, Hellman P, Dralle H, Carling T, Akerstrom G, Westin G (2002) 25-hydroxyvitamin D3\u20131\u03b1-hydroxylase expression in normal and pathological parathyroid glands. J Clin Endocrinol Metab 87:2967\u20132972", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2603", "doi-asserted-by": "crossref", "first-page": "771", "DOI": "10.1016/j.jsbmb.2006.12.075", "volume": "103", "author": "S Becker", "year": "2007", "unstructured": "Becker S, Cordes T, Diesing D, Diedrich K, Friedrich M (2007) Expression of 25-hydroxyvitamin D3\u20131\u03b1-hydroxylase in human endometrial tissue. J Steroid Biochem Mol Biol 103:771\u2013775", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2604", "doi-asserted-by": "crossref", "first-page": "316", "DOI": "10.1016/j.jsbmb.2006.12.078", "volume": "103", "author": "M Hewison", "year": "2007", "unstructured": "Hewison M, Burke F, Evans KN, Lammas DA, Sansom DM, Liu P, Modlin RL, Adams JS (2007) Extra-renal 25-hydroxyvitamin D3\u20131\u03b1-hydroxylase in human health and disease. J Steroid Biochem Mol Biol 103:316\u2013321", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2605", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.1016/j.abb.2012.02.016", "volume": "523", "author": "JS Adams", "year": "2012", "unstructured": "Adams JS, Hewison M (2012) Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase. Arch Biochem Biophys 523:95\u2013102", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR2606", "doi-asserted-by": "crossref", "first-page": "1499", "DOI": "10.1089/dna.1997.16.1499", "volume": "16", "author": "GK Fu", "year": "1997", "unstructured": "Fu GK, Portale AA, Miller WL (1997) Complete structure of the human gene for the vitamin D 1\u03b1-hydroxylase, P450c1\u03b1. DNA Cell Biol 16:1499\u20131507", "journal-title": "DNA Cell Biol"}, {"key": "9_CR2607", "doi-asserted-by": "crossref", "first-page": "121", "DOI": "10.1006/abbi.2001.2279", "volume": "388", "author": "HL Brenza", "year": "2001", "unstructured": "Brenza HL, DeLuca HF (2001) Analysis of basal regulatory elements in the 25-hydroxyvitamin D3 1\u03b1-hydroxylase gene promoter. Arch Biochem Biophys 388:121\u2013126", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR2608", "first-page": "3158", "volume": "251", "author": "LA Baxter", "year": "1976", "unstructured": "Baxter LA, DeLuca HF (1976) Stimulation of 25-hydroxyvitamin D3\u20131\u03b1-hydroxylase by phosphate depletion. J Biol Chem 251:3158\u20133161", "journal-title": "J Biol Chem"}, {"key": "9_CR2609", "doi-asserted-by": "crossref", "first-page": "1720", "DOI": "10.1210/endo.142.5.8119", "volume": "142", "author": "T Yoshida", "year": "2001", "unstructured": "Yoshida T, Yoshida N, Monkawa T, Hayashi M, Saruta T (2001) Dietary phosphorus deprivation induces 25-hydroxyvitamin D3 1\u03b1-hydroxylase gene expression. Endocrinology 142:1720\u20131726", "journal-title": "Endocrinology"}, {"key": "9_CR2610", "doi-asserted-by": "crossref", "first-page": "587", "DOI": "10.1210/endo.143.2.8627", "volume": "143", "author": "MY Zhang", "year": "2002", "unstructured": "Zhang MY, Wang X, Wang JT, Compagnone NA, Mellon SH, Olson JL, Tenenhouse HS, Miller WL, Portale AA (2002) Dietary phosphorus transcriptionally regulates 25-hydroxyvitamin D-1\u03b1-hydroxylase gene expression in the proximal renal tubule. Endocrinology 143:587\u2013595", "journal-title": "Endocrinology"}, {"key": "9_CR2611", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1677/joe.0.1710249", "volume": "171", "author": "T Michigami", "year": "2001", "unstructured": "Michigami T, Yamato H, Suzuki H, Nagai-Itagaki Y, Sato K, Ozono K (2001) Conflicting actions of parathyroid hormone-related protein and serum calcium as regulators of 25-hydroxyvitamin D3\u20131\u03b1-hydroxylase expression in a nude rat model of humoral hypercalcemia of malignancy. J Endocrinol 171:249\u2013257", "journal-title": "J Endocrinol"}, {"key": "9_CR2612", "doi-asserted-by": "crossref", "first-page": "106", "DOI": "10.1016/j.jsbmb.2013.12.007", "volume": "144", "author": "N Noyola-Martinez", "year": "2014", "unstructured": "Noyola-Martinez N, Diaz L, Zaga-Clavellina V, Avila E, Halhali A, Larrea F, Barrera D (2014) Regulation of CYP27B1 and CYP24A1 gene expression by recombinant pro-inflammatory cytokines in cultured human trophoblasts. J Steroid Biochem Mol Biol 144:106\u2013109. doi:10.1016/j.jsbmb.2013.12.007", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2613", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1359/JBMR.050908", "volume": "21", "author": "K Stoffels", "year": "2006", "unstructured": "Stoffels K, Overbergh L, Giulietti A, Verlinden L, Bouillon R, Mathieu C (2006) Immune regulation of 25-hydroxyvitamin-D3\u20131\u03b1-hydroxylase in human monocytes. J Bone Miner Res 21:37\u201347", "journal-title": "J Bone Miner Res"}, {"key": "9_CR2614", "doi-asserted-by": "crossref", "first-page": "497", "DOI": "10.1159/000345146", "volume": "36", "author": "L Viaene", "year": "2012", "unstructured": "Viaene L, Evenepoel P, Meijers B, Vanderschueren D, Overbergh L, Mathieu C (2012) Uremia suppresses immune signal-induced CYP27B1 expression in human monocytes. Am J Nephrol 36:497\u2013508", "journal-title": "Am J Nephrol"}, {"key": "9_CR2615", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1007/978-3-642-55580-0_11", "volume": "164", "author": "B Diesel", "year": "2003", "unstructured": "Diesel B, Fischer U, Meese E (2003) Gene amplification and splice variants of 25-hydroxyvitamin D3 1,\u03b1-hydroxylase (CYP27B1) in glioblastoma multiforme\u2014a possible role in tumor progression? Recent Results Cancer Res 164:151\u2013155", "journal-title": "Recent Results Cancer Res"}, {"key": "9_CR2616", "doi-asserted-by": "crossref", "first-page": "351", "DOI": "10.1677/erc.1.00920", "volume": "12", "author": "PP Dwivedi", "year": "2005", "unstructured": "Dwivedi PP, Anderson PH, Omdahl JL, Grimes HL, Morris HA, May BK (2005) Identification of growth factor independent-1 (GFI1) as a repressor of 25-hydroxyvitamin D 1-\u03b1 hydroxylase (CYP27B1) gene expression in human prostate cancer cells. Endocr Relat Cancer 12:351\u2013365", "journal-title": "Endocr Relat Cancer"}, {"key": "9_CR2617", "doi-asserted-by": "crossref", "first-page": "322", "DOI": "10.1016/j.jsbmb.2006.12.041", "volume": "103", "author": "AG Turner", "year": "2007", "unstructured": "Turner AG, Dwivedi PP, May BK, Morris HA (2007) Regulation of the CYP27B1 5-flanking region by transforming growth factor-\u03b2 in ROS 17/2.8 osteoblast-like cells. J Steroid Biochem Mol Biol 103:322\u2013325", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2618", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1016/j.abb.2006.11.028", "volume": "460", "author": "C Zierold", "year": "2007", "unstructured": "Zierold C, Nehring JA, DeLuca HF (2007) Nuclear receptor 4A2 and C/EBP\u03b2 regulate the parathyroid hormone-mediated transcriptional regulation of the 25-hydroxyvitamin D3-1\u03b1-hydroxylase. Arch Biochem Biophys 460:233\u2013239", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR2619", "doi-asserted-by": "crossref", "first-page": "609", "DOI": "10.1210/en.2012-1647", "volume": "154", "author": "M Kozai", "year": "2013", "unstructured": "Kozai M, Yamamoto H, Ishiguro M, Harada N, Masuda M, Kagawa T, Takei Y, Otani A, Nakahashi O, Ikeda S, Taketani Y, Takeyama K, Kato S, Takeda E (2013) Thyroid hormones decrease plasma 1\u03b1,25-dihydroxyvitamin D levels through transcriptional repression of the renal 25-hydroxyvitamin D3 1\u03b1-hydroxylase gene (CYP27B1). Endocrinology 154:609\u2013622", "journal-title": "Endocrinology"}, {"key": "9_CR2620", "doi-asserted-by": "crossref", "first-page": "2440", "DOI": "10.1210/me.2002-0441", "volume": "18", "author": "R Ebert", "year": "2004", "unstructured": "Ebert R, Jovanovic M, Ulmer M, Schneider D, Meissner-Weigl J, Adamski J, Jakob F (2004) Down-regulation by nuclear factor kB of human 25-hydroxyvitamin D3 1\u03b1-hydroxylase promoter. Mol Endocrinol 18:2440\u20132450", "journal-title": "Mol Endocrinol"}, {"key": "9_CR2621", "doi-asserted-by": "crossref", "first-page": "208", "DOI": "10.1271/bbb.100684", "volume": "75", "author": "K Takeyama", "year": "2011", "unstructured": "Takeyama K, Kato S (2011) The vitamin D3 1\u03b1-hydroxylase gene and its regulation by active vitamin D3. Biosci Biotechnol Biochem 75:208\u2013213", "journal-title": "Biosci Biotechnol Biochem"}, {"key": "9_CR2622", "doi-asserted-by": "crossref", "first-page": "90", "DOI": "10.1016/j.jsbmb.2006.07.010", "volume": "103", "author": "E Avila", "year": "2007", "unstructured": "Avila E, Diaz L, Barrera D, Halhali A, Mendez I, Gonzalez L, Zuegel U, Steinmeyer A, Larrea F (2007) Regulation of vitamin D hydroxylases gene expression by 1,25-dihydroxyvitamin D3 and cyclic AMP in cultured human syncytiotrophoblasts. J Steroid Biochem Mol Biol 103:90\u201396", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2623", "doi-asserted-by": "crossref", "first-page": "3177", "DOI": "10.1210/jc.2006-2664", "volume": "92", "author": "CJ Kim", "year": "2007", "unstructured": "Kim CJ, Kaplan LE, Perwad F, Huang N, Sharma A, Choi Y, Miller WL, Portale AA (2007) Vitamin D 1\u03b1-hydroxylase gene mutations in patients with 1\u03b1-hydroxylase deficiency. J Clin Endocrinol Metab 92:3177\u20133182", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2624", "first-page": "73", "volume": "57", "author": "S Kato", "year": "2002", "unstructured": "Kato S, Yoshizazawa T, Kitanaka S, Murayama A, Takeyama K (2002) Molecular genetics of vitamin D-dependent hereditary rickets. Horm Res 57:73\u201378", "journal-title": "Horm Res"}, {"key": "9_CR2625", "doi-asserted-by": "crossref", "first-page": "1694", "DOI": "10.1086/302156", "volume": "63", "author": "JT Wang", "year": "1998", "unstructured": "Wang JT, Lin CJ, Burridge SM, Fu GK, Labuda M, Portale AA, Miller WL (1998) Genetics of vitamin D 1\u03b1-hydroxylase deficiency in 17 families. Am J Hum Genet 63:1694\u20131702", "journal-title": "Am J Hum Genet"}, {"key": "9_CR2626", "doi-asserted-by": "crossref", "first-page": "620", "DOI": "10.1007/PL00009639", "volume": "14", "author": "AA Portale", "year": "2000", "unstructured": "Portale AA, Miller WL (2000) Human 25-hydroxyvitamin D-1\u03b1-hydroxylase: cloning, mutations, and gene expression. Pediatr Nephrol 14:620\u2013625", "journal-title": "Pediatr Nephrol"}, {"key": "9_CR2627", "doi-asserted-by": "crossref", "first-page": "557", "DOI": "10.1007/BF03345500", "volume": "25", "author": "L Porcu", "year": "2002", "unstructured": "Porcu L, Meloni A, Casula L, Asunis I, Marini MG, Cao A, Moi P (2002) A novel splicing defect (IVS6 + 1G > T) in a patient with pseudovitamin D deficiency rickets. J Endocrinol Invest 25:557\u2013560", "journal-title": "J Endocrinol Invest"}, {"key": "9_CR2628", "doi-asserted-by": "crossref", "first-page": "653", "DOI": "10.1056/NEJM199803053381004", "volume": "338", "author": "S Kitanaka", "year": "1998", "unstructured": "Kitanaka S, Takeyama K, Murayama A, Sato T, Okumura K, Nogami M, Hasegawa Y, Niimi H, Yanagisawa J, Tanaka T, Kato S (1998) Inactivating mutations in the 25-hydroxyvitamin D3 1\u03b1-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. New Engl J Med 338:653\u2013661", "journal-title": "New Engl J Med"}, {"key": "9_CR2629", "doi-asserted-by": "crossref", "first-page": "730", "DOI": "10.1359/jbmr.1999.14.5.730", "volume": "14", "author": "SJ Smith", "year": "1999", "unstructured": "Smith SJ, Rucka AK, Berry JL, Davies M, Mylchreest S, Paterson CR, Heath DA, Tassabehji M, Read AP, Mee AP, Mawer EB (1999) Novel mutations in the 1\u03b1-hydroxylase (P450c1) gene in three families with pseudovitamin D-deficiency rickets resulting in loss of functional enzyme activity in blood-derived macrophages. J Bone Miner Res 14:730\u2013739", "journal-title": "J Bone Miner Res"}, {"key": "9_CR2630", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1016/j.jsbmb.2004.03.095", "volume": "89\u201390", "author": "ER Lopez", "year": "2004", "unstructured": "Lopez ER, Regulla K, Pani MA, Krause M, Usadel KH, Badenhoop K (2004) CYP27B1 polymorphisms variants are associated with type 1 diabetesmellitus in Germans. J Steroid Biochem Mol Biol 89\u201390:155\u2013157", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2631", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1530/eje.0.1510193", "volume": "151", "author": "ER Lopez", "year": "2004", "unstructured": "Lopez ER, Zwermann O, Segni M, Meyer G, Reincke M, Seissler J, Herwig J, Usadel KH, Badenhoop K (2004) A promoter polymorphism of the CYP27B1 gene is associated with Addison\u2019s disease, Hashimoto\u2019s thyroiditis, Graves\u2019 disease and type 1 diabetes mellitus in Germans. Eur J Endocrinol 151:193\u2013197", "journal-title": "Eur J Endocrinol"}, {"key": "9_CR2632", "doi-asserted-by": "crossref", "first-page": "2616", "DOI": "10.2337/db07-0652", "volume": "56", "author": "R Bailey", "year": "2007", "unstructured": "Bailey R, Cooper JD, Zeitels L, Smyth DJ, Yang JH, Walker NM, Hypponen E, Dunger DB, Ramos-Lopez E, Badenhoop K, Nejentsev S, Todd JA (2007) Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 56:2616\u20132621", "journal-title": "Diabetes"}, {"key": "9_CR2633", "doi-asserted-by": "crossref", "first-page": "527", "DOI": "10.1016/j.jsbmb.2004.03.062", "volume": "89\u201390", "author": "B Diesel", "year": "2004", "unstructured": "Diesel B, Seifert M, Radermacher J, Fischer U, Tilgen W, Reichrath J, Meese E (2004) Towards a complete picture of splice variants of the gene for 25-hydroxyvitamin D3 1\u03b1-hydroxylase in brain and skin cancer. J Steroid Biochem Mol Biol 89\u201390:527\u2013532", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2634", "doi-asserted-by": "crossref", "first-page": "859", "DOI": "10.1677/jme.1.01760", "volume": "34", "author": "CE Jennings", "year": "2005", "unstructured": "Jennings CE, Owen CJ, Wilson V, Pearce SH (2005) A haplotype of the CYP27B1 promoter is associated with autoimmune Addison\u2019s disease but not with Graves\u2019 disease in a UK population. J Mol Endocrinol 34:859\u2013863", "journal-title": "J Mol Endocrinol"}, {"key": "9_CR2635", "doi-asserted-by": "crossref", "first-page": "1107", "DOI": "10.1089/thy.2005.15.1107", "volume": "15", "author": "A Kurylowicz", "year": "2005", "unstructured": "Kurylowicz A, Badenhoop K (2005) CYP27B1 gene polymorphism is associated with Graves\u2019 disease in a Polish population study. Thyroid 15:1107\u20131108", "journal-title": "Thyroid"}, {"key": "9_CR2636", "doi-asserted-by": "crossref", "first-page": "544", "DOI": "10.1055/s-0029-1241206", "volume": "118", "author": "M Fichna", "year": "2010", "unstructured": "Fichna M, Zurawek M, Januszkiewicz-Lewandowska D, Gryczynska M, Fichna P, Sowinski J, Nowak J (2010) Association of the CYP27B1 C(\u2212 1260)A polymorphism with autoimmune Addison\u2019s disease. Exp Clin Endocrinol 118:544\u2013549", "journal-title": "Exp Clin Endocrinol"}, {"key": "9_CR2637", "doi-asserted-by": "crossref", "first-page": "1789", "DOI": "10.2217/pgs.09.101", "volume": "10", "author": "RA Wilke", "year": "2009", "unstructured": "Wilke RA, Simpson RU, Mukesh BN, Bhupathi SV, Dart RA, Ghebranious NR, McCarty CA (2009) Genetic variation in CYP27B1 is associated with congestive heart failure in patients with hypertension. Pharmacogenomics 10:1789\u20131797", "journal-title": "Pharmacogenomics"}, {"key": "9_CR2638", "doi-asserted-by": "crossref", "first-page": "1349", "DOI": "10.1038/ejhg.2010.113", "volume": "18", "author": "E Sundqvist", "year": "2010", "unstructured": "Sundqvist E, Baarnhielm M, Alfredsson L, Hillert J, Olsson T, Kockum I (2010) Confirmation of association between multiple sclerosis and CYP27B1. Eur J Hum Genet 18:1349\u20131352", "journal-title": "Eur J Hum Genet"}, {"key": "9_CR2639", "doi-asserted-by": "crossref", "first-page": "881", "DOI": "10.1002/ana.22678", "volume": "70", "author": "SV Ramagopalan", "year": "2011", "unstructured": "Ramagopalan SV, Dyment DA, Cader MZ, Morrison KM, Disanto G, Morahan JM, Berlanga-Taylor AJ, Handel A, De Luca GC, Sadovnick AD, Lepage P, Montpetit A, Ebers GC (2011) Rare variants in the CYP27B1 gene are associated with multiple sclerosis. Ann Neurol 70:881\u2013886", "journal-title": "Ann Neurol"}, {"key": "9_CR2640", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1097/WCO.0b013e3283533a93", "volume": "25", "author": "SE Baranzini", "year": "2012", "unstructured": "Baranzini SE, Nickles D (2012) Genetics of multiple sclerosis: swimming in an ocean of data. Curr Opin Neurol 25:239\u2013245", "journal-title": "Curr Opin Neurol"}, {"key": "9_CR2641", "doi-asserted-by": "crossref", "first-page": "3410", "DOI": "10.1210/en.2006-1388", "volume": "148", "author": "S Wu", "year": "2007", "unstructured": "Wu S, Ren S, Nguyen L, Adams JS, Hewison M (2007) Splice variants of the CYP27B1 gene and the regulation of 1,25-dihydroxyvitamin D3 production. Endocrinology 148:3410\u20133418", "journal-title": "Endocrinology"}, {"key": "9_CR2642", "doi-asserted-by": "crossref", "first-page": "4176", "DOI": "10.1210/jc.2009-2278", "volume": "95", "author": "AS Alzahrani", "year": "2010", "unstructured": "Alzahrani AS, Zou M, Baitei EY, Alshaikh OM, Al-Rijjal RA, Meyer BF, Shi Y (2010) A novel G102E mutation of CYP27B1 in a large family with vitamin D-dependent ricketstype 1. J Clin Endocrinol Metab 95:4176\u20134183", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2643", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1007/s00223-010-9434-4", "volume": "88", "author": "RJ Clifton-Bligh", "year": "2011", "unstructured": "Clifton-Bligh RJ, Nguyen TV, Au A, Bullock M, Cameron I, Cumming R, Chen JS, March LM, Seibel MJ, Sambrook PN (2011) Contribution of a common variant in the promoter of the 1\u03b1-hydroxylase gene (CYP27B1) to fracture risk in the elderly. Calcif Tissue Int 88:109\u2013116", "journal-title": "Calcif Tissue Int"}, {"key": "9_CR2644", "doi-asserted-by": "crossref", "first-page": "950", "DOI": "10.1046/j.1432-1327.1999.00794.x", "volume": "265", "author": "N Sawada", "year": "1999", "unstructured": "Sawada N, Sakaki T, Kitanaka S, Takeyama K, Kato S, Inouye K (1999) Enzymatic properties of human 25-hydroxyvitamin D3 1\u03b1-hydroxylase coexpression with adrenodoxin and NADPH-adrenodoxin reductase in Escherichia coli. Eur J Biochem 265:950\u2013956", "journal-title": "Eur J Biochem"}, {"key": "9_CR2645", "doi-asserted-by": "crossref", "first-page": "3901", "DOI": "10.1096/fj.12-208975", "volume": "26", "author": "AT Slominski", "year": "2012", "unstructured": "Slominski AT, Kim TK, Shehabi HZ, Semak I, Tang EK, Nguyen MN, Benson HA, Korik E, Janjetovic Z, Chen J, Yates CR, Postlethwaite A, Li W, Tuckey RC (2012) In vivo evidence for a novel pathway of vitamin D3 metabolism initiated by P450scc and modified by CYP27B1. FASEB J 26:3901\u20133915", "journal-title": "FASEB J"}, {"key": "9_CR2646", "doi-asserted-by": "crossref", "first-page": "1112", "DOI": "10.1124/dmd.113.050955", "volume": "41", "author": "EK Tang", "year": "2013", "unstructured": "Tang EK, Chen J, Janjetovic Z, Tieu EW, Slominski AT, Li W, Tuckey RC (2013) Hydroxylation of CYP11A1-derived products of vitamin D3 metabolism by human and mouse CYP27B1. Drug Metab Dispos 41:1112\u20131124", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR2647", "first-page": "2424", "volume": "87", "author": "X Wang", "year": "2002", "unstructured": "Wang X, Zhang MY, Miller WL, Portale AA (2002) Novel gene mutations in patients with 1\u03b1-hydroxylase deficiency that confer partial enzyme activity in vitro. J Clin Endocrinol Metab 87:2424\u20132430", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2648", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1016/j.jsbmb.2004.03.098", "volume": "89\u201390", "author": "K Yamamoto", "year": "2004", "unstructured": "Yamamoto K, Masuno H, Sawada N, Sakaki T, Inouye K, Ishiguro M, Yamada S (2004) Homology modeling of human 25-hydroxyvitamin D3 1\u03b1-hydroxylase (CYP27B1) based on the crystal structure of rabbit CYP2C5. J Steroid Biochem Mol Biol 89\u201390:167\u2013171", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2649", "doi-asserted-by": "crossref", "first-page": "30511", "DOI": "10.1074/jbc.M505244200", "volume": "280", "author": "K Yamamoto", "year": "2005", "unstructured": "Yamamoto K, Uchida E, Urushino N, Sakaki T, Kagawa N, Sawada N, Kamakura M, Kato S, Inouye K, Yamada S (2005) Identification of the amino acid residue of CYP27B1 responsible for binding of 25-hydroxyvitamin D3 whose mutation causes vitamin D-dependent rickets type 1. J Biol Chem 280:30511\u201330516", "journal-title": "J Biol Chem"}, {"key": "9_CR2650", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1016/S0960-0760(97)00015-0", "volume": "62", "author": "KR Muralidharan", "year": "1997", "unstructured": "Muralidharan KR, Rowland-Goldsmith M, Lee AS, Park G, Norman AW, Henry HL, Okamura WH (1997) Inhibitors of 25-hydroxyvitamin D3\u20131\u03b1-hydroxylase: thiavitamin D analogs and biological evaluation. J Steroid Biochem 62:73\u201378", "journal-title": "J Steroid Biochem"}, {"key": "9_CR2651", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1677/jme.0.0250141", "volume": "25", "author": "M Hewison", "year": "2000", "unstructured": "Hewison M, Zehnder D, Bland R, Stewart PM (2000) 1\u03b1-Hydroxylase and the action of vitamin D. J Mol Endocrinol 25:141\u2013148", "journal-title": "J Mol Endocrinol"}, {"key": "9_CR2652", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.1507/endocrj.48.427", "volume": "48", "author": "S Kitanaka", "year": "2001", "unstructured": "Kitanaka S, Takeyama K, Murayama A, Kato S (2001) The molecular basis of vitamin D-dependent rickets type I. Endocr J 48:427\u2013432", "journal-title": "Endocr J"}, {"key": "9_CR2653", "doi-asserted-by": "crossref", "first-page": "620", "DOI": "10.1007/PL00009639", "volume": "14", "author": "AA Portale", "year": "2000", "unstructured": "Portale AA, Miller WL (2000) Human 25-hydroxyvitamin D-1\u03b1-hydroxylase: cloning, mutations, and gene expression. Pediatr Nephrol 14:620\u2013625", "journal-title": "Pediatr Nephrol"}, {"key": "9_CR2654", "first-page": "4111", "volume": "84", "author": "S Kitanaka", "year": "1999", "unstructured": "Kitanaka S, Murayama A, Sakaki T, Inouye K, Seino Y, Fukumoto S, Shima M, Yukizane S, Takayanagi M, Niimi H, Takeyama K, Kato S (1999) No enzyme activity of 25-hydroxyvitamin D3 1\u03b1-hydroxylase gene product in pseudovitamin D deficiency rickets, including that with mild clinical manifestation. J Clin Endocrinol Metab 84:4111\u20134117", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2655", "doi-asserted-by": "crossref", "first-page": "3135", "DOI": "10.1210/endo.142.7.8281", "volume": "142", "author": "O Dardenne", "year": "2001", "unstructured": "Dardenne O, Prud\u2019homme J, Arabian A, Glorieux FH, St-Arnaud R (2001) Targeted inactivation of the 25-hydroxyvitamin D3\u20131\u03b1-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 142:3135\u20133141", "journal-title": "Endocrinology"}, {"key": "9_CR2656", "doi-asserted-by": "crossref", "first-page": "7498", "DOI": "10.1073/pnas.131029498", "volume": "98", "author": "DK Panda", "year": "2001", "unstructured": "Panda DK, Miao D, Tremblay ML, Sirois J, Farookhi R, Hendy GN, Goltzman D (2001) Targeted ablation of the 25-hydroxyvitamin D 1\u03b1-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci U S A 98:7498\u20137503", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR2657", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1002/jcb.10348", "volume": "88", "author": "R St-Arnaud", "year": "2003", "unstructured": "St-Arnaud R, Dardenne O, Prud\u2019homme J, Hacking SA, Glorieux FH (2003) Conventional and tissue-specific inactivation of the 25-hydroxyvitamin D-1\u03b1-hydroxylase (CYP27B1). J Cell Biochem 88:245\u2013251", "journal-title": "J Cell Biochem"}, {"key": "9_CR2658", "doi-asserted-by": "crossref", "first-page": "712", "DOI": "10.1038/ki.1988.237", "volume": "34", "author": "K Satomura", "year": "1988", "unstructured": "Satomura K, Seino Y, Yamaoka K, Tanaka Y, Ishida M, Yabuuchi H, DeLuca HF (1988) Renal 25-hydroxyvitamin D3-1-hydroxylase in patients with renal disease. Kidney Int 34:712\u2013716", "journal-title": "Kidney Int"}, {"key": "9_CR2659", "doi-asserted-by": "crossref", "first-page": "5826", "DOI": "10.1210/jc.2002-021356", "volume": "87", "author": "P Correa", "year": "2002", "unstructured": "Correa P, Segersten U, Hellman P, Akerstrom G, Westin G (2002) Increased 25-hydroxyvitamin D3 1\u03b1-hydroxylase and reduced 25-hydroxyvitamin D3 24-hydroxylase expression in parathyroid tumors \u00b1 new prospects for treatment of hyperparathyroidism with vitamin D. J Clin Endocrinol Metab 87:5826\u20135829", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2660", "first-page": "868", "volume": "7", "author": "RM Maas", "year": "2001", "unstructured": "Maas RM, Reus K, Diesel B, Steudel WI, Feiden W, Fischer U, Meese E (2001) Amplification and expression of splice variants of the gene encoding the P450 cytochrome 25-hydroxyvitamin D3 1,\u03b1-hydroxylase (CYP 27B1) in human malignant glioma. Clin Cancer Res 7:868\u2013875", "journal-title": "Clin Cancer Res"}, {"key": "9_CR2661", "doi-asserted-by": "crossref", "first-page": "1673", "DOI": "10.1016/S0140-6736(00)04831-5", "volume": "357", "author": "V Tangpricha", "year": "2001", "unstructured": "Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, Holt PR, Lipkin MS, Holick MF (2001) 25-Hydroxyvitamin D-1\u03b1-hydroxylase in normal and malignant colon tissue. Lancet 357:1673\u20131674", "journal-title": "Lancet"}, {"key": "9_CR2662", "doi-asserted-by": "crossref", "first-page": "287", "DOI": "10.1016/S0039-128X(00)00153-7", "volume": "66", "author": "HS Cross", "year": "2001", "unstructured": "Cross HS, Bareis P, Hofer H, Bischof MG, Bajna E, Kriwanek S, Bonner E, Peterlik M (2001) 25-Hydroxyvitamin D3\u20131\u03b1-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66:287\u2013292", "journal-title": "Steroids"}, {"key": "9_CR2663", "doi-asserted-by": "crossref", "first-page": "1831", "DOI": "10.1016/S0140-6736(02)08680-4", "volume": "359", "author": "BW Ogunkolade", "year": "2002", "unstructured": "Ogunkolade BW, Boucher BJ, Fairclough PD, Hitman GA, Dorudi S, Jenkins PJ, Bustin SA (2002) Expression of 25-hydroxyvitamin D-1-\u03b1-hydroxylase mRNA in individuals with colorectal cancer. Lancet 359:1831\u20131832", "journal-title": "Lancet"}, {"key": "9_CR2664", "first-page": "2852", "volume": "61", "author": "JY Hsu", "year": "2001", "unstructured": "Hsu JY, Feldman D, McNeal JE, Peehl DM (2001) Reduced 1\u03b1-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition. Cancer Res 61:2852\u20132856", "journal-title": "Cancer Res"}, {"key": "9_CR2665", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1016/S0960-0760(02)00053-5", "volume": "81", "author": "LW Whitlatch", "year": "2002", "unstructured": "Whitlatch LW, Young MV, Schwartz GG, Flanagan JN, Burnstein KL, Lokeshwar BL, Rich ES, Holick MF, Chen TC (2002) 25-Hydroxyvitamin D-1\u03b1-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. J Steroid Biochem Mol Biol 81:135\u2013140", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "9_CR2666", "doi-asserted-by": "crossref", "first-page": "910", "DOI": "10.1046/j.1523-1747.2001.01360.x", "volume": "116", "author": "JN Flanagan", "year": "2001", "unstructured": "Flanagan JN, Whitlatch LW, Chen TC, Zhu XH, Holick MT, Kong XF, Holick MF (2001) Enhancing 1\u03b1-hydroxylase activity with the 25-hydroxyvitamin D-1\u03b1-hydroxylase gene in cultured human keratinocytes and mouse skin. J Invest Dermatol 116:910\u2013914", "journal-title": "J Invest Dermatol"}, {"key": "9_CR2667", "doi-asserted-by": "crossref", "first-page": "197", "DOI": "10.1016/j.ymgme.2004.07.006", "volume": "83", "author": "Q Dong", "year": "2004", "unstructured": "Dong Q, Miller WL (2004) Vitamin D 25-hydroxylasedeficiency. Mol Genet Metab 83:197\u2013198", "journal-title": "Mol Genet Metab"}, {"key": "9_CR2668", "doi-asserted-by": "crossref", "first-page": "1898", "DOI": "10.1001/jama.2012.17304", "volume": "308", "author": "GP Levin", "year": "2012", "unstructured": "Levin GP, Robinson-Cohen C, de Boer IH, Houston DK, Lohman K, Liu Y, Kritchevsky SB, Cauley JA, Tanaka T, Ferrucci L, Bandinelli S, Patel KV, Hagstrom E, Michaelsson K, Melhus H, Wang T, Wolf M, Psaty BM, Siscovick D, Kestenbaum B (2012) Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. J Am Med Assoc 308:1898\u20131905", "journal-title": "J Am Med Assoc"}, {"issue": "Suppl 2", "key": "9_CR2669", "first-page": "354", "volume": "10", "author": "R Bouillon", "year": "2013", "unstructured": "Bouillon R, Lieben L, Mathieu C, Verstuyf A, Carmeliet G (2013) Vitamin D action: lessons from VDR and Cyp27b1 null mice. Pediatr Endocrin Rev 10(Suppl 2):354\u2013366", "journal-title": "Pediatr Endocrin Rev"}, {"key": "9_CR2670", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1016/j.abb.2005.11.002", "volume": "445", "author": "ZL Wu", "year": "2006", "unstructured": "Wu ZL, Bartleson CJ, Ham AJ, Guengerich FP (2006) Heterologous expression, purification, and properties of human cytochrome P450 27C1. Arch Biochem Biophys 445:138\u2013146", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR2671", "first-page": "14", "volume": "34", "author": "JT Hwang", "year": "2011", "unstructured": "Hwang JT, Baik SH, Choi JS, Lee KH, Rhee SK (2011) Genetic traits of avascular necrosis of the femoral head analyzed by array comparative genomic hybridization and real-time polymerase chain reaction. Orthopedics 34:14", "journal-title": "Orthopedics"}, {"key": "9_CR2672", "doi-asserted-by": "crossref", "first-page": "16543", "DOI": "10.1074/jbc.M001810200", "volume": "275", "author": "J Li-Hawkins", "year": "2000", "unstructured": "Li-Hawkins J, Lund EG, Bronson AD, Russell DW (2000) Expression cloning of an oxysterol 7\u03b1-hydroxylase selective for 24-hydroxycholesterol. J Biol Chem 275:16543\u201316549", "journal-title": "J Biol Chem"}, {"key": "9_CR2673", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1097/01.LAB.0000059933.35157.40", "volume": "83", "author": "H Ikeda", "year": "2003", "unstructured": "Ikeda H, Ueda M, Ikeda M, Kobayashi H, Honda Y (2003) Oxysterol 7\u03b1-hydroxylase (CYP39A1) in the ciliary nonpigmented epithelium of bovine eye. Lab Invest 83:349\u2013355", "journal-title": "Lab Invest"}, {"key": "9_CR2674", "doi-asserted-by": "crossref", "first-page": "1516", "DOI": "10.1111/j.1742-4658.2011.08432.x", "volume": "279", "author": "G Lorbek", "year": "2012", "unstructured": "Lorbek G, Lewinska M, Rozman D (2012) Cytochrome P450s in the synthesis of cholesterol and bile acids\u2014from mouse models to human diseases. FEBS J 279:1516\u20131533", "journal-title": "FEBS J"}, {"key": "9_CR2675", "doi-asserted-by": "crossref", "first-page": "440", "DOI": "10.1016/j.clpt.2006.08.013", "volume": "80", "author": "M Oscarson", "year": "2006", "unstructured": "Oscarson M, Zanger UM, Rifki OF, Klein K, Eichelbaum M, Meyer UA (2006) Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine. Clin Pharmacol Ther 80:440\u2013456", "journal-title": "Clin Pharmacol Ther"}, {"key": "9_CR2676", "doi-asserted-by": "crossref", "first-page": "1683", "DOI": "10.2217/pgs.13.159", "volume": "14", "author": "MH ten Brink", "year": "2013", "unstructured": "ten Brink MH, van Bavel T, Swen JJ, van der Straaten T, Bredius RG, Lankester AC, Zwaveling J, Guchelaar HJ (2013) Effect of genetic variants GSTA1 and CYP39A1 and age on busulfan clearance in pediatric patients undergoing hematopoietic stem cell transplantation. Pharmacogenomics 14:1683\u20131690", "journal-title": "Pharmacogenomics"}, {"key": "9_CR2677", "doi-asserted-by": "crossref", "first-page": "1617", "DOI": "10.1007/s00280-012-1872-4", "volume": "69", "author": "T Uchiyama", "year": "2012", "unstructured": "Uchiyama T, Kanno H, Ishitani K, Fujii H, Ohta H, Matsui H, Kamatani N, Saito K (2012) An SNP in CYP39A1 is associated with severe neutropenia induced by docetaxel. Cancer Chemother Pharmacol 69:1617\u20131624", "journal-title": "Cancer Chemother Pharmacol"}, {"key": "9_CR2678", "doi-asserted-by": "crossref", "first-page": "7238", "DOI": "10.1073/pnas.96.13.7238", "volume": "96", "author": "EG Lund", "year": "1999", "unstructured": "Lund EG, Guileyardo JM, Russell DW (1999) cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci U S A 96:7238\u20137243", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR2679", "doi-asserted-by": "crossref", "first-page": "1017", "DOI": "10.1146/annurev.biochem.78.072407.103859", "volume": "78", "author": "DW Russell", "year": "2009", "unstructured": "Russell DW, Halford RW, Ramirez DM, Shah R, Kotti T (2009) Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. Annu Rev Biochem 78:1017\u20131040", "journal-title": "Annu Rev Biochem"}, {"key": "9_CR2680", "doi-asserted-by": "crossref", "first-page": "361", "DOI": "10.1080/02713680701231857", "volume": "32", "author": "L Bretillon", "year": "2007", "unstructured": "Bretillon L, Diczfalusy U, Bjorkhem I, Maire MA, Martine L, Joffre C, Acar N, Bron A, Creuzot-Garcher C (2007) Cholesterol-24S-hydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina. Curr Eye Res 32:361\u2013366", "journal-title": "Curr Eye Res"}, {"key": "9_CR2681", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1021/pr1008898", "volume": "10", "author": "WL Liao", "year": "2011", "unstructured": "Liao WL, Heo GY, Dodder NG, Reem RE, Mast N, Huang S, Dipatre PL, Turko IV, Pikuleva IA (2011) Quantification of cholesterol-metabolizing P450s CYP27A1 and CYP46A1 in neural tissues reveals a lack of enzyme-product correlations in human retina but not human brain. J Proteome Res 10:241\u2013248", "journal-title": "J Proteome Res"}, {"key": "9_CR2682", "doi-asserted-by": "crossref", "first-page": "5186", "DOI": "10.1021/ac300587v", "volume": "84", "author": "M Wang", "year": "2012", "unstructured": "Wang M, Heo GY, Omarova S, Pikuleva IA, Turko IV (2012) Sample prefractionation for mass spectrometry quantification of low-abundance membrane proteins. Anal Chem 84:5186\u20135191", "journal-title": "Anal Chem"}, {"key": "9_CR2683", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1016/S0304-3940(01)02277-7", "volume": "314", "author": "N Bogdanovic", "year": "2001", "unstructured": "Bogdanovic N, Bretillon L, Lund EG, Diczfalusy U, Lannfelt L, Winblad B, Russell DW, Bj\u00f6rkhem I (2001) On the turnover of brain cholesterolin patients with Alzheimer\u2019s disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells. Neurosci Lett 314:45\u201348", "journal-title": "Neurosci Lett"}, {"key": "9_CR2684", "doi-asserted-by": "crossref", "first-page": "835", "DOI": "10.1111/j.1471-4159.2008.05442.x", "volume": "106", "author": "I Milagre", "year": "2008", "unstructured": "Milagre I, Nunes MJ, Gama MJ, Silva RF, Pascussi JM, Lechner MC, Rodrigues E (2008) Transcriptional regulation of the human CYP46A1 brain-specific expression by Sp transcription factors. J Neurochem 106:835\u2013849", "journal-title": "J Neurochem"}, {"key": "9_CR2685", "doi-asserted-by": "crossref", "first-page": "418", "DOI": "10.1111/j.1471-4159.2010.06612.x", "volume": "113", "author": "MJ Nunes", "year": "2010", "unstructured": "Nunes MJ, Milagre I, Schnekenburger M, Gama MJ, Diederich M, Rodrigues E (2010) Sp proteins play a critical role in histone deacetylase inhibitor-mediated derepression of CYP46A1 gene transcription. J Neurochem 113:418\u2013431", "journal-title": "J Neurochem"}, {"key": "9_CR2686", "doi-asserted-by": "crossref", "first-page": "1209", "DOI": "10.3233/JAD-2010-100651", "volume": "22", "author": "I Milagre", "year": "2010", "unstructured": "Milagre I, Nunes MJ, Moutinho M, Rivera I, Fuso A, Scarpa S, Gama MJ, Rodrigues E (2010) Chromatin-modifying agents increase transcription of CYP46A1, a key player in brain cholesterol elimination. J Alzheimer\u2019s Dis 22:1209\u20131221", "journal-title": "J Alzheimer\u2019s Dis"}, {"key": "9_CR2687", "doi-asserted-by": "crossref", "first-page": "1910", "DOI": "10.1194/jlr.M027680", "volume": "53", "author": "MJ Nunes", "year": "2012", "unstructured": "Nunes MJ, Moutinho M, Milagre I, Gama MJ, Rodrigues E (2012) Okadaic acid inhibits the trichostatin A-mediated increase of human CYP46A1 neuronal expression in a ERK1/2-Sp3-dependent pathway. J Lipid Res 53:1910\u20131919", "journal-title": "J Lipid Res"}, {"key": "9_CR2688", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/S0304-3940(02)00443-3", "volume": "328", "author": "P Desai", "year": "2002", "unstructured": "Desai P, DeKosky ST, Kamboh MI (2002) Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer\u2019s disease. Neurosci Lett 328:9\u201312", "journal-title": "Neurosci Lett"}, {"key": "9_CR2689", "doi-asserted-by": "crossref", "first-page": "899", "DOI": "10.1038/sj.mp.4001109", "volume": "7", "author": "H Kolsch", "year": "2002", "unstructured": "Kolsch H, Lutjohann D, Ludwig M, Schulte A, Ptok U, Jessen F, von Bergmann K, Rao ML, Maier W, Heun R (2002) Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer\u2019s disease. Mol Psychiatry 7:899\u2013902", "journal-title": "Mol Psychiatry"}, {"key": "9_CR2690", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.1001/archneur.60.1.16", "volume": "60", "author": "B Wolozin", "year": "2003", "unstructured": "Wolozin B (2003) CYP46 (24S-cholesterolhydroxylase): a genetic risk factor for Alzheimer disease. Arch Neurol 60:16\u201318", "journal-title": "Arch Neurol"}, {"key": "9_CR2691", "doi-asserted-by": "crossref", "first-page": "581", "DOI": "10.1007/s00439-004-1107-9", "volume": "114", "author": "A Johansson", "year": "2004", "unstructured": "Johansson A, Katzov H, Zetterberg H, Feuk L, Johansson B, Bogdanovic N, Andreasen N, Lenhard B, Brookes AJ, Pedersen NL, Blennow K, Prince JA (2004) Variants of CYP46A1 may interact with age and APOE to influence CSF Ab42 levels in Alzheimer\u2019s disease. Hum Genet 114:581\u2013587", "journal-title": "Hum Genet"}, {"key": "9_CR2692", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.1097/00001756-200401190-00019", "volume": "15", "author": "KA Chalmers", "year": "2004", "unstructured": "Chalmers KA, Culpan D, Kehoe PG, Wilcock GK, Hughes A, Love S (2004) APOE promoter, ACE1 and CYP46 polymorphisms and \u03b2-amyloid in Alzheimer\u2019s disease. Neuroreport 15:95\u201398", "journal-title": "Neuroreport"}, {"key": "9_CR2693", "doi-asserted-by": "crossref", "first-page": "34674", "DOI": "10.1074/jbc.M402324200", "volume": "279", "author": "J Brown 3rd", "year": "2004", "unstructured": "Brown J 3rd, Theisler C, Silberman S, Magnuson D, Gottardi-Littell N, Lee JM, Yager D, Crowley J, Sambamurti K, Rahman MM, Reiss AB, Eckman CB, Wolozin B (2004) Differential expression of cholesterolhydroxylases in Alzheimer\u2019s disease. J Biol Chem 279:34674\u201334681", "journal-title": "J Biol Chem"}, {"key": "9_CR2694", "doi-asserted-by": "crossref", "first-page": "747", "DOI": "10.1016/j.neurobiolaging.2003.08.004", "volume": "25", "author": "B Borroni", "year": "2004", "unstructured": "Borroni B, Archetti S, Agosti C, Akkawi N, Brambilla C, Caimi L, Caltagirone C, Di Luca M, Padovani A (2004) Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer disease: from risk factors to disease modulators. Neurobiol Aging 25:747\u2013751", "journal-title": "Neurobiol Aging"}, {"key": "9_CR2695", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1159/000080025", "volume": "18", "author": "O Combarros", "year": "2004", "unstructured": "Combarros O, Infante J, Llorca J, Berciano J (2004) Genetic association of CYP46 and risk for Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 18:257\u2013260", "journal-title": "Dement Geriatr Cogn Disord"}, {"key": "9_CR2696", "doi-asserted-by": "crossref", "first-page": "104", "DOI": "10.1016/j.neulet.2004.07.020", "volume": "369", "author": "B Wang", "year": "2004", "unstructured": "Wang B, Zhang C, Zheng W, Lu Z, Zheng C, Yang Z, Wang L, Jin F (2004) Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer\u2019s disease in Chinese. Neurosci Lett 369:104\u2013107", "journal-title": "Neurosci Lett"}, {"key": "9_CR2697", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.2174/1567205043480546", "volume": "1", "author": "GL Vega", "year": "2004", "unstructured": "Vega GL, Weiner M, Kolsch H, von Bergmann K, Heun R, Lutjohan D, Nguyen A, Moore C (2004) The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer\u2019s patients treated with statins. Curr Alzheimer Res 1:71\u201377", "journal-title": "Curr Alzheimer Res"}, {"key": "9_CR2698", "doi-asserted-by": "crossref", "first-page": "940", "DOI": "10.4088/JCP.v66n0720", "volume": "66", "author": "A Papassotiropoulos", "year": "2005", "unstructured": "Papassotiropoulos A, Wollmer MA, Tsolaki M, Brunner F, Molyva D, Lutjohann D, Nitsch RM, Hock C (2005) A cluster of cholesterol-related genes confers susceptibility for Alzheimer\u2019s disease. J Clin Psychiatry 66:940\u2013947", "journal-title": "J Clin Psychiatry"}, {"key": "9_CR2699", "doi-asserted-by": "crossref", "first-page": "142", "DOI": "10.1016/j.neulet.2005.08.048", "volume": "391", "author": "N Shibata", "year": "2006", "unstructured": "Shibata N, Kawarai T, Lee JH, Lee HS, Shibata E, Sato C, Liang Y, Duara R, Mayeux RP, St George-Hyslop PH, Rogaeva E (2006) Association studies of cholesterolmetabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer\u2019s disease. Neurosci Lett 391:142\u2013146", "journal-title": "Neurosci Lett"}, {"key": "9_CR2700", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1159/000090215", "volume": "21", "author": "V Fernandez Del Pozo", "year": "2006", "unstructured": "Fernandez Del Pozo V, Alvarez Alvarez M, Fernandez Martinez M, Galdos Alcelay L, Gomez Busto F, Pena JA, Alfonso-Sanchez MA, Zarranz Imirizaldu JJ, de Pancorbo MM (2006) Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APO\u03b53 allele increases the risk of Alzheimer\u2019s disease and of mild cognitive impairment progressing to Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 21:81\u201387", "journal-title": "Dement Geriatr Cogn Disord"}, {"key": "9_CR2701", "doi-asserted-by": "crossref", "first-page": "421", "DOI": "10.1136/jnnp.2005.071928", "volume": "77", "author": "S Helisalmi", "year": "2006", "unstructured": "Helisalmi S, Vepsalainen S, Koivisto AM, Mannermaa A, Iivonen S, Hiltunen M, Kiviniemi V, Soininen H (2006) Association of CYP46 intron 2 polymorphism in Finnish Alzheimer\u2019s disease samples and a global scale summary. J Neurol Neurosurg Psychiatry 77:421\u2013422", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "9_CR2702", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1017/S1041610205003108", "volume": "18", "author": "SL Ma", "year": "2006", "unstructured": "Ma SL, Tang NL, Lam LC, Chiu HF (2006) Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer\u2019s disease in a Chinese population. Int Psychogeriatr 18:37\u201345", "journal-title": "Int Psychogeriatr"}, {"key": "9_CR2703", "doi-asserted-by": "crossref", "first-page": "399", "DOI": "10.1159/000095723", "volume": "22", "author": "Y Li", "year": "2006", "unstructured": "Li Y, Chu LW, Chen YQ, Cheung BM, Leung RY, Yik PY, Ng KM, Mak W, Jin DY, St George-Hyslop P, Song YQ (2006) Intron 2 (T/C) CYP46 polymorphism is associated with Alzheimer\u2019s disease in Chinese patients. Dement Geriatr Cogn Disord 22:399\u2013404", "journal-title": "Dement Geriatr Cogn Disord"}, {"key": "9_CR2704", "doi-asserted-by": "crossref", "first-page": "34", "DOI": "10.1016/j.brainres.2007.02.005", "volume": "1147", "author": "F Wang", "year": "2007", "unstructured": "Wang F, Jia J (2007) Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer\u2019s disease in Chinese. Brain Res 1147:34\u201338", "journal-title": "Brain Res"}, {"key": "9_CR2705", "doi-asserted-by": "crossref", "first-page": "921", "DOI": "10.1002/gps.2196", "volume": "24", "author": "BY Fu", "year": "2009", "unstructured": "Fu BY, Ma SL, Tang NL, Tam CW, Lui VW, Chiu HF, Lam LC (2009) Cholesterol 24-hydroxylase (CYP46A1) polymorphisms are associated with faster cognitive deterioration in Chinese older persons: a two-year follow up study. Int J Geriatr Psychiatry 24:921\u2013926", "journal-title": "Int J Geriatr Psychiatry"}, {"key": "9_CR2706", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1016/j.eurpsy.2008.12.005", "volume": "24", "author": "H Kolsch", "year": "2009", "unstructured": "Kolsch H, Lutjohann D, Jessen F, Popp J, Hentschel F, Kelemen P, Schmitz S, Maier W, Heun R (2009) CYP46A1 variants influence Alzheimer\u2019s disease risk and brain cholesterol metabolism. Eur Psychiatry 24:183\u2013190", "journal-title": "Eur Psychiatry"}, {"key": "9_CR2707", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.3233/JAD-2009-1055", "volume": "17", "author": "E Golanska", "year": "2009", "unstructured": "Golanska E, Hulas-Bigoszewska K, Sieruta M, Zawlik I, Witusik M, Gresner SM, Sobow T, Styczynska M, Peplonska B, Barcikowska M, Liberski PP, Corder EH (2009) Earlier onset of Alzheimer\u2019s disease: risk polymorphisms within PRNP, PRND, CYP46, and APOE genes. J Alzheimer\u2019s Dis 17:359\u2013368", "journal-title": "J Alzheimer\u2019s Dis"}, {"key": "9_CR2708", "doi-asserted-by": "crossref", "first-page": "5712", "DOI": "10.1167/iovs.09-3655", "volume": "50", "author": "C Fourgeux", "year": "2009", "unstructured": "Fourgeux C, Martine L, Bj\u00f6rkhem I, Diczfalusy U, Joffre C, Acar N, Creuzot-Garcher C, Bron A, Bretillon L (2009) Primary open-angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels. Invest Ophthalmol Vis Sci 50:5712\u20135717", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "9_CR2709", "doi-asserted-by": "crossref", "first-page": "1023", "DOI": "10.1016/j.neurobiolaging.2009.07.001", "volume": "32", "author": "J Hanggi", "year": "2011", "unstructured": "Hanggi J, Mondadori CR, Buchmann A, Henke K, Hock C (2011) A CYP46 T/C SNP modulates parahippocampal and hippocampal morphology in young subjects. Neurobiol Aging 32:1023\u20131032", "journal-title": "Neurobiol Aging"}, {"key": "9_CR2710", "doi-asserted-by": "crossref", "first-page": "342", "DOI": "10.1007/s12031-009-9227-2", "volume": "39", "author": "AN Garcia", "year": "2009", "unstructured": "Garcia AN, Muniz MT, Souza e Silva HR, da Silva HA, Athayde-Junior L (2009) CYP46 polymorphisms in Alzheimer\u2019s disease: a review. J Mol Neurosci 39:342\u2013345", "journal-title": "J Mol Neurosci"}, {"key": "9_CR2711", "doi-asserted-by": "crossref", "first-page": "1572", "DOI": "10.1111/j.1469-8986.2011.01221.x", "volume": "48", "author": "CL Lai", "year": "2011", "unstructured": "Lai CL, Hsu CY, Liou LM, Hsieh HY, Hsieh YH, Liu CK (2011) Effect of cholesterol and CYP46 polymorphism on cognitive event-related potentials. Psychophysiology 48:1572\u20131577", "journal-title": "Psychophysiology"}, {"key": "9_CR2712", "doi-asserted-by": "crossref", "first-page": "1701", "DOI": "10.1007/s00415-012-6690-4", "volume": "260", "author": "L Li", "year": "2013", "unstructured": "Li L, Yin Z, Liu J, Li G, Wang Y, Yan J, Zhou H (2013) CYP46A1 T/C polymorphism associated with the APOE \u03b54 allele increases the risk of Alzheimer\u2019s disease. J Neurol 260:1701\u20131708", "journal-title": "J Neurol"}, {"key": "9_CR2713", "doi-asserted-by": "crossref", "first-page": "228", "DOI": "10.1016/j.neulet.2004.06.011", "volume": "367", "author": "M Ingelsson", "year": "2004", "unstructured": "Ingelsson M, Jesneck J, Irizarry MC, Hyman BT, Rebeck GW (2004) Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer\u2019s disease. Neurosci Lett 367:228\u2013231", "journal-title": "Neurosci Lett"}, {"key": "9_CR2714", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1016/j.neulet.2005.03.049", "volume": "383", "author": "E Golanska", "year": "2005", "unstructured": "Golanska E, Hulas-Bigoszewska K, Wojcik I, Rieske P, Styczynska M, Peplonska B, Pfeffer A, Luczywek E, Wasiak B, Gabryelewicz T, Religa D, Chodakowska-Zebrowska M, Barcikowska M, Sobow T, Liberski PP (2005) CYP46: a risk factor for Alzheimer\u2019s disease or a coincidence? Neurosci Lett 383:105\u2013108", "journal-title": "Neurosci Lett"}, {"key": "9_CR2715", "doi-asserted-by": "crossref", "first-page": "771", "DOI": "10.1016/j.neurobiolaging.2005.03.029", "volume": "27", "author": "A Tedde", "year": "2006", "unstructured": "Tedde A, Rotondi M, Cellini E, Bagnoli S, Muratore L, Nacmias B, Sorbi S (2006) Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer\u2019s disease. Neurobiol Aging 27:771\u2013773", "journal-title": "Neurobiol Aging"}, {"key": "9_CR2716", "doi-asserted-by": "crossref", "first-page": "943", "DOI": "10.1007/s11064-005-5979-4", "volume": "30", "author": "A Juhasz", "year": "2005", "unstructured": "Juhasz A, Rimanoczy A, Boda K, Vincze G, Szlavik G, Zana M, Bjelik A, Pakaski M, Bodi N, Palotas A, Janka Z, Kalman J (2005) CYP46 T/C polymorphism is not associated with Alzheimer\u2019s dementia in a population from Hungary. Neurochem Res 30:943\u2013948", "journal-title": "Neurochem Res"}, {"key": "9_CR2717", "doi-asserted-by": "crossref", "first-page": "18", "DOI": "10.1016/j.neulet.2013.06.011", "volume": "549", "author": "M Li", "year": "2013", "unstructured": "Li M, Wang W, Li Y, Wang L, Shen X, Tang Z (2013) CYP46A1 intron-2T/C polymorphism and Alzheimer\u2019s disease: an updated meta-analysis of 16 studies including 3960 cases and 3828 controls. Neurosci Lett 549:18\u201323", "journal-title": "Neurosci Lett"}, {"key": "9_CR2718", "doi-asserted-by": "crossref", "first-page": "7026", "DOI": "10.1167/iovs.12-9652", "volume": "53", "author": "C Fourgeux", "year": "2012", "unstructured": "Fourgeux C, Dugas B, Richard F, Bjorkhem I, Acar N, Bron AM, Korobelnik JF, Leveziel N, Zerbib J, Puche N, Creuzot-Garcher CP, Souied E, Bretillon L (2012) Single nucleotide polymorphism in the cholesterol-24S-hydroxylase (CYP46A1) gene and its association with CFH and LOC387715 gene polymorphisms in age-related macular degeneration. Invest Ophthalmol Vis Sci 53:7026\u20137033", "journal-title": "Invest Ophthalmol Vis Sci"}, {"key": "9_CR2719", "doi-asserted-by": "crossref", "first-page": "14284", "DOI": "10.1021/bi035512f", "volume": "42", "author": "N Mast", "year": "2003", "unstructured": "Mast N, Norcross R, Andersson U, Shou M, Nakayama K, Bj\u00f6rkhem I, Pikuleva IA (2003) Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain. Biochemistry 42:14284\u201314292", "journal-title": "Biochemistry"}, {"key": "9_CR2720", "first-page": "366", "volume": "42", "author": "I Bj\u00f6rkhem", "year": "2001", "unstructured": "Bj\u00f6rkhem I, Starck L, Andersson U, Lutjohann D, von Bahr S, Pikuleva I, Babiker A, Diczfalusy U (2001) Oxysterols in the circulation of patients with the Smith-Lemli-Opitz syndrome: abnormal levels of 24S- and 27-hydroxycholesterol. J Lipid Res 42:366\u2013371", "journal-title": "J Lipid Res"}, {"key": "9_CR2721", "doi-asserted-by": "crossref", "first-page": "1933", "DOI": "10.1194/jlr.M051508", "volume": "55", "author": "S Goyal", "year": "2014", "unstructured": "Goyal S, Xu L, Porter NA, Guengerich FP (2014) Oxidation of 7-dehydrocholesterol and desmosterol by human cytochrome P450 46A1. J Lipid Res 55:1933\u20131943", "journal-title": "J Lipid Res"}, {"key": "9_CR2722", "doi-asserted-by": "crossref", "first-page": "31783", "DOI": "10.1074/jbc.M110.143313", "volume": "285", "author": "N Mast", "year": "2010", "unstructured": "Mast N, Charvet C, Pikuleva IA, Stout CD (2010) Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain. J Biol Chem 285:31783\u201331795", "journal-title": "J Biol Chem"}, {"key": "9_CR2723", "doi-asserted-by": "crossref", "first-page": "3529", "DOI": "10.1074/jbc.M113.532846", "volume": "289", "author": "N Mast", "year": "2014", "unstructured": "Mast N, Li Y, Linger M, Clark M, Wiseman J, Pikuleva IA (2014) Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice. J Biol Chem 289:3529\u20133538", "journal-title": "J Biol Chem"}, {"key": "9_CR2724", "doi-asserted-by": "crossref", "first-page": "9546", "DOI": "10.1073/pnas.0803717105", "volume": "105", "author": "N Mast", "year": "2008", "unstructured": "Mast N, White MA, Bj\u00f6rkhem I, Johnson EF, Stout CD, Pikuleva IA (2008) Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain. Proc Natl Acad Sci U S A 105:9546\u20139551", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "9_CR2725", "doi-asserted-by": "crossref", "first-page": "824", "DOI": "10.1124/mol.112.080424", "volume": "82", "author": "N Mast", "year": "2012", "unstructured": "Mast N, Linger M, Clark M, Wiseman J, Stout CD, Pikuleva IA (2012) In silico and intuitive predictions of CYP46A1 inhibition by marketed drugs with subsequent enzyme crystallization in complex with fluvoxamine. Mol Pharmacol 82:824\u2013834", "journal-title": "Mol Pharmacol"}, {"key": "9_CR2726", "doi-asserted-by": "crossref", "first-page": "86", "DOI": "10.1124/mol.113.085902", "volume": "84", "author": "N Mast", "year": "2013", "unstructured": "Mast N, Zheng W, Stout CD, Pikuleva IA (2013) Antifungal azoles: structural insights into undesired tight binding to cholesterol-metabolizing CYP46A1. Mol Pharmacol 84:86\u201394", "journal-title": "Mol Pharmacol"}, {"key": "9_CR2727", "doi-asserted-by": "crossref", "first-page": "318", "DOI": "10.1194/jlr.M900174-JLR200", "volume": "51", "author": "M Shafaati", "year": "2010", "unstructured": "Shafaati M, Mast N, Beck O, Nayef R, Heo GY, Bj\u00f6rkhem-Bergman L, Lutjohann D, Bj\u00f6rkhem I, Pikuleva IA (2010) The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo. J Lipid Res 51:318\u2013323", "journal-title": "J Lipid Res"}, {"key": "9_CR2728", "doi-asserted-by": "crossref", "first-page": "e68534", "DOI": "10.1371/journal.pone.0068534", "volume": "8", "author": "S Maioli", "year": "2013", "unstructured": "Maioli S, Bavner A, Ali Z, Heverin M, Ismail MA, Puerta E, Olin M, Saeed A, Shafaati M, Parini P, Cedazo-Minguez A, Bj\u00f6rkhem I (2013) Is it possible to improve memory function by upregulation of the cholesterol 24S-hydroxylase (CYP46A1) in the brain? PLoS One 8:e68534", "journal-title": "PLoS One"}, {"key": "9_CR2729", "doi-asserted-by": "crossref", "first-page": "595", "DOI": "10.1016/j.biochi.2012.09.025", "volume": "95", "author": "V Leoni", "year": "2013", "unstructured": "Leoni V, Caccia C (2013) 24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases. Biochimie 95:595\u2013612", "journal-title": "Biochimie"}, {"key": "9_CR2730", "doi-asserted-by": "crossref", "first-page": "192", "DOI": "10.1016/j.neuint.2011.12.003", "volume": "60", "author": "I Milagre", "year": "2012", "unstructured": "Milagre I, Olin M, Nunes MJ, Moutinho M, Lovgren-Sandblom A, Gama MJ, Bjorkhem I, Rodrigues E (2012) Marked change in the balance between CYP27A1 and CYP46A1 mediated elimination of cholesterol during differentiation of human neuronal cells. Neurochem Int 60:192\u2013198", "journal-title": "Neurochem Int"}, {"key": "9_CR2731", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1007/s00418-010-0718-6", "volume": "134", "author": "K Smiljanic", "year": "2010", "unstructured": "Smiljanic K, Lavrnja I, Mladenovic Djordjevic A, Ruzdijic S, Stojiljkovic M, Pekovic S, Kanazir S (2010) Brain injury induces cholesterol 24-hydroxylase (Cyp46) expression in glial cells in a time-dependent manner. Histochem Cell Biol 134:159\u2013169", "journal-title": "Histochem Cell Biol"}, {"key": "9_CR2732", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.brainres.2009.12.080", "volume": "1319", "author": "CM Cartagena", "year": "2010", "unstructured": "Cartagena CM, Burns MP, Rebeck GW (2010) 24S-Hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury. Brain Res 1319:1\u201312", "journal-title": "Brain Res"}, {"key": "9_CR2733", "doi-asserted-by": "crossref", "first-page": "1499", "DOI": "10.1002/jnr.21266", "volume": "85", "author": "CE Teunissen", "year": "2007", "unstructured": "Teunissen CE, Floris S, Sonke M, Dijkstra CD, De Vries HE, Lutjohann D (2007) 24S-hydroxycholesterol in relation to disease manifestations of acute experimental autoimmune encephalomyelitis. J Neurosci Res 85:1499\u20131505", "journal-title": "J Neurosci Res"}, {"key": "9_CR2734", "doi-asserted-by": "crossref", "first-page": "1320", "DOI": "10.1006/bbrc.1994.1848", "volume": "201", "author": "Y Aoyama", "year": "1994", "unstructured": "Aoyama Y, Funae Y, Noshiro M, Horiuchi T, Yoshida Y (1994) Occurrence of a P450 showing high homology to yeast lanosterol 14-demethylase (P45014DM) in rat liver. Biochem Biophys Res Commun 201:1320\u20131326", "journal-title": "Biochem Biophys Res Commun"}, {"key": "9_CR2735", "doi-asserted-by": "crossref", "first-page": "982", "DOI": "10.1093/oxfordjournals.jbchem.a021516", "volume": "120", "author": "Y Aoyama", "year": "1996", "unstructured": "Aoyama Y, Horiuchi T, Yoshida Y (1996) Lanosterol 14-demethylase activity expressed in rat brain microsomes. J Biochem (Tokyo) 120:982\u2013986", "journal-title": "J Biochem (Tokyo)"}, {"key": "9_CR2736", "doi-asserted-by": "crossref", "first-page": "466", "DOI": "10.1006/abbi.1996.0416", "volume": "333", "author": "D Rozman", "year": "1996", "unstructured": "Rozman D, Str\u00f6mstedt M, Waterman MR (1996) The three human cytochrome P450 lanosterol 14\u03b1-deethylase (CYP51) genes reside on chromosomes 3, 7, and 13: structure of the two retrotransposed pseudogenes, association with a line-1 element, and evolution of the human CYP51 family. Arch Biochem Biophys 333:466\u2013474", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR2737", "doi-asserted-by": "crossref", "first-page": "R16", "DOI": "10.1007/s004240100011", "volume": "442", "author": "M Cotman", "year": "2001", "unstructured": "Cotman M, Rozma D, Banek L, Jezek D (2001) Localisation of lanosterol 14\u03b1-demethylase in round and elongated spermatids of the mouse testis: an immunoelectron microscopic and stereological study. Pflugers Arch 442:R167\u2013168", "journal-title": "Pflugers Arch"}, {"key": "9_CR2738", "doi-asserted-by": "crossref", "first-page": "R56", "DOI": "10.1007/s004240000090", "volume": "439", "author": "D Rozman", "year": "2000", "unstructured": "Rozman D (2000) Lanosterol 14\u03b1-demethylase (CYP51)\u2014a cholesterolbiosynthetic enzyme involved in production of meiosis activating sterols in oocytes and testis\u2014a minireview. Pflugers Arch 439:R56\u201357", "journal-title": "Pflugers Arch"}, {"key": "9_CR2739", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1016/S0003-9861(02)00418-6", "volume": "409", "author": "N Debeljak", "year": "2003", "unstructured": "Debeljak N, Fink M, Rozman D (2003) Many facets of mammalian lanosterol 14\u03b1-demethylase from the evolutionarily conserved cytochrome P450 family CYP51. Arch Biochem Biophys 409:159\u2013171", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR2740", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1006/abbi.1996.0193", "volume": "329", "author": "M Str\u00f6mstedt", "year": "1996", "unstructured": "Str\u00f6mstedt M, Rozman D, Waterman MR (1996) The ubiquitously expressed human CYP51 cDNA encodes lanosterol 14\u03b1-demethylase, a cytochrome P450 whose expression is regulated by oxysterols. Arch Biochem Biophys 329:73\u201381", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR2741", "first-page": "1951", "volume": "13", "author": "D Rozman", "year": "1999", "unstructured": "Rozman D, Fink M, Fimia GM, Sassone-Corsi P, Waterman MR (1999) Cyclic adenosine 3\u2032,5\u2032-monophosphate(cAMP)/cAMP-responsive element modulator (CREM)-dependent regulation of cholesterogenic lanosterol 14\u03b1-demethylase (CYP51) in spermatids. Mol Endocrinol 13:1951\u20131962", "journal-title": "Mol Endocrinol"}, {"key": "9_CR2742", "doi-asserted-by": "crossref", "first-page": "1853", "DOI": "10.1210/me.2001-0262", "volume": "16", "author": "SK Halder", "year": "2002", "unstructured": "Halder SK, Fink M, Waterman MR, Rozman D (2002) A cAMP-responsive element binding site is essential for sterol regulation of the human lanosterol 14\u03b1-demethylase gene (CYP51). Mol Endocrinol 16:1853\u20131863", "journal-title": "Mol Endocrinol"}, {"key": "9_CR2743", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1093/oxfordjournals.jbchem.a022734", "volume": "128", "author": "C Yamashita", "year": "2000", "unstructured": "Yamashita C, Kudo M, Ishida H, Noshiro M, Aoyama Y, Yoshida Y (2000) Insulin is the essential factor maintaining the constitutive expression of hepatic sterol 14-demethylase P450 (CYP51). J Biochem (Tokyo) 128:93\u201399", "journal-title": "J Biochem (Tokyo)"}, {"key": "9_CR2744", "doi-asserted-by": "crossref", "first-page": "268", "DOI": "10.1161/01.RES.88.3.268", "volume": "88", "author": "C Rodriguez", "year": "2001", "unstructured": "Rodriguez C, Martinez-Gonzalez J, Sanchez-Gomez S, Badimon L (2001) LDL downregulates CYP51 in porcine vascular endothelial cells and in the arterial wall through a sterol regulatory element binding protein-2-dependent mechanism. Cir Res 88:268\u2013274", "journal-title": "Cir Res"}, {"key": "9_CR2745", "doi-asserted-by": "crossref", "first-page": "5321", "DOI": "10.1210/en.2005-0781", "volume": "146", "author": "M Fink", "year": "2005", "unstructured": "Fink M, Acimovic J, Rezen T, Tansek N, Rozman D (2005) Cholesterogenic lanosterol 14\u03b1-demethylase (CYP51) is an immediate early response gene. Endocrinology 146:5321\u20135331", "journal-title": "Endocrinology"}, {"key": "9_CR2746", "doi-asserted-by": "crossref", "first-page": "e82554", "DOI": "10.1371/journal.pone.0082554", "volume": "8", "author": "M Lewinska", "year": "2013", "unstructured": "Lewinska M, Zelenko U, Merzel F, Golic Grdadolnik S, Murray JC, Rozman D (2013) Polymorphisms of CYP51A1 from cholesterol synthesis: associations with birth weight and maternal lipid levels and impact on CYP51 protein structure. PLoS One 8:e82554", "journal-title": "PLoS One"}, {"key": "9_CR2747", "first-page": "875", "volume": "60", "author": "M Lewinska", "year": "2013", "unstructured": "Lewinska M, Zmrzljak UP, Rozman D (2013) Low nucleotide variability of CYP51A1 in humans: meta-analysis of cholesterol and bile acid synthesis and xenobiotic metabolism pathways. Acta Chim Slovenica 60:875\u2013883", "journal-title": "Acta Chim Slovenica"}, {"key": "9_CR2748", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.1006/abbi.2001.2566", "volume": "395", "author": "DC Lamb", "year": "2001", "unstructured": "Lamb DC, Kaderbhai NN, Venkateswarlu K, Kelly DE, Kelly SL, Kaderbhai MA (2001) Human sterol 14\u03b1-demethylase activity is enhanced by the membrane-bound state of cytochrome b 5. Arch Biochem Biophys 395:78\u201384", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR2749", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1016/S0014-5793(98)00247-6", "volume": "425", "author": "DC Lamb", "year": "1998", "unstructured": "Lamb DC, Kelly DE, Kelly SL (1998) Molecular diversity of sterol 14\u03b1-demethylase substrates in plants, fungi and humans. FEBS Lett 425:263\u2013265", "journal-title": "FEBS Lett"}, {"key": "9_CR2750", "doi-asserted-by": "crossref", "first-page": "1067", "DOI": "10.1016/j.jmb.2010.01.075", "volume": "397", "author": "N Strushkevich", "year": "2010", "unstructured": "Strushkevich N, Usanov SA, Park HW (2010) Structural basis of human CYP51 inhibition by antifungal azoles. J Mol Biol 397:1067\u20131078", "journal-title": "J Mol Biol"}, {"key": "9_CR2751", "doi-asserted-by": "crossref", "first-page": "755", "DOI": "10.1002/(SICI)1097-0061(19990630)15:9<755::AID-YEA417>3.0.CO;2-8", "volume": "15", "author": "DC Lamb", "year": "1999", "unstructured": "Lamb DC, Kelly DE, Waterman MR, Stromstedt M, Rozman D, Kelly SL (1999) Characteristics of the heterologously expressed human lanosterol 14\u03b1-demethylase (other names: P45014DM, CYP51, P45051) and inhibition of the purified human and Candida albicans CYP51 with azoleantifungal agents. Yeast 15:755\u2013763", "journal-title": "Yeast"}, {"key": "9_CR2752", "doi-asserted-by": "crossref", "first-page": "24", "DOI": "10.1016/j.tox.2006.08.007", "volume": "228", "author": "ER Trosken", "year": "2006", "unstructured": "Trosken ER, Adamska M, Arand M, Zarn JA, Patten C, Volkel W, Lutz WK (2006) Comparison of lanosterol-14\u03b1-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles. Toxicology 228:24\u201332", "journal-title": "Toxicology"}, {"key": "9_CR2753", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1016/j.bmc.2007.10.001", "volume": "16", "author": "T Korosec", "year": "2008", "unstructured": "Korosec T, Acimovic J, Seliskar M, Kocjan D, Tacer KF, Rozman D, Urleb U (2008) Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14\u03b1-demethylase (CYP51). Bioorg Med Chem 16:209\u2013221", "journal-title": "Bioorg Med Chem"}, {"key": "9_CR2754", "first-page": "1199", "volume": "26", "author": "D Rozman", "year": "1998", "unstructured": "Rozman D, Waterman MR (1998) Lanosterol 14\u03b1-demethylase (CYP51) and spermatogenesis. Drug Metab Dispos 26:1199\u20131201", "journal-title": "Drug Metab Dispos"}, {"key": "9_CR2755", "doi-asserted-by": "crossref", "first-page": "463", "DOI": "10.1677/joe.0.1660463", "volume": "166", "author": "G Majdic", "year": "2000", "unstructured": "Majdic G, Parvinen M, Bellamine A, Harwood HJ Jr, Ku WW, Waterman MR, Rozman D (2000) Lanosterol 14\u03b1-demethylase (CYP51), NADPH-cytochrome P450 reductase and squalene synthase in spermatogenesis: late spermatids of the rat express proteins needed to synthesize follicular fluid meiosis activating sterol. J Endocrinol 166:463\u2013474", "journal-title": "J Endocrinol"}, {"key": "9_CR2756", "doi-asserted-by": "crossref", "first-page": "849", "DOI": "10.1093/oxfordjournals.jbchem.a003057", "volume": "130", "author": "C Yamashita", "year": "2001", "unstructured": "Yamashita C, Aoyama Y, Noshiro M, Yoshida Y (2001) Gonadotropin-dependent expression of sterol 14-demethylase P450 (CYP51) in rat ovaries and its contribution to the production of a meiosis-activating steroid. J Biochem (Tokyo) 130:849\u2013856", "journal-title": "J Biochem (Tokyo)"}, {"key": "9_CR2757", "doi-asserted-by": "crossref", "first-page": "179", "DOI": "10.1016/S0303-7207(01)00693-1", "volume": "187", "author": "D Rozman", "year": "2002", "unstructured": "Rozman D, Cotman M, Frangez R (2002) Lanosterol 14\u03b1-demethylase and MAS sterols in mammalian gametogenesis. Mol Cell Endocrinol 187:179\u2013187", "journal-title": "Mol Cell Endocrinol"}, {"key": "9_CR2758", "doi-asserted-by": "crossref", "first-page": "414", "DOI": "10.1210/jc.2004-0810", "volume": "90", "author": "M Fukami", "year": "2005", "unstructured": "Fukami M, Horikawa R, Nagai T, Tanaka T, Naiki Y, Sato N, Okuyama T, Nakai H, Soneda S, Tachibana K, Matsuo N, Sato S, Homma K, Nishimura G, Hasegawa T, Ogata T (2005) Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients. J Clin Endocrinol Metab 90:414\u2013426", "journal-title": "J Clin Endocrinol Metab"}, {"key": "9_CR2759", "doi-asserted-by": "crossref", "first-page": "29086", "DOI": "10.1074/jbc.M111.253245", "volume": "286", "author": "R Keber", "year": "2011", "unstructured": "Keber R, Motaln H, Wagner KD, Debeljak N, Rassoulzadegan M, Acimovic J, Rozman D, Horvat S (2011) Mouse knockout of the cholesterogenic cytochrome P450 lanosterol 14\u03b1-demethylase (Cyp51) resembles Antley-Bixler syndrome. J Biol Chem 286:29086\u201329097", "journal-title": "J Biol Chem"}, {"key": "9_CR2760", "author": "FP Guengerich", "year": "2014", "unstructured": "Guengerich FP (2014) Fifty years of progress in drug metabolism and toxicology: what do we still need to know about cytochrome P450 enzymes? In: Yamazaki H (ed) Fifty years of cytochrome P450 research. Springer, Tokyo, pp 17\u201341", "volume-title": "Fifty years of cytochrome P450 research"}, {"key": "9_CR2761", "doi-asserted-by": "crossref", "first-page": "487", "DOI": "10.1126/science.286.5439.487", "volume": "286", "author": "WE Evans", "year": "1999", "unstructured": "Evans WE, Relling MV (1999) Pharmacogenomics: translating function genomics into rational therapeutics. Science 286:487\u2013491", "journal-title": "Science"}, {"key": "9_CR2762", "first-page": "2946", "volume": "48", "author": "FP Guengerich", "year": "1988", "unstructured": "Guengerich FP (1988) Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res 48:2946\u20132954", "journal-title": "Cancer Res"}, {"key": "9_CR2763", "doi-asserted-by": "crossref", "first-page": "1213", "DOI": "10.1289/ehp.021101213", "volume": "110", "author": "J Wan", "year": "2002", "unstructured": "Wan J, Shi J, Hui L, Wu D, Jin X, Zhao N, Huang W, Xia Z, Hu G (2002) Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning. Environ Health Perspect 110:1213\u20131218", "journal-title": "Environ Health Perspect"}, {"key": "9_CR2764", "doi-asserted-by": "crossref", "first-page": "254", "DOI": "10.1111/j.1349-7006.1991.tb01838.x", "volume": "82", "author": "F Uematsu", "year": "1991", "unstructured": "Uematsu F, Kikuchi H, Motomiya M, Abe T, Sagami I, Ohmachi T, Wakui A, Kanamaru R, Watanabe M (1991) Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer. Jpn J Cancer Res 82:254\u2013256", "journal-title": "Jpn J Cancer Res"}, {"key": "9_CR2765", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1152/physrev.00021.2001", "volume": "82", "author": "RJ Roman", "year": "2002", "unstructured": "Roman RJ (2002) P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82:131\u2013185", "journal-title": "Physiol Rev"}, {"key": "9_CR2766", "doi-asserted-by": "crossref", "first-page": "99", "DOI": "10.1016/j.abb.2004.05.012", "volume": "428", "author": "N Mast", "year": "2004", "unstructured": "Mast N, Andersson U, Nakayama K, Bjorkhem I, Pikuleva IA (2004) Expression of human cytochrome P450 46A1 in Escherichia coli: effects of N- and C-terminal modifications. Arch Biochem Biophys 428:99\u2013108", "journal-title": "Arch Biochem Biophys"}, {"key": "9_CR2767", "doi-asserted-by": "crossref", "first-page": "1500", "DOI": "10.1093/jnci/djh279", "volume": "96", "author": "R Dagher", "year": "2004", "unstructured": "Dagher R, Johnson J, Williams G, Keegan P, Pazdur R (2004) Accelerated approval of oncology products: a decade of experience. J Natl Cancer Inst 96:1500\u20131509", "journal-title": "J Natl Cancer Inst"}, {"key": "9_CR2768", "first-page": "167", "volume": "82", "author": "T Tateishi", "year": "1996", "unstructured": "Tateishi T, Krivoruk Y, Ueng YF, Wood AJ, Guengerich FP, Wood M (1996) Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation. Anesth Analg 82:167\u2013172", "journal-title": "Anesth Analg"}, {"key": "9_CR2769", "unstructured": "Pallan PS, Wang C, Lei L, Yoshimoto FK, Auchus RJ, Wawrzak Z, Waterman MR, Guengerich FP, Egli M (2015) Human cytochrome P450 21A2, the major steroid 21-hydroxylase. Structure of the progesterone substrate-enzyme complex and ratelimiting C-H bond cleavage. J Biol Chem 290, submitted", "DOI": "10.1074/jbc.M115.646307", "doi-asserted-by": "crossref"}], "container-title": ["Cytochrome P450"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-12108-6_9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 8, 21]], "date-time": "2019-08-21T23:42:50Z", "timestamp": 1566430970000}, "score": 30.167105, "issued": {"date-parts": [[2015]]}, "ISBN": ["9783319121079", "9783319121086"], "references-count": 2769, "URL": "http://dx.doi.org/10.1007/978-3-319-12108-6_9", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T19:49:26Z", "timestamp": 1575229766774}, "reference-count": 0, "publisher": "FASEB", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The FASEB Journal"], "published-print": {"date-parts": [[1992, 1, 6]]}, "DOI": "10.1096/fasebj.6.2.1537457", "type": "journal-article", "created": {"date-parts": [[2018, 1, 18]], "date-time": "2018-01-18T13:40:14Z", "timestamp": 1516282814000}, "page": "686-694", "source": "Crossref", "is-referenced-by-count": 46, "title": ["Mechanisms of cytochrome P450 and peroxidase-catalyzed xenobiotic metabolism."], "prefix": "10.1096", "volume": "6", "author": [{"given": "P F", "family": "Hollenberg", "sequence": "first", "affiliation": [{"name": "Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan 48201."}]}], "member": "86", "container-title": ["The FASEB Journal"], "language": "en", "deposited": {"date-parts": [[2018, 1, 25]], "date-time": "2018-01-25T10:27:15Z", "timestamp": 1516876035000}, "score": 29.99136, "issued": {"date-parts": [[1992, 1, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1992, 1, 6]]}, "issue": "2"}, "alternative-id": ["10.1096/fasebj.6.2.1537457"], "URL": "http://dx.doi.org/10.1096/fasebj.6.2.1537457", "ISSN": ["0892-6638", "1530-6860"], "issn-type": [{"value": "0892-6638", "type": "print"}, {"value": "1530-6860", "type": "electronic"}], "subject": ["Biotechnology", "Genetics", "Biochemistry", "Molecular Biology"]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T14:36:07Z", "timestamp": 1574865367779}, "reference-count": 0, "publisher": "Worldwide Protein Data Bank", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.2210/pdb6gun/pdb", "type": "component", "created": {"date-parts": [[2018, 8, 14]], "date-time": "2018-08-14T18:04:08Z", "timestamp": 1534269848000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Siderophore hydrolase EstB from Aspergillus nidulans"], "prefix": "10.2210", "author": [{"given": "F.", "family": "Ecker", "sequence": "first", "affiliation": []}, {"given": "H.", "family": "Haas", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Groll", "sequence": "additional", "affiliation": []}, {"given": "E.M.", "family": "Huber", "sequence": "additional", "affiliation": []}], "member": "7763", "published-online": {"date-parts": [[2018, 8, 15]]}, "deposited": {"date-parts": [[2019, 9, 30]], "date-time": "2019-09-30T15:02:03Z", "timestamp": 1569855723000}, "score": 29.976196, "issued": {"date-parts": [[2018, 8, 15]]}, "references-count": 0, "URL": "http://dx.doi.org/10.2210/pdb6gun/pdb"}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T14:36:07Z", "timestamp": 1574865367785}, "reference-count": 0, "publisher": "Worldwide Protein Data Bank", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.2210/pdb6guo/pdb", "type": "component", "created": {"date-parts": [[2018, 8, 14]], "date-time": "2018-08-14T18:04:08Z", "timestamp": 1534269848000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Siderophore hydrolase EstA from Aspergillus nidulans"], "prefix": "10.2210", "author": [{"given": "F.", "family": "Ecker", "sequence": "first", "affiliation": []}, {"given": "H.", "family": "Haas", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Groll", "sequence": "additional", "affiliation": []}, {"given": "E.M.", "family": "Huber", "sequence": "additional", "affiliation": []}], "member": "7763", "published-online": {"date-parts": [[2018, 8, 15]]}, "deposited": {"date-parts": [[2019, 9, 30]], "date-time": "2019-09-30T15:02:03Z", "timestamp": 1569855723000}, "score": 29.976196, "issued": {"date-parts": [[2018, 8, 15]]}, "references-count": 0, "URL": "http://dx.doi.org/10.2210/pdb6guo/pdb"}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T10:59:26Z", "timestamp": 1575111566811}, "reference-count": 0, "publisher": "American Chemical Society (ACS)", "issue": "49", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biochemistry"], "published-print": {"date-parts": [[1995, 12]]}, "DOI": "10.1021/bi00049a015", "type": "journal-article", "created": {"date-parts": [[2005, 3, 8]], "date-time": "2005-03-08T11:22:13Z", "timestamp": 1110280933000}, "page": "16013-16021", "source": "Crossref", "is-referenced-by-count": 19, "title": ["Identification of a Common Cytochrome P450 Epitope near the Conserved Heme-Binding Peptide with Antibodies Raised against Recombinant Cytochrome P450 Family 2 Proteins"], "prefix": "10.1021", "volume": "34", "author": [{"given": "Pavel", "family": "Soucek", "sequence": "first", "affiliation": []}, {"given": "Martha V.", "family": "Martin", "sequence": "additional", "affiliation": []}, {"given": "Yune-Fang", "family": "Ueng", "sequence": "additional", "affiliation": []}, {"given": "F. Peter", "family": "Guengerich", "sequence": "additional", "affiliation": []}], "member": "316", "container-title": ["Biochemistry"], "language": "en", "link": [{"URL": "https://pubs.acs.org/doi/pdf/10.1021/bi00049a015", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 29]], "date-time": "2019-09-29T01:22:53Z", "timestamp": 1569720173000}, "score": 29.880556, "issued": {"date-parts": [[1995, 12]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1995, 12]]}, "issue": "49"}, "alternative-id": ["10.1021/bi00049a015"], "URL": "http://dx.doi.org/10.1021/bi00049a015", "ISSN": ["0006-2960", "1520-4995"], "issn-type": [{"value": "0006-2960", "type": "print"}, {"value": "1520-4995", "type": "electronic"}], "subject": ["Biochemistry"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T17:29:34Z", "timestamp": 1574270974326}, "publisher-location": "Boston, MA", "reference-count": 77, "publisher": "Springer US", "isbn-type": [{"value": "9780306483240", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1007/0-387-27447-2_3", "type": "book-chapter", "created": {"date-parts": [[2007, 2, 4]], "date-time": "2007-02-04T12:39:28Z", "timestamp": 1170592768000}, "page": "87-114", "source": "Crossref", "is-referenced-by-count": 36, "title": ["Structures of Cytochrome P450 Enzymes"], "prefix": "10.1007", "author": [{"given": "Thomas L.", "family": "Poulos", "sequence": "first", "affiliation": []}, {"given": "Eric F.", "family": "Johnson", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "3_CR1", "doi-asserted-by": "publisher", "first-page": "687", "DOI": "10.1016/0022-2836(87)90190-2", "volume": "195", "author": "T.L. Poulos", "year": "1987", "unstructured": "Poulos, T.L., B.C. Finzel, and A.J. Howard (1987). High-resolution crystal structure of cytochrome P450cam. J. Mol. Biol.\n              195, 687\u2013700.", "journal-title": "J. Mol. Biol."}, {"key": "3_CR2", "doi-asserted-by": "publisher", "first-page": "731", "DOI": "10.1126/science.8342039", "volume": "261", "author": "K.G. Ravichandran", "year": "1993", "unstructured": "Ravichandran, K.G., S.S. Boddupalli, C.A. Hasermann, J.A. Peterson, and J. Deisenhofer (1993). Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450\u2019s. Science\n              261, 731\u2013736.", "journal-title": "Science"}, {"key": "3_CR3", "doi-asserted-by": "publisher", "first-page": "1367", "DOI": "10.1016/S0969-2126(01)00274-X", "volume": "3", "author": "M. Sundaramoorthy", "year": "1995", "unstructured": "Sundaramoorthy, M., J. Terner, and T.L. Poulos (1995). The crystal structure of chloroperoxidase: A heme peroxidase-cytochrome P450 functional hybrid. Structure\n              3, 1367\u20131377.", "journal-title": "Structure"}, {"key": "3_CR4", "doi-asserted-by": "publisher", "first-page": "2121", "DOI": "10.1126/science.279.5359.2121", "volume": "279", "author": "B.R. Crane", "year": "1998", "unstructured": "Crane, B.R., A.S. Arvai, D.K. Ghosh, C. Wu, E.D. Getzoff, D.J. Stuehr et al. (1998). Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science\n              279, 2121\u20132126.", "journal-title": "Science"}, {"key": "3_CR5", "doi-asserted-by": "publisher", "first-page": "233", "DOI": "10.1038/6675", "volume": "6", "author": "T.O. Fischmann", "year": "1999", "unstructured": "Fischmann, T.O., A. Hruza, X.D. Niu, J.D. Fossetta, C.A. Lunn, E. Dolphin et al. (1999). Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation. Nat. Struct. Biol.\n              6, 233\u2013242.", "journal-title": "Nat. Struct. Biol."}, {"key": "3_CR6", "doi-asserted-by": "publisher", "first-page": "939", "DOI": "10.1016/S0092-8674(00)81718-3", "volume": "95", "author": "C.S. Raman", "year": "1998", "unstructured": "Raman, C.S., H. Li, P. Martasek, V. Kral, B.S. Masters, and T.L. Poulos (1998). Crystal structure of constitutive endothelial nitric oxide synthase: A paradigm for pterin function involving a novel metal center. Cell\n              95, 939\u2013950.", "journal-title": "Cell"}, {"key": "3_CR7", "doi-asserted-by": "publisher", "first-page": "4854", "DOI": "10.1073/pnas.72.12.4854", "volume": "72", "author": "E. Adman", "year": "1975", "unstructured": "Adman, E., K.D. Watenpaugh, and L.H. Jensen (1975). NH-S hydrogen bonds in Peptococcus aerogenes ferredoxin, Clostridium pasteurianum rubredoxin, and Chromatium high potential iron protein. Proc. Natl. Acad. Sci. USA\n              72, 4854\u20134858.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "3_CR8", "doi-asserted-by": "publisher", "first-page": "7098", "DOI": "10.1021/ja00362a013", "volume": "105", "author": "N. Ueyama", "year": "1983", "unstructured": "Ueyama, N., T. Terakawa, M. Nakata, and A. Nakamura (1983). Positive shift of redox potential of [Fe2S4(Z-cys-Gly-Ala-OMe)4]2\u2212 in dichloromethane. J. Am. Chem. Soc.\n              105, 7098\u20137102.", "journal-title": "J. Am. Chem. Soc."}, {"key": "3_CR9", "doi-asserted-by": "publisher", "first-page": "1286", "DOI": "10.1021/ja9622970", "volume": "118", "author": "N. Ueyama", "year": "1996", "unstructured": "Ueyama, N., N. Nishikawa, Y. Yamada, T. Okamura, and A. Nakamura (1996). Cytochrome P-450 model (porphinato)(thiolatio)iron(III) complexes with and double NH-S hydrogen bonds. J. Am. Chem. Soc.\n              118, 1286\u20131287.", "journal-title": "J. Am. Chem. Soc."}, {"key": "3_CR10", "author": "T.L. Poulos", "first-page": "115", "year": "1984", "unstructured": "Poulos, T.L. and B.C. Finzel (1984). Heme enzyme structure and function. In M.T. Mearn (ed.), Peptide and Protein Reviews, Vol. 4. Marcel Dekker, New York, pp. 115\u2013171.", "volume-title": "Peptide and Protein Reviews"}, {"key": "3_CR11", "doi-asserted-by": "publisher", "first-page": "8477", "DOI": "10.1021/ja00806a062", "volume": "95", "author": "C.K. Chang", "year": "1973", "unstructured": "Chang, C.K. and T.G. Traylor (1973). Proximal base influence on the binding of oxygen and carbon monoxide to heme. J. Am. Chem. Soc.\n              95, 8477\u20138479.", "journal-title": "J. Am. Chem. Soc."}, {"key": "3_CR12", "doi-asserted-by": "publisher", "first-page": "851", "DOI": "10.1021/ic00147a035", "volume": "22", "author": "M.M. Doef", "year": "1983", "unstructured": "Doef, M.M., D.A. Sweigart, and P. O\u2019Brien (1983). Hydrogen bonding from coordinated imidazole in ferric porphyrin complexes. Effect on the Fe(III)/Fe(II) reduction potential. Inorg. Chem.\n              22, 851\u2013852.", "journal-title": "Inorg. Chem."}, {"key": "3_CR13", "doi-asserted-by": "publisher", "first-page": "5799", "DOI": "10.1021/ja00459a045", "volume": "99", "author": "M. Nappa", "year": "1977", "unstructured": "Nappa, M., J.S. Valentine, and P.A. Snyder (1977). Imidazolate complexes of ferric porphyrins. J. Am. Chem. Soc.\n              99, 5799\u20135800.", "journal-title": "J. Am. Chem. Soc."}, {"key": "3_CR14", "doi-asserted-by": "publisher", "first-page": "1009", "DOI": "10.1073/pnas.76.3.1009", "volume": "76", "author": "J.S. Valentine", "year": "1979", "unstructured": "Valentine, J.S., R.P. Sheridan, L.C. Allen, and P.C. Kahn (1979). Coupling between oxidation state and hydrogen bond conformation in heme proteins. Proc. Nat. Acad. Sci. USA\n              76, 1009\u20131013.", "journal-title": "Proc. Nat. Acad. Sci. USA"}, {"key": "3_CR15", "doi-asserted-by": "publisher", "first-page": "10009", "DOI": "10.1021/bi00156a021", "volume": "31", "author": "L. Banci", "year": "1992", "unstructured": "Banci, L., I.I. Bertin, E.A. Pease, M. Tien, and P. Turano (1992). 1H NMR investigation of manganese peroxidase from Phanerochaete chrysosporium. A comparison with other peroxidases. Biochemistry\n              31, 10009\u201310017.", "journal-title": "Biochemistry"}, {"key": "3_CR16", "doi-asserted-by": "publisher", "first-page": "9211", "DOI": "10.1021/bi980189f", "volume": "37", "author": "M. Vidakovic", "year": "1998", "unstructured": "Vidakovic, M., S.G. Sligar, H. Li, and T.L. Poulos (1998). Understanding the role of the essential Asp251 in cytochrome p450cam using site-directed mutagenesis, crystallography, and kinetic solvent isotope effect. Biochemistry\n              37, 9211\u20139219.", "journal-title": "Biochemistry"}, {"key": "3_CR17", "doi-asserted-by": "publisher", "first-page": "5104", "DOI": "10.1021/bi963170q", "volume": "36", "author": "D.E. Benson", "year": "1997", "unstructured": "Benson, D.E., K.S. Suslick, and S.G. Sligar (1997). Reduced oxy intermediate observed in D251N cytochrome P450cam. Biochemistry\n              36, 5104\u20135107.", "journal-title": "Biochemistry"}, {"key": "3_CR18", "doi-asserted-by": "publisher", "first-page": "1615", "DOI": "10.1126/science.287.5458.1615", "volume": "287", "author": "I. Schlichting", "year": "2000", "unstructured": "Schlichting, I., J. Berendzen, K. Chu, A.M. Stock, S.A. Maves, D.E. Benson et al. (2000). The catalytic pathway of cytochrome p450cam at atomic resolution. Science\n              287, 1615\u20131622.", "journal-title": "Science"}, {"key": "3_CR19", "doi-asserted-by": "publisher", "first-page": "632", "DOI": "10.1038/nsb0796-632", "volume": "3", "author": "J.R. Cupp-Vickery", "year": "1996", "unstructured": "Cupp-Vickery, J.R., O. Han, C.R. Hutchinson, and T.L. Poulos (1996). Substrate-assisted cataly-sis in cytochrome P450eryF. Nat. Struc. Biol.\n              3, 632\u2013637.", "journal-title": "Nat. Struc. Biol."}, {"key": "3_CR20", "doi-asserted-by": "publisher", "first-page": "235", "DOI": "10.1016/0014-5793(96)00322-5", "volume": "384", "author": "R.L. Wright", "year": "1996", "unstructured": "Wright, R.L., K. Harris, B. Solow, R.H. White, and P.J. Kennelly (1996). Cloning of a potential cytochrome P450 from the archaeon Sulfolobus solfataricus. FEBS Lett. 384, 235\u2013239.", "journal-title": "FEBS Lett"}, {"key": "3_CR21", "doi-asserted-by": "publisher", "first-page": "166", "DOI": "10.1006/bbrc.1998.9584", "volume": "252", "author": "M.A. McLean", "year": "1998", "unstructured": "McLean, M.A., S.A. Maves, K.E. Weiss, S. Krepich, and S.G. Sligar (1998). Characterization of a cytochrome P450 from the acidothermophilic archaea Sulfolobus solfataricus. Biochem. Biophys. Res. Comm.\n              252, 166\u2013172.", "journal-title": "Biochem. Biophys. Res. Comm."}, {"key": "3_CR22", "doi-asserted-by": "publisher", "first-page": "31086", "DOI": "10.1074/jbc.M004281200", "volume": "275", "author": "J.K. Yano", "year": "2000", "unstructured": "Yano, J.K., L.S. Koo, D.J. Schuller, H. Li, P.R. Ortiz de Montellano, and T.L. Poulos (2000). Crystal structure of a thermophilic cytochrome P450 from the archaeon Sulfolobus solfataricus. J. Biol. Chem.\n              275, 31086\u201331092.", "journal-title": "J. Biol. Chem."}, {"key": "3_CR23", "doi-asserted-by": "publisher", "first-page": "491", "DOI": "10.1016/S0162-0134(02)00446-4", "volume": "91", "author": "S.Y. Park", "year": "2002", "unstructured": "Park, S.Y., K. Yamane, S. Adachi, Y. Shiro, S.A. Maves, K.E. Weiss et al. (2002). Thermophilic Cytochrome P450 (CYP119) from Sulfolobus solfataricus: High resolution structural origin of its thermostability and functional properties. J. Inorg. Biochem.\n              91, 491\u2013501.", "journal-title": "J. Inorg. Biochem."}, {"key": "3_CR24", "doi-asserted-by": "publisher", "first-page": "52", "DOI": "10.1016/S0003-9861(02)00402-2", "volume": "409", "author": "A.V. Puchkaev", "year": "2003", "unstructured": "Puchkaev, A.V., L.S. Koo, and P.R. Ortiz de Montellano (2003). Aromatic stacking as a determinant of the thermal stability of CYP119 from Sulfolobus solfataricus. Arch. Biochem. Biophys.\n              409, 52\u201358.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "3_CR25", "doi-asserted-by": "publisher", "first-page": "608", "DOI": "10.1074/jbc.M206568200", "volume": "278", "author": "J.K. Yano", "year": "2003", "unstructured": "Yano, J.K., F. Blasco, H. Li, R.D. Schmid, A. Henne, and T.L. Poulos (2003). Preliminary characterization and crystal structure of a thermostable cytochrome P450 from Thermus thermophilus. J. Biol. Chem.\n              278, 608\u2013616.", "journal-title": "J. Biol. Chem."}, {"key": "3_CR26", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1016/0076-6879(91)06078-H", "volume": "206", "author": "T. Omura", "year": "1991", "unstructured": "Omura, T. and A. Ito (1991). Biosynthesis and intracellular sorting of mitochondrial forms of cytochrome P450. Meth. Enzymol.\n              206, 75\u201381.", "journal-title": "Meth. Enzymol."}, {"key": "3_CR27", "author": "M. Sakaguchi", "year": "1993", "unstructured": "Sakaguchi, M. and T. Omura (1993). Topology and biogenesis of microsomal cytochrome P-450s. In K. Ruckpaul and H. Rein (eds.), Medicinal Implications in Cytochrome P-450 Catalyzed Biotransformations. Akademie Verlag, Berlin.", "volume-title": "Medicinal Implications in Cytochrome P-450 Catalyzed Biotransformations"}, {"key": "3_CR28", "doi-asserted-by": "publisher", "first-page": "107", "DOI": "10.1006/abbi.1996.9859", "volume": "339", "author": "C. Wachenfeldt Von", "year": "1997", "unstructured": "Von Wachenfeldt, C., T.H. Richardson, J. Cosme, and E.F. Johnson (1997). Microsomal P450 2C3 is expressed as a soluble dimer in Escherichia coli following modifications of its N-terminus. Arch. Biochem. Biophys.\n              339, 107\u2013114.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "3_CR29", "doi-asserted-by": "publisher", "first-page": "2545", "DOI": "10.1074/jbc.275.4.2545", "volume": "28", "author": "J. Cosme", "year": "2000", "unstructured": "Cosme, J. and E.F. Johnson (2000). Engineering microsomal cytochrome P450 2C5 to be a soluble, monomeric enzyme. Mutations that alter aggregation, phospholipid dependence of catalysis, and membrane binding. J. Biol. Chem.\n              28, 2545\u20132553.", "journal-title": "J. Biol. Chem."}, {"key": "3_CR30", "first-page": "19186", "volume": "266", "author": "Y.C. Li", "year": "1991", "unstructured": "Li, Y.C. and J.Y.L. Chiang (1991). The expression of a catalytically active cholesterol 7alpha-hydroxylase cytochrome P450 in Escherichia coli. J. Biol. Chem.\n              266, 19186\u201319191.", "journal-title": "J. Biol. Chem."}, {"key": "3_CR31", "doi-asserted-by": "publisher", "first-page": "272", "DOI": "10.1006/abbi.1993.1349", "volume": "304", "author": "Y. Sagara", "year": "1993", "unstructured": "Sagara, Y., H.J. Barnes, and M.R. Waterman (1993). Expression in Escherichia coli of functional cytochrome P450c17 lacking its hydrophobic amino-terminal signal anchor. Arch. Biochem. Biophys.\n              304, 272\u2013278.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "3_CR32", "doi-asserted-by": "crossref", "first-page": "2651", "DOI": "10.1073/pnas.90.7.2651", "volume": "90", "author": "S.J. Pernecky", "year": "1993", "unstructured": "Pernecky, S.J., J.R. Larson, R.M. Philpot, and M.J. Coon (1993). Expression of truncated forms of liver microsomal P450 cytochromes 2B4 and 2E1 in Escherichia coli: Influence of NH2-terminal region on localization in cytosol and membranes. Proc. Natl. Acad. Sci. USA [vn90, 2651\u20132655.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "3_CR33", "doi-asserted-by": "publisher", "first-page": "121", "DOI": "10.1016/S1097-2765(00)80408-6", "volume": "5", "author": "P.A. Williams", "year": "2000", "unstructured": "Williams, P.A., J. Cosme, V. Sridhar, E.F. Johnson, and D.E. McRee (2000). The crystallographic structure of a mammalian microsomal cytochrome P450 monooxygenase: Structural adaptations for membrane binding and functional diversity. Mol. Cell\n              5, 121\u2013132.", "journal-title": "Mol. Cell"}, {"key": "3_CR34", "doi-asserted-by": "publisher", "first-page": "209", "DOI": "10.1083/jcb.104.2.209", "volume": "104", "author": "C. Lemos-Chiarandini De", "year": "1987", "unstructured": "De Lemos-Chiarandini, C., A.B. Frey, D.D. Sabatini, and G. Kreibich (1987). Determination of the membrane topology of the phenobarbital-inducible rat liver cytochrome P-450 isoenzyme PB-4 using site-specific antibodies. J. Cell Biol.\n              104, 209\u2013219.", "journal-title": "J. Cell Biol."}, {"key": "3_CR35", "author": "C. Wachenfeldt Von", "year": "1995", "unstructured": "Von Wachenfeldt, C. and E.F. Johnson (1995). Structures of eukaryotic cytochrome P450 enzymes. In P.R. Ortiz de Montellano (ed.), Cytochrome P450: Structure, Mechanism, and Biochemistry. Plenum Press, New York.", "volume-title": "Cytochrome P450: Structure, Mechanism, and Biochemistry"}, {"key": "3_CR36", "doi-asserted-by": "publisher", "first-page": "12680", "DOI": "10.1021/bi00165a019", "volume": "31", "author": "Y. Ohta", "year": "1992", "unstructured": "Ohta, Y., S. Kawato, H. Tagashira, S. Takemori, and S. Kominami (1992). Dynamic structures of adrenocortical cytochrome P-450 in proteoliposomes and microsomes: Protein rotation study. Biochemistry\n              31, 12680\u201312687.", "journal-title": "Biochemistry"}, {"key": "3_CR37", "doi-asserted-by": "publisher", "first-page": "6725", "DOI": "10.1073/pnas.062565599", "volume": "99", "author": "T.H. Bayburt", "year": "2002", "unstructured": "Bayburt, T.H. and S.G. Sligar (2002). Single-molecule height measurements on microsomal cytochrome P450 in nanometer-scale phospholipid bilayer disks. Proc. Natl. Acad. Sci. USA\n              99, 6725\u20136730.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "3_CR38", "doi-asserted-by": "publisher", "first-page": "82", "DOI": "10.1006/abbi.1998.0889", "volume": "359", "author": "M.L. Shank-Retzlaff", "year": "1998", "unstructured": "Shank-Retzlaff, M.L., G.M. Raner, M.J. Coon, and S.G. Sligar (1998). Membrane topology of cytochrome P450 2B4 in langmuir-blodgett monolayers. Arch. Biochem. Biophys.\n              359, 82\u201388.", "journal-title": "Arch. Biochem. Biophys."}, {"key": "3_CR39", "doi-asserted-by": "publisher", "first-page": "32395", "DOI": "10.1074/jbc.R100008200", "volume": "276", "author": "S.H. White", "year": "2001", "unstructured": "White, S.H., A.S. Ladokhin, S. Jayasinghe, and K. Hristova (2001). How membranes shape protein structure. J. Biol. Chem.\n              276, 32395\u201332398.", "journal-title": "J. Biol. Chem."}, {"key": "3_CR40", "doi-asserted-by": "publisher", "first-page": "17036", "DOI": "10.1074/jbc.273.27.17036", "volume": "273", "author": "A. Bridges", "year": "1998", "unstructured": "Bridges, A., L. Gruenke, Y.T. Chang, I.A. Vakser, G. Loew, and L. Waskell (1998). Identification of the binding site on cytochrome P450 2B4 for cytochrome b5 and cytochrome P450 reductase. J. Biol. Chem.\n              273, 17036\u201317049.", "journal-title": "J. Biol. Chem."}, {"key": "3_CR41", "doi-asserted-by": "publisher", "first-page": "8411", "DOI": "10.1073/pnas.94.16.8411", "volume": "94", "author": "M. Wang", "year": "1997", "unstructured": "Wang, M., D.L. Roberts, R. Paschke, T.M. Shea, B.S. Masters, and J.J. Kim (1997). Three-dimensional structure of NADPH-cytochrome P450 reductase: Prototype for FMN-and FAD-containing enzymes. Proc. Natl. Acad. Sci. USA\n              94, 8411\u20138416.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "3_CR42", "doi-asserted-by": "publisher", "first-page": "1863", "DOI": "10.1073/pnas.96.5.1863", "volume": "96", "author": "I.F. Sevrioukova", "year": "1999", "unstructured": "Sevrioukova, I.F., H. Li, H. Zhang, J.A. Peterson, and T.L. Poulos (1999). Structure of a cytochrome P450-redox partner electron-transfer complex. Proc. Natl. Acad. Sci. USA\n              96, 1863\u20131868.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "3_CR43", "doi-asserted-by": "publisher", "first-page": "199", "DOI": "10.1006/jmbi.2000.3748", "volume": "299", "author": "A. Gruez", "year": "2000", "unstructured": "Gruez, A., D. Pignol, M. Zeghouf, J. Coves, M. Fontecave, J.-L. Ferrer et al. (2000). Four crystal structures of the 60kDa falvoprotein monomer of the sulfite reductase indicate a disordered flavodoxin-like module. J. Mol. Biol.\n              299, 199\u2013212.", "journal-title": "J. Mol. Biol."}, {"key": "3_CR44", "doi-asserted-by": "publisher", "first-page": "36097", "DOI": "10.1074/jbc.274.51.36097", "volume": "274", "author": "I.F. Sevrioukova", "year": "1999", "unstructured": "Sevrioukova, I.F., J.T. Hazzard, G. Tollin, and T.L. Poulos (1999). The FMN to heme electron transfer in cytochrome P450BM-3. Effect of chemical modification of cysteines engineered at the FMN-heme domain interaction site. J. Biol. Chem.\n              274, 36097\u201336106.", "journal-title": "J. Biol. Chem."}, {"key": "3_CR45", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1560/VRGJ-DE54-XDNM-5PH3", "volume": "40", "author": "I.F. Sevrioukova", "year": "2000", "unstructured": "Sevrioukova, I.F., C.E. Immoos, T.L. Poulos, and P. Farmer (2000). Electron transfer in the ruthenated heme domain of cytochrome P450BM-3. Isr. J. Chem.\n              40, 47\u201353.", "journal-title": "Isr. J. Chem."}, {"key": "3_CR46", "doi-asserted-by": "publisher", "first-page": "377", "DOI": "10.1016/j.jmb.2003.08.028", "volume": "333", "author": "I.F. Sevrioukova", "year": "2003", "unstructured": "Sevrioukova, I.F., C. Gracia, H. Li, B. Bhaskar, T.L. Poulos (2003). Crystal structure of putidaredoxin, the [2Fe-2S] component of the P450cam monooxygenase system from Pseudomonas putida. J. Molec. Biol.\n              333, 377\u2013392.", "journal-title": "J. Molec. Biol."}, {"key": "3_CR47", "doi-asserted-by": "publisher", "first-page": "889", "DOI": "10.1016/j.jmb.2003.12.067", "volume": "236", "author": "I.F. Sevrioukova", "year": "2004", "unstructured": "Sevrioukova, I.F., H. Li, T.L. Poulos (2004). Crystal structure of putidaredoxin reductase from pseudomonas putida, the final structural component of the P450cam monooxygenase system. J. Mol. Biol.\n              236, 889\u2013902.", "journal-title": "J. Mol. Biol."}, {"key": "3_CR48", "doi-asserted-by": "publisher", "first-page": "2786", "DOI": "10.1074/jbc.M008501200", "volume": "276", "author": "J.J. Muller", "year": "2000", "unstructured": "Muller, J.J., A. Lapko, G. Bourenkov, K. Ruckpaul, and U. Heinemann (2000). Adrenodoxin reductase-adrenodoxin complex structure suggests electron transfer path in steroid biosynthesis. J. Biol. Chem.\n              276, 2786\u20132789.", "journal-title": "J. Biol. Chem."}, {"key": "3_CR49", "doi-asserted-by": "publisher", "first-page": "269", "DOI": "10.1016/S0969-2126(98)00031-8", "volume": "6", "author": "A. Muller", "year": "1998", "unstructured": "Muller, A., J.J. Muller, Y.A. Muller, H. Uhlmann, R. Bernhardt, and U. Heinemann (1998). New aspects of electron transfer revealed by the crystal structure of a truncated bovine adrenodoxin, Adx(4\u2013108). Structure\n              6, 269\u2013280.", "journal-title": "Structure"}, {"key": "3_CR50", "doi-asserted-by": "publisher", "first-page": "10986", "DOI": "10.1021/bi000079k", "volume": "39", "author": "G.A. Ziegler", "year": "2000", "unstructured": "Ziegler, G.A. and G.E. Schulz (2000). Crystal structures of adrenodoxin reductase in complex with NADP(+) and NADPH suggesting a mechanism for the electron transfer of an enzyme family. Biochemistry\n              39, 10986\u201310995.", "journal-title": "Biochemistry"}, {"key": "3_CR51", "doi-asserted-by": "crossref", "first-page": "799", "DOI": "10.1002/pro.5560030509", "volume": "3", "author": "P.R.E. Mittl", "year": "1994", "unstructured": "Mittl, P.R.E. and G.E. Schulz (1994). The structure of glutathione reductase from Escherichia coli at 1.86\u00c5 resolution: Comparison with the enzyme from human erythrocytes. Protein Sci. 3, 799\u2013809.", "journal-title": "Protein Sci"}, {"key": "3_CR52", "doi-asserted-by": "publisher", "first-page": "25831", "DOI": "10.1074/jbc.M201110200", "volume": "277", "author": "I.F. Sevrioukova", "year": "2002", "unstructured": "Sevrioukova, I.F. and T.L. Poulos (2002). Putidaredoxin reductase, a new function for an old protein. J. Biol. Chem.\n              277, 25831\u201325839.", "journal-title": "J. Biol. Chem."}, {"key": "3_CR53", "doi-asserted-by": "crossref", "first-page": "157", "DOI": "10.1016/S0167-4838(98)00094-6", "volume": "1386", "author": "M. Aoki", "year": "1998", "unstructured": "Aoki, M., K. Ishimori, and I. Morishima (1998). Roles of negatively charged surface residues of putidaredoxin in interactions with redox partners in P450cam monooxygenase system. Biochim. Biophys. Acta\n              1386, 157\u2013167.", "journal-title": "Biochim. Biophys. Acta"}, {"key": "3_CR54", "doi-asserted-by": "publisher", "first-page": "10592", "DOI": "10.1021/bi010874d", "volume": "40", "author": "I.F. Sevrioukova", "year": "2001", "unstructured": "Sevrioukova, I.F., J.T. Hazzard, G. Tollin, and T.L. Poulos (2001). Laser flash induced electron transfer in P450cam monooxygenase: Putidaredoxin reductase-putidaredoxin interaction. Biochemistry\n              40, 10592\u201310600.", "journal-title": "Biochemistry"}, {"key": "3_CR55", "doi-asserted-by": "publisher", "first-page": "6424", "DOI": "10.1021/bi00187a006", "volume": "33", "author": "T.C. Pochapsky", "year": "1994", "unstructured": "Pochapsky, T.C., X.M. Ye, G. Ratnaswamy, and T.A. Lyons (1994). An NMR-derived model for the solution structure of oxidized putidaredoxin, a 2-Fe, 2-S ferredoxin from Pseudomonas. Biochemistry\n              33, 6424\u20136432.", "journal-title": "Biochemistry"}, {"key": "3_CR56", "doi-asserted-by": "publisher", "first-page": "44886", "DOI": "10.1074/jbc.M308115200", "volume": "278", "author": "S. Nagano", "year": "2003", "unstructured": "Nagano, S., H. Li, H. Shimizu, C. Nishida, H. Ogura, P.R. Ortiz de Montellano et al. (2003). Crystal structures of epothilone-D bound, epothilone-B bound, and substrate-free forms of cytochrome P450epoK. J. Biol. Chem.\n              278, 44886\u201344893.", "journal-title": "J. Biol. Chem."}, {"key": "3_CR57", "doi-asserted-by": "publisher", "first-page": "640", "DOI": "10.1126/science.287.5453.640", "volume": "287", "author": "L. Tang", "year": "2000", "unstructured": "Tang, L., S. Shah, L. Chung, J. Carney, L. Kaz, C. Khosla et al. (2000). Cloning and heterologous expression of the epothilone gene cluster. Science\n              287, 640\u2013642.", "journal-title": "Science"}, {"key": "3_CR58", "doi-asserted-by": "publisher", "first-page": "9761", "DOI": "10.1074/jbc.M211575200", "volume": "278", "author": "D.-S. Lee", "year": "2003", "unstructured": "Lee, D.-S., A. Yamada, H. Sugimoto, I. Matsunaga, H. Ogura, K. Ichihara et al. (2003). Substrate recognition and molecular mechanism of fatty acid hydroxylation by cytochrome P450 from Bacillus subtilis. J. Biol. Chem.\n              278, 9761\u20139767.", "journal-title": "J. Biol. Chem."}, {"key": "3_CR59", "doi-asserted-by": "publisher", "first-page": "140", "DOI": "10.1038/nsb0297-140", "volume": "4", "author": "H. Li", "year": "1997", "unstructured": "Li, H. and T.L. Poulos (1997). The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid. Nat. Struct. Biol.\n              4, 140\u2013146.", "journal-title": "Nat. Struct. Biol."}, {"key": "3_CR60", "doi-asserted-by": "publisher", "first-page": "13456", "DOI": "10.1021/bi011197q", "volume": "40", "author": "D.C. Haines", "year": "2001", "unstructured": "Haines, D.C., D.R. Tomchick, M. Machius, and J.A. Peterson (2001). Pivotal role of water in the mechanism of P450BM-3. Biochemistry\n              40, 13456\u201313465.", "journal-title": "Biochemistry"}, {"key": "3_CR61", "doi-asserted-by": "publisher", "first-page": "414", "DOI": "10.1038/nsb0596-414", "volume": "3", "author": "S. Modi", "year": "1996", "unstructured": "Modi, S., M.J. Sutcliffe, W.U. Primrose, L.Y. Lian, and G.C. Roberts (1996). The catalytic mechanism of cytochrome P450 BM3 involves a 6 \u00c5 movement of the bound substrate on reduction. Nat. Struc. Biol.\n              3, 414\u2013417.", "journal-title": "Nat. Struc. Biol."}, {"key": "3_CR62", "doi-asserted-by": "publisher", "first-page": "9335", "DOI": "10.1021/bi034556l", "volume": "42", "author": "M.R. Wester", "year": "2003", "unstructured": "Wester, M.R., E.F. Johnson, C. Marques-Soares, S. Dijols, P.M. Dansette, D. Mansuy (2003). The structure of mammalian cytochrome P450 2C5 complexed with diclofenac at 2.1 \u00c5 resolution: Evidence for an induced fit model of substrate binding. Biochemistry\n              42, 9335\u20139345.", "journal-title": "Biochemistry"}, {"key": "3_CR63", "doi-asserted-by": "publisher", "first-page": "6370", "DOI": "10.1021/bi0273922", "volume": "42", "author": "M.R. Wester", "year": "2003", "unstructured": "Wester, M.R., E.F. Johnson, C. Marques-Soares, P.M. Dansette, D. Mansuy, and C.D. Stout (2003, submitted). The structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3 \u00c5 resolution: Evidence for multiple substrate binding modes. Biochemistry\n              42, 6370\u20136379.", "journal-title": "Biochemistry"}, {"key": "3_CR64", "doi-asserted-by": "publisher", "first-page": "6363", "DOI": "10.1021/bi027391+", "volume": "42", "author": "C. Marques-Soares", "year": "2003", "unstructured": "Marques-Soares, C., S. Dijols, A. Macherey, M.R. Wester, E.F. Johnson, P.M. Dansette et al. (2003, submitted). Sulfaphenazole derivatives as tools for comparing cytochrome P450 2C5 and human cytochrome P450 2Cs: Identification of a new high affinity substrate common to those enzymes. Biochemistry\n              42, 6363\u20136369.", "journal-title": "Biochemistry"}, {"key": "3_CR65", "doi-asserted-by": "publisher", "first-page": "5314", "DOI": "10.1021/bi00366a049", "volume": "25", "author": "T.L. Poulos", "year": "1986", "unstructured": "Poulos, T.L., B.C. Finzel, and A.J. Howard (1986). Crystal structure of substrate-free Pseudomonas putida cytochrome P450. Biochemistry\n              25, 5314\u20135322.", "journal-title": "Biochemistry"}, {"key": "3_CR66", "doi-asserted-by": "publisher", "first-page": "46", "DOI": "10.1021/ja972473k", "volume": "120", "author": "K. DiGleria", "year": "1998", "unstructured": "DiGleria, K., D.P. Nickerson, H.A.O. Hill, L.L. Wong, and V. Fulop (1998). Covalent attachment of an electroactive sulfhydryl reagent in the active site of cytochrome P450cam as revealed by the crystal structure on the modified protein. J. Am. Chem. Soc.\n              120, 46\u201352.", "journal-title": "J. Am. Chem. Soc."}, {"key": "3_CR67", "doi-asserted-by": "publisher", "first-page": "12987", "DOI": "10.1073/pnas.96.23.12987", "volume": "9", "author": "I.J. Dmochowski", "year": "1999", "unstructured": "Dmochowski, I.J., B.R. Crane, J.J. Wilker, J.R. Winkler, and H.B. Gray (1999). Optical detection of cytochrome P450 by sensitizer-linked substrates. Proc. Natl. Acad. Sci. USA\n              9, 12987\u201312990.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "3_CR68", "doi-asserted-by": "publisher", "first-page": "10254", "DOI": "10.1021/ja0271678", "volume": "124", "author": "A.R. Dunn", "year": "2002", "unstructured": "Dunn, A.R., A.M. Hays, D.B. Goodin, C.D. Stout, R. Chiu, J.R. Winkler et al. (2002). Fluorescent probes for cytochrome P450 structural characterization and inhibitor screening. J. Am. Chem. Soc.\n              124, 10254\u201310255.", "journal-title": "J. Am. Chem. Soc."}, {"key": "3_CR69", "doi-asserted-by": "publisher", "first-page": "21", "DOI": "10.1107/S0907444994009194", "volume": "51", "author": "H. Li", "year": "1995", "unstructured": "Li, H. and T.L. Poulos (1995). Modeling protein substrate interactions in the heme domain of cytochrome P450BM-3. Acta Crystallogr. D\n              51, 21\u201332.", "journal-title": "Acta Crystallogr. D"}, {"key": "3_CR70", "doi-asserted-by": "publisher", "first-page": "237", "DOI": "10.1002/prot.340210306", "volume": "21", "author": "M.D. Paulsen", "year": "1995", "unstructured": "Paulsen, M.D. and R.L. Ornstein (1995). Dramatic differences in the motions of the mouth of open and closed cytochrome P450BM-3 by molecular dynamics simulations. Proteins\n              21, 237\u2013243.", "journal-title": "Proteins"}, {"key": "3_CR71", "doi-asserted-by": "publisher", "first-page": "827", "DOI": "10.1038/nsb1097-827", "volume": "4", "author": "S.Y. Park", "year": "1997", "unstructured": "Park, S.Y., H. Shimizu, S. Adachi, A. Nakagawa, I. Tanaka, K. Nakahara et al. (1997). Crystal structure of nitric oxide reductase from denitryfying fungus Fusarium oxysporum. Nat. Struc. Biol.\n              4, 827\u2013832.", "journal-title": "Nat. Struc. Biol."}, {"key": "3_CR72", "doi-asserted-by": "publisher", "first-page": "47476", "DOI": "10.1074/jbc.M206342200", "volume": "277", "author": "K. Zerbe", "year": "2002", "unstructured": "Zerbe, K., O. Pylypenko, F. Vitali, W. Zhang, S. Rouset, M. Heck et al. (2002). Crystal structure of OxyB, a cytochrome P450 implicated in an oxidative phenol coupling reaction during vancomycin biosynthesis. J. Biol. Chem.\n              277, 47476\u201347485.", "journal-title": "J. Biol. Chem."}, {"key": "3_CR73", "doi-asserted-by": "publisher", "first-page": "12214", "DOI": "10.1074/jbc.M212210200", "volume": "278", "author": "L. Podust", "year": "2003", "unstructured": "Podust, L., Y. Kim, M. Arase, B. Neely, B. Beck, H. Bach et al. (2003). The 1.92 A structure of Streptomyces coelicolor A3 (2) Cyp154C1: A new monooxygenase that functionalizes macrolide ring systems. J. Biol. Chem.\n              278, 12214\u201312221.", "journal-title": "J. Biol. Chem."}, {"key": "3_CR74", "doi-asserted-by": "publisher", "first-page": "3068", "DOI": "10.1073/pnas.061562898", "volume": "98", "author": "L.M. Podust", "year": "2001", "unstructured": "Podust, L.M., T.L. Poulos, and M.R. Waterman (2001). Crystal structure of cytochrome P450 14alpha-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc. Natl. Acad. Sci. USA\n              98, 3068\u20133073.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "3_CR75", "doi-asserted-by": "publisher", "first-page": "13196", "DOI": "10.1073/pnas.2133986100", "volume": "100", "author": "E.E. Scott", "year": "2003", "unstructured": "Scott, E.E., Y.A. He, M.R. Wester, M.A. White, C.C. Chin, J.R. Halpert, E.F. Johnson, and D. Stout (2003). An open confirmation of mammalian cytochrome P450 2B4 at 1.6\u00c5 resolution. Proc. Natl. Acad. Sci. USA\n              100, 13196\u201313201.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "3_CR76", "doi-asserted-by": "publisher", "first-page": "5361", "DOI": "10.1073/pnas.082522999", "volume": "99", "author": "P.J. Winn", "year": "2002", "unstructured": "Winn, P.J., S.K. Ldemann, R. Gauges, V. Lounnas, and R.C. Wade (2002). Comparison of the dynamics of substrate access channels in three cytochrome P450s reveals different opening mechanisms and a novel functional role for a buried arginine. Proc. Natl. Acad. Sci. USA\n              99, 5361\u20135366.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "3_CR77", "doi-asserted-by": "publisher", "first-page": "723", "DOI": "10.1016/S0300-9084(97)82530-8", "volume": "78", "author": "T. Pochapsky", "year": "1996", "unstructured": "Pochapsky, T., T.A. Lyons, S. Kazanis, T. Arakaki, and G. Ratnaswamy (1996). A structure-based model for cytochrome P450cam-putidaredoxin interactions. Biochimie\n              78, 723\u2013733.", "journal-title": "Biochimie"}], "container-title": ["Cytochrome P450"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/0-387-27447-2_3", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 15]], "date-time": "2019-02-15T22:30:14Z", "timestamp": 1550269814000}, "score": 29.501905, "issued": {"date-parts": [[null]]}, "ISBN": ["9780306483240"], "references-count": 77, "URL": "http://dx.doi.org/10.1007/0-387-27447-2_3", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T12:07:00Z", "timestamp": 1575202020023}, "publisher-location": "Totowa, NJ", "reference-count": 7, "publisher": "Humana Press", "isbn-type": [{"value": "9781627033206", "type": "print"}, {"value": "9781627033213", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2013]]}, "DOI": "10.1007/978-1-62703-321-3_6", "type": "book-chapter", "created": {"date-parts": [[2013, 3, 25]], "date-time": "2013-03-25T16:23:07Z", "timestamp": 1364228587000}, "page": "71-77", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Identification of Endogenous Substrates of Orphan Cytochrome P450 Enzymes Through the Use of Untargeted Metabolomics Approaches"], "prefix": "10.1007", "author": [{"given": "Qian", "family": "Cheng", "sequence": "first", "affiliation": []}, {"given": "F. Peter", "family": "Guengerich", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2013, 2, 5]]}, "reference": [{"key": "6_CR00061", "doi-asserted-by": "publisher", "first-page": "139", "DOI": "10.1016/j.bbapap.2010.05.005", "volume": "1814", "author": "FP Guengerich", "year": "2011", "unstructured": "Guengerich FP et al (2011) Approaches to deorphanization of human and microbial cytochrome P450 enzymes. Biochim Biophys Acta 1814:139\u2013145", "journal-title": "Biochim Biophys Acta"}, {"key": "6_CR00062", "doi-asserted-by": "publisher", "first-page": "684", "DOI": "10.1124/pr.110.003525", "volume": "63", "author": "FP Guengerich", "year": "2011", "unstructured": "Guengerich FP, Cheng Q (2011) Orphans in the human cytochrome P450 superfamily: approaches to discovering functions and relevance in pharmacology. Pharmacol Rev 63:684\u2013699", "journal-title": "Pharmacol Rev"}, {"key": "6_CR00063", "doi-asserted-by": "publisher", "first-page": "153", "DOI": "10.1124/mi.10.3.6", "volume": "10", "author": "FP Guengerich", "year": "2010", "unstructured": "Guengerich FP et al (2010) Characterizing proteins of unknown function: orphan cytochrome P450 enzymes as a paradigm. Mol Interv 10:153\u2013163", "journal-title": "Mol Interv"}, {"key": "6_CR00064", "doi-asserted-by": "publisher", "first-page": "4165", "DOI": "10.1021/ac1003568", "volume": "82", "author": "CG Fraga", "year": "2010", "unstructured": "Fraga CG et al (2010) Signature-discovery approach for sample matching of a nerve-agent precursor using liquid chromatography-mass spectrometry, XCMS, and chemometrics. Anal Chem 82:4165\u20134173", "journal-title": "Anal Chem"}, {"key": "6_CR00065", "doi-asserted-by": "publisher", "first-page": "779", "DOI": "10.1021/ac051437y", "volume": "78", "author": "CA Smith", "year": "2006", "unstructured": "Smith CA et al (2006) XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 78:779\u2013787", "journal-title": "Anal Chem"}, {"key": "6_CR00066", "doi-asserted-by": "publisher", "first-page": "15173", "DOI": "10.1021/ja107801v", "volume": "132", "author": "Q Cheng", "year": "2010", "unstructured": "Cheng Q et al (2010) Cyclization of a cellular dipentaenone by Streptomyces coelicolor cytochrome P450 154A1 without oxidation/reduction. J Am Chem Soc 132:15173\u201315175", "journal-title": "J Am Chem Soc"}, {"key": "6_CR00067", "doi-asserted-by": "publisher", "first-page": "324", "DOI": "10.1006/abbi.1997.0534", "volume": "350", "author": "IH Hanna", "year": "1998", "unstructured": "Hanna IH et al (1998) Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities. Arch Biochem Biophys 350:324\u2013332", "journal-title": "Arch Biochem Biophys"}], "container-title": ["Methods in Molecular Biology", "Cytochrome P450 Protocols"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-62703-321-3_6", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 11]], "date-time": "2019-05-11T16:29:38Z", "timestamp": 1557592178000}, "score": 29.494303, "issued": {"date-parts": [[2013]]}, "ISBN": ["9781627033206", "9781627033213"], "references-count": 7, "URL": "http://dx.doi.org/10.1007/978-1-62703-321-3_6", "relation": {"cites": []}, "ISSN": ["1064-3745", "1940-6029"], "issn-type": [{"value": "1064-3745", "type": "print"}, {"value": "1940-6029", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T01:20:28Z", "timestamp": 1574126428781}, "reference-count": 21, "publisher": "Elsevier", "isbn-type": [{"value": "9780121821074", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1991]]}, "DOI": "10.1016/0076-6879(91)06092-h", "type": "book-chapter", "created": {"date-parts": [[2004, 5, 19]], "date-time": "2004-05-19T00:12:22Z", "timestamp": 1084925542000}, "page": "210-220", "source": "Crossref", "is-referenced-by-count": 1, "title": ["[21] Identification of human cytochrome P450s as autoantigens"], "prefix": "10.1016", "author": [{"given": "Michael P.", "family": "Manns", "sequence": "first", "affiliation": []}, {"given": "Eric F.", "family": "Johnson", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Methods in Enzymology", "Cytochrome P450"], "deposited": {"date-parts": [[2019, 2, 9]], "date-time": "2019-02-09T05:27:55Z", "timestamp": 1549690075000}, "score": 29.107292, "issued": {"date-parts": [[1991]]}, "ISBN": ["9780121821074"], "references-count": 21, "URL": "http://dx.doi.org/10.1016/0076-6879(91)06092-h", "ISSN": ["0076-6879"], "issn-type": [{"value": "0076-6879", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}